{"title":"Hyperplasia, Hyperplasia","references":"","biologicalOrganisationLevel":"Tissue","organTerm":{"name":"liver","sourceId":"UBERON:0002107"},"biologicalEvents":[{"action":"increased","process":"hyperplasia","object":{}}],"id":142}
{"title":"Promotion, Hepatocelluar carcinoma","references":"","biologicalOrganisationLevel":"Individual","organTerm":{"name":"liver","sourceId":"UBERON:0002107"},"biologicalEvents":[{"action":"increased","process":"hepatocellular carcinoma","object":{}}],"id":334}
{"title":"Proliferation, Cell proliferation in the absence of cytotoxicity","references":"","biologicalOrganisationLevel":"Cellular","organTerm":{},"biologicalEvents":[{"action":"increased","process":"cell proliferation","object":{}}],"id":57}
{"title":"N/A, Unknown","references":"","biologicalOrganisationLevel":"Molecular","organTerm":{},"biologicalEvents":[{"object":{}}],"id":294}
{"title":"Inhibition, NADH-ubiquinone oxidoreductase  (complex I)","references":"<p><br />\nBaradaran R., John M. Berrisford, Gurdeep S. Minhas , Leonid A. Sazanov. Crystal structure of the entire respiratory complex I. Nature , 2013,| 494,443&ndash;448.</p>\n\n<p>Barrientos A., and Moraes C.T. (1999) Titrating the Effects of Mitochondrial Complex I Impairment in the Cell Physiology. Vol. 274, No. 23, pp. 16188&ndash;16197.</p>\n\n<p>Cleeter MW, Cooper JM, Schapira AH. Irreversible inhibition of mitochondrial complex I by 1-methyl-4-phenylpyridinium: evidence for free radical involvement. J Neurochem. 1992 Feb;58(2):786-9.</p>\n\n<p>Degli Esposti (1998) Inhibitors of NADH-ubiquinone reductase: an overview Biochimica et Biophysica Acta 1364-222-235.</p>\n\n<p>Ernster L, Lee C (1967) Energy-linked reduction of NAD+ by succinate. Methods Enzym. 10:729-738.</p>\n\n<p>Friedrich, T., Steinm&uuml;ller, K. &amp; Weiss, H. (1995) The proton-pumping respiratory complex I of bacteria and mitochondria and is homologue of chloroplasts. FEBS Lett. (Minireview), 367, 107-111.</p>\n\n<p>Garrett and Grisham, Biochemistry, Brooks/Cole, 2010, pp 598-611.</p>\n\n<p>Greenamyre, J T., Sherer, T.B., Betarbet, R., and Panov A.V. (2001) Critical Review Complex I and Parkinson&rsquo;s Disease Life, 52: 135&ndash;141.</p>\n\n<p>Hofhaus, G., Weiss, H. and Leonard, K. (1991): Electron microscopic analysis of the peripheral and the membrane parts of mitochondrial NADH dehydrogenase (Complex I). J. Mol. Biol. 221, 1027-1043.</p>\n\n<p>Kerscher, S. Dr&ouml;se, K. Zwicker, V. Zickermann, U. Brandt Yarrowia lipolytica, a yeast genetic system to study mitochondrial complex I. Biochim. Biophys. Acta 1555, 83&ndash;91 (2002).</p>\n\n<p>Kirby DM, Thorburn DR, Turnbull DM, Taylor RW (2007) Biochemical assays of respiratory chain complex activity. Methods Cell Biol. 80:93-119.</p>\n\n<p>Leist M, Single B, Castoldi AF, K&uuml;hnle S, Nicotera P (1997) Intracellular adenosine triphosphate (ATP) concentration: a switch in the decision between apoptosis and necrosis. J Exp Med. 185:1481-6.</p>\n\n<p>Leist M. Current approaches and future role of high content imaging in safety sciences and drug discovery. ALTEX. 2014;31(4):479-93.</p>\n\n<p>Lenaz G, Fato R, Baracca A, Genova ML (2004) Mitochondrial quinone reductases: complex I. Methods Enzymol. 382:3-20.</p>\n\n<p>Long J, Ma J, Luo C, Mo X, Sun L, Zang W, Liu J (2009) Comparison of two methods for assaying complex I activity in mitochondria isolated from rat liver, brain and heart. Life Sci. 85(7-8):276-80.</p>\n\n<p>Nguyen VT, Morange M, Bensaude O. (1988) Firefly luciferase luminescence assays using scintillation counters for quantitation in transfected mammalian cells. Anal Biochem. 171(2):404-8.</p>\n\n<p>van Vliet E, Daneshian M, Beilmann M, Davies A, Fava E, Fleck R, Jul&eacute; Y, Kansy M, Kustermann S, Macko P, Mundy WR, Roth A, Shah I, Uteng M, van de Water B, Hartung T, Spinazzi M, Casarin A, Pertegato V, Salviati L, Angelini C (2012) Assessment of mitochondrial respiratory chain enzymatic activities on tissues and cultured cells. Nat Protoc. 7(6):1235-46.</p>\n\n<p>Salabei J.K., Gibb A.A. and Hill BG. (2014) Comprehensive measurement of respiratory activity in permeabilized cells using extracellular flux analysis. Nature Protocols, 9, 421&ndash;438.</p>\n\n<p>Stetter JR, Li J (2008) Amperometric gas sensors--a review. Chem Rev. 108(2):352-66.</p>\n\n<p>Wang XD, Wolfbeis OS (2014) Optical methods for sensing and imaging oxygen: materials, spectroscopies and applications. Chem Soc Rev. 43(10):3666-761.</p>\n\n<p>Voet DJ and Voet JG; Pratt CW (2008). Chapter 18, Mitochondrial ATP synthesis. Principles of Biochemistry, 3rd Edition. Wiley. p. 608. <a class=\"internal mw-magiclink-isbn\" href=\"/wiki/index.php/Special:BookSources/9780470233962\">ISBN 978-0-470-23396-2</a>.</p>\n\n<p>Willis JH, Capaldi RA, Huigsloot M, Rodenburg RJ, Smeitink J, Marusich MF (2009) Isolated deficiencies of OXPHOS complexes I and IV are identified accurately and quickly by simple enzyme activity immunocapture assays. Biochim Biophys Acta. 1787(5):533-8.</p>\n\n<p>Zickermann V., Christophe Wirth, Hamid Nasiri, Karin Siegmund, Harald Schwalbe, Carola Hunte, Ulrich Brandt. Mechanistic insight from the crystal structure of mitochondrial complex I. Science 2 January 2015: Vol. 347 no. 6217 pp. 44-49.</p>\n","biologicalOrganisationLevel":"Cellular","organTerm":{},"biologicalEvents":[{"action":"decreased","process":"NADH dehydrogenase (ubiquinone) activity","object":{"name":"NADH-ubiquinone oxidoreductase chain 1","source":"PR","sourceId":"PR:000031316"}}],"keyEventStressors":["1',2'-dihydrorotenone"],"id":887}
{"title":"Binding of inhibitor, NADH-ubiquinone oxidoreductase (complex I)","references":"<p>&nbsp;</p>\n\n<p>Betarbet R, Sherer TB, MacKenzie G, Garcia-Osuna M, Panov AV, Greenamyre JT. (2000). Chronic systemic pesticide exposure reproduces features of Parkinson&#39;s disease. Nat Neurosci 3:1301-1306.</p>\n\n<p>Cardol, P., (2011) Mitochondrial NADH:ubiquinone oxidoreductase (complex I) in eukaryotes: A highly conserved subunit composition highlighted by mining of protein databases Biochimica et Biophysica Acta 1807, 1390&ndash;1397.</p>\n\n<p>Choi WS., Kruse S.E., Palmiter R, Xia Z., (2008) Mitochondrial complex I inhibition is not required for dopaminergic neuron death induced by rotenone, MPP, or paraquat. PNAS, 105, 39, 15136-15141.</p>\n\n<p>Degli Esposti (1998) Inhibitors of NADH-ubiquinone reductase: an overview Biochimica et Biophysica Acta 1364-222-235.</p>\n\n<p>Desplats P, Patel P, Kosberg K, Mante M, Patrick C, Rockenstein E, Fujita M, Hashimoto M, Masliah E. (2012). Combined exposure to Maneb and Paraquat alters transcriptional regulation of neurogenesis-related genes in mice models of Parkinson&rsquo;s disease. Mol Neurodegener 7:49.</p>\n\n<p><a href=\"https://www.ncbi.nlm.nih.gov/pubmed/?term=Fendel%20U%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=18486594\">Fendel U</a>,&nbsp;<a href=\"https://www.ncbi.nlm.nih.gov/pubmed/?term=Tocilescu%20MA%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=18486594\">Tocilescu MA</a>,&nbsp;<a href=\"https://www.ncbi.nlm.nih.gov/pubmed/?term=Kerscher%20S%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=18486594\">Kerscher S</a>,&nbsp;<a href=\"https://www.ncbi.nlm.nih.gov/pubmed/?term=Brandt%20U%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=18486594\">Brandt U</a>. (2008) Exploring the inhibitor binding pocket of respiratory complex I.<a href=\"https://www.ncbi.nlm.nih.gov/pubmed/18486594\" title=\"Biochimica et biophysica acta.\">Biochim Biophys Acta.</a>&nbsp;2008, 1777(7-8):660-5.</p>\n\n<p>Ferguson SJ. Similarities between mitochondrial and bacterial electron transport with particular reference to the action of inhibitors. Biochem Soc Trans. 1994 Feb;22(1):181-3.</p>\n\n<p>Friedrich T, van Heek P, Leif H, Ohnishi T, Forche E, Kunze B, Jansen R, TrowitzschKienast W, Hofle G &amp; Reichenbach H (1994) Two binding sites of inhibitors in NADH: ubiquinone oxidoreductase (complex I). Relationship of one site with the ubiquinone-binding site of bacterial glucose:ubiquinone oxidoreductase. Eur J Biochem 219(1&ndash;2): 691&ndash;698.</p>\n\n<p>Gabaldon, T., Rainey, D., Huynen, M.A. (2005) Tracing the evolution of a large protein complex in the eukaryotes, NADH:ubiquinone oxidoreductase (Complex I), J. Mol. Biol. 348; 857&ndash;870.</p>\n\n<p>Greenamyre, J T., Sherer, T.B., Betarbet, R., and Panov A.V. (2001) Critical Review Complex I and Parkinson&rsquo;s Disease Life, 52: 135&ndash;141.</p>\n\n<p>Greenamyre JT, Higgins DS, Eller RV (1992) Quantitative autoradiography of dihydrorotenone binding to complex I of the electron transport chain. J Neurochem. 59(2):746-9.</p>\n\n<p>Grivennikova, V.G., Maklashina, E.O., E.V. Gavrikova, A.D. Vinogradov (1997) Interaction of the mitochondrial NADH-ubiquinone reductase with rotenone as related to the enzyme active/inactive transition Biochim. Biophys. Acta, 1319 (1997), pp. 223&ndash;232.</p>\n\n<p>Haefeli, RH (2012) Molecular Effects of Idebenone. Doctoral thesis <a class=\"external free\" href=\"http://edoc.unibas.ch/19016/1/Molecular_Effects_of_Idebenone_Roman_Haefeli.pdf\" rel=\"nofollow\" target=\"_blank\">http://edoc.unibas.ch/19016/1/Molecular_Effects_of_Idebenone_Roman_Haefeli.pdf</a>.</p>\n\n<p>Hassinen I (2007) Regulation of Mitochondrial Respiration in Heart Muscle. In Mitochondria &ndash; The Dynamic Organelle Edited by Schaffer &amp; Suleiman. Springer ISBN-13: 978-0-387-69944-8.</p>\n\n<p>Hideto M. Structure&ndash;activity relationships of some complex I inhibitors. Biochimica et Biophysica Acta 1364 _1998. 236&ndash;244.</p>\n\n<p>Higgins DS Jr1, Greenamyre JT. (1996). [3H]dihydrorotenone binding to NADH: ubiquinone reductase (complex I) of the electron transport chain: an autoradiographic study. J Neurosci. 1996 Jun 15;16(12):3807-16.</p>\n\n<p>Ichimaru, N., Murai, M., Kakutani, N., Kako, J., Ishihara, A., Nakagawa, Y., &hellip; Miyoshi, H. (2008). Synthesis and Characterization of New Piperazine-Type Inhibitors for Mitochondrial NADH-Ubiquinone Oxidoreductase (Complex I). Biochemistry, 47(40), 10816&ndash;10826.</p>\n\n<p>Ino T, Takaaki N, Hideto M. Characterization of inhibitor binding sites of mitochondrial complex I using fluorescent inhibitor. Biochimica et Biophysica Acta 1605 (2003) 15&ndash; 20.</p>\n\n<p>Janssen RJ, Nijtmans LG, van den Heuvel LP, Smeitink JA. Mitochondrial complex I: structure, function and pathology. J Inherit Metab Dis. 2006 Aug;29(4):499-515.</p>\n\n<p>Keeney PM, Xie J,Capaldi RA,Bennett JP Jr. (2006) Parkinson&#39;s disease brain mitochondrial complex I has oxidatively damaged subunits and is functionally impaired and misassembled. J Neurosci. 10;26(19):5256-64.</p>\n\n<p>Lin CJ, Lee CC, Shih YL, Lin CH, Wang SH, Chen TH, Shih CM. (2012). Inhibition of Mitochondria- and Endoplasmic Reticulum Stress-Mediated Autophagy Augments Temozolomide-Induced Apoptosis in Glioma Cells. PLoS ONE 7:e38706.</p>\n\n<p>L&uuml;mmen, P., (1998) Complex I inhibitors as insecticides and acaricides1, Biochimica et Biophysica Acta (BBA) - Bioenergetics, Volume 1364, Issue 2, Pages 287-296.</p>\n\n<p>Majander A, Finel M, Wikstrom M. (1994) Diphenyleneiodonium inhibits reduction of iron&ndash;sulfur clusters in the mitochondrial NADH&ndash;ubiquinone oxidoreductase (complex I) J Biol Chem. 269:21037&ndash;21042.</p>\n\n<p>Miao YJ, Xu XF, Xu F, Chen Y, Chen JW, Li X. (2014) The structure-activity relationships of mono-THF ACGs on mitochondrial complex I with a molecular modelling study. Nat Prod Res.28(21):1929-35.</p>\n\n<p>Mimaki M, Wang X, McKenzie M, Thorburn DR, Ryan MT. Understanding mitochondrial complex I assembly in health and disease. Biochim Biophys Acta. 2012 Jun;1817(6):851-62. doi: 10.1016/j.bbabio.2011.08.010.</p>\n\n<p>Miyoshi H. Structure-activity relationships of some complex I inhibitors. Biochim Biophys Acta. 1998, 6:236-244.</p>\n\n<p>Okun, J.G, L&uuml;mmen, P and Brandt U., (1999) Three Classes of Inhibitors Share a Common Binding Domain in Mitochondrial Complex I (NADH:Ubiquinone Oxidoreductase) J. Biol. Chem. 274: 2625-2630. doi:10.1074/jbc.274.5.2625.</p>\n\n<p>Ramsay R., Krueger MJ., Youngster SK., Gluck MR., Casida J.E. and Singer T.P. Interaction of 1-Methyl-4-Phenylpyridinium Ion (MPP+) and Its Analogs with the Rotenone/Piericidin Binding Site of NADH Dehydrogenase. Journal of Neurochemistry, 1991, 56: 4, 1184&ndash;1190.</p>\n\n<p>Sava V, Velasquez A, Song S, Sanchez-Ramos J. (2007). Dieldrin elicits a widespread DNA repair and antioxidative response in mouse brain. J Biochem Mol Toxicol 21:125-135.</p>\n\n<pre>\n<span style=\"font-size:12px\"><span style=\"font-family:arial,helvetica,sans-serif\">Schuler, F. and Casida, JE. (2001) Functional coupling of PSST and ND1 subunits in NADH:ubiquinone oxidoreductase established by photoaffinity labeling, Biochimica et Biophysica Acta (BBA) - Bioenergetics, Volume 1506, Issue 1, 2 July 2001, Pages 79-87, ISSN 0005-2728, https://doi.org/10.1016/S0005-2728(01)00183-9.</span></span></pre>\n\n<p>Talpade DJ, Greene JG, Higgins DS Jr, Greenamyre JT (2000) In vivo labeling of mitochondrial complex I (NADH:ubiquinone oxidoreductase) in rat brain using [(3)H]dihydrorotenone. J Neurochem. 75(6):2611-21.</p>\n\n<p>Vogel R.O., van den Brand M.A., Rodenburg R.J., van den Heuvel L.P., Tsuneoka M., Smeitink J.A., Nijtmans L.G. (2007a). Investigation of the complex I assembly chaperones B17.2L and NDUFAF1 in a cohort of CI deficient patients. Mol. Genet. Metab. 91:176&ndash;182.</p>\n\n<p>Vogel, R.O. Smeitink, J.A. Nijtmans L.G. (2007b) Human mitochondrial complex I assembly: a dynamic and versatile process Biochim. Biophys. Acta, 1767-. 1215&ndash;1227.</p>\n\n<p>Zharova, TV, and Vinogradov, A.(1997) A competitive inhibition of the mitochondrial NADH-ubiquinone oxidoreductase (Complex I) by ADP-ribose. Biochimica et Biophysica Acta, 1320:256-64.</p>\n","biologicalOrganisationLevel":"Molecular","organTerm":{},"biologicalEvents":[{"action":"decreased","process":"mitochondrial electron transport, NADH to ubiquinone","object":{"name":"NADH-ubiquinone oxidoreductase chain 1","source":"PR","sourceId":"PR:000031316"}}],"keyEventStressors":["Pyridaben","1',2'-dihydrorotenone","Fenpyroximate"],"id":888}
{"title":"N/A, Mitochondrial dysfunction 1","references":"<p>&nbsp;</p>\n\n<p>Adam-Vizi V. Production of reactive oxygen species in brain mitochondria: contribution by electron transport chain and non-electron transport chain sources. Antioxid Redox Signal. 2005, 7(9-10):1140-1149.</p>\n\n<p>Bal-Price A. and Guy C. Brown. Nitric-oxide-induced necrosis and apoptosis in PC12 cells mediated by mitochondria. J. Neurochemistry, 2000, 75: 1455-1464.</p>\n\n<p>Bal-Price A, Matthias A, Brown GC., Stimulation of the NADPH oxidase in activated rat microglia removes nitric oxide but induces peroxynitrite production. J. Neurochem. 2002, 80: 73-80.</p>\n\n<p>Brand MD, Nicholls DG. Assessing mitochondrial dysfunction in cells. Biochem J. 2011 Apr 15;435(2):297-312.</p>\n\n<p>Braun RJ. (2012). Mitochondrion-mediated cell death: dissecting yeast apoptosis for a better understanding of neurodegeneration. Front Oncol 2:182.</p>\n\n<p>Barrientos A., and Moraes C.T. (1999) Titrating the Effects of Mitochondrial Complex I Impairment in the Cell Physiology. Vol. 274, No. 23, pp. 16188&ndash;16197.</p>\n\n<p>Cammen M. Corwin, Susannah Christensen. John P. (1990) Electron transport system (ETS) activity as a measure of benthic macrofaunal metabolism MARINE ECOLOGY PROGRESS SERIES- (65)&nbsp;: 171-182.</p>\n\n<p>Ciapaite, Lolita Van Eikenhorst, Gerco Bakker, Stephan J.L. Diamant, Michaela. Heine, Robert J Wagner, Marijke J. V. Westerhoff, Hans and Klaas Krab (2005) Modular Kinetic Analysis of the Adenine Nucleotide Translocator&ndash;Mediated Effects of Palmitoyl-CoA on the Oxidative Phosphorylation in Isolated Rat Liver Mitochondria Diabetes 54:4 944-951.</p>\n\n<p>Correia SC, Santos RX, Perry G, Zhu X, Moreira PI, Smith MA. (2012). Mitochondrial importance in Alzheimer&rsquo;s, Huntington&rsquo;s and Parkinson&rsquo;s diseases. Adv Exp Med Biol 724:205 &ndash; 221.</p>\n\n<p>Cozzolino M, Ferri A, Valle C, Carri MT. (2013). Mitochondria and ALS: implications from novel genes and pathways. Mol Cell Neurosci 55:44 &ndash; 49.</p>\n\n<p>Diepart, C, Verrax, J Calderon, PU, Feron, O., Jordan, BF, Gallez, B (2010) Comparison of methods for measuring oxygen consumption in tumor cells in vitroAnalytical Biochemistry 396 (2010) 250&ndash;256.</p>\n\n<p>Farooqui T. and . Farooqui, A. A (2012) Oxidative stress in Vertebrates and Invertebrate: molecular aspects of cell signalling. Wiley-Blackwell,Chapter 27, pp:377- 385.</p>\n\n<p>Fan LM, Li JM. Evaluation of methods of detecting cell reactive oxygen species production for drug screening and cell cycle studies. J Pharmacol Toxicol Methods. 2014 Jul-Aug;70(1):40-7.</p>\n\n<p>Fiskum G. Mitochondrial participation in ischemic and traumatic neural cell death. J Neurotrauma. 2000 Oct;17(10):843-55.</p>\n\n<p>Friberg H, Wieloch T. (2002). Mitochondrial permeability transition in acute neurodegeneration. Biochimie 84:241&ndash;250.</p>\n\n<p>Fujikawa DG, The Role of Excitotoxic Programmed Necrosis in Acute Brain Injury. Computational and Structural Biotechnology Journal, 2015, 13: 212&ndash;221.</p>\n\n<p>Graier WF, Frieden M, Malli R. (2007). Mitochondria and Ca2+ signaling: old guests, new functions. Pflugers Arch 455:375&ndash;396.</p>\n\n<p>Green DR. (1998). Apoptotic pathways: the roads to ruin. Cell 94:695-698.</p>\n\n<p>Grivennikova VG, Vinogradov AD. Generation of superoxide by the mitochondrial Complex I. Biochim Biophys Acta. 2006, 1757(5-6):553-61.</p>\n\n<p>Hafner RP, Brown GC, Brand MD: Analysis of the control of respiration rate, phosphorylation rate, proton leak rate and protonmotive force in isolated mitochondria using the &lsquo;top-down&rsquo; approach of metabolic control theory. Eur J Biochem188&nbsp;:313 &ndash;319,1990.</p>\n\n<p>Hinkle PC (1995) Measurement of ADP/O ratios. In Bioenergetics: A Practical Approach. Brown GC, Cooper CE, Eds. Oxford, U.K., IRL Press, p.5 &ndash;6.</p>\n\n<p>Hynes, J.. Marroquin, L.D Ogurtsov, V.I. Christiansen, K.N. Stevens, G.J. Papkovsky, D.B. Will, Y. (2006)) Investigation of drug-induced mitochondrial toxicity using fluorescence-based oxygen-sensitive probes, Toxicol. Sci. 92 186&ndash;200.</p>\n\n<p>James, P.E. Jackson, S.K.. Grinberg, O.Y Swartz, H.M. (1995) The effects of endotoxin on oxygen consumption of various cell types in vitro: an EPR oximetry study, Free Radic. Biol. Med. 18 (1995) 641&ndash;647.</p>\n\n<p>Kang J, Pervaiz S. (2012). Mitochondria: Redox Metabolism and Dysfunction. Biochem Res Int 2012:896751.</p>\n\n<p>Kann O, Kov&aacute;cs R. (2007). Mitochondria and neuronal activity. Am J Physiol Cell Physiol 292:C641-576.</p>\n\n<p>Knott Andrew B., Guy Perkins, Robert Schwarzenbacher &amp; Ella Bossy-Wetzel. Mitochondrial fragmentation in neurodegeneration. Nature Reviews Neuroscience, 2008, 229: 505-518.</p>\n\n<p>Llaudet E, Hatz S, Droniou M, Dale N. Microelectrode biosensor for real-time measurement of ATP in biological tissue. Anal Chem. 2005, 77(10):3267-73.</p>\n\n<p>Lee HC, Wei YH. (2012). Mitochondria and aging. Adv Exp Med Biol 942:311-327.</p>\n\n<p>Li N, Ragheb K, Lawler G, Sturgis J, Rajwa B, et al. Mitochondrial complex I inhibitor rotenone induces apoptosis through enhancing mitochondrial reactive oxygen species production. J Biol Chem.2003;278:8516&ndash;8525.</p>\n\n<p>Lin MT, Beal MF. Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases. Nature 2006. 443:787-795.</p>\n\n<p>Martin LJ. (2011). Mitochondrial pathobiology in ALS. J Bioenerg Biomembr 43:569 &ndash; 579.</p>\n\n<p>Martinez-Cruz, Oliviert Sanchez-Paz, Arturo Garcia-Carre&ntilde;o, Fernando Jimenez-Gutierrez, Laura Ma. de los Angeles Navarrete del Toro and Adriana Muhlia-Almazan. Invertebrates Mitochondrial Function and Energetic Challenges (www.intechopen.com), Bioenergetics, Edited by Dr Kevin Clark, <a class=\"internal mw-magiclink-isbn\" href=\"/wiki/index.php/Special:BookSources/9789535100904\">ISBN 978-953-51-0090-4</a>, Publisher InTech, 2012, 181-218.</p>\n\n<p>McBride HM, Neuspiel M, Wasiak S. (2006). Mitochondria: more than just a powerhouse. Curr Biol 16:R551&ndash;560.</p>\n\n<p>McCord, J.M. and I. Fidovich (1968) The Reduction of Cytochrome C by Milk Xanthine Oxidase. J. Biol. Chem. 243:5733-5760.</p>\n\n<p>Mei Y, Thompson MD, Cohen RA, Tong X. (2013) Endoplasmic Reticulum Stress and Related Pathological Processes. J Pharmacol Biomed Anal.. 1:100-107.</p>\n\n<p>Modjtahedi N, Giordanetto F, Madeo F, Kroemer G. Apoptosis-inducing factor: vital and lethal. Trends Cell Biol. 2006 May;16(5):264-72.</p>\n\n<p>Nunnari J, Suomalainen A. (2012). Mitochondria: in sickness and in health. Cell 148:1145&ndash;1159. Hajn&oacute;czky G, Csord&aacute;s G, Das S, Garcia-Perez C, Saotome M, Sinha Roy S, Yi M. (2006). Mitochondrial calcium signalling and cell death: approaches for assessing the role of mitochondrial Ca2+ uptake in apoptosis. Cell Calcium 40:553-560.</p>\n\n<p>Oliviert Martinez-Cruz, Arturo Sanchez-Paz, Fernando Garcia-Carre&ntilde;o, Laura Jimenez-Gutierrez, Ma. de los Angeles Navarrete del Toro and Adriana Muhlia-Almazan. Invertebrates Mitochondrial Function and Energetic Challenges (www.intechopen.com), Bioenergetics, Edited by Dr Kevin Clark, <a class=\"internal mw-magiclink-isbn\" href=\"/wiki/index.php/Special:BookSources/9789535100904\">ISBN 978-953-51-0090-4</a>, Publisher InTech, 2012, 181-218.</p>\n\n<p>Owens R.G. and King F.D. The measurement of respiratory lectron-transport system activity in marine zooplankton. Mar. Biol. 1975, 30:27-36.</p>\n\n<p>Petronilli V, Miotto G, Canton M, Brini M, Colonna R, Bernardi P, Di Lisa F: Transient and long-lasting openings of the mitochondrial permeability transition pore can be monitored directly in intact cells by changes in mitochondrial calcein fluorescence. Biophys J 1999, 76:725-734.</p>\n\n<p>Promega GSH-Glo Glutathione Assay Technical Bulletin, TB369, Promega Corporation, Madison, WI.</p>\n\n<p>Pryor, W.A., J.P. Stanley, and E. Blair. (1976) Autoxidation of polyunsaturated fatty acids: II. A Suggested mechanism for the Formation of TBA-reactive materials from prostaglandin-like Endoperoxides. Lipids, 11:370-379.</p>\n\n<p>Radkowsky, A.E. and E.M. Kosower (1986) Bimanes 17. (Haloalkyl)-1,5-diazabicyclo[3.3.O]octadienediones (halo-9,10- dioxabimanes): reactivity toward the tripeptide thiol, glutathione, J. Am. Chem. Soc 108:4527-4531.</p>\n\n<p>Ruch, W., P.H. Cooper, and M. Baggiollini (1983) Assay of H2O2 production by macrophages and neutrophils with Homovanillic acid and horseradish peroxidase. J. Immunol Methods 63:347-357.</p>\n\n<p>Sanders LH, McCoy J, Hu X, Mastroberardino PG, Dickinson BC, Chang CJ, Chu CT, Van Houten B, Greenamyre JT. (2014a). Mitochondrial DNA damage: molecular marker of vulnerable nigral neurons in Parkinson&#39;s disease. Neurobiol Dis. 70:214-23.</p>\n\n<p>Sanders LH, Howlett EH2, McCoy J, Greenamyre JT. (2014b) Mitochondrial DNA damage as a peripheral biomarker for mitochondrial toxin exposure in rats. Toxicol Sci. Dec;142(2):395-402.</p>\n\n<p>Single B, Leist M, Nicotera P. Simultaneous release of adenylate kinase and cytochrome c in cell death. Cell Death Differ. 1998 Dec;5(12):1001-3.</p>\n\n<p>Tahira Farooqui and Akhlaq A. Farooqui. (2012) Oxidative stress in Vertebrates and Invertebrate: molecular aspects of cell signalling. Wiley-Blackwell,Chapter 27, pp:377- 385.</p>\n\n<p>Tarpley, M.M., D.A. Wink, and M.B. Grisham (2004) Methods for detection of reactive Metabolites of Oxygen and Nitrogen: in vitro and in vivo considerations. Am . J. Physiol Regul Integr Comp Physiol. 286:R431-R444.</p>\n\n<p>von Heimburg, D. Hemmrich, K. Zachariah S.,. Staiger, H Pallua, N.(2005) Oxygen consumption in undifferentiated versus differentiated adipogenic mesenchymal precursor cells, Respir. Physiol. Neurobiol. 146 (2005) 107&ndash;116.</p>\n\n<p>Waerzeggers, Yannic Monfared, Parisa Viel, Thomas Winkeler, Alexandra Jacobs, Andreas H. (2010) Mouse models in neurological disorders: Applications of non-invasive imaging, Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, Volume 1802, Issue 10, Pages 819-839.</p>\n\n<p>Walker JE, Skehel JM, Buchanan SK. (1995) Structural analysis of NADH: ubiquinone oxidoreductase from bovine heart mitochondria. Methods Enzymol.;260:14&ndash;34.</p>\n\n<p>Wang A, Costello S, Cockburn M, Zhang X, Bronstein J, Ritz B. (2011). Parkinson&rsquo;s disease risk from ambient exposure to pesticides. Eur J Epidemiol 26:547-555.</p>\n\n<p>Wang Y., and Qin ZH., Molecular and cellular mechanisms of excitotoxic neuronal death, Apoptosis, 2010, 15:1382-1402.</p>\n\n<p>Wieloch T. (2001). Mitochondrial Involvement in Acute Neurodegeneration 52:247&ndash;254.</p>\n\n<p>Winklhofer, K. Haass,C (2010) Mitochondrial dysfunction in Parkinson&#39;s disease, Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 1802: 29-44.</p>\n\n<p>Zhou, M., Z.Diwu, Panchuk-Voloshina, N. and R.P. Haughland (1997), A Stable nonfluorescent derivative of resorufin for the fluorometric determination of trace hydrogen peroxide: application in detecting the activity of phagocyte NADPH oxidase and other oxidases. Anal. Biochem 253:162-168.</p>\n","biologicalOrganisationLevel":"Cellular","organTerm":{},"biologicalEvents":[{"action":"functional change","object":{"name":"mitochondrion","source":"GO","sourceId":"GO:0005739"}}],"id":177}
{"title":"Impaired, Proteostasis","references":"<p>Barth S., Danielle Glick, and Kay F Macleod, Autophagy: assays and artifacts. J Pathol. 2010 Jun; 221(2): 117&ndash;124.</p>\n\n<p>Bartels T, Choi JG, Selkoe DJ (Sep 2011). &quot;&alpha;-Synuclein occurs physiologically as a helically folded tetramer that resists aggregation&quot;. Nature 477 (7362): 107&ndash;10.</p>\n\n<p>Bauvy C, Meijer AJ, Codogno P. Assaying of autophagic protein degradation. Methods Enzymol. 2009;452:47&ndash;61.</p>\n\n<p>Bellucci A., M. Zaltieri, L. Navarria, J. Grigoletto, C. Missale, and P. Spano, &ldquo;From &alpha;-synuclein to synaptic dysfunctions: new insights into the pathophysiology of Parkinson&rsquo;s disease,&rdquo; Brain Research, vol. 1476, pp. 183&ndash;202, 2012.</p>\n\n<p>Bence NF, Sampat RM, Kopito RR. Impairment of the ubiquitin&ndash;proteasome system by protein aggregation. Science 2001;292:1552&ndash;5.</p>\n\n<p>Ciechanover A. (1998) The ubiquitin-proteasome pathway: on protein death and cell life. EMBO J. 17, 7151&plusmn;7160.</p>\n\n<p>Ciechanover A., and Brundin P., 2003, The Ubiquitin Proteasome System in Neurodegenerative Diseases: Sometimes the Chicken, Sometimes the Egg. Neuron, 427&ndash;446</p>\n\n<p>Cookson MR., &ldquo;The biochemistry of Parkinson&rsquo;s disease,&rdquo; Annual Review of Biochemistry, vol. 74, pp. 29&ndash;52, 2005.</p>\n\n<p>Cuervo A.M., &ldquo;Autophagy: many paths to the same end,&rdquo; Molecular and Cellular Biochemistry, vol. 263, no. 1, pp. 55&ndash;72, 2004.</p>\n\n<p>Exner N, Lutz AK, Haass C, Winklhofer KF. Mitochondrial dysfunction in Parkinson&#39;s disease: molecular mechanisms and pathophysiological consequences. EMBO J. 2012 Jun 26;31(14):3038-62.</p>\n\n<p>Esteves AR, Ardu&iacute;no DM, Silva DF, Oliveira CR, Cardoso SM. 2011. Mitochondrial Dysfunction: The Road to Alpha-Synuclein Oligomerization in PD. Parkinsons Dis. 2011:693761.</p>\n\n<p>Foghsgaard L, Wissing D, Mauch D, Lademann U, Bastholm L, Boes M, Elling F, Leist M, J&auml;&auml;ttel&auml; M. Cathepsin B acts as a dominant execution protease in tumor cell apoptosis induced by tumor necrosis factor. J Cell Biol. 2001 May 28;153(5):999-1010.</p>\n\n<p>Games D., P. Seubert, E. Rockenstein et al., &ldquo;Axonopathy in an &alpha;-synuclein transgenic model of Lewy body disease is associated with extensive accumulation of c-terminal-truncated &alpha;-synuclein,&rdquo; American Journal of Pathology, vol. 182, no. 3, pp. 940&ndash;953, 2013.</p>\n\n<p>Grafstein B., and Forman DS. Intracellular transport in neurons. Physiological Reviews Published 1 October 1980 Vol. 60 no. 4.</p>\n\n<p>Hardy J. Rideout, Kristin E. Larsen, David Sulzer and Leonidas Stefanis, Proteasomal inhibition leads to formation of ubiquitin/a-synuclein-immunoreactive inclusions in PC12 cells. Journal of Neurochemistry, 2001, 78, 899&plusmn;908</p>\n\n<p>Hunn BH., S. J. Cragg, J. P. Bolam, M. G. Spillantini, and R. Wade-Martins, &ldquo;Impaired intracellular trafficking defines early Parkinson&rsquo;s disease,&rdquo; Trends in Neurosciences, vol. 38, no. 3, pp.178&ndash;188, 2015.</p>\n\n<p>Ii K., Ito H., Tanaka K. and Hirano A. (1997) Immunocytochemical co-localization of the proteasome in ubiquitinated structures in neurodegenerative diseases and the elderly. J. Neuropathol. Exp. Neurol. 56, 125-131.</p>\n\n<p>Jakobs S., High resolution imaging of live mitochondria, 2006, Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1763, Issues 5&ndash;6 Pages 561&ndash;575</p>\n\n<p>Kadowaki M, Karim MR. Cytosolic LC3 ratio as a quantitative index of macroautophagy. Methods Enzymol. 2009;452:199&ndash;213. [PubMed]</p>\n\n<p>Kisselev AF, Goldberg AL. Monitoring activity and inhibition of 26S proteasomes with fluorogenic peptide substrates. Methods Enzymol. 2005;398:364&ndash;378.</p>\n\n<p>Klionsky DJ., Ana Maria Cuervo &amp; Per O. Seglen. Methods for Monitoring Autophagy from Yeast to Human. Autophagy 2007, 3:3, 181-206; Klionsky D.J., Abeliovich H., Agostinis P., Agrawal D.K., Aliev G., Askew D.S., Baba M., Baehrecke E.H., Bahr B.A., Ballabio A., et al Guidelines for the use and interpretation of assays for monitoring autophagy in higher eukaryotes. Autophagy 2008;4:151-175.</p>\n\n<p>Korolchuk VI, Menzies FM, Rubinsztein DC (2010) Mechanisms of cross-talk between the ubiquitin&ndash;proteasome and autophagy&ndash;lysosome systems. FEBS Lett 584:1393&ndash;1398</p>\n\n<p>Kroemer G, Mari&ntilde;o G, Levine B (2010) Autophagy and the integrated stress response. J. Molecular cell 40:280&ndash;293.</p>\n\n<p>Kuma A, Hatano M, Matsui M, Yamamoto A, Nakaya H, Yoshimori T, et al. The role of autophagy during the early neonatal starvation period. Nature. 2004;432:1032&ndash;1036.</p>\n\n<p>Lee J, Giordano S, Zhang J; Giordano; Zhang (January 2012). &quot;Autophagy, mitochondria and oxidative stress: cross-talk and redox signalling&quot;. Biochem. J. 441 (2): 523&ndash;40.</p>\n\n<p>Lee FK, Wong AK, Lee YW, Wan OW, Chan HY, Chung KK. The role of ubiquitin linkages on alpha-synuclein induced-toxicity in a Drosophila model of Parkinson&#39;s disease. J Neurochem. 2009 Jul;110(1):208-19</p>\n\n<p>McNaught K. S. and Jenner P. (2001) Proteasomal function is impaired in substantia nigra in Parkinson&#39;s disease. Neurosci. Lett. 297, 191-194.</p>\n\n<p>Mizushima N. et al., 2008. Autophagy fights disease through cellular self-digestion. Nature. 451(7182):1069-75. Review.</p>\n\n<p>Munaf&oacute; DB, Colombo MI. Induction of autophagy causes dramatic changes in the subcellular distribution of GFP-Rab24. Traffic. 2002 Jul;3(7):472-82.</p>\n\n<p>Ortega Z. and Lucas J.J. (2014) Ubiquitin&ndash;proteasome system involvement in Huntington&rsquo;s disease Front Mol Neurosci. 2014; 7: 77.</p>\n\n<p>Pool M., Rippstein P., Mcbride H. Kothary R., 2006 Trafficking of Macromolecules and Organelles in Cultured Dystonia musculorum Sensory Neurons Is Normal. J. Comparative Neurology 494:549&ndash;558 (2006)</p>\n\n<p>Rajapakshe AR, Podyma-Inoue KA, Terasawa K, Hasegawa K, Namba T, Kumei Y, Yanagishita M, Hara-Yokoyama M. Lysosome-associated membrane proteins (LAMPs) regulate intracellular positioning of mitochondria in MC3T3-E1 cells. Exp Cell Res. 2015 Feb 1;331(1):211-22. doi: 10.1016/j.yexcr.2014.09.014.</p>\n\n<p>Ravikumar B, Sarkar S, Davies JE et al (2010) Regulation of mammalian autophagy in physiology and pathophysiology. Physiol Rev 90:1383&ndash;1435. doi:10.1152/physrev.00030.2009</p>\n\n<p>Rothermel BA, Hill JA (2007) Myocyte autophagy in heart disease: friend or foe? Autophagy 3:632&ndash;634.</p>\n\n<p>Rideout HJ, Larsen KE, Sulzer D, Stefanis L. 2001.Proteasomal inhibition leads to formation of ubiquitin/a-synuclein-immunoreactive inclusions in PC12 cells. Journal of Neurochemistry. 78, 899-908.</p>\n\n<p>Schildknecht S, Karreman C, P&ouml;ltl D, Efr&eacute;mova L, Kullmann C, Gutbier S, Krug A, Scholz D, Gerding HR, Leist M. Generation of genetically-modified human differentiated cells for toxicological tests and the study of neurodegenerative diseases. ALTEX. 2013;30(4):427-44.</p>\n\n<p>Schwarz TL.Mitochondrial trafficking in neurons. Cold Spring Harb Perspect Biol. 2013 Jun 1;5(6). pii: a011304.</p>\n\n<p>Sheng ZH., Mitochondrial trafficking and anchoring in neurons: new insight and implications. J of Cell Biology, vol. 204. No.7 pp. 1087-1098, 2014.</p>\n\n<p>Spillantini M. G., Schmidt M. L., Lee V. M., Trojanowski J. Q., Jakes R. and Goedert M. (1997) Alpha-synuclein in Lewy bodies.Nature 388, 839-840.</p>\n\n<p>Sulzer D. and Zecca L. (2000) Intraneuronal dopamine-quinonem synthesis: a review. Neurotoxicity Res. 1, 181-195.</p>\n\n<p>Zhu XH, Qiao H, Du F, Xiong Q, Liu X, Zhang X, Ugurbil K, Chen W. Quantitative imaging of energy expenditure in human brain. Neuroimage. 2012;60(4):2107-17)</p>\n","biologicalOrganisationLevel":"Cellular","organTerm":{},"biologicalEvents":[{"action":"abnormal","process":"Proteostasis deficiencies","object":{"name":"protein","source":"CHEBI","sourceId":"CHEBI:36080"}}],"keyEventStressors":["1',2'-dihydrorotenone"],"id":889}
{"title":"Neuroinflammation","references":"<p>Aguzzi, A., Barres, B.A., Bennett, M.L., 2013. Microglia: scapegoat, saboteur, or something else? Science 339(6116), 156-161.</p>\n\n<p>Aloisi, F., 2001. Immune function of microglia. Glia 36, 165-179.</p>\n\n<p>Aschner M (1998) Immune and inflammatory responses in the CNS: modulation by astrocytes. ToxicolLett 103: 283-287</p>\n\n<p>Banati, R. B. (2002). &quot;Visualising microglial activation <em>in vivo</em>.&quot; Glia 40: 206-217.&nbsp; &nbsp;</p>\n\n<p>Baburamani AA, Supramaniam VG, Hagberg H, Mallard C (2014) Microglia toxicity in preterm brain injury. <em>Reprod Toxicol</em> <strong>48:</strong> 106-112</p>\n\n<p>Brown GC, Bal-Price A (2003) Inflammatory neurodegeneration mediated by nitric oxide, glutamate, and mitochondria. Mol Neurobiol 27: 325-355</p>\n\n<p>Carson, M.J., Thrash, J.C., Walter, B., 2006. The cellular response in neuroinflammation: The role of leukocytes, microglia and astrocytes in neuronal death and survival. Clin Neurosci Res 6(5), 237-245.</p>\n\n<p>Charleston JS, Body RL, Bolender RP, Mottet NK, Vahter ME, Burbacher TM. 1996. Changes in the number of astrocytes and microglia in the thalamus of the monkey Macaca fascicularis following long-term subclinical methylmercury exposure. NeuroToxicology 17: 127-138.</p>\n\n<p>Charleston JS, Bolender RP, Mottet NK, Body RL, Vahter ME, Burbacher TM. 1994. Increases in the number of reactive glia in the visual cortex of Macaca fascicularis following subclinical long-term methyl mercury exposure. ToxicolApplPharmacol 129: 196-206.</p>\n\n<p>Claycomb, K.I., Johnson, K.M., Winokur, P.N., Sacino, A.V., Crocker, S.J., 2013. Astrocyte regulation of CNS inflammation and remyelination. Brain Sci 3(3), 1109-1127.</p>\n\n<p>Dong Y, Benveniste EN (2001) Immune Function of Astrocytes. Glia 36: 180-190</p>\n\n<p>Eng LF, Ghirnikar RS, Lee YL (2000) Glial Fibrillary Acidic Protein: GFAP-Thirty-One Years (1969-2000). NeurochemRes 25: 1439-1451</p>\n\n<p>Eskes C, Honegger P, Juillerat-Jeanneret L, Monnet-Tschudi F. 2002. Microglial reaction induced by noncytotoxic methylmercury treatment leads to neuroprotection via interactions with astrocytes and IL-6 release. Glia 37(1): 43-52.</p>\n\n<p>Falsig J, Latta M, Leist M. Defined inflammatory states in astrocyte cultures correlation with susceptibility towards CD95-driven apoptosis. J Neurochem. 2004 &nbsp;Jan;88(1):181-93.</p>\n\n<p>Falsig J, P&ouml;rzgen P, Lund S, Schrattenholz A, Leist M. The inflammatory transcriptome of reactive murine astrocytes and implications for their innate immune function. J Neurochem. 2006 Feb;96(3):893-907.</p>\n\n<p>Falsig J, van Beek J, Hermann C, Leist M. Molecular basis for detection of invading pathogens in the brain. J Neurosci Res. 2008 May 15;86(7):1434-47.</p>\n\n<p>Glass CK, Saijo K, Winner B, Marchetto MC, Gage FH (2010). Mechanisms underlying inflammation in neurodegeneration. Cell. 2010 Mar 19;140(6):918-34.</p>\n\n<p>Gordon S (2003) Alternative activation of macrophages. Nat Rev Immunol 3: 23-35</p>\n\n<p>Graeber MB, Streit WJ (1990) Microglia: immune network in the CNS. Brain Pathol 1: 2-5</p>\n\n<p>Harry GJ and Kraft AD (2012) Microglia in the developing brain: apotential target with lifetime effects. <a href=\"https://www.ncbi.nlm.nih.gov/pubmed/22322212\" title=\"Neurotoxicology.\">Neurotoxicology.</a>&nbsp;33(2):191-206.</p>\n\n<p>Harry GJ (2013) Microglia during development and aging. <em>Pharmacology &amp; therapeutics</em> <strong>139:</strong> 313-326</p>\n\n<p><span style=\"font-size:11pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#0070c0\">Kanberg N, et al. Neurochemical evidence of astrocytic and neuronal injury commonly found in COVID-19. Neurology. 2020 Sep 22;95(12):e1754-e1759</span></span></span></p>\n\n<p>Kigerl KA, Gensel JC, Ankeny DP, Alexander JK, Donnelly DJ, Popovich PG (2009) Identification of two distinct macrophage subsets with divergent effects causing either neurotoxicity or regeneration in the injured mouse spinal cord. J Neurosci 29: 13435-13444</p>\n\n<p>Kraft AD, Harry GJ., Features of microglia and neuroinflammation relevant to environmental exposure and neurotoxicity. International Journal of Environmental research and Public Health., 2011, 8(7): 2980-3018.</p>\n\n<p>Kreutzberg GW (1995) Microglia, the first line of defence in brain pathologies. Arzneimttelforsch 45: 357-360</p>\n\n<p>Kreutzberg GW (1996) Microglia : a sensor for pathological events in the CNS. Trends Neurosci 19: 312-318</p>\n\n<p>Kuegler PB, Zimmer B, Waldmann T, Baudis B, Ilmj&auml;rv S, Hescheler J, Gaughwin P, Brundin P, Mundy W, Bal-Price AK, Schrattenholz A, Krause KH, van Thriel C, Rao MS, Kadereit S, Leist M. Markers of murine embryonic and neural stem cells, neurons and astrocytes: reference points for developmental neurotoxicity testing. ALTEX. 2010;27(1):17-42</p>\n\n<p>Leonardo CC, Pennypacker KR (2009) Neuroinflammation and MMPs: potential therapeutic targets in neonatal hypoxic-ischemic injury. <em>J Neuroinflammation</em> <strong>6:</strong> 13</p>\n\n<p>Liddelow SA, Guttenplan KA, Clarke LE, Bennett FC, Bohlen CJ, Schirmer L, et al. 2017. Neurotoxic reactive astrocytes are induced by activated microglia. Nature 541(7638): 481-487.</p>\n\n<p>Little AR, Miller DB, Li S, Kashon ML, O&#39;Callaghan JP. 2012. Trimethyltin-induced neurotoxicity: gene expression pathway analysis, q-RT-PCR and immunoblotting reveal early effects associated with hippocampal damage and gliosis. Neurotoxicol Teratol 34(1): 72-82.</p>\n\n<p>Liu Y, Hu J, Wu J, Zhu C, Hui Y, Han Y, et al. 2012. alpha7 nicotinic acetylcholine receptor-mediated neuroprotection against dopaminergic neuron loss in an MPTP mouse model via inhibition of astrocyte activation. J Neuroinflammation 9: 98.</p>\n\n<p>Lund S, Christensen KV, Hedtj&auml;rn M, Mortensen AL, Hagberg H, Falsig J, Hasseldam H, Schrattenholz A, P&ouml;rzgen P, Leist M. The dynamics of the LPS triggered inflammatory response of murine microglia under different culture and <em>in vivo</em> conditions. J Neuroimmunol. 2006 Nov;180(1-2):71-87.</p>\n\n<p>Maresz K, Ponomarev ED, Barteneva N, Tan Y, Mann MK, Dittel BN (2008) IL-13 induces the expression of the alternative activation marker Ym1 in a subset of testicular macrophages. J Reprod Immunol 78: 140-148</p>\n\n<p>Moehle MS, West AB (2015) M1 and M2 immune activation in Parkinson&#39;s Disease: Foe and ally? Neuroscience 302:59-73 doi:10.1016/j.neuroscience.2014.11.018</p>\n\n<p>Monnet-Tschudi F, Zurich MG, Honegger P (2007) Neurotoxicant-induced inflammatory response in three-dimensional brain cell cultures. Hum Exp Toxicol 26: 339-346</p>\n\n<p>Monnet-Tschudi, F., A. Defaux, et al. (2011). &quot;Methods to assess neuroinflammation.&quot; Curr Protoc Toxicol Chapter 12: Unit12 19.&nbsp; &nbsp; &nbsp; &nbsp; &nbsp;</p>\n\n<p>Mosser DM, Edwards JP (2008) Exploring the full spectrum of macrophage activation. Nat Rev Immunol 8: 958-969</p>\n\n<p>Nakajima K, Kohsaka S. 2004. Microglia: Neuroprotective and neurotrophic cells in the central nervous system. Current Drug Targets-Cardiovasc &amp; Haematol Disorders 4: 65-84.</p>\n\n<p>Perego C, Fumagalli S, De Simoni MG (2011) Temporal pattern of expression and colocalization of microglia/macrophage phenotype markers following brain ischemic injury in mice. J Neuroinflammation 8: 174</p>\n\n<p>Ponomarev ED, Maresz K, Tan Y, Dittel BN (2007) CNS-derived interleukin-4 is essential for the regulation of autoimmune inflammation and induces a state of alternative activation in microglial cells. J Neurosci 27: 10714-10721</p>\n\n<p>Ponomarev ED, Shriver LP, Maresz K, Dittel BN (2005) Microglial cell activation and proliferation precedes the onset of CNS autoimmunity. J Neurosci Res 81: 374-389</p>\n\n<p><a href=\"https://www.ncbi.nlm.nih.gov/pubmed/?term=Rajendran%20L%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=29563239\">Rajendran&nbsp;L</a><sup>1</sup>,&nbsp;<a href=\"https://www.ncbi.nlm.nih.gov/pubmed/?term=Paolicelli%20RC%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=29563239\">Paolicelli&nbsp;RC</a> (2018). Microglia-Mediated Synapse Loss in Alzheimer&#39;s Disease. <a href=\"https://www.ncbi.nlm.nih.gov/pubmed/29563239\" title=\"The Journal of neuroscience : the official journal of the Society for Neuroscience.\">J Neurosci.</a>&nbsp; 38:2911-2919.</p>\n\n<p>Ransohoff RM. 2016. A polarizing question: do M1 and M2 microglia exist? Nat Neurosci 19(8): 987-991.</p>\n\n<p><a href=\"https://www.ncbi.nlm.nih.gov/pubmed/?term=Reemst%20K%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=27877121\">Reemst K</a>,&nbsp;<a href=\"https://www.ncbi.nlm.nih.gov/pubmed/?term=Noctor%20SC%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=27877121\">Noctor SC</a>,&nbsp;<a href=\"https://www.ncbi.nlm.nih.gov/pubmed/?term=Lucassen%20PJ%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=27877121\">Lucassen PJ</a>,&nbsp;<a href=\"https://www.ncbi.nlm.nih.gov/pubmed/?term=Hol%20EM%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=27877121\">Hol EM</a>. (2016) The Indispensable Roles of Microglia and&nbsp;Astrocytes&nbsp;during&nbsp;Brain Development. <a href=\"https://www.ncbi.nlm.nih.gov/pubmed/27877121\" title=\"Frontiers in human neuroscience.\">Front Hum Neurosci.</a>&nbsp; 10:566. DOI:10.3389/fnhum.2016.00566</p>\n\n<p>Rivest, S., 2009. Regulation of innate immune responses in the brain. Nat Rev Immunol 9(6), 429-439.</p>\n\n<p>Sandstrom von Tobel, J., D. Zoia, et al. (2014). &quot;Immediate and delayed effects of subchronic Paraquat exposure during an early differentiation stage in 3D-rat brain cell cultures.&quot; Toxicol Lett. DOI : 10.1016/j.toxlet.2014.02.001</p>\n\n<p>Sandstrom J, Broyer A, Zoia D, et al. (2017a) Potential mechanisms of development-dependent adverse effects of the herbicide paraquat in 3D rat brain cell cultures. Neurotoxicology 60:116-124 doi:10.1016/j.neuro.2017.04.010</p>\n\n<p>Sandstrom J, Eggermann E, Charvet I, et al. (2017b) Development and characterization of a human embryonic stem cell-derived 3D neural tissue model for neurotoxicity testing. Toxicol In Vitro 38:124-135 doi:10.1016/j.tiv.2016.10.001</p>\n\n<p>Streit, W.J., Walter, S.A., Pennell, N.A., 1999. Reactive microgliosis. Progress in Neurobiol. 57, 563-581.</p>\n\n<p>Struzynska L, Dabrowska-Bouta B, Koza K, Sulkowski G (2007) Inflammation-Like Glial Response in Lead-Exposed Immature Rat Brain. Toxicol Sc 95:156-162</p>\n\n<p>Venneti S, Lopresti BJ, Wiley CA. 2006. The peripheral benzodiazepine receptor (Translocator protein 18kDa) in microglia: from pathology to imaging. Prog Neurobiol 80(6): 308-322.</p>\n\n<p>von Tobel, J. S., P. Antinori, et al. (2014). &quot;Repeated exposure to Ochratoxin A generates a neuroinflammatory response, characterized by neurodegenerative M1 microglial phenotype.&quot; Neurotoxicology 44C: 61-70.</p>\n\n<p>Xu DP, Zhang K, Zhang ZJ, Sun YW, Guo BJ, Wang YQ, et al. 2014. A novel tetramethylpyrazine bis-nitrone (TN-2) protects against 6-hydroxyldopamine-induced neurotoxicity via modulation of the NF-kappaB and the PKCalpha/PI3-K/Akt pathways. Neurochem Int 78: 76-85.</p>\n\n<p>Zurich M-G, Eskes C, Honegger P, B&eacute;rode M, Monnet-Tschudi F. 2002. Maturation-dependent neurotoxicity of lead aceate <em>in vitro</em>: Implication of glial reactions. J Neurosc Res 70: 108-116.</p>\n","biologicalOrganisationLevel":"Tissue","organTerm":{"name":"brain","sourceId":"UBERON:0000955"},"biologicalEvents":[{"action":"pathological","process":"brain inflammation","object":{"name":"microglial cell","source":"CL","sourceId":"CL:0000129"}},{"action":"pathological","process":"brain inflammation","object":{"name":"astrocyte","source":"CL","sourceId":"CL:0000127"}}],"keyEventStressors":["Chemical","SARS-CoV","Sars-CoV-2","Virus","bacteria"],"id":188}
{"title":"Neuroinflammation","references":"<p>Aguzzi, A., Barres, B.A., Bennett, M.L., 2013. Microglia: scapegoat, saboteur, or something else? Science 339(6116), 156-161.</p>\n\n<p>Aloisi, F., 2001. Immune function of microglia. Glia 36, 165-179.</p>\n\n<p>Aschner M (1998) Immune and inflammatory responses in the CNS: modulation by astrocytes. ToxicolLett 103: 283-287</p>\n\n<p>Banati, R. B. (2002). &quot;Visualising microglial activation <em>in vivo</em>.&quot; Glia 40: 206-217.&nbsp; &nbsp;</p>\n\n<p>Baburamani AA, Supramaniam VG, Hagberg H, Mallard C (2014) Microglia toxicity in preterm brain injury. <em>Reprod Toxicol</em> <strong>48:</strong> 106-112</p>\n\n<p>Brown GC, Bal-Price A (2003) Inflammatory neurodegeneration mediated by nitric oxide, glutamate, and mitochondria. Mol Neurobiol 27: 325-355</p>\n\n<p>Carson, M.J., Thrash, J.C., Walter, B., 2006. The cellular response in neuroinflammation: The role of leukocytes, microglia and astrocytes in neuronal death and survival. Clin Neurosci Res 6(5), 237-245.</p>\n\n<p>Charleston JS, Body RL, Bolender RP, Mottet NK, Vahter ME, Burbacher TM. 1996. Changes in the number of astrocytes and microglia in the thalamus of the monkey Macaca fascicularis following long-term subclinical methylmercury exposure. NeuroToxicology 17: 127-138.</p>\n\n<p>Charleston JS, Bolender RP, Mottet NK, Body RL, Vahter ME, Burbacher TM. 1994. Increases in the number of reactive glia in the visual cortex of Macaca fascicularis following subclinical long-term methyl mercury exposure. ToxicolApplPharmacol 129: 196-206.</p>\n\n<p>Claycomb, K.I., Johnson, K.M., Winokur, P.N., Sacino, A.V., Crocker, S.J., 2013. Astrocyte regulation of CNS inflammation and remyelination. Brain Sci 3(3), 1109-1127.</p>\n\n<p>Dong Y, Benveniste EN (2001) Immune Function of Astrocytes. Glia 36: 180-190</p>\n\n<p>Eng LF, Ghirnikar RS, Lee YL (2000) Glial Fibrillary Acidic Protein: GFAP-Thirty-One Years (1969-2000). NeurochemRes 25: 1439-1451</p>\n\n<p>Eskes C, Honegger P, Juillerat-Jeanneret L, Monnet-Tschudi F. 2002. Microglial reaction induced by noncytotoxic methylmercury treatment leads to neuroprotection via interactions with astrocytes and IL-6 release. Glia 37(1): 43-52.</p>\n\n<p>Falsig J, Latta M, Leist M. Defined inflammatory states in astrocyte cultures correlation with susceptibility towards CD95-driven apoptosis. J Neurochem. 2004 &nbsp;Jan;88(1):181-93.</p>\n\n<p>Falsig J, P&ouml;rzgen P, Lund S, Schrattenholz A, Leist M. The inflammatory transcriptome of reactive murine astrocytes and implications for their innate immune function. J Neurochem. 2006 Feb;96(3):893-907.</p>\n\n<p>Falsig J, van Beek J, Hermann C, Leist M. Molecular basis for detection of invading pathogens in the brain. J Neurosci Res. 2008 May 15;86(7):1434-47.</p>\n\n<p>Glass CK, Saijo K, Winner B, Marchetto MC, Gage FH (2010). Mechanisms underlying inflammation in neurodegeneration. Cell. 2010 Mar 19;140(6):918-34.</p>\n\n<p>Gordon S (2003) Alternative activation of macrophages. Nat Rev Immunol 3: 23-35</p>\n\n<p>Graeber MB, Streit WJ (1990) Microglia: immune network in the CNS. Brain Pathol 1: 2-5</p>\n\n<p>Harry GJ and Kraft AD (2012) Microglia in the developing brain: apotential target with lifetime effects. <a href=\"https://www.ncbi.nlm.nih.gov/pubmed/22322212\" title=\"Neurotoxicology.\">Neurotoxicology.</a>&nbsp;33(2):191-206.</p>\n\n<p>Harry GJ (2013) Microglia during development and aging. <em>Pharmacology &amp; therapeutics</em> <strong>139:</strong> 313-326</p>\n\n<p><span style=\"font-size:11pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#0070c0\">Kanberg N, et al. Neurochemical evidence of astrocytic and neuronal injury commonly found in COVID-19. Neurology. 2020 Sep 22;95(12):e1754-e1759</span></span></span></p>\n\n<p>Kigerl KA, Gensel JC, Ankeny DP, Alexander JK, Donnelly DJ, Popovich PG (2009) Identification of two distinct macrophage subsets with divergent effects causing either neurotoxicity or regeneration in the injured mouse spinal cord. J Neurosci 29: 13435-13444</p>\n\n<p>Kraft AD, Harry GJ., Features of microglia and neuroinflammation relevant to environmental exposure and neurotoxicity. International Journal of Environmental research and Public Health., 2011, 8(7): 2980-3018.</p>\n\n<p>Kreutzberg GW (1995) Microglia, the first line of defence in brain pathologies. Arzneimttelforsch 45: 357-360</p>\n\n<p>Kreutzberg GW (1996) Microglia : a sensor for pathological events in the CNS. Trends Neurosci 19: 312-318</p>\n\n<p>Kuegler PB, Zimmer B, Waldmann T, Baudis B, Ilmj&auml;rv S, Hescheler J, Gaughwin P, Brundin P, Mundy W, Bal-Price AK, Schrattenholz A, Krause KH, van Thriel C, Rao MS, Kadereit S, Leist M. Markers of murine embryonic and neural stem cells, neurons and astrocytes: reference points for developmental neurotoxicity testing. ALTEX. 2010;27(1):17-42</p>\n\n<p>Leonardo CC, Pennypacker KR (2009) Neuroinflammation and MMPs: potential therapeutic targets in neonatal hypoxic-ischemic injury. <em>J Neuroinflammation</em> <strong>6:</strong> 13</p>\n\n<p>Liddelow SA, Guttenplan KA, Clarke LE, Bennett FC, Bohlen CJ, Schirmer L, et al. 2017. Neurotoxic reactive astrocytes are induced by activated microglia. Nature 541(7638): 481-487.</p>\n\n<p>Little AR, Miller DB, Li S, Kashon ML, O&#39;Callaghan JP. 2012. Trimethyltin-induced neurotoxicity: gene expression pathway analysis, q-RT-PCR and immunoblotting reveal early effects associated with hippocampal damage and gliosis. Neurotoxicol Teratol 34(1): 72-82.</p>\n\n<p>Liu Y, Hu J, Wu J, Zhu C, Hui Y, Han Y, et al. 2012. alpha7 nicotinic acetylcholine receptor-mediated neuroprotection against dopaminergic neuron loss in an MPTP mouse model via inhibition of astrocyte activation. J Neuroinflammation 9: 98.</p>\n\n<p>Lund S, Christensen KV, Hedtj&auml;rn M, Mortensen AL, Hagberg H, Falsig J, Hasseldam H, Schrattenholz A, P&ouml;rzgen P, Leist M. The dynamics of the LPS triggered inflammatory response of murine microglia under different culture and <em>in vivo</em> conditions. J Neuroimmunol. 2006 Nov;180(1-2):71-87.</p>\n\n<p>Maresz K, Ponomarev ED, Barteneva N, Tan Y, Mann MK, Dittel BN (2008) IL-13 induces the expression of the alternative activation marker Ym1 in a subset of testicular macrophages. J Reprod Immunol 78: 140-148</p>\n\n<p>Moehle MS, West AB (2015) M1 and M2 immune activation in Parkinson&#39;s Disease: Foe and ally? Neuroscience 302:59-73 doi:10.1016/j.neuroscience.2014.11.018</p>\n\n<p>Monnet-Tschudi F, Zurich MG, Honegger P (2007) Neurotoxicant-induced inflammatory response in three-dimensional brain cell cultures. Hum Exp Toxicol 26: 339-346</p>\n\n<p>Monnet-Tschudi, F., A. Defaux, et al. (2011). &quot;Methods to assess neuroinflammation.&quot; Curr Protoc Toxicol Chapter 12: Unit12 19.&nbsp; &nbsp; &nbsp; &nbsp; &nbsp;</p>\n\n<p>Mosser DM, Edwards JP (2008) Exploring the full spectrum of macrophage activation. Nat Rev Immunol 8: 958-969</p>\n\n<p>Nakajima K, Kohsaka S. 2004. Microglia: Neuroprotective and neurotrophic cells in the central nervous system. Current Drug Targets-Cardiovasc &amp; Haematol Disorders 4: 65-84.</p>\n\n<p>Perego C, Fumagalli S, De Simoni MG (2011) Temporal pattern of expression and colocalization of microglia/macrophage phenotype markers following brain ischemic injury in mice. J Neuroinflammation 8: 174</p>\n\n<p>Ponomarev ED, Maresz K, Tan Y, Dittel BN (2007) CNS-derived interleukin-4 is essential for the regulation of autoimmune inflammation and induces a state of alternative activation in microglial cells. J Neurosci 27: 10714-10721</p>\n\n<p>Ponomarev ED, Shriver LP, Maresz K, Dittel BN (2005) Microglial cell activation and proliferation precedes the onset of CNS autoimmunity. J Neurosci Res 81: 374-389</p>\n\n<p><a href=\"https://www.ncbi.nlm.nih.gov/pubmed/?term=Rajendran%20L%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=29563239\">Rajendran&nbsp;L</a><sup>1</sup>,&nbsp;<a href=\"https://www.ncbi.nlm.nih.gov/pubmed/?term=Paolicelli%20RC%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=29563239\">Paolicelli&nbsp;RC</a> (2018). Microglia-Mediated Synapse Loss in Alzheimer&#39;s Disease. <a href=\"https://www.ncbi.nlm.nih.gov/pubmed/29563239\" title=\"The Journal of neuroscience : the official journal of the Society for Neuroscience.\">J Neurosci.</a>&nbsp; 38:2911-2919.</p>\n\n<p>Ransohoff RM. 2016. A polarizing question: do M1 and M2 microglia exist? Nat Neurosci 19(8): 987-991.</p>\n\n<p><a href=\"https://www.ncbi.nlm.nih.gov/pubmed/?term=Reemst%20K%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=27877121\">Reemst K</a>,&nbsp;<a href=\"https://www.ncbi.nlm.nih.gov/pubmed/?term=Noctor%20SC%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=27877121\">Noctor SC</a>,&nbsp;<a href=\"https://www.ncbi.nlm.nih.gov/pubmed/?term=Lucassen%20PJ%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=27877121\">Lucassen PJ</a>,&nbsp;<a href=\"https://www.ncbi.nlm.nih.gov/pubmed/?term=Hol%20EM%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=27877121\">Hol EM</a>. (2016) The Indispensable Roles of Microglia and&nbsp;Astrocytes&nbsp;during&nbsp;Brain Development. <a href=\"https://www.ncbi.nlm.nih.gov/pubmed/27877121\" title=\"Frontiers in human neuroscience.\">Front Hum Neurosci.</a>&nbsp; 10:566. DOI:10.3389/fnhum.2016.00566</p>\n\n<p>Rivest, S., 2009. Regulation of innate immune responses in the brain. Nat Rev Immunol 9(6), 429-439.</p>\n\n<p>Sandstrom von Tobel, J., D. Zoia, et al. (2014). &quot;Immediate and delayed effects of subchronic Paraquat exposure during an early differentiation stage in 3D-rat brain cell cultures.&quot; Toxicol Lett. DOI : 10.1016/j.toxlet.2014.02.001</p>\n\n<p>Sandstrom J, Broyer A, Zoia D, et al. (2017a) Potential mechanisms of development-dependent adverse effects of the herbicide paraquat in 3D rat brain cell cultures. Neurotoxicology 60:116-124 doi:10.1016/j.neuro.2017.04.010</p>\n\n<p>Sandstrom J, Eggermann E, Charvet I, et al. (2017b) Development and characterization of a human embryonic stem cell-derived 3D neural tissue model for neurotoxicity testing. Toxicol In Vitro 38:124-135 doi:10.1016/j.tiv.2016.10.001</p>\n\n<p>Streit, W.J., Walter, S.A., Pennell, N.A., 1999. Reactive microgliosis. Progress in Neurobiol. 57, 563-581.</p>\n\n<p>Struzynska L, Dabrowska-Bouta B, Koza K, Sulkowski G (2007) Inflammation-Like Glial Response in Lead-Exposed Immature Rat Brain. Toxicol Sc 95:156-162</p>\n\n<p>Venneti S, Lopresti BJ, Wiley CA. 2006. The peripheral benzodiazepine receptor (Translocator protein 18kDa) in microglia: from pathology to imaging. Prog Neurobiol 80(6): 308-322.</p>\n\n<p>von Tobel, J. S., P. Antinori, et al. (2014). &quot;Repeated exposure to Ochratoxin A generates a neuroinflammatory response, characterized by neurodegenerative M1 microglial phenotype.&quot; Neurotoxicology 44C: 61-70.</p>\n\n<p>Xu DP, Zhang K, Zhang ZJ, Sun YW, Guo BJ, Wang YQ, et al. 2014. A novel tetramethylpyrazine bis-nitrone (TN-2) protects against 6-hydroxyldopamine-induced neurotoxicity via modulation of the NF-kappaB and the PKCalpha/PI3-K/Akt pathways. Neurochem Int 78: 76-85.</p>\n\n<p>Zurich M-G, Eskes C, Honegger P, B&eacute;rode M, Monnet-Tschudi F. 2002. Maturation-dependent neurotoxicity of lead aceate <em>in vitro</em>: Implication of glial reactions. J Neurosc Res 70: 108-116.</p>\n","biologicalOrganisationLevel":"Tissue","organTerm":{"name":"brain","sourceId":"UBERON:0000955"},"biologicalEvents":[{"action":"pathological","process":"brain inflammation","object":{"name":"microglial cell","source":"CL","sourceId":"CL:0000129"}},{"action":"pathological","process":"brain inflammation","object":{"name":"astrocyte","source":"CL","sourceId":"CL:0000127"}}],"keyEventStressors":["Chemical","SARS-CoV","Sars-CoV-2","Virus","bacteria"],"id":188}
{"title":"Degeneration of dopaminergic neurons of the nigrostriatal pathway","references":"<p>Ayton S and Lei P. 2014. Nigral Iron Elevation Is an Invariable Feature of Parkinson&rsquo;s Disease and Is a Sufficient Cause of Neurodegeneration. Biomed Research Inernational. (2014) 1-9.</p>\n\n<p>Asanuma M, Miyazaki I, Ogawa N. (3003). Dopamine or L-DOPA-induced neurotoxicity: the role of dopamine quinone formation and tyrosinase in a model of Parkinson&rsquo;s disease. Neurotox Res (5) 165-76.</p>\n\n<p>Barron AB, S&oslash;vik E, Cornish JL (2010). The roles of dopamine and related compounds in reward-seeking behavior across animal phyla&quot;. Frontiers in Behavioral Neuroscience 4: 163.</p>\n\n<p>Ben-Shachar D, Youdim MBH. 1991.Intranigral Iron Injection Induces Behavioral and Biochemical &ldquo;Parkinsonism&rdquo; in Rat. Journal of Neurochemistry . 57(6), 2133&ndash;5.</p>\n\n<p>Bernhaimer H, Birkmayer W, Hornykiewicz O, Jellinger K, Seitelberger F. 1973. Brain dopamine and the syndrome of Parkinson and Huntington. Clinical, morphological and neurochemical correlations. J Neurol.Sci.(20) 415-5.</p>\n\n<p>Betarbet R, Sherer TB, MacKenzie G, Garcia-Osuna M, Panov AV, Greenamyre JT. 2000. Chronic systemic pesticide exposure reproduces features of Parkinson&rsquo;s disease. Nature neuroscience. 3 (12) 1301-6.</p>\n\n<p>Betarbet R, Canet-Aviles RM, Sherer TB, Mastroberardino PG,Mc Lendon C, Kim JH, Lund S, Na HM, taylor G, Bence NF, kopito R, seo BB, Yagi T, Yagi A, Klinfelter G, Cookson MR, Greenmyre JT. 2006. Intersecting pathways to neurodegeneration in Parkinson&rsquo;s disease: effects of the pesticide rotenone on DJ-1, &alpha;-synuclein, and the ubiquitin-proteasome system. Neurobiology disease. (22) 404-20.</p>\n\n<p>Braak H, Ghebremedhin E, Rub U, Bratzke H, Del Tredici K. 2004.Stages in the development of Parkinson&rsquo;s disease-related pathology. CellTissue Res. (318) 121-4.</p>\n\n<p>Braak H, Del Tredici K. 2009. Neuroanatomy and pathology of sporadic Parkinson&rsquo;s disease. Adv Anat Embryol Cell Biol (201) 1-119. Brooks AI, Chadwick CA, Gelbard HA, Cory-Slechta DA, Federoff HJ. 1999. Paraquat elicited neurobehavioral syndrome caused by dopaminergic neuron loss. Brain Research (823) 1-10.</p>\n\n<p>Canuti-Silvestri I, Shukitt-Hale B, Joseph JA. (2003). Dopamine neurotoxicity: age dependent behavioural and histological effects. Neurobiol aging (24) 697-6.</p>\n\n<p>Dale GE, Probst A, Luthert P, Martin J, Anderton BH, Leigh PN. 1992.Relationships between Lewy bodies and pale bodies in Parkinson&#39;s disease. Acta Neuropathol. 83(5):525-9.</p>\n\n<p>Dauer W, Przerdborski S. 2003. Parkinson&rsquo;sdisease: Mechanisms and Models.Neuron. 39, 889-9.</p>\n\n<p>Dickinson D. 2012. Parkinson&rsquo;s disease and parkinsonism: Neuropathology.Cold Spring Harb Perspect Med. 2:a009258.</p>\n\n<p>Efremova L, Scildknecht S, Adam M, pape R, Gutbier S, Hanf B, Burkle A, Leist M. 2015. Prevention of the degeneration of dopaminergic neurons in an astrocyte co-culture system allowing endogenous drug metabolism. British Journal of Pharmacology; 172; 4119-32.</p>\n\n<p>Fetissov SO, Marsais F. 1998. Combination of immunohistochemical and in situ hybridization methods to reveal tyrosine hydroxylase and oxytocin and vasopressin mRNA in magnocellular neurons of obese Zucker rats. Braian research Protocols. 4, 36-3.</p>\n\n<p>Fornai F, Lenzi P, Gesi M, Ferrucci M, Lazzeri G, Busceti C, Ruffoli R, Soldani P, Ruggieri S, Alessandri&rsquo; MG, Paparelli A. 2003. Fine structure and mechanisms underlying nigrostriatal inclusions and cell death after proteasome inhibition. The journal of neuroscience. 23 (26) 8955-6.</p>\n\n<p>Forno LS, DeLanney LE, Irwin I, Langston JW. (1992). Electron microscopy of lewy bodies in the amigdala-parahippocampal region. Comparison eith inclusion bodies in the MPTP-treated squirrel monkey. Adv.neurol.(69) 217-8.</p>\n\n<p>Forno LS. (1969). Concentric hyaline intraneuronal inclusion of Lewy type in brains of elderly person (50 incident cases): Relationship to parkinsonism. J Am Geriatr Soc. (6) 557-5.</p>\n\n<p>Fujita KA, Ostaszewski M, Matsuoka Y, Ghosh S, Glaab E, Trefois C, Crespo I, Perumal TM, Jurkowski W, Antony PM, Diederich N, Buttini M, Kodama A, Satagopam VP, Eifes S, Del Sol A, Schneider R, Kitano H, Balling R. Integrating pathways of Parkinson&#39;s disease in a molecular interaction map. Mol Neurobiol. 2014 Feb;49(1):88-102.</p>\n\n<p>Galloway PG, Mulvihill P, perry G. 1992. Filaments of Lewy bodies contain insoluble cytoskeletal elements. AmJ Pathol. (140) 809-2. Gotz ME, Double K, Gerlach M, Youdim MBH, Riederer P. 2004. The relevance of iron in the pathogenesis of Parkinson&rsquo;s disease. Ann.N.Y. Acad. Sci. (1012) 193-8.</p>\n\n<p>Hirata Y, suzuno S, tsuruta T, OH-hashi K, Kiuchi K. 2008. The role of dopamine transporter in selective toxicity of manganese and rotenone. Toxicology. (244). 249-6.</p>\n\n<p>Hornykiewicz O, Kish SJ. 1987. Biochemical pathophysiology of parkinson&rsquo;s disease. In Parkinson&rsquo;s Disease. M Yahr and K.J. Bergmann, eds (New.York: Raven Press) 19-34.</p>\n\n<p>Kapuscinski J. 1995. Biotechnic and Histochemistry, 70(5), 220-3.</p>\n\n<p>Kim-Han JS, Dorsey JA, O&rsquo;Malley KL. 2011. The parkinsonian mimetic MPP+, specifically impairs mitochondrial transport in dopamine axons. The Journal of Neuroscience. 31(19) 7212-1.</p>\n\n<p>Kuusisto E, Parkkinen L, Alafuzoff I. 2003. Morphogenesis of Lewy bodies: dissimilar incorporation of &alpha;-synuclein, ubiquitin and 62. J Neuropathol Exp Neurol. (62)1241-3.</p>\n\n<p>Kuzuhara S, mori H, Izumiyama N, Yoshimura M, Ihara Y. 1988. Lewy bodues are ubiquinated. A light and electron microscopic immunocytochemical study. Acta Neuropathol. (75) 345-3.</p>\n\n<p>Jellinger KA. 2009. A critical evaluation of current staging of &alpha;-synuclein pathology in Lewy body disorders. Biochemica and Biophysica Acta. 730-0.</p>\n\n<p>Johnson ME, Bobrovskaya L. 2015. An update on the rotenone models of parkinson&rsquo;s disease: Their ability to reproduce features of clinical disease and model gene-environment interactions. 946). 101-16.</p>\n\n<p>Latt, SA; Stetten, G; Juergens, LA; Willard, HF; Scher, CD .1975. Recent developments in the detection of deoxyribonucleic acid synthesis by 33258 Hoechst fluorescence. The journal of histochemistry and cytochemistry&nbsp;: Official Journal of the Histochemistry Society 23 (7): 493&ndash;5.</p>\n\n<p>Liang CL; wang TT; Luby-Phelps K, German DC. 2007. Mitochondria mass is low in mouse substantia nigra dopamine neurons: Implication for Parkinson&rsquo;s disease. Experimental Neurology (203) 370-80.</p>\n\n<p>Lotharius, J., Brundin, P., 2002. Pathogenesis of Parkinson&rsquo;s disease: dopamine, vesicles and &alpha;-synuclein. Nat. Rev., Neurosci. 3, 932&ndash; 2.</p>\n\n<p>Magnusson O., Nilsson LB, Westerlund D. 1980). Simultaneous determination of dopamine, DOPAC, and homovanilic acid. Direct injection of supernatants from the brain tissue homogenates in a liquid chromatography-electrochemical detection system. J.Chromatogr, 221, 237-47.</p>\n\n<p>Minnema DJ, Travis KZ, Breckenridge CB, Sturgess NC, Butt M, Wolf JC, Zadory D, Beck MJ, Mathews JM, tisdel MO, Cook AR, Botham PA, Smith LL. 2014. Dietary administration of paraquat for 13 weeks does not result in a loss of dopaminergic neurons in the substantia nigra of C57BL/6J mice. (68). 250-8.</p>\n\n<p>O&rsquo;Malley KL. 2010. The role of axonopathy in Parkinson&rsquo;s disease. 2010. Experimental Neurobiology. (19). 115-19.</p>\n\n<p>Orimo S, Amino T, Itoh Y, Takahashi A, Kojo T, Uchihara T, Tsuchiya K, Mori F, Wakabayashi K, Takahashi h. 2005. Cardiac sympathetic denervation precedes neuronal loss in the sympathetic ganglia in Lewy body disease. Acta Neuropathol (109) 583-8.</p>\n\n<p>Ossowska K., Wardas J, Smialowska M, Kuter K, Lenda T, Wieronska JM, Zieba B, Nowak P, Dabrowska J, Bortel A, Kwiecinski A, Wolfarth S. 2005. A slowly developing dysfunction of dopaminergiv nigrostriatal neurons induced by long-term paraquat administration in rats: an animal model of preclinical stages of Parkinso&rsquo;s disease&nbsp;? European Journal of Neurosciences. (22) 1294-04.</p>\n\n<p>Pappolla MA, Shank DL, Alzofon J, Dudley AW.1988. Colloid (hyaline) inclusion bodies in the central nervous system: their presence in the substantia nigra is diagnostic of Parkinson&#39;s disease. Hum. Pathol.19(1):27-1.</p>\n\n<p>Pavese N, Brooks DJ. 2009. Imaging neurodegeneration in parkinson&rsquo;s disease.. Biochimica and Biophysica Acta (1972) 722-9. Pissadaki EK, Bolam JP. 2013. The energy cost of action potential propagation in dopamine neurons: clues to susceptibility in Parkinson&rsquo;s disease. (7) 1-17.</p>\n\n<p>Raff MC, Whitemore AV, Finn JT. 2002. Axonal self-destruction and neurodegeneration. Science (296) 868-1.</p>\n\n<p>Robinson D.1997. Neurobiology. Published by Springer-Verlag. 245-247.</p>\n\n<p>Schapira AHV. 2013. Recent developments in biomarkers in Parkinson disease. Neurology. 26 (4) 395-0.</p>\n\n<p>Shmued LC, Albertson C, Sikker W. 1997. Fluoro-jade: a novel fluorochrome for the sensitive and reliable histochemical localization of neuronal degeneration. Brain research. 751, 37-6.</p>\n\n<p>Shulman JM, DeJager PL, Feany MB. 2011. Parkinson&rsquo;s disease: Genetics and Pathogenesis. Annu.Rev.Pathol.Mech.Dis. 6:193-2.</p>\n\n<p>Switzer RC. 2000. Application of silver degeneration stains for neurotoxicity testing. Toxicologic pathology. 28(1) 70-83.</p>\n\n<p>Thiruchelvam M, Brockel BJ, Richfield EK, Bags RB, Cory-Slechta DA. (2000a). potential and preferential effects of combined paraquat and maneb on nigrostriatal dopamine system: environmental risk factor for Parkinson&rsquo;s disease? Brian research (873) 225-4.</p>\n\n<p>Thiruchelvam M, Richfield EK, Bags RB, tank AW, Cory-Slechta DA. (2000b). The nigrostriatal dopaminergic system as a potential target of repeated exposuresto combined paraquat and maneb: implication for Parkinson&rsquo;s disease. J.neurosci. (20). 9207-4.</p>\n\n<p>Tieu K. 2011. A guide to neurotoxic animal models of Parkinson&#39;s disease.<a href=\"https://www.ncbi.nlm.nih.gov/pubmed/22229125#\" title=\"Cold Spring Harbor perspectives in medicine.\">Cold Spring Harb Perspect Med.</a>&nbsp;2011 Sep;1(1):a009316. doi: 10.1101/cshperspect.a009316.</p>\n\n<p>Tong J, Boileau I, Furukawa Y, Chang LJ, Wilson AA, Houle S, Kish S. 2011. Distribution of vescicular monoamine transporter 2 protein in human brain: implications for brain imaging studies. Journal of cerebral blood flow &amp; metabolism. (31) 20165-5.</p>\n\n<p>Tiller-Borcich JK, Forno LS.(1988) Parkinson&rsquo;s disease and dementia with neuronal inclusions in the cerebral cortex: lewy bodies or Pick bodies. J Neuropathol Exp. Neurol. (5) 526-5.</p>\n\n<p>Zhao Hong-Xia, Mu Hui, Bai Yan-Hong, Hu Yu, Hu Ying-Mei.2011. A rapid method for the determination in porcine muscle by pre-column derivatization and HPLC with fluorescin detection. Journal of pharmaceutical analysis. 1(3); 208-12.</p>\n","biologicalOrganisationLevel":"Organ","organTerm":{},"biologicalEvents":[{"action":"increased","process":"loss of dopaminergic neurons","object":{}}],"id":890}
{"title":"Parkinsonian motor deficits","references":"<p>Alexander GE, Crutcher MD. Functional architecture of basal ganglia circuits: neural substrates of parallel processing. Trends Neurosci. 1990 Jul;13(7):266-71.</p>\n\n<p>Aznavour N, Cendres-Bozzi C, Lemoine L, Buda C, Sastre JP, Mincheva Z, Zimmer L, Lin JS. MPTP animal model of Parkinsonism: dopamine cell death or only tyrosine hydroxylase impairment? A study using PET imaging, autoradiography, and immunohistochemistry in the cat. CNS Neurosci Ther. 2012 Nov;18(11):934-41.</p>\n\n<p>Barnes CD. The basal ganglia in extrapyramidal dysfunction. Brain Res Bull. 1983 Aug;11(2):271-5.</p>\n\n<p>Bernheimer H, Birkmayer W, Hornykiewicz O, Jellinger K, Seitelberger F. Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations. J Neurol Sci. 1973 Dec;20(4):415-55.</p>\n\n<p>Bolam JP, Hanley JJ, Booth PA, Bevan MD. Synaptic organisation of the basal ganglia. J Anat. 2000 May;196 ( Pt 4):527-42. Brain Res. 1998 Apr 27;791(1-2):335-40.</p>\n\n<p>Brooks VB, Stoney SD Jr. Motor mechanisms: the role of the pyramidal system in motor control. Annu Rev Physiol. 1971;33:337-92.</p>\n\n<p>Burns RS, Chiueh CC, Markey SP, Ebert MH, Jacobowitz DM, Kopin IJ. A primate model of parkinsonism: selective destruction of dopaminergic neurons in the pars compacta of the substantia nigra by N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Proc Natl Acad Sci U S A. 1983 Jul;80(14):4546-50.</p>\n\n<p>Crawley JN. Behavioral phenotyping of transgenic and knockout mice: experimental design and evaluation of general health, sensory functions, motor abilities, and specific behavioral tests. Brain Res. 1999 Jul 17;835(1):18-26.</p>\n\n<p>Cui M, Aras R, Christian WV, Rappold PM, Hatwar M, Panza J, Jackson-Lewis V, Javitch JA, Ballatori N, Przedborski S, Tieu K. The organic cation transporter-3 is a pivotal modulator of neurodegeneration in the nigrostriatal dopaminergic pathway. Proc Natl Acad Sci U S A. 2009 May 12;106(19):8043-8.</p>\n\n<p>Dickinson D. 2012. Parkinson&rsquo;s disease and parkinsonism: Neuropathology.Cold Spring Harb Perspect Med. 2:a009258. Fallon JH, Moore RY. Catecholamine innervation of the basal forebrain. IV. Topography of the dopamine projection to the basal forebrain and neostriatum. J Comp Neurol. 1978 Aug 1;180(3):545-80.</p>\n\n<p>Efremova L, Scildknecht S, Adam M, pape R, Gutbier S, Hanf B, Burkle A, Leist M. 2015. Prevention of the degeneration of dopaminergic neurons in an astrocyte co-culture system allowing endogenous drug metabolism. British Journal of Pharmacology; 172; 4119-32</p>\n\n<p>Fujita KA, Ostaszewski M, Matsuoka Y, Ghosh S, Glaab E, Trefois C, Crespo I, Perumal TM, Jurkowski W, Antony PM, Diederich N, Buttini M, Kodama A, Satagopam VP, Eifes S, Del Sol A, Schneider R, Kitano H, Balling R. Integrating pathways of Parkinson&#39;s disease in a molecular interaction map. Mol Neurobiol. 2014 Feb;49(1):88-102</p>\n\n<p>Gerfen CR, Engber TM, Mahan LC, Susel Z, Chase TN, Monsma FJ Jr, Sibley DR. D1 and D2 dopamine receptor-regulated gene expression of striatonigral and striatopallidal neurons. Science. 1990 Dec 7;250(4986):1429-32.</p>\n\n<p>Gonz&aacute;lez RR, Fern&aacute;ndez RF, Vidal JL, Frenich AG, P&eacute;rez ML. Development and validation of an ultra-high performance liquid chromatography-tandem mass-spectrometry (UHPLC-MS/MS) method for the simultaneous determination of neurotransmitters in rat brain samples. J Neurosci Methods. 2011 Jun 15;198(2):187-94.</p>\n\n<p>Heimer G, Rivlin-Etzion M, Bar-Gad I, Goldberg JA, Haber SN, Bergman H. Dopamine replacement therapy does not restore the full spectrum of normal pallidal activity in the 1-methyl-4-phenyl-1,2,3,6-tetra-hydropyridine primate model of Parkinsonism. J Neurosci. 2006 Aug 2;26(31):8101-14.</p>\n\n<p>Irwin JK, 1993, Parkinson&rsquo;s disease: Past, Present and Future. Neuropsycopharmacology. 9(1). 1-1.</p>\n\n<p>Jones BJ, Roberts DJ. The quantiative measurement of motor inco-ordination in naive mice using an acelerating rotarod. J Pharm Pharmacol. 1968 Apr;20(4):302-4.</p>\n\n<p>Klapdor K, Dulfer BG, Hammann A, Van der Staay FJ. A low-cost method to analyse footprint patterns. J Neurosci Methods. 1997 Jul 18;75(1):49-54.</p>\n\n<p>Kolata G. Monkey model of Parkinson&#39;s disease. Science. 1983 May 13;220(4598):705.</p>\n\n<p>Leenders KL, Palmer AJ, Quinn N, Clark JC, Firnau G, Garnett ES, Nahmias C, Jones T, Marsden CD. Brain dopamine metabolism in patients with Parkinson&#39;s disease measured with positron emission tomography. J Neurol Neurosurg Psychiatry. 1986 Aug;49(8):853-60.</p>\n\n<p>Ling H, Kearney S, Yip HL, Silveira-Moriyama L, Revesz T, Holton JL, Strand C, Davey K, Mok KY, Polke JM, Lees AJ. Parkinson&#39;s disease without nigral degeneration: a pathological correlate of scans without evidence of dopaminergic deficit (SWEDD)? J Neurol Neurosurg Psychiatry. 2015 Jul 24. pii: jnnp-2015-310756. doi: 10.1136/jnnp-2015-310756.</p>\n\n<p>Mazzone P. Deep brain stimulation in Parkinson&#39;s disease: bilateral implantation of globus pallidus and subthalamic nucleus. J Neurosurg Sci. 2003 Mar;47(1):47-51.</p>\n\n<p>Minnema DJ, Travis KZ, Breckenridge CB, Sturgess NC, Butt M, Wolf JC, Zadory D, Beck MJ, Mathews JM, tisdel MO, Cook AR, Botham PA, Smith LL. 2014. Dietary administration of paraquat for 13 weeks does not result in a loss of dopaminergic neurons in the substantia nigra of C57BL/6J mice. (68). 250-8.</p>\n\n<p>Mitchell IJ, Clarke CE, Boyce S, Robertson RG, Peggs D, Sambrook MA, Crossman AR. Neural mechanisms underlying parkinsonian symptoms based upon regional uptake of 2-deoxyglucose in monkeys exposed to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Neuroscience. 1989;32(1):213-26.</p>\n\n<p>Morris ED, Babich JW, Alpert NM, Bonab AA, Livni E, Weise S, Hsu H, Christian BT, Madras BK, Fischman AJ. Quantification of dopamine transporter density in monkeys by dynamic PET imaging of multiple injections of 11C-CFT. Synapse. 1996 Nov;24(3):262-72.</p>\n\n<p>Neural mechanisms underlying parkinsonian symptoms based upon regional uptake of 2-deoxyglucose in monkeys exposed to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.</p>\n\n<p>Obeso JA, Rodr&iacute;guez-Oroz MC, Benitez-Temino B, Blesa FJ, Guridi J, Marin C, Rodriguez M. Functional organization of the basal ganglia: therapeutic implications for Parkinson&#39;s disease. Mov Disord. 2008;23 Suppl 3:S548-59.</p>\n\n<p>Odekerken VJ, van Laar T, Staal MJ, Mosch A, Hoffmann CF, Nijssen PC, Beute GN, van Vugt JP, Lenders MW, Contarino MF, Mink MS, Bour LJ, van den Munckhof P, Schmand BA, de Haan RJ, Schuurman PR, de Bie RM. Subthalamic nucleus versus globus pallidus bilateral deep brain stimulation for advanced Parkinson&#39;s disease (NSTAPS study): a randomised controlled trial. Lancet Neurol. 2013 Jan;12(1):37-44.</p>\n\n<p>Ossowska K., Wardas J, Smialowska M, Kuter K, Lenda T, Wieronska JM, Zieba B, Nowak P, Dabrowska J, Bortel A, Kwiecinski A, Wolfarth S. 2005. A slowly developing dysfunction of dopaminergiv nigrostriatal neurons induced by long-term paraquat administration in rats: an animal model of preclinical stagesof Parkinso&rsquo;s disease.</p>\n\n<p>Ovadia A, Zhang Z, Gash DM. 1995. Increased susceptibility to MPTP in middle-aged Rhesus Monkeys. Neurobiology of aging. 16 (6) 931-7</p>\n\n<p>Parent A, Hazrati LN. Functional anatomy of the basal ganglia. I. The cortico-basal ganglia-thalamo-cortical loop. Brain Res Brain Res Rev. 1995 Jan;20(1):91-127.</p>\n\n<p>Ramaker C, Marinus J, Stiggelbout AM, Van Hilten BJ. Systematic evaluation of rating scales for impairment and disability in Parkinson&#39;s disease. Mov Disord. 2002 Sep;17(5):867-76.</p>\n\n<p>Rose S N M, Jackson EA, Gibb WR, Jaehnig P, Jenner P, Marsden CD. 1993. Age-related effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine treatment of common marmosets. Eur J Pharmacol. 230(2).177-85.</p>\n\n<p>Saraswat LD, Holdiness MR, Justice JB, Salamone JD, Neill DB. Determination of dopamine, homovanillic acid and 3,4-dihydroxyphenylacetic acid in rat brain striatum by high-performance liquid chromatography with electrochemical detection. J Chromatogr. 1981 Mar 13;222(3):353-62.</p>\n\n<p>Silverdale MA, Fox SH, Crossman AR, Brotchie JM. Potential nondopaminergic drugs for Parkinson&#39;s disease. Adv Neurol. 2003;91:273-91.</p>\n\n<p>Smith Y, Bennett BD, Bolam JP, Parent A, Sadikot AF. Synaptic relationships between dopaminergic afferents and cortical or thalamic input in the sensorimotor territory of the striatum in monkey. J Comp Neurol. 1994 Jun 1;344(1):1-19.</p>\n\n<p>Smith Y, Kieval JZ. Anatomy of the dopamine system in the basal ganglia. Trends Neurosci. 2000 Oct;23(10 Suppl):S28-33.</p>\n\n<p>Surmeier DJ, Song WJ, Yan Z. Coordinated expression of dopamine receptors in neostriatal medium spiny neurons. J Neurosci. 1996 Oct 15;16(20):6579-91.</p>\n\n<p>Switzer RC. 2000. Application of silver degeneration stains for neurotoxicity testing. Toxicologic pathology. 28(1) 70-83.</p>\n\n<p>Takada M, Tokuno H, Nambu A, Inase M. Corticostriatal input zones from the supplementary motor area overlap those from the contra- rather than ipsilateral primary motor cortex.</p>\n\n<p>Tillerson JL, Caudle WM, Rever&oacute;n ME, Miller GW. Detection of behavioral impairments correlated to neurochemical deficits in mice treated with moderate doses of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Exp Neurol. 2002 Nov;178(1):80-90.</p>\n\n<p>Ungerstedt U, Arbuthnott GW. Quantitative recording of rotational behavior in rats after 6-hydroxy-dopamine lesions of the nigrostriatal dopamine system. Brain Res. 1970 Dec 18;24(3):485-93.</p>\n\n<p>Winogrodzka A, Bergmans P, Booij J, van Royen EA, Stoof JC, Wolters EC. [(123)I]beta-CIT SPECT is a useful method for monitoring dopaminergic degeneration in early stage Parkinson&#39;s disease. J Neurol Neurosurg Psychiatry. 2003 Mar;74(3):294-8.</p>\n\n<p>Yuan H, Zhang ZW, Liang LW, Shen Q, Wang XD, Ren SM, Ma HJ, Jiao SJ, Liu P. Treatment strategies for Parkinson&#39;s disease. Neurosci Bull. 2010 Feb;26(1):66-76.</p>\n","biologicalOrganisationLevel":"Individual","organTerm":{},"biologicalEvents":[{"action":"occurrence","object":{"name":"Parkinsonian disorders","source":"MESH","sourceId":"D020734"}}],"id":896}
{"title":"Increase, Ecdysone receptor agonism","references":"","biologicalOrganisationLevel":"Molecular","organTerm":{},"biologicalEvents":[{"action":"increased","process":"ecdysone receptor-mediated signaling pathway","object":{"name":"ecdysone receptor holocomplex","source":"GO","sourceId":"GO:0008230"}}],"keyEventStressors":["Halofenozide","Methoxyfenozide"],"id":103}
{"title":"Decrease, Circulating ecdysis triggering hormone","references":"","biologicalOrganisationLevel":"Tissue","organTerm":{},"biologicalEvents":[{"action":"decreased","process":"ecdysis-triggering hormone activity","object":{}}],"id":988}
{"title":"Increase, Incomplete ecdysis","references":"","biologicalOrganisationLevel":"Individual","organTerm":{},"biologicalEvents":[{"action":"increased","process":"chitin biosynthetic process","object":{"name":"chitin","source":"CHEBI","sourceId":"CHEBI:17029"}}],"id":990}
{"title":"Decrease, Abdominal muscle contraction","references":"","biologicalOrganisationLevel":"Tissue","organTerm":{"name":"somatic muscle","sourceId":"UBERON:0014895"},"biologicalEvents":[{"action":"increased","process":"muscle contraction","object":{}}],"id":993}
{"title":"Increase, Nuclear receptor E75b gene expression","references":"","biologicalOrganisationLevel":"Molecular","organTerm":{},"biologicalEvents":[{"action":"increased","process":"gene expression","object":{"name":"Eip75B protein, Drosophila","source":"MESH","sourceId":"C061375"}}],"id":1264}
{"title":"Increase, Fushi tarazu factor-1 gene expression","references":"","biologicalOrganisationLevel":"Molecular","organTerm":{},"biologicalEvents":[{"action":"increased","process":"gene expression","object":{"name":"nuclear hormone receptor FTZ-F1 (fruit fly)","source":"PR","sourceId":"PR:P33244"}}],"id":1265}
{"title":"Decrease, Circulating crustacean cardioactive peptide","references":"","biologicalOrganisationLevel":"Tissue","organTerm":{"name":"haemolymphatic fluid","sourceId":"UBERON:0000179"},"biologicalEvents":[{"action":"decreased","process":"peptide secretion","object":{"name":"cardioactive peptide (fruit fly)","source":"PR","sourceId":"PR:Q9VCW0"}}],"id":1266}
{"title":"Decrease, Ecdysis motoneuron bursts","references":"","biologicalOrganisationLevel":"Tissue","organTerm":{"name":"nervous system","sourceId":"UBERON:0001016"},"biologicalEvents":[{"action":"decreased","process":"transmission of nerve impulse","object":{"name":"motor neuron","source":"CL","sourceId":"CL:0000100"}}],"id":1267}
{"title":"Decrease, Excitatory postsynaptic potential","references":"","biologicalOrganisationLevel":"Tissue","organTerm":{"name":"somatic muscle","sourceId":"UBERON:0014895"},"biologicalEvents":[{"action":"decreased","process":"excitatory postsynaptic potential","object":{}}],"id":1268}
{"title":"Increase, Mortality","references":"<p><span style=\"font-size:14px\">Arakawa T, Yukuhiro F, Noda H. 2008. Insecticidal effect of a fungicide containing polyoxin B on the larvae of <em>Bombyx mori</em> (Lepidoptera: Bombycidae), <em>Mamestra brassicae</em>, <em>Mythimna separata</em>, and <em>Spodoptera litura</em> (Lepidoptera: Noctuidae). Appl Entomol Zool. 43(2):173&ndash;181. doi:10.1303/aez.2008.173.</span></p>\n\n<p><span style=\"font-size:14px\">Gijswijt MJ, Deul DH, de Jong BJ. 1979. Inhibition of chitin synthesis by benzoyl-phenylurea insecticides, III. Similarity in action in <em>Pieris brassicae</em> (L.) with Polyoxin D. Pestic Biochem Physiol. 12(1):87&ndash;94. doi:10.1016/0048-3575(79)90098-1.</span></p>\n\n<p><span style=\"font-size:14px\">OECD. 2004. Test No. 202: <em>Daphnia sp.</em> Acute Immobilisation Test. OECD OECD Guidelines for the Testing of Chemicals, Section 2. [accessed 2020 Mar 3]. https://www.oecd-ilibrary.org/environment/test-no-202-daphnia-sp-acute-immobilisation-test_9789264069947-en.</span></p>\n\n<p><span style=\"font-size:14px\">Tellam RL, Vuocolo T, Johnson SE, Jarmey J, Pearson RD. 2000. Insect chitin synthase. cDNA sequence, gene organization and expression. Eur J Biochem. 267(19):6025&ndash;6043. doi:10.1046/j.1432-1327.2000.01679.x.</span></p>\n","biologicalOrganisationLevel":"Individual","organTerm":{},"biologicalEvents":[{"action":"increased","process":"mortality","object":{}}],"keyEventStressors":["Polyoxin D","Nikkomycins"],"id":350}
{"title":"Decreased, PPARalpha transactivation of gene expression","references":"<p>Ahmed, W., Ziouzenkova, O., Brown, J., Devchand, P., Francis, S., Kadakia, M., Kanda, T., Orasanu, G., Sharlach, M., Zandbergen, F., Plutzky, J., 2007. PPARs and their metabolic modulation: new mechanisms for transcriptional regulation? <em>J. Intern. Med.</em> 262, 184-198.</p>\n\n<p>&nbsp;</p>\n\n<p>Desvergne B, Wahli W (1999) Peroxisome proliferator-activated receptors: nuclear control of metabolism. Endocrine Reviews 20(5): 649-688.</p>\n\n<p>&nbsp;</p>\n\n<p>DiRenzo, J., Soderstrom, M., Kurokawa, R., Ogliastro, M.H., Ricote, M., Ingrey, S., Horlein, A., Rosenfeld, M.G., Glass, C.K., 1997. Peroxisome proliferator-activated receptors and retinoic acid receptors differentially control the interactions of retinoid X receptor heterodimers with ligands, coactivators, and corepressors. <em>Mol. Cell. Biol.</em> 17, 2166-2176.</p>\n\n<p>&nbsp;</p>\n\n<p>Evans RM, Barish GD, Wang YX: PPARs and the complex journey to obesity. Nat Med 2004, 10(4):355-361.</p>\n\n<p>&nbsp;</p>\n\n<p>Feige, J.N., Gerber, A., Casals-Casas, C., Yang, Q., Winkler, C., Bedu, E., Bueno, M., Gelman, L., Auwerx, J., Gonzalez, F.J., Desvergne, B., 2010. The pollutant diethylhexyl phthalate regulates hepatic energy metabolism via species-specific PPARalpha-dependent mechanisms. <em>Environ. Health Perspect.</em> 118, 234-241.</p>\n\n<p>&nbsp;</p>\n\n<p>Hihi, A.K., Michalik, L., Wahli, W., 2002. PPARs: transcriptional effectors of fatty acids and their derivatives. <em>Cell Molec Life Sci</em> 59, 790-798.</p>\n\n<p>&nbsp;</p>\n\n<p>Janssen, A.W., Betzel, B., Stoopen, G., Berends, F.J., Janssen, I.M., Peijnenburg, A.A., Kersten, S., 2015. The impact of PPARalpha activation on whole genome gene expression in human precision cut liver slices. <em>BMC Genomics</em> 16, 760.</p>\n\n<p>&nbsp;</p>\n\n<p>Kersten S.&nbsp; 2014. Integrated physiology and systems biology of PPARalpha. Molecular Metabolism 2014, 3(4):354-371.</p>\n\n<p>&nbsp;</p>\n\n<p>Levine, M., Cattoglio, C., Tjian, R., 2014. Looping Back to Leap Forward: Transcription Enters a New Era. <em>Cell</em> 157, 13-25.</p>\n\n<p>&nbsp;</p>\n\n<p>Liu, M.H., Li, J., Shen, P., Husna, B., Tai, E.S., Yong, E.L., 2008. A natural polymorphism in peroxisome proliferator-activated receptor-alpha hinge region attenuates transcription due to defective release of nuclear receptor corepressor from chromatin. <em>Mol. Endocrinol.</em> 22, 1078-1092.</p>\n\n<p>&nbsp;</p>\n\n<p>McMullen, P.D., Bhattacharya, S., Woods, C.G., Sun, B., Yarborough, K., Ross, S.M., Miller, M.E., McBride, M.T., LeCluyse, E.L., Clewell, R.A., Andersen, M.E., 2014. A map of the PPARalpha transcription regulatory network for primary human hepatocytes. <em>Chem. Biol. Interact.</em> 209, 14-24.</p>\n\n<p>&nbsp;</p>\n\n<p>Rakhshandehroo, M., Hooiveld, G., Muller, M., Kersten, S., 2009. Comparative analysis of gene regulation by the transcription factor PPARalpha between mouse and human. <em>PLoS One</em> 4, e6796.</p>\n\n<p>&nbsp;</p>\n\n<p>Wolfrum C, Borrmann CM, Borchers T, Spener F (2001) Fatty acids and hypolipidemic drugs regulate peroxisome proliferator-activated receptors alpha - and gamma-mediated gene expression via liver fatty acid binding protein: a signaling path to the nucleus. Proc Natl Acad Sci USA 98(5):2323-2328.</p>\n\n<p>&nbsp;</p>\n\n<p>Xu HE, Lambert MH, Montana VG, Plunket KD, Moore LB, Collins JL, Oplinger JA, Kliewer SA, Gampe RT, McKee DD<em> et al</em>: Structural determinants of ligand binding selectivity between the peroxisome proliferator-activated receptors. <em>Proceedings of the National Academy of Sciences </em>2001, 98(24):13919-13924.</p>\n\n<p>&nbsp;</p>\n\n<p>Xu HE, Stanley TB, Montana VG, Lambert MH, Shearer BG, Cobb JE, McKee DD, Galardi CM, Plunket KD, Nolte RT<em> et al</em>: Structural basis for antagonist-mediated recruitment of nuclear co-repressors by PPAR[alpha]. <em>Nature </em>2002, 415(6873):813-817.</p>\n\n<p>&nbsp;</p>\n","biologicalOrganisationLevel":"Molecular","organTerm":{},"biologicalEvents":[{"action":"decreased","process":"receptor transactivation","object":{"name":"peroxisome proliferator-activated receptor alpha","source":"PR","sourceId":"PR:000013056"}}],"keyEventStressors":["PPARalpha antagonists"],"id":858}
{"title":"Decreased, Ketogenesis (production of ketone bodies)","references":"<p><a name=\"OLE_LINK160\">Badman MK, Pissios P, Kennedy AR, Koukos G, Flier JS, Maratos-Flier E: Hepatic fibroblast growth factor 21 is regulated by PPARalpha and is a key mediator of hepatic lipid metabolism in ketotic states. <em>Cell metabolism </em>2007, 5(6):426-437.</a></p>\n\n<p>&nbsp;</p>\n\n<p>Cahill Jr., G.F., 2006. Fuel metabolism in starvation. Annual Review of Nutrition 26:1e22.</p>\n\n<p>&nbsp;</p>\n\n<p>Desvergne B, Wahli W (1999) Peroxisome proliferator-activated receptors: nuclear control of metabolism. Endocrine Reviews 20(5): 649-688.</p>\n\n<p>&nbsp;</p>\n\n<p>Evans RM, Barish GD, Wang YX: PPARs and the complex journey to obesity. Nat Med 2004, 10(4):355-361.</p>\n\n<p><a name=\"OLE_LINK208\"></a><a name=\"OLE_LINK207\">&nbsp;</a></p>\n\n<p>Gerich JE, Meyer C, Woerle HJ, Stumvoll M: Renal gluconeogenesis: its importance in human glucose homeostasis. <em>Diabetes Care </em>2001, 24(2):382-391.</p>\n\n<p>&nbsp;</p>\n\n<p>Kersten S.&nbsp; 2014. Integrated physiology and systems biology of PPARalpha. Molecular Metabolism 2014, 3(4):354-371.</p>\n\n<p>&nbsp;</p>\n\n<p>Kersten S, Seydoux J, Peters JM, Gonzalez FJ, Desvergne B, Wahli W: Peroxisome proliferator-activated receptor alpha mediates the adaptive response to fasting. J Clin Invest 1999, 103(11):1489-1498.</p>\n\n<p>&nbsp;</p>\n\n<p>Le May et al., 2000. Reduced hepatic fatty acid oxidation in fasting PPARK null mice is due to impaired mitochondrial hydroxymethylglutaryl-CoA synthase gene expression. FEBS Lett. 475: 163-166.</p>\n\n<p>&nbsp;</p>\n\n<p>Muoio, D.M., MacLean, P.S., Lang, D.B., Li, S., Houmard, J.A., Way, J.M., Winegar, D.A., Corton, J.C., Dohm, G.L., Kraus, W.E., 2002. Fatty acid homeostasis and induction of lipid regulatory genes in skeletal muscles of peroxisome proliferator-activated receptor (PPAR) alpha knock-out mice. Evidence for compensatory regulation by PPAR delta. J. Biol. Chem. 277, 26089-26097.</p>\n\n<p><a name=\"OLE_LINK34\"></a><a name=\"OLE_LINK33\">&nbsp;</a></p>\n\n<p>Owen OE: Ketone bodies as a fuel for the brain during starvation. Biochem Mol Biol Educ 2005, 33(4):246-251.</p>\n\n<p>&nbsp;</p>\n\n<p>Penders J, Fiers T, Giri M, Wuyts B, Ysewyn L, Delanghe JR: Quantitative measurement of ketone bodies in urine using reflectometry. <em>Clin Chem Lab Med </em>2005, 43(7):724-729.</p>\n\n<p>&nbsp;</p>\n\n<p>Potthoff MJ, Inagaki T, Satapati S, Ding X, He T, Goetz R, Mohammadi M, Finck BN, Mangelsdorf DJ,</p>\n\n<p>&nbsp;</p>\n\n<p>Kliewer SA<em> et al</em>: FGF21 induces PGC-1&alpha; and regulates carbohydrate and fatty acid metabolism during the adaptive starvation response. <em>Proceedings of the National Academy of Sciences </em>2009, 106(26):10853-10858.</p>\n\n<p>&nbsp;</p>\n\n<p>Sengupta S, Peterson TR, Laplante M, Oh S, Sabatini DM: mTORC1 controls fasting-induced ketogenesis and its modulation by ageing. <em>Nature </em>2010, 468(7327):1100-1104.</p>\n\n<p>&nbsp;</p>\n\n<p>Williamson DH, Mellanby J, Krebs HA: Enzymic determination of d(&minus;)-&beta;-hydroxybutyric acid and acetoacetic acid in blood. <em>Biochem J </em>1962, 82(1):90-96.</p>\n","biologicalOrganisationLevel":"Cellular","organTerm":{},"biologicalEvents":[{"action":"decreased","process":"ketosis","object":{}}],"keyEventStressors":["PPARalpha antagonists"],"id":861}
{"title":"Not Increased, Circulating Ketone Bodies","references":"<p>Aubert, G., Martin, O.J., Horton, J.L., Lai, L., Vega, R.B., Leone, T.C., Koves, T., Gardell, S.J., Kruger, M., Hoppel, C.L., Lewandowski, E.D., Crawford, P.A., Muoio, D.M., Kelly, D.P., 2016. The Failing Heart Relies on Ketone Bodies as a Fuel. Circulation 133, 698-705.</p>\n\n<p>&nbsp;</p>\n\n<p>Badman MK, Pissios P, Kennedy AR, Koukos G, Flier JS, Maratos-Flier E: Hepatic fibroblast growth factor 21 is regulated by PPARalpha and is a key mediator of hepatic lipid metabolism in ketotic states. <em>Cell metabolism </em>2007, 5(6):426-437.</p>\n\n<p>&nbsp;</p>\n\n<p>Cahill GF, Jr. Fuel metabolism in starvation. <em>Annu Rev Nutr</em> 2006, 26:1-22.</p>\n\n<p>&nbsp;</p>\n\n<p>Desvergne B, Wahli W (1999) Peroxisome proliferator-activated receptors: nuclear control of metabolism. <em>Endocrine Reviews</em> 20(5): 649-688.</p>\n\n<p>&nbsp;</p>\n\n<p>Evans RM, Barish GD, Wang YX: PPARs and the complex journey to obesity. Nat Med 2004, 10(4):355-361.</p>\n\n<p>&nbsp;</p>\n\n<p>Gerich JE, Meyer C, Woerle HJ, Stumvoll M: Renal gluconeogenesis: its importance in human glucose homeostasis. <em>Diabetes Care </em>2001, 24(2):382-391.</p>\n\n<p>&nbsp;</p>\n\n<p>Muoio, D.M., MacLean, P.S., Lang, D.B., Li, S., Houmard, J.A., Way, J.M., Winegar, D.A., Corton, J.C., Dohm, G.L., Kraus, W.E., 2002. Fatty acid homeostasis and induction of lipid regulatory genes in skeletal muscles of peroxisome proliferator-activated receptor (PPAR) alpha knock-out mice. Evidence for compensatory regulation by PPAR delta. J. Biol. Chem. 277, 26089-26097.</p>\n\n<p>&nbsp;</p>\n\n<p>Owen OE: Ketone bodies as a fuel for the brain during starvation. <em>Biochem Mol Biol Educ </em>2005, 33(4):246-251.</p>\n\n<p>&nbsp;</p>\n\n<p>Potthoff MJ, Inagaki T, Satapati S, Ding X, He T, Goetz R, Mohammadi M, Finck BN, Mangelsdorf DJ, Kliewer SA<em> et al</em>: FGF21 induces PGC-1&alpha; and regulates carbohydrate and fatty acid metabolism during the adaptive starvation response. <em>Proceedings of the National Academy of Sciences </em>2009, 106(26):10853-10858.</p>\n\n<p>&nbsp;</p>\n\n<p>Veech RL: The therapeutic implications of ketone bodies: the effects of ketone bodies in pathological conditions: ketosis, ketogenic diet, redox states, insulin resistance, and mitochondrial metabolism. <em>Prostaglandins Leukot Essent Fatty Acids </em>2004, 70(3):309-319.</p>\n\n<p>&nbsp;</p>\n\n<p>Williamson DH, Mellanby J, Krebs HA: Enzymic determination of d(&minus;)-&beta;-hydroxybutyric acid and acetoacetic acid in blood. <em>Biochem J </em>1962, 82(1):90-96.</p>\n\n<p>&nbsp;</p>\n","biologicalOrganisationLevel":"Tissue","organTerm":{"name":"blood","sourceId":"UBERON:0000178"},"biologicalEvents":[{"action":"abnormal","process":"abnormal lipid homeostasis","object":{}},{"action":"abnormal","object":{"name":"ketone body","source":"CHEBI","sourceId":"CHEBI:73693"}}],"id":862}
{"title":"Not Increased, Circulating Ketone Bodies","references":"<p>Aubert, G., Martin, O.J., Horton, J.L., Lai, L., Vega, R.B., Leone, T.C., Koves, T., Gardell, S.J., Kruger, M., Hoppel, C.L., Lewandowski, E.D., Crawford, P.A., Muoio, D.M., Kelly, D.P., 2016. The Failing Heart Relies on Ketone Bodies as a Fuel. Circulation 133, 698-705.</p>\n\n<p>&nbsp;</p>\n\n<p>Badman MK, Pissios P, Kennedy AR, Koukos G, Flier JS, Maratos-Flier E: Hepatic fibroblast growth factor 21 is regulated by PPARalpha and is a key mediator of hepatic lipid metabolism in ketotic states. <em>Cell metabolism </em>2007, 5(6):426-437.</p>\n\n<p>&nbsp;</p>\n\n<p>Cahill GF, Jr. Fuel metabolism in starvation. <em>Annu Rev Nutr</em> 2006, 26:1-22.</p>\n\n<p>&nbsp;</p>\n\n<p>Desvergne B, Wahli W (1999) Peroxisome proliferator-activated receptors: nuclear control of metabolism. <em>Endocrine Reviews</em> 20(5): 649-688.</p>\n\n<p>&nbsp;</p>\n\n<p>Evans RM, Barish GD, Wang YX: PPARs and the complex journey to obesity. Nat Med 2004, 10(4):355-361.</p>\n\n<p>&nbsp;</p>\n\n<p>Gerich JE, Meyer C, Woerle HJ, Stumvoll M: Renal gluconeogenesis: its importance in human glucose homeostasis. <em>Diabetes Care </em>2001, 24(2):382-391.</p>\n\n<p>&nbsp;</p>\n\n<p>Muoio, D.M., MacLean, P.S., Lang, D.B., Li, S., Houmard, J.A., Way, J.M., Winegar, D.A., Corton, J.C., Dohm, G.L., Kraus, W.E., 2002. Fatty acid homeostasis and induction of lipid regulatory genes in skeletal muscles of peroxisome proliferator-activated receptor (PPAR) alpha knock-out mice. Evidence for compensatory regulation by PPAR delta. J. Biol. Chem. 277, 26089-26097.</p>\n\n<p>&nbsp;</p>\n\n<p>Owen OE: Ketone bodies as a fuel for the brain during starvation. <em>Biochem Mol Biol Educ </em>2005, 33(4):246-251.</p>\n\n<p>&nbsp;</p>\n\n<p>Potthoff MJ, Inagaki T, Satapati S, Ding X, He T, Goetz R, Mohammadi M, Finck BN, Mangelsdorf DJ, Kliewer SA<em> et al</em>: FGF21 induces PGC-1&alpha; and regulates carbohydrate and fatty acid metabolism during the adaptive starvation response. <em>Proceedings of the National Academy of Sciences </em>2009, 106(26):10853-10858.</p>\n\n<p>&nbsp;</p>\n\n<p>Veech RL: The therapeutic implications of ketone bodies: the effects of ketone bodies in pathological conditions: ketosis, ketogenic diet, redox states, insulin resistance, and mitochondrial metabolism. <em>Prostaglandins Leukot Essent Fatty Acids </em>2004, 70(3):309-319.</p>\n\n<p>&nbsp;</p>\n\n<p>Williamson DH, Mellanby J, Krebs HA: Enzymic determination of d(&minus;)-&beta;-hydroxybutyric acid and acetoacetic acid in blood. <em>Biochem J </em>1962, 82(1):90-96.</p>\n\n<p>&nbsp;</p>\n","biologicalOrganisationLevel":"Tissue","organTerm":{"name":"blood","sourceId":"UBERON:0000178"},"biologicalEvents":[{"action":"abnormal","process":"abnormal lipid homeostasis","object":{}},{"action":"abnormal","object":{"name":"ketone body","source":"CHEBI","sourceId":"CHEBI:73693"}}],"id":862}
{"title":"Decreased, Body Weight","references":"<p>Badman MK, Pissios P, Kennedy AR, Koukos G, Flier JS, Maratos-Flier E: Hepatic fibroblast growth factor 21 is regulated by PPARalpha and is a key mediator of hepatic lipid metabolism in ketotic states. <em>Cell metabolism </em>2007, 5(6):426-437.</p>\n\n<p>&nbsp;</p>\n\n<p>Cahill GF, Jr.: Fuel metabolism in starvation. Annu Rev Nutr 2006, 26:1-22.</p>\n\n<p>&nbsp;</p>\n\n<p>Deng Y, Meyer SA, Guan X, Escalon BL, Ai J, Wilbanks MS, Welti R, Garcia-Reyero N, Perkins EJ (2011) Analysis of common and specific mechanisms of liver function affected by nitrotoluene compounds. PLoS One 6(2): e14662.</p>\n\n<p><a name=\"OLE_LINK4\"></a><a name=\"OLE_LINK3\">&nbsp;</a></p>\n\n<p>Desvergne B, Wahli W (1999) Peroxisome proliferator-activated receptors: nuclear control of metabolism. Endocrine Reviews 20(5): 649-688.</p>\n\n<p>Evans RM, Barish GD, Wang YX: PPARs and the complex journey to obesity. Nat Med 2004, 10(4):355-361.</p>\n\n<p><a name=\"OLE_LINK2\"></a><a name=\"OLE_LINK1\">&nbsp;</a></p>\n\n<p>Kersten S.&nbsp; 2014. Integrated physiology and systems biology of PPARalpha. Molecular Metabolism 2014, 3(4):354-371.</p>\n\n<p>&nbsp;</p>\n\n<p>Kersten S, Seydoux J, Peters JM, Gonzalez FJ, Desvergne B, Wahli W: Peroxisome proliferator-activated receptor alpha mediates the adaptive response to fasting. J Clin Invest 1999, 103(11):1489-1498.</p>\n\n<p><a name=\"OLE_LINK190\"></a><a name=\"OLE_LINK189\">&nbsp;</a></p>\n\n<p>Martin TE: Food as a limit on breeding birds: a life-history perspective. <em>Annu Rev Ecol Syst </em>1987:453-487.</p>\n\n<p>&nbsp;</p>\n\n<p>Nisbet R, Muller E, Lika K, Kooijman S: From molecules to ecosystems through dynamic energy budget models. <em>J Anim Ecol </em>2000, 69(6):913-926.</p>\n\n<p>&nbsp;</p>\n\n<p>Quinn MJ Jr, Bazar MA, McFarland CA, Perkins EJ, Gust KA, Gogal Jr RM, Johnson MS (2007) Effects of subchronic exposure to 2,6-dinitrotoluene in the northern bobwhite (Colinus virginianus). Environmental Toxicology and Chemistry 26(10):2202-2207.</p>\n\n<p>&nbsp;</p>\n\n<p>Rawat A, Gust KA, Deng Y, Garcia-Reyero N, Quinn MJ, Jr., Johnson MS, Indest KJ, Elasri MO, Perkins EJ (2010) From raw materials to validated system: the construction of a genomic library and microarray to interpret systemic perturbations in Northern bobwhite. Physiological Genomics 42(2):219-235.</p>\n\n<p>&nbsp;</p>\n\n<p>Sanderson, L.M., Boekschoten, M.V., Desvergne, B., Muller, M., Kersten, S., 2010. Transcriptional profiling reveals divergent roles of PPARalpha and PPARbeta/delta in regulation of gene expression in mouse liver. Physiological Genomics 41:42e52.</p>\n\n<p>&nbsp;</p>\n\n<p>Wang YX: PPARs: diverse regulators in energy metabolism and metabolic diseases. Cell Res 2010, 20(2):124-137.</p>\n\n<p>&nbsp;</p>\n\n<p>Wilbanks, M., Gust, K.A., Atwa, S., Sunesara, I., Johnson, D., Ang, C.Y., Meyer., S.A., and Perkins, E.J. 2014. Validation of a genomics-based hypothetical adverse outcome pathway: 2,4-dinitrotoluene perturbs PPAR signaling thus impairing energy metabolism and exercise endurance. Toxicological Sciences. 141(1):44-58.</p>\n","biologicalOrganisationLevel":"Individual","organTerm":{},"biologicalEvents":[{"action":"decreased","process":"weight loss","object":{}}],"id":864}
{"title":"Increased, Catabolism of Muscle Protein","references":"<p>Cahill GF, Jr. Fuel metabolism in starvation. <em>Annu Rev Nutr</em> 2006, 26:1-22.</p>\n\n<p><a name=\"OLE_LINK136\"></a><a name=\"OLE_LINK135\">&nbsp;</a></p>\n\n<p>Felig P, Pozefsky T, Marliss E, Cahill GF, Jr.: Alanine: key role in gluconeogenesis. <em>Science </em>1970A, 167(3920):1003-1004.</p>\n\n<p><a name=\"OLE_LINK224\"></a><a name=\"OLE_LINK223\">&nbsp;</a></p>\n\n<p>Felig P, Marliss E, Pozefsky T, Cahill GF, Jr.: Amino acid metabolism in the regulation of gluconeogenesis in man. <em>Am J Clin Nutr </em>1970B, 23(7):986-992.</p>\n\n<p><a name=\"OLE_LINK182\"></a><a name=\"OLE_LINK181\">&nbsp;</a></p>\n\n<p>Goodman AD, Fuisz RE, Cahill GF: Renal gluconeogenesis in acidosis, alkalosis, and potassium deficiency: its possible role in regulation of renal ammonia production. <em>J Clin Invest</em> 1966, 45(4):612-619.</p>\n\n<p><a name=\"OLE_LINK138\"></a><a name=\"OLE_LINK137\">&nbsp;</a></p>\n\n<p>Kashiwaya Y, Sato K, Tsuchiya N, Thomas S, Fell DA, Veech RL, Passonneau JV: Control of glucose utilization in working perfused rat heart. <em>J Biol Chem </em>1994, 269(41):25502-25514.</p>\n\n<p><a name=\"OLE_LINK184\"></a><a name=\"OLE_LINK183\">&nbsp;</a></p>\n\n<p>Marliss EB, Aoki TT, Pozefsky T, Most AS, Cahill GF: Muscle and splanchnic glutamine and glutamate metabolism in postabsorptive and starved man. <em>J Clin Invest </em>1971, 50(4):814-817.</p>\n\n<p>&nbsp;</p>\n\n<p>Muoio, D.M., MacLean, P.S., Lang, D.B., Li, S., Houmard, J.A., Way, J.M., Winegar, D.A., Corton, J.C., Dohm, G.L., Kraus, W.E., 2002. Fatty acid homeostasis and induction of lipid regulatory genes in skeletal muscles of peroxisome proliferator-activated receptor (PPAR) alpha knock-out mice. Evidence for compensatory regulation by PPAR delta. J. Biol. Chem. 277, 26089-26097.</p>\n","biologicalOrganisationLevel":"Organ","organTerm":{"name":"musculoskeletal system","sourceId":"UBERON:0002204"},"biologicalEvents":[{"action":"increased","process":"protein catabolic process","object":{"name":"muscle protein","source":"MESH","sourceId":"D009124"}}],"id":863}
{"title":"Binding of antagonist, PPAR alpha","references":"<p>Nagy L, Kao H-Y, Love JD, Li C, Banayo E, Gooch JT, Krishna V, Chatterjee K, Evans RM, Schwabe JWR: Mechanism of corepressor binding and release from nuclear hormone receptors. Genes Dev 1999, 13(24):3209-3216.</p>\n\n<p>Xu HE, Lambert MH, Montana VG, Plunket KD, Moore LB, Collins JL, Oplinger JA, Kliewer SA, Gampe RT, McKee DD et al: Structural determinants of ligand binding selectivity between the peroxisome proliferator-activated receptors. Proceedings of the National Academy of Sciences 2001, 98(24):13919-13924.</p>\n\n<p><span style=\"font-family:calibri,sans-serif; font-size:11.0pt\">Wilbanks, M., Gust, K.A., Atwa, S., Sunesara, I., Johnson, D., Ang, C.Y., Meyer., S.A., and Perkins, E.J. 2014. Validation of a genomics-based hypothetical adverse outcome pathway: 2,4-dinitrotoluene perturbs PPAR signaling thus impairing energy metabolism and exercise endurance. Toxicological Sciences. 141(1):44-58. </span></p>\n\n<p>Willson TM, Brown PJ, Sternbach DD, Henke BR: The PPARs:&thinsp; From Orphan Receptors to Drug Discovery. J Med Chem 2000, 43(4):527-550.</p>\n\n<p>Xu HE, Stanley TB, Montana VG, Lambert MH, Shearer BG, Cobb JE, McKee DD, Galardi CM, Plunket KD, Nolte RT et al: Structural basis for antagonist-mediated recruitment of nuclear co-repressors by PPAR[alpha]. Nature 2002, 415(6873):813-817.</p>\n","biologicalOrganisationLevel":"Molecular","organTerm":{},"biologicalEvents":[{"action":"increased","process":"receptor antagonist activity","object":{"name":"peroxisome proliferator-activated receptor alpha","source":"PR","sourceId":"PR:000013056"}}],"keyEventStressors":["GW6471"],"id":998}
{"title":"stabilization, PPAR alpha co-repressor","references":"<p>Chan, E., Tan, C.S., Deurenberg-Yap, M., Chia, K.S., Chew, S.K., Tai, E.S., 2006. The V227A polymorphism at the PPAR&alpha; locus is associated with serum lipid concentrations and modulates the association between dietary polyunsaturated fatty acid intake and serum high density lipoprotein concentrations in Chinese women. <em>Atherosclerosis</em> 187, 309-315.</p>\n\n<p>&nbsp;</p>\n\n<p>Gust KA, Nanduri B, Rawat A, Wilbanks MS, Ang CY, Johnson DR, Pendarvis K, Chen X, Quinn Jr. MJ, Johnson MS, Burgess SC, Perkins EJ. 2015. Systems Toxicology Identifies Mechanistic Impacts of 2-amino-4,6-dinitrotoluene (2A-DNT) Exposure in Northern Bobwhite. BMC Genomics. 16:587 &nbsp;doi:10.1186/s12864-015-1798-4.</p>\n\n<p>&nbsp;</p>\n\n<p>Liu, M.H., Li, J., Shen, P., Husna, B., Tai, E.S., Yong, E.L., 2008. A natural polymorphism in peroxisome proliferator-activated receptor-alpha hinge region attenuates transcription due to defective release of nuclear receptor corepressor from chromatin. <em>Mol. Endocrinol</em>. 22, 1078-1092.</p>\n\n<p>&nbsp;</p>\n\n<p>Nagy L, Kao H-Y, Love JD, Li C, Banayo E, Gooch JT, Krishna V, Chatterjee K, Evans RM, Schwabe JWR: Mechanism of corepressor binding and release from nuclear hormone receptors. <em>Genes Dev </em>1999, 13(24):3209-3216.</p>\n\n<p>&nbsp;</p>\n\n<p>Wilbanks, M., Gust, K.A., Atwa, S., Sunesara, I., Johnson, D., Ang, C.Y., Meyer., S.A., and Perkins, E.J. 2014. Validation of a genomics-based hypothetical adverse outcome pathway: 2,4-dinitrotoluene perturbs PPAR signaling thus impairing energy metabolism and exercise endurance. Toxicological Sciences. 141(1):44-58.</p>\n\n<p>&nbsp;</p>\n\n<p>Xu HE, Lambert MH, Montana VG, Plunket KD, Moore LB, Collins JL, Oplinger JA, Kliewer SA, Gampe RT, McKee DD<em> et al</em>: Structural determinants of ligand binding selectivity between the peroxisome proliferator-activated receptors. <em>Proceedings of the National Academy of Sciences </em>2001, 98(24):13919-13924.</p>\n\n<p>&nbsp;</p>\n\n<p>Xu HE, Stanley TB, Montana VG, Lambert MH, Shearer BG, Cobb JE, McKee DD, Galardi CM, Plunket KD, Nolte RT<em> et al</em>: Structural basis for antagonist-mediated recruitment of nuclear co-repressors by PPAR[alpha]. <em>Nature </em>2002, 415(6873):813-817.</p>\n\n<p>&nbsp;</p>\n","biologicalOrganisationLevel":"Molecular","organTerm":{},"biologicalEvents":[{"action":"increased","process":"transcription corepressor activity","object":{"name":"nuclear receptor corepressor 2","source":"PR","sourceId":"PR:000011048"}},{"action":"increased","process":"transcription corepressor activity","object":{"name":"nuclear receptor corepressor 1","source":"PR","sourceId":"PR:000011047"}}],"keyEventStressors":["GW6471"],"id":1000}
{"title":"stabilization, PPAR alpha co-repressor","references":"<p>Chan, E., Tan, C.S., Deurenberg-Yap, M., Chia, K.S., Chew, S.K., Tai, E.S., 2006. The V227A polymorphism at the PPAR&alpha; locus is associated with serum lipid concentrations and modulates the association between dietary polyunsaturated fatty acid intake and serum high density lipoprotein concentrations in Chinese women. <em>Atherosclerosis</em> 187, 309-315.</p>\n\n<p>&nbsp;</p>\n\n<p>Gust KA, Nanduri B, Rawat A, Wilbanks MS, Ang CY, Johnson DR, Pendarvis K, Chen X, Quinn Jr. MJ, Johnson MS, Burgess SC, Perkins EJ. 2015. Systems Toxicology Identifies Mechanistic Impacts of 2-amino-4,6-dinitrotoluene (2A-DNT) Exposure in Northern Bobwhite. BMC Genomics. 16:587 &nbsp;doi:10.1186/s12864-015-1798-4.</p>\n\n<p>&nbsp;</p>\n\n<p>Liu, M.H., Li, J., Shen, P., Husna, B., Tai, E.S., Yong, E.L., 2008. A natural polymorphism in peroxisome proliferator-activated receptor-alpha hinge region attenuates transcription due to defective release of nuclear receptor corepressor from chromatin. <em>Mol. Endocrinol</em>. 22, 1078-1092.</p>\n\n<p>&nbsp;</p>\n\n<p>Nagy L, Kao H-Y, Love JD, Li C, Banayo E, Gooch JT, Krishna V, Chatterjee K, Evans RM, Schwabe JWR: Mechanism of corepressor binding and release from nuclear hormone receptors. <em>Genes Dev </em>1999, 13(24):3209-3216.</p>\n\n<p>&nbsp;</p>\n\n<p>Wilbanks, M., Gust, K.A., Atwa, S., Sunesara, I., Johnson, D., Ang, C.Y., Meyer., S.A., and Perkins, E.J. 2014. Validation of a genomics-based hypothetical adverse outcome pathway: 2,4-dinitrotoluene perturbs PPAR signaling thus impairing energy metabolism and exercise endurance. Toxicological Sciences. 141(1):44-58.</p>\n\n<p>&nbsp;</p>\n\n<p>Xu HE, Lambert MH, Montana VG, Plunket KD, Moore LB, Collins JL, Oplinger JA, Kliewer SA, Gampe RT, McKee DD<em> et al</em>: Structural determinants of ligand binding selectivity between the peroxisome proliferator-activated receptors. <em>Proceedings of the National Academy of Sciences </em>2001, 98(24):13919-13924.</p>\n\n<p>&nbsp;</p>\n\n<p>Xu HE, Stanley TB, Montana VG, Lambert MH, Shearer BG, Cobb JE, McKee DD, Galardi CM, Plunket KD, Nolte RT<em> et al</em>: Structural basis for antagonist-mediated recruitment of nuclear co-repressors by PPAR[alpha]. <em>Nature </em>2002, 415(6873):813-817.</p>\n\n<p>&nbsp;</p>\n","biologicalOrganisationLevel":"Molecular","organTerm":{},"biologicalEvents":[{"action":"increased","process":"transcription corepressor activity","object":{"name":"nuclear receptor corepressor 2","source":"PR","sourceId":"PR:000011048"}},{"action":"increased","process":"transcription corepressor activity","object":{"name":"nuclear receptor corepressor 1","source":"PR","sourceId":"PR:000011047"}}],"keyEventStressors":["GW6471"],"id":1000}
{"title":"Fatty Acid Beta Oxidation, Decreased","references":"<p>Aoyama, T., Peters, J.M., Iritani, N., Nakajima, T., Furihata, K., Hashimoto, T., et al., 1998. Altered constitutive expression of fatty acid-metabolizing enzymes in mice lacking the peroxisome proliferator-activated receptor alpha (PPARalpha). Journal of Biological Chemistry 273:5678e5684.</p>\n\n<p>&nbsp;</p>\n\n<p>Brandt, J.M., Djouadi, F., Kelly, D.P., 1998. Fatty acids activate transcription of the muscle carnitine palmitoyltransferase I gene in cardiac myocytes via the peroxisome proliferator-activated receptor alpha. Journal of Biological Chemistry 273:23786e23792.</p>\n\n<p>&nbsp;</p>\n\n<p>Cheung, C., Akiyama, T.E., Ward, J.M., Nicol, C.J., Feigenbaum, L., Vinson, C., Gonzalez, F.J., 2004. Diminished hepatocellular proliferation in mice humanized for the nuclear receptor peroxisome proliferator-activated receptor alpha. Cancer Res. 64, 3849-3854.</p>\n\n<p>&nbsp;</p>\n\n<p>Desvergne B, Wahli W (1999) Peroxisome proliferator-activated receptors: nuclear control of metabolism. Endocrine Reviews 20(5): 649-688.</p>\n\n<p>&nbsp;</p>\n\n<p>Gulick, T., Cresci, S., Caira, T., Moore, D.D., Kelly, D.P., 1994. The peroxisome proliferator-activated receptor regulates mitochondrial fatty acid oxidative enzyme gene expression. Proceedings of the National Academy of Sciences of the United States of America 91:11012e11016.</p>\n\n<p>&nbsp;</p>\n\n<p>Harrington, W.W., C, S.B., J, G.W., N, O.M., J, G.B., D, C.L., W, R.O., M, C.L., D, M.I., 2007. The Effect of PPARalpha, PPARdelta, PPARgamma, and PPARpan Agonists on Body Weight, Body Mass, and Serum Lipid Profiles in Diet-Induced Obese AKR/J Mice. PPAR research 2007, 97125.</p>\n\n<p>&nbsp;</p>\n\n<p>Kersten S.&nbsp; 2014. Integrated physiology and systems biology of PPAR&alpha;. Molecular Metabolism 2014, 3(4):354-371.</p>\n\n<p>&nbsp;</p>\n\n<p>Lazarow PB: Rat liver peroxisomes catalyze the beta oxidation of fatty acids. J Biol Chem 1978, 253(5):1522-1528.</p>\n\n<p>&nbsp;</p>\n\n<p>Mannaerts GP, Van Veldhoven PP 1993 Metabolic role of mammalian peroxisomes. In: Gibson G, Lake B (eds) Peroxisomes: Biology and Importance in Toxicology and Medicine. Taylor &amp; Francis, London, pp 19&ndash;62.</p>\n\n<p>&nbsp;</p>\n\n<p>Mascaro, C., Acosta, E., Ortiz, J.A., Marrero, P.F., Hegardt, F.G., Haro, D., 1998. Control of human muscle-type carnitine palmitoyltransferase I gene transcription by peroxisome proliferator-activated receptor. Journal of Biological Chemistry 273:8560e8563.</p>\n\n<p>&nbsp;</p>\n\n<p>Muoio, D.M., MacLean, P.S., Lang, D.B., Li, S., Houmard, J.A., Way, J.M., Winegar, D.A., Corton, J.C., Dohm, G.L., Kraus, W.E., 2002. Fatty acid homeostasis and induction of lipid regulatory genes in skeletal muscles of peroxisome proliferator-activated receptor (PPAR) alpha knock-out mice. Evidence for compensatory regulation by PPAR delta. J. Biol. Chem. 277, 26089-26097.</p>\n\n<p>&nbsp;</p>\n\n<p>Nelson DL, Cox MM 2000A.&nbsp; The Citric Acid Cycle. <em>Lehninger Principles of Biochemistry</em>. 3<sup>rd</sup> Edition.&nbsp; Worth Publishers.&nbsp; New York, NY. p567-592.</p>\n\n<p>&nbsp;</p>\n\n<p>Nelson DL, Cox MM 2000B.&nbsp; Carbohydrate Biosynthesis. <em>Lehninger Principles of Biochemistry</em>. 3<sup>rd</sup> Edition.&nbsp; Worth Publishers.&nbsp; New York, NY. p722-764.</p>\n\n<p>&nbsp;</p>\n\n<p>Nelson DL, Cox MM 2000C.&nbsp; Lipid Biosynthesis. <em>Lehninger Principles of Biochemistry</em>. 3<sup>rd</sup> Edition.&nbsp; Worth Publishers.&nbsp; New York, NY. p770-814.</p>\n\n<p>&nbsp;</p>\n\n<p>Rakhshandehroo, M., Hooiveld, G., Muller, M., Kersten, S., 2009. Comparative analysis of gene regulation by the transcription factor PPARalpha between mouse and human. <em>PLoS One</em> 4, e6796.</p>\n\n<p>&nbsp;</p>\n\n<p>Sanderson, L.M., de Groot, P.J., Hooiveld, G.J., Koppen, A., Kalkhoven, E., Muller, M., et al., 2008. Effect of synthetic dietary triglycerides: a novel research paradigm for nutrigenomics. PLoS One 3:e1681.</p>\n","biologicalOrganisationLevel":"Molecular","organTerm":{},"biologicalEvents":[{"action":"decreased","process":"fatty acid beta-oxidation","object":{}}],"keyEventStressors":["PPARalpha antagonists"],"id":1528}
{"title":"Reduction, Plasma 17beta-estradiol concentrations","references":"<ul>\n\t<li>Jensen K, Korte J, Kahl M, Pasha M, Ankley G. 2001. Aspects of basic reproductive biology and endocrinology in the fathead minnow (Pimephales promelas). Comparative Biochemistry and Physiology Part C 128: 127-141.</li>\n\t<li>Baker ME. 2011. Origin and diversification of steroids: co-evolution of enzymes and nuclear receptors. Molecular and cellular endocrinology 334(1-2): 14-20.</li>\n\t<li>Owen LJ, Wu FC, Keevil BG. 2014. A rapid direct assay for the routine measurement of oestradiol and oestrone by liquid chromatography tandem mass spectrometry. Ann. Clin. Biochem. 51(pt 3):360-367.</li>\n\t<li>Gorelick DA, Halpern ME. Visualization of estrogen receptor transcriptional activation in zebrafish. Endocrinology. 2011 Jul;152(7):2690-703. doi: 10.1210/en.2010-1257. Epub 2011 May 3. PubMed PMID: 21540282</li>\n</ul>\n","biologicalOrganisationLevel":"Organ","organTerm":{"name":"blood plasma","sourceId":"UBERON:0001969"},"biologicalEvents":[{"action":"decreased","object":{"name":"17beta-estradiol","source":"CHEBI","sourceId":"CHEBI:16469"}}],"id":219}
{"title":"Reduction, 17beta-estradiol synthesis by ovarian granulosa cells","references":"<ul>\n\t<li>Ankley GT, Jensen KM, Kahl MD, Makynen EA, Blake LS, Greene KJ, et al. 2007. Ketoconazole in the fathead minnow (Pimephales promelas): reproductive toxicity and biological compensation. Environ Toxicol Chem 26(6): 1214-1223.</li>\n\t<li>Baker ME. 2011. Origin and diversification of steroids: co-evolution of enzymes and nuclear receptors. Molecular and cellular endocrinology 334(1-2): 14-20.</li>\n\t<li>EURL ECVAM Method Summary no 92. Granulosa and Theca Cell Culture Systems - Summary</li>\n\t<li>EURL ECVAM Protocol no 92 Culture of Human Cumulus Granulosa Cells. Primary cell culture method. Contact Person: Dr. Mahadevan Maha M.</li>\n\t<li>Havelock JC, Rainey WE, Carr BR. 2004. Ovarian granulosa cell lines. Molecular and cellular endocrinology 228(1-2): 67-78.</li>\n\t<li>Jensen K, Korte J, Kahl M, Pasha M, Ankley G. 2001. Aspects of basic reproductive biology and endocrinology in the fathead minnow (Pimephales promelas). Comparative Biochemistry and Physiology Part C 128: 127-141.</li>\n\t<li>McMaster ME MK, Jardine JJ, Robinson RD, Van Der Kraak GJ. 1995. Protocol for measuring in vitro steroid production by fish gonadal tissue. Canadian Technical Report of Fisheries and Aquatic Sciences 1961 1961: 1-78.</li>\n\t<li>Norris DO. 2007. Vertebrate Endocrinology. Fourth ed. New York: Academic Press.</li>\n\t<li>OECD (2011), Test No. 456: H295R Steroidogenesis Assay, OECD Guidelines for the Testing of Chemicals, Section 4, OECD Publishing, Paris.DOI: <a href=\"http://dx.doi.org/10.1787/9789264122642-en\" target=\"_blank\">http://dx.doi.org/10.1787/9789264122642-en</a></li>\n\t<li>Owen LJ, Wu FC, Keevil BG. 2014. A rapid direct assay for the routine measurement of oestradiol and oestrone by liquid chromatography tandem mass spectrometry. Ann. Clin. Biochem. 51(pt 3):360-367.</li>\n\t<li>Villeneuve DL, Ankley GT, Makynen EA, Blake LS, Greene KJ, Higley EB, et al. 2007. Comparison of fathead minnow ovary explant and H295R cell-based steroidogenesis assays for identifying endocrine-active chemicals. Ecotoxicol Environ Saf 68(1): 20-32.</li>\n\t<li>Villeneuve DL, Mueller ND, Martinovic D, Makynen EA, Kahl MD, Jensen KM, et al. 2009. Direct effects, compensation, and recovery in female fathead minnows exposed to a model aromatase inhibitor. Environ Health Perspect 117(4): 624-631.</li>\n\t<li>Yaron Z. 1995. Endocrine control of gametogenesis and spawning induction in the carp. Aquaculture 129: 49-73.</li>\n</ul>\n","biologicalOrganisationLevel":"Cellular","organTerm":{},"biologicalEvents":[{"action":"decreased","process":"estrogen biosynthetic process","object":{"name":"17beta-estradiol","source":"CHEBI","sourceId":"CHEBI:16469"}}],"id":3}
{"title":"impaired, Fertility","references":"","biologicalOrganisationLevel":"Individual","organTerm":{},"biologicalEvents":[{"action":"decreased","process":"fertility","object":{}}],"id":406}
{"title":"irregularities, ovarian cycle","references":"<p>Byers, S. L., Wiles, M. V, Dunn, S. L., &amp; Taft, R. A. (2012). Mouse estrous cycle identification tool and images. PloS One, 7(4), e35538. doi:10.1371/journal.pone.0035538\n</p><p>Cortvrindt, R. G., &amp; Smitz, J. E. J. (2002). Follicle culture in reproductive toxicology: a tool for in-vitro testing of ovarian function? Human Reproduction Update, 8(3), 24354.\n</p><p>Davis, B. J., Maronpot, R. R., &amp; Heindel, J. J. (1994). Di-(2-ethylhexyl) phthalate suppresses estradiol and ovulation in cycling rats. Toxicology and Applied Pharmacology, 128(2), 21623. doi:10.1006/taap.1994.1200\n</p><p>Goldman, J. M., Murr, A. S., &amp; Cooper, R. L. (2007). The rodent estrous cycle: characterization of vaginal cytology and its utility in toxicological studies. Birth Defects Research. Part B, Developmental and Reproductive Toxicology, 80(2), 8497. doi:10.1002/bdrb.20106\n</p><p>OECD. (2008). No 43: Guidance document on mammalian reproductive toxicity testing and assessment.\n</p><p>Rasier, G., Toppari, J., Parent, A.-S., &amp; Bourguignon, J.-P. (2006). Female sexual maturation and reproduction after prepubertal exposure to estrogens and endocrine disrupting chemicals: a review of rodent and human data. Molecular and Cellular Endocrinology, 254-255, 187201. doi:10.1016/j.mce.2006.04.002\n</p><p>Ryan, K. J. (1982). Biochemistry of aromatase: significance to female reproductive physiology. Cancer Research, 42(8 Suppl), 3342s3344s.\n</p><p>Stefansdottir, A., Fowler, P. A., Powles-Glover, N., Anderson, R. A., &amp; Spears, N. (2014). Use of ovary culture techniques in reproductive toxicology. Reproductive Toxicology (Elmsford, N.Y.), 49C, 117135. doi:10.1016/j.reprotox.2014.08.001\n</p><p>Test No. 407: Repeated Dose 28-day Oral Toxicity Study in Rodents. (2008). OECD Publishing. doi:10.1787/9789264070684-en\n</p><p>Test No. 416: Two-Generation Reproduction Toxicity. (2001). OECD Publishing. doi:10.1787/9789264070868-en\n</p><p>Test No. 443: Extended One-Generation Reproductive Toxicity Study. (2012). OECD Publishing. doi:10.1787/9789264185371-en\n</p><p>Westwood, F. R. (2008). The female rat reproductive cycle: a practical histological guide to staging. Toxicologic Pathology, 36(3), 37584. doi:10.1177/0192623308315665\n</p>","biologicalOrganisationLevel":"Individual","organTerm":{},"biologicalEvents":[{"action":"disrupted","process":"ovulation cycle","object":{}}],"id":405}
{"title":"reduction in ovarian granulosa cells, Aromatase (Cyp19a1)","references":"<p>Bulun, S. E., Lin, Z., Imir, G., Amin, S., Demura, M., Yilmaz, B., &hellip; Deb, S. (2005). Regulation of aromatase expression in estrogen-responsive breast and uterine disease: from bench to treatment. Pharmacological Reviews, 57(3), 359&ndash;83. doi:10.1124/pr.57.3.6</p>\n\n<p>Hillier, S. G. (1985). Sex steroid metabolism and follicular development in the ovary. Oxford Reviews of Reproductive Biology, 7, 168&ndash;222.</p>\n\n<p>Ryan, K. J. (1982). Biochemistry of aromatase: significance to female reproductive physiology. Cancer Research, 42(8 Suppl), 3342s&ndash;3344s.</p>\n\n<p>Simpson, E. R. (2004). Aromatase: biologic relevance of tissue-specific expression. Seminars in Reproductive Medicine, 22(1), 11&ndash;23. doi:10.1055/s-2004-823023</p>\n\n<p>Simpson, E. R., Clyne, C., Rubin, G., Boon, W. C., Robertson, K., Britt, K., &hellip; Jones, M. (2002). Aromatase--a brief overview. Annual Review of Physiology, 64, 93&ndash;127. doi:10.1146/annurev.physiol.64.081601.142703</p>\n\n<p>Simpson, E. R., Mahendroo, M. S., Means, G. D., Kilgore, M. W., Hinshelwood, M. M., Graham-Lorence, S., &hellip; Michael, M. D. (1994). Aromatase cytochrome P450, the enzyme responsible for estrogen biosynthesis. Endocrine Reviews, 15(3), 342&ndash;55. doi:10.1210/edrv-15-3-342</p>\n\n<p>Stocco, C. (2008). Aromatase expression in the ovary: hormonal and molecular regulation. Steroids, 73(5), 473&ndash;87. doi:10.1016/j.steroids.2008.01.017</p>\n","biologicalOrganisationLevel":"Cellular","organTerm":{},"biologicalEvents":[{"action":"decreased","process":"aromatase activity","object":{"name":"aromatase","source":"PR","sourceId":"PR:000006100"}},{"action":"decreased","process":"mRNA transcription","object":{"name":"aromatase","source":"PR","sourceId":"PR:000006100"}}],"id":408}
{"title":"reduction in ovarian granulosa cells, Aromatase (Cyp19a1)","references":"<p>Bulun, S. E., Lin, Z., Imir, G., Amin, S., Demura, M., Yilmaz, B., &hellip; Deb, S. (2005). Regulation of aromatase expression in estrogen-responsive breast and uterine disease: from bench to treatment. Pharmacological Reviews, 57(3), 359&ndash;83. doi:10.1124/pr.57.3.6</p>\n\n<p>Hillier, S. G. (1985). Sex steroid metabolism and follicular development in the ovary. Oxford Reviews of Reproductive Biology, 7, 168&ndash;222.</p>\n\n<p>Ryan, K. J. (1982). Biochemistry of aromatase: significance to female reproductive physiology. Cancer Research, 42(8 Suppl), 3342s&ndash;3344s.</p>\n\n<p>Simpson, E. R. (2004). Aromatase: biologic relevance of tissue-specific expression. Seminars in Reproductive Medicine, 22(1), 11&ndash;23. doi:10.1055/s-2004-823023</p>\n\n<p>Simpson, E. R., Clyne, C., Rubin, G., Boon, W. C., Robertson, K., Britt, K., &hellip; Jones, M. (2002). Aromatase--a brief overview. Annual Review of Physiology, 64, 93&ndash;127. doi:10.1146/annurev.physiol.64.081601.142703</p>\n\n<p>Simpson, E. R., Mahendroo, M. S., Means, G. D., Kilgore, M. W., Hinshelwood, M. M., Graham-Lorence, S., &hellip; Michael, M. D. (1994). Aromatase cytochrome P450, the enzyme responsible for estrogen biosynthesis. Endocrine Reviews, 15(3), 342&ndash;55. doi:10.1210/edrv-15-3-342</p>\n\n<p>Stocco, C. (2008). Aromatase expression in the ovary: hormonal and molecular regulation. Steroids, 73(5), 473&ndash;87. doi:10.1016/j.steroids.2008.01.017</p>\n","biologicalOrganisationLevel":"Cellular","organTerm":{},"biologicalEvents":[{"action":"decreased","process":"aromatase activity","object":{"name":"aromatase","source":"PR","sourceId":"PR:000006100"}},{"action":"decreased","process":"mRNA transcription","object":{"name":"aromatase","source":"PR","sourceId":"PR:000006100"}}],"id":408}
{"title":"Activation, Pregnane-X receptor, NR1l2","references":"","biologicalOrganisationLevel":"Molecular","organTerm":{},"biologicalEvents":[{"action":"increased","process":"signaling","object":{"name":"nuclear receptor subfamily 1 group I member 2","source":"PR","sourceId":"PR:000011397"}},{"action":"increased","process":"signaling","object":{"name":"nuclear receptor subfamily 1 group I member 3","source":"PR","sourceId":"PR:000011398"}}],"id":239}
{"title":"Activation, Pregnane-X receptor, NR1l2","references":"","biologicalOrganisationLevel":"Molecular","organTerm":{},"biologicalEvents":[{"action":"increased","process":"signaling","object":{"name":"nuclear receptor subfamily 1 group I member 2","source":"PR","sourceId":"PR:000011397"}},{"action":"increased","process":"signaling","object":{"name":"nuclear receptor subfamily 1 group I member 3","source":"PR","sourceId":"PR:000011398"}}],"id":239}
{"title":"Loss, Cochlear function","references":"","biologicalOrganisationLevel":"Organ","organTerm":{"name":"ear","sourceId":"UBERON:0001690"},"biologicalEvents":[{"action":"increased","process":"cochlear degeneration","object":{}}],"id":319}
{"title":"Thyroxine (T4) in neuronal tissue, Decreased ","references":"<p>Bansal R, You SH, Herzig CT, Zoeller RT (2005). Maternal thyroid hormone increases HES expression in the fetal rat brain: an effect mimicked by exposure to a mixture of polychlorinated biphenyls (PCBs). Brain Res Dev Brain Res 156:13-22.</p>\n\n<p>Bates JM, St Germain DL, Galton VA. Expression profiles of the three iodothyronine deiodinases, D1, D2, and D3, in the developing rat. Endocrinology. 1999 Feb;140(2):844-51.</p>\n\n<p>Bernal J. (2013). Thyroid Hormones in Brain Development and Function. &nbsp;In: De Groot LJ, Chrousos G, Dungan K, Feingold KR, Grossman A, Hershman JM, Koch C, Korbonits M, McLachlan R, New M, Purnell J, Rebar R, Singer F, Vinik A, editors. Endotext [Internet]. South Dartmouth (MA): MDText.com, Inc.; 2000-2015.&nbsp;www.thyroidmanager.org</p>\n\n<p>Calvo R, Obreg&oacute;n MJ, Ruiz de O&ntilde;a C, Escobar del Rey F, Morreale de Escobar G. (1990). Congenital hypothyroidism, as studied in rats. Crucial role of maternal thyroxine but not of 3,5,3&prime;-triiodothyronine in the protection of the fetal brain. J. Clin. Invest. 86:889-899.</p>\n\n<p>Chatonnet F., Picou F., Fauquier T., and Flamant F., (2011). Thyroid Hormone Action in Cerebellum and Cerebral Cortex Development, Journal of Thyroid Research, Volume 2011, Article ID 145762, 8 pages http://dx.doi.org/10.4061/2011/145762)</p>\n\n<p>Denver, RJ 1998 The molecular basis of thyroid hormone-dependent central nervous system remodeling during amphibian metamorphosis. Comparative Biochemistry and Physiology Part C: Pharmacology, Toxicology and Endocrinology, 119:219-228.</p>\n\n<p>Donzelli R, Colligiani D, Kusmic C, Sabatini M, Lorenzini L, Accorroni A, Nannipieri M, Saba A, Iervasi G, Zucchi R. Effect of Hypothyroidism and Hyperthyroidism on Tissue Thyroid Hormone Concentrations in Rat. Eur Thyroid J. 2016 Mar;5(1):27-34.</p>\n\n<p>Friesema EC, Jansen J, Milici C, Visser TJ (2005) Thyroid hormone transporters. Vitam Horm 70:137-167.</p>\n\n<p>Galton VH 1983 Thyroid hormone action in amphibian metamorphosis. In: Oppenheimer JH, Samuels HH (eds) Molecular Basis of Thyroid Hormone Action. Academic Press, New York, pp 445&ndash;483.</p>\n\n<p>Gilbert ME, Hedge JM, Valentin-Blasini L, Blount BC, Kannan K, Tietge J, Zoeller RT, Crofton KM, Jarrett JM, Fisher JW (2013) An animal model of marginal iodine deficiency during development: the thyroid axis and neurodevelopmental outcome. Toxicol Sci 132:177-195.</p>\n\n<p>Grijota-Martinez C, Diez D, Morreale de Escobar G, Bernal J, Morte B. (2011). Lack of action of exogenously administered T3 on the fetal rat brain despite expression of the monocarboxylate transporter 8. Endocrinology. 152:1713-1721.</p>\n\n<p>Guadano-Ferraz A, Obregon MJ, St Germain DL, Bernal J. (1997). The type 2 iodothyronine deiodinase is expressed primarily in glial cells in the neonatal rat brain. Proc Natl Acad Sci USA. 94: 10391&ndash;10396.</p>\n\n<p>Hennemann G, Docter R, Friesema EC, de Jong M, Krenning EP, Visser TJ. (2001). Plasma membrane transport of thyroid hormones and its role in thyroid hormone metabolism and bioavailability. Endocr Rev. 22:451-476.</p>\n\n<p>Hernandez A, Quignodon L, Martinez ME, Flamant F, St Germain DL. Type 3 deiodinase deficiency causes spatial and temporal alterations in brain T3 signaling that are dissociated from serum thyroid hormone levels. Endocrinology. 2010 Nov;151(11):5550-8.</p>\n\n<p>Heuer H. (2007). The importance of thyroid hormone transporters for brain development and function. Best Pract Res Clin Endocrinol Metab. 21:265&ndash;276.</p>\n\n<p>Heuer H, Maier MK, Iden S, Mittag J, Friesema EC, Visser TJ, Bauer K. (2005). The monocarboxylate transporter 8 linked to human psychomotor retardation is highly expressed in thyroid hormone-sensitive neuron populations. Endocrinology 146:1701&ndash;1706.</p>\n\n<p>Jansen J, Friesema EC, Kester MH, Milici C, Reeser M, Gruters A, Barrett TG, Mancilla EE, Svensson J, Wemeau JL, Busi da Silva Canalli MH, Lundgren J, McEntagart ME, Hopper N, Arts WF, Visser TJ (2007) Functional analysis of monocarboxylate transporter 8 mutations identified in patients with X-linked psychomotor retardation and elevated serum triiodothyronine. J Clin Endocrinol Metab 92:2378-2381.</p>\n\n<p>Kester MH, Martinez de Mena R, Obregon MJ, Marinkovic D, Howatson A, Visser TJ, Hume R, Morreale de Escobar G. (2004). Iodothyronine levels in the human developing brain: major regulatory roles of iodothyronine deiodinases in different areas. J Clin Endocrinol Metab 89:3117&ndash;3128.</p>\n\n<p>Mayer S, M&uuml;ller J, Bauer R, Richert S, Kassmann CM, Darras VM, Buder K, Boelen A, Visser TJ, Heuer H. Transporters MCT8 and OATP1C1 maintain murine brain thyroid hormone homeostasis. J Clin Invest. 2014 May 1;124(5):1987-99.</p>\n\n<p>Moog N.K., Entringer S., Heim Ch., Wadhwa PD., Kathmann N., Buss C. (2017). Influence of maternal thyroid hormones during gestation on fetal&nbsp; brain development. Neuroscience, 2017, 342: 68&ndash;100. doi:10.1016/j.neuroscience.2015.09.0</p>\n\n<p>Morse DC, Wehler EK, Wesseling W, Koeman JH, Brouwer A. Alterations in rat brain thyroid hormone status following pre- and postnatal exposure to polychlorinated biphenyls (Aroclor 1254). Toxicol Appl Pharmacol. 1996 Feb;136(2):269-79</p>\n\n<p>M&uuml;ller J, Heuer H. Expression pattern of thyroid hormone transporters in the postnatal mouse brain. Front Endocrinol (Lausanne). 2014 Jun 18:5:92.</p>\n\n<p>Obregon MJ, Mallol J, Escobar del Rey F, Morreale de Escobar G. (1981). Presence of l-thyroxine and 3,5,3-triiodo-l-thyronine in tissues from thyroidectomised rats. Endocrinology 109:908-913.</p>\n\n<p>Power DM, Llewellyn L, Faustino M, Nowell MA, Bj&ouml;rnsson BT, Einarsdottir IE, Canario AV, Sweeney GE. Thyroid hormones in growth and development of fish. Comp Biochem Physiol C Toxicol Pharmacol. 2001 Dec;130(4):447-59.</p>\n\n<p>Ruiz de O&ntilde;a C, Obreg&oacute;n MJ, Escobar del Rey F, Morreale de Escobar G. Developmental changes in rat brain 5&#39;-deiodinase and thyroid hormones during the fetal period: the effects of fetal hypothyroidism and maternal thyroid hormones. Pediatr Res. 1988 Nov;24(5):588-94.</p>\n\n<p>Simon R, Tietge JE, Michalke B, Degitz S, Schramm KW. Iodine species and the endocrine system: thyroid hormone levels in adult Danio rerio and developing Xenopus laevis. Anal Bioanal Chem. 2002 Feb;372(3):481-5.</p>\n\n<p>St Germain DL, Galton VA, Hernandez A. (2009). Minireview: Defining the roles of the iodothyronine deiodinases: current concepts and challenges. Endocrinology. 150:1097-107.</p>\n\n<p>Sugiyama D, Kusuhara H, Taniguchi H, Ishikawa S, Nozaki Y, Aburatani H, Sugiyama Y. (2003). Functional characterization of rat brain-specific organic anion transporter (Oatp14) at the blood&ndash;brain barrier: high affinity transporter for thyroxine. J Biol Chem. 278:43489&ndash;43495.</p>\n\n<p>Tietge JE, Butterworth BC, Haselman JT, Holcombe GW, Hornung MW, Korte JJ, Kosian PA, Wolfe M, Degitz SJ. Early temporal effects of three thyroid hormone synthesis inhibitors in Xenopus laevis. Aquat Toxicol. 2010 Jun 1;98(1):44-50.</p>\n\n<p>Tohyama K, Kusuhara H, Sugiyama Y. (2004). Involvement of multispecific organic anion transporter, Oatp14 (Slc21a14), in the transport of thyroxine across the blood-brain barrier. Endocrinology. 145: 4384&ndash;4391.</p>\n\n<p>Tu HM, Legradi G, Bartha T, Salvatore D, Lechan RM, Larsen PR. (1999). Regional expression of the type 3 iodothyronine deiodinase messenger ribonucleic acid in the rat central nervous system and its regulation by thyroid hormone. Endocrinology. 140: 784&ndash;790.</p>\n\n<p>Van Herck SL, Geysens S, Delbaere J, Darras VM. Regulators of thyroid hormone availability and action in embryonic chicken brain development. Gen Comp Endocrinol. 2013.190:96-104.</p>\n\n<p>Visser EW, Visser TJ. (2012). Finding the way into the brain without MCT8. J Clin Enodcrinol Metab. 97:4362-4365.</p>\n\n<p>Visser WE, Friesema EC, Jansen J, Visser TJ. (2007). Thyroid hormone transport by monocarboxylate transporters. Best Pract Res Clin Endocrinol Metab. 21:223&ndash;236.</p>\n\n<p>Wang, D. and Stapleton, HM. (2010) Analysis of thyroid hormones in serum by liquid chromatography -tandem mass spectrometry. Anal Bioanal Chem. 2010 Jul; 397(5): 1831&ndash;1839</p>\n","biologicalOrganisationLevel":"Organ","organTerm":{"name":"brain","sourceId":"UBERON:0000955"},"biologicalEvents":[{"action":"decreased","process":"regulation of hormone levels","object":{"name":"thyroxine","source":"CHEBI","sourceId":"CHEBI:30660"}}],"keyEventStressors":["Methimazole","Propylthiouracil"],"id":280}
{"title":" Thyroxine (T4) in serum, Decreased","references":"<p>Axelrad DA, Baetcke K, Dockins C, Griffiths CW, Hill RN, Murphy PA, Owens N, Simon NB, Teuschler LK. Risk assessment for benefits analysis: framework for analysis of a thyroid-disrupting chemical. J Toxicol Environ Health A. 2005 68(11-12):837-55.</p>\n\n<p>Baret A. and Fert V.&nbsp; T4 and ultrasensitive TSH immunoassays using luminescent enhanced xanthine oxidase assay. J Biolumin Chemilumin. 1989. 4(1):149-153</p>\n\n<p>Bartalena L, Robbins J. Thyroid hormone transport proteins. Clin Lab Med. 1993 Sep;13(3):583-98. Bassett JH, Harvey CB, Williams GR. (2003). Mechanisms of thyroid hormone receptor-specific nuclear and extra nuclear actions. Mol Cell Endocrinol. 213:1-11.</p>\n\n<p>Capen CC. Mechanistic data and risk assessment of selected toxic end points of the thyroid gland. Toxicol Pathol. 1997 25(1):39-48.</p>\n\n<p>Cope RB, Kacew S, Dourson M. A reproductive, developmental and neurobehavioral study following oral exposure of tetrabromobisphenol A on Sprague-Dawley rats. Toxicology. 2015 329:49-59.</p>\n\n<p>Corcoran JM, Eastman CJ, Carter JN, Lazarus L. (1977). Circulating thyroid hormone levels in children. Arch Dis Child. 52: 716-720.</p>\n\n<p>Crofton KM. Developmental disruption of thyroid hormone: correlations with hearing dysfunction in rats. Risk Anal. 2004 Dec;24(6):1665-71.</p>\n\n<p>DeVito M, Biegel L, Brouwer A, Brown S, Brucker-Davis F, Cheek AO, Christensen R, Colborn T, Cooke P, Crissman J, Crofton K, Doerge D, Gray E, Hauser P, Hurley P, Kohn M, Lazar J, McMaster S, McClain M, McConnell E, Meier C, Miller R, Tietge J, Tyl R. (1999). Screening methods for thyroid hormone disruptors. Environ Health Perspect. 107:407-415.</p>\n\n<p>D&ouml;hler KD, Wong CC, von zur M&uuml;hlen A (1979).&nbsp;&nbsp; The rat as model for the study of drug effects on thyroid function: consideration of methodological problems.&nbsp; Pharmacol Ther B. 5:305-18.</p>\n\n<p>Eales JG. (1997). Iodine metabolism and thyroid related functions in organisms lacking thyroid follicles: Are thyroid hormones also vitaminsProc Soc Exp Biol Med. 214:302-317.</p>\n\n<p>Furlow JD, Neff ES. (2006). A developmental switch induced by thyroid hormone: Xenopus laevis metamorphosis. Trends Endocrinol Metab. 17:40&ndash;47.</p>\n\n<p>Goldey ES, Crofton KM. Thyroxine replacement attenuates hypothyroxinemia, hearing loss, and motor deficits following developmental exposure to Aroclor 1254 in rats. Toxicol Sci. 1998 45(1):94-10</p>\n\n<p>Goldey ES, Kehn LS, Lau C, Rehnberg GL, Crofton KM.&nbsp; Developmental exposure to polychlorinated biphenyls (Aroclor 1254) reduces circulating thyroid hormone concentrations and causes hearing deficits in rats. Tox Appl Pharmacol. 1995 135(1):77-88.</p>\n\n<p>Harris AR, Fang SL, Prosky J, Braverman LE, Vagenakis AG.&nbsp; Decreased outer ring monodeiodination of thyroxine and reverse triiodothyronine in the fetal and neonatal rat.&nbsp; Endocrinology. 1978 Dec;103(6):2216-22</p>\n\n<p>Heyland A, Hodin J. (2004). Heterochronic developmental shift caused by thyroid hormone in larval sand dollars and its implications for phenotypic plasticity and the evolution of non-feeding development. Evolution. 58: 524-538.</p>\n\n<p>Heyland A, Moroz LL. (2005). Cross-kingdom hormonal signaling: an insight from thyroid hormone functions in marine larvae. J Exp Biol. 208:4355-4361.</p>\n\n<p>&nbsp;Hill RN, Crisp TM, Hurley PM, Rosenthal SL, Singh DV. Risk assessment of thyroid follicular cell tumors.&nbsp; Environ Health Perspect. 1998 Aug;106(8):447-57.</p>\n\n<p>Hornung MW, Kosian P, Haselman J, Korte J, Challis K, Macherla C, Nevalainen E, Degitz S (2015) In vitro, ex vivo and in vivo determination of thyroid hormone modulating activity of benzothiazoles. Toxicol Sci 146:254-264.</p>\n\n<p>Hulbert AJ. Thyroid hormones and their effects: a new perspective. Biol Rev Camb Philos Soc. 2000 Nov;75(4):519-631. Review.</p>\n\n<p>Kapelari K, Kirchlechner C,&nbsp;H&ouml;gler W,&nbsp;Schweitzer K,&nbsp;Virgolini I,&nbsp;Moncayo R. 2008. Pediatric reference intervals for thyroid hormone levels from birth to adulthood: a retrospective study. BMC Endocr Disord. 8: 15.</p>\n\n<p>Lau C, Thibodeaux JR, Hanson RG, Rogers JM, Grey BE, Stanton ME, Butenhoff JL, Stevenson LA.&nbsp; Exposure to perfluorooctane sulfonate during pregnancy in rat and mouse. II: postnatal evaluation.&nbsp; Toxicol Sci. 2003 Aug;74(2):382-92.</p>\n\n<p>Leloup, J., and M. Buscaglia. La triiodothyronine: hormone de la m&eacute;tamorphose des amphibiens. CR Acad Sci 284 (1977): 2261-2263.</p>\n\n<p>Liu J, Liu Y, Barter RA, Klaassen CD.: Alteration of thyroid homeostasis by UDP-glucuronosyltransferase inducers in rats: a dose-response study. J Pharmacol Exp Ther 273, 977-85, 1994</p>\n\n<p>Manzon RG, Youson JH. (1997). The effects of exogenous thyroxine (T4) or triiodothyronine (T3), in the presence and absence of potassium perchlorate, on the incidence of metamorphosis and on serum T4 and T3 concentrations in larval sea lampreys (Petromyzon marinus L.). Gen Comp Endocrinol. 106:211-220.&nbsp;</p>\n\n<p>McClain RM. Mechanistic considerations for the relevance of animal data on thyroid neoplasia to human risk assessment. Mutat Res. 1995 Dec;333(1-2):131-42</p>\n\n<p>Miller MD, Crofton KM, Rice DC, Zoeller RT.&nbsp; Thyroid-disrupting chemicals: interpreting upstream biomarkers of adverse outcomes. Environ Health Perspect. 2009 117(7):1033-41</p>\n\n<p>Morse DC, Wehler EK, Wesseling W, Koeman JH, Brouwer A. Alterations in rat brain thyroid hormone status following pre- and postnatal exposure to polychlorinated biphenyls (Aroclor 1254). Toxicol Appl Pharmacol. 1996 Feb;136(2):269-79.</p>\n\n<p>NTP National Toxicology Program.: NTP toxicology and carcinogenesis studies of 3,3&#39;-dimethylbenzidine dihydrochloride (CAS no. 612-82-8) in F344/N rats (drinking water studies). Natl Toxicol Program Tech Rep Ser 390, 1-238, 1991.</p>\n\n<p>O&#39;Connor, J. C., J. C. Cook, et al. (1998). &quot;An ongoing validation of a Tier I screening battery for detecting endocrine-active compounds (EACs).&quot; Toxicol Sci 46(1): 45-60.</p>\n\n<p>O&#39;Connor, J. C., L. G. Davis, et al. (2000). &quot;Detection of dopaminergic modulators in a tier I screening battery for identifying endocrine-active compounds (EACs).&quot; Reprod Toxicol 14(3): 193-205.</p>\n\n<p>Rathmann D, Rijntjes E, Lietzow J, K&ouml;hrle J. (2015) Quantitative Analysis of Thyroid Hormone Metabolites in Cell Culture Samples Using LC-MS/MS. Eur Thyroid J. Sep;4(Suppl 1):51-8.</p>\n\n<p>Rouaze-Romet M, Savu L, Vranckx R, Bleiberg-Daniel F, Le Moullac B, Gouache P, Nunez EA. 1992. Reexpression of thyroxine-binding globulin in postweaning rats during protein or energy malnutrition. Acta Endocrinol (Copenh).127:441-448.</p>\n\n<p>Samanidou VF, Kourti PV. (2009) Rapid HPLC method for the simultaneous monitoring of duloxetine, venlaflaxine, fluoxetine and paroxetine in biofluids. Bioanalysis. 2009 Aug;1(5):905-17.</p>\n\n<p>Savu L, Vranckx R, Maya M, Gripois D, Blouquit MF, Nunez EA. 1989. Thyroxine-binding globulin and thyroxinebinding prealbumin in hypothyroid and hyperthyroid developing rats. BiochimBiophys Acta. 992:379-384.</p>\n\n<p>Schneider S, Kaufmann W, Strauss V, van Ravenzwaay B.&nbsp;&nbsp;&nbsp; Vinclozolin: a feasibility and sensitivity study of the ILSI-HESI F1-extended one-generation rat reproduction protocol. Regul Toxicol Pharmacol. 2011 Feb;59(1):91-100.</p>\n\n<p>Schussler, G.C. (2000). The thyroxine-binding proteins. Thyroid 10:141&ndash;149.</p>\n\n<p>Spencer, CA. (2013). Assay of thyroid hormone and related substances. In De Groot, LJ et al. (Eds). Endotext. South Dartmouth, MA</p>\n\n<p>Sternberg RM, Thoemke KR, Korte JJ, Moen SM, Olson JM, Korte L, Tietge JE, Degitz SJ Jr. Control of pituitary thyroid-stimulating hormone synthesis and secretion by thyroid hormones during Xenopus metamorphosis. Gen Comp Endocrinol. 2011. 173(3):428-37</p>\n\n<p>Taurog A. 2005. Hormone synthesis. In: Werner and Ingbar&rsquo;s The Thyroid: A Fundamental and Clinical Text (Braverman LE, Utiger RD, eds). Philadelphia:Lippincott, Williams and Wilkins, 47&ndash;81Walker P, Dubois JD, Dussault JH.&nbsp; Free thyroid hormone concentrations during postnatal development in the rat.&nbsp; Pediatr Res. 1980 Mar;14(3):247-9.</p>\n\n<p><a href=\"https://www.ncbi.nlm.nih.gov/pubmed/?term=Thienpont%20B%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=21800831\">Thienpont B</a>, <a href=\"https://www.ncbi.nlm.nih.gov/pubmed/?term=Tingaud-Sequeira%20A%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=21800831\">Tingaud-Sequeira A</a>, <a href=\"https://www.ncbi.nlm.nih.gov/pubmed/?term=Prats%20E%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=21800831\">Prats E</a>, <a href=\"https://www.ncbi.nlm.nih.gov/pubmed/?term=Barata%20C%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=21800831\">Barata C</a>, <a href=\"https://www.ncbi.nlm.nih.gov/pubmed/?term=Babin%20PJ%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=21800831\">Babin PJ</a>, <a href=\"https://www.ncbi.nlm.nih.gov/pubmed/?term=Rald%C3%BAa%20D%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=21800831\">Rald&uacute;a D</a>. Zebrafish eleutheroembryos provide a suitable vertebrate model for screening chemicals that impair thyroid hormone synthesis. <a href=\"https://www.ncbi.nlm.nih.gov/pubmed/21800831\" title=\"Environmental science &amp; technology.\">Environ Sci Technol.</a> 2011 Sep 1;45(17):7525-32.</p>\n\n<p>Yamauchi K1, Ishihara A. Evolutionary changes to transthyretin: developmentally regulated and tissue-specific gene expression. FEBS J. 2009. 276(19):5357-66.</p>\n\n<p>Yaoita Y, Brown DD. (1990). A correlation of thyroid hormone receptor gene expression with amphibian metamorphosis. Genes Dev. 4:1917-1924.</p>\n\n<p>Yen PM. (2001). Physiological and molecular basis of thyroid hormone action. Physiol Rev. 81:1097-1142.</p>\n\n<p>Zoeller, R. T., R. Bansal, et al. (2005). &quot;Bisphenol-A, an environmental contaminant that acts as a thyroid hormone receptor antagonist in vitro, increases serum thyroxine, and alters RC3/neurogranin expression in the developing rat brain.&quot; Endocrinology 146(2): 607-612.</p>\n\n<p>Zoeller RT, Tan SW, Tyl RW. General background on the hypothalamic-pituitary-thyroid (HPT) axis. Crit Rev Toxicol. 2007 Jan-Feb;37(1-2):11-53</p>\n","biologicalOrganisationLevel":"Tissue","organTerm":{"name":"serum","sourceId":"UBERON:0001977"},"biologicalEvents":[{"action":"decreased","process":"abnormal circulating thyroxine level","object":{"name":"thyroxine","source":"CHEBI","sourceId":"CHEBI:30660"}}],"keyEventStressors":["Methimazole","Propylthiouracil"],"id":281}
{"title":"Induction, Upregulation of glucuronyltransferase activity","references":"","biologicalOrganisationLevel":"Molecular","organTerm":{},"biologicalEvents":[{"action":"increased","process":"glucuronosyltransferase activity","object":{"name":"beta-1,3-glucuronyltransferase","source":"PR","sourceId":"PR:000001325"}},{"action":"increased","process":"catalytic activity","object":{"name":"beta-1,3-glucuronyltransferase","source":"PR","sourceId":"PR:000001325"}}],"id":295}
{"title":"Induction, Upregulation of glucuronyltransferase activity","references":"","biologicalOrganisationLevel":"Molecular","organTerm":{},"biologicalEvents":[{"action":"increased","process":"glucuronosyltransferase activity","object":{"name":"beta-1,3-glucuronyltransferase","source":"PR","sourceId":"PR:000001325"}},{"action":"increased","process":"catalytic activity","object":{"name":"beta-1,3-glucuronyltransferase","source":"PR","sourceId":"PR:000001325"}}],"id":295}
{"title":"Increase, Biliary excretion TH glucuronide","references":"","biologicalOrganisationLevel":"Organ","organTerm":{"name":"biliary system","sourceId":"UBERON:0002294"},"biologicalEvents":[{"action":"increased","process":"excretion","object":{"name":"Tetrahydroaldosterone-3-glucuronide","source":"CHEBI","sourceId":"CHEBI:88728"}}],"id":401}
{"title":"Hippocampal anatomy, Altered ","references":"<p>Altman J, Bayer SA. Migration and distribution of two populations of hippocampal granule cell precursors during the perinatal and postnatal periods. J Comp Neurol. 1990a Nov 15;301(3):365-81.</p>\n\n<p>Altman J, Bayer SA. Prolonged sojourn of developing pyramidal cells in the intermediate zone of the hippocampus and their settling in the stratum pyramidale. J Comp Neurol. 1990b Nov 15;301(3):343-64.</p>\n\n<p>Amaral D, Lavenex P (2006). &quot;Ch 3. Hippocampal Neuroanatomy&quot;. In Andersen P, Morris R, Amaral D, Bliss T, O&#39;Keefe J. The Hippocampus Book. Oxford University Press. ISBN 978-0-19-510027-3.</p>\n\n<p>Garman RH, Fix AS, Jortner BS, Jensen KF, Hardisty JF, Claudio L, Ferenc S. Methods to identify and characterize developmental neurotoxicity for human health risk assessment. II: neuropathology. Environ Health Perspect. 2001 Mar;109 Suppl 1:93-100.</p>\n\n<p>Hasegawa M, Kida I, Wada H.&nbsp; A volumetric analysis of the brain and hippocampus of rats rendered perinatal hypothyroid. Neurosci Lett. 2010 Aug 2;479(3):240-4.</p>\n\n<p>Hevner RF. Layer-specific markers as probes for neuron type identity in human neocortex and malformations of cortical development. J Neuropathol Exp Neurol. 2007 66(2):101-9.</p>\n\n<p>Kier, EL, Kim, JH, Fulbright, K, Bronen, RA. Embryology of the human fetal hippocampus: MR imaging, anatomy, and histology. AJNR Am J Neuroradiol: 1997, 18(3);525-32.</p>\n\n<p>Mechelli A, Price C, Friston K, Ashburner J (2005) Voxel-Based Morphometry of the Human Brain: Methods and Applications. Curr Med Imaging Rev 1:105-113.</p>\n\n<p>OECD. 2007. OECD guidelines for the testing of chemicals/ section 4: Health effects. Test no. 426: Developmental neurotoxicity study. http://www.oecd.org/dataoecd/20/52/37622194.</p>\n\n<p>Pirko I, Fricke ST, Johnson AJ, Rodriguez M, Macura SI. Magnetic resonance imaging, microscopy, and spectroscopy of the central nervous system in experimental animals. NeuroRx. 2005 Apr;2(2):250-64.</p>\n\n<p>Pirko I, Johnson AJ. Neuroimaging of demyelination and remyelination models. Curr Top Microbiol Immunol. 2008; 318:241-66.</p>\n\n<p>Powell MH, Nguyen HV, Gilbert M, Parekh M, Colon-Perez LM, Mareci TH, Montie E. Magnetic resonance imaging and volumetric analysis: novel tools to study the effects of thyroid hormone disruption on white matter development. Neurotoxicology. 2012 Oct;33(5):1322-9.</p>\n\n<p>U.S.EPA. 1998. Health effects guidelines OPPTS 870.6300 developmental neurotoxicity study. EPA Document 712-C-98-239.Office of Prevention Pesticides and Toxic Substances.</p>\n\n<p>Utsunomiya, H., K Takano, M Okazaki, A Mitsudome Development of the temporal lobe in infants and children: analysis by MR-based volumetry. AJNR Am J Neuroradiol: 1999, 20(4);717-23.</p>\n\n<p>West MJ (1990). &quot;Stereological studies of the hippocampus: a comparison of the hippocampal subdivisions of diverse species including hedgehogs, laboratory rodents, wild mice and men&quot;. Progress in Brain Research. Progress in Brain Research 83: 13&ndash;36.</p>\n\n<p>Zgraggen E, Boitard M, Roman I, Kanemitsu M, Potter G, Salmon P, Vutskits L, Dayer AG, Kiss JZ. Early postnatal migration and development of layer II pyramidal neurons in the rodent cingulate/retrosplenial cortex. Cereb Cortex. 2012 Jan;22(1):144-57.&nbsp;</p>\n\n<p>&nbsp;</p>\n","biologicalOrganisationLevel":"Tissue","organTerm":{"name":"brain","sourceId":"UBERON:0000955"},"biologicalEvents":[{"action":"morphological change","process":"brain development","object":{"name":"hippocampal formation","source":"UBERON","sourceId":"UBERON:0002421"}}],"keyEventStressors":["Methimazole","Propylthiouracil"],"id":757}
{"title":"Hippocampal Physiology, Altered","references":"<p>Bekenstein JW, Lothman EW. An in vivo study of the ontogeny of long-term potentiation (LTP) in the CA1 region and in the dentate gyrus of the rat hippocampal formation. Brain Res Dev Brain Res. 1991 Nov 19;63(1-2):245-</p>\n\n<p>Bramham CR, Messaoudi E (2005) BDNF function in adult synaptic plasticity: the synaptic consolidation hypothesis. Prog Neurobiol 76:99-125.</p>\n\n<p>Clapp WC, Hamm JP, Kirk IJ, Teyler TJ. Translating long-term potentiation from animals to humans: a novel method for noninvasive assessment of cortical plasticity. Biol Psychiatry. 2012 Mar 15;71(6):496-502.</p>\n\n<p>Gilbert, M.E. and Burdette, L.J. (1995). Hippocampal Field Potentials: A Model System to Characterize Neurotoxicity. In Neurotoxicology: Approaches and Methods. L.W Chang and W. Slikker (Eds). Academic Press:New York, 183-204.</p>\n\n<p>Gilbert ME, Mack CM. Chronic lead exposure accelerates decay of long-term potentiation in rat dentate gyrus in vivo. Brain Res. 1998 Apr 6;789(1):139-49.</p>\n\n<p>Harris KM, Teyler TJ. Developmental onset of long-term potentiation in area CA1 of the rat hippocampus. J Physiol. 1984. 346:27-48.</p>\n\n<p>Kandell, E., Schwartz, J., Siegelbaum, A. and Hudspeth, A.J.&nbsp; (2012) Principles of Neural Science, 5<sup>th</sup> Edition. &nbsp;Elsevier, North Holland.</p>\n\n<p>Kutsarova E, Munz M, Ruthazer ES.&nbsp; Rules for Shaping Neural Connections in the Developing Brain.&nbsp; Front Neural Circuits. 2017 Jan 10;10:111. doi: 10.3389/fncir.2016.00111.</p>\n\n<p>Malenka RC, Bear MF (2004) LTP and LTD: an embarrassment of riches. Neuron 44:5-21.</p>\n\n<p>McCarthy, G. (1995) Review: Functional Neuroimaging and Memory. The Neuroscientist, 1:155-163.</p>\n\n<p>Michelson HB, Lothman EW. An in vivo electrophysiological study of the ontogeny of excitatory and inhibitory processes in the rat hippocampus. Brain Res Dev Brain Res. 1989 May 1;47(1):113-22.</p>\n\n<p>Muller D, Oliver M, Lynch G. Developmental changes in synaptic properties in hippocampus of neonatal rats. Brain Res Dev Brain Res. 1989 Sep 1;49(1):105-14.</p>\n\n<p>Smith, E and Jonides, J. (1997). Working Memory: A View from Neuroimaging. Cognitive Psychology, 33:5-42.</p>\n\n<p>Tietze, KJ. (2012). Review of Laboratory and Diagnostic Tests- Positron Emission Tomography. In Clinical Sills for Pharmacists, 3rd Edition, pp 86-122.&nbsp;</p>\n\n<p>Wheeler SM, McLelland VC, Sheard E, McAndrews MP, Rovet JF (2015) Hippocampal Functioning and Verbal Associative Memory in Adolescents with Congenital Hypothyroidism. Front Endocrinol (Lausanne) 6:163.</p>\n\n<p>Willoughby KA, McAndrews MP, Rovet JF (2014) Effects of maternal hypothyroidism on offspring hippocampus and memory. Thyroid 24:576-584.</p>\n","biologicalOrganisationLevel":"Tissue","organTerm":{"name":"brain","sourceId":"UBERON:0000955"},"biologicalEvents":[{"action":"abnormal","process":"chemical synaptic transmission","object":{"name":"synapse","source":"GO","sourceId":"GO:0045202"}}],"keyEventStressors":["Iodine deficiency","Methimazole","Propylthiouracil"],"id":758}
{"title":"Hippocampal gene expression, Altered ","references":"<p>Altman J, Bayer SA. Migration and distribution of two populations of hippocampal granule cell precursors during the perinatal and postnatal periods. J Comp Neurol. 1990a Nov 15;301(3):365-81.</p>\n\n<p>Altman J, Bayer SA. Prolonged sojourn of developing pyramidal cells in the intermediate zone of the hippocampus and their settling in the stratum pyramidale. J Comp Neurol. 1990b Nov 15;301(3):343-64.</p>\n\n<p>Alvarez-Dolado M, Ruiz M, Del Rio JA, Alcantara S, Burgaya F, Sheldon M, Nakajima K, Bernal J, Howell BW, Curran T, Soriano E, Munoz A (1999) Thyroid hormone regulates reelin and dab1 expression during brain development. J Neurosci 19:6979-6993.</p>\n\n<p>Bernal J. (2105)&nbsp; Thyroid Hormones in Brain Development and Function. In: De Groot LJ, Chrousos G, Dungan K, Feingold KR, Grossman A, Hershman JM, Koch C, Korbonits M, McLachlan R, New M, Purnell J, Rebar R, Singer F, Vinik A, editors. Endotext [Internet]. South Dartmouth (MA): MDText.com, Inc..</p>\n\n<p>Dong H, You SH, Williams A, Wade MG, Yauk CL, Thomas Zoeller R (2015) Transient Maternal Hypothyroxinemia Potentiates the Transcriptional Response to Exogenous Thyroid Hormone in the Fetal Cerebral Cortex Before the Onset of Fetal Thyroid Function: A Messenger and MicroRNA Profiling Study. Cereb Cortex 25:1735-1745.</p>\n\n<p>Dowling AL, Zoeller RT. 2000. Thyroid hormone of maternal origin regulates the expression of RC3/neurogranin mRNA in the fetal rat brain. Brain Res: Molec Brain Res. &nbsp;82:126-132.</p>\n\n<p>Gilbert ME, Sui L, Walker MJ, Anderson W, Thomas S, Smoller SN, Schon JP, Phani S, Goodman JH (2007) Thyroid hormone insufficiency during brain development reduces parvalbumin immunoreactivity and inhibitory function in the hippocampus. Endocrinology 148:92-102.</p>\n\n<p>Gil-Ibanez P, Garcia-Garcia F, Dopazo J, Bernal J, Morte B. 2015. Global Transcriptome Analysis of Primary Cerebrocortical Cells: Identification of Genes Regulated by Triiodothyronine in Specific Cell Types. Cerebral cortex. Nov 2.</p>\n\n<p style=\"margin-left:13.5pt !msorm\">Kempermann G.&nbsp; New neurons for &#39;survival of the fittest&#39;.&nbsp; Nat Rev Neurosci. 2012 Oct;13(10):727-36.</p>\n\n<p>Mody M, Cao Y, Cui Z, Tay KY, Shyong A, Shimizu E, Pham K, Schultz P, Welsh D, Tsien JZ. Genome-wide gene expression profiles of the developing mouse hippocampus. Proc Natl Acad Sci U S A. 2001 Jul 17;98(15):8862-7.</p>\n\n<p>Morte B, Ceballos A, Diez D, Grijota-Martinez C, Dumitrescu AM, Di Cosmo C, Galton VA, Refetoff S, Bernal J. &nbsp;Thyroid hormone-regulated mouse cerebral cortex genes are differentially dependent on the source of the hormone: a study in monocarboxylate transporter-8- and deiodinase-2-deficient mice. Endocrinology. 2010. 151:2381-2387.</p>\n\n<p>Royland JE, Parker JS, Gilbert ME. A genomic analysis of subclinical hypothyroidism in hippocampus and neocortex of the developing rat brain. J Neuroendocrinol. 2008 Dec;20(12):1319-38.</p>\n\n<p>Zhang Y, Mei P, Lou R, Zhang MQ, Wu G, Qiang B, Zhang Z, Shen Y. Gene expression profiling in developing human hippocampus. J Neurosci Res. 2002 Oct 15;70(2):200-8.</p>\n","biologicalOrganisationLevel":"Tissue","organTerm":{"name":"brain","sourceId":"UBERON:0000955"},"biologicalEvents":[{"action":"abnormal","process":"regulation of gene expression","object":{"name":"hippocampal formation","source":"UBERON","sourceId":"UBERON:0002421"}}],"keyEventStressors":["Methimazole","Propylthiouracil"],"id":756}
{"title":"Reduction, Ionotropic GABA receptor chloride channel conductance","references":"<p>Babot Z, Vilaro MT, Sunol C. (2007) Long-term exposure to dieldrin reduces gamma-aminobutyric acid type A and N-methyl-D-aspartate receptor function in primary cultures of mouse cerebellar granule cells. J. Neurosci. Res. 85(16), 3687-3695.</p>\n\n<p>Banerjee PK, Olsen RW, Snead OC, III. (1999) Zinc inhibition of gamma-aminobutyric acid(A) receptor function is decreased in the cerebral cortex during pilocarpine-induced status epilepticus. J Pharmacol Exp Ther 1999; 291(1):361-366.</p>\n\n<p>Bromfield EB, Cavazos JE, Sirven JI. (2006) Chapter 1, Basic Mechanisms Underlying Seizures and Epilepsy. In: An Introduction to Epilepsy [Internet]. West Hartford (CT): American Epilepsy Society; Available from: <a class=\"external free\" href=\"http://www.ncbi.nlm.nih.gov/books/NBK2510\" rel=\"nofollow\" target=\"_blank\">http://www.ncbi.nlm.nih.gov/books/NBK2510</a></p>\n\n<p>Costa LG. (2015)&nbsp;The neurotoxicity of&nbsp;organochlorine&nbsp;and pyrethroid pesticides. Handb Clin Neurol. 131:135-48.</p>\n\n<p>Dichter MA, Ayala GF. (1987) Cellular mechanisms of epilepsy: a status report. Science 237(4811), 157-164.</p>\n\n<p>Gong P. Hong HH, Perkins EJ. (2015) Ionotropic GABA receptor antagonism-induced adverse outcome pathways for potential neurotoxicity biomarkers. Biomark. Med. 9(11):1225-39.</p>\n\n<p>Grolleau F, Sattelle DB. (2000) Single channel analysis of the blocking actions of BIDN and fipronil on a Drosophila melanogaster GABA receptor (RDL) stably expressed in a Drosophila cell line. Br J Pharmacol. 130(8):1833-42.</p>\n\n<p>Inglefield JR, Schwartz-Bloom RD. (1998)&nbsp;Optical imaging of hippocampal neurons with a chloride-sensitive dye: early effects of in vitro ischemia. J Neurochem. 70(6):2500-9.</p>\n\n<p>Narahashi T. (1996).&nbsp;Neuronal ion channels as the target sites of insecticides.&nbsp;Pharmacol Toxicol.&nbsp;79(1):1-14.</p>\n","biologicalOrganisationLevel":"Cellular","organTerm":{"name":"brain","sourceId":"UBERON:0000955"},"biologicalEvents":[{"action":"decreased","process":"GABA-gated chloride ion channel activity","object":{"name":"chloride","source":"CHEBI","sourceId":"CHEBI:17996"}}],"id":64}
{"title":"Occurrence, A paroxysmal depolarizing shift","references":"<p>Bromfield EB, Cavazos JE, Sirven JI. 2006. An Introduction to Epilepsy [Internet]. West Hartford (CT): American Epilepsy Society; Chapter 1, Basic Mechanisms Underlying Seizures and Epilepsy. Available from: <a class=\"external free\" href=\"http://www.ncbi.nlm.nih.gov/books/NBK2510/\" rel=\"nofollow\" target=\"_blank\">http://www.ncbi.nlm.nih.gov/books/NBK2510/</a>.</p>\n\n<p>Kapur J. 2009.&nbsp;GABA | Pathophysiology of Status Epilepticus.&nbsp;Encyclopedia of Basic Epilepsy Research,&nbsp;pp&nbsp;304-8.</p>\n\n<p>Lomen-Hoerth C, Messing RO. 2010. Chapter 7: Nervous system disorders. Edited by Stephen J. McPhee, and Gary D. Hammer, Pathophysiology of disease: an introduction to clinical medicine (6th Edition). New York: McGraw-Hill Medical. <a class=\"internal mw-magiclink-isbn\" href=\"/wiki/index.php/Special:BookSources/9780071621670\">ISBN 9780071621670</a>.</p>\n\n<p>Novellino A,&nbsp;Scelfo B,&nbsp;Palosaari T,&nbsp;Price A,&nbsp;Sobanski T,&nbsp;Shafer TJ,&nbsp;Johnstone AF,&nbsp;Gross GW,&nbsp;Gramowski A,&nbsp;Schroeder O,&nbsp;J&uuml;gelt K,&nbsp;Chiappalone M,&nbsp;Benfenati F,&nbsp;Martinoia S,&nbsp;Tedesco MT,&nbsp;Defranchi E,&nbsp;D&#39;Angelo P,&nbsp;Whelan M. 2011. Development of micro-electrode array based tests for neurotoxicity: assessment of interlaboratory reproducibility with neuroactive chemicals. Front Neuroeng. 4:4.</p>\n\n<p>Niedermeyer E, da Silva FL. 2005. Electroencephalography: basic principles, clinical applications, and related fields. Lippincott Williams &amp; Wilkins.</p>\n\n<p>Somjen GG. 2004. Ions in the Brain Normal Function, Seizures, and Stroke. New York: Oxford University Press. p. 167.</p>\n\n<p>&nbsp;</p>\n","biologicalOrganisationLevel":"Tissue","organTerm":{"name":"brain","sourceId":"UBERON:0000955"},"biologicalEvents":[{"action":"occurrence","process":"membrane depolarization","object":{}}],"id":616}
{"title":"Occurrence, Epileptic seizure","references":"<p>Bloomquist JR. 2003. Chloride channels as tools for developing selective insecticides. Arch. Insect Biochem. Physiol 54(4), 145-156.</p>\n\n<p>Bromfield EB, Cavazos JE, Sirven JI, editors. 2006. An Introduction to Epilepsy [Internet]. West Hartford (CT): American Epilepsy Society. Chapter 1 Basic Mechanisms Underlying Seizures and Epilepsy. Available from: <a class=\"external free\" href=\"http://www.ncbi.nlm.nih.gov/books/NBK2510/\" rel=\"nofollow\" target=\"_blank\">http://www.ncbi.nlm.nih.gov/books/NBK2510/</a></p>\n\n<p>De Deyn PP, Marescau B, Macdonald RL. 1990. Epilepsy and the GABA-hypothesis a brief review and some examples. Acta Neurol. Belg. 90(2), 65-81.</p>\n\n<p>Dossi E,&nbsp;Blauwblomme T,&nbsp;Nabbout R,&nbsp;Huberfeld G,&nbsp;Rouach N. 2014. Multi-electrode array recordings of human epileptic postoperative cortical tissue.J Vis Exp. (92):e51870.</p>\n\n<p>Gao JR, Kozaki T, Leichter CA, Rinkevich FD, Shono T, Scott JG. 2007. The A302S mutation in Rdl that confers resistance to cyclodienes and limited crossresistance to fipronil is undetectable in field populations of house flies from the USA. Pestic. Biochem. Physiol. 88, 66&minus;70.</p>\n\n<p>Gunasekara AS, Truong T, Goh KS, Spurlock F, Tjeerdema RS. 2007. Environmental fate and toxicology of fipronil. J. Pestic. Sci. 32(3), 189-199.</p>\n\n<p>Jackson D, Cornell CB, Luukinen B, Buhl K, Stone D. 2009. Fipronil Technical Fact Sheet. National Pesticide Information Center, Oregon State University Extension Services,</p>\n\n<p>Novellino A,&nbsp;Scelfo B,&nbsp;Palosaari T,&nbsp;Price A,&nbsp;Sobanski T,&nbsp;Shafer TJ,&nbsp;Johnstone AF,&nbsp;Gross GW,&nbsp;Gramowski A,&nbsp;Schroeder O,&nbsp;J&uuml;gelt K,&nbsp;Chiappalone M,&nbsp;Benfenati F,&nbsp;Martinoia S,&nbsp;Tedesco MT,&nbsp;Defranchi E,&nbsp;D&#39;Angelo P,&nbsp;Whelan M. 2011. Development of micro-electrode array based tests for neurotoxicity: assessment of interlaboratory reproducibility with neuroactive chemicals.Front Neuroeng. 4:4.</p>\n\n<p>Stilwell GE, Saraswati S, J. Troy Littleton JT, Chouinard SW. 2006. Development of a Drosophila seizure model for in vivo high-throughput drug screening. European J Neurosci. 24, 2211-2222.</p>\n\n<p>Tingle CC, Rother JA, Dewhurst CF, Lauer S, King WJ. 2003. Fipronil: environmental fate, ecotoxicology, and human health concerns. Rev. Environ. Contam Toxicol. 176, 1-66.</p>\n\n<p>Ulate-Campos A, Coughlin F, Ga&iacute;nza-Lein M, Fern&aacute;ndez IS, Pearl PL, Loddenkemper T. 2016. Automated seizure detection systems and their effectiveness for each type of seizure. Seizure. 40:88-101.</p>\n\n<p>Werner FM, Covenas R. 2011. Classical neurotransmitters and neuropeptides involved in generalized epilepsy: a focus on antiepileptic drugs. Curr. Med. Chem. 18(32), 4933-4948.</p>\n\n<p>&nbsp;</p>\n","biologicalOrganisationLevel":"Individual","organTerm":{},"biologicalEvents":[{"action":"occurrence","process":"seizures","object":{}}],"id":613}
{"title":"Binding at picrotoxin site, iGABAR chloride channel","references":"<p>Atack JR, Ohashi Y, McKernan RM. 2007. Characterization of [<sup>35</sup>S]t-butylbicyclophosphorothionate ([<sup>35</sup>S]TBPS) binding to GABA<sub>A</sub> receptors in postmortem human brain. Br J Pharmacol. 150(8):1066-74.</p>\n\n<p>Buckingham SD, Biggin PC, Sattelle BM, Brown LA, Sattelle DB. 2005. Insect GABA receptors: splicing, editing, and targeting by antiparasitics and insecticides. Mol Pharmacol 68(4):942-951.</p>\n\n<p>Ben-Ari Y. 2006. Seizures beget seizures: the quest for GABA as a key player. Crit&nbsp;Rev Neurobiol 18(1-2): 135-44.</p>\n\n<p>Carpenter TS, Lau EY, Lightstone FC. 2013. Identification of a possible secondary picrotoxin-binding site on the GABAA receptor. Chem Res Toxicol. 26(10):1444-54.</p>\n\n<p>Chen L, Durkin KA, Casida JE. 2006. Structural model for gamma-aminobutyric acid receptor noncompetitive antagonist binding: widely diverse structures fit the same site. Proc Natl Acad Sci USA 103(13):5185-5190.</p>\n\n<p>Ernst M, Bruckner S, Boresch S, Sieghart W. 2005. Comparative models of GABA<sub>A</sub> receptor extracellular and transmembrane domains: important insights in pharmacology and function. Mol Pharmacol 68(5):1291-1300.</p>\n\n<p>Ffrench-Constant RH, Mortlock DP, Shaffer CD, MacIntyre RJ, Roush RT. 1991. Molecular cloning and transformation of cyclodiene resistance in Drosophila: an invertebrate gamma-aminobutyric acid subtype A receptor locus. Proc Natl Acad Sci USA 88:7209&ndash;7213.</p>\n\n<p>Ffrench-Constant RH and Rocheleau TA. 1993 Drosophila gamma-aminobutyric acid receptor gene Rdl shows extensive alternative splicing. J Neurochem 60:2323&ndash;2326.</p>\n\n<p>Ffrench-Constant RH, Steichen JC, Rocheleau TA, Aronstein K, and Roush RT. 1993. A single-amino acid substitution in a gamma-aminobutyric acid subtype A receptor locus is associated with cyclodiene insecticide resistance in Drosophila populations. Proc Natl Acad Sci USA 90:1957&ndash;1961.</p>\n\n<p>Galanopoulou AS. 2008.&nbsp;GABA<sub>A</sub>&nbsp;Receptors in Normal Development and Seizures: Friends or Foes? Curr Neuropharmacol. 6(1):1-20.</p>\n\n<p>Gong P, Hong H, Perkins EJ. 2015. Ionotropic GABA receptor antagonism-induced adverse outcome pathways for potential neurotoxicity biomarkers. Biomarkers in Medicine 9(11):1225-39.</p>\n\n<p>Han HA, Cortez MA, Snead OC III. 2012. GABA<sub>B</sub> Receptor and Absence Epilepsy. In: Noebels JL, Avoli M, Rogawski MA, et al., editors. Jasper&#39;s Basic Mechanisms of the Epilepsies [Internet]. 4th edition. Bethesda (MD): National Center for Biotechnology Information (US); 2012.&nbsp;Available from: https://www.ncbi.nlm.nih.gov/books/NBK98192/.</p>\n\n<p>Hosie AM, Aronstein K, Sattelle DB, Ffrench-Constant RH. 1997. Molecular biology of insect neuronal GABA receptors. Trends Neurosci 20(12):578-583.</p>\n\n<p>Johnston GA. 2005. GABA(A) receptor channel pharmacology. Curr Pharm Des 11(15):1867-1885.</p>\n\n<p>Kalueff AV. 2007. Mapping convulsants&#39; binding to the GABA-A receptor chloride ionophore: a proposed model for channel binding sites. Neurochem Int 50(1): 61-68.</p>\n\n<p>Michels G, Moss SJ. 2007. GABAA receptors: properties and trafficking. Crit Rev Biochem Mol Biol 42(1):3-14.</p>\n\n<p>Olsen RW.&nbsp;2006. Picrotoxin-like channel blockers of GABA<sub>A</sub> receptors. Proc Natl Acad Sci USA. 103:6081-82.</p>\n\n<p>Olsen RW, Chang C-SS, Li G, Hanchar HJ, Wallner M. 2004. Fishing for allosteric sites on GABAa receptors. Biochem Pharmacol. 68:1675-84.</p>\n\n<p>Olsen RW, Sieghart W. 2009. GABA<sub>A</sub> receptors: subtypes provide diversity of function and pharmacology. Neuropharmacology. 56(1):141-8.</p>\n\n<p>Sander T, Frolund B, Bruun AT, Ivanov I, McCammon JA, Balle T. 2011. New insights into the GABAA receptor structure and orthosteric ligand binding: receptor modeling guided by experimental data. Proteins. 79(5):1458-77.</p>\n\n<p>Simon J, Wakimoto H, Fujita N, Lalande M, Barnard EA. 2004. Analysis of the set of GABA(A) receptor genes in the human genome. J. Biol. Chem. 279(40), 41422&ndash;41435.</p>\n\n<p>Taketo M, Yoshioka T. 2000.&nbsp;Developmental change of GABA<sub>A</sub>&nbsp;receptor-mediated current in rat hippocampus. Neuroscience 96(3):507-514.</p>\n\n<p>Unwin N. 2005. Refined structure of the nicotinic acetylcholine receptor at 4 A resolution. J Mol Biol. 346:967-89.</p>\n\n<p>Zheng N, Cheng J, Zhang W, Li W, Shao X, Xu Z, Xu X, Li Z. 2014. Binding difference of fipronil with GABAARs in fruitfly and zebrafish: insights from homology modeling, docking, and molecular dynamics simulation studies. J Agric Food Chem 62(44):10646-53.</p>\n\n<p>&nbsp;</p>\n","biologicalOrganisationLevel":"Molecular","organTerm":{"name":"brain","sourceId":"UBERON:0000955"},"biologicalEvents":[{"action":"increased","process":"GABA receptor binding","object":{"name":"gamma-aminobutyric acid receptor subunit alpha-1","source":"PR","sourceId":"PR:000007766"}},{"action":"increased","process":"GABA receptor binding","object":{"name":"gamma-aminobutyric acid receptor subunit alpha-5","source":"PR","sourceId":"PR:000007770"}},{"action":"increased","process":"GABA receptor binding","object":{"name":"gamma-aminobutyric acid receptor subunit alpha-6","source":"PR","sourceId":"PR:000007771"}}],"keyEventStressors":["RDX","Fipronil","Alpha-endosulfan","Picrotoxin","Lindane","Penicillin"],"id":667}
{"title":"Binding at picrotoxin site, iGABAR chloride channel","references":"<p>Atack JR, Ohashi Y, McKernan RM. 2007. Characterization of [<sup>35</sup>S]t-butylbicyclophosphorothionate ([<sup>35</sup>S]TBPS) binding to GABA<sub>A</sub> receptors in postmortem human brain. Br J Pharmacol. 150(8):1066-74.</p>\n\n<p>Buckingham SD, Biggin PC, Sattelle BM, Brown LA, Sattelle DB. 2005. Insect GABA receptors: splicing, editing, and targeting by antiparasitics and insecticides. Mol Pharmacol 68(4):942-951.</p>\n\n<p>Ben-Ari Y. 2006. Seizures beget seizures: the quest for GABA as a key player. Crit&nbsp;Rev Neurobiol 18(1-2): 135-44.</p>\n\n<p>Carpenter TS, Lau EY, Lightstone FC. 2013. Identification of a possible secondary picrotoxin-binding site on the GABAA receptor. Chem Res Toxicol. 26(10):1444-54.</p>\n\n<p>Chen L, Durkin KA, Casida JE. 2006. Structural model for gamma-aminobutyric acid receptor noncompetitive antagonist binding: widely diverse structures fit the same site. Proc Natl Acad Sci USA 103(13):5185-5190.</p>\n\n<p>Ernst M, Bruckner S, Boresch S, Sieghart W. 2005. Comparative models of GABA<sub>A</sub> receptor extracellular and transmembrane domains: important insights in pharmacology and function. Mol Pharmacol 68(5):1291-1300.</p>\n\n<p>Ffrench-Constant RH, Mortlock DP, Shaffer CD, MacIntyre RJ, Roush RT. 1991. Molecular cloning and transformation of cyclodiene resistance in Drosophila: an invertebrate gamma-aminobutyric acid subtype A receptor locus. Proc Natl Acad Sci USA 88:7209&ndash;7213.</p>\n\n<p>Ffrench-Constant RH and Rocheleau TA. 1993 Drosophila gamma-aminobutyric acid receptor gene Rdl shows extensive alternative splicing. J Neurochem 60:2323&ndash;2326.</p>\n\n<p>Ffrench-Constant RH, Steichen JC, Rocheleau TA, Aronstein K, and Roush RT. 1993. A single-amino acid substitution in a gamma-aminobutyric acid subtype A receptor locus is associated with cyclodiene insecticide resistance in Drosophila populations. Proc Natl Acad Sci USA 90:1957&ndash;1961.</p>\n\n<p>Galanopoulou AS. 2008.&nbsp;GABA<sub>A</sub>&nbsp;Receptors in Normal Development and Seizures: Friends or Foes? Curr Neuropharmacol. 6(1):1-20.</p>\n\n<p>Gong P, Hong H, Perkins EJ. 2015. Ionotropic GABA receptor antagonism-induced adverse outcome pathways for potential neurotoxicity biomarkers. Biomarkers in Medicine 9(11):1225-39.</p>\n\n<p>Han HA, Cortez MA, Snead OC III. 2012. GABA<sub>B</sub> Receptor and Absence Epilepsy. In: Noebels JL, Avoli M, Rogawski MA, et al., editors. Jasper&#39;s Basic Mechanisms of the Epilepsies [Internet]. 4th edition. Bethesda (MD): National Center for Biotechnology Information (US); 2012.&nbsp;Available from: https://www.ncbi.nlm.nih.gov/books/NBK98192/.</p>\n\n<p>Hosie AM, Aronstein K, Sattelle DB, Ffrench-Constant RH. 1997. Molecular biology of insect neuronal GABA receptors. Trends Neurosci 20(12):578-583.</p>\n\n<p>Johnston GA. 2005. GABA(A) receptor channel pharmacology. Curr Pharm Des 11(15):1867-1885.</p>\n\n<p>Kalueff AV. 2007. Mapping convulsants&#39; binding to the GABA-A receptor chloride ionophore: a proposed model for channel binding sites. Neurochem Int 50(1): 61-68.</p>\n\n<p>Michels G, Moss SJ. 2007. GABAA receptors: properties and trafficking. Crit Rev Biochem Mol Biol 42(1):3-14.</p>\n\n<p>Olsen RW.&nbsp;2006. Picrotoxin-like channel blockers of GABA<sub>A</sub> receptors. Proc Natl Acad Sci USA. 103:6081-82.</p>\n\n<p>Olsen RW, Chang C-SS, Li G, Hanchar HJ, Wallner M. 2004. Fishing for allosteric sites on GABAa receptors. Biochem Pharmacol. 68:1675-84.</p>\n\n<p>Olsen RW, Sieghart W. 2009. GABA<sub>A</sub> receptors: subtypes provide diversity of function and pharmacology. Neuropharmacology. 56(1):141-8.</p>\n\n<p>Sander T, Frolund B, Bruun AT, Ivanov I, McCammon JA, Balle T. 2011. New insights into the GABAA receptor structure and orthosteric ligand binding: receptor modeling guided by experimental data. Proteins. 79(5):1458-77.</p>\n\n<p>Simon J, Wakimoto H, Fujita N, Lalande M, Barnard EA. 2004. Analysis of the set of GABA(A) receptor genes in the human genome. J. Biol. Chem. 279(40), 41422&ndash;41435.</p>\n\n<p>Taketo M, Yoshioka T. 2000.&nbsp;Developmental change of GABA<sub>A</sub>&nbsp;receptor-mediated current in rat hippocampus. Neuroscience 96(3):507-514.</p>\n\n<p>Unwin N. 2005. Refined structure of the nicotinic acetylcholine receptor at 4 A resolution. J Mol Biol. 346:967-89.</p>\n\n<p>Zheng N, Cheng J, Zhang W, Li W, Shao X, Xu Z, Xu X, Li Z. 2014. Binding difference of fipronil with GABAARs in fruitfly and zebrafish: insights from homology modeling, docking, and molecular dynamics simulation studies. J Agric Food Chem 62(44):10646-53.</p>\n\n<p>&nbsp;</p>\n","biologicalOrganisationLevel":"Molecular","organTerm":{"name":"brain","sourceId":"UBERON:0000955"},"biologicalEvents":[{"action":"increased","process":"GABA receptor binding","object":{"name":"gamma-aminobutyric acid receptor subunit alpha-1","source":"PR","sourceId":"PR:000007766"}},{"action":"increased","process":"GABA receptor binding","object":{"name":"gamma-aminobutyric acid receptor subunit alpha-5","source":"PR","sourceId":"PR:000007770"}},{"action":"increased","process":"GABA receptor binding","object":{"name":"gamma-aminobutyric acid receptor subunit alpha-6","source":"PR","sourceId":"PR:000007771"}}],"keyEventStressors":["RDX","Fipronil","Alpha-endosulfan","Picrotoxin","Lindane","Penicillin"],"id":667}
{"title":"Binding at picrotoxin site, iGABAR chloride channel","references":"<p>Atack JR, Ohashi Y, McKernan RM. 2007. Characterization of [<sup>35</sup>S]t-butylbicyclophosphorothionate ([<sup>35</sup>S]TBPS) binding to GABA<sub>A</sub> receptors in postmortem human brain. Br J Pharmacol. 150(8):1066-74.</p>\n\n<p>Buckingham SD, Biggin PC, Sattelle BM, Brown LA, Sattelle DB. 2005. Insect GABA receptors: splicing, editing, and targeting by antiparasitics and insecticides. Mol Pharmacol 68(4):942-951.</p>\n\n<p>Ben-Ari Y. 2006. Seizures beget seizures: the quest for GABA as a key player. Crit&nbsp;Rev Neurobiol 18(1-2): 135-44.</p>\n\n<p>Carpenter TS, Lau EY, Lightstone FC. 2013. Identification of a possible secondary picrotoxin-binding site on the GABAA receptor. Chem Res Toxicol. 26(10):1444-54.</p>\n\n<p>Chen L, Durkin KA, Casida JE. 2006. Structural model for gamma-aminobutyric acid receptor noncompetitive antagonist binding: widely diverse structures fit the same site. Proc Natl Acad Sci USA 103(13):5185-5190.</p>\n\n<p>Ernst M, Bruckner S, Boresch S, Sieghart W. 2005. Comparative models of GABA<sub>A</sub> receptor extracellular and transmembrane domains: important insights in pharmacology and function. Mol Pharmacol 68(5):1291-1300.</p>\n\n<p>Ffrench-Constant RH, Mortlock DP, Shaffer CD, MacIntyre RJ, Roush RT. 1991. Molecular cloning and transformation of cyclodiene resistance in Drosophila: an invertebrate gamma-aminobutyric acid subtype A receptor locus. Proc Natl Acad Sci USA 88:7209&ndash;7213.</p>\n\n<p>Ffrench-Constant RH and Rocheleau TA. 1993 Drosophila gamma-aminobutyric acid receptor gene Rdl shows extensive alternative splicing. J Neurochem 60:2323&ndash;2326.</p>\n\n<p>Ffrench-Constant RH, Steichen JC, Rocheleau TA, Aronstein K, and Roush RT. 1993. A single-amino acid substitution in a gamma-aminobutyric acid subtype A receptor locus is associated with cyclodiene insecticide resistance in Drosophila populations. Proc Natl Acad Sci USA 90:1957&ndash;1961.</p>\n\n<p>Galanopoulou AS. 2008.&nbsp;GABA<sub>A</sub>&nbsp;Receptors in Normal Development and Seizures: Friends or Foes? Curr Neuropharmacol. 6(1):1-20.</p>\n\n<p>Gong P, Hong H, Perkins EJ. 2015. Ionotropic GABA receptor antagonism-induced adverse outcome pathways for potential neurotoxicity biomarkers. Biomarkers in Medicine 9(11):1225-39.</p>\n\n<p>Han HA, Cortez MA, Snead OC III. 2012. GABA<sub>B</sub> Receptor and Absence Epilepsy. In: Noebels JL, Avoli M, Rogawski MA, et al., editors. Jasper&#39;s Basic Mechanisms of the Epilepsies [Internet]. 4th edition. Bethesda (MD): National Center for Biotechnology Information (US); 2012.&nbsp;Available from: https://www.ncbi.nlm.nih.gov/books/NBK98192/.</p>\n\n<p>Hosie AM, Aronstein K, Sattelle DB, Ffrench-Constant RH. 1997. Molecular biology of insect neuronal GABA receptors. Trends Neurosci 20(12):578-583.</p>\n\n<p>Johnston GA. 2005. GABA(A) receptor channel pharmacology. Curr Pharm Des 11(15):1867-1885.</p>\n\n<p>Kalueff AV. 2007. Mapping convulsants&#39; binding to the GABA-A receptor chloride ionophore: a proposed model for channel binding sites. Neurochem Int 50(1): 61-68.</p>\n\n<p>Michels G, Moss SJ. 2007. GABAA receptors: properties and trafficking. Crit Rev Biochem Mol Biol 42(1):3-14.</p>\n\n<p>Olsen RW.&nbsp;2006. Picrotoxin-like channel blockers of GABA<sub>A</sub> receptors. Proc Natl Acad Sci USA. 103:6081-82.</p>\n\n<p>Olsen RW, Chang C-SS, Li G, Hanchar HJ, Wallner M. 2004. Fishing for allosteric sites on GABAa receptors. Biochem Pharmacol. 68:1675-84.</p>\n\n<p>Olsen RW, Sieghart W. 2009. GABA<sub>A</sub> receptors: subtypes provide diversity of function and pharmacology. Neuropharmacology. 56(1):141-8.</p>\n\n<p>Sander T, Frolund B, Bruun AT, Ivanov I, McCammon JA, Balle T. 2011. New insights into the GABAA receptor structure and orthosteric ligand binding: receptor modeling guided by experimental data. Proteins. 79(5):1458-77.</p>\n\n<p>Simon J, Wakimoto H, Fujita N, Lalande M, Barnard EA. 2004. Analysis of the set of GABA(A) receptor genes in the human genome. J. Biol. Chem. 279(40), 41422&ndash;41435.</p>\n\n<p>Taketo M, Yoshioka T. 2000.&nbsp;Developmental change of GABA<sub>A</sub>&nbsp;receptor-mediated current in rat hippocampus. Neuroscience 96(3):507-514.</p>\n\n<p>Unwin N. 2005. Refined structure of the nicotinic acetylcholine receptor at 4 A resolution. J Mol Biol. 346:967-89.</p>\n\n<p>Zheng N, Cheng J, Zhang W, Li W, Shao X, Xu Z, Xu X, Li Z. 2014. Binding difference of fipronil with GABAARs in fruitfly and zebrafish: insights from homology modeling, docking, and molecular dynamics simulation studies. J Agric Food Chem 62(44):10646-53.</p>\n\n<p>&nbsp;</p>\n","biologicalOrganisationLevel":"Molecular","organTerm":{"name":"brain","sourceId":"UBERON:0000955"},"biologicalEvents":[{"action":"increased","process":"GABA receptor binding","object":{"name":"gamma-aminobutyric acid receptor subunit alpha-1","source":"PR","sourceId":"PR:000007766"}},{"action":"increased","process":"GABA receptor binding","object":{"name":"gamma-aminobutyric acid receptor subunit alpha-5","source":"PR","sourceId":"PR:000007770"}},{"action":"increased","process":"GABA receptor binding","object":{"name":"gamma-aminobutyric acid receptor subunit alpha-6","source":"PR","sourceId":"PR:000007771"}}],"keyEventStressors":["RDX","Fipronil","Alpha-endosulfan","Picrotoxin","Lindane","Penicillin"],"id":667}
{"title":"Reduction, Neuronal synaptic inhibition","references":"<p>Newland C F, Cull-Candy S G. On the mechanism of action of picrotoxin on GABA receptor channels in dissociated sympathetic neurones of the rat. J Physiol 1992; 447: 191&ndash;213.</p>\n\n<p>Juarez E H, Ochoa-Cortes F, Miranda-Morales M, Espinosa-Luna R, Montano L M, Barajas-Lopez C. Selectivity of antagonists for the Cys-loop native receptors for ACh, 5-HT and GABA in guinea-pig myenteric neurons. Auton Autacoid Pharmacol 2013; 34(1-2):1-8.</p>\n\n<p>Williams L R, Aroniadou-Anderjaska V, Qashu F, Finne H, Pidoplichko V, Bannon D I et al. RDX binds to the GABA(A) receptor-convulsant site and blocks GABA(A) receptor-mediated currents in the amygdala: a mechanism for RDX-induced seizures. Environ Health Perspect 2011; 119(3):357-363.</p>\n\n<p>&nbsp;</p>\n","biologicalOrganisationLevel":"Cellular","organTerm":{},"biologicalEvents":[{"action":"decreased","process":"chemical synaptic transmission","object":{}}],"id":669}
{"title":"Generation, Amplified excitatory postsynaptic potential (EPSP)","references":"<p>Acker CD, Hoyos E,&nbsp;Loew LM. (2016)&nbsp;EPSPs Measured in Proximal Dendritic Spines of Cortical Pyramidal Neurons. eNeuro. 3(2) ENEURO.0050-15.2016.</p>\n\n<p>Bromfield EB, Cavazos JE, Sirven JI. (2006) Chapter 1, Basic Mechanisms Underlying Seizures and Epilepsy. In: An Introduction to Epilepsy [Internet]. West Hartford (CT): American Epilepsy Society; Available from: <a class=\"external free\" href=\"http://www.ncbi.nlm.nih.gov/books/NBK2510/\" rel=\"nofollow\" target=\"_blank\">http://www.ncbi.nlm.nih.gov/books/NBK2510/</a>.</p>\n\n<p>Dichter MA, Ayala GF. (1987) Cellular mechanisms of epilepsy: A status report. Science 237:157-64.</p>\n\n<p>Lopantsev V, Both M, Draguhn A. 2009. Rapid Plasticity at Inhibitory and Excitatory Synapses in the Hippocampus Induced by Ictal Epileptiform Discharges. Eur J Neurosci 29(6):1153&ndash;64.</p>\n\n<p>Miura M, Yoshioka M, Miyakawa H, Kato H, Ito KI. (1997) Properties of calcium spikes revealed during GABA<sub>A</sub> receptor antagonism in hippocampal CA1 neurons from guinea pigs. J Neurophysiol. 78(5):2269-79.</p>\n\n<p>Popovic MA,&nbsp;Carnevale N,&nbsp;Rozsa B,&nbsp;Zecevic D. (2015)&nbsp;&nbsp;Electrical behaviour of dendritic spines as revealed by voltage imaging.&nbsp;Nature Communications.&nbsp;6:8436.</p>\n\n<p>Purves D, Augustine GJ, Fitzpatrick D, Katz LC, LaMantia A-S, McNamara JO, Williams SM (Eds). 2001. Neuroscience. 2nd edition. Chapter 7. Neurotransmitter Receptors and Their Effects. Sunderland (MA): Sinauer Associates. Available from: <a class=\"external free\" href=\"http://www.ncbi.nlm.nih.gov/books/NBK10799/\" rel=\"nofollow\" target=\"_blank\">http://www.ncbi.nlm.nih.gov/books/NBK10799/</a>.</p>\n","biologicalOrganisationLevel":"Cellular","organTerm":{"name":"brain","sourceId":"UBERON:0000955"},"biologicalEvents":[{"action":"occurrence","process":"excitatory postsynaptic potential","object":{}}],"id":682}
{"title":"Activation, PXR/SXR","references":"","biologicalOrganisationLevel":"Molecular","organTerm":{},"biologicalEvents":[{"action":"increased","process":"signaling","object":{"name":"nuclear receptor subfamily 1 group I member 2","source":"PR","sourceId":"PR:000011397"}}],"id":245}
{"title":"Inhibition, NMDARs","references":"<p><br />\nBarria A, Malinow R. (2002) Subunit-specific NMDA receptor trafficking to synapses. Neuron 35: 345-353. \n</p><p>Blanke ML, VanDongen AMJ. (2009) Activation Mechanisms of the NMDA Receptor. In: Van Dongen AM, editor. Biology of the NMDA Receptor. Boca Raton (FL): CRC Press; Chapter 13. Available from: <a rel=\"nofollow\" target=\"_blank\" class=\"external free\" href=\"http://www.ncbi.nlm.nih.gov/books/NBK5274/\">http://www.ncbi.nlm.nih.gov/books/NBK5274/</a>\n</p><p>Cohen S, Greenberg ME. (2008) Communication between the synapse and the nucleus in neuronal development, plasticity, and disease. Ann Rev Cell Dev Biol 24: 183-209. \n</p><p>Gopal K. (2003) Neurotoxic effects of mercury on auditory cortex networks growing on microelectrode arrays: a preliminary analysis. Neurotoxicol Teratol. 25: 69-76.\n</p><p>Gramowski A, Schiffmann D, Gross GW. (2000) Quantification of acute neurotoxic effects of trimethyltin using neuronal networks cultures on microelectrode arrays. Neurotoxicology 21: 331-342.\n</p><p>Johnstone  AFM, Gross GW, Weiss D, Schroeder O, Shafer TJ.  (2010). Use of microelectrode arrays for neurotoxicity testing in the 21st century Neurotoxicology 31: 331-350.  \n</p><p>Keefer  E, Norton S, Boyle N, Talesa V, Gross G. (2001) Acute toxicity screening of novel AChE inhibitors using neuronal networks on microelectrode arrays. Neurotoxicology 22: 3-12.\n</p><p>Law AJ, Weickert CS, Webster MJ, Herman MM, Kleinman JE, Harrison PJ. (2003) Expression of NMDA receptor NR1, NR2A and NR2B subunit mRNAs during development of the human hippocampal formation. Eur J Neurosci. 18: 1197-1205.\n</p><p>Lieberman DN, Mody I. (1999) Properties of single NMDA receptor channels in human dentate gyrus granule cells. J Physiol. 518: 55-70.\n</p><p>Ludolph AG, Udvardi PT, Schaz U, Henes C, Adolph O, Weigt HU, Fegert JM, Boeckers TM, Fhr KJ. (2010) Atomoxetine acts as an NMDA receptor blocker in clinically relevant concentrations. Br J Pharmacol. 160: 283-291. \n</p><p>McConnell ER, McClain MA, Ross J, LeFew WR, Shafer TJ (2012). Evaluation of multi-well microelectrode arrays for neurotoxicity screening using a chemical training set  Neurotoxicology 33: 1048-1057.\n</p><p>Ogdon D, Stanfield P. (2009) Patch clamp techniques for single channel and whole-cell recording. Chapter 4, pages 53-78. <a rel=\"nofollow\" target=\"_blank\" class=\"external free\" href=\"http://www.utdallas.edu/~tres/microelectrode/microelectrodes_ch04.pdf\">http://www.utdallas.edu/~tres/microelectrode/microelectrodes_ch04.pdf</a>\n</p><p>Scherzer CR, Landwehrmeyer GB, Kerner JA, Counihan TJ, Kosinski CM, Standaert DG, Daggett LP, Velielebi G, Penney JB, Young AB. (1998) Expression of N-methyl-D-aspartate receptor subunit mRNAs in the human brain: hippocampus and cortex. J Comp Neurol. 390: 75-90.\n</p><p>Tovar KR, Westbrook GL. (1999) The incorporation of NMDA receptors with a distinct subunit composition at nascent hippocampal synapses in vitro. J Neurosci. 19: 41804188. \n</p><p>Traynelis S, Wollmuth LP, McBain CJ, Menniti FS, Vance KM, Ogden KK, Hansen KB, Yuan H, Myers SJ, Dingledine R. (2010) Glutamate receptor ion channels: structure, regulation, and function. Pharmacol Rev. 62: 405-496. \n</p><p>Zhao Y, Inayat S, Dikin DA, Singer JH, Ruoff RS, Troy JB. (2009) Patch clamp technique: review of the current state of the art and potential contributions from Nanoengineering. Proc. IMechE 222, Part N: J. Nanoengineering and Nanosystems 149. DOI: 10.1243/17403499JNN149\n</p>","biologicalOrganisationLevel":"Molecular","organTerm":{},"biologicalEvents":[{"action":"decreased","process":"NMDA glutamate receptor activity","object":{"name":"NMDA selective glutamate receptor complex","source":"GO","sourceId":"GO:0017146"}}],"id":195}
{"title":"N/A, Neurodegeneration","references":"<p>Aravind, L., Dixit, V. M., and Koonin, E. V. (2001). Apoptotic Molecular Machinery: Vastly Increased Complexity in Vertebrates Revealed by Genome Comparisons. Science 291, 1279-1284.</p>\n\n<p>Baum, J. S., Arama, E., Steller, H., and McCall, K. (2007). The Drosophila caspases Strica and Dronc function redundantly in programmed cell death during oogenesis. Cell Death Differ 14, 1508-1517.</p>\n\n<p>Blackstone, N. W., and Green, D. R. (1999). The evolution of a mechanism of cell suicide. Bioessays 21, 84-88.</p>\n\n<p>Cobley JN, Fiorello ML, Bailey DM (2018) 13 reasons why the brain is susceptible to oxidative stress. Redox Biol 15: 490-503</p>\n\n<p>Ehara A, Ueda S. 2009. Application of Fluoro-Jade C in acute and chronic neurodegeneration models: utilities and staining differences. Acta histochemica et cytochemica 42(6): 171-179.</p>\n\n<p>Evin G, Sernee MF, Masters CL (2006) Inhibition of gamma-secretase as a therapeutic intervention for Alzheimer&#39;s disease: prospects, limitations and strategies. CNS Drugs 20: 351-72</p>\n\n<p>Greicius MD, Kimmel DL (2012) Neuroimaging insights into network-based neurodegeneration. Curr Opin Neurol 25: 727-34</p>\n\n<p>Kazim SF, Iqbal K (2016) Neurotrophic factor small-molecule mimetics mediated neuroregeneration and synaptic repair: emerging therapeutic modality for Alzheimer&#39;s disease. Mol Neurodegener 11: 50</p>\n\n<p>Kumar V, Sami N, Kashav T, Islam A, Ahmad F, Hassan MI (2016) Protein aggregation and neurodegenerative diseases: From theory to therapy. Eur J Med Chem 124: 1105-1120</p>\n\n<p>Lansbury1 PT &amp; Lashuel HA (2006) A century-old debate on protein aggregation and neurodegeneration enters the clinic. Nature 443, 774-779.</p>\n\n<p>Lin1 MT &amp; Beal MF (2006) Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases. Nature 443, 787-795</p>\n\n<p>Machado V, Zoller T, Attaai A, Spittau B (2016) Microglia-Mediated Neuroinflammation and Neurotrophic Factor-Induced Protection in the MPTP Mouse Model of Parkinson&#39;s Disease-Lessons from Transgenic Mice. Int J Mol Sci 17</p>\n\n<p>Narayan P, Dragunow M (2017) Alzheimer&#39;s Disease and Histone Code Alterations. Adv Exp Med Biol 978: 321-336</p>\n\n<p>Palop JJ, Chin1 J &amp; Mucke L, Review Article A network dysfunction perspective on neurodegenerative diseases. 2006, Nature 443, 768-773</p>\n\n<p>Rodrigues TM, Jeronimo-Santos A, Outeiro TF, Sebastiao AM, Diogenes MJ (2014) Challenges and promises in the development of neurotrophic factor-based therapies for Parkinson&#39;s disease. Drugs Aging 31: 239-61</p>\n\n<p>Schmued LC, Stowers CC, Scallet AC, Xu L. 2005. Fluoro-Jade C results in ultra high resolution and contrast labeling of degenerating neurons. Brain Res 1035(1): 24-31.</p>\n\n<p>Zuccato C &amp; Cattaneo E, Brain-derived neurotrophic factor in neurodegenerative diseases.2009, Nature Reviews Neurology 5, 311-3</p>\n\n<p><span style=\"font-size:11pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong><span style=\"color:#0070c0\">COVID19-related references relevant to KE Neurodegeneration:</span></strong></span></span></p>\n\n<p><span style=\"font-size:11pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#0070c0\">Alexopoulos et al. Anti-SARS-CoV-2 antibodies in the CSF, blood-brain barrier dysfunction, and neurological outcome: Studies in 8 stuporous and comatose patients. Neurol Neuroimmunol Neuroinflamm. 2020 Sep 25;7(6):e893.</span></span></span></p>\n\n<p><span style=\"font-size:11pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#0070c0\">Archie SR, Cucullo L. Cerebrovascular and neurological dysfunction under the threat of COVID-19: is there a comorbid role for smoking and vaping? Int J Mol Sci. 2020 21(11):3916 12. </span></span></span></p>\n\n<p><span style=\"font-size:11pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#0070c0\">Gu J et al. Multiple organ infection and the pathogenesis of SARS. J Exp Med. 2005;202:415&ndash;424.</span></span></span></p>\n\n<p><span style=\"font-size:11pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#0070c0\">Heneka MT, et al. Immediate and long-term consequences of COVID-19 infections for the development of neurological disease. Alzheimers Res Ther. 2020 12(1):1&ndash;3.</span></span></span></p>\n\n<p><span style=\"font-size:11pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#0070c0\">Kandemirli SG, et al. Brain MRI findings in patients in the intensive care unit with COVID-19 infection. Radiology. 2020 Oct;297(1):E232-E235.</span></span></span></p>\n\n<p><span style=\"font-size:11pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#0070c0\">Kanberg N, et al. Neurochemical evidence of astrocytic and neuronal injury commonly found in COVID-19. Neurology. 2020 Sep 22;95(12):e1754-e1759.</span></span></span></p>\n\n<p><span style=\"font-size:11pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#0070c0\">Kremer S, et al. Brain MRI findings in severe COVID-19: a retrospective observational study. Radiology. 2020 Nov;297(2):E242-E251.</span></span></span></p>\n\n<p><span style=\"font-size:11pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#0070c0\">Mohammadi S. et al. Understanding the Immunologic Characteristics of Neurologic Manifestations of SARS-CoV-2 and Potential Immunological Mechanisms. Mol Neurobiol. 2020 Dec;57(12):5263-5275.</span></span></span></p>\n","biologicalOrganisationLevel":"Tissue","organTerm":{"name":"brain","sourceId":"UBERON:0000955"},"biologicalEvents":[{"action":"increased","process":"neurodegeneration","object":{}}],"keyEventStressors":["Chemical","SARS-CoV","Sars-CoV-2","Virus"],"id":352}
{"title":"Decreased, Calcium influx","references":"<p>Barhoumi R, Qian Y, Burghardt RC, Tiffany-Castiglioni E. (2010) Image analysis of Ca2+ signals as a basis for neurotoxicity assays: promises and challenges. Neurotoxicol Teratol. 32: 16-24.</p>\n\n<p>Berridge MJ, Lipp P, Bootman MD. (2000) The versatility and universality of calcium signalling. Nat Rev Mol Cell Biol. 1:11-21.</p>\n\n<p>Berridge MJ. (2012) Calcium signalling remodelling and disease. Biochem Soc Trans. 40: 297-309.</p>\n\n<p>Blanke ML, VanDongen AMJ. (2009) Activation Mechanisms of the NMDA Receptor. In: Van Dongen AM, editor. Biology of the NMDA Receptor. Boca Raton (FL): CRC Press; Chapter 13. Available from: <a class=\"external free\" href=\"http://www.ncbi.nlm.nih.gov/books/NBK5274/\" rel=\"nofollow\" target=\"_blank\">http://www.ncbi.nlm.nih.gov/books/NBK5274/</a></p>\n\n<p>Calvo M, Villalobos C, N&uacute;&ntilde;ez L. (2015) Calcium imaging in neuron cell death. Methods Mol Biol. 1254: 73-85.</p>\n\n<p>Case RM, Eisner D, Gurney A, Jones O, Muallem S, Verkhratsky A. (2007) Evolution of calcium homeostasis: from birth of the first cell to an omnipresent signalling system. Cell Calcium 42: 345-350.</p>\n\n<p>Chen JL, Andermann ML, Keck T, Xu NL, Ziv Y. (2013) Imaging neuronal populations in behaving rodents: paradigms for studying neural circuits underlying behavior in the mammalian cortex. J Neurosci. 33: 17631-17640.</p>\n\n<p>Clapham DE. (2007) Calcium signaling. Cell 131: 1047-1058.</p>\n\n<p>Grienberger C, Konnerth A. (2012) Imaging calcium in neurons. Neuron 73: 862-885.</p>\n\n<p>Hagenston AM, Bading H. (2011) Calcium Signaling in Synapse-to-Nucleus Communication. Cold Spring Harb Perspect Biol. 3: a004564.</p>\n\n<p>Higley MJ, Sabatini BL. (2012) Calcium signalling in dendritic spines. Cold Spring Harb Perspect Biol. 4: a005686.</p>\n\n<p>Kettunen P. (2012) Calcium imaging in the zebrafish. Adv Exp Med Biol. 740: 1039-1071.</p>\n\n<p>Lewit-Bentley A, R&eacute;ty S. (2000) EF-hand calcium-binding proteins. Curr Opin Struct Biol. 2000 Dec;10(6):637-43.</p>\n\n<p>Meijer M, Hendriks HS, Heusinkveld HJ, Langeveld WT, Westerink RH. 2014. Comparison of plate reader-based methods with fluorescence microscopy for measurements of intracellular calcium levels for the assessment of in vitro neurotoxicity. Neurotoxicology 45: 31-37.</p>\n\n<p>Neher E., Sakaba T. (2008). Multiple roles of calcium ions in the regulation of neurotransmitter release. Neuron 59: 861-872.</p>\n\n<p>Traynelis S, Wollmuth LP, McBain CJ, Menniti FS, Vance KM, Ogden KK, Hansen KB, Yuan H, Myers SJ, Dingledine R. (2010) Glutamate receptor ion channels: structure, regulation, and function. Pharmacol Rev. 62: 405-496.</p>\n\n<p>Vijverberg HP, Westerink RH. 2012. Sense in Pb2+ sensing. Toxicol Sci 130(1): 1-3.</p>\n","biologicalOrganisationLevel":"Cellular","organTerm":{},"biologicalEvents":[{"action":"decreased","process":"calcium ion transport","object":{"name":"calcium ion","source":"CHEBI","sourceId":"CHEBI:39124"}}],"id":52}
{"title":"Binding of antagonist, NMDA receptors","references":"<p>Bale AS, Jackson MD, Krantz QT, Benignus VA, Bushnell PJ, Shafer TJ, Boyes WK. (2007) Evaluating the NMDA-glutamate receptor as a site of action for toluene, in vivo. Toxicol Sci. 98: 159-66.</p>\n\n<p>Barria A, Malinow R. (2002) Subunit-specific NMDA receptor trafficking to synapses. Neuron 35: 345-353.</p>\n\n<p>Chandrasekar R. (2013) Alcohol and NMDA receptor: current research and future direction. Front Mol Neurosci. 6: 14.</p>\n\n<p>Chtitaa S, Larifb M, Ghamalia M, Bouachrinec M, Lakhlifia T. (2015) DFT-based QSAR Studies of MK801 derivatives for non competitive antagonists of NMDA using electronic and topological descriptors. Journal of Taibah University for Science. 9: 143-154.</p>\n\n<p>Cohen S, Greenberg ME. (2008) Communication between the synapse and the nucleus in neuronal development, plasticity, and disease. Ann Rev Cell Dev Biol 24: 183-209.</p>\n\n<p>Eldefrawi ME, Anis NA, Eldefrawi AT. (1993) Glutamate receptor inhibitors as potential insecticides. Arch Insect Biochem Physiol. 22: 25-39.</p>\n\n<p>Evans RH, Francis AA, Jones AW, Smith DA, Watkins JC. (1982) The Effects of a Series of &omega;-Phosphonic &alpha;-Carboxylic Amino Acids on Electrically Evoked and Excitant Amino Acid-Induced Responses in Isolated Spinal Cord Preparations. Br J Pharmac. 75: 65-75.</p>\n\n<p>Ewald RC, Cline HT. (2009) Cloning and phylogentic analysis of NMDA receptor subunits NR1, NR2A and NR2B in Xenopus laevis tadpoles. Front Mol Neurosci. 2: 4.</p>\n\n<p>Flores-soto ME, Chaparro-Huerta V, Escoto-Delgadillo M, Vazuez-Valls E, Gonzalez-Castaneda RE, Beas-Zarate C. (2012) Structure and function of NMDA-type glutamate receptor subunits. Neurologia 27: 301-310.</p>\n\n<p>Gao L, Fang JS, Bai XY, Zhou D, Wang YT, Liu AL, Du GH. (2013) In silico Target Fishing for the Potential Targets and Molecular Mechanisms of Baicalein as an Antiparkinsonian Agent: Discovery of the Protective Effects on NMDA Receptor-Mediated Neurotoxicity. Chem Biol Drug Des. 81: 675-87.</p>\n\n<p>Koo JCP, Hampson DR. (2010) Phylogenic and evolutionary analysis of glutamate receptor based on extant invertebrate genes. JULS 1: 42-48.</p>\n\n<p>Korkut A, Varnali T. (2003) Quantitative structure activity relationship (QSAR) of competitive N-methyl-D-aspartate (NMDA) antagonists. Mol Phys 101: 3285-3291.</p>\n\n<p>Koutsoukas A, Simms B, Kirchmair J, Bond PJ, Whitmore AV, Zimmer S, Young MP, Jenkins JL, Glick M, Glen RC, Bender A. (2011) From in silico target prediction to multi-target drug design: current databases, methods and applications. J Proteomics 74: 2554-2574.</p>\n\n<p>Lovinger DM. (1995) Developmental decrease in ethanol inhibition of N-methyl-D-aspartate receptors in rat neocortical neurons: relation to the actions of ifenprodil. J Pharmacol Exp Ther. 274: 164-172.</p>\n\n<p>Mazumder MK, Borah A. (2014) Piroxicam inhibits NMDA receptor-mediated excitotoxicity through allosteric inhibition of the GluN2B subunit: An in silico study elucidating a novel mechanism of action of the drug. Medical Hypotheses 83: 740&ndash;746.</p>\n\n<p>Morris RJ. (1989) Synaptic Plasticity and Learning: Selective Impairment of Learning in Rats and Blockade of Long-Term Potentiation in vivo by the N-Methyl-D-Aspartate Receptor Antagonist AP5. J Neurosci 9: 3040-3057.</p>\n\n<p>Mugnaini M, van Amsterdam FT, Ratti E, Trist DG, Bowery NG. (1996) Regionally different N-methyl-D-aspartate receptors distinguished by ligand binding and quantitative autoradiography of [3H]-CGP 39653 in rat brain. Br J Pharmacol 119: 819&ndash;828.</p>\n\n<p>Nagy J. (2008) Alcohol related changes in regulation of NMDA receptor functions. Curr Neuropharmacol 6: 39-54.</p>\n\n<p>Neal AP, Guilarte TR. (2010) Molecular Neurobiology of Lead (Pb2+): Effects on Synaptic Function. Mol Neurobiol. 42: 151-160.</p>\n\n<p>Neal AP. Worley PF. Guilarte TR (2011) Lead exposure during synaptogenesis alters NMDA receptor targeting via NMDA receptor inhibition. Neurotoxicology. 32:281-289.</p>\n\n<p>Nihei MK, Guilarte TR. (1999) NMDAR-2A subunit protein expression is reduced in the hippocampus of rats exposed to Pb2+ during development. Brain Res Mol Brain Res. 66: 42-49.</p>\n\n<p>Reynolds IJ. (2001) [3H](+)MK801 radioligand binding assay at the N-methyl-D-aspartate receptor. Curr Protoc Pharmacol. Chapter 1:Unit 1.20. doi: 10.1002/0471141755.ph0120s11.</p>\n\n<p>Scheuhammer AM, Basu N, Burgess NM, Elliott JE, Campbell GD, Wayland M, Champoux L, Rodrigue J. (2008) Relationships among mercury, selenium, and neurochemical parameters in common loons (Gavia immer) and bald eagles (Haliaeetus leucocephalus). Ecotoxicology 17: 93-101.</p>\n\n<p>Slater P, McConnell SE, D&#39;Souza SW, Barson AJ. (1993) Postnatal changes in N-methyl-D-aspartate receptor binding and stimulation by glutamate and glycine of [3H]-MK-801 binding in human temporal cortex. Br J Pharmacol. 108: 1143-1149.</p>\n\n<p>Smothers CT, Woodward JJ. (2007) Pharmacological characterization of glycine-activated currents in HEK 293 cells expressing N-methyl-d-aspartate NR1 and NR3 subunits. J Pharmacol Exp Ther. 322: 739-748.</p>\n\n<p>Teng H, Cai W, Zhou L, Zhang J, Liu Q, Wang Y, et al. (2010) Evolutionary mode of functional divergence of vertebrate NMDA receptor subunit 2 Genes. PLoS ONE. 5(10): e13342.</p>\n\n<p>Tikhonov DB, Magazanik LG. (2009) Origin and molecular evolution of ionotropic glutamate receptors. Neurosci Behav Physiol. 39: 763-772.</p>\n\n<p>Tovar KR, Westbrook GL. (1999) The incorporation of NMDA receptors with a distinct subunit composition at nascent hippocampal synapses in vitro. J Neurosci. 19: 4180&ndash;4188.</p>\n\n<p>Traynelis S, Wollmuth LP, McBain CJ, Menniti FS, Vance KM, Ogden KK, Hansen KB, Yuan H, Myers SJ, Dingledine R. (2010) Glutamate receptor ion channels: structure, regulation, and function. Pharmacol Rev. 62: 405-496.</p>\n\n<p>Woodruff GN, Foster AC, Gill R, Kemp JA, Wong EH, Iversen LL. (1987) The interaction between MK-801 and receptors for N-methyl-D-aspartate: functional consequences. Neuropharmacology 26(7B): 903-909.</p>\n\n<p>Xia S, Chiang AS. (2009) NMDA Receptors in Drosophila. In: Van Dongen AM, editor. Biology of the NMDA Receptor. Boca Raton (FL): CRC Press; Chapter 10. Available from: <a class=\"external free\" href=\"http://www.ncbi.nlm.nih.gov/books/NBK5286/\" rel=\"nofollow\" target=\"_blank\">http://www.ncbi.nlm.nih.gov/books/NBK5286/</a></p>\n","biologicalOrganisationLevel":"Molecular","organTerm":{},"biologicalEvents":[{"object":{}}],"keyEventStressors":["Lead"],"id":201}
{"title":"Reduced levels of BDNF","references":"<p><br />\nAid T, Kazantseva A, Piirsoo M, Palm K, Timmusk T. (2007) Mouse and rat BDNF gene structure and expression revisited. J Neurosci Res. 85: 525-535.</p>\n\n<p>Balkowiec A, Katz DM. (2002) Cellular mechanisms regulating activity-dependent release of native brain-derived neurotrophic factor from hippocampal neurons. J Neurosci. 22: 10399-10407.</p>\n\n<p>Brenowitz EA. (2013) Testosterone and brain-derived neurotrophic factor interactions in the avian song control system. Neuroscience 239: 115-123.</p>\n\n<p>Coco M, Caggia S, Musumeci G, Perciavalle V, Graziano AC, Pannuzzo G, Cardile V. (2013) Sodium L-lactate differently affects brain-derived neurothrophic factor, inducible nitric oxide synthase, and heat shock protein 70 kDa production in human astrocytes and SH-SY5Y cultures.J Neurosci Res. 91: 313-320.</p>\n\n<p>Cohen-Cory S, Kidane AH, Shirkey NJ, Marshak S. (2010) Brain-derived neurotrophic factor and the development of structural neuronal connectivity. Dev Neurobiol. 70: 271-288.</p>\n\n<p><a href=\"https://www.ncbi.nlm.nih.gov/pubmed/?term=D%27Angelo%20L%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=23983038\">D&#39;Angelo L</a>, <a href=\"https://www.ncbi.nlm.nih.gov/pubmed/?term=De%20Girolamo%20P%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=23983038\">De Girolamo P</a>, <a href=\"https://www.ncbi.nlm.nih.gov/pubmed/?term=Lucini%20C%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=23983038\">Lucini C</a>, <a href=\"https://www.ncbi.nlm.nih.gov/pubmed/?term=Terzibasi%20ET%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=23983038\">Terzibasi ET</a>, <a href=\"https://www.ncbi.nlm.nih.gov/pubmed/?term=Baumgart%20M%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=23983038\">Baumgart M</a>, <a href=\"https://www.ncbi.nlm.nih.gov/pubmed/?term=Castaldo%20L%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=23983038\">Castaldo L</a>, <a href=\"https://www.ncbi.nlm.nih.gov/pubmed/?term=Cellerino%20A%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=23983038\">Cellerino A</a> (2014). Brain-derived neurotrophic factor: mRNA expression and protein distribution in the brain of the teleost Nothobranchius furzeri. <a href=\"https://www.ncbi.nlm.nih.gov/pubmed/23983038\" title=\"The Journal of comparative neurology.\">J Comp Neurol.</a> 1;522(5):1004-30.</p>\n\n<p>Dubreuil CI, Winton MJ, McKerracher L. (2003) Rho activation patterns after spinal cord injury and the role of activated Rho in apoptosis in the central nervous system. J Cell Biol. 162: 233-243.</p>\n\n<p>Elfving B, Plougmann PH, Wegener G. (2010) Detection of brain-derived neurotrophic factor (BDNF) in rat blood and brain preparations using ELISA: pitfalls and solutions. J Neurosci Methods 187: 73-77.</p>\n\n<p>Endo T. (2005) Glycans and glycan-binding proteins in brain: galectin-1-induced expression of neurotrophic factors in astrocytes. Curr Drug Targets. 6:427-436.</p>\n\n<p>Head BP, Patel HH, Niesman IR, Drummond JC, Roth DM, Patel PM. (2009) Inhibition of p75 neurotrophin receptor attenuates isoflurane-mediated neuronal apoptosis in the neonatal central nervous system. Anesthesiology 110: 813-825.</p>\n\n<p>Heinrich G, Pagtakhan CJ. (2004) Both 5&#39; and 3&#39; flanks regulate Zebrafish brain-derived neurotrophic factor gene expression. BMC Neurosci. 5: 19.</p>\n\n<p>Klein AB, Williamson R, Santini MA, Clemmensen C, Ettrup A, Rios M, Knudsen GM, Aznar S. (2011) Blood BDNF concentrations reflect brain-tissue BDNF levels across species. Int J Neuropsychopharmacol. 14: 347-353.</p>\n\n<p>Lessmann V, Gottmann K, Malcangio M. (2003) Neurotrophin secretion: current facts and future prospects. Prog Neurobiol. 69: 341-374.</p>\n\n<p>Lu B, Pang PT, Woo NH. (2005) The yin and yang of neurotrophin action. Nat Rev Neurosci. 6: 603-614.</p>\n\n<p>Marshak S, Nikolakopoulou AM, Dirks R, Martens GJ, Cohen-Cory S (2007)Cell-autonomous TrkB signaling in presynaptic retinal ganglion cells mediates axon arbor growth and synapse maturation during the establishment of retinotectal synaptic connectivity. J Neurosci 27:2444 &ndash;2456.</p>\n\n<p>Nelson TJ, Alkon DL. (2014) Molecular regulation of synaptogenesis during associative learning and memory. Brain Res. pii: S0006-8993(14)01660-6. doi: 10.1016/j.brainres.2014.11.054.</p>\n\n<p>Pang PT, Teng HK, Zaitsev E, Woo NT, Sakata K, Zhen S, Teng KK, Yung WH, Hempstead BL, Lu B. (2004) Cleavage of proBDNF by tPA/plasmin is essential for long-term hippocampal plasticity. Science. 306: 487-491.</p>\n\n<p>Pruunsild P, Kazantseva A, Aid T, Palm K, Timmusk T. (2007) Dissecting the human BDNF locus: bidirectional transcription, complex splicing, and multiple promoters. Genomics. 90: 397-406.</p>\n\n<p>Sanchez AL, Matthews BJ, Meynard MM, Hu B, Javed S, Cohen Cory S (2006) BDNF increases synapse density in dendrites of developing tectal neurons in vivo. Development 133:2477&ndash;2486.</p>\n\n<p>Soul&eacute; J, Messaoudi E, Bramham CR. (2006) Brain-derived neurotrophic factor and control of synaptic consolidation in the adult brain. Biochem Soc Trans. 34&nbsp;:600-604.</p>\n\n<p>Trajkovska V, Marcussen AB, Vinberg M, Hartvig P, Aznar S, Knudsen GM. (2007) Measurements of brain-derived neurotrophic factor: methodological aspects and demographical data. Brain Res Bull. 73: 143-149.</p>\n\n<p>Waterhouse EG, Xu B. (2009) New insights into the role of brain-derived neurotrophic factor in synaptic plasticity. Mol Cell Neurosci. 42: 81-89.</p>\n\n<p>Wessels JM, Wu L, Leyland NA, Wang H, Foster WG. (2014) The Brain-Uterus Connection: Brain Derived Neurotrophic Factor (BDNF) and Its Receptor (Ntrk2) Are Conserved in the Mammalian Uterus. PLoS ONE 9: e94036.</p>\n\n<p>Yamauchi J, Chan JR, Shooter EM. (2004) Neurotrophins regulate Schwann cell migration by activating divergent signaling pathways dependent on Rho GTPases. Proc Natl Acad Sci U S A. 101: 8774-8779.</p>\n\n<p>Zhang J, Sokal I, Peskind ER, Quinn JF, Jankovic J, Kenney C, Chung KA, Millard SP, Nutt JG, Montine TJ. (2008) CSF multianalyte profile distinguishes Alzheimer and Parkinson diseases. Am J Clin Pathol. 129: 526-529.</p>\n","biologicalOrganisationLevel":"Molecular","organTerm":{},"biologicalEvents":[{"action":"decreased","process":"gene expression","object":{"name":"brain-derived neurotrophic factor","source":"PR","sourceId":"PR:000004716"}},{"action":"decreased","process":"secretion","object":{"name":"brain-derived neurotrophic factor","source":"PR","sourceId":"PR:000004716"}}],"id":381}
{"title":"Reduced levels of BDNF","references":"<p><br />\nAid T, Kazantseva A, Piirsoo M, Palm K, Timmusk T. (2007) Mouse and rat BDNF gene structure and expression revisited. J Neurosci Res. 85: 525-535.</p>\n\n<p>Balkowiec A, Katz DM. (2002) Cellular mechanisms regulating activity-dependent release of native brain-derived neurotrophic factor from hippocampal neurons. J Neurosci. 22: 10399-10407.</p>\n\n<p>Brenowitz EA. (2013) Testosterone and brain-derived neurotrophic factor interactions in the avian song control system. Neuroscience 239: 115-123.</p>\n\n<p>Coco M, Caggia S, Musumeci G, Perciavalle V, Graziano AC, Pannuzzo G, Cardile V. (2013) Sodium L-lactate differently affects brain-derived neurothrophic factor, inducible nitric oxide synthase, and heat shock protein 70 kDa production in human astrocytes and SH-SY5Y cultures.J Neurosci Res. 91: 313-320.</p>\n\n<p>Cohen-Cory S, Kidane AH, Shirkey NJ, Marshak S. (2010) Brain-derived neurotrophic factor and the development of structural neuronal connectivity. Dev Neurobiol. 70: 271-288.</p>\n\n<p><a href=\"https://www.ncbi.nlm.nih.gov/pubmed/?term=D%27Angelo%20L%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=23983038\">D&#39;Angelo L</a>, <a href=\"https://www.ncbi.nlm.nih.gov/pubmed/?term=De%20Girolamo%20P%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=23983038\">De Girolamo P</a>, <a href=\"https://www.ncbi.nlm.nih.gov/pubmed/?term=Lucini%20C%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=23983038\">Lucini C</a>, <a href=\"https://www.ncbi.nlm.nih.gov/pubmed/?term=Terzibasi%20ET%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=23983038\">Terzibasi ET</a>, <a href=\"https://www.ncbi.nlm.nih.gov/pubmed/?term=Baumgart%20M%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=23983038\">Baumgart M</a>, <a href=\"https://www.ncbi.nlm.nih.gov/pubmed/?term=Castaldo%20L%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=23983038\">Castaldo L</a>, <a href=\"https://www.ncbi.nlm.nih.gov/pubmed/?term=Cellerino%20A%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=23983038\">Cellerino A</a> (2014). Brain-derived neurotrophic factor: mRNA expression and protein distribution in the brain of the teleost Nothobranchius furzeri. <a href=\"https://www.ncbi.nlm.nih.gov/pubmed/23983038\" title=\"The Journal of comparative neurology.\">J Comp Neurol.</a> 1;522(5):1004-30.</p>\n\n<p>Dubreuil CI, Winton MJ, McKerracher L. (2003) Rho activation patterns after spinal cord injury and the role of activated Rho in apoptosis in the central nervous system. J Cell Biol. 162: 233-243.</p>\n\n<p>Elfving B, Plougmann PH, Wegener G. (2010) Detection of brain-derived neurotrophic factor (BDNF) in rat blood and brain preparations using ELISA: pitfalls and solutions. J Neurosci Methods 187: 73-77.</p>\n\n<p>Endo T. (2005) Glycans and glycan-binding proteins in brain: galectin-1-induced expression of neurotrophic factors in astrocytes. Curr Drug Targets. 6:427-436.</p>\n\n<p>Head BP, Patel HH, Niesman IR, Drummond JC, Roth DM, Patel PM. (2009) Inhibition of p75 neurotrophin receptor attenuates isoflurane-mediated neuronal apoptosis in the neonatal central nervous system. Anesthesiology 110: 813-825.</p>\n\n<p>Heinrich G, Pagtakhan CJ. (2004) Both 5&#39; and 3&#39; flanks regulate Zebrafish brain-derived neurotrophic factor gene expression. BMC Neurosci. 5: 19.</p>\n\n<p>Klein AB, Williamson R, Santini MA, Clemmensen C, Ettrup A, Rios M, Knudsen GM, Aznar S. (2011) Blood BDNF concentrations reflect brain-tissue BDNF levels across species. Int J Neuropsychopharmacol. 14: 347-353.</p>\n\n<p>Lessmann V, Gottmann K, Malcangio M. (2003) Neurotrophin secretion: current facts and future prospects. Prog Neurobiol. 69: 341-374.</p>\n\n<p>Lu B, Pang PT, Woo NH. (2005) The yin and yang of neurotrophin action. Nat Rev Neurosci. 6: 603-614.</p>\n\n<p>Marshak S, Nikolakopoulou AM, Dirks R, Martens GJ, Cohen-Cory S (2007)Cell-autonomous TrkB signaling in presynaptic retinal ganglion cells mediates axon arbor growth and synapse maturation during the establishment of retinotectal synaptic connectivity. J Neurosci 27:2444 &ndash;2456.</p>\n\n<p>Nelson TJ, Alkon DL. (2014) Molecular regulation of synaptogenesis during associative learning and memory. Brain Res. pii: S0006-8993(14)01660-6. doi: 10.1016/j.brainres.2014.11.054.</p>\n\n<p>Pang PT, Teng HK, Zaitsev E, Woo NT, Sakata K, Zhen S, Teng KK, Yung WH, Hempstead BL, Lu B. (2004) Cleavage of proBDNF by tPA/plasmin is essential for long-term hippocampal plasticity. Science. 306: 487-491.</p>\n\n<p>Pruunsild P, Kazantseva A, Aid T, Palm K, Timmusk T. (2007) Dissecting the human BDNF locus: bidirectional transcription, complex splicing, and multiple promoters. Genomics. 90: 397-406.</p>\n\n<p>Sanchez AL, Matthews BJ, Meynard MM, Hu B, Javed S, Cohen Cory S (2006) BDNF increases synapse density in dendrites of developing tectal neurons in vivo. Development 133:2477&ndash;2486.</p>\n\n<p>Soul&eacute; J, Messaoudi E, Bramham CR. (2006) Brain-derived neurotrophic factor and control of synaptic consolidation in the adult brain. Biochem Soc Trans. 34&nbsp;:600-604.</p>\n\n<p>Trajkovska V, Marcussen AB, Vinberg M, Hartvig P, Aznar S, Knudsen GM. (2007) Measurements of brain-derived neurotrophic factor: methodological aspects and demographical data. Brain Res Bull. 73: 143-149.</p>\n\n<p>Waterhouse EG, Xu B. (2009) New insights into the role of brain-derived neurotrophic factor in synaptic plasticity. Mol Cell Neurosci. 42: 81-89.</p>\n\n<p>Wessels JM, Wu L, Leyland NA, Wang H, Foster WG. (2014) The Brain-Uterus Connection: Brain Derived Neurotrophic Factor (BDNF) and Its Receptor (Ntrk2) Are Conserved in the Mammalian Uterus. PLoS ONE 9: e94036.</p>\n\n<p>Yamauchi J, Chan JR, Shooter EM. (2004) Neurotrophins regulate Schwann cell migration by activating divergent signaling pathways dependent on Rho GTPases. Proc Natl Acad Sci U S A. 101: 8774-8779.</p>\n\n<p>Zhang J, Sokal I, Peskind ER, Quinn JF, Jankovic J, Kenney C, Chung KA, Millard SP, Nutt JG, Montine TJ. (2008) CSF multianalyte profile distinguishes Alzheimer and Parkinson diseases. Am J Clin Pathol. 129: 526-529.</p>\n","biologicalOrganisationLevel":"Molecular","organTerm":{},"biologicalEvents":[{"action":"decreased","process":"gene expression","object":{"name":"brain-derived neurotrophic factor","source":"PR","sourceId":"PR:000004716"}},{"action":"decreased","process":"secretion","object":{"name":"brain-derived neurotrophic factor","source":"PR","sourceId":"PR:000004716"}}],"id":381}
{"title":"Cell injury/death","references":"<ul>\n\t<li>Fujikawa, D.G. (2015), The role of excitotoxic programmed necrosis in acute brain injury, Comput Struct Biotechnol J, vol. 13, pp. 212-221.</li>\n\t<li>Malhi, H. et al. (2010), Hepatocyte death: a clear and present danger, Physiol Rev, vol. 90, no. 3, pp. 1165-1194.</li>\n\t<li>Kaplowitz, N. (2002), Biochemical and Cellular Mechanisms of Toxic Liver Injury, Semin Liver Dis, vol. 22, no. 2, <a class=\"external free\" href=\"http://www.medscape.com/viewarticle/433631\" rel=\"nofollow\" target=\"_blank\">http://www.medscape.com/viewarticle/433631</a> (accessed on 20 January 2016).</li>\n\t<li>Kroemer, G. et al., (2009), Classification of cell death: recommendations of the Nomenclature Committee on Cell Death, Cell Death Differ, vol. 16, no. 1, pp. 3-11.</li>\n\t<li>Chan, F.K., K. Moriwaki and M.J. De Rosa (2013), Detection of necrosis by release of lactate dehydrogenase (LDH) activity, Methods Mol Biol, vol. 979, pp. 65&ndash;70.</li>\n\t<li>Berridge, M.V., P.M. Herst and A.S. Tan (2005), Tetrazolium dyes as tools in cell biology: new insights into their cellular reduction. Biotechnology Annual Review, vol. 11, pp 127-152.</li>\n\t<li>Moore, A, et al.(1998), Simultaneous measurement of cell cycle and apoptotic cell death,Methods Cell Biol, vol. 57, pp. 265&ndash;278.</li>\n\t<li>Li, Peng et al. (2004), Mitochondrial activation of apoptosis, Cell, vol. 116, no. 2 Suppl,pp. S57-59, 2 p following S59.</li>\n\t<li>Loo, D.T. (2002), TUNEL Assay an overview of techniques, Methods in Molecular Biology, vol. 203: In Situ Detection of DNA Damage, chapter 2, Didenko VV (ed.), Humana Press Inc.</li>\n\t<li>Kubbies, M. and P.S. Rabinovitch (1983), Flow cytometric analysis of factors which influence the BrdUrd-Hoechst quenching effect in cultivated human fibroblasts and lymphocytes, Cytometry, vol. 3, no. 4, pp. 276&ndash;281.</li>\n\t<li>Fink, S.L. and B.T. Cookson (2005), Apoptosis, pyroptosis, and necrosis: mechanistic description of dead and dying eukaryotic cells, Infect Immun, vol. 73, no. 4, pp.1907-1916.</li>\n\t<li>O&#39;Brien J, Wilson I, Orton T, Pognan F. 2000. Investigation of the Alamar Blue (resazurin) fluorescent dye for the assessment of mammalian cell cytotoxicity. European journal of biochemistry / FEBS 267(17): 5421-5426.</li>\n\t<li>Repetto G, del Peso A, Zurita JL. 2008. Neutral red uptake assay for the estimation of cell viability/cytotoxicity. Nature protocols 3(7): 1125-1131.</li>\n</ul>\n","biologicalOrganisationLevel":"Cellular","organTerm":{},"biologicalEvents":[{"action":"increased","process":"cell death","object":{}}],"id":55}
{"title":"Impairment, Learning and memory","references":"<p>Aggleton JP, Brown MW. (1999) Episodic memory, amnesia, and the hippocampal-anterior thalamic axis. Behav Brain Sci. 22: 425-489.</p>\n\n<p>Alexander RD (1990) Epigenetic rules and Darwinian algorithms: The adaptive study of learning and development. Ethology and Sociobiology 11:241-303.</p>\n\n<p>Bellinger DC (2012) A strategy for comparing the contributions of environmental chemicals and other risk factors to neurodevelopment of children. Environ Health Perspect 120:501-507.</p>\n\n<p>Burgess N (2002) The hippocampus, space, and viewpoints in episodic memory. Q J Exp Psychol A 55:1057-1080. Cohen, SJ and Stackman, RW. (2015). Assessing rodent hippocampal involvement in the novel object recognition task. A review. Behav. Brain Res. 285: 105-1176.</p>\n\n<p>Cohen, SJ and Stackman, RW. (2015). Assessing rodent hippocampal involvement in the novel object recognition task. A review. Behav. Brain Res. 285: 105-1176.</p>\n\n<p>Curzon P, Rustay NR, Browman KE. Cued and Contextual Fear Conditioning for Rodents. In: Buccafusco JJ, editor. Methods of Behavior Analysis in Neuroscience. 2nd edition. Boca Raton (FL): CRC Press/Taylor &amp; Francis; 2009.</p>\n\n<p>D&#39;Hooge R, De Deyn PP (2001) Applications of the Morris water maze in the study of learning and memory. Brain Res Brain Res Rev 36:60-90.</p>\n\n<p>Doya K. (2000) Complementary roles of basal ganglia and cerebellum in learning and motor control. Curr Opin Neurobiol. 10: 732-739.</p>\n\n<p>Eichenbaum H (2000) A cortical-hippocampal system for declarative memory. Nat Rev Neurosci 1:41-50.</p>\n\n<p>Fivush R. The development of autobiographical memory. Annu Rev Psychol. 2011;62:559-82.</p>\n\n<p>Gilbert ME, Sanchez-Huerta K, Wood C (2016) Mild Thyroid Hormone Insufficiency During Development Compromises Activity-Dependent Neuroplasticity in the Hippocampus of Adult Male Rats. Endocrinology 157:774-787.</p>\n\n<p>Gilbert ME, Rovet J, Chen Z, Koibuchi N. (2012) Developmental thyroid hormone disruption: prevalence, environmental contaminants and neurodevelopmental consequences. Neurotoxicology 33: 842-52.</p>\n\n<p>Gilbert ME, Sui L (2006) Dose-dependent reductions in spatial learning and synaptic function in the dentate gyrus of adult rats following developmental thyroid hormone insufficiency. Brain Res 1069:10-22.</p>\n\n<p>Guirfa, M., Sandoz, J.C., 2012. Invertebrate learning and memory: fifty years of olfactory conditioning of the proboscis extension response in honeybees. Learn. Mem. 19 (2),<br />\n54&ndash;66.</p>\n\n<p>Herold, C, L&auml;sser, MM, Schmid, LA, Seidl, U, Kong, L, Fellhauer, I, Thomann,PA, Essig, M and Schr&ouml;der, J. (2015). Neuropsychology, Autobiographical Memory, and Hippocampal Volume in &ldquo;Younger&rdquo; and &ldquo;Older&rdquo; Patients with Chronic Schizophrenia. Front. Psychiatry, 6: 53.</p>\n\n<p>LaLone, C.A., Villeneuve, D.L., Wu-Smart, J., Milsk, R.Y., Sappington, K., Garber, K.V., Housenger, J. and Ankley, G.T., 2017. Weight of evidence evaluation of a network of adverse outcome pathways linking activation of the nicotinic acetylcholine receptor in honey bees to colony death.<em> </em>STOTEN. 584-585, 751-775.</p>\n\n<p>Lezak MD (1984) Neuropsychological assessment in behavioral toxicology--developing techniques and interpretative issues. Scand J Work Environ Health 10 Suppl 1:25-29.</p>\n\n<p>Lezak MD (1994) Domains of behavior from a neuropsychological perspective: the whole story. Nebr Symp Motiv 41:23-55.</p>\n\n<p>Makris SL, Raffaele K, Allen S, Bowers WJ, Hass U, Alleva E, Calamandrei G, Sheets L, Amcoff P, Delrue N, Crofton KM.(2009) A retrospective performance assessment of the developmental neurotoxicity study in support of OECD test guideline 426. Environ Health Perspect.&nbsp; Jan;117(1):17-25.</p>\n\n<p>Menzel, R., 2012. The honeybee as a model for understanding the basis of cognition. Nat. Rev. Neurosci. 13 (11), 758&ndash;768.</p>\n\n<p>Mitchell AS, Dalrymple-Alford JC, Christie MA. (2002) Spatial working memory and the brainstem cholinergic innervation to the anterior thalamus. J Neurosci. 22: 1922-1928.</p>\n\n<p>OECD. 2007. OECD guidelines for the testing of chemicals/ section 4: Health effects. Test no. 426: Developmental neurotoxicity study. www.Oecd.Org/dataoecd/20/52/37622194.Pdf [accessed may 21, 2012].</p>\n\n<p>OECD (2008) Nr 43 GUIDANCE DOCUMENT ON MAMMALIAN REPRODUCTIVE TOXICITY TESTING AND ASSESSMENT. ENV/JM/MONO(2008)16</p>\n\n<p>Ono T. (2009) Learning and Memory. Encyclopedia of neuroscience. M D. Binder, N. Hirokawa and U. Windhorst (Eds). Springer-Verlag GmbH Berlin Heidelberg. pp 2129-2137.</p>\n\n<p>Puig, M.V., Antzoulatos, E.G., Miller, E.K., 2014. Prefrontal dopamine in associative learning and memory. Neuroscience 282, 217&ndash;229.</p>\n\n<p>Roberts AC, Bill BR, Glanzman DL. (2013) Learning and memory in zebrafish larvae. Front Neural Circuits 7: 126.</p>\n\n<p>Rohlman DS, Lucchini R, Anger WK, Bellinger DC, van Thriel C. (2008) Neurobehavioral testing in human risk assessment. Neurotoxicology. 29: 556-567.</p>\n\n<p>Shin, MS, Park, SY, Park, SR, Oeol, SH and Kwon, JS. (2006). Clinical and empirical applications of the Rey-Osterieth complex figure test. Nature Protocols, 1: 892-899.</p>\n\n<p>Shors TJ, Miesegaes G, Beylin A, Zhao M, Rydel T, Gould E (2001) Neurogenesis in the adult is involved in the formation of trace memories. Nature 410:372-376.</p>\n\n<p>Stanton ME, Spear LP (1990) Workshop on the qualitative and quantitative comparability of human and animal developmental neurotoxicity, Work Group I report: comparability of measures of developmental neurotoxicity in humans and laboratory animals. Neurotoxicol Teratol 12:261-267.</p>\n\n<p>Talley, JL. (1986). Memory in learning disabled children: Digit span and eh Rey Auditory verbal learning test. Archives of Clinical Neuropsychology, Elseiver.</p>\n\n<p>Toscano CD, Guilarte TR. (2005) Lead neurotoxicity: From exposure to molecular effects. Brain Res Rev. 49: 529-554.</p>\n\n<p>U.S.EPA. 1998. Health effects guidelines OPPTS 870.6300 developmental neurotoxicity study. EPA Document 712-C-98-239.Office of Prevention Pesticides and Toxic Substances.</p>\n\n<p>Vorhees CV, Williams MT (2014) Assessing spatial learning and memory in rodents. ILAR J 55:310-332.</p>\n\n<p>Willoughby KA, McAndrews MP, Rovet JF. Accuracy of episodic autobiographical memory in children with early thyroid hormone deficiency using a staged event. Dev Cogn Neurosci. 2014 Jul;9:1-11.</p>\n\n<p>&nbsp;</p>\n","biologicalOrganisationLevel":"Individual","organTerm":{},"biologicalEvents":[{"action":"decreased","process":"learning","object":{}},{"action":"decreased","process":"memory","object":{}}],"id":341}
{"title":"Impairment, Learning and memory","references":"<p>Aggleton JP, Brown MW. (1999) Episodic memory, amnesia, and the hippocampal-anterior thalamic axis. Behav Brain Sci. 22: 425-489.</p>\n\n<p>Alexander RD (1990) Epigenetic rules and Darwinian algorithms: The adaptive study of learning and development. Ethology and Sociobiology 11:241-303.</p>\n\n<p>Bellinger DC (2012) A strategy for comparing the contributions of environmental chemicals and other risk factors to neurodevelopment of children. Environ Health Perspect 120:501-507.</p>\n\n<p>Burgess N (2002) The hippocampus, space, and viewpoints in episodic memory. Q J Exp Psychol A 55:1057-1080. Cohen, SJ and Stackman, RW. (2015). Assessing rodent hippocampal involvement in the novel object recognition task. A review. Behav. Brain Res. 285: 105-1176.</p>\n\n<p>Cohen, SJ and Stackman, RW. (2015). Assessing rodent hippocampal involvement in the novel object recognition task. A review. Behav. Brain Res. 285: 105-1176.</p>\n\n<p>Curzon P, Rustay NR, Browman KE. Cued and Contextual Fear Conditioning for Rodents. In: Buccafusco JJ, editor. Methods of Behavior Analysis in Neuroscience. 2nd edition. Boca Raton (FL): CRC Press/Taylor &amp; Francis; 2009.</p>\n\n<p>D&#39;Hooge R, De Deyn PP (2001) Applications of the Morris water maze in the study of learning and memory. Brain Res Brain Res Rev 36:60-90.</p>\n\n<p>Doya K. (2000) Complementary roles of basal ganglia and cerebellum in learning and motor control. Curr Opin Neurobiol. 10: 732-739.</p>\n\n<p>Eichenbaum H (2000) A cortical-hippocampal system for declarative memory. Nat Rev Neurosci 1:41-50.</p>\n\n<p>Fivush R. The development of autobiographical memory. Annu Rev Psychol. 2011;62:559-82.</p>\n\n<p>Gilbert ME, Sanchez-Huerta K, Wood C (2016) Mild Thyroid Hormone Insufficiency During Development Compromises Activity-Dependent Neuroplasticity in the Hippocampus of Adult Male Rats. Endocrinology 157:774-787.</p>\n\n<p>Gilbert ME, Rovet J, Chen Z, Koibuchi N. (2012) Developmental thyroid hormone disruption: prevalence, environmental contaminants and neurodevelopmental consequences. Neurotoxicology 33: 842-52.</p>\n\n<p>Gilbert ME, Sui L (2006) Dose-dependent reductions in spatial learning and synaptic function in the dentate gyrus of adult rats following developmental thyroid hormone insufficiency. Brain Res 1069:10-22.</p>\n\n<p>Guirfa, M., Sandoz, J.C., 2012. Invertebrate learning and memory: fifty years of olfactory conditioning of the proboscis extension response in honeybees. Learn. Mem. 19 (2),<br />\n54&ndash;66.</p>\n\n<p>Herold, C, L&auml;sser, MM, Schmid, LA, Seidl, U, Kong, L, Fellhauer, I, Thomann,PA, Essig, M and Schr&ouml;der, J. (2015). Neuropsychology, Autobiographical Memory, and Hippocampal Volume in &ldquo;Younger&rdquo; and &ldquo;Older&rdquo; Patients with Chronic Schizophrenia. Front. Psychiatry, 6: 53.</p>\n\n<p>LaLone, C.A., Villeneuve, D.L., Wu-Smart, J., Milsk, R.Y., Sappington, K., Garber, K.V., Housenger, J. and Ankley, G.T., 2017. Weight of evidence evaluation of a network of adverse outcome pathways linking activation of the nicotinic acetylcholine receptor in honey bees to colony death.<em> </em>STOTEN. 584-585, 751-775.</p>\n\n<p>Lezak MD (1984) Neuropsychological assessment in behavioral toxicology--developing techniques and interpretative issues. Scand J Work Environ Health 10 Suppl 1:25-29.</p>\n\n<p>Lezak MD (1994) Domains of behavior from a neuropsychological perspective: the whole story. Nebr Symp Motiv 41:23-55.</p>\n\n<p>Makris SL, Raffaele K, Allen S, Bowers WJ, Hass U, Alleva E, Calamandrei G, Sheets L, Amcoff P, Delrue N, Crofton KM.(2009) A retrospective performance assessment of the developmental neurotoxicity study in support of OECD test guideline 426. Environ Health Perspect.&nbsp; Jan;117(1):17-25.</p>\n\n<p>Menzel, R., 2012. The honeybee as a model for understanding the basis of cognition. Nat. Rev. Neurosci. 13 (11), 758&ndash;768.</p>\n\n<p>Mitchell AS, Dalrymple-Alford JC, Christie MA. (2002) Spatial working memory and the brainstem cholinergic innervation to the anterior thalamus. J Neurosci. 22: 1922-1928.</p>\n\n<p>OECD. 2007. OECD guidelines for the testing of chemicals/ section 4: Health effects. Test no. 426: Developmental neurotoxicity study. www.Oecd.Org/dataoecd/20/52/37622194.Pdf [accessed may 21, 2012].</p>\n\n<p>OECD (2008) Nr 43 GUIDANCE DOCUMENT ON MAMMALIAN REPRODUCTIVE TOXICITY TESTING AND ASSESSMENT. ENV/JM/MONO(2008)16</p>\n\n<p>Ono T. (2009) Learning and Memory. Encyclopedia of neuroscience. M D. Binder, N. Hirokawa and U. Windhorst (Eds). Springer-Verlag GmbH Berlin Heidelberg. pp 2129-2137.</p>\n\n<p>Puig, M.V., Antzoulatos, E.G., Miller, E.K., 2014. Prefrontal dopamine in associative learning and memory. Neuroscience 282, 217&ndash;229.</p>\n\n<p>Roberts AC, Bill BR, Glanzman DL. (2013) Learning and memory in zebrafish larvae. Front Neural Circuits 7: 126.</p>\n\n<p>Rohlman DS, Lucchini R, Anger WK, Bellinger DC, van Thriel C. (2008) Neurobehavioral testing in human risk assessment. Neurotoxicology. 29: 556-567.</p>\n\n<p>Shin, MS, Park, SY, Park, SR, Oeol, SH and Kwon, JS. (2006). Clinical and empirical applications of the Rey-Osterieth complex figure test. Nature Protocols, 1: 892-899.</p>\n\n<p>Shors TJ, Miesegaes G, Beylin A, Zhao M, Rydel T, Gould E (2001) Neurogenesis in the adult is involved in the formation of trace memories. Nature 410:372-376.</p>\n\n<p>Stanton ME, Spear LP (1990) Workshop on the qualitative and quantitative comparability of human and animal developmental neurotoxicity, Work Group I report: comparability of measures of developmental neurotoxicity in humans and laboratory animals. Neurotoxicol Teratol 12:261-267.</p>\n\n<p>Talley, JL. (1986). Memory in learning disabled children: Digit span and eh Rey Auditory verbal learning test. Archives of Clinical Neuropsychology, Elseiver.</p>\n\n<p>Toscano CD, Guilarte TR. (2005) Lead neurotoxicity: From exposure to molecular effects. Brain Res Rev. 49: 529-554.</p>\n\n<p>U.S.EPA. 1998. Health effects guidelines OPPTS 870.6300 developmental neurotoxicity study. EPA Document 712-C-98-239.Office of Prevention Pesticides and Toxic Substances.</p>\n\n<p>Vorhees CV, Williams MT (2014) Assessing spatial learning and memory in rodents. ILAR J 55:310-332.</p>\n\n<p>Willoughby KA, McAndrews MP, Rovet JF. Accuracy of episodic autobiographical memory in children with early thyroid hormone deficiency using a staged event. Dev Cogn Neurosci. 2014 Jul;9:1-11.</p>\n\n<p>&nbsp;</p>\n","biologicalOrganisationLevel":"Individual","organTerm":{},"biologicalEvents":[{"action":"decreased","process":"learning","object":{}},{"action":"decreased","process":"memory","object":{}}],"id":341}
{"title":"Aberrant, Dendritic morphology","references":"<p><br />\nCheng C, Trzcinski O, Doering LC. (2014) Fluorescent labeling of dendritic spines in cell cultures with the carbocyanine dye \"DiI\". Front Neuroanat. 8: 30.\n</p><p>Dailey ME, Smith SJ. (1996) The dynamics of dendritic structure in developing hippocampal slices. J Neurosci. 16: 2983-2994.\n</p><p>Fiala JC, Feinberg M, Popov V, Harris KM. (1998) Synaptogenesis via dendritic filopodia in developing hippocampal area CA1. J Neurosci. 18: 8900-8911.\n</p><p>Grueber WB, Jan LY, Jan YN. (2002) Tiling of the Drosophila epidermis by multidendritic sensory neurons. Development 129: 2867-2878.\n</p><p>Harrill JA, Mundy WR. (2011) Quantitative assessment of neurite outgrowth in PC12 cells. Methods Mol Biol. 758: 331-348. \n</p><p>Khazipov R, Esclapez M, Caillard O, Bernard C, Khalilov I, Tyzio R, Hirsch J, Dzhala V, Berger B, Ben-Ari Y. (2001) Early development of neuronal activity in the primate hippocampus in utero. J Neurosci. 21: 977097-81.\n</p><p>Kornau HC, LT Schenker, MB Kennedy, PH Seeburg. Domain interaction between NMDA receptor subunits and the postsynaptic density protein PSD-95. Science 22 September 1995: Vol. 269 no. 5231 pp. 1737-1740\n</p><p>Levine ND, Rademacher DJ, Collier TJ, O'Malley JA, Kells AP, San Sebastian W, Bankiewicz KS, Steece-Collier K. (2013) Advances in thin tissue Golgi-Cox impregnation: fast, reliable methods for multi-assay analyses in rodent and non-human primate brain. J Neurosci Methods 213: 214-227. \n</p><p>Mrzljak L, Uylings HB, Kostovic I, Van Eden CG. (1988). Prenatal development of neurons in the human prefrontal cortex: I. A qualitative Golgi study. J Compar Neurol. 271: 355-386.\n</p><p>Mrzljak L, Uylings HB, Van Eden CG, Judas M. (1990). Neuronal development in human prefrontal cortex in prenatal and postnatal stages. Prog Brain Res. 85: 185-222.\n</p><p>Redmond L. (2008) Translating neuronal activity into dendrite elaboration: signaling to the nucleus. Neurosignals 16: 194-208.\n</p><p>Rubel EW, Fritzsch B. (2002) Auditory system development: primary auditory neurons and their targets. Annu Rev Neurosci. 25: 51-101.\n</p><p>Scott EK, Luo L: (2001) How do dendrites take their shape? Nat Neurosci. 4: 359-365.\n</p><p>Sjstrm PJ, Rancz EA, Roth A, Husser M. (2008) Dendritic excitability and synaptic plasticity. Physiol Rev. 88: 769-840.\n</p><p>Stansfield KH, Pilsner JR, Lu Q, Wright RO, Guilarte TR. (2012) Dysregulation of BDNF-TrkB signaling in developing hippocampal neurons by Pb(2+): implications for an environmental basis of neurodevelopmental disorders. Toxicol Sci. 127: 277-295.\n</p>","biologicalOrganisationLevel":"Cellular","organTerm":{},"biologicalEvents":[{"action":"abnormal","process":"dendrite morphogenesis","object":{"name":"dendrite","source":"GO","sourceId":"GO:0030425"}}],"id":382}
{"title":"Decrease of synaptogenesis","references":"<p><br />\nBai X, Twaroski D, Bosnjak ZJ. (2013) Modeling anesthetic developmental neurotoxicity using human stem cells. Semin Cardiothorac Vasc Anesth. 17: 276-287.</p>\n\n<p>Col&oacute;n -Ramos DA. (2009) Synapse formation in developing neural circuits. Curr Top Devel Biol. 87: 53-79.</p>\n\n<p>Dean C, Dresbach T. (2006) Neuroligins and neurexins: linking cell adhesion, synapse formation and cognitive function. Trends Neurosci. 29:21-29.</p>\n\n<p>Erecinska M, Cherian S, Silver IA. (2004) Energy metabolism in mammalian brain during development. Prog Neurobiol. 73: 397-445.</p>\n\n<p>Erik I. Charyc, Barbara F. Akum, Joshua S. Goldber, Rebecka J. J&ouml;rnsten, Christopher Rongo, James Q. Zheng and Bonnie L. Firestein. Activity-Independent Regulation of Dendrite Patterning by Postsynaptic Density Protein PSD-95. Journal of Neuroscience 2006, 26(40): 10164-10176.</p>\n\n<p>Garner CC, Zhai RC, Gundelfinger ED, Ziv NE. (2002) Molecular mechanisms of CNS synaptogenesis. Cell Press 25: 243-250.</p>\n\n<p>Gatto CL, Broadie K. (2010) Genetic controls balancing excitatory and inhibitory synaptogenesis in neurodevelopmental disorder models. Front Syn Neurosci. 2: 4.</p>\n\n<p>Grabrucker A, Vaida B, Bockmann J, Boeckers TM. (2009) Synaptogenesis of hippocampal neurons in primary cell culture. Cell Tissue Res. 338: 333-341.</p>\n\n<p>Megias M, Emri Z, Freund TF, Gulyas AI. (2001) Total number and distribution of inhibitory and excitatory synapses on hippocampal CA1 pyramidal cells. Neuroscience 102: 527-540.</p>\n\n<p>Munno DW, Syed NI. (2003) Synaptogenesis in the CNS: an odyssey from wiring together to firing together. J Physiol. 552: 1-11.</p>\n\n<p>Nieland TJF, Logan DJ, Saulnier J, Lam D, Johnson C, et al. (2014) High Content Image Analysis Identifies Novel Regulators of Synaptogenesis in a High-Throughput RNAi Screen of Primary Neurons. PLoS ONE. 9: e91744.</p>\n\n<p>Schummers J, Mari&ntilde;o J, Sur M. (2002) Synaptic integration by V1 neurons depends on location within the orientation map. Neuron. 36: 969-978.</p>\n\n<p>Tau GZ, Peterson BS. (2010) Normal Development of Brain Circuits. Neuropsychopharmacology 35: 147-168.</p>\n","biologicalOrganisationLevel":"Cellular","organTerm":{},"biologicalEvents":[{"action":"decreased","process":"synapse assembly","object":{"name":"synapse","source":"GO","sourceId":"GO:0045202"}}],"id":385}
{"title":"Decrease of neuronal network function","references":"<p>Adams MM, Flagg RA, Gore AC., Perinatal changes in hypothalamic N-methyl-D-aspartate receptors and their relationship to gonadotropin-releasing hormone neurons. Endocrinology. 1999 May;140(5):2288-96.</p>\n\n<p>Binienda ZK, Beaudoin MA, Thorn BT, Ali SF. (2011) Analysis of electrical brain waves in neurotoxicology: &gamma;-hydroxybutyrate. Curr Neuropharmacol. 9: 236-239.</p>\n\n<p>Bosca, A., M. Martina, and C. Py (2014) Planar patch clamp for neuronal networks--considerations and future perspectives. Methods Mol Biol, 2014. 1183: p. 93-113.</p>\n\n<p>Erecinska M, Cherian S, Silver IA. (2004) Energy metabolism in mammalian brain during development. Prog Neurobiol. 73: 397-445.</p>\n\n<p>Gambrill AC, Barria A. NMDA receptor subunit composition controls synaptogenesis and synapse stabilization. Proc Natl Acad Sci U S A. 2011:108(14):5855-60.</p>\n\n<p>Gopal K. (2003) Neurotoxic effects of mercury on auditory cortex networks growing on microelectrode arrays: a preliminary analysis. Neurotoxicol Teratol. 25: 69-76.</p>\n\n<p>Gramowski A, Schiffmann D, Gross GW. (2000) Quantification of acute neurotoxic effects of trimethyltin using neuronal networks cultures on microelectrode arrays. Neurotoxicology 21: 331-342.</p>\n\n<p>Henson MA, Larsen RS, Lawson SN, P&eacute;rez-Ota&ntilde;o I, Nakanishi N, Lipton SA, Philpot BD. (2012) Genetic deletion of NR3A accelerates glutamatergic synapse maturation. PLoS One. 7(8).</p>\n\n<p>Hogberg HT, Sobanski T, Novellino A, Whelan M, Weiss DG, Bal-Price AK. (2011) Application of micro-electrode arrays (MEAs) as an emerging technology for developmental neurotoxicity: evaluation of domoic acid-induced effects in primary cultures of rat cortical neurons. Neurotoxicology 32: 158-168.</p>\n\n<p>Johnstone AFM, Gross GW, Weiss D, Schroeder O, Shafer TJ. (2010) Use of microelectrode arrays for neurotoxicity testing in the 21st century Neurotoxicology 31: 331-350.</p>\n\n<p>Keefer E, Norton S, Boyle N, Talesa V, Gross G. (2001) Acute toxicity screening of novel AChE inhibitors using neuronal networks on microelectrode arrays. Neurotoxicology 22: 3-12.</p>\n\n<p>Liu G. (2004) Local structural balance and functional interaction of excitatory and inhibitory synapses in hippocampal dendrites. Nat Neurosci. 7: 373-379.</p>\n\n<p>Mayford M, Siegelbaum SA, Kandel ER. (2012) Synapses and memory storage. Cold Spring Harb Perspect Biol. 4. pii: a005751.</p>\n\n<p>McConnell ER, McClain MA, Ross J, LeFew WR, Shafer TJ. (2012) Evaluation of multi-well microelectrode arrays for neurotoxicity screening using a chemical training set. Neurotoxicology 33: 1048-1057.</p>\n\n<p>Novellino A, Scelfo B, Palosaari T, Price A, Sobanski T, Shafer TJ, Johnstone AF, Gross GW, Gramowski A, Schroeder O, J&uuml;gelt K, Chiappalone M, Benfenati F, Martinoia S, Tedesco MT, Defranchi E, D&#39;Angelo P, Whelan M. (2011) Development of micro-electrode array based tests for neurotoxicity: assessment of interlaboratory reproducibility with neuroactive chemicals. Front Neuroeng. 4: 4.</p>\n\n<p>Yuste R, Peinado A, Katz LC. (1992) Neuronal domains in developing neocortex. Science 257: 665-669.</p>\n","biologicalOrganisationLevel":"Organ","organTerm":{"name":"brain","sourceId":"UBERON:0000955"},"biologicalEvents":[{"action":"decreased","process":"synaptic signaling","object":{}}],"id":386}
{"title":"Reduced, Presynaptic release of glutamate","references":"<p>Blanke ML, VanDongen AMJ. (2009) Activation Mechanisms of the NMDA Receptor. In: Van Dongen AM, editor. Biology of the NMDA Receptor. Boca Raton (FL): CRC Press; Chapter 13. Available from: <a rel=\"nofollow\" target=\"_blank\" class=\"external free\" href=\"http://www.ncbi.nlm.nih.gov/books/NBK5274/\">http://www.ncbi.nlm.nih.gov/books/NBK5274/</a>\n</p><p>Cleland TA. (1996) Inhibitory glutamate receptor channels. Mol Neurobiol. 13: 97-136.\n</p><p>Mattson MP. (1996) Calcium and free radicals: mediators of neurotrophic factor and excitatory transmitter regulated developmental plasticity and cell death. Perspect Dev Neurobiol. 3: 79-91.\n</p><p>Mattson MP. (2008) Glutamate and neurotrophic factors in neuronal plasticity and disease. Ann N Y Acad Sci. 1144: 97-112.\n</p><p>Meldrum BS. (2000) Glutamate as a neurotransmitter in the brain: review of physiology and pathology. J Nutr. 130: 1007S-1015S.\n</p><p>Nedergaard M, Takano T, Hansen AJ. (2002) Beyond the role of glutamate as a neurotransmitter. Nat Rev Neurosci. 3: 748-755.\n</p><p>Platt SR. (2007) The role of glutamate in central nervous system health and disease-a review. Vet J. 173: 278-286.\n</p><p>Rundfeldt C, Wla P, Lscher W. (1994) Anticonvulsant activity of antagonists and partial agonists for the NMDAR-associated glycine site in the kindling model of epilepsy. Brain Res. 653: 125-130.\n</p><p>Wieronska JM, Keczek N, Woniak M, Gruca P, aso-Tyburkiewicz M, Papp M, Braski P, Burnat G, Pilc A. (2015) mGlu-GABAB interplay in animal models of positive, negative and cognitive symptoms of schizophrenia.Neurochem Int. 88: 97-109.\n</p>","biologicalOrganisationLevel":"Molecular","organTerm":{},"biologicalEvents":[{"action":"decreased","process":"glutamate secretion","object":{"name":"glutamate(1-)","source":"CHEBI","sourceId":"CHEBI:14321"}}],"id":383}
{"title":"Activation, Glucocorticoid Receptor","references":"<p style=\"margin-left:0.5in\">Garland MA, Sengupta S, Mathew LK, Truong L, Jong ED, Piersma AH, Du JL, Tanguay RL. 2019. <em>Glucocorticoid receptor-dependent induction of </em>cripto-1<em> (one-eyed pinhead) inhibits zebrafish caudal fin regeneration. </em>Toxicology Reports 6:529-537. https://doi.org/10.1016/j.toxrep.2019.05.013</p>\n\n<p style=\"margin-left:0.5in\">Solte EH, Lidy Verberg van Kemenade BM, Savelkoul FJ, Flik G. 2006. <em>Evolution of glucocorticoid receptors with different glucocorticoid sensitivity.</em> Journal of Endocrinology 190:17-28. DOI: 10.1677/joe.1.06703</p>\n\n<p style=\"margin-left:0.5in\">Medlock Kakaley EK, Blackwell BR, Cardon MC, Conley JM, Evans N, Feifarek DJ, Furlong ET, Glassmeyer ST, Gray LE Jr, Hartig PC, Kolpin DW, Mills MA, Rosenblum L, Villeneuve DL, Wilson VS. <em>De Facto Water Reuse: Bioassay suite approach delivers depth and breadth in endocrine active compound detection</em>. Sci Total Environ. 2020 Jan 10;699:134297. doi: 10.1016/j.scitotenv.2019.134297. Epub 2019 Sep 4. PubMed PMID: 31683213.</p>\n\n<p>Conley JM, Lambright CS, Evans N, Strynar MJ, McCord J, McIntyre BS, Travlos GS, Cardon MC, Medlock-Kakaley E, Hartig PC, Wilson VS, Gray LE Jr. <em>Adverse Maternal, Fetal, and Postnatal Effects of Hexafluoropropylene Oxide Dimer Acid (GenX) from Oral Gestational Exposure in Sprague-Dawley Rats. Environ Health Perspect</em>. 2019 Mar;127(3):37008. doi: 10.1289/EHP4372. PubMed PMID: 30920876;PubMed Central PMCID: PMC6768323.</p>\n\n<p>Medlock Kakaley E, Cardon MC, Gray LE, Hartig PC, Wilson VS. <em>Generalized Concentration Addition Model Predicts Glucocorticoid Activity Bioassay Responses to Environmentally Detected Receptor-Ligand Mixtures</em>. Toxicol Sci. 2019 Mar 1;168(1):252-263. doi: 10.1093/toxsci/kfy290. PubMed PMID: 30535411; PubMed Central PMCID: PMC6709530.&nbsp;</p>\n\n<p>Conley JM, Evans N, Cardon MC, Rosenblum L, Iwanowicz LR, Hartig PC, Schenck KM, Bradley PM, Wilson VS. <em>Occurrence and In Vitro Bioactivity of Estrogen, Androgen, and Glucocorticoid Compounds in a Nationwide Screen of United States Stream Waters</em>. Environ Sci Technol. 2017 May 2;51(9):4781-4791. doi:10.1021/acs.est.6b06515. Epub 2017 Apr 12. PubMed PMID: 28401766.&nbsp;</p>\n\n<p>Hartig PC, Bobseine KL, Britt BH, Cardon MC, Lambright CR, Wilson VS, Gray LE Jr. <em>Development of two androgen receptor assays using adenoviral transduction of MMTV-luc reporter and/or hAR for endocrine screening</em>. Toxicol Sci. 2002 Mar;66(1):82-90. PubMed PMID: 11861975.</p>\n\n<p>&nbsp;</p>\n","biologicalOrganisationLevel":"Molecular","organTerm":{},"biologicalEvents":[{"action":"increased","process":"glucocorticoid receptor activity","object":{"name":"glucocorticoid receptor","source":"PR","sourceId":"PR:000011406"}}],"id":122}
{"title":"Inhibition, Nuclear factor kappa B (NF-kB)","references":"<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Abadi MT Condensed Extra Bold&quot;,sans-serif\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\">Chaudhary, D., Robinson, S., Romero, D.L. (2015), Recent advances in the discovery of small molecule inhibitors of interleukin-1 receptor-associated kinase 4 (IRAK4) as a therapeutic target for inflammation and oncology disorders.<em> J Med Chem</em> 58: 96-110, 10.1021/jm5016044</span></span></span></p>\n\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Abadi MT Condensed Extra Bold&quot;,sans-serif\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\">Church, L.D., McDermott, M.F. (2009), Canakinumab, a fully-human mAb against IL-1beta for the potential treatment of inflammatory disorders.<em> Curr Opin Mol Ther</em> 11: 81-89, </span></span></span></p>\n\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Abadi MT Condensed Extra Bold&quot;,sans-serif\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\">Dripps, D.J., Brandhuber, B.J., Thompson, R.C., et al. (1991), Interleukin-1 (IL-1) receptor antagonist binds to the 80-kDa IL-1 receptor but does not initiate IL-1 signal transduction.<em> J Biol Chem</em> 266: 10331-10336, </span></span></span></p>\n\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Abadi MT Condensed Extra Bold&quot;,sans-serif\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\">Gupta, S.C., Sundaram, C., Reuter, S., et al. (2010), Inhibiting NF-kappaB activation by small molecules as a therapeutic strategy.<em> Biochim Biophys Acta</em> 1799: 775-787, 10.1016/j.bbagrm.2010.05.004</span></span></span></p>\n\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Abadi MT Condensed Extra Bold&quot;,sans-serif\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\">Ho, S.C., Chang, Y.H., Chang, K.S. (2018), Structural Moieties Required for Cinnamaldehyde-Related Compounds to Inhibit Canonical IL-1beta Secretion.<em> Molecules</em> 23, 10.3390/molecules23123241</span></span></span></p>\n\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Abadi MT Condensed Extra Bold&quot;,sans-serif\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\">Huang, H., Wang, Y. (2017), The protective effect of cinnamaldehyde on lipopolysaccharide induced acute lung injury in mice.<em> Cell Mol Biol (Noisy-le-grand)</em> 63: 58-63, 10.14715/cmb/2017.63.8.13</span></span></span></p>\n\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Abadi MT Condensed Extra Bold&quot;,sans-serif\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\">Jeon, Y.J., Han, S.H., Lee, Y.W., et al. (2000), Dexamethasone inhibits IL-1 beta gene expression in LPS-stimulated RAW 264.7 cells by blocking NF-kappa B/Rel and AP-1 activation.<em> Immunopharmacology</em> 48: 173-183, </span></span></span></p>\n\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Abadi MT Condensed Extra Bold&quot;,sans-serif\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\">Kapur, S., Bonk, M.E. (2009), Rilonacept (arcalyst), an interleukin-1 trap for the treatment of cryopyrin-associated periodic syndromes.<em> P t</em> 34: 138-141, </span></span></span></p>\n\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Abadi MT Condensed Extra Bold&quot;,sans-serif\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\">Klein, S.L., Flanagan, K.L. (2016), Sex differences in immune responses.<em> Nat Rev Immunol</em> 16: 626-638, 10.1038/nri.2016.90</span></span></span></p>\n\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Abadi MT Condensed Extra Bold&quot;,sans-serif\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\">Lee, K.L., Ambler, C.M., Anderson, D.R., et al. (2017), Discovery of Clinical Candidate 1-{[(2S,3S,4S)-3-Ethyl-4-fluoro-5-oxopyrrolidin-2-yl]methoxy}-7-methoxyisoquinoli ne-6-carboxamide (PF-06650833), a Potent, Selective Inhibitor of Interleukin-1 Receptor Associated Kinase 4 (IRAK4), by Fragment-Based Drug Design.<em> J Med Chem</em> 60: 5521-5542, 10.1021/acs.jmedchem.7b00231</span></span></span></p>\n\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Abadi MT Condensed Extra Bold&quot;,sans-serif\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\">Liu, T., Zhang, L., Joo, D., et al. (2017), NF-kappaB signaling in inflammation.<em> Signal Transduct Target Ther</em> 2, 10.1038/sigtrans.2017.23</span></span></span></p>\n\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Abadi MT Condensed Extra Bold&quot;,sans-serif\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\">Matsunaga, N., Tsuchimori, N., Matsumoto, T., et al. (2011), TAK-242 (resatorvid), a small-molecule inhibitor of Toll-like receptor (TLR) 4 signaling, binds selectively to TLR4 and interferes with interactions between TLR4 and its adaptor molecules.<em> Mol Pharmacol</em> 79: 34-41, 10.1124/mol.110.068064</span></span></span></p>\n\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Abadi MT Condensed Extra Bold&quot;,sans-serif\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\">McGuire, V.A., Ruiz-Zorrilla Diez, T., Emmerich, C.H., et al. (2016), Dimethyl fumarate blocks pro-inflammatory cytokine production via inhibition of TLR induced M1 and K63 ubiquitin chain formation.<em> Sci Rep</em> 6: 31159, 10.1038/srep31159</span></span></span></p>\n\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Abadi MT Condensed Extra Bold&quot;,sans-serif\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\">McKay, L.I., Cidlowski, J.A. (1999), Molecular control of immune/inflammatory responses: interactions between nuclear factor-kappa B and steroid receptor-signaling pathways.<em> Endocr Rev</em> 20: 435-459, 10.1210/edrv.20.4.0375</span></span></span></p>\n\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Abadi MT Condensed Extra Bold&quot;,sans-serif\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\">Mucke, H.A. (2012), Iguratimod: a new disease-modifying antirheumatic drug.<em> Drugs Today (Barc)</em> 48: 577-586, 10.1358/dot.2012.48.9.1855758</span></span></span></p>\n\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Abadi MT Condensed Extra Bold&quot;,sans-serif\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\">Peng, H., Guerau-de-Arellano, M., Mehta, V.B., et al. (2012), Dimethyl fumarate inhibits dendritic cell maturation via nuclear factor kappaB (NF-kappaB) and extracellular signal-regulated kinase 1 and 2 (ERK1/2) and mitogen stress-activated kinase 1 (MSK1) signaling.<em> J Biol Chem</em> 287: 28017-28026, 10.1074/jbc.M112.383380</span></span></span></p>\n\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Abadi MT Condensed Extra Bold&quot;,sans-serif\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\">Pernis, A.B. (2007), Estrogen and CD4+ T cells.<em> Curr Opin Rheumatol</em> 19: 414-420, 10.1097/BOR.0b013e328277ef2a</span></span></span></p>\n\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Abadi MT Condensed Extra Bold&quot;,sans-serif\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\">Quartier, P. (2011), Interleukin-1 antagonists in the treatment of autoinflammatory syndromes, including cryopyrin-associated periodic syndrome.<em> Open Access Rheumatol</em> 3: 9-18, 10.2147/oarrr.S6696</span></span></span></p>\n\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Abadi MT Condensed Extra Bold&quot;,sans-serif\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\">Ravizza, T., Lucas, S.M., Balosso, S., et al. (2006), Inactivation of caspase-1 in rodent brain: a novel anticonvulsive strategy.<em> Epilepsia</em> 47: 1160-1168, 10.1111/j.1528-1167.2006.00590.x</span></span></span></p>\n\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Abadi MT Condensed Extra Bold&quot;,sans-serif\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\">Roell, M.K., Issafras, H., Bauer, R.J., et al. (2010), Kinetic approach to pathway attenuation using XOMA 052, a regulatory therapeutic antibody that modulates interleukin-1beta activity.<em> J Biol Chem</em> 285: 20607-20614, 10.1074/jbc.M110.115790</span></span></span></p>\n\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Abadi MT Condensed Extra Bold&quot;,sans-serif\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\">Stack, J.H., Beaumont, K., Larsen, P.D., et al. (2005), IL-converting enzyme/caspase-1 inhibitor VX-765 blocks the hypersensitive response to an inflammatory stimulus in monocytes from familial cold autoinflammatory syndrome patients.<em> J Immunol</em> 175: 2630-2634, </span></span></span></p>\n\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Abadi MT Condensed Extra Bold&quot;,sans-serif\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\">Straub, R.H. (2007), The complex role of estrogens in inflammation.<em> Endocr Rev</em> 28: 521-574, 10.1210/er.2007-0001</span></span></span></p>\n\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Abadi MT Condensed Extra Bold&quot;,sans-serif\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\">Suzuki, E., Umezawa, K. (2006), Inhibition of macrophage activation and phagocytosis by a novel NF-kappaB inhibitor, dehydroxymethylepoxyquinomicin.<em> Biomed Pharmacother</em> 60: 578-586, 10.1016/j.biopha.2006.07.089</span></span></span></p>\n\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Abadi MT Condensed Extra Bold&quot;,sans-serif\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\">Wang, A.L., Yu, A.C., Lau, L.T., et al. (2005), Minocycline inhibits LPS-induced retinal microglia activation.<em> Neurochem Int</em> 47: 152-158, 10.1016/j.neuint.2005.04.018</span></span></span></p>\n\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Abadi MT Condensed Extra Bold&quot;,sans-serif\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\">Wang, F., Han, Y., Xi, S., et al. (2020), Catechins reduce inflammation in lipopolysaccharide-stimulated dental pulp cells by inhibiting activation of the NF-kappaB pathway.<em> Oral Dis</em> 26: 815-821, 10.1111/odi.13290</span></span></span></p>\n\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Abadi MT Condensed Extra Bold&quot;,sans-serif\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\">Wang, Y., Tang, Q., Duan, P., et al. (2018), Curcumin as a therapeutic agent for blocking NF-kappaB activation in ulcerative colitis.<em> Immunopharmacol Immunotoxicol</em> 40: 476-482, 10.1080/08923973.2018.1469145</span></span></span></p>\n\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Abadi MT Condensed Extra Bold&quot;,sans-serif\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\">Wheeler, D.S., Catravas, J.D., Odoms, K., et al. (2004), Epigallocatechin-3-gallate, a green tea-derived polyphenol, inhibits IL-1 beta-dependent proinflammatory signal transduction in cultured respiratory epithelial cells.<em> J Nutr</em> 134: 1039-1044, 10.1093/jn/134.5.1039</span></span></span></p>\n\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Abadi MT Condensed Extra Bold&quot;,sans-serif\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\">Xu, F., Wang, F., Wen, T., et al. (2017), Inhibition of NLRP3 inflammasome: a new protective mechanism of cinnamaldehyde in endotoxin poisoning of mice.<em> Immunopharmacol Immunotoxicol</em> 39: 296-304, 10.1080/08923973.2017.1355377</span></span></span></p>\n\n<p style=\"margin-left:-10px\">&nbsp;</p>\n","biologicalOrganisationLevel":"Molecular","organTerm":{"name":"immune system","sourceId":"UBERON:0002405"},"biologicalEvents":[{"action":"decreased","process":"I-kappaB kinase/NF-kappaB signaling","object":{"name":"transcription factor NF-kappa-B subunit","source":"PR","sourceId":"PR:000001753"}}],"keyEventStressors":["IL-1 receptor antagonistIL-1Ra(Anakinra)","anti-IL-1b antibody (Canakinumab)","soluble IL-1R (Rilonacept)"],"id":202}
{"title":"Suppression, Inflammatory cytokines","references":"","biologicalOrganisationLevel":"Individual","organTerm":{},"biologicalEvents":[{"action":"decreased","process":"cytokine production involved in inflammatory response","object":{}}],"id":152}
{"title":"Decreased, Lymphocytes","references":"","biologicalOrganisationLevel":"Individual","organTerm":{},"biologicalEvents":[{"action":"decreased","object":{"name":"lymphocyte","source":"CL","sourceId":"CL:0000542"}}],"id":168}
{"title":"Induction, IKB inhibitory protein","references":"","biologicalOrganisationLevel":"Cellular","organTerm":{},"biologicalEvents":[{"action":"increased","process":"I-kappaB phosphorylation","object":{"name":"NF-kappa-B inhibitor","source":"PR","sourceId":"PR:000003292"}}],"id":145}
{"title":"Increased, Disease susceptibility","references":"","biologicalOrganisationLevel":"Individual","organTerm":{},"biologicalEvents":[{"action":"increased","process":"Disease Susceptibility","object":{}}],"id":323}
{"title":"Suppression, Immune system","references":"","biologicalOrganisationLevel":"Individual","organTerm":{},"biologicalEvents":[{"action":"increased","process":"suppression of host defenses","object":{"name":"immune system","source":"UBERON","sourceId":"UBERON:0002405"}}],"id":403}
{"title":"Increase, Heritable mutations in offspring","references":"<p><br />\n</p><p>Adewoye, A.B., S.J. Lindsay, Y.E. Dubrova and M.E. Hurles (2015), \"The genome-wide effects of ionizing radiation on mutation induction in the mammalian germline\", <i>Nat Commun.</i>, 6: 6684. \n</p><p>Beal, M.A., T.C. Glenn and C.M. Somers (2011), \"Whole genome sequencing for quantifying germline mutation frequency in humans and model species: cautious optimism\", <i>Mutation Research</i>, 750(2): 96-106\n</p><p>Beal, M.A., A. Rowan-Carroll, C. Campbell, A. Williams, C.M. Somers, F. Marchetti and C.L. Yauk (2015), \"Single-molecule PCR analysis of an unstable microsatellite for detecting mutations in sperm of mice exposed to chemical mutagens\", <i>Mutat. Res.</i>, 775: 26-32. \n</p><p>BEIR VII (2006), \"Health Risks from Exposure to Low Levels of Ionizing Radiation\", Academies NRCotN, editor. Washington, D.C.: National Academies Press.\n</p><p>Campbell, C.D. and E.E. Eichler (2013), \"Properties and rates of germline mutations in humans\", <i>Trends Genet.</i>, 29(10): 575-584.\n</p><p>Cimino, M.C. (2006), \"Comparative overview of current international strategies and guidelines for genetic toxicology testing for regulatory purposes\", <i>Environ. Mol. Mutagen.</i>, 47: 362390.\n</p><p>Davis, A.P. and M.J. Justice (1998), \"An Oak Ridge legacy: the specific locus test and its role in mouse mutagenesis\", <i>Genetics</i>, 148(1): 7-12.\n</p><p>Geschwind, D.H. and J. Flint (2015), \"Genetics and genomics of psychiatric disease\", <i>Science</i>, 349(6255): 1489-1494\n</p><p>Green, P. and B. Ewing (2013), \"Comment on Evidence of abundant purifying selection in humans for recently acquired regulatory functions\", <i>Science</i>, 340(682) discussion 682. \n</p><p>Gilissen, C., J.Y. Hehir-Kwa, D.T. Thung, M. van de Vorst, B.W. van Bon, M.H. Willemsen, M. Kwint, I.M. Janssen, A. Hoischen, A. Schenck, R. Leach, R. Klein, R. Tearle, T. Bo, R. Pfundt, H.G. Yntema, B.B. de Vries, T. Kleefstra, H.G. Brunner, L.E. Vissers and J.A. Veltman (2014), \"Genome sequencing identifies major causes of severe intellectual disability\", <i>Nature</i>, 511(7509): 344-347.\n</p><p>Eastmond, D.A., A. Hartwig, D. Anderson, W.A. Anwar, M.C. Cimino, I. Dobrev, G.R. Douglas, T. Nohmi, D.H. Phillips and C. Vickers (2009), \"Mutagenicity testing for chemical risk assessment: update of the WHO/IPCS Harmonized Scheme\", <i>Mutagenesis</i>, 24(4): 341-349.\n</p><p>Kong, A., M.L. Frigge, G. Masson, S. Besenbacher, P. Sulem, G. Magnusson, S.A. Gudjonsson, A. Sigurdsson, A. Jonasdottir, W.S. Wong, G. Sigurdsson, G.B. Walters, S. Steinberg, H. Helgason, G. Thorleifsson, D.F. Gudbjartsson, A. Helgason, O.T. Magnusson, U. Thorsteinsdottir and K. Stefansson K. (2012), \"Rate of de novo mutations and the importance of father's age to disease risk\", <i>Nature</i>, 488(7412): 471-475.\n</p><p>Hurles, M. (2012), Older males beget more mutations\", <i>Nature Genetics</i>, 44(11): 1174-1176.\n</p><p>International Conference on Harmonisation (ICH) (2011), \"Guidance On Genotoxicity Testing And Data Interpretation For Pharmaceuticals Intended For Human Use S2(R1)\" ICH Harmonised Tripartite Guideline, International Conference on Harmonization, Geneva, Switzerland.\n</p><p>Keightley, P.D. (2012), \"Rates and Fitness Consequences of New Mutations in Humans\", <i>Genetics</i>, 190(2): 295304.\n</p><p>Ku, C. S., E.K. Tan and D.N. Cooper (2013), \"From the periphery to centre stage: de novo single nucleotide variants play a key role in human genetic disease\", <i>J. Med. Genet.</i>, 50(4): 203-211.\n</p><p>Lewis, S.E., L.B. Barnett, B.M. Sadler and M.D. Shelby MD (1991), \"ENU mutagenesis in the mouse electrophoretic specific-locus test, 1. Dose-response relationship of electrophoretically-detected mutations arising from mouse spermatogonia treated with ethylnitrosourea\", <i>Mutat Res.</i>, 249(2): 311-5.\n</p><p>Lupski, J.R., J.W. Belmont, E. Boerwinkle and R.A. Gibbs (2011), \"Clan genomics and the complex architecture of human disease\", <i>Cell</i>, 147(1): 32-43.\n</p><p>Marchetti, F. and A.J. Wyrobek (2005), \"Mechanisms and consequences of paternally-transmitted chromosomal abnormalities\", <i>Birth Defects Res C Embryo Today</i>, 75(2): 112-129.\n</p><p>Mirkin, S.M. (2007), \"Expandable DNA repeats and human disease\", <i>Nature</i>, 447(7147): 932-940.\n</p><p>Russell, W.L., E.M. Kelly, P.R. Hunsicker, J.W. Bangham, S.C. Maddux and E.L. Phipps (1979), \"Specific-locus test shows ethylnitrosourea to be the most potent mutagen in the mouse\" <i>Proceedings of the National Academy of Sciences of the United States of America</i>, 76(11): 5818-5819.\n</p><p>Russel, L.B. (2004), \"Effects of male germ-cell stage on the frequency, nature and spectrum of induced specific-locus mutations in the mouse\", <i>Genetica</i>, 122: 25-36.\n</p><p>Shendure, J. and J.M. Akey (2015), \"The origins, determinants, and consequences of human mutations\", <i>Science</i>, 349(6255): 1478-1483.\n</p><p>Sun, J.X., A. Helgason, G. Masson, S.S. Ebenesersdottir, H. Li, S. Mallick, S. Gnerre, N. Patterson, A. Kong, D. Reich and K. Stefansson (2012), \"A direct characterization of human mutation based on microsatellites\", <i>Nat. Genet.</i>, 44(10): 1161-1165.\n</p><p>Veltman, J.A. and H.G. Brunner (2012), \"De novo mutations in human genetic disease\", <i>Nat. Rev. Genet.</i>, 13(8): 565-575. \n</p><p>Vilarino-Guell, C., A.G. Smith and Y.E. Dubrova (2003), \"Germline mutation induction at mouse repeat DNA loci by chemical mutagens\" <i>Mutation Research</i>, 526(1-2): 63-73.\n</p><p>Walsh, T., M.K. Lee, S. Casadei, A.M. Thornton, S.M. Stray, C. Pennil, A.S. Nord, J.B. Mandell, E.M. Swisher and M.C. King (2010) \"Detection of inherited mutations for breast and ovarian cancer using genomic capture and massively parallel sequencing\", <i>Proc Natl Acad Sci U S A.</i>,  107(28): 12629-12633. \n</p><p>United Nations (UN) (2013), \"Globally Harmonized System of Classification and Labelling of Chemicals (GHS)\", United Nations, New York, USA.\n</p><p>Yauk, C.L., Y.E. Dubrova, G.R. Grant and A.J. Jeffreys (2002), \"A novel single molecule analysis of spontaneous and radiation-induced mutation at a mouse tandem repeat locus\" <i>Mutation Research</i>. 500(1-2): 147-56.\n</p><p>Yauk, C.L., L.J. Argueso, S.S. Auerbach, P. Awadalla, S.R. Davis, D.M. Demarini, G.R. Douglas, Y.E. Dubrova, R.K. Elespuru, T.M. Glover, B.F. Hales , M.E. Hurles, C.B. Klein, J.R. Lupski, D.K. Manchester, F. Marchetti, A. Montpetit, J.J. Mulvihill, B. Robaire, W.A. Robbins, G.A. Rouleau, D.T. Shaughnessy, C.M. Somers, J.G. Taylor 6th, J. Trasler, M.D. Waters, T.E. Wilson, K.L. Witt and J.B. Bishop (2013), \"Harnessing genomics to identify environmental determinants of heritable disease\" <i>Mutation Research</i>, 752(1): 6-9.\n</p><p>Yauk, C.L., M.J. Aardema, J. van Benthem, J.B. Bishop, K.L. Dearfield, D.M. DeMarini, Y.E. Dubrova, M. Honma, J.R. Lupski, F. Marchetti, M.L. Meistrich, F. Pacchierotti, J. Stewart, M.D. Waters and G.R. Douglas (2015), \"Approaches for Identifying Germ Cell Mutagens: Report of the 2013 IWGT Workshop on Germ Cell Assays\", <i>Mutat. Res. Genet. Toxicol. Environ. Mutagen</i>. 783:36-54.\n</p>","biologicalOrganisationLevel":"Individual","organTerm":{},"biologicalEvents":[{"action":"increased","process":"mutation","object":{"name":"deoxyribonucleic acid","source":"CHEBI","sourceId":"CHEBI:16991"}}],"id":336}
{"title":"Alkylation, DNA","references":"<p><br />\nBenigni, R. (2005), \"Structure-activity relationship studies of chemical mutagens and carcinogens: mechanistic investigations and prediction and approaches\", <i>Chem. Rev.</i>, 105: 1767-1800.\n</p><p>Beranek, D.T. (1990), \"Distribution of methyl and ethyl adducts following alkylation with monofunctional alkylating agents\", <i>Mutation Res.</i>, 231: 11-30.\n</p><p>Collins, A.R., M. Dusinsk and A. Horsk (2001), \"A Detection of alkylation damage in human lymphocyte DNA with the comet assay\". <i>Acta Biochim Pol.</i>, 48: 611-4.\n</p><p>Dai, Q.H. and R.G. Zhong  (1989), \"Quantitative pattern recognition for structure-carcinogenic activity relationship of N-nitroso compounds based upon Di-region theory\", <i>Sci China B.</i>, 32:776-790.\n</p><p>de Groot, A.J., J.G. Jansen, C.F. van Valkenburg and A.A. van Zeeland (1994), \"Molecular dosimetry of 7-alkyl- and O6-alkylguanine in DNA by electrochemical detection\", <i>Mutat Res.</i>, 307: 61-6.\n</p><p>Haplov, K., A. Hudecov, Z. Magdolnov, M. Bjras, E. Glov, E. Miadokov and M. Duinsk (2012), \"DNA alkylation lesions and their repair in human cells: modification of the comet assay with 3-methyladenine DNA glycosylase (AlkD)\", <i>Toxicol Lett.</i>, 208: 76-81. \n</p><p>Himmelstein, M.W., P.J. Boogaard, J. Cadet, P.B. Farmer, J.J. Kim, E.A. Martin, R. Persaud and D.E. Shuker (2009), \"Creating context for the use of DNA adduct data in cancer risk assessment: II. Overview of methods of identification and quantitation of DNA damage\", <i>Crit. Rev. Toxicol.</i>, 39: 679-94.\n</p><p>Kamino, K., F. Seiler, M. Emura, J. Thomale, M.F. Rajewsky and U. Mohr (1995), \"Formation of O6-ethylguanine in spermatogonial DNA of adult Syrian golden hamster by intraperitoneal injection of diethylnitrosamine\", <i>Exp. Toxicol. Pathol.</i>, 47: 443-445.\n</p><p>Kang, H.I., C. Konishi, G. Eberle, M.F. Rajewsky, T. Kuroki and N.H. Huh (1992), \"Highly sensitive, specific detection of O6-methylguanine, O4-methylthymine, and O4-ethylthymine by the combination of high-performance liquid chromatography prefractionation, 32P postlabeling, and immunoprecipitation\", <i>Cancer Res.</i>, 52: 5307-5312.\n</p><p>Lewis, D.F. and V.S. Griffiths (1987), \"Molecular electrostatic potential energies and methylation of DNA bases: a molecular orbital-generated quantitative structure-activity relationship\", <i>Xenobiotica</i>, 17: 769-776.\n</p><p>Mientjes, E.J., K. Hochleitner, A. Luiten-Schuite, J.H. van Delft, J. Thomale, F. Berends, M.F. Rajewsky, P.H. Lohman and R.A. Baan (1996), \"Formation and persistence of O6-ethylguanine in genomic and transgene DNA in liver and brain of lambda(lacZ) transgenic mice treated with N-ethyl-N-nitrosourea\", <i>Carcinogenesis</i>, 17: 2449-2454.\n</p><p>Nehls, P., M.F. Rajewsky, E. Spiess, D. Werner (1984), \"Highly sensitive sites for guanine-O6 ethylation in rat brain DNA exposed to N-ethyl-N-nitrosourea in vivo\", <i>EMBO J.</i>, 3:327-332.\n</p><p>Phillips, D.H., P.B. Farmer, F.A. Beland, R.G. Nath, M.C. Poirier, M.V. Reddy and K.W. Turteltaub (2000), \"Methods of DNA adduct determination and their application to testing compounds for genotoxicity\", <i>Environ. Mol. Mutagen.</i>, 35: 222-233.\n</p><p>Scherer, E., A.A. Jenner  and L. den Engelse (1987), \"Immunocytochemical studies on the formation and repair of O6-alkylguanine in rat tissues\", <i>IARC Sci. Publ.</i>, 84: 55-58.\n</p><p>Sega, G.A., C.R. Rohrer, H.R. Harvey and A.E. Jetton (1986), \"Chemical dosimetry of ethyl nitrosourea in the mouse testis\", <i>Mutat. Res.</i>, 159: 65-74.\n</p><p>Seiler, F., K. Kamino, M. Emura, U. Mohr and J. Thomale (1997), \"Formation and persistence of the miscoding DNA alkylation product O6-ethylguanine in male germ cells of the hamster\", <i>Mutat. Res.</i>, 385: 205-211.\n</p><p>van Zeeland, A.A., A. de Groot and A. Neuhuser-Klaus (1990), \"DNA adduct formation in mouse testis by ethylating agents: a comparison with germ-cell mutagenesis\", <i>Mutat. Res.</i> 231: 55-62.\n</p><p>Vogel, E.W., Ashby, J. (1994), \"Structure-activity relationships: experimental approaches.\" In: Methods to asses DNA Damage and repair: Interspecies comparisons. Edited by R.T. Tardiff, P.H.M. Lohman and G.N. Wogan, SCOPE, Wiley and Sons LTD.\n</p>","biologicalOrganisationLevel":"Molecular","organTerm":{},"biologicalEvents":[{"action":"increased","process":"DNA alkylation","object":{"name":"deoxyribonucleic acid","source":"CHEBI","sourceId":"CHEBI:16991"}}],"keyEventStressors":["Ethyl-N'-nitro-N-nitrosoguanidine","Ethyl nitrosourea","Isopropyl methanesulfonate","Methyl-l-N'-nitro-N-nitroguanidine","Dimethyl sulfate","Methyl methanesulfonate","Diethyl nitrosamine","Ethyl methanesulfonate","Diethyl sulfate","Dimethyl nitrosamine"],"id":97}
{"title":"Increase, Mutations","references":"<p><span style=\"color:#0000CD\">Adewoye, A.B. et al. (2015), &quot;The genome-wide effects of ionizing radiation on mutation induction in the mammalian germline&quot;, <em>Nat. Commu.</em>, 6:6684. Doi: 10.1038/ncomms7684.</span></p>\n\n<p><span style=\"color:#0000CD\">Ayres, M. F. et al. (2006), &nbsp;&ldquo;Low doses of gamma ionizing radiation increase hprt mutant frequencies of TK6 cells without triggering the mutator phenotype pathway&rdquo;, &nbsp;<em>Genetics and Molecular Biology</em>. 2(3): 558-561. Doi:10.1590/S1415-4757200600030002.</span></p>\n\n<p><span style=\"color:#0000CD\">Banda M, Recio L, and Parsons BL. (2013), &ldquo;ACB-PCR measurement of spontaneous and furan-induced H-ras codon 61 CAA to CTA and CAA to AAA mutation in B6C3F1 mouse liver&rdquo;, <em>Environ Mol Mutagen</em>. 54(8):659-67. Doi:10.1002/em.21808.</span></p>\n\n<p><span style=\"color:#0000CD\">Banda, &nbsp;M. et al. (2015), &ldquo;Quantification of Kras mutant fraction in the lung DNA of mice exposed to aerosolized particulate vanadium pentoxide by inhalation&rdquo;, &nbsp;<em>Mutat Res Genet Toxicol Environ Mutagen</em>. 789-790:53-60. Doi: 10.1016/j.mrgentox.2015.07.003</span></p>\n\n<p><span style=\"color:#0000CD\">Campbell, C.D. &amp; E.E. Eichler (2013), &quot;Properties and rates of germline mutations in humans&quot;, <em>Trends Genet</em>., 29(10): 575-84. Doi: &nbsp;10.1016/j.tig.2013.04.005</span></p>\n\n<p><span style=\"color:#0000CD\">Chikura, S. et al. (2019), &ldquo;Standard protocol for the total red blood cell Pig-a assay used in the interlaboratory trial organized by the Mammalian Mutagenicity Study Group of the Japanese Environmental Mutagen Society&rdquo;, &nbsp;<em>Genes Environ</em>.&nbsp; 27:41-5. Doi: 10.1186/s41021-019-0121-z.</span></p>\n\n<p><span style=\"color:#0000CD\">Dobrovolsky, V.N. et al. (2015), &quot;CD48-deficient T-lymphocytes from DMBA-treated rats have de novo mutations in the endogenous Pig-a gene. CD48-Deficient T-Lymphocytes from DMBA-Treated Rats Have De Novo Mutations in the Endogenous Pig-a Gene&quot;, Environ. Mol. Mutagen., (6): 674-683. Doi: 10.1002/em.21959.</span></p>\n\n<p><span style=\"color:#0000CD\">Douglas, G.R. et al. (1995), &quot;Temporal and molecular characteristics of mutations induced by ethylnitrosourea in germ cells isolated from seminiferous tubules and in spermatozoa of lacZ transgenic mice&quot;, <em>Proceedings of the National Academy of Sciences of the United States of America</em>, 92(16): 7485-7489. Doi: 10.1073/pnas.92.16.7485.</span></p>\n\n<p><span style=\"color:#0000CD\">Kraytsberg,Y. &amp; &nbsp;Khrapko, K. (2005), &nbsp;&ldquo;Single-molecule PCR: an artifact-free PCR approach for the analysis of somatic mutations&rdquo;, &nbsp;<em>Expert Rev Mol Diagn</em>. 5(5):809-15. Doi: 10.1586/14737159.5.5.809.</span></p>\n\n<p><span style=\"color:#0000CD\">Kr&uuml;ger, T. C., Hofmann, M., &amp; Hartwig, A. (2015), &ldquo;The in vitro PIG-A gene mutation assay: mutagenicity testing via flow cytometry based on the glycosylphosphatidylinositol (GPI) status of TK6 cells&rdquo;, <em>Arch Toxicol</em>. 89(12), 2429-43. Doi: 10.1007/s00204-014-1413-5.</span></p>\n\n<p><span style=\"color:#0000CD\">Lambert, I.B. et al. (2005), &quot;Detailed review of transgenic rodent mutation assays&quot;, <em>Mutat Res.</em>, 590(1-3):1-280. Doi: 10.1016/j.mrrev.2005.04.002.</span></p>\n\n<p><span style=\"color:#0000CD\">Liber, L. H., &amp; Thilly, G. W. (1982), &nbsp;&ldquo;Mutation assay at the thymidine kinase locus in diploid human lymphoblasts&rdquo;, &nbsp;<em>Mutation Research</em>. 94: 467-485. Doi:10.1016/0027-5107(82)90308-6.</span></p>\n\n<p><span style=\"color:#0000CD\">Lloyd, M., &amp; Kidd, D. (2012), &ldquo;The Mouse Lymphoma Assay. In: Parry J., Parry E. (eds) Genetic Toxicology, Methods in Molecular Biology (Methods and Protocols), 817. Springer, New York, NY.</span></p>\n\n<p><span style=\"color:#0000CD\">Myers, M. B. et al., (2014), &ldquo;ACB-PCR Quantification of Somatic Oncomutation&rdquo;, &nbsp;<em>Molecular Toxicology Protocols, Methods in Molecular Biology</em>. DOI: 10.1007/978-1-62703-739-6_27</span></p>\n\n<p><span style=\"color:#0000CD\">Nakamura, J. et al., (2012), &ldquo;Detection of PIGO-deficient cells using proaerolysin: a valuable tool to investigate mechanisms of mutagenesis in the DT40 cell system&rdquo;, <em>PLoS One</em>.7(3): e33563. Doi:10.1371/journal.pone.0033563.</span></p>\n\n<p><span style=\"color:#0000CD\">Nicklas, J.A., E.W. Carter and R.J. Albertini (2015), &quot;Both PIGA and PIGL mutations cause GPI-a deficient isolates in the Tk6 cell line&quot;, Environ. Mol. Mutagen., 6(8):663-73. Doi: 10.1002/em.21953.</span></p>\n\n<p><span style=\"color:#0000CD\">Norris, M.B. and R.N. Winn (2010), &quot;Isolated spermatozoa as indicators of mutations transmitted to progeny&quot;, Mutat Res., 688(1-2): 36&ndash;40. Doi: 10.1016/j.mrfmmm.2010.02.008.</span></p>\n\n<p><span style=\"color:#0000CD\">O&#39;Brien, J.M. et al.(2013), &quot;No evidence for transgenerational genomic instability in the F1 or F2 descendants of Muta&trade;Mouse males exposed to N-ethyl-N-nitrosourea&quot;, <em>Mutat. Res</em>., 741-742:11-7. Doi: 10.1016/j.mrfmmm.2013.02.004.</span></p>\n\n<p><span style=\"color:#0000CD\">O&#39;Brien, J.M. et al. (2014), &quot;Transgenic rodent assay for quanitifying male germ cell mutation frequency&quot;, <em>Journal of Visual Experimentation</em>, Aug 6;(90). Doi: 10.3791/51576.</span></p>\n\n<p><span style=\"color:#0000CD\">O&rsquo;Brien, J.M. et al. (2015), &quot;Sublinear response in lacZ mutant frequency of Muta&trade; Mouse spermatogonial stem cells after low dose subchronic exposure to N-ethyl-N-nitrosourea&quot;, <em>Environ. Mol. Mutagen.</em>, 6(4): 347-355. Doi: 10.1002/em.21932.</span></p>\n\n<p><span style=\"color:#0000CD\">OECD (1997), Test No. 471: Bacterial Reverse Mutation Test, OECD Guidelines for the Testing of Chemicals, Section 4, OECD Publishing, Paris.</span></p>\n\n<p><span style=\"color:#0000CD\">OECD (1997), Test No. 476: In vitro Mammalian Cell Gene Mutation Test, OECD Guidelines for the Testing of Chemicals, Section 4, OECD Publishing, Paris.</span></p>\n\n<p><span style=\"color:#0000CD\">OECD (2009), Detailed Review Paper on Transgenic Rodent Mutation Assays, Series on Testing and Assessment, N&deg; 103, ENV/JM/MONO 7, OECD, Paris.</span></p>\n\n<p><span style=\"color:#0000CD\">OECD (2011), Test No. 488: Transgenic Rodent Somatic and Germ Cell Gene Mutation Assays, OECD Guidelines for the Testing of Chemicals, Section 4, OECD Publishing, Paris.</span></p>\n\n<p><span style=\"color:#0000CD\">OECD (2015), Test. No. 490: In vitro mammalian cell gene mutation mutation tests using the thymidine kinase gene, OECD Guidelines for the Testing of Chemicals, Section 4, OECD Publishing, Paris.</span></p>\n\n<p><span style=\"color:#0000CD\">OECD. (2013), &ldquo;Transgenic Rodent Somatic and Germ Cell Gene Mutation Assays.&rdquo;</span></p>\n\n<p><span style=\"color:#0000CD\">OECD Guidelines for the Testing of Chemicals, Section 4, OECD Publishing, Paris.</span></p>\n\n<p><span style=\"color:#0000CD\">OECD. 2015. Test. No. 490: In vitro mammalian cell gene mutation mutation tests using the thymidine kinase gene. OECD Guidelines for the Testing of Chemicals, Section 4, OECD Publishing, Paris.</span></p>\n\n<p><span style=\"color:#0000CD\">Parry MJ, &amp; Parry ME. 2012. Genetic Toxicology Principles and Methods. Humana Press. Springer Protocols.</span></p>\n\n<p><span style=\"color:#0000CD\">Parsons BL, McKim KL, Myers MB. 2017. Variation in organ-specific PIK3CA and KRAS mutant levels in normal human tissues correlates with mutation prevalence in corresponding carcinomas. Environ Mol Mutagen. 58(7):466-476. Doi: 10.1002/em.22110.</span></p>\n\n<p><span style=\"color:#0000CD\">Parsons BL. Multiclonal tumor origin: Evidence and implications<em>. Mutat Res</em>. 2018. 777:1-18. doi: 10.1016/j.mrrev.2018.05.001.</span></p>\n\n<p><span style=\"color:#0000CD\">Salk JJ, Schmitt MW, &amp;Loeb LA. (2018), &ldquo;Enhancing the accuracy of next-generation sequencing for detecting rare and subclonal mutations&rdquo;, <em>Nat Rev Genet</em>. 19(5):269-285. Doi: 10.1038/nrg.2017.117.</span></p>\n\n<p><span style=\"color:#0000CD\">Shen, T., S.H. Pajaro-Van de Stadt, N.C. Yeat and J.C. Lin (2015), &quot;Clinical applications of next generation sequencing in cancer: from panels, to exomes, to genomes&quot; <em>Front. Genet.</em>, 6: 215. Doi: 10.3389/fgene.2015.00215.</span></p>\n\n<p><span style=\"color:#0000CD\">Singer, T.M. and C.L. Yauk CL (2010), &quot;Germ cell mutagens: risk assessment challenges in the 21st century&quot;, <em>Environ. Mol. Mutagen.</em>, 51(8-9): 919-928. Doi: 10.1002/em.20613.</span></p>\n\n<p><span style=\"color:#0000CD\">Tindall, R. K., &amp; Stankowski Jr., F. L. (1989), &nbsp;&ldquo;Molecular analysis of spontaneous mutations at the GPT locus in Chinese hamster ovary (AS52) cells&rdquo;, <em>Mutation Research</em>, 220, 241-53. Doi: 10.1016/0165-1110(89)90028-6.</span></p>\n\n<p><span style=\"color:#0000CD\">Waters, M.D. et al. (1994), &quot;The performance of short-term tests in identifying potential germ cell mutagens: a qualitative and quantitative analysis&quot;, <em>Mutat. Res.</em>, 341(2): 109-31. Doi: 10.1016/0165-1218(94)90093-0.</span></p>\n\n<p><span style=\"color:#0000CD\">Yamamoto, A. et al. (2017), &ldquo;Radioprotective activity of blackcurrant extract evaluated by in vitro micronucleus and gene mutation assays in TK6 human lymphoblastoid cells&rdquo;,<em> Genes and Environment. </em>39: 22. Doi: 10.1186/s41021-017-0082-z.</span></p>\n\n<p><span style=\"color:#0000CD\">Yauk, C.L. et al. (2002), &quot;A novel single molecule analysis of spontaneous and radiation-induced mutation at a mouse tandem repeat locus&quot;, Mutat. Res., 500(1-2): 147-56. Doi: 10.1016/s0027-5107(02)00005-2.</span></p>\n\n<p><span style=\"color:#0000CD\">Yauk, C.L. et al. (2015), &quot;Approaches for Identifying Germ Cell Mutagens: Report of the 2013 IWGT Workshop on Germ Cell Assays&quot;, <em>Mutat. Res. Genet. Toxicol. Environ. Mutagen.</em>, 783: 36-54. Doi: 10.1016/j.mrgentox.2015.01.008.</span></p>\n\n<p><span style=\"color:#0000CD\">Yeat and J.C. Lin. 2015. Clinical applications of next generation sequencing in cancer: from panels, to exomes, to genomes. <em>Front. Genet</em>., 6: 215. Doi: 10.3389/fgene.2015.00215.</span></p>\n","biologicalOrganisationLevel":"Molecular","organTerm":{},"biologicalEvents":[{"action":"increased","process":"mutation","object":{"name":"deoxyribonucleic acid","source":"CHEBI","sourceId":"CHEBI:16991"}}],"keyEventStressors":["Ionizing Radiation"],"id":185}
{"title":"N/A, Inadequate DNA repair","references":"<p><span style=\"color:#0000cd\"><span style=\"font-size:14px\"><span style=\"font-family:arial,helvetica,sans-serif\">Adimoolam, S. &amp; J.M. Ford (2003), &quot;p53 and regulation of DNA damage recognition during nucleotide excision repair&quot; <em>DNA Repair</em> (Amst), 2(9): 947-54.</span></span></span></p>\n\n<p><span style=\"font-size:14px\"><span style=\"font-family:arial,helvetica,sans-serif\"><span style=\"color:#0000cd\">Allgayer, J. et al. (2013), &quot;Modulation of base excision repair of 8-oxoguanine by the nucleotide sequence&quot;, <em>Nucleic Acids Res</em>, 41(18): 8559-8571. Doi: </span><a href=\"https://doi.org/10.1093/nar/gkt620\" target=\"_blank\"><span style=\"color:#0000cd\">10.1093/nar/gkt620</span></a><span style=\"color:#0000cd\">.</span></span></span></p>\n\n<p><span style=\"color:#0000cd\"><span style=\"font-size:14px\"><span style=\"font-family:arial,helvetica,sans-serif\">Beranek, D.T. (1990), &quot;Distribution of methyl and ethyl adducts following alkylation with monofunctional alkylating agents&quot;, <em>Mutation Research</em>, 231(1): 11-30. Doi: 10.1016/0027-5107(90)90173-2.</span></span></span></p>\n\n<p><span style=\"color:#0000cd\"><span style=\"font-size:14px\"><span style=\"font-family:arial,helvetica,sans-serif\">Bhatti, A. et al.,&nbsp;(2016), &ldquo;Homologous Recombination Biology.&rdquo;, <em>Encyclopedia Britannica</em>.</span></span></span></p>\n\n<p><span style=\"color:#0000cd\"><span style=\"font-size:14px\"><span style=\"font-family:arial,helvetica,sans-serif\">Bhowmick, R., S. et al. (2016), &quot;RAD52 Facilitates Mitotic DNA Synthesis Following Replication Stress&quot;, <em>Mol Cell</em>, 64:1117-1126. Doi: 10.1016/j.molcel.2016.10.037.</span></span></span></p>\n\n<p><span style=\"color:#0000cd\"><span style=\"font-size:14px\"><span style=\"font-family:arial,helvetica,sans-serif\">Biedermann, A. K. et al. (1991), &ldquo;SCID mutation in mice confers hypersensitivity to ionizing radiation and a deficiency in DNA double-strand break repair&rdquo;, <em>Cell Biology</em>, 88(4): 1394-7. Doi: 10.1073/pnas.88.4.1394.</span></span></span></p>\n\n<p><span style=\"color:#0000cd\"><span style=\"font-size:14px\"><span style=\"font-family:arial,helvetica,sans-serif\">Boboila, C., F. W. Alt &amp; B. Schwer. (2012), &ldquo;Classical and alternative end-joining pathways for repair of lymphocyte-specific and general DNA double-strand breaks.&rdquo; <em>Adv Immunol</em>, 116, 1-49. doi:10.1016/B978-0-12-394300-2.00001-6</span></span></span></p>\n\n<p><span style=\"color:#0000cd\"><span style=\"font-size:14px\"><span style=\"font-family:arial,helvetica,sans-serif\">Bronstein, S.M. et al. (1991), &quot;Toxicity, mutagenicity, and mutational spectra of N-ethyl-N-nitrosourea in human cell lines with different DNA repair phenotypes&quot;, <em>Cancer Research</em>, 51(19): 5188-5197.</span></span></span></p>\n\n<p><span style=\"color:#0000cd\"><span style=\"font-size:14px\"><span style=\"font-family:arial,helvetica,sans-serif\">Bronstein, S.M. et al. (1992), &quot;Efficient repair of O6-ethylguanine, but not O4-ethylthymine or O2-ethylthymine, is dependent upon O6-alkylguanine-DNA alkyltransferase and nucleotide excision repair activities in human cells&quot;, <em>Cancer Research</em>, 52(7): 2008-2011.&nbsp;</span></span></span></p>\n\n<p><span style=\"color:#0000cd\"><span style=\"font-size:14px\"><span style=\"font-family:arial,helvetica,sans-serif\">Brown, J.A. et al. (2011), &quot;Efficiency and fidelity of human DNA polymerases &lambda; and &beta; during gap-filling DNA synthesis&quot;, <em>DNA Repair (Amst).</em>, 10(1):24-33.</span></span></span></p>\n\n<p><span style=\"color:#0000cd\"><span style=\"font-size:14px\"><span style=\"font-family:arial,helvetica,sans-serif\">Butterworth, E. B. et al.,&nbsp;(1987), A protocol and guide for the in vitro rat hepatocyte DNA-repair assay. <em>Mutation Research</em>. 189, 113-21. Doi: 10.1016/0165-1218(87)90017-6.</span></span></span></p>\n\n<p><span style=\"color:#0000cd\"><span style=\"font-size:14px\"><span style=\"font-family:arial,helvetica,sans-serif\">Chen, L. et al.,&nbsp;(2001), Promotion of DNA ligase IV-catalyzed DNA end-joining by the Rad50/Mre11/Xrs2 and Hdf1/Hdf2 complexes. <em>Mol Cell</em>. 8(5), 1105-15.</span></span></span></p>\n\n<p><span style=\"color:#0000cd\"><span style=\"font-size:14px\"><span style=\"font-family:arial,helvetica,sans-serif\">Chiruvella, K. K., Z. Liang &amp; T. E. Wilson, (2013),&nbsp;Repair of Double-Strand Breaks by End Joining. <em>Cold Spring Harbor Perspectives in Biology</em>, 5(5):127-57. Doi: 10.1101/cshperspect.a012757.</span></span></span></p>\n\n<p><span style=\"color:#0000cd\"><span style=\"font-size:14px\"><span style=\"font-family:arial,helvetica,sans-serif\">Deem, A. et al. (2011), &quot;Break-Induced Replication Is Highly Inaccurate.&quot;, <em>PLoS Biol</em>. &nbsp;9:e1000594. Doi: 10.1371/journal.pbio.1000594.</span></span></span></p>\n\n<p><span style=\"color:#0000cd\"><span style=\"font-size:14px\"><span style=\"font-family:arial,helvetica,sans-serif\">Dianov, G.L. &amp; U. H&uuml;bscher (2013), &quot;Mammalian base excision repair: the forgotten archangel&quot;, <em>Nucleic Acids Res.</em>, 41(6):3483-90. Doi: 10.1093/nar/gkt076.</span></span></span></p>\n\n<p><span style=\"color:#0000cd\"><span style=\"font-size:14px\"><span style=\"font-family:arial,helvetica,sans-serif\">Dilley, R.L. et al. &nbsp;Greenberg (2016), &quot;Break-induced telomere synthesis underlies alternative telomere maintenance&quot;, <em>Nature</em>, 539:54-58. Doi: 10.1038/nature20099.</span></span></span></p>\n\n<p><span style=\"color:#0000cd\"><span style=\"font-size:14px\"><span style=\"font-family:arial,helvetica,sans-serif\">Douglas, G.R. et al. &nbsp;(1995), &quot;Temporal and molecular characteristics of mutations induced by ethylnitrosourea in germ cells isolated from seminiferous tubules and in spermatozoa of lacZ transgenic mice&quot;, <em>Proceedings of the National Academy of Sciences of the United States of America</em>, 92(16):7485-7489. Doi: 10.1073/pnas.92.16.7485.</span></span></span></p>\n\n<p><span style=\"color:#0000cd\"><span style=\"font-size:14px\"><span style=\"font-family:arial,helvetica,sans-serif\">Fattah, F. et al.,&nbsp;(2010), Ku regulates the non-homologous end joining pathway choice of DNA double-strand break repair in human somatic cells. PLoS Genet, 6(2), doi:10.1371/journal.pgen.1000855</span></span></span></p>\n\n<p><span style=\"color:#0000cd\"><span style=\"font-size:14px\"><span style=\"font-family:arial,helvetica,sans-serif\">Fitzgerald, D.M., P.J. Hastings, and S.M. Rosenberg (2017), &quot;Stress-Induced Mutagenesis: Implications in Cancer and Drug Resistance&quot;, Ann Rev Cancer Biol, 1:119-140. Doi: 10.1146/annurev-cancerbio-050216-121919.</span></span></span></p>\n\n<p><span style=\"color:#0000cd\"><span style=\"font-size:14px\"><span style=\"font-family:arial,helvetica,sans-serif\">Hammel, M. et al.,&nbsp;(2011), XRCC4 protein interactions with XRCC4-like factor (XLF) create an extended grooved scaffold for DNA ligation and double strand break repair. J Biol Chem, 286(37), 32638-32650. doi:10.1074/jbc.M111.272641.</span></span></span></p>\n\n<p><span style=\"color:#0000cd\"><span style=\"font-size:14px\"><span style=\"font-family:arial,helvetica,sans-serif\">Hanawalt, P.C., J.M. Ford and D.R. Lloyd (2003), &quot;Functional characterization of global genomic DNA repair and its implications for cancer&quot;, <em>Mutation Research</em>, 544(2-3): 107&ndash;114.</span></span></span></p>\n\n<p><span style=\"color:#0000cd\"><span style=\"font-size:14px\"><span style=\"font-family:arial,helvetica,sans-serif\">Harbach, P. R. et al., (1989), &ldquo;The in vitro unscheduled DNA synthesis (UDS) assay in rat primary hepatocytes&rdquo;, <em>Mutation Research</em>, 216(2):101-10. Doi:10.1016/0165-1161(89)90010-1.</span></span></span></p>\n\n<p><span style=\"color:#0000cd\"><span style=\"font-size:14px\"><span style=\"font-family:arial,helvetica,sans-serif\">Iyama, T. and D.M. Wilson III (2013), &quot;DNA repair mechanisms in dividing and non-dividing cells&quot;, <em>DNA Repair</em>, 12(8): 620&ndash; 636.</span></span></span></p>\n\n<p><span style=\"color:#0000cd\"><span style=\"font-size:14px\"><span style=\"font-family:arial,helvetica,sans-serif\">Jeffrey, M. A.&amp; M. G. Williams, (2000), &ldquo;Lack of DNA-damaging Activity of Five Non-nutritive Sweeteners in the Rat Hepatocyte/DNA Repair Assay&rdquo;, &nbsp;<em>Food and Chemical Toxicology</em>, 38: 335-338. Doi: 10.1016/S0278-6915(99)00163-5.</span></span></span></p>\n\n<p><span style=\"font-size:14px\"><span style=\"font-family:arial,helvetica,sans-serif\"><span style=\"color:#0000cd\">K&ouml;berle, B. et al. (1999), &quot;Defective repair of cisplatin-induced DNA damage caused by reduced XPA protein in testicular germ cell tumours&quot;, <em>Curr. Biol.</em>, 9(5):273-6. Doi: </span><a href=\"https://doi.org/10.1016/s0960-9822(99)80118-3\" target=\"_blank\"><span style=\"color:#0000cd\">10.1016/s0960-9822(99)80118-3</span></a><span style=\"color:#0000cd\">.</span></span></span></p>\n\n<p><span style=\"color:#0000cd\"><span style=\"font-size:14px\"><span style=\"font-family:arial,helvetica,sans-serif\">Kozmin, S.G. &amp; S. Jinks-Robertson S. (2013), &ldquo;The mechanism of nucleotide excision repair-mediated UV-induced mutagenesis in nonproliferating cells&rdquo;, <em>Genetics</em>, 193(3): 803-17. Doi: 10.1534/genetics.112.147421.</span></span></span></p>\n\n<p><span style=\"color:#0000cd\"><span style=\"font-size:14px\"><span style=\"font-family:arial,helvetica,sans-serif\">Kramara, J., B. Osia, and A. Malkova (2018), &quot;Break-Induced Replication: The Where, The Why, and The How&quot;, <em>Trends Genet</em>, 34:518-531. Doi: 10.1016/j.tig.2018.04.002.</span></span></span></p>\n\n<p><span style=\"color:#0000cd\"><span style=\"font-size:14px\"><span style=\"font-family:arial,helvetica,sans-serif\">Lieber, M. R., (2010), &ldquo;The mechanism of double-strand DNA break repair by the nonhomologous DNA end-joining pathway.&rdquo; <em>Annu Rev Biochem</em>. 79:181-211. doi:10.1146/annurev.biochem.052308.093131.</span></span></span></p>\n\n<p><span style=\"color:#0000cd\"><span style=\"font-size:14px\"><span style=\"font-family:arial,helvetica,sans-serif\">Lieber, M. R. et al., (2003), &ldquo;Mechanism and regulation of human non-homologous DNA end-joining&rdquo;, <em>Nat Rev Mol Cell Biol</em>. 4(9):712-720. doi:10.1038/nrm1202.</span></span></span></p>\n\n<p><span style=\"color:#0000cd\"><span style=\"font-size:14px\"><span style=\"font-family:arial,helvetica,sans-serif\">Liu, Y. et al. (2009), &quot;Coordination between polymerase beta and FEN1 can modulate CAG repeat expansion&quot;, J. Biol. Chem., 284(41): 28352-28366. Doi: 10.1074/jbc.M109.050286.</span></span></span></p>\n\n<p><span style=\"color:#0000cd\"><span style=\"font-size:14px\"><span style=\"font-family:arial,helvetica,sans-serif\">Mao, Z. et al.,&nbsp;(2011), &ldquo;SIRT6 promotes DNA repair under stress by activating PARP1&rdquo;, <em>Science</em>. 332(6036): 1443-1446. doi:10.1126/science.1202723.</span></span></span></p>\n\n<p><span style=\"color:#0000cd\"><span style=\"font-size:14px\"><span style=\"font-family:arial,helvetica,sans-serif\">Matthews, L. A., &amp; L. A. Simmons, (2014), &ldquo;Bacterial nonhomologous end joining requires teamwork&rdquo;, <em>J Bacteriol</em>. 196(19): 3363-3365. doi:10.1128/JB.02042-14.</span></span></span></p>\n\n<p><span style=\"font-size:14px\"><span style=\"font-family:arial,helvetica,sans-serif\"><span style=\"color:#0000cd\">Menoni, H. et al. (2012), &quot;Base excision repair of 8-oxoG in dinucleosomes&quot;, <em>Nucleic Acids Res.</em> ,40(2): 692-700. Doi: </span><a href=\"https://doi.org/10.1093/nar/gkr761\" target=\"_blank\"><span style=\"color:#0000cd\">10.1093/nar/gkr761</span></a><span style=\"color:#0000cd\">.</span></span></span></p>\n\n<p><span style=\"color:#0000cd\"><span style=\"font-size:14px\"><span style=\"font-family:arial,helvetica,sans-serif\">Minocherhomji, S. et al. (2015), &quot;Replication stress activates DNA repair synthesis in mitosis&quot;, <em>Nature</em>, 528:286-290. Doi: 10.1038/nature16139.</span></span></span></p>\n\n<p><span style=\"color:#0000cd\"><span style=\"font-size:14px\"><span style=\"font-family:arial,helvetica,sans-serif\">Miyaoka, Y. et al.,&nbsp;(2016), &ldquo;Systematic quantification of HDR and NHEJ reveals effects of locus, nuclease, and cell type on genome-editing&rdquo;, <em>Sci Rep</em>, 6, 23549. doi:10.1038/srep23549/.</span></span></span></p>\n\n<p><span style=\"color:#0000cd\"><span style=\"font-size:14px\"><span style=\"font-family:arial,helvetica,sans-serif\">Moore, J. K., &amp; J. E. Haber, (1996), &ldquo;Cell cycle and genetic requirements of two pathways of nonhomologous end-joining repair of double-strand breaks in Saccharomyces cerevisiae&rdquo;, <em>Molecular and Cellular Biology</em>, 16(5), 2164&ndash;73. &nbsp;Doi: 10.1128/MCB.16.5.2164.</span></span></span></p>\n\n<p><span style=\"color:#0000cd\"><span style=\"font-size:14px\"><span style=\"font-family:arial,helvetica,sans-serif\">Nagel, Z.D. et al. (2014), &quot;Multiplexed DNA repair assays for multiple lesions and multiple doses via transcription inhibition and transcriptional mutagenesis&quot;, <em>Proc. Natl. Acad. Sci. USA</em>, 111(18):E1823-32. Doi: 10.1073/pnas.1401182111.</span></span></span></p>\n\n<p><span style=\"color:#0000cd\"><span style=\"font-size:14px\"><span style=\"font-family:arial,helvetica,sans-serif\">O&rsquo;Brien, J.M. et al. (2015), &quot;Sublinear response in lacZ mutant frequency of Muta&trade; Mouse spermatogonial stem cells after low dose subchronic exposure to N-ethyl-N-nitrosourea&quot;, <em>Environ. Mol. Mutagen.</em>, 56(4): 347-55. Doi: 10.1002/em.21932.</span></span></span></p>\n\n<p><span style=\"color:#0000cd\"><span style=\"font-size:14px\"><span style=\"font-family:arial,helvetica,sans-serif\">Olive, L. P., J. P. Bnath &amp; E. R. Durand, (1990), &ldquo;Heterogeneity in Radiation-Induced DNA Damage and Repairing Tumor and Normal Cells Measured Using the &quot;Comet&quot; Assay&rdquo;, <em>Radiation Research</em>. 122: 86-94. Doi: 10.1667/rrav04.1.</span></span></span></p>\n\n<p><span style=\"color:#0000cd\"><span style=\"font-size:14px\"><span style=\"font-family:arial,helvetica,sans-serif\">Pardo, B., B. Gomez-Gonzalez &amp; A. Aguilera, (2009), &ldquo;DNA repair in mammalian cells: DNA double-strand break repair: how to fix a broken relationship<em>&rdquo;, Cell Mol Life Sci</em>, 66(6), 1039-1056. doi:10.1007/s00018-009-8740-3.</span></span></span></p>\n\n<p><span style=\"color:#0000cd\"><span style=\"font-size:14px\"><span style=\"font-family:arial,helvetica,sans-serif\">Pegg, A.E. (2011), &quot;Multifaceted roles of alkyltransferase and related proteins in DNA repair, DNA damage, resistance to chemotherapy, and research tools&quot;, <em>Chem. Res. Toxicol.</em>, 4(5): 618-39. Doi: 10.1021/tx200031q.</span></span></span></p>\n\n<p><span style=\"color:#0000cd\"><span style=\"font-size:14px\"><span style=\"font-family:arial,helvetica,sans-serif\">Sancar, A. (2003), &quot;Structure and function of DNA photolyase and cryptochrome blue-light photoreceptors&quot;, <em>Chem Rev.</em>, 103(6): 2203-37. Doi: 10.1021/cr0204348.</span></span></span></p>\n\n<p><span style=\"color:#0000cd\"><span style=\"font-size:14px\"><span style=\"font-family:arial,helvetica,sans-serif\">Saini, N. et al. (2017), &quot;Migrating bubble during break-induced replication drives conservative DNA synthesis&quot;, <em>Nature</em>, 502:389-392. Doi: 10.1038/nature12584.</span></span></span></p>\n\n<p><span style=\"color:#0000cd\"><span style=\"font-size:14px\"><span style=\"font-family:arial,helvetica,sans-serif\">Sakofsky, C.J. et al. (2015), &quot;Translesion Polymerases Drive Microhomology-Mediated Break-Induced Replication Leading to Complex Chromosomal Rearrangements&quot;, <em>Mol Cell</em>, 60:860-872. Doi: 10.1016/j.molcel.2015.10.041.</span></span></span></p>\n\n<p><span style=\"color:#0000cd\"><span style=\"font-size:14px\"><span style=\"font-family:arial,helvetica,sans-serif\">Sch&auml;rer, O.D. (2013), &quot;Nucleotide excision repair in eukaryotes&quot;, <em>Cold Spring Harb. Perspect. Biol.</em>, 5(10): a012609. Doi: 10.1101/cshperspect.a012609.</span></span></span></p>\n\n<p><span style=\"color:#0000cd\"><span style=\"font-size:14px\"><span style=\"font-family:arial,helvetica,sans-serif\">Scherer, E., A.A. Jenner and L. den Engelse (1987), &quot;Immunocytochemical studies on the formation and repair of O6-alkylguanine in rat tissues&quot;, <em>IARC Sci Publ.</em>, 84: 55-8.</span></span></span></p>\n\n<p><span style=\"color:#0000cd\"><span style=\"font-size:14px\"><span style=\"font-family:arial,helvetica,sans-serif\">Seiler, F., K. Kamino, M. Emura, U. Mohr and J. Thomale (1997), &quot;Formation and persistence of the miscoding DNA alkylation product O6-ethylguanine in male germ cells of the hamster&quot;, <em>Mutat Res.</em>, 385(3): 205-211. Doi: 10.1016/s0921-8777(97)00043-8.</span></span></span></p>\n\n<p><span style=\"color:#0000cd\"><span style=\"font-size:14px\"><span style=\"font-family:arial,helvetica,sans-serif\">Shelby, M.D. and K.R. Tindall (1997), &quot;Mammalian germ cell mutagenicity of ENU, IPMS and MMS, chemicals selected for a transgenic mouse collaborative study&quot;,<em> Mutation Research</em>, 388(2-3): 99-109. Doi: 10.1016/s1383-5718(96)00106-4.</span></span></span></p>\n\n<p><span style=\"color:#0000cd\"><span style=\"font-size:14px\"><span style=\"font-family:arial,helvetica,sans-serif\">Seo, Y.R. and H.J. Jung (2004), &quot;The potential roles of p53 tumor suppressor in nucleotide excision repair (NER) and base excision repair (BER)&quot;, <em>Exp. Mol. Med.</em>, 36(6): 505-509. Doi: 10.1038/emm.2004.64.</span></span></span></p>\n\n<p><span style=\"font-size:14px\"><span style=\"font-family:arial,helvetica,sans-serif\"><span style=\"color:#0000cd\">Sundheim, O. et al. (2008), &quot;AlkB demethylases flip out in different ways&quot;,<em> DNA Repair (Amst)</em>., 7(11): 1916-1923. Doi: </span><a href=\"https://doi.org/10.1016/j.dnarep.2008.07.015\" target=\"_blank\"><span style=\"color:#0000cd\">10.1016/j.dnarep.2008.07.015</span></a><span style=\"color:#0000cd\">.</span></span></span></p>\n\n<p><span style=\"color:#0000cd\"><span style=\"font-size:14px\"><span style=\"font-family:arial,helvetica,sans-serif\">Sung, P., &amp; H.&nbsp;Klein, (2006), &ldquo;Mechanism of homologous recombination: mediators and helicases take on regulatory functions&rdquo;, &nbsp;<em>Nat Rev Mol Cell Biol</em>, 7(10), 739-750. Doi:10. 1038/nrm2008.</span></span></span></p>\n\n<p><span style=\"color:#0000cd\"><span style=\"font-size:14px\"><span style=\"font-family:arial,helvetica,sans-serif\">Trucco, C., et al., (1998), &ldquo;DNA repair defect i poly(ADP-ribose) polymerase-deficient cell lines&rdquo;, Nucleic Acids Research. 26(11): 2644&ndash;2649. Doi: 10.1093/nar/26.11.2644.</span></span></span></p>\n\n<p><span style=\"color:#0000cd\"><span style=\"font-size:14px\"><span style=\"font-family:arial,helvetica,sans-serif\">Wyrick, J.J. &amp;&nbsp;S. A.&nbsp;Roberts, (2015), &ldquo;Genomic approaches to DNA repair and mutagenesis&rdquo;, DNA Repair (Amst). 36:146-155. doi: 10.1016/j.dnarep.2015.09.018.</span></span></span></p>\n\n<p><span style=\"color:#0000cd\"><span style=\"font-size:14px\"><span style=\"font-family:arial,helvetica,sans-serif\">van Zeeland, A.A., A. de Groot and A. Neuh&auml;user-Klaus (1990), &quot;DNA adduct formation in mouse testis by ethylating agents: a comparison with germ-cell mutagenesis&quot;, <em>Mutat. Res.</em>, 231(1): 55-62.</span></span></span></p>\n","biologicalOrganisationLevel":"Cellular","organTerm":{},"biologicalEvents":[{"action":"functional change","process":"DNA repair","object":{"name":"deoxyribonucleic acid","source":"CHEBI","sourceId":"CHEBI:16991"}}],"keyEventStressors":["Ionizing Radiation"],"id":155}
{"title":"Increased Mortality","references":"","biologicalOrganisationLevel":"Population","organTerm":{},"biologicalEvents":[{"action":"increased","process":"mortality","object":{}}],"id":351}
{"title":"Acetylcholinesterase (AchE) Inhibition","references":"<ul>\n\t<li dir=\"ltr\">\n\t<p dir=\"ltr\">Augustinsson KB. 1957. Assay methods for cholinesterases. Methods of Biochemical Analysis, Vol 5, Interscience Publishers, Inc., New York, NY, USA, pp 1-63.</p>\n\t</li>\n\t<li dir=\"ltr\">\n\t<p dir=\"ltr\">Ecobichon, D.J. 2001. Toxic effects of pesticides. In: C.D. Klaassen (Ed.), Casarett and Doull&rsquo;s Toxicology: The Basic Science of Poisons; Sixth Edition. (pp. 763-810). McGraw-Hill, New York, NY.</p>\n\t</li>\n\t<li dir=\"ltr\">\n\t<p dir=\"ltr\">Ellman GL, Courtney KD, Andres V Jr, Featherstone RM. 1961. A new and rapid colormetric determination of acetylcholinesterase activity. Biochem Pharmacol 7:88-95.</p>\n\t</li>\n\t<li dir=\"ltr\">\n\t<p dir=\"ltr\">Fukuto, TR. 1990. Mechanism of action of organophosphorus and carbamate insecticides. Environ Health Perspect. 87:245-254.</p>\n\t</li>\n\t<li dir=\"ltr\">\n\t<p dir=\"ltr\">Guo, J.-X., J.J.-Q. Wu, J.B. Wright, and G.H. Lushington. 2006. Mechanistic insight into acetylcholinesterase inhibition and acute toxicity of organophosphorus compounds: A molecular modeling study. Chem. Res. Toxicol. 19: 209-216.</p>\n\t</li>\n\t<li dir=\"ltr\">\n\t<p dir=\"ltr\">Johnson CD, Russell RL. 1975. A rapid, simple radiometric assay for cholinesterase suitable for multiple determinations. Anal Biochem 64:229-238.</p>\n\t</li>\n\t<li dir=\"ltr\">\n\t<p dir=\"ltr\">Kropp, T.J., and Richardson, R.J. 2003. Relative inhibitory potencies of chlorpyrifos oxon, chlorpyrifos methyl oxon, and mipafox for acetylcholinesterase versus neuropathy target esterase. J. Toxicol. Environ.l Health, Part A, 66:1145&ndash;1157.</p>\n\t</li>\n\t<li dir=\"ltr\">\n\t<p dir=\"ltr\">Lu Y, Park Y, Gao X, Zhang X, Yoo J, Pang X-P, Jiang H, Zhu KY. 2012. Cholinergic and non-cholinergic functions of two acetylcholinesterase genes revealed by gene-silencing in Tribolium castaneum. Sci Rep 2:1-7.</p>\n\t</li>\n\t<li dir=\"ltr\">\n\t<p dir=\"ltr\">Ludke JL, Hill EF, Dieter MP. 1975. Cholinesterase (ChE) response and related mortality among birds fed ChE inhibitors. Arch Environ ContamToxicol 3:1&ndash;21.</p>\n\t</li>\n\t<li dir=\"ltr\">\n\t<p dir=\"ltr\">Lushington, G.H., J-X. Guo, and M.M. Hurley. 2006. Acetylcholinesterase: Molecular modeling with the whole toolkit. Curr. Topics Medic. Chem. 6: 57-73.</p>\n\t</li>\n\t<li dir=\"ltr\">\n\t<p dir=\"ltr\">Mileson, BE, Chambers JE, Chen WL, Dettbarn W, Ehrich M, Eldefrawi AT, Gaylor DW, Hamernik K, Hodgson E, Karczmar AG, Padilla S, Pope CN, Richardson RJ, Saunders DR, Sheets LP, Sultatos LG, Wallace KB.&nbsp; 1998. Common mechanism of toxicity: A case study of organophosphorus pesticides. Toxicol Sci 41:8-20.</p>\n\t</li>\n\t<li dir=\"ltr\">\n\t<p dir=\"ltr\">Moser, Virginia C. 2011. &ldquo;Age-Related Differences in Acute Neurotoxicity Produced by Mevinphos, Monocrotophos, Dicrotophos, and Phosphamidon.&rdquo; Neurotoxicology and Teratology 33 (4): 451&ndash;57.<a href=\"https://doi.org/10.1016/j.ntt.2011.05.012\"> https://doi.org/10.1016/j.ntt.2011.05.012</a>.</p>\n\t</li>\n\t<li dir=\"ltr\">\n\t<p dir=\"ltr\">Monserrat, J.M. and A. Bianchini. 2001. Anticholinesterase effect of eserine (physostigmine) in fish and crustacean species. Braz. Arch. Biol. Technol. 44(1): 63-68.</p>\n\t</li>\n\t<li dir=\"ltr\">\n\t<p dir=\"ltr\">Russom, Christine L., Carlie A. LaLone, Daniel L. Villeneuve, and Gerald T. Ankley. 2014. &ldquo;Development of an Adverse Outcome Pathway for Acetylcholinesterase Inhibition Leading to Acute Mortality.&rdquo; Environmental Toxicology and Chemistry 33 (10): 2157&ndash;69.<a href=\"https://doi.org/10.1002/etc.2662\"> https://doi.org/10.1002/etc.2662</a>.</p>\n\t</li>\n\t<li dir=\"ltr\">\n\t<p dir=\"ltr\">Schrmann G. 1992. Ecotoxicology and structure-activity studies of organophosphorus compounds. Rational Approaches to Structure, Activity, and Ecotoxicology of Agrochemicals, CRC Press, Boca Raton, FL, USA pp 485-541</p>\n\t</li>\n\t<li dir=\"ltr\">\n\t<p dir=\"ltr\">Sogob MA, Vilanova E. 2002. Enzymes involved in the detoxification of organophosphorus, carbamate and pyrethroid insecticides through hydrolysis. Toxicol Lett 128:215-228.</p>\n\t</li>\n\t<li dir=\"ltr\">\n\t<p dir=\"ltr\">Soreq H, Seidman S. 2001. Acetylcholinesterase -- New roles for an old actor. Nature Reviews Neurosci 2:294-302.</p>\n\t</li>\n\t<li dir=\"ltr\">\n\t<p dir=\"ltr\">Stenersen, J. 2004. Specific enzyme inhibitors. In: Chemical Pesticides: Mode of action and toxicology. (41 p). CRC Press, Boca Raton, FL.</p>\n\t</li>\n\t<li dir=\"ltr\">\n\t<p dir=\"ltr\">Taylor P. 2011. Anticholinesterase agents. Goodman and Gilman&rsquo;s The Pharmacological Basis of Therapeutics, 12th ed, McGraw Hill, New York, NY, USA, pp 255-276.</p>\n\t</li>\n\t<li dir=\"ltr\">\n\t<p dir=\"ltr\">Tretyn A, Kendrick RE. 1991. Acetylcholine in plants: Metabolism and mechanism of action. Bot Rev 57:33-73.</p>\n\t</li>\n\t<li dir=\"ltr\">\n\t<p dir=\"ltr\">Wilson BW, Padilla S, Henderson JD, Brimijoin S, Dass PD, Elliot G, Jaeger B, Lanz D, Pearson R, Spies R. 1996. Factors in standardizing automated cholinesterase assays. J Toxicol Environ Health 48:187-195.</p>\n\t</li>\n\t<li dir=\"ltr\">\n\t<p dir=\"ltr\">Wilson, B.W. and J.D. Henderson. 2007. Determination of cholinesterase in blood and tissue. Current Protocols in Toxicology 12.13.1-12.13.16.</p>\n\t</li>\n\t<li dir=\"ltr\">\n\t<p dir=\"ltr\">Wilson BW. 2010. Cholinesterases. Hayes&rsquo; Handbook of Pesticide Toxicology, 3rd ed, Vol 2. Elsevier, Amsterdam, The Netherlands, pp 1457-1478.</p>\n\t</li>\n</ul>\n","biologicalOrganisationLevel":"Cellular","organTerm":{"name":"nervous system","sourceId":"UBERON:0001016"},"biologicalEvents":[{"action":"decreased","process":"acetylcholinesterase activity","object":{"name":"acetylcholinesterase","source":"PR","sourceId":"PR:000003626"}}],"keyEventStressors":["Organophosphates","N-methyl Carbamates"],"id":12}
{"title":"Acetylcholine accumulation in synapses","references":"<ul>\n\t<li dir=\"ltr\">\n\t<p dir=\"ltr\">Augustinsson, K.B. 1957. In: Glick,D.(Ed.); Methods of Biochemical Analysis, Interscience Publishers, Inc., New York, NY.</p>\n\t</li>\n\t<li>G&oacute;mez-Canela, C., D. Tornero-Ca&ntilde;adas, E. Prats, B. Pi&ntilde;a, R. Tauler and D. Rald&uacute;a (2018), &quot;Comprehensive characterization of neurochemicals in three zebrafish chemical models of human acute organophosphorus poisoning using liquid chromatography-tandem mass spectrometry&rdquo;, <em>Analytical and Bioanalytical Chemistry</em> <strong>410</strong>(6): 1735-1748. DOI: 10.1007/s00216-017-0827-3.</li>\n\t<li dir=\"ltr\">\n\t<p dir=\"ltr\">Fukuto TR.&nbsp; 1990. Mechanism of action of organophosphorus and carbamate insecticides.&nbsp; Environ Health Perspect 87:245-254.&nbsp;&nbsp;&nbsp;&nbsp;</p>\n\t</li>\n\t<li dir=\"ltr\">\n\t<p dir=\"ltr\">Hestrin, S. (1949). The Reaction of Acetylcholine and Other Carboxylic Acid Derivatives with Hydroxylamine, and its Analytical Application. J. Biol. Chem. 180(1): 249-61.</p>\n\t</li>\n\t<li dir=\"ltr\">\n\t<p dir=\"ltr\">Karanth, S., Pope, C. 2003. Age-related effects of chlorpyrifos and parathion on acetylcholine synthesis in rat striatum. Neurotoixol. Teratol. 25(5): 599-606.&nbsp;&nbsp;</p>\n\t</li>\n</ul>\n\n<ul>\n\t<li dir=\"ltr\">\n\t<p dir=\"ltr\">Kobayashi H, Yuyama A, Kudo M, Matsusaka N. 1983. Effects of organophosphorus compounds, O,Odimethylo(2,2dichlorovinyl)phosphate (DDVP) and O,Odimethylo(3methyl 4nitrophenyl)phosphorothioate (fenitrothion), on brain acetylcholine content and acetylcholinesterase activity in Japanese quail. Toxicology 28:219&ndash;227.</p>\n\t</li>\n\t<li dir=\"ltr\">\n\t<p dir=\"ltr\">Kobayashi, H., Yuyama, A., Ohkawa, T., and Kajita, T. 1988. Effect of Single or Chronic Injection with a Carbamate, Propoxur, on the Brain Cholinergic System and Behavior of Mice. Jpn.J.Pharmacol. 47[1], 21-27.</p>\n\t</li>\n\t<li dir=\"ltr\">\n\t<p dir=\"ltr\">Lushington GH, Guo J-X, Hurley MM.&nbsp; 2006. Acetylcholinesterase: Molecular modeling with the whole toolkit.&nbsp; Curr Topics Medic Chem 6:57-73.</p>\n\t</li>\n\t<li dir=\"ltr\">\n\t<p dir=\"ltr\">Mileson, BE, Chambers JE, Chen WL, Dettbarn W, Ehrich M, Eldefrawi AT, Gaylor DW, Hamernik K, Hodgson E, Karczmar AG, Padilla S, Pope CN, Richardson RJ, Saunders DR, Sheets LP, Sultatos LG, Wallace KB.&nbsp; 1998. Common mechanism of toxicity: A case study of organophosphorus pesticides. Toxicol Sci 41:8-20.</p>\n\t</li>\n\t<li dir=\"ltr\">\n\t<p dir=\"ltr\">Molecular Probes. (2004). Amplex Red Acetylcholine/Acetylcholinesterase Assay Kit (A12217). Retrieved from: <a href=\"http://tools.thermofisher.com/content/sfs/manuals/mp12217.pdf\">http://tools.thermofisher.com/content/sfs/manuals/mp12217.pdf</a></p>\n\t</li>\n\t<li dir=\"ltr\">\n\t<p dir=\"ltr\">Nayeemunnisa, Yasmeen N. 1986. On the presence of calmodulin in the brain of control&nbsp;and methyl parathionexposed developing tadpoles of frog, Rana cyanophlictis. Curr Sci (Bangalore) 55:546&ndash;548.</p>\n\t</li>\n\t<li dir=\"ltr\">\n\t<p dir=\"ltr\">Nirogi, R., Mudigonda, K., Kandikere, V. Ponnamaneni, R. (2010). Quantification of Acetylcholine, an Essential Neurotransmitter, in Brain Microdialysis Samples by Liquid Chromatography Mass Spectrometry. Biomed Chromatogr. 24(1), 39-48.&nbsp;</p>\n\t</li>\n\t<li dir=\"ltr\">\n\t<p dir=\"ltr\">Rao KSP, Rao KVR. 1984. Impact of methyl parathion toxicity and eserine inhibition on acetylcholinesterase activity in tissues of the teleost (Tilapia mossambica)&mdash;A correlative study. Toxicol Lett 22:351&ndash;356.</p>\n\t</li>\n\t<li dir=\"ltr\">\n\t<p dir=\"ltr\">Reddy MS, Jayaprada P, Rao KVR. 1990. Impact of methyl parathion and malathion on cholinergic and noncholinergic enzyme systems of penaeid prawn, Metapenaeus monoceros. Biochem Int 22:769&ndash;780.</p>\n\t</li>\n\t<li dir=\"ltr\">\n\t<p dir=\"ltr\">Sogob MA, Vilanova E.&nbsp; 2002. Enzymes involved in the detoxification of organophosphorus, carbamate and pyrethroid insecticides through hydrolysis.&nbsp; Toxicol&nbsp; Lett 128:215-228.</p>\n\t</li>\n\t<li dir=\"ltr\">\n\t<p dir=\"ltr\">Szilagyi, P.I.A., Schmidt, D.E., Green, J.P. (1968). Microanalytical determination of acetylcholine, other choline esters, and choline by pyrolysis-gas chromatography. Analytical Chemistry. 40(13), 2009-2013.&nbsp;</p>\n\t</li>\n\t<li dir=\"ltr\">\n\t<p dir=\"ltr\">Zapata, A., V.I. Chefer, T.S. Shippenberg, and L. Denoroy. 2009. Detection and quantification of neurotransmitters in dialysates. Curr. Protoc. Neurosci. Chapter 7:Unit 7.4.1-30.</p>\n\t</li>\n</ul>\n","biologicalOrganisationLevel":"Cellular","organTerm":{},"biologicalEvents":[{"action":"increased","object":{"name":"acetylcholine","source":"CHEBI","sourceId":"CHEBI:15355"}}],"id":10}
{"title":"Respiratory distress/arrest","references":"<ul>\n\t<li dir=\"ltr\">\n\t<p dir=\"ltr\">Carey, J.L., Dunn, C., Gaspari, R.J. 2013. Central respiratory failure during acute organophosphate poisoning. Respiratory Physiology &amp; Neurobiology. 189(2), 403-410.</p>\n\t</li>\n\t<li dir=\"ltr\">\n\t<p dir=\"ltr\">Chokrovetry, S. 2011. Chapter 64- Sleep and breathing in neuromuscular disorders. Handbook of Clinical Neurology. 99, 1087-1108.</p>\n\t</li>\n\t<li dir=\"ltr\">\n\t<p dir=\"ltr\">De Candole, C.A., Douglas, W.W., Evans, C.L., Holmes, R., Spencer, K.E., Torrance, R.W., Wilson, K.M. 1953. The failure of respiration in death by anticholinesterase poisoning. Br J Pharmacol Chemother. 8(4):466-75.</p>\n\t</li>\n\t<li dir=\"ltr\">\n\t<p dir=\"ltr\">Leikauf, G.D. Toxic responses of the Respiratory System.&nbsp; In Casarett and Doull&#39;s Toxicology: The Basic Science of Poisons. 9th ed. pp 793-837.</p>\n\t</li>\n\t<li dir=\"ltr\">\n\t<p dir=\"ltr\">Hulse, E.J., Davies, J.O., John Simpson, A., Sciuto, A.M., Eddleston, M. 2013. Respiratory Complications of Organophosphorus Nerve Agent and Insecticide Poisoning. Implications for Respiratory and Critical Care. American Journal of Respiratory and Critical Care Medicine. 190(12).</p>\n\t</li>\n\t<li dir=\"ltr\">\n\t<p dir=\"ltr\">McKim, J.M., Schmieder, P.K., Carlson, R.W., Hunt, E.P. (1987). Use of respiratory-cardiovascular responses of rainbow trout (Salmo gairdneri) in identifying acute toxicity syndromes in fish: Part 1. Pentachlorophenol, 2,4-dinitrophenol, tricaine methanesulfonate and 1-octanol. Environmental Toxicology and Chemistry, Vol. 6, 295-312.</p>\n\t</li>\n</ul>\n","biologicalOrganisationLevel":"Organ","organTerm":{"name":"respiration organ","sourceId":"UBERON:0000171"},"biologicalEvents":[{"action":"increased","process":"respiratory distress","object":{}}],"id":445}
{"title":"Increased Cholinergic Signaling","references":"<ul>\n\t<li dir=\"ltr\">\n\t<p dir=\"ltr\">Costa.&nbsp; Toxic effects of pesticides.&nbsp; In Casarett and Doull&#39;s Toxicology: The Basic Science of Poisons. 9th ed. pp 1055-1106.</p>\n\t</li>\n\t<li dir=\"ltr\">\n\t<p dir=\"ltr\">De Candole, C.A., Douglas, W.W., Evans, C.L., Holmes, R., Spencer, K.E., Torrance, R.W., Wilson, K.M. 1953. The failure of respiration in death by anticholinesterase poisoning. Br J Pharmacol Chemother. 8(4):466-75.</p>\n\t</li>\n\t<li dir=\"ltr\">\n\t<p dir=\"ltr\">Picciotto MR, Higley MJ, Mineur YS., Acetylcholine as a neuromodulator: cholinergic signaling shapes nervous system function and behavior. Neuron. 2012 Oct 4;76(1):116-29.</p>\n\t</li>\n\t<li dir=\"ltr\">\n\t<p dir=\"ltr\">Luchicchi A, Bloem B, Via&ntilde;a JN, Mansvelder HD, Role LW., Illuminating the role of cholinergic signaling in circuits of attention and emotionally salient behaviors. Front Synaptic Neurosci. 2014 Oct 27;6:24. doi: 10.3389/fnsyn.2014.00024. eCollection 2014.</p>\n\t</li>\n\t<li dir=\"ltr\">\n\t<p dir=\"ltr\">Wadia RS, Sadagopan C, Amin RB, Sardesai HV. Neurological manifestations of organophosphorous insecticide poisoning. J Neurol Neurosurg Psychiatry. 1974 Jul;37(7):841-7.</p>\n\t</li>\n\t<li dir=\"ltr\">\n\t<p dir=\"ltr\">Watson, Fiona L., Hayden Schmidt, Zackery K. Turman, Natalie Hole, Hena Garcia, Jonathan Gregg, Joseph Tilghman, and Erica A. Fradinger. 2014. &ldquo;Organophosphate Pesticides Induce Morphological Abnormalities and Decrease Locomotor Activity and Heart Rate in Danio Rerio and Xenopus Laevis.&rdquo; Environmental Toxicology and Chemistry 33 (6): 1337&ndash;45.<a href=\"https://doi.org/10.1002/etc.2559\"> https://doi.org/10.1002/etc.2559</a>.</p>\n\t</li>\n\t<li dir=\"ltr\">\n\t<p dir=\"ltr\">Peter, John Victor, Thomas Sudarsan, and John Moran. 2014. &ldquo;Clinical Features of Organophosphate Poisoning: A Review of Different Classification Systems and Approaches.&rdquo; Indian Journal of Critical Care Medicine 18 (11): 735&ndash;45.<a href=\"https://doi.org/10.4103/0972-5229.144017\"> https://doi.org/10.4103/0972-5229.144017</a>.</p>\n\t</li>\n\t<li dir=\"ltr\">\n\t<p dir=\"ltr\">Lodish, Harvey, Arnold Berk, S. Lawrence Zipursky, Paul Matsudaira, David Baltimore, and James Darnell. 2000. &ldquo;Neurotransmitters, Synapses, and Impulse Transmission.&rdquo; Molecular Cell Biology. 4th Edition.<a href=\"https://www.ncbi.nlm.nih.gov/books/NBK21521/\"> https://www.ncbi.nlm.nih.gov/books/NBK21521/</a>.</p>\n\t</li>\n\t<li dir=\"ltr\">\n\t<p dir=\"ltr\">Coulson FR, Fryer AD. <a href=\"https://www.ncbi.nlm.nih.gov/pubmed/12667888\">Muscarinic acetylcholine receptors and airway diseases. </a>Pharmacol Ther. 2003 Apr;98(1):59-69.</p>\n\t</li>\n</ul>\n","biologicalOrganisationLevel":"Organ","organTerm":{"name":"nervous system","sourceId":"UBERON:0001016"},"biologicalEvents":[{"action":"increased","process":"ataxia","object":{}},{"action":"increased","process":"hyperactivity","object":{}},{"action":"increased","process":"paralysis","object":{}}],"id":39}
{"title":"Increased Cholinergic Signaling","references":"<ul>\n\t<li dir=\"ltr\">\n\t<p dir=\"ltr\">Costa.&nbsp; Toxic effects of pesticides.&nbsp; In Casarett and Doull&#39;s Toxicology: The Basic Science of Poisons. 9th ed. pp 1055-1106.</p>\n\t</li>\n\t<li dir=\"ltr\">\n\t<p dir=\"ltr\">De Candole, C.A., Douglas, W.W., Evans, C.L., Holmes, R., Spencer, K.E., Torrance, R.W., Wilson, K.M. 1953. The failure of respiration in death by anticholinesterase poisoning. Br J Pharmacol Chemother. 8(4):466-75.</p>\n\t</li>\n\t<li dir=\"ltr\">\n\t<p dir=\"ltr\">Picciotto MR, Higley MJ, Mineur YS., Acetylcholine as a neuromodulator: cholinergic signaling shapes nervous system function and behavior. Neuron. 2012 Oct 4;76(1):116-29.</p>\n\t</li>\n\t<li dir=\"ltr\">\n\t<p dir=\"ltr\">Luchicchi A, Bloem B, Via&ntilde;a JN, Mansvelder HD, Role LW., Illuminating the role of cholinergic signaling in circuits of attention and emotionally salient behaviors. Front Synaptic Neurosci. 2014 Oct 27;6:24. doi: 10.3389/fnsyn.2014.00024. eCollection 2014.</p>\n\t</li>\n\t<li dir=\"ltr\">\n\t<p dir=\"ltr\">Wadia RS, Sadagopan C, Amin RB, Sardesai HV. Neurological manifestations of organophosphorous insecticide poisoning. J Neurol Neurosurg Psychiatry. 1974 Jul;37(7):841-7.</p>\n\t</li>\n\t<li dir=\"ltr\">\n\t<p dir=\"ltr\">Watson, Fiona L., Hayden Schmidt, Zackery K. Turman, Natalie Hole, Hena Garcia, Jonathan Gregg, Joseph Tilghman, and Erica A. Fradinger. 2014. &ldquo;Organophosphate Pesticides Induce Morphological Abnormalities and Decrease Locomotor Activity and Heart Rate in Danio Rerio and Xenopus Laevis.&rdquo; Environmental Toxicology and Chemistry 33 (6): 1337&ndash;45.<a href=\"https://doi.org/10.1002/etc.2559\"> https://doi.org/10.1002/etc.2559</a>.</p>\n\t</li>\n\t<li dir=\"ltr\">\n\t<p dir=\"ltr\">Peter, John Victor, Thomas Sudarsan, and John Moran. 2014. &ldquo;Clinical Features of Organophosphate Poisoning: A Review of Different Classification Systems and Approaches.&rdquo; Indian Journal of Critical Care Medicine 18 (11): 735&ndash;45.<a href=\"https://doi.org/10.4103/0972-5229.144017\"> https://doi.org/10.4103/0972-5229.144017</a>.</p>\n\t</li>\n\t<li dir=\"ltr\">\n\t<p dir=\"ltr\">Lodish, Harvey, Arnold Berk, S. Lawrence Zipursky, Paul Matsudaira, David Baltimore, and James Darnell. 2000. &ldquo;Neurotransmitters, Synapses, and Impulse Transmission.&rdquo; Molecular Cell Biology. 4th Edition.<a href=\"https://www.ncbi.nlm.nih.gov/books/NBK21521/\"> https://www.ncbi.nlm.nih.gov/books/NBK21521/</a>.</p>\n\t</li>\n\t<li dir=\"ltr\">\n\t<p dir=\"ltr\">Coulson FR, Fryer AD. <a href=\"https://www.ncbi.nlm.nih.gov/pubmed/12667888\">Muscarinic acetylcholine receptors and airway diseases. </a>Pharmacol Ther. 2003 Apr;98(1):59-69.</p>\n\t</li>\n</ul>\n","biologicalOrganisationLevel":"Organ","organTerm":{"name":"nervous system","sourceId":"UBERON:0001016"},"biologicalEvents":[{"action":"increased","process":"ataxia","object":{}},{"action":"increased","process":"hyperactivity","object":{}},{"action":"increased","process":"paralysis","object":{}}],"id":39}
{"title":"Increased Cholinergic Signaling","references":"<ul>\n\t<li dir=\"ltr\">\n\t<p dir=\"ltr\">Costa.&nbsp; Toxic effects of pesticides.&nbsp; In Casarett and Doull&#39;s Toxicology: The Basic Science of Poisons. 9th ed. pp 1055-1106.</p>\n\t</li>\n\t<li dir=\"ltr\">\n\t<p dir=\"ltr\">De Candole, C.A., Douglas, W.W., Evans, C.L., Holmes, R., Spencer, K.E., Torrance, R.W., Wilson, K.M. 1953. The failure of respiration in death by anticholinesterase poisoning. Br J Pharmacol Chemother. 8(4):466-75.</p>\n\t</li>\n\t<li dir=\"ltr\">\n\t<p dir=\"ltr\">Picciotto MR, Higley MJ, Mineur YS., Acetylcholine as a neuromodulator: cholinergic signaling shapes nervous system function and behavior. Neuron. 2012 Oct 4;76(1):116-29.</p>\n\t</li>\n\t<li dir=\"ltr\">\n\t<p dir=\"ltr\">Luchicchi A, Bloem B, Via&ntilde;a JN, Mansvelder HD, Role LW., Illuminating the role of cholinergic signaling in circuits of attention and emotionally salient behaviors. Front Synaptic Neurosci. 2014 Oct 27;6:24. doi: 10.3389/fnsyn.2014.00024. eCollection 2014.</p>\n\t</li>\n\t<li dir=\"ltr\">\n\t<p dir=\"ltr\">Wadia RS, Sadagopan C, Amin RB, Sardesai HV. Neurological manifestations of organophosphorous insecticide poisoning. J Neurol Neurosurg Psychiatry. 1974 Jul;37(7):841-7.</p>\n\t</li>\n\t<li dir=\"ltr\">\n\t<p dir=\"ltr\">Watson, Fiona L., Hayden Schmidt, Zackery K. Turman, Natalie Hole, Hena Garcia, Jonathan Gregg, Joseph Tilghman, and Erica A. Fradinger. 2014. &ldquo;Organophosphate Pesticides Induce Morphological Abnormalities and Decrease Locomotor Activity and Heart Rate in Danio Rerio and Xenopus Laevis.&rdquo; Environmental Toxicology and Chemistry 33 (6): 1337&ndash;45.<a href=\"https://doi.org/10.1002/etc.2559\"> https://doi.org/10.1002/etc.2559</a>.</p>\n\t</li>\n\t<li dir=\"ltr\">\n\t<p dir=\"ltr\">Peter, John Victor, Thomas Sudarsan, and John Moran. 2014. &ldquo;Clinical Features of Organophosphate Poisoning: A Review of Different Classification Systems and Approaches.&rdquo; Indian Journal of Critical Care Medicine 18 (11): 735&ndash;45.<a href=\"https://doi.org/10.4103/0972-5229.144017\"> https://doi.org/10.4103/0972-5229.144017</a>.</p>\n\t</li>\n\t<li dir=\"ltr\">\n\t<p dir=\"ltr\">Lodish, Harvey, Arnold Berk, S. Lawrence Zipursky, Paul Matsudaira, David Baltimore, and James Darnell. 2000. &ldquo;Neurotransmitters, Synapses, and Impulse Transmission.&rdquo; Molecular Cell Biology. 4th Edition.<a href=\"https://www.ncbi.nlm.nih.gov/books/NBK21521/\"> https://www.ncbi.nlm.nih.gov/books/NBK21521/</a>.</p>\n\t</li>\n\t<li dir=\"ltr\">\n\t<p dir=\"ltr\">Coulson FR, Fryer AD. <a href=\"https://www.ncbi.nlm.nih.gov/pubmed/12667888\">Muscarinic acetylcholine receptors and airway diseases. </a>Pharmacol Ther. 2003 Apr;98(1):59-69.</p>\n\t</li>\n</ul>\n","biologicalOrganisationLevel":"Organ","organTerm":{"name":"nervous system","sourceId":"UBERON:0001016"},"biologicalEvents":[{"action":"increased","process":"ataxia","object":{}},{"action":"increased","process":"hyperactivity","object":{}},{"action":"increased","process":"paralysis","object":{}}],"id":39}
{"title":"Dysregulation of heart rate and vascular tone","references":"<ul>\n\t<li dir=\"ltr\">\n\t<p dir=\"ltr\">Steele SL, Lo KH, Li VW, Cheng SH, Ekker M, Perry SF. 10.1152/ajpregu.00036.2009. Epub 2009 Jun 10. <a href=\"https://www.physiology.org/doi/full/10.1152/ajpregu.00036.2009?url_ver=Z39.88-2003&amp;rfr_id=ori%3Arid%3Acrossref.org&amp;rfr_dat=cr_pub%3Dpubmed\">Loss of M2 muscarinic receptor function inhibits development of hypoxic bradycardia and alters cardiac beta-adrenergic sensitivity in larval zebrafish (Danio rerio)</a>. Am J Physiol Regul Integr Comp Physiol. 2009 Aug;297(2)</p>\n\t</li>\n\t<li dir=\"ltr\">\n\t<p dir=\"ltr\">Gaspari RJ, Paydarfar D. <a href=\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2041827/\">Pathophysiology of respiratory failure following acute dichlorvos poisoning in a rodent model.</a> Neurotoxicology. 2007 May;28(3):664-71.</p>\n\t</li>\n\t<li dir=\"ltr\">\n\t<p dir=\"ltr\">Campen. Toxic Responses of the Heart and Vascular System. In Casarett and Doull&#39;s Toxicology: The Basic Science of Poisons. 9th ed. 999-952.</p>\n\t</li>\n\t<li dir=\"ltr\">\n\t<p dir=\"ltr\">Karki P, Ansari JA, Bhandary S, Koirala S. Cardiac and electrocardiographical manifestations of acute organophosphate poisoning. Singapore Med J. 2004;45:385&ndash;9.&nbsp;</p>\n\t</li>\n\t<li dir=\"ltr\">\n\t<p dir=\"ltr\">Lodish, Harvey, Arnold Berk, S. Lawrence Zipursky, Paul Matsudaira, David Baltimore, and James Darnell. 2000. &ldquo;Neurotransmitters, Synapses, and Impulse Transmission.&rdquo; Molecular Cell Biology. 4th Edition.<a href=\"https://www.ncbi.nlm.nih.gov/books/NBK21521/\"> https://www.ncbi.nlm.nih.gov/books/NBK21521/</a>.</p>\n\t</li>\n\t<li dir=\"ltr\">\n\t<p dir=\"ltr\">McKim, JM, Goeden, HM. <a href=\"https://www.sciencedirect.com/science/article/pii/0306449282902064\">A direct measure of the uptake efficiency of a xenobiotic chemical across the gills of brook trout (Salvelinus fontinalis) under normoxic and hypoxic conditions</a>, Comparative Biochemistry and Physiology Part C: Comparative Pharmacology, Volume 72, Issue 1, 1982, pgs 65-74</p>\n\t</li>\n\t<li dir=\"ltr\">\n\t<p dir=\"ltr\">McKim, James M., Patricia K. Schmieder, Richard W. Carlson, Evelyn P. Hunt, and Gerald J. Niemi. 1987. &ldquo;Use of Respiratory-Cardiovascular Responses of Rainbow Trout (Salmo Gairdneri) in Identifying Acute Toxicity Syndromes in Fish: Part 1. Pentachlorophenol, 2,4-Dinitrophenol, Tricaine Methanesulfonate and 1-Octanol.&rdquo;&nbsp;Environmental Toxicology and Chemistry 6 (4): 295&ndash;312.<a href=\"https://doi.org/10.1002/etc.5620060407\"> https://doi.org/10.1002/etc.5620060407</a>.</p>\n\t</li>\n\t<li dir=\"ltr\">\n\t<p dir=\"ltr\">Peter, J.V., Sudarsan, T.I. and Moran, J.L. 2014. vas. Indian J Crit Care Med. 18(11): 735&ndash;745.</p>\n\t</li>\n</ul>\n","biologicalOrganisationLevel":"Organ","organTerm":{},"biologicalEvents":[{"object":{}}],"id":1703}
{"title":"Decrease, Population trajectory","references":"<ul>\n\t<li>Miller DH, Ankley GT. 2004. Modeling impacts on populations: fathead minnow (Pimephales promelas) exposure to the endocrine disruptor 17&szlig;-trenbolone as a case study. Ecotoxicology and Environmental Safety 59: 1-9.</li>\n</ul>\n","biologicalOrganisationLevel":"Population","organTerm":{},"biologicalEvents":[{"action":"decreased","process":"population growth rate","object":{"name":"population of organisms","source":"PCO","sourceId":"PCO:0000001"}}],"id":360}
{"title":"Binding, Thiol/seleno-proteins involved in protection against oxidative stress","references":"<p>Arnold, A.P.,K.-S. Tan, D.L. Rabenstein (1986), Nuclear Magnetic Resonance Studies of the Solution Chemistry of Metal Complexes. 23. Complexation of Methylmercury by Selenohydryl-Containing Amino Acids and Related Molecules. <em>Inorganic Chemistry</em>, 25 (14), pp. 2433-2437.</p>\n\n<p>Barbosa, N.V., et al. (2017), Organoselenium compounds as mimics of selenoproteins and thiol modifier agents (2017) Metallomics, 9 (12), pp. 1703-1734.</p>\n\n<p>Berntssen, M.H, A. Aatland, R.D. Handy (2003), Chronic dietary mercury exposure causes oxidative stress, brain lesions, and altered behaviour in Atlantic salmon (Salmo salar) parr. <em>Aquatic Toxicology</em>. 65, pp.55-72.</p>\n\n<p>Branco V. et al. (2011), Inhibition of the thioredoxin system in the brain and liver of zebra-seabreams exposed to waterborne methylmercury. <em>Toxicology and applied pharmacology</em>. 251(2), pp. 95-103.</p>\n\n<p>Branco, V. et al. (2012a), Mercury and selenium interaction in vivo: on thioredoxin reductase and glutathione peroxidase.Free Radical in&nbsp; Biology and&nbsp; Medicine, 52(4): 781-793.</p>\n\n<p>Branco, V., et al. (2012b), Biomarkers of adverse response to mercury: histopathology versus thioredoxin reductase activity. <em>Journal of Biomedicine and Biotechnology,</em> 2012:359879. doi: 10.1155/2012/359879.</p>\n\n<p>Branco, V, (2014), Mitochondrial thioredoxin reductase inhibition, selenium status, and Nrf-2 activation are determinant factors modulating the toxicity of mercury compounds. <em>Free Radical Biology and Medicine</em> 73: 95-105.</p>\n\n<p>Branco, V. et al. (2017), Impaired cross-talk between the thioredoxin and glutathione systems is related to ASK-1 mediated apoptosis in neuronal cells exposed to mercury. Redox Biol 13, 278-287.</p>\n\n<p>Carvalho, C.M. et al. (2008a) Inhibition of the human thioredoxin system. A molecular mechanism of mercury toxicity. J Biol Chem 283, 11913-11923.</p>\n\n<p>Carvalho, M.C. et al. (2008b); Behavioral, morphological, and biochemical changes after in ovo exposure to methylmercury in chicks. <em>Toxicological sciences</em>, 106(1), pp.180-185.</p>\n\n<p>Carvalho, C.M.L. et al. (2011), Effects of selenite and chelating agents on mammalian thioredoxin reductase inhibited by mercury: Implications for treatment of mercury poisoning . <em>FASEB Journal</em>, 25 (1), pp. 370-381.</p>\n\n<p>Cambier S., et al. (2012), Effects of dietary methylmercury on the zebrafish brain: histological, mitochondrial, and gene transcription analyses. <em>Biometals.</em> 25(1):165-180.</p>\n\n<p>Chehimi L, et al. (2012), Chronic exposure to mercuric chloride during gestation affects sensorimotor development and later behaviour in rats. <em>Behav. Brain Res.</em> 234:43&ndash;50. https:// doi.org/10.1016/j.bbr.2012.06.005</p>\n\n<p>Cheng JP, Yang YC, Hu WX, Yang L, Wang WH, Jia JP, Lin XY(2005) Effect of methylmercury on some neurotransmitters and oxidative damage of rats. J Environ&nbsp; Sci (China) 17:469-473.</p>\n\n<p>Comini, M.A., (2016), Measurement and meaning of cellular thiol: disufhide redox status. <em>Free Radical Research, </em>50(2):246-271.</p>\n\n<p>Dalla Corte CL, Wagner C, Sudati JH, Comparsi B, Leite GO, Busanello A, Soares FAA, Aschner M, Rocha JBT.(2013) Effects of diphenyl diselenide on methylmercury toxicity in rats. BioMed Res Int 983821, doi: 10.1155/2013/983821.</p>\n\n<p>D&oacute;rea JG, Farina M, Rocha JBT. Toxicity of ethylmercury (and Thimerosal): A comparison with methylmercury. J Appl Toxicol 33:700-711, 2013.</p>\n\n<p>Farina, M. et al. (2009) Probucol increases glutathione peroxidase-1 activity and displays long-lasting protection against methylmercury toxicity in cerebellar granule cells. <em>Toxicological Sciences</em> 112, 416-426.</p>\n\n<p>Farina, M. et al. (2011) Oxidative stress in MeHg-induced neurotoxicity. Toxicol Appl Pharmacol 256, 405-417.</p>\n\n<p>Farina M. , Aschner M., Rocha J.B. (2017),The catecholaminergic neurotransmitter system in methylmercury-Induced neurotoxicity. In Advances in Neurotoxicology (Vol. 1, pp. 47-81). Academic Press.</p>\n\n<p>Floh&eacute;, L., W.A. G&uuml;nzler (1984),&nbsp;&nbsp; Assays of Glutathione Peroxidase.&nbsp; <em>Methods in Enzymology</em>, 105 : 114-120.</p>\n\n<p>Franciscato, C., (2009), ZnCl2 exposure protects against behavioral and acetylcholinesterase changes induced by HgCl2. <em>Int. J. Dev. Neurosci.</em> 27:459&ndash;468. https://doi.org/10.1016/j. ijdevneu.2009.05.002</p>\n\n<p>Franco, J.L., (2009), Methylmercury neurotoxicity is associated with inhibition of the antioxidant enzyme glutathione peroxidase.<em>Free Radical Biology and Medicine</em>, 47 (4), pp. 449-457.</p>\n\n<p>George, G.N., et al. (2008) Chemical forms of mercury and selenium in fish following digestion with simulated gastric fluid. <em>Chemical Research in Toxicology</em>, 21 (11), pp. 2106-2110.</p>\n\n<p>Glaser V, Leipnitz G, Straliotto MR, Oliveira J, dos Santos VV, Wannmacher CMD, de Bem AF, Rocha JBT, Farina M, Latini A. Oxidative stress-mediated inhibition of brain creatine kinase activity by methylmercury. NeuroToxicology 31:454-460, 2010b.</p>\n\n<p>Glaser V, Moritz B, Schmitz A, Dafr&eacute; AL, Nazari EM, M&uuml;ller YM, Feksa L, Straliottoa MR, de Bem AF, Farina M, Rocha JBT. Protective effects of diphenyl diselenide in a mouse model of brain toxicity. Chem-Biol Interac 206:18-26, 2013.</p>\n\n<p>Go, Y.M., D.P. Jones (2014), Redox biology: interface of the exposome with the proteome, epigenome and genome. <em>Redox Biology</em>, 2:358-60.</p>\n\n<p>Go, Y.M., et al. (2013). Selective targeting of the cysteine proteome by thioredoxin and glutathione redox systems. <em>Molecular Cell Proteomics</em>. 12(11): 3285-3296.</p>\n\n<p>Han S, Zhu M, Yuan Z, Li X (2001) A methylene blue-mediated enzyme electrode for the determination of trace mercury (II), mercury (I), methylmercury, and mercury-glutathione complex. Biosensors &amp; Bioelectronics. 16&nbsp;: 9-16.</p>\n\n<p>Holmgren, A., M. Bj&ouml;rnstedt (1995), Thioredoxin and thioredoxin reductase. <em>Methods in Enzymolozy,</em> 252: 199-208.</p>\n\n<p>&nbsp;Heinz, G.H., (2009), &nbsp;Species differences in the sensitivity of avian embryos to methylmercury. <em>Archives of Environmental Contamination and Toxicology,</em> 56(1)&nbsp;: &nbsp;pp.129-138.</p>\n\n<p>Heinz, G.H., (1979), Methylmercury: reproductive and behavioral effects on three generations of mallard ducks. The Journal of Wildlife Management, pp.394-401.</p>\n\n<p>Hoppe, B., et al (2008), Biochemical analysis of selenoprotein expression in brain cell lines and in distinct brain regions.<em> Cell and Tissue Research</em>, 332 (3), pp. 403-414.</p>\n\n<p>Jones, D.P. (2015), Redox theory of aging. Redox Biology, 5: 71-79. Liem-Nguyen V, (2017), Thermodynamic stability of mercury(II) complexes formed with environmentally relevant low-molecular-mass thiols studied by competing ligand exchange and density functional theory. <em>Environ. Chem.</em>14:243-253, 2017.</p>\n\n<p>Li, Y., Shi, W., Li, Y., Zhou, Y., Hu, X., Song, C., Ma, H., Wang, C., Li, Y. Neuroprotective effects of chlorogenic acid against apoptosis of PC12 cells induced by methylmercury (2008) Environmental Toxicology and Pharmacology, 26 (1), pp. 13-21.al. 1990 neuroblastoma gpx</p>\n\n<p>Liem-Nguyen V, Skyllberg U, Nam K, Bj&ouml;rn E. Thermodynamic stability of mercury(II) complexes formed with environmentally relevant low-molecular-mass thiols studied by competing ligand exchange and density functional theory. Environ Chem 14:243-253, 2017.</p>\n\n<p>Malagutti, K.S., da Silva, A.P., Braga, H.C., Mitozo, P.A., Soares dos Santos, A.R., Dafre, A.L., de Bem, A.F., Farina, M. 17&beta;-estradiol decreases methylmercury-induced neurotoxicity in male mice (2009) Environmental Toxicology and Pharmacology, 27 (2), pp. 293-297.</p>\n\n<p>Martyniuk, C. J., Feswick, A., Fang, B., Koomen, J. M., Barber, D. S., Gavin, T., &amp; LoPachin, R. M. (2013). Protein targets of acrylamide adduct formation in cultured rat dopaminergic cells. Toxicology letters, 219(3), 279-287.</p>\n\n<p>Meinerz, DF, &nbsp;et al.&nbsp; (2017) . Diphenyl diselenide&nbsp; protects against methylmercury-induced inhibition of thioredoxin reductase and glutathione peroxidase in human neuroblastoma cells: a comparison with ebselen. <em>Journal of Applied Toxicology</em> 37(9):1073-1081. doi: 10.1002/jat.3458.</p>\n\n<p>Mello-Carpes, P.B. et al. &nbsp;(2013), Chronic exposure to low mercury chloride concentration induces object recognition and aversive memories deficits in rats. <em>Int J Dev Neurosci</em> 31:468&ndash;472.</p>\n\n<p>Mori N, Yasutake A, Hirayama K. Comparative study of activities in reactive oxygen species production/defense system in mitochondria of rat brain and liver, and their susceptibility to methylmercury toxicity. Archives of toxicology. 2007 Nov 1;81(11):769-76.</p>\n\n<p>Mousavi A. (2011), Predicting mercury(II) binding by organic ligands: A chemical model of therapeutic and environmental interests. <em>Environ Forensics</em> 12:327&ndash;332.</p>\n\n<p>Oliveira CS., et al. (2017)Chemical Speciation of Selenium&nbsp; and Mercury as Determinant of Their Neurotoxicity. <em>Advances in&nbsp; Neurobiology</em>&nbsp;18:53-83. doi: 10.1007/978-3-319-60189-2_4.&nbsp;</p>\n\n<p>Pillai, R., J.H.Uyehara-Lock, F.P. Bellinger (2014), Selenium and selenoprotein function in brain disorders. <em>IUBMB Life</em>, 66(4): 229-39. doi: 10.1002/iub.1262.</p>\n\n<p>Pisoschi, A.M., Pop, A. (2015) The role of antioxidants in the chemistry of oxidative stress: A review. <em>Eur J Med. Chem. &nbsp;</em>97, 55-74.</p>\n\n<p>Peixoto, N.C., &nbsp;et al. &nbsp;(2007), Behavioral alterations induced by HgCl2 depend on the postnatal period of exposure. <em>Int. J. Dev. Neurosc.i</em> 25:39&ndash;46</p>\n\n<p>Qiao Y, Huang X, Chen B, He M, Hu B 2017. In vitro study on antagonism mechanism of glutathione, sodium selenite and mercuric chloride. Talanta 171&nbsp;: 262-269.</p>\n\n<p>Rabenstein, D.L. (1978a), The chemistry of methylmercury toxicology. Journal of Chemical Education 54: 292-296.</p>\n\n<p>Rabenstein, D.L. (1978b), The Aqueous Solution Chemistry of Methylmercury and Its Complexes.<em>Accounts of Chemical Research</em>, 11 (3), pp. 100-107.</p>\n\n<p>Rabenstein, D.L., A.P. Arnold, R.D. Guy, (1986), 1H-NMR study of the removal of methylmercury from intact erythrocytes by sulfhydryl compounds.<em>Journal of Inorganic Biochemistry</em>, 28 (2-3), pp. 279-287.</p>\n\n<p>Rabenstein, D.L., J. Bravo (1987), Nuclear Magnetic Resonance Studies of the Solution Chemistry of Metal Complexes: 24: Arylmercury(II) Complexes of Sulfhydryl-Containing Ligands.<em>Inorganic Chemistry</em>, 26 (17), pp. 2784-2787.</p>\n\n<p>Rabenstein, D.L., M.T. Fairhurst (1975), Nuclear Magnetic Resonance Studies of the Solution Chemistry of Metal Complexes. XI. Binding of Methylmercury by Sulfhydryl-Containing Amino Acids and by Glutathione.<em>Journal of the American Chemical Society</em>, 97 (8), pp. 2086-2092.</p>\n\n<p>Rabenstein, D.L., R.S. Reid (1984), Nuclear Magnetic Resonance Studies of the Solution Chemistry of Metal Complexes. 20. Ligand-Exchange Kinetics of Methylmercury(II)-Thiol Complexes.<em>Inorganic Chemistry</em>, 23 (9), pp. 1246-1250.</p>\n\n<p>Rabenstein, D.L., R.S. Reid, A.A. Isab (1983) 1H nmr study of the effectiveness of various thiols for removal of methylmercury from hemolyzed erythrocytes.<em>Journal of Inorganic Biochemistry</em>, 18 (3), pp. 241-251.</p>\n\n<p>Reid, R.S., D.L. Rabenstein (1982), Nuclear Magnetic Resonance Studies of the Solution Chemistry of Metal Complexes. 19. Formation Constants for the Complexation of Methylmercury by Glutathione, Ergothioneine, and Hemoglobin. <em>Journal of the American Chemical Society</em>, 104 (24), pp. 6733-6737.</p>\n\n<p>Reeves, M.A., Hoffmann, P.R. (2009) The human selenoproteome: recent insights into functions and regulation. Cell Mol Life Sci 66, 2457-2478.</p>\n\n<p>Ren X, Zou L, Zhang X, Branco V, Wang J, Carvalho C, Holmgren A, Lu J. Redox Signaling Mediated by Thioredoxin and Glutathione Systems in the Central Nervous System. Antioxid Redox Signal. 2017 Nov 1;27(13):989-1010. doi: 10.1089/ars.2016.6925.</p>\n\n<p>Ruszkiewicz, J.A.&nbsp; et al. (2016), Sex-and structure-specific differences in antioxidant responses to methylmercury during early development. <em>Neurotoxicology</em>, 56, pp.118-126.</p>\n\n<p>Sorg, O., (1998), Increased vulnerability of neurones and glial cells to low concentrations of methylmercury in a prooxidant situation. <em>Acta Neuropathologica</em>, 96 (6), pp. 621-627.</p>\n\n<p>Stricks, W., I.M. Kolthoff (1953), Reactions between mercuric mercury and cysteine and glutathione. Apparent dissociation constants, heats and entropies of formation of various forms of mercuric mercaptocysteine and -glutathione. <em>J Am Chem Soc</em> 75:5673-5681, 1953.</p>\n\n<p>Stringari, J. (2008), Prenatal methylmercury exposure hampers glutathione antioxidant system ontogenesis and causes long-lasting oxidative stress in the mouse brain.<em>Toxicology and Applied Pharmacology</em>, 227 (1), pp. 147-154.</p>\n\n<p>Sugiura, Y., et al.(1976), Selenium protection against mercury toxicity. Binding of methylmercury by the selenohydryl-containing ligand. <em>Journal of the American Chemical Society</em>,&nbsp; 98:2339&ndash;2341.</p>\n\n<p>Sugiura Y, Tamai Y, Tanaka H. (1978) Selenium protection against mercury toxicity&nbsp;: high binding affinity of methylmercury by selenium-containing ligands in comparison with sulfur-containing ligands. Bioinorg. Chem. 9&nbsp;:167-180.</p>\n\n<p>Wagner, C.et al. (2010), In vivo and in vitro inhibition of mice thioredoxin reductase by methylmercury . <em>BioMetals</em>, 23 (6), pp. 1171-1177.</p>\n\n<p>Wiederhold JG, Cramer CJ, Daniel K, Infante I, Bourdon B, Kretzschmar R. (2010) Equilibrium mercury isotope fractionation between dissolved Hg(II) species and thiol-bound Hg. Environ Sci Technol. 44&nbsp;:4191-7. Doi&nbsp;: 10.1021/es100205t.</p>\n\n<p>Yang, L. (2007), Transcriptional profiling reveals barcode-like toxicogenomic responses in the zebrafish embryo. Genome biology. 8(10):R227.</p>\n\n<p>Xu, X., (2012), Developmental methylmercury exposure affects avoidance learning outcomes in adult zebrafish. <em>Journal of Toxicology and Environmental Health Sciences</em>, &nbsp;4, no. 5 (2012): 85-91.</p>\n\n<p>Xu X, et al (2016), &nbsp;Trans-generational transmission of neurobehavioral impairments produced by developmental methylmercury exposure in zebrafish (<em>Danio rerio</em>). <em>Neurotoxicology and Teratology</em>, 53:19-23.</p>\n\n<p>Zemolin, A.P.P.,et al. (2012),&nbsp; Evidences for a role of glutathione peroxidase 4 (GPx4) in Methylmercury induced neurotoxicity in vivo. <em>Toxicology</em>, 302 (1), pp. 60-67.</p>\n\n<p>Zhu, S.-Y., et al. (2017), Biochemical characterization of the selenoproteome in Gallus gallus via bioinformatics analysis: structure-function relationships and interactions of binding molecules.<em>Metallomics</em>, 9 (2), pp. 124-131.</p>\n\n<p>&nbsp;</p>\n","biologicalOrganisationLevel":"Molecular","organTerm":{"name":"brain","sourceId":"UBERON:0000955"},"biologicalEvents":[{"object":{}}],"keyEventStressors":["Methylmercuric(II) chloride","Acrylamide","Mercury chloride"],"id":1487}
{"title":"Oxidative Stress ","references":"<p>Antelmann, H., Helmann, J.D., 2011. Thiol-based redox switches and gene regulation. Antioxid. Redox Signal. 14, 1049-1063.</p>\n\n<p>Chepelev, N.L., Kennedy, D.A., Gagne, R., White, T., Long, A.S., Yauk, C.L., White, P.A., 2015. HPLC Measurement of the DNA Oxidation Biomarker, 8-oxo-7,8-dihydro-2&#39;-deoxyguanosine, in Cultured Cells and Animal Tissues. J. Vis. Exp. (102):e52697. doi, e52697.</p>\n\n<p>Emerit, J., Edeas, M., Bricaire, F., 2004. Neurodegenerative diseases and oxidative stress. Biomed. Pharmacotherapy. 58(1): 39-46.</p>\n\n<p>Frauenberger, E.A., Scola, G., Lalibert&eacute;, V.L.M., Duong, A., Andreazza, A.C., 2015. Redox modulations, Antioxidants, and Neuropsychitrica Disorders. Ox. Med. Cell. Longevity. Vol. 2016, Article ID 4729192.</p>\n\n<p>Halliwell, B., 2006. Oxidative stress and neurodegeneration: where are we now? J. Neurochem. 97(6):1634-1658.</p>\n\n<p>Itoh, K., Mimura, J., Yamamoto, M., 2010. Discovery of the negative regulator of Nrf2, Keap1: a historical overview. Antioxid. Redox Signal. 13, 1665-1678.</p>\n\n<p>Jackson, A.F., Williams, A., Recio, L., Waters, M.D., Lambert, I.B., Yauk, C.L., 2014. Case study on the utility of hepatic global gene expression profiling in the risk assessment of the carcinogen furan. Toxicol. Applied Pharmacol.274, 63-77.</p>\n\n<p>Nguyen, T., Nioi, P., Pickett, C.B., 2009. The Nrf2-antioxidant response element signaling pathway and its activation by oxidative stress. J. Biol. Chem. 284, 13291-13295.</p>\n\n<p>OECD (2018), Test No. 442D: In Vitro Skin Sensitisation: ARE-Nrf2 Luciferase Test Method, OECD Guidelines for the Testing of Chemicals, Section 4, OECD Publishing, Paris, https://doi.org/10.1787/9789264229822-en.</p>\n\n<p>OECD (2019), Test No. 495: Ros (Reactive Oxygen Species) Assay for Photoreactivity, OECD Guidelines for the Testing of Chemicals, Section 4, OECD Publishing, Paris, https://doi.org/10.1787/915e00ac-en.</p>\n","biologicalOrganisationLevel":"Molecular","organTerm":{},"biologicalEvents":[{"object":{}}],"keyEventStressors":["furan","Chloroform","Acetaminophen"],"id":1392}
{"title":"Glutamate dyshomeostasis","references":"<p>Abe K, Abe Y, Saito H. Evaluation of L-glutamate clearance capacity of cultured rat cortical astrocytes. Biol Pharm Bull. 2000 Feb;23(2):204-7.</p>\n\n<p>Arriza JL, Fairman WA, Wadiche JI, Murdoch GH, Kavanaugh MP, Amara SG (1994) Functional comparisons of three glutamate transporter subtypes cloned from human motor cortex. J Neurosci 14(9):5559&ndash;5569.</p>\n\n<p>Bellocchio EE, Hu H, Pohorille A, Chan J, Pickel VM, Edwards RH. The localization of the brain-specific inorganic phosphate transporter suggests a specific presynaptic role in glutamatergic transmission.&nbsp;J Neurosci.&nbsp;1998;18:8648&ndash;59.</p>\n\n<p>Bridges RJ, Kavanaugh MP, Chamberlin AR. A pharmacological review of competitive inhibitors and substrates of high-affinity, sodium-dependent glutamate transport in the central nervous system. 1999; Curr. Pharm. Des. 5, 363e379.</p>\n\n<p>Brison E, Jacomy H, Desforges M, Talbot PJ. Novel Treatment with Neuroprotective and Antiviral Properties against a Neuroinvasive Human Respiratory Virus. J Virol. 2014 Feb; 88(3): 1548&ndash;1563.</p>\n\n<p>Bristol LA, Rothstein JD. Glutamate transporter gene expression in amyotrophic lateral sclerosis motor cortex.&nbsp;Annals of neurology.&nbsp;1996;39:676&ndash;679.</p>\n\n<p>Chai L, Guo H, Li H, Wang S, Wang YL, Shi F, Hu LM, Liu Y, Adah D. Scutellarin and caffeic acid ester fraction, active components of Dengzhanxixin injection, upregulate neurotrophins synthesis and release in hypoxia/reoxygenation rat astrocytes.&nbsp;Journal of ethnopharmacology.&nbsp;2013;150:100&ndash;107.</p>\n\n<p>Chaudhry FA, Reimer RJ, Edwards RH. The glutamine commute: take the N line and transfer to the A.&nbsp;J Cell Biol.&nbsp;2002;157:349&ndash;55.</p>\n\n<p>Chiocchetti, A. G., H. S. Bour and C. M. Freitag (2014). &quot;Glutamatergic candidate genes in autism spectrum disorder: an overview.&quot; <u>J Neural Transm (Vienna)</u> <strong>121</strong>(9): 1081-1106.</p>\n\n<p>Danbolt NC. Glutamate uptake.&nbsp;Progress in neurobiology.&nbsp;2001;65:1&ndash;105.</p>\n\n<p>Danbolt NC, Furness DN, Zhou Y. Neuronal vs glial glutamate uptake: Resolving the conundrum. Neurochem Int. 2016 Sep;98:29-45.</p>\n\n<p>Doble A. The role of excitotoxicity in neurodegenerative disease: implications for therapy.&nbsp;Pharmacology &amp; therapeutics.&nbsp;1999;81:163&ndash;221.</p>\n\n<p>Dunlop J, McIlvain HB, Carrick TA, Jow B, Lu Q, Kowal D, Lin S, Greenfield A, Grosanu C, Fan K, Petroski R, Williams J, Foster A, Butera J. Characterization of novel aryl-ether, biaryl, and fluorene aspartic acid and diaminopropionic acid analogs as potent inhibitors of the high-affinity glutamate transporter EAAT2. Mol Pharmacol. 2005 Oct;68(4):974-82.</p>\n\n<p>Erichsen MN, Huynh TH, Abrahamsen B, Bastlund JF, Bundgaard C, Monrad O, Bekker-Jensen A, Nielsen CW, Frydenvang K, Jensen AA, Bunch L. Structure-activity relationship study of first selective inhibitor of excitatory amino acid transporter subtype 1: 2-Amino-4-(4-methoxyphenyl)-7-(naphthalen-1-yl)-5-oxo-5,6,7,8-tetrahydro-4H-chromene-3-carbonitrile (UCPH-101). J Med Chem. 2010 Oct 14;53(19):7180-91.</p>\n\n<p>Fagnou DD, Tuchek JM (1995) The biochemistry of learning and memory. Mol Cell Biochem 149-150:279-86</p>\n\n<p>Featherstone, D. E. (2010). &quot;Intercellular glutamate signaling in the nervous system and beyond.&quot; <u>ACS Chem Neurosci</u> <strong>1</strong>(1): 4-12.</p>\n\n<p>Furuta A, Rothstein JD, Martin LJ. Glutamate transporter protein subtypes are expressed differentially during rat CNS development.&nbsp;The Journal of neuroscience : the official journal of the Society for Neuroscience.&nbsp;1997;17:8363&ndash;8375.</p>\n\n<p>Furuta, A., S. Takashima, H. Yokoo, J. D. Rothstein, K. Wada and T. Iwaki (2005). &quot;Expression of glutamate transporter subtypes during normal human corticogenesis and type II lissencephaly.&quot; <u>Brain Res Dev Brain Res</u> <strong>155</strong>(2): 155-164.</p>\n\n<p>Gegelashvili G, Danbolt NC, Schousboe A, Neuronal soluble factors differentially regulate the expression of the GLT1 and GLAST glutamate transporters in cultured astroglia. J. Neurochem. 1997; 69, 2612e2615.</p>\n\n<p>Gegelashvili G, Dehnes Y, Danbolt NC, Schousboe A, The high-affinity glutamate transporters GLT1, GLAST and EAAT4 are regulated via different signalling mechanisms. Neurochem. Int. 2000; 37, 163e170.</p>\n\n<p>Grewal S, Defamie N, Zhang X, et al. SNAT2 amino acid transporter is regulated by amino acids of the SLC6 gamma-aminobutyric acid transporter subfamily in neocortical neurons and may play no role in delivering glutamine for glutamatergic transmission.&nbsp;J Biol Chem.&nbsp;2009;284:11224&ndash;36.</p>\n\n<p>Gu L, Xu H, Wang F, Xu G, Sinha D, Wang J, Xu JY, Tian H, Gao F, Li W, Lu L, Zhang J, Xu GT, Erythropoietin Exerts a Neuroprotective Function Against Glutamate Neurotoxicity in Experimental Diabetic Retina. Invest. Ophthalmol. Vis. Sci., Dec 2014; 55: 8208 - 8222.</p>\n\n<p>Hazell AS, Pannunzio P, Rama Rao KV, Pow DV, Rambaldi A. Thiamine deficiency results in downregulation of the GLAST glutamate transporter in cultured astrocytes. Glia. 2003 Aug;43(2):175-84.</p>\n\n<p>Jin LW, Horiuchi M, Wulff H, Liu XB, Cortopassi GA, Erickson JD, Maezawa I., Rett Syndrome Microglia: A Mechanism for Mitochondrial Dysfunction and Neurotoxicity. J. Neurosci., Feb 2015; 35: 2516 &ndash; 2529</p>\n\n<p>Kim K, Lee SG, Kegelman TP, Su ZZ, Das SK, Dash R, Dasgupta S, Barral PM, Hedvat M, Diaz P, Reed JC, Stebbins JL, Pellecchia M, Sarkar D, Fisher PB. Role of excitatory amino acid transporter-2 (EAAT2) and glutamate in neurodegeneration: opportunities for developing novel therapeutics.&nbsp;Journal of cellular physiology.&nbsp;2011;226:2484&ndash;2493.</p>\n\n<p>Kvamme E, Torgner IA, Roberg B. Kinetics and localization of brain phosphate activated glutaminase.&nbsp;J Neurosci Res.&nbsp;2001;66:951&ndash;8.</p>\n\n<p>Lebrun B, Sakaitani M, Shimamoto K, Yasudakamatani Y, Nakajima T, New beta-hydroxyaspartate derivatives are competitive blockers for the bovine glutamate/aspartate transporter. 1997; J. Biol. Chem. 272, 20336e20339.</p>\n\n<p>Lehre KP, Levy LM, Ottersen OP, Storm-Mathisen J, Danbolt NC. Differential expression of two glial glutamate transporters in the rat brain: quantitative and immunocytochemical observations.&nbsp;The Journal of neuroscience : the official journal of the Society for Neuroscience.&nbsp;1995;15:1835&ndash;1853.</p>\n\n<p>Li LB, Toan SV, Zelenaia O, Watson DJ, Wolfe JH, Rothstein JD, Robinson MB. Regulation of astrocytic glutamate transporter expression by Akt: evidence for a selective transcriptional effect on the GLT-1/EAAT2 subtype. J Neurochem. 2006 May;97(3):759-71.</p>\n\n<p>Martinez-Lozada Z, Guillem AM, Robinson MB. Transcriptional Regulation of Glutamate Transporters: From Extracellular Signals to Transcription Factors. Adv Pharmacol. 2016;76:103-45.</p>\n\n<p>Meldrum, B. S. (2000). &quot;Glutamate as a neurotransmitter in the brain: review of physiology and pathology.&quot; <u>J Nutr</u> <strong>130</strong>(4S Suppl): 1007S-1015S.</p>\n\n<p>Melone M, Quagliano F, Barbaresi P, Varoqui H, Erickson JD, Conti F. Localization of the glutamine transporter SNAT1 in rat cerebral cortex and neighboring structures, with a note on its localization in human cortex.&nbsp;Cereb Cortex.&nbsp;2004;14:562&ndash;74.</p>\n\n<p>Matos M, Augusto E, Oliveira CR, Agostinho P. Amyloid-beta peptide decreases glutamate uptake in cultured astrocytes: involvement of oxidative stress and mitogen-activated protein kinase cascades. Neuroscience. 2008 Oct 28;156(4):898-910.</p>\n\n<p>Murphy-Royal C, Dupuis J, Groc L, Oliet SHR. Astroglial glutamate transporters in the brain: Regulating neurotransmitter homeostasis and synaptic transmission. J Neurosci Res. 2017 Nov;95(11):2140-2151.</p>\n\n<p>Mutkus, L., J. L. Aschner, T. Syversen and M. Aschner (2005). &quot;Methylmercury alters the in vitro uptake of glutamate in GLAST- and GLT-1-transfected mutant CHO-K1 cells.&quot; <u>Biol Trace Elem Res</u> <strong>107</strong>(3): 231-245.</p>\n\n<p>Ozawa, S., H. Kamiya and K. Tsuzuki (1998). &quot;Glutamate receptors in the mammalian central nervous system.&quot; <u>Prog Neurobiol</u> <strong>54</strong>(5): 581-618.</p>\n\n<p>Pajarillo E, Rizor A, Lee J, Aschner M, Lee E. The role of astrocytic glutamate transporters GLT-1 and GLAST in neurological disorders: Potential targets for neurotherapeutics. Neuropharmacology. 2019 Mar 6:107559.</p>\n\n<p>P&eacute;rez-Dom&iacute;nguez M, Hern&aacute;ndez-Ben&iacute;tez R, Pe&ntilde;a Segura C, Pasantes-Morales H. Thrombin-facilitated efflux of D-[3H]-aspartate from cultured astrocytes and neurons under hyponatremia and chemical ischemia. Neurochem Res. 2014 Jul;39(7):1219-31.</p>\n\n<p>Plachez C, Danbolt NC, Recasens M. Transient expression of the glial glutamate transporters GLAST and GLT in hippocampal neurons in primary culture. 2000; J. Neurosci. Res. 59, 587e593.</p>\n\n<p>Platt SR. The role of glutamate in central nervous system health and disease--a review.&nbsp;Veterinary journal (London, England : 1997)&nbsp;2007;173:278&ndash;286.</p>\n\n<p>Regan MR, Huang YH, Kim YS, Dykes-Hoberg MI, Jin L, Watkins AM, Bergles DE, Rothstein JD. Variations in promoter activity reveal a differential expression and physiology of glutamate transporters by glia in the developing and mature CNS.&nbsp;The Journal of neuroscience : the official journal of the Society for Neuroscience.&nbsp;2007;27:6607&ndash;6619.</p>\n\n<p>Rothstein JD, Martin L, Levey AI, et al. Localization of neuronal and glial glutamate transporters.&nbsp;Neuron.&nbsp;1994;13:713&ndash;25.</p>\n\n<p>Rothstein JD, Van Kammen M, Levey AI, Martin LJ, Kuncl RW. Selective loss of glial glutamate transporter GLT-1 in amyotrophic lateral sclerosis.&nbsp;Annals of neurology.&nbsp;1995;38:73&ndash;84.</p>\n\n<p>Rothstein JD, Dykes-Hoberg M, Pardo CA, Bristol LA, Jin L, Kuncl RW, Kanai Y, Hediger MA, Wang Y, Schielke JP, Welty DF. Knockout of glutamate transporters reveals a major role for astroglial transport in excitotoxicity and clearance of glutamate.&nbsp;Neuron.&nbsp;1996;16:675&ndash;686.</p>\n\n<p>Sattler R, Tymianski M. Molecular mechanisms of glutamate receptor-mediated excitotoxic neuronal cell death.&nbsp;Molecular neurobiology.&nbsp;2001;24:107&ndash;129.</p>\n\n<p>Schwartz, C. E. and G. Neri (2012). &quot;Autism and intellectual disability: two sides of the same coin.&quot; <u>Am J Med Genet C Semin Med Genet</u> <strong>160C</strong>(2): 89-90.</p>\n\n<p>Selkirk JV, Nottebaum LM, Vana AM, Verge GM, Mackay KB, Stiefel TH, Naeve GS, Pomeroy JE, Petroski RE, Moyer J, Dunlop J, Foster AC. Role of the GLT-1 subtype of glutamate transporter in glutamate homeostasis: the GLT-1-preferring inhibitor WAY-855 produces marginal neurotoxicity in the rat hippocampus. Eur J Neurosci. 2005 Jun;21(12):3217-28.</p>\n\n<p>Sheldon AL, Robinson MB. The role of glutamate transporters in neurodegenerative diseases and potential opportunities for intervention.&nbsp;Neurochemistry international.&nbsp;2007;51:333&ndash;355.</p>\n\n<p>Shen J, Petersen KF, Behar KL, et al. Determination of the rate of the glutamate/glutamine cycle in the human brain by in vivo 13C NMR.&nbsp;Proc Natl Acad Sci U S A.&nbsp;1999;96:8235&ndash;40.</p>\n\n<p>Shimamoto K, Lebrun B, Yasudakamatani Y., Sakaitani M, Shigeri Y, Yumoto N, Nakajima T. DL-threo-beta-benzyloxyaspartate, a potent blocker of excitatory amino acid transporters. 1998; Mol. Pharmacol. 53, 195e201.</p>\n\n<p>Shimamoto K. Glutamate transporter blockers for elucidation of the function of excitatory neurotransmission systems, 2008; Chem Rec. 8, 182e199.</p>\n\n<p><a href=\"https://www.ncbi.nlm.nih.gov/pubmed/?term=Sidoryk-Wegrzynowicz%20M%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=23360507\">Sidoryk-Wegrzynowicz M</a><sup>1</sup>,&nbsp;<a href=\"https://www.ncbi.nlm.nih.gov/pubmed/?term=Aschner%20M%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=23360507\">Aschner M</a>. Manganese&nbsp;toxicity&nbsp;in the&nbsp;central nervous system: the&nbsp;glutamine/glutamate-&gamma;-aminobutyric acid cycle. <a href=\"https://www.ncbi.nlm.nih.gov/pubmed/23360507\" title=\"Journal of internal medicine.\">J Intern Med.</a>&nbsp;2013 May;273(5):466-77. doi: 10.1111/joim.12040.</p>\n\n<p>Sogaard R, Borre L, Braunstein TH, Madsen KL, MacAulay N. Functional modulation of the glutamate transporter variant GLT1b by the PDZ domain protein PICK1. J Biol Chem. 2013 Jul 12;288(28):20195-207.</p>\n\n<p>Tanaka K. Functions of glutamate transporters in the brain.&nbsp;Neuroscience research.&nbsp;2000;37:15&ndash;19.</p>\n\n<p>Trotti D, Peng JB, Dunlop J, Hediger MA. Inhibition of the glutamate transporter EAAC1 expressed in Xenopus oocytes by phorbol esters. Brain Res. 2001 Sep 28;914(1-2):196-203.</p>\n\n<p>Watts SD, Torres-Salazar D, Divito CB, Amara SG, Cysteine transport</p>\n\n<p>through excitatory amino acid transporter 3 (EAAT3). PLoS One 2014; 9 e109245.</p>\n\n<p>Xin W, Oligodendrocytes Support Neuronal Glutamatergic Transmission via Expression of Glutamine Synthetase. Cell Rep., May 2019; 31116973.</p>\n\n<p>Zhang X, Qu S. The Accessibility in the External Part of the TM5 of the Glutamate Transporter EAAT1 Is Conformationally Sensitive during the Transport Cycle. PLoS One. 2012; 7(1): e30961.</p>\n\n<p>&nbsp;</p>\n","biologicalOrganisationLevel":"Cellular","organTerm":{"name":"brain","sourceId":"UBERON:0000955"},"biologicalEvents":[{"object":{}}],"id":1488}
{"title":"Tissue resident cell activation","references":"<p>Chan JK, Roth J, Oppenheim JJ, Tracey KJ, Vogl T, Feldmann M, Horwood N, Nanchahal J., Alarmins: awaiting a clinical response. J Clin Invest. 2012 Aug;122(8):2711-9.</p>\n\n<p>Davies LC, Jenkins SJ, Allen JE, Taylor PR, Tissue-resident macrophages, Nat Immunol. 2013 Oct;14(10):986-95.&nbsp;</p>\n\n<p>Escamilla-Tilch M, Filio-Rodr&iacute;guez G, Garc&iacute;a-Rocha R, Mancilla-Herrera I, Mitchison NA, Ruiz-Pacheco JA, S&aacute;nchez-Garc&iacute;a FJ, Sandoval-Borrego D, V&aacute;zquez-S&aacute;nchez EA, The interplay between pathogen-associated and danger-associated molecular patterns: an inflammatory code in cancer? Immunol Cell Biol. 2013 Nov-Dec;91(10):601-10.</p>\n\n<p>Hussell T, Bell TJ, Alveolar macrophages: plasticity in a tissue-specific context, Nat Rev Immunol. 2014 Feb;14(2):81-93.</p>\n\n<p>Kim ND, Luster AD. The role of tissue resident cells in neutrophil recruitment ,Trends Immunol. 2015 Sep;36(9):547-55.</p>\n\n<p>Sa&iuml;d-Sadier N, Ojcius DM., Alarmins, inflammasomes and immunity. Biomed J. 2012 Nov-Dec;35(6):437-49.</p>\n\n<p>Schaefer L, Complexity of danger: the diverse nature of damage-associated molecular patterns, J Biol Chem. 2014 Dec 19;289(51):35237-45.</p>\n\n<p><span style=\"font-size:18px\"><strong>BRAIN:</strong></span></p>\n\n<p>Aschner M (1998) Immune and inflammatory responses in the CNS: modulation by astrocytes. ToxicolLett 103: 283-287</p>\n\n<p>Banati, R. B. (2002). &quot;Visualising microglial activation in vivo.&quot; Glia 40: 206-217.</p>\n\n<p>Brown GC, Bal-Price A (2003) Inflammatory neurodegeneration mediated by nitric oxide, glutamate, and mitochondria. Mol Neurobiol 27: 325-355</p>\n\n<p>Charleston JS, Body RL, Bolender RP, Mottet NK, Vahter ME, Burbacher TM. 1996. Changes in the number of astrocytes and microglia in the thalamus of the monkey Macaca fascicularis following long-term subclinical methylmercury exposure. NeuroToxicology 17: 127-138.</p>\n\n<p>Charleston JS, Bolender RP, Mottet NK, Body RL, Vahter ME, Burbacher TM. 1994. Increases in the number of reactive glia in the visual cortex of Macaca fascicularis following subclinical long-term methyl mercury exposure. ToxicolApplPharmacol 129: 196-206.</p>\n\n<p>Dong Y, Benveniste EN (2001) Immune Function of Astrocytes. Glia 36: 180-190</p>\n\n<p>Eng LF, Ghirnikar RS, Lee YL (2000) Glial Fibrillary Acidic Protein: GFAP-Thirty-One Years (1969-2000). NeurochemRes 25: 1439-1451</p>\n\n<p>Eskes C, Honegger P, Juillerat-Jeanneret L, Monnet-Tschudi F. 2002. Microglial reaction induced by noncytotoxic methylmercury treatment leads to neuroprotection via interactions with astrocytes and IL-6 release. Glia 37(1): 43-52.</p>\n\n<p>Falsig J, Latta M, Leist M. Defined inflammatory states in astrocyte cultures correlation with susceptibility towards CD95-driven apoptosis. J Neurochem. 2004 &nbsp;Jan;88(1):181-93.</p>\n\n<p>Falsig J, P&ouml;rzgen P, Lund S, Schrattenholz A, Leist M. The inflammatory transcriptome of reactive murine astrocytes and implications for their innate immune function. J Neurochem. 2006 Feb;96(3):893-907.</p>\n\n<p>Falsig J, van Beek J, Hermann C, Leist M. Molecular basis for detection of invading pathogens in the brain. J Neurosci Res. 2008 May 15;86(7):1434-47.</p>\n\n<p>Glass CK, Saijo K, Winner B, Marchetto MC, Gage FH (2010). Mechanisms underlying inflammation in neurodegeneration. Cell. 2010 Mar 19;140(6):918-34.</p>\n\n<p>Gordon S (2003) Alternative activation of macrophages. Nat Rev Immunol 3: 23-35</p>\n\n<p>Graeber MB, Streit WJ (1990) Microglia: immune network in the CNS. Brain Pathol 1: 2-5</p>\n\n<p>Kigerl KA, Gensel JC, Ankeny DP, Alexander JK, Donnelly DJ, Popovich PG (2009) Identification of two distinct macrophage subsets with divergent effects causing either neurotoxicity or regeneration in the injured mouse spinal cord. J Neurosci 29: 13435-13444</p>\n\n<p>Kuegler PB, Zimmer B, Waldmann T, Baudis B, Ilmj&auml;rv S, Hescheler J, Gaughwin P, Brundin P, Mundy W, Bal-Price AK, Schrattenholz A, Krause KH, van Thriel C, Rao MS, Kadereit S, Leist M. Markers of murine embryonic and neural stem cells, neurons and astrocytes: reference points for developmental neurotoxicity testing. ALTEX. 2010;27(1):17-42</p>\n\n<p>Kreutzberg GW (1995) Microglia, the first line of defence in brain pathologies. Arzneimttelforsch 45: 357-360</p>\n\n<p>Kreutzberg GW (1996) Microglia : a sensor for pathological events in the CNS. Trends Neurosci 19: 312-318</p>\n\n<p>Liddelow SA, Guttenplan KA, Clarke LE, Bennett FC, Bohlen CJ, Schirmer L, et al. 2017. Neurotoxic reactive astrocytes are induced by activated microglia. Nature 541(7638): 481-487.</p>\n\n<p>Little AR, Miller DB, Li S, Kashon ML, O&#39;Callaghan JP. 2012. Trimethyltin-induced neurotoxicity: gene expression pathway analysis, q-RT-PCR and immunoblotting reveal early effects associated with hippocampal damage and gliosis. Neurotoxicol Teratol 34(1): 72-82.</p>\n\n<p>Liu Y, Hu J, Wu J, Zhu C, Hui Y, Han Y, et al. 2012. alpha7 nicotinic acetylcholine receptor-mediated neuroprotection against dopaminergic neuron loss in an MPTP mouse model via inhibition of astrocyte activation. J Neuroinflammation 9: 98.</p>\n\n<p>Lund S, Christensen KV, Hedtj&auml;rn M, Mortensen AL, Hagberg H, Falsig J, Hasseldam H, Schrattenholz A, P&ouml;rzgen P, Leist M. The dynamics of the LPS triggered inflammatory response of murine microglia under different culture and in vivo conditions. J Neuroimmunol. 2006 Nov;180(1-2):71-87.</p>\n\n<p>Maresz K, Ponomarev ED, Barteneva N, Tan Y, Mann MK, Dittel BN (2008) IL-13 induces the expression of the alternative activation marker Ym1 in a subset of testicular macrophages. J Reprod Immunol 78: 140-148</p>\n\n<p>Monnet-Tschudi F, Zurich MG, Honegger P (2007) Neurotoxicant-induced inflammatory response in three-dimensional brain cell cultures. Hum Exp Toxicol 26: 339-346</p>\n\n<p>Monnet-Tschudi, F., A. Defaux, et al. (2011). &quot;Methods to assess neuroinflammation.&quot; Curr Protoc Toxicol Chapter 12: Unit12 19.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p>\n\n<p>Mosser DM, Edwards JP (2008) Exploring the full spectrum of macrophage activation. Nat Rev Immunol 8: 958-969</p>\n\n<p>Nakajima K, Kohsaka S. 2004. Microglia: Neuroprotective and neurotrophic cells in the central nervous system. Current Drug Targets-Cardiovasc &amp; Haematol Disorders 4: 65-84.</p>\n\n<p>Perego C, Fumagalli S, De Simoni MG (2011) Temporal pattern of expression and colocalization of microglia/macrophage phenotype markers following brain ischemic injury in mice. J Neuroinflammation 8: 174</p>\n\n<p>Ponomarev ED, Maresz K, Tan Y, Dittel BN (2007) CNS-derived interleukin-4 is essential for the regulation of autoimmune inflammation and induces a state of alternative activation in microglial cells. J Neurosci 27: 10714-10721</p>\n\n<p>Ponomarev ED, Shriver LP, Maresz K, Dittel BN (2005) Microglial cell activation and proliferation precedes the onset of CNS autoimmunity. J Neurosci Res 81: 374-389</p>\n\n<p>Ransohoff RM. 2016. A polarizing question: do M1 and M2 microglia exist? Nat Neurosci 19(8): 987-991.</p>\n\n<p>Sandstrom von Tobel, J., D. Zoia, et al. (2014). &quot;Immediate and delayed effects of subchronic Paraquat exposure during an early differentiation stage in 3D-rat brain cell cultures.&quot; Toxicol Lett. DOI : 10.1016/j.toxlet.2014.02.001</p>\n\n<p>Struzynska L, Dabrowska-Bouta B, Koza K, Sulkowski G (2007) Inflammation-Like Glial Response in Lead-Exposed Immature Rat Brain. Toxicol Sc 95:156-162</p>\n\n<p>von Tobel, J. S., P. Antinori, et al. (2014). &quot;Repeated exposure to Ochratoxin A generates a neuroinflammatory response, characterized by neurodegenerative M1 microglial phenotype.&quot; Neurotoxicology 44C: 61-70.</p>\n\n<p>Venneti S, Lopresti BJ, Wiley CA. 2006. The peripheral benzodiazepine receptor (Translocator protein 18kDa) in microglia: from pathology to imaging. Prog Neurobiol 80(6): 308-322.</p>\n\n<p>Xu DP, Zhang K, Zhang ZJ, Sun YW, Guo BJ, Wang YQ, et al. 2014. A novel tetramethylpyrazine bis-nitrone (TN-2) protects against 6-hydroxyldopamine-induced neurotoxicity via modulation of the NF-kappaB and the PKCalpha/PI3-K/Akt pathways. Neurochem Int 78: 76-85.</p>\n\n<p>Zurich M-G, Eskes C, Honegger P, B&eacute;rode M, Monnet-Tschudi F. 2002. Maturation-dependent neurotoxicity of lead aceate in vitro: Implication of glial reactions. J Neurosc Res 70: 108-116.</p>\n\n<p><span style=\"font-size:14px\"><strong>LIVER:</strong></span></p>\n\n<ul style=\"list-style-type:circle\">\n\t<li>Baeck, C. et al. (2012), Pharmacological inhibition of the chemokine CCL2 (MCP-1) diminishes liver macrophage infiltration and steatohepatitis in chronic hepatic injury, Gut, vol. 61, no. 3, pp.416&ndash;426.</li>\n\t<li>Boltjes, A. et al. (2014), The role of Kupffer cells in hepatitis B and hepatitis C virus infections, J Hepatol, vol. 61, no. 3, pp. 660-671.</li>\n\t<li>Bouwens, L. et al. (1986), Quantitation, tissue distribution and proliferation kinetics of Kupffer cells in normal rat liver, Hepatology, vol. 6, no. 6, pp. 718-722.</li>\n\t<li>Dalton, S.R. et al. (2009), Carbon tetrachloride-induced liver damage in asialoglycoprotein receptor-deficient mice, Biochem Pharmacol, vol. 77, no. 7, pp. 1283-1290.</li>\n\t<li>Friedman, S.L. (2002), Hepatic Fibrosis-Role of Hepatic Stellate Cell Activation, MedGenMed, vol. 4, no. 3, pp. 27.</li>\n\t<li>Gr&oslash;nbaek, H. et al. (2012), Soluble CD163, a marker of Kupffer cell activation, is related to portal hypertension in patients with liver cirrhosis, Aliment Pharmacol Ther, vol 36, no. 2, pp. 173-180.</li>\n\t<li>Guo, J. and S.L. Friedman (2007), Hepatic Fibrogenesis, Semin Liver Dis, vol. 27, no. 4, pp. 413-426.</li>\n\t<li>Haubrich, W.S. (2004), Kupffer of Kupffer cells, Gastroenterology, vol. 127, no. 1, p. 16</li>\n\t<li>Ide, M. et al. (2005), Effects of gadolinium chloride (GdCl(3)) on the appearance of macrophage populations and fibrogenesis in thioacetamide-induced rat hepatic lesions, J. Comp. Path, vol. 133, no. 2-3, pp. 92&ndash;102.</li>\n\t<li>Kegel, V. et al. (2015), Subtoxic concentrations of hepatotoxic drugs lead to Kupffer cell activation in a human in vitro liver model: an approach to study DILI, Mediators Inflamm, 2015:640631, <a href=\"http://doi.org/10.1155/2015/640631\">http://doi.org/10.1155/2015/640631</a>.</li>\n\t<li>Kershenobich Stalnikowitz, D. and A.B. Weissbrod (2003), Liver Fibrosis and Inflammation. A Review, Annals of Hepatology, vol. 2, no. 4, pp.159-163.</li>\n\t<li>Kolios, G., V. Valatas and E. Kouroumalis (2006), Role of Kupffer Cells in the Pathogenesis of Liver Disease, World J.Gastroenterol, vol. 12, no. 46, pp. 7413-7420.</li>\n\t<li>Luckey, S.W., and D.R. Petersen (2001), Activation of Kupffer cells during the course of carbon tetrachloride-induced liver injury and fibrosis in rats, Exp Mol Pathol, vol. 71, no. 3, pp. 226-240.</li>\n\t<li>M&oslash;ller, H.J. (2012), Soluble CD163.Scand J Clin Lab Invest, vol. 72, no. 1, pp. 1-13.</li>\n\t<li>Roberts, R.A. et al. (2007), Role of the Kupffer cell in mediating hepatic toxicity and carcinogenesis, Toxicol Sci, vol. 96, no. 1, pp. 2-15.</li>\n\t<li>Su, G.L. et al. (2002), Activation of human and mouse Kupffer cells by lipopolysaccharide is mediated by CD14, Am J Physiol Gastrointest Liver Physiol, vol. 283, no. 3, pp. G640-645.</li>\n\t<li>Tacke, F. and H.W. Zimmermann (2014), Macrophage heterogeneity in liver injury and fibrosis, J Hepatol, vol. 60, no. 5, pp. 1090-1096.</li>\n\t<li>Takahara, T et al. (2006), Gene expression profiles of hepatic cell-type specific marker genes in progression of liver fibrosis, World J Gastroenterol, vol. 12, no. 40, pp. 6473-6499.</li>\n\t<li>Vajdova, K. et al. (2004), Ischemic preconditioning and intermittent clamping improve murine hepatic microcirculation and Kupffer cell function after ischemic injury, Liver Transpl, vol. 10, no. 4, pp. 520&ndash;528</li>\n\t<li>Winwood, P.J., and M.J. Arthur (1993), Kupffer cells: their activation and role in animal models of liver injury and human liver disease, Semin Liver Dis, vol. 13, no. 1, pp. 50-59.</li>\n</ul>\n\n<p>&nbsp;</p>\n","biologicalOrganisationLevel":"Cellular","organTerm":{},"biologicalEvents":[{"action":"increased","process":"cell activation involved in immune response","object":{}}],"id":1492}
{"title":"Increased Pro-inflammatory mediators","references":"<p>&nbsp;<span style=\"color:windowtext\">Brown GC, Bal-Price A (2003) Inflammatory neurodegeneration mediated by nitric oxide, glutamate, and mitochondria. Mol Neurobiol 27: 325-355</span></p>\n\n<p><span style=\"font-size:14px\"><span style=\"color:windowtext\">Dong Y, Benveniste EN (2001) Immune Function of Astrocytes. Glia 36: 180-190</span></span></p>\n\n<p><span style=\"font-size:14px\"><span style=\"color:windowtext\">Falsig J, Latta M, Leist M. Defined inflammatory states in astrocyte cultures correlation with susceptibility towards CD95-driven apoptosis. J Neurochem. 2004 &nbsp;Jan;88(1):181-93. </span></span></p>\n\n<p><span style=\"font-size:14px\"><span style=\"color:windowtext\">Falsig J, P&ouml;rzgen P, Lund S, Schrattenholz A, Leist M. The inflammatory transcriptome of reactive murine astrocytes and implications for their innate immune function. J Neurochem. 2006 Feb;96(3):893-907. </span></span></p>\n\n<p><span style=\"font-size:14px\"><span style=\"color:windowtext\">Falsig J, van Beek J, Hermann C, Leist M. Molecular basis for detection of invading pathogens in the brain. J Neurosci Res. 2008 May 15;86(7):1434-47.</span></span></p>\n\n<p><span style=\"font-size:14px\"><span style=\"color:windowtext\">Hamadi N, Sheikh A, Madjid N, Lubbad L, Amir N, Shehab SA, Khelifi-Touhami F, Adem A: Increased pro-inflammatory cytokines, glial activation and oxidative stress in the hippocampus after short-term bilateral adrenalectomy. BMC Neurosci 2016, <strong>17:</strong>61.</span></span></p>\n\n<p><span style=\"font-size:14px\"><span style=\"color:windowtext\">Kuegler PB, Zimmer B, Waldmann T, Baudis B, Ilmj&auml;rv S, Hescheler J, Gaughwin P, Brundin P, Mundy W, Bal-Price AK, Schrattenholz A, Krause KH, van Thriel C, Rao MS, Kadereit S, Leist M. Markers of murine embryonic and neural stem cells, neurons and astrocytes: reference points for developmental neurotoxicity testing. ALTEX. 2010;27(1):17-42</span></span></p>\n\n<p><span style=\"font-size:14px\"><span style=\"color:windowtext\">Lund S, Christensen KV, Hedtj&auml;rn M, Mortensen AL, Hagberg H, Falsig J, Hasseldam H, Schrattenholz A, P&ouml;rzgen P, Leist M. The dynamics of the LPS triggered inflammatory response of murine microglia under different culture and in vivo conditions. J Neuroimmunol. 2006 Nov;180(1-2):71-87. </span></span></p>\n\n<p><span style=\"font-size:14px\"><span style=\"color:windowtext\">Monnet-Tschudi, F., A. Defaux, et al. (2011). &quot;Methods to assess neuroinflammation.&quot; Curr Protoc Toxicol Chapter 12: Unit12 19.</span></span></p>\n\n<p><span style=\"font-size:14px\"><span style=\"color:windowtext\">Sandstrom von Tobel, J., D. Zoia, et al. (2014). &quot;Immediate and delayed effects of subchronic Paraquat exposure during an early differentiation stage in 3D-rat brain cell cultures.&quot; Toxicol Lett. DOI : 10.1016/j.toxlet.2014.02.001</span></span></p>\n\n<p><span style=\"font-size:14px\"><span style=\"color:windowtext\">Taetzsch T, Levesque S, McGraw C, Brookins S, Luqa R, Bonini MG, Mason RP, Oh U, Block ML (2015) Redox regulation of NF-kappaB p50 and M1 polarization in microglia. Glia 5, <strong>63:</strong>423-440.</span></span></p>\n\n<p><span style=\"font-size:14px\"><span style=\"color:windowtext\">Vesce S, Rossi D, Brambilla L, Volterra A (2007) Glutamate release from astrocytes in physiological conditions and in neurodegenerative disorders characterized by neuroinflammation. Int Rev Neurobiol. 82&nbsp;:57-71.</span></span></p>\n\n<p><span style=\"font-size:14px\"><span style=\"color:windowtext\">&nbsp;<strong>LIVER:</strong></span></span></p>\n\n<ul style=\"list-style-type:circle\">\n\t<li><span style=\"font-size:14px\">Bataller, R. and D.A. Brenner (2005), Liver Fibrosis, J.Clin. Invest, vol. 115, no. 2, pp. 209-218.</span></li>\n\t<li><span style=\"font-size:14px\">Branton, M.H. and J.B. Kopp (1999), TGF-beta and fibrosis, Microbes Infect, vol. 1, no. 15, pp. 1349-1365.</span></li>\n\t<li><span style=\"font-size:14px\">Brenner, D.A. (2009), Molecular Pathogenesis of Liver Fibrosis, Trans Am Clin Climatol Assoc, vol. 120, pp. 361&ndash;368.</span></li>\n\t<li><span style=\"font-size:14px\">Cheng, K., N.Yang and R.I. Mahato (2009), TGF-beta1 gene silencing for treating liver fibrosis, Mol Pharm, vol. 6, no. 3, pp. 772&ndash;779.</span></li>\n\t<li><span style=\"font-size:14px\">Clark, D.A. and R.Coker (1998), Transforming growth factor-beta (TGF-beta), Int J Biochem Cell Biol, vol. 30, no. 3, pp. 293-298.</span></li>\n\t<li><span style=\"font-size:14px\">Dardalhon V, Awasthi A, Kwon H, Galileos G, Gao W, Sobel RA, Mitsdoerffer M, Strom TB,</span></li>\n\t<li><span style=\"font-size:14px\">De Gouville, A.C. et al. (2005), Inhibition of TGF-beta signaling by an ALK5 inhibitor protects rats from dimethylnitrosamine-induced liver fibrosis, Br J Pharmacol, vol. 145, no. 2, pp. 166&ndash;177.</span></li>\n\t<li><span style=\"font-size:14px\">Filippi CM, Juedes AE, Oldham JE, Ling E, Togher L, Peng Y, Flavell RA, von Herrath MG, Transforming growth factor-beta suppresses the activation of CD8+ T-cells when naive but promotes their survival and function once antigen experienced: a two-faced impact on autoimmunity. Diabetes 2008;57:2684&ndash;2692.</span></li>\n\t<li><span style=\"font-size:14px\">Friedman, S.L. (2008), Mechanisms of Hepatic Fibrogenesis, Gastroenterology, vol. 134, no. 6, pp. 1655&ndash;1669.</span></li>\n\t<li><span style=\"font-size:14px\">Gordon, K.J. and G.C. Blobe (2008), Role of transforming growth factor-&beta; superfamily signalling pathways in human disease, Biochim Biophys Acta, vol. 1782, no. 4, pp. 197&ndash;228.</span></li>\n\t<li><span style=\"font-size:14px\">Govinden, R. and K.D. Bhoola (2003), Genealogy, expression, and cellular function of transforming growth factor-&beta;, Pharmacol. Ther, vol. 98, no. 2, pp. 257&ndash;265.</span></li>\n\t<li><span style=\"font-size:14px\">Gressner, A.M. et al. (2002), Roles of TGF-&beta; in hepatic fibrosis. Front Biosci, vol. 7, pp. 793-807.</span></li>\n\t<li><span style=\"font-size:14px\">Guo, J. and S.L. Friedman (2007), Hepatic fibrogenesis, Semin Liver Dis, vol. 27, no. 4, pp. 413-426.</span></li>\n\t<li><span style=\"font-size:14px\">Kaimori, A. et al. (2007), Transforming growth factor-beta1 induces an epithelial-to-mesenchymal transition state in mouse hepatocytes in vitro, J Biol Chem, vol. 282, no. 30, pp. 22089-22101.</span></li>\n\t<li><span style=\"font-size:14px\">Kershenobich Stalnikowitz, D. and A.B. Weisssbrod (2003), Liver Fibrosis and Inflammation. A Review, Annals of Hepatology, vol. 2, no. 4, pp.159-163.</span></li>\n\t<li><span style=\"font-size:14px\">Kisseleva T and Brenner DA, (2008), Mechanisms of Fibrogenesis, Exp Biol Med, vol. 233, no. 2, pp. 109-122.</span></li>\n\t<li><span style=\"font-size:14px\">Kisseleva, T. and Brenner, D.A. (2007), Role of hepatic stellate cells in fibrogenesis and the reversal of fibrosis, Journal of Gastroenterology and Hepatology, vol. 22, Suppl. 1; pp. S73&ndash;S78.</span></li>\n\t<li><span style=\"font-size:14px\">Kolios, G., V. Valatas and E. Kouroumalis (2006), Role of Kupffer cells in the pathogenesis of liver disease, World J.Gastroenterol, vol. 12, no. 46, pp. 7413-7420.</span></li>\n\t<li>Korn T, Mitsdoerffer M, Croxford AL, Awasthi A, Dardalhon VA, Galileos G, Vollmar P, Stritesky GL, Kaplan MH, Waisman A, Kuchroo VK, Oukka M., IL-6 controls Th17 immunity in vivo by inhibiting the conversion of conventional T cells into Foxp3+ regulatory T cells, Proceedings of the National Academy of Sciences Nov 2008, 105 (47) 18460-18465; DOI: 10.1073/pnas.0809850105</li>\n\t<li><span style=\"font-size:14px\">Korn T, Bettelli E, Oukka M, Kuchroo VK. IL-17 and Th17 Cells. Annu Rev Immunol. 2009</span></li>\n\t<li><span style=\"font-size:14px\">Kubiczkova, L. et al, (2012), TGF-&beta; - an excellent servant but a bad master, J Transl Med, vol. 10, p. 183.</span></li>\n\t<li><span style=\"font-size:14px\">Letterio, J.J. and A.B. Roberts (1998), Regulation of immune responses by TGF-beta, Annu Rev Immunol, vol.16, pp. 137-161.</span></li>\n\t<li><span style=\"font-size:14px\">Li MO, Flavell RA. Contextual regulation of inflammation: a duet by transforming growth factor-beta and interleukin-10. Immunity 2008a;28:468&ndash;476.</span></li>\n\t<li><span style=\"font-size:14px\">Li MO, Flavell RA. TGF-beta: a master of all T cell trades. Cell 2008b;134:392&ndash;404.</span></li>\n\t<li><span style=\"font-size:14px\">Li MO, Sanjabi S, Flavell RA. Transforming growth factor-beta controls development, homeostasis, and tolerance of T cells by regulatory T cell-dependent and -independent mechanisms. Immunity 2006b;25:455&ndash;471.</span></li>\n\t<li><span style=\"font-size:14px\">Li MO, Wan YY, Sanjabi S, Robertson AK, Flavell RA. Transforming growth factor-beta regulation of immune responses. Annu Rev Immunol 2006a;24:99&ndash;146.</span></li>\n\t<li><span style=\"font-size:14px\">Li, Jing-Ting et al. (2008), Molecular mechanism of hepatic stellate cell activation and antifibrotic therapeutic strategies, J Gastroenterol, vol. 43, no. 6, pp. 419&ndash;428.</span></li>\n\t<li><span style=\"font-size:14px\">Liu, Xingjun et al. (2006), Therapeutic strategies against TGF-beta signaling pathway in hepatic fibrosis. Liver Int, vol.26, no.1, pp. 8-22.</span></li>\n\t<li><span style=\"font-size:14px\">Luckey, S.W., and D.R. Petersen (2001), Activation of Kupffer cells during the course of carbon tetrachloride-induced liver injury and fibrosis in rats, Exp Mol Pathol, vol. 71, no. 3, pp. 226-240.</span></li>\n\t<li><span style=\"font-size:14px\">Marie JC, Liggitt D, Rudensky AY. Cellular mechanisms of fatal early-onset autoimmunity in mice with the T cell-specific targeting of transforming growth factor-beta receptor. Immunity 2006;25:441&ndash;454.</span></li>\n\t<li><span style=\"font-size:14px\">Matsuoka, M. and H. Tsukamoto, (1990), Stimulation of hepatic lipocyte collagen production by Kupffer cell-derived transforming growth factor beta: implication for a pathogenetic role in alcoholic liver fibrogenesis, Hepatology, vol. 11, no. 4, pp. 599-605.</span></li>\n\t<li><span style=\"font-size:14px\">Mazzieri, R .et al. (2000), Measurements of Active TGF-&beta; Generated by Culture Cells, Methods in Molecular Biology, vol. 142, pp. 13-27.</span></li>\n\t<li><span style=\"font-size:14px\">Nan, Y.M. et al. (2013), Activation of peroxisome proliferator activated receptor alpha ameliorates ethanol mediated liver fibrosis in mice, Lipids Health Dis, vol. 12, p.11.</span></li>\n\t<li><span style=\"font-size:14px\">Parsons, C.J., M.Takashima and R.A. Rippe (2007), Molecular mechanisms of hepatic fibrogenesis. J Gastroenterol Hepatol, vol. 22, Suppl.1, pp. S79-S84.</span></li>\n\t<li><span style=\"font-size:14px\">Pohlers , D. et al. (2009), TGF-&beta; and fibrosis in different organs &ndash; molecular pathway imprints, Biochim. Biophys. Acta, vol. 1792, no. 8, pp.746&ndash;756.</span></li>\n\t<li><span style=\"font-size:14px\">Poli, G. (2000), Pathogenesis of liver fibrosis: role of oxidative stress, Mol Aspects Med, vol. 21, no. 3, pp. 49 &ndash; 98.</span></li>\n\t<li><span style=\"font-size:14px\">Qi Z et al.(1999),Blockade of type beta transforming growth factor signalling prevents liver fibrosis and dysfunction in the rat, Proc Natl Acad Sci USA, vol. 96, no. 5, pp. 2345-2349.</span></li>\n\t<li><span style=\"font-size:14px\">Roberts, A.B. (1998), Molecular and cell biology of TGF-&beta;, Miner Electrolyte Metab, vol. 24, no. 2-3, pp. 111-119.</span></li>\n\t<li><span style=\"font-size:14px\">Roth, S., K. Michel and A.M. Gressner (1998), (Latent) transforming growth factor beta in liver parenchymal cells, its injury-dependent release, and paracrine effects on rat HSCs, Hepatology, vol. 27, no. 4, pp. 1003-1012.</span></li>\n\t<li><span style=\"font-size:14px\">Sanjabi S, Zenewicz LA, Kamanaka M, Flavell RA. Anti- and Pro-inflammatory Roles of TGF-&beta;, IL-10, and IL-22 In Immunity and Autoimmunity. Current opinion in pharmacology. 2009;9(4):447-453.</span></li>\n\t<li><span style=\"font-size:14px\">Santiba&ntilde;ez J.F., M. Quintanilla and C. Bernabeu (2011), TGF-&beta;/TGF-&beta; receptor system and its role in physiological and pathological conditions, Clin Sci (Lond), vol. 121, no. 6, pp. 233-251.</span></li>\n\t<li><span style=\"font-size:14px\">Shek, F.W. and R.C. Benyon (2004), How can transforming growth factor beta be targeted usefully to combat liver fibrosis? Eur J Gastroenterol Hepatol, vol. 16, no. 2, pp.123-126.</span></li>\n\t<li><span style=\"font-size:14px\">Shull MM, Ormsby I, Kier AB, Pawlowski S, Diebold RJ, Yin M, Allen R, Sidman C, Proetzel G,&nbsp;</span> <span style=\"font-family:times new roman,serif; font-size:10.5pt\">Calvin D, et al.</span> Targeted disruption of the mouse transforming growth factor-beta 1 gene results in multifocal inflammatory disease. Nature. 1992 Oct 22;359(6397):693-9.</li>\n\t<li><span style=\"font-size:14px\">Veldhoen M, Uyttenhove C, van Snick J, Helmby H, Westendorf A, Buer J, Martin B, Wilhelm C, Stockinger B. Transforming growth factor-beta &#39;reprograms&#39; the differentiation of T helper 2 cells and promotes an interleukin 9-producing subset. Nat Immunol 2008;9:1341&ndash;1346.</span></li>\n</ul>\n\n<p><span style=\"font-size:14px\"><span style=\"color:windowtext\">&nbsp;</span></span>&nbsp;</p>\n","biologicalOrganisationLevel":"Tissue","organTerm":{},"biologicalEvents":[{"action":"increased","process":"acute inflammatory response","object":{}}],"id":1493}
{"title":"Decreased protection against oxidative stress","references":"<p style=\"margin-left:21.3pt\"><span style=\"font-size:10.0pt\">Bjornstedt, M., Hamberg, M., Kumar, S., Xue, J., Holmgre, A. (1995) Human thioredoxin reductase directly reduces lipid hydroperoxides by nadph and selenocysteine strongly stimulates the reaction via catalytically generated selenols. <em>J Biol Chem</em> <strong>270</strong>, 11761-11764.</span></p>\n\n<p style=\"margin-left:21.3pt\"><span style=\"font-size:10.0pt\">Brigelius-Flohe, R., Maiorino, M. (2013) Glutathione peroxidases. <em>Biochim Biophys Acta</em> <strong>1830</strong>, 3289-3303.</span></p>\n\n<p style=\"margin-left:21.3pt\"><span style=\"font-size:10.0pt\">Chen, P.<em> et al.</em> (2013) Direct Interaction of Selenoprotein R with Clusterin and Its Possible Role in Alzheimer&#39;s Disease. <em>PLoS One</em> <strong>8</strong>, e66384.</span></p>\n\n<p style=\"margin-left:21.3pt\"><span style=\"font-size:10.0pt\">Forman, H.J., Zhang, H., Rinna, A. (2009) Glutathione: overview of its protective roles, measurement, and biosynthesis. <em>Mol Aspects Med</em> <strong>30</strong>, 1-12.</span></p>\n\n<p style=\"margin-left:21.3pt\"><span style=\"font-size:10.0pt\">Lee, J.H.<em> et al.</em> (2015) Selenoprotein S-dependent Selenoprotein K Binding to p97(VCP) Protein Is Essential for Endoplasmic Reticulum-associated Degradation. <em>J Biol Chem</em> <strong>290</strong>, 29941-29952.</span></p>\n\n<p style=\"margin-left:21.3pt\"><span style=\"font-size:10.0pt\">Novoselov, S.V.<em> et al.</em> (2007) Selenoprotein H is a nucleolar thioredoxin-like protein with a unique expression pattern. <em>J Biol Chem</em> <strong>282</strong>, 11960-11968.</span></p>\n\n<p style=\"margin-left:21.3pt\"><span style=\"font-size:10.0pt\">Pisoschi, A.M., Pop, A. (2015) The role of antioxidants in the chemistry of oxidative stress: A review. <em>Eur J Med Chem</em> <strong>97</strong>, 55-74.</span></p>\n\n<p style=\"margin-left:21.3pt\"><span style=\"font-size:10.0pt\">Rayman, M.P. (2000) The importance of selenium to human health. <em>Lancet</em> <strong>356</strong>, 233-241.</span></p>\n\n<p style=\"margin-left:21.3pt\"><span style=\"font-size:10.0pt\">Reeves, M.A., Hoffmann, P.R. (2009) The human selenoproteome: recent insights into functions and regulation. <em>Cell Mol Life Sci</em> <strong>66</strong>, 2457-2478.</span></p>\n\n<p style=\"margin-left:21.3pt\"><span style=\"font-size:10.0pt\">Zhong, L., Holmgren, A. (2002) Mammalian thioredoxin reductases as hydroperoxide reductases. <em>Methods Enzymol</em> <strong>347</strong>, 236-243.</span></p>\n","biologicalOrganisationLevel":"Cellular","organTerm":{"name":"brain","sourceId":"UBERON:0000955"},"biologicalEvents":[{"object":{}}],"keyEventStressors":["Acrylamide","Mercury"],"id":1538}
{"title":"Activation, PPAR","references":"<p>Bhattacharya, Nandini, Jannette M Dufour, My-Nuong Vo, Janice Okita, Richard Okita, and Kwan Hee Kim. 2005. &ldquo;Differential Effects of Phthalates on the Testis and the Liver.&rdquo; Biology of Reproduction 72 (3) (March): 745&ndash;54. doi:10.1095/biolreprod.104.031583.</p>\n\n<p>Bility, Moses T, Jerry T Thompson, Richard H McKee, Raymond M David, John H Butala, John P Vanden Heuvel, and Jeffrey M Peters. 2004. &ldquo;Activation of Mouse and Human Peroxisome Proliferator-Activated Receptors (PPARs) by Phthalate Monoesters.&rdquo; Toxicological Sciences: An Official Journal of the Society of Toxicology 82 (1) (November): 170&ndash;82. doi:10.1093/toxsci/kfh253.</p>\n\n<p>Chow, C. C., Ong, K. M., Dougherty, E. J., &amp; Simons, S. S. (2011). Inferring mechanisms from dose-response curves. Methods Enzymol, 487, 465-483. https://doi.org/10.1016/B978-0-12-381270-4.00016-0</p>\n\n<p>Corton, J. C., Hill, T., Sutherland, J. J., Stevens, J. L., &amp; Rooney, J. (2020). A Set of Six Gene Expression Biomarkers Identify Rat Liver Tumorigens in Short-Term Assays. Toxicol Sci. https://doi.org/10.1093/toxsci/kfaa101</p>\n\n<p>De Vos, D., Bruggeman, F. J., Westerhoff, H. V., &amp; Bakker, B. M. (2011). How molecular competition influences fluxes in gene expression networks. PLoS One, 6(12), e28494. https://doi.org/10.1371/journal.pone.0028494</p>\n\n<p>Dufour, Jannette M, My-Nuong Vo, Nandini Bhattacharya, Janice Okita, Richard Okita, and Kwan Hee Kim. 2003. &ldquo;Peroxisome Proliferators Disrupt Retinoic Acid Receptor Alpha Signaling in the Testis.&rdquo; Biology of Reproduction 68 (4) (April): 1215&ndash;24. doi:10.1095/biolreprod.102.010488.</p>\n\n<p>Feige, J&eacute;r&ocirc;me N, Laurent Gelman, Daniel Rossi, Vincent Zoete, Rapha&euml;l M&eacute;tivier, Cicerone Tudor, Silvia I Anghel, et al. 2007. &ldquo;The Endocrine Disruptor Monoethyl-Hexyl-Phthalate Is a Selective Peroxisome Proliferator-Activated Receptor Gamma Modulator That Promotes Adipogenesis.&rdquo; The Journal of Biological Chemistry 282 (26) (June 29): 19152&ndash;66. doi:10.1074/jbc.M702724200.</p>\n\n<p>Gaillard, S., Grasfeder, L. L., Haeffele, C. L., Lobenhofer, E. K., Chu, T.-M., Wolfinger, R., Kazmin, D., Koves, T. R., Muoio, D. M., Chang, C.-y., &amp; McDonnell, D. P. (2006). Receptor-selective coactivators as tools to define the biology of specific receptor-coactivator pairs. Mol Cell, 24(5), 797-803. https://doi.org/10.1016/j.molcel.2006.10.012</p>\n\n<p>Hill, T., Rooney, J., Abedini, J., El-Masri, H., Wood, C. E., &amp; Corton, J. C. (2020). Gene Expression Thresholds Derived From Short-Term Exposures Identify Rat Liver Tumorigens. Toxicol Sci. https://doi.org/10.1093/toxsci/kfaa102</p>\n\n<p>Hurst, Christopher H, and David J Waxman. 2003. &ldquo;Activation of PPARalpha and PPARgamma by Environmental Phthalate Monoesters.&rdquo; Toxicological Sciences: An Official Journal of the Society of Toxicology 74 (2) (August): 297&ndash;308. doi:10.1093/toxsci/kfg145.</p>\n\n<p>Igarashi, Y., Nakatsu, N., Yamashita, T., Ono, A., Ohno, Y., Urushidani, T., &amp; Yamada, H. (2015). Open TG-GATEs: a large-scale toxicogenomics database. Nucleic Acids Res, 43(Database issue), D921-7. https://doi.org/10.1093/nar/gku955</p>\n\n<p>Kamata S, Oyama T, Saito K, Honda A, Yamamoto Y, Suda K, Ishikawa R, Itoh T, Watanabe Y, Shibata T, Uchida K, Suematsu M, Ishii I. PPAR&alpha; Ligand-Binding Domain Structures with Endogenous Fatty Acids and Fibrates. iScience. 2020;23(11):101727. 10.1016/j.isci.2020.101727</p>\n\n<p>Kaya, Taner, Scott C Mohr, David J Waxman, and Sandor Vajda. 2006. &ldquo;Computational Screening of Phthalate Monoesters for Binding to PPARgamma.&rdquo; Chemical Research in Toxicology 19 (8) (August): 999&ndash;1009. doi:10.1021/tx050301s.</p>\n\n<p>Koppen, A., Houtman, R., Pijnenburg, D., Jeninga, E. H., Ruijtenbeek, R., &amp; Kalkhoven, E. (2009). Nuclear receptor-coregulator interaction profiling identifies TRIP3 as a novel peroxisome proliferator-activated receptor gamma cofactor. Mol Cell Proteomics, 8(10), 2212-2226. https://doi.org/10.1074/mcp.M900209-MCP200</p>\n\n<p>Kupershmidt, I., Su, Q. J., Grewal, A., Sundaresh, S., Halperin, I., Flynn, J., Shekar, M., Wang, H., Park, J., Cui, W., Wall, G. D., Wisotzkey, R., Alag, S., Akhtari, S., &amp; Ronaghi, M. (2010). Ontology-based meta-analysis of global collections of high-throughput public data. PLoS One, 5(9). https://doi.org/10.1371/journal.pone.0013066</p>\n\n<p>Lampen, Alfonso, Susan Zimnik, and Heinz Nau. 2003. &ldquo;Teratogenic Phthalate Esters and Metabolites Activate the Nuclear Receptors PPARs and Induce Differentiation of F9 Cells.&rdquo; Toxicology and Applied Pharmacology 188 (1) (April): 14&ndash;23. doi:10.1016/S0041-008X(03)00014-0.</p>\n\n<p>Lapinskas, Paula J., Sherri Brown, Lisa M. Leesnitzer, Steven Blanchard, Cyndi Swanson, Russell C. Cattley, and J. Christopher Corton. 2005. &ldquo;Role of PPAR&alpha; in Mediating the Effects of Phthalates and Metabolites in the Liver.&rdquo; Toxicology 207 (1): 149&ndash;163.</p>\n\n<p>Le Maire, Albane, Marina Grimaldi, Dominique Roecklin, Sonia Dagnino, Val&eacute;rie Vivat-Hannah, Patrick Balaguer, and William Bourguet. 2009. &ldquo;Activation of RXR-PPAR Heterodimers by Organotin Environmental Endocrine Disruptors.&rdquo; EMBO Reports 10 (4) (April): 367&ndash;73. doi:10.1038/embor.2009.8.</p>\n\n<p>LeBlanc, GA, DO Norris, and W Kloas. 2011. &ldquo;Detailed Review Paper State of the Science on Novel In Vitro and In Vivo Screening and Testing Methods and Endpoints for Evaluating Endocrine Disruptors&rdquo; (178).</p>\n\n<p>Lefebvre, Philippe, Giulia Chinetti, Jean-Charles Fruchart, and Bart Staels. 2006. &ldquo;Sorting out the Roles of PPAR Alpha in Energy Metabolism and Vascular Homeostasis.&rdquo; The Journal of Clinical Investigation 116 (3) (March): 571&ndash;80. doi:10.1172/JCI27989.</p>\n\n<p>Lewis, R. W., Hill, T., &amp; Corton, J. C. (2020). A set of six Gene expression biomarkers and their thresholds identify rat liver tumorigens in short-term assays. Toxicology, 443, 152547. https://doi.org/10.1016/j.tox.2020.152547</p>\n\n<p>Maloney, Erin K., and David J. Waxman. 1999. &ldquo;Trans-Activation of PPAR&alpha; and PPAR&gamma; by Structurally Diverse Environmental Chemicals.&rdquo; Toxicology and Applied Pharmacology 161 (2): 209&ndash;218.</p>\n\n<p>Michalik, Liliane, Johan Auwerx, Joel P Berger, V Krishna Chatterjee, Christopher K Glass, Frank J Gonzalez, Paul A Grimaldi, et al. 2006. &ldquo;International Union of Pharmacology. LXI. Peroxisome Proliferator-Activated Receptors.&rdquo; Pharmacological Reviews 58 (4) (December): 726&ndash;41. doi:10.1124/pr.58.4.5.</p>\n\n<p>Mukherjee, R, L Jow, G E Croston, and J R Paterniti. 1997. &ldquo;Identification, Characterization, and Tissue Distribution of Human Peroxisome Proliferator-Activated Receptor (PPAR) Isoforms PPARgamma2 versus PPARgamma1 and Activation with Retinoid X Receptor Agonists and Antagonists.&rdquo; The Journal of Biological Chemistry 272 (12) (March 21): 8071&ndash;6.</p>\n\n<p>Ong, K. M., Blackford, J. A., Kagan, B. L., Simons, S. S., &amp; Chow, C. C. (2010). A theoretical framework for gene induction and experimental comparisons. Proc Natl Acad Sci U S A, 107(15), 7107-7112. https://doi.org/10.1073/pnas.0911095107</p>\n\n<p>Rooney, J., Hill, T., Qin, C., Sistare, F. D., &amp; Corton, J. C. (2018). Adverse outcome pathway-driven identification of rat liver tumorigens in short-term assays. Toxicol Appl Pharmacol, 356, 99-113. https://doi.org/10.1016/j.taap.2018.07.023</p>\n\n<p>Schultz, R, W Yan, J Toppari, A V&ouml;lkl, J A Gustafsson, and M Pelto-Huikko. 1999. &ldquo;Expression of Peroxisome Proliferator-Activated Receptor Alpha Messenger Ribonucleic Acid and Protein in Human and Rat Testis.&rdquo; Endocrinology 140 (7) (July): 2968&ndash;75. doi:10.1210/endo.140.7.6858.</p>\n\n<p>Simon, T. W., Budinsky, R. A., &amp; Rowlands, J. C. (2015). A model for aryl hydrocarbon receptor-activated gene expression shows potency and efficacy changes and predicts squelching due to competition for transcription co-activators. PLoS One, 10(6), e0127952. https://doi.org/10.1371/journal.pone.0127952.</p>\n\n<p>Staels, B., J. Dallongeville, J. Auwerx, K. Schoonjans, E. Leitersdorf, and J.-C. Fruchart. 1998. &ldquo;Mechanism of Action of Fibrates on Lipid and Lipoprotein Metabolism.&rdquo; Circulation 98 (19) (November 10): 2088&ndash;2093. doi:10.1161/01.CIR.98.19.2088.</p>\n\n<p>Svoboda, D. L., Saddler, T., &amp; Auerbach, S. S. (2019). An Overview of National Toxicology Program&rsquo;s Toxicogenomic Applications: DrugMatrix and ToxFX.&nbsp; In Advances in Computational Toxicology (pp. 141-157). Springer. https://link.springer.com/chapter/10.1007/978-3-030-16443-0_8</p>\n\n<p>ToxCastTM Data. &ldquo;ToxCastTM Data.&rdquo; US Environmental Protection Agency. <a class=\"external free\" href=\"http://www.epa.gov/ncct/toxcast/data.html\" rel=\"nofollow\" target=\"_blank\">http://www.epa.gov/ncct/toxcast/data.html</a></p>\n\n<p>Vanden Heuvel, John P, Jerry T Thompson, Steven R Frame, and Peter J Gillies. 2006. &ldquo;Differential Activation of Nuclear Receptors by Perfluorinated Fatty Acid Analogs and Natural Fatty Acids: A Comparison of Human, Mouse, and Rat Peroxisome Proliferator-Activated Receptor-Alpha, -Beta, and -Gamma, Liver X Receptor-Beta, and Retinoid X Rec.&rdquo; Toxicological Sciences: An Official Journal of the Society of Toxicology 92 (2) (August): 476&ndash;89. doi:10.1093/toxsci/kfl014.</p>\n\n<p>Venkata, Nagaraj Gopisetty, Jodie a Robinson, Peter J Cabot, Barbara Davis, Greg R Monteith, and Sarah J Roberts-Thomson. 2006. &ldquo;Mono(2-Ethylhexyl)phthalate and Mono-N-Butyl Phthalate Activation of Peroxisome Proliferator Activated-Receptors Alpha and Gamma in Breast.&rdquo; Toxicology Letters 163 (3) (June 1): 224&ndash;34. doi:10.1016/j.toxlet.2005.11.001.</p>\n\n<p>Viswakarma, Navin, Yuzhi Jia, Liang Bai, Aurore Vluggens, Jayme Borensztajn, Jianming Xu, and Janardan K Reddy. 2010. &ldquo;Coactivators in PPAR-Regulated Gene Expression.&rdquo; PPAR Research 2010 (January). doi:10.1155/2010/250126.</p>\n\n<p>Wahli, Walter, and B Desvergne. 1999. &ldquo;Peroxisome Proliferator-Activated Receptors: Nuclear Control of Metabolism.&rdquo; Endocrine Reviews 20 (5) (October): 649&ndash;88. Wu, Bin, Jie Gao, and Ming-wei Wang. 2005. &ldquo;Development of a Complex Scintillation Proximity Assay for High-Throughput Screening of PPARgamma Modulators.&rdquo; Acta Pharmacologica Sinica 26 (3) (March): 339&ndash;44. doi:10.1111/j.1745-7254.2005.00040.x.</p>\n\n<p>Xu, Chuan, Ji-An Chen, Zhiqun Qiu, Qing Zhao, Jiaohua Luo, Lan Yang, Hui Zeng, et al. 2010. &ldquo;Ovotoxicity and PPAR-Mediated Aromatase Downregulation in Female Sprague-Dawley Rats Following Combined Oral Exposure to Benzo[a]pyrene and Di-(2-Ethylhexyl) Phthalate.&rdquo; Toxicology Letters 199 (3) (December 15): 323&ndash;32. doi:10.1016/j.toxlet.2010.09.015.</p>\n\n<p>Yessoufou, a, and W Wahli. 2010. &ldquo;Multifaceted Roles of Peroxisome Proliferator-Activated Receptors (PPARs) at the Cellular and Whole Organism Levels.&rdquo; Swiss Medical Weekly 140 (September) (January): w13071. doi:10.4414/smw.2010.13071.</p>\n\n<p>Yu, Songtao, and Janardan K Reddy. 2007. &ldquo;Transcription Coactivators for Peroxisome Proliferator-Activated Receptors.&rdquo; Biochimica et Biophysica Acta 1771 (8) (August): 936&ndash;51. doi:10.1016/j.bbalip.2007.01.008.</p>\n","biologicalOrganisationLevel":"Molecular","organTerm":{"name":"liver","sourceId":"UBERON:0002107"},"biologicalEvents":[{"action":"increased","process":"peroxisome proliferator activated receptor signaling pathway","object":{"name":"peroxisome proliferator-activated receptor alpha","source":"PR","sourceId":"PR:000013056"}}],"keyEventStressors":["Stressor:205 pirinixic acid (WY-14,643)","ciprofibrate","Mono(2-ethylhexyl) phthalate","Bezafibrate","Clofibrate","PERFLUOROOCTANOIC ACID","Nafenopin","Gemfibrozil","Di(2-ethylhexyl) phthalate","Fenofibrate","Simvastatin"],"id":227}
{"title":"Decrease, Steroidogenic acute regulatory protein (STAR)","references":"<p>Bauer, M P, J T Bridgham, D M Langenau, A L Johnson, and F W Goetz. 2000. Conservation of Steroidogenic Acute Regulatory (StAR) Protein Structure and Expression in Vertebrates. Molecular and Cellular Endocrinology 168 (1-2) (October 25): 11925.\n</p><p>Hum, D W, and W L Miller. 1993. Transcriptional Regulation of Human Genes for Steroidogenic Enzymes. Clinical Chemistry 39 (2) (February): 33340.\n</p><p>Manna, P R, J Kero, M Tena-Sempere, P Pakarinen, D M Stocco, and I T Huhtaniemi. 2001. Assessment of Mechanisms of Thyroid Hormone Action in Mouse Leydig Cells: Regulation of the Steroidogenic Acute Regulatory Protein, Steroidogenesis, and Luteinizing Hormone Receptor Function. Endocrinology 142 (1) (January): 31931. doi:10.1210/endo.142.1.7900.\n</p><p>Stocco, D M. 2001. StAR Protein and the Regulation of Steroid Hormone Biosynthesis. Annual Review of Physiology 63 (January): 193213. doi:10.1146/annurev.physiol.63.1.193.\n</p>","biologicalOrganisationLevel":"Cellular","organTerm":{},"biologicalEvents":[{"action":"decreased","process":"gene expression","object":{"name":"STAR","source":"PR","sourceId":"PR:000015715"}}],"id":266}
{"title":"Reduction, Cholesterol transport in mitochondria","references":"<p>Albalat, Ricard, Frdric Brunet, Vincent Laudet, and Michael Schubert. 2011. Evolution of Retinoid and Steroid Signaling: Vertebrate Diversification from an Amphioxus Perspective. Genome Biology and Evolution 3: 9851005. doi:10.1093/gbe/evr084.\n</p><p>Baulieu, E E. 1998. Neurosteroids: A Novel Function of the Brain. Psychoneuroendocrinology 23 (8) (November): 96387.\n</p><p>Charman, Mark, Barry E Kennedy, Nolan Osborne, and Barbara Karten. 2010. MLN64 Mediates Egress of Cholesterol from Endosomes to Mitochondria in the Absence of Functional Niemann-Pick Type C1 Protein. Journal of Lipid Research 51 (5) (May): 102334. doi:10.1194/jlr.M002345.\n</p><p>Kayes-Wandover, K M, and P C White. 2000. Steroidogenic Enzyme Gene Expression in the Human Heart. The Journal of Clinical Endocrinology and Metabolism 85 (7) (July): 251925. doi:10.1210/jcem.85.7.6663.\n</p><p>Miller, Walter L, and Richard J Auchus. 2011. The Molecular Biology, Biochemistry, and Physiology of Human Steroidogenesis and Its Disorders. Endocrine Reviews 32 (1) (February): 81151. doi:10.1210/er.2010-0013.\n</p><p>Rone, Malena B, Jinjiang Fan, and Vassilios Papadopoulos. 2009. Cholesterol Transport in Steroid Biosynthesis: Role of Protein-Protein Interactions and Implications in Disease States. Biochimica et Biophysica Acta 1791 (7) (July): 64658. doi:10.1016/j.bbalip.2009.03.001.\n</p><p>Schroeder, F, J F Holland, and L L Bieber. 1971. Fluorometric Evidence for the Binding of Cholesterol to the Filipin Complex. The Journal of Antibiotics 24 (12) (December): 8469.\n</p><p>Steer, C. 1984. Detection of Membrane Cholesterol by Filipin in Isolated Rat Liver Coated Vesicles Is Dependent upon Removal of the Clathrin Coat. The Journal of Cell Biology 99 (1) (July 1): 315319. doi:10.1083/jcb.99.1.315.\n</p>","biologicalOrganisationLevel":"Cellular","organTerm":{},"biologicalEvents":[{"action":"decreased","process":"mitochondrial transport","object":{"name":"cholesterol","source":"CHEBI","sourceId":"CHEBI:16113"}}],"id":447}
{"title":"Reduction, Testosterone synthesis in Leydig cells","references":"<p>Chandrashekar, V, and A Bartke. 1998. The Role of Growth Hormone in the Control of Gonadotropin Secretion in Adult Male Rats. Endocrinology 139 (3) (March): 106774. doi:10.1210/endo.139.3.5816.\n</p><p>Ellis, G B, C Desjardins, and H M Fraser. 1983. Control of Pulsatile LH Release in Male Rats. Neuroendocrinology 37 (3) (September): 17783.\nHuhtaniemi, I, and L J Pelliniemi. 1992. Fetal Leydig Cells: Cellular Origin, Morphology, Life Span, and Special Functional Features. Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.) 201 (2) (November): 12540.\n</p><p>Manson, Jeanne M, and Michael C Carr. 2003. Molecular Epidemiology of Hypospadias: Review of Genetic and Environmental Risk Factors. Birth Defects Research. Part A, Clinical and Molecular Teratology 67 (10) (October): 82536. doi:10.1002/bdra.10084.\n</p><p>Nef, S. 2000. Hormones in Male Sexual Development. Genes &amp; Development 14 (24) (December 15): 30753086. doi:10.1101/gad.843800.\n</p><p>Rouiller-Fabre, Virginie, Vincent Muczynski, Romain Lambrot, Charlotte Lcureuil, Herv Coffigny, Catherine Pairault, Delphine Moison, et al. 2009. Ontogenesis of Testicular Function in Humans. Folia Histochemica et Cytobiologica / Polish Academy of Sciences, Polish Histochemical and Cytochemical Society 47 (5) (January): S1924. doi:10.2478/v10042-009-0065-4.\n</p>","biologicalOrganisationLevel":"Cellular","organTerm":{},"biologicalEvents":[{"action":"decreased","process":"testosterone biosynthetic process","object":{"name":"testosterone","source":"CHEBI","sourceId":"CHEBI:17347"}}],"id":413}
{"title":"Reduction, testosterone level","references":"<p>Heemers, H. V, Verhoeven, G., &amp; Swinnen, J. V. (2006). Androgen activation of the sterol regulatory element-binding protein pathway: Current insights. Molecular Endocrinology (Baltimore, Md.), 20(10), 2265&ndash;77. doi:10.1210/me.2005-0479</p>\n\n<p>Murashima, A., Kishigami, S., Thomson, A., &amp; Yamada, G. (2015). Androgens and mammalian male reproductive tract development. Biochimica et Biophysica Acta, 1849(2), 163&ndash;170. doi:10.1016/j.bbagrm.2014.05.020</p>\n\n<p>Paduch, D. A., Brannigan, R. E., Fuchs, E. F., Kim, E. D., Marmar, J. L., &amp; Sandlow, J. I. (2014). The laboratory diagnosis of testosterone deficiency. Urology, 83(5), 980&ndash;8. doi:10.1016/j.urology.2013.12.024</p>\n\n<p>Taieb, J., Mathian, B., Millot, F., Patricot, M.-C., Mathieu, E., Queyrel, N., &hellip; Boudou, P. (2003). Testosterone measured by 10 immunoassays and by isotope-dilution gas chromatography-mass spectrometry in sera from 116 men, women, and children. Clinical Chemistry, 49(8), 1381&ndash;95.</p>\n","biologicalOrganisationLevel":"Tissue","organTerm":{"name":"blood","sourceId":"UBERON:0000178"},"biologicalEvents":[{"action":"decreased","object":{"name":"testosterone","source":"CHEBI","sourceId":"CHEBI:17347"}}],"id":446}
{"title":"Decrease, Translocator protein (TSPO)","references":"<p>Amsterdam, A. &amp; Suh, B.S., 1991. An inducible functional peripheral benzodiazepine receptor in mitochondria of steroidogenic granulosa cells. Endocrinology, 129(1), pp.503&ndash;10.</p>\n\n<p>Anholt, R. et al., 1986. The peripheral-type benzodiazepine receptor. Localization to the mitochondrial outer membrane. J. Biol. Chem., 261(2), pp.576&ndash;583.</p>\n\n<p>Anholt, R.R. et al., 1985. Peripheral-type benzodiazepine receptors: autoradiographic localization in whole-body sections of neonatal rats. The Journal of pharmacology and experimental therapeutics, 233(2), pp.517&ndash;26.</p>\n\n<p>Besman, M.J. et al., 1989. Identification of des-(Gly-Ile)-endozepine as an effector of corticotropin-dependent adrenal steroidogenesis: stimulation of cholesterol delivery is mediated by the peripheral benzodiazepine receptor. Proceedings of the National Academy of Sciences of the United States of America, 86(13), pp.4897&ndash;901.</p>\n\n<p>Lacap&egrave;re, J.J. &amp; Papadopoulos, V., 2003. Peripheral-type benzodiazepine receptor: structure and function of a cholesterol-binding protein in steroid and bile acid biosynthesis. Steroids, 68(7-8), pp.569&ndash;85.</p>\n\n<p>Morohaku, K. et al., 2014. Translocator protein/peripheral benzodiazepine receptor is not required for steroid hormone biosynthesis. Endocrinology, 155(1), pp.89&ndash;97. Morohaku, K., Phuong, N.S. &amp; Selvaraj, V., 2013. Developmental expression of translocator protein/peripheral benzodiazepine receptor in reproductive tissues. W. Yan, ed. PloS one, 8(9), p.e74509.</p>\n\n<p>Papadopoulos, V. et al., 1997. Targeted disruption of the peripheral-type benzodiazepine receptor gene inhibits steroidogenesis in the R2C Leydig tumor cell line. The Journal of biological chemistry, 272(51), pp.32129&ndash;35.</p>\n\n<p>Tu, L.N. et al., 2014. Peripheral benzodiazepine receptor/translocator protein global knock-out mice are viable with no effects on steroid hormone biosynthesis. The Journal of biological chemistry, 289(40), pp.27444&ndash;54.</p>\n\n<p>Wang, H.-J., Fan, J. &amp; Papadopoulos, V., 2012. Translocator protein (Tspo) gene promoter-driven green fluorescent protein synthesis in transgenic mice: an in vivo model to study Tspo transcription. Cell and tissue research, 350(2), pp.261&ndash;75.</p>\n\n<p>Yeliseev, A.A., Krueger, K.E. &amp; Kaplan, S., 1997. A mammalian mitochondrial drug receptor functions as a bacterial &ldquo;oxygen&rdquo; sensor. Proceedings of the National Academy of Sciences of the United States of America, 94(10), pp.5101&ndash;6. Zisterer, D.M. &amp; Williams, D.C., 1997. Peripheral-type benzodiazepine receptors. General pharmacology, 29(3), pp.305&ndash;14.</p>\n","biologicalOrganisationLevel":"Cellular","organTerm":{},"biologicalEvents":[{"action":"decreased","process":"gene expression","object":{"name":"translocator protein","source":"PR","sourceId":"PR:000016757"}}],"id":289}
{"title":"Malformation, Male reproductive tract","references":"<p><br />\nArbuckle, Tye E, Russ Hauser, Shanna H Swan, Catherine S Mao, Matthew P Longnecker, Katharina M Main, Robin M Whyatt, et al. 2008. &ldquo;Meeting Report: Measuring Endocrine-Sensitive Endpoints within the First Years of Life.&rdquo; Environmental Health Perspectives 116 (7) (July): 948&ndash;51. doi:10.1289/ehp.11226.</p>\n\n<p>Barrett, Emily S, Lauren E Parlett, J Bruce Redmon, and Shanna H Swan. 2014. &ldquo;Evidence for Sexually Dimorphic Associations between Maternal Characteristics and Anogenital Distance, a Marker of Reproductive Development.&rdquo; American Journal of Epidemiology 179 (1) (January 1): 57&ndash;66. doi:10.1093/aje/kwt220.</p>\n\n<p>Baskin, L S, K Himes, and T Colborn. 2001. &ldquo;Hypospadias and Endocrine Disruption: Is There a Connection?&rdquo; Environmental Health Perspectives 109 (11) (November): 1175&ndash;83.</p>\n\n<p>Bowman, Christopher J, Norman J Barlow, Katie J Turner, Duncan G Wallace, and Paul M D Foster. 2003. &ldquo;Effects of in Utero Exposure to Finasteride on Androgen-Dependent Reproductive Development in the Male Rat.&rdquo; Toxicological Sciences: An Official Journal of the Society of Toxicology 74 (2) (August): 393&ndash;406. doi:10.1093/toxsci/kfg128.</p>\n\n<p>Dean, Afshan, and Richard M Sharpe. 2013. &ldquo;Clinical Review: Anogenital Distance or Digit Length Ratio as Measures of Fetal Androgen Exposure: Relationship to Male Reproductive Development and Its Disorders.&rdquo; The Journal of Clinical Endocrinology and Metabolism 98 (6) (June): 2230&ndash;8. doi:10.1210/jc.2012-4057.</p>\n\n<p>Gray, L E, J Ostby, J Furr, C J Wolf, C Lambright, L Parks, D N Veeramachaneni, et al. 2001. &ldquo;Effects of Environmental Antiandrogens on Reproductive Development in Experimental Animals.&rdquo; Human Reproduction Update 7 (3): 248&ndash;64.</p>\n\n<p>Hayes, Tyrone B, Atif Collins, Melissa Lee, Magdelena Mendoza, Nigel Noriega, A Ali Stuart, and Aaron Vonk. 2002. &ldquo;Hermaphroditic, Demasculinized Frogs after Exposure to the Herbicide Atrazine at Low Ecologically Relevant Doses.&rdquo; Proceedings of the National Academy of Sciences of the United States of America 99 (8) (April 16): 5476&ndash;80. doi:10.1073/pnas.082121499.</p>\n\n<p>Howdeshell, Kembra L, Johnathan Furr, Christy R Lambright, Cynthia V Rider, Vickie S Wilson, and L Earl Gray. 2007. &ldquo;Cumulative Effects of Dibutyl Phthalate and Diethylhexyl Phthalate on Male Rat Reproductive Tract Development: Altered Fetal Steroid Hormones and Genes.&rdquo; Toxicological Sciences: An Official Journal of the Society of Toxicology 99 (1) (September): 190&ndash;202. doi:10.1093/toxsci/kfm069.</p>\n\n<p>Kalfa, Nicolas, Benchun Liu, Ophir Klein, Ming-Hsieh Wang, Mei Cao, and Laurence S Baskin. 2008. &ldquo;Genomic Variants of ATF3 in Patients with Hypospadias.&rdquo; The Journal of Urology 180 (5) (November): 2183&ndash;8; discussion 2188. doi:10.1016/j.juro.2008.07.066.</p>\n\n<p>Kalfa, Nicolas, Pascal Philibert, and Charles Sultan. 2009. &ldquo;Is Hypospadias a Genetic, Endocrine or Environmental Disease, or Still an Unexplained Malformation?&rdquo; International Journal of Andrology 32 (3) (June): 187&ndash;97. doi:10.1111/j.1365-2605.2008.00899.x.</p>\n\n<p>Macleod, D J, R M Sharpe, M Welsh, M Fisken, H M Scott, G R Hutchison, A J Drake, and S van den Driesche. 2010. &ldquo;Androgen Action in the Masculinization Programming Window and Development of Male Reproductive Organs.&rdquo; International Journal of Andrology 33 (2) (April): 279&ndash;87. doi:10.1111/j.1365-2605.2009.01005.x.</p>\n\n<p>Manson, Jeanne M, and Michael C Carr. 2003. &ldquo;Molecular Epidemiology of Hypospadias: Review of Genetic and Environmental Risk Factors.&rdquo; Birth Defects Research. Part A, Clinical and Molecular Teratology 67 (10) (October): 825&ndash;36. doi:10.1002/bdra.10084.</p>\n\n<p>McIntyre, B S, N J Barlow, and P M Foster. 2001. &ldquo;Androgen-Mediated Development in Male Rat Offspring Exposed to Flutamide in Utero: Permanence and Correlation of Early Postnatal Changes in Anogenital Distance and Nipple Retention with Malformations in Androgen-Dependent Tissues.&rdquo; Toxicological Sciences: An Official Journal of the Society of Toxicology 62 (2) (August): 236&ndash;49.</p>\n\n<p>Mendiola, Jaime, Manuela Roca, Lidia M&iacute;nguez-Alarc&oacute;n, Maria-Pilar Mira-Escolano, Jos&eacute; J L&oacute;pez-Esp&iacute;n, Emily S Barrett, Shanna H Swan, and Alberto M Torres-Cantero. 2012. &ldquo;Anogenital Distance Is Related to Ovarian Follicular Number in Young Spanish Women: A Cross-Sectional Study.&rdquo; Environmental Health: A Global Access Science Source 11 (January): 90. doi:10.1186/1476-069X-11-90.</p>\n\n<p>OECD. 2012. Test No. 443: Extended One-Generation Reproductive Toxicity Study. OECD Guidelines for the Testing of Chemicals, Section 4. OECD Publishing. doi:10.1787/9789264185371-en.</p>\n\n<p>Rey, Rodolfo A, Ethel Codner, Germ&aacute;n I&ntilde;&iacute;guez, Patricia Bedecarr&aacute;s, Romina Trigo, Cecilia Okuma, Silvia Gottlieb, Ignacio Bergad&aacute;, Stella M Campo, and Fernando G Cassorla. 2005. &ldquo;Low Risk of Impaired Testicular Sertoli and Leydig Cell Functions in Boys with Isolated Hypospadias.&rdquo; The Journal of Clinical Endocrinology and Metabolism 90 (11) (November): 6035&ndash;40. doi:10.1210/jc.2005-1306.</p>\n\n<p>Wolf, C., C. Lambright, P. Mann, M. Price, R. L. Cooper, J. Ostby, and L. E. Gray. 1999. &ldquo;Administration of Potentially Antiandrogenic Pesticides (procymidone, Linuron, Iprodione, Chlozolinate, P,p&rsquo;-DDE, and Ketoconazole) and Toxic Substances (dibutyl- and Diethylhexyl Phthalate, PCB 169, and Ethane Dimethane Sulphonate) during Sexual Differen.&rdquo; Toxicology and Industrial Health 15 (1-2) (February 1): 94&ndash;118. doi:10.1177/074823379901500109.</p>\n","biologicalOrganisationLevel":"Organ","organTerm":{"name":"male reproductive system","sourceId":"UBERON:0000079"},"biologicalEvents":[{"action":"morphological change","object":{"name":"male reproductive organ","source":"UBERON","sourceId":"UBERON:0003135"}}],"id":348}
{"title":"N/A, Androgen receptor, Antagonism","references":"","biologicalOrganisationLevel":"Molecular","organTerm":{},"biologicalEvents":[{"action":"decreased","process":"androgen receptor activity","object":{"name":"androgen receptor","source":"PR","sourceId":"PR:000004191"}}],"id":27}
{"title":"Alteration, Wnt pathway","references":"","biologicalOrganisationLevel":"Cellular","organTerm":{},"biologicalEvents":[{"action":"abnormal","process":"Wnt signaling pathway","object":{"name":"Wnt signalosome","source":"GO","sourceId":"GO:1990909"}}],"id":310}
{"title":"Feminisation or incomplete development, Primary and accessory male sex organs","references":"","biologicalOrganisationLevel":"Organ","organTerm":{"name":"male reproductive system","sourceId":"UBERON:0000079"},"biologicalEvents":[{"action":"arrested","process":"developmental process","object":{"name":"male reproductive organ","source":"UBERON","sourceId":"UBERON:0003135"}}],"id":240}
{"title":"Altered, Transcription of genes by AR","references":"<p>Bevan C, Parker M (1999) The role of coactivators in steroid hormone action. Exp. Cell Res. 253:349&ndash;356</p>\n\n<p>Bolton EC, So AY, Chaivorapol C, et al (2007) Cell- and gene-specific regulation of primary target genes by the androgen receptor. Genes Dev 21:2005&ndash;2017. doi: 10.1101/gad.1564207</p>\n\n<p>Davey RA, Grossmann M (2016) Androgen Receptor Structure, Function and Biology: From Bench to Bedside. Clin Biochem Rev 37:3&ndash;15</p>\n\n<p>Draskau MK, Boberg J, Taxvig C, et al (2019) In&nbsp;vitro and in&nbsp;vivo endocrine disrupting effects of the azole fungicides triticonazole and flusilazole. Environ Pollut 255:113309. doi: 10.1016/j.envpol.2019.113309</p>\n\n<p>Estrada M, Espinosa A, M&uuml;ller M, Jaimovich E (2003) Testosterone Stimulates Intracellular Calcium Release and Mitogen-Activated Protein Kinases Via a G Protein-Coupled Receptor in Skeletal Muscle Cells. Endocrinology 144:3586&ndash;3597. doi: 10.1210/en.2002-0164</p>\n\n<p>Heemers H V., Tindall DJ (2007) Androgen receptor (AR) coregulators: A diversity of functions converging on and regulating the AR transcriptional complex. Endocr. Rev. 28:778&ndash;808</p>\n\n<p>Jiang M, Ma Y, Chen C, et al (2009) Androgen-Responsive Gene Database: Integrated Knowledge on Androgen-Responsive Genes. Mol Endocrinol 23:1927&ndash;1933. doi: 10.1210/me.2009-0103</p>\n\n<p>Kj&aelig;rstad MB, Taxvig C, Nellemann C, et al (2010) Endocrine disrupting effects in vitro of conazole antifungals used as pesticides and pharmaceuticals. Reprod Toxicol 30:573&ndash;582. doi: 10.1016/J.REPROTOX.2010.07.009</p>\n\n<p>Laier P, Metzdorff SB, Borch J, et al (2006) Mechanisms of action underlying the antiandrogenic effects of the fungicide prochloraz. Toxicol Appl Pharmacol 213:160&ndash;71. doi: 10.1016/j.taap.2005.10.013</p>\n\n<p>Maclean HE, Chu S, Warne GL, Zajact JD Related Individuals with Different Androgen Receptor Gene Deletions</p>\n\n<p>MacLeod DJ, Sharpe RM, Welsh M, et al (2010) Androgen action in the masculinization programming window and development of male reproductive organs. In: International Journal of Andrology. Blackwell Publishing Ltd, pp 279&ndash;287</p>\n\n<p>Ngan S, Stronach EA, Photiou A, et al (2009) Microarray coupled to quantitative RT&amp;ndash;PCR analysis of androgen-regulated genes in human LNCaP prostate cancer cells. Oncogene 28:2051&ndash;2063. doi: 10.1038/onc.2009.68</p>\n\n<p>OECD (2016) Test No. 458: Stably Transfected Human Androgen Receptor Transcriptional Activation Assay for Detection of Androgenic Agonist and Antagonist Activity of Chemicals, OECD Guide. OECD Publishing</p>\n\n<p>Rana K, Davey RA, Zajac JD (2014) Human androgen deficiency: Insights gained from androgen receptor knockout mouse models. Asian J. Androl. 16:169&ndash;177</p>\n\n<p>Sonneveld E, Jansen HJ, Riteco JAC, et al (2005) Development of Androgen-and Estrogen-Responsive Bioassays, Members of a Panel of Human Cell Line-Based Highly Selective Steroid-Responsive Bioassays. Toxicol Sci 83:136&ndash;148. doi: 10.1093/toxsci/kfi005</p>\n\n<p>van der Burg B, Winter R, Man H yen, et al (2010) Optimization and prevalidation of the in vitro AR CALUX method to test androgenic and antiandrogenic activity of compounds. Reprod Toxicol 30:18&ndash;24. doi: 10.1016/j.reprotox.2010.04.012</p>\n\n<p>Walters KA, Simanainen U, Handelsman DJ (2010) Molecular insights into androgen actions in male and female reproductive function from androgen receptor knockout models. Hum Reprod Update 16:543&ndash;558. doi: 10.1093/humupd/dmq003</p>\n","biologicalOrganisationLevel":"Cellular","organTerm":{},"biologicalEvents":[{"action":"decreased","process":"regulation of gene expression","object":{"name":"androgen receptor","source":"PR","sourceId":"PR:000004191"}}],"keyEventStressors":["Stressor:286 Tebuconazole","Prochloraz","Bicalutamide","Epoxiconazole","Vinclozalin","Cyproterone acetate","Flutamide","Flusilazole","Triticonazole","Propiconazole"],"id":286}
{"title":"N/A, Impairment of reproductive capacity","references":"","biologicalOrganisationLevel":"Individual","organTerm":{},"biologicalEvents":[{"action":"decreased","object":{"name":"fertility","source":"MESH","sourceId":"D005298"}}],"id":337}
{"title":"Activation, AhR","references":"<ol>\n\t<li>&uarr; <sup><a href=\"#cite_ref-Okey2007_1-0\">1.0</a></sup> <sup><a href=\"#cite_ref-Okey2007_1-1\">1.1</a></sup> Okey, A. B. (2007). An aryl hydrocarbon receptor odyssey to the shores of toxicology: the Deichmann Lecture, International Congress of Toxicology-XI. <em>Toxicol.Sci.</em> <strong>98</strong>, 5-38.</li>\n\t<li><a href=\"#cite_ref-Hoffman1991_2-0\">&uarr;</a> Hoffman, E. C., Reyes, H., Chu, F. F., Sander, F., Conley, L. H., Brooks, B. A., and Hankinson, O. (1991). Cloning of a factor required for activity of the Ah (dioxin) receptor. <em>Science</em> <strong>252</strong>, 954-958.</li>\n\t<li>&uarr; <sup><a href=\"#cite_ref-Poland1976_3-0\">3.0</a></sup> <sup><a href=\"#cite_ref-Poland1976_3-1\">3.1</a></sup> Poland, A., Glover, E., and Kende, A. S. (1976). Stereospecific, high affinity binding of 2,3,7,8-tetrachlorodibenzo-p-dioxin by hepatic cytosol. Evidence that the binding species is receptor for induction of aryl hydrocarbon hydroxylase. <em>J.Biol.Chem.</em> <strong>251</strong>, 4936-4946.</li>\n\t<li>&uarr; <sup><a href=\"#cite_ref-Gu2000_4-0\">4.0</a></sup> <sup><a href=\"#cite_ref-Gu2000_4-1\">4.1</a></sup> Gu, Y. Z., Hogenesch, J. B., and Bradfield, C. A. (2000). The PAS superfamily: sensors of environmental and developmental signals. <em>Annu.Rev.Pharmacol.Toxicol.</em> <strong>40</strong>, 519-561.</li>\n\t<li><a href=\"#cite_ref-Kewley2004_5-0\">&uarr;</a> Kewley, R. J., Whitelaw, M. L., and Chapman-Smith, A. (2004). The mammalian basic helix-loop-helix/PAS family of transcriptional regulators. <em>Int.J.Biochem.Cell Biol.</em> <strong>36</strong>, 189-204.</li>\n\t<li>&uarr; <sup><a href=\"#cite_ref-Fujii2010_6-0\">6.0</a></sup> <sup><a href=\"#cite_ref-Fujii2010_6-1\">6.1</a></sup> <sup><a href=\"#cite_ref-Fujii2010_6-2\">6.2</a></sup> <sup><a href=\"#cite_ref-Fujii2010_6-3\">6.3</a></sup> Fujii-Kuriyama, Y., and Kawajiri, K. (2010). Molecular mechanisms of the physiological functions of the aryl hydrocarbon (dioxin) receptor, a multifunctional regulator that senses and responds to environmental stimuli. <em>Proc.Jpn.Acad.Ser.B Phys.Biol.Sci.</em> <strong>86</strong>, 40-53.</li>\n\t<li>&uarr; <sup><a href=\"#cite_ref-Mimura2003_7-0\">7.0</a></sup> <sup><a href=\"#cite_ref-Mimura2003_7-1\">7.1</a></sup> Mimura, J., and Fujii-Kuriyama, Y. (2003). Functional role of AhR in the expression of toxic effects by TCDD. <em>Biochimica et Biophysica Acta - General Subjects</em> <strong>1619</strong>, 263-268.</li>\n\t<li><a href=\"#cite_ref-Giesy2006_8-0\">&uarr;</a> Giesy, J. P., Kannan, K., Blankenship, A. L., Jones, P. D., and Newsted, J. L. (2006). Toxicology of PCBs and related compounds. In Endocrine Disruption Biological Bases for Health Effects in Wildlife and Humans (D. O. Norris, and J. A. Carr, Eds.), pp. 245-331. Oxford University Press, New York.</li>\n\t<li>&uarr; <sup><a href=\"#cite_ref-Safe1994_9-0\">9.0</a></sup> <sup><a href=\"#cite_ref-Safe1994_9-1\">9.1</a></sup> <sup><a href=\"#cite_ref-Safe1994_9-2\">9.2</a></sup> Safe, S. (1994). Polychlorinated biphenyls (PCBs): Environmental impact, biochemical and toxic responses, and implications for risk assessment. <em>Critical Reviews in Toxicology</em> <strong>24</strong>, 87-149.</li>\n\t<li>&uarr; <sup><a href=\"#cite_ref-Yasui2007_10-0\">10.0</a></sup> <sup><a href=\"#cite_ref-Yasui2007_10-1\">10.1</a></sup> <sup><a href=\"#cite_ref-Yasui2007_10-2\">10.2</a></sup> Yasui, T., Kim, E. Y., Iwata, H., Franks, D. G., Karchner, S. I., Hahn, M. E., and Tanabe, S. (2007). Functional characterization and evolutionary history of two aryl hydrocarbon receptor isoforms (AhR1 and AhR2) from avian species. <em>Toxicol.Sci</em>. <strong>99</strong>, 101-117.</li>\n\t<li>&uarr; <sup><a href=\"#cite_ref-Lee2009_11-0\">11.0</a></sup> <sup><a href=\"#cite_ref-Lee2009_11-1\">11.1</a></sup> Lee, J. S., Kim, E. Y., and Iwata, H. (2009). Dioxin activation of CYP1A5 promoter/enhancer regions from two avian species, common cormorant (Phalacrocorax carbo) and chicken (Gallus gallus): association with aryl hydrocarbon receptor 1 and 2 isoforms. <em>Toxicol.Appl.Pharmacol</em>. <strong>234</strong>, 1-13.</li>\n\t<li>&uarr; <sup><a href=\"#cite_ref-Raucy2010_12-0\">12.0</a></sup> <sup><a href=\"#cite_ref-Raucy2010_12-1\">12.1</a></sup> <sup><a href=\"#cite_ref-Raucy2010_12-2\">12.2</a></sup> <sup><a href=\"#cite_ref-Raucy2010_12-3\">12.3</a></sup> <sup><a href=\"#cite_ref-Raucy2010_12-4\">12.4</a></sup> <sup><a href=\"#cite_ref-Raucy2010_12-5\">12.5</a></sup> Raucy, J. L., and Lasker, J. M. (2010). Current in vitro high throughput screening approaches to assess nuclear receptor activation. <em>Curr. Drug Metab</em> <strong>11</strong> (9), 806-814.</li>\n\t<li>&uarr; <sup><a href=\"#cite_ref-Farmahin2012_13-0\">13.0</a></sup> <sup><a href=\"#cite_ref-Farmahin2012_13-1\">13.1</a></sup> <sup><a href=\"#cite_ref-Farmahin2012_13-2\">13.2</a></sup> Farmahin, R., Wu, D., Crump, D., Herv&eacute;, J. C., Jones, S. P., Hahn, M. E., Karchner, S. I., Giesy, J. P., Bursian, S. J., Zwiernik, M. J., and Kennedy, S. W. (2012). Sequence and in vitro function of chicken, ring-necked pheasant, and Japanese quail AHR1 predict in vivo sensitivity to dioxins. Environ.Sci.Technol. 46, 2967-2975.</li>\n\t<li>&uarr; <sup><a href=\"#cite_ref-Farmahin2013b_14-0\">14.0</a></sup> <sup><a href=\"#cite_ref-Farmahin2013b_14-1\">14.1</a></sup> <sup><a href=\"#cite_ref-Farmahin2013b_14-2\">14.2</a></sup> <sup><a href=\"#cite_ref-Farmahin2013b_14-3\">14.3</a></sup> Farmahin, R., Manning, G. E., Crump, D., Wu, D., Mundy, L. J., Jones, S. P., Hahn, M. E., Karchner, S. I., Giesy, J. P., Bursian, S. J., Zwiernik, M. J., Fredricks, T. B., and Kennedy, S. W. (2013b). Amino acid sequence of the ligand binding domain of the aryl hydrocarbon receptor 1 (AHR1) predicts sensitivity of wild birds to effects of dioxin-like compounds. Toxicol.Sci. 131, 139-152.</li>\n\t<li><a href=\"#cite_ref-Fujisawa2012_15-0\">&uarr;</a> Fujisawa, N., Ikenaka, Y., Kim, E. Y., Lee, J. S., Iwata, H., and Ishizuka, M. (2012). Molecular evidence predicts aryl hydrocarbon receptor ligand insensitivity in the peregrine falcon (Falco peregrines). European Journal of Wildlife Research 58, 167-175.</li>\n\t<li>&uarr; <sup><a href=\"#cite_ref-Manning2012_16-0\">16.0</a></sup> <sup><a href=\"#cite_ref-Manning2012_16-1\">16.1</a></sup> <sup><a href=\"#cite_ref-Manning2012_16-2\">16.2</a></sup> Manning, G. E., Farmahin, R., Crump, D., Jones, S. P., Klein, J., Konstantinov, A., Potter, D., and Kennedy, S. W. (2012). A luciferase reporter gene assay and aryl hydrocarbon receptor 1 genotype predict the embryolethality of polychlorinated biphenyls in avian species. Toxicol.Appl.Pharmacol. 263, 390-399.</li>\n\t<li><a href=\"#cite_ref-Mol2012_17-0\">&uarr;</a> Mol, T. L., Kim, E. Y., Ishibashi, H., and Iwata, H. (2012). In vitro transactivation potencies of black-footed albatross (Phoebastria nigripes) AHR1 and AHR2 by dioxins to predict CYP1A expression in the wild population. Environ.Sci.Technol. 46, 525-533.</li>\n\t<li><a href=\"#cite_ref-Yueh2005_18-0\">&uarr;</a> Yueh, M. F., Kawahara, M., and Raucy, J. (2005). Cell-based high-throughput bioassays to assess induction and inhibition of CYP1A enzymes. <em>Toxicol. In Vitro</em> <strong>19</strong> (2), 275-287.</li>\n\t<li>&uarr; <sup><a href=\"#cite_ref-Poland1982_19-0\">19.0</a></sup> <sup><a href=\"#cite_ref-Poland1982_19-1\">19.1</a></sup> Poland, A., and Knutson, J. C. (1982). 2,3,7,8-tetrachlorodibenzo-p-dioxin and related halogenated aromatic hydrocarbons: examination of the mechanism of toxicity. <em>Annu. Rev. Pharmacol. Toxicol. </em> <strong>22</strong>, 517-554.</li>\n\t<li>&uarr; <sup><a href=\"#cite_ref-Hesterman2000_20-0\">20.0</a></sup> <sup><a href=\"#cite_ref-Hesterman2000_20-1\">20.1</a></sup> Hestermann, E. V., Stegeman, J. J., and Hahn, M. E. (2000). Relative contributions of affinity and intrinsic efficacy to aryl hydrocarbon receptor ligand potency. <em>Toxicol. Appl. Pharmacol </em> <strong>168</strong> (2), 160-172.</li>\n\t<li>&uarr; <sup><a href=\"#cite_ref-Farmahin2014_21-0\">21.0</a></sup> <sup><a href=\"#cite_ref-Farmahin2014_21-1\">21.1</a></sup> <sup><a href=\"#cite_ref-Farmahin2014_21-2\">21.2</a></sup> <sup><a href=\"#cite_ref-Farmahin2014_21-3\">21.3</a></sup> <sup><a href=\"#cite_ref-Farmahin2014_21-4\">21.4</a></sup> Farmahin, R., Jones, S. P., Crump, D., Hahn, M. E., Giesy, J. P., Zwiernik, M. J., Bursian, S. J., and Kennedy, S. W. (2014). Species-specific relative AHR1 binding affinities of 2,3,4,7,8-pentachlorodibenzofuran explain avian species differences in its relative potency. <em>Comp Biochem. Physiol C. Toxicol. Pharmacol.</em> <strong>161C</strong>, 21-25.</li>\n\t<li>&uarr; <sup><a href=\"#cite_ref-Karchner2006_22-0\">22.0</a></sup> <sup><a href=\"#cite_ref-Karchner2006_22-1\">22.1</a></sup> <sup><a href=\"#cite_ref-Karchner2006_22-2\">22.2</a></sup> <sup><a href=\"#cite_ref-Karchner2006_22-3\">22.3</a></sup> <sup><a href=\"#cite_ref-Karchner2006_22-4\">22.4</a></sup> <sup><a href=\"#cite_ref-Karchner2006_22-5\">22.5</a></sup> <sup><a href=\"#cite_ref-Karchner2006_22-6\">22.6</a></sup> Karchner, S. I., Franks, D. G., Kennedy, S. W., and Hahn, M. E. (2006). The molecular basis for differential dioxin sensitivity in birds: Role of the aryl hydrocarbon receptor. <em>Proc. Natl. Acad. Sci. U. S. A</em> <strong>103</strong> (16), 6252-6257.</li>\n\t<li><a href=\"#cite_ref-Lee2015_23-0\">&uarr;</a> Lee, S., Shin, W. H., Hong, S., Kang, H., Jung, D., Yim, U. H., Shim, W. J., Khim, J. S., Seok, C., Giesy, J. P., and Choi, K. (2015). Measured and predicted affinities of binding and relative potencies to activate the AhR of PAHs and their alkylated analogues. <em>Chemosphere</em> <strong>139</strong>, 23-29.</li>\n\t<li><a href=\"#cite_ref-Jones2003_24-0\">&uarr;</a> Jones, S. A., Parks, D. J., and Kliewer, S. A. (2003). Cell-free ligand binding assays for nuclear receptors. <em>Methods Enzymol. </em> <strong>364</strong>, 53-71.</li>\n\t<li><a href=\"#cite_ref-Gasiewicz1982_25-0\">&uarr;</a> Gasiewicz, T. A., and Neal, R. A. (1982). The examination and quantitation of tissue cytosolic receptors for 2,3,7,8-tetrachlorodibenzo-p-dioxin using hydroxylapatite. <em>Anal. Biochem. </em> <strong>124</strong> (1), 1-11.</li>\n\t<li><a href=\"#cite_ref-Nakai1995_26-0\">&uarr;</a> Nakai, J. S., and Bunce, N. J. (1995). Characterization of the Ah receptor from human placental tissue. <em>J Biochem. Toxicol. </em> <strong>10</strong> (3), 151-159.</li>\n\t<li><a href=\"#cite_ref-Dold1990_27-0\">&uarr;</a> Dold, K. M., and Greenlee, W. F. (1990). Filtration assay for quantitation of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) specific binding to whole cells in culture. <em>Anal. Biochem. </em> <strong>184</strong> (1), 67-73.</li>\n\t<li><a href=\"#cite_ref-Perez2007_28-0\">&uarr;</a> Perez-Romero, P., and Imperiale, M. J. (2007). Assaying protein-DNA interactions in vivo and in vitro using chromatin immunoprecipitation and electrophoretic mobility shift assays. <em>Methods Mol. Med. </em> <strong>131</strong>, 123-139.</li>\n\t<li><a href=\"#cite_ref-Heid2001_29-0\">&uarr;</a> Heid, S. E., Walker, M. K., and Swanson, H. I. (2001). Correlation of cardiotoxicity mediated by halogenated aromatic hydrocarbons to aryl hydrocarbon receptor activation. <em>Toxicol. Sci</em> <strong>61</strong> (1), 187-196.</li>\n\t<li>&uarr; <sup><a href=\"#cite_ref-Ema1994_30-0\">30.0</a></sup> <sup><a href=\"#cite_ref-Ema1994_30-1\">30.1</a></sup> Ema, M., Ohe, N., Suzuki, M., Mimura, J., Sogawa, K., Ikawa, S., and Fujii-Kuriyama, Y. (1994). Dioxin binding activities of polymorphic forms of mouse and human arylhydrocarbon receptors. J.Biol.Chem. 269, 27337-27343.</li>\n\t<li>&uarr; <sup><a href=\"#cite_ref-Poland1994_31-0\">31.0</a></sup> <sup><a href=\"#cite_ref-Poland1994_31-1\">31.1</a></sup> Poland, A., Palen, D., and Glover, E. (1994). Analysis of the four alleles of the murine aryl hydrocarbon receptor. Mol.Pharmacol. 46, 915-921.</li>\n\t<li><a href=\"#cite_ref-Backlund2004_32-0\">&uarr;</a> Backlund, M., and Ingelman-Sundberg, M. (2004). Different structural requirements of the ligand binding domain of the aryl hydrocarbon receptor for high- and low-affinity ligand binding and receptor activation. Mol.Pharmacol. 65, 416-425.</li>\n\t<li><a href=\"#cite_ref-Murray2005_33-0\">&uarr;</a> Murray, I. A., Reen, R. K., Leathery, N., Ramadoss, P., Bonati, L., Gonzalez, F. J., Peters, J. M., and Perdew, G. H. (2005). Evidence that ligand binding is a key determinant of Ah receptor-mediated transcriptional activity. Arch.Biochem.Biophys. 442, 59-71.</li>\n\t<li><a href=\"#cite_ref-Pandini2007_34-0\">&uarr;</a> Pandini, A., Denison, M. S., Song, Y., Soshilov, A. A., and Bonati, L. (2007). Structural and functional characterization of the aryl hydrocarbon receptor ligand binding domain by homology modeling and mutational analysis. Biochemistry 46, 696-708.</li>\n\t<li>&uarr; <sup><a href=\"#cite_ref-Pandini2009_35-0\">35.0</a></sup> <sup><a href=\"#cite_ref-Pandini2009_35-1\">35.1</a></sup> <sup><a href=\"#cite_ref-Pandini2009_35-2\">35.2</a></sup> Pandini, A., Soshilov, A. A., Song, Y., Zhao, J., Bonati, L., and Denison, M. S. (2009). Detection of the TCDD binding-fingerprint within the Ah receptor ligand binding domain by structurally driven mutagenesis and functional analysis. Biochemistry 48, 5972-5983.</li>\n\t<li><a href=\"#cite_ref-Ramadoss2004_36-0\">&uarr;</a> Ramadoss, P., and Perdew, G. H. (2004). Use of 2-azido-3-[125I]iodo-7,8-dibromodibenzo-p-dioxin as a probe to determine the relative ligand affinity of human versus mouse aryl hydrocarbon receptor in cultured cells. Mol.Pharmacol. 66, 129-136.</li>\n\t<li>&uarr; <sup><a href=\"#cite_ref-Head2008_37-0\">37.0</a></sup> <sup><a href=\"#cite_ref-Head2008_37-1\">37.1</a></sup> <sup><a href=\"#cite_ref-Head2008_37-2\">37.2</a></sup> Head, J. A., Hahn, M. E., and Kennedy, S. W. (2008). Key amino acids in the aryl hydrocarbon receptor predict dioxin sensitivity in avian species. <em>Environ.Sci.Technol. </em> <strong>42</strong>, 7535-7541.</li>\n\t<li>&uarr; <sup><a href=\"#cite_ref-Denison2011_38-0\">38.0</a></sup> <sup><a href=\"#cite_ref-Denison2011_38-1\">38.1</a></sup> Denison, M. S., Soshilov, A. A., He, G., DeGroot, D. E., and Zhao, B. (2011). Exactly the same but different: promiscuity and diversity in the molecular mechanisms of action of the aryl hydrocarbon (dioxin) receptor. <em>Toxicol.Sci.</em> <strong>124</strong>, 1-22.</li>\n\t<li><a href=\"#cite_ref-Van1998_39-0\">&uarr;</a> van den Berg, M., Birnbaum, L. S., Bosveld, A. T., Brunstr&ouml;m, B., Cook, P., Feeley, M., Giesy, J. P., Hanberg, A., Hasegawa, R., Kennedy, S. W., Kubiak, T. J., Larsen, J. C., Van Leeuwen, F. X. R., Liem, A. K. D., Nolt, C., Peterson, R. E., Poellinger, L., Safe, S., Schrenk, D., Tillitt, D. E., Tysklind, M., Younes, M., W&aelig;rn, F., and Zacharewski, T. R. (1998). Toxic equivalency factors (TEFs) for PCBs, PCDDs, PCDFs for humans and wildlife. <em>Environ.Health Perspect</em>. <strong>106</strong>, 775-792.</li>\n\t<li><a href=\"#cite_ref-Cohen2011b_40-0\">&uarr;</a> Cohen-Barnhouse, A. M., Zwiernik, M. J., Link, J. E., Fitzgerald, S. D., Kennedy, S. W., Herv&eacute;, J. C., Giesy, J. P., Wiseman, S. B., Yang, Y., Jones, P. D., Wan, Y., Collins, B., Newsted, J. L., Kay, D. P., and Bursian, S. J. (2011b). Sensitivity of Japanese quail (Coturnix japonica), Common pheasant (Phasianus colchicus), and White Leghorn chicken (Gallus gallus domesticus) embryos to in ovo exposure to TCDD, PeCDF, and TCDF. <em>Toxicol.Sci.</em> <strong>119</strong>, 93-103.</li>\n\t<li><a href=\"#cite_ref-Farmahin2013a_41-0\">&uarr;</a> Farmahin, R., Crump, D., Jones, S. P., Mundy, L. J., and Kennedy, S. W. (2013a). Cytochrome P4501A induction in primary cultures of embryonic European starling hepatocytes exposed to TCDD, PeCDF and TCDF. <em>Ecotoxicology</em> <strong>22</strong>(4), 731-739.</li>\n\t<li><a href=\"#cite_ref-Herve2010a_42-0\">&uarr;</a> Herv&eacute;, J. C., Crump, D., Jones, S. P., Mundy, L. J., Giesy, J. P., Zwiernik, M. J., Bursian, S. J., Jones, P. D., Wiseman, S. B., Wan, Y., and Kennedy, S. W. (2010a). Cytochrome P4501A induction by 2,3,7,8-tetrachlorodibenzo-p-dioxin and two chlorinated dibenzofurans in primary hepatocyte cultures of three avian species. <em>Toxicol. Sci.</em> <strong>113</strong>(2), 380-391.</li>\n\t<li><a href=\"#cite_ref-Herve2010b_43-0\">&uarr;</a> Herv&eacute;, J. C., Crump, D. L., McLaren, K. K., Giesy, J. P., Zwiernik, M. J., Bursian, S. J., and Kennedy, S. W. (2010b). 2,3,4,7,8-pentachlorodibenzofuran is a more potent cytochrome P4501A inducer than 2,3,7,8-tetrachlorodibenzo-p-dioxin in herring gull hepatocyte cultures. <em>Environ. Toxicol. Chem.</em> <strong>29</strong>(9), 2088-2095.</li>\n\t<li><a href=\"#cite_ref-Poland1973_44-0\">&uarr;</a> Poland, A., and Glover, E. (1973). Studies on the mechanism of toxicity of the chlorinated dibenzo-p-dioxins. <em>Environ.Health Perspect</em>. <strong>5</strong>, 245-251.</li>\n\t<li>&uarr; <sup><a href=\"#cite_ref-McFarland1989_45-0\">45.0</a></sup> <sup><a href=\"#cite_ref-McFarland1989_45-1\">45.1</a></sup> McFarland, V. A., and Clarke, J. U. (1989). Environmental occurrence, abundance, and potential toxicity of polychlorinated biphenyl congeners: Considerations for a congener-specific analysis. <em>Environ.Health Perspect</em>. <strong>81</strong>, 225-239.</li>\n\t<li>&uarr; <sup><a href=\"#cite_ref-Omie2011_46-0\">46.0</a></sup> <sup><a href=\"#cite_ref-Omie2011_46-1\">46.1</a></sup> Omiecinski, C. J., Vanden Heuvel, J. P., Perdew, G. H., and Peters, J. M. (2011). Xenobiotic metabolism, disposition, and regulation by receptors: from biochemical phenomenon to predictors of major toxicities. <em>Toxicol.Sci.</em> <strong>120</strong> Suppl 1, S49-S75.</li>\n\t<li><a href=\"#cite_ref-Swed2010_47-0\">&uarr;</a> Swedenborg, E., and Pongratz, I. (2010). AhR and ARNT modulate ER signaling. <em>Toxicology</em> <strong>268</strong>, 132-138.</li>\n\t<li><a href=\"#cite_ref-Diani2011_48-0\">&uarr;</a> Diani-Moore, S., Ma, Y., Labitzke, E., Tao, H., David, W. J., Anderson, J., Chen, Q., Gross, S. S., and Rifkind, A. B. (2011). Discovery and biological characterization of 1-(1H-indol-3-yl)-9H-pyrido[3,4-b]indole as an aryl hydrocarbon receptor activator generated by photoactivation of tryptophan by sunlight. <em>Chem. Biol. Interact.</em> <strong>193</strong>(2), 119-128.</li>\n\t<li><a href=\"#cite_ref-Wincent2012_49-0\">&uarr;</a> Wincent, E., Bengtsson, J., Mohammadi, B. A., Alsberg, T., Luecke, S., Rannug, U., and Rannug, A. (2012). Inhibition of cytochrome P4501-dependent clearance of the endogenous agonist FICZ as a mechanism for activation of the aryl hydrocarbon receptor. <em>Proc. Natl. Acad. Sci. U. S. A</em> <strong>109</strong>(12), 4479-4484.</li>\n\t<li><a href=\"#cite_ref-Baba2005_50-0\">&uarr;</a> Baba, T., Mimura, J., Nakamura, N., Harada, N., Yamamoto, M., Morohashi, K., and Fujii-Kuriyama, Y. (2005). Intrinsic function of the aryl hydrocarbon (dioxin) receptor as a key factor in female reproduction. <em>Mol.Cell Biol</em>. <strong>25</strong>, 10040-10051.</li>\n\t<li><a href=\"#cite_ref-Fernandez1995_51-0\">&uarr;</a> Fernandez-Salguero, P. M., Pineau, T., Hilbert, D. M., McPhail, T., Lee, S. S., Kimura, S., Nebert, D. W., Rudikoff, S., Ward, J. M., and Gonzalez, F. J. (1995). Immune system impairment and hepatic fibrosis in mice lacking the dioxin-binding Ah receptor. <em>Science</em> <strong>268</strong>, 722-726.</li>\n\t<li><a href=\"#cite_ref-Ichihara2007_52-0\">&uarr;</a> Ichihara, S., Yamada, Y., Ichihara, G., Nakajima, T., Li, P., Kondo, T., Gonzalez, F. J., and Murohara, T. (2007). A role for the aryl hydrocarbon receptor in regulation of ischemia-induced angiogenesis. <em>Arterioscler.Thromb.Vasc.Biol</em>. <strong>27</strong>, 1297-1304.</li>\n\t<li><a href=\"#cite_ref-Lahvis2000_53-0\">&uarr;</a> Lahvis, G. P., Lindell, S. L., Thomas, R. S., McCuskey, R. S., Murphy, C., Glover, E., Bentz, M., Southard, J., and Bradfield, C. A. (2000). Portosystemic shunting and persistent fetal vascular structures in aryl hydrocarbon receptor-deficient mice. <em>Proc.Natl.Acad.Sci U.S.A</em> <strong>97</strong>, 10442-10447.</li>\n\t<li><a href=\"#cite_ref-Mimura1997_54-0\">&uarr;</a> Mimura, J., Yamashita, K., Nakamura, K., Morita, M., Takagi, T. N., Nakao, K., Ema, M., Sogawa, K., Yasuda, M., Katsuki, M., and Fujii-Kuriyama, Y. (1997). Loss of teratogenic response to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in mice lacking the Ah (dioxin) receptor. <em>Genes Cells</em> <strong>2</strong>, 645-654.</li>\n\t<li><a href=\"#cite_ref-Schmidt1996_55-0\">&uarr;</a> Schmidt, J. V., Su, G. H., Reddy, J. K., Simon, M. C., and Bradfield, C. A. (1996). Characterization of a murine Ahr null allele: involvement of the Ah receptor in hepatic growth and development. <em>Proc.Natl.Acad.Sci U.S.A</em> <strong>93</strong>, 6731-6736.</li>\n\t<li><a href=\"#cite_ref-Thack2002_56-0\">&uarr;</a> Thackaberry, E. A., Gabaldon, D. M., Walker, M. K., and Smith, S. M. (2002). Aryl hydrocarbon receptor null mice develop cardiac hypertrophy and increased hypoxia-inducible factor-1alpha in the absence of cardiac hypoxia. <em>Cardiovasc.Toxicol.</em> <strong>2</strong>, 263-274.</li>\n\t<li><a href=\"#cite_ref-Zhang2010_57-0\">&uarr;</a> Zhang, N., Agbor, L. N., Scott, J. A., Zalobowski, T., Elased, K. M., Trujillo, A., Duke, M. S., Wolf, V., Walsh, M. T., Born, J. L., Felton, L. A., Wang, J., Wang, W., Kanagy, N. L., and Walker, M. K. (2010). An activated renin-angiotensin system maintains normal blood pressure in aryl hydrocarbon receptor heterozygous mice but not in null mice. <em>Biochem.Pharmacol.</em> <strong>80</strong>, 197-2040.</li>\n</ol>\n\n<p>Abnet, C.C.; Tanguay, R.L.; Heideman, W.; Peterson, R.E. 1999. Transactivation activity of human, zebrafish, and rainbow trout aryl hydrocarbon receptors expressed in COS-7 cells: Greater insight into species differences in toxic potency of polychlorinated dibenzo-p-dioxin, dibenzofuran, and biphenyl congeners. Toxicol. Appl. Pharmacol<em>.</em> 159, 41-51.</p>\n\n<p>&nbsp;</p>\n\n<p>Andreasen, E.A.; Tanguay, R.L.; Peterson, R.E.; Heideman, W. 2002. Identification of a critical amino acid in the aryl hydrocarbon receptor. J. Biol. Chem. 277 (15), 13210-13218.</p>\n\n<p>&nbsp;</p>\n\n<p>Bak, S.M.; Lida, M.; Hirano, M.; Iwata, H.; Kim, E.Y. 2013. Potencies of red seabream AHR1- and AHR2-mediated transactivation by dioxins: implications of both AHRs in dioxin toxicity. Environ. Sci. Technol. 47 (6), 2877-2885.</p>\n\n<p>&nbsp;</p>\n\n<p>Clark, B.W.; Matson, C.W.; Jung, D.; Di Giulio, R.T. 2010. AHR2 mediates cardiac teratogenesis of polycyclic aromatic hydrocarbons and PCB-126 in Atlantic killifish (<em>Fundulus heteroclitus</em>). Aquat. Toxicol. 99, 232-240.</p>\n\n<p>&nbsp;</p>\n\n<p>Doering, J.A.; Farmahin, R.; Wiseman, S.; Beitel, S.C.; Kennedy, S.W.; Giesy, J.P.; Hecker, M. 2015. Differences in activation of aryl hydrocarbon receptors of white sturgeon relative to lake sturgeon are predicted by identities of key amino acids in the ligand binding domain. Enviro. Sci. Technol. 49, 4681-4689.</p>\n\n<p>&nbsp;</p>\n\n<p>Doering, J.A.; Farmahin, R.; Wiseman, S.; Kennedy, S.; Giesy J.P.; Hecker, M. 2014. Functionality of aryl hydrocarbon receptors (AhR1 and AhR2) of white sturgeon (Acipenser transmontanus) and implications for the risk assessment of dioxin-like compounds. Enviro. Sci. Technol. 48, 8219-8226.</p>\n\n<p>&nbsp;</p>\n\n<p>Doering, J.A.; Giesy, J.P.; Wiseman, S.; Hecker, M. Predicting the sensitivity of fishes to dioxin-like compounds: possible role of the aryl hydrocarbon receptor (AhR) ligand binding domain. <em>Environ. Sci. Pollut. Res. Int.</em> <strong>2013</strong>, 20(3), 1219-1224.</p>\n\n<p>&nbsp;</p>\n\n<p>Doering, J.A.; Wiseman, S; Beitel, S.C.; Giesy, J.P.; Hecker, M. 2014. Identification and expression of aryl hydrocarbon receptors (AhR1 and AhR2) provide insight in an evolutionary context regarding sensitivity of white sturgeon (<em>Acipenser transmontanus</em>) to dioxin-like compounds. Aquat. Toxicol. 150, 27-35.</p>\n\n<p>&nbsp;</p>\n\n<p>Duncan, D.M.; Burgess, E.A.; Duncan, I. 1998. Control of distal antennal identity and tarsal development in Drosophila by spineless-aristapedia, a homolog of the mammalian dioxin receptor. Genes Dev. 12, 1290-1303.</p>\n\n<p>&nbsp;</p>\n\n<p>Eisner, B.K.; Doering, J.A.; Beitel, S.C.; Wiseman, S.; Raine, J.C.; Hecker, M. 2016. Cross-species comparison of relative potencies and relative sensitivities of fishes to dibenzo-p-dioxins, dibenzofurans, and polychlorinated biphenyls in vitro. Enviro. Toxicol. Chem. 35 (1), 173-181.</p>\n\n<p>&nbsp;</p>\n\n<p>Emmons, R.B.; Duncan, D.; Estes, P.A.; Kiefel, P.; Mosher, J.T.; Sonnenfeld, M.; Ward, M.P.; Duncan, I.; Crews, S.T. 1999. The spineless-aristapedia and tango bHLH-PAS proteins interact to control antennal and tarsal development in Drosophila. Development. 126, 3937-3945.</p>\n\n<p>&nbsp;</p>\n\n<p>Evans, B.R.; Karchner, S.I.; Franks, D.G.; Hahn, M.E. 2005. Duplicate aryl hydrocarbon receptor repressor genes (ahrr1 and ahrr2) in the zebrafish <em>Danio rerio</em>: structure, function, evolution, and AHR-dependent regulation <em>in vivo</em>. Arch. Biochem. Biophys. 441, 151-167.</p>\n\n<p>&nbsp;</p>\n\n<p>Hahn, M.E. 2002. Aryl hydrocarbon receptors: diversity and evolution. Chemico-Biol. Interact. 141, 131-160.</p>\n\n<p>&nbsp;</p>\n\n<p>Hahn, M.E.; Karchner, S.I.; Evans, B.R.; Franks, D.G.; Merson, R.R.; Lapseritis, J.M. 2006. Unexpected diversity of aryl hydrocarbon receptors in non-mammalian vertebrates: Insights from comparative genomics. J. Exp. Zool. A. Comp. Exp. Biol. 305, 693-706.</p>\n\n<p>&nbsp;</p>\n\n<p>Hahn, M.E.; Poland, A.; Glover, E.; Stegeman, J.J. 1994. Photoaffinity labeling of the Ah receptor: phylogenetic survey of diverse vertebrate and invertebrate species. Arch. Biochem. Biophys. 310, 218-228.</p>\n\n<p>&nbsp;</p>\n\n<p>Hansson, M.C.; Hahn, M.E. 2008. Functional properties of the four Atlantic salmon (<em>Salmo salar</em>) aryl hydrocarbon receptor type 2 (AHR2) isoforms. Aquat. Toxicol. 86, 121-130.</p>\n\n<p>&nbsp;</p>\n\n<p>Hansson, M.C.; Wittzell, H.; Persson, K.; von Schantz, T. 2004. Unprecedented genomic diversity of AhR1 and AhR2 genes in Atlantic salmon (<em>Salmo salar </em>L.). Aquat. Toxicol. 68 (3), 219-232.</p>\n\n<p>&nbsp;</p>\n\n<p>Karchner, S.I.; Franks, D.G.; Hahn, M.E. (2005). AHR1B, a new functional aryl hydrocarbon receptor in zebrafish: tandem arrangement of ahr1b and ahr2 genes. Biochem. J. 392 (1), 153-161.</p>\n\n<p>&nbsp;</p>\n\n<p>Karchner, S.I.; Powell, W.H.; Hahn, M.E. 1999. Identification and functional characterization of two highly divergent aryl hydrocarbon receptors (AHR1 and AHR2) in the Teleost <em>Fundulus heteroclitus</em>. Evidence for a novel subfamily of ligand-binding basic helix loop helix-Per-ARNT-Sim (bHLH-PAS) factors. J. Biol. Chem. 274, 33814-33824.</p>\n\n<p>&nbsp;</p>\n\n<p>Lahvis, G.P.; Bradfield, C.A. 1998. Ahr null alleles: distinctive or different? Biochem. Pharmacol. 56, 781-787.</p>\n\n<p>&nbsp;</p>\n\n<p>Lavine, J.A.; Rowatt, A.J.; Klimova, T.; Whitington, A.J.; Dengler, E.; Beck, C.; Powell, W.H. 2005. Aryl hydrocarbon receptors in the frog Xenopus laevis: two AhR1 paralogs exhibit low affinity for 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD). Toxicol. Sci. 88 (1), 60-72.</p>\n\n<p>&nbsp;</p>\n\n<p>Oka, K.; Kohno, S.; Ohta, Y.; Guillette, L.J.; Iguchi, T.; Katsu, Y. (2016). Molecular cloning and characterization of the aryl hydrocarbon receptors and aryl hydrocarbon receptor nuclear translocators in the American alligator. Gen. Comp. Endo. 238, 13-22.</p>\n\n<p>&nbsp;</p>\n\n<p>Pongratz, I.; Mason, G.G.; Poellinger, L. Dual roles of the 90-kDa heat shock protein hsp90 in modulating functional activities of the dioxin receptor. Evidence that the dioxin receptor functionally belongs to a subclass of nuclear receptors which require hsp90 both for ligand binding activity and repression of intrinsic DNA binding activity. J. Biol. Chem. 1992, 267 (19), 13728-13734</p>\n\n<p>&nbsp;</p>\n\n<p>Prasch, A.L.; Teraoka, H.; Carney, S.A.; Dong, W.; Hiraga, T.; Stegeman, J.J.; Heideman, W.; Peterson, R.E. 2003. Toxicol. Sci. Aryl hydrocarbon receptor 2 mediated 2,3,7,8-tetrachlorodibenzo-<em>p</em>-dioxin developmental toxicity in zebrafish. 76 (1), 138-150.</p>\n\n<p>&nbsp;</p>\n\n<p>Shoots, J.; Fraccalvieri, D.; Franks, D.G.; Denison, M.S.; Hahn, M.E.; Bonati, L.; Powell, W.H. 2015. An aryl hydrocarbon receptor from the salamander Ambystoma mexicanum exhibits low sensitivity to 2,3,7,8-tetrachlorodibenzo-p-dioxin. Enviro. Sci. Technol<em>. </em>49, 6993-7001.</p>\n\n<p>&nbsp;</p>\n\n<p>Tanguay, R.L.; Abnet, C.C.; Heideman, W. Peterson, R.E. (1999). Cloning and characterization of the zebrafish (Danio rerio) aryl hydrocarbon receptor1. Biochimica et Biophysica Act 1444, 35-48.</p>\n\n<p>&nbsp;</p>\n\n<p>Van den Berg, M.; Birnbaum, L.; Bosveld, A.T.C.; Brunstrom, B.; Cook, P.; Feeley, M.; Giesy, J.P.; Hanberg, A.; Hasegawa, R.; Kennedy, S.W.; Kubiak, T.; Larsen, J.C.; van Leeuwen, R.X.R.; Liem, A.K.D.; Nolt, C.; Peterson, R.E.; Poellinger, L.; Safe, S.; Schrenk, D.; Tillitt, D.; Tysklind, M.; Younes, M.; Waern, F.; Zacharewski, T. Toxic equivalency factors (TEFs) for PCBs, PCDDs, PECDFs for human and wildlife. Enviro. Hlth. Persp. <strong>1998</strong>, 106, 775-792.</p>\n\n<p>&nbsp;</p>\n\n<p>Van Tiem, L.A.; Di Giulio, R.T. 2011. AHR2 knockdown prevents PAH-mediated cardiac toxicity and XRE- and ARE-associated gene induction in zebrafish (<em>Danio rerio</em>). Toxicol. Appl. Pharmacol. 254 (3), 280-287.</p>\n\n<p>&nbsp;</p>\n\n<p>Whitlock, J.P.; Okino, S.T.; Dong, L.Q.; Ko, H.S.P.; Clarke Katzenberg, R.; Qiang, M.; Li, W. 1996. Induction of cytochrome P4501A1: a model for analyzing mammalian gene transcription. Faseb. J. 10, 809-818.</p>\n\n<p>&nbsp;</p>\n\n<p>Wirgin, I.; Roy, N.K.; Loftus, M.; Chambers, R.C.; Franks, D.G.; Hahn, M.E. 2011. Mechanistic basis of resistance to PCBs in Atlantic tomcod from the Hudson River. Science. 331, 1322-1324.</p>\n\n<p>&nbsp;</p>\n\n<p>Yamauchi, M.; Kim, E.Y.; Iwata, H.; Shima, Y.; Tanabe, S. Toxic effects of 2,3,7,8-tetrachlorodibenzo-<em>p</em>-dioxin (TCDD) in developing red seabream (<em>Pagrus major</em>) embryos: an association of morphological deformities with AHR1, AHR2 and CYP1A expressions. <em>Aquat. Toxicol.</em> <strong>2006</strong>, 16, 166-179.</p>\n\n<p>&nbsp;</p>\n\n<p>Yasui, T.; Kim, E.Y.; Iawata, H.; Franks, D.G.; Karchner, S.I.; Hahn, M.E.; Tanabe, S. 2007. Functional characterization and evolutionary history of two aryl hydrocarbon receptor isoforms (AhR1 and AhR2) from avian species. Toxicol. Sci. 99 (1), 101-117.</p>\n\n<div>Hirano, M.; Hwang, JH; Park, HJ; Bak, SM; Iwata, H. and Kim, EY (2015) In Silico Analysis of the Interaction of Avian Aryl Hydrocarbon Receptors and Dioxins to Decipher Isoform-, Ligand-, and Species-Specific Activations.<cite> Environmental Science &amp; Technology</cite> <strong>49 </strong>(6): 3795-3804.DOI: 10.1021/es505733f</div>\n\n<div>&nbsp;</div>\n\n<p>Bonati, L.; Corrada, D.; Tagliabue, S.G.; Motta, S. (2017) Molecular modeling of the AhR structure and interactions can shed light on ligand-dependent activation and transformation mechanisms. <em>Current Opinion in Toxicology </em><strong>2</strong>: 42-49. https://doi.org/10.1016/j.cotox.2017.01.011.</p>\n\n<p>Sovadinov&aacute;, I. , Bl&aacute;ha, L. , Jano&scaron;ek, J. , Hilscherov&aacute;, K. , Giesy, J. P., Jones, P. D. and Holoubek, I. (2006), Cytotoxicity and aryl hydrocarbon receptormediated activity of Nheterocyclic polycyclic aromatic hydrocarbons: Structureactivity relationships. <em>Environmental Toxicology and Chemistry</em>, <strong>25</strong>: 1291-1297. doi:<a href=\"https://doi.org/10.1897/05-388R.1\">10.1897/05-388R.1</a></p>\n","biologicalOrganisationLevel":"Molecular","organTerm":{},"biologicalEvents":[{"action":"increased","process":"aryl hydrocarbon receptor activity","object":{"name":"aryl hydrocarbon receptor","source":"PR","sourceId":"PR:000003858"}}],"keyEventStressors":["Benzidine","Dibenzo-p-dioxin","Polycyclic aromatic hydrocarbons (PAHs)","Polychlorinated dibenzofurans","Hexachlorobenzene","Polychlorinated biphenyl"],"id":18}
{"title":"dimerization, AHR/ARNT","references":"<p>1. Fujii-Kuriyama, Y., and Kawajiri, K. (2010). Molecular mechanisms of the physiological functions of the aryl hydrocarbon (dioxin) receptor, a multifunctional regulator that senses and responds to environmental stimuli. Proc. Jpn. Acad. Ser. B Phys. Biol. Sci. 86(1), 40-53.</p>\n\n<p>2. Giesy, J. P., Kannan, K., Blankenship, A. L., Jones, P. D., and Newsted, J. L. (2006). Toxicology of PCBs and related compounds. In Endocrine Disruption Biological Bases for Health Effects in Wildlife and Humans (D.O.Norris and J.A.Carr, Eds.), pp. 245-331. Oxford University Press, New York.</p>\n\n<p>3. Hahn, M. E., Karchner, S. I., Evans, B. R., Franks, D. G., Merson, R. R., and Lapseritis, J. M. (2006). Unexpected diversity of aryl hydrocarbon receptors in non-mammalian vertebrates: insights from comparative genomics. J. Exp. Zool. A Comp Exp. Biol. 305(9), 693-706.</p>\n\n<p>4. Heid, S. E., Walker, M. K., and Swanson, H. I. (2001). Correlation of cardiotoxicity mediated by halogenated aromatic hydrocarbons to aryl hydrocarbon receptor activation. Toxicol. Sci 61(1), 187-196.</p>\n\n<p>5. Mimura, J., and Fujii-Kuriyama, Y. (2003). Functional role of AhR in the expression of toxic effects by TCDD. Biochimica et Biophysica Acta - General Subjects 1619(3), 263-268.</p>\n\n<p>6. Perez-Romero, P., and Imperiale, M. J. (2007). Assaying protein-DNA interactions in vivo and in vitro using chromatin immunoprecipitation and electrophoretic mobility shift assays. Methods Mol. Med. 131, 123-139.</p>\n\n<p>7. Prasch, A. L., Tanguay, R. L., Mehta, V., Heideman, W., and Peterson, R. E. (2006). Identification of zebrafish ARNT1 homologs: 2,3,7,8-tetrachlorodibenzo-p-dioxin toxicity in the developing zebrafish requires ARNT1. Mol. Pharmacol. 69(3), 776-787.</p>\n\n<p>8. Safe, S. (1994). Polychlorinated biphenyls (PCBs): Environmental impact, biochemical and toxic responses, and implications for risk assessment. Critical Reviews in Toxicology 24(2), 87-149.</p>\n\n<p>Abnet, C.C.; Tanguay, R.L.; Heideman, W.; Peterson, R.E. 1999. Transactivation activity of human, zebrafish, and rainbow trout aryl hydrocarbon receptors expressed in COS-7 cells: Greater insight into species differences in toxic potency of polychlorinated dibenzo-p-dioxin, dibenzofuran, and biphenyl congeners. Toxicol. Appl. Pharmacol<em>.</em> 159, 41-51.</p>\n\n<p>&nbsp;</p>\n\n<p>Andreasen, E.A.; Hahn, M.E.; Heideman, W.; Peterson, R.E.; Tanguay, R.L. 2002. The zebrafish (<em>Danio rerio</em>) aryl hydrocarbon receptor type 1 is a novel vertebrate receptor. Molec. Pharmacol. 62, 234-249.</p>\n\n<p>&nbsp;</p>\n\n<p>Andreasen, E.A.; Tanguay, R.L.; Peterson, R.E.; Heideman, W. 2002. Identification of a critical amino acid in the aryl hydrocarbon receptor. J. Biol. Chem. 277 (15), 13210-13218.</p>\n\n<p>&nbsp;</p>\n\n<p>Antkiewicz, D.S.; Burns, C.G.; Carney, S.A.; Peterson, R.E.; Heideman, W. 2005. Heart malformation is an early response to TCDD in embryonic zebrafish. Toxicol. Sci. 84, 368-377.</p>\n\n<p>&nbsp;</p>\n\n<p>Bak, S.M.; Lida, M.; Hirano, M.; Iwata, H.; Kim, E.Y. 2013. Potencies of red seabream AHR1- and AHR2-mediated transactivation by dioxins: implications of both AHRs in dioxin toxicity. Environ. Sci. Technol. 47 (6), 2877-2885.</p>\n\n<p>&nbsp;</p>\n\n<p>Billiard, S.M.; Hahn, M.E.; Franks, D.G.; Peterson, R.E.; Bols, N.C.; Hodson, P.V. (2002). Binding of polycyclic aromatic hydrocarbons (PAHs) to teleost aryl hydrocarbon receptors (AHRs). Comp. Biochem. Physiol. B. Biochem. Mol. Biol. 133 (1), 55-68.</p>\n\n<p>&nbsp;</p>\n\n<p>Chen, G.; Bunce, N.J. (2003). Polybrominated diphenyl ethers as Ah receptor agonists and antagonists. Toxicol. Sci. 76 (2), 310-320.</p>\n\n<p>&nbsp;</p>\n\n<p>Denison, M.S.; Heath-Pagliuso, S. The Ah receptor: a regulator of the biochemical and toxicological actions of structurally diverse chemicals. Bull. Environ. Contam. Toxicol. <strong>1998</strong>, 61 (5), 557-568.</p>\n\n<p>&nbsp;</p>\n\n<p>Doering, J.A.; Tang, S.; Peng, H.; Eisner, B.K.; Sun, J.; Giesy, J.P.; Wiseman, S.; Hecker, M. 2016. High conservation in transcriptomic and proteomic response of white sturgeon to equipotent concentrations of 2,3,7,8-TCDD, PCB 77, and benzo[a]pyrene. Enviro. Sci. Technol. 50 (9), 4826-4835.</p>\n\n<p>&nbsp;</p>\n\n<p>Doering, J.A.; Farmahin, R.; Wiseman, S.; Kennedy, S.; Giesy J.P.; Hecker, M. 2014. Functionality of aryl hydrocarbon receptors (AhR1 and AhR2) of white sturgeon (Acipenser transmontanus) and implications for the risk assessment of dioxin-like compounds. Enviro. Sci. Technol. 48, 8219-8226.</p>\n\n<p>&nbsp;</p>\n\n<p>Doering, J.A.; Farmahin, R.; Wiseman, S.; Beitel, S.C.; Kennedy, S.W.; Giesy, J.P.; Hecker, M. 2015. Differences in activation of aryl hydrocarbon receptors of white sturgeon relative to lake sturgeon are predicted by identities of key amino acids in the ligand binding domain. Enviro. Sci. Technol. 49, 4681-4689.</p>\n\n<p>&nbsp;</p>\n\n<p>Doering, J.A.; Wiseman, S; Beitel, S.C.; Giesy, J.P.; Hecker, M. 2014b. Identification and expression of aryl hydrocarbon receptors (AhR1 and AhR2) provide insight in an evolutionary context regarding sensitivity of white sturgeon (<em>Acipenser transmontanus</em>) to dioxin-like compounds. Aquat. Toxicol. 150, 27-35.</p>\n\n<p>&nbsp;</p>\n\n<p>Drutel, G.; Kathmann, M.; Heron, A.; Schwartz, J.; Arrang, J. (1996). Cloning and selective expression in brain and kidney of ARNT2 homologous to the Ah receptor nuclear translocator (ARNT). Biochem. Biophys. Res. Comm. 225 (2), 333-339.</p>\n\n<p>&nbsp;</p>\n\n<p>Farmahin, R.; Crump, D.; O&rsquo;Brien, J.M.; Jones, S.P.; Kennedy, S.W. (2016). Time-dependent transcriptomic and biochemical responses of 6-formylindolo[3,2-b]carbazole (FICZ) and 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) are explained by AHR activation time. Biochem. Pharmacol. 115 (1), 134-143.</p>\n\n<p>&nbsp;</p>\n\n<p>Farmahin, R.; Manning, G.E.; Crump, D.; Wu, D.; Mundy, L.J.; Jones, S.P.; Hahn, M.E.; Karchner, S.I.; Giesy, J.P.; Bursian, S.J.; Zwiernik, M.J.; Fredricks, T.B.; Kennedy, S.W. 2013. Amino acid sequence of the ligand-binding domain of the aryl hydrocarbon receptor 1 predicts sensitivity of wild birds to effects of dioxin-like compounds. Toxicol. Sci. 131 (1), 139-152.</p>\n\n<p>&nbsp;</p>\n\n<p>Farmahin, R.; Wu, D.; Crump, D.; Herve, J.C.; Jones, S.P.; Hahn, M.E.; Karchner, S.I.; Giesy, J.P.; Bursian, S.J.; Zwiernik, M.J.; Kennedy, S.W. 2012. Sequence and <em>in vitro </em>function of chicken, ring-necked pheasant, and Japanese quail AHR1 predict <em>in vivo </em>sensitivity to dioxins. Enviro. Sci. Toxicol. 46 (5), 2967-2975.</p>\n\n<p>&nbsp;</p>\n\n<p>Gekakis, N., Staknis, D., Nguyen, H.B., Davis, F.C., Wilsbacher, L.D., King, D.P., Takahashi, J.S., Weitz, C.J. 1998. Role of the CLOCK protein in the mammalian circadian mechanism. Science. 280, 1564-1569.</p>\n\n<p>&nbsp;</p>\n\n<p>Gu, Y.; Hogenesch, J.B.; Bradfield, C.A. 2000. The PAS superfamily: Sensors of environmental and developmental signals. Annu. Rev. Pharmacol. Toxicol. 40, 519-561.</p>\n\n<p>&nbsp;</p>\n\n<p>Hansson, M.C.; Hahn, M.E. 2008. Functional properties of the four Atlantic salmon (<em>Salmo salar</em>) aryl hydrocarbon receptor type 2 (AHR2) isoforms. Aquat. Toxicol. 86, 121-130.</p>\n\n<p>&nbsp;</p>\n\n<p>Hill, A.J.; King-Heiden, T.C.; Heideman, W.; Peterson, R.E. (2009). Potential roles of Arnt2 in zebrafish larval development. Zebrafish. 6 (1), 79-91.</p>\n\n<p>&nbsp;</p>\n\n<p>Hirose, K., Morita, M., Ema, M., Mimura, J., Hamada, H., Fujii, H., Saijo, Y., Gotoh, O., Sogawa, K., Fujii-Kuriyama, Y. 1996. cDNA cloning and tissue-specific expression of a novel basic helix-loop-helix/ PAS factor (Arnt2) with close sequence similarity to the aryl hydrocarbon nuclear translocator (Arnt). Mol. Cell. Biol. 16, 1706-1713.</p>\n\n<p>&nbsp;</p>\n\n<p>Hoffman, E.C., Reyes, H., Chu, F.F., Sander, F., Conley, L.H., Brooks, B.A., Hankinson, O. 1991. Cloning of a factor required for activity of the Ah (dioxin) receptor. Science. 252, 954-958.</p>\n\n<p>&nbsp;</p>\n\n<p>Karchner, S.I.; Powell, W.H.; Hahn, M.E. 1999. Identification and functional characterization of two highly divergent aryl hydrocarbon receptors (AHR1 and AHR2) in the Teleost <em>Fundulus heteroclitus</em>. Evidence for a novel subfamily of ligand-binding basic helix loop helix-Per-ARNT-Sim (bHLH-PAS) factors. J. Biol. Chem. 274, 33814-33824.</p>\n\n<p>&nbsp;</p>\n\n<p>Lavine, J.A.; Rowatt, A.J.; Klimova, T.; Whitington, A.J.; Dengler, E.; Beck, C.; Powell, W.H. 2005. Aryl hydrocarbon receptors in the frog Xenopus laevis: two AhR1 paralogs exhibit low affinity for 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD). Toxicol. Sci. 88 (1), 60-72.</p>\n\n<p>&nbsp;</p>\n\n<p>Lee, J., Kim, E., Iwata, H., Tanabe, S. 2007. Molecular characterization and tissue distribution of aryl hydrocarbon receptor nuclear translocator isoforms, ARNT1 and ARNT2, and identification of novel splice variants in common cormorant (<em>Phalacrocorax carbo</em>). Comp. Biochem. Physiol. C. 145, 379-393.</p>\n\n<p>&nbsp;</p>\n\n<p>Lee, J., Kim, E., Iwabuchi, H., Iwata, H. (2011). Molecular and functional characterization of aryl hydrocarbon receptor nuclear translocator 1 (ARNT1) and ARNT2 in chicken (Gallus gallus). Comp. Biochem. Physiol. C. Toxicol. Pharmacol. 153 (3), 269-279.</p>\n\n<p>&nbsp;</p>\n\n<p>Mandl, M.; Depping, R. (2014). Hypoxia-inducible aryl hydrocarbon receptor nuclear translocator (ARNT) (HIF-1B): Is it a rare exception? Mol. Med. 20 (1), 215-220.</p>\n\n<p>&nbsp;</p>\n\n<p>Murk, A.J.; Legler, J.; Denison, M.S.; Giesy, J.P.; Van De Guchte, C.; Brouwer, A. (1996). Chemical-activated luciferase gene expression (CALUX): A novel in vitro bioassay for Ah receptor active compounds in sediments and pore water. Toxicol. Sci. 33 (1), 149-160.</p>\n\n<p>&nbsp;</p>\n\n<p>Oka, K.; Kohno, S.; Ohta, Y.; Guillette, L.J.; Iguchi, T.; Katsu, Y. (2016). Molecular cloning and characterization of the aryl hydrocarbon receptors and aryl hydrocarbon receptor nuclear translocators in the American alligator. Gen. Comp. Endo. 238, 13-22.</p>\n\n<p>&nbsp;</p>\n\n<p>Powell, W.H.; Hahn, M.E. (2002). Identification and functional characterization of hypoxia-inducible factor 2a from the estuarine teleost, Fundulus heteroclitus: Interaction of HIF-2a with two ARNT2 splice variants. J. Exp. Zoo. A. 294 (1), 17-29.</p>\n\n<p>&nbsp;</p>\n\n<p>Prasch, A.L.; Tanguay, R.L.; Mehta, V.; Heideman, W.; Peterson, R.E. (2006). Identification of zebrafish ARNT1 homologs: 2,3,7,8-tetrachlorodibenzo-p-dioxin toxicity in the developing zebrafish requires ARNT1. Mol. Pharmacol. 69 (3), 776-787.</p>\n\n<p>&nbsp;</p>\n\n<p>Prasch, A.L.; Teraoka, H.; Carney, S.A.; Dong, W.; Hiraga, T.; Stegeman, J.J.; Heideman, W.; Peterson, R.E. 2003. Toxicol. Sci. Aryl hydrocarbon receptor 2 mediated 2,3,7,8-tetrachlorodibenzo-<em>p</em>-dioxin developmental toxicity in zebrafish. 76 (1), 138-150.</p>\n\n<p>&nbsp;</p>\n\n<p>Shoots, J.; Fraccalvieri, D.; Franks, D.G.; Denison, M.S.; Hahn, M.E.; Bonati, L.; Powell, W.H. 2015. An aryl hydrocarbon receptor from the salamander Ambystoma mexicanum exhibits low sensitivity to 2,3,7,8-tetrachlorodibenzo-p-dioxin. Enviro. Sci. Technol<em>. </em>49, 6993-7001.</p>\n\n<p>&nbsp;</p>\n\n<p>Tanguay, R.L.; Abnett, C.C.; Heideman, W.; Peterson, R.E. 1999. Cloning and characterization of the zebrafish (<em>Danio rerio</em>) aryl hydrocarbon receptor. Biochem. Biophys. Acta. 1444, 35-48.</p>\n\n<p>&nbsp;</p>\n\n<p>Tanguay, R.L.; Andreasen, E.; Heideman, W.; Peterson, R.E. (2000). Identification and expression of alternatively spliced aryl hydrocarbon nuclear translocator 2 (ARNT2) cDNAs from zebrafish with distinct functions. BBA. 1494 (1-2), 117-128.</p>\n\n<p>&nbsp;</p>\n\n<p>Van den Berg, M.; Birnbaum, L.; Bosveld, A.T.C.; Brunstrom, B.; Cook, P.; Feeley, M.; Giesy, J.P.; Hanberg, A.; Hasegawa, R.; Kennedy, S.W.; Kubiak, T.; Larsen, J.C.; van Leeuwen, R.X.R.; Liem, A.K.D.; Nolt, C.; Peterson, R.E.; Poellinger, L.; Safe, S.; Schrenk, D.; Tillitt, D.; Tysklind, M.; Younes, M.; Waern, F.; Zacharewski, T. Toxic equivalency factors (TEFs) for PCBs, PCDDs, PECDFs for human and wildlife. Enviro. Hlth. Persp. <strong>1998</strong>, 106, 775-792.</p>\n\n<p>&nbsp;</p>\n\n<p>Van den Berg, M.; Birnbaum, L.S.; Dension, M.; De Vito, M.; Farland, W.; Feeley, M.; Fiedler, H.; Hakansson, H.; Hanberg, A.; Haws, L.; Rose, M.; Safe, S.; Schrenk, D.; Tohyama, C.; Tritscher, A.; Tuomisto, J.; Tysklind, M.; Walker, N.; Peterson, R.E. 2006. The 2005 World Health Organization reevaluation of human and mammalian toxic equivalency factors for dioxins and dioxin-like compounds. Toxicol. Sci. 93 (2), 223-241.</p>\n\n<p>&nbsp;</p>\n\n<p>Waller, C.L.; McKinney, J.D. (1992). Comparative molecular field analysis of polyhalogenated dibenzo-p-dioixns, dibenzofurans, and biphenyls. J. Med. Chem. 35, 3660-2666.</p>\n\n<p>&nbsp;</p>\n\n<p>Waller, C.; McKinney, J. (1995). Three-dimensional quantitative structure-activity relationships of dioxins and dioxin-like compounds: model validation and Ah receptor characterization. Chem. Res. Toxicol. 8, 847-858.</p>\n\n<p>&nbsp;</p>\n\n<p>Wang, G.L., Jiang, B.H., Rue, E.A., Semenza, G.L. 1995. Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2 tension. Proc. Natl. Acad. Sci. U.S.A. 92, 5510-5514.</p>\n\n<p>&nbsp;</p>\n\n<p>Whitlock, J.P.; Okino, S.T.; Dong, L.Q.; Ko, H.S.P.; Clarke Katzenberg, R.; Qiang, M.; Li, W. 1996. Induction of cytochrome P4501A1: a model for analyzing mammalian gene transcription. Faseb. J. 10, 809-818.</p>\n\n<p>&nbsp;</p>\n\n<p>Whyte, J.J.; Jung, R.E.; Schmitt, C.J.; Tillitt, D.E. (2008). Ethoxyresorufin-O-deethylase (EROD) activity in fish as a biomarker of chemical exposure. Crit. Rev. Toxicol. 30 (4), 347-570.</p>\n\n<p>&nbsp;</p>\n\n<p>Wirgin, I.; Roy, N.K.; Loftus, M.; Chambers, R.C.; Franks, D.G.; Hahn, M.E. 2011. Mechanistic basis of resistance to PCBs in Atlantic tomcod from the Hudson River. Science. 331, 1322-1324.</p>\n\n<p>Jain, S.; Maltepe, E.; Lu, M.M.; Simon, C.; Bradfield, C.A. 1998. Expression of ARNT, ARNT2, HIF1 alpha, HIF2 alpha, and Ah receptor mRNAs in the developing mouse. Mech. Dev. 73, 117-123.</p>\n","biologicalOrganisationLevel":"Molecular","organTerm":{},"biologicalEvents":[{"action":"increased","process":"protein dimerization activity","object":{"name":"aryl hydrocarbon receptor","source":"PR","sourceId":"PR:000003858"}},{"action":"increased","process":"protein dimerization activity","object":{"name":"aryl hydrocarbon receptor nuclear translocator","source":"PR","sourceId":"PR:000004303"}}],"keyEventStressors":["Polychlorinated dibenzofurans","Stressor:147 Dibenzo-p-dioxin","2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD)","Polycyclic aromatic hydrocarbons","Polychlorinated biphenyl"],"id":944}
{"title":"dimerization, AHR/ARNT","references":"<p>1. Fujii-Kuriyama, Y., and Kawajiri, K. (2010). Molecular mechanisms of the physiological functions of the aryl hydrocarbon (dioxin) receptor, a multifunctional regulator that senses and responds to environmental stimuli. Proc. Jpn. Acad. Ser. B Phys. Biol. Sci. 86(1), 40-53.</p>\n\n<p>2. Giesy, J. P., Kannan, K., Blankenship, A. L., Jones, P. D., and Newsted, J. L. (2006). Toxicology of PCBs and related compounds. In Endocrine Disruption Biological Bases for Health Effects in Wildlife and Humans (D.O.Norris and J.A.Carr, Eds.), pp. 245-331. Oxford University Press, New York.</p>\n\n<p>3. Hahn, M. E., Karchner, S. I., Evans, B. R., Franks, D. G., Merson, R. R., and Lapseritis, J. M. (2006). Unexpected diversity of aryl hydrocarbon receptors in non-mammalian vertebrates: insights from comparative genomics. J. Exp. Zool. A Comp Exp. Biol. 305(9), 693-706.</p>\n\n<p>4. Heid, S. E., Walker, M. K., and Swanson, H. I. (2001). Correlation of cardiotoxicity mediated by halogenated aromatic hydrocarbons to aryl hydrocarbon receptor activation. Toxicol. Sci 61(1), 187-196.</p>\n\n<p>5. Mimura, J., and Fujii-Kuriyama, Y. (2003). Functional role of AhR in the expression of toxic effects by TCDD. Biochimica et Biophysica Acta - General Subjects 1619(3), 263-268.</p>\n\n<p>6. Perez-Romero, P., and Imperiale, M. J. (2007). Assaying protein-DNA interactions in vivo and in vitro using chromatin immunoprecipitation and electrophoretic mobility shift assays. Methods Mol. Med. 131, 123-139.</p>\n\n<p>7. Prasch, A. L., Tanguay, R. L., Mehta, V., Heideman, W., and Peterson, R. E. (2006). Identification of zebrafish ARNT1 homologs: 2,3,7,8-tetrachlorodibenzo-p-dioxin toxicity in the developing zebrafish requires ARNT1. Mol. Pharmacol. 69(3), 776-787.</p>\n\n<p>8. Safe, S. (1994). Polychlorinated biphenyls (PCBs): Environmental impact, biochemical and toxic responses, and implications for risk assessment. Critical Reviews in Toxicology 24(2), 87-149.</p>\n\n<p>Abnet, C.C.; Tanguay, R.L.; Heideman, W.; Peterson, R.E. 1999. Transactivation activity of human, zebrafish, and rainbow trout aryl hydrocarbon receptors expressed in COS-7 cells: Greater insight into species differences in toxic potency of polychlorinated dibenzo-p-dioxin, dibenzofuran, and biphenyl congeners. Toxicol. Appl. Pharmacol<em>.</em> 159, 41-51.</p>\n\n<p>&nbsp;</p>\n\n<p>Andreasen, E.A.; Hahn, M.E.; Heideman, W.; Peterson, R.E.; Tanguay, R.L. 2002. The zebrafish (<em>Danio rerio</em>) aryl hydrocarbon receptor type 1 is a novel vertebrate receptor. Molec. Pharmacol. 62, 234-249.</p>\n\n<p>&nbsp;</p>\n\n<p>Andreasen, E.A.; Tanguay, R.L.; Peterson, R.E.; Heideman, W. 2002. Identification of a critical amino acid in the aryl hydrocarbon receptor. J. Biol. Chem. 277 (15), 13210-13218.</p>\n\n<p>&nbsp;</p>\n\n<p>Antkiewicz, D.S.; Burns, C.G.; Carney, S.A.; Peterson, R.E.; Heideman, W. 2005. Heart malformation is an early response to TCDD in embryonic zebrafish. Toxicol. Sci. 84, 368-377.</p>\n\n<p>&nbsp;</p>\n\n<p>Bak, S.M.; Lida, M.; Hirano, M.; Iwata, H.; Kim, E.Y. 2013. Potencies of red seabream AHR1- and AHR2-mediated transactivation by dioxins: implications of both AHRs in dioxin toxicity. Environ. Sci. Technol. 47 (6), 2877-2885.</p>\n\n<p>&nbsp;</p>\n\n<p>Billiard, S.M.; Hahn, M.E.; Franks, D.G.; Peterson, R.E.; Bols, N.C.; Hodson, P.V. (2002). Binding of polycyclic aromatic hydrocarbons (PAHs) to teleost aryl hydrocarbon receptors (AHRs). Comp. Biochem. Physiol. B. Biochem. Mol. Biol. 133 (1), 55-68.</p>\n\n<p>&nbsp;</p>\n\n<p>Chen, G.; Bunce, N.J. (2003). Polybrominated diphenyl ethers as Ah receptor agonists and antagonists. Toxicol. Sci. 76 (2), 310-320.</p>\n\n<p>&nbsp;</p>\n\n<p>Denison, M.S.; Heath-Pagliuso, S. The Ah receptor: a regulator of the biochemical and toxicological actions of structurally diverse chemicals. Bull. Environ. Contam. Toxicol. <strong>1998</strong>, 61 (5), 557-568.</p>\n\n<p>&nbsp;</p>\n\n<p>Doering, J.A.; Tang, S.; Peng, H.; Eisner, B.K.; Sun, J.; Giesy, J.P.; Wiseman, S.; Hecker, M. 2016. High conservation in transcriptomic and proteomic response of white sturgeon to equipotent concentrations of 2,3,7,8-TCDD, PCB 77, and benzo[a]pyrene. Enviro. Sci. Technol. 50 (9), 4826-4835.</p>\n\n<p>&nbsp;</p>\n\n<p>Doering, J.A.; Farmahin, R.; Wiseman, S.; Kennedy, S.; Giesy J.P.; Hecker, M. 2014. Functionality of aryl hydrocarbon receptors (AhR1 and AhR2) of white sturgeon (Acipenser transmontanus) and implications for the risk assessment of dioxin-like compounds. Enviro. Sci. Technol. 48, 8219-8226.</p>\n\n<p>&nbsp;</p>\n\n<p>Doering, J.A.; Farmahin, R.; Wiseman, S.; Beitel, S.C.; Kennedy, S.W.; Giesy, J.P.; Hecker, M. 2015. Differences in activation of aryl hydrocarbon receptors of white sturgeon relative to lake sturgeon are predicted by identities of key amino acids in the ligand binding domain. Enviro. Sci. Technol. 49, 4681-4689.</p>\n\n<p>&nbsp;</p>\n\n<p>Doering, J.A.; Wiseman, S; Beitel, S.C.; Giesy, J.P.; Hecker, M. 2014b. Identification and expression of aryl hydrocarbon receptors (AhR1 and AhR2) provide insight in an evolutionary context regarding sensitivity of white sturgeon (<em>Acipenser transmontanus</em>) to dioxin-like compounds. Aquat. Toxicol. 150, 27-35.</p>\n\n<p>&nbsp;</p>\n\n<p>Drutel, G.; Kathmann, M.; Heron, A.; Schwartz, J.; Arrang, J. (1996). Cloning and selective expression in brain and kidney of ARNT2 homologous to the Ah receptor nuclear translocator (ARNT). Biochem. Biophys. Res. Comm. 225 (2), 333-339.</p>\n\n<p>&nbsp;</p>\n\n<p>Farmahin, R.; Crump, D.; O&rsquo;Brien, J.M.; Jones, S.P.; Kennedy, S.W. (2016). Time-dependent transcriptomic and biochemical responses of 6-formylindolo[3,2-b]carbazole (FICZ) and 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) are explained by AHR activation time. Biochem. Pharmacol. 115 (1), 134-143.</p>\n\n<p>&nbsp;</p>\n\n<p>Farmahin, R.; Manning, G.E.; Crump, D.; Wu, D.; Mundy, L.J.; Jones, S.P.; Hahn, M.E.; Karchner, S.I.; Giesy, J.P.; Bursian, S.J.; Zwiernik, M.J.; Fredricks, T.B.; Kennedy, S.W. 2013. Amino acid sequence of the ligand-binding domain of the aryl hydrocarbon receptor 1 predicts sensitivity of wild birds to effects of dioxin-like compounds. Toxicol. Sci. 131 (1), 139-152.</p>\n\n<p>&nbsp;</p>\n\n<p>Farmahin, R.; Wu, D.; Crump, D.; Herve, J.C.; Jones, S.P.; Hahn, M.E.; Karchner, S.I.; Giesy, J.P.; Bursian, S.J.; Zwiernik, M.J.; Kennedy, S.W. 2012. Sequence and <em>in vitro </em>function of chicken, ring-necked pheasant, and Japanese quail AHR1 predict <em>in vivo </em>sensitivity to dioxins. Enviro. Sci. Toxicol. 46 (5), 2967-2975.</p>\n\n<p>&nbsp;</p>\n\n<p>Gekakis, N., Staknis, D., Nguyen, H.B., Davis, F.C., Wilsbacher, L.D., King, D.P., Takahashi, J.S., Weitz, C.J. 1998. Role of the CLOCK protein in the mammalian circadian mechanism. Science. 280, 1564-1569.</p>\n\n<p>&nbsp;</p>\n\n<p>Gu, Y.; Hogenesch, J.B.; Bradfield, C.A. 2000. The PAS superfamily: Sensors of environmental and developmental signals. Annu. Rev. Pharmacol. Toxicol. 40, 519-561.</p>\n\n<p>&nbsp;</p>\n\n<p>Hansson, M.C.; Hahn, M.E. 2008. Functional properties of the four Atlantic salmon (<em>Salmo salar</em>) aryl hydrocarbon receptor type 2 (AHR2) isoforms. Aquat. Toxicol. 86, 121-130.</p>\n\n<p>&nbsp;</p>\n\n<p>Hill, A.J.; King-Heiden, T.C.; Heideman, W.; Peterson, R.E. (2009). Potential roles of Arnt2 in zebrafish larval development. Zebrafish. 6 (1), 79-91.</p>\n\n<p>&nbsp;</p>\n\n<p>Hirose, K., Morita, M., Ema, M., Mimura, J., Hamada, H., Fujii, H., Saijo, Y., Gotoh, O., Sogawa, K., Fujii-Kuriyama, Y. 1996. cDNA cloning and tissue-specific expression of a novel basic helix-loop-helix/ PAS factor (Arnt2) with close sequence similarity to the aryl hydrocarbon nuclear translocator (Arnt). Mol. Cell. Biol. 16, 1706-1713.</p>\n\n<p>&nbsp;</p>\n\n<p>Hoffman, E.C., Reyes, H., Chu, F.F., Sander, F., Conley, L.H., Brooks, B.A., Hankinson, O. 1991. Cloning of a factor required for activity of the Ah (dioxin) receptor. Science. 252, 954-958.</p>\n\n<p>&nbsp;</p>\n\n<p>Karchner, S.I.; Powell, W.H.; Hahn, M.E. 1999. Identification and functional characterization of two highly divergent aryl hydrocarbon receptors (AHR1 and AHR2) in the Teleost <em>Fundulus heteroclitus</em>. Evidence for a novel subfamily of ligand-binding basic helix loop helix-Per-ARNT-Sim (bHLH-PAS) factors. J. Biol. Chem. 274, 33814-33824.</p>\n\n<p>&nbsp;</p>\n\n<p>Lavine, J.A.; Rowatt, A.J.; Klimova, T.; Whitington, A.J.; Dengler, E.; Beck, C.; Powell, W.H. 2005. Aryl hydrocarbon receptors in the frog Xenopus laevis: two AhR1 paralogs exhibit low affinity for 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD). Toxicol. Sci. 88 (1), 60-72.</p>\n\n<p>&nbsp;</p>\n\n<p>Lee, J., Kim, E., Iwata, H., Tanabe, S. 2007. Molecular characterization and tissue distribution of aryl hydrocarbon receptor nuclear translocator isoforms, ARNT1 and ARNT2, and identification of novel splice variants in common cormorant (<em>Phalacrocorax carbo</em>). Comp. Biochem. Physiol. C. 145, 379-393.</p>\n\n<p>&nbsp;</p>\n\n<p>Lee, J., Kim, E., Iwabuchi, H., Iwata, H. (2011). Molecular and functional characterization of aryl hydrocarbon receptor nuclear translocator 1 (ARNT1) and ARNT2 in chicken (Gallus gallus). Comp. Biochem. Physiol. C. Toxicol. Pharmacol. 153 (3), 269-279.</p>\n\n<p>&nbsp;</p>\n\n<p>Mandl, M.; Depping, R. (2014). Hypoxia-inducible aryl hydrocarbon receptor nuclear translocator (ARNT) (HIF-1B): Is it a rare exception? Mol. Med. 20 (1), 215-220.</p>\n\n<p>&nbsp;</p>\n\n<p>Murk, A.J.; Legler, J.; Denison, M.S.; Giesy, J.P.; Van De Guchte, C.; Brouwer, A. (1996). Chemical-activated luciferase gene expression (CALUX): A novel in vitro bioassay for Ah receptor active compounds in sediments and pore water. Toxicol. Sci. 33 (1), 149-160.</p>\n\n<p>&nbsp;</p>\n\n<p>Oka, K.; Kohno, S.; Ohta, Y.; Guillette, L.J.; Iguchi, T.; Katsu, Y. (2016). Molecular cloning and characterization of the aryl hydrocarbon receptors and aryl hydrocarbon receptor nuclear translocators in the American alligator. Gen. Comp. Endo. 238, 13-22.</p>\n\n<p>&nbsp;</p>\n\n<p>Powell, W.H.; Hahn, M.E. (2002). Identification and functional characterization of hypoxia-inducible factor 2a from the estuarine teleost, Fundulus heteroclitus: Interaction of HIF-2a with two ARNT2 splice variants. J. Exp. Zoo. A. 294 (1), 17-29.</p>\n\n<p>&nbsp;</p>\n\n<p>Prasch, A.L.; Tanguay, R.L.; Mehta, V.; Heideman, W.; Peterson, R.E. (2006). Identification of zebrafish ARNT1 homologs: 2,3,7,8-tetrachlorodibenzo-p-dioxin toxicity in the developing zebrafish requires ARNT1. Mol. Pharmacol. 69 (3), 776-787.</p>\n\n<p>&nbsp;</p>\n\n<p>Prasch, A.L.; Teraoka, H.; Carney, S.A.; Dong, W.; Hiraga, T.; Stegeman, J.J.; Heideman, W.; Peterson, R.E. 2003. Toxicol. Sci. Aryl hydrocarbon receptor 2 mediated 2,3,7,8-tetrachlorodibenzo-<em>p</em>-dioxin developmental toxicity in zebrafish. 76 (1), 138-150.</p>\n\n<p>&nbsp;</p>\n\n<p>Shoots, J.; Fraccalvieri, D.; Franks, D.G.; Denison, M.S.; Hahn, M.E.; Bonati, L.; Powell, W.H. 2015. An aryl hydrocarbon receptor from the salamander Ambystoma mexicanum exhibits low sensitivity to 2,3,7,8-tetrachlorodibenzo-p-dioxin. Enviro. Sci. Technol<em>. </em>49, 6993-7001.</p>\n\n<p>&nbsp;</p>\n\n<p>Tanguay, R.L.; Abnett, C.C.; Heideman, W.; Peterson, R.E. 1999. Cloning and characterization of the zebrafish (<em>Danio rerio</em>) aryl hydrocarbon receptor. Biochem. Biophys. Acta. 1444, 35-48.</p>\n\n<p>&nbsp;</p>\n\n<p>Tanguay, R.L.; Andreasen, E.; Heideman, W.; Peterson, R.E. (2000). Identification and expression of alternatively spliced aryl hydrocarbon nuclear translocator 2 (ARNT2) cDNAs from zebrafish with distinct functions. BBA. 1494 (1-2), 117-128.</p>\n\n<p>&nbsp;</p>\n\n<p>Van den Berg, M.; Birnbaum, L.; Bosveld, A.T.C.; Brunstrom, B.; Cook, P.; Feeley, M.; Giesy, J.P.; Hanberg, A.; Hasegawa, R.; Kennedy, S.W.; Kubiak, T.; Larsen, J.C.; van Leeuwen, R.X.R.; Liem, A.K.D.; Nolt, C.; Peterson, R.E.; Poellinger, L.; Safe, S.; Schrenk, D.; Tillitt, D.; Tysklind, M.; Younes, M.; Waern, F.; Zacharewski, T. Toxic equivalency factors (TEFs) for PCBs, PCDDs, PECDFs for human and wildlife. Enviro. Hlth. Persp. <strong>1998</strong>, 106, 775-792.</p>\n\n<p>&nbsp;</p>\n\n<p>Van den Berg, M.; Birnbaum, L.S.; Dension, M.; De Vito, M.; Farland, W.; Feeley, M.; Fiedler, H.; Hakansson, H.; Hanberg, A.; Haws, L.; Rose, M.; Safe, S.; Schrenk, D.; Tohyama, C.; Tritscher, A.; Tuomisto, J.; Tysklind, M.; Walker, N.; Peterson, R.E. 2006. The 2005 World Health Organization reevaluation of human and mammalian toxic equivalency factors for dioxins and dioxin-like compounds. Toxicol. Sci. 93 (2), 223-241.</p>\n\n<p>&nbsp;</p>\n\n<p>Waller, C.L.; McKinney, J.D. (1992). Comparative molecular field analysis of polyhalogenated dibenzo-p-dioixns, dibenzofurans, and biphenyls. J. Med. Chem. 35, 3660-2666.</p>\n\n<p>&nbsp;</p>\n\n<p>Waller, C.; McKinney, J. (1995). Three-dimensional quantitative structure-activity relationships of dioxins and dioxin-like compounds: model validation and Ah receptor characterization. Chem. Res. Toxicol. 8, 847-858.</p>\n\n<p>&nbsp;</p>\n\n<p>Wang, G.L., Jiang, B.H., Rue, E.A., Semenza, G.L. 1995. Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2 tension. Proc. Natl. Acad. Sci. U.S.A. 92, 5510-5514.</p>\n\n<p>&nbsp;</p>\n\n<p>Whitlock, J.P.; Okino, S.T.; Dong, L.Q.; Ko, H.S.P.; Clarke Katzenberg, R.; Qiang, M.; Li, W. 1996. Induction of cytochrome P4501A1: a model for analyzing mammalian gene transcription. Faseb. J. 10, 809-818.</p>\n\n<p>&nbsp;</p>\n\n<p>Whyte, J.J.; Jung, R.E.; Schmitt, C.J.; Tillitt, D.E. (2008). Ethoxyresorufin-O-deethylase (EROD) activity in fish as a biomarker of chemical exposure. Crit. Rev. Toxicol. 30 (4), 347-570.</p>\n\n<p>&nbsp;</p>\n\n<p>Wirgin, I.; Roy, N.K.; Loftus, M.; Chambers, R.C.; Franks, D.G.; Hahn, M.E. 2011. Mechanistic basis of resistance to PCBs in Atlantic tomcod from the Hudson River. Science. 331, 1322-1324.</p>\n\n<p>Jain, S.; Maltepe, E.; Lu, M.M.; Simon, C.; Bradfield, C.A. 1998. Expression of ARNT, ARNT2, HIF1 alpha, HIF2 alpha, and Ah receptor mRNAs in the developing mouse. Mech. Dev. 73, 117-123.</p>\n","biologicalOrganisationLevel":"Molecular","organTerm":{},"biologicalEvents":[{"action":"increased","process":"protein dimerization activity","object":{"name":"aryl hydrocarbon receptor","source":"PR","sourceId":"PR:000003858"}},{"action":"increased","process":"protein dimerization activity","object":{"name":"aryl hydrocarbon receptor nuclear translocator","source":"PR","sourceId":"PR:000004303"}}],"keyEventStressors":["Polychlorinated dibenzofurans","Stressor:147 Dibenzo-p-dioxin","2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD)","Polycyclic aromatic hydrocarbons","Polychlorinated biphenyl"],"id":944}
{"title":"Altered, Cardiovascular development/function","references":"<p><br />\n1. Carro, T., Dean, K., and Ottinger, M. A. (2013a). Effects of an environmentally relevant polychlorinated biphenyl (PCB) mixture on embryonic survival and cardiac development in the domestic chicken. Environ. Toxicol. Chem. 23(6), 1325-1331.</p>\n\n<p>2. Carro, T., Taneyhill, L. A., and Ottinger, M. A. (2013b). The effects of an environmentally relevant 58 congener polychlorinated biphenyl (PCB) mixture on cardiac development in the chick embryo. Environ. Toxicol. Chem.</p>\n\n<p>3. DeWitt, J. C., Millsap, D. S., Yeager, R. L., Heise, S. S., Sparks, D. W., and Henshel, D. S. (2006). External heart deformities in passerine birds exposed to environmental mixtures of polychlorinated biphenyls during development. Environ. Toxicol. Chem. 25(2), 541-551.</p>\n\n<p>4. Heid, S. E., Walker, M. K., and Swanson, H. I. (2001). Correlation of cardiotoxicity mediated by halogenated aromatic hydrocarbons to aryl hydrocarbon receptor activation. Toxicol. Sci 61(1), 187-196.</p>\n\n<p>5. Walker, M. K., and Catron, T. F. (2000). Characterization of cardiotoxicity induced by 2,3,7,8-tetrachlorodibenzo-p-dioxin and related chemicals during early chick embryo development. Toxicol. Appl. Pharmacol. 167(3), 210-221.</p>\n\n<p>6. Walker, M. K., Pollenz, R. S., and Smith, S. M. (1997). Expression of the aryl hydrocarbon receptor (AhR) and AhR nuclear translocator during chick cardiogenesis is consistent with 2,3,7,8-tetrachlorodibenzo-p-dioxin-induced heart defects. Toxicol. Appl. Pharmacol. 143(2), 407-419.</p>\n\n<p>7. Kopf, P. G., and Walker, M. K. (2009). Overview of developmental heart defects by dioxins, PCBs, and pesticides. J. Environ. Sci. Health C. Environ. Carcinog. Ecotoxicol. Rev. 27(4), 276-285.</p>\n\n<p>Bishopric, N.H. (2005). Evolution of the heart from bacteria to man. Ann. N. Y. Acad. Sci. 1047, 13-29.</p>\n\n<p>&nbsp;</p>\n\n<p>Buckler J.; Candrl, J.S.; McKee, M.J.; Papoulias, D.M.; Tillitt, D.E.; Galat, D.L. Sensitivity of shovelnose sturgeon (<em>Scaphirhynchus platorynchus</em>) and pallid sturgeon (<em>S. albus</em>) early life stages to PCB-126 and 2,3,7,8-TCDD exposure. <em>Enviro. Toxicol. Chem. </em><strong>2015</strong>, 34(6), 1417-1424.</p>\n\n<p>&nbsp;</p>\n\n<p>Carney, S.A.; Prasch, A.L.; Heideman, W.; Peterson, R.E. 2006. Understanding dioxin developmental toxicity using the zebrafish model. Birth Defects Research. A. 76, 7-18.</p>\n\n<p>&nbsp;</p>\n\n<p>Cohen-Barnhouse, A.M.; Zwiernik, M.J.; Link, J.E.; Fitzgerald, S.D.; Kennedy, S.W.; Herve, J.C.; Giesy, J.P.; Wiseman, S.; Yang, Y.; Jones, P.D.; Yi, W.; Collins, B.; Newsted, J.L.; Kay, D.; Bursian, S.J. 2011. Sensitivity of Japanese quail (<em>Coturnix japonica</em>), common pheasant (<em>Phasianus colchicus</em>), and white leghorn chicken (<em>Gallus gallus domesticus</em>) embryos to <em>in ovo</em> exposure to TCDD, PeCDF, and TCDF. Toxicol. Sci. 119, 93-102.</p>\n\n<p>&nbsp;</p>\n\n<p>Elonen, G.E.; Spehar, R.L.; Holcombe, G.W.; Johnson, R.D.; Fernandez, J.D.; Erickson, R.J.; Tietge, J.E.; Cook, P.M. Comparative toxicity of 2,3,7,8-tetrachlorodibenzo-<em>p</em>-dioxin to seven freshwater fish species during early life-stage development.<em> Enviro. Toxico. Chem. </em><strong>1998</strong>, 17, 472-483.</p>\n\n<p>&nbsp;</p>\n\n<p>Goldstone, H.M.H.; Stegeman, J.J. (2008). Molecular mechanisms of 2,3,7,8-tetrachlorodibenzo-p-dioxin cardiovascular embryotoxicity. Drug. Metab. Rev. 38, 261-289.</p>\n\n<p>&nbsp;</p>\n\n<p>Heid, S.E.; Walker, M.K.; Swanson, H.I. (2001). Correlation of cardiotoxicity mediated by halogenated aromatic hydrocarbons to aryl hydrocarbon receptor activation. Toxicol. Sci. 61 (1), 187-196.</p>\n\n<p>&nbsp;</p>\n\n<p>Huang, L.; Wang, C.; Zhang, Y.; Li, J.; Zhong, Y.; Zhou, Y.; Chen, Y.; Zuo, Z. (2012). Benzo[a]pyrene exposure influences the cardiac development and the expression of cardiovascular relative genes in zebrafish (Daniorerio) embryos. Chemosphere. 87 (4), 369-375.</p>\n\n<p>&nbsp;</p>\n\n<p>Johnson, R.D.; Tietge, J.E.; Jensen, K.M.; Fernandez, J.D.; Linnum, A.L.; Lothenbach, D.B.; Holcombe, G.W.; Cook, P.M.; Christ, S.A.; Lattier, D.L.; Gordon, D.A. Toxicity of 2,3,7,8-tetrachlorodibenzo-<em>p</em>-dioxin to early life stage brooke trout (<em>Salvelinus fontinalis</em>) following parental dietary exposure. <em>Enviro. Toxicol. Chem.</em> <strong>1998</strong>, 17 (12), 2408-2421.</p>\n\n<p>&nbsp;</p>\n\n<p>Kardong, K.V. (2006). Vertebrates: comparative anatomy, function, evolution. McGraw-Hill Higher Eduction. Boston, USA.</p>\n\n<p>&nbsp;</p>\n\n<p>Lemly, A.D. (2002). Symptoms and implications of selenium toxicity in fish: the Belews Lake case example. Aquat. Toxicol. 57 (1-2), 39-49.</p>\n\n<p>&nbsp;</p>\n\n<p>Park, Y.J.; Lee, M.J.; Kim, H.R.; Chung, K.H.; Oh, S.M. Developmental toxicity of 2,3,7,8-tetrachlorodibenzo-p-dioxin in artificially fertilized crucian carp (Carassius auratus) embryo. <em>Sci. Totl. Enviro.</em> <strong>2014</strong>, 491-492, 271-278.</p>\n\n<p>Teraoka, H.; Dong, W.; Hiraga, T. (2003). Zebrafish as a novel experimental model for development toxicology. Congenit. Anom. 43, 123-132.</p>\n\n<p>&nbsp;</p>\n\n<p>Teraoka, T.; Dong, W.; Ogawa, S.; Tsukiyama, S.; Okuhara, Y.; Niiyama, M.; Ueno, N.; Peterson, R.E. (2002). 2,3,7,8-tetrachlorodibenzo-p-dioxin toxicity in the zebrafish embryo: Altered regional blood flow and impaired lower jaw development. Toxicol. Sci. 65, 192-199.</p>\n\n<p>&nbsp;</p>\n\n<p>Tillitt, D.E.; Buckler, J.A.; Nicks, D.K.; Candrl, J.S.; Claunch, R.A.; Gale, R.W.; Puglis, H.J.; Little, E.E.; Linbo, T.L.; Baker, M. Sensitivity of lake sturgeon (Acipenser fulvescens) early life stages to 2,3,7,8-tetrachlorodibenzo-p-dioxin and 3,3&rsquo;,4,4&rsquo;,5-pentachlorobiphenyl. 2015. Enviro. Toxicol. Chem. DOI: 10.1002/etc.3614.</p>\n\n<p>&nbsp;</p>\n\n<p>Toomey, B.H.; Bello, S.; Hahn, M.E.; Cantrell, S.; Wright, P.; Tillitt, D.; Di Giulio, R.T. TCDD induces apoptotic cell death and cytochrome P4501A expression in developing <em>Fundulus heteroclitus</em> embryos. <em>Aquat. Toxicol.</em> <strong>2001</strong>, 53, 127-138.</p>\n\n<p>&nbsp;</p>\n\n<p>Walker, M.K.; Spitsbergen, J.M.; Olson, J.R.; Peterson, R.E. 2,3,7,8-tetrachlorodibenzo-para-dioxin (TCDD) toxicity during early life stage development of lake trout (<em>Salvelinus namaycush</em>). <em>Canad. J. Fisheries Aqua. Sci.</em> <strong>1991</strong>, 48, 875-883.</p>\n\n<p>&nbsp;</p>\n\n<p>Yamauchi, M.; Kim, E.Y.; Iwata, H.; Shima, Y.; Tanabe, S. Toxic effects of 2,3,7,8-tetrachlorodibenzo-<em>p</em>-dioxin (TCDD) in developing red seabream (<em>Pagrus major</em>) embryos: an association of morphological deformities with AHR1, AHR2 and CYP1A expressions. <em>Aquat. Toxicol.</em> <strong>2006</strong>, 16, 166-179.</p>\n\n<p>&nbsp;</p>\n\n<p>Zabel, E.W; Cook, P.M.; Peterson, R.E. Toxic equivalency factors of polychlorinated dibenzo-p-dioxin, dibenzofuran and biphenyl congeners based on early-life stage mortality in rainbow trout (Oncorhynchus mykiss). Aquat Toxicol. <strong>1995</strong>. 31, 315-328.</p>\n","biologicalOrganisationLevel":"Organ","organTerm":{"name":"heart","sourceId":"UBERON:0000948"},"biologicalEvents":[{"action":"morphological change","process":"abnormal cardiovascular system physiology","object":{}},{"action":"abnormal","process":"cardiovascular system development","object":{"name":"cardiovascular system","source":"UBERON","sourceId":"UBERON:0004535"}}],"keyEventStressors":["2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD)"],"id":317}
{"title":"Altered, Cardiovascular development/function","references":"<p><br />\n1. Carro, T., Dean, K., and Ottinger, M. A. (2013a). Effects of an environmentally relevant polychlorinated biphenyl (PCB) mixture on embryonic survival and cardiac development in the domestic chicken. Environ. Toxicol. Chem. 23(6), 1325-1331.</p>\n\n<p>2. Carro, T., Taneyhill, L. A., and Ottinger, M. A. (2013b). The effects of an environmentally relevant 58 congener polychlorinated biphenyl (PCB) mixture on cardiac development in the chick embryo. Environ. Toxicol. Chem.</p>\n\n<p>3. DeWitt, J. C., Millsap, D. S., Yeager, R. L., Heise, S. S., Sparks, D. W., and Henshel, D. S. (2006). External heart deformities in passerine birds exposed to environmental mixtures of polychlorinated biphenyls during development. Environ. Toxicol. Chem. 25(2), 541-551.</p>\n\n<p>4. Heid, S. E., Walker, M. K., and Swanson, H. I. (2001). Correlation of cardiotoxicity mediated by halogenated aromatic hydrocarbons to aryl hydrocarbon receptor activation. Toxicol. Sci 61(1), 187-196.</p>\n\n<p>5. Walker, M. K., and Catron, T. F. (2000). Characterization of cardiotoxicity induced by 2,3,7,8-tetrachlorodibenzo-p-dioxin and related chemicals during early chick embryo development. Toxicol. Appl. Pharmacol. 167(3), 210-221.</p>\n\n<p>6. Walker, M. K., Pollenz, R. S., and Smith, S. M. (1997). Expression of the aryl hydrocarbon receptor (AhR) and AhR nuclear translocator during chick cardiogenesis is consistent with 2,3,7,8-tetrachlorodibenzo-p-dioxin-induced heart defects. Toxicol. Appl. Pharmacol. 143(2), 407-419.</p>\n\n<p>7. Kopf, P. G., and Walker, M. K. (2009). Overview of developmental heart defects by dioxins, PCBs, and pesticides. J. Environ. Sci. Health C. Environ. Carcinog. Ecotoxicol. Rev. 27(4), 276-285.</p>\n\n<p>Bishopric, N.H. (2005). Evolution of the heart from bacteria to man. Ann. N. Y. Acad. Sci. 1047, 13-29.</p>\n\n<p>&nbsp;</p>\n\n<p>Buckler J.; Candrl, J.S.; McKee, M.J.; Papoulias, D.M.; Tillitt, D.E.; Galat, D.L. Sensitivity of shovelnose sturgeon (<em>Scaphirhynchus platorynchus</em>) and pallid sturgeon (<em>S. albus</em>) early life stages to PCB-126 and 2,3,7,8-TCDD exposure. <em>Enviro. Toxicol. Chem. </em><strong>2015</strong>, 34(6), 1417-1424.</p>\n\n<p>&nbsp;</p>\n\n<p>Carney, S.A.; Prasch, A.L.; Heideman, W.; Peterson, R.E. 2006. Understanding dioxin developmental toxicity using the zebrafish model. Birth Defects Research. A. 76, 7-18.</p>\n\n<p>&nbsp;</p>\n\n<p>Cohen-Barnhouse, A.M.; Zwiernik, M.J.; Link, J.E.; Fitzgerald, S.D.; Kennedy, S.W.; Herve, J.C.; Giesy, J.P.; Wiseman, S.; Yang, Y.; Jones, P.D.; Yi, W.; Collins, B.; Newsted, J.L.; Kay, D.; Bursian, S.J. 2011. Sensitivity of Japanese quail (<em>Coturnix japonica</em>), common pheasant (<em>Phasianus colchicus</em>), and white leghorn chicken (<em>Gallus gallus domesticus</em>) embryos to <em>in ovo</em> exposure to TCDD, PeCDF, and TCDF. Toxicol. Sci. 119, 93-102.</p>\n\n<p>&nbsp;</p>\n\n<p>Elonen, G.E.; Spehar, R.L.; Holcombe, G.W.; Johnson, R.D.; Fernandez, J.D.; Erickson, R.J.; Tietge, J.E.; Cook, P.M. Comparative toxicity of 2,3,7,8-tetrachlorodibenzo-<em>p</em>-dioxin to seven freshwater fish species during early life-stage development.<em> Enviro. Toxico. Chem. </em><strong>1998</strong>, 17, 472-483.</p>\n\n<p>&nbsp;</p>\n\n<p>Goldstone, H.M.H.; Stegeman, J.J. (2008). Molecular mechanisms of 2,3,7,8-tetrachlorodibenzo-p-dioxin cardiovascular embryotoxicity. Drug. Metab. Rev. 38, 261-289.</p>\n\n<p>&nbsp;</p>\n\n<p>Heid, S.E.; Walker, M.K.; Swanson, H.I. (2001). Correlation of cardiotoxicity mediated by halogenated aromatic hydrocarbons to aryl hydrocarbon receptor activation. Toxicol. Sci. 61 (1), 187-196.</p>\n\n<p>&nbsp;</p>\n\n<p>Huang, L.; Wang, C.; Zhang, Y.; Li, J.; Zhong, Y.; Zhou, Y.; Chen, Y.; Zuo, Z. (2012). Benzo[a]pyrene exposure influences the cardiac development and the expression of cardiovascular relative genes in zebrafish (Daniorerio) embryos. Chemosphere. 87 (4), 369-375.</p>\n\n<p>&nbsp;</p>\n\n<p>Johnson, R.D.; Tietge, J.E.; Jensen, K.M.; Fernandez, J.D.; Linnum, A.L.; Lothenbach, D.B.; Holcombe, G.W.; Cook, P.M.; Christ, S.A.; Lattier, D.L.; Gordon, D.A. Toxicity of 2,3,7,8-tetrachlorodibenzo-<em>p</em>-dioxin to early life stage brooke trout (<em>Salvelinus fontinalis</em>) following parental dietary exposure. <em>Enviro. Toxicol. Chem.</em> <strong>1998</strong>, 17 (12), 2408-2421.</p>\n\n<p>&nbsp;</p>\n\n<p>Kardong, K.V. (2006). Vertebrates: comparative anatomy, function, evolution. McGraw-Hill Higher Eduction. Boston, USA.</p>\n\n<p>&nbsp;</p>\n\n<p>Lemly, A.D. (2002). Symptoms and implications of selenium toxicity in fish: the Belews Lake case example. Aquat. Toxicol. 57 (1-2), 39-49.</p>\n\n<p>&nbsp;</p>\n\n<p>Park, Y.J.; Lee, M.J.; Kim, H.R.; Chung, K.H.; Oh, S.M. Developmental toxicity of 2,3,7,8-tetrachlorodibenzo-p-dioxin in artificially fertilized crucian carp (Carassius auratus) embryo. <em>Sci. Totl. Enviro.</em> <strong>2014</strong>, 491-492, 271-278.</p>\n\n<p>Teraoka, H.; Dong, W.; Hiraga, T. (2003). Zebrafish as a novel experimental model for development toxicology. Congenit. Anom. 43, 123-132.</p>\n\n<p>&nbsp;</p>\n\n<p>Teraoka, T.; Dong, W.; Ogawa, S.; Tsukiyama, S.; Okuhara, Y.; Niiyama, M.; Ueno, N.; Peterson, R.E. (2002). 2,3,7,8-tetrachlorodibenzo-p-dioxin toxicity in the zebrafish embryo: Altered regional blood flow and impaired lower jaw development. Toxicol. Sci. 65, 192-199.</p>\n\n<p>&nbsp;</p>\n\n<p>Tillitt, D.E.; Buckler, J.A.; Nicks, D.K.; Candrl, J.S.; Claunch, R.A.; Gale, R.W.; Puglis, H.J.; Little, E.E.; Linbo, T.L.; Baker, M. Sensitivity of lake sturgeon (Acipenser fulvescens) early life stages to 2,3,7,8-tetrachlorodibenzo-p-dioxin and 3,3&rsquo;,4,4&rsquo;,5-pentachlorobiphenyl. 2015. Enviro. Toxicol. Chem. DOI: 10.1002/etc.3614.</p>\n\n<p>&nbsp;</p>\n\n<p>Toomey, B.H.; Bello, S.; Hahn, M.E.; Cantrell, S.; Wright, P.; Tillitt, D.; Di Giulio, R.T. TCDD induces apoptotic cell death and cytochrome P4501A expression in developing <em>Fundulus heteroclitus</em> embryos. <em>Aquat. Toxicol.</em> <strong>2001</strong>, 53, 127-138.</p>\n\n<p>&nbsp;</p>\n\n<p>Walker, M.K.; Spitsbergen, J.M.; Olson, J.R.; Peterson, R.E. 2,3,7,8-tetrachlorodibenzo-para-dioxin (TCDD) toxicity during early life stage development of lake trout (<em>Salvelinus namaycush</em>). <em>Canad. J. Fisheries Aqua. Sci.</em> <strong>1991</strong>, 48, 875-883.</p>\n\n<p>&nbsp;</p>\n\n<p>Yamauchi, M.; Kim, E.Y.; Iwata, H.; Shima, Y.; Tanabe, S. Toxic effects of 2,3,7,8-tetrachlorodibenzo-<em>p</em>-dioxin (TCDD) in developing red seabream (<em>Pagrus major</em>) embryos: an association of morphological deformities with AHR1, AHR2 and CYP1A expressions. <em>Aquat. Toxicol.</em> <strong>2006</strong>, 16, 166-179.</p>\n\n<p>&nbsp;</p>\n\n<p>Zabel, E.W; Cook, P.M.; Peterson, R.E. Toxic equivalency factors of polychlorinated dibenzo-p-dioxin, dibenzofuran and biphenyl congeners based on early-life stage mortality in rainbow trout (Oncorhynchus mykiss). Aquat Toxicol. <strong>1995</strong>. 31, 315-328.</p>\n","biologicalOrganisationLevel":"Organ","organTerm":{"name":"heart","sourceId":"UBERON:0000948"},"biologicalEvents":[{"action":"morphological change","process":"abnormal cardiovascular system physiology","object":{}},{"action":"abnormal","process":"cardiovascular system development","object":{"name":"cardiovascular system","source":"UBERON","sourceId":"UBERON:0004535"}}],"keyEventStressors":["2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD)"],"id":317}
{"title":"Increase, COX-2 expression","references":"<p>Bacchi, S., Palumbo, P., Sponta, A., &amp; Coppolino, M. F. (2012). Clinical pharmacology of non-steroidal anti-inflammatory drugs: a review. Anti-Inflammatory &amp; Anti-Allergy Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry-Anti-Inflammatory and Anti-Allergy Agents), 11(1), 52-64.</p>\n\n<p>&nbsp;</p>\n\n<p>Botting, R. M., &amp; Botting, J. H. (2011). C14 Non-steroidal anti-inflammatory drugs. In Principles of Immunopharmacology (pp. 573-584). Birkh&auml;user Basel.</p>\n\n<p>&nbsp;</p>\n\n<p>Chien, P.; Lin, C.; Hsiao, L.; Yang, C. (2015). c-SRC/Pyk2/EGFR/PI3K/Akt/CREB-activated pathway contributes to human cardiomyocyte hypertrophy: Role of COX-2 induction. Mol. Cell. Endocrin. 409. 59-72.</p>\n\n<p>&nbsp;</p>\n\n<p>Chandrasekharan, N. V., Dai, H., Roos, K. L. T., Evanson, N. K., Tomsik, J., Elton, T. S., &amp; Simmons, D. L. (2002). COX-3, a cyclooxygenase-1 variant inhibited by acetaminophen and other analgesic/antipyretic drugs: cloning, structure, and expression. Proceedings of the National Academy of Sciences,99(21), 13926-13931.</p>\n\n<p>&nbsp;</p>\n\n<p>Crofford, L.J. (1997). COX-1 and COX-2 tissue expression: implications and predictions. J. Rheumatol. Suppl. 49, 15-90.</p>\n\n<p>&nbsp;</p>\n\n<p>Degner, S.C.; Kemp, M.Q.; Hockings, J.K.; Romagnolo, D.F. (2007). Cyclooxygenase-2 promoter activation by the aromatic hydrocarbon receptor in breast cancer MCF-7 cells: Repressive effects of conjugated linoleic acid. Nutri. Canc. 56 (2), 248-257.</p>\n\n<p>&nbsp;</p>\n\n<p>Delgado R.; Newar, M.; Zewail, A.; Kar, B.; Vaughn, W.; Wu, K.; Aleksic, N,; Sivasubramanian, N.; McKay, K.; Mann, D. (2004). Cyclooxygenase-2 inhibitor treatment improves left ventricle function and mortality in a murine model of doxorubicin-induced heart failure. Circulation. 109, 1428-1433.</p>\n\n<p>&nbsp;</p>\n\n<p>Dong, W.; Matsumura, F.; Kullman, S.W. (2010). TCDD induced pericardial edema and relative COX-2 expression in medaka (Oryzias latipes) embryos. Toxicol. Sci. 118 (1), 213-223.</p>\n\n<p>&nbsp;</p>\n\n<p>Fujisaw, N.; Nakayama, S.M.M.; Ikenaka, Y.; Ishizuka, M. 2014. TCDD-induced chick cardiotoxicity is abolished by a selective cyclooxygenase-2 (COX-2) inhibitor NS398. Arch. Toxicol. 88, 1739-1748.</p>\n\n<p>&nbsp;</p>\n\n<p>Gullestad, L.; Aukrust, P. (2005). Review of trials in chronic heart failure showing broad-spectrum anti-inflammatory approaches. Am. J. Cardiol. 95, 17C-23C; discussion 38C-40C.</p>\n\n<p>&nbsp;</p>\n\n<p>Havird, J. C., Kocot, K. M., Brannock, P. M., Cannon, J. T., Waits, D. S., Weese, D. A., ... &amp; Halanych, K. M. (2015). Reconstruction of Cyclooxygenase Evolution in Animals Suggests Variable, Lineage-Specific Duplications, and Homologs with Low Sequence Identity. Journal of molecular evolution, 1-16.</p>\n\n<p>&nbsp;</p>\n\n<p>Havird, J. C., Miyamoto, M. M., Choe, K. P., &amp; Evans, D. H. (2008). Gene duplications and losses within the cyclooxygenase family of teleosts and other chordates. Molecular biology and evolution, 25(11), 2349-2359.</p>\n\n<p>&nbsp;</p>\n\n<p>Hocherl, K.; Dreher, F.; Kurtz, A.; Bucher, M. (2002). Cyclooxygenase-2 inhibition attenuates liposaccaride-induced cardiovascular failure. Hypertension. 40, 947-953.</p>\n\n<p>&nbsp;</p>\n\n<p>Huang, C.; Chen, P., Huang, C.; Yu J. (2007). Aristolochic acid induces heart failure in zebrafish embryos that is mediated by inflammation. Toxicol, Sci. 100 (2), 486-494.</p>\n\n<p>&nbsp;</p>\n\n<p>Ishikawa, T. O., Griffin, K. J., Banerjee, U., &amp; Herschman, H. R. (2007). The zebrafish genome contains two inducible, functional cyclooxygenase-2 genes.Biochemical and biophysical research communications, 352(1), 181-187.</p>\n\n<p>&nbsp;</p>\n\n<p>Jonsson, M.E.; Kubota, A.; Timme-Laragy, A.R.; Woodin, B.; Stegeman, J.J. (2012). Ahr2-dependence of PCB126 effects on the swim bladder in relation to expression of CYP1 and cox-2 genes in developing zebrafish. Toxicol. Appl. Pharmacol. 265 (2), 166-174.</p>\n\n<p>&nbsp;</p>\n\n<p>Picot, D.; Loll, P.J.; Garavito, R.M. (1994). The X-ray crystal structure of the membrane protein prostaglandin H2 synthase-1. Nature. 367 (6460), 243-290.</p>\n\n<p>&nbsp;</p>\n\n<p>Simmons, D. L., Botting, R. M., &amp; Hla, T. (2004). Cyclooxygenase isozymes: the biology of prostaglandin synthesis and inhibition. Pharmacological reviews,56(3), 387-437.</p>\n\n<p>&nbsp;</p>\n\n<p>Smith WL, DeWitt DL, Garavito RM. Cyclooxygenases: structural, cellular, and molecular biology.&nbsp;Annu Rev Biochem<em>.&nbsp;</em>2000;&nbsp;69:&nbsp;145&ndash;182.</p>\n\n<p>&nbsp;</p>\n\n<p>Streicher, J.M.; Kamei, K.; Ishikawa, T.; Herschman, H.; Wang, Y. (2010). Compensatory hypertrophy induced by ventricular cardiomyocyte specific COX-2 expression in mice. J. Mol. Cell. Cardiol. 49 (1), 88-94.</p>\n\n<p>&nbsp;</p>\n\n<p>Teraoka, H.; Kubota, A.; Kawai, Y.; Hiraga, T. (2008). Prostanoid signaling mediates circulation failure caused by TCDD in developing zebrafish. Interdis. Studies Environ. Chem. Biol. Resp. Chem. Pollut. 61-80.</p>\n\n<p>&nbsp;</p>\n\n<p>Teraoka, H.; Okuno, Y.; Nijoukubo, D.; Yamakoshi, A.; Peterson, R.E.; Stegeman, J.J.; Kitazawa, T.; Hiraga, T.; Kubota, A. (2014). Involvement of COX2-thromboxane pathway in TCDD-induced precardiac edema in developing zebrafish. Aquat. Toxicol. 154, 19-25.</p>\n\n<p>&nbsp;</p>\n\n<p>Tilley SL, Coffman TM, Koller BH. Mixed messages: modulation of inflammation and immune responses by prostaglandins and thromboxanes.&nbsp;J Clin Invest<em>.&nbsp;</em>2001;&nbsp;108:&nbsp;15&ndash;23.</p>\n\n<p>&nbsp;</p>\n\n<p>Vane JR, Mitchell JA, Appleton I, Tomlinson A, Bishop-Bailey D, Croxtall J, Willoughby DA. Inducible isoforms of cyclooxygenase and nitric-oxide synthase in inflammation.&nbsp;Proc Natl Acad Sci U S A<em>.&nbsp;</em>1994;91:&nbsp;2046&ndash;2050.</p>\n\n<p>&nbsp;</p>\n\n<p>Wong, S.; Fukuchi, M.; Melnyk, P.; Rodger, I.; Giaid, A. (1998). Induction of cyclooxygenase-2 and activation of nuclear factor-kappaB in myocardium of patients with congestive heart failure. Circulation, 98, 100-103.</p>\n","biologicalOrganisationLevel":"Molecular","organTerm":{},"biologicalEvents":[{"action":"increased","process":"gene expression","object":{"name":"prostaglandin G/H synthase 2","source":"PR","sourceId":"PR:000013428"}}],"keyEventStressors":["Doxorubicin","2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD)","Aristolochic acid"],"id":1269}
{"title":"Increase, Early Life Stage Mortality","references":"<p>1. Flores, L.E., Hildebrandt, T.B., Kuhl, A.A., and Drews, B. (2014) Early detection and staging of spontaneous embryo resorption by ultrasound biomicroscopy in murine pregnancy. <em>Reproductive Biology and Endocrinology</em> <strong>12</strong>(38). DOI: 10.1186/1477-7827-12-38</p>\n\n<p>2. <span style=\"font-family:calibri,sans-serif; font-size:11.0pt\">Weinstein, B. M. (1999). What guides early embryonic blood vessel formation? <em>Dev. Dyn.</em> <strong>215</strong>(1), 2-11.</span></p>\n\n<p>Doering, J.A.; Giesy, J.P.; Wiseman S.; Hecker, M. (2013). Predicting the sensivity of fishes to dioxin-like compounds: possible role of the aryl hydrocarbon receptor (AhR) ligand binding domain. Environmental Science and Pollution Research. 20 (3), 1219-1224.</p>\n","biologicalOrganisationLevel":"Individual","organTerm":{},"biologicalEvents":[{"action":"increased","process":"embryonic lethality","object":{}},{"action":"increased","process":"mortality","object":{}}],"keyEventStressors":["2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD)"],"id":947}
{"title":"Increase, Early Life Stage Mortality","references":"<p>1. Flores, L.E., Hildebrandt, T.B., Kuhl, A.A., and Drews, B. (2014) Early detection and staging of spontaneous embryo resorption by ultrasound biomicroscopy in murine pregnancy. <em>Reproductive Biology and Endocrinology</em> <strong>12</strong>(38). DOI: 10.1186/1477-7827-12-38</p>\n\n<p>2. <span style=\"font-family:calibri,sans-serif; font-size:11.0pt\">Weinstein, B. M. (1999). What guides early embryonic blood vessel formation? <em>Dev. Dyn.</em> <strong>215</strong>(1), 2-11.</span></p>\n\n<p>Doering, J.A.; Giesy, J.P.; Wiseman S.; Hecker, M. (2013). Predicting the sensivity of fishes to dioxin-like compounds: possible role of the aryl hydrocarbon receptor (AhR) ligand binding domain. Environmental Science and Pollution Research. 20 (3), 1219-1224.</p>\n","biologicalOrganisationLevel":"Individual","organTerm":{},"biologicalEvents":[{"action":"increased","process":"embryonic lethality","object":{}},{"action":"increased","process":"mortality","object":{}}],"keyEventStressors":["2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD)"],"id":947}
{"title":"Agonism, Androgen receptor","references":"<ul>\n\t<li>Ankley GT, Gray LE. Cross-species conservation of endocrine pathways: a critical analysis of tier 1 fish and rat screening assays with 12 model chemicals. Environ Toxicol Chem. 2013 Apr;32(5):1084-7. doi: 10.1002/etc.2151. Epub 2013 Mar 19. PubMed PMID: 23401061.</li>\n\t<li>Ankley GT, Jensen KM, Kahl MD, Durhan EJ, Makynen EA, Cavallin JE, Martinovi D, Wehmas LC, Mueller ND, Villeneuve DL. Use of chemical mixtures to differentiate mechanisms of endocrine action in a small fish model. Aquat Toxicol. 2010 Sep 1;99(3):389-96. doi: 10.1016/j.aquatox.2010.05.020. Epub 2010 Jun 4. PubMed PMID: 20573408.</li>\n\t<li>Ankley GT, Jensen KM, Makynen EA, Kahl MD, Korte JJ, Hornung MW, Henry TR, Denny JS, Leino RL, Wilson VS, Cardon MC, Hartig PC, Gray LE. Effects of the androgenic growth promoter 17-beta-trenbolone on fecundity and reproductive endocrinology of the fathead minnow. Environ Toxicol Chem. 2003 Jun;22(6):1350-60. PubMed PMID: 12785594.</li>\n\t<li>Araki N, Ohno K, Nakai M, Takeyoshi M, Iida M. 2005. Screening for androgen receptor activities in 253 industrial chemicals by in vitro reporter gene assays using AR-EcoScreen cells. Toxicology in vitro&nbsp;: an international journal published in association with BIBRA 19(6): 831-842.</li>\n\t<li>Bain PA, Ogino Y, Miyagawa S, Iguchi T, Kumar A. Differential ligand selectivity of androgen receptors &alpha; and &beta; from Murray-Darling rainbowfish (Melanotaenia fluviatilis). Gen Comp Endocrinol. 2015 Feb 1;212:84-91. doi: 10.1016/j.ygcen.2015.01.024. PubMed PMID: 25644213.</li>\n\t<li>Baker ME. 1997. Steroid receptor phylogeny and vertebrate origins. Molecular and cellular endocrinology 135(2): 101-107.</li>\n\t<li>Bohl CE, Chang C, Mohler ML, Chen J, Miller DD, Swaan PW, et al. 2004. A ligand-based approach to identify quantitative structure-activity relationships for the androgen receptor. Journal of medicinal chemistry 47(15): 3765-3776.</li>\n\t<li>Centenera MM, Harris JM, Tilley WD, Butler LM. 2008. The contribution of different androgen receptor domains to receptor dimerization and signaling. Molecular endocrinology 22(11): 2373-2382.</li>\n\t<li>Claessens F, Denayer S, Van Tilborgh N, Kerkhofs S, Helsen C, Haelens A. 2008. Diverse roles of androgen receptor (AR) domains in AR-mediated signaling. Nuclear receptor signaling 6: e008.</li>\n\t<li>Cutress ML, Whitaker HC, Mills IG, Stewart M, Neal DE. 2008. Structural basis for the nuclear import of the human androgen receptor. Journal of cell science 121(Pt 7): 957-968.</li>\n\t<li>Douard V, Brunet F, Boussau B, Ahrens-Fath I, Vlaeminck-Guillem V, Haendler B, Laudet V, Guiguen Y. The fate of the duplicated androgen receptor in fishes: a late neofunctionalization event? BMC Evol Biol. 2008 Dec 18;8:336. doi: 10.1186/1471-2148-8-336. PubMed PMID: 19094205</li>\n\t<li>Eick GN, Thornton JW. 2011. Evolution of steroid receptors from an estrogen-sensitive ancestral receptor. Molecular and cellular endocrinology 334(1-2): 31-38.</li>\n\t<li>Hahlbeck E, Katsiadaki I, Mayer I, Adolfsson-Erici M, James J, Bengtsson BE. The juvenile three-spined stickleback (Gasterosteus aculeatus L.) as a model organism for endocrine disruption II--kidney hypertrophy, vitellogenin and spiggin induction. Aquat Toxicol. 2004 Dec 20;70(4):311-26</li>\n\t<li>Hong H, Fang H, Xie Q, Perkins R, Sheehan DM, Tong W. 2003. Comparative molecular field analysis (CoMFA) model using a large diverse set of natural, synthetic and environmental chemicals for binding to the androgen receptor. SAR and QSAR in environmental research 14(5-6): 373-388.</li>\n\t<li>Jakobsson, S., Borg, B., Haux, C. et al. Fish Physiology and Biochemistry (1999) 20: 79. doi:10.1023/A:1007776016610</li>\n\t<li>Jensen KM, Makynen EA, Kahl MD, Ankley GT. Effects of the feedlot contaminant 17alpha-trenbolone on reproductive endocrinology of the fathead minnow. Environ Sci Technol. 2006 May 1;40(9):3112-7. PubMed PMID: 16719119.</li>\n\t<li>Jolly C, Katsiadaki I, Le Belle N, Mayer I, Dufour S. 2006. Development of a stickleback kidney cell culture assay for the screening of androgenic and anti-androgenic endocrine disrupters. Aquatic toxicology 79(2): 158-166.</li>\n\t<li>Kim TS, Yoon CY, Jung KK, Kim SS, Kang IH, Baek JH, et al. 2010. In vitro study of Organization for Economic Co-operation and Development (OECD) endocrine disruptor screening and testing methods- establishment of a recombinant rat androgen receptor (rrAR) binding assay. The Journal of toxicological sciences 35(2): 239-243.</li>\n\t<li>LaLone CA, Villeneuve DL, Cavallin JE, Kahl MD, Durhan EJ, Makynen EA, Jensen KM, Stevens KE, Severson MN, Blanksma CA, Flynn KM, Hartig PC, Woodard JS, Berninger JP, Norberg-King TJ, Johnson RD, Ankley GT. Cross-species sensitivity to a novel androgen receptor agonist of potential environmental concern, spironolactone. Environ Toxicol Chem. 2013 Nov;32(11):2528-41. doi: 10.1002/etc.2330. Epub 2013 Sep 6. PubMed PMID: 23881739.</li>\n\t<li>Mak P, Cruz FD, Chen S. 1999. A yeast screen system for aromatase inhibitors and ligands for androgen receptor: yeast cells transformed with aromatase and androgen receptor. Environmental health perspectives 107(11): 855-860.</li>\n\t<li>Markov GV, Laudet V. 2011. Origin and evolution of the ligand-binding ability of nuclear receptors. Molecular and cellular endocrinology 334(1-2): 21-30.</li>\n\t<li>Norris JD, Joseph JD, Sherk AB, Juzumiene D, Turnbull PS, Rafferty SW, et al. 2009. Differential presentation of protein interaction surfaces on the androgen receptor defines the pharmacological actions of bound ligands. Chemistry &amp; biology 16(4): 452-460.</li>\n\t<li>OECD&nbsp;(2012),&nbsp;<em>Test No. 229: Fish Short Term Reproduction Assay</em>, OECD Publishing, Paris.<br />\n\tDOI: <a href=\"http://dx.doi.org/10.1787/9789264185265-en\" target=\"_blank\" title=\"http://dx.doi.org/10.1787/9789264185265-en\">http://dx.doi.org/10.1787/9789264185265-en</a></li>\n\t<li>OECD&nbsp;(2016),&nbsp;<em>Test No. 458: Stably Transfected Human Androgen Receptor Transcriptional Activation Assay for Detection of Androgenic Agonist and Antagonist Activity of Chemicals</em>, OECD Publishing, Paris.<br />\n\tDOI: <a href=\"http://dx.doi.org/10.1787/9789264264366-en\" target=\"_blank\" title=\"http://dx.doi.org/10.1787/9789264264366-en\">http://dx.doi.org/10.1787/9789264264366-en</a></li>\n\t<li>Olsson P-E, Berg A, von Hofsten J, Grahn B, Hellqvist A, Larsson A, et al. 2005. Molecular cloning and characterization of a nuclear androgen receptor activated by 11-ketotestosterone. Reproductive Biology and Endocrinology 3: 1-17.</li>\n\t<li>Prescott J, Coetzee GA. 2006. Molecular chaperones throughout the life cycle of the androgen receptor. Cancer letters 231(1): 12-19.</li>\n\t<li>Serafimova R, Walker J, Mekenyan O. 2002. Androgen receptor binding affinity of pesticide &quot;active&quot; formulation ingredients. QSAR evaluation by COREPA method. SAR and QSAR in environmental research 13(1): 127-134.</li>\n\t<li>Sone K, Hinago M, Itamoto M, Katsu Y, Watanabe H, Urushitani H, Tooi O, Guillette LJ Jr, Iguchi T. Effects of an androgenic growth promoter 17beta-trenbolone on masculinization of Mosquitofish (Gambusia affinis affinis). Gen Comp Endocrinol. 2005 Sep 1;143(2):151-60. Epub 2005 Apr 13. PubMed PMID: 16061073.</li>\n\t<li>Sperry TS, Thomas P. 1999. Identification of two nuclear androgen receptors in kelp bass (Paralabrax clathratus) and their binding affinities for xenobiotics: comparison with Atlantic croaker (Micropogonias undulatus) androgen receptors. Biology of reproduction 61(4): 1152-1161.</li>\n\t<li>Stanko JP, Angus RA. In vivo assessment of the capacity of androstenedione to masculinize female mosquitofish (Gambusia affinis) exposed through dietary and static renewal methods. Environ Toxicol Chem. 2007 May;26(5):920-6. PubMed PMID: 17521138.</li>\n\t<li>Thornton JW. 2001. Evolution of vertebrate steroid receptors from an ancestral estrogen receptor by ligand exploitation and serial genome expansions. Proceedings of the National Academy of Sciences of the United States of America 98(10): 5671-5676.</li>\n\t<li>Tilley WD, Marcelli M, Wilson JD, McPhaul MJ. 1989. Characterization and expression of a cDNA encoding the human androgen receptor. Proceedings of the National Academy of Sciences of the United States of America 86(1): 327-331.</li>\n\t<li>Todorov M, Mombelli E, Ait-Aissa S, Mekenyan O. 2011. Androgen receptor binding affinity: a QSAR evaluation. SAR and QSAR in environmental research 22(3): 265-291.</li>\n\t<li>van der Burg B, Winter R, Man HY, Vangenechten C, Berckmans P, Weimer M, et al. 2010. Optimization and prevalidation of the in vitro AR CALUX method to test androgenic and antiandrogenic activity of compounds. Reproductive toxicology 30(1): 18-24.</li>\n\t<li>Waller CL, Juma BW, Gray EJ, Kelce WR. 1996. Three-dimensional quantitative structure-activity relationships for androgen receptor ligands. Toxicology and Applied Pharmacolgy 137: 219-227.</li>\n\t<li>Wilson VS, Bobseine K, Lambright CR, Gray LE. 2002. A novel cell line, MDA-kb2, that stably expresses an androgen- and glucocorticoid-responsive reporter for the detection of hormone receptor agonists and antagonists. Toxicological Sciences 66: 69-81.</li>\n\t<li>Wilson VS, Cardon MC, Gray LE, Jr., Hartig PC. 2007. Competitive binding comparison of endocrine-disrupting compounds to recombinant androgen receptor from fathead minnow, rainbow trout, and human. Environmental toxicology and chemistry / SETAC 26(9): 1793-1802.</li>\n\t<li>Yin D, He Y, Perera MA, Hong SS, Marhefka C, Stourman N, et al. 2003. Key structural features of nonsteroidal ligands for binding and activation of the androgen receptor. Molecular pharmacology 63(1): 211-223.</li>\n</ul>\n","biologicalOrganisationLevel":"Molecular","organTerm":{},"biologicalEvents":[{"action":"increased","process":"androgen receptor activity","object":{"name":"androgen receptor","source":"PR","sourceId":"PR:000004191"}}],"keyEventStressors":["17beta-Trenbolone","5alpha-Dihydrotestosterone","Spironolactone"],"id":25}
{"title":"Reduction, Testosterone synthesis by ovarian theca cells","references":"<ul>\n\t<li>Ankley GT, Jensen KM, Kahl MD, Makynen EA, Blake LS, Greene KJ, et al. 2007. Ketoconazole in the fathead minnow (Pimephales promelas): reproductive toxicity and biological compensation. Environ Toxicol Chem 26(6): 1214-1223.</li>\n\t<li>Baker ME. 2011. Origin and diversification of steroids: Co-evolution of enzymes and nuclear receptors. Mol Cell Endocrinol 334: 14-20.</li>\n\t<li>Benninghoff AD, Thomas P. 2006. Gonadotropin regulation of testosterone production by primary cultured theca and granulosa cells of Atlantic croaker: I. Novel role of CaMKs and interactions between calcium- and adenylyl cyclase-dependent pathways. General and comparative endocrinology 147(3): 276-287.</li>\n\t<li>Campbell BK, Baird DT, Webb R. 1998. Effects of dose of LH on androgen production and luteinization of ovine theca cells cultured in a serum-free system. Journal of reproduction and fertility 112(1): 69-77.</li>\n\t<li>Havelock JC, Rainey WE, Carr BR. 2004. Ovarian granulosa cell lines. Molecular and cellular endocrinology 228(1-2): 67-78.</li>\n\t<li>Magoffin DA. 2005. Ovarian theca cell. The international journal of biochemistry &amp; cell biology 37(7): 1344-1349.</li>\n\t<li>Markov GV, Tavares R, Dauphin-Villemant C, Demeneix BA, Baker ME, Laudet V. Independent elaboration of steroid hormone signaling pathways in metazoans. Proc Natl Acad Sci U S A. 2009 Jul 21;106(29):11913-8. doi: 10.1073/pnas.0812138106.</li>\n\t<li>McMaster ME MK, Jardine JJ, Robinson RD, Van Der Kraak GJ. 1995. Protocol for measuring in vitro steroid production by fish gonadal tissue. Canadian Technical Report of Fisheries and Aquatic Sciences 1961 1961: 1-78.</li>\n\t<li>Miller WL, Strauss JF, 3rd. 1999. Molecular pathology and mechanism of action of the steroidogenic acute regulatory protein, StAR. The Journal of steroid biochemistry and molecular biology 69(1-6): 131-141.</li>\n\t<li>Miller WL. 1988. Molecular biology of steroid hormone synthesis. Endocrine reviews 9(3): 295-318.</li>\n\t<li>Payne AH, Hales DB. 2004. Overview of steroidogenic enzymes in the pathway from cholesterol to active steroid hormones. Endocrine reviews 25(6): 947-970</li>\n\t<li>Villeneuve DL, Ankley GT, Makynen EA, Blake LS, Greene KJ, Higley EB, et al. 2007. Comparison of fathead minnow ovary explant and H295R cell-based steroidogenesis assays for identifying endocrine-active chemicals. Ecotoxicol Environ Saf 68(1): 20-32.</li>\n\t<li>Young JM, McNeilly AS. 2010. Theca: the forgotten cell of the ovarian follicle. Reproduction 140(4): 489-504.</li>\n</ul>\n","biologicalOrganisationLevel":"Cellular","organTerm":{},"biologicalEvents":[{"action":"decreased","process":"testosterone biosynthetic process","object":{"name":"testosterone","source":"CHEBI","sourceId":"CHEBI:17347"}}],"id":274}
{"title":"Reduction, Vitellogenin synthesis in liver","references":"<ul>\n\t<li>Biales AD, Bencic DC, Lazorchak JL, Lattier DL. 2007. A quantitative real-time polymerase chain reaction method for the analysis of vitellogenin transcripts in model and nonmodel fish species. Environ Toxicol Chem 26(12): 2679-2686.</li>\n\t<li>Navas JM, Segner H. 2006. Vitellogenin synthesis in primary cultures of fish liver cells as endpoint for in vitro screening of the (anti)estrogenic activity of chemical substances. Aquat Toxicol 80(1): 1-22.</li>\n\t<li>Schmieder P, Tapper M, Linnum A, Denny J, Kolanczyk R, Johnson R. 2000. Optimization of a precision-cut trout liver tissue slice assay as a screen for vitellogenin induction: comparison of slice incubation techniques. Aquat Toxicol 49(4): 251-268.</li>\n\t<li>Wahli W. 1988. Evolution and expression of vitellogenin genes. Trends in Genetics. 4:227-232.</li>\n\t<li>\n\t<p><span style=\"font-size:16px\"><span style=\"color:#212121\"><span style=\"font-family:&quot;Segoe UI&quot;,sans-serif\">H Holbech,&nbsp;L Andersen,&nbsp;</span></span><span style=\"color:#212121\"><span style=\"font-family:&quot;Segoe UI&quot;,sans-serif\">G I Petersen</span></span><span style=\"color:#212121\"><span style=\"font-family:&quot;Segoe UI&quot;,sans-serif\">,&nbsp;</span></span><span style=\"color:#212121\"><span style=\"font-family:&quot;Segoe UI&quot;,sans-serif\">B Korsgaard</span></span><span style=\"color:#212121\"><span style=\"font-family:&quot;Segoe UI&quot;,sans-serif\">,&nbsp;</span></span><span style=\"color:#212121\"><span style=\"font-family:&quot;Segoe UI&quot;,sans-serif\">K L Pedersen,&nbsp;P Bjerregaard, </span><span style=\"font-family: \">Development of an ELISA for vitellogenin in whole body homogenate of zebrafish (Danio rerio), Comp Biochem Physiol C Toxicol Pharmacol. 2001, 130(1):119-31</span></span></span></p>\n\t</li>\n</ul>\n","biologicalOrganisationLevel":"Tissue","organTerm":{"name":"liver","sourceId":"UBERON:0002107"},"biologicalEvents":[{"action":"decreased","process":"gene expression","object":{"name":"vitellogenins","source":"MESH","sourceId":"D014819"}},{"action":"decreased","process":"protein secretion","object":{"name":"vitellogenins","source":"MESH","sourceId":"D014819"}}],"id":285}
{"title":"Reduction, Vitellogenin synthesis in liver","references":"<ul>\n\t<li>Biales AD, Bencic DC, Lazorchak JL, Lattier DL. 2007. A quantitative real-time polymerase chain reaction method for the analysis of vitellogenin transcripts in model and nonmodel fish species. Environ Toxicol Chem 26(12): 2679-2686.</li>\n\t<li>Navas JM, Segner H. 2006. Vitellogenin synthesis in primary cultures of fish liver cells as endpoint for in vitro screening of the (anti)estrogenic activity of chemical substances. Aquat Toxicol 80(1): 1-22.</li>\n\t<li>Schmieder P, Tapper M, Linnum A, Denny J, Kolanczyk R, Johnson R. 2000. Optimization of a precision-cut trout liver tissue slice assay as a screen for vitellogenin induction: comparison of slice incubation techniques. Aquat Toxicol 49(4): 251-268.</li>\n\t<li>Wahli W. 1988. Evolution and expression of vitellogenin genes. Trends in Genetics. 4:227-232.</li>\n\t<li>\n\t<p><span style=\"font-size:16px\"><span style=\"color:#212121\"><span style=\"font-family:&quot;Segoe UI&quot;,sans-serif\">H Holbech,&nbsp;L Andersen,&nbsp;</span></span><span style=\"color:#212121\"><span style=\"font-family:&quot;Segoe UI&quot;,sans-serif\">G I Petersen</span></span><span style=\"color:#212121\"><span style=\"font-family:&quot;Segoe UI&quot;,sans-serif\">,&nbsp;</span></span><span style=\"color:#212121\"><span style=\"font-family:&quot;Segoe UI&quot;,sans-serif\">B Korsgaard</span></span><span style=\"color:#212121\"><span style=\"font-family:&quot;Segoe UI&quot;,sans-serif\">,&nbsp;</span></span><span style=\"color:#212121\"><span style=\"font-family:&quot;Segoe UI&quot;,sans-serif\">K L Pedersen,&nbsp;P Bjerregaard, </span><span style=\"font-family: \">Development of an ELISA for vitellogenin in whole body homogenate of zebrafish (Danio rerio), Comp Biochem Physiol C Toxicol Pharmacol. 2001, 130(1):119-31</span></span></span></p>\n\t</li>\n</ul>\n","biologicalOrganisationLevel":"Tissue","organTerm":{"name":"liver","sourceId":"UBERON:0002107"},"biologicalEvents":[{"action":"decreased","process":"gene expression","object":{"name":"vitellogenins","source":"MESH","sourceId":"D014819"}},{"action":"decreased","process":"protein secretion","object":{"name":"vitellogenins","source":"MESH","sourceId":"D014819"}}],"id":285}
{"title":"Reduction, Cumulative fecundity and spawning","references":"<ul>\n\t<li>OECD 2008. Series on testing and assessment, Number 95. Detailed Review Paper on Fish Life-cycle Tests. OECD Publishing, Paris. ENV/JM/MONO(2008)22.</li>\n\t<li>OECD&nbsp;(2015),&nbsp;<em>Test No. 240: Medaka Extended One Generation Reproduction Test (MEOGRT)</em>, OECD Publishing, Paris.<br />\n\tDOI:&nbsp;<a href=\"http://dx.doi.org/10.1787/9789264242258-en\" target=\"_blank\" title=\"http://dx.doi.org/10.1787/9789264242258-en\">http://dx.doi.org/10.1787/9789264242258-en</a></li>\n\t<li>OECD. 2012a. Test no. 229: Fish short term reproduction assay. Paris, France:Organization for Economic Cooperation and Development.</li>\n</ul>\n","biologicalOrganisationLevel":"Individual","organTerm":{},"biologicalEvents":[{"action":"decreased","process":"egg quantity","object":{}}],"keyEventStressors":["Tris(1,3-dichloropropyl)phosphate - TDCPP"],"id":78}
{"title":"Reduction, Plasma vitellogenin concentrations","references":"<ul>\n\t<li>Fenske M, van Aerle R, Brack S, Tyler CR, Segner H. Development and validation of a homologous zebrafish (Danio rerio Hamilton-Buchanan) vitellogenin enzyme-linked immunosorbent assay (ELISA) and its application for studies on estrogenic chemicals. Comp Biochem Physiol C Toxicol Pharmacol. 2001. Jul;129(3):217-32.</li>\n\t<li>Holbech H, Andersen L, Petersen GI, Korsgaard B, Pedersen KL, Bjerregaard P. Development of an ELISA for vitellogenin in whole body homogenate of zebrafish (Danio rerio). Comp Biochem Physiol C Toxicol Pharmacol. 2001 Sep;130(1):119-31.</li>\n\t<li>Korte JJ, Kahl MD, Jensen KM, Mumtaz SP, Parks LG, LeBlanc GA, et al. 2000. Fathead minnow vitellogenin: complementary DNA sequence and messenger RNA and protein expression after 17B-estradiol treatment. Environmental Toxicology and Chemistry 19(4): 972-981.</li>\n\t<li>Tyler C, van der Eerden B, Jobling S, Panter G, Sumpter J. 1996. Measurement of vitellogenin, a biomarker for exposure to oestrogenic chemicals, in a wide variety of cyprinid fish. Journal of Comparative Physiology and Biology 166: 418-426.</li>\n\t<li>Wahli W. 1988. Evolution and expression of vitellogenin genes. Trends in Genetics. 4:227-232.</li>\n</ul>\n","biologicalOrganisationLevel":"Organ","organTerm":{"name":"blood plasma","sourceId":"UBERON:0001969"},"biologicalEvents":[{"action":"decreased","object":{"name":"vitellogenins","source":"MESH","sourceId":"D014819"}}],"id":221}
{"title":"Reduction, Vitellogenin accumulation into oocytes and oocyte growth/development","references":"<ul>\n\t<li>Leino R, Jensen K, Ankley G. 2005. Gonadal histology and characteristic histopathology associated with endocrine disruption in the adult fathead minnow. Environmental Toxicology and Pharmacology 19: 85-98.</li>\n\t<li>Tyler C, Sumpter J. 1996. Oocyte growth and development in teleosts. Reviews in Fish Biology and Fisheries 6: 287-318.</li>\n\t<li>Wolf JC, Dietrich DR, Friederich U, Caunter J, Brown AR. 2004. Qualitative and quantitative histomorphologic assessment of fathead minnow Pimephales promelas gonads as an endpoint for evaluating endocrine-active compounds: a pilot methodology study. Toxicol Pathol 32(5): 600-612.</li>\n</ul>\n","biologicalOrganisationLevel":"Cellular","organTerm":{},"biologicalEvents":[{"action":"decreased","process":"receptor-mediated endocytosis","object":{"name":"vitellogenins","source":"MESH","sourceId":"D014819"}},{"action":"decreased","process":"oocyte growth","object":{}},{"action":"decreased","process":"oocyte development","object":{}}],"id":309}
{"title":"Reduction, Vitellogenin accumulation into oocytes and oocyte growth/development","references":"<ul>\n\t<li>Leino R, Jensen K, Ankley G. 2005. Gonadal histology and characteristic histopathology associated with endocrine disruption in the adult fathead minnow. Environmental Toxicology and Pharmacology 19: 85-98.</li>\n\t<li>Tyler C, Sumpter J. 1996. Oocyte growth and development in teleosts. Reviews in Fish Biology and Fisheries 6: 287-318.</li>\n\t<li>Wolf JC, Dietrich DR, Friederich U, Caunter J, Brown AR. 2004. Qualitative and quantitative histomorphologic assessment of fathead minnow Pimephales promelas gonads as an endpoint for evaluating endocrine-active compounds: a pilot methodology study. Toxicol Pathol 32(5): 600-612.</li>\n</ul>\n","biologicalOrganisationLevel":"Cellular","organTerm":{},"biologicalEvents":[{"action":"decreased","process":"receptor-mediated endocytosis","object":{"name":"vitellogenins","source":"MESH","sourceId":"D014819"}},{"action":"decreased","process":"oocyte growth","object":{}},{"action":"decreased","process":"oocyte development","object":{}}],"id":309}
{"title":"Reduction, Vitellogenin accumulation into oocytes and oocyte growth/development","references":"<ul>\n\t<li>Leino R, Jensen K, Ankley G. 2005. Gonadal histology and characteristic histopathology associated with endocrine disruption in the adult fathead minnow. Environmental Toxicology and Pharmacology 19: 85-98.</li>\n\t<li>Tyler C, Sumpter J. 1996. Oocyte growth and development in teleosts. Reviews in Fish Biology and Fisheries 6: 287-318.</li>\n\t<li>Wolf JC, Dietrich DR, Friederich U, Caunter J, Brown AR. 2004. Qualitative and quantitative histomorphologic assessment of fathead minnow Pimephales promelas gonads as an endpoint for evaluating endocrine-active compounds: a pilot methodology study. Toxicol Pathol 32(5): 600-612.</li>\n</ul>\n","biologicalOrganisationLevel":"Cellular","organTerm":{},"biologicalEvents":[{"action":"decreased","process":"receptor-mediated endocytosis","object":{"name":"vitellogenins","source":"MESH","sourceId":"D014819"}},{"action":"decreased","process":"oocyte growth","object":{}},{"action":"decreased","process":"oocyte development","object":{}}],"id":309}
{"title":"Reduction, Gonadotropins, circulating concentrations","references":"<ul>\n\t<li>\n\t<p>Amano M, Iigo M, Ikuta K, Kitamura S, Yamada H, Yamamori K. 2000. Roles of melatonin in gonadal maturation of underyearling precocious male masu salmon. General and comparative endocrinology 120(2): 190-197.</p>\n\t</li>\n\t<li>Cheng GF, Yuen CW, Ge W. 2007. Evidence for the existence of a local activin follistatin negative feedback loop in the goldfish pituitary and its regulation by activin and gonadal steroids. The Journal of endocrinology 195(3): 373-384.</li>\n\t<li>Govoroun M, Chyb J, Breton B. 1998. Immunological cross-reactivity between rainbow trout GTH I and GTH II and their alpha and beta subunits: application to the development of specific radioimmunoassays. General and comparative endocrinology 111(1): 28-37.</li>\n\t<li>Habibi HR, Huggard DL. 1998. Testosterone regulation of gonadotropin production in goldfish. Comparative biochemistry and physiology Part C, Pharmacology, toxicology &amp; endocrinology 119(3): 339-344.</li>\n\t<li>Kah O, Pontet A, Nunez Rodriguez J, Calas A, Breton B. 1989. Development of an enzyme-linked immunosorbent assay for goldfish gonadotropin. Biology of reproduction 41(1): 68-73.</li>\n\t<li>Levavi-Sivan B, Bogerd J, Mananos EL, Gomez A, Lareyre JJ. 2010. Perspectives on fish gonadotropins and their receptors. General and comparative endocrinology 165(3): 412-437.</li>\n\t<li>Norris DO. 2007. Vertebrate Endocrinology. Fourth ed. New York: Academic Press.</li>\n\t<li>Oakley AE, Clifton DK, Steiner RA. 2009. Kisspeptin signaling in the brain. Endocrine reviews 30(6): 713-743.</li>\n\t<li>Prat F, Sumpter JP, Tyler CR. 1996. Validation of radioimmunoassays for two salmon gonadotropins (GTH I and GTH II) and their plasma concentrations throughout the reproductivecycle in male and female rainbow trout (Oncorhynchus mykiss). Biology of reproduction 54(6): 1375-1382.</li>\n\t<li>Sower SA, Freamat M, Kavanaugh SI. 2009. The origins of the vertebrate hypothalamic-pituitary-gonadal (HPG) and hypothalamic-pituitary-thyroid (HPT) endocrine systems: new insights from lampreys. General and comparative endocrinology 161(1): 20-29.</li>\n\t<li>Trudeau VL, Spanswick D, Fraser EJ, Larivi&eacute;re K, Crump D, Chiu S, et al. 2000. The role of amino acid neurotransmitters in the regulation of pituitary gonadotropin release in fish. Biochemistry and Cell Biology 78: 241-259.</li>\n\t<li>Trudeau VL. 1997. Neuroendocrine regulation of gonadotropin II release and gonadal growth in the goldfish, Carassius auratus. Reviews of Reproduction 2: 55-68.</li>\n</ul>\n","biologicalOrganisationLevel":"Organ","organTerm":{"name":"blood plasma","sourceId":"UBERON:0001969"},"biologicalEvents":[{"action":"decreased","object":{"name":"Luteinizing hormone","source":"CHEBI","sourceId":"CHEBI:81568"}},{"action":"decreased","object":{"name":"Follicle stimulating hormone","source":"CHEBI","sourceId":"CHEBI:81569"}}],"keyEventStressors":["n/a"],"id":129}
{"title":"Reduction, Gonadotropins, circulating concentrations","references":"<ul>\n\t<li>\n\t<p>Amano M, Iigo M, Ikuta K, Kitamura S, Yamada H, Yamamori K. 2000. Roles of melatonin in gonadal maturation of underyearling precocious male masu salmon. General and comparative endocrinology 120(2): 190-197.</p>\n\t</li>\n\t<li>Cheng GF, Yuen CW, Ge W. 2007. Evidence for the existence of a local activin follistatin negative feedback loop in the goldfish pituitary and its regulation by activin and gonadal steroids. The Journal of endocrinology 195(3): 373-384.</li>\n\t<li>Govoroun M, Chyb J, Breton B. 1998. Immunological cross-reactivity between rainbow trout GTH I and GTH II and their alpha and beta subunits: application to the development of specific radioimmunoassays. General and comparative endocrinology 111(1): 28-37.</li>\n\t<li>Habibi HR, Huggard DL. 1998. Testosterone regulation of gonadotropin production in goldfish. Comparative biochemistry and physiology Part C, Pharmacology, toxicology &amp; endocrinology 119(3): 339-344.</li>\n\t<li>Kah O, Pontet A, Nunez Rodriguez J, Calas A, Breton B. 1989. Development of an enzyme-linked immunosorbent assay for goldfish gonadotropin. Biology of reproduction 41(1): 68-73.</li>\n\t<li>Levavi-Sivan B, Bogerd J, Mananos EL, Gomez A, Lareyre JJ. 2010. Perspectives on fish gonadotropins and their receptors. General and comparative endocrinology 165(3): 412-437.</li>\n\t<li>Norris DO. 2007. Vertebrate Endocrinology. Fourth ed. New York: Academic Press.</li>\n\t<li>Oakley AE, Clifton DK, Steiner RA. 2009. Kisspeptin signaling in the brain. Endocrine reviews 30(6): 713-743.</li>\n\t<li>Prat F, Sumpter JP, Tyler CR. 1996. Validation of radioimmunoassays for two salmon gonadotropins (GTH I and GTH II) and their plasma concentrations throughout the reproductivecycle in male and female rainbow trout (Oncorhynchus mykiss). Biology of reproduction 54(6): 1375-1382.</li>\n\t<li>Sower SA, Freamat M, Kavanaugh SI. 2009. The origins of the vertebrate hypothalamic-pituitary-gonadal (HPG) and hypothalamic-pituitary-thyroid (HPT) endocrine systems: new insights from lampreys. General and comparative endocrinology 161(1): 20-29.</li>\n\t<li>Trudeau VL, Spanswick D, Fraser EJ, Larivi&eacute;re K, Crump D, Chiu S, et al. 2000. The role of amino acid neurotransmitters in the regulation of pituitary gonadotropin release in fish. Biochemistry and Cell Biology 78: 241-259.</li>\n\t<li>Trudeau VL. 1997. Neuroendocrine regulation of gonadotropin II release and gonadal growth in the goldfish, Carassius auratus. Reviews of Reproduction 2: 55-68.</li>\n</ul>\n","biologicalOrganisationLevel":"Organ","organTerm":{"name":"blood plasma","sourceId":"UBERON:0001969"},"biologicalEvents":[{"action":"decreased","object":{"name":"Luteinizing hormone","source":"CHEBI","sourceId":"CHEBI:81568"}},{"action":"decreased","object":{"name":"Follicle stimulating hormone","source":"CHEBI","sourceId":"CHEBI:81569"}}],"keyEventStressors":["n/a"],"id":129}
{"title":"Inhibition, Aromatase","references":"<p>See <a href=\"/wiki/index.php?title=Aromatase_inhibition_leading_to_reproductive_dysfunction_(in_fish)&amp;action=edit&amp;redlink=1\" class=\"new\" title=\"Aromatase inhibition leading to reproductive dysfunction (in fish) (page does not exist)\">Aromatase inhibition leading to reproductive dysfunction (in fish)</a>\n</p>\n<ul>\n<li>Petkov PI, Temelkov S, Villeneuve DL, Ankley GT, Mekenyan OG. 2009. Mechanism-based categorization of aromatase inhibitors: a potential discovery and screening tool. SAR QSAR Environ Res 20(7-8): 657-678.\n</li>\n</ul>\n<ul>\n<li>Lephart ED, Simpson ER. 1991. Assay of aromatase activity. Methods Enzymol 206: 477-483.\n</li>\n</ul>\n<ul>\n<li>Letcher RJ, van Holsteijn I, Drenth H-J, Norstrom RJ, Bergman A, Safe S, et al. 1999. Cytotoxicity and aromatase (CYP19) activity modulation by organochlorines in human placental JEG-3 and JAR choriocarcinoma cells. Toxico App Pharm 160: 10-20.\n</li>\n</ul>\n<ul>\n<li>Sanderson J, Seinen W, Giesy J, van den Berg M. 2000. 2-chloro-triazine herbicides induce aromatase (CYP19) activity in H295R human adrenocortical carcinoma cells:  a novel mechanism for estrogenicity. Toxicol Sci 54: 121-127.\n</li>\n</ul>\n<ul>\n<li>Villeneuve DL, Knoebl I, Kahl MD, Jensen KM, Hammermeister DE, Greene KJ, et al. 2006. Relationship between brain and ovary aromatase activity and isoform-specific aromatase mRNA expression in the fathead minnow (Pimephales promelas). Aquat Toxicol 76(3-4): 353-368.\n</li>\n</ul>\n<ul>\n<li>Ankley GT, Kahl MD, Jensen KM, Hornung MW, Korte JJ, Makynen EA, et al. 2002. Evaluation of the aromatase inhibitor fadrozole in a short-term reproduction assay with the fathead minnow (Pimephales promelas). Toxicol Sci 67: 121-130.\n</li>\n</ul>\n<ul>\n<li>Castro LF, Santos MM, Reis-Henriques MA. 2005. The genomic environment around the Aromatase gene: evolutionary insights. BMC Evol Biol 5: 43.\n</li>\n</ul>\n<ul>\n<li>Callard GV, Tchoudakova AV, Kishida M, Wood E. 2001. Differential tissue distribution, developmental programming, estrogen regulation and promoter characteristics of cyp19 genes in teleost fish. J Ster Biochem Mol Biol 79: 305-314.\n</li>\n</ul>\n<ul>\n<li>Cheshenko K, Pakdel F, Segner H, Kah O, Eggen RI. Interference of endocrine disrupting chemicals with aromatase CYP19 expression or activity, and consequences for reproduction of teleost fish. Gen Comp Endocrinol. 2008 Jan 1;155(1):31-62.\n</li>\n</ul>\n<ul>\n<li>Hinfray N, Porcher JM, Brion F. Inhibition of rainbow trout (Oncorhynchus mykiss) P450 aromatase activities in brain and ovarian microsomes by various environmental substances. Comp Biochem Physiol C Toxicol Pharmacol. 2006 Nov;144(3):252-62\n</li>\n</ul>","biologicalOrganisationLevel":"Molecular","organTerm":{},"biologicalEvents":[{"action":"decreased","process":"aromatase activity","object":{"name":"aromatase","source":"PR","sourceId":"PR:000006100"}}],"keyEventStressors":["Prochloraz","Letrozole","Fadrozole"],"id":36}
{"title":"Inhibition, Ca++ ATPase","references":"<ol class=\"references\">\n<li id=\"cite_note-1\"><span class=\"mw-cite-backlink\"><a href=\"#cite_ref-1\"></a></span> <span class=\"reference-text\">He, T, et al. 2009. Chronic lead exposure alters presynaptic calcium regulation and synaptic facilitation in Drosophila larvae. NeuroToxicology 30(5): 777-84.</span>\n</li>\n</ol>","biologicalOrganisationLevel":"Molecular","organTerm":{},"biologicalEvents":[{"action":"decreased","process":"calcium-transporting ATPase activity","object":{"name":"calcium ion-transporting ATPase complex","source":"GO","sourceId":"GO:0090534"}}],"keyEventStressors":["Lead(II)"],"id":51}
{"title":"Increase, Ca++ (intracellular)","references":"<ol class=\"references\">\n<li id=\"cite_note-1\"><span class=\"mw-cite-backlink\"><a href=\"#cite_ref-1\"></a></span> <span class=\"reference-text\">He, T., et al. 2009. Chronic lead exposure alters presynaptic calcium regulation and synaptic facilitation in Drosophila larvae. NeuroToxicology 30(5): 777-84.</span>\n</li>\n</ol>","biologicalOrganisationLevel":"Cellular","organTerm":{},"biologicalEvents":[{"action":"increased","object":{"name":"calcium ion","source":"CHEBI","sourceId":"CHEBI:39124"}}],"id":50}
{"title":"Disruption, Mitochondrial electron transport chain","references":"","biologicalOrganisationLevel":"Cellular","organTerm":{},"biologicalEvents":[{"action":"disrupted","object":{"name":"mitochondrial respiratory chain","source":"GO","sourceId":"GO:0005746"}}],"id":178}
{"title":"Decrease, Mitochondrial ATP production","references":"","biologicalOrganisationLevel":"Cellular","organTerm":{},"biologicalEvents":[{"action":"decreased","process":"ATP biosynthetic process","object":{"name":"ATP","source":"CHEBI","sourceId":"CHEBI:15422"}}],"id":40}
{"title":"Increase, Reactive Oxygen Species production","references":"","biologicalOrganisationLevel":"Molecular","organTerm":{},"biologicalEvents":[{"action":"increased","process":"reactive oxygen species biosynthetic process","object":{"name":"reactive oxygen species","source":"CHEBI","sourceId":"CHEBI:26523"}}],"id":257}
{"title":"Decreased, Nitric Oxide","references":"","biologicalOrganisationLevel":"Cellular","organTerm":{},"biologicalEvents":[{"action":"decreased","object":{"name":"nitric oxide","source":"CHEBI","sourceId":"CHEBI:16480"}}],"id":193}
{"title":"Decreased, Long-term potentiation (LTP)","references":"","biologicalOrganisationLevel":"Organ","organTerm":{"name":"nervous system","sourceId":"UBERON:0001016"},"biologicalEvents":[{"action":"decreased","process":"long-term synaptic potentiation","object":{}}],"id":166}
{"title":"Increased, Oxidative damage","references":"","biologicalOrganisationLevel":"Individual","organTerm":{},"biologicalEvents":[{"action":"increased","process":"oxidative stress","object":{}}],"id":356}
{"title":"Inhibition, Bile Salt Export Pump (ABCB11)","references":"<p>Dawson, S., Stahl, S., Paul, N., Barber, J., Kenna, J.G. (2011). In vitro inhibition of the bile salt export pump correlates with risk of cholestatic drug-induced liver injury in humans. Drug Metab. Dispos. 40, 130-138.\n</p><p>Kis, E., Ioja, E., Rajnai, Z., Jani, M., Mhn, D., Herdi-Szab, K., Krajcsi, P. (2012). BSEP inhibition: in vitro screens to assess cholestatic potential of drugs. Toxicol. In Vitro 26, 1294-1299.\n</p><p>Kuntz, E., Kuntz, H.D. (2008). Cholestasis. In Hepatology: Textbook and Atlas&#160;: History, Morphology, Biochemistry, Diagnostics, Clinic, Therapy 3rd edition (E. Kuntz E., H.-D. Kuntz Eds.), pp. 235-250. Springer, Heidelberg.\n</p><p>Morgan, R.E., Trauner, M., van Staden, C.J., Lee, P.H., Ramachandran, B., Eschenberg, M., Afshari, C.A., Qualls, C.W. Jr., Lightfoot-Dunn, R., Hamadeh, H.K. (2010). Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development. Toxicol. Sci. 118, 485-500.\n</p><p>Padda, M.S., Sanchez, M., Akhtar, A.J., Boyer, J.L. (2011). Drug-induced cholestasis. Hepatology 53, 1377-1387.\n</p><p>Wagner, M., Zollner, G., Trauner, M. (2009). New molecular insights into the mechanisms of cholestasis. J. Hepatol. 51, 565-580.\n</p><p>Zollner, G., Trauner, M. (2006). Molecular mechanisms of cholestasis. Wien. Med. Wochenschr. 156, 380-385.\n</p><p>Zollner, G., Trauner, M. (2008). Mechanisms of cholestasis. Clin. Liver Dis. 12, 1-26.\n</p>","biologicalOrganisationLevel":"Molecular","organTerm":{},"biologicalEvents":[{"action":"decreased","process":"transport","object":{"name":"bile salt export pump","source":"PR","sourceId":"PR:000003549"}}],"id":41}
{"title":"Activation of specific nuclear receptors, Transcriptional change","references":"","biologicalOrganisationLevel":"Cellular","organTerm":{},"biologicalEvents":[{"action":"increased","process":"gene expression","object":{"name":"bile acid receptor","source":"PR","sourceId":"PR:000011396"}}],"id":288}
{"title":"Bile accumulation, Pathological condition","references":"","biologicalOrganisationLevel":"Cellular","organTerm":{},"biologicalEvents":[{"action":"increased","object":{"name":"bile","source":"UBERON","sourceId":"UBERON:0001970"}}],"id":214}
{"title":"Release, Cytokine","references":"<ol class=\"references\">\n<li id=\"cite_note-1\"><span class=\"mw-cite-backlink\"><a href=\"#cite_ref-1\"></a></span> <span class=\"reference-text\">Zhang JM, An J. Cytokines, inflammation, and pain. Int Anesthesiol Clin. 2007 Spring;45(2):27-37</span>\n</li>\n<li id=\"cite_note-Braunersreuther2012-2\"><span class=\"mw-cite-backlink\"> <sup><a href=\"#cite_ref-Braunersreuther2012_2-0\">2.0</a></sup> <sup><a href=\"#cite_ref-Braunersreuther2012_2-1\">2.1</a></sup></span> <span class=\"reference-text\">Braunersreuther V, Viviani GL, Mach F, Montecucco F. Role of cytokines and chemokines in non-alcoholic fatty liver disease. World J Gastroenterol. 2012 Feb  28;18(8):727-35</span>\n</li>\n<li id=\"cite_note-Cullen2013-3\"><span class=\"mw-cite-backlink\"> <sup><a href=\"#cite_ref-Cullen2013_3-0\">3.0</a></sup> <sup><a href=\"#cite_ref-Cullen2013_3-1\">3.1</a></sup> <sup><a href=\"#cite_ref-Cullen2013_3-2\">3.2</a></sup> <sup><a href=\"#cite_ref-Cullen2013_3-3\">3.3</a></sup></span> <span class=\"reference-text\">Cullen SP, Henry CM, Kearney CJ, Logue SE, Feoktistova M, Tynan GA, Lavelle EC, Leverkus M, Martin SJ. Fas/CD95-induced chemokines can serve as \"find-me\" signals for apoptotic cells. Mol Cell. 2013 Mar 28;49(6):1034-48</span>\n</li>\n<li id=\"cite_note-Cui2011-4\"><span class=\"mw-cite-backlink\"> <sup><a href=\"#cite_ref-Cui2011_4-0\">4.0</a></sup> <sup><a href=\"#cite_ref-Cui2011_4-1\">4.1</a></sup></span> <span class=\"reference-text\">Cui Y, Liu H, Zhou M, Duan Y, Li N, Gong X, Hu R, Hong M, Hong F. Signaling pathway of inflammatory responses in the mouse liver caused by TiO2 nanoparticles. 2011; J. Biomed. Mater. Res. - Part A 96 A:221229</span>\n</li>\n<li id=\"cite_note-Faouzi2001-5\"><span class=\"mw-cite-backlink\"> <sup><a href=\"#cite_ref-Faouzi2001_5-0\">5.0</a></sup> <sup><a href=\"#cite_ref-Faouzi2001_5-1\">5.1</a></sup></span> <span class=\"reference-text\">Faouzi S, Burckhardt BE, Hanson JC, Campe CB, Schrum LW, Rippe RA, Maher JJ. Anti-Fas induces hepatic chemokines and promotes inflammation by an NF-kappa B-independent, caspase-3-dependent pathway. J Biol Chem. 2001 Dec 28;276(52):49077-82</span>\n</li>\n<li id=\"cite_note-Ma2009-6\"><span class=\"mw-cite-backlink\"> <sup><a href=\"#cite_ref-Ma2009_6-0\">6.0</a></sup> <sup><a href=\"#cite_ref-Ma2009_6-1\">6.1</a></sup></span> <span class=\"reference-text\">Ma L, Zhao J, Wang J, Liu J, Duan Y, Liu H, Li N, Yan J, Ruan J, Wang H, Hong F. The Acute Liver Injury in Mice Caused by Nano-Anatase TiO2. Nanoscale Res Lett. 2009 Aug 1;4(11):1275-85</span>\n</li>\n<li id=\"cite_note-Stiegel2015-7\"><span class=\"mw-cite-backlink\"> <sup><a href=\"#cite_ref-Stiegel2015_7-0\">7.0</a></sup> <sup><a href=\"#cite_ref-Stiegel2015_7-1\">7.1</a></sup></span> <span class=\"reference-text\">Stiegel MA, Pleil JD, Sobus JR, Morgan MK, Madden MC. Analysis of inflammatory cytokines in human blood, breath condensate, and urine using a multiplex immunoassay platform. Biomarkers. 2015 Feb;20(1):35-46</span>\n</li>\n</ol>","biologicalOrganisationLevel":"Cellular","organTerm":{},"biologicalEvents":[{"action":"increased","process":"cytokine secretion","object":{"name":"Cytokine","source":"FMA","sourceId":"FMA:84050"}}],"id":87}
{"title":"Increase, Inflammation","references":"<p>Flake, G. P., &amp; Morgan, D. L. (2017). Pathology of diacetyl and 2,3-pentanedione airway lesions in a rat model of obliterative bronchiolitis. <em>Toxicology</em>, <em>388</em>, 40&ndash;47. <a href=\"https://doi.org/10.1016/j.tox.2016.10.013\"><u>https://doi.org/10.1016/j.tox.2016.10.013</u></a></p>\n\n<p>Palmer, S. M., Flake, G. P., Kelly, F. L., Zhang, H. L., Nugent, J. L., Kirby, P. J., &hellip; Morgan, D. L. (2011). Severe airway epithelial injury, aberrant repair and Bronchiolitis obliterans develops after diacetyl instillation in rats. <em>PLoS ONE</em>, <em>6</em>(3). <a href=\"https://doi.org/10.1371/journal.pone.0017644\"><u>https://doi.org/10.1371/journal.pone.0017644</u></a></p>\n","biologicalOrganisationLevel":"Cellular","organTerm":{},"biologicalEvents":[{"action":"increased","process":"inflammatory response","object":{}}],"id":149}
{"title":"Production, Reactive oxygen species","references":"","biologicalOrganisationLevel":"Tissue","organTerm":{},"biologicalEvents":[{"action":"increased","process":"reactive oxygen species biosynthetic process","object":{"name":"reactive oxygen species","source":"CHEBI","sourceId":"CHEBI:26523"}}],"id":249}
{"title":"Peptide Oxidation","references":"<p>Ballatori, N., Krance, S.M., Notenboom, S., Shi, S., Tieu, K., and Hammond, C.L. (2009). Glutathione dysregulation and the etiology and progression of human diseases. Biol. Chem. 390, 191&ndash;214.</p>\n\n<p>Chen, C.-A., Wang, T.-Y., Varadharaj, S., Reyes, L.A., Hemann, C., Talukder, M.A.H., Chen, Y.-R., Druhan, L.J., and Zweier, J.L. (2010). S-glutathionylation uncouples eNOS and regulates its cellular and vascular function. Nature 468, 1115&ndash;1118.</p>\n\n<p>Giustarini, D., Dalle-Donne, I., Milzani, A., Fanti, P., and Rossi, R. (2013). Analysis of GSH and GSSG after derivatization with N-ethylmaleimide. Nat. Protoc. 8, 1660&ndash;1669.</p>\n\n<p>Held P., 2010 Biotek, Measurement of ROS in Cells, <a class=\"external free\" href=\"http://www.biotek.com/assets/tech_resources/ROS%20Application%20Guide.pdf\" rel=\"nofollow\" target=\"_blank\">http://www.biotek.com/assets/tech_resources/ROS%20Application%20Guide.pdf</a></p>\n\n<p>Kalinina, E.V., Chernov, N.N., and Novichkova, M.D. (2014). Role of glutathione, glutathione transferase, and glutaredoxin in regulation of redox-dependent processes. Biochem. Biokhimiia 79, 1562&ndash;1583.</p>\n\n<p>Kamencic, H., Lyon, A., Paterson, P.G., and Juurlink, B.H. (2000). Monochlorobimane fluorometric method to measure tissue glutathione. Anal. Biochem. 286, 35&ndash;37.</p>\n\n<p>Parola, M. and Robino, G. (2001). Oxidative stress-related molecules and liver fibrosis. J Hepatol. 35, 297-306</p>\n\n<p>Reuter S. et al., (2010) Oxidative stress, inflammation, and cancer: how are they linked? Free Radic Biol Med.49, 1603-1616</p>\n\n<p>S&aacute;nchez-Valle V. et al., (2012) Role of oxidative stress and molecular changes in liver fibrosis: a review. Curr Med Chem. 19, 4850-4860</p>\n\n<p>Tipple, T.E., and Rogers, L.K. (2012). Methods for the Determination of Plasma or Tissue Glutathione Levels. Methods Mol. Biol. Clifton NJ 889, 315&ndash;324</p>\n","biologicalOrganisationLevel":"Molecular","organTerm":{},"biologicalEvents":[{"action":"increased","process":"oxidative stress","object":{}}],"id":209}
{"title":"Cholestasis, Pathology","references":"","biologicalOrganisationLevel":"Individual","organTerm":{},"biologicalEvents":[{"action":"occurrence","object":{"name":"cholestasis","source":"MESH","sourceId":"D002779"}}],"id":357}
{"title":"Inhibition, Cyclooxygenase activity","references":"<p>Bacchi, S., Palumbo, P., Sponta, A., &amp; Coppolino, M. F. (2012). Clinical pharmacology of non-steroidal anti-inflammatory drugs: a review. Anti-Inflammatory &amp; Anti-Allergy Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry-Anti-Inflammatory and Anti-Allergy Agents), 11(1), 52-64.\n</p><p>Botting, R. M., &amp; Botting, J. H. (2011). C14 Non-steroidal anti-inflammatory drugs. In Principles of Immunopharmacology (pp. 573-584). Birkhuser Basel.\n</p><p>Cao, H., Yu, R., Tao, Y., Nikolic, D., &amp; van Breemen, R. B. (2011). Measurement of cyclooxygenase inhibition using liquid chromatographytandem mass spectrometry. Journal of pharmaceutical and biomedical analysis, 54(1), 230-235.\n</p><p>Chandrasekharan, N. V., Dai, H., Roos, K. L. T., Evanson, N. K., Tomsik, J., Elton, T. S., &amp; Simmons, D. L. (2002). COX-3, a cyclooxygenase-1 variant inhibited by acetaminophen and other analgesic/antipyretic drugs: cloning, structure, and expression. Proceedings of the National Academy of Sciences,99(21), 13926-13931.\n</p><p>Cuendet, M., Mesecar, A. D., DeWitt, D. L., &amp; Pezzuto, J. M. (2006). An ELISA method to measure inhibition of the COX enzymes. Nature protocols,1(4), 1915-1921.\nGreen, T., Gonzalez, A. A., Mitchell, K. D., &amp; Navar, L. G. (2012). The Complex Interplay between COX-2 and Angiotensin II in Regulating Kidney Function. Current opinion in nephrology and hypertension, 21(1), 7.\n</p><p>Havird, J. C., Kocot, K. M., Brannock, P. M., Cannon, J. T., Waits, D. S., Weese, D. A., ... &amp; Halanych, K. M. (2015). Reconstruction of Cyclooxygenase Evolution in Animals Suggests Variable, Lineage-Specific Duplications, and Homologs with Low Sequence Identity. Journal of molecular evolution, 1-16.\n</p><p>Havird, J. C., Miyamoto, M. M., Choe, K. P., &amp; Evans, D. H. (2008). Gene duplications and losses within the cyclooxygenase family of teleosts and other chordates. Molecular biology and evolution, 25(11), 2349-2359.\n</p><p>Ishikawa, T. O., Griffin, K. J., Banerjee, U., &amp; Herschman, H. R. (2007). The zebrafish genome contains two inducible, functional cyclooxygenase-2 genes.Biochemical and biophysical research communications, 352(1), 181-187.\n</p><p>Jang, M. S., &amp; Pezzuto, J. M. (1997). Assessment of cyclooxygenase inhibitors using in vitro assay systems. Methods in cell science, 19(1), 25-31.\n</p><p>Kristensen, D. M., Skalkam, M. L., Audouze, K., Lesn, L., Desdoits-Lethimonier, C., Frederiksen, H., ... &amp; Leffers, H. (2011). Many putative endocrine disruptors inhibit prostaglandin synthesis. Environmental health perspectives, 119(4), 534-41.\n</p><p>Liedtke, A. J., Crews, B. C., Daniel, C. M., Blobaum, A. L., Kingsley, P. J., Ghebreselasie, K., &amp; Marnett, L. J. (2012). Cyclooxygenase-1-selective inhibitors based on the (E)-2-des-methyl-sulindac sulfide scaffold. Journal of medicinal chemistry, 55(5), 2287-2300.\n</p><p>Lister, A. L., &amp; Van Der Kraak, G. (2008). An investigation into the role of prostaglandins in zebrafish oocyte maturation and ovulation. General and comparative endocrinology, 159(1), 46-57.\n</p><p>Simmons, D. L., Botting, R. M., &amp; Hla, T. (2004). Cyclooxygenase isozymes: the biology of prostaglandin synthesis and inhibition. Pharmacological reviews,56(3), 387-437.\n</p><p>Willoughby, D. A., Moore, A. R., &amp; Colville-Nash, P. R. (2000). COX-1, COX-2, and COX-3 and the future treatment of chronic inflammatory disease. The Lancet, 355(9204), 646-648.\n</p>","biologicalOrganisationLevel":"Molecular","organTerm":{},"biologicalEvents":[{"action":"decreased","process":"prostaglandin-endoperoxide synthase activity","object":{"name":"prostaglandin G/H synthase 1","source":"PR","sourceId":"PR:000013427"}},{"action":"decreased","process":"prostaglandin-endoperoxide synthase activity","object":{"name":"prostaglandin G/H synthase 2","source":"PR","sourceId":"PR:000013428"}}],"keyEventStressors":["Diclofenac sodium","Tetraconazole","Ibuprofen","1-Chloro-4-nitrobenzene","3-(Difluoromethyl)-1-(4-methoxyphenyl)-5-[4-(methylsulfinyl)phenyl]-1H-pyrazole","169590-42-5","Emamectin benzoate","Naproxen","2058-46-0","Sodium (4-fluoro-2-{[(1S)-1-phenylpropyl]carbamoyl}phenyl)(quinolin-8-ylsulfonyl)azanide","Oxytetracycline hydrochloride","Celecoxib","Indomethacin","Aceytlsalicylic acid"],"id":79}
{"title":"Inhibition, Cyclooxygenase activity","references":"<p>Bacchi, S., Palumbo, P., Sponta, A., &amp; Coppolino, M. F. (2012). Clinical pharmacology of non-steroidal anti-inflammatory drugs: a review. Anti-Inflammatory &amp; Anti-Allergy Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry-Anti-Inflammatory and Anti-Allergy Agents), 11(1), 52-64.\n</p><p>Botting, R. M., &amp; Botting, J. H. (2011). C14 Non-steroidal anti-inflammatory drugs. In Principles of Immunopharmacology (pp. 573-584). Birkhuser Basel.\n</p><p>Cao, H., Yu, R., Tao, Y., Nikolic, D., &amp; van Breemen, R. B. (2011). Measurement of cyclooxygenase inhibition using liquid chromatographytandem mass spectrometry. Journal of pharmaceutical and biomedical analysis, 54(1), 230-235.\n</p><p>Chandrasekharan, N. V., Dai, H., Roos, K. L. T., Evanson, N. K., Tomsik, J., Elton, T. S., &amp; Simmons, D. L. (2002). COX-3, a cyclooxygenase-1 variant inhibited by acetaminophen and other analgesic/antipyretic drugs: cloning, structure, and expression. Proceedings of the National Academy of Sciences,99(21), 13926-13931.\n</p><p>Cuendet, M., Mesecar, A. D., DeWitt, D. L., &amp; Pezzuto, J. M. (2006). An ELISA method to measure inhibition of the COX enzymes. Nature protocols,1(4), 1915-1921.\nGreen, T., Gonzalez, A. A., Mitchell, K. D., &amp; Navar, L. G. (2012). The Complex Interplay between COX-2 and Angiotensin II in Regulating Kidney Function. Current opinion in nephrology and hypertension, 21(1), 7.\n</p><p>Havird, J. C., Kocot, K. M., Brannock, P. M., Cannon, J. T., Waits, D. S., Weese, D. A., ... &amp; Halanych, K. M. (2015). Reconstruction of Cyclooxygenase Evolution in Animals Suggests Variable, Lineage-Specific Duplications, and Homologs with Low Sequence Identity. Journal of molecular evolution, 1-16.\n</p><p>Havird, J. C., Miyamoto, M. M., Choe, K. P., &amp; Evans, D. H. (2008). Gene duplications and losses within the cyclooxygenase family of teleosts and other chordates. Molecular biology and evolution, 25(11), 2349-2359.\n</p><p>Ishikawa, T. O., Griffin, K. J., Banerjee, U., &amp; Herschman, H. R. (2007). The zebrafish genome contains two inducible, functional cyclooxygenase-2 genes.Biochemical and biophysical research communications, 352(1), 181-187.\n</p><p>Jang, M. S., &amp; Pezzuto, J. M. (1997). Assessment of cyclooxygenase inhibitors using in vitro assay systems. Methods in cell science, 19(1), 25-31.\n</p><p>Kristensen, D. M., Skalkam, M. L., Audouze, K., Lesn, L., Desdoits-Lethimonier, C., Frederiksen, H., ... &amp; Leffers, H. (2011). Many putative endocrine disruptors inhibit prostaglandin synthesis. Environmental health perspectives, 119(4), 534-41.\n</p><p>Liedtke, A. J., Crews, B. C., Daniel, C. M., Blobaum, A. L., Kingsley, P. J., Ghebreselasie, K., &amp; Marnett, L. J. (2012). Cyclooxygenase-1-selective inhibitors based on the (E)-2-des-methyl-sulindac sulfide scaffold. Journal of medicinal chemistry, 55(5), 2287-2300.\n</p><p>Lister, A. L., &amp; Van Der Kraak, G. (2008). An investigation into the role of prostaglandins in zebrafish oocyte maturation and ovulation. General and comparative endocrinology, 159(1), 46-57.\n</p><p>Simmons, D. L., Botting, R. M., &amp; Hla, T. (2004). Cyclooxygenase isozymes: the biology of prostaglandin synthesis and inhibition. Pharmacological reviews,56(3), 387-437.\n</p><p>Willoughby, D. A., Moore, A. R., &amp; Colville-Nash, P. R. (2000). COX-1, COX-2, and COX-3 and the future treatment of chronic inflammatory disease. The Lancet, 355(9204), 646-648.\n</p>","biologicalOrganisationLevel":"Molecular","organTerm":{},"biologicalEvents":[{"action":"decreased","process":"prostaglandin-endoperoxide synthase activity","object":{"name":"prostaglandin G/H synthase 1","source":"PR","sourceId":"PR:000013427"}},{"action":"decreased","process":"prostaglandin-endoperoxide synthase activity","object":{"name":"prostaglandin G/H synthase 2","source":"PR","sourceId":"PR:000013428"}}],"keyEventStressors":["Diclofenac sodium","Tetraconazole","Ibuprofen","1-Chloro-4-nitrobenzene","3-(Difluoromethyl)-1-(4-methoxyphenyl)-5-[4-(methylsulfinyl)phenyl]-1H-pyrazole","169590-42-5","Emamectin benzoate","Naproxen","2058-46-0","Sodium (4-fluoro-2-{[(1S)-1-phenylpropyl]carbamoyl}phenyl)(quinolin-8-ylsulfonyl)azanide","Oxytetracycline hydrochloride","Celecoxib","Indomethacin","Aceytlsalicylic acid"],"id":79}
{"title":"Reduction, Prostaglandin E2 concentration","references":"","biologicalOrganisationLevel":"Tissue","organTerm":{"name":"blood","sourceId":"UBERON:0000178"},"biologicalEvents":[{"action":"decreased","object":{"name":"prostaglandin E2","source":"CHEBI","sourceId":"CHEBI:15551"}}],"id":243}
{"title":"Reduction, Ca and HCO3 transport to shell gland","references":"","biologicalOrganisationLevel":"Tissue","organTerm":{"name":"oviduct shell gland","sourceId":"UBERON:0008975"},"biologicalEvents":[{"action":"decreased","process":"calcium ion transport","object":{"name":"calcium ion","source":"CHEBI","sourceId":"CHEBI:39124"}},{"action":"decreased","process":"bicarbonate transport","object":{"name":"hydrogencarbonate","source":"CHEBI","sourceId":"CHEBI:17544"}}],"id":49}
{"title":"Reduction, Ca and HCO3 transport to shell gland","references":"","biologicalOrganisationLevel":"Tissue","organTerm":{"name":"oviduct shell gland","sourceId":"UBERON:0008975"},"biologicalEvents":[{"action":"decreased","process":"calcium ion transport","object":{"name":"calcium ion","source":"CHEBI","sourceId":"CHEBI:39124"}},{"action":"decreased","process":"bicarbonate transport","object":{"name":"hydrogencarbonate","source":"CHEBI","sourceId":"CHEBI:17544"}}],"id":49}
{"title":"Reduction, Eggshell thickness","references":"","biologicalOrganisationLevel":"Tissue","organTerm":{"name":"eggshell","sourceId":"UBERON:0005079"},"biologicalEvents":[{"action":"decreased","object":{"name":"eggshell","source":"UBERON","sourceId":"UBERON:0005079"}}],"id":106}
{"title":"N/A, Gap","references":"","biologicalOrganisationLevel":"Tissue","organTerm":{"name":"eggshell","sourceId":"UBERON:0005079"},"biologicalEvents":[{"action":"functional change","object":{"name":"eggshell","source":"UBERON","sourceId":"UBERON:0005079"}}],"id":119}
{"title":"N/A, Reproductive failure","references":"","biologicalOrganisationLevel":"Individual","organTerm":{},"biologicalEvents":[{"action":"abnormal","process":"multi-organism reproductive process","object":{}}],"id":253}
{"title":"Agonism, Estrogen receptor","references":"","biologicalOrganisationLevel":"Molecular","organTerm":{},"biologicalEvents":[{"action":"increased","process":"estrogen receptor activity","object":{"name":"estrogen receptor","source":"PR","sourceId":"PR:000007204"}}],"id":111}
{"title":"Increase, Plasma vitellogenin concentrations","references":"","biologicalOrganisationLevel":"Organ","organTerm":{"name":"blood plasma","sourceId":"UBERON:0001969"},"biologicalEvents":[{"action":"increased","object":{"name":"vitellogenins","source":"MESH","sourceId":"D014819"}}],"id":220}
{"title":"Increase, Vitellogenin synthesis in liver","references":"","biologicalOrganisationLevel":"Tissue","organTerm":{"name":"liver","sourceId":"UBERON:0002107"},"biologicalEvents":[{"action":"increased","process":"gene expression","object":{"name":"vitellogenins","source":"MESH","sourceId":"D014819"}}],"id":307}
{"title":"Increase, Renal pathology due to VTG deposition","references":"","biologicalOrganisationLevel":"Organ","organTerm":{"name":"kidney","sourceId":"UBERON:0002113"},"biologicalEvents":[{"action":"increased","process":"Kidney Diseases","object":{}}],"id":252}
{"title":"Altered, Reproductive behaviour","references":"","biologicalOrganisationLevel":"Individual","organTerm":{},"biologicalEvents":[{"action":"abnormal","process":"reproductive behavior","object":{}}],"id":363}
{"title":"Altered, Larval development","references":"","biologicalOrganisationLevel":"Individual","organTerm":{},"biologicalEvents":[{"action":"abnormal","process":"larval development","object":{}}],"id":339}
{"title":"Impaired development of, Reproductive organs","references":"","biologicalOrganisationLevel":"Individual","organTerm":{},"biologicalEvents":[{"action":"abnormal","process":"developmental process","object":{"name":"reproductive organ","source":"UBERON","sourceId":"UBERON:0003133"}}],"id":364}
{"title":"Antagonism, Estrogen receptor","references":"<ul>\n\t<li>Brzozowski AM, Pike AC, Dauter Z, Hubbard RE, Bonn T, Engstrom O, et al. 1997. Molecular basis of agonism and antagonism in the oestrogen receptor. Nature 389:753-758.</li>\n\t<li>Katzenellenbogen B. 1996. Estrogen receptors: Bioactivities and interactions with cell signaling pathways. Biology of Reproduction 54:287-293.</li>\n\t<li>Brooks SC, Wappler NL, Corombos JD, Doherty LM, Horwitz JP. 1987. Estrogen structure-fuction relationships. Berlin:Walter de Gruyter &amp; Co., 443-466.</li>\n\t<li>Brooks SC, Skafar DF. 2004. From ligand structure to biological activity: Modified estratrienes and their estrogenic and antiestrogenic effects in mcf-7 cells. Steroids 69:401-418.</li>\n\t<li>Lloyd DG, Smith HM, O&#39;Sullivan T, Knox AS, Zisterer DM, Meegan MJ. 2006. Antiestrogenically active 2-benzyl-1,1-diarylbut-2-enes: Synthesis, structure-activity relationships and molecular modeling study for flexible estrogen receptor antagonists. Medicinal chemistry 2:147-168.</li>\n\t<li>Sodero AC, Romeiro NC, da Cunha EF, de Oliveira Magalhaaes U, de Alencastro RB, Rodrigues CR, et al. 2012. Application of 4d-qsar studies to a series of raloxifene analogs and design of potential selective estrogen receptor modulators. Molecules 17:7415-7439.</li>\n\t<li>Vedani A, Dobler M, Smiesko M. 2012. Virtualtoxlab - a platform for estimating the toxic potential of drugs, chemicals and natural products. Toxicology and applied pharmacology 261:142-153.</li>\n\t<li>Wang CY, Ai N, Arora S, Erenrich E, Nagarajan K, Zauhar R, et al. 2006. Identification of previously unrecognized antiestrogenic chemicals using a novel virtual screening approach. Chemical research in toxicology 19:1595-1601.</li>\n\t<li>Denny JS, Tapper MA, Schmieder PK, Hornung MW, Jensen KM, Ankley GT, et al. 2005. Comparison of relative binding affinities of endocrine active compounds to fathead minnow and rainbow trout estrogen receptors. Environmental toxicology and chemistry / SETAC 24:2948-2953.</li>\n\t<li>Lee HK, Kim TS, Kim CY, Kang IH, Kim MG, Jung KK, et al. 2012. Evaluation of in vitro screening system for estrogenicity: Comparison of stably transfected human estrogen receptor-alpha transcriptional activation (oecd tg455) assay and estrogen receptor (er) binding assay. The Journal of toxicological sciences 37:431-437.</li>\n\t<li>Rider CV, Hartig PC, Cardon MC, Lambright CR, Bobseine KL, Guillette LJ, Jr., et al. 2010. Differences in sensitivity but not selectivity of xenoestrogen binding to alligator versus human estrogen receptor alpha. Environmental toxicology and chemistry / SETAC 29:2064-2071.</li>\n\t<li>OECD. 2012b. Test no. 457: Bg1luc estrogen receptor transactivation test method for identifying estrogen receptor agonists and antagonists:OECD Publishing.</li>\n\t<li>Wilson VS, Bobseine K, Gray LE, Jr. 2004. Development and characterization of a cell line that stably expresses an estrogen-responsive luciferase reporter for the detection of estrogen receptor agonist and antagonists. Toxicological sciences&nbsp;: an official journal of the Society of Toxicology 81:69-77.</li>\n\t<li>van der Burg B, Winter R, Weimer M, Berckmans P, Suzuki G, Gijsbers L, et al. 2010. Optimization and prevalidation of the in vitro eralpha calux method to test estrogenic and antiestrogenic activity of compounds. Reproductive toxicology 30:73-80.</li>\n\t<li>Witters H, Freyberger A, Smits K, Vangenechten C, Lofink W, Weimer M, et al. 2010. The assessment of estrogenic or anti-estrogenic activity of chemicals by the human stably transfected estrogen sensitive meln cell line: Results of test performance and transferability. Reproductive toxicology 30:60-72.</li>\n\t<li>De Boever P, Demare W, Vanderperren E, Cooreman K, Bossier P, Verstraete W. 2001. Optimization of a yeast estrogen screen and its applicability to study the release of estrogenic isoflavones from a soygerm powder. Environmental health perspectives 109:691-697.</li>\n\t<li>Bickley LK, Lange A, Winter MJ, Tyler CR. 2009. Evaluation of a carp primary hepatocyte culture system for screening chemicals for oestrogenic activity. Aquatic toxicology 94:195-203.</li>\n\t<li>Navas JM, Segner H. 2006. Vitellogenin synthesis in primary cultures of fish liver cells as endpoint for in vitro screening of the (anti)estrogenic activity of chemical substances. Aquatic toxicology 80:1-22.</li>\n\t<li>Schmieder P, Tapper M, Linnum A, Denny J, Kolanczyk R, Johnson R. 2000. Optimization of a precision-cut trout liver tissue slice assay as a screen for vitellogenin induction: Comparison of slice incubation techniques. Aquatic toxicology 49:251-268.</li>\n\t<li>Schmieder PK, Tapper MA, Denny JS, Kolanczyk RC, Sheedy BR, Henry TR, et al. 2004. Use of trout liver slices to enhance mechanistic interpretation of estrogen receptor binding for cost-effective prioritization of chemicals within large inventories. Environmental science &amp; technology 38:6333-6342.</li>\n\t<li>Sun L, Wen L, Shao X, Qian H, Jin Y, Liu W, et al. 2010. Screening of chemicals with anti-estrogenic activity using in vitro and in vivo vitellogenin induction responses in zebrafish (danio rerio). Chemosphere 78:793-799.</li>\n\t<li>Baker ME. 1997. Steroid receptor phylogeny and vertebrate origins. Molecular and cellular endocrinology 135:101-107.</li>\n\t<li>Baker ME. 2003. Evolution of adrenal and sex steroid action in vertebrates: A ligand-based mechanism for complexity. BioEssays&nbsp;: news and reviews in molecular, cellular and developmental biology 25:396-400.</li>\n\t<li>Thornton JW. 2001. Evolution of vertebrate steroid receptors from an ancestral estrogen receptor by ligand exploitation and serial genome expansions. Proceedings of the National Academy of Sciences of the United States of America 98:5671-5676.</li>\n\t<li>Thornton JW, Need E, Crews D. 2003. Resurrecting the ancestral steroid receptor: Ancient origin of estrogen signaling. Science 301:1714-1717.</li>\n</ul>\n","biologicalOrganisationLevel":"Molecular","organTerm":{},"biologicalEvents":[{"action":"decreased","process":"estrogen receptor activity","object":{"name":"estrogen receptor","source":"PR","sourceId":"PR:000007204"}}],"id":112}
{"title":"N/A, Parent compound is converted to the reactive metabolite and forms free radicals leading to oxidation of heme iron(II) in hemoglobin to iron(III)","references":"","biologicalOrganisationLevel":"Molecular","organTerm":{},"biologicalEvents":[{"action":"increased","process":"heme oxidation","object":{}}],"id":213}
{"title":"Altered regulation, Alpha hemoglobin","references":"","biologicalOrganisationLevel":"Cellular","organTerm":{},"biologicalEvents":[{"action":"abnormal","process":"gene expression","object":{"name":"hemoglobin subunit alpha (human)","source":"PR","sourceId":"PR:P69905"}}],"id":21}
{"title":"Propagation, Oxidative stress","references":"","biologicalOrganisationLevel":"Molecular","organTerm":{},"biologicalEvents":[{"action":"increased","process":"oxidative stress","object":{}}],"id":211}
{"title":"Damaging, Red blood cells; hemolysis","references":"","biologicalOrganisationLevel":"Cellular","organTerm":{},"biologicalEvents":[{"action":"increased","object":{"name":"hemolysis","source":"MESH","sourceId":"D006461"}}],"id":250}
{"title":"Formation, Formation of hemoglobin adducts","references":"","biologicalOrganisationLevel":"Cellular","organTerm":{},"biologicalEvents":[{"action":"increased","process":"hemoglobin biosynthetic process","object":{"name":"xenobiotic","source":"CHEBI","sourceId":"CHEBI:35703"}},{"action":"increased","process":"hemoglobin binding","object":{}}],"id":118}
{"title":"Formation, Formation of hemoglobin adducts","references":"","biologicalOrganisationLevel":"Cellular","organTerm":{},"biologicalEvents":[{"action":"increased","process":"hemoglobin biosynthetic process","object":{"name":"xenobiotic","source":"CHEBI","sourceId":"CHEBI:35703"}},{"action":"increased","process":"hemoglobin binding","object":{}}],"id":118}
{"title":"Down Regulation, Gulcose-6-phosphate dehydrogenase","references":"","biologicalOrganisationLevel":"Cellular","organTerm":{},"biologicalEvents":[{"action":"decreased","process":"gene expression","object":{"name":"glucose-6-phosphate 1-dehydrogenase","source":"PR","sourceId":"PR:000007749"}}],"id":131}
{"title":"Increase, RBC congestion in liver","references":"","biologicalOrganisationLevel":"Organ","organTerm":{"name":"liver","sourceId":"UBERON:0002107"},"biologicalEvents":[{"action":"increased","object":{"name":"erythrocyte","source":"CL","sourceId":"CL:0000232"}},{"action":"increased","process":"liver vascular congestion","object":{}}],"id":246}
{"title":"Increase, RBC congestion in liver","references":"","biologicalOrganisationLevel":"Organ","organTerm":{"name":"liver","sourceId":"UBERON:0002107"},"biologicalEvents":[{"action":"increased","object":{"name":"erythrocyte","source":"CL","sourceId":"CL:0000232"}},{"action":"increased","process":"liver vascular congestion","object":{}}],"id":246}
{"title":"Increase, Liver and splenic hemosiderosis","references":"","biologicalOrganisationLevel":"Organ","organTerm":{"name":"liver","sourceId":"UBERON:0002107"},"biologicalEvents":[{"action":"increased","object":{"name":"hemosiderosis","source":"MESH","sourceId":"D006486"}}],"id":161}
{"title":"N/A, Methemoglobinemia, decreased hemoglobin, hematocrit, red blood cell number","references":"","biologicalOrganisationLevel":"Organ","organTerm":{"name":"blood","sourceId":"UBERON:0000178"},"biologicalEvents":[{"action":"increased","object":{"name":"Methemoglobinemia","source":"MESH","sourceId":"D008708"}},{"action":"decreased","object":{"name":"hemoglobin","source":"CHEBI","sourceId":"CHEBI:35143"}},{"action":"increased","object":{"name":"erythrocyte","source":"CL","sourceId":"CL:0000232"}}],"id":173}
{"title":"N/A, Methemoglobinemia, decreased hemoglobin, hematocrit, red blood cell number","references":"","biologicalOrganisationLevel":"Organ","organTerm":{"name":"blood","sourceId":"UBERON:0000178"},"biologicalEvents":[{"action":"increased","object":{"name":"Methemoglobinemia","source":"MESH","sourceId":"D008708"}},{"action":"decreased","object":{"name":"hemoglobin","source":"CHEBI","sourceId":"CHEBI:35143"}},{"action":"increased","object":{"name":"erythrocyte","source":"CL","sourceId":"CL:0000232"}}],"id":173}
{"title":"N/A, Methemoglobinemia, decreased hemoglobin, hematocrit, red blood cell number","references":"","biologicalOrganisationLevel":"Organ","organTerm":{"name":"blood","sourceId":"UBERON:0000178"},"biologicalEvents":[{"action":"increased","object":{"name":"Methemoglobinemia","source":"MESH","sourceId":"D008708"}},{"action":"decreased","object":{"name":"hemoglobin","source":"CHEBI","sourceId":"CHEBI:35143"}},{"action":"increased","object":{"name":"erythrocyte","source":"CL","sourceId":"CL:0000232"}}],"id":173}
{"title":"N/A, Cyanosis occurs","references":"","biologicalOrganisationLevel":"Individual","organTerm":{},"biologicalEvents":[{"action":"occurrence","object":{"name":"Cyanosis","source":"MESH","sourceId":"D003490"}}],"id":321}
{"title":"Production, Critical Metabolites (CGA 330050 and CGA 265307)","references":"","biologicalOrganisationLevel":"Cellular","organTerm":{},"biologicalEvents":[{"action":"increased","process":"metabolic process","object":{"name":"thiamethoxam","source":"CHEBI","sourceId":"CHEBI:39185"}},{"action":"increased","process":"metabolic process","object":{"name":"metabolite","source":"CHEBI","sourceId":"CHEBI:25212"}}],"id":77}
{"title":"Production, Critical Metabolites (CGA 330050 and CGA 265307)","references":"","biologicalOrganisationLevel":"Cellular","organTerm":{},"biologicalEvents":[{"action":"increased","process":"metabolic process","object":{"name":"thiamethoxam","source":"CHEBI","sourceId":"CHEBI:39185"}},{"action":"increased","process":"metabolic process","object":{"name":"metabolite","source":"CHEBI","sourceId":"CHEBI:25212"}}],"id":77}
{"title":"Induction, Liver Dysfunctional Changes by CGA 330050","references":"","biologicalOrganisationLevel":"Organ","organTerm":{"name":"liver","sourceId":"UBERON:0002107"},"biologicalEvents":[{"action":"decreased","process":"Decreased liver function","object":{}}],"id":164}
{"title":"Inhibition, Inducible Nitric Oxide Synthase by Metabolite CGA 265307","references":"","biologicalOrganisationLevel":"Cellular","organTerm":{},"biologicalEvents":[{"action":"decreased","process":"nitric-oxide synthase activity","object":{"name":"nitric oxide synthase, brain","source":"PR","sourceId":"PR:000011326"}}],"id":147}
{"title":"Induction, Sustained Hepatotoxicity","references":"","biologicalOrganisationLevel":"Individual","organTerm":{},"biologicalEvents":[{"action":"increased","process":"hepatotoxicity","object":{}}],"id":270}
{"title":"Induction, Sustained Cell Proliferation","references":"","biologicalOrganisationLevel":"Cellular","organTerm":{},"biologicalEvents":[{"action":"increased","process":"hepatocyte proliferation","object":{}}],"id":269}
{"title":"Formation, Liver tumor","references":"","biologicalOrganisationLevel":"Individual","organTerm":{},"biologicalEvents":[{"action":"increased","object":{"name":"hepatocellular carcinoma","source":"MESH","sourceId":"D006528"}}],"id":347}
{"title":"Activation, 5HT2c","references":"","biologicalOrganisationLevel":"Molecular","organTerm":{},"biologicalEvents":[{"action":"increased","process":"signaling","object":{"name":"5-hydroxytryptamine receptor 2C","source":"PR","sourceId":"PR:000001168"}}],"id":9}
{"title":"Increased, Kidney Failure","references":"","biologicalOrganisationLevel":"Population","organTerm":{},"biologicalEvents":[{"action":"increased","process":"kidney failure","object":{}}],"id":759}
{"title":"Activation, LXR","references":"<ol class=\"references\">\n<li id=\"cite_note-1\"><span class=\"mw-cite-backlink\"><a href=\"#cite_ref-1\"></a></span> <span class=\"reference-text\">Peet 1998</span>\n</li>\n<li id=\"cite_note-2\"><span class=\"mw-cite-backlink\"><a href=\"#cite_ref-2\"></a></span> <span class=\"reference-text\">Edwardsa et al. 2002</span>\n</li>\n</ol>","biologicalOrganisationLevel":"Molecular","organTerm":{},"biologicalEvents":[{"action":"increased","process":"signaling","object":{"name":"oxysterols receptor LXR-beta","source":"PR","sourceId":"PR:000011394"}},{"action":"increased","process":"signaling","object":{"name":"oxysterols receptor LXR-alpha","source":"PR","sourceId":"PR:000011395"}}],"id":167}
{"title":"Activation, LXR","references":"<ol class=\"references\">\n<li id=\"cite_note-1\"><span class=\"mw-cite-backlink\"><a href=\"#cite_ref-1\"></a></span> <span class=\"reference-text\">Peet 1998</span>\n</li>\n<li id=\"cite_note-2\"><span class=\"mw-cite-backlink\"><a href=\"#cite_ref-2\"></a></span> <span class=\"reference-text\">Edwardsa et al. 2002</span>\n</li>\n</ol>","biologicalOrganisationLevel":"Molecular","organTerm":{},"biologicalEvents":[{"action":"increased","process":"signaling","object":{"name":"oxysterols receptor LXR-beta","source":"PR","sourceId":"PR:000011394"}},{"action":"increased","process":"signaling","object":{"name":"oxysterols receptor LXR-alpha","source":"PR","sourceId":"PR:000011395"}}],"id":167}
{"title":"Up Regulation, CD36","references":"<ol class=\"references\">\n<li id=\"cite_note-1\"><span class=\"mw-cite-backlink\"><a href=\"#cite_ref-1\"></a></span> <span class=\"reference-text\">Su &amp; Abumrad 2009</span>\n</li>\n<li id=\"cite_note-2\"><span class=\"mw-cite-backlink\"><a href=\"#cite_ref-2\"></a></span> <span class=\"reference-text\">He et al. 2011</span>\n</li>\n<li id=\"cite_note-3\"><span class=\"mw-cite-backlink\"><a href=\"#cite_ref-3\"></a></span> <span class=\"reference-text\">Krammer 2011</span>\n</li>\n<li id=\"cite_note-4\"><span class=\"mw-cite-backlink\"><a href=\"#cite_ref-4\"></a></span> <span class=\"reference-text\">Pohl et al. 2005</span>\n</li>\n<li id=\"cite_note-5\"><span class=\"mw-cite-backlink\"><a href=\"#cite_ref-5\"></a></span> <span class=\"reference-text\">Cheung et al. 2007</span>\n</li>\n<li id=\"cite_note-6\"><span class=\"mw-cite-backlink\"><a href=\"#cite_ref-6\"></a></span> <span class=\"reference-text\">Ehehalt et al. 2008</span>\n</li>\n<li id=\"cite_note-7\"><span class=\"mw-cite-backlink\"><a href=\"#cite_ref-7\"></a></span> <span class=\"reference-text\">Pohl et al. 2005</span>\n</li>\n<li id=\"cite_note-8\"><span class=\"mw-cite-backlink\"><a href=\"#cite_ref-8\"></a></span> <span class=\"reference-text\">Krammer 2011</span>\n</li>\n<li id=\"cite_note-9\"><span class=\"mw-cite-backlink\"><a href=\"#cite_ref-9\"></a></span> <span class=\"reference-text\">Zhou 2008</span>\n</li>\n<li id=\"cite_note-10\"><span class=\"mw-cite-backlink\"><a href=\"#cite_ref-10\"></a></span> <span class=\"reference-text\">Febbraio et al. 1999</span>\n</li>\n<li id=\"cite_note-11\"><span class=\"mw-cite-backlink\"><a href=\"#cite_ref-11\"></a></span> <span class=\"reference-text\">Lee et al. 2008</span>\n</li>\n<li id=\"cite_note-12\"><span class=\"mw-cite-backlink\"><a href=\"#cite_ref-12\"></a></span> <span class=\"reference-text\">Zhu et al. 2011</span>\n</li>\n<li id=\"cite_note-13\"><span class=\"mw-cite-backlink\"><a href=\"#cite_ref-13\"></a></span> <span class=\"reference-text\">Love-Gregory et al. 2011</span>\n</li>\n<li id=\"cite_note-14\"><span class=\"mw-cite-backlink\"><a href=\"#cite_ref-14\"></a></span> <span class=\"reference-text\">Miquilena-Colina et al. 2011</span>\n</li>\n<li id=\"cite_note-15\"><span class=\"mw-cite-backlink\"><a href=\"#cite_ref-15\"></a></span> <span class=\"reference-text\">Bechmann et al. 2010</span>\n</li>\n</ol>","biologicalOrganisationLevel":"Molecular","organTerm":{},"biologicalEvents":[{"action":"increased","process":"gene expression","object":{"name":"platelet glycoprotein 4","source":"PR","sourceId":"PR:000001905"}}],"id":54}
{"title":"Increase, FA Influx","references":"<ol class=\"references\">\n<li id=\"cite_note-1\"><span class=\"mw-cite-backlink\"><a href=\"#cite_ref-1\"></a></span> <span class=\"reference-text\">Amacher 2011</span>\n</li>\n<li id=\"cite_note-2\"><span class=\"mw-cite-backlink\"><a href=\"#cite_ref-2\"></a></span> <span class=\"reference-text\">Baranowski 2008</span>\n</li>\n<li id=\"cite_note-3\"><span class=\"mw-cite-backlink\"><a href=\"#cite_ref-3\"></a></span> <span class=\"reference-text\">Su &amp; Abumrad 2009</span>\n</li>\n</ol>","biologicalOrganisationLevel":"Cellular","organTerm":{},"biologicalEvents":[{"action":"increased","process":"positive regulation of fatty acid transport","object":{"name":"fatty acid","source":"CHEBI","sourceId":"CHEBI:35366"}}],"id":115}
{"title":"Activation, ChREBP","references":"<ol class=\"references\">\n<li id=\"cite_note-1\"><span class=\"mw-cite-backlink\"><a href=\"#cite_ref-1\"></a></span> <span class=\"reference-text\">Cha &amp; Repa 2007</span>\n</li>\n<li id=\"cite_note-2\"><span class=\"mw-cite-backlink\"><a href=\"#cite_ref-2\"></a></span> <span class=\"reference-text\">Denechaud et al. 2008</span>\n</li>\n</ol>","biologicalOrganisationLevel":"Molecular","organTerm":{},"biologicalEvents":[{"action":"increased","process":"signaling","object":{"name":"carbohydrate-responsive element-binding protein","source":"PR","sourceId":"PR:000010460"}}],"id":66}
{"title":"Activation, SREBP-1c","references":"<ol class=\"references\">\n<li id=\"cite_note-1\"><span class=\"mw-cite-backlink\"><a href=\"#cite_ref-1\"></a></span> <span class=\"reference-text\">Liang et al. 2002</span>\n</li>\n<li id=\"cite_note-2\"><span class=\"mw-cite-backlink\"><a href=\"#cite_ref-2\"></a></span> <span class=\"reference-text\">Schultz et al. 2000</span>\n</li>\n<li id=\"cite_note-3\"><span class=\"mw-cite-backlink\"><a href=\"#cite_ref-3\"></a></span> <span class=\"reference-text\">Horton et al. 2002</span>\n</li>\n<li id=\"cite_note-4\"><span class=\"mw-cite-backlink\"><a href=\"#cite_ref-4\"></a></span> <span class=\"reference-text\">Shimano et al. 1999</span>\n</li>\n<li id=\"cite_note-5\"><span class=\"mw-cite-backlink\"><a href=\"#cite_ref-5\"></a></span> <span class=\"reference-text\">Liang et al. 2002</span>\n</li>\n<li id=\"cite_note-6\"><span class=\"mw-cite-backlink\"><a href=\"#cite_ref-6\"></a></span> <span class=\"reference-text\">Ishii et al. 2004</span>\n</li>\n<li id=\"cite_note-7\"><span class=\"mw-cite-backlink\"><a href=\"#cite_ref-7\"></a></span> <span class=\"reference-text\">Bcard et al. 2001</span>\n</li>\n<li id=\"cite_note-8\"><span class=\"mw-cite-backlink\"><a href=\"#cite_ref-8\"></a></span> <span class=\"reference-text\">Ferre 2007</span>\n</li>\n<li id=\"cite_note-9\"><span class=\"mw-cite-backlink\"><a href=\"#cite_ref-9\"></a></span> <span class=\"reference-text\">Fleischmann 1999</span>\n</li>\n</ol>","biologicalOrganisationLevel":"Molecular","organTerm":{},"biologicalEvents":[{"action":"increased","process":"SREBP signaling pathway","object":{"name":"sterol regulatory element-binding protein 1","source":"PR","sourceId":"PR:000015611"}}],"id":264}
{"title":"Activation, FAS","references":"<ol class=\"references\">\n<li id=\"cite_note-1\"><span class=\"mw-cite-backlink\"><a href=\"#cite_ref-1\"></a></span> <span class=\"reference-text\">Oisterveer et al. 2010</span>\n</li>\n<li id=\"cite_note-Liang_et_al._2002-2\"><span class=\"mw-cite-backlink\"> <sup><a href=\"#cite_ref-Liang_et_al._2002_2-0\">2.0</a></sup> <sup><a href=\"#cite_ref-Liang_et_al._2002_2-1\">2.1</a></sup></span> <span class=\"reference-text\">Liang et al. 2002</span>\n</li>\n<li id=\"cite_note-Schultz_et_al._2000-3\"><span class=\"mw-cite-backlink\"> <sup><a href=\"#cite_ref-Schultz_et_al._2000_3-0\">3.0</a></sup> <sup><a href=\"#cite_ref-Schultz_et_al._2000_3-1\">3.1</a></sup></span> <span class=\"reference-text\">Schultz et al. 2000</span>\n</li>\n<li id=\"cite_note-4\"><span class=\"mw-cite-backlink\"><a href=\"#cite_ref-4\"></a></span> <span class=\"reference-text\">Horton et al. 2002</span>\n</li>\n</ol>","biologicalOrganisationLevel":"Molecular","organTerm":{},"biologicalEvents":[{"action":"increased","process":"fatty acid synthase activity","object":{"name":"fatty acid synthase","source":"PR","sourceId":"PR:000007348"}}],"id":116}
{"title":"Activation, SCD-1","references":"<ol class=\"references\">\n<li id=\"cite_note-1\"><span class=\"mw-cite-backlink\"><a href=\"#cite_ref-1\"></a></span> <span class=\"reference-text\">Oisterveer et al. 2010</span>\n</li>\n<li id=\"cite_note-2\"><span class=\"mw-cite-backlink\"><a href=\"#cite_ref-2\"></a></span> <span class=\"reference-text\">Liang et al. 2002</span>\n</li>\n<li id=\"cite_note-3\"><span class=\"mw-cite-backlink\"><a href=\"#cite_ref-3\"></a></span> <span class=\"reference-text\">Schultz et al. 2000</span>\n</li>\n<li id=\"cite_note-4\"><span class=\"mw-cite-backlink\"><a href=\"#cite_ref-4\"></a></span> <span class=\"reference-text\">Chu et al. 2006</span>\n</li>\n</ol>","biologicalOrganisationLevel":"Molecular","organTerm":{},"biologicalEvents":[{"action":"increased","process":"gene expression","object":{"name":"acyl-CoA desaturase","source":"PR","sourceId":"PR:000014497"}}],"id":258}
{"title":"Synthesis, De Novo FA","references":"<ol class=\"references\">\n<li id=\"cite_note-Postic_.26_Girard_2008-1\"><span class=\"mw-cite-backlink\"> <sup><a href=\"#cite_ref-Postic_.26_Girard_2008_1-0\">1.0</a></sup> <sup><a href=\"#cite_ref-Postic_.26_Girard_2008_1-1\">1.1</a></sup></span> <span class=\"reference-text\">Postic &amp; Girard 2008</span>\n</li>\n</ol>","biologicalOrganisationLevel":"Cellular","organTerm":{},"biologicalEvents":[{"action":"increased","process":"fatty acid biosynthetic process","object":{"name":"fatty acid","source":"CHEBI","sourceId":"CHEBI:35366"}}],"id":89}
{"title":"Accumulation, Triglyceride","references":"","biologicalOrganisationLevel":"Cellular","organTerm":{},"biologicalEvents":[{"action":"increased","object":{"name":"triglyceride","source":"CHEBI","sourceId":"CHEBI:17855"}}],"id":291}
{"title":"Damaging, Mitochondria","references":"","biologicalOrganisationLevel":"Cellular","organTerm":{},"biologicalEvents":[{"action":"functional change","process":"mitochondrion disassembly","object":{"name":"mitochondrion","source":"GO","sourceId":"GO:0005739"}}],"id":176}
{"title":"N/A, Liver Steatosis","references":"","biologicalOrganisationLevel":"Organ","organTerm":{"name":"liver","sourceId":"UBERON:0002107"},"biologicalEvents":[{"action":"occurrence","object":{"name":"fatty liver","source":"MESH","sourceId":"D005234"}}],"id":345}
{"title":"peroxisome proliferator activated receptor promoter demethylation","references":"<p>Barak, Y., Nelson, M. C., Ong, E. S., Jones, Y. Z., Ruiz-Lozano, P., Chien, K. R., &hellip; Evans, R. M. (1999). PPAR gamma is required for placental, cardiac, and adipose tissue development. Molecular Cell, 4(4), 585&ndash;95.</p>\n\n<p>Braissant, O., Foufelle, F., Scotto, C., Dau&ccedil;a, M., &amp; Wahli, W. (1996). Differential expression of peroxisome proliferator-activated receptors (PPARs): tissue distribution of PPAR-alpha, -beta, and -gamma in the adult rat. Endocrinology, 137(1), 354&ndash;66.</p>\n\n<p>Burns, K. A., &amp; Vanden Heuvel, J. P. (2007). Modulation of PPAR activity via phosphorylation. Biochimica et Biophysica Acta, 1771(8), 952&ndash;60. doi:10.1016/j.bbalip.2007.04.018</p>\n\n<p>Fajas, L., Auboeuf, D., Rasp&eacute;, E., Schoonjans, K., Lefebvre, A. M., Saladin, R., &hellip; Auwerx, J. (1997). The organization, promoter analysis, and expression of the human PPARgamma gene. The Journal of Biological Chemistry, 272(30), 18779&ndash;89.</p>\n\n<p>Fajas, L., Fruchart, J.-C., &amp; Auwerx, J. (1998). PPAR&gamma;3 mRNA: a distinct PPAR&gamma; mRNA subtype transcribed from an independent promoter. FEBS Letters, 438(1-2), 55&ndash;60. doi:10.1016/S0014-5793(98)01273-3</p>\n\n<p>Feige, J. N., Gelman, L., Michalik, L., Desvergne, B., &amp; Wahli, W. (2006). From molecular action to physiological outputs: peroxisome proliferator-activated receptors are nuclear receptors at the crossroads of key cellular functions. Progress in Lipid Research, 45(2), 120&ndash;59. doi:10.1016/j.plipres.2005.12.002</p>\n\n<p>Feige, J. N., Gelman, L., Rossi, D., Zoete, V., M&eacute;tivier, R., Tudor, C., &hellip; Desvergne, B. (2007). The endocrine disruptor monoethyl-hexyl-phthalate is a selective peroxisome proliferator-activated receptor gamma modulator that promotes adipogenesis. The Journal of Biological Chemistry, 282(26), 19152&ndash;66. doi:10.1074/jbc.M702724200</p>\n\n<p>Gijsbers, Linda, Henri&euml;tte D L M van Eekelen, Laura H J de Haan, Jorik M Swier, Nienke L Heijink, Samantha K Kloet, Hai-Yen Man, et al. 2013. &ldquo;Induction of Peroxisome Proliferator-Activated Receptor &Gamma; (PPAR&gamma;)-Mediated Gene Expression by Tomato (Solanum Lycopersicum L.) Extracts.&rdquo; Journal of Agricultural and Food Chemistry 61 (14) (April 10): 3419&ndash;27. doi:10.1021/jf304790a.</p>\n\n<p>Issemann, I., &amp; Green, S. (1990). Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators. Nature, 347(6294), 645&ndash;650.</p>\n\n<p>Kaya, T., Mohr, S. C., Waxman, D. J., &amp; Vajda, S. (2006). Computational screening of phthalate monoesters for binding to PPARgamma. Chemical Research in Toxicology, 19(8), 999&ndash;1009. doi:10.1021/tx050301s</p>\n\n<p>Lapinskas, P. J., Brown, S., Leesnitzer, L. M., Blanchard, S., Swanson, C., Cattley, R. C., &amp; Corton, J. C. (2005). Role of PPAR&alpha; in mediating the effects of phthalates and metabolites in the liver. Toxicology, 207(1), 149&ndash;163.</p>\n\n<p>Le Maire, A., Grimaldi, M., Roecklin, D., Dagnino, S., Vivat-Hannah, V., Balaguer, P., &amp; Bourguet, W. (2009). Activation of RXR-PPAR heterodimers by organotin environmental endocrine disruptors. EMBO Reports, 10(4), 367&ndash;73. doi:10.1038/embor.2009.8</p>\n\n<p>LeBlanc, G., Norris, D., &amp; Kloas, W. (2011). Detailed Review Paper State of the Science on Novel In Vitro and In Vivo Screening and Testing Methods and Endpoints for Evaluating Endocrine Disruptors, (178).</p>\n\n<p>Lehmann, J. M., Moore, L. B., Smith-Oliver, T. A., Wilkison, W. O., Willson, T. M., &amp; Kliewer, S. A. (1995). An Antidiabetic Thiazolidinedione Is a High Affinity Ligand for Peroxisome Proliferator-activated Receptor (PPAR ). Journal of Biological Chemistry, 270(22), 12953&ndash;12956. doi:10.1074/jbc.270.22.12953</p>\n\n<p>Maloney, E. K., &amp; Waxman, D. J. (1999). trans-Activation of PPAR&alpha; and PPAR&gamma; by Structurally Diverse Environmental Chemicals. Toxicology and Applied Pharmacology, 161(2), 209&ndash;218.</p>\n\n<p>Michalik, L., Zoete, V., Krey, G., Grosdidier, A., Gelman, L., Chodanowski, P., &hellip; Michielin, O. (2007). Combined simulation and mutagenesis analyses reveal the involvement of key residues for peroxisome proliferator-activated receptor alpha helix 12 dynamic behavior. The Journal of Biological Chemistry, 282(13), 9666&ndash;77. doi:10.1074/jbc.M610523200</p>\n\n<p>Mor&aacute;n-Salvador, E., L&oacute;pez-Parra, M., Garc&iacute;a-Alonso, V., Titos, E., Mart&iacute;nez-Clemente, M., Gonz&aacute;lez-P&eacute;riz, A., &hellip; Cl&agrave;ria, J. (2011). Role for PPAR&gamma; in obesity-induced hepatic steatosis as determined by hepatocyte- and macrophage-specific conditional knockouts. FASEB Journal: Official Publication of the Federation of American Societies for Experimental Biology, 25(8), 2538&ndash;50. doi:10.1096/fj.10-173716</p>\n\n<p>Pereira-Fernandes, A., Demaegdt, H., Vandermeiren, K., Hectors, T. L. M., Jorens, P. G., Blust, R., &amp; Vanparys, C. (2013). Evaluation of a screening system for obesogenic compounds: screening of endocrine disrupting compounds and evaluation of the PPAR dependency of the effect. PloS One, 8(10), e77481. doi:10.1371/journal.pone.0077481</p>\n\n<p>ToxCastTM Data, US Environmental Protection Agency. <a class=\"external free\" href=\"http://www.epa.gov/ncct/toxcast/data.html\" rel=\"nofollow\" target=\"_blank\">http://www.epa.gov/ncct/toxcast/data.html</a>.</p>\n\n<p><br />\nVanden Heuvel, J. P. (1999). Peroxisome proliferator-activated receptors (PPARS) and carcinogenesis. Toxicological Sciences: An Official Journal of the Society of Toxicology, 47(1), 1&ndash;8.</p>\n\n<p>Viswakarma, N., Jia, Y., Bai, L., Vluggens, A., Borensztajn, J., Xu, J., &amp; Reddy, J. K. (2010). Coactivators in PPAR-Regulated Gene Expression. PPAR Research, 2010. doi:10.1155/2010/250126</p>\n\n<p>Wahli, W., &amp; Desvergne, B. (1999). Peroxisome proliferator-activated receptors: nuclear control of metabolism. Endocrine Reviews, 20(5), 649&ndash;88.</p>\n\n<p>Wu, B., Gao, J., &amp; Wang, M. (2005). Development of a complex scintillation proximity assay for high-throughput screening of PPARgamma modulators. Acta Pharmacologica Sinica, 26(3), 339&ndash;44. doi:10.1111/j.1745-7254.2005.00040.x</p>\n\n<p>Yu, S., &amp; Reddy, J. K. (2007). Transcription coactivators for peroxisome proliferator-activated receptors. Biochimica et Biophysica Acta, 1771(8), 936&ndash;51. doi:10.1016/j.bbalip.2007.01.008</p>\n","biologicalOrganisationLevel":"Molecular","organTerm":{},"biologicalEvents":[{"action":"increased","process":"peroxisome proliferator activated receptor signaling pathway","object":{"name":"peroxisome proliferator-activated receptor gamma","source":"PR","sourceId":"PR:000013058"}}],"keyEventStressors":["Troglitazone","Mono(2-ethylhexyl) phthalate","Tributyltin","Di(2-ethylhexyl) phthalate"],"id":228}
{"title":"Accumulation, Biological membranes","references":"","biologicalOrganisationLevel":"Cellular","organTerm":{},"biologicalEvents":[{"action":"increased","object":{"name":"membrane","source":"GO","sourceId":"GO:0016020"}}],"keyEventStressors":["Phenanthrene"],"id":46}
{"title":"Disruption, Membrane integrity","references":"","biologicalOrganisationLevel":"Cellular","organTerm":{},"biologicalEvents":[{"action":"abnormal","object":{"name":"plasma membrane","source":"GO","sourceId":"GO:0005886"}}],"id":169}
{"title":"Decreased, PPAR-alpha activation","references":"","biologicalOrganisationLevel":"Molecular","organTerm":{},"biologicalEvents":[{"action":"decreased","process":"peroxisome proliferator activated receptor signaling pathway","object":{"name":"peroxisome proliferator-activated receptor alpha","source":"PR","sourceId":"PR:000013056"}}],"keyEventStressors":["Benzo(k)fluoranthene"],"id":231}
{"title":"Decreased, PPAR-beta activation","references":"","biologicalOrganisationLevel":"Molecular","organTerm":{},"biologicalEvents":[{"action":"decreased","process":"peroxisome proliferator activated receptor signaling pathway","object":{"name":"peroxisome proliferator-activated receptor delta","source":"PR","sourceId":"PR:000013057"}}],"id":232}
{"title":"Decreased, PPAR-gamma activation","references":"","biologicalOrganisationLevel":"Molecular","organTerm":{},"biologicalEvents":[{"action":"decreased","process":"peroxisome proliferator activated receptor signaling pathway","object":{"name":"peroxisome proliferator-activated receptor gamma","source":"PR","sourceId":"PR:000013058"}}],"id":233}
{"title":"Accumulation, Fatty acid","references":"","biologicalOrganisationLevel":"Organ","organTerm":{"name":"liver","sourceId":"UBERON:0002107"},"biologicalEvents":[{"action":"increased","object":{"name":"fatty acid","source":"CHEBI","sourceId":"CHEBI:35366"}}],"id":327}
{"title":"Decreased, HSD17B10 expression","references":"","biologicalOrganisationLevel":"Cellular","organTerm":{},"biologicalEvents":[{"action":"decreased","process":"gene expression","object":{"name":"3-hydroxyacyl-CoA dehydrogenase type-2","source":"PR","sourceId":"PR:000008774"}}],"id":140}
{"title":"Decreased, Mitochondrial fatty acid beta-oxidation","references":"<p><br />\nDesvergne B, Wahli W (1999) Peroxisome proliferator-activated receptors: nuclear control of metabolism. Endocrine Reviews 20(5): 649-688. \n</p><p>Evans RM, Barish GD, Wang YX: PPARs and the complex journey to obesity. Nat Med 2004, 10(4):355-361.\n</p>","biologicalOrganisationLevel":"Molecular","organTerm":{},"biologicalEvents":[{"action":"decreased","process":"fatty acid beta-oxidation","object":{"name":"fatty acid","source":"CHEBI","sourceId":"CHEBI:35366"}}],"id":179}
{"title":"Decreased, 3-hydroxyacyl-CoA dehydrogenase type-2 activity","references":"","biologicalOrganisationLevel":"Cellular","organTerm":{},"biologicalEvents":[{"action":"decreased","process":"3-hydroxyacyl-CoA dehydrogenase activity","object":{"name":"3-hydroxyacyl-CoA dehydrogenase type-2","source":"PR","sourceId":"PR:000008774"}}],"id":8}
{"title":"Increased, Liver Steatosis","references":"<p>Landesmann, B. (2016). Adverse Outcome Pathway on Protein Alkylation Leading to Liver Fibrosis, (2).</p>\n\n<p>https://doi.org/10.1016/j.molcel.2005.08.010</p>\n\n<p>Koo, J. H., Lee, H. J., Kim, W., &amp; Kim, S. G. (2016). Endoplasmic Reticulum Stress in Hepatic Stellate Cells Promotes Liver Fibrosis via PERK-Mediated Degradation of HNRNPA1 and Up-regulation of SMAD2. <em>Gastroenterology</em>, <em>150</em>(1), 181&ndash;193.e8. https://doi.org/10.1053/j.gastro.2015.09.039</p>\n","biologicalOrganisationLevel":"Organ","organTerm":{"name":"liver","sourceId":"UBERON:0002107"},"biologicalEvents":[{"object":{}}],"id":459}
{"title":"Increase, Phenotypic enzyme activity","references":"","biologicalOrganisationLevel":"Cellular","organTerm":{"name":"liver","sourceId":"UBERON:0002107"},"biologicalEvents":[{"object":{}}],"keyEventStressors":["Phthalates","Bezafibrate","Wy-14,6423","Clofibrate","Perflourinated chemicals","Gemfibrozil","Simvastatin"],"id":1170}
{"title":"Increase, cell proliferation (hepatocytes)","references":"<p><a name=\"_ENREF_1\">Barberan, S. and Cebria, F. (2018), The role of the EGFR signaling pathway in stem cell differentiation during planarian regeneration and homeostasis. <em>Semin Cell Dev Biol</em>, 10.1016/j.semcdb.2018.05.011. </a></p>\n\n<p><a name=\"_ENREF_2\">Becker, R. A., Patlewicz, G., Simon, T. W., Rowlands, J. C. and Budinsky, R. A. (2015), The adverse outcome pathway for rodent liver tumor promotion by sustained activation of the aryl hydrocarbon receptor. <em>Regul Toxicol Pharmacol</em> <strong>73</strong>, 172-90, 10.1016/j.yrtph.2015.06.015. </a></p>\n\n<p><a name=\"_ENREF_3\">Berasain, C. and Avila, M. A. (2014), The EGFR signalling system in the liver: from hepatoprotection to hepatocarcinogenesis. <em>J Gastroenterol</em> <strong>49</strong>, 9-23, 10.1007/s00535-013-0907-x. </a></p>\n\n<p>&nbsp;</p>\n\n<p><a name=\"_ENREF_4\">Bowen, W. C., Michalopoulos, A. W., Orr, A., Ding, M. Q., Stolz, D. B. and Michalopoulos, G. K. (2014), Development of a chemically defined medium and discovery of new mitogenic growth factors for mouse hepatocytes: mitogenic effects of FGF1/2 and PDGF. <em>PLoS One</em> <strong>9</strong>, e95487, 10.1371/journal.pone.0095487. </a></p>\n\n<p>&nbsp;</p>\n\n<p><a name=\"_ENREF_5\">Budinsky, R. A., Schrenk, D., Simon, T., Van den Berg, M., Reichard, J. F., Silkworth, J. B., Aylward, L. L., Brix, A., Gasiewicz, T., Kaminski, N., Perdew, G., Starr, T. B., Walker, N. J. and Rowlands, J. C. (2014), Mode of action and dose-response framework analysis for receptor-mediated toxicity: The aryl hydrocarbon receptor as a case study. <em>Crit Rev Toxicol</em> <strong>44</strong>, 83-119, 10.3109/10408444.2013.835787. </a></p>\n\n<p><a name=\"_ENREF_6\">Cavanagh, B. L., Walker, T., Norazit, A. and Meedeniya, A. C. (2011), Thymidine analogues for tracking DNA synthesis. <em>Molecules</em> <strong>16</strong>, 7980-93, 10.3390/molecules16097980. </a></p>\n\n<p><a name=\"_ENREF_7\">Cohen, S. M. (2010), Evaluation of possible carcinogenic risk to humans based on liver tumors in rodent assays: the two-year bioassay is no longer necessary. <em>Toxicol Pathol</em> <strong>38</strong>, 487-501, 10.1177/0192623310363813. </a></p>\n\n<p><a name=\"_ENREF_8\">Columbano, A. and Shinozuka, H. (1996), Liver regeneration versus direct hyperplasia. <em>FASEB J</em> <strong>10</strong>, 1118-28. </a></p>\n\n<p><a name=\"_ENREF_9\">Corton, J. C., Peters, J. M. and Klaunig, J. E. (2018), The PPARalpha-dependent rodent liver tumor response is not relevant to humans: addressing misconceptions. <em>Arch Toxicol</em> <strong>92</strong>, 83-119, 10.1007/s00204-017-2094-7. </a></p>\n\n<p><a name=\"_ENREF_10\">Dietrich, D. R. (1993), Toxicological and pathological applications of proliferating cell nuclear antigen (PCNA), a novel endogenous marker for cell proliferation. <em>Crit Rev Toxicol</em> <strong>23</strong>, 77-109, 10.3109/10408449309104075. </a></p>\n\n<p><a name=\"_ENREF_11\">Eldrige, S. R., Butterworth, B. E. and Goldsworthy, T. L. (1993), Proliferating cell nuclear antigen: a marker for hepatocellular proliferation in rodents. <em>Environ Health Perspect</em> <strong>101 Suppl 5</strong>, 211-8, 10.1289/ehp.93101s5211. </a></p>\n\n<p><a name=\"_ENREF_12\">Haines, C., Elcombe, B. M., Chatham, L. R., Vardy, A., Higgins, L. G., Elcombe, C. R. and Lake, B. G. (2018c), Comparison of the effects of sodium phenobarbital in wild type and humanized constitutive androstane receptor (CAR)/pregnane X receptor (PXR) mice and in cultured mouse, rat and human hepatocytes. <em>Toxicology</em> <strong>396-397</strong>, 23-32, 10.1016/j.tox.2018.02.001. </a></p>\n\n<p><a name=\"_ENREF_13\">Hirose, Y., Nagahori, H., Yamada, T., Deguchi, Y., Tomigahara, Y., Nishioka, K., Uwagawa, S., Kawamura, S., Isobe, N., Lake, B. G. and Okuno, Y. (2009), Comparison of the effects of the synthetic pyrethroid Metofluthrin and phenobarbital on CYP2B form induction and replicative DNA synthesis in cultured rat and human hepatocytes. <em>Toxicology</em> <strong>258</strong>, 64-9. </a></p>\n\n<p><a name=\"_ENREF_14\">Hodges, N. J., Orton, T. C., Strain, A. J. and Chipman, J. K. (2000), Potentiation of epidermal growth factor-induced DNA synthesis in rat hepatocytes by phenobarbitone: possible involvement of oxidative stress and kinase activation. <em>Carcinogenesis</em> <strong>21</strong>, 2041-7. </a></p>\n\n<p><a name=\"_ENREF_15\">Jones, H. B., Orton, T. C. and Lake, B. G. (2009), Effect of chronic phenobarbitone administration on liver tumour formation in the C57BL/10J mouse. <em>Food Chem Toxicol</em> <strong>47</strong>, 1333-40, 10.1016/j.fct.2009.03.014. </a></p>\n\n<p><a name=\"_ENREF_16\">Kee, N., Sivalingam, S., Boonstra, R. and Wojtowicz, J. M. (2002), The utility of Ki-67 and BrdU as proliferative markers of adult neurogenesis. <em>J Neurosci Methods</em> <strong>115</strong>, 97-105. </a></p>\n\n<p><a name=\"_ENREF_17\">Kolaja, K. L., Stevenson, D. E., Johnson, J. T., Walborg, E. F., Jr. and Klaunig, J. E. (1996a), Subchronic effects of dieldrin and phenobarbital on hepatic DNA synthesis in mice and rats. <em>Fundam Appl Toxicol</em> <strong>29</strong>, 219-28. </a></p>\n\n<p><a name=\"_ENREF_18\">Komposch, K. and Sibilia, M. (2015), EGFR Signaling in Liver Diseases. <em>Int J Mol Sci</em> <strong>17</strong>, 10.3390/ijms17010030. </a></p>\n\n<p><a name=\"_ENREF_19\">Muskhelishvili, L., Latendresse, J. R., Kodell, R. L. and Henderson, E. B. (2003), Evaluation of cell proliferation in rat tissues with BrdU, PCNA, Ki-67(MIB-5) immunohistochemistry and in situ hybridization for histone mRNA. <em>J Histochem Cytochem</em> <strong>51</strong>, 1681-8. </a></p>\n\n<p><a name=\"_ENREF_20\">Parzefall, W., Erber, E., Sedivy, R. and Schulte-Hermann, R. (1991), Testing for induction of DNA synthesis in human hepatocyte primary cultures by rat liver tumor promoters. <em>Cancer Res</em> <strong>51</strong>, 1143-7. </a></p>\n\n<p><a name=\"_ENREF_21\">Peffer, R. C., LeBaron, M. J., Battalora, M., Bomann, W. H., Werner, C., Aggarwal, M., Rowe, R. R. and Tinwell, H. (2018b), Minimum datasets to establish a CAR-mediated mode of action for rodent liver tumors. <em>Regul Toxicol Pharmacol</em> <strong>96</strong>, 106-120, 10.1016/j.yrtph.2018.04.001. </a></p>\n\n<p><a name=\"_ENREF_22\">Scholzen, T. and Gerdes, J. (2000), The Ki-67 protein: from the known and the unknown. <em>J Cell Physiol</em> <strong>182</strong>, 311-22, 10.1002/(sici)1097-4652(200003)182:3&lt;311::aid-jcp1&gt;3.0.co;2-9. </a></p>\n\n<p><a name=\"_ENREF_23\">Wood, C. E., Hukkanen, R. R., Sura, R., Jacobson-Kram, D., Nolte, T., Odin, M. and Cohen, S. M. (2015), Scientific and Regulatory Policy Committee (SRPC) Review: Interpretation and Use of Cell Proliferation Data in Cancer Risk Assessment. <em>Toxicol Pathol</em> <strong>43</strong>, 760-75, 10.1177/0192623315576005. </a></p>\n\n<p><a name=\"_ENREF_24\">Yamada, T., Okuda, Y., Kushida, M., Sumida, K., Takeuchi, H., Nagahori, H., Fukuda, T., Lake, B. G., Cohen, S. M. and Kawamura, S. (2014), Human hepatocytes support the hypertrophic but not the hyperplastic response to the murine nongenotoxic hepatocarcinogen sodium phenobarbital in an in vivo study using a chimeric mouse with humanized liver. <em>Toxicol Sci</em> <strong>142</strong>, 137-57, 10.1093/toxsci/kfu173. </a></p>\n","biologicalOrganisationLevel":"Cellular","organTerm":{"name":"liver","sourceId":"UBERON:0002107"},"biologicalEvents":[{"action":"increased","process":"cell proliferation","object":{"name":"mitogenic signaling cell","source":"CL","sourceId":"CL:0000422"}},{"action":"increased","process":"hepatocyte proliferation","object":{"name":"hepatocyte","source":"CL","sourceId":"CL:0000182"}}],"keyEventStressors":["pirinixic acid","Phenobarbital","2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD)","Epidermal growth factor"],"id":716}
{"title":"Increase, cell proliferation (hepatocytes)","references":"<p><a name=\"_ENREF_1\">Barberan, S. and Cebria, F. (2018), The role of the EGFR signaling pathway in stem cell differentiation during planarian regeneration and homeostasis. <em>Semin Cell Dev Biol</em>, 10.1016/j.semcdb.2018.05.011. </a></p>\n\n<p><a name=\"_ENREF_2\">Becker, R. A., Patlewicz, G., Simon, T. W., Rowlands, J. C. and Budinsky, R. A. (2015), The adverse outcome pathway for rodent liver tumor promotion by sustained activation of the aryl hydrocarbon receptor. <em>Regul Toxicol Pharmacol</em> <strong>73</strong>, 172-90, 10.1016/j.yrtph.2015.06.015. </a></p>\n\n<p><a name=\"_ENREF_3\">Berasain, C. and Avila, M. A. (2014), The EGFR signalling system in the liver: from hepatoprotection to hepatocarcinogenesis. <em>J Gastroenterol</em> <strong>49</strong>, 9-23, 10.1007/s00535-013-0907-x. </a></p>\n\n<p>&nbsp;</p>\n\n<p><a name=\"_ENREF_4\">Bowen, W. C., Michalopoulos, A. W., Orr, A., Ding, M. Q., Stolz, D. B. and Michalopoulos, G. K. (2014), Development of a chemically defined medium and discovery of new mitogenic growth factors for mouse hepatocytes: mitogenic effects of FGF1/2 and PDGF. <em>PLoS One</em> <strong>9</strong>, e95487, 10.1371/journal.pone.0095487. </a></p>\n\n<p>&nbsp;</p>\n\n<p><a name=\"_ENREF_5\">Budinsky, R. A., Schrenk, D., Simon, T., Van den Berg, M., Reichard, J. F., Silkworth, J. B., Aylward, L. L., Brix, A., Gasiewicz, T., Kaminski, N., Perdew, G., Starr, T. B., Walker, N. J. and Rowlands, J. C. (2014), Mode of action and dose-response framework analysis for receptor-mediated toxicity: The aryl hydrocarbon receptor as a case study. <em>Crit Rev Toxicol</em> <strong>44</strong>, 83-119, 10.3109/10408444.2013.835787. </a></p>\n\n<p><a name=\"_ENREF_6\">Cavanagh, B. L., Walker, T., Norazit, A. and Meedeniya, A. C. (2011), Thymidine analogues for tracking DNA synthesis. <em>Molecules</em> <strong>16</strong>, 7980-93, 10.3390/molecules16097980. </a></p>\n\n<p><a name=\"_ENREF_7\">Cohen, S. M. (2010), Evaluation of possible carcinogenic risk to humans based on liver tumors in rodent assays: the two-year bioassay is no longer necessary. <em>Toxicol Pathol</em> <strong>38</strong>, 487-501, 10.1177/0192623310363813. </a></p>\n\n<p><a name=\"_ENREF_8\">Columbano, A. and Shinozuka, H. (1996), Liver regeneration versus direct hyperplasia. <em>FASEB J</em> <strong>10</strong>, 1118-28. </a></p>\n\n<p><a name=\"_ENREF_9\">Corton, J. C., Peters, J. M. and Klaunig, J. E. (2018), The PPARalpha-dependent rodent liver tumor response is not relevant to humans: addressing misconceptions. <em>Arch Toxicol</em> <strong>92</strong>, 83-119, 10.1007/s00204-017-2094-7. </a></p>\n\n<p><a name=\"_ENREF_10\">Dietrich, D. R. (1993), Toxicological and pathological applications of proliferating cell nuclear antigen (PCNA), a novel endogenous marker for cell proliferation. <em>Crit Rev Toxicol</em> <strong>23</strong>, 77-109, 10.3109/10408449309104075. </a></p>\n\n<p><a name=\"_ENREF_11\">Eldrige, S. R., Butterworth, B. E. and Goldsworthy, T. L. (1993), Proliferating cell nuclear antigen: a marker for hepatocellular proliferation in rodents. <em>Environ Health Perspect</em> <strong>101 Suppl 5</strong>, 211-8, 10.1289/ehp.93101s5211. </a></p>\n\n<p><a name=\"_ENREF_12\">Haines, C., Elcombe, B. M., Chatham, L. R., Vardy, A., Higgins, L. G., Elcombe, C. R. and Lake, B. G. (2018c), Comparison of the effects of sodium phenobarbital in wild type and humanized constitutive androstane receptor (CAR)/pregnane X receptor (PXR) mice and in cultured mouse, rat and human hepatocytes. <em>Toxicology</em> <strong>396-397</strong>, 23-32, 10.1016/j.tox.2018.02.001. </a></p>\n\n<p><a name=\"_ENREF_13\">Hirose, Y., Nagahori, H., Yamada, T., Deguchi, Y., Tomigahara, Y., Nishioka, K., Uwagawa, S., Kawamura, S., Isobe, N., Lake, B. G. and Okuno, Y. (2009), Comparison of the effects of the synthetic pyrethroid Metofluthrin and phenobarbital on CYP2B form induction and replicative DNA synthesis in cultured rat and human hepatocytes. <em>Toxicology</em> <strong>258</strong>, 64-9. </a></p>\n\n<p><a name=\"_ENREF_14\">Hodges, N. J., Orton, T. C., Strain, A. J. and Chipman, J. K. (2000), Potentiation of epidermal growth factor-induced DNA synthesis in rat hepatocytes by phenobarbitone: possible involvement of oxidative stress and kinase activation. <em>Carcinogenesis</em> <strong>21</strong>, 2041-7. </a></p>\n\n<p><a name=\"_ENREF_15\">Jones, H. B., Orton, T. C. and Lake, B. G. (2009), Effect of chronic phenobarbitone administration on liver tumour formation in the C57BL/10J mouse. <em>Food Chem Toxicol</em> <strong>47</strong>, 1333-40, 10.1016/j.fct.2009.03.014. </a></p>\n\n<p><a name=\"_ENREF_16\">Kee, N., Sivalingam, S., Boonstra, R. and Wojtowicz, J. M. (2002), The utility of Ki-67 and BrdU as proliferative markers of adult neurogenesis. <em>J Neurosci Methods</em> <strong>115</strong>, 97-105. </a></p>\n\n<p><a name=\"_ENREF_17\">Kolaja, K. L., Stevenson, D. E., Johnson, J. T., Walborg, E. F., Jr. and Klaunig, J. E. (1996a), Subchronic effects of dieldrin and phenobarbital on hepatic DNA synthesis in mice and rats. <em>Fundam Appl Toxicol</em> <strong>29</strong>, 219-28. </a></p>\n\n<p><a name=\"_ENREF_18\">Komposch, K. and Sibilia, M. (2015), EGFR Signaling in Liver Diseases. <em>Int J Mol Sci</em> <strong>17</strong>, 10.3390/ijms17010030. </a></p>\n\n<p><a name=\"_ENREF_19\">Muskhelishvili, L., Latendresse, J. R., Kodell, R. L. and Henderson, E. B. (2003), Evaluation of cell proliferation in rat tissues with BrdU, PCNA, Ki-67(MIB-5) immunohistochemistry and in situ hybridization for histone mRNA. <em>J Histochem Cytochem</em> <strong>51</strong>, 1681-8. </a></p>\n\n<p><a name=\"_ENREF_20\">Parzefall, W., Erber, E., Sedivy, R. and Schulte-Hermann, R. (1991), Testing for induction of DNA synthesis in human hepatocyte primary cultures by rat liver tumor promoters. <em>Cancer Res</em> <strong>51</strong>, 1143-7. </a></p>\n\n<p><a name=\"_ENREF_21\">Peffer, R. C., LeBaron, M. J., Battalora, M., Bomann, W. H., Werner, C., Aggarwal, M., Rowe, R. R. and Tinwell, H. (2018b), Minimum datasets to establish a CAR-mediated mode of action for rodent liver tumors. <em>Regul Toxicol Pharmacol</em> <strong>96</strong>, 106-120, 10.1016/j.yrtph.2018.04.001. </a></p>\n\n<p><a name=\"_ENREF_22\">Scholzen, T. and Gerdes, J. (2000), The Ki-67 protein: from the known and the unknown. <em>J Cell Physiol</em> <strong>182</strong>, 311-22, 10.1002/(sici)1097-4652(200003)182:3&lt;311::aid-jcp1&gt;3.0.co;2-9. </a></p>\n\n<p><a name=\"_ENREF_23\">Wood, C. E., Hukkanen, R. R., Sura, R., Jacobson-Kram, D., Nolte, T., Odin, M. and Cohen, S. M. (2015), Scientific and Regulatory Policy Committee (SRPC) Review: Interpretation and Use of Cell Proliferation Data in Cancer Risk Assessment. <em>Toxicol Pathol</em> <strong>43</strong>, 760-75, 10.1177/0192623315576005. </a></p>\n\n<p><a name=\"_ENREF_24\">Yamada, T., Okuda, Y., Kushida, M., Sumida, K., Takeuchi, H., Nagahori, H., Fukuda, T., Lake, B. G., Cohen, S. M. and Kawamura, S. (2014), Human hepatocytes support the hypertrophic but not the hyperplastic response to the murine nongenotoxic hepatocarcinogen sodium phenobarbital in an in vivo study using a chimeric mouse with humanized liver. <em>Toxicol Sci</em> <strong>142</strong>, 137-57, 10.1093/toxsci/kfu173. </a></p>\n","biologicalOrganisationLevel":"Cellular","organTerm":{"name":"liver","sourceId":"UBERON:0002107"},"biologicalEvents":[{"action":"increased","process":"cell proliferation","object":{"name":"mitogenic signaling cell","source":"CL","sourceId":"CL:0000422"}},{"action":"increased","process":"hepatocyte proliferation","object":{"name":"hepatocyte","source":"CL","sourceId":"CL:0000182"}}],"keyEventStressors":["pirinixic acid","Phenobarbital","2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD)","Epidermal growth factor"],"id":716}
{"title":"Increase, Clonal Expansion of Altered Hepatic Foci","references":"<p>Conolly, R. B., &amp; Andersen, M. E. (1991). Biologically based pharmacodynamic models: tools for toxicological research and risk assessment. Annu Rev Pharmacol Toxicol, 31, 503-523. https://doi.org/10.1146/annurev.pa.31.040191.002443</p>\n\n<p>Corton, J. C., Cunningham, M. L., Hummer, T. B., Lau, C, Meek, B, Peters, JM, Popp, JA, Rhomberg, L, Seed, J., &amp; Klaunig, J. E. (2014). Mode of action framework analysis for receptor-mediated toxicity: The peroxisome proliferator-activated receptor alpha (PPAR&OElig;&plusmn;) as a case study. Crit Rev Toxicol, 44(1), 1-49. https://doi.org/10.3109/10408444.2013.835784</p>\n\n<p>Cox, L. A., &amp; Huber, W. A. (2007). Symmetry, identifiability, and prediction uncertainties in multistage clonal expansion (MSCE) models of carcinogenesis. Risk Anal, 27(6), 1441-1453. https://doi.org/10.1111/j.1539-6924.2007.00980.x</p>\n\n<p>Dragan, Y. P., Rizvi, T., Xu, Y. H., Hully, J. R., Bawa, N., Campbell, H. A. et al. (1991). An initiation-promotion assay in rat liver as a potential complement to the 2-year carcinogenesis bioassay. Fundam Appl Toxicol, 16(3), 525-547.</p>\n\n<p>Glauert, H. P., &amp; Pitot, H. C. (1986). Influence of dietary fat on the promotion of diethylnitrosamine-induced hepatocarcinogenesis in female rats. &hellip;&nbsp;of the Society for Experimental Biology&nbsp;&hellip;. https://journals.sagepub.com/doi/abs/10.3181/00379727-181-42283.</p>\n\n<p style=\"text-align:start\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"color:#000000\"><span style=\"font-size:12pt\"><span style=\"font-family:Arial,sans-serif\">Grasl-Kraupp B, Huber W, Just W, et al. (1993a). Enhancement of peroxisomal enzymes, cytochrome P-452 and DNA synthesis in putative preneoplastic foci of rat liver treated with the peroxisome proliferator nafenopin. Carcinogenesis, 14, 1007&ndash;12.</span></span></span></span></span></p>\n\n<p style=\"text-align:start\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"color:#000000\"><span style=\"font-size:12pt\"><span style=\"font-family:Arial,sans-serif\">Grasl-Kraupp B, Huber W, Timmermann-Trosiener I, Schulte-Hermann R. (1993b). Peroxisomal enzyme induction uncoupled from enhanced DNA synthesis in putative preneoplastic liver foci of rats treated with a single dose of the peroxisome proliferator nafenopin. Carcinogenesis, 14, 2435&ndash;7</span></span></span></span></span></p>\n\n<p style=\"text-align:start\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"color:#000000\"><span style=\"font-size:12pt\"><span style=\"font-family:Arial,sans-serif\">Grasl-Kraupp B, Waldhor T, Huber W, Schulte-Hermann R. (1993c). Glutathione S-transferase isoenzyme patterns in different subtypes of enzyme-altered rat liver foci treated with the peroxisome proliferator nafenopin or with phenobarbital. Carcinogenesis, 14, 2407&ndash;12</span></span></span></span></span></p>\n\n<p>Grompe, M. (2009). Adult Liver Stem Cells.&nbsp; In Essentials of Stem Cell Biology (pp. 285-298). Elsevier. https://www.sciencedirect.com/science/article/pii/B9780123747297000342</p>\n\n<p>Hendrich, S., Campbell, H. A., &amp; Pitot, H. C. (1987). Quantitative stereological evaluation of four histochemical markers of altered foci in multistage hepatocarcinogenesis in the rat. Carcinogenesis, 8(9), 1245-1250.</p>\n\n<p style=\"text-align:start\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"color:#000000\"><span style=\"font-size:12pt\"><span style=\"font-family:Arial,sans-serif\">Isenberg JS, Kolaja KL, Ayoubi SA, et al. (1997). Inhibition of WY 14&thinsp;643-induced hepatic lesion growth in mice by rotenone. Carcinogenesis, 18, 1511&ndash;9</span></span></span></span></span></p>\n\n<p>Kaplanski, C., Pauley, C. J., Griffiths, T. G., Kawabata, T. T., &amp; Ledwith, B. J. (2000). Differentiation of rat oval cells after activation of peroxisome proliferator-activated receptor alpha43. Cancer Res, 60(3), 580-587. https://pubmed.ncbi.nlm.nih.gov/10676640</p>\n\n<p>Kuwata, K., Inoue, K., Ichimura, R., Takahashi, M., Kodama, Y., &amp; Yoshida, M. (2016). Constitutive active/androstane receptor, peroxisome proliferator-activated receptor &alpha;, and cytotoxicity are involved in oxadiazon-induced liver tumor development in mice. Food Chem Toxicol, 88, 75-86.</p>\n\n<p>Marsman, D. S., &amp; Popp, J. A. (1994). Biological potential of basophilic hepatocellular foci and hepatic adenoma induced by the peroxisome proliferator, Wy-14,643. Carcinogenesis, 15(1), 111-117. https://doi.org/10.1093/carcin/15.1.111</p>\n\n<p>Moolgavkar, S. H., &amp; Luebeck, E. G. (2003). Multistage carcinogenesis and the incidence of human cancer. Genes Chromosomes Cancer, 38(4), 302-306. https://doi.org/10.1002/gcc.10264</p>\n\n<p>Pitot, H. C., Campbell, H. A., Maronpot, R., Bawa, N., Rizvi, T. A., Xu, Y. H. et al. (1989). Critical parameters in the quantitation of the stages of initiation, promotion, and progression in one model of hepatocarcinogenesis in the rat. Toxicol Pathol, 17(4 Pt 1), 594-611; discussion 611.</p>\n\n<p>Pitot, H. C., Dragan, Y., Xu, Y. H., &amp; Pyron&hellip;, M. (1990). Role of altered hepatic foci in the stages of carcinogenesis. Progress in clinical&nbsp;&hellip;. https://europepmc.org/article/med/2196586.</p>\n\n<p>Scherer, E. (1987). Relationship among histochemically distinguishable early lesions in multistep-multistage hepatocarcinogenesis. Mouse Liver Tumors. https://link.springer.com/chapter/10.1007/978-3-642-71617-1_7</p>\n","biologicalOrganisationLevel":"Cellular","organTerm":{"name":"liver","sourceId":"UBERON:0002107"},"biologicalEvents":[{"object":{}}],"id":1171}
{"title":"Increase, hepatocellular adenomas and carcinomas","references":"","biologicalOrganisationLevel":"Tissue","organTerm":{"name":"liver","sourceId":"UBERON:0002107"},"biologicalEvents":[{"action":"increased","object":{"name":"Adenoma","source":"MESH","sourceId":"D000236"}},{"action":"increased","object":{"name":"Carcinoma","source":"MESH","sourceId":"D002277"}},{"action":"increased","process":"hepatocellular carcinoma","object":{"name":"Adenoma","source":"MESH","sourceId":"D000236"}}],"id":719}
{"title":"Increase, hepatocellular adenomas and carcinomas","references":"","biologicalOrganisationLevel":"Tissue","organTerm":{"name":"liver","sourceId":"UBERON:0002107"},"biologicalEvents":[{"action":"increased","object":{"name":"Adenoma","source":"MESH","sourceId":"D000236"}},{"action":"increased","object":{"name":"Carcinoma","source":"MESH","sourceId":"D002277"}},{"action":"increased","process":"hepatocellular carcinoma","object":{"name":"Adenoma","source":"MESH","sourceId":"D000236"}}],"id":719}
{"title":"Increase, hepatocellular adenomas and carcinomas","references":"","biologicalOrganisationLevel":"Tissue","organTerm":{"name":"liver","sourceId":"UBERON:0002107"},"biologicalEvents":[{"action":"increased","object":{"name":"Adenoma","source":"MESH","sourceId":"D000236"}},{"action":"increased","object":{"name":"Carcinoma","source":"MESH","sourceId":"D002277"}},{"action":"increased","process":"hepatocellular carcinoma","object":{"name":"Adenoma","source":"MESH","sourceId":"D000236"}}],"id":719}
{"title":"N/A, Liver fibrosis","references":"<ul>\n\t<li>Bataller, R. and D.A. Brenner (2005), Liver Fibrosis, J.Clin. Invest, vol. 115, no. 2, pp. 209-218.</li>\n\t<li>Merck Manual available at: <a class=\"external free\" href=\"http://www.merckmanuals.com/professional/hepatic_and_biliary_disorders/fibrosis_and_cirrhosis/hepatic_fibrosis.html,(accessed\" rel=\"nofollow\" target=\"_blank\">http://www.merckmanuals.com/professional/hepatic_and_biliary_disorders/fibrosis_and_cirrhosis/hepatic_fibrosis.html,(accessed</a> 10 February 2015).</li>\n\t<li>Lim, Y. and W. Kim (2008), The global impact of hepatic fibrosis and end-stage liver disease, Clin Liver Dis, vol. 12, no. 4, pp. 733-746.</li>\n\t<li>Blachier, M. et al. (2013), The burden of liver disease in Europe: a review of available epidemiological data, J Hepatol, vol. 58, no. 3, pp. 593-608.</li>\n\t<li>Van Agthoven, M. et al. (2001), A comparison of the costs and effects of liver transplantation for acute and for chronic liver failure. Transpl Int, vol. 14, no. 2, pp. 87-94.</li>\n\t<li>Goodman, Z.D. (2007), Grading and staging systems for inflammation and fibrosis in chronic liver diseases, Journal of Hepatology, vol. 47, no. 4, pp. 598-607.</li>\n\t<li>Carey, E. (2010), Noninvasive tests for liver disease, fibrosis, and cirrhosis: Is liver biopsy obsolete? Cleveland Clinic Journal of Medicine, vol. 77, no. 8, pp. 519-527.</li>\n\t<li>Germani, G. et al. (2011), Assessment of Fibrosis and Cirrhosis in Liver Biopsies, Semin Liver Dis, vol. 31, no. 1, pp. 82-90. available at <a class=\"external free\" href=\"http://www.medscape.com/viewarticle/743946_2,(accessed\" rel=\"nofollow\" target=\"_blank\">http://www.medscape.com/viewarticle/743946_2,(accessed</a> 10 February 2015).</li>\n\t<li>Liedtke, C. et al. (2013), Experimental liver fibrosis research: update on animal models, legal issues and translational aspects, Fibrogenesis Tissue Repair, vol. 6, no. 1, p. 19.</li>\n</ul>\n","biologicalOrganisationLevel":"Organ","organTerm":{"name":"liver","sourceId":"UBERON:0002107"},"biologicalEvents":[{"action":"occurrence","process":"liver fibrosis","object":{"name":"liver","source":"UBERON","sourceId":"UBERON:0002107"}}],"id":344}
{"title":"Alkylation, Protein","references":"<ol class=\"references\">\n<li id=\"cite_note-1\"><span class=\"mw-cite-backlink\"><a href=\"#cite_ref-1\"></a></span> <span class=\"reference-text\">The European Bioinformatics Institute <a rel=\"nofollow\" target=\"_blank\" class=\"external free\" href=\"http://www.ebi.ac.uk/QuickGO/GTerm?id=GO:0008213\">http://www.ebi.ac.uk/QuickGO/GTerm?id=GO:0008213</a> (accessed on 20 January 2016).</span>\n</li>\n<li id=\"cite_note-2\"><span class=\"mw-cite-backlink\"><a href=\"#cite_ref-2\"></a></span> <span class=\"reference-text\">NLM, Medical Subject Headings, National Library of Medicine, <a rel=\"nofollow\" target=\"_blank\" class=\"external free\" href=\"http://www.nlm.nih.gov/cgi/mesh/2011/MB_cgi?mode=&amp;term=Alkylating+agents\">http://www.nlm.nih.gov/cgi/mesh/2011/MB_cgi?mode=&amp;term=Alkylating+agents</a> (accessed on 20 January 2016).</span>\n</li>\n<li id=\"cite_note-Codreanu_2014-3\"><span class=\"mw-cite-backlink\"> <sup><a href=\"#cite_ref-Codreanu_2014_3-0\">3.0</a></sup> <sup><a href=\"#cite_ref-Codreanu_2014_3-1\">3.1</a></sup> <sup><a href=\"#cite_ref-Codreanu_2014_3-2\">3.2</a></sup></span> <span class=\"reference-text\">Codreanu, S.G. et al. (2014), Alkylation damage by lipid electrophiles targets functional protein systems, Molecular &amp; Cellular Proteomics, vol. 13, no. 3, pp.849859.</span>\n</li>\n<li id=\"cite_note-4\"><span class=\"mw-cite-backlink\"><a href=\"#cite_ref-4\"></a></span> <span class=\"reference-text\">Grattagliano, I. et al. (2009), Biochemical mechanisms in drug-induced liver injury: certainties and doubts, World J Gastroenterol, vol. 15, no. 39, pp. 4865-4876.</span>\n</li>\n<li id=\"cite_note-5\"><span class=\"mw-cite-backlink\"><a href=\"#cite_ref-5\"></a></span> <span class=\"reference-text\">Livertox <a rel=\"nofollow\" target=\"_blank\" class=\"external free\" href=\"http://livertox.nlm.nih.gov/AlkylatingAgents.htm\">http://livertox.nlm.nih.gov/AlkylatingAgents.htm</a></span>\n</li>\n<li id=\"cite_note-Kehrer2000-6\"><span class=\"mw-cite-backlink\"> <sup><a href=\"#cite_ref-Kehrer2000_6-0\">6.0</a></sup> <sup><a href=\"#cite_ref-Kehrer2000_6-1\">6.1</a></sup></span> <span class=\"reference-text\">Kehrer, J.P. and S. Biswal (2000), The Molecular Effects of Acrolein, Toxicol. Sciences,vol.57,pp.6-15.</span>\n</li>\n<li id=\"cite_note-7\"><span class=\"mw-cite-backlink\"><a href=\"#cite_ref-7\"></a></span> <span class=\"reference-text\">Schopfer, F.J., C. Cipollina and B.A. Freeman (2011), Formation and Signaling Actions of Electrophilic Lipids, Chem Rev, vol. 111, no. 10,pp.59976021.</span>\n</li>\n<li id=\"cite_note-8\"><span class=\"mw-cite-backlink\"><a href=\"#cite_ref-8\"></a></span> <span class=\"reference-text\">Zhang F et al. (2005), Differential adduction of proteins vs. deoxynucleosides by methyl methanesulfonate and 1-methyl-1-nitrosourea in vitro, Mass Spectrom, vol 19, no. 4, pp. 438448.</span>\n</li>\n<li id=\"cite_note-9\"><span class=\"mw-cite-backlink\"><a href=\"#cite_ref-9\"></a></span> <span class=\"reference-text\">Gundry, R.L. et al. (2009), Preparation of proteins and peptides for mass spectrometry analysis in a bottom-up proteomics workflow, Curr Protoc Mol Biol, chapter 10, section VI, unit 10.25, pp. 1-23.</span>\n</li>\n<li id=\"cite_note-10\"><span class=\"mw-cite-backlink\"><a href=\"#cite_ref-10\"></a></span> <span class=\"reference-text\">Kislinger, T. et al. (2005), Analysis of protein glycation products by MALDI-TOF/MS, Ann N Y Acad Sci, vol. 1043, pp. 249-259.</span>\n</li>\n<li id=\"cite_note-EPA_2010-11\"><span class=\"mw-cite-backlink\"> <sup><a href=\"#cite_ref-EPA_2010_11-0\">11.0</a></sup> <sup><a href=\"#cite_ref-EPA_2010_11-1\">11.1</a></sup></span> <span class=\"reference-text\">EPA Toxicological review of Carbon Tetrachloride (CAS No. 56-23-5). March 2010 EPA/635/R-08/005F available at: <a rel=\"nofollow\" target=\"_blank\" class=\"external free\" href=\"http://cfpub.epa.gov/ncea/iris/iris_documents/documents/toxreviews/0020tr.pdf\">http://cfpub.epa.gov/ncea/iris/iris_documents/documents/toxreviews/0020tr.pdf</a> (accessed 24.10.2015)</span>\n</li>\n<li id=\"cite_note-12\"><span class=\"mw-cite-backlink\"><a href=\"#cite_ref-12\"></a></span> <span class=\"reference-text\">Auerbach, S.S. et al. (2008), A comparative 90 day toxicity study of allyl acetate, allyl alcohol and acrolein, Toxicology, Vol. 253, No.1-3, pp.7988.</span>\n</li>\n<li id=\"cite_note-13\"><span class=\"mw-cite-backlink\"><a href=\"#cite_ref-13\"></a></span> <span class=\"reference-text\">Huang, L. et al. (2008), Genes related to apoptosis predict necrosis of the liver as a phenotype observed in rats exposed to a compendium of hepatotoxicants, BMC Genomics, vol. 9: 288.</span>\n</li>\n<li id=\"cite_note-14\"><span class=\"mw-cite-backlink\"><a href=\"#cite_ref-14\"></a></span> <span class=\"reference-text\">Mohammad, M.K. et al. (2012), Acrolein cytotoxicity in hepatocytes involves endoplasmic reticulum stress, mitochondrial dysfunction and oxidative stress, Toxicol Appl Pharmacol, vol. 265, no. 1, pp. 73-82.</span>\n</li>\n<li id=\"cite_note-15\"><span class=\"mw-cite-backlink\"><a href=\"#cite_ref-15\"></a></span> <span class=\"reference-text\">Yamada T et al., (2013), A category approach to predicting the repeated-dose hepatotoxicity of allyl esters, Regulatory Toxicology and Pharmacology, vol. 65, no. 2, pp. 189195.</span>\n</li>\n<li id=\"cite_note-16\"><span class=\"mw-cite-backlink\"><a href=\"#cite_ref-16\"></a></span> <span class=\"reference-text\">Basu, S. (2003), Carbon tetrachloride-induced lipid peroxidation: eicosanoid formation and their regulation by antioxidant nutrients, Toxicology,vol.189, no.1-2, pp. 113-127.</span>\n</li>\n<li id=\"cite_note-17\"><span class=\"mw-cite-backlink\"><a href=\"#cite_ref-17\"></a></span> <span class=\"reference-text\">Calabrese, E.J., L.A. Baldwin and H.M. Mehendale (1993), G2 subpopulation in rat liver induced into mitosis by low-level  exposure to carbon tetrachloride: an adaptive response, Toxicol Appl Pharmacol, vol. 121. no. 1, pp. 1-7.</span>\n</li>\n<li id=\"cite_note-18\"><span class=\"mw-cite-backlink\"><a href=\"#cite_ref-18\"></a></span> <span class=\"reference-text\">Clawson, G.A. (1989), Mechanisms of carbon tetrachloride hepatotoxicity, Pathol Immunopathol Res, vol. 8, no. 2, pp.104-112.</span>\n</li>\n<li id=\"cite_note-19\"><span class=\"mw-cite-backlink\"><a href=\"#cite_ref-19\"></a></span> <span class=\"reference-text\">Knockaert, L. et al. (2012), Carbon tetrachloride-mediated lipid peroxidation induces early mitochondrial alterations in mouse liver, Lab Invest, vol. 92, no. 3, pp. 396-410.</span>\n</li>\n<li id=\"cite_note-20\"><span class=\"mw-cite-backlink\"><a href=\"#cite_ref-20\"></a></span> <span class=\"reference-text\">Lee Kwang-Jong  et al. (2004), Induction of molecular chaperones in carbon tetrachloride-treated rat liver: implications in protection against liver damage, Cell Stress Chaperones, vol. 9, no. 1, pp. 58-68.</span>\n</li>\n<li id=\"cite_note-21\"><span class=\"mw-cite-backlink\"><a href=\"#cite_ref-21\"></a></span> <span class=\"reference-text\">Li, Xiaowei et al. (2014), NMR-based metabonomic and quantitative real-time PCR in the profiling of metabolic changes in carbon tetrachloride-induced rat liver injury, J Pharm Biomed Anal; vol. 89, pp.42-49.</span>\n</li>\n<li id=\"cite_note-22\"><span class=\"mw-cite-backlink\"><a href=\"#cite_ref-22\"></a></span> <span class=\"reference-text\">Manibusan, M.K., M. Odin and D.A. Eastmond (2007), Postulated carbon tetrachloride mode of action: a review, J Environ Sci Health C Environ Carcinog Ecotoxicol Rev, vol. 25, no. 3,pp. 185-209.</span>\n</li>\n<li id=\"cite_note-23\"><span class=\"mw-cite-backlink\"><a href=\"#cite_ref-23\"></a></span> <span class=\"reference-text\">Masuda, Y. (2006), [Learning toxicology from carbon tetrachloride-induced hepatotoxicity],Yakugaku Zasshi, vol. 126, no. 10, pp. 885-899.</span>\n</li>\n<li id=\"cite_note-24\"><span class=\"mw-cite-backlink\"><a href=\"#cite_ref-24\"></a></span> <span class=\"reference-text\">Nagano, K. et al. (2007), Inhalation carcinogenicity and chronic toxicity of carbon tetrachloride in rats and mice, Inhal Toxicol, vol 19, no. 13, pp. 1089-1103.</span>\n</li>\n<li id=\"cite_note-25\"><span class=\"mw-cite-backlink\"><a href=\"#cite_ref-25\"></a></span> <span class=\"reference-text\">Recknagel, R.O. (1976), Carbon tetrachloride hepatotoxicity, Pharmacol Rev, vol. 19, no. 2,pp.145-208.</span>\n</li>\n<li id=\"cite_note-26\"><span class=\"mw-cite-backlink\"><a href=\"#cite_ref-26\"></a></span> <span class=\"reference-text\">Weber, L.W., M. Boll and A. Stampfl (2003), Hepatotoxicity and mechanism of action of haloalkanes: carbon tetrachloride as a toxicological model, Crit Rev Toxicol, vol. 33, \nno. 2, pp. 105-136.</span>\n</li>\n<li id=\"cite_note-27\"><span class=\"mw-cite-backlink\"><a href=\"#cite_ref-27\"></a></span> <span class=\"reference-text\">Bauman, J.N. et al. (2009), Can in vitro metabolism-dependent covalent binding data distinguish hepatotoxic from nonhepatotoxic drugs? An analysis using human \nhepatocytes and liver S-9 fraction, Chem Res Toxicol, vol. 22, no. 2, pp. 332-340.</span>\n</li>\n<li id=\"cite_note-28\"><span class=\"mw-cite-backlink\"><a href=\"#cite_ref-28\"></a></span> <span class=\"reference-text\">Chen, Q. et al. (1990), The mechanism of cysteine conjugate cytotoxicity in renal epithelial cells. Covalent binding leads to thiol depletion and lipid peroxidation, J Biol Chem, vol. 265, no. 35, pp. 21603-21611.</span>\n</li>\n<li id=\"cite_note-29\"><span class=\"mw-cite-backlink\"><a href=\"#cite_ref-29\"></a></span> <span class=\"reference-text\">Dennehy, M.K. et al. (2006), Cytosolic and nuclear protein targets of thiol-reactive electrophiles, Chem Res Toxicol, vol. 19, no. 1, pp. 20-29.</span>\n</li>\n<li id=\"cite_note-30\"><span class=\"mw-cite-backlink\"><a href=\"#cite_ref-30\"></a></span> <span class=\"reference-text\">Shin, N.Y. et al. (2007), Protein targets of reactive electrophiles in human liver microsomes, Chem Res Toxicol, vol. 20, no. 6, pp. 859-867.</span>\n</li>\n</ol>","biologicalOrganisationLevel":"Molecular","organTerm":{},"biologicalEvents":[{"action":"increased","process":"protein alkylation","object":{}}],"keyEventStressors":["Carbon tetrachloride","Allyl Alcohol","Thioacetamide","Retinol","Dimethyl nitrosamine"],"id":244}
{"title":"Activation, Stellate cells","references":"<ul>\n\t<li>Lee, U.E. and S.L. Friedman (2011), Mechanisms of Hepatic Fibrogenesis, Best Pract Res Clin Gastroenterol, vol. 25, no. 2, pp. 195-206.</li>\n\t<li>Friedman, S.L (2010), Evolving challenges in hepatic fibrosis, Nat. Rev. Gastroenterol. Hepatol, vol. 7, no. 8, pp. 425&ndash;436.</li>\n\t<li>Friedman, S.L. (2008), Mechanisms of Hepatic Fibrogenesis, Gastroenterology, vol. 134, no. 6, pp. 1655&ndash;1669.</li>\n\t<li>Friedman, S.L (2000), Molecular regulation of hepatic fibrosis, an integrated cellular response to tissue injury, J. Biol. Chem, vol. 275, no. 4, pp. 2247-2250.</li>\n\t<li>Bataller, R. and D.A. Brenner (2005), Liver Fibrosis, J.Clin. Invest, vol. 115, no. 2, pp. 209-218.</li>\n\t<li>Lotersztain, S. et al. (2005), Hepatic fibrosis: molecular mechanisms and drug targets, Annu. Rev. Pharmacol. Toxicol, vol. 45, pp. 605&ndash;628.</li>\n\t<li>Poli, G. (2000), Pathogenesis of liver fibrosis: role of oxidative stress, Mol Aspects Med, vol. 21, no. 3, pp. 49 &ndash; 98.</li>\n\t<li>Li, Jing-Ting et al. (2008), Molecular mechanism of hepatic stellate cell activation and antifibrotic therapeutic strategies, J Gastroenterol, vol. 43, no. 6, pp. 419&ndash;428.</li>\n\t<li>George, J. et al. (1999), In vivo inhibition of rat stellate cell activation by soluble transforming growth factor beta type II receptor: a potential new therapy for hepatic fibrosis. Proc Natl Acad Sci, vol. 96, no. 22, pp. 12719-12724.</li>\n\t<li>Morini, S. et al. (2005), GFAP expression in the liver as an early marker of stellate cells activation, Ital J Anat Embryol, vol. 110, no. 4, pp. 193-207.</li>\n\t<li>Mannaerts, I. et al. (2013), Gene expression profiling of early hepatic stellate cell activation reveals a role for Igfbp3 in cell migration, PLoS One, vol. 8, no.12, e84071.</li>\n\t<li>Chang et al., 2014, Isolation and culture of hepatic stellate cells from mouse liver. Acta Biochim Biophys Sin (Shanghai).;46(4):291-8.</li>\n\t<li>Costa et al., 2001, Early activation of hepatic stellate cells and perisinusoidal extracellular matrix changes during ex vivo pig liver perfusion. J Submicrosc Cytol Pathol.;33(3):231-40.</li>\n</ul>\n","biologicalOrganisationLevel":"Cellular","organTerm":{},"biologicalEvents":[{"action":"increased","process":"hepatic stellate cell activation","object":{"name":"hepatic stellate cell","source":"CL","sourceId":"CL:0000632"}}],"id":265}
{"title":"Accumulation, Collagen","references":"<ul>\n\t<li>Henderson, N.C. and J.P. Iredale (2007), Liver fibrosis: cellular mechanisms of progression and resolution, Clin Sci (Lond), vol. 112, no. 5, pp. 265-280.</li>\n\t<li>Diegelmann, R.F. (2001), Collagen Metabolism, Wounds, vol. 13, no. 5, available at www.medscape.com/viewarticle/423231 (accessed on 20 Jamuary 2016).</li>\n\t<li>Di Lullo, G.A. et al. (2001), Mapping the Ligand-binding Sites and Disease-associated Mutations on the Most Abundant Protein in the Human, Type I Collagen, J. Biol. Chem, vol. 277, no. 6, pp. 4223&ndash;4231.</li>\n\t<li>Prockop, D.J. and K.I. Kivirikko (1995), Collagens: molecular biology, diseases, and potentials for therapy, Annu Rev Biochem, vol. 64, pp. 403-434.</li>\n\t<li>Miller, E.J. and S. Gay (1987), The collagens: an overview and update, Methods Enzymol, vol. 144, pp. 3-41.</li>\n\t<li>Kivirikko, K.I. and L. Risteli (1976), Biosynthesis of collagen and its alterations in pathological states, Med Biol, vol. 54, no. 3, pp. 159-186.</li>\n\t<li>Rishikof, D.C. et al. (2005), Methods for measuring type I collagen synthesis in vitro, Methods, Mol Med, vol. 117, pp.129-140.</li>\n\t<li>Bataller, R. and D.A. Brenner (2005), Liver Fibrosis, J.Clin. Invest, vol. 115, no. 2, pp. 209-218.</li>\n\t<li>Decaris, M.L. et al. (2015), Turnover rates of hepatic collagen and circulating collagen- associated proteins in humans with chronic liver disease, PLoS One, vol. 10, no. 4, e0123311.</li>\n\t<li>Dalton, S.R. et al. (2009), Carbon tetrachloride-induced liver damage in asialoglycoprotein receptor-deficient mice, Biochem Pharmacol, vol. 77, no. 7, pp. 1283-1290.</li>\n\t<li>Leung, T.M. et al. (2008), Endothelial nitric oxide synthase is a critical factor in experimental liver fibrosis, Int J Exp Pathol, vol. 89, no. 4, pp. 241-250.</li>\n\t<li>Nan, Y.M. et al. (2013), Activation of peroxisome proliferator activated receptor alpha ameliorates ethanol mediated liver fibrosis in mice, Lipids in Health and Disease, vol. 12, p. 11.</li>\n\t<li>Hamdy, N. and E. El-Demerdash. (2012), New therapeutic aspect for carvedilol: antifibrotic effects of carvedilol in chronic carbon tetrachloride-induced liver damage, Toxicol Appl Pharmacol, vol. 261, no. 3, pp. 292-299.</li>\n\t<li>Li, Li et al. (2012), Establishment of a standardized liver fibrosis model with different pathological stages in rats, Gastroenterol Res Pract; vol. 2012, Article ID 560345.Natajaran, S.K. et al. (2006), Oxidative stress in the development of liver cirrhosis: a comparison of two different experimental models, J Gastroenterol Hepatol, vol. 21, no. 6, pp. 947-957.</li>\n\t<li>Natarajan SK, Thomas S, Ramamoorthy P, et al. Oxidative stress in the development of liver cirrhosis: a comparison of two different experimental models. J Gastroenterol Hepatol. 2006;21:947&ndash;957. doi: 10.1111/j.1440-1746.2006.04231.x</li>\n\t<li>Luckey, S.W., and D.R. Petersen (2001), Activation of Kupffer cells during the course of carbon tetrachloride-induced liver injury and fibrosis in rats, Exp Mol Pathol, vol. 71, no. 3, pp. 226-240.</li>\n</ul>\n","biologicalOrganisationLevel":"Tissue","organTerm":{"name":"connective tissue","sourceId":"UBERON:0002384"},"biologicalEvents":[{"action":"increased","process":"collagen biosynthetic process","object":{"name":"collagen","source":"CHEBI","sourceId":"CHEBI:3815"}}],"id":68}
{"title":"Activation, Inflammatory cytokines, chemokines, cytoprotective gene pathways","references":"<p>EMTER, R., ELLIS, G. &amp; NATSCH, A. 2010. Performance of a novel keratinocyte-based reporter cell line to screen skin sensitizers in vitro. Toxicol Appl Pharmacol, 245, 281-90.</p>\n\n<p>HOLGATE, S. T. 2012. Innate and adaptive immune responses in asthma. Nat Med, 18, 673-83.</p>\n\n<p>HUANG, S., WISZNIEWSKI, L., CONSTANT, S. &amp; ROGGEN, E. 2013. Potential of in vitro reconstituted 3D human airway epithelia (MucilAir&trade;) to assess respiratory sensitizers. Toxicol In Vitro, 27, 1151-6.</p>\n\n<p>KAWAI, T. &amp; AKIRA, S. 2009. The roles of TLRs, RLRs and NLRs in pathogen recognition. Int Immunol, 21, 317-37.</p>\n\n<p>KAWAI, T. &amp; AKIRA, S. 2010. The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors. Nat Immunol, 11, 373-84.</p>\n\n<p>LAUENSTEIN, L., SWITALLA, S., PRENZLER, F., SEEHASE, S., PFENNIG, O., F&Ouml;RSTER, C., FIEGUTH, H., BRAUN, A. &amp; SEWALD, K. 2014. Assessment of immunotoxicity induced by chemicals in human precision-cut lung slices (PCLS). Toxicol In Vitro, 28, 588-99.</p>\n\n<p>MIGDAL, C., BOTTON, J., EL ALI, Z., AZOURY, M. E., GULDEMANN, J., GIM&Eacute;NEZ-ARNAU, E., LEPOITTEVIN, J. P., KERDINE-R&Ouml;MER, S. &amp; PALLARDY, M. 2013. Reactivity of chemical sensitizers toward amino acids in cellulo plays a role in the activation of the Nrf2-ARE pathway in human monocyte dendritic cells and the THP-1 cell line. Toxicol Sci, 133, 259-74.</p>\n\n<p>NATSCH, A., RYAN, C. A., FOERTSCH, L., EMTER, R., JAWORSKA, J., GERBERICK, F. &amp; KERN, P. 2013. A dataset on 145 chemicals tested in alternative assays for skin sensitization undergoing prevalidation. J Appl Toxicol, 33, 1337-52.</p>\n\n<p>POYNTER, M. E. 2012. Airway epithelial regulation of allergic sensitization in asthma. Pulm Pharmacol Ther, 25, 438-46.</p>\n\n<p>RAMIREZ, T., MEHLING, A., KOLLE, S. N., WRUCK, C. J., TEUBNER, W., ELTZE, T., AUMANN, A., URBISCH, D., VAN RAVENZWAAY, B. &amp; LANDSIEDEL, R. 2014. LuSens: a keratinocyte based ARE reporter gene assay for use in integrated testing strategies for skin sensitization hazard identification. Toxicol In Vitro, 28, 1482-97.</p>\n\n<p>REMY, S., VERSTRAELEN, S., VAN DEN HEUVEL, R., NELISSEN, I., LAMBRECHTS, N., HOOYBERGHS, J. &amp; SCHOETERS, G. 2014. Gene expressions changes in bronchial epithelial cells: markers for respiratory sensitizers and exploration of the NRF2 pathway. Toxicol In Vitro, 28, 209-17.</p>\n\n<p>SALAZAR, F. &amp; GHAEMMAGHAMI, A. M. 2013. Allergen recognition by innate immune cells: critical role of dendritic and epithelial cells. Front Immunol, 4, 356.</p>\n\n<p>SEONG, S. Y. &amp; MATZINGER, P. 2004. Hydrophobicity: an ancient damage-associated molecular pattern that initiates innate immune responses. Nat Rev Immunol, 4, 469-78.</p>\n\n<p>VERSTRAELEN, S., BLOEMEN, K., NELISSEN, I., WITTERS, H., SCHOETERS, G. &amp; VAN DEN HEUVEL, R. 2008. Cell types involved in allergic asthma and their use in in vitro models to assess respiratory sensitization. Toxicol In Vitro, 22, 1419-31.</p>\n\n<p>VERSTRAELEN, S., NELISSEN, I., HOOYBERGHS, J., WITTERS, H., SCHOETERS, G., VAN CAUWENBERGE, P. &amp; VAN DEN HEUVEL, R. 2009. Gene profiles of a human alveolar epithelial cell line after in vitro exposure to respiratory (non-)sensitizing chemicals: identification of discriminating genetic markers and pathway analysis. Toxicol Lett, 185, 16-22.</p>\n\n<p>WANNER, R., SONNENBURG, A., QUATCHADZE, M., SCHREINER, M., PEISER, M., ZUBERBIER, T. &amp; STAHLMANN, R. 2010. Classification of sensitizing and irritative potential in a combined in-vitro assay. Toxicol Appl Pharmacol, 245, 211-8.</p>\n\n<p>WHEELER, D. S., CHASE, M. A., SENFT, A. P., POYNTER, S. E., WONG, H. R. &amp; PAGE, K. 2009. Extracellular Hsp72, an endogenous DAMP, is released by virally infected airway epithelial cells and activates neutrophils via Toll-like receptor (TLR)-4. Respir Res, 10, 31.</p>\n","biologicalOrganisationLevel":"Molecular","organTerm":{},"biologicalEvents":[{"action":"increased","process":"chemokine activity","object":{"name":"Chemokine","source":"FMA","sourceId":"FMA:241981"}},{"action":"increased","process":"cytokine activity","object":{"name":"Cytokine","source":"FMA","sourceId":"FMA:84050"}}],"id":151}
{"title":"Activation, Inflammatory cytokines, chemokines, cytoprotective gene pathways","references":"<p>EMTER, R., ELLIS, G. &amp; NATSCH, A. 2010. Performance of a novel keratinocyte-based reporter cell line to screen skin sensitizers in vitro. Toxicol Appl Pharmacol, 245, 281-90.</p>\n\n<p>HOLGATE, S. T. 2012. Innate and adaptive immune responses in asthma. Nat Med, 18, 673-83.</p>\n\n<p>HUANG, S., WISZNIEWSKI, L., CONSTANT, S. &amp; ROGGEN, E. 2013. Potential of in vitro reconstituted 3D human airway epithelia (MucilAir&trade;) to assess respiratory sensitizers. Toxicol In Vitro, 27, 1151-6.</p>\n\n<p>KAWAI, T. &amp; AKIRA, S. 2009. The roles of TLRs, RLRs and NLRs in pathogen recognition. Int Immunol, 21, 317-37.</p>\n\n<p>KAWAI, T. &amp; AKIRA, S. 2010. The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors. Nat Immunol, 11, 373-84.</p>\n\n<p>LAUENSTEIN, L., SWITALLA, S., PRENZLER, F., SEEHASE, S., PFENNIG, O., F&Ouml;RSTER, C., FIEGUTH, H., BRAUN, A. &amp; SEWALD, K. 2014. Assessment of immunotoxicity induced by chemicals in human precision-cut lung slices (PCLS). Toxicol In Vitro, 28, 588-99.</p>\n\n<p>MIGDAL, C., BOTTON, J., EL ALI, Z., AZOURY, M. E., GULDEMANN, J., GIM&Eacute;NEZ-ARNAU, E., LEPOITTEVIN, J. P., KERDINE-R&Ouml;MER, S. &amp; PALLARDY, M. 2013. Reactivity of chemical sensitizers toward amino acids in cellulo plays a role in the activation of the Nrf2-ARE pathway in human monocyte dendritic cells and the THP-1 cell line. Toxicol Sci, 133, 259-74.</p>\n\n<p>NATSCH, A., RYAN, C. A., FOERTSCH, L., EMTER, R., JAWORSKA, J., GERBERICK, F. &amp; KERN, P. 2013. A dataset on 145 chemicals tested in alternative assays for skin sensitization undergoing prevalidation. J Appl Toxicol, 33, 1337-52.</p>\n\n<p>POYNTER, M. E. 2012. Airway epithelial regulation of allergic sensitization in asthma. Pulm Pharmacol Ther, 25, 438-46.</p>\n\n<p>RAMIREZ, T., MEHLING, A., KOLLE, S. N., WRUCK, C. J., TEUBNER, W., ELTZE, T., AUMANN, A., URBISCH, D., VAN RAVENZWAAY, B. &amp; LANDSIEDEL, R. 2014. LuSens: a keratinocyte based ARE reporter gene assay for use in integrated testing strategies for skin sensitization hazard identification. Toxicol In Vitro, 28, 1482-97.</p>\n\n<p>REMY, S., VERSTRAELEN, S., VAN DEN HEUVEL, R., NELISSEN, I., LAMBRECHTS, N., HOOYBERGHS, J. &amp; SCHOETERS, G. 2014. Gene expressions changes in bronchial epithelial cells: markers for respiratory sensitizers and exploration of the NRF2 pathway. Toxicol In Vitro, 28, 209-17.</p>\n\n<p>SALAZAR, F. &amp; GHAEMMAGHAMI, A. M. 2013. Allergen recognition by innate immune cells: critical role of dendritic and epithelial cells. Front Immunol, 4, 356.</p>\n\n<p>SEONG, S. Y. &amp; MATZINGER, P. 2004. Hydrophobicity: an ancient damage-associated molecular pattern that initiates innate immune responses. Nat Rev Immunol, 4, 469-78.</p>\n\n<p>VERSTRAELEN, S., BLOEMEN, K., NELISSEN, I., WITTERS, H., SCHOETERS, G. &amp; VAN DEN HEUVEL, R. 2008. Cell types involved in allergic asthma and their use in in vitro models to assess respiratory sensitization. Toxicol In Vitro, 22, 1419-31.</p>\n\n<p>VERSTRAELEN, S., NELISSEN, I., HOOYBERGHS, J., WITTERS, H., SCHOETERS, G., VAN CAUWENBERGE, P. &amp; VAN DEN HEUVEL, R. 2009. Gene profiles of a human alveolar epithelial cell line after in vitro exposure to respiratory (non-)sensitizing chemicals: identification of discriminating genetic markers and pathway analysis. Toxicol Lett, 185, 16-22.</p>\n\n<p>WANNER, R., SONNENBURG, A., QUATCHADZE, M., SCHREINER, M., PEISER, M., ZUBERBIER, T. &amp; STAHLMANN, R. 2010. Classification of sensitizing and irritative potential in a combined in-vitro assay. Toxicol Appl Pharmacol, 245, 211-8.</p>\n\n<p>WHEELER, D. S., CHASE, M. A., SENFT, A. P., POYNTER, S. E., WONG, H. R. &amp; PAGE, K. 2009. Extracellular Hsp72, an endogenous DAMP, is released by virally infected airway epithelial cells and activates neutrophils via Toll-like receptor (TLR)-4. Respir Res, 10, 31.</p>\n","biologicalOrganisationLevel":"Molecular","organTerm":{},"biologicalEvents":[{"action":"increased","process":"chemokine activity","object":{"name":"Chemokine","source":"FMA","sourceId":"FMA:241981"}},{"action":"increased","process":"cytokine activity","object":{"name":"Cytokine","source":"FMA","sourceId":"FMA:84050"}}],"id":151}
{"title":"Increase, Allergic Respiratory Hypersensitivity Response","references":"<p>Boverhof DR, Billington R, Bhaskar Gollapudi B, Hotchkiss JA, Krieger SM, Poole A, Wiescinski CM, and Woolhiser MR. 2008. Respiratory sensitization and allergy: Current research approaches and needs. Tox Appl Pharm 226:1-13.</p>\n\n<p>Dearman RJ, Betts CJ, Humphreys N, Flanagan BF, Gilmour NJ, Basketter DA, Kimber I. 2003. Chemical allergy: considerations for the practical application of cytokine profiling. Toxicol. Sci. 71, 137&ndash;145.</p>\n\n<p>Lauenstein L, Switalla S, Prenzler F, Seehase S, Pfennig O, F&ouml;rster C, Fieguth H, Braun A and Sewald K. 2014. Assessment of immunotoxicity induced by chemicals in human precision-cut lung slices (PCLS). Tox in Vitro 28:588&ndash;599.</p>\n\n<p>OECD (2010) Test No. 429: Skin Sensitisation: Local Lymph Node Assay, OECD Guidelines for the Testing of Chemicals, Section 4, OECD Publishing. doi: 10.1787/9789264071100-en.</p>\n\n<p>Pauluhn J. 2014. Development of a respiratory sensitization/elicitation protocol of toluene diisocyanate (TDI) in Brown Norway rats to derive an elicitation-based occupational exposure level. Toxicology 319: 10&ndash;22.</p>\n\n<p>BERNSTEIN, J. A., GHOSH, D., SUBLETT, W. J., WELLS, H. &amp; LEVIN, L. 2011. Is trimellitic anhydride skin testing a sufficient screening tool for selectively identifying TMA-exposed workers with TMA-specific serum IgE antibodies? J Occup Environ Med, 53, 1122-7.</p>\n\n<p>DAVIES, J. M., PLATTS-MILLS, T. A. &amp; AALBERSE, R. C. 2013. The enigma of IgE+ B-cell memory in human subjects. J Allergy Clin Immunol, 131, 972-6.</p>\n\n<p>KIMBER, I., DEARMAN, R. J. &amp; BASKETTER, D. A. 2014. Diisocyanates, occupational asthma and IgE antibody: implications for hazard characterization. J Appl Toxicol, 34, 1073-7.</p>\n\n<p>MOV&Eacute;RARE, R., BLUME, K., LIND, P., CREVEL, R., MARKNELL DEWITT, &Aring;. &amp; COCHRANE, S. 2017. Human Allergen-Specific IgG Subclass Antibodies Measured Using ImmunoCAP Technology. Int Arch Allergy Immunol, 172, 1-10.</p>\n\n<p>QUIRCE, S. 2014. IgE antibodies in occupational asthma: are they causative or an associated phenomenon? Curr Opin Allergy Clin Immunol, 14, 100-5.</p>\n\n<p>VERA-BERRIOS, R. N., FEARY, J. &amp; CULLINAN, P. 2019. Basophil activation testing in occupational respiratory allergy to low molecular weight compounds. Curr Opin Allergy Clin Immunol, 19, 92-97.</p>\n","biologicalOrganisationLevel":"Organ","organTerm":{"name":"lung","sourceId":"UBERON:0002048"},"biologicalEvents":[{"action":"increased","process":"Respiratory Hypersensitivity","object":{}}],"id":313}
{"title":"Activation, Dendritic Cells","references":"<ol>\n\t<li><a href=\"#cite_ref-Ryan_2005_1-0\">&uarr;</a> Ryan CA, Gerberick GF, Gildea LA, Hulette BC, Bettis CJ, Cumberbatch M, Dearman RJ, Kimber I. 2005. Interactions of contact allergens with dendritic cells: opportunities and challenges for the development of novel approaches to hazard assessment. Toxicol. Sci. 88: 4-11.</li>\n\t<li><a href=\"#cite_ref-Ryan_2007_2-0\">&uarr;</a> Ryan CA, Kimber I, Basketter, DA, Pallardy M, Gildea LA, Gerberick GF. 2007. Dendritic cells and skin sensitisation. Biological roles and uses in hazard identification. Toxicol. Appl. Pharmacol. 221: 384-394.</li>\n\t<li>&uarr; <sup><a href=\"#cite_ref-dos_Santos_2009_3-0\">3.0</a></sup> <sup><a href=\"#cite_ref-dos_Santos_2009_3-1\">3.1</a></sup> <sup><a href=\"#cite_ref-dos_Santos_2009_3-2\">3.2</a></sup> <sup><a href=\"#cite_ref-dos_Santos_2009_3-3\">3.3</a></sup> <sup><a href=\"#cite_ref-dos_Santos_2009_3-4\">3.4</a></sup> <sup><a href=\"#cite_ref-dos_Santos_2009_3-5\">3.5</a></sup> dos Santos GG, Reinders J, Ouwhand K, Rustemeyer T, Scheper RJ, Gibbs S. 2009. Progress on the development of human <em>in vitro</em> dendritic cell based assays for assessment of skin sensitizing potential of compounds. Toxicol. Appl. Pharmacol. 236: 372-382.</li>\n\t<li>&uarr; <sup><a href=\"#cite_ref-Kimber_2011_4-0\">4.0</a></sup> <sup><a href=\"#cite_ref-Kimber_2011_4-1\">4.1</a></sup> <sup><a href=\"#cite_ref-Kimber_2011_4-2\">4.2</a></sup> Kimber I, Basketter DA, Gerberick GF, Ryan CA, Dearman, R.J. 2011. Chemical allergy: Translating biology into hazard characterization. Toxicol. Sci. 120(S1): S238-S268.</li>\n\t<li>&uarr; <sup><a href=\"#cite_ref-Antonopoulos_2008_5-0\">5.0</a></sup> <sup><a href=\"#cite_ref-Antonopoulos_2008_5-1\">5.1</a></sup> Antonopoulos C, Cumberbatch M, Mee JB, Dearman RJ, Wei XQ, Liew FY, Kimber I, Groves RW. 2008. IL-18 is a key proximal mediator of contact hypersensitivity and allergen induced Langerhans cell migration in murine epidermis. J. Leukoc. Biol. 83: 361-367.</li>\n\t<li><a href=\"#cite_ref-Ouwehand_2008_6-0\">&uarr;</a> Ouwehand K, Santegoets SJAM, Bruynzeel DP, Scheper RJ, de Gruijl TD, Gibbs S. 2008. CXCL12 is essential for migration of activated Langerhans cells for epidermis to dermis. Eur. J. Immunol. 38: 3050-3059.</li>\n\t<li><a href=\"#cite_ref-Vanderbriel_2010_7-0\">&uarr;</a> Vandebriel RJ and van Loveren H. 2010. Non-animal sensitisation testing: State-of-the-art. Crit. Rev. Toxicol. 40: 389-404.</li>\n\t<li><a href=\"#cite_ref-Trompezinski_2008_8-0\">&uarr;</a> Trompezinski S, Migdal C, Tailhardat M, Le Varlet B, Courtellemont P, Haftek M and Serres M. 2008. Charaterization of early events involved in human dendritic cell maturation induced by sensitizers: cross talk between MAPK signalling pathways. Toxicol. Appl. Pharmacol. 230: 397-406.</li>\n\t<li><a href=\"#cite_ref-Lambrechts_2010_9-0\">&uarr;</a> Lambrechts N, Vanheel H, Hooyberghs J, De Boever P, Witters H, Van Den Heuval R, Van Tendeloom V, Nelissen I, Schoeters G. 2010. Gene markers in dendritic cells unravel pieces of the skin sensitisation puzzle. Toxicol. Letters 196: 95-103.</li>\n\t<li><a href=\"#cite_ref-Migdal_2010_10-0\">&uarr;</a> Migdal C, Tailhardat M, Courtellemont P, Haftek M, Serres M. 2010. Responsiveness of human monocyte-derived dendritic cells to thimerosal and mercury derivatives. Toxicol. Appl. Pharmacol. 246: 66-73.</li>\n\t<li><a href=\"#cite_ref-Aeby_2010_11-0\">&uarr;</a> Aeby P, Ashikaga T, Bessou-Touya S, Schapky A, Geberick F, Kern P, Marrec-Fairley M, Maxwell G, Ovigne JM, Sakaguchi H, Reisinger K, Tailhardat M, Martinozzi-Teisser S, Winkler P. 2010. Identifying and characterizing chemical skin sensitizers without animal testing; Colipa&rsquo;s research and methods development program. Toxicol. In Vitro 24: 1465-1473.</li>\n\t<li><a href=\"#cite_ref-Hooyberghs_2008_12-0\">&uarr;</a> Hooyberghs J, Schoeters E, Lambrechts N, Nelissen I, Witters H, Schoeters G, Van Den Heuvel R. 2008. A cell-based in vitro alternative to identify skin sensitizers by gene expression. Toxicol. Appl. Pharmacol. 231: 103-111.</li>\n\t<li><a href=\"#cite_ref-Borrebaeck_2009_13-0\">&uarr;</a> Borrebaeck CA and Wingren C. 2009. Design of high-density antibody microarrays for disease proteomics: key technological issues. J. Proteomics 72: 928-935.</li>\n\t<li><a href=\"#cite_ref-Groux_2010_14-0\">&uarr;</a> Groux H and Sabatier JM. 2010. Polypeptides for the <em>in vitro</em> assessment of the sensitising potential of a test compound. International Application Patent No.: PCT/EP2010/055895.</li>\n\t<li><a href=\"#cite_ref-Sakaguchi_2009_15-0\">&uarr;</a> Sakaguchi H, Ashikaga T, Miyazawa M, Kosaka N, Ito Y, Yoneyama K, Sono S, Itagaki H, Toyoda H, Suzuki H. 2009. The relationship between CD86/CD54 expression and THP-1 cell viability in an <em>in vitro</em> skin sensitisation test-human cell line activation test (h-CLAT). Cell Biol. Toxicol. 25: 109-126.</li>\n\t<li><a href=\"#cite_ref-Ashikaga_2010_16-0\">&uarr;</a> Ashikaga T, Sakaguchi H, Sono S, Kosaka N, Ishikawa M, Nukada Y, Miyazawa M, Ito Y, Nishiyama N, Itagaki H. 2010. A comparative evaluation of <em>in vitro</em> skin sensitisation tests: the human cell-line activation test (h-CLAT) versus the local lymph node assay (LLNA). Altern. Lab. Anim. 38:275-84.</li>\n\t<li><a href=\"#cite_ref-DB.E2.80.94ALM_158_17-0\">&uarr;</a> EURL ECVAM DB-ALM. Protocol No158: Human Cell Line Activation Test (h-CLAT) Available on: <a class=\"external free\" href=\"http://ecvam-dbalm.jrc.ec.europa.eu/\" rel=\"nofollow\" target=\"_blank\">http://ecvam-dbalm.jrc.ec.europa.eu/</a>.</li>\n\t<li><a href=\"#cite_ref-Ade_2006_18-0\">&uarr;</a> Ade N, Martinozzi-Teissier S, Pallaardy M, Rousset F. 2006. Activation of U937 cells by contact sensitizers: CD86 expression is independent of apoptosis. J. Immunotoxicol. 3: 189-197.</li>\n\t<li><a href=\"#cite_ref-Python_2007_19-0\">&uarr;</a> Python F, Goebel C, Aeby P. 2007. Assessment of the U937 cell line for detection of contact allergens. Toxicol. Appl. Pharmacol. 220: 113-124.</li>\n\t<li><a href=\"#cite_ref-Ovigne_2008_20-0\">&uarr;</a> Ovigne JM, Martinozzi-Teissier S, Verda D, Abdou D, Piroird C, Ade N, Rousset F. 2008. The MUSST for <em>in vitro</em> skin sensitisation prediction: Applicability domains and complementary protocols to adapt to the physico-chemical diversity of chemicals. Toxicology Letters, 180: Supplement 1, 5, S216.</li>\n</ol>\n\n<p>ASHIKAGA&nbsp;T, YOSHIDA Y, HIROTA M, YONEYAMA K, ITAGAKI&nbsp;H, SAKAGUCHI&nbsp;H, MIYAZAWA M, ITO Y, SUZUKI&nbsp;H, TOYODA H. 2006. Development of an in vitro skin sensitization test using human cell lines: the human Cell Line Activation Test (h-CLAT). I. Optimization of the h-CLAT protocol. <em>Toxicol In Vitro. </em>20(5), 767-73.&nbsp;</p>\n\n<p>BASKETTER, D., POOLE, A., KIMBER, I., 2017. Behaviour of chemical respiratory allergens in novel predictive methods for skin sensitisation, <em>Reg Tox and Pharmacol. 86,</em>101-106,</p>\n\n<p>DOS SANTOS, G. G., REINDERS, J., OUWEHAND, K., RUSTEMEYER, T., SCHEPER, R. J. &amp; GIBBS, S. 2009. Progress on the development of human in vitro dendritic cell based assays for assessment of the sensitizing potential of a compound. <em>Toxicol Appl Pharmacol,</em> 236<strong>,</strong> 372-82.</p>\n\n<p>FORRERYD&nbsp;A, JOHANSSON&nbsp;H, ALBREKT&nbsp;AS, BORREBAECK&nbsp;CA, LINDSTEDT&nbsp;M. 2015. Prediction of chemical respiratory sensitizers using GARD, a novel in vitro assay based on a genomic biomarker signature. <em>PLoS One.</em>11;10(3):e0118808.</p>\n\n<p>JOHANSSON&nbsp;H, LINDSTEDT&nbsp;M, ALBREKT&nbsp;AS, BORREBAECK&nbsp;CA. 2011. A genomic biomarker signature can predict skin sensitizers using a cell-based in vitro alternative to animal tests. <em>BMC Genomics.</em>&nbsp;8;12:399.&nbsp;</p>\n\n<p>REES&nbsp;B, SPIEKSTRA SW, CARFI M, OUWEHAND&nbsp;K, WILLIAMS&nbsp;CA, CORSINI E, MCLEOD J.D., GIBBS S. 2011. Inter-laboratory study of the in vitro dendritic cell migration assay for identification of contact allergens. <em>Toxicol In Vitro</em>. 25(8), 2124-34.</p>\n\n<p>SAKAGUCHI&nbsp;H, ASHIKAGA&nbsp;T, MIYAZAWA M, YOSHIDA Y, ITO&nbsp;Y, YONEYAMA K, HIROTA M, ITAGAKI&nbsp;H, TOYODA H, SUZUKI&nbsp;H. 2006. Development of an in vitro skin sensitization test using human cell lines; human Cell Line Activation Test (h-CLAT). II. An inter-laboratory study of the h-CLAT. <em>Toxicol In Vitro</em>. 20(5), 774-84.&nbsp;</p>\n","biologicalOrganisationLevel":"Cellular","organTerm":{},"biologicalEvents":[{"action":"increased","process":"cell activation","object":{}},{"action":"increased","process":"MHC protein complex assembly","object":{}}],"id":398}
{"title":"Activation, Dendritic Cells","references":"<ol>\n\t<li><a href=\"#cite_ref-Ryan_2005_1-0\">&uarr;</a> Ryan CA, Gerberick GF, Gildea LA, Hulette BC, Bettis CJ, Cumberbatch M, Dearman RJ, Kimber I. 2005. Interactions of contact allergens with dendritic cells: opportunities and challenges for the development of novel approaches to hazard assessment. Toxicol. Sci. 88: 4-11.</li>\n\t<li><a href=\"#cite_ref-Ryan_2007_2-0\">&uarr;</a> Ryan CA, Kimber I, Basketter, DA, Pallardy M, Gildea LA, Gerberick GF. 2007. Dendritic cells and skin sensitisation. Biological roles and uses in hazard identification. Toxicol. Appl. Pharmacol. 221: 384-394.</li>\n\t<li>&uarr; <sup><a href=\"#cite_ref-dos_Santos_2009_3-0\">3.0</a></sup> <sup><a href=\"#cite_ref-dos_Santos_2009_3-1\">3.1</a></sup> <sup><a href=\"#cite_ref-dos_Santos_2009_3-2\">3.2</a></sup> <sup><a href=\"#cite_ref-dos_Santos_2009_3-3\">3.3</a></sup> <sup><a href=\"#cite_ref-dos_Santos_2009_3-4\">3.4</a></sup> <sup><a href=\"#cite_ref-dos_Santos_2009_3-5\">3.5</a></sup> dos Santos GG, Reinders J, Ouwhand K, Rustemeyer T, Scheper RJ, Gibbs S. 2009. Progress on the development of human <em>in vitro</em> dendritic cell based assays for assessment of skin sensitizing potential of compounds. Toxicol. Appl. Pharmacol. 236: 372-382.</li>\n\t<li>&uarr; <sup><a href=\"#cite_ref-Kimber_2011_4-0\">4.0</a></sup> <sup><a href=\"#cite_ref-Kimber_2011_4-1\">4.1</a></sup> <sup><a href=\"#cite_ref-Kimber_2011_4-2\">4.2</a></sup> Kimber I, Basketter DA, Gerberick GF, Ryan CA, Dearman, R.J. 2011. Chemical allergy: Translating biology into hazard characterization. Toxicol. Sci. 120(S1): S238-S268.</li>\n\t<li>&uarr; <sup><a href=\"#cite_ref-Antonopoulos_2008_5-0\">5.0</a></sup> <sup><a href=\"#cite_ref-Antonopoulos_2008_5-1\">5.1</a></sup> Antonopoulos C, Cumberbatch M, Mee JB, Dearman RJ, Wei XQ, Liew FY, Kimber I, Groves RW. 2008. IL-18 is a key proximal mediator of contact hypersensitivity and allergen induced Langerhans cell migration in murine epidermis. J. Leukoc. Biol. 83: 361-367.</li>\n\t<li><a href=\"#cite_ref-Ouwehand_2008_6-0\">&uarr;</a> Ouwehand K, Santegoets SJAM, Bruynzeel DP, Scheper RJ, de Gruijl TD, Gibbs S. 2008. CXCL12 is essential for migration of activated Langerhans cells for epidermis to dermis. Eur. J. Immunol. 38: 3050-3059.</li>\n\t<li><a href=\"#cite_ref-Vanderbriel_2010_7-0\">&uarr;</a> Vandebriel RJ and van Loveren H. 2010. Non-animal sensitisation testing: State-of-the-art. Crit. Rev. Toxicol. 40: 389-404.</li>\n\t<li><a href=\"#cite_ref-Trompezinski_2008_8-0\">&uarr;</a> Trompezinski S, Migdal C, Tailhardat M, Le Varlet B, Courtellemont P, Haftek M and Serres M. 2008. Charaterization of early events involved in human dendritic cell maturation induced by sensitizers: cross talk between MAPK signalling pathways. Toxicol. Appl. Pharmacol. 230: 397-406.</li>\n\t<li><a href=\"#cite_ref-Lambrechts_2010_9-0\">&uarr;</a> Lambrechts N, Vanheel H, Hooyberghs J, De Boever P, Witters H, Van Den Heuval R, Van Tendeloom V, Nelissen I, Schoeters G. 2010. Gene markers in dendritic cells unravel pieces of the skin sensitisation puzzle. Toxicol. Letters 196: 95-103.</li>\n\t<li><a href=\"#cite_ref-Migdal_2010_10-0\">&uarr;</a> Migdal C, Tailhardat M, Courtellemont P, Haftek M, Serres M. 2010. Responsiveness of human monocyte-derived dendritic cells to thimerosal and mercury derivatives. Toxicol. Appl. Pharmacol. 246: 66-73.</li>\n\t<li><a href=\"#cite_ref-Aeby_2010_11-0\">&uarr;</a> Aeby P, Ashikaga T, Bessou-Touya S, Schapky A, Geberick F, Kern P, Marrec-Fairley M, Maxwell G, Ovigne JM, Sakaguchi H, Reisinger K, Tailhardat M, Martinozzi-Teisser S, Winkler P. 2010. Identifying and characterizing chemical skin sensitizers without animal testing; Colipa&rsquo;s research and methods development program. Toxicol. In Vitro 24: 1465-1473.</li>\n\t<li><a href=\"#cite_ref-Hooyberghs_2008_12-0\">&uarr;</a> Hooyberghs J, Schoeters E, Lambrechts N, Nelissen I, Witters H, Schoeters G, Van Den Heuvel R. 2008. A cell-based in vitro alternative to identify skin sensitizers by gene expression. Toxicol. Appl. Pharmacol. 231: 103-111.</li>\n\t<li><a href=\"#cite_ref-Borrebaeck_2009_13-0\">&uarr;</a> Borrebaeck CA and Wingren C. 2009. Design of high-density antibody microarrays for disease proteomics: key technological issues. J. Proteomics 72: 928-935.</li>\n\t<li><a href=\"#cite_ref-Groux_2010_14-0\">&uarr;</a> Groux H and Sabatier JM. 2010. Polypeptides for the <em>in vitro</em> assessment of the sensitising potential of a test compound. International Application Patent No.: PCT/EP2010/055895.</li>\n\t<li><a href=\"#cite_ref-Sakaguchi_2009_15-0\">&uarr;</a> Sakaguchi H, Ashikaga T, Miyazawa M, Kosaka N, Ito Y, Yoneyama K, Sono S, Itagaki H, Toyoda H, Suzuki H. 2009. The relationship between CD86/CD54 expression and THP-1 cell viability in an <em>in vitro</em> skin sensitisation test-human cell line activation test (h-CLAT). Cell Biol. Toxicol. 25: 109-126.</li>\n\t<li><a href=\"#cite_ref-Ashikaga_2010_16-0\">&uarr;</a> Ashikaga T, Sakaguchi H, Sono S, Kosaka N, Ishikawa M, Nukada Y, Miyazawa M, Ito Y, Nishiyama N, Itagaki H. 2010. A comparative evaluation of <em>in vitro</em> skin sensitisation tests: the human cell-line activation test (h-CLAT) versus the local lymph node assay (LLNA). Altern. Lab. Anim. 38:275-84.</li>\n\t<li><a href=\"#cite_ref-DB.E2.80.94ALM_158_17-0\">&uarr;</a> EURL ECVAM DB-ALM. Protocol No158: Human Cell Line Activation Test (h-CLAT) Available on: <a class=\"external free\" href=\"http://ecvam-dbalm.jrc.ec.europa.eu/\" rel=\"nofollow\" target=\"_blank\">http://ecvam-dbalm.jrc.ec.europa.eu/</a>.</li>\n\t<li><a href=\"#cite_ref-Ade_2006_18-0\">&uarr;</a> Ade N, Martinozzi-Teissier S, Pallaardy M, Rousset F. 2006. Activation of U937 cells by contact sensitizers: CD86 expression is independent of apoptosis. J. Immunotoxicol. 3: 189-197.</li>\n\t<li><a href=\"#cite_ref-Python_2007_19-0\">&uarr;</a> Python F, Goebel C, Aeby P. 2007. Assessment of the U937 cell line for detection of contact allergens. Toxicol. Appl. Pharmacol. 220: 113-124.</li>\n\t<li><a href=\"#cite_ref-Ovigne_2008_20-0\">&uarr;</a> Ovigne JM, Martinozzi-Teissier S, Verda D, Abdou D, Piroird C, Ade N, Rousset F. 2008. The MUSST for <em>in vitro</em> skin sensitisation prediction: Applicability domains and complementary protocols to adapt to the physico-chemical diversity of chemicals. Toxicology Letters, 180: Supplement 1, 5, S216.</li>\n</ol>\n\n<p>ASHIKAGA&nbsp;T, YOSHIDA Y, HIROTA M, YONEYAMA K, ITAGAKI&nbsp;H, SAKAGUCHI&nbsp;H, MIYAZAWA M, ITO Y, SUZUKI&nbsp;H, TOYODA H. 2006. Development of an in vitro skin sensitization test using human cell lines: the human Cell Line Activation Test (h-CLAT). I. Optimization of the h-CLAT protocol. <em>Toxicol In Vitro. </em>20(5), 767-73.&nbsp;</p>\n\n<p>BASKETTER, D., POOLE, A., KIMBER, I., 2017. Behaviour of chemical respiratory allergens in novel predictive methods for skin sensitisation, <em>Reg Tox and Pharmacol. 86,</em>101-106,</p>\n\n<p>DOS SANTOS, G. G., REINDERS, J., OUWEHAND, K., RUSTEMEYER, T., SCHEPER, R. J. &amp; GIBBS, S. 2009. Progress on the development of human in vitro dendritic cell based assays for assessment of the sensitizing potential of a compound. <em>Toxicol Appl Pharmacol,</em> 236<strong>,</strong> 372-82.</p>\n\n<p>FORRERYD&nbsp;A, JOHANSSON&nbsp;H, ALBREKT&nbsp;AS, BORREBAECK&nbsp;CA, LINDSTEDT&nbsp;M. 2015. Prediction of chemical respiratory sensitizers using GARD, a novel in vitro assay based on a genomic biomarker signature. <em>PLoS One.</em>11;10(3):e0118808.</p>\n\n<p>JOHANSSON&nbsp;H, LINDSTEDT&nbsp;M, ALBREKT&nbsp;AS, BORREBAECK&nbsp;CA. 2011. A genomic biomarker signature can predict skin sensitizers using a cell-based in vitro alternative to animal tests. <em>BMC Genomics.</em>&nbsp;8;12:399.&nbsp;</p>\n\n<p>REES&nbsp;B, SPIEKSTRA SW, CARFI M, OUWEHAND&nbsp;K, WILLIAMS&nbsp;CA, CORSINI E, MCLEOD J.D., GIBBS S. 2011. Inter-laboratory study of the in vitro dendritic cell migration assay for identification of contact allergens. <em>Toxicol In Vitro</em>. 25(8), 2124-34.</p>\n\n<p>SAKAGUCHI&nbsp;H, ASHIKAGA&nbsp;T, MIYAZAWA M, YOSHIDA Y, ITO&nbsp;Y, YONEYAMA K, HIROTA M, ITAGAKI&nbsp;H, TOYODA H, SUZUKI&nbsp;H. 2006. Development of an in vitro skin sensitization test using human cell lines; human Cell Line Activation Test (h-CLAT). II. An inter-laboratory study of the h-CLAT. <em>Toxicol In Vitro</em>. 20(5), 774-84.&nbsp;</p>\n","biologicalOrganisationLevel":"Cellular","organTerm":{},"biologicalEvents":[{"action":"increased","process":"cell activation","object":{}},{"action":"increased","process":"MHC protein complex assembly","object":{}}],"id":398}
{"title":"Activation/Proliferation, T-cells","references":"<ol>\n\t<li>&uarr; <sup><a href=\"#cite_ref-Martin_2010_1-0\">1.0</a></sup> <sup><a href=\"#cite_ref-Martin_2010_1-1\">1.1</a></sup> <sup><a href=\"#cite_ref-Martin_2010_1-2\">1.2</a></sup> Martin SF, Esser PR, Schmucker S, Dietz L, Naisbitt DJ, Park BK, Vocanson M, Nicolas JF, Keller M, Pichler WJ, Peiser M, Luch A, Wanner R, Maggi E, Cavani A, Rustemeyer T, Richter A, Thierse HJ, Sallusto F. 2010. T-cell recognition of chemical, protein allergens and drugs; toward the development of <em>in vitro</em> assays. Cell. Mol. Life Sci. 67: 4171-4184.</li>\n\t<li><a href=\"#cite_ref-Vocanson_2009_2-0\">&uarr;</a> Vocanson M, Hennino A, Rozieres A, Poyet G, Nicolas JF. 2009. Effector and regulatory mechanisms in allergic contact dermatitis. Allergy 64: 1699-1714.</li>\n\t<li><a href=\"#cite_ref-OECD_2010a_3-0\">&uarr;</a> OECD 2010. Test No.429: Skin sensitization: Local Lymph Node Assay. OECD Guidelines for the Testing of Chemicals, Section 4: Health effects. OECD Publishing. Doi: 10.1787/9789264071100-en.</li>\n\t<li><a href=\"#cite_ref-OECD_2010b_4-0\">&uarr;</a> OECD 2010. Test No442A: Skin sensitization: Local Lymph Node Assay:DA. OECD Guidelines for the Testing of Chemicals, Section 4: Health effects. OECD Publishing. Doi: 10.1787/9789264090972-en.</li>\n\t<li><a href=\"#cite_ref-OECD_2010c_5-0\">&uarr;</a> OECD 2010. Test No.442B: Skin sensitization: Local Lymph Node Assay: BrdU-ELISA. OECD Guidelines for the Testing of Chemicals, Section 4: Health effects. OECD Publishing. Doi: 10.1787/9789264090996-en.</li>\n</ol>\n\n<p>BERNSTEIN, J. A., GHOSH, D., SUBLETT, W. J., WELLS, H. &amp; LEVIN, L. 2011. Is trimellitic anhydride skin testing a sufficient screening tool for selectively identifying TMA-exposed workers with TMA-specific serum IgE antibodies? J Occup Environ Med, 53, 1122-7.</p>\n\n<p>HOLDEN, N. J., BEDFORD, P. A., MCCARTHY, N. E., MARKS, N. A., IND, P. W., JOWSEY, I. R., BASKETTER, D. A. &amp; KNIGHT, S. C. 2008. Dendritic cells from control but not atopic donors respond to contact and respiratory sensitizer treatment in vitro with differential cytokine production and altered stimulatory capacity. Clin Exp Allergy, 38, 1148-59.</p>\n","biologicalOrganisationLevel":"Organ","organTerm":{"name":"lymph node","sourceId":"UBERON:0000029"},"biologicalEvents":[{"action":"increased","process":"T cell activation","object":{"name":"T cell","source":"CL","sourceId":"CL:0000084"}},{"action":"increased","process":"cell proliferation","object":{"name":"memory T cell","source":"CL","sourceId":"CL:0000813"}}],"id":272}
{"title":"Activation/Proliferation, T-cells","references":"<ol>\n\t<li>&uarr; <sup><a href=\"#cite_ref-Martin_2010_1-0\">1.0</a></sup> <sup><a href=\"#cite_ref-Martin_2010_1-1\">1.1</a></sup> <sup><a href=\"#cite_ref-Martin_2010_1-2\">1.2</a></sup> Martin SF, Esser PR, Schmucker S, Dietz L, Naisbitt DJ, Park BK, Vocanson M, Nicolas JF, Keller M, Pichler WJ, Peiser M, Luch A, Wanner R, Maggi E, Cavani A, Rustemeyer T, Richter A, Thierse HJ, Sallusto F. 2010. T-cell recognition of chemical, protein allergens and drugs; toward the development of <em>in vitro</em> assays. Cell. Mol. Life Sci. 67: 4171-4184.</li>\n\t<li><a href=\"#cite_ref-Vocanson_2009_2-0\">&uarr;</a> Vocanson M, Hennino A, Rozieres A, Poyet G, Nicolas JF. 2009. Effector and regulatory mechanisms in allergic contact dermatitis. Allergy 64: 1699-1714.</li>\n\t<li><a href=\"#cite_ref-OECD_2010a_3-0\">&uarr;</a> OECD 2010. Test No.429: Skin sensitization: Local Lymph Node Assay. OECD Guidelines for the Testing of Chemicals, Section 4: Health effects. OECD Publishing. Doi: 10.1787/9789264071100-en.</li>\n\t<li><a href=\"#cite_ref-OECD_2010b_4-0\">&uarr;</a> OECD 2010. Test No442A: Skin sensitization: Local Lymph Node Assay:DA. OECD Guidelines for the Testing of Chemicals, Section 4: Health effects. OECD Publishing. Doi: 10.1787/9789264090972-en.</li>\n\t<li><a href=\"#cite_ref-OECD_2010c_5-0\">&uarr;</a> OECD 2010. Test No.442B: Skin sensitization: Local Lymph Node Assay: BrdU-ELISA. OECD Guidelines for the Testing of Chemicals, Section 4: Health effects. OECD Publishing. Doi: 10.1787/9789264090996-en.</li>\n</ol>\n\n<p>BERNSTEIN, J. A., GHOSH, D., SUBLETT, W. J., WELLS, H. &amp; LEVIN, L. 2011. Is trimellitic anhydride skin testing a sufficient screening tool for selectively identifying TMA-exposed workers with TMA-specific serum IgE antibodies? J Occup Environ Med, 53, 1122-7.</p>\n\n<p>HOLDEN, N. J., BEDFORD, P. A., MCCARTHY, N. E., MARKS, N. A., IND, P. W., JOWSEY, I. R., BASKETTER, D. A. &amp; KNIGHT, S. C. 2008. Dendritic cells from control but not atopic donors respond to contact and respiratory sensitizer treatment in vitro with differential cytokine production and altered stimulatory capacity. Clin Exp Allergy, 38, 1148-59.</p>\n","biologicalOrganisationLevel":"Organ","organTerm":{"name":"lymph node","sourceId":"UBERON:0000029"},"biologicalEvents":[{"action":"increased","process":"T cell activation","object":{"name":"T cell","source":"CL","sourceId":"CL:0000084"}},{"action":"increased","process":"cell proliferation","object":{"name":"memory T cell","source":"CL","sourceId":"CL:0000813"}}],"id":272}
{"title":"Covalent Binding, Protein","references":"<ol>\n\t<li>&uarr; <sup><a href=\"#cite_ref-Gerberick_2008_1-0\">1.0</a></sup> <sup><a href=\"#cite_ref-Gerberick_2008_1-1\">1.1</a></sup> <sup><a href=\"#cite_ref-Gerberick_2008_1-2\">1.2</a></sup> <sup><a href=\"#cite_ref-Gerberick_2008_1-3\">1.3</a></sup> Gerberick F, Aleksic M, Basketter D, Casati S, Karlberg AT, Kern P, Kimber I, Lepoittevin JP, Natsch A, Ovigne JM, Rovida C, Sakaguchi H and Schultz T. 2008. Chemical reactivity measurement and the predictive identification of skin sensitisers. Altern. Lab. Anim. 36: 215-242.</li>\n\t<li><a href=\"#cite_ref-2\">&uarr;</a> Karlberg AT, Bergstr&ouml;m MA, B&ouml;rje A, Luthman K and Nilsson JL. 2008. Allergic contact dermatitis- formation, structural requirements, and reactivity of skin sensitizers. Chem. Res. Toxicol. 21: 53-69.</li>\n\t<li>&uarr; <sup><a href=\"#cite_ref-Schw.C3.B6bel_2011_3-0\">3.0</a></sup> <sup><a href=\"#cite_ref-Schw.C3.B6bel_2011_3-1\">3.1</a></sup> <sup><a href=\"#cite_ref-Schw.C3.B6bel_2011_3-2\">3.2</a></sup> <sup><a href=\"#cite_ref-Schw.C3.B6bel_2011_3-3\">3.3</a></sup> <sup><a href=\"#cite_ref-Schw.C3.B6bel_2011_3-4\">3.4</a></sup> <sup><a href=\"#cite_ref-Schw.C3.B6bel_2011_3-5\">3.5</a></sup> Schw&ouml;bel JAH, Koleva YK, Bajot F, Enoch SJ, Hewitt M, Madden JC, Roberts DW, Schultz TW and Cronin MTD. 2011. Measurement and estimation of electrophilic reactivity for predictive toxicology. Chem. Rev. 111: 2562-2596.</li>\n\t<li><a href=\"#cite_ref-Hopkins_2005_4-0\">&uarr;</a> Hopkins JE, Naisbitt DJ, Kitteringham NR, Dearman RJ, Kimber I and Park BK. 2005. Selective haptenation of cellular or extracellular proteins by chemical allergens: Association with cytokine polarization. Chem. Res. Toxicol. 18: 375-381.</li>\n\t<li><a href=\"#cite_ref-Lepoittevin_2006_5-0\">&uarr;</a> Lepoittevin JP. 2006. Metabolism versus chemical transformation or pro-versus prehaptens? Contact Dermatitis 54: 73-74.</li>\n\t<li><a href=\"#cite_ref-Freidig_2001_6-0\">&uarr;</a> Freidig AP and Hermens JLM. 2001. Narcosis and chemical reactivity QSARs for acute toxicity. Quant. Struct. Act. Rel. 19: 547-553.</li>\n\t<li><a href=\"#cite_ref-Roberts_2008_7-0\">&uarr;</a> Roberts DW, Aptula AO, Patlewicz G, Pease C. 2008. Chemical reactivity indices and mechanism-based read-across for non-animal based assessment of skin sensitisation potential. J.Appl. Toxicol. 28: 443-454.</li>\n\t<li><a href=\"#cite_ref-Enoch_2011_8-0\">&uarr;</a> Enoch SJ, Ellison CM, Schultz TW, Cronin MTD. 2011. A review of the electrophilic reaction chemistry involved on covalent protein binding relevant to toxicity. Crit. Rev. Toxicol. 41: 783&ndash; 802.</li>\n\t<li>&uarr; <sup><a href=\"#cite_ref-OECD_2011_9-0\">9.0</a></sup> <sup><a href=\"#cite_ref-OECD_2011_9-1\">9.1</a></sup> OECD 2011. Report of the Expert Consultation on Scientific and Regulatory Evaluation of Organic Chemistry-based Structural Alerts for the Identification of Protein-binding Chemicals. OECD Environment, Health and Safety Publications Series on Testing and Assessment No. 139. ENV/JM/MONO(2011).</li>\n\t<li><a href=\"#cite_ref-Basketter_2007_10-0\">&uarr;</a> Basketter DA, Pease C, Kasting G, Kimber I, Casati S, Cronin MTD, Diembeck W, Gerberick F, Hadgraft J, Hartung J, Marty JP, Nikolaidis E, Patlewicz G, Roberts DW, Roggen E, Rovida C, van de Sandt J. 2007. Skin sensitisation and epidermal disposition: The relevance of epidermal disposition for sensitisation hazard identification and risk assessment. The report of ECVAM workshop 59. Altern. Lab. Anim. 35: 137-154.</li>\n\t<li><a href=\"#cite_ref-Schw.C3.B6bel_2010_11-0\">&uarr;</a> Schw&ouml;bel J, Wondrousch D, Koleva YK, Madden JC, Cronin MTD, Sch&uuml;&uuml;rmann G. 2010. Prediction of Michael type acceptor reactivity toward glutathione. Chem. Res. Toxicol. 23: 1576-1585.</li>\n\t<li><a href=\"#cite_ref-Kato_2003_12-0\">&uarr;</a> Kato H, Okamoto M, Yamashita K, Nakamura Y, Fukumori Y, Nakai K, Kaneko H. 2003. Peptide-binding assessment using mass spectrometry as a new screening method for skin sensitization. J. Toxicol. Sci. 28: 19-24.</li>\n\t<li><a href=\"#cite_ref-Schulz_2005_13-0\">&uarr;</a> Schultz TW, Yarbrough JW, Woldemeskel M. 2005. Toxicity to Tetrahymena and abiotic thiol reactivity of aromatic isothiocyanates. Cell. Biol. Toxicol. 21: 181-189.</li>\n\t<li>&uarr; <sup><a href=\"#cite_ref-B.C3.B6hme_2009_14-0\">14.0</a></sup> <sup><a href=\"#cite_ref-B.C3.B6hme_2009_14-1\">14.1</a></sup> B&ouml;hme A, Thaens D, Paschke A, Sch&uuml;&uuml;rmann G. 2009. Kinetic glutathione chemoassay to quantify thiol reactivity of organic electrophiles &ndash; Application to &alpha;, &beta;-unsaturated ketones, acrylates, and propiolates, Chem. Res. Toxicol. 22: 742-750.</li>\n\t<li><a href=\"#cite_ref-OECD_2015_15-0\">&uarr;</a> OECD. Test No 442C: In chemico skin sensitisation: Direct Peptide Reactivity Assay (DPRA). 2015. OECD Guidelines for the Testing of Chemicals, Section 4: Health Effects, OECD Publishing. Doi 10.1787/9789264229709-en.</li>\n\t<li><a href=\"#cite_ref-DB.E2.80.94ALM_154_16-0\">&uarr;</a> EURL ECVAM DB-ALM. Protocol No154: Direct Peptide Reactivity Assay for skin sensitisation testing. Available on: <a class=\"external free\" href=\"http://ecvam-dbalm.jrc.ec.europa.eu/\" rel=\"nofollow\" target=\"_blank\">http://ecvam-dbalm.jrc.ec.europa.eu/</a>.</li>\n\t<li><a href=\"#cite_ref-Yarbrough_2007_17-0\">&uarr;</a> Yarbrough JW and Schultz TW. 2007. Abiotic sulfhydryl reactivity: A predictor of aquatic toxicity for carbonyl-containing &alpha;,&beta;-unsaturated compounds. Chem. Res. Toxicol. 20: 558-562.</li>\n\t<li><a href=\"#cite_ref-Roberts_2009_18-0\">&uarr;</a> Roberts DW and Natsch A. 2009. High throughput kinetic profiling approach for covalent binding to peptides: Application to skin sensitisation potency of Michael acceptor electrophiles. Chem. Res. Toxicol. 22: 592-603.</li>\n\t<li><a href=\"#cite_ref-Karlberg_2008_19-0\">&uarr;</a> Karlberg AT, Bergstr&ouml;m MA, B&ouml;rje A, Luthman K, Nilsson JL. 2008. Allergic contact dermatitisformation, structural requirements, and reactivity of skin sensitizers. Chem. Res. Toxicol. 21: 53-69.</li>\n\t<li>&uarr; <sup><a href=\"#cite_ref-Adler_2011_20-0\">20.0</a></sup> <sup><a href=\"#cite_ref-Adler_2011_20-1\">20.1</a></sup> Adler S, Basketter D, Creton S, Pelkonen O, van Benthem J, Zuang V, Andersen KE, Angers-Loustau A, Aptula A, Bal-Price A, Benfenati E, Bernauer U, Bessems J, Bois FY, Boobis A, Brandon E, Bremer S, Broschard T, Casati S, Coecke S, Corvi R, Cronin M, Daston G, Dekant W, Felter S, Grignard E, Gundert-Remy U, Heinonen T, Kimber I, Kleinjans J, Komulainen H, Kreiling R, Kreysa J, Leite SB, Loizou G, Maxwell G, Mazzatorta P, Munn S, Pfuhler S, Phrakonkham P, Piersma A, Poth A, Prieto P, Repetto G, Rogiers V, Schoeters G, Schwarz M, Serafimova R, T&auml;hti H, Testai E, van Delft J, van Loveren H, Vinken M, Worth A, Zaldivar JM.2011. Alternative (non-animal) methods for cosmetics testing: current status and future prospects-2010. Arch Toxicol.85(5):367-485.</li>\n\t<li><a href=\"#cite_ref-OECD_2012_21-0\">&uarr;</a> OECD. 2012. The Adverse Outcome Pathway for Skin Sensitisation Initiated by Covalent Binding to Proteins. Part 1: Scientific Evidence. Series on Testing and Assessment No. 168.</li>\n\t<li>&uarr; <sup><a href=\"#cite_ref-Lepoittevin_1998_22-0\">22.0</a></sup> <sup><a href=\"#cite_ref-Lepoittevin_1998_22-1\">22.1</a></sup> Lepoittevin JP, Basketter DA, Goossens A and Karlberg AT (eds) 1998. Allergic contact dermatitis: the molecular basis. Springer, Berlin.</li>\n\t<li><a href=\"#cite_ref-Vocanson_2009_23-0\">&uarr;</a> Vocanson M, Hennino A, Rozieres A, Poyet G, Nicolas JF. 2009. Effector and regulatory mechanisms in allergic contact dermatitis. Allergy 64: 1699-1714.</li>\n\t<li><a href=\"#cite_ref-Aeby_2010_24-0\">&uarr;</a> Aeby P, Ashikaga T, Bessou-Touya S, Schapky A, Geberick F, Kern P, Marrec-Fairley M, Maxwell G, Ovigne JM, Sakaguchi H, Reisinger K, Tailhardat M, Martinozzi-Teisser S and Winkler P. 2010. Identifying and characterizing chemical skin sensitizers without animal testing; Colipa&rsquo;s research and methods development program. Toxicol. In Vitro 24: 1465-1473.</li>\n\t<li><a href=\"#cite_ref-Basketter_2010_25-0\">&uarr;</a> Basketter DA and Kimber I. 2010. Contact hypersensitivity. In: McQueen, C.A. (ed) Comparative Toxicology Vol. 5, 2nd Ed. Elsevier, Kidlington, UK, pp. 397-411.</li>\n</ol>\n\n<p>BASKETTER, D., POOLE, A. &amp; KIMBER, I. 2017. Behaviour of chemical respiratory allergens in novel predictive methods for skin sensitisation. Regul Toxicol Pharmacol, 86, 101-106.</p>\n\n<p>DIK, S., RORIJE, E., SCHWILLENS, P., VAN LOVEREN, H. &amp; EZENDAM, J. 2016. Can the Direct Peptide Reactivity Assay Be Used for the Identification of Respiratory Sensitization Potential of Chemicals? Toxicol Sci, 153, 361-71.</p>\n\n<p>HETTICK, J. M. &amp; SIEGEL, P. D. 2011. Determination of the toluene diisocyanate binding sites on human serum albumin by tandem mass spectrometry. Anal Biochem, 414, 232-8.</p>\n\n<p>HETTICK, J. M., SIEGEL, P. D., GREEN, B. J., LIU, J. &amp; WISNEWSKI, A. V. 2012. Vapor conjugation of toluene diisocyanate to specific lysines of human albumin. Anal Biochem, 421, 706-11.</p>\n\n<p>HOLSAPPLE, M. P., JONES, D., KAWABATA, T. T., KIMBER, I., SARLO, K., SELGRADE, M. K., SHAH, J. &amp; WOOLHISER, M. R. 2006. Assessing the potential to induce respiratory hypersensitivity. Toxicol Sci, 91, 4-13.</p>\n\n<p>HOPKINS, J. E., NAISBITT, D. J., KITTERINGHAM, N. R., DEARMAN, R. J., KIMBER, I. &amp; PARK, B. K. 2005. Selective haptenation of cellular or extracellular protein by chemical allergens: association with cytokine polarization. Chem Res Toxicol, 18, 375-81.</p>\n\n<p>LALKO, J. F., KIMBER, I., GERBERICK, G. F., FOERTSCH, L. M., API, A. M. &amp; DEARMAN, R. J. 2012. The direct peptide reactivity assay: selectivity of chemical respiratory allergens. Toxicol Sci, 129, 421-31.</p>\n\n<p>NATSCH, A. &amp; GFELLER, H. 2008. LC-MS-based characterization of the peptide reactivity of chemicals to improve the in vitro prediction of the skin sensitization potential. Toxicol Sci, 106, 464-78.</p>\n\n<p>WISNEWSKI, A. V., LIU, J. &amp; REDLICH, C. A. 2013a. Connecting glutathione with immune responses to occupational methylene diphenyl diisocyanate exposure. Chem Biol Interact, 205, 38-45.</p>\n\n<p>WISNEWSKI, A. V., MHIKE, M., HETTICK, J. M., LIU, J. &amp; SIEGEL, P. D. 2013b. Hexamethylene diisocyanate (HDI) vapor reactivity with glutathione and subsequent transfer to human albumin. Toxicol In Vitro, 27, 662-71.</p>\n","biologicalOrganisationLevel":"Molecular","organTerm":{},"biologicalEvents":[{"action":"increased","process":"protein binding","object":{"name":"electrophilic reagant","source":"CHEBI","sourceId":"CHEBI:59739"}}],"keyEventStressors":["1-CHLORO-2,4- DINITROBENZENE"],"id":396}
{"title":"sensitisation, skin","references":"<ol class=\"references\">\n<li id=\"cite_note-1\"><span class=\"mw-cite-backlink\"><a href=\"#cite_ref-1\"></a></span> <span class=\"reference-text\">Api AM, Basketter DA, Cadby PA, Cano MF, Ellis G, Gerberick GF, Griem P, McNamee PM, Ryan CA, Safford B. 2008. Dermal sensitisation quantitative risk assessment (QRA) for fragrance ingredients. Regul Toxicol Pharmacol. 52(1):3-23.</span>\n</li>\n<li id=\"cite_note-2\"><span class=\"mw-cite-backlink\"><a href=\"#cite_ref-2\"></a></span> <span class=\"reference-text\">Hogan DJ and  James WD.2015. Allergic Contact Dermatitis Workup Updated: Apr 22, 2015. Available on: <a rel=\"nofollow\" target=\"_blank\" class=\"external free\" href=\"http://emedicine.medscape.com/article/1049216-overview\">http://emedicine.medscape.com/article/1049216-overview</a> accessed 17.9.2015</span>\n</li>\n<li id=\"cite_note-3\"><span class=\"mw-cite-backlink\"><a href=\"#cite_ref-3\"></a></span> <span class=\"reference-text\">Bernstein IL, Li JT, Bernstein DI et al.2008. Allergy diagnostic testing: an updated practice parameter. Ann Allergy Asthma Immunol. 100(3 Suppl 3):S1-148.</span>\n</li>\n<li id=\"cite_note-McNamee2008-4\"><span class=\"mw-cite-backlink\"> <sup><a href=\"#cite_ref-McNamee2008_4-0\">4.0</a></sup> <sup><a href=\"#cite_ref-McNamee2008_4-1\">4.1</a></sup></span> <span class=\"reference-text\">McNamee PM, Api AM, Basketter DA, Frank Gerberick G, Gilpin DA, Hall BM, Jowsey I, Robinson MK.2008. A review of critical factors in the conduct and interpretation of the human repeat insult patch test. Regul Toxicol Pharmacol. 52(1):24-34.</span>\n</li>\n<li id=\"cite_note-5\"><span class=\"mw-cite-backlink\"><a href=\"#cite_ref-5\"></a></span> <span class=\"reference-text\">Larkin A and Rietschel RL.1998. The utility of patch tests using larger screening series of allergens. Am. J. Contact Dermat. 9(3):142-5.</span>\n</li>\n<li id=\"cite_note-Adler_2011-6\"><span class=\"mw-cite-backlink\"> <sup><a href=\"#cite_ref-Adler_2011_6-0\">6.0</a></sup> <sup><a href=\"#cite_ref-Adler_2011_6-1\">6.1</a></sup> <sup><a href=\"#cite_ref-Adler_2011_6-2\">6.2</a></sup></span> <span class=\"reference-text\">Adler S, Basketter D, Creton S, Pelkonen O, van Benthem J, Zuang V, Ejner-Andersen K, Angers- Loustau A, Aptula A, Bal-Price A, Benfenati E, Bernauer U, Bessems J, Bois FY, Boobis A, Brandon E, Bremer S, Broschard T, Casati S, Coecke S, Corvi R, Cronin M, Daston G, Dekant W, Felter S, Grignard E, Gundert-Remy U, Heinonen T, Kimber I, Kleinjans J, Komulainen H, Kreiling R, Kreysa J, Batista Leite S, Loizou G, Maxwell G, Mazzatorta P, Munn S, Pfuhler S, Phrakonkham P, Piersma A, Poth A, Prieto P, Repetto G, Rogiers V, Schoeters G, Schwarz M, Serafimova R, Tahti H, Testai E, van Delft J, van Loveren H, Vinken M, Worth A, Zaldivar JM. 2011. Alternative (non-animal) methods for cosmetics testing: current status and future prospects-2010. Arch. Toxicol. 85: 367-485.</span>\n</li>\n<li id=\"cite_note-OECD_1992-7\"><span class=\"mw-cite-backlink\"> <sup><a href=\"#cite_ref-OECD_1992_7-0\">7.0</a></sup> <sup><a href=\"#cite_ref-OECD_1992_7-1\">7.1</a></sup></span> <span class=\"reference-text\"> OECD 1992. Test No. 406: Skin Sensitisation, OECD Guidelines for the Testing of Chemicals, Section 4: Health Effects, OECD Publishing. doi: 10.1787/9789264070660-en.</span>\n</li>\n<li id=\"cite_note-Buehler_1965-8\"><span class=\"mw-cite-backlink\"><a href=\"#cite_ref-Buehler_1965_8-0\"></a></span> <span class=\"reference-text\">Buehler EV. 1965. Delayed hypersensitivity in the guinea pig. Arch. Dermatol. 91: 171-177.</span>\n</li>\n<li id=\"cite_note-Magnusson_1970-9\"><span class=\"mw-cite-backlink\"><a href=\"#cite_ref-Magnusson_1970_9-0\"></a></span> <span class=\"reference-text\">Magnusson B and Kligman  AM. 1970. Allergic Contact Dermatitis in the Guinea Pig. Identification of Contact Allergens. Charles C Thomas; Springfield, IL USA.</span>\n</li>\n<li id=\"cite_note-Maurer_1994-10\"><span class=\"mw-cite-backlink\"><a href=\"#cite_ref-Maurer_1994_10-0\"></a></span> <span class=\"reference-text\">Maurer T, Arthur A and Bentley P. 1994. Guinea-pig contact sensitisation assays. Toxicology 93: 47-54.</span>\n</li>\n<li id=\"cite_note-OECD_2010-11\"><span class=\"mw-cite-backlink\"> <sup><a href=\"#cite_ref-OECD_2010_11-0\">11.0</a></sup> <sup><a href=\"#cite_ref-OECD_2010_11-1\">11.1</a></sup></span> <span class=\"reference-text\">OECD 2010. Test No429: Skin Sensitisation: Local Lymph Node Assay, OECD Guidelines for the Testing of Chemicals, Section 4: Health Effects, OECD Publishing. doi: 10.1787/9789264071100-en </span>\n</li>\n<li id=\"cite_note-OECD_2010b-12\"><span class=\"mw-cite-backlink\"> <sup><a href=\"#cite_ref-OECD_2010b_12-0\">12.0</a></sup> <sup><a href=\"#cite_ref-OECD_2010b_12-1\">12.1</a></sup></span> <span class=\"reference-text\"> OECD 2010b. Test No442A: Skin Sensitisation: Local Lymph Node Assay: DA, OECD Guidelines for the Testing of Chemicals, Section 4: Health Effects, OECD Publishing. doi: 10.1787/9789264090972- en.</span>\n</li>\n<li id=\"cite_note-OECD_2010c-13\"><span class=\"mw-cite-backlink\"> <sup><a href=\"#cite_ref-OECD_2010c_13-0\">13.0</a></sup> <sup><a href=\"#cite_ref-OECD_2010c_13-1\">13.1</a></sup></span> <span class=\"reference-text\"> OECD 2010c. Test No442B: Skin Sensitisation: Local Lymph Node Assay: BrdU-ELISA, OECD Guidelines for the Testing of Chemicals, Section 4: Health Effects, OECD Publishing. doi: 10.1787/9789264090996-en </span>\n</li>\n<li id=\"cite_note-Basketter_2009-14\"><span class=\"mw-cite-backlink\"><a href=\"#cite_ref-Basketter_2009_14-0\"></a></span> <span class=\"reference-text\">Basketter DA, McFadden JF, Gerberick F, Cochshott A and Kimber I. 2009. Nothing is perfect, not even the local lymph node assay: a commentary and the implications for REACH. Contact Dermat. 60: 65-69.</span>\n</li>\n<li id=\"cite_note-15\"><span class=\"mw-cite-backlink\"><a href=\"#cite_ref-15\"></a></span> <span class=\"reference-text\">OECD 1992. Test No 406: Skin Sensitisation, OECD Guidelines for the Testing of Chemicals, Section 4: Health Effects, OECD Publishing. doi: 10.1787/9789264070660-en</span>\n</li>\n<li id=\"cite_note-16\"><span class=\"mw-cite-backlink\"><a href=\"#cite_ref-16\"></a></span> <span class=\"reference-text\">Magnusson B, Kligman AM. The identification of contact allergens by animal assay.1969. The guinea pig maximization test. J. Invest. Dermatol. 52(3):268-76.</span>\n</li>\n</ol>","biologicalOrganisationLevel":"Organ","organTerm":{},"biologicalEvents":[{"object":{}}],"id":827}
{"title":"Activation, Keratinocytes","references":"<ol class=\"references\">\n<li id=\"cite_note-Sutterwala_2006-1\"><span class=\"mw-cite-backlink\"><a href=\"#cite_ref-Sutterwala_2006_1-0\"></a></span> <span class=\"reference-text\">Sutterwala FS, Ogura Y, Szczepanik M, Lara-Tejero M, Lichtenberger GS, Grant EP, Bertin J, Coyle AJ, Galn JE, Askenase PW, Flavell RA. 2006. Critical role for NALP3/CIAS1/Cryopyrin in innate and adaptive immunity through its regulation of caspase-1. Immunity 24: 317-327.</span>\n</li>\n<li id=\"cite_note-Watanabe_2007-2\"><span class=\"mw-cite-backlink\"><a href=\"#cite_ref-Watanabe_2007_2-0\"></a></span> <span class=\"reference-text\">Watanabe H, Gaide O, Ptrilli V, Martinon F, Contassot E, Roques S, Kummer JA, Tschopp J, French LE. 2007. Activation of the IL-1beta-processing inflammasome is involved in contact hypersensitivity. J. Invest. Dermatol. 127: 1956-1963.</span>\n</li>\n<li id=\"cite_note-Martinon_2009-3\"><span class=\"mw-cite-backlink\"><a href=\"#cite_ref-Martinon_2009_3-0\"></a></span> <span class=\"reference-text\">Martinon F, Mayor A and Tschopp J. 2009. The inflammasomes: guardians of the body. Ann. Rev. Immunol. 27: 229-265.</span>\n</li>\n<li id=\"cite_note-Van_Och_2005-4\"><span class=\"mw-cite-backlink\"> <sup><a href=\"#cite_ref-Van_Och_2005_4-0\">4.0</a></sup> <sup><a href=\"#cite_ref-Van_Och_2005_4-1\">4.1</a></sup></span> <span class=\"reference-text\">Van Och FMM, Van Loveren H, Van Wolfswinkel JC, Machielsen AJC, Vandebriel RJ. 2005. Assessment of potency of allergenic activity of low molecular weight compounds based on IL-1 and IL-18 production by a murine and human keratinocyte cell line. Toxicology 210: 95-109.</span>\n</li>\n<li id=\"cite_note-Natsch_2008-5\"><span class=\"mw-cite-backlink\"> <sup><a href=\"#cite_ref-Natsch_2008_5-0\">5.0</a></sup> <sup><a href=\"#cite_ref-Natsch_2008_5-1\">5.1</a></sup></span> <span class=\"reference-text\">Natsch A and Emter R. 2008. Skin sensitizers induce antioxidant response element dependent genes: Application to the <i>in vitro</i> testing of the sensitisation potential of chemicals. Toxicol. Sci. 102:110-119.</span>\n</li>\n<li id=\"cite_note-Ade_2009-6\"><span class=\"mw-cite-backlink\"><a href=\"#cite_ref-Ade_2009_6-0\"></a></span> <span class=\"reference-text\">Ade N, Leon F, Pallardy M, Pfeiffer JL, Kerdine-Romer S, Tissier MH, Bonnet PA, Fabre I Ourlin JC. 2009. HMOX1 and NQO1 genes are upregulated in response to contact sensitizers in dendritic cells and THP-1 cell line: role of the Keap1/Nrf2 pathway. Toxicol. Sci. 107: 451-460.</span>\n</li>\n<li id=\"cite_note-OECD_2015-7\"><span class=\"mw-cite-backlink\"><a href=\"#cite_ref-OECD_2015_7-0\"></a></span> <span class=\"reference-text\">OECD 2015. Test No442D: <i>In vitro</i> Skin Sensitisation: ARE-Nrf2 Luciferase Test Method. OECD  Guidelines for the Testing of Chemicals, Section 4: Health effects. OECD Publishing. Doi: 10.1787/9789264229822-en.</span>\n</li>\n<li id=\"cite_note-Emter_2010-8\"><span class=\"mw-cite-backlink\"> <sup><a href=\"#cite_ref-Emter_2010_8-0\">8.0</a></sup> <sup><a href=\"#cite_ref-Emter_2010_8-1\">8.1</a></sup></span> <span class=\"reference-text\">Emter R, Ellis G, Natsch A. 2010. Performance of a novel keratinocyte-based reporter cell line in screen skin sensitizers <i>in vitro</i>. Toxicol. Appl. Pharmacol. 245: 281-290.</span>\n</li>\n<li id=\"cite_note-DB.E2.80.94ALM_155-9\"><span class=\"mw-cite-backlink\"><a href=\"#cite_ref-DB.E2.80.94ALM_155_9-0\"></a></span> <span class=\"reference-text\">EURL ECVAM DB-ALM. Protocol No155: KeratinoSensTM. Available on: <a rel=\"nofollow\" target=\"_blank\" class=\"external free\" href=\"http://ecvam-dbalm.jrc.ec.europa.eu/\">http://ecvam-dbalm.jrc.ec.europa.eu/</a>.</span>\n</li>\n<li id=\"cite_note-McKim_2010-10\"><span class=\"mw-cite-backlink\"> <sup><a href=\"#cite_ref-McKim_2010_10-0\">10.0</a></sup> <sup><a href=\"#cite_ref-McKim_2010_10-1\">10.1</a></sup></span> <span class=\"reference-text\">McKim JM Jr, Keller DJ III, Gorski JR. 2010. A new <i>in vitro</i> method for identifying chemical sensitizers combining peptide binding with ARE/EpRE-mediated gene expression in human skin cells. Cutan. Ocul. Toxicol. 29: 171-192.</span>\n</li>\n<li id=\"cite_note-Corsini_2009-11\"><span class=\"mw-cite-backlink\"> <sup><a href=\"#cite_ref-Corsini_2009_11-0\">11.0</a></sup> <sup><a href=\"#cite_ref-Corsini_2009_11-1\">11.1</a></sup></span> <span class=\"reference-text\">Corsini E, Mitjans M, Galbiati V, Lucchi L, Galli CL, Marinovich M. 2009. Use of IL-18 production in a human keratinocyte cell line to discriminate contact sensitizers from irritants and low molecular weight respiratory allergens. Toxicol. In Vitro 23: 769-796.</span>\n</li>\n<li id=\"cite_note-Mitjans_2010-12\"><span class=\"mw-cite-backlink\"><a href=\"#cite_ref-Mitjans_2010_12-0\"></a></span> <span class=\"reference-text\">Mitjans M, Galbiati V, Lucchi L, Viviani B, Marinovich M, Galli CL, Corsini E. 2010. Use of IL-8 release and p38 MAPK activation in THP-1 cells to identify allergens and to assess their potency <i>in vitro</i>. Toxicol. In Vitro 24: 1803-1809.</span>\n</li>\n<li id=\"cite_note-dos_Santos_2009-13\"><span class=\"mw-cite-backlink\"><a href=\"#cite_ref-dos_Santos_2009_13-0\"></a></span> <span class=\"reference-text\">dos Santos GG, Reinders J, Ouwhand K, Rustemeyer T, Scheper RJ, Gibbs S. 2009. Progress on the development of human in vitro dendritic cell based assays for assessment of skin sensitizing potential of compounds. Toxicol. Appl. Pharmacol. 236: 372-382.</span>\n</li>\n</ol>","biologicalOrganisationLevel":"Cellular","organTerm":{},"biologicalEvents":[{"action":"increased","process":"keratinocyte activation","object":{}},{"action":"increased","process":"cytokine production involved in inflammatory response","object":{}}],"id":826}
{"title":"Activation, Keratinocytes","references":"<ol class=\"references\">\n<li id=\"cite_note-Sutterwala_2006-1\"><span class=\"mw-cite-backlink\"><a href=\"#cite_ref-Sutterwala_2006_1-0\"></a></span> <span class=\"reference-text\">Sutterwala FS, Ogura Y, Szczepanik M, Lara-Tejero M, Lichtenberger GS, Grant EP, Bertin J, Coyle AJ, Galn JE, Askenase PW, Flavell RA. 2006. Critical role for NALP3/CIAS1/Cryopyrin in innate and adaptive immunity through its regulation of caspase-1. Immunity 24: 317-327.</span>\n</li>\n<li id=\"cite_note-Watanabe_2007-2\"><span class=\"mw-cite-backlink\"><a href=\"#cite_ref-Watanabe_2007_2-0\"></a></span> <span class=\"reference-text\">Watanabe H, Gaide O, Ptrilli V, Martinon F, Contassot E, Roques S, Kummer JA, Tschopp J, French LE. 2007. Activation of the IL-1beta-processing inflammasome is involved in contact hypersensitivity. J. Invest. Dermatol. 127: 1956-1963.</span>\n</li>\n<li id=\"cite_note-Martinon_2009-3\"><span class=\"mw-cite-backlink\"><a href=\"#cite_ref-Martinon_2009_3-0\"></a></span> <span class=\"reference-text\">Martinon F, Mayor A and Tschopp J. 2009. The inflammasomes: guardians of the body. Ann. Rev. Immunol. 27: 229-265.</span>\n</li>\n<li id=\"cite_note-Van_Och_2005-4\"><span class=\"mw-cite-backlink\"> <sup><a href=\"#cite_ref-Van_Och_2005_4-0\">4.0</a></sup> <sup><a href=\"#cite_ref-Van_Och_2005_4-1\">4.1</a></sup></span> <span class=\"reference-text\">Van Och FMM, Van Loveren H, Van Wolfswinkel JC, Machielsen AJC, Vandebriel RJ. 2005. Assessment of potency of allergenic activity of low molecular weight compounds based on IL-1 and IL-18 production by a murine and human keratinocyte cell line. Toxicology 210: 95-109.</span>\n</li>\n<li id=\"cite_note-Natsch_2008-5\"><span class=\"mw-cite-backlink\"> <sup><a href=\"#cite_ref-Natsch_2008_5-0\">5.0</a></sup> <sup><a href=\"#cite_ref-Natsch_2008_5-1\">5.1</a></sup></span> <span class=\"reference-text\">Natsch A and Emter R. 2008. Skin sensitizers induce antioxidant response element dependent genes: Application to the <i>in vitro</i> testing of the sensitisation potential of chemicals. Toxicol. Sci. 102:110-119.</span>\n</li>\n<li id=\"cite_note-Ade_2009-6\"><span class=\"mw-cite-backlink\"><a href=\"#cite_ref-Ade_2009_6-0\"></a></span> <span class=\"reference-text\">Ade N, Leon F, Pallardy M, Pfeiffer JL, Kerdine-Romer S, Tissier MH, Bonnet PA, Fabre I Ourlin JC. 2009. HMOX1 and NQO1 genes are upregulated in response to contact sensitizers in dendritic cells and THP-1 cell line: role of the Keap1/Nrf2 pathway. Toxicol. Sci. 107: 451-460.</span>\n</li>\n<li id=\"cite_note-OECD_2015-7\"><span class=\"mw-cite-backlink\"><a href=\"#cite_ref-OECD_2015_7-0\"></a></span> <span class=\"reference-text\">OECD 2015. Test No442D: <i>In vitro</i> Skin Sensitisation: ARE-Nrf2 Luciferase Test Method. OECD  Guidelines for the Testing of Chemicals, Section 4: Health effects. OECD Publishing. Doi: 10.1787/9789264229822-en.</span>\n</li>\n<li id=\"cite_note-Emter_2010-8\"><span class=\"mw-cite-backlink\"> <sup><a href=\"#cite_ref-Emter_2010_8-0\">8.0</a></sup> <sup><a href=\"#cite_ref-Emter_2010_8-1\">8.1</a></sup></span> <span class=\"reference-text\">Emter R, Ellis G, Natsch A. 2010. Performance of a novel keratinocyte-based reporter cell line in screen skin sensitizers <i>in vitro</i>. Toxicol. Appl. Pharmacol. 245: 281-290.</span>\n</li>\n<li id=\"cite_note-DB.E2.80.94ALM_155-9\"><span class=\"mw-cite-backlink\"><a href=\"#cite_ref-DB.E2.80.94ALM_155_9-0\"></a></span> <span class=\"reference-text\">EURL ECVAM DB-ALM. Protocol No155: KeratinoSensTM. Available on: <a rel=\"nofollow\" target=\"_blank\" class=\"external free\" href=\"http://ecvam-dbalm.jrc.ec.europa.eu/\">http://ecvam-dbalm.jrc.ec.europa.eu/</a>.</span>\n</li>\n<li id=\"cite_note-McKim_2010-10\"><span class=\"mw-cite-backlink\"> <sup><a href=\"#cite_ref-McKim_2010_10-0\">10.0</a></sup> <sup><a href=\"#cite_ref-McKim_2010_10-1\">10.1</a></sup></span> <span class=\"reference-text\">McKim JM Jr, Keller DJ III, Gorski JR. 2010. A new <i>in vitro</i> method for identifying chemical sensitizers combining peptide binding with ARE/EpRE-mediated gene expression in human skin cells. Cutan. Ocul. Toxicol. 29: 171-192.</span>\n</li>\n<li id=\"cite_note-Corsini_2009-11\"><span class=\"mw-cite-backlink\"> <sup><a href=\"#cite_ref-Corsini_2009_11-0\">11.0</a></sup> <sup><a href=\"#cite_ref-Corsini_2009_11-1\">11.1</a></sup></span> <span class=\"reference-text\">Corsini E, Mitjans M, Galbiati V, Lucchi L, Galli CL, Marinovich M. 2009. Use of IL-18 production in a human keratinocyte cell line to discriminate contact sensitizers from irritants and low molecular weight respiratory allergens. Toxicol. In Vitro 23: 769-796.</span>\n</li>\n<li id=\"cite_note-Mitjans_2010-12\"><span class=\"mw-cite-backlink\"><a href=\"#cite_ref-Mitjans_2010_12-0\"></a></span> <span class=\"reference-text\">Mitjans M, Galbiati V, Lucchi L, Viviani B, Marinovich M, Galli CL, Corsini E. 2010. Use of IL-8 release and p38 MAPK activation in THP-1 cells to identify allergens and to assess their potency <i>in vitro</i>. Toxicol. In Vitro 24: 1803-1809.</span>\n</li>\n<li id=\"cite_note-dos_Santos_2009-13\"><span class=\"mw-cite-backlink\"><a href=\"#cite_ref-dos_Santos_2009_13-0\"></a></span> <span class=\"reference-text\">dos Santos GG, Reinders J, Ouwhand K, Rustemeyer T, Scheper RJ, Gibbs S. 2009. Progress on the development of human in vitro dendritic cell based assays for assessment of skin sensitizing potential of compounds. Toxicol. Appl. Pharmacol. 236: 372-382.</span>\n</li>\n</ol>","biologicalOrganisationLevel":"Cellular","organTerm":{},"biologicalEvents":[{"action":"increased","process":"keratinocyte activation","object":{}},{"action":"increased","process":"cytokine production involved in inflammatory response","object":{}}],"id":826}
{"title":"N/A, Hepatotoxicity, Hepatopathy, including a constellation of observable effects","references":"<p>Boverhof, D.R., Burgoon, L.D., Tashiro, C., Chittim, B., Harkema, J.R., Jump, D.B., Zacharewski, T.R., 2005. Temporal and dose-dependent hepatic gene expression patterns in mice provide new insights into TCDD-Mediated hepatotoxicity. Toxicol. Sci. 85, 1048-1063.\n</p><p>Chang, H., Wang, Y.J., Chang, L.W., Lin, P., 2005. A histochemical and pathological study on the interrelationship between TCDD-induced AhR expression, AhR activation, and hepatotoxicity in mice. J. Toxicol. Environ. Heal. A. 68, 1567-1579.\n</p><p>Hailey, J.R., Walker, N.J., Sells, D.M., Brix, A.E., Jokinen, M.P., Nyska, A., 2005. Clas- sification of proliferative hepatocellular lesions in harlan sprague-dawley rats chronically exposed to dioxin-like compounds. Toxicol. Pathol. 33, 165-174.\n</p><p>Ip, B.C., Wang, X.-D., 2014. Non-alcoholic steatohepatitis and hepatocellular carci- noma: implications for lycopene intervention. Nutrients 6, 124-162.\n</p><p>Jones, G., Greig, J.B., 1975. Pathological changes in the liver of mice given 2,3,7,8-tetrachlorodibenzo-p-dioxin. Experientia 31, 1315-1317.\n</p><p>Nakamura, A., Terauchi, Y., 2013. Lessons from mouse models of high-fat diet- induced NAFLD. Int. J. Mol. Sci. 14, 21240-21257. \n</p><p>NTP, 2006a. NTP technical report on the toxicology and carcinogenesis studies of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) (CAS No. 1746-01-6) in female Harlan Sprague-Dawley rats (Gavage Studies). Natl. Toxicol. Program Tech. Rep. Ser. 4-232.\n</p><p>NTP, 2006b. NTP toxicology and carcinogenesis studies of 2,3,4,7,8- Pentachlorodibenzofuran (PeCDF) (CAS No. 57117-31-4) in female Harlan Sprague-Dawley rats (Gavage studies). Natl. Toxicol. Program Tech. Rep. Ser. 1-198.\n</p><p>NTP, 2006c. NTP toxicology and carcinogenesis studies of 3,3',4,4',5- pentachlorobiphenyl (PCB 126) (CAS No. 57465-28-8) in female Harlan Sprague-Dawley rats (Gavage Studies). Natl. Toxicol. Program Tech. Rep. Ser. 4-246.\n</p><p>NTP, 2006d. NTP technical report on the toxicology and carcinogenesis studies of 2,2',4,4',5,5'-hexachlorobiphenyl (PCB 153) (CAS No. 35065-27-1) in female Harlan Sprague-Dawley rats (Gavage studies). Natl. Toxicol. Program Tech. Rep. Ser. 4-168.\n</p><p>NTP, 2006e. NTP toxicology and carcinogenesis studies of a binary mixture of 3,3' ,4,4' ,5-Pentachlorobiphenyl (PCB 126) (CAS No. 57465-28-8) and 2,20,4,40,5,50-Hexachlorobiphenyl (PCB 153) (CAS No. 35065-27-1) in female Harlan Sprague-Dawley rats (Gavage studies). Natl. Toxicol. Program Tech. Rep. Ser. 1-258.\n</p><p>NTP, 2006f. NTP toxicology and carcinogenesis studies of a mixture of 2,3,7,8- tetrachlorodibenzo-p-dioxin (TCDD) (CAS No. 1746-01-6), 2,3,4,7,8- pentachlorodibenzofuran (PeCDF) (CAS No. 57117-31-4), and 3,3',,4,4' ,5- pentachlorobiphenyl (PCB 126) (CAS No. 57465-28-8) in female Harlan Sprague-Dawley rats (Gavage studies). Natl. Toxicol. Program Tech. Rep. Ser. 1-180.\n</p><p>Simon, T., Aylward, L.L., Kirman, C.R., Rowlands, J.C., Budinsky, R.A., 2009. Estimates of cancer potency of 2,3,7,8-tetrachlorodibenzo(p)dioxin using linear and nonlinear dose-response modeling and toxicokinetics. Toxicol. Sci. 112, 490-506.\n</p><p>Walker, N.J., Wyde, M.E., Fischer, L.J., Nyska, A., Bucher, J.R., 2006. Comparison of chronic toxicity and carcinogenicity of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in 2-year bioassays in female Sprague-Dawley rats. Mol. Nutr. Food Res. 50, 934-944.\n</p>","biologicalOrganisationLevel":"Tissue","organTerm":{},"biologicalEvents":[{"action":"occurrence","object":{"name":"Liver Diseases","source":"MESH","sourceId":"D008107"}}],"id":139}
{"title":"Activation, Long term AHR receptor driven direct and indirect gene expression changes","references":"<p>Abel, J., Haarmann-Stemmann, T., 2010. An introduction to the molecular basics of aryl hydrocarbon receptor biology. Biol. Chem. 391, 1235e1248. http:// dx.doi.org/10.1515/BC.2010.128.</p>\n\n<p>Andersen, M.E., Preston, R.J., Maier, A., Willis, A.M., Patterson, J., 2014. Dose- response approaches for nuclear receptor-mediated modes of action for liver carcinogenicity: results of a workshop. Crit. Rev. Toxicol. 44, 50e63. http:// dx.doi.org/10.3109/10408444.2013.835785.</p>\n\n<p>Angrish, M.M., Jones, A.D., Harkema, J.R., Zacharewski, T.R., 2011. Aryl hydrocarbon receptor-mediated induction of stearoyl-CoA desaturase 1 alters hepatic fatty acid composition in TCDD-elicited steatosis. Toxicol. Sci. 124, 299e310. http:// dx.doi.org/10.1093/toxsci/kfr226.</p>\n\n<p>Beischlag, T.V., Luis Morales, J., Hollingshead, B.D., Perdew, G.H., 2008. The aryl hydrocarbon receptor complex and the control of gene expression. Crit. Rev. Eukaryot. Gene. Expr. 18, 207e250, 6f28b0540a5e6e63,5ec7b3e06964879d [pii].</p>\n\n<p>Bendall, S.C., Nolan, G.P., 2012. From single cells to deep phenotypes in cancer. Nat. Biotechnol. 30, 639e647. <a class=\"external free\" href=\"http://dx.doi.org/10.1038/nbt.2283\" rel=\"nofollow\" target=\"_blank\">http://dx.doi.org/10.1038/nbt.2283</a>.</p>\n\n<p>Black, M.B., Budinsky, R.A., Dombkowski, A., Lecluyse, E.L., Ferguson, S.S., Thomas, R.S., Rowlands, J.C., 2012. Cross-species comparisons of transcriptomic alterations in human and rat primary hepatocytes exposed to 2,3,7,8- tetrachlorodibenzo-p-dioxin. Toxicol. Sci. 127, 199e215. <a class=\"external free\" href=\"http://dx.doi.org/\" rel=\"nofollow\" target=\"_blank\">http://dx.doi.org/</a> 10.1093/toxsci/kfs069.</p>\n\n<p>Boutros, P.C., Bielefeld, K.A., Pohjanvirta, R., Harper, P.A., 2009. Dioxin-dependent and dioxin-independent gene batteries: comparison of liver and kidney in AHR- null mice. Toxicol. Sci. 112, 245e256 kfp191 [pii] 10.1093/toxsci/kfp191.</p>\n\n<p>Boutros, P.C., Moffat, I.D., Franc, M.A., Tijet, N., Tuomisto, J., Pohjanvirta, R., Okey, A.B., 2004. Dioxin-responsive AHRE-II gene battery: identification by phylogenetic footprinting. Biochem. Biophys. Res. Commun. 321, 707e715.</p>\n\n<p>Boutros, P.C., Yao, C.Q., Watson, J.D., Wu, A.H., Moffat, I.D., Prokopec, S.D., Smith, A.B., Okey, A.B., Pohjanvirta, R., 2011. Hepatic transcriptomic responses to TCDD in dioxin-sensitive and dioxin-resistant rats during the onset of toxicity. Toxicol. Appl. Pharmacol. 251, 119e129. <a class=\"external free\" href=\"http://dx.doi.org/10.1016/\" rel=\"nofollow\" target=\"_blank\">http://dx.doi.org/10.1016/</a> j.taap.2010.12.010. S0041-008X(10)00467-9 [pii].</p>\n\n<p>Boverhof, D.R., Burgoon, L.D., Tashiro, C., Chittim, B., Harkema, J.R., Jump, D.B., Zacharewski, T.R., 2005. Temporal and dose-dependent hepatic gene expression patterns in mice provide new insights into TCDD-Mediated hepatotoxicity. Toxicol. Sci. 85, 1048e1063.</p>\n\n<p>Boverhof, D.R., Burgoon, L.D., Tashiro, C., Sharratt, B., Chittim, B., Harkema, J.R., Mendrick, D.L., Zacharewski, T.R., 2006. Comparative toxicogenomic analysis of the hepatotoxic effects of TCDD in Sprague Dawley rats and C57BL/6 mice. Toxicol. Sci. 94, 398e416.</p>\n\n<p><br />\nBrauze, D., Rawuszko, A.A., 2012. The effect of aryl hydrocarbon receptor ligands on the expression of polymerase (DNA directed) kappa (Polk), polymerase RNA II (DNA directed) polypeptide A (PolR2a), CYP1B1 and CYP1A1 genes in rat liver. Environ. Toxicol. Pharmacol. 34, 819e825. <a class=\"external free\" href=\"http://dx.doi.org/10.1016/\" rel=\"nofollow\" target=\"_blank\">http://dx.doi.org/10.1016/</a> j.etap.2012.09.004.</p>\n\n<p>Budinsky, R.A., LeCluyse, E.L., Ferguson, S.S., Rowlands, J.C., Simon, T., 2010. Human and rat primary hepatocyte CYP1A1 and 1A2 induction with 2,3,7,8- tetrachlorodibenzo-p-dioxin, 2,3,7,8-tetrachlorodibenzofuran, and 2,3,4,7,8- pentachlorodibenzofuran. Toxicol. Sci. 118, 224e235 kfq238 [pii] 10.1093/ toxsci/kfq238.</p>\n\n<p>Budinsky, R.A., Schrenk, D., Simon, T., Van den Berg, M., Reichard, J.F., Silkworth, J.B., Aylward, L.L., Brix, A., Gasiewicz, T., Kaminski, N., Perdew, G., Starr, T.B., Walker, N.J., Rowlands, J.C., 2014. Mode of action and dose-response framework analysis for receptor-mediated toxicity: the aryl hydrocarbon receptor as a case study. Crit. Rev. Toxicol. 44, 83e119. <a class=\"external free\" href=\"http://dx.doi.org/10.3109/\" rel=\"nofollow\" target=\"_blank\">http://dx.doi.org/10.3109/</a> 10408444.2013.835787.</p>\n\n<p>Connor, K.T., Aylward, L.L., 2006. Human response to dioxin: aryl hydrocarbon re- ceptor (AhR) molecular structure, function, and dose-response data for enzyme induction indicate an impaired human AhR. J. Toxicol. Environ. Health B Crit. Rev. 9, 147e171.</p>\n\n<p>Carlson, E.A., McCulloch, C., Koganti, A., Goodwin, S.B., Sutter, T.R., Silkworth, J.B., 2009. Divergent transcriptomic responses to aryl hydrocarbon receptor agonists between rat and human primary hepatocytes. Toxicol. Sci. 112, 257e272. http:// dx.doi.org/10.1093/toxsci/kfp200 kfp200 [pii].</p>\n\n<p><br />\nChia, N.-Y., Ng, H.-H., 2012. Stem cell genome-to-systems biology. Wiley Interdiscip. Rev. Syst. Biol. Med. 4, 39e49. <a class=\"external free\" href=\"http://dx.doi.org/10.1002/wsbm.151\" rel=\"nofollow\" target=\"_blank\">http://dx.doi.org/10.1002/wsbm.151</a>.</p>\n\n<p>Dere, E., Lee, A.W., Burgoon, L.D., Zacharewski, T.R., 2011. Differences in TCDD- elicited gene expression profiles in human HepG2, mouse Hepa1c1c7 and rat H4IIE hepatoma cells. BMC Genomics 12, 193. <a class=\"external free\" href=\"http://dx.doi.org/10.1186/1471-\" rel=\"nofollow\" target=\"_blank\">http://dx.doi.org/10.1186/1471-</a> 2164-12-193.</p>\n\n<p>Denison, M.S., Soshilov, A.A., He, G., DeGroot, D.E., Zhao, B., 2011. Exactly the same but different: promiscuity and diversity in the molecular mechanisms of action of the aryl hydrocarbon (dioxin) receptor. Toxicol. Sci. 124, 1e22. http:// dx.doi.org/10.1093/toxsci/kfr218.</p>\n\n<p>Dietrich, C., Kaina, B., 2010. The aryl hydrocarbon receptor (AhR) in the regulation of cell-cell contact and tumor growth. Carcinogenesis 31, 1319e1328. http:// dx.doi.org/10.1093/carcin/bgq028 bgq028 [pii].</p>\n\n<p>Ellinger-Ziegelbauer, H., Gmuender, H., Bandenburg, A., Ahr, H.J., 2008. Prediction of a carcinogenic potential of rat hepatocarcinogens using toxicogenomics analysis of short-term in vivo studies. Mutat. Res. 637, 23e39. <a class=\"external free\" href=\"http://dx.doi.org/10.1016/\" rel=\"nofollow\" target=\"_blank\">http://dx.doi.org/10.1016/</a> j.mrfmmm.2007.06.010.</p>\n\n<p>Ellinger-Ziegelbauer, H., Stuart, B., Wahle, B., Bomann, W., Ahr, H.J., 2005. Com- parison of the expression profiles induced by genotoxic and nongenotoxic carcinogens in rat liver. Mutat. Res. 575, 61e84. <a class=\"external free\" href=\"http://dx.doi.org/10.1016/\" rel=\"nofollow\" target=\"_blank\">http://dx.doi.org/10.1016/</a> j.mrfmmm.2005.02.004.</p>\n\n<p>Fielden, M.R., Adai, A., Dunn, R.T., Olaharski, A., Searfoss, G., Sina, J., Aubrecht, J., Boitier, E., Nioi, P., Auerbach, S., Jacobson-Kram, D., Raghavan, N., Yang, Y., Kincaid, A., Sherlock, J., Chen, S.-J., Car, B., Predictive Safety Testing Consortium, Carcinogenicity Working Group, 2011. Development and evaluation of a genomic signature for the prediction and mechanistic assessment of non- genotoxic hepatocarcinogens in the rat. Toxicol. Sci. 124, 54e74. http:// dx.doi.org/10.1093/toxsci/kfr202.</p>\n\n<p>Fielden, M.R., Brennan, R., Gollub, J., 2007. A gene expression biomarker provides early prediction and mechanistic assessment of hepatic tumor induction by nongenotoxic chemicals. Toxicol. Sci. 99, 90e100. <a class=\"external free\" href=\"http://dx.doi.org/10.1093/\" rel=\"nofollow\" target=\"_blank\">http://dx.doi.org/10.1093/</a> toxsci/kfm156.</p>\n\n<p>Flaveny, C.A., Murray, I.A., Perdew, G.H., 2010. Differential gene regulation by the human and mouse aryl hydrocarbon receptor. Toxicol. Sci. 114, 217e225. http:// dx.doi.org/10.1093/toxsci/kfp308 kfp308 [pii].</p>\n\n<p>Fletcher, N., Wahlstrom, D., Lundberg, R., Nilsson, C.B., Nilsson, K.C., Stockling, K., Hellmold, H., Hakansson, H., 2005. 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) alters the mRNA expression of critical genes associated with cholesterol metabolism, bile acid biosynthesis, and bile transport in rat liver: a microarray study. Toxicol. Appl. Pharmacol. 207, 1e24.</p>\n\n<p>Forgacs, A.L., Burgoon, L.D., Lynn, S.G., LaPres, J.J., Zacharewski, T., 2010. Effects of TCDD on the expression of nuclear encoded mitochondrial genes. Toxicol. Appl. Pharmacol. 246, 58e65. <a class=\"external free\" href=\"http://dx.doi.org/10.1016/j.taap.2010.04.006\" rel=\"nofollow\" target=\"_blank\">http://dx.doi.org/10.1016/j.taap.2010.04.006</a>. S0041- 008X(10)00133-X [pii].</p>\n\n<p>Franc, M.A., Moffat, I.D., Boutros, P.C., Tuomisto, J.T., Tuomisto, J., Pohjanvirta, R., Okey, A.B., 2008. Patterns of dioxin-altered mRNA expression in livers of dioxin- sensitive versus dioxin-resistant rats. Arch. Toxicol. 82, 809e830. http:// dx.doi.org/10.1007/s00204-008-0303-0.</p>\n\n<p>Furness, S.G., Whelan, F., 2009. The pleiotropy of dioxin toxicityexenobiotic misappropriation of the aryl hydrocarbon receptor&#39;s alternative physiological roles. Pharmacol. Ther. 124, 336e353. <a class=\"external free\" href=\"http://dx.doi.org/10.1016/j.pharm-\" rel=\"nofollow\" target=\"_blank\">http://dx.doi.org/10.1016/j.pharm-</a> thera.2009.09.004. S0163-7258(09)00187-9 [pii].</p>\n\n<p>Gasiewicz, T.A., Henry, E.C., Collins, L.L., 2008. Expression and activity of aryl hy- drocarbon receptors in development and cancer. Crit. Rev. Eukaryot. Gene Expr. 18, 279e321, 4de8c9fe5b6af78b,714c550a3fb330d1 [pii].</p>\n\n<p>George, C.L., Lightman, S.L., Biddie, S.C., 2011. Transcription factor interactions in genomic nuclear receptor function. Epigenomics 3, 471e485. <a class=\"external free\" href=\"http://dx.doi.org/\" rel=\"nofollow\" target=\"_blank\">http://dx.doi.org/</a> 10.2217/epi.11.66.</p>\n\n<p>Hailey, J.R., Walker, N.J., Sells, D.M., Brix, A.E., Jokinen, M.P., Nyska, A., 2005. Clas- sification of proliferative hepatocellular lesions in harlan sprague-dawley rats chronically exposed to dioxin-like compounds. Toxicol. Pathol. 33, 165e174. <a class=\"external free\" href=\"http://dx.doi.org/10.1080/01926230590888324\" rel=\"nofollow\" target=\"_blank\">http://dx.doi.org/10.1080/01926230590888324</a>. TBE21PK0FLEJ66J7 [pii].</p>\n\n<p>Harrill, J.A., Hukkanen, R.R., Lawson, M., Martin, G., Gilger, B., Soldatow, V., Lecluyse, E.L., Budinsky, R.A., Rowlands, J.C., Thomas, R.S., 2013. Knockout of the aryl hydrocarbon receptor results in distinct hepatic and renal phenotypes in rats and mice. Toxicol. Appl. Pharmacol. 272, 503e518. <a class=\"external free\" href=\"http://dx.doi.org/\" rel=\"nofollow\" target=\"_blank\">http://dx.doi.org/</a> 10.1016/j.taap.2013.06.024.</p>\n\n<p><br />\nHeise, T., Schug, M., Storm, D., Ellinger-Ziegelbauer, H., Ahr, H.J., Hellwig, B., Rahnenfuhrer, J., Ghallab, A., Guenther, G., Sisnaiske, J., Reif, R., Godoy, P., Mielke, H., Gundert-Remy, U., Lampen, A., Oberemm, A., Hengstler, J.G., 2012. In vitro e in vivo correlation of gene expression alterations induced by liver carcinogens. Curr. Med. Chem. 19, 1721e1730.</p>\n\n<p>Ikeda, H., Nishi, S., Sakai, M., 2004. Transcription factor Nrf2/MafK regulates rat placental glutathione S-transferase gene during hepatocarcinogenesis. Bio- chem.. J. 380, 515e521. <a class=\"external free\" href=\"http://dx.doi.org/10.1042/BJ20031948\" rel=\"nofollow\" target=\"_blank\">http://dx.doi.org/10.1042/BJ20031948</a>.</p>\n\n<p>Jaramillo, M.C., Zhang, D.D., 2013. The emerging role of the Nrf2-Keap1 signaling pathway in cancer. Genes. Dev. 27, 2179e2191. <a class=\"external free\" href=\"http://dx.doi.org/10.1101/gad.225680.113\" rel=\"nofollow\" target=\"_blank\">http://dx.doi.org/10.1101/gad.225680.113</a>.</p>\n\n<p>Julien, E., Boobis, A.R., Olin, S.S., Ilsi Research Foundation Threshold Working Group, 2009. The key events dose-response framework: a cross-disciplinary mode-of- action based approach to examining dose-response and thresholds. Crit. Rev. Food. Sci. Nutr. 49, 682e689. <a class=\"external free\" href=\"http://dx.doi.org/10.1080/10408390903110692\" rel=\"nofollow\" target=\"_blank\">http://dx.doi.org/10.1080/10408390903110692</a>.</p>\n\n<p>Kumar, M.B., Ramadoss, P., Reen, R.K., Vanden Heuvel, J.P., Perdew, G.H., 2001. The Q-rich subdomain of the human Ah receptor transactivation domain is required for dioxin-mediated transcriptional activity. J. Biol. Chem. 276, 42302e42310. <a class=\"external free\" href=\"http://dx.doi.org/10.1074/jbc.M104798200\" rel=\"nofollow\" target=\"_blank\">http://dx.doi.org/10.1074/jbc.M104798200</a>. M104798200 [pii].</p>\n\n<p>Kumar, R., Wang, R.-A., Barnes, C.J., 2004. Coregulators and chromatin remodeling in transcriptional control. Mol. Carcinog. 41, 221e230. <a class=\"external free\" href=\"http://dx.doi.org/\" rel=\"nofollow\" target=\"_blank\">http://dx.doi.org/</a> 10.1002/mc.20056.</p>\n\n<p>Kwak, M.K., Itoh, K., Yamamoto, M., Sutter, T.R., Kensler, T.W., 2001. Role of tran- scription factor Nrf2 in the induction of hepatic phase 2 and antioxidative enzymes in vivo by the cancer chemoprotective agent, 3H-1, 2-dimethiole-3- thione. Mol. Med. 7, 135e145.</p>\n\n<p>Le Vee, M., Jouan, E., Fardel, O., 2010. Involvement of aryl hydrocarbon receptor in basal and 2,3,7,8-tetrachlorodibenzo-p-dioxin-induced expression of target genes in primary human hepatocytes. Toxicol. In Vitro 24, 1775e1781. http:// dx.doi.org/10.1016/j.tiv.2010.07.001.</p>\n\n<p>Lee, K.C., Lee Kraus, W., 2001. Nuclear receptors, coactivators and chromatin: new approaches, new insights. Trends Endocrinol. Metab. 12, 191e197.</p>\n\n<p>Lees, M.J., Whitelaw, M.L., 1999. Multiple roles of ligand in transforming the dioxin receptor to an active basic helix-loop-helix/PAS transcription factor complex with the nuclear protein Arnt. Mol. Cell. Biol. 19, 5811e5822.</p>\n\n<p>Liby, K.T., Sporn, M.B., 2012. Synthetic oleanane triterpenoids: multifunctional drugs with a broad range of applications for prevention and treatment of chronic disease. Pharmacol. Rev. 64, 972e1003. <a class=\"external free\" href=\"http://dx.doi.org/10.1124/\" rel=\"nofollow\" target=\"_blank\">http://dx.doi.org/10.1124/</a> pr.111.004846.</p>\n\n<p>Lu, H., Cui, W., Klaassen, C.D., 2011. Nrf2 protects against 2,3,7,8-tetrachlorodibenzo- p-dioxin (TCDD)-induced oxidative injury and steatohepatitis. Toxicol. Appl. Pharmacol. 256, 122e135. <a class=\"external free\" href=\"http://dx.doi.org/10.1016/j.taap.2011.07.019\" rel=\"nofollow\" target=\"_blank\">http://dx.doi.org/10.1016/j.taap.2011.07.019</a>.</p>\n\n<p>Ma, Q., Baldwin, K.T., Renzelli, A.J., McDaniel, A., Dong, L., 2001. TCDD-inducible poly(ADP-ribose) polymerase: a novel response to 2,3,7,8-tetrachlorodibenzo- p-dioxin. Biochem. Biophys. Res. Commun. 289, 499e506. <a class=\"external free\" href=\"http://dx.doi.org/\" rel=\"nofollow\" target=\"_blank\">http://dx.doi.org/</a> 10.10 06/bbrc.20 01.5987.</p>\n\n<p>Ma, Q., 2011. Influence of light on aryl hydrocarbon receptor signaling and conse- quences in drug metabolism, physiology and disease. Expert. Opin. Drug. Metab. Toxicol. 7, 1267e1293. <a class=\"external free\" href=\"http://dx.doi.org/10.1517/17425255.2011.614947\" rel=\"nofollow\" target=\"_blank\">http://dx.doi.org/10.1517/17425255.2011.614947</a>.</p>\n\n<p>Ma, Q., He, X., 2012. Molecular basis of electrophilic and oxidative defense: promises and perils of Nrf2. Pharmacol. Rev. 64, 1055e1081. <a class=\"external free\" href=\"http://dx.doi.org/\" rel=\"nofollow\" target=\"_blank\">http://dx.doi.org/</a> 10.1124/pr.110.004333.</p>\n\n<p>Matthews, J., Gustafsson, J.A., 2006. Estrogen receptor and aryl hydrocarbon re- ceptor signaling pathways. Nucl. Recept. Signal 4, e016. <a class=\"external free\" href=\"http://dx.doi.org/\" rel=\"nofollow\" target=\"_blank\">http://dx.doi.org/</a> 10.1621/nrs.04016.</p>\n\n<p>Matthews, J., Wihlen, B., Thomsen, J., Gustafsson, J.A., 2005. Aryl hydrocarbon receptor-mediated transcription: ligand-dependent recruitment of estrogen receptor alpha to 2,3,7,8-tetrachlorodibenzo-p-dioxin-responsive promoters. Mol. Cell Biol. 25, 5317e5328. <a class=\"external free\" href=\"http://dx.doi.org/10.1128/MCB.25.13.5317-\" rel=\"nofollow\" target=\"_blank\">http://dx.doi.org/10.1128/MCB.25.13.5317-</a> 5328.2005, 25/13/5317 [pii].</p>\n\n<p>Moffat, I.D., Boutros, P.C., Chen, H., Okey, A.B., Pohjanvirta, R., 2010. Aryl hydro- carbon receptor (AHR)-regulated transcriptomic changes in rats sensitive or resistant to major dioxin toxicities. BMC Genomics 11, 263. <a class=\"external free\" href=\"http://dx.doi.org/\" rel=\"nofollow\" target=\"_blank\">http://dx.doi.org/</a> 10.1186/1471-2164-11-263.</p>\n\n<p>Nie, A.Y., McMillian, M., Parker, J.B., Leone, A., Bryant, S., Yieh, L., Bittner, A., Nelson, J., Carmen, A., Wan, J., Lord, P.G., 2006. Predictive toxicogenomics ap- proaches reveal underlying molecular mechanisms of nongenotoxic carcino- genicity. Mol. Carcinog. 45, 914e933. <a class=\"external free\" href=\"http://dx.doi.org/10.1002/mc.20205.NTP\" rel=\"nofollow\" target=\"_blank\">http://dx.doi.org/10.1002/mc.20205.NTP</a>, 2006a. NTP technical report on the toxicology and carcinogenesis studies of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) (CAS No. 1746-01-6) in female Harlan Sprague-Dawley rats (Gavage Studies). Natl. Toxicol. Program Tech. Rep. Ser. 4e232.</p>\n\n<p>NTP, 2006b. NTP toxicology and carcinogenesis studies of 2,3,4,7,8- Pentachlorodibenzofuran (PeCDF) (CAS No. 57117-31-4) in female Harlan Sprague-Dawley rats (Gavage studies). Natl. Toxicol. Program Tech. Rep. Ser. 1e198.</p>\n\n<p>NTP, 2006c. NTP toxicology and carcinogenesis studies of 3,30,4,40,5- pentachlorobiphenyl (PCB 126) (CAS No. 57465-28-8) in female Harlan Sprague-Dawley rats (Gavage Studies). Natl. Toxicol. Program Tech. Rep. Ser. 4e246.</p>\n\n<p>NTP, 2006d. NTP technical report on the toxicology and carcinogenesis studies of 2,20,4,40,5,50-hexachlorobiphenyl (PCB 153) (CAS No. 35065-27-1) in female Harlan Sprague-Dawley rats (Gavage studies). Natl. Toxicol. Program Tech. Rep. Ser. 4E168.</p>\n\n<p>NTP, 2006e. NTP toxicology and carcinogenesis studies of a binary mixture of 3,30 ,4,40 ,5-Pentachlorobiphenyl (PCB 126) (CAS No. 57465-28-8) and 2,20,4,40,5,50-Hexachlorobiphenyl (PCB 153) (CAS No. 35065-27-1) in female Harlan Sprague-Dawley rats (Gavage studies). Natl. Toxicol. Program Tech. Rep. Ser. 1E258.</p>\n\n<p>NTP, 2006f. NTP toxicology and carcinogenesis studies of a mixture of 2,3,7,8- tetrachlorodibenzo-p-dioxin (TCDD) (CAS No. 1746-01-6), 2,3,4,7,8- pentachlorodibenzofuran (PeCDF) (CAS No. 57117-31-4), and 3,30 ,4,40 ,5- pentachlorobiphenyl (PCB 126) (CAS No. 57465-28-8) in female Harlan Sprague-Dawley rats (Gavage studies). Natl. Toxicol. Program Tech. Rep. Ser. 1E180.</p>\n\n<p>NTP, 2010. Toxicology and carcinogenesis studies of 2,30 ,4,40 ,5-pentachlorobiphenyl (PCB 118) (CAS No. 31508-00-6) in female harlan Sprague-Dawley rats (gavage studies). Natl. Toxicol. Program. Tech. Rep. Ser. 1E174.</p>\n\n<p>Osburn, W.O., Yates, M.S., Dolan, P.D., Chen, S., Liby, K.T., Sporn, M.B., Taguchi, K., Yamamoto, M., Kensler, T.W., 2008. Genetic or pharmacologic amplification of nrf2 signaling inhibits acute inflammatory liver injury in mice. Toxicol. Sci. 104, 218e227. <a class=\"external free\" href=\"http://dx.doi.org/10.1093/toxsci/kfn079\" rel=\"nofollow\" target=\"_blank\">http://dx.doi.org/10.1093/toxsci/kfn079</a>.</p>\n\n<p>Ovando, B.J., Ellison, C.A., Vezina, C.M., Olson, J.R., 2010. Toxicogenomic analysis of exposure to TCDD, PCB126 and PCB153: identification of genomic biomarkers of exposure to AhR ligands, BMC. Genomics 11, 583. <a class=\"external free\" href=\"http://dx.doi.org/10.1186/\" rel=\"nofollow\" target=\"_blank\">http://dx.doi.org/10.1186/</a> 1471-2164-11-583, 1471-2164-11-583 [pii].</p>\n\n<p>Ovando, B.J., Vezina, C.M., McGarrigle, B.P., Olson, J.R., 2006. Hepatic gene down- regulation following acute and subchronic exposure to 2,3,7,8- tetrachlorodibenzo-p-dioxin. Toxicol. Sci. 94, 428e438.</p>\n\n<p>Partch, C.L., Gardner, K.H., 2010. Coactivator recruitment: a new role for PAS do- mains in transcriptional regulation by the bHLH-PAS family. J. Cell. Physiol. 223, 553e557. <a class=\"external free\" href=\"http://dx.doi.org/10.1002/jcp.22067\" rel=\"nofollow\" target=\"_blank\">http://dx.doi.org/10.1002/jcp.22067</a>.</p>\n\n<p>Perissi, V., Rosenfeld, M.G., 2005. Controlling nuclear receptors: the circular logic of cofactor cycles. Nat. Rev. Mol. Cell. Biol. 6, 542e554. <a class=\"external free\" href=\"http://dx.doi.org/10.1038/\" rel=\"nofollow\" target=\"_blank\">http://dx.doi.org/10.1038/</a> nrm1682.</p>\n\n<p>Reen, R.K., Cadwallader, A., Perdew, G.H., 2002. The subdomains of the trans- activation domain of the aryl hydrocarbon receptor (AhR) inhibit AhR and es- trogen receptor transcriptional activity. Arch. Biochem. Biophys. 408, 93e102.</p>\n\n<p>Rowlands, J.C., McEwan, I.J., Gustafsson, J.A., 1996. Trans-activation by the human aryl hydrocarbon receptor and aryl hydrocarbon receptor nuclear translocator proteins: direct interactions with basal transcription factors. Mol. Pharmacol. 50, 538e548.</p>\n\n<p>Rowlands, J.C., Budinsky, R., Gollapudi, B., Novak, R., Abdelmegeed, M., Cukovic, D., Dombkowski, A., 2011. Transcriptional profiles induced by the Aryl hydrocarbon receptor agonists 2,3,7,8-tetrachlorodibenzo-p-dioxin, 2,3,7,8- tetrachlorodibenzofuran and 2,3,4,7,8-pentachlorodibenzofuran in primary rat hepatocytes. Chemosphere. <a class=\"external free\" href=\"http://dx.doi.org/10.1016/j.chemo-\" rel=\"nofollow\" target=\"_blank\">http://dx.doi.org/10.1016/j.chemo-</a> sphere.2011.06.026. S0045e6535(11)00669-2 [pii].</p>\n\n<p>Sato, S., Shirakawa, H., Tomita, S., Tohkin, M., Gonzalez, F.J., Komai, M., 2013. The aryl hydrocarbon receptor and glucocorticoid receptor interact to activate human metallothionein 2A. Toxicol. Appl. Pharmacol. 273, 90e99. <a class=\"external free\" href=\"http://dx.doi.org/\" rel=\"nofollow\" target=\"_blank\">http://dx.doi.org/</a> 10.1016/j.taap.2013.08.017.</p>\n\n<p>Shelton, P., Jaiswal, A.K., 2013. The transcription factor NF-E2-related factor 2 (Nrf2): a protooncogene? FASEB. J. 27, 414e423. <a class=\"external free\" href=\"http://dx.doi.org/10.1096/fj.12-217257\" rel=\"nofollow\" target=\"_blank\">http://dx.doi.org/10.1096/fj.12-217257</a>.</p>\n\n<p>Simon, T.W., Simons, S.S., Preston, R.J., Boobis, A.R., Cohen, S.M., Doerrer, N.G., Fenner-Crisp, P.A., McMullin, T.S., McQueen, C.A., Rowlands, J.C., RISK21 Dose- Response Subteam, 2014. The use of mode of action information in risk assessment: quantitative key events/dose-response framework for modeling the dose-response for key events. Crit. Rev. Toxicol. 44 (Suppl. 3), 17e43. http:// dx.doi.org/10.3109/10408444.2014.931925.</p>\n\n<p>Soshilov, A., Denison, M.S., 2011. Ligand displaces heat shock protein 90 from overlapping binding sites within the aryl hydrocarbon receptor ligand-binding domain. J. Biol. Chem. 286, 35275e35282. <a class=\"external free\" href=\"http://dx.doi.org/10.1074/\" rel=\"nofollow\" target=\"_blank\">http://dx.doi.org/10.1074/</a> jbc.M111.246439.</p>\n\n<p>Tanaka, M., Itoh, T., Tanimizu, N., Miyajima, A., 2011. Liver stem/progenitor cells: their characteristics and regulatory mechanisms. J. Biochem. 149, 231e239. <a class=\"external free\" href=\"http://dx.doi.org/10.1093/jb/mvr001\" rel=\"nofollow\" target=\"_blank\">http://dx.doi.org/10.1093/jb/mvr001</a>.</p>\n\n<p>Tappenden, D.M., Hwang, H.J., Yang, L., Thomas, R.S., Lapres, J.J., 2013. The aryl- hydrocarbon receptor protein interaction network (AHR-PIN) as identified by tandem affinity purification (TAP) and mass spectrometry. J. Toxicol. 2013, 279829. <a class=\"external free\" href=\"http://dx.doi.org/10.1155/2013/279829\" rel=\"nofollow\" target=\"_blank\">http://dx.doi.org/10.1155/2013/279829</a>.</p>\n\n<p>Tsai, C.-C., Fondell, J.D., 2004. Nuclear receptor recruitment of histone-modifying enzymes to target gene promoters. Vitam. Horm. 68, 93e122. http:// dx.doi.org/10.1016/S0083-6729(04)68003-4.</p>\n\n<p>van Delft, J.H.M., van Agen, E., van Breda, S.G.J., Herwijnen, M.H., Staal, Y.C.M., Kleinjans, J.C.S., 2005. Comparison of supervised clustering methods to discriminate genotoxic from non-genotoxic carcinogens by gene expression profiling. Mutat. Res. 575, 17e33. <a class=\"external free\" href=\"http://dx.doi.org/10.1016/\" rel=\"nofollow\" target=\"_blank\">http://dx.doi.org/10.1016/</a> j.mrfmmm.2005.02.006.</p>\n\n<p>Van den Berg, M., Birnbaum, L.S., Denison, M., De, V.M., Farland, W., Feeley, M., Fiedler, H., Hakansson, H., Hanberg, A., Haws, L., Rose, M., Safe, S., Schrenk, D., Tohyama, C., Tritscher, A., Tuomisto, J., Tysklind, M., Walker, N., Peterson, R.E., 2006. The 2005 world health organization reevaluation of human and mammalian toxic equivalency factors for dioxins and dioxin-like compounds. Toxicol. Sci. 93, 223e241.</p>\n\n<p>Vezina, C.M., Walker, N.J., Olson, J.R., 2004. Subchronic exposure to TCDD, PeCDF, PCB126, and PCB153: effect on hepatic gene expression. Environ. Heal. Perspect. 112, 1636e1644.</p>\n\n<p>Wang, L., He, X., Szklarz, G.D., Bi, Y., Rojanasakul, Y., Ma, Q., 2013. The aryl hydro- carbon receptor interacts with nuclear factor erythroid 2-related factor 2 to mediate induction of NAD(P)H:quinoneoxidoreductase 1 by 2,3,7,8-tetrachlorodibenzo-p-dioxin. Arch. Biochem. Biophys. 537, 31e38. http:// dx.doi.org/10.1016/j.abb.2013.06.001.</p>\n\n<p>Watanabe, T., Suzuki, T., Natsume, M., Nakajima, M., Narumi, K., Hamada, S., Sakuma, T., Koeda, A., Oshida, K., Miyamoto, Y., Maeda, A., Hirayama, M., Sanada, H., Honda, H., Ohyama, W., Okada, E., Fujiishi, Y., Sutou, S., Tadakuma, A., Ishikawa, Y., Kido, M., Minamiguchi, R., Hanahara, I., Furihata, C., 2012. Discrimination of genotoxic and non-genotoxic hepatocarcinogens by statistical analysis based on gene expression profiling in the mouse liver as determined by quantitative real-time PCR. Mutat. Res. 747, 164e175. http:// dx.doi.org/10.1016/j.mrgentox.2012.04.011.</p>\n\n<p>Yao, C.Q., Prokopec, S.D., Watson, J.D., Pang, R., P&#39;ng, C., Chong, L.C., Harding, N.J., Pohjanvirta, R., Okey, A.B., Boutros, P.C., 2012. Inter-strain heterogeneity in rat hepatic transcriptomic responses to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD). Toxicol. Appl. Pharmacol. 260, 135e145. <a class=\"external free\" href=\"http://dx.doi.org/10.1016/\" rel=\"nofollow\" target=\"_blank\">http://dx.doi.org/10.1016/</a> j.taap.2012.02.001.</p>\n\n<p>Yates, M.S., Kensler, T.W., 2007. Keap1 eye on the target: chemoprevention of liver cancer. Acta Pharmacol. Sin. 28, 1331e1342. <a class=\"external free\" href=\"http://dx.doi.org/10.1111/j.1745-\" rel=\"nofollow\" target=\"_blank\">http://dx.doi.org/10.1111/j.1745-</a> 7254.2007.00688.x.</p>\n\n<p>Yates, M.S., Tauchi, M., Katsuoka, F., Flanders, K.C., Liby, K.T., Honda, T., Gribble, G.W., Johnson, D.A., Johnson, J.A., Burton, N.C., Guilarte, T.R., Yamamoto, M., Sporn, M.B., Kensler, T.W., 2007. Pharmacodynamic characterization of che- mopreventive triterpenoids as exceptionally potent inducers of Nrf2-regulated genes. Mol. Cancer Ther. 6, 154e162. <a class=\"external free\" href=\"http://dx.doi.org/10.1158/1535-7163.MCT-\" rel=\"nofollow\" target=\"_blank\">http://dx.doi.org/10.1158/1535-7163.MCT-</a> 06-0516.</p>\n\n<p>Zhang, Q., Andersen, M.E., 2007. Dose response relationship in anti-stress gene regulatory networks. PLoS Comput. Biol. 3, e24. <a class=\"external free\" href=\"http://dx.doi.org/10.1371/\" rel=\"nofollow\" target=\"_blank\">http://dx.doi.org/10.1371/</a> journal.pcbi.0030024.</p>\n","biologicalOrganisationLevel":"Cellular","organTerm":{},"biologicalEvents":[{"action":"increased","process":"signaling","object":{"name":"aryl hydrocarbon receptor","source":"PR","sourceId":"PR:000003858"}}],"keyEventStressors":["Dioxin and dioxin-like compounds"],"id":165}
{"title":"Changes/Inhibition, Cellular Homeostasis and Apoptosis","references":"<p>Ambolet-Camoit, A., Bui, L.C., Pierre, S., Chevallier, A., Marchand, A., Coumoul, X., Garlatti, M., Andreau, K., Barouki, R., Aggerbeck, M., 2010. 2,3,7,8- tetrachlorodibenzo-p-dioxin counteracts the p53 response to a genotoxicant by upregulating expression of the metastasis marker agr2 in the hep- atocarcinoma cell line HepG2. Toxicol. Sci. 115, 501-512.\n</p><p>Chopra, M., Dharmarajan, A.M., Meiss, G., Schrenk, D., 2009. Inhibition of UV-C light-induced apoptosis in liver cells by 2,3,7,8-tetrachlorodibenzo-p-dioxin. Toxicol. Sci. 111, 49-63.\n</p><p>Chopra, M., Gahrs, M., Haben, M., Michels, C., Schrenk, D., 2010. Inhibition of apoptosis by 2,3,7,8-tetrachlorodibenzo-p-dioxin depends on protein biosyn- thesis. Cell Biol. Toxicol. 26, 391-401.\n</p><p>Chopra, M., Schrenk, D., 2011. Dioxin toxicity, aryl hydrocarbon receptor signaling, and apoptosis-Persistent pollutants affect programmed cell death. Crit. Rev. Toxicol. 41:292-320.\n</p><p>Davis W., J.W., Lauer, F.T., Burdick, A.D., Hudson, L.G., Burchiel, S.W., 2001. Prevention of apoptosis by 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in the MCF-10A cell line: correlation with increased transforming growth factor alpha production. Cancer. Res. 61, 3314-3320.\n</p><p>Dragan, Y. P., Campbell, H. A., Xu, X. H., Pitot, H. C., 1997. Quantitative stereological studies of a 'selection' protocol of hepatocarcinogenesis following initiation in neonatal male and female rats. Carcinogenesis. 18, 149-58.\n</p><p>Dragan, Y.P., Schrenk, D., 2000. Animal studies addressing the carcinogenicity of TCDD (or related compounds) with an emphasis on tumour promotion. Food. Addit. Contam. 17, 289-302.\n</p><p>Franc, M.A., Moffat, I.D., Boutros, P.C., Tuomisto, J.T., Tuomisto, J., Pohjanvirta, R., Okey, A.B., 2008. Patterns of dioxin-altered mRNA expression in livers of dioxin- sensitive versus dioxin-resistant rats. Arch. Toxicol. 82, 809-830. \n</p><p>Goodman, D.G., Sauer, R.M., 1992. Hepatotoxicity and carcinogenicity in female Sprague-Dawley rats treated with 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD): a pathology working group reevaluation. Regul. Toxicol. Pharmacol. 15, 245-252.\n</p><p>Hailey, J.R., Walker, N.J., Sells, D.M., Brix, A.E., Jokinen, M.P., Nyska, A., 2005. Clas- sification of proliferative hepatocellular lesions in harlan sprague-dawley rats chronically exposed to dioxin-like compounds. Toxicol. Pathol. 33, 165-174.\n</p><p>Hendrich, S., Campbell, H. A., Pitot, H. C., 1987. Quantitative stereological evaluation of four histochemical markers of altered foci in multistage hepatocarcinogenesis in the rat. Carcinogenesis. 8, 1245-50.\n</p><p>Kociba, R.J., Keyes, D.G., Beyer, J.E., Carreon, R.M., Wade, C.E., Dittenber, D.A., Kalnins, R.P., Frauson, L.E., Park, C.N., Barnard, S.D., Hummel, R.A., Humiston, C.G., 1978. Results of a two-year chronic toxicity and oncogenicity study of 2,3,7,8-tetrachlorodibenzo-p-dioxin in rats. Toxicol. Appl. Pharmacol. 46, 279-303.\n</p><p>Luebeck, E.G., Buchmann, A., Stinchcombe, S., Moolgavkar, S.H., Schwarz, M., 2000. Effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin on initiation and promotion of GST-P-positive foci in rat liver: a quantitative analysis of experimental data using a stochastic model. Toxicol. Appl. Pharmacol. 167, 63-73.\n</p><p>Moolgavkar, S.H., Luebeck, E.G., Buchmann, A., Bock, K.W., 1996. Quantitative analysis of enzyme-altered liver foci in rats initiated with diethylnitrosamine and promoted with 2,3,7,8-tetrachlorodibenzo-p-dioxin or 1,2,3,4,6,7,8- heptachlorodibenzo-p-dioxin. Toxicol. Appl. Pharmacol. 138, 31-42.\n</p><p>Paajarvi, G., Viluksela, M., Pohjanvirta, R., Stenius, U., Hogberg, J., 2005. TCDD ac- tivates Mdm2 and attenuates the p53 response to DNA damaging agents. Carcinogenesis 26, 201-208. \n</p><p>Roberts, R.A., Nebert, D.W., Hickman, J.A., Richburg, J.H., Goldsworthy, T.L., 1997. Perturbation of the mitosis/apoptosis balance: a fundamental mechanism in toxicology. Fundam. Appl. Toxicol. 38, 107-115.\n</p><p>Schwarz, M., Buchmann, A., Stinchcombe, S., Kalkuhl, A., Bock, K., 2000. Ah receptor ligands and tumor promotion: survival of neoplastic cells. Toxicol. Lett. 112e113, 69-77.\n</p><p>Stinchcombe, S., Buchmann, A., Bock, K.W., Schwarz, M., 1995. Inhibition of apoptosis during 2,3,7,8-tetrachlorodibenzo-p-dioxin-mediated tumour pro- motion in rat liver. Carcinogenesis 16, 1271-1275.\n</p><p>Teeguarden, J.G., Dragan, Y.P., Singh, J., Vaughan, J., Xu, Y.H., Goldsworthy, T., Pitot, H.C., 1999. Quantitative analysis of dose- and time-dependent promotion of four phenotypes of altered hepatic foci by 2,3,7,8-tetrachlorodibenzo-p- dioxin in female Sprague-Dawley rats. Toxicol. Sci. 51, 211-223.\n</p><p>Viluksela, M., Bager, Y., Tuomisto, J. T., Scheu, G., Unkila, M., Pohjanvirta, R., Flodstrom, S., Kosma, V. M., Maki-Paakkanen, J., Vartiainen, T., Klimm, C., Schramm, K. W., Warngard, L., Tuomisto, J., 2000. Liver tumor-promoting activity of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in TCDD-sensitive and TCDD-resistant rat strains 27. Cancer Res. 60, 6911-6920.\n</p><p>Worner, W., Schrenk, D., 1996. Influence of liver tumor promoters on apoptosis in rat hepatocytes induced by 2-acetylaminofluorene, ultraviolet light, or transforming growth factor beta 1. Cancer. Res. 56, 1272-1278.\n</p>","biologicalOrganisationLevel":"Cellular","organTerm":{},"biologicalEvents":[{"action":"abnormal","process":"cellular homeostasis","object":{}},{"action":"decreased","process":"apoptotic process","object":{}}],"id":853}
{"title":"Changes/Inhibition, Cellular Homeostasis and Apoptosis","references":"<p>Ambolet-Camoit, A., Bui, L.C., Pierre, S., Chevallier, A., Marchand, A., Coumoul, X., Garlatti, M., Andreau, K., Barouki, R., Aggerbeck, M., 2010. 2,3,7,8- tetrachlorodibenzo-p-dioxin counteracts the p53 response to a genotoxicant by upregulating expression of the metastasis marker agr2 in the hep- atocarcinoma cell line HepG2. Toxicol. Sci. 115, 501-512.\n</p><p>Chopra, M., Dharmarajan, A.M., Meiss, G., Schrenk, D., 2009. Inhibition of UV-C light-induced apoptosis in liver cells by 2,3,7,8-tetrachlorodibenzo-p-dioxin. Toxicol. Sci. 111, 49-63.\n</p><p>Chopra, M., Gahrs, M., Haben, M., Michels, C., Schrenk, D., 2010. Inhibition of apoptosis by 2,3,7,8-tetrachlorodibenzo-p-dioxin depends on protein biosyn- thesis. Cell Biol. Toxicol. 26, 391-401.\n</p><p>Chopra, M., Schrenk, D., 2011. Dioxin toxicity, aryl hydrocarbon receptor signaling, and apoptosis-Persistent pollutants affect programmed cell death. Crit. Rev. Toxicol. 41:292-320.\n</p><p>Davis W., J.W., Lauer, F.T., Burdick, A.D., Hudson, L.G., Burchiel, S.W., 2001. Prevention of apoptosis by 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in the MCF-10A cell line: correlation with increased transforming growth factor alpha production. Cancer. Res. 61, 3314-3320.\n</p><p>Dragan, Y. P., Campbell, H. A., Xu, X. H., Pitot, H. C., 1997. Quantitative stereological studies of a 'selection' protocol of hepatocarcinogenesis following initiation in neonatal male and female rats. Carcinogenesis. 18, 149-58.\n</p><p>Dragan, Y.P., Schrenk, D., 2000. Animal studies addressing the carcinogenicity of TCDD (or related compounds) with an emphasis on tumour promotion. Food. Addit. Contam. 17, 289-302.\n</p><p>Franc, M.A., Moffat, I.D., Boutros, P.C., Tuomisto, J.T., Tuomisto, J., Pohjanvirta, R., Okey, A.B., 2008. Patterns of dioxin-altered mRNA expression in livers of dioxin- sensitive versus dioxin-resistant rats. Arch. Toxicol. 82, 809-830. \n</p><p>Goodman, D.G., Sauer, R.M., 1992. Hepatotoxicity and carcinogenicity in female Sprague-Dawley rats treated with 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD): a pathology working group reevaluation. Regul. Toxicol. Pharmacol. 15, 245-252.\n</p><p>Hailey, J.R., Walker, N.J., Sells, D.M., Brix, A.E., Jokinen, M.P., Nyska, A., 2005. Clas- sification of proliferative hepatocellular lesions in harlan sprague-dawley rats chronically exposed to dioxin-like compounds. Toxicol. Pathol. 33, 165-174.\n</p><p>Hendrich, S., Campbell, H. A., Pitot, H. C., 1987. Quantitative stereological evaluation of four histochemical markers of altered foci in multistage hepatocarcinogenesis in the rat. Carcinogenesis. 8, 1245-50.\n</p><p>Kociba, R.J., Keyes, D.G., Beyer, J.E., Carreon, R.M., Wade, C.E., Dittenber, D.A., Kalnins, R.P., Frauson, L.E., Park, C.N., Barnard, S.D., Hummel, R.A., Humiston, C.G., 1978. Results of a two-year chronic toxicity and oncogenicity study of 2,3,7,8-tetrachlorodibenzo-p-dioxin in rats. Toxicol. Appl. Pharmacol. 46, 279-303.\n</p><p>Luebeck, E.G., Buchmann, A., Stinchcombe, S., Moolgavkar, S.H., Schwarz, M., 2000. Effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin on initiation and promotion of GST-P-positive foci in rat liver: a quantitative analysis of experimental data using a stochastic model. Toxicol. Appl. Pharmacol. 167, 63-73.\n</p><p>Moolgavkar, S.H., Luebeck, E.G., Buchmann, A., Bock, K.W., 1996. Quantitative analysis of enzyme-altered liver foci in rats initiated with diethylnitrosamine and promoted with 2,3,7,8-tetrachlorodibenzo-p-dioxin or 1,2,3,4,6,7,8- heptachlorodibenzo-p-dioxin. Toxicol. Appl. Pharmacol. 138, 31-42.\n</p><p>Paajarvi, G., Viluksela, M., Pohjanvirta, R., Stenius, U., Hogberg, J., 2005. TCDD ac- tivates Mdm2 and attenuates the p53 response to DNA damaging agents. Carcinogenesis 26, 201-208. \n</p><p>Roberts, R.A., Nebert, D.W., Hickman, J.A., Richburg, J.H., Goldsworthy, T.L., 1997. Perturbation of the mitosis/apoptosis balance: a fundamental mechanism in toxicology. Fundam. Appl. Toxicol. 38, 107-115.\n</p><p>Schwarz, M., Buchmann, A., Stinchcombe, S., Kalkuhl, A., Bock, K., 2000. Ah receptor ligands and tumor promotion: survival of neoplastic cells. Toxicol. Lett. 112e113, 69-77.\n</p><p>Stinchcombe, S., Buchmann, A., Bock, K.W., Schwarz, M., 1995. Inhibition of apoptosis during 2,3,7,8-tetrachlorodibenzo-p-dioxin-mediated tumour pro- motion in rat liver. Carcinogenesis 16, 1271-1275.\n</p><p>Teeguarden, J.G., Dragan, Y.P., Singh, J., Vaughan, J., Xu, Y.H., Goldsworthy, T., Pitot, H.C., 1999. Quantitative analysis of dose- and time-dependent promotion of four phenotypes of altered hepatic foci by 2,3,7,8-tetrachlorodibenzo-p- dioxin in female Sprague-Dawley rats. Toxicol. Sci. 51, 211-223.\n</p><p>Viluksela, M., Bager, Y., Tuomisto, J. T., Scheu, G., Unkila, M., Pohjanvirta, R., Flodstrom, S., Kosma, V. M., Maki-Paakkanen, J., Vartiainen, T., Klimm, C., Schramm, K. W., Warngard, L., Tuomisto, J., 2000. Liver tumor-promoting activity of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in TCDD-sensitive and TCDD-resistant rat strains 27. Cancer Res. 60, 6911-6920.\n</p><p>Worner, W., Schrenk, D., 1996. Influence of liver tumor promoters on apoptosis in rat hepatocytes induced by 2-acetylaminofluorene, ultraviolet light, or transforming growth factor beta 1. Cancer. Res. 56, 1272-1278.\n</p>","biologicalOrganisationLevel":"Cellular","organTerm":{},"biologicalEvents":[{"action":"abnormal","process":"cellular homeostasis","object":{}},{"action":"decreased","process":"apoptotic process","object":{}}],"id":853}
{"title":"Alterations, Cellular proliferation / hyperplasia","references":"<p>Andersen, M.E., Birnbaum, L.S., Barton, H.A., Eklund, C.R., 1997. Regional hepatic CYP1A1 and CYP1A2 induction with 2,3,7,8-tetrachlorodibenzo-p-dioxin eval- uated with a multicompartment geometric model of hepatic zonation. Toxicol. Appl. Pharmacol. 144, 145-155.\n</p><p>Conolly, R.B., Andersen, M.E., 1997. Hepatic foci in rats after diethylnitrosamine initiation and 2,3,7,8-tetrachlorodibenzo-p-dioxin promotion: evaluation of a quantitative two-cell model and of CYP 1A1/1A2 as a dosimeter. Toxicol. Appl. Pharmacol. 146, 281-293.\n</p><p>Dietrich, C., Faust, D., Budt, S., Moskwa, M., Kunz, A., Bock, K.W., Oesch, F., 2002. 2,3,7,8-tetrachlorodibenzo-p-dioxin-dependent release from contact inhibition in WB-F344 cells: involvement of cyclin A. Toxicol. Appl. Pharmacol. 183, 117-126.\n</p><p>Fletcher, N., Hanberg, A., Hkansson, H., 2001. Hepatic vitamin a depletion is a sensitive marker of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) exposure in four rodent species. Toxicol. Sci. 62, 166-175.\n</p><p>Hailey, J.R., Walker, N.J., Sells, D.M., Brix, A.E., Jokinen, M.P., Nyska, A., 2005. Clas- sification of proliferative hepatocellular lesions in harlan sprague-dawley rats chronically exposed to dioxin-like compounds. Toxicol. Pathol. 33, 165-174.\n</p><p>Hoegberg, P., Schmidt, C.K., Fletcher, N., Nilsson, C.B., Trossvik, C., Gerlienke Schuur, A., Brouwer, A., Nau, H., Ghyselinck, N.B., Chambon, P., Hkansson, H., 2005. Retinoid status and responsiveness to 2,3,7,8-tetrachlorodibenzo-p- dioxin (TCDD) in mice lacking retinoid binding protein or retinoid receptor forms. Chem. Biol. Interact. 156, 25-39.\n</p><p>Knight, B., Yeoh, G.C., Husk, K.L., Ly, T., Abraham, L.J., Yu, C., Rhim, J.A., Fausto, N., 2000. Impaired preneoplastic changes and liver tumor formation in tumor necrosis factor receptor type 1 knockout mice. J. Exp. Med. 192, 1809-1818.\n</p><p>Maronpot, R.R., Foley, J.F., Takahashi, K., Goldsworthy, T., Clark, G., Tritscher, A.,Portier, C., Lucier, G., 1993. Dose response for TCDD promotion of hep- atocarcinogenesis in rats initiated with DEN: histologic, biochemical, and cell proliferation endpoints 8. Environ. Heal. Perspect. 101, 634-642.\n</p><p>Paku, S., Schnur, J., Nagy, P., Thorgeirsson, S.S., 2001. Origin and structural evolution of the early proliferating oval cells in rat liver. Am. J. Pathol. 158, 1313-1323.\n</p><p>Pierre, S., Chevallier, A., Teixeira-Clerc, F., Ambolet-Camoit, A., Bui, L.-C., Bats, A.-S., Fournet, J.-C., Fernandez-Salguero, P., Aggerbeck, M., Lotersztajn, S., Barouki, R., Coumoul, X., 2014. Aryl hydrocarbon receptor-dependent induction of liver fibrosis by dioxin. Toxicol. Sci. 137, 114-124. \n</p><p>Pintilie, D.G., Shupe, T.D., Oh, S.-H., Salganik, S.V., Darwiche, H., Petersen, B.E., 2010. Hepatic stellate cells' involvement in progenitor-mediated liver regeneration. Lab. Invest. 90, 1199-1208.\n</p><p>Prochazkova, J., Kabatkova, M., Bryja, V., Umannova, L., Bernatk, O., Kozubk, A., Machala, M., Vondracek, J., 2011. The interplay of the aryl hydrocarbon receptor and b-catenin alters both AhR-dependent transcription and Wnt/b-catenin signaling in liver progenitors. Toxicol. Sci. 122, 349-360.\n</p><p>Sahin, M.B., Schwartz, R.E., Buckley, S.M., Heremans, Y., Chase, L., Hu, W.-S., Verfaillie, C.M., 2008. Isolation and characterization of a novel population of progenitor cells from unmanipulated rat liver. Liver Transpl. 14, 333-345.\n</p><p>Schmidt, C.K., Hoegberg, P., Fletcher, N., Nilsson, C.B., Trossvik, C., Hakansson, H., Nau, H., 2003. 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) alters the endoge- nous metabolism of all-trans-retinoic acid in the rat. Arch. Toxicol. 77, 371-383.\n</p><p>Senoo, H., Yoshikawa, K., Morii, M., Miura, M., Imai, K., Mezaki, Y., 2010. Hepatic stellate cell (vitamin A-storing cell) and its relativeepast, present and future. Cell. Biol. Int. 34, 1247-1272.\n</p><p>Tanaka, M., Itoh, T., Tanimizu, N., Miyajima, A., 2011. Liver stem/progenitor cells: their characteristics and regulatory mechanisms. J. Biochem. 149, 231-239.\n</p><p>Teeguarden, J.G., Dragan, Y.P., Singh, J., Vaughan, J., Xu, Y.H., Goldsworthy, T., Pitot, H.C., 1999. Quantitative analysis of dose- and time-dependent promotion of four phenotypes of altered hepatic foci by 2,3,7,8-tetrachlorodibenzo-p- dioxin in female Sprague-Dawley rats. Toxicol. Sci. 51, 211-223.\n</p><p>Tritscher, A.M., Goldstein, J.A., Portier, C.J., McCoy, Z., Clark, G.C., Lucier, G.W., 1992. Dose-response relationships for chronic exposure to 2,3,7,8- tetrachlorodibenzo-p-dioxin in a rat tumor promotion model: quantification and immunolocalization of CYP1A1 and CYP1A2 in the liver. Cancer. Res. 52, 3436-3442.\n</p><p>Umannova, L., Zatloukalova, J., Machala, M., Krcmar, P., Majkova, Z., Hennig, B., Kozubk, A., Vondracek, J., 2007. Tumor necrosis factor-alpha modulates effects of aryl hydrocarbon receptor ligands on cell proliferation and expression of cytochrome P450 enzymes in rat liver stem-like cells. Toxicol. Sci. 99, 79-89.\n</p><p>Vondracek, J., Krcmar, P., Prochazkova, J., Trilecova, L., Gavelova, M., Skalova, L., Szotakova, B., Buncek, M., Radilova, H., Kozubik, A., Machala, M., 2009. The role of aryl hydrocarbon receptor in regulation of enzymes involved in metabolic activation of polycyclic aromatic hydrocarbons in a model of rat liver progenitor cells. Chem. Biol. Interact. 180, 226-237.\n</p><p>Wang, X., Foster, M., Al-Dhalimy, M., Lagasse, E., Finegold, M., Grompe, M., 2003. The origin and liver repopulating capacity of murine oval cells. Proc. Natl. Acad. Sci. U. S. A. 100 (Suppl. 1), 11881-11888. \n</p><p>Weiss, C., Faust, D., Schreck, I., Ruff, A., Farwerck, T., Melenberg, A., Schneider, S., Oesch-Bartlomowicz, B., Zatloukalova, J., Vondracek, J., Oesch, F., Dietrich, C., 2008. TCDD deregulates contact inhibition in rat liver oval cells via Ah receptor, JunD and cyclin A. Oncogene 27, 2198-2207.\n</p>","biologicalOrganisationLevel":"Tissue","organTerm":{"name":"liver","sourceId":"UBERON:0002107"},"biologicalEvents":[{"action":"abnormal","process":"cell proliferation","object":{"name":"Liver cell","source":"FMA","sourceId":"FMA:63179"}},{"action":"increased","process":"hyperplasia","object":{"name":"hepatic oval stem cell","source":"CL","sourceId":"CL:0002196"}},{"action":"increased","process":"hyperplasia","object":{"name":"intrahepatic bile duct epithelial cell","source":"CL","sourceId":"CL:0002538"}}],"id":854}
{"title":"Alterations, Cellular proliferation / hyperplasia","references":"<p>Andersen, M.E., Birnbaum, L.S., Barton, H.A., Eklund, C.R., 1997. Regional hepatic CYP1A1 and CYP1A2 induction with 2,3,7,8-tetrachlorodibenzo-p-dioxin eval- uated with a multicompartment geometric model of hepatic zonation. Toxicol. Appl. Pharmacol. 144, 145-155.\n</p><p>Conolly, R.B., Andersen, M.E., 1997. Hepatic foci in rats after diethylnitrosamine initiation and 2,3,7,8-tetrachlorodibenzo-p-dioxin promotion: evaluation of a quantitative two-cell model and of CYP 1A1/1A2 as a dosimeter. Toxicol. Appl. Pharmacol. 146, 281-293.\n</p><p>Dietrich, C., Faust, D., Budt, S., Moskwa, M., Kunz, A., Bock, K.W., Oesch, F., 2002. 2,3,7,8-tetrachlorodibenzo-p-dioxin-dependent release from contact inhibition in WB-F344 cells: involvement of cyclin A. Toxicol. Appl. Pharmacol. 183, 117-126.\n</p><p>Fletcher, N., Hanberg, A., Hkansson, H., 2001. Hepatic vitamin a depletion is a sensitive marker of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) exposure in four rodent species. Toxicol. Sci. 62, 166-175.\n</p><p>Hailey, J.R., Walker, N.J., Sells, D.M., Brix, A.E., Jokinen, M.P., Nyska, A., 2005. Clas- sification of proliferative hepatocellular lesions in harlan sprague-dawley rats chronically exposed to dioxin-like compounds. Toxicol. Pathol. 33, 165-174.\n</p><p>Hoegberg, P., Schmidt, C.K., Fletcher, N., Nilsson, C.B., Trossvik, C., Gerlienke Schuur, A., Brouwer, A., Nau, H., Ghyselinck, N.B., Chambon, P., Hkansson, H., 2005. Retinoid status and responsiveness to 2,3,7,8-tetrachlorodibenzo-p- dioxin (TCDD) in mice lacking retinoid binding protein or retinoid receptor forms. Chem. Biol. Interact. 156, 25-39.\n</p><p>Knight, B., Yeoh, G.C., Husk, K.L., Ly, T., Abraham, L.J., Yu, C., Rhim, J.A., Fausto, N., 2000. Impaired preneoplastic changes and liver tumor formation in tumor necrosis factor receptor type 1 knockout mice. J. Exp. Med. 192, 1809-1818.\n</p><p>Maronpot, R.R., Foley, J.F., Takahashi, K., Goldsworthy, T., Clark, G., Tritscher, A.,Portier, C., Lucier, G., 1993. Dose response for TCDD promotion of hep- atocarcinogenesis in rats initiated with DEN: histologic, biochemical, and cell proliferation endpoints 8. Environ. Heal. Perspect. 101, 634-642.\n</p><p>Paku, S., Schnur, J., Nagy, P., Thorgeirsson, S.S., 2001. Origin and structural evolution of the early proliferating oval cells in rat liver. Am. J. Pathol. 158, 1313-1323.\n</p><p>Pierre, S., Chevallier, A., Teixeira-Clerc, F., Ambolet-Camoit, A., Bui, L.-C., Bats, A.-S., Fournet, J.-C., Fernandez-Salguero, P., Aggerbeck, M., Lotersztajn, S., Barouki, R., Coumoul, X., 2014. Aryl hydrocarbon receptor-dependent induction of liver fibrosis by dioxin. Toxicol. Sci. 137, 114-124. \n</p><p>Pintilie, D.G., Shupe, T.D., Oh, S.-H., Salganik, S.V., Darwiche, H., Petersen, B.E., 2010. Hepatic stellate cells' involvement in progenitor-mediated liver regeneration. Lab. Invest. 90, 1199-1208.\n</p><p>Prochazkova, J., Kabatkova, M., Bryja, V., Umannova, L., Bernatk, O., Kozubk, A., Machala, M., Vondracek, J., 2011. The interplay of the aryl hydrocarbon receptor and b-catenin alters both AhR-dependent transcription and Wnt/b-catenin signaling in liver progenitors. Toxicol. Sci. 122, 349-360.\n</p><p>Sahin, M.B., Schwartz, R.E., Buckley, S.M., Heremans, Y., Chase, L., Hu, W.-S., Verfaillie, C.M., 2008. Isolation and characterization of a novel population of progenitor cells from unmanipulated rat liver. Liver Transpl. 14, 333-345.\n</p><p>Schmidt, C.K., Hoegberg, P., Fletcher, N., Nilsson, C.B., Trossvik, C., Hakansson, H., Nau, H., 2003. 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) alters the endoge- nous metabolism of all-trans-retinoic acid in the rat. Arch. Toxicol. 77, 371-383.\n</p><p>Senoo, H., Yoshikawa, K., Morii, M., Miura, M., Imai, K., Mezaki, Y., 2010. Hepatic stellate cell (vitamin A-storing cell) and its relativeepast, present and future. Cell. Biol. Int. 34, 1247-1272.\n</p><p>Tanaka, M., Itoh, T., Tanimizu, N., Miyajima, A., 2011. Liver stem/progenitor cells: their characteristics and regulatory mechanisms. J. Biochem. 149, 231-239.\n</p><p>Teeguarden, J.G., Dragan, Y.P., Singh, J., Vaughan, J., Xu, Y.H., Goldsworthy, T., Pitot, H.C., 1999. Quantitative analysis of dose- and time-dependent promotion of four phenotypes of altered hepatic foci by 2,3,7,8-tetrachlorodibenzo-p- dioxin in female Sprague-Dawley rats. Toxicol. Sci. 51, 211-223.\n</p><p>Tritscher, A.M., Goldstein, J.A., Portier, C.J., McCoy, Z., Clark, G.C., Lucier, G.W., 1992. Dose-response relationships for chronic exposure to 2,3,7,8- tetrachlorodibenzo-p-dioxin in a rat tumor promotion model: quantification and immunolocalization of CYP1A1 and CYP1A2 in the liver. Cancer. Res. 52, 3436-3442.\n</p><p>Umannova, L., Zatloukalova, J., Machala, M., Krcmar, P., Majkova, Z., Hennig, B., Kozubk, A., Vondracek, J., 2007. Tumor necrosis factor-alpha modulates effects of aryl hydrocarbon receptor ligands on cell proliferation and expression of cytochrome P450 enzymes in rat liver stem-like cells. Toxicol. Sci. 99, 79-89.\n</p><p>Vondracek, J., Krcmar, P., Prochazkova, J., Trilecova, L., Gavelova, M., Skalova, L., Szotakova, B., Buncek, M., Radilova, H., Kozubik, A., Machala, M., 2009. The role of aryl hydrocarbon receptor in regulation of enzymes involved in metabolic activation of polycyclic aromatic hydrocarbons in a model of rat liver progenitor cells. Chem. Biol. Interact. 180, 226-237.\n</p><p>Wang, X., Foster, M., Al-Dhalimy, M., Lagasse, E., Finegold, M., Grompe, M., 2003. The origin and liver repopulating capacity of murine oval cells. Proc. Natl. Acad. Sci. U. S. A. 100 (Suppl. 1), 11881-11888. \n</p><p>Weiss, C., Faust, D., Schreck, I., Ruff, A., Farwerck, T., Melenberg, A., Schneider, S., Oesch-Bartlomowicz, B., Zatloukalova, J., Vondracek, J., Oesch, F., Dietrich, C., 2008. TCDD deregulates contact inhibition in rat liver oval cells via Ah receptor, JunD and cyclin A. Oncogene 27, 2198-2207.\n</p>","biologicalOrganisationLevel":"Tissue","organTerm":{"name":"liver","sourceId":"UBERON:0002107"},"biologicalEvents":[{"action":"abnormal","process":"cell proliferation","object":{"name":"Liver cell","source":"FMA","sourceId":"FMA:63179"}},{"action":"increased","process":"hyperplasia","object":{"name":"hepatic oval stem cell","source":"CL","sourceId":"CL:0002196"}},{"action":"increased","process":"hyperplasia","object":{"name":"intrahepatic bile duct epithelial cell","source":"CL","sourceId":"CL:0002538"}}],"id":854}
{"title":"Alterations, Cellular proliferation / hyperplasia","references":"<p>Andersen, M.E., Birnbaum, L.S., Barton, H.A., Eklund, C.R., 1997. Regional hepatic CYP1A1 and CYP1A2 induction with 2,3,7,8-tetrachlorodibenzo-p-dioxin eval- uated with a multicompartment geometric model of hepatic zonation. Toxicol. Appl. Pharmacol. 144, 145-155.\n</p><p>Conolly, R.B., Andersen, M.E., 1997. Hepatic foci in rats after diethylnitrosamine initiation and 2,3,7,8-tetrachlorodibenzo-p-dioxin promotion: evaluation of a quantitative two-cell model and of CYP 1A1/1A2 as a dosimeter. Toxicol. Appl. Pharmacol. 146, 281-293.\n</p><p>Dietrich, C., Faust, D., Budt, S., Moskwa, M., Kunz, A., Bock, K.W., Oesch, F., 2002. 2,3,7,8-tetrachlorodibenzo-p-dioxin-dependent release from contact inhibition in WB-F344 cells: involvement of cyclin A. Toxicol. Appl. Pharmacol. 183, 117-126.\n</p><p>Fletcher, N., Hanberg, A., Hkansson, H., 2001. Hepatic vitamin a depletion is a sensitive marker of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) exposure in four rodent species. Toxicol. Sci. 62, 166-175.\n</p><p>Hailey, J.R., Walker, N.J., Sells, D.M., Brix, A.E., Jokinen, M.P., Nyska, A., 2005. Clas- sification of proliferative hepatocellular lesions in harlan sprague-dawley rats chronically exposed to dioxin-like compounds. Toxicol. Pathol. 33, 165-174.\n</p><p>Hoegberg, P., Schmidt, C.K., Fletcher, N., Nilsson, C.B., Trossvik, C., Gerlienke Schuur, A., Brouwer, A., Nau, H., Ghyselinck, N.B., Chambon, P., Hkansson, H., 2005. Retinoid status and responsiveness to 2,3,7,8-tetrachlorodibenzo-p- dioxin (TCDD) in mice lacking retinoid binding protein or retinoid receptor forms. Chem. Biol. Interact. 156, 25-39.\n</p><p>Knight, B., Yeoh, G.C., Husk, K.L., Ly, T., Abraham, L.J., Yu, C., Rhim, J.A., Fausto, N., 2000. Impaired preneoplastic changes and liver tumor formation in tumor necrosis factor receptor type 1 knockout mice. J. Exp. Med. 192, 1809-1818.\n</p><p>Maronpot, R.R., Foley, J.F., Takahashi, K., Goldsworthy, T., Clark, G., Tritscher, A.,Portier, C., Lucier, G., 1993. Dose response for TCDD promotion of hep- atocarcinogenesis in rats initiated with DEN: histologic, biochemical, and cell proliferation endpoints 8. Environ. Heal. Perspect. 101, 634-642.\n</p><p>Paku, S., Schnur, J., Nagy, P., Thorgeirsson, S.S., 2001. Origin and structural evolution of the early proliferating oval cells in rat liver. Am. J. Pathol. 158, 1313-1323.\n</p><p>Pierre, S., Chevallier, A., Teixeira-Clerc, F., Ambolet-Camoit, A., Bui, L.-C., Bats, A.-S., Fournet, J.-C., Fernandez-Salguero, P., Aggerbeck, M., Lotersztajn, S., Barouki, R., Coumoul, X., 2014. Aryl hydrocarbon receptor-dependent induction of liver fibrosis by dioxin. Toxicol. Sci. 137, 114-124. \n</p><p>Pintilie, D.G., Shupe, T.D., Oh, S.-H., Salganik, S.V., Darwiche, H., Petersen, B.E., 2010. Hepatic stellate cells' involvement in progenitor-mediated liver regeneration. Lab. Invest. 90, 1199-1208.\n</p><p>Prochazkova, J., Kabatkova, M., Bryja, V., Umannova, L., Bernatk, O., Kozubk, A., Machala, M., Vondracek, J., 2011. The interplay of the aryl hydrocarbon receptor and b-catenin alters both AhR-dependent transcription and Wnt/b-catenin signaling in liver progenitors. Toxicol. Sci. 122, 349-360.\n</p><p>Sahin, M.B., Schwartz, R.E., Buckley, S.M., Heremans, Y., Chase, L., Hu, W.-S., Verfaillie, C.M., 2008. Isolation and characterization of a novel population of progenitor cells from unmanipulated rat liver. Liver Transpl. 14, 333-345.\n</p><p>Schmidt, C.K., Hoegberg, P., Fletcher, N., Nilsson, C.B., Trossvik, C., Hakansson, H., Nau, H., 2003. 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) alters the endoge- nous metabolism of all-trans-retinoic acid in the rat. Arch. Toxicol. 77, 371-383.\n</p><p>Senoo, H., Yoshikawa, K., Morii, M., Miura, M., Imai, K., Mezaki, Y., 2010. Hepatic stellate cell (vitamin A-storing cell) and its relativeepast, present and future. Cell. Biol. Int. 34, 1247-1272.\n</p><p>Tanaka, M., Itoh, T., Tanimizu, N., Miyajima, A., 2011. Liver stem/progenitor cells: their characteristics and regulatory mechanisms. J. Biochem. 149, 231-239.\n</p><p>Teeguarden, J.G., Dragan, Y.P., Singh, J., Vaughan, J., Xu, Y.H., Goldsworthy, T., Pitot, H.C., 1999. Quantitative analysis of dose- and time-dependent promotion of four phenotypes of altered hepatic foci by 2,3,7,8-tetrachlorodibenzo-p- dioxin in female Sprague-Dawley rats. Toxicol. Sci. 51, 211-223.\n</p><p>Tritscher, A.M., Goldstein, J.A., Portier, C.J., McCoy, Z., Clark, G.C., Lucier, G.W., 1992. Dose-response relationships for chronic exposure to 2,3,7,8- tetrachlorodibenzo-p-dioxin in a rat tumor promotion model: quantification and immunolocalization of CYP1A1 and CYP1A2 in the liver. Cancer. Res. 52, 3436-3442.\n</p><p>Umannova, L., Zatloukalova, J., Machala, M., Krcmar, P., Majkova, Z., Hennig, B., Kozubk, A., Vondracek, J., 2007. Tumor necrosis factor-alpha modulates effects of aryl hydrocarbon receptor ligands on cell proliferation and expression of cytochrome P450 enzymes in rat liver stem-like cells. Toxicol. Sci. 99, 79-89.\n</p><p>Vondracek, J., Krcmar, P., Prochazkova, J., Trilecova, L., Gavelova, M., Skalova, L., Szotakova, B., Buncek, M., Radilova, H., Kozubik, A., Machala, M., 2009. The role of aryl hydrocarbon receptor in regulation of enzymes involved in metabolic activation of polycyclic aromatic hydrocarbons in a model of rat liver progenitor cells. Chem. Biol. Interact. 180, 226-237.\n</p><p>Wang, X., Foster, M., Al-Dhalimy, M., Lagasse, E., Finegold, M., Grompe, M., 2003. The origin and liver repopulating capacity of murine oval cells. Proc. Natl. Acad. Sci. U. S. A. 100 (Suppl. 1), 11881-11888. \n</p><p>Weiss, C., Faust, D., Schreck, I., Ruff, A., Farwerck, T., Melenberg, A., Schneider, S., Oesch-Bartlomowicz, B., Zatloukalova, J., Vondracek, J., Oesch, F., Dietrich, C., 2008. TCDD deregulates contact inhibition in rat liver oval cells via Ah receptor, JunD and cyclin A. Oncogene 27, 2198-2207.\n</p>","biologicalOrganisationLevel":"Tissue","organTerm":{"name":"liver","sourceId":"UBERON:0002107"},"biologicalEvents":[{"action":"abnormal","process":"cell proliferation","object":{"name":"Liver cell","source":"FMA","sourceId":"FMA:63179"}},{"action":"increased","process":"hyperplasia","object":{"name":"hepatic oval stem cell","source":"CL","sourceId":"CL:0002196"}},{"action":"increased","process":"hyperplasia","object":{"name":"intrahepatic bile duct epithelial cell","source":"CL","sourceId":"CL:0002538"}}],"id":854}
{"title":"Formation, Hepatocellular and Bile duct tumors","references":"<p>Abraham, K., Geusau, A., Tosun, Y., Helge, H., Bauer, S., Brockmoller, J., 2002. Severe 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) intoxication: insights into the measurement of hepatic cytochrome P450 1A2 induction. Clin. Pharmacol. Ther. 72, 163-174.\n</p><p>Akintobi, A.M., Villano, C.M., White, L.A., 2007. 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) exposure of normal human dermal fibroblasts results in AhR-dependent and -independent changes in gene expression. Toxicol. Appl. Pharmacol. 220, 9-17.\n</p><p>Bertazzi, P.A., Zocchetti, C., Pesatori, A.C., Guercilena, S., Sanarico, M., Radice, L., 1989. Ten-year mortality study of the population involved in the Seveso inci- dent in 1976. Am. J. Epidemiol. 129, 1187-1200.\n</p><p>Budinsky, R.A., LeCluyse, E.L., Ferguson, S.S., Rowlands, J.C., Simon, T., 2010. Human and rat primary hepatocyte CYP1A1 and 1A2 induction with 2,3,7,8- tetrachlorodibenzo-p-dioxin, 2,3,7,8-tetrachlorodibenzofuran, and 2,3,4,7,8- pentachlorodibenzofuran. Toxicol. Sci. 118, 224-235.\n</p><p>Calvert, G.M., Hornung, R.W., Sweeney, M.H., Fingerhut, M.A., Halperin, W.E., 1992. Hepatic and gastrointestinal effects in an occupational cohort exposed to 2,3,7,8-tetrachlorodibenzo-para-dioxin. JAMA 267, 2209-2214.\n</p><p>Coenraads, P.J., Olie, K., Tang, N.J., 1999. Blood lipid concentrations of dioxins and dibenzofurans causing chloracne. Br. J. Dermatol. 141, 694-697.\n</p><p>Collins, J.J., Bodner, K., Aylward, L.L., Wilken, M., Bodnar, C.M., 2009a. Mortality rates among trichlorophenol workers with exposure to 2,3,7,8-tetrachlorodibenzo-p- dioxin. Am. J. Epidemiol. 170, 501-506.\n</p><p>Collins, J.J., Bodner, K., Aylward, L.L., Wilken, M., Swaen, G., Budinsky, R., Rowlands, C., Bodnar, C.M., 2009b. Mortality rates among workers exposed to dioxins in the manufacture of pentachlorophenol. J. Occup. Environ. Med. 51, 1212-1219. .\n</p><p>Du, L., Neis, M.M., Ladd, P.A., Keeney, D.S., 2006. Differentiation-specific factors modulate epidermal CYP1-4 gene expression in human skin in response to retinoic acid and classic aryl hydrocarbon receptor ligands. J. Pharmacol. Exp. Ther. 319, 1162-1171.\n</p><p>Forrester, A.R., Elias, M.S., Woodward, E.L., Graham, M., Williams, F.M., Reynolds, N.J., 2014. Induction of a chloracne phenotype in an epidermal equivalent model by 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) is dependent on aryl hydrocarbon receptor activation and is not reproduced by aryl hydro- carbon receptor knock down. J. Dermatol. Sci. 73, 10-22.\n</p><p>Geusau, A., Abraham, K., Geissler, K., Sator, M.O., Stingl, G., Tschachler, E., 2001. Severe 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) intoxication: clinical and laboratory effects. Environ. Heal. Perspect. 109, 865-869.\n</p><p>Geusau, A., Khorchide, M., Mildner, M., Pammer, J., Eckhart, L., Tschachler, E., 2005. 2,3,7,8-tetrachlorodibenzo-p-dioxin impairs differentiation of normal human epidermal keratinocytes in a skin equivalent model. J. Invest. Dermatol. 124, 275-277.\n</p><p>Ghezzi, I., Cannatelli, P., Assennato, G., Merlo, F., Mocarelli, P., Brambilla, P., Sicurello, F., 1982. Potential 2,3,7,8-tetrachlorodibenzo-p-dioxin exposure of Seveso decontamination workers: a controlled prospective study. Scand. J. Work. Environ. Heal. 8 (Suppl. 1), 176-179.\n</p><p>Goodman, D.G., Sauer, R.M., 1992. Hepatotoxicity and carcinogenicity in female Sprague-Dawley rats treated with 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD): a pathology working group reevaluation. Regul. Toxicol. Pharmacol. 15, 245-252.\n</p><p>Hailey, J.R., Walker, N.J., Sells, D.M., Brix, A.E., Jokinen, M.P., Nyska, A., 2005. Clas- sification of proliferative hepatocellular lesions in harlan sprague-dawley rats chronically exposed to dioxin-like compounds. Toxicol. Pathol. 33, 165-174.\n</p><p>Hankinson, O., 2009. Repression of aryl hydrocarbon receptor transcriptional ac- tivity by epidermal growth factor. Mol. Interv. 9, 116-118.\n</p><p>Ju, Q., Fimmel, S., Hinz, N., Stahlmann, R., Xia, L., Zouboulis, C.C., 2011. 2,3,7,8- Tetrachlorodibenzo-p-dioxin alters sebaceous gland cell differentiation in vitro. Exp. Dermatol. 20, 320-325.\n</p><p>Kociba, R.J., Keyes, D.G., Beyer, J.E., Carreon, R.M., Wade, C.E., Dittenber, D.A., Kalnins, R.P., Frauson, L.E., Park, C.N., Barnard, S.D., Hummel, R.A., Humiston, C.G., 1978. Results of a two-year chronic toxicity and oncogenicity study of 2,3,7,8-tetrachlorodibenzo-p-dioxin in rats. Toxicol. Appl. Pharmacol. 46, 279-303.\n</p><p>Lambert, G.H., Needham, L.L., Turner, W., Lai, T.J., Patterson, D.G.J., Guo, Y.L., 2006. Induced CYP1A2 activity as a phenotypic biomarker in humans highly exposed to certain PCBs/PCDFs. Environ. Sci. Technol. 40, 6176-6180.\n</p><p>Libbrecht, L., 2006. Hepatic progenitor cells in human liver tumor development. World. J. Gastroenterol. 12, 6261-6265.\n</p><p>Libbrecht, L., De Vos, R., Cassiman, D., Desmet, V., Aerts, R., Roskams, T., 2001. He- patic progenitor cells in hepatocellular adenomas. Am. J. Surg. Pathol. 25, 1388-1396.\n</p><p>Loertscher, J.A., Sattler, C.A., Allen-Hoffmann, B.L., 2001. 2,3,7,8-Tetrachlorodibenzo- p-dioxin alters the differentiation pattern of human keratinocytes in organo- typic culture. Toxicol. Appl. Pharmacol. 175, 121-129. \n</p><p>McBride, D.I., Collins, J.J., Humphry, N.F., Herbison, P., Bodner, K.M., Aylward, L.L., Burns, C.J., Wilken, M., 2009. Mortality in workers exposed to 2,3,7,8- tetrachlorodibenzo-p-dioxin at a trichlorophenol plant in New Zealand. J. Occup. Environ. Med. 51, 1049-1056.\n</p><p>Mocarelli, P., Marocchi, A., Brambilla, P., Gerthoux, P., Young, D.S., Mantel, N., 1986. Clinical laboratory manifestations of exposure to dioxin in children. A six-year study of the effects of an environmental disaster near Seveso, Italy. JAMA 256, 2687-2695.\n</p><p>Mocarelli, P., Needham, L.L., Marocchi, A., Patterson, D.G.J., Brambilla, P., Gerthoux, P.M., Meazza, L., Carreri, V., 1991. Serum concentrations of 2,3,7,8- tetrachlorodibenzo-p-dioxin and test results from selected residents of Sev- eso, Italy. J. Toxicol. Environ. Heal. 32, 357-366.\n</p><p>Moses, M., Prioleau, P.G., 1985. Cutaneous histologic findings in chemical workers with and without chloracne with past exposure to 2,3,7,8-tetrachlorodibenzo- p-dioxin. J. Am. Acad. Dermatol. 12, 497-506.\n</p><p>Onozuka, D., Yoshimura, T., Kaneko, S., Furue, M., 2009. Mortality after exposure to polychlorinated biphenyls and polychlorinated dibenzofurans: a 40-year follow-up study of Yusho patients. Am. J. Epidemiol. 169, 86-95.\n</p><p>Pocchiari, F., Silano, V., Zampieri, A., 1979. Human health effects from accidental release of tetrachlorodibenzo-p-dioxin (TCDD) at Seveso, Italy. Ann. N. Y. Acad. Sci. 320, 311-320.\n</p><p>Reggiani, G., 1980. Acute human exposure to TCDD in Seveso, Italy. J. Toxicol. Environ. Heal. 6, 27-43.\n</p><p>Saurat, J.H., Sorg, O., 2010. Chloracne, a misnomer and its implications. Dermatology 221, 23-26. \n</p><p>Saurat, J.H., Kaya, G., Saxer-Sekulic, N., Pardo, B., Becker, M., Fontao, L., Mottu, F., Carraux, P., Pham, X.C., Barde, C., Fontao, F., Zennegg, M., Schmid, P., Schaad, O., Descombes, P., Sorg, O., 2012. The cutaneous lesions of dioxin exposure: lessons from the poisoning of Victor Yushchenko. Toxicol. Sci. 125, 310-317.\n</p><p>Simon, T., Aylward, L.L., Kirman, C.R., Rowlands, J.C., Budinsky, R.A., 2009. Estimates of cancer potency of 2,3,7,8-tetrachlorodibenzo(p)dioxin using linear and nonlinear dose-response modeling and toxicokinetics. Toxicol. Sci. 112, 490-506.\n</p><p>Sorg, O., 2014. AhR signalling and dioxin toxicity. Toxicol. Lett. 230, 225-233. \n</p><p>Sutter, C.H., Bodreddigari, S., Campion, C., Wible, R.S., Sutter, T.R., 2011. 2,3,7,8- Tetrachlorodibenzo-p-dioxin increases the expression of genes in the human epidermal differentiation complex and accelerates epidermal barrier formation. Toxicol. Sci. 124, 128-137.\n</p><p>Sutter, C.H., Bodreddigari, S., Sutter, T.R., Carlson, E.A., Silkworth, J.B., 2010. Analysis of the CYP1A1 mRNA dose response in human keratinocytes indicates that relative potencies of dioxins, furans, and PCBs are species and congener specific. Toxicol. Sci. 118, 704-715.\n</p><p>Sutter, C.H., Yin, H., Li, Y., Mammen, J.S., Bodreddigari, S., Stevens, G., Cole, J.A., Sutter, T.R., 2009. EGF receptor signaling blocks aryl hydrocarbon receptor- mediated transcription and cell differentiation in human epidermal keratino- cytes. Proc. Natl. Acad. Sci. U. S. A. 106, 4266-4271.\n</p><p>Tang, N.J., Liu, J., Coenraads, P.J., Dong, L., Zhao, L.J., Ma, S.W., Chen, X., Zhang, C.M., Ma, X.M., Wei, W.G., Zhang, P., Bai, Z.P., 2008. Expression of AhR, CYP1A1, GSTA1, c-fos and TGF-alpha in skin lesions from dioxin-exposed humans with chlor- acne. Toxicol. Lett. 177, 182-187. \n</p><p>Tsai, P.-C., Ko, Y.-C., Huang, W., Liu, H.-S., Guo, Y.L., 2007. Increased liver and lupus mortalities in 24-year follow-up of the Taiwanese people highly exposed to polychlorinated biphenyls and dibenzofurans. Sci. Total. Environ. 374, 216-222.\n</p>","biologicalOrganisationLevel":"Organ","organTerm":{"name":"hepatobiliary system","sourceId":"UBERON:0002423"},"biologicalEvents":[{"action":"increased","object":{"name":"hepatocellular carcinoma","source":"MESH","sourceId":"D006528"}},{"action":"increased","object":{"name":"Bile Duct Neoplasms","source":"MESH","sourceId":"D001650"}}],"id":856}
{"title":"Formation, Hepatocellular and Bile duct tumors","references":"<p>Abraham, K., Geusau, A., Tosun, Y., Helge, H., Bauer, S., Brockmoller, J., 2002. Severe 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) intoxication: insights into the measurement of hepatic cytochrome P450 1A2 induction. Clin. Pharmacol. Ther. 72, 163-174.\n</p><p>Akintobi, A.M., Villano, C.M., White, L.A., 2007. 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) exposure of normal human dermal fibroblasts results in AhR-dependent and -independent changes in gene expression. Toxicol. Appl. Pharmacol. 220, 9-17.\n</p><p>Bertazzi, P.A., Zocchetti, C., Pesatori, A.C., Guercilena, S., Sanarico, M., Radice, L., 1989. Ten-year mortality study of the population involved in the Seveso inci- dent in 1976. Am. J. Epidemiol. 129, 1187-1200.\n</p><p>Budinsky, R.A., LeCluyse, E.L., Ferguson, S.S., Rowlands, J.C., Simon, T., 2010. Human and rat primary hepatocyte CYP1A1 and 1A2 induction with 2,3,7,8- tetrachlorodibenzo-p-dioxin, 2,3,7,8-tetrachlorodibenzofuran, and 2,3,4,7,8- pentachlorodibenzofuran. Toxicol. Sci. 118, 224-235.\n</p><p>Calvert, G.M., Hornung, R.W., Sweeney, M.H., Fingerhut, M.A., Halperin, W.E., 1992. Hepatic and gastrointestinal effects in an occupational cohort exposed to 2,3,7,8-tetrachlorodibenzo-para-dioxin. JAMA 267, 2209-2214.\n</p><p>Coenraads, P.J., Olie, K., Tang, N.J., 1999. Blood lipid concentrations of dioxins and dibenzofurans causing chloracne. Br. J. Dermatol. 141, 694-697.\n</p><p>Collins, J.J., Bodner, K., Aylward, L.L., Wilken, M., Bodnar, C.M., 2009a. Mortality rates among trichlorophenol workers with exposure to 2,3,7,8-tetrachlorodibenzo-p- dioxin. Am. J. Epidemiol. 170, 501-506.\n</p><p>Collins, J.J., Bodner, K., Aylward, L.L., Wilken, M., Swaen, G., Budinsky, R., Rowlands, C., Bodnar, C.M., 2009b. Mortality rates among workers exposed to dioxins in the manufacture of pentachlorophenol. J. Occup. Environ. Med. 51, 1212-1219. .\n</p><p>Du, L., Neis, M.M., Ladd, P.A., Keeney, D.S., 2006. Differentiation-specific factors modulate epidermal CYP1-4 gene expression in human skin in response to retinoic acid and classic aryl hydrocarbon receptor ligands. J. Pharmacol. Exp. Ther. 319, 1162-1171.\n</p><p>Forrester, A.R., Elias, M.S., Woodward, E.L., Graham, M., Williams, F.M., Reynolds, N.J., 2014. Induction of a chloracne phenotype in an epidermal equivalent model by 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) is dependent on aryl hydrocarbon receptor activation and is not reproduced by aryl hydro- carbon receptor knock down. J. Dermatol. Sci. 73, 10-22.\n</p><p>Geusau, A., Abraham, K., Geissler, K., Sator, M.O., Stingl, G., Tschachler, E., 2001. Severe 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) intoxication: clinical and laboratory effects. Environ. Heal. Perspect. 109, 865-869.\n</p><p>Geusau, A., Khorchide, M., Mildner, M., Pammer, J., Eckhart, L., Tschachler, E., 2005. 2,3,7,8-tetrachlorodibenzo-p-dioxin impairs differentiation of normal human epidermal keratinocytes in a skin equivalent model. J. Invest. Dermatol. 124, 275-277.\n</p><p>Ghezzi, I., Cannatelli, P., Assennato, G., Merlo, F., Mocarelli, P., Brambilla, P., Sicurello, F., 1982. Potential 2,3,7,8-tetrachlorodibenzo-p-dioxin exposure of Seveso decontamination workers: a controlled prospective study. Scand. J. Work. Environ. Heal. 8 (Suppl. 1), 176-179.\n</p><p>Goodman, D.G., Sauer, R.M., 1992. Hepatotoxicity and carcinogenicity in female Sprague-Dawley rats treated with 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD): a pathology working group reevaluation. Regul. Toxicol. Pharmacol. 15, 245-252.\n</p><p>Hailey, J.R., Walker, N.J., Sells, D.M., Brix, A.E., Jokinen, M.P., Nyska, A., 2005. Clas- sification of proliferative hepatocellular lesions in harlan sprague-dawley rats chronically exposed to dioxin-like compounds. Toxicol. Pathol. 33, 165-174.\n</p><p>Hankinson, O., 2009. Repression of aryl hydrocarbon receptor transcriptional ac- tivity by epidermal growth factor. Mol. Interv. 9, 116-118.\n</p><p>Ju, Q., Fimmel, S., Hinz, N., Stahlmann, R., Xia, L., Zouboulis, C.C., 2011. 2,3,7,8- Tetrachlorodibenzo-p-dioxin alters sebaceous gland cell differentiation in vitro. Exp. Dermatol. 20, 320-325.\n</p><p>Kociba, R.J., Keyes, D.G., Beyer, J.E., Carreon, R.M., Wade, C.E., Dittenber, D.A., Kalnins, R.P., Frauson, L.E., Park, C.N., Barnard, S.D., Hummel, R.A., Humiston, C.G., 1978. Results of a two-year chronic toxicity and oncogenicity study of 2,3,7,8-tetrachlorodibenzo-p-dioxin in rats. Toxicol. Appl. Pharmacol. 46, 279-303.\n</p><p>Lambert, G.H., Needham, L.L., Turner, W., Lai, T.J., Patterson, D.G.J., Guo, Y.L., 2006. Induced CYP1A2 activity as a phenotypic biomarker in humans highly exposed to certain PCBs/PCDFs. Environ. Sci. Technol. 40, 6176-6180.\n</p><p>Libbrecht, L., 2006. Hepatic progenitor cells in human liver tumor development. World. J. Gastroenterol. 12, 6261-6265.\n</p><p>Libbrecht, L., De Vos, R., Cassiman, D., Desmet, V., Aerts, R., Roskams, T., 2001. He- patic progenitor cells in hepatocellular adenomas. Am. J. Surg. Pathol. 25, 1388-1396.\n</p><p>Loertscher, J.A., Sattler, C.A., Allen-Hoffmann, B.L., 2001. 2,3,7,8-Tetrachlorodibenzo- p-dioxin alters the differentiation pattern of human keratinocytes in organo- typic culture. Toxicol. Appl. Pharmacol. 175, 121-129. \n</p><p>McBride, D.I., Collins, J.J., Humphry, N.F., Herbison, P., Bodner, K.M., Aylward, L.L., Burns, C.J., Wilken, M., 2009. Mortality in workers exposed to 2,3,7,8- tetrachlorodibenzo-p-dioxin at a trichlorophenol plant in New Zealand. J. Occup. Environ. Med. 51, 1049-1056.\n</p><p>Mocarelli, P., Marocchi, A., Brambilla, P., Gerthoux, P., Young, D.S., Mantel, N., 1986. Clinical laboratory manifestations of exposure to dioxin in children. A six-year study of the effects of an environmental disaster near Seveso, Italy. JAMA 256, 2687-2695.\n</p><p>Mocarelli, P., Needham, L.L., Marocchi, A., Patterson, D.G.J., Brambilla, P., Gerthoux, P.M., Meazza, L., Carreri, V., 1991. Serum concentrations of 2,3,7,8- tetrachlorodibenzo-p-dioxin and test results from selected residents of Sev- eso, Italy. J. Toxicol. Environ. Heal. 32, 357-366.\n</p><p>Moses, M., Prioleau, P.G., 1985. Cutaneous histologic findings in chemical workers with and without chloracne with past exposure to 2,3,7,8-tetrachlorodibenzo- p-dioxin. J. Am. Acad. Dermatol. 12, 497-506.\n</p><p>Onozuka, D., Yoshimura, T., Kaneko, S., Furue, M., 2009. Mortality after exposure to polychlorinated biphenyls and polychlorinated dibenzofurans: a 40-year follow-up study of Yusho patients. Am. J. Epidemiol. 169, 86-95.\n</p><p>Pocchiari, F., Silano, V., Zampieri, A., 1979. Human health effects from accidental release of tetrachlorodibenzo-p-dioxin (TCDD) at Seveso, Italy. Ann. N. Y. Acad. Sci. 320, 311-320.\n</p><p>Reggiani, G., 1980. Acute human exposure to TCDD in Seveso, Italy. J. Toxicol. Environ. Heal. 6, 27-43.\n</p><p>Saurat, J.H., Sorg, O., 2010. Chloracne, a misnomer and its implications. Dermatology 221, 23-26. \n</p><p>Saurat, J.H., Kaya, G., Saxer-Sekulic, N., Pardo, B., Becker, M., Fontao, L., Mottu, F., Carraux, P., Pham, X.C., Barde, C., Fontao, F., Zennegg, M., Schmid, P., Schaad, O., Descombes, P., Sorg, O., 2012. The cutaneous lesions of dioxin exposure: lessons from the poisoning of Victor Yushchenko. Toxicol. Sci. 125, 310-317.\n</p><p>Simon, T., Aylward, L.L., Kirman, C.R., Rowlands, J.C., Budinsky, R.A., 2009. Estimates of cancer potency of 2,3,7,8-tetrachlorodibenzo(p)dioxin using linear and nonlinear dose-response modeling and toxicokinetics. Toxicol. Sci. 112, 490-506.\n</p><p>Sorg, O., 2014. AhR signalling and dioxin toxicity. Toxicol. Lett. 230, 225-233. \n</p><p>Sutter, C.H., Bodreddigari, S., Campion, C., Wible, R.S., Sutter, T.R., 2011. 2,3,7,8- Tetrachlorodibenzo-p-dioxin increases the expression of genes in the human epidermal differentiation complex and accelerates epidermal barrier formation. Toxicol. Sci. 124, 128-137.\n</p><p>Sutter, C.H., Bodreddigari, S., Sutter, T.R., Carlson, E.A., Silkworth, J.B., 2010. Analysis of the CYP1A1 mRNA dose response in human keratinocytes indicates that relative potencies of dioxins, furans, and PCBs are species and congener specific. Toxicol. Sci. 118, 704-715.\n</p><p>Sutter, C.H., Yin, H., Li, Y., Mammen, J.S., Bodreddigari, S., Stevens, G., Cole, J.A., Sutter, T.R., 2009. EGF receptor signaling blocks aryl hydrocarbon receptor- mediated transcription and cell differentiation in human epidermal keratino- cytes. Proc. Natl. Acad. Sci. U. S. A. 106, 4266-4271.\n</p><p>Tang, N.J., Liu, J., Coenraads, P.J., Dong, L., Zhao, L.J., Ma, S.W., Chen, X., Zhang, C.M., Ma, X.M., Wei, W.G., Zhang, P., Bai, Z.P., 2008. Expression of AhR, CYP1A1, GSTA1, c-fos and TGF-alpha in skin lesions from dioxin-exposed humans with chlor- acne. Toxicol. Lett. 177, 182-187. \n</p><p>Tsai, P.-C., Ko, Y.-C., Huang, W., Liu, H.-S., Guo, Y.L., 2007. Increased liver and lupus mortalities in 24-year follow-up of the Taiwanese people highly exposed to polychlorinated biphenyls and dibenzofurans. Sci. Total. Environ. 374, 216-222.\n</p>","biologicalOrganisationLevel":"Organ","organTerm":{"name":"hepatobiliary system","sourceId":"UBERON:0002423"},"biologicalEvents":[{"action":"increased","object":{"name":"hepatocellular carcinoma","source":"MESH","sourceId":"D006528"}},{"action":"increased","object":{"name":"Bile Duct Neoplasms","source":"MESH","sourceId":"D001650"}}],"id":856}
{"title":"Thyroperoxidase, Inhibition","references":"<p>Brown RS, Shalhoub V, Coulter S, Alex S, Joris I, De Vito W, Lian J, Stein GS.&nbsp; Developmental regulation of thyrotropin receptor gene expression in the fetal and neonatal rat thyroid: relation to thyroid morphology and to thyroid-specific gene expression.&nbsp; Endocrinology. 2000 Jan;141(1):340-5.</p>\n\n<p>Brucker-Davis F. 1998. Effects of environmental synthetic chemicals on thyroid function. Thyroid 8:827-856.</p>\n\n<p>Chang, H. C. and D. R. Doerge (2000) Dietary genistein inactivates rat thyroid peroxidase in vivo without an apparent hypothyroid effect. Toxicol Appl Pharmacol. 168:244-252.</p>\n\n<p>Divi, R. L., &amp; Doerge, D. R. (1994). Mechanism-based inactivation of lactoperoxidase and thyroid peroxidase by resorcinol derivatives. Biochemistry 33(32), 9668&ndash;9674.</p>\n\n<p>Divi, R. L., Chang, H. C., &amp; Doerge, D. R. (1997). Anti-Thyroid Isoflavones from Soybean. Biochem. Pharmacol. &nbsp;54(10), 1087&ndash;1096.</p>\n\n<p>Doerge DR, Chang HC. Inactivation of thyroid peroxidase by soy isoflavones, in vitro and in vivo. J Chromatogr B Analy Technol Biomed Life Sci. 2002 Sep 25;777(1-2):269-79.</p>\n\n<p>Ealey PA, Henderson B, Loveridge N.A quantitative study of peroxidase activity in unfixed tissue sections of the guinea-pig thyroid gland. Histochem J. 1984 Feb;16(2):111-22.</p>\n\n<p>Fukiishi Y, Harauchi T, Yoshizaki T, Hasegawa Y, Eguchi Y.&nbsp; Ontogeny of thyroid peroxidase activity in perinatal rats. Acta Endocrinol (Copenh). 1982 101(3):397-402.</p>\n\n<p>Holzer G, Morishita Y, Fini JB, Lorin T, Gillet B, Hughes S, Tohm&eacute; M, Del&eacute;age G, Demeneix B, Arvan P, Laudet V. Thyroglobulin Represents a Novel Molecular Architecture of Vertebrates. J Biol Chem. 2016 Jun 16.</p>\n\n<p>Hornung, M. W., Degitz, S. J., Korte, L. M., Olson, J. M., Kosian, P. a, Linnum, A. L., &amp; Tietge, J. E. (2010). Inhibition of thyroid hormone release from cultured amphibian thyroid glands by methimazole, 6-propylthiouracil, and perchlorate. Toxicol Sci 118(1), 42&ndash;51.</p>\n\n<p>Hurley PM. 1998. Mode of carcinogenic action of pesticides inducing thyroid follicular cell tumors in rodents. Environ Health Perspect 106:437-445.</p>\n\n<p>Kaczur, V., Vereb, G., Moln&aacute;r, I., Krajcz&aacute;r, G., Kiss, E., Farid, N. R., &amp; Bal&aacute;zs, C. (1997). Effect of anti-thyroid peroxidase (TPO) antibodies on TPO activity measured by chemiluminescence assay. Clin. Chem 43(8 Pt 1), 1392&ndash;6.</p>\n\n<p>Kessler, J., Obinger, C., Eales, G., 2008. Factors influencing the study of peroxidase- generated iodine species and implications for thyroglobulin synthesis. Thyroid 18, 769&ndash;774.</p>\n\n<p>OECD (2017) New Scoping Document on in vitro and ex vivo Assays for the Identification of Modulators of Thyroid Hormone Signalling. Series on Testing and Assessment. No. 207. &nbsp;ISSN: 20777876 (online) http://dx.doi.org/10.1787/20777876</p>\n\n<p>Paul KB, Hedge JM, Macherla C, Filer DL, Burgess E, Simmons SO, Crofton KM, Hornung MW. Cross-species analysis of thyroperoxidase inhibition by xenobiotics demonstrates conservation of response between pig and rat. Toxicology. 2013. 312:97-107</p>\n\n<p>Paul, K.B., Hedge, J.M., Rotroff, D.M., Hornung, M.W., Crofton, K.M., Simmons, S.O. 2014. Development of a thyroperoxidase inhibition assay for high-throughput screening. Chem. &nbsp;Res. Toxicol. 27(3), 387-399.</p>\n\n<p>Paul-Friedman K, Watt ED, Hornung MW, Hedge JM, Judson RS, Crofton KM, Houck KA, Simmons SO. 2016. Tiered High-Throughput Screening Approach to Identify Thyroperoxidase Inhibitors Within the ToxCast Phase I and II Chemical Libraries.&nbsp; Toxicol Sci. 151:160-80.</p>\n\n<p>Pintar, J.E. (2000) Normal development of the hypothalamic-pituitary-thyroid axis. In. Werner &amp; Ingbar&rsquo;s The Thyroid. (8<sup>th</sup> ed), Braverman. L.E. and Utiger, R.D. (eds) Lippincott Williams and Wilkins, Philadelphia.</p>\n\n<p>Remy L, Michel-Bechet M, Athouel-Haon AM, Magre S. Critical study of endogenous peroxidase activity: its role in the morphofunctional setting of the thyroid follicle in the rat fetus. Acta Histochem. 1980;67(2):159-72.</p>\n\n<p>Ruf, J., &amp; Carayon, P. (2006). Structural and functional aspects of thyroid peroxidase. Archives of Biochemistry and Biophysics, 445(2), 269&ndash;77.</p>\n\n<p>Santisteban P, Bernal J. Thyroid development and effect on the nervous system. Rev Endocr Metab Disord. 2005 Aug;6(3):217-28.</p>\n\n<p>Schmutzler, C., Bacinski, A., Gotthardt, I., Huhne, K., Ambrugger, P., Klammer, H., Schlecht, C., Hoang-Vu, C., Gruters, A., Wuttke, W., Jarry, H., Kohrle, J., 2007a. The ultraviolet filter benzophenone 2 interferes with the thyroid hormone axis in rats and is a potent in vitro inhibitor of human recombinant thyroid peroxidase. Endocrinology 148, 2835&ndash;2844.</p>\n\n<p>Taurog A. 2005. Hormone synthesis. In: Werner and Ingbar&rsquo;s The Thyroid: A Fundamental and Clinical Text (Braverman LE, Utiger RD, eds). Philadelphia:Lippincott, Williams and Wilkins, 47&ndash;81</p>\n\n<p>Taurog, a, Dorris, M. L., &amp; Doerge, D. R. (1996). Mechanism of simultaneous iodination and coupling catalyzed by thyroid peroxidase. Archives of Biochemistry and Biophysics, Taurog A. Molecular evolution of thyroid peroxidase. Biochimie. 1999 May;81(5):557-62</p>\n\n<p>Takayama S, Aihara K, Onodera T, Akimoto T. Antithyroid effects of propylthiouracil and sulfamonomethoxine in rats and monkeys. Toxicol Appl Pharmacol. 1986 Feb;82(2):191-9.</p>\n\n<p>Thorne N, Auld DS, Inglese J.&nbsp; Apparent activity in high-throughput screening: origins of compound-dependent assay interference. Curr Opin Chem Biol. 2010 Jun;14(3):315-24.</p>\n\n<p>Thorpe-Beeston JG, Nicolaides KH, McGregor AM. Fetal thyroid function. Thyroid. 1992 Fall;2(3):207-17. Review.</p>\n\n<p>Vickers AE, Heale J, Sinclair JR, Morris S, Rowe JM, Fisher RL. Thyroid organotypic rat and human cultures used to investigate drug effects on thyroid function, hormone synthesis and release pathways. Toxicol Appl Pharmacol. 2012 Apr 1;260(1):81-8.</p>\n\n<p>Zoeller, R. T., Tan, S. W., &amp; Tyl, R. W. (2007). General background on the hypothalamic-pituitary-thyroid (HPT) axis. Critical Reviews in Toxicology, 37(1-2), 11&ndash;53.</p>\n","biologicalOrganisationLevel":"Molecular","organTerm":{"name":"thyroid follicle","sourceId":"UBERON:0005305"},"biologicalEvents":[{"action":"decreased","process":"iodide peroxidase activity","object":{"name":"thyroid peroxidase","source":"PR","sourceId":"PR:000016584"}}],"keyEventStressors":["Genistein","Thiouracil","Ethylene thiourea","2,2',4,4'-Tetrahydroxybenzophenone","131-55-5","Propylthiouracil","2(3H)-Benzothiazolethione","Amitrole","2-mercaptobenzothiazole","Mercaptobenzothiazole","Daidzein","4-Nonylphenol","Methimazole","Ethylenethiourea","Resorcinol","4-propoxyphenol","Sulfamethazine"],"id":279}
{"title":"Thyroid hormone synthesis, Decreased","references":"<p>Bakker B, Bikker H, Vulsma T, de Randamie JS, Wiedijk BM, De Vijlder JJ. 2000. Two decades of screening for congenital hypothyroidism in The Netherlands: TPO gene mutations in total iodide organification defects (an update). The Journal of clinical endocrinology and metabolism.&nbsp; 85:3708-3712.</p>\n\n<p>Bianco AC, Kim BW. (2006). Deiodinases: implications of the local control of thyroid hormone action. J Clin Invest. 116: 2571&ndash;2579.</p>\n\n<p>Dossena S,&nbsp;Nofziger C,&nbsp;Brownstein Z,&nbsp;Kanaan M,&nbsp;Avraham KB,&nbsp;Paulmichl M. (2011). Functional characterization of&nbsp;pendrin&nbsp;mutations found in the Israeli and Palestinian populations. Cell Physiol Biochem. 28: 477-484.Gereben B, Zavacki AM, Ribich S, Kim BW, Huang SA, Simonides WS, Ze&ouml;ld A, Bianco AC. (2008). Cellular and molecular basis of deiodinase-regulated thyroid hormone signalling. Endocr Rev. 29:898&ndash;938.</p>\n\n<p>Gereben B, Ze&ouml;ld A, Dentice M, Salvatore D, Bianco AC.&nbsp; Activation and inactivation of thyroid hormone by deiodinases: local action with general consequences.&nbsp; Cell Mol Life Sci. 2008 Feb;65(4):570-90</p>\n\n<p>Greer MA, Goodman G, Pleus RC, Greer SE. Health effects assessment for environmental perchlorate contamination: the dose response for inhibition of thyroidal radioiodine uptake in humans. Environ Health Perspect. 2002. 110:927-937.</p>\n\n<p>Howdeshell KL. 2002. A model of the development of the brain as a construct of the thyroid system. Environ Health Perspect. 110 Suppl 3:337-48.</p>\n\n<p>Hornung MW, Degitz SJ, Korte LM, Olson JM, Kosian PA, Linnum AL, Tietge JE. 2010. Inhibition of thyroid hormone release from cultured amphibian thyroid glands by methimazole, 6-propylthiouracil, and perchlorate. Toxicol Sci 118:42-51.</p>\n\n<p>Huang CJ and Jap TS. 2015. A systematic review of genetic studies of thyroid disorders in Taiwan. J Chin Med Assoc. 78: 145-153.</p>\n\n<p>Kessler J, Obinger C, Eales G. Factors influencing the study of peroxidase-generated iodine species and implications for thyroglobulin synthesis. Thyroid. 2008 Jul;18(7):769-74. doi: 10.1089/thy.2007.0310</p>\n\n<p>Larsen PR. (2009). Type 2 iodothyronine deiodinase in human skeletal muscle: new insights into its physiological role and regulation. J Clin Endocrinol Metab. 94:1893-1895.</p>\n\n<p>Romaldini JH, Farah CS, Werner RS, Dall&#39;Antonia J&uacute;nior RP, Camargo RS. 1988.&nbsp; &quot;In vitro&quot; study on release of cyclic AMP and thyroid hormone in autonomously functioning thyroid nodules.&nbsp; Horm Metab Res.20:510-2.</p>\n\n<p>Santisteban P, Bernal J. Thyroid development and effect on the nervous system. Rev Endocr Metab Disord. 2005 Aug;6(3):217-28.</p>\n\n<p>Spitzweg C, Morris JC. 2010. Genetics and phenomics of hypothyroidism and goiter due to NIS mutations. Molecular and cellular endocrinology. 322:56-63.</p>\n\n<p>Thienpont B, Tingaud-Sequeira A, Prats E, Barata C, Babin PJ, Rald&uacute;a D.&nbsp; Zebrafish eleutheroembryos provide a suitable vertebrate model for screening chemicals that impair thyroid hormone synthesis.&nbsp; Environ Sci Technol. 2011. 45(17):7525-32.</p>\n\n<p>Yi X, Yamamoto K, Shu L, Katoh R, Kawaoi A. Effects of Propyithiouracil (PTU) Administration on the Synthesis and Secretion of Thyroglobulin in the Rat Thyroid Gland: A Quantitative Immuno-electron Microscopic Study Using Immunogold Technique. Endocr Pathol. 1997 Winter;8(4):315-325.</p>\n\n<p>Zoeller RT.&nbsp; Interspecies differences in susceptibility to perturbation of thyroid hormone homeostasis requires a definition of &quot;sensitivity&quot; that is informative for risk analysis. Regul Toxicol Pharmacol. 2004 Dec;40(3):380.</p>\n\n<p>Zoeller RT, Crofton KM. 2005.&nbsp; Mode of action: developmental thyroid hormone insufficiency--neurological abnormalities resulting from exposure to propylthiouracil. Crit Rev Toxicol. 35:771-81</p>\n\n<p>Zoeller RT, Tan SW, Tyl RW. 2007. General background on the hypothalamic-pituitary-thyroid (HPT) axis. Critical reviews in toxicology. &nbsp;37:11-53.</p>\n","biologicalOrganisationLevel":"Cellular","organTerm":{"name":"thyroid gland","sourceId":"UBERON:0002046"},"biologicalEvents":[{"action":"decreased","process":"thyroid hormone generation","object":{"name":"thyroid hormone","source":"CHEBI","sourceId":"CHEBI:60311"}}],"keyEventStressors":["Methimazole","Propylthiouracil"],"id":277}
{"title":"Cognitive Function, Decreased ","references":"<p>Alexander RD (1990) Epigenetic rules and Darwinian algorithms: The adaptive study of learning and development. Ethology and Sociobiology 11:241-303.</p>\n\n<p>Bellinger DC (2012) A strategy for comparing the contributions of environmental chemicals and other risk factors to neurodevelopment of children. Environ Health Perspect 120:501-507.</p>\n\n<p>Burgess N (2002) The hippocampus, space, and viewpoints in episodic memory. Q J Exp Psychol A 55:1057-1080.</p>\n\n<p>Cohen, SJ and Stackman, RW. (2015). Assessing rodent hippocampal involvement in the novel object recognition task. A review. Behav. Brain Res. 285: 105-1176.</p>\n\n<p>Curzon P, Rustay NR, Browman KE. Cued and Contextual Fear Conditioning for Rodents. In: Buccafusco JJ, editor. Methods of Behavior Analysis in Neuroscience. 2nd edition. Boca Raton (FL): CRC Press/Taylor &amp; Francis; 2009</p>\n\n<p>D&#39;Hooge R, De Deyn PP (2001) Applications of the Morris water maze in the study of learning and memory. Brain Res Brain Res Rev 36:60-90.</p>\n\n<p>Eichenbaum H (2000) A cortical-hippocampal system for declarative memory. Nat Rev Neurosci 1:41-50.</p>\n\n<p>Fivush R. The development of autobiographical memory. Annu Rev Psychol. 2011. 62:559-82.</p>\n\n<p>Gilbert ME, Sanchez-Huerta K, Wood C (2016) Mild Thyroid Hormone Insufficiency During Development Compromises Activity-Dependent Neuroplasticity in the Hippocampus of Adult Male Rats. Endocrinology 157:774-787.</p>\n\n<p>Gilbert ME, Sui L (2006) Dose-dependent reductions in spatial learning and synaptic function in the dentate gyrus of adult rats following developmental thyroid hormone insufficiency. Brain Res 1069:10-22.</p>\n\n<p>Herold, C, L&auml;sser, MM, Schmid, LA, Seidl, U, Kong, L, Fellhauer, I, Thomann, PA, Essig, M and Schr&ouml;der, J. (2015). Neuropsychology, Autobiographical Memory, and Hippocampal Volume in &ldquo;Younger&rdquo; and &ldquo;Older&rdquo; Patients with Chronic Schizophrenia. Front. Psychiatry, 6: 53.</p>\n\n<p>Lezak MD (1984) Neuropsychological assessment in behavioral toxicology--developing techniques and interpretative issues. Scand J Work Environ Health 10 Suppl 1:25-29.</p>\n\n<p>Lezak MD (1994) Domains of behavior from a neuropsychological perspective: the whole story. Nebr Symp Motiv 41:23-55.</p>\n\n<p>Lynch, M.A. (2004). Long-Term Potentiation and Memory. Physiological Reviews. 84:87-136.</p>\n\n<p>Makris SL, Raffaele K, Allen S, Bowers WJ, Hass U, Alleva E, Calamandrei G, Sheets L, Amcoff P, Delrue N, Crofton KM. A retrospective performance assessment of the developmental neurotoxicity study in support of OECD test guideline 426. Environ Health Perspect. 2009 Jan;117(1):17-25.</p>\n\n<p>Morris RG, Frey U. Hippocampal synaptic plasticity: role in spatial learning or the automaticrecording of attended experience? Philos Trans R Soc Lond B Biol Sci. 1997 Oct 29;352(1360):1489-503. Review</p>\n\n<p>O&rsquo;Keefe, J. and Nadel, L. (1978). The Hippocampus as a Cognitive Map. Oxford: Oxford University Press.</p>\n\n<p>OECD. 2007. OECD guidelines for the testing of chemicals/ section 4: Health effects. Test no. 426: Developmental neurotoxicity study.&nbsp; www.Oecd.Org/dataoecd/20/52/37622194.Pdf [accessed May 21, 2012].</p>\n\n<p>Samuels BA, Hen R (2011) Neurogenesis and affective disorders. Eur J Neurosci 33:1152-1159.</p>\n\n<p>Shin, MS, Park, SY, Park, SR, Oeol, SH and Kwon, JS. (2006). Clinical and empirical appliations fo the Rey-Osterrieth complex figure test. Nature Protocols, 1: 892-899.</p>\n\n<p>Shors TJ, Miesegaes G, Beylin A, Zhao M, Rydel T, Gould E (2001) Neurogenesis in the adult is involved in the formation of trace memories. Nature 410:372-376.Squire LR (2004) Memory systems of the brain: a brief history and current perspective. Neurobiol Learn Mem 82:171-177.</p>\n\n<p>Stanton ME, Spear LP (1990) Workshop on the qualitative and quantitative comparability of human and animal developmental neurotoxicity, Work Group I report: comparability of measures of developmental neurotoxicity in humans and laboratory animals. Neurotoxicol Teratol 12:261-267.</p>\n\n<p>Talley, JL. (1986). Memory in learning disabled children: Digit span and eh Rey Auditory verbal learning test. Archives of Clinical Neuropsychology, Elseiver.</p>\n\n<p>U.S.EPA. 1998. Health effects guidelines OPPTS 870.6300 developmental neurotoxicity study. EPA Document 712-C-98-239.Office of Prevention Pesticides and Toxic Substances.</p>\n\n<p>Vorhees CV, Williams MT (2014) Assessing spatial learning and memory in rodents. ILAR J 55:310-332.</p>\n\n<p>Willoughby KA, McAndrews MP, Rovet JF. Accuracy of episodic autobiographical memory in children with early thyroid hormone deficiency using a staged event. Dev Cogn Neurosci. 2014. 9:1-11.</p>\n","biologicalOrganisationLevel":"Individual","organTerm":{},"biologicalEvents":[{"action":"decreased","process":"learning or memory","object":{}},{"action":"decreased","process":"cognition","object":{}}],"keyEventStressors":["Iodine deficiency","Methimazole","Propylthiouracil"],"id":402}
{"title":"Cognitive Function, Decreased ","references":"<p>Alexander RD (1990) Epigenetic rules and Darwinian algorithms: The adaptive study of learning and development. Ethology and Sociobiology 11:241-303.</p>\n\n<p>Bellinger DC (2012) A strategy for comparing the contributions of environmental chemicals and other risk factors to neurodevelopment of children. Environ Health Perspect 120:501-507.</p>\n\n<p>Burgess N (2002) The hippocampus, space, and viewpoints in episodic memory. Q J Exp Psychol A 55:1057-1080.</p>\n\n<p>Cohen, SJ and Stackman, RW. (2015). Assessing rodent hippocampal involvement in the novel object recognition task. A review. Behav. Brain Res. 285: 105-1176.</p>\n\n<p>Curzon P, Rustay NR, Browman KE. Cued and Contextual Fear Conditioning for Rodents. In: Buccafusco JJ, editor. Methods of Behavior Analysis in Neuroscience. 2nd edition. Boca Raton (FL): CRC Press/Taylor &amp; Francis; 2009</p>\n\n<p>D&#39;Hooge R, De Deyn PP (2001) Applications of the Morris water maze in the study of learning and memory. Brain Res Brain Res Rev 36:60-90.</p>\n\n<p>Eichenbaum H (2000) A cortical-hippocampal system for declarative memory. Nat Rev Neurosci 1:41-50.</p>\n\n<p>Fivush R. The development of autobiographical memory. Annu Rev Psychol. 2011. 62:559-82.</p>\n\n<p>Gilbert ME, Sanchez-Huerta K, Wood C (2016) Mild Thyroid Hormone Insufficiency During Development Compromises Activity-Dependent Neuroplasticity in the Hippocampus of Adult Male Rats. Endocrinology 157:774-787.</p>\n\n<p>Gilbert ME, Sui L (2006) Dose-dependent reductions in spatial learning and synaptic function in the dentate gyrus of adult rats following developmental thyroid hormone insufficiency. Brain Res 1069:10-22.</p>\n\n<p>Herold, C, L&auml;sser, MM, Schmid, LA, Seidl, U, Kong, L, Fellhauer, I, Thomann, PA, Essig, M and Schr&ouml;der, J. (2015). Neuropsychology, Autobiographical Memory, and Hippocampal Volume in &ldquo;Younger&rdquo; and &ldquo;Older&rdquo; Patients with Chronic Schizophrenia. Front. Psychiatry, 6: 53.</p>\n\n<p>Lezak MD (1984) Neuropsychological assessment in behavioral toxicology--developing techniques and interpretative issues. Scand J Work Environ Health 10 Suppl 1:25-29.</p>\n\n<p>Lezak MD (1994) Domains of behavior from a neuropsychological perspective: the whole story. Nebr Symp Motiv 41:23-55.</p>\n\n<p>Lynch, M.A. (2004). Long-Term Potentiation and Memory. Physiological Reviews. 84:87-136.</p>\n\n<p>Makris SL, Raffaele K, Allen S, Bowers WJ, Hass U, Alleva E, Calamandrei G, Sheets L, Amcoff P, Delrue N, Crofton KM. A retrospective performance assessment of the developmental neurotoxicity study in support of OECD test guideline 426. Environ Health Perspect. 2009 Jan;117(1):17-25.</p>\n\n<p>Morris RG, Frey U. Hippocampal synaptic plasticity: role in spatial learning or the automaticrecording of attended experience? Philos Trans R Soc Lond B Biol Sci. 1997 Oct 29;352(1360):1489-503. Review</p>\n\n<p>O&rsquo;Keefe, J. and Nadel, L. (1978). The Hippocampus as a Cognitive Map. Oxford: Oxford University Press.</p>\n\n<p>OECD. 2007. OECD guidelines for the testing of chemicals/ section 4: Health effects. Test no. 426: Developmental neurotoxicity study.&nbsp; www.Oecd.Org/dataoecd/20/52/37622194.Pdf [accessed May 21, 2012].</p>\n\n<p>Samuels BA, Hen R (2011) Neurogenesis and affective disorders. Eur J Neurosci 33:1152-1159.</p>\n\n<p>Shin, MS, Park, SY, Park, SR, Oeol, SH and Kwon, JS. (2006). Clinical and empirical appliations fo the Rey-Osterrieth complex figure test. Nature Protocols, 1: 892-899.</p>\n\n<p>Shors TJ, Miesegaes G, Beylin A, Zhao M, Rydel T, Gould E (2001) Neurogenesis in the adult is involved in the formation of trace memories. Nature 410:372-376.Squire LR (2004) Memory systems of the brain: a brief history and current perspective. Neurobiol Learn Mem 82:171-177.</p>\n\n<p>Stanton ME, Spear LP (1990) Workshop on the qualitative and quantitative comparability of human and animal developmental neurotoxicity, Work Group I report: comparability of measures of developmental neurotoxicity in humans and laboratory animals. Neurotoxicol Teratol 12:261-267.</p>\n\n<p>Talley, JL. (1986). Memory in learning disabled children: Digit span and eh Rey Auditory verbal learning test. Archives of Clinical Neuropsychology, Elseiver.</p>\n\n<p>U.S.EPA. 1998. Health effects guidelines OPPTS 870.6300 developmental neurotoxicity study. EPA Document 712-C-98-239.Office of Prevention Pesticides and Toxic Substances.</p>\n\n<p>Vorhees CV, Williams MT (2014) Assessing spatial learning and memory in rodents. ILAR J 55:310-332.</p>\n\n<p>Willoughby KA, McAndrews MP, Rovet JF. Accuracy of episodic autobiographical memory in children with early thyroid hormone deficiency using a staged event. Dev Cogn Neurosci. 2014. 9:1-11.</p>\n","biologicalOrganisationLevel":"Individual","organTerm":{},"biologicalEvents":[{"action":"decreased","process":"learning or memory","object":{}},{"action":"decreased","process":"cognition","object":{}}],"keyEventStressors":["Iodine deficiency","Methimazole","Propylthiouracil"],"id":402}
{"title":"Inhibition, VegfR2","references":"<p>Argraves WS, Larue AC, Fleming PA, Drake CJ. VEGF signaling is required for the assembly but not the maintenance of embryonic blood vessels. Developmental dynamics&nbsp;: an official publication of the American Association of Anatomists. 2002;225(3):298-304.</p>\n\n<p>Belair DG, Schwartz MP, Knudsen T and Murphy WL. Human iPSC-derived endothelial cell sprouting assay in synthetic hydrogel arrays. Acta Biomater. 2016; 39: 12-24. PMID:27181878.</p>\n\n<p>Bhattacharya R1, Kwon J, Li X, Wang E, Patra S, Bida JP, Bajzer Z, Claesson-Welsh L and Mukhopadhyay D (2009) Distinct role of PLCbeta3 in VEGF-mediated directional migration and vascular sprouting. J Cell Sci. 122: 1025-1034.</p>\n\n<p>Carmellet P, Ferreira V, Breier G, Pollefeyt S, Kleckens L, Gertsenstein M, Fahrig M, Vandenhoeck A, Harpal K, Eberhardt C, Declercq C, Pawlling J, Moons L, Collen D, Resau W, Nagy A (1996) Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele. Nature 380: 435&ndash;439.</p>\n\n<p>Chan J, Bayliss PE, Wood JM, Roberts TM (2002) Dissection of angiogenic signaling in zebrafish using a chemical genetic approach. Cancer Cell. 1: 257-267. (Note: this paper describes the use of Vatalanib to inhibit VEGFR; PTK787 is a synonym for Vatalanib.)</p>\n\n<p>Chappell JC, Taylor SM, Ferrara N, Bautch VL. Local guidance of emerging vessel sprouts requires soluble Flt-1. Developmental cell. 2009;17(3):377-86.</p>\n\n<p>Chen DB, Zheng J. Regulation of placental angiogenesis. Microcirculation (New York, NY&nbsp;: 1994). 2014;21(1):15-25. Douglas NC, Tang H, Gomez R, Pytowski B, Hicklin DJ, Sauer CM, et al. Vascular endothelial growth factor receptor 2 (VEGFR-2) functions to promote uterine decidual angiogenesis during early pregnancy in the mouse. Endocrinology. 2009;150(8):3845-54.</p>\n\n<p>Dorrell MI, Aguilar E, Friedlander M. Retinal vascular development is mediated by endothelial filopodia, a preexisting astrocytic template and specific R-cadherin adhesion. Investigative ophthalmology &amp; visual science. 2002;43(11):3500-10.</p>\n\n<p>Eichmann A, Thomas JL. Molecular parallels between neural and vascular development. Cold Spring Harbor perspectives in medicine. 2013;3(1):a006551. Habeck H, Odenthal J, Walderich B, Maischein H, Schulte-Merker S. Analysis of a zebrafish VEGF receptor mutant reveals specific disruption of angiogenesis. Current biology&nbsp;: CB. 2002;12(16):1405-12.</p>\n\n<p>Ferrara N, Carver-Moore K, Chen H, Dowd M, Lu L, O&rsquo;Shea KS, Powell-Braxton L, Hillan KJ, Moore MW (1996) Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene. Nature. 380: 439&ndash;442.</p>\n\n<p>Fischer et. al (2008) Nat Rev Cancer 8: 942&ndash;956.</p>\n\n<p>Fong GH, Rossant J, Gertsenstein M, Breitman ML (1995) Role of the Flt-1 receptor tyrosine kinase in regulating the assembly of vascular endothelium. Nature 376: 66-70.</p>\n\n<p>Gustafsdottir SM, Wennstrom S, Fredriksson S, Schallmeiner E, Hamilton AD, Sebti SM and Landegren U (2008) Use of proximity ligation to screen for inhibitors of interactions between vascular endothelial growth factor A and its receptors. Clinical Chem 54: 1218-1225.</p>\n\n<p>Hiratsuka S, Minowa O, Kuno J, Noda T, Shibuya M (1998) Flt-1 lacking the tyrosine kinase domain is sufficient for normal development and angiogenesis in mice. Proc Natl Acad Sci USA 95: 9349-9354.</p>\n\n<p>Hogan KA, Ambler CA, Chapman DL, Bautch VL. The neural tube patterns vessels developmentally using the VEGF signaling pathway. Development (Cambridge, England). 2004;131(7):1503-13.</p>\n\n<p>Jang GH, Park IS, Lee SH, Huh TL, Lee YM. Malachite green induces cardiovascular defects in developing zebrafish (Danio rerio) embryos by blocking VEGFR-2 signaling. Biochemical and biophysical research communications. 2009;382(3):486-91.</p>\n\n<p>Kendall RL, Rutledge RZ, Mao X, Tebben AJ, Hungate RW and Thomas KA (1999) J Biol Chem 274: 6453-6460.</p>\n\n<p>Kleinstreuer N, Dix D, Rountree M, Baker N, Sipes N, Reif D, Spencer R and Knudsen T (2013) A computational model predicting disruption of blood vessel development. PLoS Comp Biol 9(4): 1-20. e1002996.</p>\n\n<p>Kleinstreuer NC, Judson RS, Reif DM, Sipes NS, Singh AV, Chandler KJ, DeWoskin R, Dix D, Kavlock R and Knudsen TB (2011) Environmental impact on vascular development predicted by high-throughput screening. Environmental Hlth Persp 119: 1596-1603.</p>\n\n<p>Kleinstreuer N, Yang J, Berg E, Knudsen T, Richard A, Martin M, Reif D, Judson R, Polokoff M, Kavlock R, Dix D and Houck K (2014) Phenotypic screening of the ToxCast chemical library to classify toxic and therapeutic mechanisms. Nature Biotech 32: 583-591.</p>\n\n<p>Knudsen TB, Houck K, Sipes NS, Judson RS, Singh AV, Weissman A, Kleinstreuer NC, Mortensen H, Reif D, Setzer RW, Martin MT, Richard A, Dix DJ, and Kavlock RJ (2011) Activity profiles of 320 ToxCast&trade; chemicals evaluated Across 292 biochemical targets. Toxicology 282: 1-15</p>\n\n<p>Knudsen TB, Kleinstreuer NC (2011). Disruption of embryonic vascular development in predictive toxicology. Birth defects research Part C 93: 312-323.</p>\n\n<p>Ligi I, Simoncini S, Tellier E, Grandvuillemin I, Marcelli M, Bikfalvi A, et al. Altered angiogenesis in low birth weight individuals: a role for anti-angiogenic circulating factors. The journal of maternal-fetal &amp; neonatal medicine&nbsp;: the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstet. 2014;27(3):233-8.</p>\n\n<p>Liu H, Yang Q, Radhakrishnan K, Whitfield DE, Everhart CL, Parsons-Wingerter P, et al. Role of VEGF and tissue hypoxia in patterning of neural and vascular cells recruited to the embryonic heart. Developmental dynamics&nbsp;: an official publication of the American Association of Anatomists. 2009;238(11):2760-9.</p>\n\n<p>Nimmagadda S, Geetha Loganathan P, Huang R, Scaal M, Schmidt C, Christ B. BMP4 and noggin control embryonic blood vessel formation by antagonistic regulation of VEGFR-2 (Quek1) expression. Developmental biology. 2005;280(1):100-10.</p>\n\n<p>Roberts DM, Kearney JB, Johnson JH, Rosenberg MP, Kumar R, Bautch VL. The vascular endothelial growth factor (VEGF) receptor Flt-1 (VEGFR-1) modulates Flk-1 (VEGFR-2) signaling during blood vessel formation. The American journal of pathology. 2004;164(5):1531-5.</p>\n\n<p>Saili KS, Franzosa JA, Baker NC, Ellis-Hutchings RG, Settivari RS, Carney EW, Spencer R, Zurlinden TJ, Kleinstreuer NC, Li S, Xia M and Knudsen TB. Systems Modeling of Developmental Vascular Toxicity. Curr Opin Toxicol. 2019; 15(1): 55-63. PMID:32030360.</p>\n\n<p>Shalaby F, Rossant J, Yamaguchi TP, Gertsenstein M, Wu XF, Breitman ML, Schuh AC (1995) Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice. Nature 376: 62-66.</p>\n\n<p>Shibuya M (2013) Vascular endothelial growth factor and its receptor system: physiological functions in angiogenesis and pathological roles in various diseases. J Biochem. 153: 13-19.</p>\n\n<p>Shirinifard A, McCollum CW, Bolin MB, Gustafsson JA, Glazier JA, Clendenon SG. 3D quantitative analyses of angiogenic sprout growth dynamics. Developmental dynamics&nbsp;: an official publication of the American Association of Anatomists. 2013;242(5):518-26.</p>\n\n<p>Sipes NS, Martin MT, Kothiya P, Reif DM, Judson R, Richard A, Houck KA, Dix DJ, Kavlock RJ and Knudsen TB (2013) Profiling 976 ToxCast chemicals across 331 enzymatic and receptor signaling assays Chem Res Toxicol 26: 878-895.</p>\n\n<p>Stankunas K, Ma GK, Kuhnert FJ, Kuo CJ, Chang CP. VEGF signaling has distinct spatiotemporal roles during heart valve development. Developmental biology. 2010;347(2):325-36.</p>\n\n<p>Tal TL, McCollum CW, Harris PS, Olin J, Kleinstreuer N, Wood CE, Hans C, Shah S, Merchant FA, Bondesson M, Knudsen TB, Padilla S and Hemmer MJ. Immediate and long-term consequences of vascular toxicity during zebrafish development. Reprod Toxicol. 2014; 48: 51-61. PMID:24907688.</p>\n\n<p>van den Akker NM, Molin DG, Peters PP, Maas S, Wisse LJ, van Brempt R, et al. Tetralogy of fallot and alterations in vascular endothelial growth factor-A signaling and notch signaling in mouse embryos solely expressing the VEGF120 isoform. Circulation research. 2007;100(6):842-9.</p>\n\n<p>Williams CK, Li JL, Murga M, Harris AL, Tosato G. Up-regulation of the Notch ligand Delta-like 4 inhibits VEGF-induced endothelial cell function. Blood. 2006;107(3):931-9.</p>\n\n<p>Wood JM, Bold G, Buchdunger E, Cozens R, Ferrari S, Frei J, Hofmann F, Mestan J, Mett H, O&#39;Reilly T, Persohn E, R&ouml;sel J, Schnell C, Stover D, Theuer A, Towbin H, Wenger F, Woods-Cook K, Menrad A, Siemeister G, Schirner M, Thierauch KH, Schneider MR, Drevs J, Martiny-Baron G, Totzke F (2000) PTK787/ZK 222584, a novel and potent inhibitor of vascular endothelial growth factor receptor tyrosine kinases, impairs vascular endothelial growth factor-induced responses and tumor growth after oral administration. Cancer Res 60: 2178-2189.</p>\n\n<p>Xia M, Bi K, Huang R, Cho MH, Sakamuru S, Miller SC, et al. Identification of small molecule compounds that inhibit the HIF-1 signaling pathway. Molecular cancer. 2009;8:117.</p>\n\n<p>Yabu T, Tomimoto H, Taguchi Y, Yamaoka S, Igarashi Y, Okazaki T. Thalidomide-induced antiangiogenic action is mediated by ceramide through depletion of VEGF receptors, and is antagonized by sphingosine-1-phosphate. Blood. 2005;106(1):125-34.</p>\n\n<p>&nbsp;</p>\n","biologicalOrganisationLevel":"Molecular","organTerm":{},"biologicalEvents":[{"action":"decreased","process":"vascular endothelial growth factor receptor 2 binding","object":{"name":"vascular endothelial growth factor receptor 2","source":"PR","sourceId":"PR:000002112"}},{"action":"decreased","process":"vascular endothelial growth factor receptor 2 binding","object":{"name":"vascular endothelial growth factor receptor 1","source":"PR","sourceId":"PR:000007563"}}],"keyEventStressors":["Vatalanib","Sunitinib malate Sunitinib (INN)"],"id":305}
{"title":"Inhibition, VegfR2","references":"<p>Argraves WS, Larue AC, Fleming PA, Drake CJ. VEGF signaling is required for the assembly but not the maintenance of embryonic blood vessels. Developmental dynamics&nbsp;: an official publication of the American Association of Anatomists. 2002;225(3):298-304.</p>\n\n<p>Belair DG, Schwartz MP, Knudsen T and Murphy WL. Human iPSC-derived endothelial cell sprouting assay in synthetic hydrogel arrays. Acta Biomater. 2016; 39: 12-24. PMID:27181878.</p>\n\n<p>Bhattacharya R1, Kwon J, Li X, Wang E, Patra S, Bida JP, Bajzer Z, Claesson-Welsh L and Mukhopadhyay D (2009) Distinct role of PLCbeta3 in VEGF-mediated directional migration and vascular sprouting. J Cell Sci. 122: 1025-1034.</p>\n\n<p>Carmellet P, Ferreira V, Breier G, Pollefeyt S, Kleckens L, Gertsenstein M, Fahrig M, Vandenhoeck A, Harpal K, Eberhardt C, Declercq C, Pawlling J, Moons L, Collen D, Resau W, Nagy A (1996) Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele. Nature 380: 435&ndash;439.</p>\n\n<p>Chan J, Bayliss PE, Wood JM, Roberts TM (2002) Dissection of angiogenic signaling in zebrafish using a chemical genetic approach. Cancer Cell. 1: 257-267. (Note: this paper describes the use of Vatalanib to inhibit VEGFR; PTK787 is a synonym for Vatalanib.)</p>\n\n<p>Chappell JC, Taylor SM, Ferrara N, Bautch VL. Local guidance of emerging vessel sprouts requires soluble Flt-1. Developmental cell. 2009;17(3):377-86.</p>\n\n<p>Chen DB, Zheng J. Regulation of placental angiogenesis. Microcirculation (New York, NY&nbsp;: 1994). 2014;21(1):15-25. Douglas NC, Tang H, Gomez R, Pytowski B, Hicklin DJ, Sauer CM, et al. Vascular endothelial growth factor receptor 2 (VEGFR-2) functions to promote uterine decidual angiogenesis during early pregnancy in the mouse. Endocrinology. 2009;150(8):3845-54.</p>\n\n<p>Dorrell MI, Aguilar E, Friedlander M. Retinal vascular development is mediated by endothelial filopodia, a preexisting astrocytic template and specific R-cadherin adhesion. Investigative ophthalmology &amp; visual science. 2002;43(11):3500-10.</p>\n\n<p>Eichmann A, Thomas JL. Molecular parallels between neural and vascular development. Cold Spring Harbor perspectives in medicine. 2013;3(1):a006551. Habeck H, Odenthal J, Walderich B, Maischein H, Schulte-Merker S. Analysis of a zebrafish VEGF receptor mutant reveals specific disruption of angiogenesis. Current biology&nbsp;: CB. 2002;12(16):1405-12.</p>\n\n<p>Ferrara N, Carver-Moore K, Chen H, Dowd M, Lu L, O&rsquo;Shea KS, Powell-Braxton L, Hillan KJ, Moore MW (1996) Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene. Nature. 380: 439&ndash;442.</p>\n\n<p>Fischer et. al (2008) Nat Rev Cancer 8: 942&ndash;956.</p>\n\n<p>Fong GH, Rossant J, Gertsenstein M, Breitman ML (1995) Role of the Flt-1 receptor tyrosine kinase in regulating the assembly of vascular endothelium. Nature 376: 66-70.</p>\n\n<p>Gustafsdottir SM, Wennstrom S, Fredriksson S, Schallmeiner E, Hamilton AD, Sebti SM and Landegren U (2008) Use of proximity ligation to screen for inhibitors of interactions between vascular endothelial growth factor A and its receptors. Clinical Chem 54: 1218-1225.</p>\n\n<p>Hiratsuka S, Minowa O, Kuno J, Noda T, Shibuya M (1998) Flt-1 lacking the tyrosine kinase domain is sufficient for normal development and angiogenesis in mice. Proc Natl Acad Sci USA 95: 9349-9354.</p>\n\n<p>Hogan KA, Ambler CA, Chapman DL, Bautch VL. The neural tube patterns vessels developmentally using the VEGF signaling pathway. Development (Cambridge, England). 2004;131(7):1503-13.</p>\n\n<p>Jang GH, Park IS, Lee SH, Huh TL, Lee YM. Malachite green induces cardiovascular defects in developing zebrafish (Danio rerio) embryos by blocking VEGFR-2 signaling. Biochemical and biophysical research communications. 2009;382(3):486-91.</p>\n\n<p>Kendall RL, Rutledge RZ, Mao X, Tebben AJ, Hungate RW and Thomas KA (1999) J Biol Chem 274: 6453-6460.</p>\n\n<p>Kleinstreuer N, Dix D, Rountree M, Baker N, Sipes N, Reif D, Spencer R and Knudsen T (2013) A computational model predicting disruption of blood vessel development. PLoS Comp Biol 9(4): 1-20. e1002996.</p>\n\n<p>Kleinstreuer NC, Judson RS, Reif DM, Sipes NS, Singh AV, Chandler KJ, DeWoskin R, Dix D, Kavlock R and Knudsen TB (2011) Environmental impact on vascular development predicted by high-throughput screening. Environmental Hlth Persp 119: 1596-1603.</p>\n\n<p>Kleinstreuer N, Yang J, Berg E, Knudsen T, Richard A, Martin M, Reif D, Judson R, Polokoff M, Kavlock R, Dix D and Houck K (2014) Phenotypic screening of the ToxCast chemical library to classify toxic and therapeutic mechanisms. Nature Biotech 32: 583-591.</p>\n\n<p>Knudsen TB, Houck K, Sipes NS, Judson RS, Singh AV, Weissman A, Kleinstreuer NC, Mortensen H, Reif D, Setzer RW, Martin MT, Richard A, Dix DJ, and Kavlock RJ (2011) Activity profiles of 320 ToxCast&trade; chemicals evaluated Across 292 biochemical targets. Toxicology 282: 1-15</p>\n\n<p>Knudsen TB, Kleinstreuer NC (2011). Disruption of embryonic vascular development in predictive toxicology. Birth defects research Part C 93: 312-323.</p>\n\n<p>Ligi I, Simoncini S, Tellier E, Grandvuillemin I, Marcelli M, Bikfalvi A, et al. Altered angiogenesis in low birth weight individuals: a role for anti-angiogenic circulating factors. The journal of maternal-fetal &amp; neonatal medicine&nbsp;: the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstet. 2014;27(3):233-8.</p>\n\n<p>Liu H, Yang Q, Radhakrishnan K, Whitfield DE, Everhart CL, Parsons-Wingerter P, et al. Role of VEGF and tissue hypoxia in patterning of neural and vascular cells recruited to the embryonic heart. Developmental dynamics&nbsp;: an official publication of the American Association of Anatomists. 2009;238(11):2760-9.</p>\n\n<p>Nimmagadda S, Geetha Loganathan P, Huang R, Scaal M, Schmidt C, Christ B. BMP4 and noggin control embryonic blood vessel formation by antagonistic regulation of VEGFR-2 (Quek1) expression. Developmental biology. 2005;280(1):100-10.</p>\n\n<p>Roberts DM, Kearney JB, Johnson JH, Rosenberg MP, Kumar R, Bautch VL. The vascular endothelial growth factor (VEGF) receptor Flt-1 (VEGFR-1) modulates Flk-1 (VEGFR-2) signaling during blood vessel formation. The American journal of pathology. 2004;164(5):1531-5.</p>\n\n<p>Saili KS, Franzosa JA, Baker NC, Ellis-Hutchings RG, Settivari RS, Carney EW, Spencer R, Zurlinden TJ, Kleinstreuer NC, Li S, Xia M and Knudsen TB. Systems Modeling of Developmental Vascular Toxicity. Curr Opin Toxicol. 2019; 15(1): 55-63. PMID:32030360.</p>\n\n<p>Shalaby F, Rossant J, Yamaguchi TP, Gertsenstein M, Wu XF, Breitman ML, Schuh AC (1995) Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice. Nature 376: 62-66.</p>\n\n<p>Shibuya M (2013) Vascular endothelial growth factor and its receptor system: physiological functions in angiogenesis and pathological roles in various diseases. J Biochem. 153: 13-19.</p>\n\n<p>Shirinifard A, McCollum CW, Bolin MB, Gustafsson JA, Glazier JA, Clendenon SG. 3D quantitative analyses of angiogenic sprout growth dynamics. Developmental dynamics&nbsp;: an official publication of the American Association of Anatomists. 2013;242(5):518-26.</p>\n\n<p>Sipes NS, Martin MT, Kothiya P, Reif DM, Judson R, Richard A, Houck KA, Dix DJ, Kavlock RJ and Knudsen TB (2013) Profiling 976 ToxCast chemicals across 331 enzymatic and receptor signaling assays Chem Res Toxicol 26: 878-895.</p>\n\n<p>Stankunas K, Ma GK, Kuhnert FJ, Kuo CJ, Chang CP. VEGF signaling has distinct spatiotemporal roles during heart valve development. Developmental biology. 2010;347(2):325-36.</p>\n\n<p>Tal TL, McCollum CW, Harris PS, Olin J, Kleinstreuer N, Wood CE, Hans C, Shah S, Merchant FA, Bondesson M, Knudsen TB, Padilla S and Hemmer MJ. Immediate and long-term consequences of vascular toxicity during zebrafish development. Reprod Toxicol. 2014; 48: 51-61. PMID:24907688.</p>\n\n<p>van den Akker NM, Molin DG, Peters PP, Maas S, Wisse LJ, van Brempt R, et al. Tetralogy of fallot and alterations in vascular endothelial growth factor-A signaling and notch signaling in mouse embryos solely expressing the VEGF120 isoform. Circulation research. 2007;100(6):842-9.</p>\n\n<p>Williams CK, Li JL, Murga M, Harris AL, Tosato G. Up-regulation of the Notch ligand Delta-like 4 inhibits VEGF-induced endothelial cell function. Blood. 2006;107(3):931-9.</p>\n\n<p>Wood JM, Bold G, Buchdunger E, Cozens R, Ferrari S, Frei J, Hofmann F, Mestan J, Mett H, O&#39;Reilly T, Persohn E, R&ouml;sel J, Schnell C, Stover D, Theuer A, Towbin H, Wenger F, Woods-Cook K, Menrad A, Siemeister G, Schirner M, Thierauch KH, Schneider MR, Drevs J, Martiny-Baron G, Totzke F (2000) PTK787/ZK 222584, a novel and potent inhibitor of vascular endothelial growth factor receptor tyrosine kinases, impairs vascular endothelial growth factor-induced responses and tumor growth after oral administration. Cancer Res 60: 2178-2189.</p>\n\n<p>Xia M, Bi K, Huang R, Cho MH, Sakamuru S, Miller SC, et al. Identification of small molecule compounds that inhibit the HIF-1 signaling pathway. Molecular cancer. 2009;8:117.</p>\n\n<p>Yabu T, Tomimoto H, Taguchi Y, Yamaoka S, Igarashi Y, Okazaki T. Thalidomide-induced antiangiogenic action is mediated by ceramide through depletion of VEGF receptors, and is antagonized by sphingosine-1-phosphate. Blood. 2005;106(1):125-34.</p>\n\n<p>&nbsp;</p>\n","biologicalOrganisationLevel":"Molecular","organTerm":{},"biologicalEvents":[{"action":"decreased","process":"vascular endothelial growth factor receptor 2 binding","object":{"name":"vascular endothelial growth factor receptor 2","source":"PR","sourceId":"PR:000002112"}},{"action":"decreased","process":"vascular endothelial growth factor receptor 2 binding","object":{"name":"vascular endothelial growth factor receptor 1","source":"PR","sourceId":"PR:000007563"}}],"keyEventStressors":["Vatalanib","Sunitinib malate Sunitinib (INN)"],"id":305}
{"title":"Reduction, Angiogenesis","references":"<p>Belair DG, Schwartz MP, Knudsen T and Murphy WL. Human iPSC-derived endothelial cell sprouting assay in synthetic hydrogel arrays. Acta Biomater. 2016; 39: 12-24. PMID:27181878.</p>\n\n<p>Knudsen TB, Kleinstreuer NC. Disruption of embryonic vascular development in predictive toxicology. Birth defects research Part C, Embryo today: reviews. 2011 Dec;93(4):312-23. PubMed PMID: 22271680.</p>\n\n<p>Lamalice L, Le Boeuf F and Huot J. Endothelial cell migration during angiogenesis. Circ Res. 2007 Mar 30;100(6):782-94.</p>\n\n<p>Eilken HM and Adams RH. Dynamics of endothelial cell behavior in sprouting angiogenesis. Curr Opin Cell Biol. 2010 Oct;22(5):617-25. doi: 10.1016/j.ceb.2010.08.010.</p>\n\n<p>Shirinifard A, McCollum CW, Bondesson MB, Gustafsson JA, Glazier JA and Clendenon SG. 3D Quantitative analyses of angiogenic sprout growth dynamics Devel Dynam. 2013 242(5): 518-526.</p>\n\n<p>Tal T, Kilty C, Smith A, LaLone C, Kennedy B, Tennant A, McCollum CW, Bondesson M, Knudsen T, Padilla S and Kleinstreuer N. Screening for angiogenic inhibitors in zebrafish to evaluate a predictive model for developmental vascular toxicity. Reprod Toxicol. 2017; 70: 70-81. PMID:28007540.</p>\n\n<p>&nbsp;</p>\n","biologicalOrganisationLevel":"Molecular","organTerm":{},"biologicalEvents":[{"action":"decreased","process":"angiogenesis","object":{}}],"id":28}
{"title":"Impairment, Endothelial network","references":"<p>Bishop ET, Bell GT, Bloor S, Broom IJ, Hendry NFK and Wheatley DN. An in vitro model of angiogenesis: Basic features. Angiogenesis. 1999 3(4): 335-344.</p>\n\n<p>Chung AS, Ferrara N. Developmental and pathological angiogenesis. Annual review of cell and developmental biology. 2011;27:563-84. PubMed PMID: 21756109.</p>\n\n<p>Coultas L, Chawengsaksophak K, Rossant J. Endothelial cells and VEGF in vascular development. Nature. 2005 Dec 15;438(7070):937-45. PubMed PMID: 16355211.</p>\n\n<p>Hanahan D. Signaling vascular morphogenesis and maintenance. Science. 1997 Jul 4;277(5322):48-50. PubMed PMID: 9229772.</p>\n\n<p>Knudsen TB, Kleinstreuer NC. Disruption of embryonic vascular development in predictive toxicology. Birth defects research Part C, Embryo today&nbsp;: reviews. 2011;93(4):312-23.</p>\n\n<p>Masckauchan TN, Shawber CJ, Funahashi Y, Li CM, Kitajewski J. Wnt/beta-catenin signaling induces proliferation, survival and interleukin-8 in human endothelial cells. Angiogenesis. 2005;8(1):43-51. PubMed PMID: 16132617.</p>\n\n<p>McCollum CW, Conde-Vancells J, Hans C, Vazquez-Chantada M, Kleinstreuer N, Tal T, Knudsen T, Shah SS, Merchant FA, Finnell RH, Gustafsson JA, Cabrera R and Bondesson M. Identification of vascular disruptor compounds by analysis in zebrafish embryos and mouse embryonic endothelial cells. Reprod Toxicol. 2017; 70: 60-69. PMID:27838387.</p>\n\n<p>Muller T, Bain G, Wang X, Papkoff J. Regulation of epithelial cell migration and tumor formation by beta-catenin signaling. Experimental cell research. 2002 Oct 15;280(1):119-33. PubMed PMID: 12372345.</p>\n\n<p>Nguyen EH, Daly WT, Le NNT, Farnoodian M, Belair DG, Schwartz MP, Lebakken CS, Ananiev GE, Saghiri MA, Knudsen TB, Sheibani N and Murphy WL. Versatile synthetic alternatives to Matrigel for vascular toxicity screening and stem cell expansion. Nat Biomed Eng. 2017; 1 PMID:29104816.</p>\n\n<p>Saili KS, Franzosa JA, Baker NC, Ellis-Hutchings RG, Settivari RS, Carney EW, Spencer R, Zurlinden TJ, Kleinstreuer NC, Li S, Xia M and Knudsen TB. Systems Modeling of Developmental Vascular Toxicity. Curr Opin Toxicol. 2019; 15(1): 55-63. PMID:32030360.</p>\n\n<p><span style=\"font-size:12pt\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Segoe UI&quot;,sans-serif\"><span style=\"color:#212529\">Sarkanen JR, Mannerstrom M, Vuorenpaa H, Uotila J, Ylikomi T, Heinonen T. Intra-Laboratory Pre-Validation of a Human Cell Based in vitro Angiogenesis Assay for Testing Angiogenesis Modulators. Frontiers in pharmacology. 2010;1:147.</span></span></span></span></span></p>\n\n<p>Tal T, Kilty C, Smith A, LaLone C, Kennedy B, Tennant A, McCollum CW, Bondesson M, Knudsen T, Padilla S and Kleinstreuer N. Screening for angiogenic inhibitors in zebrafish to evaluate a predictive model for developmental vascular toxicity. Reprod Toxicol. 2017; 70: 70-81. PMID:28007540.</p>\n\n<p>Vargesson N. Vascularization of the developing chick limb bud: role of the TGF&beta; signalling pathway. J Anat. 2016 Jan, 202(1): 93-103. PMCID: PMC1571066.</p>\n\n<p>Zurlinden TJ, Saili KS, Baker NC, Toimela T, Heinonen T and Knudsen TB. A cross-platform approach to characterize and screen potential neurovascular unit toxicants. Reprod Toxicol. 2020; 96: 300-315. PMID:32590145.</p>\n","biologicalOrganisationLevel":"Cellular","organTerm":{"name":"embryo","sourceId":"UBERON:0000922"},"biologicalEvents":[{"action":"abnormal","process":"endothelium development","object":{}}],"id":110}
{"title":"Insufficiency, Vascular","references":"<p><span style=\"font-size:12pt\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Segoe UI&quot;,sans-serif\"><span style=\"color:#212529\">Chung AS, Ferrara N. Developmental and pathological angiogenesis. Annual review of cell and developmental biology. 2011;27:563-84. PubMed PMID: 21756109.</span></span></span></span></span></p>\n\n<p><span style=\"font-size:12pt\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Segoe UI&quot;,sans-serif\"><span style=\"color:#212529\">Clendenon SG, Sankaran DG, Shirinifard A, McColluma CW, Bondesson MB, Gustafssona JA and Glazier JA. Arsenic exposure inhibits angiogenesis in zebrafish via downregulation of both VEGFA and VEGFR2. Microscopy and Microanalysis. 2013 19(S2): 778-779.</span></span></span></span></span></p>\n\n<p><span style=\"font-size:12pt\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Segoe UI&quot;,sans-serif\"><span style=\"color:#212529\">Ellis-Hutchings RG, Settivari RS, McCoy AT, Kleinstreuer N, Franzosa J, Knudsen TB and Carney EW. Embryonic vascular disruption adverse outcomes: Linking high throughput signaling signatures with functional consequences. Reprod Toxicol. 2017; 70: 82-96. PMID:28527947.</span></span></span></span></span></p>\n\n<p><span style=\"font-size:12pt\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Segoe UI&quot;,sans-serif\"><span style=\"color:#212529\">Eshkar-Oren I, Krief S, Ferrara N, Elliott AM, Zelzer E. Vascular patterning regulates interdigital cell death by a ROS-mediated mechanism. Development (Cambridge, England). 2015 Feb 15;142(4):672-80. PubMed PMID: 25617432.</span></span></span></span></span></p>\n\n<p><span style=\"font-size:12pt\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Segoe UI&quot;,sans-serif\"><span style=\"color:#212529\">Jin SW, Beis D, Mitchell T, Chen JN,Stainier DY. Cellular and molecular analyses of vascular tube and lumen formation in zebrafish. Development. 2005 132: 5199-209.</span></span></span></span></span></p>\n\n<p><span style=\"font-size:12pt\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Segoe UI&quot;,sans-serif\"><span style=\"color:#212529\">Kleinstreuer NC, Judson RS, Reif DM, Sipes NS, Singh AV, Chandler KJ, et al. Environmental impact on vascular development predicted by high-throughput screening. Environmental health perspectives. 2011 Nov;119(11):1596-603. PubMed PMID: 21788198. Pubmed Central PMCID: PMC3226499.</span></span></span></span></span></p>\n\n<p><span style=\"font-size:12pt\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Segoe UI&quot;,sans-serif\"><span style=\"color:#212529\">Knudsen TB, Kleinstreuer NC. Disruption of embryonic vascular development in predictive toxicology. Birth defects research Part C, Embryo today&nbsp;: reviews. 2011 Dec;93(4):312-23. PubMed PMID: 22271680.</span></span></span></span></span></p>\n\n<p><span style=\"font-size:12pt\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Segoe UI&quot;,sans-serif\"><span style=\"color:#212529\">Maltepe E, Schmidt JV, Baunoch D, Bradfield CA, Simon MC. Abnormal angiogenesis and responses to glucose and oxygen deprivation in mice lacking the protein ARNT. Nature. 1997 Mar 27;386(6623):403-7. PubMed PMID: 9121557.</span></span></span></span></span></p>\n\n<p><span style=\"font-size:12pt\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Segoe UI&quot;,sans-serif\"><span style=\"color:#212529\">McCollum CW, Conde-Vancells J, Hans C, Vazquez-Chantada M, Kleinstreuer N, Tal T, Knudsen T, Shah SS, Merchant FA, Finnell RH, Gustafsson JA, Cabrera R and Bondesson M. Identification of vascular disruptor compounds by analysis in zebrafish embryos and mouse embryonic endothelial cells. Reprod Toxicol. 2017; 70: 60-69. PMID:27838387.</span></span></span></span></span></p>\n\n<p><span style=\"font-size:12pt\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Segoe UI&quot;,sans-serif\"><span style=\"color:#212529\">Saili KS, Franzosa JA, Baker NC, Ellis-Hutchings RG, Settivari RS, Carney EW, Spencer R, Zurlinden TJ, Kleinstreuer NC, Li S, Xia M and Knudsen TB. Systems Modeling of Developmental Vascular Toxicity. Curr Opin Toxicol. 2019; 15(1): 55-63. PMID:32030360.</span></span></span></span></span></p>\n\n<p><span style=\"font-size:12pt\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Segoe UI&quot;,sans-serif\"><span style=\"color:#212529\">Shirinifard A, McCollum CW, Bondesson MB, Gustafsson JA, Glazier JA and Clendenon SG. 3D Quantitative analyses of angiogenic sprout growth dynamics Devel Dynam. 2013 242(5): 518-526.</span></span></span></span></span></p>\n\n<p><span style=\"font-size:12pt\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Segoe UI&quot;,sans-serif\"><span style=\"color:#212529\">Tal T, Kilty C, Smith A, LaLone C, Kennedy B, Tennant A, McCollum CW, Bondesson M, Knudsen T, Padilla S and Kleinstreuer N. Screening for angiogenic inhibitors in zebrafish to evaluate a predictive model for developmental vascular toxicity. Reprod Toxicol. 2017; 70: 70-81. PMID:28007540.</span></span></span></span></span></p>\n\n<p><span style=\"font-size:12pt\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Segoe UI&quot;,sans-serif\"><span style=\"color:#212529\">Tal TL, McCollum CW, Harris PS, Olin J, Kleinstreuer N, Wood CE, Hans C, Shah S, Merchant FA, Bondesson M, Knudsen TB, Padilla S and Hemmer MJ. Immediate and long-term consequences of vascular toxicity during zebrafish development. Reproductive Toxicology. 2014;48:51-61.</span></span></span></span></span></p>\n\n<p><span style=\"font-size:12pt\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Segoe UI&quot;,sans-serif\"><span style=\"color:#212529\">Therapontos C, Erskine L, Gardner ER, Figg WD, Vargesson N. Thalidomide induces limb defects by preventing angiogenic outgrowth during early limb formation. Proceedings of the National Academy of Sciences of the United States of America. 2009 May 26;106(21):8573-8. PubMed PMID: 19433787. Pubmed Central PMCID: 2688998.</span></span></span></span></span></p>\n\n<p><span style=\"font-size:12pt\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Segoe UI&quot;,sans-serif\"><span style=\"color:#212529\">Tran TC, Sneed B, Haider J, Blavo D, White A, Aiyejorun T, et al. Automated, quantitative screening assay for antiangiogenic compounds using transgenic zebrafish. Cancer research. 2007;67: 11386-92.</span></span></span></span></span></p>\n\n<p><span style=\"font-size:12pt\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Segoe UI&quot;,sans-serif\"><span style=\"color:#212529\">van Gelder MM, van Rooij IA, Miller RK, Zielhuis GA, de Jong-van den Berg LT, Roeleveld N. Teratogenic mechanisms of medical drugs. Human reproduction update. 2010 Jul-Aug;16(4):378-94. PubMed PMID: 20061329.</span></span></span></span></span></p>\n\n<p><span style=\"font-size:12pt\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Segoe UI&quot;,sans-serif\"><span style=\"color:#212529\">Vargesson N. Thalidomide-induced teratogenesis: history and mechanisms. Birth defects Research Part C, Embryo today: reviews. 2015 Jun;105(2):140-56. PubMed PMID: 26043938.</span></span></span></span></span></p>\n\n<p><span style=\"font-size:12pt\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Segoe UI&quot;,sans-serif\"><span style=\"color:#212529\">Yozzo KL, Isales GM, Raftery TD,Volz DC. High-content screening assay for identification of chemicals impacting cardiovascular function in zebrafish embryos. Environmental science &amp; technology. 2013;47: 11302-10.</span></span></span></span></span></p>\n\n<p>&nbsp;</p>\n\n<p>&nbsp;</p>\n","biologicalOrganisationLevel":"Molecular","organTerm":{"name":"embryo","sourceId":"UBERON:0000922"},"biologicalEvents":[{"action":"decreased","process":"blood circulation","object":{"name":"blood","source":"UBERON","sourceId":"UBERON:0000178"}},{"action":"abnormal","object":{"name":"capillary plexus","source":"UBERON","sourceId":"UBERON:0035753"}}],"id":298}
{"title":"Insufficiency, Vascular","references":"<p><span style=\"font-size:12pt\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Segoe UI&quot;,sans-serif\"><span style=\"color:#212529\">Chung AS, Ferrara N. Developmental and pathological angiogenesis. Annual review of cell and developmental biology. 2011;27:563-84. PubMed PMID: 21756109.</span></span></span></span></span></p>\n\n<p><span style=\"font-size:12pt\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Segoe UI&quot;,sans-serif\"><span style=\"color:#212529\">Clendenon SG, Sankaran DG, Shirinifard A, McColluma CW, Bondesson MB, Gustafssona JA and Glazier JA. Arsenic exposure inhibits angiogenesis in zebrafish via downregulation of both VEGFA and VEGFR2. Microscopy and Microanalysis. 2013 19(S2): 778-779.</span></span></span></span></span></p>\n\n<p><span style=\"font-size:12pt\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Segoe UI&quot;,sans-serif\"><span style=\"color:#212529\">Ellis-Hutchings RG, Settivari RS, McCoy AT, Kleinstreuer N, Franzosa J, Knudsen TB and Carney EW. Embryonic vascular disruption adverse outcomes: Linking high throughput signaling signatures with functional consequences. Reprod Toxicol. 2017; 70: 82-96. PMID:28527947.</span></span></span></span></span></p>\n\n<p><span style=\"font-size:12pt\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Segoe UI&quot;,sans-serif\"><span style=\"color:#212529\">Eshkar-Oren I, Krief S, Ferrara N, Elliott AM, Zelzer E. Vascular patterning regulates interdigital cell death by a ROS-mediated mechanism. Development (Cambridge, England). 2015 Feb 15;142(4):672-80. PubMed PMID: 25617432.</span></span></span></span></span></p>\n\n<p><span style=\"font-size:12pt\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Segoe UI&quot;,sans-serif\"><span style=\"color:#212529\">Jin SW, Beis D, Mitchell T, Chen JN,Stainier DY. Cellular and molecular analyses of vascular tube and lumen formation in zebrafish. Development. 2005 132: 5199-209.</span></span></span></span></span></p>\n\n<p><span style=\"font-size:12pt\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Segoe UI&quot;,sans-serif\"><span style=\"color:#212529\">Kleinstreuer NC, Judson RS, Reif DM, Sipes NS, Singh AV, Chandler KJ, et al. Environmental impact on vascular development predicted by high-throughput screening. Environmental health perspectives. 2011 Nov;119(11):1596-603. PubMed PMID: 21788198. Pubmed Central PMCID: PMC3226499.</span></span></span></span></span></p>\n\n<p><span style=\"font-size:12pt\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Segoe UI&quot;,sans-serif\"><span style=\"color:#212529\">Knudsen TB, Kleinstreuer NC. Disruption of embryonic vascular development in predictive toxicology. Birth defects research Part C, Embryo today&nbsp;: reviews. 2011 Dec;93(4):312-23. PubMed PMID: 22271680.</span></span></span></span></span></p>\n\n<p><span style=\"font-size:12pt\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Segoe UI&quot;,sans-serif\"><span style=\"color:#212529\">Maltepe E, Schmidt JV, Baunoch D, Bradfield CA, Simon MC. Abnormal angiogenesis and responses to glucose and oxygen deprivation in mice lacking the protein ARNT. Nature. 1997 Mar 27;386(6623):403-7. PubMed PMID: 9121557.</span></span></span></span></span></p>\n\n<p><span style=\"font-size:12pt\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Segoe UI&quot;,sans-serif\"><span style=\"color:#212529\">McCollum CW, Conde-Vancells J, Hans C, Vazquez-Chantada M, Kleinstreuer N, Tal T, Knudsen T, Shah SS, Merchant FA, Finnell RH, Gustafsson JA, Cabrera R and Bondesson M. Identification of vascular disruptor compounds by analysis in zebrafish embryos and mouse embryonic endothelial cells. Reprod Toxicol. 2017; 70: 60-69. PMID:27838387.</span></span></span></span></span></p>\n\n<p><span style=\"font-size:12pt\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Segoe UI&quot;,sans-serif\"><span style=\"color:#212529\">Saili KS, Franzosa JA, Baker NC, Ellis-Hutchings RG, Settivari RS, Carney EW, Spencer R, Zurlinden TJ, Kleinstreuer NC, Li S, Xia M and Knudsen TB. Systems Modeling of Developmental Vascular Toxicity. Curr Opin Toxicol. 2019; 15(1): 55-63. PMID:32030360.</span></span></span></span></span></p>\n\n<p><span style=\"font-size:12pt\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Segoe UI&quot;,sans-serif\"><span style=\"color:#212529\">Shirinifard A, McCollum CW, Bondesson MB, Gustafsson JA, Glazier JA and Clendenon SG. 3D Quantitative analyses of angiogenic sprout growth dynamics Devel Dynam. 2013 242(5): 518-526.</span></span></span></span></span></p>\n\n<p><span style=\"font-size:12pt\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Segoe UI&quot;,sans-serif\"><span style=\"color:#212529\">Tal T, Kilty C, Smith A, LaLone C, Kennedy B, Tennant A, McCollum CW, Bondesson M, Knudsen T, Padilla S and Kleinstreuer N. Screening for angiogenic inhibitors in zebrafish to evaluate a predictive model for developmental vascular toxicity. Reprod Toxicol. 2017; 70: 70-81. PMID:28007540.</span></span></span></span></span></p>\n\n<p><span style=\"font-size:12pt\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Segoe UI&quot;,sans-serif\"><span style=\"color:#212529\">Tal TL, McCollum CW, Harris PS, Olin J, Kleinstreuer N, Wood CE, Hans C, Shah S, Merchant FA, Bondesson M, Knudsen TB, Padilla S and Hemmer MJ. Immediate and long-term consequences of vascular toxicity during zebrafish development. Reproductive Toxicology. 2014;48:51-61.</span></span></span></span></span></p>\n\n<p><span style=\"font-size:12pt\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Segoe UI&quot;,sans-serif\"><span style=\"color:#212529\">Therapontos C, Erskine L, Gardner ER, Figg WD, Vargesson N. Thalidomide induces limb defects by preventing angiogenic outgrowth during early limb formation. Proceedings of the National Academy of Sciences of the United States of America. 2009 May 26;106(21):8573-8. PubMed PMID: 19433787. Pubmed Central PMCID: 2688998.</span></span></span></span></span></p>\n\n<p><span style=\"font-size:12pt\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Segoe UI&quot;,sans-serif\"><span style=\"color:#212529\">Tran TC, Sneed B, Haider J, Blavo D, White A, Aiyejorun T, et al. Automated, quantitative screening assay for antiangiogenic compounds using transgenic zebrafish. Cancer research. 2007;67: 11386-92.</span></span></span></span></span></p>\n\n<p><span style=\"font-size:12pt\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Segoe UI&quot;,sans-serif\"><span style=\"color:#212529\">van Gelder MM, van Rooij IA, Miller RK, Zielhuis GA, de Jong-van den Berg LT, Roeleveld N. Teratogenic mechanisms of medical drugs. Human reproduction update. 2010 Jul-Aug;16(4):378-94. PubMed PMID: 20061329.</span></span></span></span></span></p>\n\n<p><span style=\"font-size:12pt\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Segoe UI&quot;,sans-serif\"><span style=\"color:#212529\">Vargesson N. Thalidomide-induced teratogenesis: history and mechanisms. Birth defects Research Part C, Embryo today: reviews. 2015 Jun;105(2):140-56. PubMed PMID: 26043938.</span></span></span></span></span></p>\n\n<p><span style=\"font-size:12pt\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Segoe UI&quot;,sans-serif\"><span style=\"color:#212529\">Yozzo KL, Isales GM, Raftery TD,Volz DC. High-content screening assay for identification of chemicals impacting cardiovascular function in zebrafish embryos. Environmental science &amp; technology. 2013;47: 11302-10.</span></span></span></span></span></p>\n\n<p>&nbsp;</p>\n\n<p>&nbsp;</p>\n","biologicalOrganisationLevel":"Molecular","organTerm":{"name":"embryo","sourceId":"UBERON:0000922"},"biologicalEvents":[{"action":"decreased","process":"blood circulation","object":{"name":"blood","source":"UBERON","sourceId":"UBERON:0000178"}},{"action":"abnormal","object":{"name":"capillary plexus","source":"UBERON","sourceId":"UBERON:0035753"}}],"id":298}
{"title":"Increased, Developmental Defects","references":"<p>Friedman JM. The principles of teratology: are they still true? Birth Defects Res A. 2010 Oct;88(10):766-8. doi: 10.1002/bdra.20697.</p>\n\n<p>Janer G, Slob W, Hakkert BC, Vermeire T and Piersma AH. A retrospective analysis of developmental toxicity studies in rat and rabbit: what is the added value of the rabbit as an additional test species? Regul Toxicol Pharmacol. 2008 50: 206-217.</p>\n\n<p>Hurtt ME, Cappon GD and Browning A. Proposal for a tiered approach to developmental toxicity testing for veterinary pharmaceutical products for food-producing animals. Food Chem Toxicol. 2003 41: 611-619.</p>\n\n<p>Knudsen TB, Martin MT, Kavlock RJ, Judson RS, Dix DJ and Singh AV. Profiling the activity of environmental chemicals in prenatal developmental toxicity studies using the U.S. EPA&#39;s ToxRefDB. Reprod Toxicol. 2009 28: 209-219.</p>\n\n<p>Rorije E, van Hienen FJ, Dang ZC, Hakkert BH, Vermeire T and Piersma AH. Relative parameter sensitivity in prenatal toxicity studies with substances classified as developmental toxicants. Reprod Toxicol. 2012 34: 284-290.</p>\n\n<p>Schardein J. Chemically Induced Birth Defects. 2000. New York, Marcel Decker Inc.</p>\n\n<p>Theunissen PT, Beken S, Beyer BK, Breslin WJ, Cappon GD, Chen C, Chmielewski G, De Schaepdrijver L, Enright B, Foreman JE, Harrouk W, Hew KW, Hoberman AM, Hui JY, Knudsen TB, Laffan SB, Makris S, Martin M, McNerney ME, Siezen CL, Stanislaus DJ, Stewart J, Thompson KE, Tornesi B, Weinbauer G, Wood S, Van der Laan JW and Piersma AH. Comparison of rat and rabbit embryo-fetal developmental toxicity data for 379 pharmaceuticals: on the nature and severity of developmental effects. Chem Rev Toxicol. 2016 (in revision).</p>\n\n<p>&nbsp;</p>\n","biologicalOrganisationLevel":"Molecular","organTerm":{},"biologicalEvents":[{"action":"morphological change","process":"anatomical structure morphogenesis","object":{}}],"id":1001}
{"title":"Formation, Pro-mutagenic DNA Adducts","references":"<p>Bailey EA, Iyer RS, Stone MP, et al. (1996). Mutational properties of the primary aflatoxin B1-DNA adduct. Proc Natl Acad Sci USA, 93, 1535&ndash;1539.</p>\n\n<p>Bedard L, Alessi, M, Davey SK, Massey TE (2005). Susceptibility to aflatoxin B1-induced carcinogenesis correlates with tissue-specific differences in DNA repair activity in mouse and in rat. Cancer Res 65:1265-1270.</p>\n\n<p>Boysen G, Pachkowski BF, Nakamura J, Swenberg JA. (2009). The formation and biological significance of N7-guanine adducts. Mutat Res, 678, 76&ndash;94.</p>\n\n<p>Brown KL, Deng JZ, Iyer RS, Iyer LG, Voehler MW, Stone MP, Harris CM, Harris TM (2006). Unraveling the aflatoxin-FAPY conundrum: Structural basis of the formamidopyrimidine-type DNA adduct of aflatoxin B1. J Am Chem Soc 128:15188-15199.</p>\n\n<p>Croy RG, Wogan GN (1981a). Temporal patterns of covalent DNA adducts in rat liver after single and multiple doses of aflatoxin B1. Cancer Res 41:197-203.</p>\n\n<p>Croy RG, Wogan GN (1981b). Quantitative comparison of covalent aflatoxin-DNA adducts formed in rat and mouse livers and kidneys. J Natl Cancer Inst 66:761-768.</p>\n\n<p>Croy RG, Essigman JM, Reinhold VN, Wogan GN (1978). Identification of the principal aflatoxin N1-DNA adduct formed in vivo in rat liver. Proc Natl Acad Sci USA 75:1745-1749.</p>\n\n<p>Cupid BC, Lightfoot TJ, Russell D, Grant SJ, Turner PC, Dingley KH, Curtis KD, Leveson SH, Turteltaub KW, Garner RC (2004). The formation of AFB1-macromolecular adducts in rats and humans at dietary levels of exposure. Food Chem Toxicol 42:559-569.</p>\n\n<p>Degen GH, Neumann HG (1981). Differences in aflatoxin B1-susceptibility of rat and mouse are correlated with the capability in vitro to inactivate aflatoxin B1-epoxide. Carcinogenesis 2:299&ndash;306.</p>\n\n<p>Denissenko MF, Koudriakova TB, Smith L, O&#39;Connor TR, Riggs AD, and Pfeifer GP. The p53 codon 249 mutational hotspot in hepatocellular carcinoma is not related to selective formation or persistence of aflatoxin B1 adducts. Oncogene. 1998, Dec 10;17(23):3007-14.</p>\n\n<p>Egner PA, Groopman JD, Wang J-S, Kensler TW, Friesen MD (2006). Quantification of aflatoxin-B1-N7-Guanine in human urine by high-performance liquid chromatography and isotope dilution tandem mass spectrometry. Chem Res Toxicol 19:1191-1195.</p>\n\n<p>Groopman JD, Roebuck BD, Kensler TW. (1992). Molecular dosimetry of aflatoxin DNA adducts in humans and experimental rat models. Prog Clin Biol Res. 374:139-155.</p>\n\n<p>Guengerich FP, Johnson WW, Ueng Y-F, Yamazaki H, Shimada T (1996). Involvement of Cytochrome P450, glutathione S-transferase, and epoxide hydrolase in the metabolism of aflatoxin B1 and relevance to risk of human liver cancer. Environ Health Perspect. 104(Suppl 3):557-562.</p>\n\n<p>Himmelstein MW, Boogaard PJ, Cadet J, et al. (2009). Creating context for the use of DNA adduct data in cancer risk assessment: II.Overview of methods of identification and quantitation of DNA damage. Crit Rev Toxicol, 39, 679&ndash;694.</p>\n\n<p>IARC (1993). Some Naturally Occurring Substances: Food Items and Constituents, Heterocyclic Aromatic Amines and Mycotoxins. IARC Monographs on the Evaluation of Carcinogenic Risk to Humans. Vol. 56, 245-395.</p>\n\n<p>Kensler TW, He X, Otieno M, et al. (1998). Oltipraz chemoprevention trial in Qidong, People&rsquo;s Republic of China: Modulation of serum aflatoxin albumin adduct biomarkers. Cancer Epidemiol Biomarkers Prev, 7, 127&ndash;34.</p>\n\n<p>Lin YC, Li L, Makarova AV, Burgers PM, Stone MP, Lloyd RS. (2014a). Error-prone replication bypass of the primary aflatoxin B1 DNA adduct, AFB1-N7-Gua. J Biol Chem. 289:18497-18506.</p>\n\n<p>Lin YC, Li L, Makarova AV, Burgers PM, Stone MP, Lloyd RS. (2014b). Molecular basis of aflatoxin-induced mutagenesis-role of the aflatoxin B1-formamidopyrimidine adduct. Carcinogenesis 35(7):1461-1468.</p>\n\n<p>Lutz, W. (1987). Quantitative evaluation of DNA-binding data in vivo for low-dose extrapolations. Arch.Toxicol, Suppl. 11: 66-74.</p>\n\n<p>Monroe DH, Eaton DL. (1987). Comparative effects of butylated hydroxyanisole on hepatic in vivo DNA binding and in vitro biotransformation of aflatoxin B1 in the rat and the mouse. Toxicol Appl Pharmacol, 90, 401&ndash;409.</p>\n\n<p>Roebuck BD, Liu Y-L, Rogers AE, et al. (1991). Protection against aflatoxin B1-induced hepatocarcinogenesis in F344 rats by 5-(2-pyrazinyl)-4-methyl-1,2-dithiole-3-thione (oltipraz): predictive role for short term molecular dosimetry. Cancer Res, 51, 5501&ndash;5506.</p>\n\n<p>Smela ME, Hamm ML, Henderson PT, Harris CM, Harris TM, Essigmann JM (2002). The aflatoxin B(1) formamidopyrimidine adduct plays a major role in causing the types of mutations observed in human hepatocellular carcinoma. Proc Natl Acad Sci USA 99:6655-6660.</p>\n\n<p>Swenberg JA, Lu K, Moeller BC, et al. (2011). Endogenous versus exogenous DNA adducts: their role in carcinogenesis, epidemiology, and risk assessment. Tox Sci, 120, S130&ndash;45.</p>\n","biologicalOrganisationLevel":"Molecular","organTerm":{},"biologicalEvents":[{"action":"abnormal","process":"DNA alkylation","object":{"name":"Nuclear deoxyribonucleic acid","source":"FMA","sourceId":"FMA:67194"}}],"keyEventStressors":["Aflatoxin B1"],"id":373}
{"title":"Tumorigenesis, Hepatocellular carcinoma","references":"<p>Caballero F, Meiss R, Gimenez A, Batlle A, Vazquez E (2004) Immunohistochemical analysis of heme oxygenase-1 in preneoplastic and neoplastic lesions during chemical hepatocarcinogenesis. Int J Exp Pathol 85: 213-222.\n</p><p>Higgs MR, Chouteau P, Lerat H (2014) 'Liver let die': oxidative DNA damage and hepatotropic viruses. J Gen Virol 95: 991-1004.\n</p><p>Johnson NM, Egner PA, Baxter VK, Sporn MB, Wible RS, et al (2014) Complete protection against aflatoxin B1-induced liver cancer with triterpenoid: DNA adduct dosimetry, molecular signature and genotoxicity threshold. Cancer Prev Res (Phila) .\n</p><p>Liby KT, Sporn MB (2012) Synthetic oleanane triterpenoids: multifunctional drugs with a broad range of applications for prevention and treatment of chronic disease. Pharmacol Rev 64: 972-1003.\n</p><p>Liby K, Yore MM, Roebuck BD, Baumgartner KJ, Honda T, et al (2008) A novel acetylenic tricyclic bis-(cyano enone) potently induces phase 2 cytoprotective pathways and blocks liver carcinogenesis induced by aflatoxin. Cancer Res 68: 6727-6733.\n</p><p>Moudgil V, Redhu D, Dhanda S, Singh J (2013) A review of molecular mechanisms in the development of hepatocellular carcinoma by aflatoxin and hepatitis B and C viruses. J Environ Pathol Toxicol Oncol 32: 165-175.\n</p><p>Ohnishi S, Ma N, Thanan R, Pinlaor S, Hammam O, et al (2013) DNA damage in inflammation-related carcinogenesis and cancer stem cells. Oxid Med Cell Longev 2013: 387014.\n</p><p>Roebuck BD (2004) Hyperplasia, partial hepatectomy, and the carcinogenicity of aflatoxin B1. J Cell Biochem 91: 243-249.\n</p><p>Shelton P, Jaiswal AK (2013) The transcription factor NF-E2-related factor 2 (Nrf2): a protooncogene? FASEB J 27: 414-423.\n</p><p>U.S. EPA IRIS, (2014) available at <a rel=\"nofollow\" target=\"_blank\" class=\"external free\" href=\"http://www.epa.gov/iris/subst/0294.htm#woe\">http://www.epa.gov/iris/subst/0294.htm#woe</a>\n</p><p>Yates MS, Tauchi M, Katsuoka F, Flanders KC, Liby KT, et al (2007) Pharmacodynamic characterization of chemopreventive triterpenoids as exceptionally potent inducers of Nrf2-regulated genes. Mol Cancer Ther 6: 154-162.\n</p><p>Yates MS, Kensler TW (2007) Keap1 eye on the target: chemoprevention of liver cancer. Acta Pharmacol Sin 28: 1331-1342.\n</p><p>Yates MS, Kwak MK, Egner PA, Groopman JD, Bodreddigari S, et al (2006) Potent protection against aflatoxin-induced tumorigenesis through induction of Nrf2-regulated pathways by the triterpenoid 1-[2-cyano-3-,12-dioxooleana-1,9(11)-dien-28-oyl]imidazole. Cancer Res 66: 2488-2494.\n</p><p>Zhang Y, Guan L, Wang X, Wen T, Xing J, Zhao J (2008) Protection of chlorophyllin against oxidative damage by inducing HO-1 and NQO1 expression mediated by PI3K/Akt and Nrf2. Free Radic Res 42: 362-371.\n</p><p>Zheng YW, Nie YZ, Taniguchi H (2013) Cellular reprogramming and hepatocellular carcinoma development. World J Gastroenterol 19: 8850-8860.\n</p>","biologicalOrganisationLevel":"Individual","organTerm":{},"biologicalEvents":[{"action":"increased","object":{"name":"hepatocellular carcinoma","source":"MESH","sourceId":"D006528"}}],"id":378}
{"title":"Increased, Induced Mutations in Critical Genes","references":"<p>Bressac, B., Kew, M., Wands, J., &amp; Ozturk, M. (1991). Selective G to T mutations of p53 gene in hepatocellular carcinoma from southern africa. Nature, 350(6317), 429-31. doi:10.1038/350429a</p>\n\n<p>Chen, T., Heflich, R. H., Moore, M. M., &amp; Mei, N. (2010). Differential mutagenicity of aflatoxin B1 in the liver of neonatal and adult mice. Environ Mol Mutagen, 51(2), 156-63. doi:10.1002/em.2051</p>\n\n<p>Denissenko MF, Koudriakova TB, Smith L, O&#39;Connor TR, Riggs AD, and Pfeifer GP). The p53 codon 249 mutational hotspot in hepatocellular carcinoma is not related to selective formation or persistence of aflatoxin B1 adducts. (Oncogene. 1998, Dec 10;17(23):3007-14.</p>\n\n<p>Dycaico, M. J., Stuart, G. R., Tobal, G. M., de Boer, J. G., Glickman, B. W., &amp; Provost, G. S. (1996). Species-specific differences in hepatic mutant frequency and mutational spectrum among lambda/laci transgenic rats and mice following exposure to aflatoxin B1. Carcinogenesis, 17(11), 2347-56</p>\n\n<p>Foster, P. L., Eisenstadt, E., &amp; Miller, J. H. (1983). Base substitution mutations induced by metabolically activated aflatoxin B1. Proceedings of the National Academy of Sciences of the United States of America, 80(9), 2695-8.</p>\n\n<p>Gouas, D., Shi, H., &amp; Hainaut, P. (2009). The aflatoxin-induced TP53 mutation at codon 249 (R249S): Biomarker of exposure, early detection and target for therapy. Cancer Lett, 286(1), 29-37. doi:10.1016/j.canlet.2009.02.057</p>\n\n<p>Hsu, I. C., Metcalf, R. A., Sun, T., Welsh, J. A., Wang, N. J., &amp; Harris, C. C. (1991). Mutational hotspot in the p53 gene in human hepatocellular carcinomas. Nature, 350(6317), 427-8. doi:10.1038/350427a</p>\n\n<p>Lin YC, Li L, Makarova AV, Burgers PM, Stone MP, Lloyd RS. (2014a). Error-prone replication bypass of the primary aflatoxin B1 DNA adduct, AFB1-N7-Gua. J Biol Chem. 289:18497-18506.</p>\n\n<p>Lin YC, Li L, Makarova AV, Burgers PM, Stone MP, Lloyd RS. (2014b). Molecular basis of aflatoxin-induced mutagenesis-role of the aflatoxin B1-formamidopyrimidine adduct. Carcinogenesis 35(7):1461-1468</p>\n\n<p>Parsons BL, Myers MB, Meng F, Wang Y, McKinzie PB. 2010. Oncomutations as biomarkers of cancer risk. Environ Mol Mutagen. 51(8-9):836-850.</p>\n\n<p>Puisieux, A., Lim, S., Groopman, J., &amp; Ozturk, M. (1991). Selective targeting of p53 gene mutational hotspots in human cancers by etiologically defined carcinogens. Cancer Res, 51(22), 6185-9.</p>\n\n<p>Wattanawaraporn, R., Kim, M. Y., Adams, J., Trudel, L. J., Woo, L. L., Croy, R. G., . . . Wogan, G. N. (2012). AFB(1) -induced mutagenesis of the gpt gene in AS52 cells. Environ Mol Mutagen, 53(7), 567-73. doi:10.1002/em.2171</p>\n","biologicalOrganisationLevel":"Cellular","organTerm":{},"biologicalEvents":[{"action":"increased","process":"mutation","object":{"name":"cellular tumor antigen p53","source":"PR","sourceId":"PR:000003035"}}],"id":376}
{"title":"Metabolism of AFB1, Production of Reactive Electrophiles","references":"<p>F.D. Asplin, R.B.A. Carnaghan, (1961). The toxicity of certain groundnut meals for poultry with special reference to their effect on ducklings and chickens. Vet. Rec. 73:1215&ndash; 1219.</p>\n\n<p>Brown KL, Deng JZ, Iyer RS, Iyer LG, Voehler MW, Stone MP, Harris CM, Harris TM (2006). Unraveling the aflatoxin-FAPY conundrum: Structural basis of the formamidopyrimidine-type DNA adduct of aflatoxin B1. J Am Chem Soc 128:15188-15199.</p>\n\n<p>Croy RG, Essigman JM, Reinhold VN, Wogan GN (1978). Identification of the principal aflatoxin N1-DNA adduct formed in vivo in rat liver. Proc Natl Acad Sci USA 75:1745-1749.</p>\n\n<p>Degen GH, Neumann HG (1981). Differences in aflatoxin B1-susceptibility of rat and mouse are correlated with the capability in vitro to inactivate aflatoxin B1-epoxide. Carcinogenesis 2:299&ndash;306.</p>\n\n<p>Eaton DL, and Gallagher EP (1994). Mechanisms of aflatoxin carcinogenesis. Annu Rev Pharmacol Toxicol 34:135-172.</p>\n\n<p>Elegbede JA, and Gould MN. (2002). Monoterpenes reduced adducts formation in rats exposed to aflatoxin B1. African J Biotech, 1, 46&ndash;49.</p>\n\n<p>Gregory 3rd JF, Goldstein SL, Edds GT. (1983). Metabolite distribution and rate of residue clearance in turkeys fed a diet containing aflatoxin B1. Food Chem Toxicol, 21, 463&ndash;7.</p>\n\n<p>Groopman JD, Kensler TW (2005). Role of metabolism and viruses in aflatoxin-induced liver cancer. Toxicol Appl Pharmacol 206:131-137.</p>\n\n<p>Guengerich FP, Johnson WW, Ueng Y-F, Yamazaki H, Shimada T (1996). Involvement of Cytochrome P450, glutathione S-transferase, and epoxide hydrolase in the metabolism of aflatoxin B1 and relevance to risk of human liver cancer. Environ Health Perspect 104(Suppl 3):557-562.</p>\n\n<p>Himmelstein MW, Boogaard PJ, Cadet J, et al. (2009). Creating context for the use of DNA adduct data in cancer risk assessment: II.Overview of methods of identification and quantitation of DNA damage. Crit Rev Toxicol, 39, 679&ndash;694.</p>\n\n<p>IARC (1993). Some Naturally Occurring Substances: Food Items and Constituents, Heterocyclic Aromatic Amines and Mycotoxins. IARC Monographs on the Evaluation of Carcinogenic Risk to Humans. Vol. 56, 245-395.</p>\n\n<p>Johnson NM, Egner PA, Baxter VK, Sporn MB, Wible RS, Sutter TR, Groopman JD, Kensler TW, Roebuck BD. (2014). Complete protection against aflatoxin B(1)-induced liver cancer with a triterpenoid: DNA adduct dosimetry, molecular signature, and genotoxicity threshold. Cancer Prev Res. 7(7):658-665.</p>\n\n<p>Kensler TW, He X, Otieno M, et al. (1998). Oltipraz chemoprevention trial in Qidong, People&rsquo;s Republic of China: Modulation of serum aflatoxin albumin adduct biomarkers. Cancer Epidemiol Biomarkers Prev, 7, 127&ndash;34.</p>\n\n<p>Larsson P, Hoedaya, WI, Tjalve H. (1990). Disposition of 3H-aflatoxin H in mice: formation and retention of tissue bound metabolites in nasal glands. Pharmacol Toxicol, 67, 162&ndash;71.</p>\n\n<p>Larsson P, and Tjalve H. (1993). Distribution and metabolism of aflatoxin B1 in the marmoset monkey (Callithrix jacchus). Carcinogenesis, 14, 1&ndash;6.</p>\n\n<p>Monroe DH, Eaton DL. (1987). Comparative effects of butylated hydroxyanisole on hepatic in vivo DNA binding and in vitro biotransformation of aflatoxin B1 in the rat and the mouse. Toxicol Appl Pharmacol, 90, 401&ndash;409.</p>\n\n<p>Pottenger, L.H., Andrews LS, Bachman AN, Boogaard PJ, Cadet J, Embry MR, Farmer PB, Himmelstein MW, Jarabek AM, Martin EA, Mauthe RJ, Persaud R, Preston RJ, Schoeny R, Skare J, Swenberg JA, Williams GM, Zeiger E, Zhang F, Kim JH. (2014). An organizational approach for the assessment of DNA adduct data in risk assessment: case studies for aflatoxin B1, tamoxifen and vinyl chloride. Crit. Rev. Toxicol. 44(4):348-391.</p>\n\n<p>Primiano T, Egner PA, Sutter TR, et al. (1995). Intermittent dosing with oltipraz: relationship between chemoprevention of aflatoxin-induced tumorigenesis and induction of glutathione-S-transferases. Cancer Res, 55, 4319&ndash;4324.</p>\n\n<p>Roebuck BD, Liu Y-L, Rogers AE, et al. (1991). Protection against aflatoxin B1-induced hepatocarcinogenesis in F344 rats by 5-(2-pyrazinyl)-4-methyl-1,2-dithiole-3-thione (oltipraz): predictive role for short term molecular dosimetry. Cancer Res, 51, 5501&ndash;5506.</p>\n\n<p>Ueng Y-F, Shimada T, Yamazaki H, Guengerich FP (1995). Oxidation of aflatoxin B1 by bacterial recombinant human cytochrome P450 enzymes. Chem Res Toxiol 8:218-225.</p>\n\n<p>Wang J-S, Shen X, He X, et al. (1999). Protective alerations in phase 1 and 2 metabolism of aflatoxin B1 by oltipraz in residents of Qidong, People&rsquo;s Republic of China. J Natl Cancer Inst, 91, 347&ndash;354.</p>\n\n<p>Yates MS, Kwak M-K, Egner PA, et al. (2006). Potent protection against aflatoxin-induced tumorigenesis through induction of Nrf2-regulated pathways by the triterpenoid 1-[2-cyano-3-,12-dioxooleana-1,9 (11)-dien-28-oyl] imidazole. Cancer Res, 66, 2488&ndash;2494.</p>\n","biologicalOrganisationLevel":"Molecular","organTerm":{},"biologicalEvents":[{"action":"increased","process":"metabolic process","object":{}}],"id":409}
{"title":"Clonal Expansion/Cell Proliferation, to form Altered Hepatic Foci (AHF)","references":"<p>1. Harada T, Maronpot RR, Morris RW, Boorman GA (1990) Effects of mononuclear cell leukemia on altered hepatocellular foci in Fischer 344 rats. Vet Pathol 27: 110-116.\n</p><p>2. Harada T, Maronpot RR, Morris RW, Stitzel KA, Boorman GA (1989) Morphological and stereological characterization of hepatic foci of cellular alteration in control Fischer 344 rats. Toxicol Pathol 17: 579-593.\n</p><p>3. Gil R, Callaghan R, Boix J, Pellin A, Llombart-Bosch A (1988) Morphometric and cytophotometric nuclear analysis of altered hepatocyte foci induced by N-nitrosomorpholine (NNM) and aflatoxin B1 (AFB1) in liver of Wistar rats. Virchows Arch B Cell Pathol Incl Mol Pathol 54: 341-349.\n</p><p>4. Bannasch P, Benner U, Enzmann H, Hacker HJ (1985) Tigroid cell foci and neoplastic nodules in the liver of rats treated with a single dose of aflatoxin B1. Carcinogenesis 6: 1641-1648.\n</p><p>5. Godlewski CE, Boyd JN, Sherman WK, Anderson JL, Stoewsand GS (1985) Hepatic glutathione S-transferase activity and aflatoxin B1-induced enzyme altered foci in rats fed fractions of brussels sprouts. Cancer Lett 28: 151-157.\n</p><p>6. Dragan Y, Teeguarden J, Campbell H, Hsia S, Pitot H (1995) The quantitation of altered hepatic foci during multistage hepatocarcinogenesis in the rat: transforming growth factor alpha expression as a marker for the stage of progression. Cancer Lett 93: 73-83.\n</p><p>7. Dragan YP, Campbell HA, Baker K, Vaughan J, Mass M, Pitot HC (1994) Focal and non-focal hepatic expression of placental glutathione S-transferase in carcinogen-treated rats. Carcinogenesis 15: 2587-2591.\n</p><p>8. Kirby GM, Stalker M, Metcalfe C, Kocal T, Ferguson H, Hayes MA (1990) Expression of immunoreactive glutathione S-transferases in hepatic neoplasms induced by aflatoxin B1 or 1,2-dimethylbenzanthracene in rainbow trout (Oncorhynchus mykiss). Carcinogenesis 11: 2255-2257.\n</p><p>9. Dragan YP, Campbell HA, Xu XH, Pitot HC (1997) Quantitative stereological studies of a 'selection' protocol of hepatocarcinogenesis following initiation in neonatal male and female rats. Carcinogenesis 18: 149-158.\n</p><p>10. Grasl-Kraupp B, Ruttkay-Nedecky B, Mllauer L, Taper H, Huber W, et al (1997) Inherent increase of apoptosis in liver tumors: implications for carcinogenesis and tumor regression. Hepatology 25: 906-912.\n11. Wyde ME, Cambre T, Lebetkin M, Eldridge SR, Walker NJ (2002) Promotion of altered hepatic foci by 2,3,7,8-tetrachlorodibenzo-p-dioxin and 17beta-estradiol in male Sprague-Dawley rats. Toxicol Sci 68: 295-303.\n12. Angsubhakorn S, Pradermwong A, Phanwichien K, Nguansangiam S (2002) Promotion of aflatoxin B1-induced hepatocarcinogenesis by dichlorodiphenyl trichloroethane (DDT). Southeast Asian J Trop Med Public Health 33: 613-623.\n13. Ohnishi S, Ma N, Thanan R, Pinlaor S, Hammam O, et al (2013) DNA damage in inflammation-related carcinogenesis and cancer stem cells. Oxid Med Cell Longev 2013: 387014.\n</p><p>14. Caballero F, Meiss R, Gimenez A, Batlle A, Vazquez E (2004) Immunohistochemical analysis of heme oxygenase-1 in preneoplastic and neoplastic lesions during chemical hepatocarcinogenesis. Int J Exp Pathol 85: 213-222.\n</p><p>15. Pitot HC, Dragan YP, Teeguarden J, Hsia S, Campbell H (1996) Quantitation of multistage carcinogenesis in rat liver. Toxicol Pathol 24: 119-128.\n</p><p>16. Xu YH, Maronpot R, Pitot HC (1990) Quantitative stereologic study of the effects of varying the time between initiation and promotion on four histochemical markers in rat liver during hepatocarcinogenesis. Carcinogenesis 11: 267-272.\n</p><p>17. Xu YH, Campbell HA, Sattler GL, Hendrich S, Maronpot R, et al (1990) Quantitative stereological analysis of the effects of age and sex on multistage hepatocarcinogenesis in the rat by use of four cytochemical markers. Cancer Res 50: 472-479.\n</p><p>18. Dewanji A, Moolgavkar SH, Luebeck EG (1991) Two-mutation model for carcinogenesis: joint analysis of premalignant and malignant lesions. Math Biosci 104: 97-109.\n</p><p>19. Dragan YP, Hully J, Baker K, Crow R, Mass MJ, Pitot HC (1995) Comparison of experimental and theoretical parameters of the Moolgavkar-Venzon-Knudson incidence function for the stages of initiation and promotion in rat hepatocarcinogenesis. Toxicology 102: 161-175.\n</p><p>20. Johnson NM, Egner PA, Baxter VK, Sporn MB, Wible RS, et al (2014) Complete protection against aflatoxin B1-induced liver cancer with triterpenoid: DNA adduct dosimetry, molecular signature and genotoxicity threshold. Cancer Prev Res (Phila) .\n</p><p>21. Ribback S, Calvisi DF, Cigliano A, Sailer V, Peters M, et al (2013) Molecular and metabolic changes in human liver clear cell foci resemble the alterations occurring in rat hepatocarcinogenesis. J Hepatol 58: 1147-1156.\n</p><p>22. Thoolen B, Ten Kate FJ, van Diest PJ, Malarkey DE, Elmore SA, Maronpot RR (2012) Comparative histomorphological review of rat and human hepatocellular proliferative lesions. J Toxicol Pathol 25: 189-199.\n</p>","biologicalOrganisationLevel":"Organ","organTerm":{"name":"liver","sourceId":"UBERON:0002107"},"biologicalEvents":[{"action":"increased","process":"hepatocyte proliferation","object":{"name":"hepatocyte","source":"CL","sourceId":"CL:0000182"}}],"id":491}
{"title":"Increased, Insufficient repair or mis-repair of pro-mutagenic DNA adducts","references":"<p>Bedard, L.L., and Massey, T.T. (2006). Aflatoxin B1-induced DNA damage and its repair. Cancer Lett. 241(2):174-183.\n</p><p>Egner PA, Groopman JD, Wang J-S, Kensler TW, Friesen MD (2006). Quantification of aflatoxin-B1-N7-Guanine in human urine by high-performance liquid chromatography and isotope dilution tandem mass spectrometry. Chem Res Toxicol 19:1191-1195.\n</p><p>Elegbede JA, and Gould MN. (2002). Monoterpenes reduced adducts formation in rats exposed to aflatoxin B1. African J Biotech, 1, 4649.\n</p><p>Gross-Steinmeyer K, and Eaton DL. (2012). Dietary modulation of the biotransformation and genetoxicity of aflatoxin B1. Toxicology, 299: 6979.\n</p><p>Guo Y, Breeden LL, Zarbl H, et al. (2005). Expression of a human cytochrome p450 in yeast permits analysis of pathways for response to and repair of aflatoxin-induced DNA damage. Mol Cell Biol, 25, 58235833.\n</p><p>Himmelstein MW, Boogaard PJ, Cadet J, et al. (2009). Creating context for the use of DNA adduct data in cancer risk assessment: II.Overview of methods of identification and quantitation of DNA damage. Crit Rev Toxicol, 39, 679694.\n</p><p>Jarabek, AM, Pottenger, LH, Andrews, LS, et al. (2009). Creating context for the use of DNA adduct data in cancer risk assessment: I. Data organization. Crit. Rev. Toxicol. 39: 659-678.\n</p><p>Johnson NM, Egner PA, Baxter VK, Sporn MB, Wible RS, Sutter TR, Groopman JD, Kensler TW, Roebuck BD. (2014).  Complete protection against aflatoxin B(1)-induced liver cancer with a triterpenoid: DNA adduct dosimetry, molecular signature, and genotoxicity threshold. Cancer Prev Res. 7(7):658-665.\n</p><p>Kensler TW, He X, Otieno M, et al. (1998). Oltipraz chemoprevention trial in Qidong, Peoples Republic of China: Modulation of serum aflatoxin albumin adduct biomarkers. Cancer Epidemiol Biomarkers Prev, 7, 127134.\n</p><p>Leadon SA, Tyrrell RM, Cerutti PA. (1981). Excision repair of aflatoxin B1-DNA adducts in human fibroblasts. Cancer Res.  41: 5125-5129.\n</p><p>Leung MC, Goldstone JV, Boyd WA, Freedman JH, and Meyer JN. (2010). Caenorhabditis elegans generates biologically relevant levels of genotoxic metabolites from aflatoxin B1 but not benzo[a]pyrene in vivo. Toxicol Sci.118(2):444-453.\n</p><p>Levy DD, Groopman JD, Lim SE, et al. (1992). Sequence specificity of aflatoxin B1-induced mutations in a plasmid replicated in xeroderma pigmentosum and DNA repair proficient human cells. Cancer Res. 52: 56685673.\nLin YC, Li L, Makarova AV, Burgers PM, Stone MP, Lloyd RS. (2014a). Error-prone replication bypass of the primary aflatoxin B1 DNA adduct, AFB1-N7-Gua. J Biol Chem. 289:18497-18506.\n</p><p>Lin YC, Li L, Makarova AV, Burgers PM, Stone MP, Lloyd RS. (2014b). Molecular basis of aflatoxin-induced mutagenesis-role of the aflatoxin B1-formamidopyrimidine adduct. Carcinogenesis 35(7):1461-1468\n</p><p>Meier B, Cooke SL, Weiss J, Bailly AP, Alexandrov LB, Marshall J, et al. (2014). C. elegans whole genome sequencing reveals mutational signatures related to carcinogens and DNA repair deficiency. Genome Res. 24(10):1624-1636.\n</p><p>Oleykowski CA, Mayernick JA, Lim SE, et al. (1993). Repair of aflatoxin B1 DNA adducts by the UvrABC endonuclease of Escherichia coli. J Biol.Chem.  268: 79008002.\n</p><p>Pottenger, L.H., Andrews LS, Bachman AN, Boogaard PJ, Cadet J, Embry MR, Farmer PB, Himmelstein MW, Jarabek AM, Martin EA, Mauthe RJ, Persaud R, Preston RJ, Schoeny R, Skare J, Swenberg JA, Williams GM, Zeiger E, Zhang F, Kim JH. (2014). An organizational approach for the assessment of DNA adduct data in risk assessment: case studies for aflatoxin B1, tamoxifen and vinyl chloride. Crit. Rev. Toxicol. 44(4):348-391.\n</p><p>Preston RJ, Williams GM. (2005). DNA-reactive carcinogens: mode of action and human cancer hazard. Crit Rev Toxicol, 35, 67383\n</p><p>Puisieux A, Lim S, Groopman J, Ozturk M. (1991). Selective targeting of p53 gene mutational hotspots in human cancers by etiologically defined carcinogens. Cancer Res. 51(22):6185-6189.\n</p><p>Roebuck BD, Liu Y-L, Rogers AE, et al. (1991). Protection against aflatoxin B1-induced hepatocarcinogenesis in F344 rats by 5-(2-pyrazinyl)-4-methyl-1,2-dithiole-3-thione (oltipraz): predictive role for short term molecular dosimetry. Cancer Res, 51, 55015506.\n</p><p>Sarasin AR, Smith CA Hanawalt PC. (1977). Repair of DNA in human cells after treatment with activated aflatoxin B1. Cancer Res. 37: 17861793.\n</p><p>Yates MS, Kwak M-K, Egner PA, et al. (2006). Potent protection against aflatoxin-induced tumorigenesis through induction of Nrf2-regulated pathways by the triterpenoid 1-[2-cyano-3-,12-dioxooleana-1,9 (11)-dien-28-oyl] imidazole. Cancer Res, 66, 24882494.\n</p>","biologicalOrganisationLevel":"Molecular","organTerm":{},"biologicalEvents":[{"action":"functional change","process":"DNA repair","object":{"name":"Nuclear deoxyribonucleic acid","source":"FMA","sourceId":"FMA:67194"}}],"id":493}
{"title":"Overactivation, NMDARs","references":"<p><br />\nBlanke ML, VanDongen AMJ., Activation Mechanisms of the NMDA Receptor. In: Van Dongen AM, editor. Biology of the NMDA Receptor. Boca Raton (FL): CRC Press; 2009, Chapter 13. Available from: <a class=\"external free\" href=\"http://www.ncbi.nlm.nih.gov/books/NBK5274/\" rel=\"nofollow\" target=\"_blank\">http://www.ncbi.nlm.nih.gov/books/NBK5274/</a>.</p>\n\n<p>Calabrese B, Saffin JM, Halpain S. Activity-dependent dendritic spine shrinkage and growth involve downregulation of cofilin via distinct mechanisms. PLoS One., 2014, 16;9(4):e94787.</p>\n\n<p>Chimura T., Launey T., Yoshida N.,Calpain-Mediated Degradation of Drebrin by Excitotoxicity In vitro and In vivo PLOS ONE, 2015, |DOI:10.1371/journal.pone.0125119.</p>\n\n<p>Deshpande, L. S., D. S. Carter, K. F. Phillips, R. E. Blair and R. J. DeLorenzo (2014), &quot;Development of status epilepticus, sustained calcium elevations and neuronal injury in a rat survival model of lethal paraoxon intoxication&rdquo;, <em>NeuroToxicology</em> <strong>44</strong>: 17-26. DOI: 10.1016/j.neuro.2014.04.006.</p>\n\n<p>Frega M, Pasquale V, Tedesco M, Marcoli M, Contestabile A, Nanni M, Bonzano L, Maura G, Chiappalone M., Cortical cultures coupled to micro-electrode arrays: a novel approach to perform in vitro excitotoxicity testing. Neurotoxicol Teratol. 2012: 34(1):116-27.</p>\n\n<p>Garcia-Reyero, N., L. Escalon, E. Prats, M. Faria, A. M. V. M. Soares and D. Rald&uacute;a (2016), &quot;Targeted Gene Expression in Zebrafish Exposed to Chlorpyrifos-Oxon Confirms Phenotype-Specific Mechanisms Leading to Adverse Outcomes&rdquo;, <em>Bulletin of Environmental Contamination and Toxicology</em> <strong>96</strong>(6): 707-713. DOI: 10.1007/s00128-016-1798-3.</p>\n\n<p>Gopal K., Neurotoxic effects of mercury on auditory cortex networks growing on microelectrode arrays: a preliminary analysis. Neurotoxicol Teratol., 2003, 25: 69-76.</p>\n\n<p>Gramowski A, Schiffmann D, Gross GW., Quantification of acute neurotoxic effects of trimethyltin using neuronal networks cultures on microelectrode arrays. Neurotoxicology, 2000, 21: 331-342.</p>\n\n<p>Johnstone AFM, Gross GW, Weiss D, Schroeder O, Shafer TJ.,Use of microelectrode arrays for neurotoxicity testing in the 21st century Neurotoxicology, 2000, 31: 331-350.</p>\n\n<p>Keefer E, Norton S, Boyle N, Talesa V, Gross G., Acute toxicity screening of novel AChE inhibitors using neuronal networks on microelectrode arrays. Neurotoxicology, 2001, 22: 3-12.</p>\n\n<p>Lantz SR, Mack CM, Wallace K, Key EF, Shafer TJ, Casida JE. Glufosinate binds N-methyl-D-aspartate receptors and increases neuronal network activity in vitro. Neurotoxicology. 2014, 45:38-47.</p>\n\n<p>Luscher C. and Malenka R.C., NMDA Receptor-Dependent Long-Term Potentiation and Long-Term Depression (LTP/LTD). Cold Spring Harb Perspect Biol., 2012, 4:a005710.</p>\n\n<p>Malenka RC, Bear MF., LTP and LTD: An embarrassment of riches. Neuron, 2004, 44: 5&ndash;21.</p>\n\n<p>Malleret G, Alarcon JM, Martel G, Takizawa S, Vronskaya S, Yin D, Chen IZ, Kandel ER, Shumyatsky GP., Bidirectional regulation of hippocampal long-term synaptic plasticity and its influence on opposing forms of memory&quot;. J Neurosci., 2010, 30 (10): 3813&ndash;25.</p>\n\n<p>McConnell ER, McClain MA, Ross J, LeFew WR, Shafer TJ., Evaluation of multi-well microelectrode arrays for neurotoxicity screening using a chemical training set Neurotoxicology, 2012, 33: 1048-1057.</p>\n\n<p>McDonough, J. H., Jr. and T. M. Shih (1997), &quot;Neuropharmacological mechanisms of nerve agent-induced seizure and neuropathology&rdquo;, <em>Neurosci Biobehav Rev</em> <strong>21</strong>(5): 559-579.</p>\n\n<p>Nicholls RE, Alarcon JM, Malleret G, Carroll RC, Grody M, Vronskaya S, Kandel ER., Transgenic mice lacking NMDAR-dependent LTD exhibit deficits in behavioral flexibility&quot;. Neuron, 2008, 58 (1): 104&ndash;17.</p>\n\n<p>Ogasawara H, Doi T, Kawato M. Systems biology perspectives on cerebellar long-term depression. Neurosignals, 2008, 16 (4): 300&ndash;17.</p>\n\n<p>Ogdon D, Stanfield P., Patch clamp techniques for single channel and whole-cell recording. Chapter 4, pages 53-78, (<a class=\"external free\" href=\"http://www.utdallas.edu/~tres/microelectrode/microelectrodes_ch04.pdf\" rel=\"nofollow\" target=\"_blank\">http://www.utdallas.edu/~tres/microelectrode/microelectrodes_ch04.pdf</a>).</p>\n\n<p>Paradiso MA, Bear MF, Connors BW., Neuroscience: exploring the brain. 2007, Hagerstwon, MD: Lippincott Williams &amp; Wilkins. p. 718. <a class=\"internal mw-magiclink-isbn\" href=\"/wiki/index.php/Special:BookSources/0781760038\">ISBN 0-7817-6003-8</a>.</p>\n\n<p>Purves D., Neuroscience (4th ed.). Sunderland, Mass: Sinauer., 2008, pp. 197&ndash;200. <a class=\"internal mw-magiclink-isbn\" href=\"/wiki/index.php/Special:BookSources/0878936971\">ISBN 0-87893-697-1</a>.</p>\n\n<p>Sekino Y, Tanaka S, Hanamura K, Yamazaki H, Sasagawa Y, Xue Y, Hayashi K, Shirao T., Activation of N-methyl-D-aspartate receptor induces a shift of drebrin distribution: disappearance from dendritic spines and appearance in dendritic shafts. Mol Cell Neurosci. 2006, 31(3):493-504.</p>\n\n<p>Quintero JE, Pomerleau F, Huettl P, Johnson KW, Offord J, Gerhardt GA. 2011. Methodology for rapid measures of glutamate release in rat brain slices using ceramic-based microelectrode arrays: basic characterization and drug pharmacology. Brain Res.2011, 1401:1-9.</p>\n\n<p>Wilt BA, Fitzgerald JE, Schnitzer MJ., Photon shot noise limits on optical detection of neuronal spikes and estimation of spike timing. Biophys J. 2013, 8; 104(1):51-62.</p>\n\n<p>Zhao Y, Inayat S, Dikin DA, Singer JH, Ruoff RS, Troy JB., Patch clamp techniques: review of the current state of art and potential contributions from nanoengineering. Proc. IMechE 222, Part N: J. Nanoengineering and Nanosystems, 2009, 149. DOI: 10.1243/17403499JNN149.</p>\n","biologicalOrganisationLevel":"Molecular","organTerm":{},"biologicalEvents":[{"action":"increased","process":"NMDA glutamate receptor activity","object":{"name":"NMDA selective glutamate receptor complex","source":"GO","sourceId":"GO:0017146"}}],"id":388}
{"title":"Increased, Intracellular Calcium overload","references":"<p>Bloodgood BL, Sabatini BL., Nonlinear regulation of unitary synaptic signals by CaV2.3 voltage-sensitive calcium channels located in dendritic spines. Neuron, 2007, 53:249&ndash;260.</p>\n\n<p>Bloodgood BL, Giessel AJ, Sabatini BL., Biphasic synaptic Ca influx arising from compartmentalized electrical signals in dendritic spines. PLoS Biol., 2009, 7: e1000190.</p>\n\n<p>Faria, M., N. Garcia-Reyero, F. Padr&oacute;s, P. J. Babin, D. Sebasti&aacute;n, J. Cachot, E. Prats, M. Arick Ii, E. Rial, A. Knoll-Gellida, G. Mathieu, F. Le Bihanic, B. L. Escalon, A. Zorzano, A. M. Soares and D. Rald&uacute;a (2015), &quot;Zebrafish Models for Human Acute Organophosphorus Poisoning.&rdquo; <em>Sci Rep</em> <strong>5</strong>. DOI: 10.1038/srep15591.</p>\n\n<p>Lledo PM, Zhang X, Sudhof TC, Malenka RC, Nicoll RA., Postsynaptic membrane fusion and long-term potentiation. Science, 1998, 279: 399&ndash;403.</p>\n\n<p>Malenka RC. Synaptic plasticity in the hippocampus: LTP and LTD. Cell, 1994, 78: 535&ndash;538.</p>\n\n<p>Luscher C. and Robert C. Malenka. NMDA Receptor-Dependent Long-Term Potentiation and Long-Term Depression (LTP/LTD). Cold Spring Harb Perspect Biol., 2012, 4: a005710.</p>\n","biologicalOrganisationLevel":"Cellular","organTerm":{},"biologicalEvents":[{"action":"increased","process":"calcium ion transport","object":{"name":"calcium ion","source":"CHEBI","sourceId":"CHEBI:39124"}}],"id":389}
{"title":"Decreased, Neuronal network function in adult brain","references":"<p><br />\nAndersen Per, Richard Morris, David Amaral, Tim Bliss and John O'Keefe, eds., The Hippocampus Book. Oxford University Press. ISBN, 2007, 978-0-19-510027-3.\n</p><p>Arenkiel BR, Peca J, Davison IG, Feliciano C, Deisseroth K, Augustine GJ, Ehlers MD, Feng G. In vivo light-induced activation of neural circuitry in transgenic mice expressing channelrhodopsin-2. Neuron, 2007, 54: 205218.\n</p><p>Blokland A, Acetylcholine:  a neurotransmitter for learning and memory? Brain Research Reviews, 1996, 21: 285-300.\n</p><p>Bracco L, Bessi V, Padiglioni S, Marini S1, Pepeu G., Do cholinesterase inhibitors act primarily on attention deficit? A naturalistic study in Alzheimer's disease patients. J Alzheimers Dis. 2014, 40(3):737-42. \n</p><p>Byrne John H, ed., Learning and Memory: A comprehensive reference. Elsevier. 2008, <a href=\"/wiki/index.php/Special:BookSources/9780123705099\" class=\"internal mw-magiclink-isbn\">ISBN 978-0-12-370509-9</a>.\n</p><p>Calabrese B., Saffin JM, Halpain SH.  Activity-Dependent Dendritic Spine Shrinkage and Growth Involve Downregulation of Cofilin via Distinct Mechanisms, 2014 DOI: 10.1371/journal.pone.0094787 \n</p><p>Cheng Da, Haixian Zhang, Yongsheng Sang. Brain CT Image Classification with Deep Neural Networks,Chapter from Proceedings of the 18th Asia Pacific Symposium on Intelligent and Evolutionary Systems, 2014, Volume 1 of the series Proceedings in Adaptation, Learning and Optimization pp 653-662.\n</p><p>Cho KK, Khibnik L, Philpot BD, Bear MF., The ratio of NR2A/B NMDA receptor subunits determines the qualities of ocular dominance plasticity in visual cortex. Proc Natl Acad Sci USA 2009, 106: 53775382.\n</p><p>Dombeck DA, Khabbaz AN, Collman F, Tank DW., Imaging large scale neural activity with cellular resolution in awake mobile mice. Neuron, 2007, 56: 4357.\n</p><p>Eichenbaum Howard, The Cognitive Neuroscience of Memory. Oxford University Press US. 2002, <a href=\"/wiki/index.php/Special:BookSources/9780195141757\" class=\"internal mw-magiclink-isbn\">ISBN 978-0-19-514175-7</a>.\n</p><p>Gazarini L, Cristina A. Jark Stern, Antnio P., Carobrez and Leandro J. Bertoglio. 2013 Enhanced noradrenergic activity potentiates fear memory consolidation and reconsolidation by differentially recruiting 1- and -adrenergic receptorsCurrent Issue Learning Memory, 2013, 20: 210-219.\n</p><p>Gbel W, Fritjof Helmchen, In Vivo Calcium Imaging of Neural Network Function, Physiology, 2007a, 22: 358-365.\n</p><p>Gbel W, Fritjof Helmchen,  New Angles on Neuronal Dendrites In Vivo, Journal of Neurophysiology, 2007b, 98: 3770-3779. \n</p><p>Goebel-Goody SM, Davies KD, Alvestad Linger RM, Freund RK, Browning MD, Phospho-regulation of synaptic and extrasynaptic N-methyl-d-aspartate receptors in adult hippocampal slices. Neuroscience 2009, 158: 14461459.\n</p><p>Garaschuk O, Milos RI, Grienberger C, Marandi N, Adelsberger H, Konnerth A., Optical monitoring of brain function in vivo: from neurons to networks. Pflgers Arch., 2006, 453: 385396.\n</p><p>Guzmn-Ramos K, Osorio-Gmez D, Moreno-Castilla P, Bermdez-Rattoni F., Post-acquisition release of glutamate and norepinephrine in the amygdala is involved in taste-aversion memory consolidation. Learn Mem., 2012, 19: 231238.\n</p><p>Jane DE, Lodge D, Collingridge GL. Kainate receptors: pharmacology, function and therapeutic potential. Neuropharmacology. 2009;56(1):90-113.\n</p><p>Jols M, Fernandez G, Roozendaal B., Stress and emotional memory: A matter of timing. Trends Cogn Sci., 2011, 15: 280288.\n</p><p>Kolb, Bryan; Whishaw, Ian Q., Fundamentals of Human Neuropsychology (5th ed.). 2003, Worth. pp. 102104. <a href=\"/wiki/index.php/Special:BookSources/9780716753001\" class=\"internal mw-magiclink-isbn\">ISBN 978-0-7167-5300-1</a>.\n</p><p>Labudda K, Brand M, Mertens M, Ollech I, Markowitsch HJ and Woermann FG., Decision making under risk condition in patients with Parkinsons disease: A behavioural and fMRI study. Behavioral Neurology. 2010, 23(3): 131-143. \n</p><p>Lantz SR1, Mack CM2, Wallace K2, Key EF3, Shafer TJ2, Casida JE3. 2014, Glufosinate binds N-methyl-D-aspartate receptors and increases neuronal network activity in vitro, Neurotoxicology. 2014, 45:38-47.\n</p><p>Lauri S.E., Mikael Segerstrle, Aino Vesikansa, Francois Maingret, Christophe Mulle, Graham L. Collingridge, John T. R. Isaac, Tomi Taira. Endogenous Activation of Kainate Receptors Regulates Glutamate Release and Network Activity in developing Hippocampus. The Journal of Neuroscience,  2005, 25(18): 4473-4484. \n</p><p>Laviv Tal, Inbal Riven, Iftach Dolev, Irena Vertkin, Bartosz Balana, Paul A. Slesinger, Inna Slutsky, Basal GABA Regulates GABABR Conformation and Release Probability at Single Hippocampal Synapses. Neuron, 2010, 67: 253267.\n</p><p>Liu L, Wong TP, Pozza MF, Lingenhoehl K, Wang Y, Sheng M, et al., Role of NMDA receptor subtypes in governing the direction of hippocampal synaptic plasticity. Science 2004, 304: 10211024.\n</p><p>Lscher C., Malenka RC. NMDA receptor-dependent longterm potentiation and long-term depression (LTP/LTD). Cold Spring Harb Perspect Biol 2012, 4: pii: a005710.\n</p><p>Marder E.,  Invertebrate neurobiology. Polymorphic neural networks. Curr Biol. 1994, 4: 752-4.\n</p><p>Myhrer T., Neurotransmitter systems involved in learning and memory in the rat: a meta-analysis based on studies of four behavioral tasks. Brain Res Brain Res Rev. 2003, 41(2-3):268-87.\n</p><p>Neves G., Sam F. Cooke &amp; Tim V. P. Bliss, Synaptic plasticity, memory and the hippocampus: a neural network approach to causality. Nature Reviews Neuroscience, 2008, 9: 65-75.\n</p><p>Reig R, Zerlaut Y, Vergara R, Destexhe A, Sanchez-Vives MV., Gain modulation of synaptic inputs by network state in auditory cortex in vivo. J Neurosci. 2015, 35(6)&#160;:2689-702.\n</p><p>Rohleder Cathrin, F. Leweke, Bernd Neumaier, Alexander Drzezga, Heike Endepols Characterization of functional neural networks using [18F]fluorodeoxyglucose (FDG)-PET in awake rats. J Nucl Med May 1, 2015, 56 no. supplement 3 1542.\n</p><p>Steinberg EE and Janak PH., Establishing causality for dopamine in neural function and behavior with optogenetics. Brain Research, 2012, 9: 52-63.\n</p><p>Valdivia P., Matt Martin,  William R. LeFew, James Ross, Keith A. Houck, Timothy J. Shafer, Multi-well microelectrode array recordings detect neuroactivity of ToxCast compounds, NeuroToxicology, 2014, 44: 204217.\n</p><p>Vigot, R., Barbieri, S., Brauner-Osborne, H., Turecek, R., Shigemoto, R., Zhang, Y.P., Lujan, R., Jacobson, L.H., Biermann, B., Fritschy, J.M., et al., Differential compartmentalization and distinct functions of GABAB receptor variants. Neuron, 2006, 50: 589601.\n</p><p>Wang M., Amy F T Arnsten, Contribution of NMDA receptors to dorsolateral prefrontal cortical networks in primates, Neurosci Bull April 1, 2015, 31(2): 191197\n</p><p>Wehrl Hans F, Mosaddek Hossain, Konrad Lankes, Chih-Chieh Liu, Ilja Bezrukov, Petros Martirosian, Fritz Schick, Gerald Reischl, Bernd J Pichler,  Simultaneous PET-MRI reveals brain function in activated and resting state on metabolic, hemodynamic and multiple temporal scales. Nature Medicine, 2013, 19: 11841189.\n</p><p>Wong Y.H. and Wong J.T.Y,  Invertebrate Neural Networks, Neuro-Signals, 2004, 13, No. 1-2.\n</p><p>Yu Y, Cao DQ, Xu HY, Sun M, Huang ZL, Yung WH, Lu N, Huang Y6., 5-HT3A receptors are required in long-term depression and AMPA receptor internalization. Neuroscience. 2014, 278:105-12.\n</p>","biologicalOrganisationLevel":"Organ","organTerm":{"name":"brain","sourceId":"UBERON:0000955"},"biologicalEvents":[{"action":"decreased","process":"synaptic signaling","object":{}}],"id":618}
{"title":"Binding of agonist, Ionotropic glutamate receptors","references":"<p><br />\n(for Abstract and MIE)\n</p><p>Barenberg P, Strahlendorf H, Strahlendorf., Hypoxia induces an excitotoxic-type of dark cell degeneration in cerebellar Purkinje neurons. J. Neurosci Res. 2001, 40(3): 245-54. \n</p><p>Barria A, Malinow R. (2002) Subunit-specific NMDA receptor trafficking to synapses. Neuron 35: 345-353.\nCohen S, Greenberg ME. (2008) Communication between the synapse and the nucleus in neuronal development, plasticity, and disease. Ann Rev Cell Dev Biol 24: 183-209.\n</p><p>Berman F.W. and T. F. Murray, Domoic acid neurotoxicity in cultured cerebellar granule neurons is mediated predominantly by NMDA receptors that are activated as a consequence of excitatory amino acid release, Journal of Neurochemistry, 1997,  69: 693703. \n</p><p>Berman W.F., K. T. LePage, and T. F. Murray, Domoic acid neurotoxicity in cultured cerebellar granule neurons is controlled preferentially by the NMDA receptor Ca2+ influx pathway, Brain Research, 2002, 924: 2029. \n</p><p>Cohen S, Greenberg ME. (2008) Communication between the synapse and the nucleus in neuronal development, plasticity, and disease. Ann Rev Cell Dev Biol 24: 183-209.\n</p><p>Daoudal G, Debanne D, Long-term plasticity of intrinsic excitability: learning rules and mechanisms. Learn Mem., 2003, 10(6):456-65.\n</p><p>Dingledine R, Borges K, Bowie D, Traynelis SF., The glutamate receptor ion channels. Pharmacol Rev., 1999, 51: 761. \n</p><p>Evans, R.H., Francis, A.A., Jones, A.W., et al., The Effects of a Series of -Phosphonic -Carboxylic Amino Acids on Electrically Evoked and Excitant Amino Acid-Induced Responses in Isolated Spinal Cord Preparations. Br J Pharmac., 1982, 75: 65-75. \n</p><p>Gill S, Goldstein T, Situ D, Zabka TS, Gulland FM, Mueller RW., Cloning and characterization of glutamate receptors in Californian sea lions (Zalophus californianus). Mar Drugs, 2010, 8: 1637-1649.\n</p><p>Glanzman DL., Associative learning: Hebbian flies. Curr Biol., 2005, 7: 15(11):R416-9.\n</p><p>Krschner VC, Petruzzi RL, Golden GT, Berrettini WH, Ferraro TN., Kainate and AMPA receptor binding in seizure-prone and seizure-resistant inbred mouse strains. Brain Res. 1998, 5: 780-788. \n</p><p>Lantz SR, Mack CM, Wallace K, Key EF, Shafer TJ, Casida JE., Glufosinate binds N-methyl-D-aspartate receptors and increases neuronal network activity in vitro. Neurotoxicology, 2014, 45: 38-47.  \n</p><p>Lefebvre KA, Robertson A., Domoic acid and human exposure risks: a review.Toxicon. 2010, 56: 218-30.\n</p><p>Luscher C. and Robert C. Malenka., NMDA Receptor-Dependent Long-Term Potentiation and Long-Term Depression (LTP/LTD). Cold Spring Harb Perspect Biol 2012, 4: a005710. \n</p><p>Matsumura N, Takeuchi C., Hishikawa K, Fujii T, Nakaki T., Glufosinate ammonium induces convulsion through N-methyl-D-aspartate receptors in mice. Neurosci Lett. 2001, 304: 123-5.\n</p><p>Mazumder MK, Borah A. Piroxicam inhibits NMDA receptor-mediated excitotoxicity through allosteric inhibition of the GluN2B subunit: an in silico study elucidating a novel mechanism of action of the drug. Med Hypotheses. 2014, 83(6): 740-6. \n</p><p>Mehta A, Prabhakar M, Kumar P, Deshmukh R, Sharma PL. Excitotoxicity: bridge to various triggers in neurodegenerative disorders. Eur J Pharmacol. 2013, 698: 6-18.\n</p><p>Morris, RJ. Synaptic Plasticity and Learning: Selective Impairment of Learning in Rats and Blockade of Long-Term Potentiation in vivo by the N-Methyl-D-Aspartate Receptor Antagonist AP5. J Neurosci., 1989, 9: 3040-3057. \n</p><p>Mugnaini M, van Amsterdam FT, Ratti E, Trist DG, Bowery NG.  Regionally different N-methyl-D-aspartate receptors distinguished by ligand binding and quantitative autoradiography of [3H]-CGP 39653 in rat brain.British Journal of Pharmacology, 1996, 119: 819828. \n</p><p>Neville KR, Lytton WW. Potentiation of Ca2+ influx through NMDA channels by action potentials: a computer model. Neuroreport., 1999, 10(17): 3711-6. \n</p><p>Pulido OM., Domoic acid toxicologic pathology: a review. Mar Drugs., 2008, 6: 180-219. \n</p><p><br /> \nReynolds IJ, Palmer AM. Regional variations in [3H]MK801 binding to rat brain N-methyl-D-aspartate receptors. J Neurochem. 1991, 56(5):1731-40. \n</p><p>Subramaniam S, McGonigle P. Quantitative autoradiographic characterization of the binding of (+)-5-methyl-10,11-dihydro-5H-dibenzo[a,d]cyclohepten-5, 10-imine ([3H]MK-801) in rat brain: regional effects of polyamines. J Pharmacol Exp Ther. 1991, 256(2): 811-9. \n</p><p>Schrattenholz A, Soskic V., NMDA receptors are not alone: dynamic regulation of NMDA receptor structure and function by neuregulins and transient cholesterol-rich membrane domains leads to disease-specific nuances of glutamate-signalling.Curr Top Med Chem., 2006, 6(7):663-86.\n</p><p>Tovar KR, Westbrook GL. (1999) The incorporation of NMDA receptors with a distinct subunit composition at nascent hippocampal synapses in vitro. J Neurosci. 19: 41804188.\n</p><p>Traynelis S, Wollmuth LP, McBain CJ, Menniti FS, Vance KM, Ogden KK, Hansen KB, Yuan H, Myers SJ, Dingledine R. Glutamate receptor ion channels: structure, regulation, and function. Pharmacol Rev., 2010, 62: 405-496. \n</p><p>Watanabe KH, Andersen ME, Basu N, Carvan MJ 3rd, Crofton KM, King KA, Suol C, Tiffany-Castiglioni E, Schultz IR. Defining and modeling known adverse outcome pathways: Domoic acid and neuronal signaling as a case study. Environ Toxicol Chem., 2011, 30: 9-21. \n</p><p>Xia S, Chiang AS. NMDA Receptors in Drosophila. In: Van Dongen AM, editor. Biology of the NMDA Receptor. Boca Raton (FL): CRC Press; 2009. Chapter 10. Available from: <a rel=\"nofollow\" target=\"_blank\" class=\"external free\" href=\"http://www.ncbi.nlm.nih.gov/books/NBK5286/\">http://www.ncbi.nlm.nih.gov/books/NBK5286/</a> \n</p><p>Retrieved from <a rel=\"nofollow\" target=\"_blank\" class=\"external free\" href=\"https://aopkb.org/aopwiki/index.php/?oldid=27027\">https://aopkb.org/aopwiki/index.php/?oldid=27027</a>\n</p>","biologicalOrganisationLevel":"Molecular","organTerm":{},"biologicalEvents":[{"action":"increased","process":"ionotropic glutamate receptor activity","object":{"name":"ionotropic glutamate receptor complex","source":"GO","sourceId":"GO:0008328"}}],"keyEventStressors":["Domoic acid"],"id":875}
{"title":"Increase, Luteinizing hormone (LH) ","references":"","biologicalOrganisationLevel":"Cellular","organTerm":{},"biologicalEvents":[{"action":"increased","process":"hormone biosynthetic process","object":{"name":"Luteinizing hormone","source":"CHEBI","sourceId":"CHEBI:81568"}}],"id":414}
{"title":"Hyperplasia, Leydig cell","references":"","biologicalOrganisationLevel":"Cellular","organTerm":{},"biologicalEvents":[{"action":"increased","process":"hyperplasia","object":{}}],"id":415}
{"title":"Increase proliferation, Leydig cell ","references":"","biologicalOrganisationLevel":"Cellular","organTerm":{},"biologicalEvents":[{"action":"increased","process":"cell proliferation","object":{}}],"id":416}
{"title":"skewed, sex ratio","references":"","biologicalOrganisationLevel":"Population","organTerm":{},"biologicalEvents":[{"action":"abnormal","process":"sex ratio","object":{}}],"id":417}
{"title":"Increased, Vitellogenin synthesis","references":"","biologicalOrganisationLevel":"Cellular","organTerm":{},"biologicalEvents":[{"action":"increased","process":"gene expression","object":{"name":"vitellogenins","source":"MESH","sourceId":"D014819"}}],"id":418}
{"title":"Increased, renal vitellogenin deposition","references":"","biologicalOrganisationLevel":"Organ","organTerm":{"name":"kidney","sourceId":"UBERON:0002113"},"biologicalEvents":[{"action":"increased","object":{"name":"vitellogenins","source":"MESH","sourceId":"D014819"}}],"id":419}
{"title":"Increased, glomerular rupture and renal hemorrhaging","references":"","biologicalOrganisationLevel":"Organ","organTerm":{"name":"kidney","sourceId":"UBERON:0002113"},"biologicalEvents":[{"action":"functional change","object":{"name":"glomerular basement membrane","source":"UBERON","sourceId":"UBERON:0005777"}},{"action":"increased","process":"hemorrhage","object":{}}],"id":421}
{"title":"Increased, glomerular rupture and renal hemorrhaging","references":"","biologicalOrganisationLevel":"Organ","organTerm":{"name":"kidney","sourceId":"UBERON:0002113"},"biologicalEvents":[{"action":"functional change","object":{"name":"glomerular basement membrane","source":"UBERON","sourceId":"UBERON:0005777"}},{"action":"increased","process":"hemorrhage","object":{}}],"id":421}
{"title":"Increased, nephropathy","references":"","biologicalOrganisationLevel":"Individual","organTerm":{},"biologicalEvents":[{"action":"increased","process":"Nephropathy","object":{}}],"id":422}
{"title":"Decrease of Thyroidal iodide","references":"<p>Ahad F, Ganie SA. (2010). Iodine, iodine metabolism and iodine deficiency disorders revisited. Indian J Endocrinol Metab. 14: 13-17.</p>\n\n<p>Bakker B, Bikker H, Vulsma T, de Randamie JS, Wiedijk BM, De Vijlder JJ. 2000. Two decades of screening for congenital hypothyroidism in The Netherlands: TPO gene mutations in total iodide organification defects (an update). The Journal of clinical endocrinology and metabolism. Oct;85:3708-3712.</p>\n\n<p>Berson SA, Yalow RS. (1955). The iodide trapping and binding functions of the thyroid. J Clin Invest. 34: 186-204.</p>\n\n<p>Cho JY, Leveille R, Kao R, Rousset B, Parlow AF, Burak WE Jr, Mazzaferri EL, Jhiang SM.(2000). Hormonal regulation of radioiodide uptake activity and Na+/I- symporter expression in mammary glands. J Clin Endocrinol Metab. 85:2936-2943.</p>\n\n<p>Degroot LJ.(1966). Kinetic analysis of iodine metabolism. J Clin Endocrinol Metab. 26: 149-173.</p>\n\n<p>Delange F. (2000). Iodine deficiency. In: Braverman L, Utiger R, editors. Werner and Ingbar&#39;s the thyroid: a fundamental and clinical text. Philadelphia: JD Lippincott. pp 295-316.</p>\n\n<p>Dunn JT. (1993). Sources of dietary iodine in industrialized countries. In: Delange F, Dunn JT, Glinoer D, editors. Iodine deficiency in Europe. A continuing concern. New York: Plenum press. pp 17-21.</p>\n\n<p>Dunn JT. (1998). What&#39;s happening to our iodine? J Clin Endocrinol Metab. 83: 3398-3400. Glinoer D. (1997). The regulation of thyroid function in pregnancy: pathways of endocrine adaptation from physiology to pathology. Endocr Rev. 18: 404-433.</p>\n\n<p><a href=\"http://www.thyca.org/pap-fol/rai/\">http://www.thyca.org/pap-fol/rai/</a>: Thyroid Cancer Survivors&#39; Association, Inc.,Radioactive Iodine (RAI)</p>\n\n<p>Jhiang SM, Cho JY, Ryu KY, DeYoung BR, Smanik PA, McGaughy VR, Fischer AH, Mazzaferri EL.(1998). An immunohistochemical study of Na+/I- symporter in human thyroid tissues and salivary gland tissues. Endocrinology. 139:4416-4419.</p>\n\n<p>Kwee, Sandi A.; Coel, Marc N.; Fitz-Patrick, David (2007). Eary, Janet F.; Brenner, Winfried, eds. &quot;Iodine-131 Radiotherapy for Benign Thyroid Disease&quot;. Nuclear Medicine Therapy. CRC Press: 172. <a href=\"https://en.wikipedia.org/wiki/International_Standard_Book_Number\" title=\"International Standard Book Number\">ISBN</a>&nbsp;<a href=\"https://en.wikipedia.org/wiki/Special:BookSources/978-0-8247-2876-2\" title=\"Special:BookSources/978-0-8247-2876-2\">978-0-8247-2876-2</a>.</p>\n\n<p>Nolan LA, Windle RJ, Wood SA, Kershaw YM, Lunness HR, Lightman SL, Ingram CD, Levy A. (2000). Chronic iodine deprivation attenuates stress-induced and diurnal variation in corticosterone secretion in female Wistar rats. J Neuroendocrinol. 12:1149-1159.</p>\n\n<p>Panneels V, Van den Bergen H, Jacoby C, Braekman JC, Van Sande J, Dumont JE, Boeynaems JM. (1994). Inhibition of H2O2 production by iodoaldehydes in cultured dog thyroid cells. Mol Cell Endocrinol. 102:167-176.</p>\n\n<p>Patrick L. (2008).Iodine:Deficiency and therapeutic considerations. Altern MedRev. 13:166-127.</p>\n\n<p>Ramesh BG, Bhargav PR, Rajesh BG, Devi NV, Vijayaraghavan R, Varma BA.(2016). Genotypephenotype correlations of dyshormonogenetic goiter in children and adolescents from South India . I J Endocrinol and Metab. 20: 816-824.</p>\n\n<p>Smyth PA. (2003). Role of iodine in antioxidant defense in thyroid and breast disease. Biofactors. 19:121-130.</p>\n\n<p>Spitzweg C, Morris JC. 2010. Genetics and phenomics of hypothyroidism and goiter due to NIS mutations. Molecular and cellular endocrinology. Jun 30;322:56-63.</p>\n\n<p>Wolff J, Chaikoff IL. (1948). Plasma inorganic iodide as a homeostatic regulator of thyroid function. J Biol Chem. 174: 555-564.</p>\n","biologicalOrganisationLevel":"Cellular","organTerm":{"name":"thyroid gland","sourceId":"UBERON:0002046"},"biologicalEvents":[{"action":"decreased","process":"iodide transport","object":{"name":"iodide","source":"CHEBI","sourceId":"CHEBI:16382"}}],"id":425}
{"title":"Decrease of GABAergic interneurons","references":"<p>Aika Y, Ren JQ, Kosaka K, Kosaka T. (1994). Quantitative analysis of GABA-like-immunoreactive and parvalbumin-containing neurons in the CA1 region of the rat hippocampus using a stereological method, the disector. Exp. Brain Res. 99: 267&ndash;276.</p>\n\n<p>Ascoli GA, Alonso-Nanclares L, Anderson SA, Barrionuevo G, Benavides-Piccione R, Burkhalter A, Buzsaki G, Cauli B, Defelipe J, Fairen A, et al. (2008). Petilla terminology: nomenclature of features of GABAergic interneurons of the cerebral cortex. Nat. Rev. Neurosci. 9: 557&ndash;568.</p>\n\n<p>Baltz T, deLima AD, Voigt T. (2010). Contribution of GABAergic interneurons to the development of spontaneous activity patterns in cultured neocortical networks. Front. Cell Neurosci. 4:15.</p>\n\n<p>Baram TZ, Hatalski CG. (1998). Neuropeptide-mediated excitability: a key triggering mechanism for seizure generation in the developing brain. Trends Neurosci 21: 471&ndash;476.</p>\n\n<p>Ben-Ari Y, Gaiarsa JL, Tyzio R, Khazipov R. (2007). GABA: a pioneer transmitter that excites immature neurons and generates primitive oscillations. Physiol Rev 87:1215&ndash;84.</p>\n\n<p>Ben-Ari Y, Khalilov I, Kahle KT, Cherubini E. (2012). The GABA excitatory/inhibitory shift in brain maturation and neurological disorders. Neuroscientist 18:467&ndash;486.</p>\n\n<p>Ben-Ari. (2014). The GABA excitatory/inhibitory developmental sequence: a personal journey. Neuroscience 279:187&ndash;219.</p>\n\n<p>Blaesse P, Airaksinen MS, Rivera C, Kaila K. (2009). Cation chloride co-transporters and neuronal function. Neuron 61:820&ndash;838.</p>\n\n<p>Blankenship AG, Feller MB. (2010). Mechanisms underlying spon&not;taneous patterned activity in develop&not;ing neural circuits. Nat. Rev. Neurosci. 11:18&ndash;29.</p>\n\n<p>DeFelipe J, L&oacute;pez-Cruz PL, Benavides-Piccione R, Bielza C, Larra&ntilde;aga P, Anderson S et al. (2013). New insights into the classification and nomenclature of cortical GABAergic interneurons. Nat Rev Neurosci. 14: 202-216.</p>\n\n<p>deLima AD, Lima BD, Voigt T. (2007). Earliest spontaneous activity differentially regulates neocortical GABAergic interneuron subpopulations. Eur.J.Neurosci. 25: 1&ndash;16.</p>\n\n<p>Ganguly K, Schinder AF, Wong ST, Poo M. (2001). GABA itself promotes the developmental switch of neuronal GABAergic responses from excitation to inhibition. Cell 105:521&ndash;532.</p>\n\n<p>Halasy K, Somogyi P. (1993). Distribution of GABAergic synapses and their targets in the dentate gyrus of rat: A quantitative immunoelectron microscopic analysis. J. Hirnforsch. 34: 299&ndash;308.</p>\n\n<p>Heck N, Kilb W, Reiprich P et al. (2007). GABA-A receptors regulate neocortical neuronalmigration in vitro and in vivo. Cereb Cortex. 17:138&ndash;148.</p>\n\n<p>Hensch TK. (2005). Critical period plasticity in local cortical circuits. Nat Rev Neurosci. 6: 877-888.</p>\n\n<p>Hu H, Gan J, Jonas P. (2014). Interneurons. Fast-spiking, parvalbumin GABAergic interneurons: from cellular design to microcircuit function. Science. 345:1255-1263.</p>\n\n<p>Jones EG. (1987). GABA-peptide neurons in primate cerebral cortex. J Mind Behav 8:519&ndash;536.</p>\n\n<p>Klausberger T, Somogyi P. (2008). Neuronal diversity and temporal dynamics: the unity of hippocampal circuit operations. Science. 321:53&ndash;57.</p>\n\n<p>Le Magueresse C, Monyer H. (2013). GABAergic interneurons shape the functional maturation of the cortex. Neuron. 77:388-405.</p>\n\n<p>LoTurco JJ, Owens DF, Heath MJS, Davis MBE, Kriegstein AR. (1995). GABA and glutamate depolarize cortical progenitor cells and inhibit DNA synthesis. Neuron. 15: 1287&ndash;1298.</p>\n\n<p>Lu J, Karadsheh M, Delpire E. (1999). Developmental regulation of the neuronal-specific isoform of K-Cl cotransporter KCC2 in postnatal rat brains. J Neurobiol 39: 558&ndash;568.</p>\n\n<p>Markram H, Toledo-Rodriguez M, Wang Y, Gupta A, Silberberg G, Wu C. (2004). Interneurons of the neocortical inhibitory system. Nature Reviews Neuroscience, 5:793&ndash;807.</p>\n\n<p>McIntire SL, Jorgensen E, Kaplan J. and Horvitz, H.R. (1993) The GABAergic nervoussystem of Caenorhabditis elegans. Nature 364, 337&ndash;341.</p>\n\n<p>Obata K. (2013).Synaptic inhibition and gamma-aminobutyric acid in the mammalian central nervous system. Proc. Jpn. Acad., Ser. B 89 (2013).</p>\n\n<p>Opitz T, De Lima AD, Voigt T. (2002). Spontaneous development of synchronous oscillatory activity during maturation of cortical networks in vitro. J Neurophysiol 88:2196&ndash;2206.</p>\n\n<p>Owens DF, Boyce LH, Davis MBE, Kriegstein AR. (1996). Excitatory GABA responses in embryonic and neonatal cortical slices demonstrated by gramicidin perforated-patch recordings and calcium imaging. J Neurosci. 16: 6414&ndash;6423.</p>\n\n<p>Owens DF, Kriegstein AR. (2002). Is there more to GABA than synaptic inhibition? Nat Rev Neurosci 3:715-727.</p>\n\n<p>Sternberg PW. and Horvitz HR. (1984) The genetic control of cell lineage during nematode</p>\n\n<p>development. Annu. Rev. Genet. 18, 489&ndash;524.</p>\n\n<p>Voigt T, Opitz T, De Lima AD. (2001). Synchronous oscillatory activity in immature cortical network is driven by GABAergic preplate neurons. J Neurosci 21: 8895&ndash;8905.</p>\n\n<p>Wang DD, Kriegstein AR. (2008). GABA regulates excitatory synapse formation in the neocortex via NMDA receptor activation. J Neurosci. 28: 5547&ndash;5558.</p>\n\n<p>Wang DD, Kriegstein AR. (2010). Blocking early GABA depolarization with bumetanide results in permanent alterations in cortical circuits and sensorimotor gating deficits. Cereb Cortex 21:574&ndash;587.</p>\n\n<p>Wang XJ, Tegner J, Constantinidis C, Goldman-Rakic PS (2004). Division of labor among distinct subtypes of inhibitory neurons in a cortical microcircuit of working memory. Proc Natl Acad Sci U S A. 101: 1368-1373.</p>\n\n<p>Wehr M, Zador AM. (2003). Balanced inhibition underlies tuning and sharpens spike timing in auditory cortex. Nature. 426: 442&ndash;446.</p>\n\n<p>Westbrook G. (2013). &ldquo;Seizures and epilepsy&rdquo; in Principles of Neural Science, E. Kandel, J. H. Schwartz, T. M. Jessell, S. Siegelbaum, A. J. Hudspeth, Eds. McGraw-Hill, New York: 1116&ndash;1139.</p>\n\n<p>Westerholz S, de Lima AD, Voigt T. (2013). Thyroid hormone-dependent development of early cortical networks: temporal specificity and the contribution of trkB and mTOR pathways. Front Cell Neurosci 7: 121.</p>\n","biologicalOrganisationLevel":"Cellular","organTerm":{},"biologicalEvents":[{"action":"abnormal","process":"abnormal neuron morphology","object":{}}],"id":851}
{"title":"Inhibition, Na+/I- symporter (NIS)","references":"<p>Alexander EK, Marqusee E, Lawrence J, Jarolim P, Fischer GA, Larsen PR (2004). Timing and magnitude of increases in levothyroxine requirements during pregnancy in women with hypothyroidism. N Engl J Med. Jul 15; 351(3):241-9.</p>\n\n<p>Alexander WD and Wolff J (1996). Thyroidal iodide transport VIII, Relation between transport goitrogenic and antigoitrogenic properties of certain anions. Endocrinology 78 581&ndash;590.</p>\n\n<p>Amitai Y, Winston G, Sack J, Wasser J, Lewis M, Blount BC, Valentin-Blasini L, Fisher N, Israeli A, Leventhal A. (2007). Gestational exposure to high perchlorate concentrations in drinking water and neonatal thyroxine levels. Thyroid. 17:843-850.</p>\n\n<p>Arriagada A.A, Eduardo Albornoz, Ma. Cecilia Opazo, Alvaro Becerra, Gonzalo Vidal, Carlos Fardella, Luis Michea, Nancy Carrasco, Felipe Simon, Alvaro A. Elorza, Susan M. Bueno, Alexis M. Kalergis, and Claudia A. &nbsp;(2015).Excess Iodide Induces an Acute Inhibition of the Sodium/Iodide Symporter in Thyroid Male Rat Cells by Increasing Reactive Oxygen Species. Endocrinology. 2015 Apr; 156(4): 1540&ndash;1551.</p>\n\n<p>Bidart JM, Lacroix L, Evain-Brion D, Caillou B, Lazar V, Frydman R, Bellet D, Filetti S, Schlumberger M. (2000). Expression of Na+/I&minus; symporter and Pendred syndrome genes in trophoblast cells. J Clin Endocrinol Metab 85:4367&ndash;4372.</p>\n\n<p>Bizhanova A, Kopp P. (2009). The sodium-iodide symporter NIS and pendrin in iodide homeostasis of the thyroid. Endocrinol 150:1084-1090.</p>\n\n<p>Blount BC, Pirkle JL, Osterloh JD, Valentin-Blasini L, Caldwell KL. (2006). Urinary perchlorate and thyroid hormone levels in adolescent and adult men and women living in the United States. Env Health Persp. 114:1865-1871.</p>\n\n<p>Cho JY, Leveille R, Kao R, Rousset B, Parlow AF, Burak WE Jr, Mazzaferri EL, Jhiang SM. (2000). Hormonal regulation of radioiodide uptake activity and Na+/I&minus; symporter expression in mammary glands. J Clin Endocrinol Metab 85:2936&ndash;2943.</p>\n\n<p>Cianchetta S, di Bernardo J, Romeo G, Rhoden KJ. (2010). Perchlorate transport and ihnibition of the sodium iodide symporter measured with the yellow fluorescent protein variant YFP-H148Q/I152L. Toxicol App Pharmacol. 243:372-380.</p>\n\n<p>Dai G, Levy O, Carrasco N. (1996). Cloning and characterization of the thyroid iodide transporter. Nature 379:458&ndash;460.</p>\n\n<p>Darrouzet E, Lindenthal S, Marcellin D, Pellequer J, Pourcher T. (2014). The sodium/iodide symporter: state of the art of its molecular characterization. Biochim Biophys Acta 1838:244-253.</p>\n\n<p>Dayem M, Basquin C, Navarro V, Carrier P, Marsault R, Chang P, Huc S, Darrouzet E, Lindenthal S, Pourcher T. (2008). Comparison of expressed human and mouse sodium/iodide symporters reveals differences in transport properties and subcellular localization. J Endocrinol. 197:95&ndash;109.</p>\n\n<p>De Groef B, Decallonne BR, Van der Geyten S, Darras VM, Bouillon R (2006). Perchlorate versus other environmental sodium/iodide symporter inhibitors: potential thyroid-related health effects. Eur J Endocrinol. Jul;155(1):17-25.</p>\n\n<p>De La Vieja A, Dohan O, Levy O, Carrasco N. (2000). Molecular analysis of the sodium/iodide symporter: impact on thyroid and extrathyroid pathophysiology. Physiol. Rev. 80: 1083&ndash;105.</p>\n\n<p>Di Bernardo J, Iosco C, Rhoden KJ. (2011). Intracellular anion fluorescence assay for sodium/iodide symporter substrates. Analyt Biochem. 415:32-38.</p>\n\n<p>Dohan O, De la Vieja A, Carrasco N. (2000). Molecular study of the sodium-iodide symporter (NIS): a new field in thyroidology. Trends Endocrinol Metab. 11:99&ndash;105.</p>\n\n<p>Dohan O, De la Vieja A, Paroder V, Riedel C, Artani M, Reed M, Ginter CS, Carrasco N. (2003). The sodium/iodide Symporter (NIS): characterization, regulation, and medical significance. Endocr Rev. 24:48&ndash;77.</p>\n\n<p>Dohan O, Portulano C, Basquin C, Reyna-Neyra A, Amzel LM, Carrasco N. (2007). The Na+/I symporter (NIS) mediates electroneutral active transport of the environmental pollutant perchlorate. Proc. Natl. Acad. Sci. U. S. A. 104:20250&ndash;20255.</p>\n\n<p>Ferreira ACF, Lima LIVP, Araujo RL, et al. Rapid regulation of thyroid sodium-iodide symporter activity by thyrotrophin and iodine. J Endocrinol. 2005;184:69&ndash;76.</p>\n\n<p>Fisher DA and Klein AH (1981). Thyroid development and disorders of thyroid function in the newborn. N Engl J Med. Mar 19; 304(12):702-12.</p>\n\n<p>Fragoso MA, Fernandez V, Forteza R, Randell SH, Salathe M, Conner GE. (2004).Transcellular thiocyanate transport by human airway epithelia. J Physiol 561:183&ndash;194.</p>\n\n<p>Gerard C, Rigot V, Penel C. (1994). Chloride channel blockers inhibit the Na+/I- symporter in thyroid follicles in culture. Biochem Biophys Res Communic. 204: 1265-1271.</p>\n\n<p>Glinoer D (1997). The regulation of thyroid function in pregnancy: pathways of endocrine adaptation from physiology to pathology. Endocr Rev. Jun; 18(3):404-33.</p>\n\n<p>Greer MA, Stott AK &amp; Milne KA (1966). Effect of thiocyanate, perchlorate and other anions on thyroidal iodine metabolism. Endocrinology 79 237&ndash;247.</p>\n\n<p>Hallinger DR, Murr AS, Buckalew AR, Simmons SO, Stoker TE, Laws SC.&nbsp; (2017).&nbsp; Development of a screening approach to detect thyroid disrupting chemicals that inhibit the human sodium iodide symporter (NIS). Toxicol In Vitro. Apr;40:66-78.</p>\n\n<p>Heltemes LM, Hagan CR, Mitrofanova EE, Panchal RG, Guo J, Link CJ. (2003). The rat sodium iodide symporter gene permits more effective radioisotope concentration than the human sodium iodide symporter gene in human and rodent cancer cells. Cancer Gene Ther. 10:14&ndash;22.</p>\n\n<p>Hingorani M, Spitzweg C, Vassaux G, Newbold K, Melcher A, Pandha H, Vile R, Harrington K. (2010). The biology of the sodium iodide symporter and its potential for targeted gene delivery. Curr Cancer Drug Targets 10:242&ndash;267.</p>\n\n<p>Horton MK, Blount BC, Valentin-Blasini L, Wapner R, Whyatt R, Gennings C, Factor-Litvak P (2015). CO-occurring exposure to perchlorate, nitrate and thiocyanate alters thyroid function in healthy pregnant women. Environ Res. Nov;143(Pt A):1-9.</p>\n\n<p>Jhiang SM, Cho JY, Ryu KY, DeYoung BR, Smanik PA, McGaughy VR, Fischer AH, Mazzaferri EL. (1998). An immunohistochemical study of Na+/I&minus; symporter in human thyroid tissues and salivary gland tissues. Endocrinology 139:4416&ndash;4419.</p>\n\n<p>Jung H. (2002). The sodium/substrate symporter family: structural and functional features. FEBS Lett. 529:73&ndash;77.</p>\n\n<p>Kaminsky SM, Levy O, Garry MT, Carrasco N. (1991). Inhibition of the Na+/I- symporter by harmaline and 3-amino-1-methyl-5H-pyridol(4,3-b)indole acetate in thyroid cells and membrane vesicles. Eur J Biochem. 200:203-207.</p>\n\n<p>Kirk AB, Martinelango PK, Tian K, Dutta A, Smith EE, Dasgupta PK (2005). Perchlorate and iodide in dairy and breast milk. Environ Sci Technol. Apr 1; 39(7):2011-7.</p>\n\n<p>Kogai T, Curcio F, Hyman S, Cornford EM, Brent GA, Hershman JM. (2000). Induction of follicle formation in long-term cultured normal human thyroid cells treated with thyrotropin stimulates iodide uptake but not sodium/iodide symporter messenger RNA and protein expression. J Endocrinol 167:125&ndash;135.</p>\n\n<p>Kotani T, Ogata Y, Yamamoto I, Aratake Y, Kawano JI, Suganuma T, Ohtaki S. (1998). Characterization of gastric Na+/I&minus; symporter of the rat. Clin Immunol Immunopathol 89:271&ndash;278.</p>\n\n<p>La Perle KM, Kim DC, Hall NC, Bobbey A, Shen DH, Nagy R, Wakely PE Jr, Leman A, Jarjoura D, Jhiang SM. (2013). Modulation of sodium/iodide symporter expression in the salivary gland. Thyroid 23:1029-1036.</p>\n\n<p>Lacroix L, Mian C, Caillou B, Talbot M, Filetti S, Schlumberger M, Bidart JM. (2001). Na+/I- symporter and pendred syndrome gene and protein expressions in human extra-thyroidal tissues. Eur J Endocrinol 144:297-302.</p>\n\n<p>Lecat-Guillet N, Ambroise Y. (2008a). Discovery of aryltrifluoroborates as potent sodium/iodide symporter (NIS) inhibitors. Chem Med Chem 3:1207&ndash;1209.</p>\n\n<p>Lecat-Guillet N, Merer G, Lopez R, Pourcher T, Rousseau B, Ambroise Y. (2008b). Small-molecule inhibitors of sodium iodide symporter function. Chembiochem 9:889&ndash;895.</p>\n\n<p>Lecat-Guillet N, Merer G, Lopez R, Pourcher T, Rousseau B, Ambroise Y. (2007). A 96-well automated radioiodide uptake assay for sodium/iodide symporter inhibitors. Assay Drug Dev Technol 5:535-540.</p>\n\n<p>Leung AM, Pearce EN, Hamilton T, He X, Pino S, Merewood A, Braverman LE (2009). Colostrum iodine and perchlorate concentrations in Boston-area women: a cross-sectional study. Clin Endocrinol (Oxf). Feb; 70(2):326-30.</p>\n\n<p>Leung AM, Pearce EN, Braverman LE (2010). Perchlorate, iodine and the thyroid. Best Pract Res Clin Endocrinol Metab. Feb;24(1):133-41.</p>\n\n<p>Lewandowski TA, Peterson MK2, Charnley G (2015). Iodine supplementation and drinking-water perchlorate mitigation. Food Chem Toxicol. Jun;80:261-70.</p>\n\n<p>Lindenthal S, Lecat-Guillet N, Ondo-Mendez A, Ambroise Y, Rousseau B, Pourcher T. (2009). Characterization of small-molecule inhibitors of the sodium iodide symporter. J Endocrinol 200:357&ndash;365.</p>\n\n<p>Matsuda A, Kosugi S. (1997). A homozygous missense mutation of the sodium/iodide symporter gene causing iodide transport defect. J Clin Endocrinol Metab 82:3966&ndash;3971.</p>\n\n<p>McMullen J, Ghassabian A, Kohn B, Trasande L (2017). Identifying Subpopulations Vulnerable to the Thyroid-Blocking Effects of Perchlorate and Thiocyanate. J Clin Endocrinol Metab. Jul 1;102(7):2637-2645.</p>\n\n<p>Nicola JP, Basquin C, Portulano C, Reyna-Neyra A, Paroder M, Carrasco N. (2009). The Na+/I&minus; symporter mediates active iodide uptake in the intestine. Am J Physiol Cell Physiol 296:C654&ndash;C662.</p>\n\n<p>OECD Series on Testing and Assessment (2017). New Scoping Document on in vitro and ex vivo Assays for the Identification of Modulators of Thyroid Hormone Signalling (page 36 - 38).</p>\n\n<p>Pearce EN, Lazarus JH, Smyth PPA, He X, Dall&#39;amico D, Parkes AB, Burns R, Smith DF, Maina A, Bestwick JP, Jooman M, Leung AM, Braverman LE. (2010). Perchlorate and thiocyanante exposure and thyroid function in first-trimester pregnant women. J Clin Endocrinol Metab. 95:3207-3215.</p>\n\n<p>Pearce EN, Leung AM, Blount BC, Bazrafshan HR, He X, Pino S, Valentin-Blasini L, Braverman LE (2007). Breast milk iodine and perchlorate concentrations in lactating Boston-area women. J Clin Endocrinol Metab. May; 92(5):1673-7.</p>\n\n<p>Perron B, Rodriguez AM, Leblanc G, Pourcher T. (2001). Cloning of the mouse sodium iodide symporter and its expression in the mammary gland and other tissues. J Endocrinol 170:185&ndash;196.</p>\n\n<p>Pohlenz J, Rosenthal IM, Weiss RE, Jhiang SM, Burant C, Refetoff S. (1998). Congenital hypothyroidism due to mutations in the sodium/iodide symporter. Identification of a nonsense mutation producing a downstream cryptic 3&#39; splice site. J Clin Invest 101:1028-1035.</p>\n\n<p>Portulano C, Paroder-Belenitsky M, Carrasco N. (2014). The Na+/I- symporter (NIS): mechanism and medical impact. Endocr Rev. 35:106-49.</p>\n\n<p>Rhoden KJ, Cianchetta S, Duchi S, Romeo G. (2008). Fluorescence quantitation of thyrocyte iodide accumulation with the yellow fluorescent protein variant YFP-H148Q/I152L. Analyt Biochem. 373:239-246.</p>\n\n<p>Riedel C, Levy O, Carrasco N. (2001). Post-transcriptional regulation of the sodium/iodide symporter by thyrotropin. J Biol Chem 276:21458&ndash;21463.</p>\n\n<p>Russo D, Damante G, Puxeddu E, Durante C, Filetti S. (2011a). Epigenetics of thyroid cancer and novel therapeutic targets. J Mol Endocrinol 46:R73&ndash;R81.</p>\n\n<p>Russo D, Scipioni A, Durante C, Ferretti E, Gandini L, Maggisano V, Paoli D, Verrienti A, Costante G, Lenzi A, Filetti S. (2011b). Expression and localization of the sodium/iodide symporter (NIS) in testicular cells. Endocrine 40:35&ndash;40.</p>\n\n<p>Saito T, Endo T, Kawaguchi A, Ikeda M, Nakazato M, Kogai T, Onaya T. (1997). Increased expression of the Na+/I&minus; symporter in cultured human thyroid cells exposed to thyrotropin and in Graves&rsquo;thyroid tissue. J Clin Endocrinol Metab 82:3331&ndash;3336.</p>\n\n<p>Selmi-Ruby S, Watrin C, Trouttet-Masson S, Bernier-Valentin F, Flachon V, Munari-Silem Y, Rousset B. (2003). The porcine sodium/iodide symporter gene exhibits an uncommon expression pattern related to the use of alternative splice sites not present in the human or murine species. Endocrinology. 144:1074&ndash;1085.</p>\n\n<p>Spitzweg C, Dutton CM, Castro MR, Bergert ER, Goellner JR, Heufelder AE, Morris JC. (2001). Expression of the sodium iodide symporter in human kidney. Kidney Int 59:1013-1023.</p>\n\n<p>Spitzweg C, Joba W, Eisenmenger W, Heufelder AE. (1998). Analysis of human sodium iodide symporter gene expression in extrathyroidal tissues and cloning of its complementary deoxyribonucleic acids from salivary gland, mammary gland, and gastric mucosa. J Clin Endocrinol Metab. 83:1746&ndash;1751.</p>\n\n<p>Spitzweg C, Morris JC. (2010). Genetics and phenomics of hypothyroidism and goiter due to NIS mutations. Mol Cell Endocrinol 322: 56-63. Steinmaus C, Miller MD, Howd R. (2007). Impact of smoking and thiocyanate on perchlorate and thyroid hormone associations in the 2001-2002 National Health and Nutrition Examination Survey. Env Health Persp. 115:1333-1338.</p>\n\n<p>Szinnai G, Lacroix L, Carr&eacute; A, Guimiot F, Talbot M, Martinovic J, Delezoide AL, Vekemans M, Michiels S, Caillou B, Schlumberger M, Bidart JM, Polak M. (2007). Sodium/iodide symporter (NIS) gene expression is the limiting step for the onset of thyroid function in the human fetus. J Clin Endocrinol Metab. 92:70&ndash;76.</p>\n\n<p>Tazebay UH, Wapnir IL, Levy O, Dohan O, Zuckier LS, Hua Zhao Q, Fu Deng H, Amenta PS, Fineberg S, Pestell RG, Carrasco N. (2000). The mammary gland iodide transporter is expressed during lactation and in breast cancer. Nat. Med. 6:871&ndash;878.</p>\n\n<p>Tellez RT, Chacon PM, Abarca CR, Blount BC, Van Landingham CB, Crump KS, Gibbs JP. (2005). Long-term environmental exposure to perchlorate through drinking water and thyroid function during pregnancy and the neonatal period. Thyroid. 15:963-975.</p>\n\n<p>Thienpont B, Tingaud-Sequeira A, Prats E, Barat, C., Babin P.J, Raldua D, 2011. Zebrafish eleutheroembryos provide a suitable vertebrate model for screening chemicals that impair thyroid hormone synthesis. Environ Sci Technol 45, 7525-7532.)</p>\n\n<p>Tonacchera M, Pinchera A, Dimida A, Ferrarini E, Agretti P, Vitti P, Santini F, Crump K, Gibbs J. (2004). Relative potencies and additivity of perchlorate, thiocyanate, nitrate and iodide on the inhibition of radioactive iodide uptake by the human sodium iodide symporter. Thyroid. 14:1012-1019.</p>\n\n<p>Van Sande J, Massart C, Beauwens R, Schoutens A, Costagliola S, Dumont JE, Wolff J. (2003). Anion selectivity by the sodium iodide symporter. Endocrinology 144:247&ndash;252.</p>\n\n<p>Vayre L, Sabourin JC, Caillou B, Ducreux M, Schlumberger M, Bidart JM. (1999). Immunohistochemical analysis of Na-/I- symporter distribution in human extra-thyroidal tissues. Eur J Endocrinol. 141:382&ndash;386.</p>\n\n<p>Waltz F, Pillette L, Ambroise Y. (2010). A nonradioactive iodide uptake assay for sodium iodide symporter function. Analytic Biochem. 396:91-95.</p>\n\n<p>Wolff J. (1998). Perchlorate and the thyroid gland. Pharmacol Rev. 50:89-105.</p>\n\n<p>Wang J, Hallinger DR, Murr AS, Buckalew AR, Simmons SO, Laws SC, Stoker TE (2018). High-Throughput Screening and Quantitative Chemical Ranking for Sodium-Iodide Symporter Inhibitors in ToxCast Phase I Chemical Library. Environ Sci Technol. 2018 May 1;52(9):5417-5426.</p>\n\n<p>Zhang Z, Liu YY, Jhiang SM. (2005). Cell surface targeting accounts for the difference in iodide uptake activity between human Na+/I&minus; symporter and rat Na+/I&minus; symporter. J Clin Endocrinol Metab. 90:6131&ndash;6140.</p>\n\n<p>Zoeller RT, Rovet J (2004). Timing of thyroid hormone action in the developing brain: clinical observations and experimental findings. J Neuroendocrinol. Oct;16(10):809-18.</p>\n","biologicalOrganisationLevel":"Molecular","organTerm":{},"biologicalEvents":[{"action":"decreased","process":"sodium:iodide symporter activity","object":{"name":"sodium/iodide cotransporter","source":"PR","sourceId":"PR:000015171"}}],"keyEventStressors":["Perchlorate","Dysidenin","Econazole","5-(N,N-hexamethylene) amiloride (HMA) ","Nitrate","Thiocyanate","Aryltrifluoroborates","Small molecules: ITB3, ITB4, ITB5, ITB9"],"id":424}
{"title":"Suppression, VLDL secretion","references":"","biologicalOrganisationLevel":"Cellular","organTerm":{},"biologicalEvents":[{"action":"decreased","process":"secretion","object":{"name":"very-low-density lipoprotein","source":"CHEBI","sourceId":"CHEBI:39027"}}],"id":450}
{"title":"Inhibition, Mitochondrial fatty acid beta-oxidation","references":"","biologicalOrganisationLevel":"Molecular","organTerm":{},"biologicalEvents":[{"action":"decreased","process":"fatty acid beta-oxidation","object":{"name":"fatty acid","source":"CHEBI","sourceId":"CHEBI:35366"}}],"id":451}
{"title":"Decreased, PCK1 expression (control point for glycolysis/gluconeogenesis pathway)","references":"","biologicalOrganisationLevel":"Cellular","organTerm":{},"biologicalEvents":[{"action":"decreased","process":"gene expression","object":{"name":"phosphoenolpyruvate carboxykinase, cytosolic [GTP]","source":"PR","sourceId":"PR:000012416"}}],"id":216}
{"title":"Accumulation, Liver lipid","references":"","biologicalOrganisationLevel":"Organ","organTerm":{},"biologicalEvents":[{"object":{}}],"id":455}
{"title":"Increased, FA Influx","references":"","biologicalOrganisationLevel":"Cellular","organTerm":{},"biologicalEvents":[{"action":"increased","process":"fatty acid transport","object":{"name":"fatty acid","source":"CHEBI","sourceId":"CHEBI:35366"}}],"id":465}
{"title":"Up Regulation, LDLR (low density lipoprotein receptor)","references":"","biologicalOrganisationLevel":"Molecular","organTerm":{},"biologicalEvents":[{"action":"increased","process":"gene expression","object":{"name":"low-density lipoprotein receptor","source":"PR","sourceId":"PR:000009744"}}],"id":466}
{"title":"Increased, LDL uptake","references":"","biologicalOrganisationLevel":"Cellular","organTerm":{},"biologicalEvents":[{"action":"increased","process":"receptor-mediated endocytosis","object":{"name":"low-density lipoprotein","source":"CHEBI","sourceId":"CHEBI:39026"}}],"id":467}
{"title":"Up Regulation, CYP1A1","references":"","biologicalOrganisationLevel":"Molecular","organTerm":{},"biologicalEvents":[{"action":"increased","process":"gene expression","object":{"name":"cytochrome P450 1A1","source":"PR","sourceId":"PR:000006101"}}],"id":80}
{"title":"Up Regulation, SCD-1","references":"","biologicalOrganisationLevel":"Molecular","organTerm":{},"biologicalEvents":[{"action":"increased","process":"gene expression","object":{"name":"acyl-CoA desaturase","source":"PR","sourceId":"PR:000014497"}}],"id":462}
{"title":"Suppression, Constitutive androstane receptor, NR1l3","references":"","biologicalOrganisationLevel":"Molecular","organTerm":{},"biologicalEvents":[{"action":"decreased","process":"signaling","object":{"name":"nuclear receptor subfamily 1 group I member 3","source":"PR","sourceId":"PR:000011398"}}],"id":456}
{"title":"Activation, SREBF1","references":"","biologicalOrganisationLevel":"Molecular","organTerm":{},"biologicalEvents":[{"action":"increased","process":"signaling","object":{"name":"sterol regulatory element-binding protein 1","source":"PR","sourceId":"PR:000015611"}},{"action":"increased","process":"SREBP signaling pathway","object":{"name":"sterol regulatory element-binding protein 1","source":"PR","sourceId":"PR:000015611"}}],"id":457}
{"title":"Activation, SREBF1","references":"","biologicalOrganisationLevel":"Molecular","organTerm":{},"biologicalEvents":[{"action":"increased","process":"signaling","object":{"name":"sterol regulatory element-binding protein 1","source":"PR","sourceId":"PR:000015611"}},{"action":"increased","process":"SREBP signaling pathway","object":{"name":"sterol regulatory element-binding protein 1","source":"PR","sourceId":"PR:000015611"}}],"id":457}
{"title":"Increased, De Novo FA synthesis","references":"","biologicalOrganisationLevel":"Cellular","organTerm":{},"biologicalEvents":[{"action":"increased","process":"fatty acid biosynthetic process","object":{"name":"fatty acid","source":"CHEBI","sourceId":"CHEBI:35366"}}],"id":458}
{"title":"Increased, Triglyceride formation","references":"","biologicalOrganisationLevel":"Cellular","organTerm":{},"biologicalEvents":[{"action":"increased","process":"triglyceride biosynthetic process","object":{"name":"triglyceride","source":"CHEBI","sourceId":"CHEBI:17855"}},{"action":"increased","process":"biosynthetic process","object":{"name":"triglyceride","source":"CHEBI","sourceId":"CHEBI:17855"}}],"id":454}
{"title":"Increased, Triglyceride formation","references":"","biologicalOrganisationLevel":"Cellular","organTerm":{},"biologicalEvents":[{"action":"increased","process":"triglyceride biosynthetic process","object":{"name":"triglyceride","source":"CHEBI","sourceId":"CHEBI:17855"}},{"action":"increased","process":"biosynthetic process","object":{"name":"triglyceride","source":"CHEBI","sourceId":"CHEBI:17855"}}],"id":454}
{"title":"Up Regulation, FAS","references":"","biologicalOrganisationLevel":"Molecular","organTerm":{},"biologicalEvents":[{"action":"increased","process":"gene expression","object":{"name":"fatty acid synthase","source":"PR","sourceId":"PR:000007348"}}],"id":463}
{"title":"Inhibition, PPAR alpha","references":"","biologicalOrganisationLevel":"Molecular","organTerm":{},"biologicalEvents":[{"action":"decreased","process":"peroxisome proliferator activated receptor signaling pathway","object":{"name":"peroxisome proliferator-activated receptor alpha","source":"PR","sourceId":"PR:000013056"}}],"id":468}
{"title":"Up Regulation, Acetyl-CoA carboxylase-1 (ACC-1)","references":"","biologicalOrganisationLevel":"Molecular","organTerm":{},"biologicalEvents":[{"action":"increased","process":"acetyl-CoA carboxylase activity","object":{"name":"acetyl-CoA carboxylase 1","source":"PR","sourceId":"PR:000003596"}}],"id":470}
{"title":"Suppression, HNF4alpha","references":"","biologicalOrganisationLevel":"Molecular","organTerm":{},"biologicalEvents":[{"action":"decreased","process":"signaling","object":{"name":"hepatocyte nuclear factor 4-alpha","source":"PR","sourceId":"PR:000008654"}}],"id":461}
{"title":"Inhibition, FoxA2","references":"","biologicalOrganisationLevel":"Molecular","organTerm":{},"biologicalEvents":[{"action":"decreased","process":"signaling","object":{"name":"hepatocyte nuclear factor 3-beta","source":"PR","sourceId":"PR:000007603"}}],"id":471}
{"title":"Down Regulation, CPT1A","references":"","biologicalOrganisationLevel":"Molecular","organTerm":{},"biologicalEvents":[{"action":"decreased","process":"gene expression","object":{"name":"carnitine O-palmitoyltransferase 1, liver isoform","source":"PR","sourceId":"PR:000005835"}}],"id":472}
{"title":"Down Regulation, HMGCS2","references":"","biologicalOrganisationLevel":"Molecular","organTerm":{},"biologicalEvents":[{"action":"decreased","process":"gene expression","object":{"name":"hydroxymethylglutaryl-CoA synthase, mitochondrial","source":"PR","sourceId":"PR:000008638"}}],"id":474}
{"title":"Decreased, Ketogenesis","references":"","biologicalOrganisationLevel":"Cellular","organTerm":{},"biologicalEvents":[{"action":"decreased","process":"ketosis","object":{}}],"id":477}
{"title":"Activation, NRF2","references":"","biologicalOrganisationLevel":"Molecular","organTerm":{},"biologicalEvents":[{"action":"increased","process":"signaling","object":{"name":"nuclear factor erythroid 2-related factor 2","source":"PR","sourceId":"PR:000011170"}}],"id":478}
{"title":"Activation, NR1H4","references":"","biologicalOrganisationLevel":"Molecular","organTerm":{},"biologicalEvents":[{"action":"increased","process":"signaling","object":{"name":"bile acid receptor","source":"PR","sourceId":"PR:000011396"}}],"id":479}
{"title":"Activation, SHP","references":"","biologicalOrganisationLevel":"Molecular","organTerm":{},"biologicalEvents":[{"action":"increased","process":"signaling","object":{"name":"nuclear receptor subfamily 0 group B member 2","source":"PR","sourceId":"PR:000011391"}}],"id":480}
{"title":"Decreased, DHB4/HSD17B4","references":"","biologicalOrganisationLevel":"Molecular","organTerm":{},"biologicalEvents":[{"action":"decreased","process":"catalytic activity","object":{"name":"17-beta-hydroxysteroid dehydrogenase 14","source":"PR","sourceId":"PR:000008778"}}],"id":482}
{"title":"Activation, LXR alpha","references":"","biologicalOrganisationLevel":"Molecular","organTerm":{},"biologicalEvents":[{"action":"increased","process":"signaling","object":{"name":"oxysterols receptor LXR-alpha","source":"PR","sourceId":"PR:000011395"}}],"id":483}
{"title":"Inhibition, SREBP1c","references":"","biologicalOrganisationLevel":"Molecular","organTerm":{},"biologicalEvents":[{"action":"increased","process":"SREBP signaling pathway","object":{"name":"sterol regulatory element-binding protein 1","source":"PR","sourceId":"PR:000015611"}}],"id":878}
{"title":"Activation, MTTP","references":"","biologicalOrganisationLevel":"Cellular","organTerm":{},"biologicalEvents":[{"action":"increased","process":"signaling","object":{"name":"microsomal triglyceride transfer protein large subunit MTTP","source":"PR","sourceId":"PR:000003392"}}],"id":879}
{"title":"Increased, ApoB100","references":"","biologicalOrganisationLevel":"Tissue","organTerm":{"name":"blood","sourceId":"UBERON:0000178"},"biologicalEvents":[{"action":"increased","process":"gene expression","object":{"name":"apolipoprotein B-100","source":"PR","sourceId":"PR:000004145"}}],"id":880}
{"title":"Increased, Triglyceride","references":"","biologicalOrganisationLevel":"Cellular","organTerm":{},"biologicalEvents":[{"action":"increased","process":"biosynthetic process","object":{"name":"triglyceride","source":"CHEBI","sourceId":"CHEBI:17855"}}],"id":881}
{"title":"Activation, AKT2","references":"","biologicalOrganisationLevel":"Molecular","organTerm":{},"biologicalEvents":[{"action":"increased","process":"signaling","object":{"name":"RAC-beta serine/threonine-protein kinase","source":"PR","sourceId":"PR:000003912"}}],"id":484}
{"title":"systemic inflammation leading to hepatic steatosis","references":"","biologicalOrganisationLevel":"Organ","organTerm":{},"biologicalEvents":[{"action":"occurrence","process":"inflammatory response","object":{}}],"id":486}
{"title":"Reduced, Reproductive Success","references":"","biologicalOrganisationLevel":"Individual","organTerm":{},"biologicalEvents":[{"action":"decreased","process":"reproductive process","object":{}},{"action":"decreased","process":"reproduction","object":{}}],"id":675}
{"title":"Reduced, Reproductive Success","references":"","biologicalOrganisationLevel":"Individual","organTerm":{},"biologicalEvents":[{"action":"decreased","process":"reproductive process","object":{}},{"action":"decreased","process":"reproduction","object":{}}],"id":675}
{"title":"Decrease, Ovulation","references":"","biologicalOrganisationLevel":"Organ","organTerm":{"name":"female gonad","sourceId":"UBERON:0000992"},"biologicalEvents":[{"action":"decreased","process":"ovulation","object":{}}],"id":488}
{"title":"Reduced, Prostaglandins, ovary","references":"","biologicalOrganisationLevel":"Organ","organTerm":{"name":"female gonad","sourceId":"UBERON:0000992"},"biologicalEvents":[{"action":"decreased","object":{"name":"prostaglandin","source":"CHEBI","sourceId":"CHEBI:26333"}}],"id":685}
{"title":"Glucocorticoid Receptor Agonist, Activation","references":"","biologicalOrganisationLevel":"Molecular","organTerm":{},"biologicalEvents":[{"action":"increased","process":"glucocorticoid receptor activity","object":{"name":"glucocorticoid receptor","source":"PR","sourceId":"PR:000011406"}}],"id":494}
{"title":"Repressed expression of steroidogenic enzymes ","references":"","biologicalOrganisationLevel":"Cellular","organTerm":{},"biologicalEvents":[{"action":"decreased","process":"hormone biosynthetic process","object":{"name":"testosterone","source":"CHEBI","sourceId":"CHEBI:17347"}}],"id":495}
{"title":"Increased apoptosis, decreased number of adult Leydig Cells ","references":"","biologicalOrganisationLevel":"Cellular","organTerm":{},"biologicalEvents":[{"action":"increased","process":"apoptotic process","object":{}}],"id":496}
{"title":"Decreased sperm quantity or quality in the adult, Decreased fertility ","references":"","biologicalOrganisationLevel":"Individual","organTerm":{},"biologicalEvents":[{"action":"decreased","process":"sperm quantity","object":{}},{"action":"morphological change","object":{"name":"sperm","source":"CL","sourceId":"CL:0000019"}},{"action":"decreased","object":{"name":"fertility","source":"MESH","sourceId":"D005298"}},{"action":"decreased","object":{"name":"sperm","source":"CL","sourceId":"CL:0000019"}}],"id":520}
{"title":"Decreased sperm quantity or quality in the adult, Decreased fertility ","references":"","biologicalOrganisationLevel":"Individual","organTerm":{},"biologicalEvents":[{"action":"decreased","process":"sperm quantity","object":{}},{"action":"morphological change","object":{"name":"sperm","source":"CL","sourceId":"CL:0000019"}},{"action":"decreased","object":{"name":"fertility","source":"MESH","sourceId":"D005298"}},{"action":"decreased","object":{"name":"sperm","source":"CL","sourceId":"CL:0000019"}}],"id":520}
{"title":"Decreased sperm quantity or quality in the adult, Decreased fertility ","references":"","biologicalOrganisationLevel":"Individual","organTerm":{},"biologicalEvents":[{"action":"decreased","process":"sperm quantity","object":{}},{"action":"morphological change","object":{"name":"sperm","source":"CL","sourceId":"CL:0000019"}},{"action":"decreased","object":{"name":"fertility","source":"MESH","sourceId":"D005298"}},{"action":"decreased","object":{"name":"sperm","source":"CL","sourceId":"CL:0000019"}}],"id":520}
{"title":"Decreased sperm quantity or quality in the adult, Decreased fertility ","references":"","biologicalOrganisationLevel":"Individual","organTerm":{},"biologicalEvents":[{"action":"decreased","process":"sperm quantity","object":{}},{"action":"morphological change","object":{"name":"sperm","source":"CL","sourceId":"CL:0000019"}},{"action":"decreased","object":{"name":"fertility","source":"MESH","sourceId":"D005298"}},{"action":"decreased","object":{"name":"sperm","source":"CL","sourceId":"CL:0000019"}}],"id":520}
{"title":"Altered, Neuroanatomy","references":"<p>Auso E, et al. A moderate and transient deficiency of maternal thyroid function at the beginning of fetal neocorticogenesis alters neuronal migration. Endocrinology 2004, 145(9), 4037-4047.\n</p><p>Berbel, P., A. Guadano-Ferraz, et al. (1994). Role of thyroid hormones in the maturation of interhemispheric connections in rats. Behav Brain Res 64(1-2): 9-14.\n</p><p>Berbel, P., A. Guadano-Ferraz, et al. (1993). Organization of auditory callosal connections in hypothyroid adult rats. Eur J Neurosci 5(11): 1465-78.\n</p><p>Cuevas E, et al. Transient maternal hypothyroxinemia at onset of corticogenesis alters tangential migration of medial ganglionic eminence-derived neurons. Eur J Neurosci 2005, 22(3), 541-551.\n</p><p>Farwell AP, Dubord-Tomasetti SA. Thyroid hormone regulates the extracellular organization of laminin on astrocytes. Endocrinology 1999, 140(11), 5014-5021.\n</p><p>Ferreira, A. A., J. C. Nazario, et al. (2004). Effects of experimental hypothyroidism on myelin sheath structural organization. J Neurocytol 33(2): 225-31.\n</p><p>Gilbert ME, Ramos RL, McCloskey DP, Goodman JH. Subcortical band heterotopia in rat offspring following maternal hypothyroxinaemia: structural and functional characteristics. J Neuroendocrinol. 2014 Aug;26(8):528-41.\n</p><p>Gilbert M, Zoeller R. Thyroid hormone - impact on the developing brain: Possible mechanisms of neurotoxicity. In: Harry GJ T, HA ed. Neurotoxicology, 3rd edition Vol 3. New York: Informa Healthcare USA, Inc; 2010:79-111.\n</p><p>Gravel C Hawkes R. Maturation of the corpus callosum of the rat: I. Influence of thyroid hormones on the topography of callosal projections. J Comp Neurol 1990, 291(1), 128-146.\n</p><p>Ibarrola, N. and A. Rodriguez-Pena (1997). \"Hypothyroidism coordinately and transiently affects myelin protein gene expression in most rat brain regions during postnatal development.\" Brain Res 752(1-2): 285-93.\n</p><p>Koibuchi N, Chin WW. Thyroid hormone action and brain development. Trends Endocrinol Metab 2000, 11(4), 123-128.\n</p><p>Madeira, MD, et al. Effects of hypothyroidism upon the granular layer of the dentate gyrus in male and female adult rats: a morphometric study. J Comp Neurol 1991, 314(1), 171-186.\n</p><p>Morte B, et al. Aberrant maturation of astrocytes in thyroid hormone receptor alpha 1 knockout mice reveals an interplay between thyroid hormone receptor isoforms. Endocrinology 2004, 145(3), 1386-1391.\n</p><p>Powell MH, Nguyen HV, Gilbert M, Parekh M, Colon-Perez LM, Mareci TH, Montie E. Magnetic resonance imaging and volumetric analysis: novel tools to study the effects of thyroid hormone disruption on white matter development. Neurotoxicology. 2012 Oct;33(5):1322-9.\n</p><p><br />\nSchoonover, C. M., M. M. Seibel, et al. (2004). Thyroid hormone regulates oligodendrocyte accumulation in developing rat brain white matter tracts. Endocrinology 145(11): 5013-20.\n</p><p>Sharlin DS, et al. The balance between oligodendrocyte and astrocyte production in major white matter tracts is linearly related to serum total thyroxine. Endocrinology 2008, 149(5), 2527-2536.\n</p><p>Shibutani M, Woo GH, Fujimoto H, Saegusa Y, Takahashi M, Inoue K, Hirose M, Nishikawa A. Assessment of developmental effects of hypothyroidism in rats from in utero and lactation exposure to anti-thyroid agents. Reproductive toxicology (Elmsford, NY). 2009;28(3):297-307.\n</p><p>Zoeller, R. T. and. Rovet, J. Timing of thyroid hormone action in the developing brain: clinical observations and experimental findings. J Neuroendocrinol, 2004; 16(10): 809-18.\n</p>","biologicalOrganisationLevel":"Organ","organTerm":{"name":"brain","sourceId":"UBERON:0000955"},"biologicalEvents":[{"action":"abnormal","process":"anatomical structure development","object":{"name":"nervous system","source":"UBERON","sourceId":"UBERON:0001016"}}],"id":186}
{"title":"Altered, Neurophysiology","references":"<p>Dong, J., H. Yin, et al. (2005). \"Congenital iodine deficiency and hypothyroidism impair LTP and decrease C-fos and C-jun expression in rat hippocampus.\" Neurotoxicology 26(3): 417-26. \n</p><p>Gilbert, M.E. and Burdette, L.J. (1995). Hippocampal Field Potentials: A Model System to Characterize Neurotoxicity. In Neurotoxicology: Approaches and Methods. L.W Chang and W. Slikker (Eds). Academic Press:New York, 183-204.\n</p><p>Gilbert, M. E. and L. Sui (2006). \"Dose-dependent reductions in spatial learning and synaptic function in the dentate gyrus of adult rats following developmental thyroid hormone insufficiency.\" Brain Res 1069(1): 10-22. \n</p><p>Malenka RC, Nicoll RA (1999) Long-term potentiation--a decade of progress? Science, 285:1870-1874.\n</p><p>Martinez, J.L. and Derrick, B.E. (1996). Long term potentiation and learning. Annual Review of Psychology, 47,173-203.\n</p><p>Opazo MC, Gianini A, Pancetti F, Azkcona G, Alarcn L, Lizana R, Noches V, Gonzalez PA, Marassi MP, Mora S, Rosenthal D, Eugenin E, Naranjo D, Bueno SM, Kalergis AM, Riedel CA (2008), Maternal hypothyroxinemia impairs spatial learning and synaptic nature and function in the offspring. Endocrinology 149:5097-5106. \n</p><p>Vara H, et al. Thyroid hormone regulates neurotransmitter release in neonatal rat hippocampus. Neuroscience 2002, 110(1), 19-28.\n</p>","biologicalOrganisationLevel":"Organ","organTerm":{"name":"brain","sourceId":"UBERON:0000955"},"biologicalEvents":[{"action":"abnormal","process":"abnormal nervous system physiology","object":{}}],"id":192}
{"title":"Decreased sperm quantity / quality in the adult, Decreased fertility ","references":"","biologicalOrganisationLevel":"Individual","organTerm":{},"biologicalEvents":[{"action":"decreased","object":{"name":"fertility","source":"MESH","sourceId":"D005298"}},{"action":"decreased","object":{"name":"sperm","source":"CL","sourceId":"CL:0000019"}}],"id":505}
{"title":"Decreased sperm quantity / quality in the adult, Decreased fertility ","references":"","biologicalOrganisationLevel":"Individual","organTerm":{},"biologicalEvents":[{"action":"decreased","object":{"name":"fertility","source":"MESH","sourceId":"D005298"}},{"action":"decreased","object":{"name":"sperm","source":"CL","sourceId":"CL:0000019"}}],"id":505}
{"title":"Decreased testosterone by the fetal Leydig cells, Increased corticosterone","references":"","biologicalOrganisationLevel":"Cellular","organTerm":{},"biologicalEvents":[{"action":"increased","object":{"name":"corticosterone","source":"CHEBI","sourceId":"CHEBI:16827"}}],"id":653}
{"title":"Decreased testosterone by the fetal Leydig cells, Activation by other glucocorticoid receptor agonists","references":"","biologicalOrganisationLevel":"Cellular","organTerm":{},"biologicalEvents":[{"action":"increased","process":"glucocorticoid receptor activity","object":{"name":"glucocorticoid receptor","source":"PR","sourceId":"PR:000011406"}}],"id":654}
{"title":"Decreased testosterone by the fetal Leydig cells, Increased COUP-TFII in fetal Leydig cells","references":"","biologicalOrganisationLevel":"Cellular","organTerm":{},"biologicalEvents":[{"action":"increased","process":"receptor transactivation","object":{"name":"COUP transcription factor 2","source":"PR","sourceId":"PR:000011405"}}],"id":655}
{"title":"Decreased number and function of adult Leydig cells, Decreased COUP-TFII stem Leydig cells","references":"","biologicalOrganisationLevel":"Cellular","organTerm":{},"biologicalEvents":[{"action":"decreased","process":"receptor transactivation","object":{"name":"COUP transcription factor 2","source":"PR","sourceId":"PR:000011405"}},{"action":"increased","process":"abnormal adult Leydig cell differentiation","object":{}}],"id":656}
{"title":"Decreased number and function of adult Leydig cells, Decreased COUP-TFII stem Leydig cells","references":"","biologicalOrganisationLevel":"Cellular","organTerm":{},"biologicalEvents":[{"action":"decreased","process":"receptor transactivation","object":{"name":"COUP transcription factor 2","source":"PR","sourceId":"PR:000011405"}},{"action":"increased","process":"abnormal adult Leydig cell differentiation","object":{}}],"id":656}
{"title":"Decreased testosterone by the fetal Leydig cells, Dysgenesis of fetal Leydig cells","references":"","biologicalOrganisationLevel":"Organ","organTerm":{},"biologicalEvents":[{"action":"increased","process":"abnormal fetal Leydig cell differentiation","object":{}},{"action":"increased","process":"Testicular dysgenesis","object":{}}],"id":657}
{"title":"Decreased testosterone by the fetal Leydig cells, Dysgenesis of fetal Leydig cells","references":"","biologicalOrganisationLevel":"Organ","organTerm":{},"biologicalEvents":[{"action":"increased","process":"abnormal fetal Leydig cell differentiation","object":{}},{"action":"increased","process":"Testicular dysgenesis","object":{}}],"id":657}
{"title":"Decreased testosterone by the fetal Leydig cells, Increased estradiol","references":"","biologicalOrganisationLevel":"Cellular","organTerm":{},"biologicalEvents":[{"action":"increased","object":{"name":"estrogen receptor","source":"PR","sourceId":"PR:000007204"}}],"id":658}
{"title":"Decreased testosterone by the fetal Leydig cells, Activation by other estradiol agonists","references":"","biologicalOrganisationLevel":"Cellular","organTerm":{},"biologicalEvents":[{"action":"increased","process":"estrogen receptor activity","object":{"name":"estrogen receptor","source":"PR","sourceId":"PR:000007204"}}],"id":659}
{"title":"decreased testosterone by fetal Leydig cells, Dysgenesis of fetal Leydig cells","references":"","biologicalOrganisationLevel":"Organ","organTerm":{"name":"testis","sourceId":"UBERON:0000473"},"biologicalEvents":[{"action":"increased","process":"abnormal fetal Leydig cell differentiation","object":{}},{"action":"increased","process":"Testicular dysgenesis","object":{}}],"id":660}
{"title":"decreased testosterone by fetal Leydig cells, Dysgenesis of fetal Leydig cells","references":"","biologicalOrganisationLevel":"Organ","organTerm":{"name":"testis","sourceId":"UBERON:0000473"},"biologicalEvents":[{"action":"increased","process":"abnormal fetal Leydig cell differentiation","object":{}},{"action":"increased","process":"Testicular dysgenesis","object":{}}],"id":660}
{"title":"Decreased testosterone by the fetal Leydig cells, Alterations in the fetal testis proteome","references":"","biologicalOrganisationLevel":"Molecular","organTerm":{},"biologicalEvents":[{"action":"abnormal","object":{"name":"fetal proteins","source":"MESH","sourceId":"D005326"}}],"id":661}
{"title":"Decreased Cholesterol, Decreased De Novo Biosynthesis of Choleseterol","references":"","biologicalOrganisationLevel":"Molecular","organTerm":{},"biologicalEvents":[{"action":"decreased","process":"cholesterol biosynthetic process","object":{"name":"cholesterol","source":"CHEBI","sourceId":"CHEBI:16113"}}],"id":642}
{"title":"Decreased Cholesterol, Decreased Uptake of Lipoproteins","references":"","biologicalOrganisationLevel":"Molecular","organTerm":{},"biologicalEvents":[{"action":"decreased","process":"lipoprotein transport","object":{"name":"lipoprotein","source":"CHEBI","sourceId":"CHEBI:6495"}}],"id":643}
{"title":"Decreased Cholesterol, Decreased Transport of Cholesterol to the Inner Mitochondrial Membrane","references":"","biologicalOrganisationLevel":"Molecular","organTerm":{},"biologicalEvents":[{"action":"decreased","process":"intracellular cholesterol transport","object":{"name":"cholesterol","source":"CHEBI","sourceId":"CHEBI:16113"}}],"id":644}
{"title":"Decreased Cholesterol, Decreased Testosterone Production by Adult Leydig Cells","references":"","biologicalOrganisationLevel":"Cellular","organTerm":{},"biologicalEvents":[{"action":"decreased","process":"testosterone biosynthetic process","object":{"name":"testosterone","source":"CHEBI","sourceId":"CHEBI:17347"}}],"id":645}
{"title":"Decreased Cholesterol, Decreased sperm quantity and/or quality in the adult testis","references":"","biologicalOrganisationLevel":"Organ","organTerm":{},"biologicalEvents":[{"action":"decreased","object":{"name":"sperm","source":"CL","sourceId":"CL:0000019"}}],"id":646}
{"title":"Decreased steroidogenesis, Proteomic alterations in the adult Leydig cell","references":"","biologicalOrganisationLevel":"Molecular","organTerm":{},"biologicalEvents":[{"action":"decreased","process":"steroid biosynthetic process","object":{}}],"id":640}
{"title":"Decreased steroidogenesis, Decreased Activity of Steroidogenic Enzymes in Adult Leydig cells","references":"","biologicalOrganisationLevel":"Cellular","organTerm":{},"biologicalEvents":[{"action":"decreased","process":"regulation of steroid biosynthetic process","object":{}}],"id":647}
{"title":"Decreased steroidogenesis, Increased Apoptosis of Adult Leydig Cells","references":"","biologicalOrganisationLevel":"Tissue","organTerm":{"name":"testis","sourceId":"UBERON:0000473"},"biologicalEvents":[{"action":"increased","process":"apoptotic process","object":{"name":"Leydig cell","source":"CL","sourceId":"CL:0000178"}}],"id":648}
{"title":"Decreased steroidogenesis, Alterations in the Leydig Cell Cytoskeleton","references":"","biologicalOrganisationLevel":"Tissue","organTerm":{"name":"testis","sourceId":"UBERON:0000473"},"biologicalEvents":[{"action":"abnormal","process":"cytoskeleton organization","object":{"name":"Leydig cell","source":"CL","sourceId":"CL:0000178"}}],"id":649}
{"title":"Apoptosis of adult Leydig cells, Decreased testosterone by adult Leydig cells","references":"","biologicalOrganisationLevel":"Cellular","organTerm":{},"biologicalEvents":[{"action":"decreased","object":{"name":"testosterone","source":"CHEBI","sourceId":"CHEBI:17347"}},{"action":"increased","process":"apoptotic process","object":{}}],"id":525}
{"title":"Apoptosis of adult Leydig cells, Decreased testosterone by adult Leydig cells","references":"","biologicalOrganisationLevel":"Cellular","organTerm":{},"biologicalEvents":[{"action":"decreased","object":{"name":"testosterone","source":"CHEBI","sourceId":"CHEBI:17347"}},{"action":"increased","process":"apoptotic process","object":{}}],"id":525}
{"title":"Stimulation of adult Leydig cells via the Adrenal Corticosterone, Increased Glucocorticoid","references":"","biologicalOrganisationLevel":"Molecular","organTerm":{},"biologicalEvents":[{"action":"increased","process":"glucocorticoid biosynthetic process","object":{"name":"glucocorticoid","source":"CHEBI","sourceId":"CHEBI:24261"}},{"action":"increased","process":"cell activation","object":{}}],"id":650}
{"title":"Stimulation of adult Leydig cells via the Adrenal Corticosterone, Increased Glucocorticoid","references":"","biologicalOrganisationLevel":"Molecular","organTerm":{},"biologicalEvents":[{"action":"increased","process":"glucocorticoid biosynthetic process","object":{"name":"glucocorticoid","source":"CHEBI","sourceId":"CHEBI:24261"}},{"action":"increased","process":"cell activation","object":{}}],"id":650}
{"title":"Glucocorticoid Receptor mediated alterations in steriodogenic enzymes, Decreased testosterone by adult Leydig cells","references":"","biologicalOrganisationLevel":"Cellular","organTerm":{},"biologicalEvents":[{"action":"abnormal","process":"glucocorticoid receptor activity","object":{"name":"glucocorticoid receptor","source":"PR","sourceId":"PR:000011406"}}],"id":651}
{"title":"Direct effects of Corticosterone on steroidogenesis, Decreased testosterone by adult Leydig cells","references":"","biologicalOrganisationLevel":"Cellular","organTerm":{},"biologicalEvents":[{"action":"abnormal","process":"regulation of steroid biosynthetic process","object":{}}],"id":652}
{"title":"Activation of specific nuclear receptors, PPAR-gamma activation","references":"","biologicalOrganisationLevel":"Molecular","organTerm":{},"biologicalEvents":[{"action":"decreased","process":"peroxisome proliferator activated receptor signaling pathway","object":{"name":"peroxisome proliferator-activated receptor gamma","source":"PR","sourceId":"PR:000013058"}}],"keyEventStressors":["Tetrabromobisphenol A"],"id":1028}
{"title":"obesity","references":"","biologicalOrganisationLevel":"Individual","organTerm":{},"biologicalEvents":[{"object":{}}],"id":1447}
{"title":"activation of CCAAT/enhancer-binding protein alpha","references":"","biologicalOrganisationLevel":"Molecular","organTerm":{},"biologicalEvents":[{"object":{}}],"id":1448}
{"title":"increased adipogenesis","references":"","biologicalOrganisationLevel":"Tissue","organTerm":{},"biologicalEvents":[{"object":{}}],"id":1449}
{"title":"decreased dopamine","references":"","biologicalOrganisationLevel":"Molecular","organTerm":{},"biologicalEvents":[{"object":{}}],"id":1450}
{"title":"decreased reward","references":"","biologicalOrganisationLevel":"Individual","organTerm":{},"biologicalEvents":[{"object":{}}],"id":1451}
{"title":"decreased DNA methylation of tyrosine hydroxylase","references":"","biologicalOrganisationLevel":"Cellular","organTerm":{},"biologicalEvents":[{"object":{}}],"id":1452}
{"title":"decreased methylation of dopamine transporter promoter","references":"","biologicalOrganisationLevel":"Cellular","organTerm":{},"biologicalEvents":[{"object":{}}],"id":1453}
{"title":"chronic high fat diet","references":"","biologicalOrganisationLevel":"Individual","organTerm":{},"biologicalEvents":[{"object":{}}],"id":1454}
{"title":"Inhibition, Inhibition of Dopamine-beta-hydroxylase","references":"","biologicalOrganisationLevel":"Molecular","organTerm":{},"biologicalEvents":[{"action":"decreased","process":"dopamine beta-monooxygenase activity","object":{"name":"dopamine beta-hydroxylase","source":"PR","sourceId":"PR:000006294"}}],"id":526}
{"title":"Decreased, Decreased fecundity ","references":"","biologicalOrganisationLevel":"Individual","organTerm":{},"biologicalEvents":[{"action":"decreased","object":{"name":"fertility","source":"MESH","sourceId":"D005298"}},{"action":"decreased","process":"reduced fertility","object":{"name":"fertility","source":"MESH","sourceId":"D005298"}}],"id":527}
{"title":"Decreased, Decreased fecundity ","references":"","biologicalOrganisationLevel":"Individual","organTerm":{},"biologicalEvents":[{"action":"decreased","object":{"name":"fertility","source":"MESH","sourceId":"D005298"}},{"action":"decreased","process":"reduced fertility","object":{"name":"fertility","source":"MESH","sourceId":"D005298"}}],"id":527}
{"title":"Decreased, Synthesis of NE","references":"","biologicalOrganisationLevel":"Cellular","organTerm":{},"biologicalEvents":[{"action":"decreased","process":"norepinephrine biosynthetic process","object":{"name":"(R)-noradrenaline","source":"CHEBI","sourceId":"CHEBI:18357"}}],"id":528}
{"title":"Decreased, GnRH cfos activity","references":"","biologicalOrganisationLevel":"Molecular","organTerm":{},"biologicalEvents":[{"action":"decreased","process":"signaling","object":{"name":"proto-oncogene c-Fos (mouse)","source":"PR","sourceId":"PR:P01101"}}],"id":529}
{"title":"Decreased, GnRH pulsatility/release","references":"","biologicalOrganisationLevel":"Cellular","organTerm":{},"biologicalEvents":[{"action":"decreased","process":"hormone secretion","object":{"name":"Gonadotropin Releasing Hormone","source":"MESH","sourceId":"D007987"}}],"id":530}
{"title":"Decreased, LH Surge","references":"","biologicalOrganisationLevel":"Cellular","organTerm":{},"biologicalEvents":[{"action":"decreased","process":"regulation of luteinizing hormone secretion","object":{"name":"Luteinizing hormone","source":"CHEBI","sourceId":"CHEBI:81568"}},{"action":"decreased","process":"hormone secretion","object":{"name":"Luteinizing hormone","source":"CHEBI","sourceId":"CHEBI:81568"}}],"id":531}
{"title":"Decreased, LH Surge","references":"","biologicalOrganisationLevel":"Cellular","organTerm":{},"biologicalEvents":[{"action":"decreased","process":"regulation of luteinizing hormone secretion","object":{"name":"Luteinizing hormone","source":"CHEBI","sourceId":"CHEBI:81568"}},{"action":"decreased","process":"hormone secretion","object":{"name":"Luteinizing hormone","source":"CHEBI","sourceId":"CHEBI:81568"}}],"id":531}
{"title":"Delayed, Ovulation","references":"","biologicalOrganisationLevel":"Individual","organTerm":{},"biologicalEvents":[{"action":"delayed","process":"abnormal ovulation","object":{}}],"id":532}
{"title":"Decreased, Cortical granule release/distribution upon fertilization","references":"","biologicalOrganisationLevel":"Cellular","organTerm":{},"biologicalEvents":[{"action":"decreased","process":"secretion","object":{"name":"cortical granule","source":"GO","sourceId":"GO:0060473"}}],"id":533}
{"title":"Altered, Formation of cortical envelope","references":"","biologicalOrganisationLevel":"Cellular","organTerm":{},"biologicalEvents":[{"action":"abnormal","object":{"name":"fertilization envelope","source":"GO","sourceId":"GO:0060387"}}],"id":534}
{"title":"Abnormal, Sperm penetration (polyspermy)","references":"","biologicalOrganisationLevel":"Cellular","organTerm":{},"biologicalEvents":[{"action":"abnormal","process":"sperm entry","object":{}}],"id":535}
{"title":"Altered, Chromosome number (polyploid) zygote","references":"","biologicalOrganisationLevel":"Cellular","organTerm":{},"biologicalEvents":[{"action":"increased","process":"abnormal chromosome number","object":{}}],"id":536}
{"title":"Decreased fertility in the adult, Decreased sperm quantity and/or quality in the adult testis","references":"","biologicalOrganisationLevel":"Individual","organTerm":{},"biologicalEvents":[{"action":"decreased","object":{"name":"fertility","source":"MESH","sourceId":"D005298"}},{"action":"decreased","object":{"name":"sperm","source":"CL","sourceId":"CL:0000019"}}],"id":543}
{"title":"Decreased fertility in the adult, Decreased sperm quantity and/or quality in the adult testis","references":"","biologicalOrganisationLevel":"Individual","organTerm":{},"biologicalEvents":[{"action":"decreased","object":{"name":"fertility","source":"MESH","sourceId":"D005298"}},{"action":"decreased","object":{"name":"sperm","source":"CL","sourceId":"CL:0000019"}}],"id":543}
{"title":"Decreased testosterone by the fetal Leydig cells, Hypermethylation in the fetal testis","references":"","biologicalOrganisationLevel":"Molecular","organTerm":{},"biologicalEvents":[{"action":"increased","process":"DNA hypermethylation","object":{}}],"id":662}
{"title":"Decreased testosterone by the fetal Leydig cells, Dysgensis of fetal Leydig cells","references":"","biologicalOrganisationLevel":"Organ","organTerm":{},"biologicalEvents":[{"action":"increased","process":"abnormal fetal Leydig cell differentiation","object":{}},{"action":"increased","process":"Testicular dysgenesis","object":{}}],"id":540}
{"title":"Decreased testosterone by the fetal Leydig cells, Dysgensis of fetal Leydig cells","references":"","biologicalOrganisationLevel":"Organ","organTerm":{},"biologicalEvents":[{"action":"increased","process":"abnormal fetal Leydig cell differentiation","object":{}},{"action":"increased","process":"Testicular dysgenesis","object":{}}],"id":540}
{"title":"Decreased testosterone by the fetal Leydig cells, Decreased COUP-TFII stem Leydig cells","references":"","biologicalOrganisationLevel":"Cellular","organTerm":{},"biologicalEvents":[{"action":"decreased","process":"receptor transactivation","object":{"name":"COUP transcription factor 2","source":"PR","sourceId":"PR:000011405"}},{"action":"increased","process":"abnormal adult Leydig cell differentiation","object":{}}],"id":541}
{"title":"Decreased testosterone by the fetal Leydig cells, Decreased COUP-TFII stem Leydig cells","references":"","biologicalOrganisationLevel":"Cellular","organTerm":{},"biologicalEvents":[{"action":"decreased","process":"receptor transactivation","object":{"name":"COUP transcription factor 2","source":"PR","sourceId":"PR:000011405"}},{"action":"increased","process":"abnormal adult Leydig cell differentiation","object":{}}],"id":541}
{"title":"Activation, Nicotinic acetylcholine receptor","references":"<p>LaLone, C.A., Villeneuve, D.L., Wu-Smart, J., Milsk, R.Y., Sappington, K., Garber, K.V., Housenger, J. and Ankley, G.T., 2017. Weight of evidence evaluation of a network of adverse outcome pathways linking activation of the nicotinic acetylcholine receptor in honey bees to colony death.<em> </em>STOTEN. 584-585, 751-775.</p>\n\n<p>Karlin, A., 2002. Emerging structure of the nicotinic acetylcholine receptors. Nat. Rev.<br />\nNeurosci. 3 (2), 102&ndash;114.</p>\n\n<p>Jones, A.K., Sattelle, D.B., 2010. Diversity of insect nicotinic acetylcholine receptor subunits.<br />\nAdv. Exp. Med. Biol. 683, 25&ndash;43.</p>\n\n<p>Lindstrom, J.M., 2003. Nicotinic acetylcholine receptors of muscles and nerves. Ann. N. Y.<br />\nAcad. Sci. 998 (1), 41&ndash;52.</p>\n\n<p>Tomizawa,M., Casida, J.E., 2003. Selective toxicity of neonictinoids attributable to specificity<br />\nof insect and mammalian nicotinic receptors. Annu. Rev. Entomol. 48, 339&ndash;364.</p>\n\n<p>Dani, J.A., Bertrand, D.D., 2007. Nicotinic acetylcholine receptors and nicotinic cholinergic<br />\nmechanisms of the central nervous system.Annu. Rev. Pharmacol. Toxicol. 47, 699&ndash;729.</p>\n\n<p>Matsuda, K., Kanaoka, S., Akamatsu,M., Sattelle, D.B., 2009. Diverse actions and target-site<br />\nselectivity of neonicotinoids: structural insights. Mol. Pharmacol. 76 (1), 1&ndash;10.</p>\n\n<p>LaLone, C.A., Villeneuve, D.L., Lyons, D., Helgen, H.W., Robinson, S.L., Swintek, J.A., Saari,<br />\nT.W., Ankley, G.T., 2016. Sequence alignment to predict across species susceptibility<br />\n(SeqAPASS): a web-based tool for addressing the challenges of cross-species extrapolation<br />\nof chemical toxicity. Toxicol. Sci. 153 (2), 228&ndash;245.</p>\n","biologicalOrganisationLevel":"Molecular","organTerm":{},"biologicalEvents":[{"action":"increased","process":"acetylcholine receptor activity","object":{"name":"Nicotinic acetylcholine receptor","source":"FMA","sourceId":"FMA:61796"}}],"keyEventStressors":["2-Imidazolidinimine, 1-[(6-chloro-3-pyridinyl)methyl]-N-nitro-, (2E)-"],"id":559}
{"title":"Abnormal, Foraging activity and behavior","references":"<p>LaLone, C.A., Villeneuve, D.L., Wu-Smart, J., Milsk, R.Y., Sappington, K., Garber, K.V., Housenger, J. and Ankley, G.T., 2017. Weight of evidence evaluation of a network of adverse outcome pathways linking activation of the nicotinic acetylcholine receptor in honey bees to colony death.<em> </em>STOTEN. 584-585, 751-775.</p>\n\n<p>Brodschneider, R., Crailsheim, K., 2010. Nutrition and health in honey bees. Apidologie 41<br />\n(3), 278&ndash;294.</p>\n\n<p>Jones, J.C., Oldroyd, B.P., 2006. Nest thermoregulation in social insects. Adv. Insect Physiol.<br />\n33, 153&ndash;191.</p>\n\n<p>Free, J.B., 1959. The transfer of food between the adult members of a honeybee community.<br />\nBee World 40 (8), 193&ndash;201.</p>\n\n<p>Winston, M.L., 1987. The Biology of the Honey Bee. Harvard University Press.</p>\n\n<p>Seeley, T.D., Visscher, P.K., 1985. Survival of honeybees in cold climates: the critical timing<br />\nof colony growth and reproduction. Ecol. Entomol. 10 (1), 81&ndash;88.</p>\n\n<p>Woyciechowski, M., Moro, D., 2009. Life expectancy and onset of foraging in the honeybee<br />\n(Apis mellifera). Insect. Soc. 56 (2), 193&ndash;201.</p>\n\n<p>Dreller, C., Tarpy, D.R., 2000. Perception of the pollen need by foragers in a honeybee colony.<br />\nAnim. Behav. 59 (1), 91&ndash;96.</p>\n\n<p>Kammer, A.E., Heinrich, B., 1978. Insect flight metabolism. Adv. Insect Physiol. 13,<br />\n133&ndash;228.</p>\n\n<p>Withers, G.S., Fahrbach, S.E., Robinson, G.E., 1995. Effects of experience and juvenile hormone<br />\non the organization of the mushroom bodies of honey bees. J. Neurobiol. 26<br />\n(1), 130&ndash;144.</p>\n\n<p>Chang, L.H., Barron, A.B., Cheng, K., 2015. Effects of the juvenile hormone analogue<br />\nmethoprene on rate of behavioural development, foraging performance and navigation<br />\nin honey bees (Apis mellifera). J. Exp. Biol. 218 (11), 1715&ndash;1724.</p>\n\n<p>Toth, A.L., Robinson, G.E., 2005. Worker nutrition and division of labour in honeybees.<br />\nAnim. Behav. 69, 427&ndash;435.</p>\n\n<p>Correa-Fernandez, F., Cruz-Landim, C., 2010. Differential flight muscle development in<br />\nworkers, queens and males of the eusocial bees, Apis mellifera and Scaptotrigona<br />\npostica. J. Insect Sci. 10, 85.</p>\n","biologicalOrganisationLevel":"Individual","organTerm":{},"biologicalEvents":[{"action":"abnormal","process":"foraging behavior","object":{}}],"id":560}
{"title":"Death/Failure, Colony","references":"<p>LaLone, C.A., Villeneuve, D.L., Wu-Smart, J., Milsk, R.Y., Sappington, K., Garber, K.V., Housenger, J. and Ankley, G.T., 2017. Weight of evidence evaluation of a network of adverse outcome pathways linking activation of the nicotinic acetylcholine receptor in honey bees to colony death.<em> </em>STOTEN. 584-585, 751-775.</p>\n\n<p>Potts, S.G., Biesmeijer, J.C., Kremen, C., Neumann, P., Schweiger, O., Kunin, W.E., 2010.<br />\nGlobal pollinator declines: trends, impacts and drivers. Trends Ecol. Evol. 25 (6),<br />\n345&ndash;353.</p>\n\n<p>Seitz, N., Traynor, K.S., Steinhauer, N., Rennich, K., Wilson, M.E., Ellis, D., Rose, R., Tarpy,<br />\nD.R., Sagili, R.R., Caron, D.M., Delaplane, K.S., Rangel, J., Lee, K., Baylis, K., Wilkes, J.T.,<br />\nSkinner, J.A., Pettis, J.S., vanEngelsdorp, D., 2015. A national survey of managed<br />\nhoney bee 2014&ndash;2015 annual colony losses in the USA. J. Apic. Res. 54 (4), 1&ndash;12.</p>\n\n<p>&nbsp;</p>\n","biologicalOrganisationLevel":"Population","organTerm":{},"biologicalEvents":[{"action":"increased","process":"colony collapse","object":{}}],"id":563}
{"title":"Weakened, Colony","references":"<p>LaLone, C.A., Villeneuve, D.L., Wu-Smart, J., Milsk, R.Y., Sappington, K., Garber, K.V., Housenger, J. and Ankley, G.T., 2017. Weight of evidence evaluation of a network of adverse outcome pathways linking activation of the nicotinic acetylcholine receptor in honey bees to colony death.<em> </em>STOTEN. 584-585, 751-775.</p>\n\n<p>Sagili, R.R., Burgett, D.M., 2011. Evaluating honey bee colonies for pollination: a guide for<br />\ncommercial growers and beekeepers. A Pacific Northwest Extension Publication. vol.<br />\n623, pp. 1&ndash;8.</p>\n\n<p>Khoury, D.S.,Myerscough,M.R., Barron, A.B., 2011. A quantitativemodel of honey bee colony<br />\npopulation dynamics. PLoS One 6 (4), e18491.</p>\n\n<p>&nbsp;</p>\n","biologicalOrganisationLevel":"Population","organTerm":{},"biologicalEvents":[{"action":"increased","process":"colony collapse","object":{}}],"id":1107}
{"title":"Altered, Ca2+-calmodulin activated signal transduction","references":"<p>LaLone, C.A., Villeneuve, D.L., Wu-Smart, J., Milsk, R.Y., Sappington, K., Garber, K.V., Housenger, J. and Ankley, G.T., 2017. Weight of evidence evaluation of a network of adverse outcome pathways linking activation of the nicotinic acetylcholine receptor in honey bees to colony death.<em> </em>STOTEN. 584-585, 751-775.</p>\n\n<p>Uteshev, V.V., 2012. alpha7 nicotinic ACh receptors as a ligand-gated source of Ca(2+)<br />\nions: the search for a Ca(2+) optimum. Adv. Exp. Med. Biol. 740, 603&ndash;638.</p>\n\n<p>Dajas-Bailador, F., Wonnacott, S., 2004. Nicotinic acetylcholine receptors and the regulation<br />\nof neuronal signalling. Trends Pharmacol. Sci. 25 (6), 317&ndash;324.</p>\n\n<p>Sweatt, J.D., 2001. The neuronalmap kinase cascade: a biochemical signal integration system<br />\nsubserving synaptic plasticity and memory. J. Neurochem. 76, 1&ndash;10.</p>\n\n<p>Impey, S., Obrietan, K., Storm, D.R., 1999. Making new connections: role of ERK/MAP kinase<br />\nsignaling in neuronal plasticity. Neuron 23, 11&ndash;14.</p>\n","biologicalOrganisationLevel":"Cellular","organTerm":{},"biologicalEvents":[{"action":"abnormal","process":"binding","object":{"name":"calcium ion","source":"CHEBI","sourceId":"CHEBI:39124"}},{"action":"abnormal","process":"signaling","object":{"name":"calmodulin","source":"PR","sourceId":"PR:000004978"}},{"action":"abnormal","process":"calmodulin binding","object":{"name":"calcium ion","source":"CHEBI","sourceId":"CHEBI:39124"}}],"id":1243}
{"title":"Altered, Ca2+-calmodulin activated signal transduction","references":"<p>LaLone, C.A., Villeneuve, D.L., Wu-Smart, J., Milsk, R.Y., Sappington, K., Garber, K.V., Housenger, J. and Ankley, G.T., 2017. Weight of evidence evaluation of a network of adverse outcome pathways linking activation of the nicotinic acetylcholine receptor in honey bees to colony death.<em> </em>STOTEN. 584-585, 751-775.</p>\n\n<p>Uteshev, V.V., 2012. alpha7 nicotinic ACh receptors as a ligand-gated source of Ca(2+)<br />\nions: the search for a Ca(2+) optimum. Adv. Exp. Med. Biol. 740, 603&ndash;638.</p>\n\n<p>Dajas-Bailador, F., Wonnacott, S., 2004. Nicotinic acetylcholine receptors and the regulation<br />\nof neuronal signalling. Trends Pharmacol. Sci. 25 (6), 317&ndash;324.</p>\n\n<p>Sweatt, J.D., 2001. The neuronalmap kinase cascade: a biochemical signal integration system<br />\nsubserving synaptic plasticity and memory. J. Neurochem. 76, 1&ndash;10.</p>\n\n<p>Impey, S., Obrietan, K., Storm, D.R., 1999. Making new connections: role of ERK/MAP kinase<br />\nsignaling in neuronal plasticity. Neuron 23, 11&ndash;14.</p>\n","biologicalOrganisationLevel":"Cellular","organTerm":{},"biologicalEvents":[{"action":"abnormal","process":"binding","object":{"name":"calcium ion","source":"CHEBI","sourceId":"CHEBI:39124"}},{"action":"abnormal","process":"signaling","object":{"name":"calmodulin","source":"PR","sourceId":"PR:000004978"}},{"action":"abnormal","process":"calmodulin binding","object":{"name":"calcium ion","source":"CHEBI","sourceId":"CHEBI:39124"}}],"id":1243}
{"title":"Altered, Ca2+-calmodulin activated signal transduction","references":"<p>LaLone, C.A., Villeneuve, D.L., Wu-Smart, J., Milsk, R.Y., Sappington, K., Garber, K.V., Housenger, J. and Ankley, G.T., 2017. Weight of evidence evaluation of a network of adverse outcome pathways linking activation of the nicotinic acetylcholine receptor in honey bees to colony death.<em> </em>STOTEN. 584-585, 751-775.</p>\n\n<p>Uteshev, V.V., 2012. alpha7 nicotinic ACh receptors as a ligand-gated source of Ca(2+)<br />\nions: the search for a Ca(2+) optimum. Adv. Exp. Med. Biol. 740, 603&ndash;638.</p>\n\n<p>Dajas-Bailador, F., Wonnacott, S., 2004. Nicotinic acetylcholine receptors and the regulation<br />\nof neuronal signalling. Trends Pharmacol. Sci. 25 (6), 317&ndash;324.</p>\n\n<p>Sweatt, J.D., 2001. The neuronalmap kinase cascade: a biochemical signal integration system<br />\nsubserving synaptic plasticity and memory. J. Neurochem. 76, 1&ndash;10.</p>\n\n<p>Impey, S., Obrietan, K., Storm, D.R., 1999. Making new connections: role of ERK/MAP kinase<br />\nsignaling in neuronal plasticity. Neuron 23, 11&ndash;14.</p>\n","biologicalOrganisationLevel":"Cellular","organTerm":{},"biologicalEvents":[{"action":"abnormal","process":"binding","object":{"name":"calcium ion","source":"CHEBI","sourceId":"CHEBI:39124"}},{"action":"abnormal","process":"signaling","object":{"name":"calmodulin","source":"PR","sourceId":"PR:000004978"}},{"action":"abnormal","process":"calmodulin binding","object":{"name":"calcium ion","source":"CHEBI","sourceId":"CHEBI:39124"}}],"id":1243}
{"title":"Abnormal, Roll change within caste","references":"","biologicalOrganisationLevel":"Population","organTerm":{},"biologicalEvents":[{"object":{}}],"id":564}
{"title":"Reduced, Brood care","references":"","biologicalOrganisationLevel":"Population","organTerm":{},"biologicalEvents":[{"action":"decreased","process":"reproductive behavior","object":{}},{"action":"decreased","process":"abnormal maternal nurturing","object":{}}],"id":565}
{"title":"Reduced, Brood care","references":"","biologicalOrganisationLevel":"Population","organTerm":{},"biologicalEvents":[{"action":"decreased","process":"reproductive behavior","object":{}},{"action":"decreased","process":"abnormal maternal nurturing","object":{}}],"id":565}
{"title":"impaired, Larval development","references":"","biologicalOrganisationLevel":"Population","organTerm":{},"biologicalEvents":[{"action":"abnormal","process":"larval development","object":{}}],"id":566}
{"title":"impaired, Hive thermoregulation","references":"","biologicalOrganisationLevel":"Population","organTerm":{},"biologicalEvents":[{"action":"abnormal","process":"thermoregulation behavior","object":{}}],"id":568}
{"title":"Accumulation, Damaged mitochondrial DNA","references":"","biologicalOrganisationLevel":"Cellular","organTerm":{},"biologicalEvents":[{"action":"functional change","process":"response to wounding","object":{"name":"Mitochondrial deoxyribonucleic acid","source":"FMA","sourceId":"FMA:67199"}}],"id":570}
{"title":"Accelerated, Aging","references":"","biologicalOrganisationLevel":"Individual","organTerm":{},"biologicalEvents":[{"action":"premature","process":"aging","object":{}}],"id":571}
{"title":"Decrease, Number of worker bees","references":"","biologicalOrganisationLevel":"Population","organTerm":{},"biologicalEvents":[{"action":"decreased","object":{"name":"population of organisms","source":"PCO","sourceId":"PCO:0000001"}}],"id":572}
{"title":"Overwhelmed, Mitochondrial DNA repair mechanisms","references":"","biologicalOrganisationLevel":"Cellular","organTerm":{},"biologicalEvents":[{"action":"abnormal","process":"DNA repair","object":{"name":"Mitochondrial deoxyribonucleic acid","source":"FMA","sourceId":"FMA:67199"}}],"id":664}
{"title":"Increase, Energetic demands and therefore metabolic stress","references":"","biologicalOrganisationLevel":"Individual","organTerm":{},"biologicalEvents":[{"action":"increased","process":"increased energy expenditure","object":{}},{"action":"increased","process":"Stress, Physiological","object":{}}],"id":573}
{"title":"Increase, Energetic demands and therefore metabolic stress","references":"","biologicalOrganisationLevel":"Individual","organTerm":{},"biologicalEvents":[{"action":"increased","process":"increased energy expenditure","object":{}},{"action":"increased","process":"Stress, Physiological","object":{}}],"id":573}
{"title":"Increased, Appetite and hunger","references":"","biologicalOrganisationLevel":"Individual","organTerm":{},"biologicalEvents":[{"action":"increased","process":"Appetite","object":{}}],"id":574}
{"title":"Increased, Viral susceptibility","references":"","biologicalOrganisationLevel":"Individual","organTerm":{},"biologicalEvents":[{"action":"increased","process":"increased susceptibility to viral infection","object":{}}],"id":576}
{"title":"impaired, Development","references":"","biologicalOrganisationLevel":"Individual","organTerm":{},"biologicalEvents":[{"action":"abnormal","process":"developmental process","object":{}}],"id":577}
{"title":"Decreased, Glucose oxidase enzyme activity","references":"","biologicalOrganisationLevel":"Molecular","organTerm":{},"biologicalEvents":[{"action":"decreased","process":"glucose oxidase activity","object":{"name":"D-glucono-1,5-lactone","source":"CHEBI","sourceId":"CHEBI:16217"}}],"id":578}
{"title":"Decreased, Hydrogen peroxide production","references":"","biologicalOrganisationLevel":"Molecular","organTerm":{},"biologicalEvents":[{"action":"decreased","process":"hydrogen peroxide biosynthetic process","object":{"name":"hydrogen peroxide","source":"CHEBI","sourceId":"CHEBI:16240"}}],"id":579}
{"title":"Reduced, Antiseptic incorporated in food","references":"","biologicalOrganisationLevel":"Population","organTerm":{},"biologicalEvents":[{"object":{}}],"id":580}
{"title":"Reduced, Food storage","references":"","biologicalOrganisationLevel":"Population","organTerm":{},"biologicalEvents":[{"action":"decreased","process":"feeding behavior","object":{}}],"id":561}
{"title":"Abnormal, Role change within caste","references":"<p>LaLone, C.A., Villeneuve, D.L., Wu-Smart, J., Milsk, R.Y., Sappington, K., Garber, K.V., Housenger, J. and Ankley, G.T., 2017. Weight of evidence evaluation of a network of adverse outcome pathways linking activation of the nicotinic acetylcholine receptor in honey bees to colony death.<em> </em>STOTEN. 584-585, 751-775.</p>\n\n<p>Seeley, T.D., 1982. Adaptive significance of the age polyethism schedule in honeybee colonies.<br />\nBehav. Ecol. Sociobiol. 11 (4), 287&ndash;293.</p>\n\n<p>Ament, S.A., Wang, Y., Robinson, G.E., 2010. Nutritional regulation of division of labor in<br />\nhoney bees: toward a systems biology perspective. Wiley Interdiscip. Rev. Syst. Biol.<br />\nMed. 2 (5), 566&ndash;576.</p>\n\n<p>Cheng, L.H., Barron, A.B., Cheng, K., 2015. Effects of the juvenile hormone analogue<br />\nmethoprene on rate of behavioural development, foraging performance and navigation<br />\nin honey bees (Apis mellifera). J. Exp. Biol. 218, 1715&ndash;1724.</p>\n\n<p>Huang, Z.Y., Robinson, G.E., 1996. Regulation of honey bee division of labor by colony age<br />\ndemography. Behav. Ecol. Sociobiol. 39 (3), 147&ndash;158.</p>\n\n<p>Woyciechowski, M., Moro, D., 2009. Life expectancy and onset of foraging in the honeybee<br />\n(Apis mellifera). Insect. Soc. 56 (2), 193&ndash;201.</p>\n\n<p>Page Jr., R.E., Rueppell, O., Amdam, G.V., 2012. Genetics of reproduction and regulation of<br />\nhoneybee (Apis mellifera L.) social behavior. Annu. Rev. Genet. 46, 97&ndash;119.</p>\n\n<p>Chang, L.H., Barron, A.B., Cheng, K., 2015. Effects of the juvenile hormone analogue<br />\nmethoprene on rate of behavioural development, foraging performance and navigation<br />\nin honey bees (Apis mellifera). J. Exp. Biol. 218 (11), 1715&ndash;1724.</p>\n\n<p>Perry, C., S&oslash;vik, E., Myerscough, M.R., Barron, A.B., 2015. Rapid behavioral maturation accelerates<br />\nfailure of stressed honey bee colonies. Proc. Natl. Acad. Sci. U. S. A. 112 (11),<br />\n3427&ndash;3432.</p>\n\n<p>Sullivan, J.P., Fahrbach, S.E., Harrison, J.F., Capaldi, E.A., Fewell, J.H., Robinson, G.E., 2003.<br />\nJuvenile hormone and division of labor in honey bee colonies: effects of allatectomy<br />\non flight behavior and metabolism. J. Exp. Biol. 206 (13), 2287&ndash;2296.</p>\n\n<p>Guidugli, K.R., Nascimento, A.M., Amdam, G.V., Barchuk, A.R., Omholt, S., Sim&otilde;es, Z.L.P.,<br />\nHartfelder, K., 2005. Vitellogenin regulates hormonal dynamics in the worker caste<br />\nof a eusocial insect. FEBS Lett. 579, 4961&ndash;4965.</p>\n\n<p>Marco Antonio, D.S., Guidugli-Lazzarini, K.R., do Nascimento, A.M., Sim&otilde;es, Z.L., Harfelder,<br />\nK., 2008. RNAi-mediated silencing of vitellogenin gene function turns honeybee (Apis<br />\nmellifera) workers into extremely precocious foragers. Naturwissenschaften 95 (10),<br />\n953&ndash;961.</p>\n\n<p>Corona,M., Velarde, R.A., Remolina, S.,Moran-Lauter, A.,Wang, Y., Hughes, K.A., Robinson,<br />\nG.E., 2007. Vitellogenin, juvenile hormone, insulin signaling, and queen honey bee<br />\nlongevity. Proc. Natl. Acad. Sci. 104 (17), 7128&ndash;7133.</p>\n\n<p>Seehuus, S.C., Norberg, K., Gimsa, U., Krekling, T., Amdam, G.V., 2006. Reproductive protein<br />\nprotects functionally sterile honey bee workers from oxidative stress. PNAS<br />\n103 (4), 962&ndash;967.</p>\n\n<p>Amdam, G.V., Sim&otilde;es, Z.L., Hagen, A., Norber, K., Schr&oslash;der, K., Mikkelsen, &Oslash;., Kirkwood,<br />\nT.B., Omholtk, S.W., 2004. Hormonal control of the yolk precursor vitellogenin regulates<br />\nimmune function and longevity in honeybees. Exp. Gerontol. 39 (5), 767&ndash;773.</p>\n\n<p>&nbsp;</p>\n","biologicalOrganisationLevel":"Population","organTerm":{},"biologicalEvents":[{"action":"abnormal","process":"role","object":{}}],"id":1108}
{"title":"Desensitization, Nicotinic acetylcholine receptor","references":"<p>LaLone, C.A., Villeneuve, D.L., Wu-Smart, J., Milsk, R.Y., Sappington, K., Garber, K.V., Housenger, J. and Ankley, G.T., 2017. Weight of evidence evaluation of a network of adverse outcome pathways linking activation of the nicotinic acetylcholine receptor in honey bees to colony death.<em> </em>STOTEN. 584-585, 751-775.</p>\n\n<p>Quick, M.W., Lester, R.A., 2002. Desensitization of neuronal nicotinic receptors.<br />\nJ. Neurobiol. 53 (4), 457&ndash;478.</p>\n\n<p>Srinivasan, R., Richards, C.I., Xiao, C., Rhee, D., Pantoja, R., Dougherty, D.A., Miwa, J.M.,<br />\nLester, H.A., 2012. Pharmacological chaperoning of nicotinic acetylcholine receptors<br />\nreduces the endoplasmic reticulumstress response.Mol. Pharmacol. 81 (6), 759&ndash;769.</p>\n\n<p>Flores, C.M., Rogers, S.W., Pabreza, L.A.,Wolfe, B.B., Kellar, K.J., 1992. A subtype of nicotinic<br />\ncholinergic receptor in rat brain is composed of alpha 4 and beta 2 subunits and is upregulated<br />\nby chronic nicotine treatment. Mol. Pharmacol. 41 (1), 31&ndash;37.</p>\n\n<p>Marszalec, W., Yeh, J.Z., Narahashi, T., 2005. Desensitization of nicotine acetylcholine receptors:<br />\nmodulation by kinase activation and phosphatase inhibition. Eur.<br />\nJ. Pharmacol. 514 (2&ndash;3), 83&ndash;90.</p>\n\n<p>Christen, V., Mittnter, F., Fent, K., 2016. Molecular effects of neonicotinoids in honey bees<br />\n(Apis mellifera). Environ. Sci. Technol. 50 (7), 4071&ndash;4081.</p>\n\n<p>Ochoa, E.L., Chattopadhyay, A., McNamee, M.G., 1989. Desensitization of the nicotinic acetylcholine<br />\nreceptor: molecular mechanisms and effect of modulators. Cell. Mol.<br />\nNeurobiol. 9 (2), 141&ndash;178.</p>\n\n<p>Simasko, S.M., Soares, J.R., Weiland, G.A., 1986. Two components of carbamylcholine-induced<br />\nloss of nicotinic acetylcholine receptor function in the neuronal cell line<br />\nPC12. Mol. Pharmacol. 30 (1), 6&ndash;12.</p>\n\n<p>Hopfield, J.F., Tank, D.W., Greengard, P., Huganir, R.L., 1988. Functional modulation of the<br />\nnicotinic acetylcholine receptor by tyrosine phosphorylation. Nature 336 (6200),<br />\n677&ndash;680.</p>\n\n<p>Thany, S.H., Lenaers, G., Raymond-Delpech, V., Sattelle, D.B., Lapied, B., 2007. Exploring the<br />\npharmacological properties of insect nicotinic acetylcholine receptors. Trends<br />\nPharmacol. Sci. 28 (1), 14&ndash;22.</p>\n\n<p>&nbsp;</p>\n","biologicalOrganisationLevel":"Molecular","organTerm":{},"biologicalEvents":[{"action":"increased","process":"acetylcholine receptor activator activity","object":{"name":"Nicotinic acetylcholine receptor","source":"FMA","sourceId":"FMA:61796"}},{"action":"decreased","process":"receptor regulator activity","object":{}}],"id":663}
{"title":"Desensitization, Nicotinic acetylcholine receptor","references":"<p>LaLone, C.A., Villeneuve, D.L., Wu-Smart, J., Milsk, R.Y., Sappington, K., Garber, K.V., Housenger, J. and Ankley, G.T., 2017. Weight of evidence evaluation of a network of adverse outcome pathways linking activation of the nicotinic acetylcholine receptor in honey bees to colony death.<em> </em>STOTEN. 584-585, 751-775.</p>\n\n<p>Quick, M.W., Lester, R.A., 2002. Desensitization of neuronal nicotinic receptors.<br />\nJ. Neurobiol. 53 (4), 457&ndash;478.</p>\n\n<p>Srinivasan, R., Richards, C.I., Xiao, C., Rhee, D., Pantoja, R., Dougherty, D.A., Miwa, J.M.,<br />\nLester, H.A., 2012. Pharmacological chaperoning of nicotinic acetylcholine receptors<br />\nreduces the endoplasmic reticulumstress response.Mol. Pharmacol. 81 (6), 759&ndash;769.</p>\n\n<p>Flores, C.M., Rogers, S.W., Pabreza, L.A.,Wolfe, B.B., Kellar, K.J., 1992. A subtype of nicotinic<br />\ncholinergic receptor in rat brain is composed of alpha 4 and beta 2 subunits and is upregulated<br />\nby chronic nicotine treatment. Mol. Pharmacol. 41 (1), 31&ndash;37.</p>\n\n<p>Marszalec, W., Yeh, J.Z., Narahashi, T., 2005. Desensitization of nicotine acetylcholine receptors:<br />\nmodulation by kinase activation and phosphatase inhibition. Eur.<br />\nJ. Pharmacol. 514 (2&ndash;3), 83&ndash;90.</p>\n\n<p>Christen, V., Mittnter, F., Fent, K., 2016. Molecular effects of neonicotinoids in honey bees<br />\n(Apis mellifera). Environ. Sci. Technol. 50 (7), 4071&ndash;4081.</p>\n\n<p>Ochoa, E.L., Chattopadhyay, A., McNamee, M.G., 1989. Desensitization of the nicotinic acetylcholine<br />\nreceptor: molecular mechanisms and effect of modulators. Cell. Mol.<br />\nNeurobiol. 9 (2), 141&ndash;178.</p>\n\n<p>Simasko, S.M., Soares, J.R., Weiland, G.A., 1986. Two components of carbamylcholine-induced<br />\nloss of nicotinic acetylcholine receptor function in the neuronal cell line<br />\nPC12. Mol. Pharmacol. 30 (1), 6&ndash;12.</p>\n\n<p>Hopfield, J.F., Tank, D.W., Greengard, P., Huganir, R.L., 1988. Functional modulation of the<br />\nnicotinic acetylcholine receptor by tyrosine phosphorylation. Nature 336 (6200),<br />\n677&ndash;680.</p>\n\n<p>Thany, S.H., Lenaers, G., Raymond-Delpech, V., Sattelle, D.B., Lapied, B., 2007. Exploring the<br />\npharmacological properties of insect nicotinic acetylcholine receptors. Trends<br />\nPharmacol. Sci. 28 (1), 14&ndash;22.</p>\n\n<p>&nbsp;</p>\n","biologicalOrganisationLevel":"Molecular","organTerm":{},"biologicalEvents":[{"action":"increased","process":"acetylcholine receptor activator activity","object":{"name":"Nicotinic acetylcholine receptor","source":"FMA","sourceId":"FMA:61796"}},{"action":"decreased","process":"receptor regulator activity","object":{}}],"id":663}
{"title":"Inhibition, sodium channel","references":"<p>Ragsdale, D.S. and Avoli, M. 1998. Sodium channels as molecular targets for antiepileptic drugs. Brain Research Reviews 26:16-28.\n</p><p>Pless, S.A., Galpin, J.D., Frankel, A., and Ahern, C.A. 2011. Molecular basis for class Ib anti-arrhythmic inhibition of cardiac sodium channels. Nat Commun 2:351.\n</p>","biologicalOrganisationLevel":"Molecular","organTerm":{},"biologicalEvents":[{"action":"decreased","process":"sodium channel inhibitor activity","object":{"name":"sodium channel protein type 1 subunit alpha","source":"PR","sourceId":"PR:000002095"}},{"action":"decreased","process":"signaling","object":{"name":"sodium channel protein type 1 subunit alpha","source":"PR","sourceId":"PR:000002095"}}],"keyEventStressors":["Valproate","Topiramate","Tetrodotoxin","Lidocaine","Zonisamide","Carbamazepine","Amiodarone","Phenytoin"],"id":584}
{"title":"Inhibition, sodium channel","references":"<p>Ragsdale, D.S. and Avoli, M. 1998. Sodium channels as molecular targets for antiepileptic drugs. Brain Research Reviews 26:16-28.\n</p><p>Pless, S.A., Galpin, J.D., Frankel, A., and Ahern, C.A. 2011. Molecular basis for class Ib anti-arrhythmic inhibition of cardiac sodium channels. Nat Commun 2:351.\n</p>","biologicalOrganisationLevel":"Molecular","organTerm":{},"biologicalEvents":[{"action":"decreased","process":"sodium channel inhibitor activity","object":{"name":"sodium channel protein type 1 subunit alpha","source":"PR","sourceId":"PR:000002095"}},{"action":"decreased","process":"signaling","object":{"name":"sodium channel protein type 1 subunit alpha","source":"PR","sourceId":"PR:000002095"}}],"keyEventStressors":["Valproate","Topiramate","Tetrodotoxin","Lidocaine","Zonisamide","Carbamazepine","Amiodarone","Phenytoin"],"id":584}
{"title":"Decreased, Sodium conductance 1","references":"","biologicalOrganisationLevel":"Cellular","organTerm":{},"biologicalEvents":[{"action":"decreased","process":"action potential","object":{}}],"id":585}
{"title":"Reduced, swimming speed","references":"<p><br />\n</p><p>De Lange, H.J., Noordoven, W., Murk, A.J., Lrling, M., and Peeters, E.T.H.M. 2006. Behavioural responses of Gammarus pulex (Crustacea, Amphipoda) to low concentrations of pharmaceuticals. Aquatic toxicology 78:209-216.\n</p><p>Kavitha, P. and Venkateswara Rao, J. 2007. Oxidative stress and locomotor behaviour response as biomarkers for assessing recovery status of mosquito fish, Gambusia affinis after lethal effect of an organophosphate pesticide, monocrotophos. Pesticide Biochemistry and Physiology 87:182-188.\n</p><p>Nassef, M., Kim, S.G., Seki, M., Kang, I.J., Hano, T., Shimasaki, Y., and Oshima, Y. 2010. In ovo nanoinjection of triclosan, diclofenac and carbamazepine affects embryonic development of medaka fish (Oryzias latipes). Chemosphere 79:966-973.\n</p><p>Quinn, B., Gagn, F., and Blaise, C. 2008. An investigation into the acute and chronic toxicity of eleven pharmaceuticals (and their solvents) found in wastewater effluent on the cnidarian, Hydra attenuata. Science of The Total Environment 389:306-314.\n</p><p>Tierney, K.B. 2011. Swimming Performance Assessment in Fishes. Journal of Visualized Experiments&#160;: JoVE 2572.\n</p>","biologicalOrganisationLevel":"Individual","organTerm":{},"biologicalEvents":[{"action":"decreased","process":"aquatic locomotion","object":{}}],"id":586}
{"title":"Reduced, feeding 1","references":"<p>Bernot, R.J., Kennedy, E.E., and Lamberti, G.A. 2005. Effects of ionic liquids on the survival, movement, and feeding behavior of the freshwater snail, Physa acuta. Environmental Toxicology and Chemistry 24:1759-1765.\n</p><p>Corts, E. 1997. A critical review of methods of studying fish feeding based on analysis of stomach contents: application to elasmobranch fishes. Canadian Journal of Fisheries and Aquatic Sciences 54:726-738.\n</p><p>Nassef, M., Matsumoto, S., Seki, M., Khalil, F., Kang, I.J., Shimasaki, Y., Oshima, Y., and Honjo, T. 2010b. Acute effects of triclosan, diclofenac and carbamazepine on feeding performance of Japanese medaka fish (Oryzias latipes). Chemosphere 80:1095-1100.\n</p>","biologicalOrganisationLevel":"Individual","organTerm":{},"biologicalEvents":[{"action":"decreased","process":"feeding behavior","object":{}}],"id":587}
{"title":"Increased, predation","references":"","biologicalOrganisationLevel":"Population","organTerm":{},"biologicalEvents":[{"action":"increased","process":"predatory behavior","object":{}}],"id":588}
{"title":"Reduced, survival","references":"","biologicalOrganisationLevel":"Population","organTerm":{},"biologicalEvents":[{"action":"decreased","process":"life span trait","object":{}}],"id":592}
{"title":"Increased, Atrioventricular block and bradycardia","references":"","biologicalOrganisationLevel":"Organ","organTerm":{"name":"heart","sourceId":"UBERON:0000948"},"biologicalEvents":[{"action":"increased","object":{"name":"atrioventricular block","source":"MESH","sourceId":"D054537"}},{"action":"increased","object":{"name":"decreased heart rate","source":"MESH","sourceId":"D001919"}}],"id":444}
{"title":"Increased, Atrioventricular block and bradycardia","references":"","biologicalOrganisationLevel":"Organ","organTerm":{"name":"heart","sourceId":"UBERON:0000948"},"biologicalEvents":[{"action":"increased","object":{"name":"atrioventricular block","source":"MESH","sourceId":"D054537"}},{"action":"increased","object":{"name":"decreased heart rate","source":"MESH","sourceId":"D001919"}}],"id":444}
{"title":"N/A, hypoxia","references":"","biologicalOrganisationLevel":"Tissue","organTerm":{},"biologicalEvents":[{"action":"decreased","process":"hypoxia","object":{}}],"id":590}
{"title":"Increased, amputations","references":"","biologicalOrganisationLevel":"Individual","organTerm":{},"biologicalEvents":[{"action":"increased","object":{"name":"Amputation, Congenital","source":"MESH","sourceId":"C565682"}}],"id":591}
{"title":"Inhibition, Ether-a-go-go (ERG) voltage-gated potassium channel ","references":"<p>Sanguinetti, M. C. and M. Tristani-Firouzi (2006). \"hERG potassium channels and cardiac arrhythmia.\" Nature 440(7083): 463-469.\n</p><p>Wymore, R. S., et al. (1997). \"Tissue and Species Distribution of mRNA for the ikr-like K+ Channel, ERG.\" Circ Res 80(2): 261-268.\n</p>","biologicalOrganisationLevel":"Molecular","organTerm":{},"biologicalEvents":[{"action":"decreased","process":"potassium channel inhibitor activity","object":{"name":"potassium voltage-gated channel subfamily H member 2 (human)","source":"PR","sourceId":"PR:Q12809"}}],"keyEventStressors":["Verapamil","Chlorpromazine","Amiodarone"],"id":593}
{"title":"modulation, sodium channel","references":"<p>Hodgkin, A. L., &amp; AF Huxley, (1952). A quantitative description of membrane current and its application to conduction and excitation in nerve. The Journal of Physiology, 117(4), 500544.\n</p><p>Vijverberg, HPM, JM Van der Zalm, J Van der Bercken (1982).  Similar mode of action of pyrethroids and DDT on sodium channel gaiting in myelinated nerves.  Nature, 295 (5850), 601-603.\n</p>","biologicalOrganisationLevel":"Molecular","organTerm":{},"biologicalEvents":[{"action":"decreased","process":"sodium channel inhibitor activity","object":{"name":"sodium channel protein type 1 subunit alpha","source":"PR","sourceId":"PR:000002095"}}],"keyEventStressors":["Lambda-Cyhalothrin","Esfenvalerate","Tralomethrin","Cyfluthrin","Permethrin","Cypermethrin","Bifenthrin"],"id":598}
{"title":"prolonged, Depolarization of neuronal membrane","references":"","biologicalOrganisationLevel":"Cellular","organTerm":{},"biologicalEvents":[{"action":"increased","process":"membrane depolarization","object":{}}],"id":599}
{"title":"Overactivation, Neuronotransmitter release","references":"","biologicalOrganisationLevel":"Molecular","organTerm":{},"biologicalEvents":[{"action":"increased","process":"neurotransmitter secretion","object":{}}],"id":600}
{"title":"Overactivation, muscle contraction","references":"","biologicalOrganisationLevel":"Tissue","organTerm":{"name":"muscle tissue","sourceId":"UBERON:0002385"},"biologicalEvents":[{"action":"increased","process":"muscle contraction","object":{}}],"id":601}
{"title":"Increased, Ataxia, paralysis, or hyperactivity","references":"","biologicalOrganisationLevel":"Organ","organTerm":{"name":"skeletal muscle tissue","sourceId":"UBERON:0001134"},"biologicalEvents":[{"action":"increased","process":"ataxia","object":{}},{"action":"increased","process":"hyperactivity","object":{}},{"action":"increased","process":"paralysis","object":{}}],"id":602}
{"title":"Increased, Ataxia, paralysis, or hyperactivity","references":"","biologicalOrganisationLevel":"Organ","organTerm":{"name":"skeletal muscle tissue","sourceId":"UBERON:0001134"},"biologicalEvents":[{"action":"increased","process":"ataxia","object":{}},{"action":"increased","process":"hyperactivity","object":{}},{"action":"increased","process":"paralysis","object":{}}],"id":602}
{"title":"Increased, Ataxia, paralysis, or hyperactivity","references":"","biologicalOrganisationLevel":"Organ","organTerm":{"name":"skeletal muscle tissue","sourceId":"UBERON:0001134"},"biologicalEvents":[{"action":"increased","process":"ataxia","object":{}},{"action":"increased","process":"hyperactivity","object":{}},{"action":"increased","process":"paralysis","object":{}}],"id":602}
{"title":"Inhibition, 5-hydroxytryptamine transporter (5-HTT; SERT)","references":"","biologicalOrganisationLevel":"Molecular","organTerm":{},"biologicalEvents":[{"action":"decreased","process":"neurotransmitter reuptake","object":{"name":"sodium-dependent serotonin transporter","source":"PR","sourceId":"PR:000015189"}},{"action":"decreased","process":"serotonin uptake","object":{"name":"sodium-dependent serotonin transporter","source":"PR","sourceId":"PR:000015189"}}],"keyEventStressors":["Fluoxetine","Fluvoxamine"],"id":619}
{"title":"Inhibition, 5-hydroxytryptamine transporter (5-HTT; SERT)","references":"","biologicalOrganisationLevel":"Molecular","organTerm":{},"biologicalEvents":[{"action":"decreased","process":"neurotransmitter reuptake","object":{"name":"sodium-dependent serotonin transporter","source":"PR","sourceId":"PR:000015189"}},{"action":"decreased","process":"serotonin uptake","object":{"name":"sodium-dependent serotonin transporter","source":"PR","sourceId":"PR:000015189"}}],"keyEventStressors":["Fluoxetine","Fluvoxamine"],"id":619}
{"title":"Increase, predation","references":"","biologicalOrganisationLevel":"Population","organTerm":{},"biologicalEvents":[{"action":"increased","process":"predatory behavior","object":{}}],"id":623}
{"title":"Increased, muscular waves in foot","references":"","biologicalOrganisationLevel":"Organ","organTerm":{"name":"muscle of pes","sourceId":"UBERON:0001498"},"biologicalEvents":[{"object":{}}],"id":625}
{"title":"Increased, water retention in foot","references":"","biologicalOrganisationLevel":"Organ","organTerm":{},"biologicalEvents":[{"object":{}}],"id":1139}
{"title":"Decline, Population","references":"","biologicalOrganisationLevel":"Population","organTerm":{},"biologicalEvents":[{"action":"decreased","process":"population growth rate","object":{}}],"id":361}
{"title":"Increased, valve movement","references":"","biologicalOrganisationLevel":"Tissue","organTerm":{},"biologicalEvents":[{"action":"increased","process":"musculoskeletal movement","object":{"name":"valve","source":"UBERON","sourceId":"UBERON:0003978"}}],"id":1142}
{"title":"Depletion, energy reserves","references":"","biologicalOrganisationLevel":"Individual","organTerm":{},"biologicalEvents":[{"object":{}}],"id":1143}
{"title":"Increased, foot detachment","references":"","biologicalOrganisationLevel":"Individual","organTerm":{},"biologicalEvents":[{"action":"increased","process":"fossorial locomotion behavior","object":{}}],"id":624}
{"title":"Increased, locomotion","references":"","biologicalOrganisationLevel":"Individual","organTerm":{},"biologicalEvents":[{"action":"increased","process":"locomotion","object":{}}],"id":622}
{"title":"Increased, serotonin (5-HT) ","references":"","biologicalOrganisationLevel":"Cellular","organTerm":{},"biologicalEvents":[{"action":"decreased","process":"serotonin secretion","object":{"name":"sodium-dependent serotonin transporter","source":"PR","sourceId":"PR:000015189"}}],"id":626}
{"title":"Decreased, anxiety","references":"","biologicalOrganisationLevel":"Individual","organTerm":{},"biologicalEvents":[{"action":"decreased","process":"fear/anxiety related behavior","object":{}}],"id":627}
{"title":"Decreased, sheltering","references":"","biologicalOrganisationLevel":"Individual","organTerm":{},"biologicalEvents":[{"action":"decreased","process":"abnormal sheltering behavior","object":{}}],"id":629}
{"title":"Decrease, histaminergic neuron excitation","references":"","biologicalOrganisationLevel":"Cellular","organTerm":{},"biologicalEvents":[{"action":"decreased","process":"rhythmic excitation","object":{"name":"histaminergic neuron","source":"CL","sourceId":"CL:0011110"}}],"id":633}
{"title":"N/A, sedation","references":"","biologicalOrganisationLevel":"Individual","organTerm":{},"biologicalEvents":[{"action":"increased","object":{"name":"anesthesia","source":"MESH","sourceId":"D000758"}}],"id":634}
{"title":"Decreased, locomotion","references":"","biologicalOrganisationLevel":"Individual","organTerm":{},"biologicalEvents":[{"action":"decreased","process":"locomotion","object":{}}],"id":635}
{"title":"Decreased, survival","references":"","biologicalOrganisationLevel":"Population","organTerm":{},"biologicalEvents":[{"action":"decreased","process":"life span trait","object":{}}],"id":636}
{"title":"Antagonism, Histamine Receptor (H2)","references":"","biologicalOrganisationLevel":"Molecular","organTerm":{},"biologicalEvents":[{"action":"decreased","process":"histamine receptor activity","object":{"name":"histamine H2 receptor","source":"PR","sourceId":"PR:000001423"}}],"id":638}
{"title":"Reduced, Prostaglandin F2alpha concentration, plasma ","references":"","biologicalOrganisationLevel":"Individual","organTerm":{},"biologicalEvents":[{"action":"decreased","object":{"name":"prostaglandin F2alpha","source":"CHEBI","sourceId":"CHEBI:15553"}}],"id":671}
{"title":"Reduced, Prostaglandin F2alpha synthesis, ovary  ","references":"","biologicalOrganisationLevel":"Organ","organTerm":{"name":"female gonad","sourceId":"UBERON:0000992"},"biologicalEvents":[{"action":"decreased","process":"prostaglandin biosynthetic process","object":{"name":"prostaglandin F2alpha","source":"CHEBI","sourceId":"CHEBI:15553"}}],"id":672}
{"title":"Reduced, Spawning behavior","references":"","biologicalOrganisationLevel":"Individual","organTerm":{},"biologicalEvents":[{"action":"abnormal","object":{"name":"fertility","source":"MESH","sourceId":"D005298"}}],"id":673}
{"title":"Reduced, Ability to attract spawning mates","references":"","biologicalOrganisationLevel":"Individual","organTerm":{},"biologicalEvents":[{"action":"decreased","process":"attraction-related behavior","object":{}}],"id":674}
{"title":"Reduced, Pheromone release","references":"","biologicalOrganisationLevel":"Individual","organTerm":{},"biologicalEvents":[{"action":"decreased","process":"mating pheromone secretion","object":{"name":"pheromone","source":"CHEBI","sourceId":"CHEBI:26013"}}],"id":678}
{"title":"Decreased, Prostaglandin F2alpha synthesis, ovary  ","references":"","biologicalOrganisationLevel":"Organ","organTerm":{"name":"female gonad","sourceId":"UBERON:0000992"},"biologicalEvents":[{"action":"decreased","process":"prostaglandin biosynthetic process","object":{"name":"prostaglandin F2alpha","source":"CHEBI","sourceId":"CHEBI:15553"}}],"id":681}
{"title":"Reduced, Prostaglandin E2 concentration, hypothalamus","references":"","biologicalOrganisationLevel":"Tissue","organTerm":{"name":"hypothalamus","sourceId":"UBERON:0001898"},"biologicalEvents":[{"action":"decreased","object":{"name":"prostaglandin E2","source":"CHEBI","sourceId":"CHEBI:15551"}}],"id":687}
{"title":"Reduced, Gonadotropin releasing hormone, hypothalamus","references":"","biologicalOrganisationLevel":"Tissue","organTerm":{"name":"hypothalamus","sourceId":"UBERON:0001898"},"biologicalEvents":[{"action":"decreased","object":{"name":"Gonadotropin Releasing Hormone","source":"MESH","sourceId":"D007987"}}],"id":689}
{"title":"Reduced, Luteinizing hormone (LH), plasma ","references":"","biologicalOrganisationLevel":"Tissue","organTerm":{"name":"blood plasma","sourceId":"UBERON:0001969"},"biologicalEvents":[{"action":"decreased","object":{"name":"Luteinizing hormone","source":"CHEBI","sourceId":"CHEBI:81568"}}],"id":690}
{"title":"Reduced, Maturation inducing steroid, plasma","references":"","biologicalOrganisationLevel":"Tissue","organTerm":{"name":"blood plasma","sourceId":"UBERON:0001969"},"biologicalEvents":[{"action":"decreased","object":{"name":"steroid hormone","source":"CHEBI","sourceId":"CHEBI:26764"}}],"id":691}
{"title":"Reduced, Maturation inducing steroid receptor signalling, oocyte","references":"","biologicalOrganisationLevel":"Tissue","organTerm":{},"biologicalEvents":[{"action":"decreased","process":"steroid hormone receptor activity","object":{"name":"steroid hormone","source":"CHEBI","sourceId":"CHEBI:26764"}},{"action":"decreased","process":"signaling","object":{"name":"steroid hormone","source":"CHEBI","sourceId":"CHEBI:26764"}}],"id":692}
{"title":"Reduced, Maturation inducing steroid receptor signalling, oocyte","references":"","biologicalOrganisationLevel":"Tissue","organTerm":{},"biologicalEvents":[{"action":"decreased","process":"steroid hormone receptor activity","object":{"name":"steroid hormone","source":"CHEBI","sourceId":"CHEBI:26764"}},{"action":"decreased","process":"signaling","object":{"name":"steroid hormone","source":"CHEBI","sourceId":"CHEBI:26764"}}],"id":692}
{"title":"Reduced, Meiotic prophase I/metaphase I transition, oocyte","references":"","biologicalOrganisationLevel":"Cellular","organTerm":{},"biologicalEvents":[{"action":"decreased","process":"G2/MI transition of meiotic cell cycle","object":{}}],"id":694}
{"title":"Increased, cyclic adenosine monophosphate","references":"","biologicalOrganisationLevel":"Tissue","organTerm":{},"biologicalEvents":[{"action":"increased","object":{"name":"3',5'-cyclic AMP(1-)","source":"CHEBI","sourceId":"CHEBI:58165"}}],"id":693}
{"title":"Upregulated, Spindle assembly checkpoint protein Mad2-oocyte","references":"","biologicalOrganisationLevel":"Molecular","organTerm":{},"biologicalEvents":[{"action":"increased","process":"deactivation of mitotic spindle assembly checkpoint","object":{"name":"MAD2 like protein (fruit fly)","source":"PR","sourceId":"PR:Q9VNE1"}}],"id":695}
{"title":"Increased, Chromosome misseggregation","references":"","biologicalOrganisationLevel":"Cellular","organTerm":{},"biologicalEvents":[{"action":"abnormal","process":"chromosome segregation","object":{}}],"id":696}
{"title":"impaired, ion channels","references":"","biologicalOrganisationLevel":"Cellular","organTerm":{},"biologicalEvents":[{"action":"decreased","process":"ion channel activity","object":{"name":"potassium voltage-gated channel subfamily H member 2 (human)","source":"PR","sourceId":"PR:Q12809"}},{"action":"decreased","process":"ion channel activity","object":{"name":"ATP-sensitive inward rectifier potassium channel 1","source":"PR","sourceId":"PR:000001978"}}],"id":697}
{"title":"impaired, ion channels","references":"","biologicalOrganisationLevel":"Cellular","organTerm":{},"biologicalEvents":[{"action":"decreased","process":"ion channel activity","object":{"name":"potassium voltage-gated channel subfamily H member 2 (human)","source":"PR","sourceId":"PR:Q12809"}},{"action":"decreased","process":"ion channel activity","object":{"name":"ATP-sensitive inward rectifier potassium channel 1","source":"PR","sourceId":"PR:000001978"}}],"id":697}
{"title":"Altered, Action Potential","references":"","biologicalOrganisationLevel":"Cellular","organTerm":{},"biologicalEvents":[{"action":"abnormal","process":"action potential","object":{}}],"id":698}
{"title":"Increased, cardiac arrthymia","references":"","biologicalOrganisationLevel":"Organ","organTerm":{"name":"heart","sourceId":"UBERON:0000948"},"biologicalEvents":[{"action":"increased","process":"Arrhythmias, Cardiac","object":{}}],"id":699}
{"title":"Increased, Accumulation of alpha2u microglobulin (proximal tubular epithelium)","references":"","biologicalOrganisationLevel":"Tissue","organTerm":{"name":"proximal tubular epithelium","sourceId":"UBERON:0008404"},"biologicalEvents":[{"action":"increased","object":{"name":"major urinary protein (rat)","source":"PR","sourceId":"PR:P02761"}}],"id":708}
{"title":"Increase, Cytotoxicity (renal tubular cell)","references":"","biologicalOrganisationLevel":"Cellular","organTerm":{},"biologicalEvents":[{"action":"increased","process":"cell death","object":{"name":"kidney tubule cell","source":"CL","sourceId":"CL:1000507"}}],"id":709}
{"title":"Increase, Regenerative cell proliferation (tubular epithelial cells)","references":"","biologicalOrganisationLevel":"Cellular","organTerm":{},"biologicalEvents":[{"action":"increased","process":"epithelial cell proliferation","object":{"name":"kidney tubule cell","source":"CL","sourceId":"CL:1000507"}}],"id":710}
{"title":"Increase, Adenomas/carcinomas (renal tubular)","references":"","biologicalOrganisationLevel":"Tissue","organTerm":{"name":"renal tubule","sourceId":"UBERON:0009773"},"biologicalEvents":[{"action":"increased","object":{"name":"Adenoma","source":"MESH","sourceId":"D000236"}},{"action":"increased","object":{"name":"Carcinoma","source":"MESH","sourceId":"D002277"}},{"action":"increased","process":"Carcinoma, Renal Cell","object":{"name":"Adenoma","source":"MESH","sourceId":"D000236"}}],"id":713}
{"title":"Increase, Adenomas/carcinomas (renal tubular)","references":"","biologicalOrganisationLevel":"Tissue","organTerm":{"name":"renal tubule","sourceId":"UBERON:0009773"},"biologicalEvents":[{"action":"increased","object":{"name":"Adenoma","source":"MESH","sourceId":"D000236"}},{"action":"increased","object":{"name":"Carcinoma","source":"MESH","sourceId":"D002277"}},{"action":"increased","process":"Carcinoma, Renal Cell","object":{"name":"Adenoma","source":"MESH","sourceId":"D000236"}}],"id":713}
{"title":"Increase, Adenomas/carcinomas (renal tubular)","references":"","biologicalOrganisationLevel":"Tissue","organTerm":{"name":"renal tubule","sourceId":"UBERON:0009773"},"biologicalEvents":[{"action":"increased","object":{"name":"Adenoma","source":"MESH","sourceId":"D000236"}},{"action":"increased","object":{"name":"Carcinoma","source":"MESH","sourceId":"D002277"}},{"action":"increased","process":"Carcinoma, Renal Cell","object":{"name":"Adenoma","source":"MESH","sourceId":"D000236"}}],"id":713}
{"title":"Increase, Hyperplasia (renal tubular cells)","references":"","biologicalOrganisationLevel":"Cellular","organTerm":{},"biologicalEvents":[{"action":"increased","process":"hyperplasia","object":{"name":"kidney tubule cell","source":"CL","sourceId":"CL:1000507"}}],"id":767}
{"title":"Increased, Binding of chemicals to 2u (serum)","references":"","biologicalOrganisationLevel":"Molecular","organTerm":{"name":"serum","sourceId":"UBERON:0001977"},"biologicalEvents":[{"action":"increased","process":"binding","object":{"name":"major urinary protein (rat)","source":"PR","sourceId":"PR:P02761"}}],"keyEventStressors":["Hydrocarbons, various","D-limonene"],"id":714}
{"title":"Binding, Tubulin","references":"<p>Berrieman HK, Lind MJ, Cawkwell L. 2004. Do beta-tubulin mutations have a role in resistance to chemotherapy? Lancet Oncol 5:158-164.</p>\n\n<p>Bhattacharya R, Cabral F. 2009. Molecular basis for class V beta-tubulin effects on microtubule assembly and paclitaxel resistance. J Biol Chem 284:13023-13032.</p>\n\n<p>Botta M, Forli S, Magnani M, Manetti F. 2009. Molecular Modeling Approaches to Study the Binding Mode on Tubulin of Microtubule Destabilizing and Stabilizing Agents. In: Carlomagno T, editor. Tubulin-Binding Agents: Springer Berlin Heidelberg. p 279-328.</p>\n\n<p>Clement MJ, Rathinasamy K, Adjadj E, Toma F, Curmi PA, Panda D. 2008. Benomyl and colchicine synergistically inhibit cell proliferation and mitosis: evidence of distinct binding sites for these agents in tubulin. Biochemistry 47:13016-13025.</p>\n\n<p>Cutts JH, Beer CT, Noble RL. 1960. Biological properties of Vincaleukoblastine, an alkaloid in Vinca rosea Linn, with reference to its antitumor action. Cancer Res 20:1023-1031.</p>\n\n<p>D&#39;Amato RJ, Lin CM, Flynn E, Folkman J, Hamel E. 1994. 2-Methoxyestradiol, an endogenous mammalian metabolite, inhibits tubulin polymerization by interacting at the colchicine site. Proc Natl Acad Sci USA 91:3964-3968.</p>\n\n<p>Desbene S, Giorgi-Renault S. 2002. Drugs that inhibit tubulin polymerization: the particular case of podophyllotoxin and analogues. Curr Med Chem Anticancer Agents 2:71-90.</p>\n\n<p>Engelborghs Y. 1998. General features of the recognition by tubulin of colchicine and related compounds. Eur Biophys J 27:437-445.</p>\n\n<p>Garland DL. 1978. Kinetics and mechanism of colchicine binding to tubulin: evidence for ligand-induced conformational change. Biochemistry 17:4266-4272.</p>\n\n<p>Gigant B, Wang C, Ravelli RB, Roussi F, Steinmetz MO, Curmi PA, Sobel A, Knossow M. 2005. Structural basis for the regulation of tubulin by vinblastine. Nature 435:519-522.</p>\n\n<p>Hamel E, Lin CM. 1981. Stabilization of the colchicine-binding activity of tubulin by organic acids. Biochim Biophys Acta 675:226-231.</p>\n\n<p>Himes RH. 1991. Interactions of the catharanthus (Vinca) alkaloids with tubulin and microtubules. Pharmacol Ther 51:257-267.</p>\n\n<p>Kingston DG. 2009. Tubulin-interactive natural products as anticancer agents. J Nat Prod 72:507-515.</p>\n\n<p>Lambeir A, Engelborghs Y. 1981. A fluorescence stopped flow study of colchicine binding to tubulin. J Biol Chem 256:3279-3282.</p>\n\n<p>Lu Y, Chen J, Xiao M, Li W, Miller DD. 2012. An overview of tubulin inhibitors that interact with the colchicine binding site. Pharm Res 29:2943-2971.</p>\n\n<p>Luduena RF. 2013. A hypothesis on the origin and evolution of tubulin. Int Rev Cell Mol Biol 302:41-185.</p>\n\n<p>Marchetti A, Massarotti A, Yauk CL, Pacchierotti F, Russo A. Submitted. The adverse outcome pathway (AOP) for chemical binding to tubulin in oocytes leading to aneuploid offspring. Environ Mol Mutagen.</p>\n\n<p>Massarotti A, Coluccia A, Silvestri R, Sorba G, Brancale A. 2012. The tubulin colchicine domain: a molecular modeling perspective. ChemMedChem 7:33-42.</p>\n\n<p>Miller HP, Wilson L. 2010. Chapter 1 - Preparation of Microtubule Protein and Purified Tubulin from Bovine Brain by Cycles of Assembly and Disassembly and Phosphocellulose Chromatography. In: Leslie W, John JC, editors. Methods Cell Biol: Academic Press. p 2-15.</p>\n\n<p>Miller LM, Xiao H, Burd B, Horwitz SB, Angeletti RH, Verdier-Pinard P. 2010. Chapter 7 - Methods in Tubulin Proteomics. In: Leslie W, John JC, editors. Methods Cell Biol: Academic Press. p 105-126.</p>\n\n<p>Rai SS, Wolff J. 1996. Localization of the vinblastine-binding site on beta-tubulin. J Biol Chem 271:14707-14711.</p>\n\n<p>Ravelli RB, Gigant B, Curmi PA, Jourdain I, Lachkar S, Sobel A, Knossow M. 2004. Insight into tubulin regulation from a complex with colchicine and a stathmin-like domain. Nature 428:198-202.</p>\n\n<p>Stanton RA, Gernert KM, Nettles JH, Aneja R. 2011. Drugs that target dynamic microtubules: a new molecular perspective. Med Res Rev 31:443-481.</p>\n\n<p>Toso RJ, Jordan MA, Farrell KW, Matsumoto B, Wilson L. 1993. Kinetic stabilization of microtubule dynamic instability in vitro by vinblastine. Biochemistry 32:1285-1293.</p>\n\n<p>Warfield RK, Bouck GB. 1974. Microtubule-macrotubule transitions: intermediates after exposure to the mitotic inhibitor vinblastine. Science 186:1219-1221.</p>\n\n<p>Weisenberg RC, Timasheff SN. 1970. Aggregation of microtubule subunit protein. Effects of divalent cations, colchicine and vinblastine. Biochemistry 9:4110-4116.</p>\n\n<p>Wilson L, Jordan MA, Morse A, Margolis RL. 1982. Interaction of vinblastine with steady-state microtubules in vitro. J Mol Biol 159:125-149.</p>\n\n<p>Xu K, Schwarz PM, Ludue&ntilde;a RF. 2002. Interaction of nocodazole with tubulin isotypes. Drug Dev Res 55:91-96.</p>\n\n<p>Zavala F, Guenard D, Robin JP, Brown E. 1980. Structure--antitubulin activity relationship in steganacin congeners and analogues. Inhibition of tubulin polymerization in vitro by (+/-)-isodeoxypodophyllotoxin. J Med Chem 23:546-549.</p>\n","biologicalOrganisationLevel":"Molecular","organTerm":{},"biologicalEvents":[{"action":"increased","process":"tubulin binding","object":{"name":"tubulin","source":"PR","sourceId":"PR:000028799"}},{"action":"disrupted","object":{"name":"tubulin complex","source":"GO","sourceId":"GO:0045298"}}],"keyEventStressors":["Vincristine","Nocodazole","Benomyl","Colchicine","Podofilox","Carbendazim","Thiabendazole","518-2-5"],"id":718}
{"title":"Binding, Tubulin","references":"<p>Berrieman HK, Lind MJ, Cawkwell L. 2004. Do beta-tubulin mutations have a role in resistance to chemotherapy? Lancet Oncol 5:158-164.</p>\n\n<p>Bhattacharya R, Cabral F. 2009. Molecular basis for class V beta-tubulin effects on microtubule assembly and paclitaxel resistance. J Biol Chem 284:13023-13032.</p>\n\n<p>Botta M, Forli S, Magnani M, Manetti F. 2009. Molecular Modeling Approaches to Study the Binding Mode on Tubulin of Microtubule Destabilizing and Stabilizing Agents. In: Carlomagno T, editor. Tubulin-Binding Agents: Springer Berlin Heidelberg. p 279-328.</p>\n\n<p>Clement MJ, Rathinasamy K, Adjadj E, Toma F, Curmi PA, Panda D. 2008. Benomyl and colchicine synergistically inhibit cell proliferation and mitosis: evidence of distinct binding sites for these agents in tubulin. Biochemistry 47:13016-13025.</p>\n\n<p>Cutts JH, Beer CT, Noble RL. 1960. Biological properties of Vincaleukoblastine, an alkaloid in Vinca rosea Linn, with reference to its antitumor action. Cancer Res 20:1023-1031.</p>\n\n<p>D&#39;Amato RJ, Lin CM, Flynn E, Folkman J, Hamel E. 1994. 2-Methoxyestradiol, an endogenous mammalian metabolite, inhibits tubulin polymerization by interacting at the colchicine site. Proc Natl Acad Sci USA 91:3964-3968.</p>\n\n<p>Desbene S, Giorgi-Renault S. 2002. Drugs that inhibit tubulin polymerization: the particular case of podophyllotoxin and analogues. Curr Med Chem Anticancer Agents 2:71-90.</p>\n\n<p>Engelborghs Y. 1998. General features of the recognition by tubulin of colchicine and related compounds. Eur Biophys J 27:437-445.</p>\n\n<p>Garland DL. 1978. Kinetics and mechanism of colchicine binding to tubulin: evidence for ligand-induced conformational change. Biochemistry 17:4266-4272.</p>\n\n<p>Gigant B, Wang C, Ravelli RB, Roussi F, Steinmetz MO, Curmi PA, Sobel A, Knossow M. 2005. Structural basis for the regulation of tubulin by vinblastine. Nature 435:519-522.</p>\n\n<p>Hamel E, Lin CM. 1981. Stabilization of the colchicine-binding activity of tubulin by organic acids. Biochim Biophys Acta 675:226-231.</p>\n\n<p>Himes RH. 1991. Interactions of the catharanthus (Vinca) alkaloids with tubulin and microtubules. Pharmacol Ther 51:257-267.</p>\n\n<p>Kingston DG. 2009. Tubulin-interactive natural products as anticancer agents. J Nat Prod 72:507-515.</p>\n\n<p>Lambeir A, Engelborghs Y. 1981. A fluorescence stopped flow study of colchicine binding to tubulin. J Biol Chem 256:3279-3282.</p>\n\n<p>Lu Y, Chen J, Xiao M, Li W, Miller DD. 2012. An overview of tubulin inhibitors that interact with the colchicine binding site. Pharm Res 29:2943-2971.</p>\n\n<p>Luduena RF. 2013. A hypothesis on the origin and evolution of tubulin. Int Rev Cell Mol Biol 302:41-185.</p>\n\n<p>Marchetti A, Massarotti A, Yauk CL, Pacchierotti F, Russo A. Submitted. The adverse outcome pathway (AOP) for chemical binding to tubulin in oocytes leading to aneuploid offspring. Environ Mol Mutagen.</p>\n\n<p>Massarotti A, Coluccia A, Silvestri R, Sorba G, Brancale A. 2012. The tubulin colchicine domain: a molecular modeling perspective. ChemMedChem 7:33-42.</p>\n\n<p>Miller HP, Wilson L. 2010. Chapter 1 - Preparation of Microtubule Protein and Purified Tubulin from Bovine Brain by Cycles of Assembly and Disassembly and Phosphocellulose Chromatography. In: Leslie W, John JC, editors. Methods Cell Biol: Academic Press. p 2-15.</p>\n\n<p>Miller LM, Xiao H, Burd B, Horwitz SB, Angeletti RH, Verdier-Pinard P. 2010. Chapter 7 - Methods in Tubulin Proteomics. In: Leslie W, John JC, editors. Methods Cell Biol: Academic Press. p 105-126.</p>\n\n<p>Rai SS, Wolff J. 1996. Localization of the vinblastine-binding site on beta-tubulin. J Biol Chem 271:14707-14711.</p>\n\n<p>Ravelli RB, Gigant B, Curmi PA, Jourdain I, Lachkar S, Sobel A, Knossow M. 2004. Insight into tubulin regulation from a complex with colchicine and a stathmin-like domain. Nature 428:198-202.</p>\n\n<p>Stanton RA, Gernert KM, Nettles JH, Aneja R. 2011. Drugs that target dynamic microtubules: a new molecular perspective. Med Res Rev 31:443-481.</p>\n\n<p>Toso RJ, Jordan MA, Farrell KW, Matsumoto B, Wilson L. 1993. Kinetic stabilization of microtubule dynamic instability in vitro by vinblastine. Biochemistry 32:1285-1293.</p>\n\n<p>Warfield RK, Bouck GB. 1974. Microtubule-macrotubule transitions: intermediates after exposure to the mitotic inhibitor vinblastine. Science 186:1219-1221.</p>\n\n<p>Weisenberg RC, Timasheff SN. 1970. Aggregation of microtubule subunit protein. Effects of divalent cations, colchicine and vinblastine. Biochemistry 9:4110-4116.</p>\n\n<p>Wilson L, Jordan MA, Morse A, Margolis RL. 1982. Interaction of vinblastine with steady-state microtubules in vitro. J Mol Biol 159:125-149.</p>\n\n<p>Xu K, Schwarz PM, Ludue&ntilde;a RF. 2002. Interaction of nocodazole with tubulin isotypes. Drug Dev Res 55:91-96.</p>\n\n<p>Zavala F, Guenard D, Robin JP, Brown E. 1980. Structure--antitubulin activity relationship in steganacin congeners and analogues. Inhibition of tubulin polymerization in vitro by (+/-)-isodeoxypodophyllotoxin. J Med Chem 23:546-549.</p>\n","biologicalOrganisationLevel":"Molecular","organTerm":{},"biologicalEvents":[{"action":"increased","process":"tubulin binding","object":{"name":"tubulin","source":"PR","sourceId":"PR:000028799"}},{"action":"disrupted","object":{"name":"tubulin complex","source":"GO","sourceId":"GO:0045298"}}],"keyEventStressors":["Vincristine","Nocodazole","Benomyl","Colchicine","Podofilox","Carbendazim","Thiabendazole","518-2-5"],"id":718}
{"title":"Disruption, Microtubule dynamics","references":"<p>Bhalla KN. 2003. Microtubule-targeted anticancer agents and apoptosis. Oncogene 22:9075-9086.</p>\n\n<p>Hamel E. 2003. Evaluation of antimitotic agents by quantitative comparisons of their effects on the polymerization of purified tubulin. Cell Biochem Biophys 38:1-22.</p>\n\n<p>Ibanez E, Albertini DF, Overstrom EW. 2003. Demecolcine-induced oocyte enucleation for somatic cell cloning: coordination between cell-cycle egress, kinetics of cortical cytoskeletal interactions, and second polar body extrusion. Biol Reprod 68:1249-1258.</p>\n\n<p>Kops GJ, Weaver BA, Cleveland DW. 2005. On the road to cancer: aneuploidy and the mitotic checkpoint. Nat Rev Cancer 5:773-785.</p>\n\n<p>Lambrus BG, Holland AJ. 2017. A new mode of mitotic surveillance. Trends Cell Biol 27:314-321.</p>\n\n<p>Liu S, Li Y, Feng HL, Yan JH, Li M, Ma SY, Chen ZJ. 2010. Dynamic modulation of cytoskeleton during in vitro maturation in human oocytes. Am J Obstet Gynecol 203:151.e151-157.</p>\n\n<p>Mailhes JB, Carabatsos MJ, Young D, London SN, Bell M, Albertini DF. 1999. Taxol-induced meiotic maturation delay, spindle defects, and aneuploidy in mouse oocytes and zygotes. Mutat Res 423:79-90.</p>\n\n<p>Marchetti F, Massarotti A, Yauk CL, Pacchierotti F, Russo A. 2016. The adverse outcome pathway (AOP) for chemical binding to tubulin in oocytes leading to aneuploid offspring. Environ Mol Mutagen 57:87-113.</p>\n\n<p>Mitchison T, Kirschner M. 1984. Dynamic instability of microtubule growth. Nature. 312:237-242.</p>\n\n<p>Panda D, Jordan MA, Chu KC, Wilson L. 1996. Differential effects of vinblastine on polymerization and dynamics at opposite microtubule ends. J Biol Chem 271:29807-29812.</p>\n\n<p>Pettit GR, Toki B, Herald DL, Verdier-Pinard P, Boyd MR, Hamel E, Pettit RK. 1998. Antineoplastic agents. 379. Synthesis of phenstatin phosphate. J Med Chem 41:1688-1695.</p>\n\n<p>Salmon ED, McKeel M, Hays T. 1984. Rapid rate of tubulin dissociation from microtubules in the mitotic spindle in vivo measured by blocking polymerization with colchicine. J Cell Biol 99:1066-1075.</p>\n\n<p>Stanton RA, Gernert KM, Nettles JH, Aneja R. 2011. Drugs that target dynamic microtubules: a new molecular perspective. Med Res Rev 31:443-481.</p>\n\n<p>Wade RH, Hyman AA. 1997. <strong>Microtubule structure and dynamics.</strong> Curr Opin Cell Biol 9:12-17.</p>\n\n<p>&nbsp;</p>\n\n<p>Wallin M, Hartley-Asp B. 1993. Effects of potential aneuploidy inducing agents on microtubule assembly in vitro. Mutat Res 287:17-22.</p>\n\n<p>Waterman-Sloter CM, Salmon ED. 1997. Microtubule dynamics: treadmilling comes around again. Curr Biol 7:R369-R372.</p>\n\n<p>Wilson L, Miller HP, Pfeffer TA, Sullivan KF, Detrich HW, 3rd. 1984. Colchicine-binding activity distinguishes sea urchin egg and outer doublet tubulins. J Cell Biol 99:37-41.</p>\n\n<p>Zavala F, Guenard D, Robin JP, Brown E. 1980. Structure--antitubulin activity relationship in steganacin congeners and analogues. Inhibition of tubulin polymerization in vitro by (+/-)-isodeoxypodophyllotoxin. J Med Chem 23:546-549.</p>\n\n<p>Zhou YB, Feng X, Wang LN, Du JQ, Zhou YY, Yu HP, Zang Y, Li YJ, Li J. 2009. LGH00031, a novel ortho-quinonoid inhibitor of cell division cycle 25B, inhibits human cancer cells via ROS generation. Acta Pharmacol Sin 30;1359-1368.</p>\n","biologicalOrganisationLevel":"Molecular","organTerm":{},"biologicalEvents":[{"action":"increased","process":"microtubule depolymerization","object":{"name":"microtubule","source":"GO","sourceId":"GO:0005874"}}],"keyEventStressors":["Colchicine","Vinblastine sulfate","colchemid"],"id":720}
{"title":"Disorganization, Meiotic Spindle","references":"<p>Andersen JS, Wilkinson CJ, Mayor T, Mortensen P, Nigg EA, Mann M. 2003. Proteomic characterization of the human centrosome by protein correlation profiling. Nature 426:570-574.</p>\n\n<p>Bettencourt-Dias M, Glover DM. 2007. Centrosome biogenesis and function: centrosomics brings new understanding. Nat Rev Mol Cell Biol 8:451-463.</p>\n\n<p>Cao Y-K, Zhong Z-S, Chen D-Y, Zhang G-X, Schatten H, Sun Q-Y. 2005. Cell cycle-dependent localization and possible roles of the small GTPase Ran in mouse oocyte maturation, fertilization and early cleavage. Reproduction 130:431-440.</p>\n\n<p>Cassimeris L, Skibbens RV. 2003. Regulated assembly of the mitotic spindle: a perspective from two ends. Curr Issues Mol Biol 5:99-112.</p>\n\n<p>Chan JY. 2011. A clinical overview of centrosome amplification in human cancers. Int J Biol Sci 7:1122-1144.</p>\n\n<p>Chavali PL, Peset I, Gergely F. 2012. Centrosomes and mitotic poles: a recent liason?&nbsp; Biochem Soc Trans 43:13-18.</p>\n\n<p>Conduit PT, Wainman A, Raff JW. 2015. Centrosome function and assembly in animal cells. Nat Rev Mol Cell Biol 16:611-624.</p>\n\n<p>Clift D, Schuh M. 2015. A three-step MTOC fragmentation mechanism facilitate bipolar spindle assembly in mouse oocytes. Nat Commun 6:7217, 10.1038/ncomm8217.</p>\n\n<p>Dumont J, Desai A. 2012. Acentrosomal spindle assembly and chromosome segregation during oocyte meiosis. Trends Cell Biol 22: 241-249.</p>\n\n<p>Eichenlaub-Ritter U, Winterscheidt U, Vogt E, Shen Y, Tinneberg HR, Sorensen R. 2007. 2-methoxyestradiol induces spindle aberrations, chromosome congression failure, and nondisjunction in mouse oocytes. Biol Reprod 76:784-793.</p>\n\n<p>Gogendeau D, Guichard P, Tassin AM. 2015. Purification of centrosomes from mammalian cell lines. Methods Cell Biol. 129:171-189.</p>\n\n<p>Hinchcliffe EH. 2014. Centrosomes and the art of mitotic spindle maintenance. Int Rev Cell Mol Biol 313:179-217.</p>\n\n<p>Holubcov&aacute; Z, Blayney M, Elder K, Schuh M. 2015. Error-prone chromosome-mediated spindle assembly favors chromosome segregation defects in human oocytes. Science 348:1143-1147.</p>\n\n<p>Ibanez E, Albertini DF, Overstrom EW. 2003. Demecolcine-induced oocyte enucleation for somatic cell cloning: coordination between cell-cycle egress, kinetics of cortical cytoskeletal interactions, and second polar body extrusion. Biol Reprod 68:1249-1258.</p>\n\n<p>Keefe D, Liu L, Wang W, Silva C. 2003. Imaging meiotic spindles by polarization light microscopy: principles and applications to IVF. Reprod Biomed Online 7:24&ndash;29.</p>\n\n<p>Kellog DR. 1989. Centrosomes. Organizing cytoplasmic events. Nature 340:99-100.</p>\n\n<p>Manandhar G, Schatten H, Sutovsky P. 2005. Centrosome reduction during gametogenesis and its significance. Biol Reprod 72:2-13.</p>\n\n<p>Marchetti F, Massarotti A, Yauk CL, Pacchierotti F, Russo A. 2016. The adverse outcome pathway (AOP) for chemical binding to tubulin in oocytes leading to aneuploid offspring. Environ Mol Mutagen 57:87-113.</p>\n\n<p>Mogessie B, Schuh M. 2017. Actin protects mammalian eggs against chromosome segregation errors. Science Aug 25;357(6353). pii: eaal1647.</p>\n\n<p>Nigg EA, Holland AI. 2018. Once and only once: mechanisms of centriole duplication and their deregulation in disease. Nat Rev Mol Cell BIol 19:297-312.</p>\n\n<p>Paintrand M, Moudjou M, Delacroix H, Bornens M. 1992. Centrosome organization and centriole architecture: their sensitivity to divalent cations<em>. </em><em>J Struct Biol</em> 108:107&ndash;128.</p>\n\n<p>Prosser SL, Pelletier L. 2017. Mitotic spindle assembly in animal cells: a fine balancing act. Nat Rev Mol Cell Biol 18:187-201.</p>\n\n<p>Rivera-Rivera Y, Saavedra HI. Centrosome - a promising anti-cancer target. 2016. Biologics 10:167-176.</p>\n\n<p>Schuh M, Ellenberg J. 2007. Self-organization of MTOCs replaces centrosome function during acentrosomal spindle assembly in live mouse oocytes. Cell 130:484-498.</p>\n\n<p>Shen Y, Betzendahl I, Sun F, Tinneberg HR, Eichenlaub-Ritter U. 2005. Non-invasive method to assess genotoxicity of nocodazole interfering with spindle formation in mammalian oocytes. Reprod Toxicol 19:459-471.</p>\n\n<p>Staessen C, Van Steirteghem AC. 1997. The chromosomal constitution of embryos developing from abnormally fertilized oocytes after intracytoplasmic sperm injection and and conventional in-vitro fertilization. Hum Reprod 12:321&ndash;327.</p>\n\n<p>Szollosi D, Calarco P, Donahue RP. 1972. Absence of centrioles in the first and second meiotic spindles of mouse oocytes. J Cell Sci 11:521-541.</p>\n\n<p>Tong C, Fan H-Y, Lian L, Li S-W, Chen D-Y, Schatten H, Sun Q-Y. 2002. Polo-like kinase-1 is a pivotal regulator of microtubule assembly during mouse oocyte meiotic maturation, fertilization, and early embryonic mitosis. Biol Reprod 67:546-554.</p>\n\n<p>Wang WH, Meng L, Hackett RJ, Odenbourg R, Keefe DL. 2001a. The spindle observation and its relationship with fertilization after intracytoplasmic sperm injection in living human oocytes. Fertil Steril 75:348&ndash;353.</p>\n\n<p>&nbsp;</p>\n\n<p>Wang WH, Meng L, Hackett RJ, Odenbourg R, Keefe DL. 2001b. Limited recovery of meiotic spindles in living human oocytes after cooling&ndash;rewarming observed using polarized light microscopy. Hum Reprod 16:2374&ndash;2378.</p>\n\n<p>Xu XL, Ma W, Zhu YB, Wang C, Wang BY, An N, An L, Liu Y, Wu ZH, Tian JH. 2012. The microtubule-associated protein ASPM regulates spindle assembly and meiotic progression in mouse oocytes. PLoS One 7:e49303.</p>\n\n<p>Yao LJ, Fan HY, Tong C, Chen DY, Schatten H, Sun QY. 2003. Polo-like kinase-1 in porcine oocyte meiotic maturation, fertilization and early embryonic mitosis. Cell Mol Biol 49:399-405.</p>\n\n<p>Yao L-J, Zhong Z-S, Zhang L-S, Chen D-Y, Schatten H, Sun Q-Y. 2004. Aurora-A is a critical regulator of microtubule assembly and nuclear activity in mouse oocytes, fertilized eggs, and early embryos. Biol Reprod 70:1392-1399.</p>\n","biologicalOrganisationLevel":"Cellular","organTerm":{},"biologicalEvents":[{"action":"decreased","process":"spindle organization","object":{"name":"spindle","source":"GO","sourceId":"GO:0005819"}}],"keyEventStressors":["Nocodazole","Colcemid","Colchicine"],"id":721}
{"title":"Increase, Aneuploid offspring","references":"<p>Benacerraf BR. 2005. The role of second trimester genetic sonogram in screening for fetal Down Syndrome. Semin Perinatol, 29:386-394.</p>\n\n<p>Bianchi DW, Parker RL, Wentworth J, Madankumar R, Saffer C, Das AF, Craig JA, Chudova DI, Devers PL, Jones KW, Oliver K, Rava RP, Sehnert AJ, CARE Study Group. 2014. DNA sequencing versus standard prenatal diagnosis. N Engl J Med 370:799-808.</p>\n\n<p>Canick JA, Lambert-Messerlian GM, Palomaki GE, Neveus LM, Malone FD, Ball RH, Nyberg DA, Comstock CH, Bukowski R, Saade GR, Berkowits RL, Dar P, Dugoff L, Craigo, SD, Timor-Trisch IE, Carr, SR, Wolfe HM, D&rsquo;Alton ME. 2006. First and Second Trimester Evaluation of Risk (FASTER) Trial Research Consortium. Comparison of serum markers in first-trimester down syndrome screening. Obstet Gynecol 108:1192-1199.</p>\n\n<p>Crandall BF, Lebherz TB. 1976. Prenatal genetic diagnosis in 350 amniocenteses. Obstet Gynecol, 48:158-162.</p>\n\n<p>Dacus JV, Wilroy RS, Summitt RL, Garbaciak JA, Abdella TN, Spinnato JA, Luthardt FW, Flinn GS, Lewis BA. 1985. Genetic amniocentesis: a twelve years&rsquo;s experience. Am J Med Genet, 20:443-452.</p>\n\n<p>Eastmond DA, Hartwig A, Anderson D, Anwar WA, Cimino MC, Dobrev I, Douglas GR, Nohmi T, Phillips DH, Vickers. 2009. Mutagenicity testing for chemical risk assessment: update of the WHO/IPCS Harmonized Scheme. Mutagenesis, 24:341-349.</p>\n\n<p>Epstein CJ. 1988. Mouse model systems for the study of aneuploidy. In: Vig BK, Sandberg AA, editors. Aneuploidy, Part B: Induction and Test Systems: Alan R. Liss, Inc. p 9-49.</p>\n\n<p>Farkas LG, Katic MJ, Forrest CR. 2002. Age-related changes in anthropometric measurements in the craniofacial regions and in height in Down&rsquo;s syndrome. J Craniofac Surg 13:614-622.</p>\n\n<p>Fink GB, Madaus WK, Walker GF. 1975. A quantitative study of the face in Down&rsquo;s syndrome. Am J Orthod, 67:540-553.</p>\n\n<p>Fragouli E, Alfarawati S, Spath K, Jaroudi S, Saras J, Enciso M, Wells D. 2013. The origin and impact of embryonic aneuploidy. Hum Genet 132:1001&ndash;1013.</p>\n\n<p>Fragouli E, Alfarawati S, Spath K, Wells D. 2014. Morphological and cytogenetic assessment of cleavage and blastocyst stage embryos. Mol Hum Reprod 20:117&ndash;126.</p>\n\n<p>Gil MM, Accurti V, Santacruz B, Plana MN, Nicolaides KH. 2017. Analysis of cell-free DNA in maternal blood in screening for aneuploidies: updated meta-analysis. Ultrasound Obstet Gynecol. Epub: April 11, 2017. doi: 10.1002/uog.17484.</p>\n\n<p>Hecht F, Hecht BK. 1987. Aneuploidy in humans: dimesions, demography, and dangers of abnormal numbers of chromosomes. In: Vig BK, Sandberg AA, editors. Aneuploidy, Part A: Incidence and Etiology: Alan R. Liss, Inc. p 9-49.</p>\n\n<p>Hogge WA, Schonberg SA, Golbus MS. 1985. Prenatal diagnosis by chorionic villus sampling: lessons of the first 600 cases. Prenat Diagn 5:393-400.</p>\n\n<p>Jenkins TM, Wapner RJ. 1999. First trimester prenatal diagnosis: chorionic villus sampling. Semin Perinatol 23:403-413.</p>\n\n<p>Lightfoot DA, Kouznetsova A, Mahdy E, Wilbertz J, Hoog C. 2006. The fate of mosaic aneuploid embryos during mouse development. Dev Biol 289:384-394.</p>\n\n<p>Magnuson T, Debrot S, Dimpfl J, Zweig A, Zamora T, Epstein CJ. 1985. The early lethality of autosomal monosomy in the mouse. J Exp Zool 236:353-360.</p>\n\n<p>Marchetti F, Massarotti A, Yauk CL, Pacchierotti F, Russo A. 2016. The adverse outcome pathway (AOP) for chemical binding to tubulin in oocytes leading to aneuploid offspring. Environ Mol Mutagen 57:87-113.</p>\n\n<p>Rao R, Platt LD. 2016. Ultrasound screening: status of markers and efficacy of screening for structural abnormalities. Seminal Perinatol 40:67-78.</p>\n\n<p>Rink BD, Norton ME. 2016. Screening for fetal aneuploidy. Semin Perinatol 40:35-43.</p>\n\n<p>Russell LB. 1976. Numerical sex-chromosome anomalies in mammals: Their spontaneous occurrence and use in mutagenesis studies. In: Hollaender A, editor. Chemical Mutagens Principles and Methods for their Detection, vol 4. New York: Plenum Press. p 55-91.</p>\n\n<p>Sehnert AJ, Rhees B, Comstock D, de Feo E, Heilek G, Burke J, Rava RP. 2011. Optimal detection of fetal chromosomal abnormalities by massively parallel DNA sequencing of cell-free DNA from maternal blood. Clin Chem 57:1042-1049.</p>\n\n<p>Valderramos SG, Rao RR, Scibetta EW, Silverman NS, Han CS, Platt LD. 2016. Cell-free DNA screening in clinical practice: abnormal autosomal aneuploidy and microdeletion results. Am J Obstet Gynecol 215:626.e1-626.e10.</p>\n\n<p>Yauk CL, Aardema MJ, Benthem Jv, Bishop JB, Dearfield KL, DeMarini DM, Dubrova YE, Honma M, Lupski JR, Marchetti F, Meistrich ML, Pacchierotti F, Stewart J, Waters MD, Douglas GR. 2015a. Approaches for identifying germ cell mutagens: Report of the 2013 IWGT workshop on germ cell assays. Mutat Res Genet Toxicol Environ Mutagen. 783:36-54.</p>\n\n<p>Yauk CL, Lambert IB, Meek ME, Douglas GR. Marchetti F. 2015b. Development of the adverse outcome pathway &ldquo;alkylation of DNA in male premeiotic germ cells leading to heritable mutations&rdquo; using the OECD&rsquo;s users&rsquo; handbook supplement. Environ Mol Mutagen 56:724-750.</p>\n\n<p>Yauk C, Lamber I, Marchetti F, Douglas G. 2016. Adverse Outcome Pathway on alkylation of DNA in male pre-meiotic germ cells leading to heritable mutations. OECD Series on Adverse Outcome Pathways, No. 3, OECD publishing. http://dx.doi.org/10.1787/5jlsvvxn1zjc-en.</p>\n","biologicalOrganisationLevel":"Individual","organTerm":{},"biologicalEvents":[{"action":"increased","process":"abnormal chromosome number","object":{}}],"keyEventStressors":["Colchicine"],"id":728}
{"title":"Altered, Meiotic chromosome dynamics","references":"<p>Eichenlaub-Ritter U, Winterscheidt U, Vogt E, Shen Y, Tinneberg HR, Sorensen R. 2007. 2-methoxyestradiol induces spindle aberrations, chromosome congression failure, and nondisjunction in mouse oocytes. Biol Reprod 76:784-793.</p>\n\n<p>Haverfield J, Dean NL, Noel D, Remillard-Labrosse G, Paradis V, Kadoch IJ, FitzHarris G. 2017. Tri-directional anaphases as a novel chromosome segregation defect in human oocytes. Hum Reprod 32:1293-1303.</p>\n\n<p>He B, Cimini D. 2016. Using photoactivable GFP to study microtubule dynamics and chromosome segregation. Methods Mol Biol 1413:15-31.</p>\n\n<p>Hu L-L, Zhou X, Zhang H-L, Wu L-L, Tang L-S, Chen L-L, Duan JL. 2018. Exposure to podophyllotoxin inhibits oocyte meiosis by disturbing meiotic spindle formation. Sci Report 8:10145.</p>\n\n<p>Lane SI, Yun Y, Jones KT. 2012. Timing of anaphase-promoting complex activation in mouse oocytes is predicted by microtubule-kinetochore attachment but not by bivalent alignment or tension. Development 139:1947-1955.</p>\n\n<p>Marchetti F, Massarotti A, Yauk CL, Pacchierotti F, Russo A. 2016. The adverse outcome pathway (AOP) for chemical binding to tubulin in oocytes leading to aneuploid offspring. Environ Mol Mutagen 57:87-113.</p>\n\n<p>McGuinness BE, Anger M, Kouznetsova A, Gil-Bernabe AM, Helmhart W, Kudo NR, Wuensche A, Taylor S, Hoog C, Novak B, Nasmyth K. 2009. Regulation of APC/C activity in oocytes by a Bub1-dependent spindle assembly checkpoint. Curr Biol 19:369-380.</p>\n\n<p>Mogessie B, Schuh M. 2017. Actin protects mammalian eggs against chromosome segregation errors. Science 357, eaal1647.</p>\n\n<p>Schuh M, Ellenberg J. 2007. Self-organization of MTOCs replaces centrosome function during acentrosomal spindle assembly in live mouse oocytes. Cell 130:484-498.</p>\n\n<p>Shen Y, Betzendahl I, Sun F, Tinneberg HR, Eichenlaub-Ritter U. 2005. Non-invasive method to assess genotoxicity of nocodazole interfering with spindle formation in mammalian oocytes. Reprod Toxicol 19:459-471.</p>\n\n<p>Silkworth WT, Nardi IK, Paul R, Mogilner A, Cimini D (2012) Timing of centrosome separation is important for accurate chromosome segregation. Mol Cell Biol 23:401-411.</p>\n","biologicalOrganisationLevel":"Cellular","organTerm":{},"biologicalEvents":[{"action":"abnormal","process":"chromosome movement towards spindle pole","object":{"name":"chromosome","source":"GO","sourceId":"GO:0005694"}}],"keyEventStressors":["2-Methoxyestradiol","Nocodazole"],"id":752}
{"title":"Altered, Chromosome number","references":"<p>Aardema MJ, Albertini S, Arni P, Henderson LM, Kirsch-Volders M, Mackay JM, Sarrif AM, Stringer DA, Taalman RD. 1998. Aneuploidy: a report of an ECETOC task force. Mutat Res 410:3-79.</p>\n\n<p>Allard P, Kleinstreuer NC, Knudsen TB, Colaiacovo MP. 2013. A C. elegans screening platform for the rapid assessment of chemical disruption of germline function. Environ Health Perspect 121:717-724.</p>\n\n<p>Angell R. 1997. First-meiotic-division non-disjunction in human oocytes. Am J Hum Genet 61:23-32.</p>\n\n<p>Birchler JA. 2013. Aneuploidy in plants and flies: the origin of studies of genomic imbalance. Semin Cell Dev Biol 24:315-319.</p>\n\n<p>Bryce SM, Bemis JC, Mereness JA, Spellman RA, Moss J, Dickinson D, Schuler MJ, Dertinger SD. 2014. Interpreting in vitro micronucleus positive results: simple biomarker matrix discriminates clastogens, aneugens, and misleading positive agents. Environ Mol Mutagen 55:542-555.</p>\n\n<p>Leland S, Nagarajan P, Polyzos A, Thomas S, Samaan G, Donnell R, Marchetti F, Venkatachalam S. 2009. Heterozygosity for a Bub1 mutation causes female-specific germ cell aneuploidy in mice. Proc Natl Acad Sci USA 106:12776-12781.</p>\n\n<p>Mailhes JB, Yuan ZP. 1987. Cytogenetic technique for mouse metaphase II oocytes. Gamete Res 18:77-83.</p>\n\n<p>Mailhes JB, Marchetti F. 1994. Chemically-induced aneuploidy in mammalian oocytes. Mutat Res 320:87-111.</p>\n\n<p>Mailhes JB, Marchetti F. 2005. Mechanisms and chemically-induced aneuploidy in rodent germ cells. Cytogenet Genome Research 111:384-391.</p>\n\n<p>Mailhe JB, Young D, London SN. 1997. 1,2-Propanediol-induced premature centromere separation in mouse oocytes and aneuploidy in one-cell zygotes. Biol Reprod 57:92-98.</p>\n\n<p>Marchetti F, Massarotti A, Yauk CL, Pacchierotti F, Russo A. 2016. The adverse outcome pathway (AOP) for chemical binding to tubulin in oocytes leading to aneuploid offspring. Environ Mol Mutagen 57:87-113.</p>\n\n<p>M&aacute;rquez C, Cohen J, Munn&eacute; S. 1998. Chromosome identification in human oocytes and polar bodies by spectral karyotyping. Cytogenet Cell Genet 81:254-258.</p>\n\n<p>Mulla W, Zhu J, Li R. 2014. Yeast: a simple model system to study complex phenomena of aneuploidy. FEMS Microbiol Rev 38:201-212.</p>\n\n<p>OECD. 2016a.&nbsp;<em>Test No. 473: In Vitro Mammalian Chromosomal Aberration Test</em>, OECD Publishing, Paris. <a href=\"http://dx.doi.org/10.1787/9789264264649-en\" target=\"_blank\" title=\"http://dx.doi.org/10.1787/9789264264649-en\">http://dx.doi.org/10.1787/9789264264649-en</a>.</p>\n\n<p>&nbsp;</p>\n\n<p>OECD. 2016b.&nbsp;<em>Test No. 475: Mammalian Bone Marrow Chromosomal Aberration Test</em>, OECD Publishing, Paris. <a href=\"http://dx.doi.org/10.1787/9789264264786-en\" target=\"_blank\" title=\"http://dx.doi.org/10.1787/9789264264786-en\">http://dx.doi.org/10.1787/9789264264786-en</a>.</p>\n\n<p>&nbsp;</p>\n\n<p>OECD. 2016c.&nbsp;<em>Test No. 474: Mammalian Erythrocyte Micronucleus Test</em>, OECD Publishing, Paris. <a href=\"http://dx.doi.org/10.1787/9789264264762-en\" target=\"_blank\" title=\"http://dx.doi.org/10.1787/9789264264762-en\">http://dx.doi.org/10.1787/9789264264762-en</a>.</p>\n\n<p>&nbsp;</p>\n\n<p>OECD. 2016d.&nbsp;<em>Test No. 487: In Vitro Mammalian Cell Micronucleus Test</em><em>,</em> OECD Publishing, Paris. <a href=\"http://dx.doi.org/10.1787/9789264264861-en\" target=\"_blank\" title=\"http://dx.doi.org/10.1787/9789264264861-en\">http://dx.doi.org/10.1787/9789264264861-en</a>.</p>\n\n<p>&nbsp;</p>\n\n<p>Pacchierotti F, Adler ID, Eichenlaub-Ritter U, Mailhes JB. 2007. Gender effects on the incidence of aneuploidy in mammalian germ cells. Environ Res 104:46-69.</p>\n\n<p>Pellestor F, Anahory T, Hamamah S. 2005. The chromosomal analysis of human oocytes. An overview of established procedures. Human Reprod Update 11:15-32.</p>\n\n<p>Salamanca F, Armendares S. 1974. C bands in human metaphase chromosomes treated by barium hydroxide. Ann Genet 17:135-136.</p>\n\n<p>Strome ED, Plon SE. 2010. Utilizing Saccharomyces cerevisiae to identify aneuploidy and cancer susceptibility genes. Methods Mol Biol 653:73-85.</p>\n\n<p>Sugawara S, Mikamo K. 1980. An experimental approach to the analysis of mechanisms of meiotic nondisjunction and anaphase lagging in primary oocytes. Cytogenet Cell Genet 28:251-264.</p>\n\n<p>Tarkowski AK. 1966. An Air-Drying Method for Chromosome Preparations from Mouse Eggs. Cytogenetic and Genome Research 5:394-400.</p>\n\n<p>Yun Y, Lane SI, Jones KT. 2014. Premature dyad separation in meiosis II is the major segregation error with maternal age in mouse oocytes. Development 141:199-208.</p>\n\n<p>Zijno A, Marcon F, Leopardi P, Crebelli R. 1996. Analysis of chromosome segregation in cytokinesis-blocked human lymphocytes: non-disjunction is the prevalent damage resulting from low dose exposure to spindle poisons. Mutagenesis. 1996 Jul;11(4):335-40</p>\n","biologicalOrganisationLevel":"Cellular","organTerm":{},"biologicalEvents":[{"action":"increased","process":"abnormal chromosome number","object":{}}],"keyEventStressors":["2-Methoxyestradiol","Nocodazole","Benomyl","Colchicine","Podophyllotoxin","Vinblastine sulfate","Carbendazim","Thiabendazole"],"id":723}
{"title":"Activation, Constitutive androstane receptor","references":"<p><a name=\"_ENREF_1\">Burke, M. D., Thompson, S., Elcombe, C. R., Halpert, J., Haaparanta, T. and Mayer, R. T. (1985), Ethoxy-, pentoxy- and benzyloxyphenoxazones and homologues: a series of substrates to distinguish between different induced cytochromes P-450. <em>Biochem Pharmacol</em> <strong>34</strong>, 3337-45. </a></p>\n\n<p>&nbsp;</p>\n\n<p><a name=\"_ENREF_2\">Burke, M. D., Thompson, S., Weaver, R. J., Wolf, C. R. and Mayer, R. T. (1994), Cytochrome P450 specificities of alkoxyresorufin O-dealkylation in human and rat liver. <em>Biochem Pharmacol</em> <strong>48</strong>, 923-36. </a></p>\n\n<p>&nbsp;</p>\n\n<p><a name=\"_ENREF_3\">Chen, T., Tompkins, L. M., Li, L., Li, H., Kim, G., Zheng, Y. and Wang, H. (2010), A single amino acid controls the functional switch of human constitutive androstane receptor (CAR) 1 to the xenobiotic-sensitive splicing variant CAR3. <em>J Pharmacol Exp Ther</em> <strong>332</strong>, 106-15, 10.1124/jpet.109.159210. </a></p>\n\n<p>&nbsp;</p>\n\n<p><a name=\"_ENREF_4\">Currie, R. A., Peffer, R. C., Goetz, A. K., Omiecinski, C. J. and Goodman, J. I. (2014), Phenobarbital and propiconazole toxicogenomic profiles in mice show major similarities consistent with the key role that constitutive androstane receptor (CAR) activation plays in their mode of action. <em>Toxicology</em> <strong>321</strong>, 80-8, 10.1016/j.tox.2014.03.003. </a></p>\n\n<p>&nbsp;</p>\n\n<p><a name=\"_ENREF_5\">Deguchi, Y., Yamada, T., Hirose, Y., Nagahori, H., Kushida, M., Sumida, K., Sukata, T., Tomigahara, Y., Nishioka, K., Uwagawa, S., Kawamura, S. and Okuno, Y. (2009), Mode of action analysis for the synthetic pyrethroid metofluthrin-induced rat liver tumors: evidence for hepatic CYP2B induction and hepatocyte proliferation. <em>Toxicol Sci</em> <strong>108</strong>, 69-80, 10.1093/toxsci/kfp006. </a></p>\n\n<p>&nbsp;</p>\n\n<p><a name=\"_ENREF_6\">Diwan, B. A., Lubet, R. A., Ward, J. M., Hrabie, J. A. and Rice, J. M. (1992), Tumor-promoting and hepatocarcinogenic effects of 1,4-bis[2-(3,5-dichloropyridyloxy)]benzene (TCPOBOP) in DBA/2NCr and C57BL/6NCr mice and an apparent promoting effect on nasal cavity tumors but not on hepatocellular tumors in F344/NCr rats initiated with N-nitrosodiethylamine. <em>Carcinogenesis</em> <strong>13</strong>, 1893-901. </a></p>\n\n<p>&nbsp;</p>\n\n<p><a name=\"_ENREF_7\">Elcombe, C. R., Peffer, R. C., Wolf, D. C., Bailey, J., Bars, R., Bell, D., Cattley, R. C., Ferguson, S. S., Geter, D., Goetz, A., Goodman, J. I., Hester, S., Jacobs, A., Omiecinski, C. J., Schoeny, R., Xie, W. and Lake, B. G. (2014), Mode of action and human relevance analysis for nuclear receptor-mediated liver toxicity: A case study with phenobarbital as a model constitutive androstane receptor (CAR) activator. <em>Crit Rev Toxicol</em> <strong>44</strong>, 64-82, 10.3109/10408444.2013.835786. </a></p>\n\n<p>&nbsp;</p>\n\n<p><a name=\"_ENREF_8\">Huang, W., Zhang, J., Washington, M., Liu, J., Parant, J. M., Lozano, G. and Moore, D. D. (2005), Xenobiotic stress induces hepatomegaly and liver tumors via the nuclear receptor constitutive androstane receptor. <em>Mol Endocrinol</em> <strong>19</strong>, 1646-53, 10.1210/me.2004-0520. </a></p>\n\n<p>&nbsp;</p>\n\n<p><a name=\"_ENREF_9\">Lake, B. G. (2018), Human relevance of rodent liver tumour formation by constitutive androstane receptor (CAR) activators. <em>Toxicology Research</em>, 10.1039/c8tx00008e. </a><a href=\"http://dx.doi.org/10.1039/C8TX00008E\">http://dx.doi.org/10.1039/C8TX00008E</a></p>\n\n<p>&nbsp;</p>\n\n<p><a name=\"_ENREF_10\">Moore, D. D., Kato, S., Xie, W., Mangelsdorf, D. J., Schmidt, D. R., Xiao, R. and Kliewer, S. A. (2006), International Union of Pharmacology. LXII. The NR1H and NR1I receptors: constitutive androstane receptor, pregnene X receptor, farnesoid X receptor alpha, farnesoid X receptor beta, liver X receptor alpha, liver X receptor beta, and vitamin D receptor. <em>Pharmacol Rev</em> <strong>58</strong>, 742-59, 10.1124/pr.58.4.6. </a></p>\n\n<p>&nbsp;</p>\n\n<p><a name=\"_ENREF_11\">Mutoh, S., Osabe, M., Inoue, K., Moore, R., Pedersen, L., Perera, L., Rebolloso, Y., Sueyoshi, T. and Negishi, M. (2009), Dephosphorylation of threonine 38 is required for nuclear translocation and activation of human xenobiotic receptor CAR (NR1I3). <em>J Biol Chem</em> <strong>284</strong>, 34785-92, 10.1074/jbc.M109.048108. </a></p>\n\n<p>&nbsp;</p>\n\n<p><a name=\"_ENREF_12\">Mutoh, S., Sobhany, M., Moore, R., Perera, L., Pedersen, L., Sueyoshi, T. and Negishi, M. (2013), Phenobarbital indirectly activates the constitutive active androstane receptor (CAR) by inhibition of epidermal growth factor receptor signaling. <em>Sci Signal</em> <strong>6</strong>, ra31, 10.1126/scisignal.2003705. </a></p>\n\n<p>&nbsp;</p>\n\n<p><a name=\"_ENREF_13\">Omiecinski, C. J., Coslo, D. M., Chen, T., Laurenzana, E. M. and Peffer, R. C. (2011b), Multi-species analyses of direct activators of the constitutive androstane receptor. <em>Toxicol Sci</em> <strong>123</strong>, 550-62, 10.1093/toxsci/kfr191. </a></p>\n\n<p>&nbsp;</p>\n\n<p><a name=\"_ENREF_14\">Omiecinski, C. J., Vanden Heuvel, J. P., Perdew, G. H. and Peters, J. M. (2011a), Xenobiotic metabolism, disposition, and regulation by receptors: from biochemical phenomenon to predictors of major toxicities. <em>Toxicol Sci</em> <strong>120 Suppl 1</strong>, S49-75, 10.1093/toxsci/kfq338. </a></p>\n\n<p>&nbsp;</p>\n\n<p><a name=\"_ENREF_15\">Oshida, K., Vasani, N., Jones, C., Moore, T., Hester, S., Nesnow, S., Auerbach, S., Geter, D. R., Aleksunes, L. M., Thomas, R. S., Applegate, D., Klaassen, C. D. and Corton, J. C. (2015a), Identification of chemical modulators of the constitutive activated receptor (CAR) in a gene expression compendium. <em>Nucl Recept Signal</em> <strong>13</strong>, e002, 10.1621/nrs.13002. </a></p>\n\n<p>&nbsp;</p>\n\n<p><a name=\"_ENREF_16\">Peffer, R. C., Cowie, D. E., Currie, R. A. and Minnema, D. J. (2018a), Sedaxane-Use of Nuclear Receptor Transactivation Assays, Toxicogenomics, and Toxicokinetics as Part of a Mode of Action Framework for Rodent Liver Tumors. <em>Toxicol Sci</em> <strong>162</strong>, 582-598, 10.1093/toxsci/kfx281. </a></p>\n\n<p>&nbsp;</p>\n\n<p><a name=\"_ENREF_17\">Peffer, R. C., LeBaron, M. J., Battalora, M., Bomann, W. H., Werner, C., Aggarwal, M., Rowe, R. R. and Tinwell, H. (2018b), Minimum datasets to establish a CAR-mediated mode of action for rodent liver tumors. <em>Regul Toxicol Pharmacol</em> <strong>96</strong>, 106-120, 10.1016/j.yrtph.2018.04.001. </a></p>\n\n<p>&nbsp;</p>\n\n<p><a name=\"_ENREF_18\">Peffer, R. C., Moggs, J. G., Pastoor, T., Currie, R. A., Wright, J., Milburn, G., Waechter, F. and Rusyn, I. (2007), Mouse liver effects of cyproconazole, a triazole fungicide: role of the constitutive androstane receptor. <em>Toxicol Sci</em> <strong>99</strong>, 315-25, 10.1093/toxsci/kfm154. </a></p>\n\n<p>&nbsp;</p>\n\n<p><a name=\"_ENREF_19\">Reschly, E. J. and Krasowski, M. D. (2006), Evolution and function of the NR1I nuclear hormone receptor subfamily (VDR, PXR, and CAR) with respect to metabolism of xenobiotics and endogenous compounds. <em>Curr Drug Metab</em> <strong>7</strong>, 349-65. </a></p>\n\n<p>&nbsp;</p>\n\n<p><a name=\"_ENREF_20\">Stanley, L. A., Horsburgh, B. C., Ross, J., Scheer, N. and Wolf, C. R. (2006), PXR and CAR: nuclear receptors which play a pivotal role in drug disposition and chemical toxicity. <em>Drug Metab Rev</em> <strong>38</strong>, 515-97, 10.1080/03602530600786232. </a></p>\n\n<p>&nbsp;</p>\n\n<p><a name=\"_ENREF_21\">Sun, G., Thai, S. F., Lambert, G. R., Wolf, D. C., Tully, D. B., Goetz, A. K., George, M. H., Grindstaff, R. D., Dix, D. J. and Nesnow, S. (2006), Fluconazole-induced hepatic cytochrome P450 gene expression and enzymatic activities in rats and mice. <em>Toxicol Lett</em> <strong>164</strong>, 44-53, 10.1016/j.toxlet.2005.11.015. </a></p>\n\n<p>&nbsp;</p>\n\n<p><a name=\"_ENREF_22\">Swales, K. and Negishi, M. (2004), CAR, driving into the future. <em>Mol Endocrinol</em> <strong>18</strong>, 1589-98, 10.1210/me.2003-0397. </a></p>\n\n<p>&nbsp;</p>\n\n<p><a name=\"_ENREF_23\">Tamura, K., Inoue, K., Takahashi, M., Matsuo, S., Irie, K., Kodama, Y., Ozawa, S., Nishikawa, A. and Yoshida, M. (2013), Dose-response involvement of constitutive androstane receptor in mouse liver hypertrophy induced by triazole fungicides. <em>Toxicol Lett</em> <strong>221</strong>, 47-56, 10.1016/j.toxlet.2013.05.011. </a></p>\n\n<p>&nbsp;</p>\n\n<p><a name=\"_ENREF_24\">Tojima, H., Kakizaki, S., Yamazaki, Y., Takizawa, D., Horiguchi, N., Sato, K. and Mori, M. (2012), Ligand dependent hepatic gene expression profiles of nuclear receptors CAR and PXR. <em>Toxicol Lett</em> <strong>212</strong>, 288-97, 10.1016/j.toxlet.2012.06.001. </a></p>\n\n<p>&nbsp;</p>\n\n<p><a name=\"_ENREF_25\">Wei, P., Zhang, J., Egan-Hafley, M., Liang, S. and Moore, D. D. (2000), The nuclear receptor CAR mediates specific xenobiotic induction of drug metabolism. <em>Nature</em> <strong>407</strong>, 920-3, 10.1038/35038112. </a></p>\n\n<p>&nbsp;</p>\n\n<p><a name=\"_ENREF_26\">Yamada, T., Uwagawa, S., Okuno, Y., Cohen, S. M. and Kaneko, H. (2009), Case study: an evaluation of the human relevance of the synthetic pyrethroid metofluthrin-induced liver tumors in rats based on mode of action. <em>Toxicol Sci</em> <strong>108</strong>, 59-68, 10.1093/toxsci/kfp007. </a></p>\n\n<p>&nbsp;</p>\n\n<p><a name=\"_ENREF_27\">Yamamoto, Y., Moore, R., Goldsworthy, T. L., Negishi, M. and Maronpot, R. R. (2004), The orphan nuclear receptor constitutive active/androstane receptor is essential for liver tumor promotion by phenobarbital in mice. <em>Cancer Res</em> <strong>64</strong>, 7197-200, 10.1158/0008-5472.can-04-1459. </a></p>\n\n<p>&nbsp;</p>\n\n<p>&nbsp;</p>\n","biologicalOrganisationLevel":"Molecular","organTerm":{},"biologicalEvents":[{"action":"increased","process":"signaling","object":{"name":"nuclear receptor subfamily 1 group I member 3","source":"PR","sourceId":"PR:000011398"}}],"keyEventStressors":["Phenobarbital","metofluthrin","TCPOBOP"],"id":715}
{"title":"Increase, Preneoplastic foci (hepatocytes)","references":"","biologicalOrganisationLevel":"Cellular","organTerm":{},"biologicalEvents":[{"action":"increased","process":"preneoplasia","object":{"name":"abnormal cell mass","source":"MP","sourceId":"MP:0003902"}}],"id":774}
{"title":"Altered gene expression specific to CAR activation, Hepatocytes","references":"<p><a name=\"_ENREF_1\">Aleksunes, L. M. and Klaassen, C. D. (2012), Coordinated regulation of hepatic phase I and II drug-metabolizing genes and transporters using AhR-, CAR-, PXR-, PPARalpha-, and Nrf2-null mice. <em>Drug Metab Dispos</em> <strong>40</strong>, 1366-79, 10.1124/dmd.112.045112. </a></p>\n\n<p>&nbsp;</p>\n\n<p><a name=\"_ENREF_2\">Burke, M. D., Thompson, S., Elcombe, C. R., Halpert, J., Haaparanta, T. and Mayer, R. T. (1985), Ethoxy-, pentoxy- and benzyloxyphenoxazones and homologues: a series of substrates to distinguish between different induced cytochromes P-450. <em>Biochem Pharmacol</em> <strong>34</strong>, 3337-45. </a></p>\n\n<p>&nbsp;</p>\n\n<p><a name=\"_ENREF_3\">Burke, M. D., Thompson, S., Weaver, R. J., Wolf, C. R. and Mayer, R. T. (1994), Cytochrome P450 specificities of alkoxyresorufin O-dealkylation in human and rat liver. <em>Biochem Pharmacol</em> <strong>48</strong>, 923-36. </a></p>\n\n<p>&nbsp;</p>\n\n<p><a name=\"_ENREF_4\">Chovan, J. P., Ring, S. C., Yu, E. and Baldino, J. P. (2007), Cytochrome P450 probe substrate metabolism kinetics in Sprague Dawley rats. <em>Xenobiotica</em> <strong>37</strong>, 459-73, 10.1080/00498250701245250. </a></p>\n\n<p>&nbsp;</p>\n\n<p><a name=\"_ENREF_5\">Chua, S. and Moore, D. (2012), Analysis of constitutive androstane receptor (CAR/Nr1i3) ligand-dependent transcriptomes in wild type, CAR/Nr1i3 null mutant and human CAR/NR1I3 knockin mouse liver., v1.0, NURSA Datasets. dx.doi.org/10.1621/datasets.01003. </a></p>\n\n<p>&nbsp;</p>\n\n<p><a name=\"_ENREF_6\">Columbano, A., Ledda-Columbano, G. M., Pibiri, M., Cossu, C., Menegazzi, M., Moore, D. D., Huang, W., Tian, J. and Locker, J. (2005), Gadd45beta is induced through a CAR-dependent, TNF-independent pathway in murine liver hyperplasia. <em>Hepatology</em> <strong>42</strong>, 1118-26, 10.1002/hep.20883. </a></p>\n\n<p>&nbsp;</p>\n\n<p><a name=\"_ENREF_7\">Cui, J. Y. and Klaassen, C. D. (2016), RNA-Seq reveals common and unique PXR- and CAR-target gene signatures in the mouse liver transcriptome. <em>Biochim Biophys Acta</em> <strong>1859</strong>, 1198-1217, 10.1016/j.bbagrm.2016.04.010. </a></p>\n\n<p>&nbsp;</p>\n\n<p><a name=\"_ENREF_8\">Deguchi, Y., Yamada, T., Hirose, Y., Nagahori, H., Kushida, M., Sumida, K., Sukata, T., Tomigahara, Y., Nishioka, K., Uwagawa, S., Kawamura, S. and Okuno, Y. (2009), Mode of action analysis for the synthetic pyrethroid metofluthrin-induced rat liver tumors: evidence for hepatic CYP2B induction and hepatocyte proliferation. <em>Toxicol Sci</em> <strong>108</strong>, 69-80, 10.1093/toxsci/kfp006. </a></p>\n\n<p>&nbsp;</p>\n\n<p><a name=\"_ENREF_9\">Diwan, B. A., Ward, J. M., Anderson, L. M., Hagiwara, A. and Rice, J. M. (1986), Lack of effect of phenobarbital on hepatocellular carcinogenesis initiated by N-nitrosodiethylamine or methylazoxymethanol acetate in male Syrian golden hamsters. <em>Toxicol Appl Pharmacol</em> <strong>86</strong>, 298-307. </a></p>\n\n<p>&nbsp;</p>\n\n<p><a name=\"_ENREF_10\">Elcombe, C. R., Peffer, R. C., Wolf, D. C., Bailey, J., Bars, R., Bell, D., Cattley, R. C., Ferguson, S. S., Geter, D., Goetz, A., Goodman, J. I., Hester, S., Jacobs, A., Omiecinski, C. J., Schoeny, R., Xie, W. and Lake, B. G. (2014), Mode of action and human relevance analysis for nuclear receptor-mediated liver toxicity: A case study with phenobarbital as a model constitutive androstane receptor (CAR) activator. <em>Crit Rev Toxicol</em> <strong>44</strong>, 64-82, 10.3109/10408444.2013.835786. </a></p>\n\n<p>&nbsp;</p>\n\n<p><a name=\"_ENREF_11\">Felter, S. P., Foreman, J. E., Boobis, A., Corton, J. C., Doi, A. M., Flowers, L., Goodman, J., Haber, L. T., Jacobs, A., Klaunig, J. E., Lynch, A. M., Moggs, J. and Pandiri, A. (2018), Human relevance of rodent liver tumors: Key insights from a Toxicology Forum workshop on nongenotoxic modes of action. <em>Regul Toxicol Pharmacol</em> <strong>92</strong>, 1-7, 10.1016/j.yrtph.2017.11.003. </a></p>\n\n<p>&nbsp;</p>\n\n<p><a name=\"_ENREF_12\">Forbes, K. P., Kouranova, E., Tinker, D., Janowski, K., Cortner, D., McCoy, A. and Cui, X. (2017), Creation and Preliminary Characterization of Pregnane X Receptor and Constitutive Androstane Receptor Knockout Rats. <em>Drug Metab Dispos</em> <strong>45</strong>, 1068-1076, 10.1124/dmd.117.075788. </a></p>\n\n<p>&nbsp;</p>\n\n<p><a name=\"_ENREF_13\">Gervot, L., Rochat, B., Gautier, J. C., Bohnenstengel, F., Kroemer, H., de Berardinis, V., Martin, H., Beaune, P. and de Waziers, I. (1999), Human CYP2B6: expression, inducibility and catalytic activities. <em>Pharmacogenetics</em> <strong>9</strong>, 295-306. </a></p>\n\n<p>&nbsp;</p>\n\n<p><a name=\"_ENREF_14\">Geter, D. R., Bhat, V. S., Gollapudi, B. B., Sura, R. and Hester, S. D. (2014), Dose-response modeling of early molecular and cellular key events in the CAR-mediated hepatocarcinogenesis pathway. <em>Toxicol Sci</em> <strong>138</strong>, 425-45, 10.1093/toxsci/kfu014. </a></p>\n\n<p>&nbsp;</p>\n\n<p><a name=\"_ENREF_15\">Hasmall, S. C. and Roberts, R. A. (1999), The perturbation of apoptosis and mitosis by drugs and xenobiotics. <em>Pharmacol Ther</em> <strong>82</strong>, 63-70. </a></p>\n\n<p>&nbsp;</p>\n\n<p><a name=\"_ENREF_16\">Kandel, B. A., Thomas, M., Winter, S., Damm, G., Seehofer, D., Burk, O., Schwab, M. and Zanger, U. M. (2016), Genomewide comparison of the inducible transcriptomes of nuclear receptors CAR, PXR and PPARalpha in primary human hepatocytes. <em>Biochim Biophys Acta</em> <strong>1859</strong>, 1218-1227, 10.1016/j.bbagrm.2016.03.007. </a></p>\n\n<p>&nbsp;</p>\n\n<p><a name=\"_ENREF_17\">Lake, B. G. (2009), Species differences in the hepatic effects of inducers of CYP2B and CYP4A subfamily forms: relationship to rodent liver tumour formation. <em>Xenobiotica</em> <strong>39</strong>, 582-96, 10.1080/00498250903098184. </a></p>\n\n<p>&nbsp;</p>\n\n<p><a name=\"_ENREF_18\">Lake, B. G. (2018), Human relevance of rodent liver tumour formation by constitutive androstane receptor (CAR) activators. <em>Toxicol Res (Camb)</em> <strong>7</strong>, 697-717, 10.1039/c8tx00008e. </a></p>\n\n<p>&nbsp;</p>\n\n<p><a name=\"_ENREF_19\">Li, D., Mackowiak, B., Brayman, T. G., Mitchell, M., Zhang, L., Huang, S. M. and Wang, H. (2015), Genome-wide analysis of human constitutive androstane receptor (CAR) transcriptome in wild-type and CAR-knockout HepaRG cells. <em>Biochem Pharmacol</em> <strong>98</strong>, 190-202, 10.1016/j.bcp.2015.08.087. </a></p>\n\n<p>&nbsp;</p>\n\n<p><a name=\"_ENREF_20\">Maglich, J. M., Parks, D. J., Moore, L. B., Collins, J. L., Goodwin, B., Billin, A. N., Stoltz, C. A., Kliewer, S. A., Lambert, M. H., Willson, T. M. and Moore, J. T. (2003), Identification of a novel human constitutive androstane receptor (CAR) agonist and its use in the identification of CAR target genes. <em>J Biol Chem</em> <strong>278</strong>, 17277-83, 10.1074/jbc.M300138200. </a></p>\n\n<p>&nbsp;</p>\n\n<p><a name=\"_ENREF_21\">Marmugi, A., Lukowicz, C., Lasserre, F., Montagner, A., Polizzi, A., Ducheix, S., Goron, A., Gamet-Payrastre, L., Gerbal-Chaloin, S., Pascussi, J. M., Moldes, M., Pineau, T., Guillou, H. and Mselli-Lakhal, L. (2016), Activation of the Constitutive Androstane Receptor induces hepatic lipogenesis and regulates Pnpla3 gene expression in a LXR-independent way. <em>Toxicol Appl Pharmacol</em> <strong>303</strong>, 90-100, 10.1016/j.taap.2016.05.006. </a></p>\n\n<p>&nbsp;</p>\n\n<p><a name=\"_ENREF_22\">Moore, D. D., Kato, S., Xie, W., Mangelsdorf, D. J., Schmidt, D. R., Xiao, R. and Kliewer, S. A. (2006), International Union of Pharmacology. LXII. The NR1H and NR1I receptors: constitutive androstane receptor, pregnene X receptor, farnesoid X receptor alpha, farnesoid X receptor beta, liver X receptor alpha, liver X receptor beta, and vitamin D receptor. <em>Pharmacol Rev</em> <strong>58</strong>, 742-59, 10.1124/pr.58.4.6. </a></p>\n\n<p>&nbsp;</p>\n\n<p><a name=\"_ENREF_23\">Omiecinski, C. J., Coslo, D. M., Chen, T., Laurenzana, E. M. and Peffer, R. C. (2011b), Multi-species analyses of direct activators of the constitutive androstane receptor. <em>Toxicol Sci</em> <strong>123</strong>, 550-62, 10.1093/toxsci/kfr191. </a></p>\n\n<p>&nbsp;</p>\n\n<p><a name=\"_ENREF_24\">Omiecinski, C. J., Vanden Heuvel, J. P., Perdew, G. H. and Peters, J. M. (2011a), Xenobiotic metabolism, disposition, and regulation by receptors: from biochemical phenomenon to predictors of major toxicities. <em>Toxicol Sci</em> <strong>120 Suppl 1</strong>, S49-75, 10.1093/toxsci/kfq338. </a></p>\n\n<p>&nbsp;</p>\n\n<p><a name=\"_ENREF_25\">Oshida, K., Vasani, N., Jones, C., Moore, T., Hester, S., Nesnow, S., Auerbach, S., Geter, D. R., Aleksunes, L. M., Thomas, R. S., Applegate, D., Klaassen, C. D. and Corton, J. C. (2015a), Identification of chemical modulators of the constitutive activated receptor (CAR) in a gene expression compendium. <em>Nucl Recept Signal</em> <strong>13</strong>, e002, 10.1621/nrs.13002. </a></p>\n\n<p>&nbsp;</p>\n\n<p><a name=\"_ENREF_26\">Peffer, R. C., Cowie, D. E., Currie, R. A. and Minnema, D. J. (2018a), Sedaxane-Use of Nuclear Receptor Transactivation Assays, Toxicogenomics, and Toxicokinetics as Part of a Mode of Action Framework for Rodent Liver Tumors. <em>Toxicol Sci</em> <strong>162</strong>, 582-598, 10.1093/toxsci/kfx281. </a></p>\n\n<p>&nbsp;</p>\n\n<p><a name=\"_ENREF_27\">Peffer, R. C., LeBaron, M. J., Battalora, M., Bomann, W. H., Werner, C., Aggarwal, M., Rowe, R. R. and Tinwell, H. (2018b), Minimum datasets to establish a CAR-mediated mode of action for rodent liver tumors. <em>Regul Toxicol Pharmacol</em> <strong>96</strong>, 106-120, 10.1016/j.yrtph.2018.04.001. </a></p>\n\n<p>&nbsp;</p>\n\n<p><a name=\"_ENREF_28\">Renwick, A. B., Lavignette, G., Worboy, P. D., Williams, B., Surry, D., Lewis, D. F., Price, R. J., Lake, B. G. and Evans, D. C. (2001), Evaluation of 7-benzyloxy-4-trifluoromethylcoumarin, some other 7-hydroxy-4-trifluoromethylcoumarin derivatives and 7-benzyloxyquinoline as fluorescent substrates for rat hepatic cytochrome P450 enzymes. <em>Xenobiotica</em> <strong>31</strong>, 861-78, 10.1080/00498250110074063. </a></p>\n\n<p>&nbsp;</p>\n\n<p><a name=\"_ENREF_29\">Reschly, E. J. and Krasowski, M. D. (2006), Evolution and function of the NR1I nuclear hormone receptor subfamily (VDR, PXR, and CAR) with respect to metabolism of xenobiotics and endogenous compounds. <em>Curr Drug Metab</em> <strong>7</strong>, 349-65. </a></p>\n\n<p>&nbsp;</p>\n\n<p><a name=\"_ENREF_30\">Stresser, D. M., Turner, S. D., Blanchard, A. P., Miller, V. P. and Crespi, C. L. (2002), Cytochrome P450 fluorometric substrates: identification of isoform-selective probes for rat CYP2D2 and human CYP3A4. <em>Drug Metab Dispos</em> <strong>30</strong>, 845-52. </a></p>\n\n<p>&nbsp;</p>\n\n<p><a name=\"_ENREF_31\">Sun, G., Thai, S. F., Lambert, G. R., Wolf, D. C., Tully, D. B., Goetz, A. K., George, M. H., Grindstaff, R. D., Dix, D. J. and Nesnow, S. (2006), Fluconazole-induced hepatic cytochrome P450 gene expression and enzymatic activities in rats and mice. <em>Toxicol Lett</em> <strong>164</strong>, 44-53, 10.1016/j.toxlet.2005.11.015. </a></p>\n\n<p>&nbsp;</p>\n\n<p><a name=\"_ENREF_32\">Tojima, H., Kakizaki, S., Yamazaki, Y., Takizawa, D., Horiguchi, N., Sato, K. and Mori, M. (2012), Ligand dependent hepatic gene expression profiles of nuclear receptors CAR and PXR. <em>Toxicol Lett</em> <strong>212</strong>, 288-97, 10.1016/j.toxlet.2012.06.001. </a></p>\n\n<p>&nbsp;</p>\n\n<p><a name=\"_ENREF_33\">Tolson, A. H. and Wang, H. (2010), Regulation of drug-metabolizing enzymes by xenobiotic receptors: PXR and CAR. <em>Adv Drug Deliv Rev</em> <strong>62</strong>, 1238-49, 10.1016/j.addr.2010.08.006. </a></p>\n\n<p>&nbsp;</p>\n\n<p><a name=\"_ENREF_34\">Ueda, A., Hamadeh, H. K., Webb, H. K., Yamamoto, Y., Sueyoshi, T., Afshari, C. A., Lehmann, J. M. and Negishi, M. (2002), Diverse roles of the nuclear orphan receptor CAR in regulating hepatic genes in response to phenobarbital. <em>Mol Pharmacol</em> <strong>61</strong>, 1-6. </a></p>\n\n<p>&nbsp;</p>\n\n<p><a name=\"_ENREF_35\">Whysner, J., Ross, P. M. and Williams, G. M. (1996), Phenobarbital mechanistic data and risk assessment: enzyme induction, enhanced cell proliferation, and tumor promotion. <em>Pharmacol Ther</em> <strong>71</strong>, 153-91. </a></p>\n\n<p>&nbsp;</p>\n\n<p><a name=\"_ENREF_36\">Yamada, T., Okuda, Y., Kushida, M., Sumida, K., Takeuchi, H., Nagahori, H., Fukuda, T., Lake, B. G., Cohen, S. M. and Kawamura, S. (2014), Human hepatocytes support the hypertrophic but not the hyperplastic response to the murine nongenotoxic hepatocarcinogen sodium phenobarbital in an in vivo study using a chimeric mouse with humanized liver. <em>Toxicol Sci</em> <strong>142</strong>, 137-57, 10.1093/toxsci/kfu173. </a></p>\n\n<p>&nbsp;</p>\n\n<p>Yamada, T., Uwagawa, S., Okuno, Y., Cohen, S. M. and Kaneko, H. (2009), Case study: an evaluation of the human relevance of the synthetic pyrethroid metofluthrin-induced liver tumors in rats based on mode of action. <em>Toxicol Sci</em> <strong>108</strong>, 59-68, 10.1093/toxsci/kfp007.</p>\n","biologicalOrganisationLevel":"Cellular","organTerm":{"name":"liver","sourceId":"UBERON:0002107"},"biologicalEvents":[{"action":"abnormal","process":"regulation of gene expression","object":{}}],"keyEventStressors":["Phenobarbital","CITCO","metofluthrin","TCPOBOP"],"id":1214}
{"title":"Increase, Cytotoxicity","references":"<ol class=\"references\">\n<li id=\"cite_note-1\"><span class=\"mw-cite-backlink\"><a href=\"#cite_ref-1\"></a></span> <span class=\"reference-text\">Bogdanffy (2002). Vinyl acetate-induced intracellular acidification: implications for risk assessment. Toxicol Sci. 66: 320-326</span>\n</li>\n<li id=\"cite_note-2\"><span class=\"mw-cite-backlink\"><a href=\"#cite_ref-2\"></a></span> <span class=\"reference-text\">Bogdanffy (2002). Vinyl acetate-induced intracellular acidification: implications for risk assessment. Toxicol Sci. 66: 320-326, Izumi, Torigoe, Ishiguchi, Uramoto, Yoshida, Tanabe, Ise, Murakami, Yoshida, Nomoto and Kohno (2003). Cellular pH regulators: potentially promising molecular targets for cancer chemotherapy. Cancer Treat Rev. 29: 541-549, Fais (2010). Proton pump inhibitor-induced tumour cell death by inhibition of a detoxification mechanism. J Intern Med. 267: 515-525</span>\n</li>\n<li id=\"cite_note-3\"><span class=\"mw-cite-backlink\"><a href=\"#cite_ref-3\"></a></span> <span class=\"reference-text\">(2008). Principles and Methods of Toxicology. Boca Raton, FL, Taylor and Francis: 2193</span>\n</li>\n<li id=\"cite_note-4\"><span class=\"mw-cite-backlink\"><a href=\"#cite_ref-4\"></a></span> <span class=\"reference-text\">Kuykendall, Taylor and Bogdanffy (1993). Cytotoxicity and DNA-protein crosslink formation in rat nasal tissues exposed to vinyl acetate are carboxylesterase-mediated. Toxicol Appl Pharmacol. 123: 283-292</span>\n</li>\n<li id=\"cite_note-5\"><span class=\"mw-cite-backlink\"><a href=\"#cite_ref-5\"></a></span> <span class=\"reference-text\">Theiszova, Jantova, Dragunova, Grznarova and Palou (2005). Comparison the cytotoxicity of hydroxyapatite measured by direct cell counting and MTT test in murine fibroblast NIH-3T3 cells. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 149: 393-396, (2008). Principles and Methods of Toxicology. Boca Raton, FL, Taylor and Francis: 2193</span>\n</li>\n<li id=\"cite_note-6\"><span class=\"mw-cite-backlink\"><a href=\"#cite_ref-6\"></a></span> <span class=\"reference-text\">Theiszova, Jantova, Dragunova, Grznarova and Palou (2005). Comparison the cytotoxicity of hydroxyapatite measured by direct cell counting and MTT test in murine fibroblast NIH-3T3 cells. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 149: 393-396, (2008). Principles and Methods of Toxicology. Boca Raton, FL, Taylor and Francis: 2193</span>\n</li>\n<li id=\"cite_note-7\"><span class=\"mw-cite-backlink\"><a href=\"#cite_ref-7\"></a></span> <span class=\"reference-text\">Weisenthal, Dill, Kurnick and Lippman (1983). Comparison of dye exclusion assays with a clonogenic assay in the determination of drug-induced cytotoxicity. Cancer Res. 43: 258-264, Elia, Storer, Harmon, Kraynak, McKelvey, Hertzog, Keenan, DeLuca and Nichols (1993). Cytotoxicity as measured by trypan blue as a potentially confounding variable in the in vitro alkaline elution/rat hepatocyte assay. Mutat Res. 291: 193-205</span>\n</li>\n</ol>","biologicalOrganisationLevel":"Cellular","organTerm":{},"biologicalEvents":[{"action":"increased","process":"cell death","object":{}},{"action":"increased","process":"leukocyte mediated cytotoxicity","object":{}}],"id":768}
{"title":"Increase, Cytotoxicity","references":"<ol class=\"references\">\n<li id=\"cite_note-1\"><span class=\"mw-cite-backlink\"><a href=\"#cite_ref-1\"></a></span> <span class=\"reference-text\">Bogdanffy (2002). Vinyl acetate-induced intracellular acidification: implications for risk assessment. Toxicol Sci. 66: 320-326</span>\n</li>\n<li id=\"cite_note-2\"><span class=\"mw-cite-backlink\"><a href=\"#cite_ref-2\"></a></span> <span class=\"reference-text\">Bogdanffy (2002). Vinyl acetate-induced intracellular acidification: implications for risk assessment. Toxicol Sci. 66: 320-326, Izumi, Torigoe, Ishiguchi, Uramoto, Yoshida, Tanabe, Ise, Murakami, Yoshida, Nomoto and Kohno (2003). Cellular pH regulators: potentially promising molecular targets for cancer chemotherapy. Cancer Treat Rev. 29: 541-549, Fais (2010). Proton pump inhibitor-induced tumour cell death by inhibition of a detoxification mechanism. J Intern Med. 267: 515-525</span>\n</li>\n<li id=\"cite_note-3\"><span class=\"mw-cite-backlink\"><a href=\"#cite_ref-3\"></a></span> <span class=\"reference-text\">(2008). Principles and Methods of Toxicology. Boca Raton, FL, Taylor and Francis: 2193</span>\n</li>\n<li id=\"cite_note-4\"><span class=\"mw-cite-backlink\"><a href=\"#cite_ref-4\"></a></span> <span class=\"reference-text\">Kuykendall, Taylor and Bogdanffy (1993). Cytotoxicity and DNA-protein crosslink formation in rat nasal tissues exposed to vinyl acetate are carboxylesterase-mediated. Toxicol Appl Pharmacol. 123: 283-292</span>\n</li>\n<li id=\"cite_note-5\"><span class=\"mw-cite-backlink\"><a href=\"#cite_ref-5\"></a></span> <span class=\"reference-text\">Theiszova, Jantova, Dragunova, Grznarova and Palou (2005). Comparison the cytotoxicity of hydroxyapatite measured by direct cell counting and MTT test in murine fibroblast NIH-3T3 cells. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 149: 393-396, (2008). Principles and Methods of Toxicology. Boca Raton, FL, Taylor and Francis: 2193</span>\n</li>\n<li id=\"cite_note-6\"><span class=\"mw-cite-backlink\"><a href=\"#cite_ref-6\"></a></span> <span class=\"reference-text\">Theiszova, Jantova, Dragunova, Grznarova and Palou (2005). Comparison the cytotoxicity of hydroxyapatite measured by direct cell counting and MTT test in murine fibroblast NIH-3T3 cells. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 149: 393-396, (2008). Principles and Methods of Toxicology. Boca Raton, FL, Taylor and Francis: 2193</span>\n</li>\n<li id=\"cite_note-7\"><span class=\"mw-cite-backlink\"><a href=\"#cite_ref-7\"></a></span> <span class=\"reference-text\">Weisenthal, Dill, Kurnick and Lippman (1983). Comparison of dye exclusion assays with a clonogenic assay in the determination of drug-induced cytotoxicity. Cancer Res. 43: 258-264, Elia, Storer, Harmon, Kraynak, McKelvey, Hertzog, Keenan, DeLuca and Nichols (1993). Cytotoxicity as measured by trypan blue as a potentially confounding variable in the in vitro alkaline elution/rat hepatocyte assay. Mutat Res. 291: 193-205</span>\n</li>\n</ol>","biologicalOrganisationLevel":"Cellular","organTerm":{},"biologicalEvents":[{"action":"increased","process":"cell death","object":{}},{"action":"increased","process":"leukocyte mediated cytotoxicity","object":{}}],"id":768}
{"title":"Increased, Induction of pyruvate dehydrogenase (PDH)","references":"","biologicalOrganisationLevel":"Molecular","organTerm":{},"biologicalEvents":[{"action":"increased","process":"pyruvate dehydrogenase activity","object":{"name":"pyruvate dehydrogenase [ubiquinone]","source":"PR","sourceId":"PR:000023575"}}],"id":726}
{"title":"Inhibition, Pyruvate dehydrogenase kinase (PDK) enzyme","references":"","biologicalOrganisationLevel":"Cellular","organTerm":{},"biologicalEvents":[{"action":"decreased","process":"pyruvate dehydrogenase activity","object":{"name":"Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 1, mitochondrial (rat)","source":"PR","sourceId":"PR:Q63065"}}],"keyEventStressors":["Dichloroacetic Acid"],"id":724}
{"title":"Increase, Oxidative metabolism","references":"","biologicalOrganisationLevel":"Cellular","organTerm":{},"biologicalEvents":[{"action":"increased","process":"cellular respiration","object":{}}],"id":769}
{"title":"Increase, Necrosis (terminal bronchiolar cells)","references":"","biologicalOrganisationLevel":"Cellular","organTerm":{},"biologicalEvents":[{"action":"increased","process":"cell death","object":{"name":"bronchial epithelial cell","source":"CL","sourceId":"CL:0002328"}}],"id":733}
{"title":"Increase, Regenerative cell proliferation (terminal bronchiolar epithelial cells)","references":"","biologicalOrganisationLevel":"Cellular","organTerm":{},"biologicalEvents":[{"action":"increased","process":"epithelial cell proliferation","object":{"name":"bronchial epithelial cell","source":"CL","sourceId":"CL:0002328"}}],"id":734}
{"title":"Increase, Hyperplasia (terminal bronchiolar cells)","references":"","biologicalOrganisationLevel":"Cellular","organTerm":{"name":"terminal bronchiole epithelium","sourceId":"UBERON:0001958"},"biologicalEvents":[{"action":"increased","process":"hyperplasia","object":{"name":"bronchial epithelial cell","source":"CL","sourceId":"CL:0002328"}}],"id":735}
{"title":"Increase, Adenomas/carcinomas (bronchioloalveolar)","references":"","biologicalOrganisationLevel":"Tissue","organTerm":{"name":"lung","sourceId":"UBERON:0002048"},"biologicalEvents":[{"action":"increased","object":{"name":"Adenoma","source":"MESH","sourceId":"D000236"}},{"action":"increased","object":{"name":"Carcinoma","source":"MESH","sourceId":"D002277"}}],"id":736}
{"title":"Increase, Adenomas/carcinomas (bronchioloalveolar)","references":"","biologicalOrganisationLevel":"Tissue","organTerm":{"name":"lung","sourceId":"UBERON:0002048"},"biologicalEvents":[{"action":"increased","object":{"name":"Adenoma","source":"MESH","sourceId":"D000236"}},{"action":"increased","object":{"name":"Carcinoma","source":"MESH","sourceId":"D002277"}}],"id":736}
{"title":"Increase, Cytotoxicity (club cells)","references":"","biologicalOrganisationLevel":"Cellular","organTerm":{},"biologicalEvents":[{"action":"increased","process":"cell death","object":{"name":"Clara cell","source":"CL","sourceId":"CL:0000158"}}],"id":770}
{"title":"Decreased, Uptake of inorganic iodide","references":"","biologicalOrganisationLevel":"Cellular","organTerm":{},"biologicalEvents":[{"action":"decreased","process":"iodide transport","object":{"name":"iodide","source":"CHEBI","sourceId":"CHEBI:16382"}}],"keyEventStressors":["Perchlorate"],"id":737}
{"title":"Increase, Hypertrophy and proliferation (follicular cell)","references":"","biologicalOrganisationLevel":"Cellular","organTerm":{},"biologicalEvents":[{"action":"increased","process":"cell proliferation","object":{"name":"thyroid follicular cell","source":"CL","sourceId":"CL:0002258"}},{"action":"increased","process":"hypertrophy","object":{"name":"thyroid follicular cell","source":"CL","sourceId":"CL:0002258"}}],"id":739}
{"title":"Increase, Hypertrophy and proliferation (follicular cell)","references":"","biologicalOrganisationLevel":"Cellular","organTerm":{},"biologicalEvents":[{"action":"increased","process":"cell proliferation","object":{"name":"thyroid follicular cell","source":"CL","sourceId":"CL:0002258"}},{"action":"increased","process":"hypertrophy","object":{"name":"thyroid follicular cell","source":"CL","sourceId":"CL:0002258"}}],"id":739}
{"title":"Increase, Hyperplasia (follicular cells)","references":"","biologicalOrganisationLevel":"Cellular","organTerm":{},"biologicalEvents":[{"action":"increased","process":"hyperplasia","object":{"name":"thyroid follicular cell","source":"CL","sourceId":"CL:0002258"}}],"id":740}
{"title":"Increase, Adenomas/carcinomas (follicular cell)","references":"","biologicalOrganisationLevel":"Tissue","organTerm":{"name":"thyroid gland","sourceId":"UBERON:0002046"},"biologicalEvents":[{"action":"increased","object":{"name":"Adenoma","source":"MESH","sourceId":"D000236"}},{"action":"increased","object":{"name":"Carcinoma","source":"MESH","sourceId":"D002277"}}],"id":741}
{"title":"Increase, Adenomas/carcinomas (follicular cell)","references":"","biologicalOrganisationLevel":"Tissue","organTerm":{"name":"thyroid gland","sourceId":"UBERON:0002046"},"biologicalEvents":[{"action":"increased","object":{"name":"Adenoma","source":"MESH","sourceId":"D000236"}},{"action":"increased","object":{"name":"Carcinoma","source":"MESH","sourceId":"D002277"}}],"id":741}
{"title":"Increase, Thyroid-stimulating hormone (TSH)","references":"","biologicalOrganisationLevel":"Tissue","organTerm":{"name":"serum","sourceId":"UBERON:0001977"},"biologicalEvents":[{"action":"increased","object":{"name":"Thyroid stimulating hormone","source":"CHEBI","sourceId":"CHEBI:81567"}},{"action":"increased","process":"increased thyroid-stimulating hormone level","object":{"name":"Thyroid stimulating hormone","source":"CHEBI","sourceId":"CHEBI:81567"}}],"id":753}
{"title":"Increase, Thyroid-stimulating hormone (TSH)","references":"","biologicalOrganisationLevel":"Tissue","organTerm":{"name":"serum","sourceId":"UBERON:0001977"},"biologicalEvents":[{"action":"increased","object":{"name":"Thyroid stimulating hormone","source":"CHEBI","sourceId":"CHEBI:81567"}},{"action":"increased","process":"increased thyroid-stimulating hormone level","object":{"name":"Thyroid stimulating hormone","source":"CHEBI","sourceId":"CHEBI:81567"}}],"id":753}
{"title":"Decrease, Serum thyroid hormone (T4/T3)","references":"","biologicalOrganisationLevel":"Tissue","organTerm":{"name":"serum","sourceId":"UBERON:0001977"},"biologicalEvents":[{"action":"decreased","object":{"name":"thyroxine","source":"CHEBI","sourceId":"CHEBI:30660"}}],"id":771}
{"title":"Decreased, Androgen receptor activity","references":"","biologicalOrganisationLevel":"Molecular","organTerm":{},"biologicalEvents":[{"action":"decreased","process":"androgen receptor activity","object":{"name":"androgen receptor","source":"PR","sourceId":"PR:000004191"}}],"keyEventStressors":["Vinclozalin","Flutamide"],"id":742}
{"title":"Decreased, Testosterone binding to androgen receptor (hypothalamus)","references":"","biologicalOrganisationLevel":"Molecular","organTerm":{},"biologicalEvents":[{"action":"decreased","process":"receptor binding","object":{"name":"testosterone","source":"CHEBI","sourceId":"CHEBI:17347"}}],"id":743}
{"title":"Increase, Hyperplasia (Leydig cells)","references":"","biologicalOrganisationLevel":"Cellular","organTerm":{},"biologicalEvents":[{"action":"increased","process":"Leydig cell hyperplasia","object":{"name":"Leydig cell","source":"CL","sourceId":"CL:0000178"}}],"id":744}
{"title":"Increase, Leydig cell tumors","references":"","biologicalOrganisationLevel":"Cellular","organTerm":{},"biologicalEvents":[{"action":"increased","process":"neoplasm","object":{}}],"id":745}
{"title":"Increased, Luteinizing hormone (LH) ","references":"","biologicalOrganisationLevel":"Tissue","organTerm":{"name":"blood","sourceId":"UBERON:0000178"},"biologicalEvents":[{"action":"increased","object":{"name":"Luteinizing hormone","source":"CHEBI","sourceId":"CHEBI:81568"}}],"id":754}
{"title":"Increase, Dopaminergic activity","references":"","biologicalOrganisationLevel":"Cellular","organTerm":{},"biologicalEvents":[{"action":"increased","process":"synaptic transmission, dopaminergic","object":{}}],"keyEventStressors":["Bromocriptine"],"id":746}
{"title":"Decreased, Prolactin","references":"","biologicalOrganisationLevel":"Tissue","organTerm":{"name":"blood","sourceId":"UBERON:0000178"},"biologicalEvents":[{"action":"decreased","object":{"name":"Prolactin","source":"CHEBI","sourceId":"CHEBI:81580"}}],"id":747}
{"title":"Increased, Estrogen receptor (ER) activity","references":"","biologicalOrganisationLevel":"Molecular","organTerm":{},"biologicalEvents":[{"action":"increased","process":"estrogen receptor activity","object":{"name":"estrogen receptor","source":"PR","sourceId":"PR:000007204"}}],"id":748}
{"title":"Decreased, Progesterone from corpus luteum","references":"","biologicalOrganisationLevel":"Tissue","organTerm":{"name":"corpus luteum","sourceId":"UBERON:0002512"},"biologicalEvents":[{"action":"decreased","process":"progesterone secretion","object":{"name":"progesterone","source":"CHEBI","sourceId":"CHEBI:17026"}}],"id":749}
{"title":"Increase, Hyperplasia (glandular epithelial cells of endometrium)","references":"","biologicalOrganisationLevel":"Cellular","organTerm":{},"biologicalEvents":[{"action":"increased","process":"endometrium hyperplasia","object":{"name":"glandular cell of endometrium","source":"CL","sourceId":"CL:0002656"}}],"id":772}
{"title":"Increase, Endometrial adenocarcinomas","references":"","biologicalOrganisationLevel":"Tissue","organTerm":{"name":"endometrium","sourceId":"UBERON:0001295"},"biologicalEvents":[{"action":"increased","object":{"name":"Adenoma","source":"MESH","sourceId":"D000236"}},{"action":"increased","object":{"name":"Carcinoma","source":"MESH","sourceId":"D002277"}}],"id":773}
{"title":"Increase, Endometrial adenocarcinomas","references":"","biologicalOrganisationLevel":"Tissue","organTerm":{"name":"endometrium","sourceId":"UBERON:0001295"},"biologicalEvents":[{"action":"increased","object":{"name":"Adenoma","source":"MESH","sourceId":"D000236"}},{"action":"increased","object":{"name":"Carcinoma","source":"MESH","sourceId":"D002277"}}],"id":773}
{"title":"Activation, Glutamate-gated chloride channel","references":"","biologicalOrganisationLevel":"Molecular","organTerm":{},"biologicalEvents":[{"action":"increased","process":"chloride channel activity","object":{"name":"glutamate-gated chloride channel (fruit fly)","source":"PR","sourceId":"PR:Q94900"}}],"id":760}
{"title":"Increased, Chloride conductance","references":"","biologicalOrganisationLevel":"Cellular","organTerm":{},"biologicalEvents":[{"action":"increased","process":"chloride transmembrane transport","object":{"name":"chloride","source":"CHEBI","sourceId":"CHEBI:17996"}}],"id":761}
{"title":"hyperpolarisation, neuron","references":"","biologicalOrganisationLevel":"Cellular","organTerm":{},"biologicalEvents":[{"action":"increased","process":"membrane hyperpolarization","object":{}}],"id":763}
{"title":"N/A, Ataxia, paralysis, or hyperactivity","references":"","biologicalOrganisationLevel":"Organ","organTerm":{"name":"skeletal muscle tissue","sourceId":"UBERON:0001134"},"biologicalEvents":[{"action":"increased","process":"ataxia","object":{}},{"action":"increased","process":"hyperactivity","object":{}},{"action":"increased","process":"paralysis","object":{}}],"id":764}
{"title":"N/A, Ataxia, paralysis, or hyperactivity","references":"","biologicalOrganisationLevel":"Organ","organTerm":{"name":"skeletal muscle tissue","sourceId":"UBERON:0001134"},"biologicalEvents":[{"action":"increased","process":"ataxia","object":{}},{"action":"increased","process":"hyperactivity","object":{}},{"action":"increased","process":"paralysis","object":{}}],"id":764}
{"title":"N/A, Ataxia, paralysis, or hyperactivity","references":"","biologicalOrganisationLevel":"Organ","organTerm":{"name":"skeletal muscle tissue","sourceId":"UBERON:0001134"},"biologicalEvents":[{"action":"increased","process":"ataxia","object":{}},{"action":"increased","process":"hyperactivity","object":{}},{"action":"increased","process":"paralysis","object":{}}],"id":764}
{"title":"Decreased, population 1","references":"","biologicalOrganisationLevel":"Population","organTerm":{},"biologicalEvents":[{"action":"decreased","object":{"name":"population quality","source":"PCO","sourceId":"PCO:0000003"}}],"id":765}
{"title":"Inhibition, 4-hydroxyphenyl-pyruvate dioxygenase (HPPD) enzyme","references":"","biologicalOrganisationLevel":"Molecular","organTerm":{},"biologicalEvents":[{"action":"decreased","process":"4-hydroxyphenylpyruvate dioxygenase activity","object":{"name":"4-hydroxyphenylpyruvate dioxygenase (rat)","source":"PR","sourceId":"PR:P32755"}}],"keyEventStressors":["Tembotrione","Nitisinone"],"id":766}
{"title":"Increased, Plasma tyrosine","references":"","biologicalOrganisationLevel":"Tissue","organTerm":{"name":"blood plasma","sourceId":"UBERON:0001969"},"biologicalEvents":[{"action":"increased","object":{"name":"tyrosine","source":"CHEBI","sourceId":"CHEBI:18186"}}],"id":775}
{"title":"Increase, Cytotoxicity (corneal cells)","references":"","biologicalOrganisationLevel":"Cellular","organTerm":{},"biologicalEvents":[{"action":"increased","process":"cell death","object":{"name":"corneal epithelial cell","source":"CL","sourceId":"CL:0000575"}}],"id":776}
{"title":"Increase, Inflammation (corneal cells)","references":"","biologicalOrganisationLevel":"Cellular","organTerm":{},"biologicalEvents":[{"action":"increased","process":"inflammatory response","object":{"name":"corneal epithelial cell","source":"CL","sourceId":"CL:0000575"}}],"id":777}
{"title":"Increase, Regenerative cell proliferation (corneal cells)","references":"","biologicalOrganisationLevel":"Cellular","organTerm":{},"biologicalEvents":[{"action":"increased","process":"cell proliferation","object":{"name":"corneal epithelial cell","source":"CL","sourceId":"CL:0000575"}}],"id":778}
{"title":"Increase, Papillomas/carcinomas (squamous cells)","references":"","biologicalOrganisationLevel":"Cellular","organTerm":{},"biologicalEvents":[{"action":"increased","object":{"name":"papilloma","source":"MESH","sourceId":"D010212"}},{"action":"increased","object":{"name":"Carcinoma","source":"MESH","sourceId":"D002277"}}],"id":779}
{"title":"Increase, Papillomas/carcinomas (squamous cells)","references":"","biologicalOrganisationLevel":"Cellular","organTerm":{},"biologicalEvents":[{"action":"increased","object":{"name":"papilloma","source":"MESH","sourceId":"D010212"}},{"action":"increased","object":{"name":"Carcinoma","source":"MESH","sourceId":"D002277"}}],"id":779}
{"title":"Increase, Cytotoxicity (epithelial cells)","references":"","biologicalOrganisationLevel":"Cellular","organTerm":{},"biologicalEvents":[{"action":"increased","process":"cell death","object":{"name":"epithelial cell","source":"CL","sourceId":"CL:0000066"}}],"keyEventStressors":["Propylene oxide"],"id":780}
{"title":"Increase, Regenerative cell proliferation (forestomach epithelial cells)","references":"","biologicalOrganisationLevel":"Cellular","organTerm":{"name":"murine forestomach","sourceId":"UBERON:0008827"},"biologicalEvents":[{"action":"increased","process":"cell proliferation","object":{"name":"epithelial cell","source":"CL","sourceId":"CL:0000066"}}],"id":781}
{"title":"Increase, Hyperplasia (forestomach epithelial cells)","references":"","biologicalOrganisationLevel":"Cellular","organTerm":{"name":"murine forestomach","sourceId":"UBERON:0008827"},"biologicalEvents":[{"action":"increased","process":"stomach epithelial hyperplasia","object":{"name":"epithelial cell","source":"CL","sourceId":"CL:0000066"}}],"id":782}
{"title":"Increase, Cytotoxicity (tubular epithelial cells)","references":"","biologicalOrganisationLevel":"Cellular","organTerm":{},"biologicalEvents":[{"action":"increased","process":"cell death","object":{"name":"nephron tubule epithelial cell","source":"CL","sourceId":"CL:1000494"}}],"keyEventStressors":["Chloroform"],"id":783}
{"title":"Increase, Hyperplasia (tubular epithelial cells)","references":"","biologicalOrganisationLevel":"Cellular","organTerm":{},"biologicalEvents":[{"action":"increased","process":"kidney epithelium hyperplasia","object":{"name":"nephron tubule epithelial cell","source":"CL","sourceId":"CL:1000494"}}],"id":784}
{"title":"Activation, Androgen receptor","references":"","biologicalOrganisationLevel":"Molecular","organTerm":{},"biologicalEvents":[{"action":"increased","process":"androgen receptor activity","object":{"name":"androgen receptor","source":"PR","sourceId":"PR:000004191"}}],"keyEventStressors":["Androstenedione"],"id":785}
{"title":"Increase, Cytotoxicity (hepatocytes)","references":"","biologicalOrganisationLevel":"Cellular","organTerm":{},"biologicalEvents":[{"action":"increased","process":"cell death","object":{"name":"hepatocyte","source":"CL","sourceId":"CL:0000182"}}],"keyEventStressors":["Thiamethoxam"],"id":786}
{"title":"Increase, Regenerative cell proliferation (hepatocytes)","references":"","biologicalOrganisationLevel":"Cellular","organTerm":{},"biologicalEvents":[{"action":"increased","process":"cell proliferation","object":{"name":"hepatocyte","source":"CL","sourceId":"CL:0000182"}}],"id":787}
{"title":"Decrease, Incorporation of active iodide into iodotyrosines","references":"","biologicalOrganisationLevel":"Cellular","organTerm":{},"biologicalEvents":[{"action":"decreased","process":"catalytic activity","object":{"name":"iodotyrosine deiodinase 1 (mouse)","source":"PR","sourceId":"PR:Q9DCX8"}}],"id":788}
{"title":"Inhibition, 5-reductase activity","references":"","biologicalOrganisationLevel":"Cellular","organTerm":{},"biologicalEvents":[{"action":"decreased","process":"catalytic activity","object":{"name":"3-oxo-5-alpha-steroid 4-dehydrogenase 2 (rat)","source":"PR","sourceId":"PR:P31214"}}],"keyEventStressors":["Finasteride"],"id":790}
{"title":"Increased, Leutinizing hormone (LH)","references":"","biologicalOrganisationLevel":"Tissue","organTerm":{"name":"serum","sourceId":"UBERON:0001977"},"biologicalEvents":[{"action":"increased","object":{"name":"Luteinizing hormone","source":"CHEBI","sourceId":"CHEBI:81568"}}],"id":791}
{"title":"Decrease, Bioactivation of testosterone","references":"","biologicalOrganisationLevel":"Tissue","organTerm":{"name":"blood","sourceId":"UBERON:0000178"},"biologicalEvents":[{"action":"decreased","process":"testosterone biosynthetic process","object":{"name":"testosterone","source":"CHEBI","sourceId":"CHEBI:17347"}}],"id":792}
{"title":"Increase, Urinary bladder calculi","references":"","biologicalOrganisationLevel":"Organ","organTerm":{},"biologicalEvents":[{"action":"increased","process":"cystolithiasis","object":{"name":"Calculi","source":"MESH","sourceId":"D002137"}}],"keyEventStressors":["SACCHARIN, CALCIUM SALT"],"id":793}
{"title":"Increase, Cytotoxicity (urothelial cells)","references":"","biologicalOrganisationLevel":"Cellular","organTerm":{},"biologicalEvents":[{"action":"increased","process":"cell death","object":{"name":"urothelial cell","source":"CL","sourceId":"CL:0000731"}}],"id":794}
{"title":"Increase, Regenerative cell proliferation (urothelial cells)","references":"","biologicalOrganisationLevel":"Cellular","organTerm":{},"biologicalEvents":[{"action":"increased","process":"cell proliferation","object":{"name":"urothelial cell","source":"CL","sourceId":"CL:0000731"}}],"id":795}
{"title":"Increase, Hyperplasia (urothelial)","references":"","biologicalOrganisationLevel":"Cellular","organTerm":{},"biologicalEvents":[{"action":"increased","process":"hyperplasia","object":{"name":"urothelial cell","source":"CL","sourceId":"CL:0000731"}}],"id":796}
{"title":"Increase, Adenomas/carcinomas (urothelial)","references":"","biologicalOrganisationLevel":"Tissue","organTerm":{"name":"urothelium","sourceId":"UBERON:0000365"},"biologicalEvents":[{"action":"increased","object":{"name":"Adenoma","source":"MESH","sourceId":"D000236"}},{"action":"increased","object":{"name":"Carcinoma","source":"MESH","sourceId":"D002277"}}],"id":797}
{"title":"Increase, Adenomas/carcinomas (urothelial)","references":"","biologicalOrganisationLevel":"Tissue","organTerm":{"name":"urothelium","sourceId":"UBERON:0000365"},"biologicalEvents":[{"action":"increased","object":{"name":"Adenoma","source":"MESH","sourceId":"D000236"}},{"action":"increased","object":{"name":"Carcinoma","source":"MESH","sourceId":"D002277"}}],"id":797}
{"title":"Inhibition, Prolyl hydroxylases","references":"","biologicalOrganisationLevel":"Cellular","organTerm":{},"biologicalEvents":[{"action":"decreased","process":"catalytic activity","object":{"name":"Prolyl hydroxylases","source":"MESH","sourceId":"D064828"}}],"id":798}
{"title":"Increased, HIF-1 heterodimer","references":"","biologicalOrganisationLevel":"Cellular","organTerm":{},"biologicalEvents":[{"action":"increased","process":"gene expression","object":{"name":"hypoxia-inducible factor 1 (Caenorhabditis elegans)","source":"PR","sourceId":"PR:G5EGD2"}},{"action":"increased","process":"gene expression","object":{"name":"hypoxia-inducible factor 1-alpha","source":"PR","sourceId":"PR:000008555"}}],"id":799}
{"title":"Increased, HIF-1 heterodimer","references":"","biologicalOrganisationLevel":"Cellular","organTerm":{},"biologicalEvents":[{"action":"increased","process":"gene expression","object":{"name":"hypoxia-inducible factor 1 (Caenorhabditis elegans)","source":"PR","sourceId":"PR:G5EGD2"}},{"action":"increased","process":"gene expression","object":{"name":"hypoxia-inducible factor 1-alpha","source":"PR","sourceId":"PR:000008555"}}],"id":799}
{"title":"Decreased, Aromatase (Cyp19a1) mRNA","references":"","biologicalOrganisationLevel":"Cellular","organTerm":{},"biologicalEvents":[{"action":"decreased","process":"aromatase activity","object":{"name":"aromatase isoform 1","source":"PR","sourceId":"PR:000038849"}},{"action":"decreased","process":"aromatase activity","object":{"name":"aromatase","source":"PR","sourceId":"PR:000006100"}}],"id":800}
{"title":"Decreased, Aromatase (Cyp19a1) mRNA","references":"","biologicalOrganisationLevel":"Cellular","organTerm":{},"biologicalEvents":[{"action":"decreased","process":"aromatase activity","object":{"name":"aromatase isoform 1","source":"PR","sourceId":"PR:000038849"}},{"action":"decreased","process":"aromatase activity","object":{"name":"aromatase","source":"PR","sourceId":"PR:000006100"}}],"id":800}
{"title":"modulation, Unknown","references":"","biologicalOrganisationLevel":"Molecular","organTerm":{},"biologicalEvents":[{"action":"abnormal","process":"signaling","object":{"name":"hypoxia-inducible factor 1-alpha","source":"PR","sourceId":"PR:000008555"}}],"id":801}
{"title":"Increased, HIF-1 alpha transcription","references":"","biologicalOrganisationLevel":"Cellular","organTerm":{},"biologicalEvents":[{"action":"increased","process":"gene expression","object":{"name":"hypoxia-inducible factor 1-alpha","source":"PR","sourceId":"PR:000008555"}}],"id":802}
{"title":"Inhibition, HMG-CoA reductase","references":"","biologicalOrganisationLevel":"Cellular","organTerm":{},"biologicalEvents":[{"action":"decreased","process":"hydroxymethylglutaryl-CoA reductase activity","object":{"name":"3-hydroxy-3-methylglutaryl-coenzyme A reductase","source":"PR","sourceId":"PR:000008636"}}],"id":804}
{"title":"Decreased, mevalonate","references":"","biologicalOrganisationLevel":"Cellular","organTerm":{},"biologicalEvents":[{"action":"decreased","object":{"name":"mevalonate","source":"CHEBI","sourceId":"CHEBI:25350"}}],"id":805}
{"title":"Decreased, cholesterol","references":"<p>Al-Habsi, A.A., A. Massarsky, T.W. Moon (2016) &ldquo;Exposure to gemfibrozil and atorvastatin affects cholesterol metabolism and steroid production in zebrafish (<em>Danio rerio</em>)&rdquo;, <em>Comparative Biochemistry and Physiology, Part B, </em>Vol. 199, Elsevier, pp. 87-96. http://dx.doi.org/10.1016/j.cbpb.2015.11.009</p>\n\n<p>Azhar, S., E. Reaven (2007) &ldquo;Regulation of Leydig cell cholesterol metabolism&rdquo;, in A.H. Payne, M.P. Hardy (eds.) <em>The Leydig Cell in Health and Disease, </em>Humana Press. https://doi.org/10.1007/978-1-59745-453-7</p>\n\n<p>Dai, W. et al. (2015) &quot;High fat plus high cholesterol diet lead to hepatic steatosis in zebrafish larvae: a novel model for screening anti-hepatic steatosis drugs&quot;,&nbsp;<em>Nutrition and Metabolism</em>, Vol. 12(42), Springer Nature.&nbsp;DOI 10.1186/s12986-015-0036-z&nbsp;</p>\n\n<p>Du, Z.Y. et al. (2008) &ldquo;Hypolipidaemic effect of fenofibrate and fasting in the herbivorous grass carp (<em>Ctenopharyngodon idella) </em>fed a high-fat diet&rdquo;, <em>British Journal of Nutrition, </em>Vol. 100, Cambridge University Press, pp. 1200-1212. doi:10.1017/S0007114508986840</p>\n\n<p>Guo, X. et al. (2015) &ldquo;Effects of lipid-lowering pharmaceutical clofibrate on lipid and lipoprotein metabolism of grass carp (<em>Ctenopharyngodon idellal </em>Val.) fed with the high non-protein energy diets&rdquo;, <em>Fish Physiology and Biochemistry, </em>Vol. 41, Springer, pp. 331-343. doi: 10.1007/s10695-014-9986-8</p>\n\n<p>Prindiville, J.S. et al. (2011) &ldquo;The fibrate drug gemfibrozil disrupts lipoprotein metabolism in rainbow trout&rdquo;, <em>Toxicology and Applied Pharmacology, </em>Vol. 251, Elsevier, pp. 201-238. doi:10.1016/j.taap.2010.12.013</p>\n\n<p>Sonawane, P.D. et al. (2016) &ldquo;Plant cholesterol biosynthetic pathway overlaps with phytosterol metabolism&rdquo;, <em>Nature Plants, </em>Vol. 3, Nature Publishing Group, https://doi.org/10.1038/nplants.2016.205</p>\n\n<p>Velasco-Santamar&iacute;a, Y.M. et al. (2011) &ldquo;Bezafibrate, a lipid-lowering pharmaceutical, as a potential endocrine disruptor in male zebrafish (<em>Danio rerio</em>)&rdquo;, <em>Aquatic Toxicology, </em>Vol. 105, Elsevier, pp. 107-118. doi:10.1016/j.aquatox.2011.05.018</p>\n\n<p>Zhang, T. et al. (2019) &ldquo;Evolution of the cholesterol biosynthesis pathway in animals&rdquo;, <em>Molecular Biology and Evolution, </em>Vol. 36(11), Oxford University Press, pp. 2548-2556. doi:10.1093/molbev/msz167</p>\n\n<p>Zhou, J. et al. (2015) &quot;Rapid analysis of hypolipidemic drugs in a live zebrafish assay&quot;,&nbsp;<em>Journal of Pharmacological and Toxicological Methods,&nbsp;</em>Vol. 72, Elsevier, pp. 47-52.&nbsp;http://dx.doi.org/10.1016/j.vascn.2014.12.002</p>\n","biologicalOrganisationLevel":"Tissue","organTerm":{"name":"blood plasma","sourceId":"UBERON:0001969"},"biologicalEvents":[{"action":"decreased","process":"cholesterol biosynthetic process","object":{"name":"cholesterol","source":"CHEBI","sourceId":"CHEBI:16113"}},{"action":"decreased","process":"cholesterol transport","object":{"name":"cholesterol","source":"CHEBI","sourceId":"CHEBI:16113"}},{"action":"decreased","process":"cholesterol transport","object":{"name":"cholesteryl ester","source":"CHEBI","sourceId":"CHEBI:17002"}}],"keyEventStressors":["Atorvastatin","Bezafibrate","Clofibrate","Gemfibrozil","Fenofibrate","Simvastatin"],"id":807}
{"title":"Decreased, cholesterol","references":"<p>Al-Habsi, A.A., A. Massarsky, T.W. Moon (2016) &ldquo;Exposure to gemfibrozil and atorvastatin affects cholesterol metabolism and steroid production in zebrafish (<em>Danio rerio</em>)&rdquo;, <em>Comparative Biochemistry and Physiology, Part B, </em>Vol. 199, Elsevier, pp. 87-96. http://dx.doi.org/10.1016/j.cbpb.2015.11.009</p>\n\n<p>Azhar, S., E. Reaven (2007) &ldquo;Regulation of Leydig cell cholesterol metabolism&rdquo;, in A.H. Payne, M.P. Hardy (eds.) <em>The Leydig Cell in Health and Disease, </em>Humana Press. https://doi.org/10.1007/978-1-59745-453-7</p>\n\n<p>Dai, W. et al. (2015) &quot;High fat plus high cholesterol diet lead to hepatic steatosis in zebrafish larvae: a novel model for screening anti-hepatic steatosis drugs&quot;,&nbsp;<em>Nutrition and Metabolism</em>, Vol. 12(42), Springer Nature.&nbsp;DOI 10.1186/s12986-015-0036-z&nbsp;</p>\n\n<p>Du, Z.Y. et al. (2008) &ldquo;Hypolipidaemic effect of fenofibrate and fasting in the herbivorous grass carp (<em>Ctenopharyngodon idella) </em>fed a high-fat diet&rdquo;, <em>British Journal of Nutrition, </em>Vol. 100, Cambridge University Press, pp. 1200-1212. doi:10.1017/S0007114508986840</p>\n\n<p>Guo, X. et al. (2015) &ldquo;Effects of lipid-lowering pharmaceutical clofibrate on lipid and lipoprotein metabolism of grass carp (<em>Ctenopharyngodon idellal </em>Val.) fed with the high non-protein energy diets&rdquo;, <em>Fish Physiology and Biochemistry, </em>Vol. 41, Springer, pp. 331-343. doi: 10.1007/s10695-014-9986-8</p>\n\n<p>Prindiville, J.S. et al. (2011) &ldquo;The fibrate drug gemfibrozil disrupts lipoprotein metabolism in rainbow trout&rdquo;, <em>Toxicology and Applied Pharmacology, </em>Vol. 251, Elsevier, pp. 201-238. doi:10.1016/j.taap.2010.12.013</p>\n\n<p>Sonawane, P.D. et al. (2016) &ldquo;Plant cholesterol biosynthetic pathway overlaps with phytosterol metabolism&rdquo;, <em>Nature Plants, </em>Vol. 3, Nature Publishing Group, https://doi.org/10.1038/nplants.2016.205</p>\n\n<p>Velasco-Santamar&iacute;a, Y.M. et al. (2011) &ldquo;Bezafibrate, a lipid-lowering pharmaceutical, as a potential endocrine disruptor in male zebrafish (<em>Danio rerio</em>)&rdquo;, <em>Aquatic Toxicology, </em>Vol. 105, Elsevier, pp. 107-118. doi:10.1016/j.aquatox.2011.05.018</p>\n\n<p>Zhang, T. et al. (2019) &ldquo;Evolution of the cholesterol biosynthesis pathway in animals&rdquo;, <em>Molecular Biology and Evolution, </em>Vol. 36(11), Oxford University Press, pp. 2548-2556. doi:10.1093/molbev/msz167</p>\n\n<p>Zhou, J. et al. (2015) &quot;Rapid analysis of hypolipidemic drugs in a live zebrafish assay&quot;,&nbsp;<em>Journal of Pharmacological and Toxicological Methods,&nbsp;</em>Vol. 72, Elsevier, pp. 47-52.&nbsp;http://dx.doi.org/10.1016/j.vascn.2014.12.002</p>\n","biologicalOrganisationLevel":"Tissue","organTerm":{"name":"blood plasma","sourceId":"UBERON:0001969"},"biologicalEvents":[{"action":"decreased","process":"cholesterol biosynthetic process","object":{"name":"cholesterol","source":"CHEBI","sourceId":"CHEBI:16113"}},{"action":"decreased","process":"cholesterol transport","object":{"name":"cholesterol","source":"CHEBI","sourceId":"CHEBI:16113"}},{"action":"decreased","process":"cholesterol transport","object":{"name":"cholesteryl ester","source":"CHEBI","sourceId":"CHEBI:17002"}}],"keyEventStressors":["Atorvastatin","Bezafibrate","Clofibrate","Gemfibrozil","Fenofibrate","Simvastatin"],"id":807}
{"title":"Decreased, cholesterol","references":"<p>Al-Habsi, A.A., A. Massarsky, T.W. Moon (2016) &ldquo;Exposure to gemfibrozil and atorvastatin affects cholesterol metabolism and steroid production in zebrafish (<em>Danio rerio</em>)&rdquo;, <em>Comparative Biochemistry and Physiology, Part B, </em>Vol. 199, Elsevier, pp. 87-96. http://dx.doi.org/10.1016/j.cbpb.2015.11.009</p>\n\n<p>Azhar, S., E. Reaven (2007) &ldquo;Regulation of Leydig cell cholesterol metabolism&rdquo;, in A.H. Payne, M.P. Hardy (eds.) <em>The Leydig Cell in Health and Disease, </em>Humana Press. https://doi.org/10.1007/978-1-59745-453-7</p>\n\n<p>Dai, W. et al. (2015) &quot;High fat plus high cholesterol diet lead to hepatic steatosis in zebrafish larvae: a novel model for screening anti-hepatic steatosis drugs&quot;,&nbsp;<em>Nutrition and Metabolism</em>, Vol. 12(42), Springer Nature.&nbsp;DOI 10.1186/s12986-015-0036-z&nbsp;</p>\n\n<p>Du, Z.Y. et al. (2008) &ldquo;Hypolipidaemic effect of fenofibrate and fasting in the herbivorous grass carp (<em>Ctenopharyngodon idella) </em>fed a high-fat diet&rdquo;, <em>British Journal of Nutrition, </em>Vol. 100, Cambridge University Press, pp. 1200-1212. doi:10.1017/S0007114508986840</p>\n\n<p>Guo, X. et al. (2015) &ldquo;Effects of lipid-lowering pharmaceutical clofibrate on lipid and lipoprotein metabolism of grass carp (<em>Ctenopharyngodon idellal </em>Val.) fed with the high non-protein energy diets&rdquo;, <em>Fish Physiology and Biochemistry, </em>Vol. 41, Springer, pp. 331-343. doi: 10.1007/s10695-014-9986-8</p>\n\n<p>Prindiville, J.S. et al. (2011) &ldquo;The fibrate drug gemfibrozil disrupts lipoprotein metabolism in rainbow trout&rdquo;, <em>Toxicology and Applied Pharmacology, </em>Vol. 251, Elsevier, pp. 201-238. doi:10.1016/j.taap.2010.12.013</p>\n\n<p>Sonawane, P.D. et al. (2016) &ldquo;Plant cholesterol biosynthetic pathway overlaps with phytosterol metabolism&rdquo;, <em>Nature Plants, </em>Vol. 3, Nature Publishing Group, https://doi.org/10.1038/nplants.2016.205</p>\n\n<p>Velasco-Santamar&iacute;a, Y.M. et al. (2011) &ldquo;Bezafibrate, a lipid-lowering pharmaceutical, as a potential endocrine disruptor in male zebrafish (<em>Danio rerio</em>)&rdquo;, <em>Aquatic Toxicology, </em>Vol. 105, Elsevier, pp. 107-118. doi:10.1016/j.aquatox.2011.05.018</p>\n\n<p>Zhang, T. et al. (2019) &ldquo;Evolution of the cholesterol biosynthesis pathway in animals&rdquo;, <em>Molecular Biology and Evolution, </em>Vol. 36(11), Oxford University Press, pp. 2548-2556. doi:10.1093/molbev/msz167</p>\n\n<p>Zhou, J. et al. (2015) &quot;Rapid analysis of hypolipidemic drugs in a live zebrafish assay&quot;,&nbsp;<em>Journal of Pharmacological and Toxicological Methods,&nbsp;</em>Vol. 72, Elsevier, pp. 47-52.&nbsp;http://dx.doi.org/10.1016/j.vascn.2014.12.002</p>\n","biologicalOrganisationLevel":"Tissue","organTerm":{"name":"blood plasma","sourceId":"UBERON:0001969"},"biologicalEvents":[{"action":"decreased","process":"cholesterol biosynthetic process","object":{"name":"cholesterol","source":"CHEBI","sourceId":"CHEBI:16113"}},{"action":"decreased","process":"cholesterol transport","object":{"name":"cholesterol","source":"CHEBI","sourceId":"CHEBI:16113"}},{"action":"decreased","process":"cholesterol transport","object":{"name":"cholesteryl ester","source":"CHEBI","sourceId":"CHEBI:17002"}}],"keyEventStressors":["Atorvastatin","Bezafibrate","Clofibrate","Gemfibrozil","Fenofibrate","Simvastatin"],"id":807}
{"title":"Decreased, Testosterone","references":"","biologicalOrganisationLevel":"Individual","organTerm":{},"biologicalEvents":[{"action":"decreased","object":{"name":"testosterone","source":"CHEBI","sourceId":"CHEBI:17347"}}],"id":808}
{"title":"malformed, Male reproductive tract","references":"","biologicalOrganisationLevel":"Individual","organTerm":{"name":"male reproductive system","sourceId":"UBERON:0000079"},"biologicalEvents":[{"action":"morphological change","object":{"name":"male reproductive system","source":"UBERON","sourceId":"UBERON:0000079"}}],"id":809}
{"title":"Decrease, Fertility","references":"","biologicalOrganisationLevel":"Individual","organTerm":{},"biologicalEvents":[{"action":"decreased","object":{"name":"fertility","source":"MESH","sourceId":"D005298"}}],"id":330}
{"title":"Decreased, Binding of NE to NE receptors on GnRH neurons","references":"","biologicalOrganisationLevel":"Cellular","organTerm":{},"biologicalEvents":[{"action":"decreased","process":"norepinephrine binding","object":{"name":"(R)-noradrenaline","source":"CHEBI","sourceId":"CHEBI:18357"}}],"id":848}
{"title":"Inhibition, Antgonism of NE receptor","references":"","biologicalOrganisationLevel":"Molecular","organTerm":{},"biologicalEvents":[{"action":"decreased","process":"signaling","object":{"name":"alpha-2A adrenergic receptor","source":"PR","sourceId":"PR:000001186"}}],"id":849}
{"title":"Decreased, Thyroxine (T4) in serum","references":"","biologicalOrganisationLevel":"Tissue","organTerm":{"name":"serum","sourceId":"UBERON:0001977"},"biologicalEvents":[{"action":"decreased","object":{"name":"thyroxine","source":"CHEBI","sourceId":"CHEBI:30660"}}],"id":426}
{"title":"Occurrence, Kidney toxicity","references":"","biologicalOrganisationLevel":"Organ","organTerm":{"name":"kidney","sourceId":"UBERON:0002113"},"biologicalEvents":[{"action":"occurrence","process":"toxicity","object":{"name":"kidney","source":"UBERON","sourceId":"UBERON:0002113"}}],"id":814}
{"title":"Decreased, Glomerular filtration","references":"","biologicalOrganisationLevel":"Tissue","organTerm":{"name":"kidney","sourceId":"UBERON:0002113"},"biologicalEvents":[{"action":"decreased","process":"glomerular filtration","object":{}}],"id":819}
{"title":"Decreased, Renal plasma flow","references":"","biologicalOrganisationLevel":"Tissue","organTerm":{"name":"kidney","sourceId":"UBERON:0002113"},"biologicalEvents":[{"action":"decreased","process":"kidney plasma flow trait","object":{}}],"id":820}
{"title":"Decreased, Sodium reabsorption","references":"","biologicalOrganisationLevel":"Organ","organTerm":{"name":"kidney","sourceId":"UBERON:0002113"},"biologicalEvents":[{"action":"decreased","process":"renal absorption","object":{"name":"sodium(1+)","source":"CHEBI","sourceId":"CHEBI:29101"}}],"id":821}
{"title":"Increased, Serum creatinine","references":"","biologicalOrganisationLevel":"Organ","organTerm":{"name":"serum","sourceId":"UBERON:0001977"},"biologicalEvents":[{"action":"increased","object":{"name":"creatinine","source":"CHEBI","sourceId":"CHEBI:16737"}},{"action":"increased","process":"abnormal amino acid level","object":{}}],"id":813}
{"title":"Increased, Serum creatinine","references":"","biologicalOrganisationLevel":"Organ","organTerm":{"name":"serum","sourceId":"UBERON:0001977"},"biologicalEvents":[{"action":"increased","object":{"name":"creatinine","source":"CHEBI","sourceId":"CHEBI:16737"}},{"action":"increased","process":"abnormal amino acid level","object":{}}],"id":813}
{"title":"Occurrence, Cystic dilatation (renal tubule)","references":"","biologicalOrganisationLevel":"Organ","organTerm":{"name":"kidney","sourceId":"UBERON:0002113"},"biologicalEvents":[{"action":"occurrence","process":"Dilatation","object":{"name":"renal tubule","source":"UBERON","sourceId":"UBERON:0009773"}}],"id":823}
{"title":"Occurrence, Cytoplasmic vacuolization (podocyte)","references":"","biologicalOrganisationLevel":"Organ","organTerm":{"name":"kidney","sourceId":"UBERON:0002113"},"biologicalEvents":[{"action":"occurrence","process":"podocyte vacuolization","object":{}}],"id":824}
{"title":"Occurrence, Cytoplasmic vacuolization (Renal tubule)","references":"","biologicalOrganisationLevel":"Organ","organTerm":{"name":"kidney","sourceId":"UBERON:0002113"},"biologicalEvents":[{"action":"occurrence","process":"autophagic cell death","object":{"name":"renal tubule","source":"UBERON","sourceId":"UBERON:0009773"}}],"id":818}
{"title":"Decreased, Renal ability to dilute urine","references":"","biologicalOrganisationLevel":"Organ","organTerm":{},"biologicalEvents":[{"action":"decreased","process":"function","object":{"name":"kidney","source":"UBERON","sourceId":"UBERON:0002113"}}],"id":825}
{"title":"Inhibition, Phospholipase A","references":"","biologicalOrganisationLevel":"Molecular","organTerm":{},"biologicalEvents":[{"action":"decreased","process":"phospholipase activity","object":{"name":"phospholipase A1 member A (human)","source":"PR","sourceId":"PR:Q53H76"}}],"id":828}
{"title":"Damage, Lipid bilayer","references":"","biologicalOrganisationLevel":"Cellular","organTerm":{},"biologicalEvents":[{"action":"functional change","object":{"name":"Lipid bilayer of wall of lysosome","source":"FMA","sourceId":"FMA:67514"}}],"id":829}
{"title":"Disturbance, Lysosomal function","references":"","biologicalOrganisationLevel":"Cellular","organTerm":{},"biologicalEvents":[{"action":"functional change","object":{"name":"lysosome","source":"GO","sourceId":"GO:0005764"}}],"id":831}
{"title":"Injury, Mitochondria","references":"","biologicalOrganisationLevel":"Cellular","organTerm":{},"biologicalEvents":[{"action":"functional change","object":{"name":"mitochondrion","source":"GO","sourceId":"GO:0005739"}}],"id":832}
{"title":"Occurrence, Cytoplasmic vacuolization (hepatocyte)","references":"","biologicalOrganisationLevel":"Cellular","organTerm":{},"biologicalEvents":[{"action":"occurrence","process":"autophagic cell death","object":{}}],"id":833}
{"title":"Occurrence, Ballooning degeneration (hepatocyte)","references":"","biologicalOrganisationLevel":"Cellular","organTerm":{},"biologicalEvents":[{"action":"occurrence","process":"autophagic cell death","object":{}}],"id":835}
{"title":"Occurrence, Cytoplasmic vacuolization (kupffer cell)","references":"","biologicalOrganisationLevel":"Cellular","organTerm":{},"biologicalEvents":[{"action":"occurrence","process":"autophagic cell death","object":{}}],"id":837}
{"title":"Induction, Microvesicular fat","references":"","biologicalOrganisationLevel":"Tissue","organTerm":{},"biologicalEvents":[{"action":"increased","process":"Microvesicular hepatic steatosis","object":{}}],"id":838}
{"title":"Formation, Mallory body","references":"","biologicalOrganisationLevel":"Cellular","organTerm":{},"biologicalEvents":[{"action":"occurrence","process":"Mallory bodies","object":{}}],"id":839}
{"title":"Formation, Liver fibrosis","references":"","biologicalOrganisationLevel":"Tissue","organTerm":{"name":"liver","sourceId":"UBERON:0002107"},"biologicalEvents":[{"action":"occurrence","process":"liver fibrosis","object":{"name":"liver","source":"UBERON","sourceId":"UBERON:0002107"}}],"id":840}
{"title":"Occurrence, Cytoplasmic vacuolization (Bile duct cell)","references":"","biologicalOrganisationLevel":"Cellular","organTerm":{},"biologicalEvents":[{"action":"occurrence","process":"autophagic cell death","object":{}}],"id":836}
{"title":"Oxidation, Uroporphyrinogen","references":"<ol>\n\t<li><a href=\"#cite_ref-1\">&uarr;</a> <a class=\"external autonumber\" href=\"https://en.wikipedia.org/wiki/Uroporphyrinogen_III\" rel=\"nofollow\" target=\"_blank\">[1]</a>&quot;Wikipedia:Uroporphyrinogen III&quot;</li>\n\t<li><a href=\"#cite_ref-Smith2010_2-0\">&uarr;</a> Smith, A. G., and Elder, G. H. (2010). Complex gene-chemical interactions: hepatic uroporphyria as a paradigm. <em>Chem. Res. Toxicol. </em> <strong>23</strong> (4), 712-723.</li>\n\t<li><a href=\"#cite_ref-Sinclair1997_3-0\">&uarr;</a> Sinclair, P. R., Gorman, N., Walton, H. S., Sinclair, J. F., Lee, C. A., and Rifkind, A. B. (1997). Identification of CYP1A5 as the CYP1A enzyme mainly responsible for uroporphyrinogen oxidation induced by AH receptor ligands in chicken liver and kidney. <em>Drug Metab. Dispos. </em> <strong>25</strong> (7), 779-783.</li>\n\t<li><a href=\"#cite_ref-Jacobs1989_4-0\">&uarr;</a> Jacobs, J. M., Sinclair, P. R., Bement, W. J., Lambrecht, R. W., Sinclair, J. F., and Goldstein, J. A. (1989). Oxidation of uroporphyrinogen by methylcholanthrene-induced cytochrome P-450. Essential role of cytochrome P-450d. <em>Biochem. J</em> <strong>258</strong> (1), 247-253.</li>\n\t<li><a href=\"#cite_ref-Wainwright1995_5-0\">&uarr;</a> Wainwright, J. S., Hopkins, K. M., Bums Jr., T.A., and Di Giulio, R. T. Investigation of potential biomarkers of exposure to bleached kraft mill effluent in North Carolina rivers. 27708-0328. 1995. Durham, NC. Ref Type: Report</li>\n\t<li>\n\t<p>Sinclair, P. R., Gorman, N., Tsyrlov, I. B., Fuhr, U., Walton, H. S., &nbsp;Sinclair, A.F. (1988). Uroporphyrinogen Oxidation Catalyzed By Human Cytochromes P450. Drug Metab. Dispos. 26(10), 1019-1025.</p>\n\t</li>\n</ol>\n","biologicalOrganisationLevel":"Cellular","organTerm":{},"biologicalEvents":[{"action":"increased","object":{"name":"uroporphyrinogen","source":"CHEBI","sourceId":"CHEBI:27258"}}],"id":844}
{"title":"Inhibition, UROD","references":"<ol>\n\t<li><a href=\"#cite_ref-Elder1995_1-0\">&uarr;</a> Elder, G. H., and Roberts, A. G. (1995). Uroporphyrinogen decarboxylase. <em>J Bioenerg. Biomembr. </em> <strong>27</strong> (2), 207-214.</li>\n\t<li><a href=\"#cite_ref-Frank2010_2-0\">&uarr;</a> Frank, J., and Poblete-Gutierrez, P. (2010). Porphyria cutanea tarda--when skin meets liver. <em>Best. Pract. Res. Clin Gastroenterol. </em> <strong>24</strong> (5), 735-745.</li>\n\t<li><a href=\"#cite_ref-Smith2010_3-0\">&uarr;</a> Smith, A. G., and Elder, G. H. (2010). Complex gene-chemical interactions: hepatic uroporphyria as a paradigm. <em>Chem. Res. Toxicol. </em> <strong>23</strong> (4), 712-723.</li>\n\t<li><a href=\"#cite_ref-Phillips2007_4-0\">&uarr;</a> Phillips, J. D., Bergonia, H. A., Reilly, C. A., Franklin, M. R., and Kushner, J. P. (2007). A porphomethene inhibitor of uroporphyrinogen decarboxylase causes porphyria cutanea tarda. <em>Proc. Natl. Acad. Sci. U. S. A</em> <strong>104</strong> (12), 5079-5084.</li>\n\t<li><a href=\"#cite_ref-Danton2007_5-0\">&uarr;</a> Danton, M., and Lim, C. K. (2007). Porphomethene inhibitor of uroporphyrinogen decarboxylase: analysis by high-performance liquid chromatography/electrospray ionization tandem mass spectrometry. <em>Biomed. Chromatogr. </em> <strong>21</strong> (7), 661-663</li>\n\t<li><a href=\"#cite_ref-Caballes2012_6-0\">&uarr;</a> Caballes F.R., Sendi, H., and Bonkovsky, H. L. (2012). Hepatitis C, porphyria cutanea tarda and liver iron: an update. <em>Liver Int. </em> <strong>32</strong> (6), 880-893.</li>\n\t<li>&uarr; <sup><a href=\"#cite_ref-Phillips2001_7-0\">7.0</a></sup> <sup><a href=\"#cite_ref-Phillips2001_7-1\">7.1</a></sup> Phillips, J. D., and Kushner, J. P. (2001). Measurement of uroporphyrinogen decarboxylase activity. <em>Curr. Protoc. Toxicol. </em> <strong>Chapter 8</strong>, Unit.</li>\n\t<li><a href=\"#cite_ref-Bergonia2009_8-0\">&uarr;</a> Bergonia, H. A., Phillips, J. D., and Kushner, J. P. (2009). Reduction of porphyrins to porphyrinogens with palladium on carbon. <em>Anal. Biochem. </em> <strong>384</strong> (1), 74-78.</li>\n\t<li><a href=\"#cite_ref-Jones2003_9-0\">&uarr;</a> Jones, M. A., Thientanavanich, P., Anderson, M. D., and Lash, T. D. (2003). Comparison of two assay methods for activities of uroporphyrinogen decarboxylase and coproporphyrinogen oxidase. J <em>Biochem. Biophys. Methods</em> <strong>55</strong> (3), 241-249.</li>\n\t<li>Smith, A. G., Francis, J. E., Kay, S. J., and Greig, J. B. (1981) Hepatic toxicity and uroporphyrinogen decarboxylase activity following a single dose of 2,3,7,8-tetrachlorodibenzo-p-dioxin to mice. <em>Biochem. Pharmacol. </em> <strong>30</strong> (20), 2825-2830.</li>\n\t<li>Rios de Molina, M.D., Wainstok de Calmanovici, R., San Martin de Viale, L.C. (1980) Investigations of the presence of porphyrinogen carboxy-lase inhibitor in the liver of rats intoxicated with hexachlorobenzene. <em>Int. J. Biochem.</em> <strong>12</strong>, 1027-32.</li>\n\t<li>Miranda, C.L., Henderson, M.C., Wang, J.-L, Nakaue, H.S., and Buhler, D.R. (1992) Comparative effects of the polychlorinated biphenyl mixture, Aroclor 1242, on porphyrin and xenobiotic metabolism in kidney of Japanese quial and rat. <em>Comp. Biochem. Physiol.</em> <strong>103C</strong>(1), 149-52.</li>\n\t<li>Kawanishi, S., Seki, Y., and Sano, S. (1983) Uroporphyrinogen decarboxilase: Purification, properties, and inhibition by polychlorinated biphenyl isomers. <em>J. Biol. Chem.</em> <strong>258</strong>(7), 4285-92.</li>\n\t<li>Lambrecht, R. W., Sinclair, P. R., Bement, W. J., Sinclair, J. F., Carpenter, H. M., Buhler, D. R., Urquhart, A. J., and Elder, G. H. (1988). Hepatic uroporphyrin accumulation and uroporphyrinogen decarboxylase activity in cultured chick-embryo hepatocytes and in Japanese quail (Coturnix coturnix japonica) and mice treated with polyhalogenated aromatic compounds. <em>Biochem. J.</em> <strong>253</strong>(1), 131-138.</li>\n\t<li>Francis, J. E., &amp; Smith, A. G. (1984). Assay of mouse liver uroporphyrinogen decarboxylase by reverse-phase high-performance liquid chromatography.&nbsp;<em>Analytical biochemistry</em>,&nbsp;<strong>138</strong>(2), 404-410.</li>\n</ol>\n","biologicalOrganisationLevel":"Molecular","organTerm":{},"biologicalEvents":[{"action":"decreased","process":"catalytic activity","object":{"name":"uroporphyrinogen decarboxylase","source":"PR","sourceId":"PR:000017134"}}],"id":845}
{"title":"Accumulation, Highly carboxylated porphyrins","references":"<ol>\n\t<li>&uarr; <sup><a href=\"#cite_ref-Marks1987_1-0\">1.0</a></sup> <sup><a href=\"#cite_ref-Marks1987_1-1\">1.1</a></sup> Marks, G. S., Powles, J., Lyon, M., McCluskey, S., Sutherland, E., and Zelt, D. (1987). Patterns of porphyrin accumulation in response to xenobiotics. Parallels between results in chick embryo and rodents. <em> Ann. N. Y. Acad. Sci. </em> <strong>514</strong>, 113-127.</li>\n\t<li><a href=\"#cite_ref-Frank2010_2-0\">&uarr;</a> Frank, J., and Poblete-Gutierrez, P. (2010) Porphyria cutanea tarda--when skin meets liver. <em>Best. Pract. Res. Clin Gastroenterol. </em> <strong>24</strong>(5), 735-745.</li>\n\t<li><a href=\"#cite_ref-Kennedy1986_3-0\">&uarr;</a> Kennedy, S. W., Wigfield, D. C., and Fox, G. A. (1986). Tissue porphyrin pattern determination by high-speed high-performance liquid chromatography. <em>Anal. Biochem. </em> <strong>157</strong> (1), 1-7.</li>\n\t<li>\n\t<p>Hahn, M. E., Gasiewicz, T. A., Linko, P., and Goldstein, J. A. (1988). The role of the Ah locus in hexachlorobenzene-induced porphyria. Studies in congenic C57BL/6J mice. Biochem. J. 254(1), 245-254.</p>\n\t</li>\n\t<li>\n\t<p>Goldstein, J. A., Linko, P., and Bergman, H. (1982). Induction of porphyria in the rat by chronic versus acute exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin. Biochem. Pharmacol. 31(8), 1607-1613.</p>\n\t</li>\n\t<li>\n\t<p>Miranda, C. L., Wang, J. L., Henderson, M. C., Carpenter, H. M., Nakaue, H. S., and Buhler, D. R. (1983). Studies on the porphyrinogenic action of 1,2,4-trichlorobenzene in birds. Toxicology 28(1-2), 83-92.</p>\n\t</li>\n\t<li>\n\t<p>Kennedy, S. W., and Fox, G. A. (1990). Highly carboxylated porphyrins as a biomarker of polyhalogenated aromatic hydrocarbon exposure in wildlife: Confirmation of their presence in Great Lakes herring gull chicks in the early 1970s and important methodological details. Chemosphere 21(3), 407-415.</p>\n\t</li>\n</ol>\n","biologicalOrganisationLevel":"Organ","organTerm":{},"biologicalEvents":[{"action":"increased","object":{"name":"porphyrins","source":"CHEBI","sourceId":"CHEBI:26214"}}],"id":846}
{"title":"Uroporphyria","references":"<ol>\n\t<li>&uarr; <sup><a href=\"#cite_ref-Kennedy1990_1-0\">1.0</a></sup> <sup><a href=\"#cite_ref-Kennedy1990_1-1\">1.1</a></sup> Kennedy, S. W., and Fox, G. A. (1990). Highly carboxylated porphyrins as a biomarker of polyhalogenated aromatic hydrocarbon exposure in wildlife: Confirmation of their presence in Great Lakes herring gull chicks in the early 1970s and important methodological details. Chemosphere 21, 407-415.</li>\n\t<li><a href=\"#cite_ref-Rifkind2006_2-0\">&uarr;</a> Rifkind, A. B. (2006). CYP1A in TCDD toxicity and in physiology - With particular reference to CYP dependent arachidonic acid metabolism and other endogenous substrates. Drug Metabolism Reviews 38, 291-335.</li>\n\t<li><a href=\"#cite_ref-Smith2001_3-0\">&uarr;</a> Smith, A. G., Clothier, B., Carthew, P., Childs, N. L., Sinclair, P. R., Nebert, D. W., and Dalton, T. P. (2001). Protection of the Cyp1a2(-/-) null mouse against uroporphyria and hepatic injury following exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin. Toxicol.Appl.Pharmacol. 173, 89-98.</li>\n\t<li>&uarr; <sup><a href=\"#cite_ref-Frank2010_4-0\">4.0</a></sup> <sup><a href=\"#cite_ref-Frank2010_4-1\">4.1</a></sup> Frank, J., and Poblete-Gutierrez, P. (2010) Porphyria cutanea tarda--when skin meets liver. <em>Best. Pract. Res. Clin Gastroenterol. </em> <strong>24</strong>(5), 735-745.</li>\n\t<li>&uarr; <sup><a href=\"#cite_ref-Smith2010_5-0\">5.0</a></sup> <sup><a href=\"#cite_ref-Smith2010_5-1\">5.1</a></sup> <sup><a href=\"#cite_ref-Smith2010_5-2\">5.2</a></sup> Smith, A. G., and Elder, G. H. (2010) Complex gene-chemical interactions: hepatic uroporphyria as a paradigm. <em>Chem. Res. Toxicol. </em> <strong>23</strong> (4), 712-723.</li>\n\t<li><a href=\"#cite_ref-Kennedy1986_6-0\">&uarr;</a> Kennedy, S. W., Wigfield, D. C., and Fox, G. A. (1986). Tissue porphyrin pattern determination by high-speed high-performance liquid chromatography. <em>Anal. Biochem. </em> <strong>157</strong> (1), 1-7.</li>\n\t<li><a href=\"#cite_ref-Fox1988_7-0\">&uarr;</a> Fox, G. A., Norstrom, R. J., Wigfield, D. C., and Kennedy, S. W. (1988) Porphyria in herring gulls: A biochemical response to chemical contamination of great lakes food chains. &lsquo;&rsquo;Environmental Toxicology and Chemistry&rsquo;&rsquo; &lsquo;&rsquo;&rsquo;7&rsquo;&rsquo;&rsquo; (10), 831-839</li>\n\t<li><a href=\"#cite_ref-Kennedy1998_8-0\">&uarr;</a> Kennedy, S. W., Fox, G. A., Trudeau, S. F., Bastien, L. J., and Jones, S. P. (1998) Highly carboxylated porphyrin concentration: A biochemical marker of PCB exposure in herring gulls. <em>Marine Environmental Research</em> <strong>46</strong> (1-5), 65-69.</li>\n\t<li><a href=\"#cite_ref-Cripps1984_9-0\">&uarr;</a> Cripps, D. J., Peters, H. A., Gocmen, A., and Dogramici, I. (1984) Porphyria turcica due to hexachlorobenzene: a 20 to 30 year follow-up study on 204 patients. <em>Br. J Dermatol. </em> <strong>111</strong> (4), 413-422.</li>\n\t<li><a href=\"#cite_ref-Wainwright1995_10-0\">&uarr;</a> Wainwright, J. S., Hopkins, K. M., Bums Jr., T.A., and Di Giulio, R. T. (1995) Investigation of potential biomarkers of exposure to bleached kraft mill effluent in North Carolina rivers. Durham, NC.</li>\n\t<li><a href=\"#cite_ref-Lorenzen1997b_11-0\">&uarr;</a> Lorenzen, A., Shutt, J. L., and Kennedy, S. W. (1997b). Sensitivity of common tern (Sterna hirundo) embryo hepatocyte cultures to CYP1A induction and porphyrin accumulation by halogenated aromatic hydrocarbons and common tern egg extracts. Archives of Environmental Contamination and Toxicology 32, 126-134.</li>\n\t<li><a href=\"#cite_ref-Lorenzen1995_12-0\">&uarr;</a> Lorenzen, A., and Kennedy, S. W. (1995). Sensitivities of Chicken and Pheasant Embryos and Cultured Embryonic Hepatocytes to Cytochrome P4501A Induction and Porphyrin Accumulation by TCDD, TCDF and PCBs. Organohalogen Compounds 25, 65-68.</li>\n\t<li><a href=\"#cite_ref-Farmahin2013b_13-0\">&uarr;</a> Farmahin, R., Manning, G. E., Crump, D., Wu, D., Mundy, L. J., Jones, S. P., Hahn, M. E., Karchner, S. I., Giesy, J. P., Bursian, S. J., Zwiernik, M. J., Fredricks, T. B., and Kennedy, S. W. (2013b). Amino acid sequence of the ligand binding domain of the aryl hydrocarbon receptor 1 (AHR1) predicts sensitivity of wild birds to effects of dioxin-like compounds. Toxicol.Sci. 131, 139-152.</li>\n\t<li><a href=\"#cite_ref-Head2008_14-0\">&uarr;</a> Head, J. A., Hahn, M. E., and Kennedy, S. W. (2008). Key amino acids in the aryl hydrocarbon receptor predict dioxin sensitivity in avian species. Environ.Sci.Technol. 42, 7535-7541.</li>\n\t<li><a href=\"#cite_ref-Manning2012_15-0\">&uarr;</a> Manning, G. E., Farmahin, R., Crump, D., Jones, S. P., Klein, J., Konstantinov, A., Potter, D., and Kennedy, S. W. (2012). A luciferase reporter gene assay and aryl hydrocarbon receptor 1 genotype predict the embryolethality of polychlorinated biphenyls in avian species. Toxicol.Appl.Pharmacol. 263, 390-399.</li>\n</ol>\n","biologicalOrganisationLevel":"Individual","organTerm":{},"biologicalEvents":[{"action":"increased","process":"porphyria","object":{}}],"id":369}
{"title":"Induction, CYP1A2/CYP1A5","references":"<ol>\n\t<li>&uarr; <sup><a href=\"#cite_ref-Fujii2010_1-0\">1.0</a></sup> <sup><a href=\"#cite_ref-Fujii2010_1-1\">1.1</a></sup> Fujii-Kuriyama, Y., and Kawajiri, K. (2010). Molecular mechanisms of the physiological functions of the aryl hydrocarbon (dioxin) receptor, a multifunctional regulator that senses and responds to environmental stimuli. Proc.Jpn.Acad.Ser.B Phys.Biol.Sci. 86, 40-53.</li>\n\t<li><a href=\"#cite_ref-Giesy2006_2-0\">&uarr;</a> Giesy, J. P., Kannan, K., Blankenship, A. L., Jones, P. D., and Newsted, J. L. (2006). Toxicology of PCBs and related compounds. In Endocrine Disruption Biological Bases for Health Effects in Wildlife and Humans (D. O. Norris, and J. A. Carr, Eds.), pp. 245-331. Oxford University Press, New York.</li>\n\t<li>&uarr; <sup><a href=\"#cite_ref-Mimura2003_3-0\">3.0</a></sup> <sup><a href=\"#cite_ref-Mimura2003_3-1\">3.1</a></sup> Mimura, J., and Fujii-Kuriyama, Y. (2003). Functional role of AhR in the expression of toxic effects by TCDD. Biochimica et Biophysica Acta - General Subjects 1619, 263-268.</li>\n\t<li><a href=\"#cite_ref-4\">&uarr;</a> <a class=\"external autonumber\" href=\"http://www.ncbi.nlm.nih.gov/gene?Db=gene&amp;Cmd=ShowDetailView&amp;TermToSearch=1544\" rel=\"nofollow\" target=\"_blank\">[1]</a>&quot;Entrez Gene: cytochrome P450; Gene ID: 1544.&quot;</li>\n\t<li><a href=\"#cite_ref-Harris2011_5-0\">&uarr;</a> Harris, M. L., and Elliott, J. E. (2011). Effects of Polychlorinated Biphenyls, Dibenzo-p-Dioxins and Dibenzofurans, and Polybrominated Diphenyl Ethers in Wild Birds. In Environmental Contaminants in Biota (J. P. Meador, Ed.), pp. 477-528. CRC Press.</li>\n\t<li><a href=\"#cite_ref-Headetal2010_6-0\">&uarr;</a> Head, J. A., Farmahin, R., Kehoe, A. S., O&#39;Brien, J. M., Shutt, J. L., and Kennedy, S. W. (2010). Characterization of the avian aryl hydrocarbon receptor 1 from blood using non-lethal sampling methods. Ecotoxicology 19, 1560-1566.</li>\n\t<li><a href=\"#cite_ref-Rifkind2006_7-0\">&uarr;</a> Rifkind, A. B. (2006). CYP1A in TCDD toxicity and in physiology - With particular reference to CYP dependent arachidonic acid metabolism and other endogenous substrates. Drug Metabolism Reviews 38, 291-335.</li>\n\t<li><a href=\"#cite_ref-Safe1987_8-0\">&uarr;</a> Safe, S. (1987). Determination of 2,3,7,8-TCDD toxic equivalent factors (TEFs): Support for the use of the in vitro AHH induction assay. Chemosphere 16, 791-802.</li>\n\t<li><a href=\"#cite_ref-Goldtone2006_9-0\">&uarr;</a> Goldstone, H. M. H., and Stegeman, J. J. (2006). A revised evolutionary history of the CYP1A subfamily: Gene duplication, gene conversion, and positive selection. Journal of Molecular Evolution 62, 708-717.</li>\n\t<li>&uarr; <sup><a href=\"#cite_ref-Jones2009_10-0\">10.0</a></sup> <sup><a href=\"#cite_ref-Jones2009_10-1\">10.1</a></sup> Jones, S. P., and Kennedy, S. W. (2009). Chicken embryo cardiomyocyte cultures--a new approach for studying effects of halogenated aromatic hydrocarbons in the avian heart. Toxicol.Sci 109, 66-74.</li>\n\t<li>&uarr; <sup><a href=\"#cite_ref-Rifkind1994_11-0\">11.0</a></sup> <sup><a href=\"#cite_ref-Rifkind1994_11-1\">11.1</a></sup> Rifkind, A. B., Kanetoshi, A., Orlinick, J., Capdevila, J. H., and Lee, C. A. (1994). Purification and biochemical characterization of two major cytochrome P-450 isoforms induced by 2,3,7,8-tetrachlorodibenzo-p-dioxin in chick embryo liver. J.Biol.Chem. 269, 3387-3396.</li>\n\t<li><a href=\"#cite_ref-Farmahin2013a_12-0\">&uarr;</a> Farmahin, R., Crump, D., Jones, S. P., Mundy, L. J., and Kennedy, S. W. (2013a). Cytochrome P4501A induction in primary cultures of embryonic European starling hepatocytes exposed to TCDD, PeCDF and TCDF. Ecotoxicology.</li>\n\t<li><a href=\"#cite_ref-Herve2010a_13-0\">&uarr;</a> Herv&eacute;, J. C., Crump, D., Jones, S. P., Mundy, L. J., Giesy, J. P., Zwiernik, M. J., Bursian, S. J., Jones, P. D., Wiseman, S. B., Wan, Y., and Kennedy, S. W. (2010a). Cytochrome P4501A induction by 2,3,7,8-tetrachlorodibenzo-p-dioxin and two chlorinated dibenzofurans in primary hepatocyte cultures of three avian species. Toxicol.Sci. 113, 380-391.</li>\n\t<li><a href=\"#cite_ref-Manning2013_14-0\">&uarr;</a> Manning, G. E., Mundy, L. J., Crump, D., Jones, S. P., Chiu, S., Klein, J., Konstantinov, A., Potter, D., and Kennedy, S. W. (2013). Cytochrome P4501A induction in avian hepatocyte cultures exposed to polychlorinated biphenyls: comparisons with AHR1-mediated reporter gene activity and in ovo toxicity. Toxicol.Appl.Pharmacol. 266, 38-47.</li>\n\t<li><a href=\"#cite_ref-Elliott1996_15-0\">&uarr;</a> Elliott, J. E., Norstrom, R. J., Lorenzen, A., Hart, L. E., Philibert, H., Kennedy, S. W., Stegeman, J. J., Bellward, G. D., and Cheng, K. M. (1996). Biological effects of polychlorinated dibenzo-p-dioxins, dibenzofurans, and biphenyls in bald eagle (Haliaeetus leucocephalus) chicks. Environ.Toxicol.Chem. 15, 782-793.</li>\n\t<li><a href=\"#cite_ref-Belward1990_16-0\">&uarr;</a> Bellward, G. D., Norstrom, R. J., Whitehead, P. E., Elliott, J. E., Bandiera, S. M., Dworschak, C., Chang, T., Forbes, S., Cadario, B., Hart, L. E., and . (1990). Comparison of polychlorinated dibenzodioxin levels with hepatic mixed-function oxidase induction in great blue herons. J.Toxicol.Environ.Health 30, 33-52.</li>\n\t<li><a href=\"#cite_ref-Sanderson1994_17-0\">&uarr;</a> Sanderson, J. T., Norstrom, R. J., Elliott, J. E., Hart, L. E., Cheng, K. M., and Bellward, G. D. (1994). Biological effects of polychlorinated dibenzo-p-dioxins, dibenzofurans, and biphenyls in double-crested cormorant chicks (Phalacrocorax auritus). J.Toxicol.Environ.Health 41, 247-265.</li>\n\t<li><a href=\"#cite_ref-Rattner_18-0\">&uarr;</a> Rattner, B. A., Hatfield, J. S., Melancon, M. J., Custer, T. W., and Tillitt, D. E. (1994). Relation among cytochrome-P450, Ah-active PCB congeners and dioxin equivalents in pipping black-crowned night-heron embryos. Environ.Toxicol.Chem. 13, 1805-1812.</li>\n\t<li><a href=\"#cite_ref-Elliott2001_19-0\">&uarr;</a> Elliott, J. E., Wilson, L. K., Henny, C. J., Trudeau, S. F., Leighton, F. A., Kennedy, S. W., and Cheng, K. M. (2001). Assessment of biological effects of chlorinated hydrocarbons in osprey chicks. Environ.Toxicol.Chem. 20, 866-879.</li>\n\t<li><a href=\"#cite_ref-Dey1999_20-0\">&uarr;</a> Dey, A., Jones, J. E., and Nebert, D. W. (1999). Tissue- and cell type-specific expression of cytochrome P450 1A1 and cytochrome P450 1A2 mRNA in the mouse localized in situ hybridization. <em>Biochem. Pharmacol. </em> <strong>58</strong> (3), 525-537.</li>\n\t<li>&uarr; <sup><a href=\"#cite_ref-Burke1994_21-0\">21.0</a></sup> <sup><a href=\"#cite_ref-Burke1994_21-1\">21.1</a></sup> Burke, M. D., Thompson, S., Weaver, R. J., Wolf, C. R., and Mayer, R. T. (1994). Cytochrome P450 specificities of alkoxyresorufin O-dealkylation in human and rat liver. <em>Biochem. Pharmacol. </em> <strong>48</strong> (5), 923-936.</li>\n\t<li><a href=\"#cite_ref-Sinclair1997_22-0\">&uarr;</a> Sinclair, P. R., Gorman, N., Walton, H. S., Sinclair, J. F., Lee, C. A., and Rifkind, A. B. (1997). Identification of CYP1A5 as the CYP1A enzyme mainly responsible for uroporphyrinogen oxidation induced by AH receptor ligands in chicken liver and kidney. <em>Drug Metab. Dispos. </em> <strong>25</strong> (7), 779-783.</li>\n\t<li><a href=\"#cite_ref-Staskal2005_23-0\">&uarr;</a> Staskal, D. F., Diliberto, J. J., DeVito, M. J., and Birnbaum, L. S. (2005). Inhibition of human and rat CYP1A2 by TCDD and dioxin-like chemicals. <em>Toxicol. Sci. </em> <strong>84</strong> (2), 225-231.</li>\n\t<li><a href=\"#cite_ref-Kalow1991_24-0\">&uarr;</a> Kalow, W., and Tang, B. K. (1991). Use of caffeine metabolite ratios to explore CYP1A2 and xanthine oxidase activities. <em>Clin Pharmacol. Ther. </em> <strong>50</strong> (5 Pt 1), 508-519.</li>\n\t<li><a href=\"#cite_ref-25\">&uarr;</a> <a class=\"external autonumber\" href=\"https://en.wikipedia.org/wiki/Real-time_polymerase_chain_reaction\" rel=\"nofollow\" target=\"_blank\">[2]</a>&quot;Real-time polymerase chain reaction&quot;</li>\n\t<li><a href=\"#cite_ref-Head2007_26-0\">&uarr;</a> Head, J. A., and Kennedy, S. W. (2007). Same-sample analysis of ethoxyresorufin-O-deethylase activity and cytochrome P4501A mRNA abundance in chicken embryo hepatocytes. <em>Anal. Biochem. </em> <strong>360</strong> (2), 294-302.</li>\n\t<li><a href=\"#cite_ref-Farmahin2013_27-0\">&uarr;</a> Farmahin, R., Manning, G. E., Crump, D., Wu, D., Mundy, L. J., Jones, S. P., Hahn, M. E., Karchner, S. I., Giesy, J. P., Bursian, S. J., Zwiernik, M. J., Fredricks, T. B., and Kennedy, S. W. (2013). Amino acid sequence of the ligand-binding domain of the aryl hydrocarbon receptor 1 predicts sensitivity of wild birds to effects of dioxin-like compounds. <em>Toxicol. Sci. </em> <strong>131</strong> (1), 139-152.</li>\n\t<li><a href=\"#cite_ref-Farmahin2012_28-0\">&uarr;</a> Farmahin, R., Wu, D., Crump, D., Herv&eacute;, J. C., Jones, S. P., Hahn, M. E., Karchner, S. I., Giesy, J. P., Bursian, S. J., Zwiernik, M. J., and Kennedy, S. W. (2012). Sequence and in vitro function of chicken, ring-necked pheasant, and Japanese quail AHR1 predict in vivo sensitivity to dioxins. <em>Environ. Sci. Technol. </em> <strong>46</strong> (5), 2967-2975.</li>\n\t<li><a href=\"#cite_ref-Garrison1996_29-0\">&uarr;</a> Garrison, P. M., Tullis, K., Aarts, J. M., Brouwer, A., Giesy, J. P., and Denison, M. S. (1996). Species-specific recombinant cell lines as bioassay systems for the detection of 2,3,7,8-tetrachlorodibenzo-p-dioxin-like chemicals. <em>Fundam. Appl. Toxicol. </em> <strong>30</strong> (2), 194-203.</li>\n\t<li>Prasch, A. L., Teraoka, H., Carney, S. A., Dong, W., Hiraga, T., Stegeman, J. J., Heideman, W., and Peterson, R. E. (2003). Aryl hydrocarbon receptor 2 mediates 2,3,7,8-tetrachlorodibenzo-p-dioxin developmental toxicity in zebrafish. Toxicol. Sci. 76(1), 138-150.</li>\n\t<li>European Union Reference Laboratory for Alternatives to Animal Testing (EURL-ECVAM), Multistudy validation trial for cytochrome P450 induction providing a reliable human metabolically competent standard model or method using the human cryopreserved primary hepatocytes and the human cryopreserved HepaRG&reg; cell line.Draft guideline, OECD.</li>\n</ol>\n","biologicalOrganisationLevel":"Molecular","organTerm":{},"biologicalEvents":[{"action":"increased","process":"gene expression","object":{"name":"cytochrome P450 1A2","source":"PR","sourceId":"PR:000006102"}},{"action":"increased","process":"gene expression","object":{"name":"cytochrome P450 1A5 (chicken)","source":"PR","sourceId":"PR:P79761"}}],"id":850}
{"title":"Induction, CYP1A2/CYP1A5","references":"<ol>\n\t<li>&uarr; <sup><a href=\"#cite_ref-Fujii2010_1-0\">1.0</a></sup> <sup><a href=\"#cite_ref-Fujii2010_1-1\">1.1</a></sup> Fujii-Kuriyama, Y., and Kawajiri, K. (2010). Molecular mechanisms of the physiological functions of the aryl hydrocarbon (dioxin) receptor, a multifunctional regulator that senses and responds to environmental stimuli. Proc.Jpn.Acad.Ser.B Phys.Biol.Sci. 86, 40-53.</li>\n\t<li><a href=\"#cite_ref-Giesy2006_2-0\">&uarr;</a> Giesy, J. P., Kannan, K., Blankenship, A. L., Jones, P. D., and Newsted, J. L. (2006). Toxicology of PCBs and related compounds. In Endocrine Disruption Biological Bases for Health Effects in Wildlife and Humans (D. O. Norris, and J. A. Carr, Eds.), pp. 245-331. Oxford University Press, New York.</li>\n\t<li>&uarr; <sup><a href=\"#cite_ref-Mimura2003_3-0\">3.0</a></sup> <sup><a href=\"#cite_ref-Mimura2003_3-1\">3.1</a></sup> Mimura, J., and Fujii-Kuriyama, Y. (2003). Functional role of AhR in the expression of toxic effects by TCDD. Biochimica et Biophysica Acta - General Subjects 1619, 263-268.</li>\n\t<li><a href=\"#cite_ref-4\">&uarr;</a> <a class=\"external autonumber\" href=\"http://www.ncbi.nlm.nih.gov/gene?Db=gene&amp;Cmd=ShowDetailView&amp;TermToSearch=1544\" rel=\"nofollow\" target=\"_blank\">[1]</a>&quot;Entrez Gene: cytochrome P450; Gene ID: 1544.&quot;</li>\n\t<li><a href=\"#cite_ref-Harris2011_5-0\">&uarr;</a> Harris, M. L., and Elliott, J. E. (2011). Effects of Polychlorinated Biphenyls, Dibenzo-p-Dioxins and Dibenzofurans, and Polybrominated Diphenyl Ethers in Wild Birds. In Environmental Contaminants in Biota (J. P. Meador, Ed.), pp. 477-528. CRC Press.</li>\n\t<li><a href=\"#cite_ref-Headetal2010_6-0\">&uarr;</a> Head, J. A., Farmahin, R., Kehoe, A. S., O&#39;Brien, J. M., Shutt, J. L., and Kennedy, S. W. (2010). Characterization of the avian aryl hydrocarbon receptor 1 from blood using non-lethal sampling methods. Ecotoxicology 19, 1560-1566.</li>\n\t<li><a href=\"#cite_ref-Rifkind2006_7-0\">&uarr;</a> Rifkind, A. B. (2006). CYP1A in TCDD toxicity and in physiology - With particular reference to CYP dependent arachidonic acid metabolism and other endogenous substrates. Drug Metabolism Reviews 38, 291-335.</li>\n\t<li><a href=\"#cite_ref-Safe1987_8-0\">&uarr;</a> Safe, S. (1987). Determination of 2,3,7,8-TCDD toxic equivalent factors (TEFs): Support for the use of the in vitro AHH induction assay. Chemosphere 16, 791-802.</li>\n\t<li><a href=\"#cite_ref-Goldtone2006_9-0\">&uarr;</a> Goldstone, H. M. H., and Stegeman, J. J. (2006). A revised evolutionary history of the CYP1A subfamily: Gene duplication, gene conversion, and positive selection. Journal of Molecular Evolution 62, 708-717.</li>\n\t<li>&uarr; <sup><a href=\"#cite_ref-Jones2009_10-0\">10.0</a></sup> <sup><a href=\"#cite_ref-Jones2009_10-1\">10.1</a></sup> Jones, S. P., and Kennedy, S. W. (2009). Chicken embryo cardiomyocyte cultures--a new approach for studying effects of halogenated aromatic hydrocarbons in the avian heart. Toxicol.Sci 109, 66-74.</li>\n\t<li>&uarr; <sup><a href=\"#cite_ref-Rifkind1994_11-0\">11.0</a></sup> <sup><a href=\"#cite_ref-Rifkind1994_11-1\">11.1</a></sup> Rifkind, A. B., Kanetoshi, A., Orlinick, J., Capdevila, J. H., and Lee, C. A. (1994). Purification and biochemical characterization of two major cytochrome P-450 isoforms induced by 2,3,7,8-tetrachlorodibenzo-p-dioxin in chick embryo liver. J.Biol.Chem. 269, 3387-3396.</li>\n\t<li><a href=\"#cite_ref-Farmahin2013a_12-0\">&uarr;</a> Farmahin, R., Crump, D., Jones, S. P., Mundy, L. J., and Kennedy, S. W. (2013a). Cytochrome P4501A induction in primary cultures of embryonic European starling hepatocytes exposed to TCDD, PeCDF and TCDF. Ecotoxicology.</li>\n\t<li><a href=\"#cite_ref-Herve2010a_13-0\">&uarr;</a> Herv&eacute;, J. C., Crump, D., Jones, S. P., Mundy, L. J., Giesy, J. P., Zwiernik, M. J., Bursian, S. J., Jones, P. D., Wiseman, S. B., Wan, Y., and Kennedy, S. W. (2010a). Cytochrome P4501A induction by 2,3,7,8-tetrachlorodibenzo-p-dioxin and two chlorinated dibenzofurans in primary hepatocyte cultures of three avian species. Toxicol.Sci. 113, 380-391.</li>\n\t<li><a href=\"#cite_ref-Manning2013_14-0\">&uarr;</a> Manning, G. E., Mundy, L. J., Crump, D., Jones, S. P., Chiu, S., Klein, J., Konstantinov, A., Potter, D., and Kennedy, S. W. (2013). Cytochrome P4501A induction in avian hepatocyte cultures exposed to polychlorinated biphenyls: comparisons with AHR1-mediated reporter gene activity and in ovo toxicity. Toxicol.Appl.Pharmacol. 266, 38-47.</li>\n\t<li><a href=\"#cite_ref-Elliott1996_15-0\">&uarr;</a> Elliott, J. E., Norstrom, R. J., Lorenzen, A., Hart, L. E., Philibert, H., Kennedy, S. W., Stegeman, J. J., Bellward, G. D., and Cheng, K. M. (1996). Biological effects of polychlorinated dibenzo-p-dioxins, dibenzofurans, and biphenyls in bald eagle (Haliaeetus leucocephalus) chicks. Environ.Toxicol.Chem. 15, 782-793.</li>\n\t<li><a href=\"#cite_ref-Belward1990_16-0\">&uarr;</a> Bellward, G. D., Norstrom, R. J., Whitehead, P. E., Elliott, J. E., Bandiera, S. M., Dworschak, C., Chang, T., Forbes, S., Cadario, B., Hart, L. E., and . (1990). Comparison of polychlorinated dibenzodioxin levels with hepatic mixed-function oxidase induction in great blue herons. J.Toxicol.Environ.Health 30, 33-52.</li>\n\t<li><a href=\"#cite_ref-Sanderson1994_17-0\">&uarr;</a> Sanderson, J. T., Norstrom, R. J., Elliott, J. E., Hart, L. E., Cheng, K. M., and Bellward, G. D. (1994). Biological effects of polychlorinated dibenzo-p-dioxins, dibenzofurans, and biphenyls in double-crested cormorant chicks (Phalacrocorax auritus). J.Toxicol.Environ.Health 41, 247-265.</li>\n\t<li><a href=\"#cite_ref-Rattner_18-0\">&uarr;</a> Rattner, B. A., Hatfield, J. S., Melancon, M. J., Custer, T. W., and Tillitt, D. E. (1994). Relation among cytochrome-P450, Ah-active PCB congeners and dioxin equivalents in pipping black-crowned night-heron embryos. Environ.Toxicol.Chem. 13, 1805-1812.</li>\n\t<li><a href=\"#cite_ref-Elliott2001_19-0\">&uarr;</a> Elliott, J. E., Wilson, L. K., Henny, C. J., Trudeau, S. F., Leighton, F. A., Kennedy, S. W., and Cheng, K. M. (2001). Assessment of biological effects of chlorinated hydrocarbons in osprey chicks. Environ.Toxicol.Chem. 20, 866-879.</li>\n\t<li><a href=\"#cite_ref-Dey1999_20-0\">&uarr;</a> Dey, A., Jones, J. E., and Nebert, D. W. (1999). Tissue- and cell type-specific expression of cytochrome P450 1A1 and cytochrome P450 1A2 mRNA in the mouse localized in situ hybridization. <em>Biochem. Pharmacol. </em> <strong>58</strong> (3), 525-537.</li>\n\t<li>&uarr; <sup><a href=\"#cite_ref-Burke1994_21-0\">21.0</a></sup> <sup><a href=\"#cite_ref-Burke1994_21-1\">21.1</a></sup> Burke, M. D., Thompson, S., Weaver, R. J., Wolf, C. R., and Mayer, R. T. (1994). Cytochrome P450 specificities of alkoxyresorufin O-dealkylation in human and rat liver. <em>Biochem. Pharmacol. </em> <strong>48</strong> (5), 923-936.</li>\n\t<li><a href=\"#cite_ref-Sinclair1997_22-0\">&uarr;</a> Sinclair, P. R., Gorman, N., Walton, H. S., Sinclair, J. F., Lee, C. A., and Rifkind, A. B. (1997). Identification of CYP1A5 as the CYP1A enzyme mainly responsible for uroporphyrinogen oxidation induced by AH receptor ligands in chicken liver and kidney. <em>Drug Metab. Dispos. </em> <strong>25</strong> (7), 779-783.</li>\n\t<li><a href=\"#cite_ref-Staskal2005_23-0\">&uarr;</a> Staskal, D. F., Diliberto, J. J., DeVito, M. J., and Birnbaum, L. S. (2005). Inhibition of human and rat CYP1A2 by TCDD and dioxin-like chemicals. <em>Toxicol. Sci. </em> <strong>84</strong> (2), 225-231.</li>\n\t<li><a href=\"#cite_ref-Kalow1991_24-0\">&uarr;</a> Kalow, W., and Tang, B. K. (1991). Use of caffeine metabolite ratios to explore CYP1A2 and xanthine oxidase activities. <em>Clin Pharmacol. Ther. </em> <strong>50</strong> (5 Pt 1), 508-519.</li>\n\t<li><a href=\"#cite_ref-25\">&uarr;</a> <a class=\"external autonumber\" href=\"https://en.wikipedia.org/wiki/Real-time_polymerase_chain_reaction\" rel=\"nofollow\" target=\"_blank\">[2]</a>&quot;Real-time polymerase chain reaction&quot;</li>\n\t<li><a href=\"#cite_ref-Head2007_26-0\">&uarr;</a> Head, J. A., and Kennedy, S. W. (2007). Same-sample analysis of ethoxyresorufin-O-deethylase activity and cytochrome P4501A mRNA abundance in chicken embryo hepatocytes. <em>Anal. Biochem. </em> <strong>360</strong> (2), 294-302.</li>\n\t<li><a href=\"#cite_ref-Farmahin2013_27-0\">&uarr;</a> Farmahin, R., Manning, G. E., Crump, D., Wu, D., Mundy, L. J., Jones, S. P., Hahn, M. E., Karchner, S. I., Giesy, J. P., Bursian, S. J., Zwiernik, M. J., Fredricks, T. B., and Kennedy, S. W. (2013). Amino acid sequence of the ligand-binding domain of the aryl hydrocarbon receptor 1 predicts sensitivity of wild birds to effects of dioxin-like compounds. <em>Toxicol. Sci. </em> <strong>131</strong> (1), 139-152.</li>\n\t<li><a href=\"#cite_ref-Farmahin2012_28-0\">&uarr;</a> Farmahin, R., Wu, D., Crump, D., Herv&eacute;, J. C., Jones, S. P., Hahn, M. E., Karchner, S. I., Giesy, J. P., Bursian, S. J., Zwiernik, M. J., and Kennedy, S. W. (2012). Sequence and in vitro function of chicken, ring-necked pheasant, and Japanese quail AHR1 predict in vivo sensitivity to dioxins. <em>Environ. Sci. Technol. </em> <strong>46</strong> (5), 2967-2975.</li>\n\t<li><a href=\"#cite_ref-Garrison1996_29-0\">&uarr;</a> Garrison, P. M., Tullis, K., Aarts, J. M., Brouwer, A., Giesy, J. P., and Denison, M. S. (1996). Species-specific recombinant cell lines as bioassay systems for the detection of 2,3,7,8-tetrachlorodibenzo-p-dioxin-like chemicals. <em>Fundam. Appl. Toxicol. </em> <strong>30</strong> (2), 194-203.</li>\n\t<li>Prasch, A. L., Teraoka, H., Carney, S. A., Dong, W., Hiraga, T., Stegeman, J. J., Heideman, W., and Peterson, R. E. (2003). Aryl hydrocarbon receptor 2 mediates 2,3,7,8-tetrachlorodibenzo-p-dioxin developmental toxicity in zebrafish. Toxicol. Sci. 76(1), 138-150.</li>\n\t<li>European Union Reference Laboratory for Alternatives to Animal Testing (EURL-ECVAM), Multistudy validation trial for cytochrome P450 induction providing a reliable human metabolically competent standard model or method using the human cryopreserved primary hepatocytes and the human cryopreserved HepaRG&reg; cell line.Draft guideline, OECD.</li>\n</ol>\n","biologicalOrganisationLevel":"Molecular","organTerm":{},"biologicalEvents":[{"action":"increased","process":"gene expression","object":{"name":"cytochrome P450 1A2","source":"PR","sourceId":"PR:000006102"}},{"action":"increased","process":"gene expression","object":{"name":"cytochrome P450 1A5 (chicken)","source":"PR","sourceId":"PR:P79761"}}],"id":850}
{"title":"Decrease, Intracellular pH","references":"<ol class=\"references\">\n<li id=\"cite_note-1\"><span class=\"mw-cite-backlink\"><a href=\"#cite_ref-1\"></a></span> <span class=\"reference-text\">Izumi, Torigoe, Ishiguchi, Uramoto, Yoshida, Tanabe, Ise, Murakami, Yoshida, Nomoto and Kohno (2003). Cellular pH regulators: potentially promising molecular targets for cancer chemotherapy. Cancer Treat Rev. 29: 541-549</span>\n</li>\n<li id=\"cite_note-2\"><span class=\"mw-cite-backlink\"><a href=\"#cite_ref-2\"></a></span> <span class=\"reference-text\">Bogdanffy (2002). Vinyl acetate-induced intracellular acidification: implications for risk assessment. Toxicol Sci. 66: 320-326, Lantz, Orozco and Bogdanffy (2003). Vinyl acetate decreases intracellular pH in rat nasal epithelial cells. Toxicol Sci. 75: 423-431, Nakamoto, Wagner, Melvin and Bogdanffy (2005). Vinyl acetate induces intracellular acidification in mouse oral buccal epithelial cells. Toxicol Lett. 158: 116-121</span>\n</li>\n<li id=\"cite_note-3\"><span class=\"mw-cite-backlink\"><a href=\"#cite_ref-3\"></a></span> <span class=\"reference-text\">Li, Wang, Yang, Zhao, Yuan, Zheng and Yang (2015). Hemicyanine-based high resolution ratiometric near-infrared fluorescent probe for monitoring pH changes in vivo. Anal Chem. 87: 2495-2503</span>\n</li>\n<li id=\"cite_note-4\"><span class=\"mw-cite-backlink\"><a href=\"#cite_ref-4\"></a></span> <span class=\"reference-text\">Bogdanffy (2002). Vinyl acetate-induced intracellular acidification: implications for risk assessment. Toxicol Sci. 66: 320-326, Lantz, Orozco and Bogdanffy (2003). Vinyl acetate decreases intracellular pH in rat nasal epithelial cells. Toxicol Sci. 75: 423-431, Nakamoto, Wagner, Melvin and Bogdanffy (2005). Vinyl acetate induces intracellular acidification in mouse oral buccal epithelial cells. Toxicol Lett. 158: 116-121</span>\n</li>\n<li id=\"cite_note-5\"><span class=\"mw-cite-backlink\"><a href=\"#cite_ref-5\"></a></span> <span class=\"reference-text\">Bogdanffy (2002). Vinyl acetate-induced intracellular acidification: implications for risk assessment. Toxicol Sci. 66: 320-326</span>\n</li>\n<li id=\"cite_note-6\"><span class=\"mw-cite-backlink\"><a href=\"#cite_ref-6\"></a></span> <span class=\"reference-text\">Lantz, Orozco and Bogdanffy (2003). Vinyl acetate decreases intracellular pH in rat nasal epithelial cells. Toxicol Sci. 75: 423-431, Nakamoto, Wagner, Melvin and Bogdanffy (2005). Vinyl acetate induces intracellular acidification in mouse oral buccal epithelial cells. Toxicol Lett. 158: 116-121</span>\n</li>\n<li id=\"cite_note-7\"><span class=\"mw-cite-backlink\"><a href=\"#cite_ref-7\"></a></span> <span class=\"reference-text\">Simon, Filser and Bolt (1985). Metabolism and pharmacokinetics of vinyl acetate. Arch Toxicol. 57: 191-195, Bogdanffy and Taylor (1993). Kinetics of nasal carboxylesterase-mediated metabolism of vinyl acetate. Drug Metabolism and Disposition. 21: 1107-1111, Bogdanffy, Sarangapani, Kimbell, Frame and Plowchalk (1998). Analysis of vinyl acetate metabolism in rat and human nasal tissues by an in vitro gas uptake technique. Toxicological Sciences. 46: 235-246, Bogdanffy, Manning and Sarangapani (1999). High-affinity nasal extraction of vinyl acetate vapor is carboxylesterase dependent. Inhal Toxicol. 11: 927-941, Morris, Symanowicz and Sarangapani (2002). Regional distribution and kinetics of vinyl acetate hydrolysis in the oral cavity of the rat and mouse. Toxicol Lett. 126: 31-39</span>\n</li>\n</ol>","biologicalOrganisationLevel":"Cellular","organTerm":{},"biologicalEvents":[{"action":"decreased","process":"regulation of intracellular pH","object":{}}],"keyEventStressors":["Ethyl acetate","Vinyl acetate","Propyl Acetate"],"id":867}
{"title":"Increase, Tissue Degeneration, Necrosis & Atrophy ","references":"<ol class=\"references\">\n<li id=\"cite_note-1\"><span class=\"mw-cite-backlink\"><a href=\"#cite_ref-1\"></a></span> <span class=\"reference-text\">Hardisty, Garman, Harkema, Lomax and Morgan (1999). Histopathology of nasal olfactory mucosa from selected inhalation toxicity studies conducted with volatile chemicals. Toxicol Pathol. 27: 618-627</span>\n</li>\n<li id=\"cite_note-2\"><span class=\"mw-cite-backlink\"><a href=\"#cite_ref-2\"></a></span> <span class=\"reference-text\">Islam, Amuzie, Harkema and Pestka (2007). Neurotoxicity and inflammation in the nasal airways of mice exposed to the macrocyclic trichothecene mycotoxin roridin a: kinetics and potentiation by bacterial lipopolysaccharide coexposure. Toxicol Sci. 98: 526-541</span>\n</li>\n</ol>","biologicalOrganisationLevel":"Tissue","organTerm":{"name":"olfactory organ","sourceId":"UBERON:0002268"},"biologicalEvents":[{"action":"increased","process":"atrophy","object":{"name":"olfactory epithelium","source":"UBERON","sourceId":"UBERON:0001997"}},{"action":"increased","process":"necrotic cell death","object":{}}],"id":868}
{"title":"Increase, Tissue Degeneration, Necrosis & Atrophy ","references":"<ol class=\"references\">\n<li id=\"cite_note-1\"><span class=\"mw-cite-backlink\"><a href=\"#cite_ref-1\"></a></span> <span class=\"reference-text\">Hardisty, Garman, Harkema, Lomax and Morgan (1999). Histopathology of nasal olfactory mucosa from selected inhalation toxicity studies conducted with volatile chemicals. Toxicol Pathol. 27: 618-627</span>\n</li>\n<li id=\"cite_note-2\"><span class=\"mw-cite-backlink\"><a href=\"#cite_ref-2\"></a></span> <span class=\"reference-text\">Islam, Amuzie, Harkema and Pestka (2007). Neurotoxicity and inflammation in the nasal airways of mice exposed to the macrocyclic trichothecene mycotoxin roridin a: kinetics and potentiation by bacterial lipopolysaccharide coexposure. Toxicol Sci. 98: 526-541</span>\n</li>\n</ol>","biologicalOrganisationLevel":"Tissue","organTerm":{"name":"olfactory organ","sourceId":"UBERON:0002268"},"biologicalEvents":[{"action":"increased","process":"atrophy","object":{"name":"olfactory epithelium","source":"UBERON","sourceId":"UBERON:0001997"}},{"action":"increased","process":"necrotic cell death","object":{}}],"id":868}
{"title":"Increase, Cell Proliferation","references":"<p><span style=\"color:mediumblue; font-family:arial,sans-serif; font-size:9pt\">Bogdanffy. et al. (1997). &ldquo;FOUR-WEEK INHALATION CELL PROLIFERATION STUDY OF THE EFFECTS OF VINYL ACETATE ON RAT NASAL EPITHELIUM&rdquo;, Inhalation Toxicology, Taylor &amp; Francis. 9: 331-350.</span></p>\n\n<p><span style=\"color:mediumblue; font-family:arial,sans-serif; font-size:9pt\">Grogan. et al. (1988). &ldquo;Independent prognostic significance of a nuclear proliferation antigen in diffuse large cell lymphomas as determined by the monoclonal antibody Ki-67&rdquo;, Blood. 71: 1157-1160.</span></p>\n\n<p><span style=\"color:mediumblue; font-family:arial,sans-serif; font-size:9pt\">H</span><span style=\"color:mediumblue; font-family:arial,sans-serif; font-size:9pt\">anahan, D. &amp; R. A. Weinberg, (2011),&rdquo; Hallmarks&nbsp;of&nbsp;cancer: the&nbsp;next&nbsp;generation&rdquo;, Cell.&nbsp;144(5):646-74. doi: 10.1016/j.cell.2011.02.013.</span></p>\n\n<p><span style=\"font-size:12px\"><span style=\"color:#4e37f9; font-family:&quot;Calibri&quot;,sans-serif\">Heidenreich WF, Paretzke HG. (2008) Promotion of initiated cells by radiation-induced cell inactivation. Radiat Res. Nov;170(5):613-7. doi: 10.1667/RR0957.1. PMID: 18959457.</span><span style=\"color:#2e75b6; font-family:&quot;Calibri&quot;,sans-serif\"> </span></span></p>\n\n<p><span style=\"color:mediumblue; font-family:arial,sans-serif; font-size:9pt\">Jones, J. L. et al. </span><span style=\"color:mediumblue; font-family:arial,sans-serif; font-size:9pt\">(2001), Sensitive determination of cell number using the CyQUANT cell proliferation assay. Journal of Immunological Methods. 254(1-2), 85-98. Doi:10.1016/s0022-1759(01)00404-5.</span></p>\n\n<p><span style=\"color:mediumblue; font-family:arial,sans-serif; font-size:9pt\">Pera, Mattias and Detzer (1977). &ldquo;Methods for determining the proliferation kinetics of cells by means of 5-bromodeoxyuridine&rdquo;, Cell Tissue Kinet.10: 255-264. Doi: 10.1111/j.1365-2184.1977.tb00293.x.</span></p>\n\n<p><span style=\"color:mediumblue; font-family:arial,sans-serif; font-size:9pt\">Portt, L. et al. (2011), &ldquo;Anti-apoptosis&nbsp;and&nbsp;cell survival: a&nbsp;review&rdquo;, Biochim Biophys Acta. 21813(1):238-59. doi: 10.1016/j.bbamcr.2010.10.010.</span></p>\n\n<p><span style=\"color:mediumblue; font-family:arial,sans-serif; font-size:9pt\">Quah, J. C. B. &amp; R. C. Parish (2012), &ldquo;New and improved methods for measuring lymphocyte proliferation in vitro and in vivo using CFSE-like fluorescent dyes&rdquo;, Journal of Immunological Methods. 379(1-2), 1-14. doi: 10.1016/j.jim.2012.02.012.</span></p>\n\n<p><span style=\"color:mediumblue; font-family:arial,sans-serif; font-size:9pt\">Roche Applied Science, (2013), &ldquo;Cell Proliferation Elisa, BrdU (Colourmetric)&nbsp;&raquo;. </span><span style=\"color:mediumblue; font-family:arial,sans-serif; font-size:9pt\">Version 16</span></p>\n\n<p><span style=\"color:mediumblue; font-family:arial,sans-serif; font-size:9pt\">Romar, A. G., S. T. Kupper &amp; J. S. Divito (2015), &ldquo;Research Techniques Made Simple: Techniques to Assess Cell Proliferation&rdquo;,&nbsp; Journal of Investigative Dermatology. 136(1), e1-7. doi: 10.1016/j.jid.2015.11.020.</span></p>\n\n<p><span style=\"color:mediumblue; font-family:arial,sans-serif; font-size:9pt\">Vega-Avila, E. &amp; K. M. Pugsley (2011), &ldquo;An Overview of Colorimetric Assay Methods Used to Assess Survival or Proliferation of Mammalian Cells&rdquo;, Proc. West. Pharmacol. Soc. 54, 10-4.</span></p>\n","biologicalOrganisationLevel":"Cellular","organTerm":{},"biologicalEvents":[{"action":"increased","process":"cell proliferation","object":{}}],"keyEventStressors":["Ionizing Radiation"],"id":870}
{"title":"Increase, Respiratory or Squamous Metaplasia","references":"<ol>\n\t<li><a href=\"#cite_ref-1\">&uarr;</a> Islam, Amuzie, Harkema and Pestka (2007). Neurotoxicity and inflammation in the nasal airways of mice exposed to the macrocyclic trichothecene mycotoxin roridin a: kinetics and potentiation by bacterial lipopolysaccharide coexposure. Toxicol Sci. 98: 526-541</li>\n\t<li><a href=\"#cite_ref-2\">&uarr;</a> Wagner, Van Dyken, Hotchkiss and Harkema (2001). Endotoxin enhancement of ozone-induced mucous cell metaplasia is neutrophil-dependent in rat nasal epithelium. Toxicol Sci. 60: 338-347</li>\n\t<li><a href=\"#cite_ref-3\">&uarr;</a> Hardisty, Garman, Harkema, Lomax and Morgan (1999). Histopathology of nasal olfactory mucosa from selected inhalation toxicity studies conducted with volatile chemicals. Toxicol Pathol. 27: 618-627</li>\n</ol>\n","biologicalOrganisationLevel":"Tissue","organTerm":{"name":"olfactory epithelium","sourceId":"UBERON:0001997"},"biologicalEvents":[{"action":"increased","object":{"name":"Metaplasia","source":"MESH","sourceId":"D008679"}}],"id":869}
{"title":"Increase, Site of Contact Nasal Tumors","references":"","biologicalOrganisationLevel":"Organ","organTerm":{"name":"olfactory organ","sourceId":"UBERON:0002268"},"biologicalEvents":[{"action":"increased","process":"neoplasm","object":{"name":"olfactory segment of nasal mucosa","source":"UBERON","sourceId":"UBERON:0005386"}}],"id":872}
{"title":"Increase, Mutations in Critical Genes","references":"<ol class=\"references\">\n<li id=\"cite_note-1\"><span class=\"mw-cite-backlink\"><a href=\"#cite_ref-1\"></a></span> <span class=\"reference-text\">Cohen and Ellwein (1991). Genetic errors, cell proliferation, and carcinogenesis. Cancer Res. 51: 6493-6505, Cohen, Purtilo and Ellwein (1991). Ideas in pathology. Pivotal role of increased cell proliferation in human carcinogenesis. Mod Pathol. 4: 371-382, Cohen (1995). Role of cell proliferation in regenerative and neoplastic disease. Toxicol Lett. 82-83: 15-21, Counts and Goodman (1995). Principles underlying dose selection for, and extrapolation from, the carcinogen bioassay: dose influences mechanism. Regul Toxicol Pharmacol. 21: 418-421</span>\n</li>\n<li id=\"cite_note-2\"><span class=\"mw-cite-backlink\"><a href=\"#cite_ref-2\"></a></span> <span class=\"reference-text\">Bertram (2000). The molecular biology of cancer. Mol Aspects Med. 21: 167-223, Hanahan and Weinberg (2000). The hallmarks of cancer. Cell. 100: 57-70</span>\n</li>\n<li id=\"cite_note-3\"><span class=\"mw-cite-backlink\"><a href=\"#cite_ref-3\"></a></span> <span class=\"reference-text\">Preston-Martin, Pike, Ross, Jones and Henderson (1990). Increased cell division as a cause of human cancer. Cancer Res. 50: 7415-7421, Cohen, Purtilo and Ellwein (1991). Ideas in pathology. Pivotal role of increased cell proliferation in human carcinogenesis. Mod Pathol. 4: 371-382</span>\n</li>\n<li id=\"cite_note-4\"><span class=\"mw-cite-backlink\"><a href=\"#cite_ref-4\"></a></span> <span class=\"reference-text\">Albertini (2013). Vinyl acetate monomer (VAM) genotoxicity profile: relevance for carcinogenicity. Crit Rev Toxicol. 43: 671-706</span>\n</li>\n<li id=\"cite_note-5\"><span class=\"mw-cite-backlink\"><a href=\"#cite_ref-5\"></a></span> <span class=\"reference-text\">Albertini (2013). Vinyl acetate monomer (VAM) genotoxicity profile: relevance for carcinogenicity. Crit Rev Toxicol. 43: 671-706</span>\n</li>\n<li id=\"cite_note-6\"><span class=\"mw-cite-backlink\"><a href=\"#cite_ref-6\"></a></span> <span class=\"reference-text\">Manjanatha, Shelton, Aidoo, Lyn-Cook and Casciano (1998). Comparison of in vivo mutagenesis in the endogenous Hprt gene and the lacI transgene of Big Blue(R) rats treated with 7, 12-dimethylbenz[a]anthracene. Mutat Res. 401: 165-178</span>\n</li>\n</ol>","biologicalOrganisationLevel":"Molecular","organTerm":{},"biologicalEvents":[{"action":"increased","process":"mutation","object":{"name":"deoxyribonucleic acid","source":"CHEBI","sourceId":"CHEBI:16991"}}],"id":876}
{"title":"Inhibition, organic anion transporter 1 (OAT1)","references":"<p><br />\n1.\tDuan, P., et al., Potent Inhibitors of Human Organic Anion Transporters 1 and 3 from Clinical Drug Libraries: Discovery and Molecular Characterization. Molecular Pharmaceutics, 2012. 9(11): p. 3340-3346.\n</p><p>2.\tNaidoo, V. and G.E. Swan, Diclofenac toxicity in Gyps vulture is associated with decreased uric acid excretion and not renal portal vasoconstriction. Comparative Biochemistry and Physiology Part C: Toxicology &amp; Pharmacology, 2009. 149(3): p. 269-274.\n</p><p>3.\tSekine, T., H. Miyazaki, and H. Endou, Molecular physiology of renal organic anion transporters. American Journal of Physiology-Renal Physiology, 2006. 290(2): p. F251-F261.\n</p><p>4.\tSekine, T., H.S. Cha, and H. Endou, The multispecific organic anion transporter (OAT) family. Pflgers Archiv. 440(3): p. 337-350.\n</p>","biologicalOrganisationLevel":"Molecular","organTerm":{"name":"proximal tubule","sourceId":"UBERON:0004134"},"biologicalEvents":[{"action":"decreased","process":"signaling","object":{"name":"solute carrier family 22 member 6","source":"PR","sourceId":"PR:000014993"}}],"keyEventStressors":["Diclofenac sodium","Phenylbutazone","Ibuprofen","Oxaprozin","Ketorolac Tromethamine","Nitazoxanide","Diflunisal","Telmisartan","Ketoprofen","Mefenamic acid","Indomethacin","Amlexanox"],"id":877}
{"title":"Increased, blood uric acid concentration","references":"","biologicalOrganisationLevel":"Tissue","organTerm":{"name":"blood","sourceId":"UBERON:0000178"},"biologicalEvents":[{"action":"increased","object":{"name":"uric acid","source":"CHEBI","sourceId":"CHEBI:27226"}}],"id":1096}
{"title":"Occurrence, renal proximal tubular necrosis","references":"","biologicalOrganisationLevel":"Tissue","organTerm":{"name":"proximal tubule","sourceId":"UBERON:0004134"},"biologicalEvents":[{"action":"occurrence","process":"renal tubular necrosis","object":{}}],"id":1097}
{"title":"Increased, blood potassium concentration","references":"","biologicalOrganisationLevel":"Tissue","organTerm":{"name":"blood","sourceId":"UBERON:0000178"},"biologicalEvents":[{"action":"increased","object":{"name":"potassium atom","source":"CHEBI","sourceId":"CHEBI:26216"}}],"id":1098}
{"title":"Occurrence, tophi (urate) deposition","references":"","biologicalOrganisationLevel":"Tissue","organTerm":{},"biologicalEvents":[{"action":"increased","object":{"name":"uric acid","source":"CHEBI","sourceId":"CHEBI:27226"}}],"id":1102}
{"title":"Occurrence, cardiac arrhythmia","references":"","biologicalOrganisationLevel":"Organ","organTerm":{"name":"heart","sourceId":"UBERON:0000948"},"biologicalEvents":[{"action":"increased","object":{"name":"Arrhythmias, Cardiac","source":"MESH","sourceId":"D001145"}}],"id":1106}
{"title":"Increased, Oxidative Stress","references":"","biologicalOrganisationLevel":"Cellular","organTerm":{},"biologicalEvents":[{"action":"increased","process":"oxidative stress","object":{}}],"id":1088}
{"title":"Increase, Cancer","references":"","biologicalOrganisationLevel":"Tissue","organTerm":{},"biologicalEvents":[{"action":"increased","object":{"name":"Neoplasms","source":"MESH","sourceId":"D009369"}}],"id":885}
{"title":"Endocytotic lysosomal uptake","references":"<ul>\n\t<li>Alberts B, Johnson A, Lewis J, et al. Molecular Biology of the Cell. 4th edition New York: Garland Science; (2002).</li>\n\t<li>Ashoor R, Yafawi R, Jessen B, Lu S. The Contribution of Lysosomotropism to Autophagy Perturbation. (2013) PLoS ONE 8(11): e82481</li>\n\t<li>Brandenberger C, Clift MJ, Vanhecke D, M&uuml;hlfeld C, Stone V, Gehr P, Rothen-Rutishauser B. Intracellular imaging of nanoparticles: is it an elemental mistake to believe what you see? Part Fibre Toxicol. (2010) 7:15.</li>\n\t<li>Brandenberger C, &nbsp;M&uuml;hlfeld C, &nbsp;Ali Z,&nbsp; Lenz AG, Otmar Schmid, &nbsp;Parak WJ, Gehr P, &nbsp;Rothen-Rutishauser B. Quantitative evaluation of cellular uptake and trafficking of plain and polyethylene glycol-coated gold nanoparticles, Small. (2010) 6(15): 1669&ndash;1678.</li>\n\t<li>Chakraborty A, Jana NR. Clathrin to Lipid Raft-Endocytosis via Controlled Surface Chemistry and Efficient Perinuclear Targeting of Nanoparticle, &nbsp;J. Phys.&nbsp; Chem.&nbsp; Lett. (2015) 6(18): 3688-3697</li>\n\t<li>Cleal K, He L, Watson PD, Jones AT. Endocytosis, intracellular traffic and fate of cell penetrating peptide based conjugates and nanoparticles, Curr Pharm Des. (2013)19(16):2878-94.</li>\n\t<li>Cooper GM. The Cell: A Molecular Approach. 2nd edition. Sunderland (MA): Sinauer Associates; (2000).</li>\n\t<li>De Duve Ch, De Barsy T, Poole B, Trouet A, Tulkens P, van Hoof F. Lysosomotropic agents, Biochemical Pharmacology, (1974)&nbsp; Volume 23, 18: 2495-2510.</li>\n\t<li>Dergai M, Iershov A, Novokhatska O, Pankivskyi S, Rynditch A. Evolutionary Changes on the Way to Clathrin-Mediated Endocytosis in Animals, Genome Biol Evol. (2016) 8(3):588-606.</li>\n\t<li>Doherty GJ, McMahon HT. &nbsp;Mechanisms of endocytosis, Annu Rev Biochem. (2009) 78:857-902.</li>\n\t<li>Fan L, Li R, Pan J3, Ding Z4, Lin J. Endocytosis and its regulation in plants, Trends Plant Sci. (2015) 20(6):388-97.</li>\n\t<li>Dykman LA, Khlebtsov NG. Uptake of engineered gold nanoparticles into mammalian cells. Chem Rev. (2014) 114(2):1258-88.</li>\n\t<li>Gilleron J, Querbes W, Zeigerer A, Borodovsky A, Marsico G, Schubert U, Manygoats K, Seifert S, Andree C, St&ouml;ter M, Epstein-Barash H, Zhang L, Koteliansky V, Fitzgerald K, Fava E, Bickle M, Kalaidzidis Y, Akinc A, Maier M, Zerial M. Image-based analysis of lipid nanoparticle-mediated siRNA delivery, intracellular trafficking and endosomal escape, Nat Biotechnol. (2013) 31(7):638-46.</li>\n\t<li>Harush-Frenkel O, Debotton N, Benita S, Altschuler Y. Targeting of nanoparticles to the clathrin-mediated endocytic pathway, Biochem Biophys Res Commun. (2007) 353(1):26-32.</li>\n\t<li>Iversen TG, Skotland T, Sandvig K. Endocytosis and intracellular transport of nanoparticles: Present knowledge and need for future studies, Nanotoday, (2011) Volume 6, 2: 176-185.</li>\n\t<li>Jin CY, Zhu BS, Wang XF, Lu QH. Cytotoxicity of Titanium Dioxide Nanoparticles in Mouse Fibroblast Cells, Chem Res Toxicol. (2008) 21(9):1871-7.</li>\n\t<li>Kirkham M, Parton RG. Clathrin-independent endocytosis: new insights into caveolae and non-caveolar lipid raft carriers, Biochim Biophys Acta. (2005) 1746(3):349-63.</li>\n\t<li>Lu F, Wu SH, Hung Y, Mou CY. Size effect on cell uptake in well-suspended, uniform mesoporous silica nanoparticles, Small. (2009) 5(12):1408-13.</li>\n\t<li>Lu S, Sung T, Lin N, Abraham RT, Jessen BA. Lysosomal adaptation: How cells respond to lysosomotropic compounds. (2017) PLoS ONE 12(3): e0173771.</li>\n\t<li>Mail&auml;nder V, Landfester K. Interaction of nanoparticles with cells, Biomacromolecules. (2009) 10(9):2379-400.</li>\n\t<li>Manunta M, Izzo L, Duncan R, Jones AT. Establishment of subcellular fractionation techniques to monitor the intracellular fate of polymer therapeutics II. Identification of endosomal and lysosomal compartments in HepG2 cells combining single-step subcellular fractionation with fluorescent imaging. J Drug Target. (2007) 15(1):37-50.</li>\n\t<li>Nadanaciva S, Lu S, Gebhard DF, Jessen BA, Pennie WD, Will Y. A high content screening assay for identifying lysosomotropic compounds, Toxicol In Vitro. (2011) 25(3):715-23.</li>\n\t<li>Ng CT, Tang FM, Li JJ, Ong C, Yung LL, Bay BH. Clathrin-mediated endocytosis of gold nanoparticles in vitro, Anat Rec (Hoboken). (2015) 298(2):418-27.</li>\n\t<li>Oh N, Park JH. Endocytosis and exocytosis of nanoparticles in mammalian cells, Int J Nanomedicine. (2014) 9 Suppl 1:51-63.</li>\n\t<li>Ouedraogo G, Morliere P, Maziere C, Maziere JC, Santus R. Alteration of the Endocytotic Pathway by Photosensitization with Fluoroquinolones, Photochemistry and Photobiology, (2000) 72(4): 458&ndash;463.</li>\n\t<li>Rejman&nbsp; J, Bragonzi&nbsp; A,Conese M. Role of Clathrin- and Caveolae-Mediated Endocytosis in Gene Transfer Mediated by Lipo- and Polyplexes Mol. Ther. (2005) (12): 468&ndash; 474.</li>\n\t<li>Sahay G, Alakhova DY, Kabanov AV. Endocytosis of Nanomedicines, J Control Release. (2010) 145(3):182-95.</li>\n\t<li>Saw WS,&nbsp; Ujihara M, &nbsp;Chong WY, Voon SH, Imae T, &nbsp;Kiew L V, &nbsp;Lee HB, Sim KS, &nbsp;Chung LY. Size-dependent effect of cystine/citric acid-capped confeito-like gold nanoparticles on cellular uptake and photothermal cancer therapy, Colloids Surf B Biointerfaces. (2017) 161: 365&ndash;374.</li>\n\t<li>Sch&uuml;tz I, Lopez-Hernandez T, Gao Q, Puchkov D, Jabs S, Nordmeyer D, Schmudde M, R&uuml;hl E, Graf CM, Haucke V. Lysosomal Dysfunction Caused by Cellular Accumulation of Silica Nanoparticles, J Biol Chem. (2016) 291(27):14170-84</li>\n\t<li>van Nierop K, Muller FJ, Stap J, Van Noorden CJ, van Eijk M, de Groot C. Lysosomal destabilization contributes to apoptosis of germinal center B-lymphocytes, J Histochem Cytochem. (2006) 54(12):1425-35.</li>\n\t<li>Verma A, Stellacci F. Effect of Surface Properties on Nanoparticle&ndash;Cell Interactions, Small. (2010) 6(1):12-21.&nbsp;</li>\n\t<li>Villamil Giraldo AM, Appelqvist H, Ederth T, &Ouml;llinger K. Lysosomotropic agents: impact on lysosomal membrane permeabilization and cell death, Biochem Soc Trans. (2014) 42(5):1460-4.</li>\n\t<li>Villamil Giraldo AM, Fyrner T, Wennmalm S, Parikh AN, Ollinger K, Ederth T. Spontaneous Vesiculation and pH-Induced Disassembly of a Lysosomotropic Detergent: Impacts on Lysosomotropism and Lysosomal Delivery, Langmuir (2016) 32: 13566&minus;13575.</li>\n\t<li>Xie J, Xu Ch, Kohler N, Hou Y, Sun S. Controlled PEGylation of Monodisperse Fe3O4 Nanoparticles for Reduced Non-Specific Uptake by Macrophage Cells, Adv. Mater. (2007) 19: 3163&ndash;3166.</li>\n\t<li>Yang L, Shang L, Nienhaus GU. Mechanistic aspects of fluorescent gold nanocluster internalization by live HeLa cells, Nanoscale. (2013) 5(4):1537-43.</li>\n\t<li>Yang ND, Tan SH, Ng S1, Shi Y, Zhou J, Tan KS, Wong WS, Shen HM. Artesunate induces cell death in human cancer cells via enhancing lysosomal function and lysosomal degradation of ferritin, J Biol Chem. (2014) 289(48):33425-41.</li>\n\t<li>Yu Z, Li W, Brunk UT. 3-Aminopropanal is a lysosomotropic aldehyde that causes oxidative stress and apoptosis by rupturing lysosomes, APMIS. &nbsp;82003) 111(6):643-52.</li>\n\t<li>Zhang LW, Monteiro-Riviere NA. Mechanisms of quantum dot nanoparticle cellular uptake, Toxicol Sci. (2009) 110(1):138-55.</li>\n\t<li>Zhang S, Gao H, Bao G. Physical Principles of Nanoparticle Cellular Endocytosis, ACS Nano. (2015) 9(9):8655-71.\n\t<p>&nbsp;</p>\n\n\t<p>&nbsp;</p>\n\t</li>\n</ul>\n","biologicalOrganisationLevel":"Molecular","organTerm":{},"biologicalEvents":[{"action":"increased","process":"endocytosis","object":{"name":"lysosomal membrane","source":"GO","sourceId":"GO:0005765"}}],"keyEventStressors":["artesunate","o-methyl-serine dodecylamide hydrochloride (MSDH)","Chloroquine bis(phosphate)","ROS","3-aminopropanal","nanoparticles","Norfloxacin","Ciprofloxacin"],"id":1539}
{"title":"Disruption, Lysosome","references":"<p>Anguissola S, Garry D, Salvati A, O&#39;Brien PJ, Dawson KA. High content analysis provides mechanistic insights on the pathways of toxicity induced by amine-modified polystyrene nanoparticles. PLoS One. (2014) 9(9):e108025.</p>\n\n<p>Antunes F, Cadenas E, Brunk UT. Apoptosis induced by exposure to a low steady-state concentration of H2O2 is a consequence of lysosomal rupture. Biochemical Journal. (2001) 356(Pt 2):549-555.</p>\n\n<p>Boya P,&nbsp; Andreau K, Poncet D,&nbsp; Zamzami N, Perfettini JL, Metivier D, Ojcius DM,&nbsp; J&auml;&auml;ttel&auml; M, Kroemer G. Lysosomal membrane permeabilization induces cell death in a mitochondrion-dependent fashion, J. Exp. Med. (2003) 197:1323&ndash;1334.</p>\n\n<p>Boya P, Gonzalez-Polo RA, Poncet D,&nbsp; Andreau K, Vieira HL,&nbsp; Roumier T, Perfettini JL, Kroemer G. Mitochondrial membrane permeabilization is a critical step of lysosome-initiated apoptosis induced by hydroxychloroquine, Oncogene (2003) 22:3927&ndash;3936.</p>\n\n<p>Bursch W. The autophagosomal-lysosomal compartment in programmed cell death. Cell Death Differ. (2001) 8(6):569-81.</p>\n\n<p>Cho W-S, Duffin R, Howie SEM, Scotton CJ, Wallace WAH, Macnee W, Bradley M, Megson IL, Donaldson K. Progressive severe lung injury by zinc oxide nanoparticles; the role of Zn2+ dissolution inside lysosomes. Part Fibre Toxicol (2011) 8:27.</p>\n\n<p>Cho W-S, Duffin R, Thielbeer F, Bradley M, Megson IL, MacNee W, Poland CA, Tran CL, Donaldson K. Zeta potential and solubility to toxic ions as mechanisms of lung inflammation caused by metal/metal oxide nanoparticles. Toxicol Sci (2012) 126:469&ndash;477.</p>\n\n<p>Cirman T, Oresi K, Droga-Mazovec G, Turk V, Reed JC, Myers RM, Salvesen GS, Turk B. Selective disruption of lysosomes in HeLa cells triggers apoptosis mediated by cleavage of Bid by multiple papain-like lysosomal cathepsins. J Biol Chem. (2004) 279(5): 3578&ndash;3587.</p>\n\n<p>de Duve C, Pressman BC, Gianetto R, Wattiaux R, Applemans F. Tissue fractionation studies. 6. Intracellular distribution patterns of enzymes in rat-liver tissue. Biochem J. (1955) 60(4):604-17.</p>\n\n<p>Droga-Mazovec G, Boji L, Petelin A, Ivanova S, Romih R, Repnik U, Salvesen GS, Stoka V, Turk V, Turk B. Cysteine cathepsins trigger caspase-dependent cell death through cleavage of bid and antiapoptotic Bcl-2 homologues, J. Biol. Chem. (2008) 283:19140&ndash;19150.</p>\n\n<p>Ghosh M, Carlsson F, Laskar A, Yuan XM, Li W. Lysosomal membrane permeabilization causes oxidative stress and ferritin induction in macrophages. FEBS Lett. (2011) 585(4):623-9.</p>\n\n<p>Goldman R, Kaplan A. Rupture of rat liver lysosomes mediated by L-amino acid esters, Biochim. Biophys. Acta&nbsp; 1973, 318: 205&ndash;216.</p>\n\n<p>Guicciardi ME, Leist M, Gores GJ. Lysosomes in cell death. Oncogene. (2004) 23(16):2881-90.</p>\n\n<p>Hamacher-Brady A, Stein HA, Turschner S, Toegel I, Mora R, Jennewein N, Efferth T, Eils R, Brady NR. Artesunate activates mitochondrial apoptosis in breast cancer cells via iron-catalyzed lysosomal reactive oxygen species production. J Biol Chem. (2011) 286(8):6587-601.</p>\n\n<p>Ishidoh K, Kominami E. Processing and activation of lysosomal proteinases. Biol Chem. (2002)&nbsp; 383(12): 1827&ndash;1831.</p>\n\n<p>Johansson AC, Appelqvist H, Nilsson C, K&aring;gedal K, Roberg K, Ollinger K. Regulation of apoptosis-associated lysosomal membrane permeabilization. Apoptosis. (2010) 15(5):527-40.</p>\n\n<p>Kagedal K, Zhao M, Svensson I, Brunk UT. Sphingosine-induced apoptosis is dependent on lysosomal proteases. The Biochemical journal.&nbsp; (2001) 359:335-43.</p>\n\n<p>Kroemer G, J&auml;&auml;ttel&auml; M. Lysosomes and autophagy in cell death control. Nat Rev Cancer. (2005) 5(11):886-97.</p>\n\n<p>Kubota C, Torii S, Hou N, Saito N, Yoshimoto Y, Imai H, Takeuchi T. Constitutive reactive oxygen species generation from autophagosome/lysosome in neuronal oxidative toxicity. J Biol Chem. (2010) 285(1):667-74.</p>\n\n<p>Kurz T, Terman A, Gustafsson B, Brunk&nbsp; UT.&nbsp; Lysosomes in iron metabolism, ageing and apoptosis. Histochem. Cell Biol. (2008) 129: 389-406.</p>\n\n<p>Li W, Yuan X, Nordgren G, Dalen H, Dubowchik GM, Firestone RA, Brunk UT. Induction of cell death by the lysosomotropic detergent MSDH, FEBS Lett. (2000) 470:35&ndash;39.</p>\n\n<p>Loos C, Syrovets T, Musyanovych A, Mail&auml;nder V, Landfester K, Nienhaus GU, Simmet T. Functionalized polystyrene nanoparticles as a platform for studying bio-nano interactions. Beilstein J Nanotechnol. (2014) 5:2403-12.</p>\n\n<p>Ostenfeld MS, Fehrenbacher N, H&oslash;yer-Hansen M, Thomsen C,&nbsp; Farkas T,&nbsp; J&auml;&auml;ttel&auml; M. Effective tumor cell death by sigma-2 receptor ligand siramesine involves lysosomal leakage and oxidative stress, Cancer Res. (2005) 65:8975&ndash;8983.</p>\n\n<p>Reiners J, Caruso J, Mathieu P, Chelladurai B, Yin X-M, Kessel D. Release of cytochrome c and activation of pro-caspase-9 following lysosomal photodamage involves bid cleavage. Cell death and differentiation. (2002) 9(9):934-944.</p>\n\n<p>Repnik U, Turk B. Lysosomal-mitochondrial cross-talk during cell death. Mitochondrion. (2010) 10(6):662-9.</p>\n\n<p>Sumoza-Toledo A, Penner R. TRPM2: a multifunctional ion channel for calcium signalling. J. Physiol. (2011) 589:1515-1525.</p>\n\n<p>Terman A, Kurz T, Navratil M, Arriaga EA, Brunk UT. Mitochondrial turnover and aging of long-lived postmitotic cells: the mitochondrial-lysosomal axis theory of aging. Antioxid Redox Signal. (2010) 12(4):503-35.</p>\n\n<p>Uchimoto T, Nohara H, Kamehara R, Iwamura M, Watanabe N, Kobayashi Y. Mechanism of apoptosis induced by a lysosomotropic agent, L-Leucyl-L-Leucine methyl ester, Apoptosis (1999) 4:357&ndash;362.</p>\n\n<p>Wang F, Bexiga MG, Anguissola S, Boya P, Simpson JC, Salvati A, Dawson KA: Time resolved study of cell death mechanisms induced by amine-modified polystyrene nanoparticles. Nanoscale (2013) 5:10868&ndash;76.</p>\n\n<p>Wang F, Salvati A, Boya P. Lysosome-dependent cell death and deregulated autophagy induced by amine-modified polystyrene nanoparticles. Open Biol. (2018) 8(4): 170271.</p>\n\n<p>Werneburg NW, Guicciardi ME, Bronk SF, Gores GJ. Tumor necrosis factor-alpha-associated lysosomal permeabilization is cathepsin B dependent. Am J Physiol Gastrointest Liver Physiol. (2002) 283:G947&ndash;G956.</p>\n\n<p>Wilson PD, Firestone RA, Lenard J. The role of lysosomal enzymes in killing of mammalian cells by the lysosomotropic detergent N-dodecylimidazole, J. Cell. Biol. (1987) 104:1223&ndash;1229.</p>\n\n<p>Zhao M, Brunk UT, Eaton JW. Delayed oxidant-induced cell death involves activation of phospholipase A2. FEBS Lett. (2001) 509:399&ndash;404.</p>\n\n<p>Zhao M, Eaton JW,&nbsp; Brunk UT. Bcl-2 phosphorylation is required for inhibition of oxidative stress induced lysosomal leak and ensuing apoptosis. FEBS Lett. (2001) 509: 405&ndash;412.</p>\n\n<p>&nbsp;</p>\n","biologicalOrganisationLevel":"Cellular","organTerm":{},"biologicalEvents":[{"action":"occurrence","process":"organelle disassembly","object":{"name":"lysosome","source":"GO","sourceId":"GO:0005764"}}],"id":898}
{"title":"Leukocyte recruitment/activation","references":"<p>Kourtzelis I and Mitroulis I, Encyclopedia of Inflammatory Diseases, Leukocyte Recruitment, pp 1-9, Compendium of Inflammatory Diseases, Editors: Michael J. Parnham , Springer Basel, 2015, DOI 10.1007/978-3-0348-0620-6_177-1</p>\n\n<p>Kumar, V.; Abbas, AK.; Fausto, N.; Aster, J. Robbins and Cotran: Pathologic Basis of Disease. 8. Elsevier; Philadelphia: 2010.</p>\n\n<p>Leick M, Azcutia V, Newton G, Luscinskas FW., Leukocyte recruitment in inflammation: basic concepts and new mechanistic insights based on new models and microscopic imaging technologies, Cell Tissue Res. 2014 Mar;355(3):647-56</p>\n\n<p>Nourshargh S, Alon R., Leukocyte migration into inflamed tissues., Immunity. 2014 Nov 20;41(5):694-707</p>\n","biologicalOrganisationLevel":"Cellular","organTerm":{},"biologicalEvents":[{"action":"increased","process":"cell activation involved in immune response","object":{"name":"leukocyte","source":"CL","sourceId":"CL:0000738"}}],"id":1494}
{"title":"Occurrence, Transdifferentiation of ciliated epithelial cells","references":"<div>Ayers, M. M., &amp; Jeffery, P. K (1998).&nbsp;Proliferation and differentiation in mammalian airway epithelium. Eur Resp J 1, 58-80.</div>\n\n<p>Casalino-Matsuda, S. M., Monz&oacute;n, M. E., &amp; Forteza, R. M (2006). Epidermal growth factor receptor activation by epidermal growth factor mediates oxidant-induced goblet cell metaplasia in human airway epithelium. Am J Resp Cell Mol Biol 34, 581-591.</p>\n\n<p>Curran, D.R., and Cohn, L (2010).&nbsp;Advances in mucous cell metaplasia: a plug for mucus as a therapeutic focus in chronic airway disease. Am J Resp Cell Mol Biol 42, 268-275.</p>\n\n<p>Fujisawa, T., Ide, K., Suda, T., Suzuki, K., Kuroishi, S., Chida, K., and Nakamura, H. (2008). Involvement of the p38 MAPK pathway in IL13induced mucous cell metaplasia in mouse tracheal epithelial cells. Respirology<em> </em>13, 191-202.</p>\n\n<p>Gomperts, B.N., Kim, L.J., Flaherty, S.A., and Hackett, B.P. (2007). IL-13 regulates cilia loss and foxj1 expression in human airway epithelium. American Journal of Respiratory Cell and Molecular Biology<em> </em>37, 339-346.</p>\n\n<p>Hays, S.R., and Fahy, J.V. (2006). Characterizing mucous cell remodeling in cystic fibrosis: relationship to neutrophils. Am J Resp Crit Care Med<em> </em>174, 1018-1024.</p>\n\n<p>Jefferey, P., Rogers, D., Ayers, M., and Shields, P. (1984). Structural aspects of cigarette smoke-induced pulmonary disease. In Smoking and the Lung (Springer), pp. 1-31.</p>\n\n<p>Laoukili, J., Perret, E., Willems, T., Minty, A., Parthoens, E., Houcine, O., Coste, A., Jorissen, M., Marano, F., Caput, D.<em>, et al.</em> (2001). IL-13 alters mucociliary differentiation and ciliary beating of human respiratory epithelial cells. J Clin Inv<em> </em>108, 1817-1824.</p>\n\n<p>Lumsden, A.B., McLean, A., and Lamb, D (1984). Goblet and Clara cells of human distal airways: evidence for smoking induced changes in their numbers. Thorax<em> </em>39, 844-849.</p>\n\n<p>Pardo-Saganta, A., Law, B.M., Gonzalez-Celeiro, M., Vinarsky, V., and Rajagopal, J. (2013). Ciliated cells of pseudostratified airway epithelium do not become mucous cells after ovalbumin challenge. Am J Resp Cell Mol Biol<em> </em>48, 364-373.</p>\n\n<p>Reader, J.R., Tepper, J.S., Schelegle, E.S., Aldrich, M.C., Putney, L.F., Pfeiffer, J.W., and Hyde, D.M. (2003). Pathogenesis of mucous cell metaplasia in a murine asthma model. Am J Pathol 162, 2069-2078.</p>\n\n<p>Rogers, D. (1994). Airway goblet cells: responsive and adaptable front-line defenders. Eur Resp J 7, 1690-1706.</p>\n\n<p>Shimizu, T., Takahashi, Y., Kawaguchi, S., and Sakakura, Y. (1996). Hypertrophic and metaplastic changes of goblet cells in rat nasal epithelium induced by endotoxin. Am J Resp Crit Care Med 153, 1412-1418.</p>\n\n<p>Silva, M.A., and Bercik, P. (2012). Macrophages are related to goblet cell hyperplasia and induce MUC5B but not MUC5AC in human bronchus epithelial cells. Lab Invest<em> </em>92, 937-948.</p>\n\n<p>Takeyama, K., Tamaoki, J., Kondo, M., Isono, K., and Nagai, A. (2008).Role of epidermal growth factor receptor in maintaining airway goblet cell hyperplasia in rats sensitized to allergen. Clin Exp Allergy<em> </em>38, 857-865.</p>\n\n<p>Taniguchi, K., Yamamoto, S., Aoki, S., Toda, S., Izuhara, K., and Hamasaki, Y. (2011). Epigen is induced during the interleukin-13&ndash;stimulated cell proliferation in murine primary airway epithelial cells. Exp Lung Res 37, 461-470.</p>\n\n<p>Tesfaigzi, Y., Harris, J.F., Hotchkiss, J.A., and Harkema, J.R. (2004). DNA synthesis and Bcl-2 expression during development of mucous cell metaplasia in airway epithelium of rats exposed to LPS. Am J Physiol Lung Cell Mol Physiol 286, L268-L274.</p>\n\n<p>Turner, J., Roger, J., Fitau, J., Combe, D., Giddings, J., Heeke, G.V., and Jones, C.E. (2011). Goblet cells are derived from a FOXJ1-expressing progenitor in a human airway epithelium. Am J Resp Cell Mol Biol 44, 276-284.</p>\n\n<p>Tyner, J.W., Kim, E.Y., Ide, K., Pelletier, M.R., Roswit, W.T., Morton, J.D., Battaile, J.T., Patel, A.C., Patterson, G.A., Castro, M.<em>, et al.</em> (2006). Blocking airway mucous cell metaplasia by inhibiting EGFR antiapoptosis and IL-13 transdifferentiation signals. J Clin Invest 116, 309-321.</p>\n","biologicalOrganisationLevel":"Cellular","organTerm":{},"biologicalEvents":[{"action":"occurrence","process":"transdifferentiation","object":{"name":"ciliated epithelial cell","source":"CL","sourceId":"CL:0000067"}}],"id":919}
{"title":"Occurrence, Metaplasia of goblet cells","references":"<p>Casalino-Matsuda, S., Monz&oacute;n, M., and Forteza, R. (2006). Epidermal Growth Factor Receptor Activation by Epidermal Growth Factor Mediates Oxidant-Induced Goblet Cell Metaplasia in Human Airway Epithelium. Am J Respir Cell Mol Biol 34, 581&ndash;591.</p>\n\n<p>Evans, C.M., Williams, O.W., Tuvim, M.J., Nigam, R., Mixides, G.P., Blackburn, M.R., DeMayo, F.J., Burns, A.R., Smith, C., Reynolds, S.D., et al. (2004). Mucin is produced by clara cells in the proximal airways of antigen-challenged mice. Am J Respir Cell Mol Biol 31, 382&ndash;394.</p>\n\n<p>Fujisawa, T., Ide, K., Holtzman, M.J., Suda, T., Suzuki, K., Kuroishi, S., Chida, K., and Nakamura, H. (2008). Involvement of the p38 MAPK pathway in IL-13-induced mucous cell metaplasia in mouse tracheal epithelial cells. Respirol 13, 191&ndash;202.</p>\n\n<p>Harkema, J., and Hotchkiss, J. (1993). Ozone- and endotoxin-induced mucous cell metaplasias in rat airway epithelium: novel animal models to study toxicant-induced epithelial transformation in airways. Toxicol Lett 68, 251&ndash;263.</p>\n\n<p>Harkema, J., and Wagner, J. (2002). Non-allergic models of mucous cell metaplasia and mucus hypersecretion in rat nasal and pulmonary airways. Novartis Found Symp 248, 181&ndash;197; discussion 197&ndash;200, 277&ndash;282.</p>\n\n<p>Hayashi, T., Ishii, A., Nakai, S., and Hasegawa, K. (2004). Ultrastructure of goblet-cell metaplasia from Clara cell in the allergic asthmatic airway inflammation in a mouse model of asthma in vivo. Virchows Arch Int J Pathol 444, 66&ndash;73.</p>\n\n<p>Lamb, D., and Reid, L. (1968). Mitotic rates, goblet cell increase and histochemical changes in mucus in rat bronchial epithelium during exposure to sulphur dioxide. J Pathol Bacteriol 96, 97&ndash;111.</p>\n\n<p>Laoukili, J., Perret, E., Willems, T., Minty, A., Parthoens, E., Houcine, O., Coste, A., Jorissen, M., Marano, F., Caput, D., et al. (2001). IL-13 alters mucociliary differentiation and ciliary beating of human respiratory epithelial cells. J Clin Invest 108, 1817&ndash;1824.</p>\n\n<p>Lumsden, A.B., McLean, A., and Lamb, D. (1984). Goblet and Clara cells of human distal airways: evidence for smoking induced changes in their numbers. Thorax<em> 39</em>, 844-849.</p>\n\n<p>Nagai, A., Thurlbeck, W.M., and Konno, K. (1995). Responsiveness and variability of airflow obstruction in chronic obstructive pulmonary disease. Clinicopathologic correlative studies. Am J Respir Crit Care Med 151, 635&ndash;639.</p>\n\n<p>Reader, J.R., Tepper, J.S., Schelegle, E.S., Aldrich, M.C., Putney, L.F., Pfeiffer, J.W., and Hyde, D.M. (2003). Pathogenesis of mucous cell metaplasia in a murine asthma model. Am J Pathol 162, 2069&ndash;2078.</p>\n\n<p>Shimizu, T., Takahashi, Y., Kawaguchi, S., and Sakakura, Y. (1996). Hypertrophic and metaplastic changes of goblet cells in rat nasal epithelium induced by endotoxin. Am J Respir Crit Care Med 153, 1412&ndash;1418.</p>\n\n<p>Turner, J., Roger, J., Fitau, J., Combe, D., Giddings, J., Heeke, G.V., and Jones, C.E. (2011). Goblet cells are derived from a FOXJ1-expressing progenitor in a human airway epithelium. Am J Respir Cell Mol Biol 44, 276&ndash;284.</p>\n\n<p>Tyner, J., Tyner, E., Ide, K., Pelletier, M., Roswit, W., Morton, J., Battaile, J., Patel, A., Patterson, G., Castro, M., et al. (2006). Blocking airway mucous cell metaplasia by inhibiting EGFR antiapoptosis and IL-13 transdifferentiation signals. J Clin Invest 116, 309&ndash;321.</p>\n\n<p>Yoshisue, H., and Hasegawa, K. (2004). Effect of MMP/ADAM inhibitors on goblet cell hyperplasia in cultured human bronchial epithelial cells. Biosci Biotechnol Biochem 68, 2024&ndash;2031.</p>\n","biologicalOrganisationLevel":"Tissue","organTerm":{},"biologicalEvents":[{"action":"occurrence","process":"Metaplasia","object":{"name":"goblet cell","source":"CL","sourceId":"CL:0000160"}}],"id":920}
{"title":"Occurrence, Hyperplasia of goblet cells","references":"<p>Allahverdian, S., Wang, A., Singhera, G.K., Wong, B.W., and Dorscheid, D.R. (2010). Sialyl Lewis X modification of the epidermal growth factor receptor regulates receptor function during airway epithelial wound repair. Clin Exp Allergy<em> </em>40, 607-618.</p>\n\n<p>Burgel, P., and Nadel, J. (2004). Roles of epidermal growth factor receptor activation in epithelial cell repair and mucin production in airway epithelium. Thorax 59, 992-996.</p>\n\n<p>Evans, C.M., Williams, O.W., Tuvim, M.J., Nigam, R., Mixides, G.P., Blackburn, M.R., DeMayo, F.J., Burns, A.R., Smith, C., Reynolds, S.D.<em>, et al.</em> (2004). Mucin Is produced by Clara cells in the proximal airways of antigen-challenged mice. Am J Resp Cell Mol Biol<em> </em>31, 382-394.</p>\n\n<p>Hackel, P.O., Zwick, E., Prenzel, N., and Ullrich, A. (1999). Epidermal growth factor receptors: critical mediators of multiple receptor pathways. Curr Opin Cell Biol<em> </em>11, 184-189.</p>\n\n<p>Hao, Y., Kuang, Z., Jing, J., Miao, J., Mei, L.Y., Lee, R.J., Kim, S., Choe, S., Krause, D.C., and Lau, G.W. (2014). <em>Mycoplasma pneumoniae</em> modulates STAT3-STAT6/EGFR-FOXA2 signaling to induce overexpression of airway mucins. Infect Immun<em> </em>82, 5246-5255.</p>\n\n<p>Hao, Y., Kuang, Z., Xu, Y., Walling, B.E., and Lau, G.W. (2013). Pyocyanin-induced mucin production is associated with redox modification of FOXA2. Respir Res<em> </em>14, 82-82.</p>\n\n<p>Harkema, J.R., and Hotchkiss, J.A. (1993). Ozone- and endotoxin-induced mucous cell metaplasias in rat airway epithelium: Novel animal models to study toxicant-induced epithelial transformation in airways. Toxicol Lett<em> </em>68, 251-263.</p>\n\n<p>Hegab, A.E., Sakamoto, T., Nomura, A., Ishii, Y., Morishima, Y., Iizuka, T., Kiwamoto, T., Matsuno, Y., Homma, S., and Sekizawa, K. (2007). Niflumic acid and AG-1478 reduce cigarette smoke-induced mucin synthesis: The role of hCLCA1. Chest<em> </em>131, 1149-1156.</p>\n\n<p>Kim, S., Schein, A.J., and Nadel, J.A. (2005). E-cadherin promotes EGFR-mediated cell differentiation and MUC5AC mucin expression in cultured human airway epithelial cells. Am J Physiol Lung Cell Mol Physiol 289, L1049-L1060.</p>\n\n<p>Kim, B.-G., Lee, P.-H., Lee, S.-H., Kim, Y.-E., Shin, M.-Y., Kang, Y., Bae, S.-H., Kim, M.-J., Rhim, T., Park, C.-S.<em>, et al.</em> (2016). Long-Term Effects of Diesel Exhaust Particles on Airway Inflammation and Remodeling in a Mouse Model. Allergy Asthma Immunol Res<em> </em>8, 246-256.</p>\n\n<p>Lamb, D., and Reid, L. (1968). Mitotic rates, goblet cell increase and histochemical changes in mucus in rat bronchial epithelium during exposure to sulphur dioxide. J Pathol Bacteriol<em> </em>96, 97-111.</p>\n\n<p>Lemjabbar, H., Li, D., Gallup, M., Sidhu, S., Drori, E., and Basbaum, C. (2003). Tobacco smoke-induced lung cell proliferation mediated by tumor necrosis factor alpha-converting enzyme and amphiregulin. J Biol Chem 278, 26202-26207.</p>\n\n<p>Lukacs, N.W., Smit, J.J., Nunez, G., and Lindell, D.M. (2010). Respiratory Virus-induced TLR7 activation controls IL-17 associated Increase in mucus via IL-23 regulation: Respiratory virus induced immune environment relies on TLR7-mediated pathways to preserve a non-pathogenic response and regulates IL-17 production. J Immunol 185, 2231-2239.</p>\n\n<p>Lumsden, A.B., McLean, A., and Lamb, D. (1984). Goblet and Clara cells of human distal airways: evidence for smoking induced changes in their numbers. Thorax<em> </em>39, 844-849.</p>\n\n<p>Miyabara, Y., Ichinose, T., Takano, H., Lim, H.-B., and Sagai, M. (1998). Effects of diesel exhaust on allergic airway inflammation in mice. J Allergy Clin Immunol 102, 805-812.</p>\n\n<p>Nagao, K., Tanaka, H., Komai, M., Masuda, T., Narumiya, S., and Nagai, H. (2003). Role of Prostaglandin I2 in Airway Remodeling Induced by Repeated Allergen Challenge in Mice. Am J Resp Cell Mol Biol<em> </em>29, 314-320.</p>\n\n<p>Nie, Y.-C., Wu, H., Li, P.-B., Luo, Y.-L., Zhang, C.-C., Shen, J.-G., and Su, W.-W. (2012). Characteristic comparison of three rat models induced by cigarette smoke or combined with LPS: to establish a suitable model for study of airway mucus hypersecretion in chronic obstructive pulmonary disease. Pulm Pharmacol Ther 25, 349-356.</p>\n\n<p>NTP (1994). NTP Toxicology and Carcinogenesis Studies of Ozone (CAS No. 10028-15-6) and Ozone/NNK (CAS No. 10028-15-6/64091-91-4) in F344/N Rats and B6C3F1 Mice (Inhalation Studies). National Toxicology Program technical report series<em> 440</em>, 1.</p>\n\n<p>Reader, J.R., Tepper, J.S., Schelegle, E.S., Aldrich, M.C., Putney, L.F., Pfeiffer, J.W., and Hyde, D.M. (2003). Pathogenesis of mucous cell metaplasia in a murine asthma model. Am J Pathol 162, 2069-2078.</p>\n\n<p>Rock, J.R., Onaitis, M.W., Rawlins, E.L., Lu, Y., Clark, C.P., Xue, Y., Randell, S.H., and Hogan, B.L. (2009). Basal cells as stem cells of the mouse trachea and human airway epithelium. PNAS 106, 12771-12775.</p>\n\n<p>Rogers, D. (1994). Airway goblet cells: responsive and adaptable front-line defenders. Eur Respir J 7, 1690-1706.</p>\n\n<p>Saetta, M., Turato, G., Baraldo, S., Zanin, A., Braccioni, F., Mapp, C.E., Maestrelli, P., Cavallesco, G., Papi, A., and Fabri, L.M. (2000). Goblet Cell Hyperplasia and Epithelial Inflammation in Peripheral Airways of Smokers with Both Symptoms of Chronic Bronchitis and Chronic Airflow Limitation. Am J Resp Crit Care Med 161, 1016-1021.</p>\n\n<p>Shimizu, T., Takahashi, Y., Kawaguchi, S., and Sakakura, Y. (1996). Hypertrophic and metaplastic changes of goblet cells in rat nasal epithelium induced by endotoxin. Am J Resp Crit Care Med 153, 1412-1418.</p>\n\n<p>Silva, M.A., and Bercik, P. (2012). Macrophages are related to goblet cell hyperplasia and induce MUC5B but not MUC5AC in human bronchus epithelial cells. Lab Invest<em> </em>92, 937-948.</p>\n\n<p>Takeyama, K., Tamaoki, J., Kondo, M., Isono, K., and Nagai, A. (2008). Role of epidermal growth factor receptor in maintaining airway goblet cell hyperplasia in rats sensitized to allergen. Clin Exp Allergy<em> </em>38, 857-865.</p>\n\n<p>Tesfaigzi, Y., Fischer, M.J., Martin, A.J., and Seagrave, J. (2000). Bcl-2 in LPS- and allergen-induced hyperplastic mucous cells in airway epithelia of Brown Norway rats. Am J Physiol Lung Cell Mol Physiol 279, L1210-L1217.</p>\n\n<p>Turner, J., Roger, J., Fitau, J., Combe, D., Giddings, J., Heeke, G.V., and Jones, C.E. (2011). Goblet cells are derived from a FOXJ1-expressing progenitor in a human airway epithelium. Am J Resp Cell Mol Biol<em> </em>44, 276-284.</p>\n\n<p>Tyner, J.W., Kim, E.Y., Ide, K., Pelletier, M.R., Roswit, W.T., Morton, J.D., Battaile, J.T., Patel, A.C., Patterson, G.A., Castro, M.<em>, et al.</em> (2006). Blocking airway mucous cell metaplasia by inhibiting EGFR antiapoptosis and IL-13 transdifferentiation signals. J Clin&nbsp;Invest<em> </em>116, 309-321.</p>\n\n<p>Van Hove, C.L., Maes, T., Cataldo, D.D., Gu&eacute;ders, M.M., Palmans, E., Joos, G.F., and Tournoy, K.G. (2009). Comparison of acute inflammatory and chronic structural asthma-like responses between C57BL/6 and BALB/c mice. Int Arch Allergy Immunol<em> </em>149, 195-207.</p>\n\n<p>Van Winkle, L.S., Isaac, J.M., and Plopper, C.G. (1997). Distribution of epidermal growth factor receptor and ligands during bronchiolar epithelial repair from naphthalene-induced Clara cell injury in the mouse. Am J Pathol<em> </em>151, 443.</p>\n\n<p>Walter, M.J., Morton, J.D., Kajiwara, N., Agapov, E., and Holtzman, M.J. (2002). Viral induction of a chronic asthma phenotype and genetic segregation from the acute response. J Clin Invest 110, 165-175.</p>\n\n<p>Werley, M.S., Kirkpatrick, D.J., Oldham, M.J., Jerome, A.M., Langston, T.B., Lilly, P.D., Smith, D.C., and McKinney, W.J. (2016). Toxicological assessment of a prototype e-cigaret device and three flavor formulations: a 90-day inhalation study in rats. Inhal Toxicol<em> </em>28, 22-38.</p>\n\n<p>Wolf, D., Morgan, K., Gross, E., Barrow, C., Moss, O., James, R., and Popp, J. (1995). Two-year inhalation exposure of female and male B6C3F1 mice and F344 rats to chlorine gas induces lesions confined to the nose. Toxicol Sci<em> </em>24, 111-131.</p>\n\n<p>Yageta, Y., Ishii, Y., Morishima, Y., Ano, S., Ohtsuka, S., Matsuyama, M., Takeuchi, K., Itoh, K., Yamamoto, M., and Hizawa, N. (2014). Carbocisteine reduces virus-induced pulmonary inflammation in mice exposed to cigarette smoke. Am J Resp Cell Mol Biol<em> </em>50, 963-973.</p>\n","biologicalOrganisationLevel":"Tissue","organTerm":{},"biologicalEvents":[{"action":"occurrence","process":"hyperplasia","object":{"name":"goblet cell","source":"CL","sourceId":"CL:0000160"}}],"id":921}
{"title":"Increase, Proliferation of goblet cells","references":"<div>Adan, A., Kiraz, Y., &amp; Baran, Y. (2016). Cell proliferation and cytotoxicity assays. Curr Pharm Biotechnol 17, 1213-1221.</div>\n\n<p>Booth, B.W., Adler, K.B., Bonner, J.C., Tournier, F., and Martin, L.D. (2001). Interleukin-13 induces proliferation of human airway epithelial cells in vitro via a mechanism mediated by transforming growth factor-alpha. Am J Respir Cell Mol Biol 25, 739&ndash;743.</p>\n\n<p>Booth, B.W., Sandifer, T., Martin, E.L., and Martin, L.D. (2007). IL-13-induced proliferation of airway epithelial cells: mediation by intracellular growth factor mobilization and ADAM17. Respir Res 8, 51.</p>\n\n<p>Camateros, P., Tamaoka, M., Hassan, M., Marino, R., Moisan, J., Marion, D., Guiot, M.-C., Martin, J.G., and Radzioch, D. (2007). Chronic asthma-induced airway remodeling is prevented by toll-like receptor-7/8 ligand S28463. Am J Respir Crit Care Med 175, 1241&ndash;1249.</p>\n\n<p>Chopra, D.P., Yeh, K., and Brockman, R.W. (1981). Isolation and characterization of epithelial cell types from the normal rat colon. Cancer Res 41, 168&ndash;175.</p>\n\n<p>Duh, G., Mouri, N., Warburton, D., and Thomas, D.W. (2000). EGF regulates early embryonic mouse gut development in chemically defined organ culture. Pediatr Res 48, 794&ndash;802.</p>\n\n<p>Gu, J., Chen, L., Shatos, M.A., Rios, J.D., Gulati, A., Hodges, R.R., and Dartt, D.A. (2008). Presence of EGF growth factor ligands and their effects on cultured rat conjunctival goblet cell proliferation. Exp Eye Res 86, 322&ndash;334.</p>\n\n<p>Ichinose, T., Sadakane, K., Takano, H., Yanagisawa, R., Nishikawa, M., Mori, I., Kawazato, H., Yasuda, A., Hiyoshi, K., and Shibamoto, T. (2006). Enhancement of mite allergen-induced eosinophil infiltration in the murine airway and local cytokine/chemokine expression by Asian sand dust. J Toxicol Environ Health A 69, 1571&ndash;1585.</p>\n\n<div>Riss TL, Moravec RA, Niles AL, et al. Cell Viability Assays. 2013 May 1 [Updated 2016 Jul 1]. In: Sittampalam GS, Coussens NP, Brimacombe K, et al., editors. Assay Guidance Manual [Internet]. Bethesda (MD): Eli Lilly &amp; Company and the National Center for Advancing Translational Sciences; 2004-. Available from: <a href=\"https://www.ncbi.nlm.nih.gov/books/NBK144065/\">https://www.ncbi.nlm.nih.gov/books/NBK144065/</a></div>\n\n<div>&nbsp;</div>\n\n<div>\n<div>Romar, G. A., Kupper, T. S., &amp; Divito, S. J. (2016). Research Techniques Made Simple: Techniques to Assess Cell Proliferation.&nbsp;J Invest Dermatol&nbsp;136, e1-e7.</div>\n</div>\n\n<p>Shatos, M.A., R&iacute;os, J.D., Horikawa, Y., Hodges, R.R., Chang, E.L., Bernardino, C.R., Rubin, P.A.D., and Dartt, D.A. (2003). Isolation and characterization of cultured human conjunctival goblet cells. Invest Ophthalmol Vis Sci 44, 2477&ndash;2486.</p>\n\n<p>Sydlik, U., Bierhals, K., Soufi, M., Abel, J., Schins, R.P.F., and Unfried, K. (2006). Ultrafine carbon particles induce apoptosis and proliferation in rat lung epithelial cells via specific signaling pathways both using EGF-R. Am J Physiol Lung Cell Mol Physiol 291, L725&ndash;L733.</p>\n\n<p>Tamaoki, J., Isono, K., Takeyama, K., Tagaya, E., Nakata, J., and Nagai, A. (2004). Ultrafine carbon black particles stimulate proliferation of human airway epithelium via EGF receptor-mediated signaling pathway. Am J Physiol Lung Cell Mol Physiol 287, L1127&ndash;L1133.</p>\n\n<p>Taniguchi, K., Yamamoto, S., Aoki, S., Toda, S., Izuhara, K., and Hamasaki, Y. (2011). Epigen is induced during the interleukin-13-stimulated cell proliferation in murine primary airway epithelial cells. Exp Lung Res 37, 461&ndash;470.</p>\n\n<p>Yadav, K. , Singhal, N. , Rishi, V. and Yadav, H. (2014). Cell Proliferation Assays. In eLS, John Wiley &amp; Sons, Ltd (Ed.). doi:<a href=\"https://doi.org/10.1002/9780470015902.a0002566\">10.1002/9780470015902.a0002566</a></p>\n","biologicalOrganisationLevel":"Cellular","organTerm":{"name":"lung","sourceId":"UBERON:0002048"},"biologicalEvents":[{"action":"increased","process":"cell proliferation","object":{"name":"goblet cell","source":"CL","sourceId":"CL:0000160"}}],"id":923}
{"title":"Activation, Sp1","references":"<p style=\"text-align: justify;\">Barbier, D., Garcia-Verdugo, I., Pothlichet, J., Khazen, R., Descamps, D., Rousseau, K., Thornton, D., Si-Tahar, M., Touqui, L., Chignard, M., et al. (2012). Influenza A Induces the Major Secreted Airway Mucin MUC5AC in a Protease&ndash;EGFR&ndash;Extracellular Regulated Kinase&ndash;Sp1&ndash;Dependent Pathway. Am J Respir Cell Mol Biol 47, 149&ndash;157.</p>\n\n<p style=\"text-align: justify;\">Chu, S., and Ferro, T.J. (2005). Sp1: Regulation of gene expression by phosphorylation. Gene 348, 1&ndash;11.</p>\n\n<p style=\"text-align: justify;\">Hewson, C.A., Edbrooke, M.R., and Johnston, S.L. (2004). PMA induces the MUC5AC respiratory mucin in human bronchial epithelial cells, via PKC, EGF/TGF-&alpha;, Ras/Raf, MEK, ERK and Sp1-dependent mechanisms. J Mol Biol<em> 344</em>, 683-695.</p>\n\n<p style=\"text-align: justify;\">Perrais, M., Pigny, P., Copin, M.C., Aubert, J.P., and Van Seuningen, I. (2002). Induction of MUC2 and MUC5AC mucins by factors of the epidermal growth factor (EGF) family is mediated by EGF receptor/Ras/Raf/extracellular signal-regulated kinase cascade and Sp1. J Biol Chem 277, 32258-32267.</p>\n\n<div style=\"text-align: justify;\">Tan, N. Y., &amp; Khachigian, L. M. (2009). Sp1 phosphorylation and its regulation of gene transcription. Mol Cell Biol 29, 2483-2488.</div>\n","biologicalOrganisationLevel":"Molecular","organTerm":{},"biologicalEvents":[{"action":"increased","process":"phosphorylation","object":{"name":"transcription factor Sp1","source":"PR","sourceId":"PR:000000133"}}],"id":924}
{"title":"Decrease, Apoptosis of ciliated epithelial cells","references":"<p>Archana, M., Yogesh, T. L., &amp; Kumaraswamy, K. L. (2013). Various methods available for detection of apoptotic cells-A review. Indian J Cancer 50, 274.</p>\n\n<p>Elmore, S. (2007). Apoptosis: A Review of Programmed Cell Death. Toxicol Pathol 35, 495&ndash;516.</p>\n\n<p>Goldkorn, T., Balaban, N., Matsukuma, K., Chea, V., Gould, R., Last, J., Chan, C., and Chavez, C. (1998). EGF-receptor phosphorylation and signaling are targeted by H2O2 redox stress. Am J Resp&nbsp;Cell Mol Biol 19, 786-798.</p>\n\n<p>Hart, B.A., Lee, C.H., Shukla, G.S., Shukla, A., Osier, M., Eneman, J.D., and Chiu, J.F. (1999). Characterization of cadmium-induced apoptosis in rat lung epithelial cells: evidence for the participation of oxidant stress. Toxicology 133, 43&ndash;58.</p>\n\n<div>Liu, Y., Pu, Y., Li, D., Zhou, L., &amp; Wan, L. (2017). Azithromycin ameliorates airway remodeling via inhibiting airway epithelium apoptosis. Life Sci 170, 1-8.</div>\n\n<p>Mart&iacute;nez-Gir&oacute;n, R., and Mart&iacute;nez-Torre, S. (2011). Apoptotic ciliated cells on sputum smear. Diagn. Cytopathol. 39, 941&ndash;942.</p>\n\n<p>Matute-Bello, G., Liles, W.C., Steinberg, K.P., Kiener, P.A., Mongovin, S., Chi, E.Y., Jonas, M., and Martin, T.R. (1999). Soluble Fas ligand induces epithelial cell apoptosis in humans with acute lung injury (ARDS). J. Immunol. Baltim. Md 1950 163, 2217&ndash;2225.</p>\n\n<p>Mebratu, Y.A., Schwalm, K., Smith, K.R., Schuyler, M., and Tesfaigzi, Y. (2011). Cigarette Smoke Suppresses Bik To Cause Epithelial Cell Hyperplasia and Mucous Cell Metaplasia. Am J Resp Crit Care Med<em> </em>183, 1531-1538.</p>\n\n<p>Monick, M.M., Cameron, K., Staber, J., Powers, L.S., Yarovinsky, T.O., Koland, J.G., and Hunninghake, G.W. (2005). Activation of the Epidermal Growth Factor Receptor by Respiratory Syncytial Virus Results in Increased Inflammation and Delayed Apoptosis. J Biol Chem 280, 2147&ndash;2158.</p>\n\n<div>Ning, Y., Shang, Y., Huang, H., Zhang, J., Dong, Y., Xu, W., &amp; Li, Q. (2013). Attenuation of cigarette smoke-induced airway mucus production by hydrogen-rich saline in rats. PLoS One 8, e83429.</div>\n\n<div>&nbsp;</div>\n\n<div>Rajan, S., Cacalano, G., Bryan, R., Ratner, A. J., Sontich, C. U., van Heerckeren, A., ... &amp; Prince, A. (2000). Pseudomonas aeruginosa induction of apoptosis in respiratory epithelial cells: analysis of the effects of cystic fibrosis transmembrane conductance regulator dysfunction and bacterial virulence factors. Am J Resp Cell Mol Biol 23, 304-312.</div>\n\n<p>Reader, J.R., Tepper, J.S., Schelegle, E.S., Aldrich, M.C., Putney, L.F., Pfeiffer, J.W., and Hyde, D.M. (2003). Pathogenesis of mucous cell metaplasia in a murine asthma model.&nbsp;Am J Pathol<em>&nbsp;</em>162, 2069-2078.</p>\n\n<p>Takeyama, K., Tamaoki, J., Kondo, M., Isono, K., and Nagai, A. (2008). Role of epidermal growth factor receptor in maintaining airway goblet cell hyperplasia in rats sensitized to allergen. Clin Exp Allergy<em> </em>38, 857-865.</p>\n\n<p>Tesfaigzi, Y., Fischer, M.J., Martin, A.J., and Seagrave, J. (2000). Bcl-2 in LPS- and allergen-induced hyperplastic mucous cells in airway epithelia of Brown Norway rats. Am J Physiol Lung Cell Mol Physiol 279, L1210-L1217.</p>\n\n<div>Triantaphyllopoulos, K., Hussain, F., Pinart, M., Zhang, M., Li, F., Adcock, I., ... &amp; Chung, K. F. (2011). A model of chronic inflammation and pulmonary emphysema after multiple ozone exposures in mice. Am J Physiol Lung Cell Mol Physiol 300, L691-L700.</div>\n\n<div>&nbsp;</div>\n\n<div>Truong-Tran, A. Q., Ruffin, R. E., Foster, P. S., Koskinen, A. M., Coyle, P., Philcox, J. C., ... &amp; Zalewski, P. D. (2002). Altered zinc homeostasis and caspase-3 activity in murine allergic airway inflammation. Am j Resp Cell Mol Biol 27, 286-296.</div>\n\n<p>Tyner, J., Tyner, E., Ide, K., Pelletier, M., Roswit, W., Morton, J., Battaile, J., Patel, A., Patterson, G., Castro, M., et al. (2006). Blocking airway mucous cell metaplasia by inhibiting EGFR antiapoptosis and IL-13 transdifferentiation signals. J Clin Invest 116, 309&ndash;321.</p>\n\n<div>Valencia-Gattas M, Conner GE, Fregien NL (2016). Gefitinib, an EGFR Tyrosine Kinase inhibitor, Prevents Smoke-Mediated Ciliated Airway Epithelial Cell Loss and Promotes Their Recovery. Ahmad S, ed. PLoS ONE 11:e0160216.</div>\n\n<p>Yang, Y.-X., Li, X.-L., Wang, L., Han, S.-Y., Zhang, Y.-R., Pratheeshkumar, P., Wang, X., Lu, J., Yin, Y.-Q., Sun, L.-J., et al. (2013). Anti-apoptotic proteins and catalase-dependent apoptosis resistance in nickel chloride-transformed human lung epithelial cells. Int. J. Oncol. 43, 936&ndash;946.</p>\n","biologicalOrganisationLevel":"Cellular","organTerm":{},"biologicalEvents":[{"action":"decreased","process":"epithelial cell apoptotic process","object":{}}],"id":914}
{"title":"Activation, EGFR","references":"<p>Aida, S., et al., Distribution of epidermal growth factor and epidermal growth factor receptor in human lung: immunohistochemical and immunoelectron-microscopic studies. Respiration, 1994. 61(3):161-166.</p>\n\n<p>Allahverdian, S., et al., Sialyl Lewis X modification of the epidermal growth factor receptor regulates receptor function during airway epithelial wound repair. Clin Exp Allergy, 2010. 40(4):607-618.</p>\n\n<p>Blanchet, S., et al., Fine particulate matter induces amphiregulin secretion by bronchial epithelial cells. Am J Resp Cell&nbsp;Mol Biol, 2004. 30(4):421-427.</p>\n\n<p>Burgel, P.-R. and J.A. Nadel, Epidermal growth factor receptor-mediated innate immune responses and their roles in airway diseases. Eur Resp J, 2008. 32(4):1068-1081.</p>\n\n<p>Ciardiello, F., and Tortora, G. (2008). EGFR antagonists in cancer treatment. N Engl J Med, 2008.&nbsp;358(11):1160&ndash;1174.</p>\n\n<p>Casalino-Matsuda, S.M., et al., Role of hyaluronan and reactive oxygen species in tissue kallikrein-mediated epidermal growth factor receptor activation in human airways. J Biol Chem, 2004. 279(20):21606-21616.</p>\n\n<p>Chen, H., et al., Epidermal growth factor receptor in adult retinal neurons of rat, mouse, and human. J Comp Neurol 2007. 500(2):299-310.</p>\n\n<p>de Boer, W.I., et al., Expression of epidermal growth factors and their receptors in the bronchial epithelium of subjects with chronic obstructive pulmonary disease. American Journal of Clinical Pathology, 2006. 125(2):184-192.</p>\n\n<p>Deshmukh, H.S., et al., Acrolein-activated matrix metalloproteinase 9 contributes to persistent mucin production. Am J Resp Cell Mol Biol, 2008. 38(4):446-454.</p>\n\n<p>Deshmukh, H.S., et al., Matrix metalloproteinase-14 mediates a phenotypic shift in the airways to increase mucin production. Am J Respir Crit Care Med, 2009. 180(9):834-845.</p>\n\n<p>DeYulia, G.J., et al., Hydrogen peroxide generated extracellularly by receptor&ndash;ligand interaction facilitates cell signaling. PNAS, 2005. 102(14):5044-5049.</p>\n\n<p>DeYulia, G.J. and J.M. C&aacute;rcamo, EGF receptor-ligand interaction generates extracellular hydrogen peroxide that inhibits EGFR-associated protein tyrosine phosphatases. Biochem Biophys Res Commun, 2005. 334(1):38-42.</p>\n\n<p>Goldkorn, T., et al., EGF-receptor phosphorylation and signaling are targeted by H2O2 redox stress. Am J Resp Cell Mol Biol, 1998. 19(5):786-798.</p>\n\n<p>Hackel, P.O., et al., Epidermal growth factor receptors: critical mediators of multiple receptor pathways. Curr Opin&nbsp;Cell Biol, 1999. 11(2):184-189.</p>\n\n<p>Higashiyama, S., et al., Membrane-anchored growth factors, the epidermal growth factor family: Beyond receptor ligands. Cancer Sci, 2008. 99(2):214-220.</p>\n\n<p>Jorissen, R.N., et al., Epidermal growth factor receptor: mechanisms of activation and signalling. Exp Cell Res 2003. 284(1):31&ndash;53.</p>\n\n<p>Kiley, S.C., and Chevalier, R.L., Species differences in renal Src activity direct EGF receptor regulation in life or death response to EGF. Am J. Physiol Renal Physiol, 2007.&nbsp;293(3):F895&ndash;F903.</p>\n\n<p>Kim, J.H., et al., Effects of matrix metalloproteinase inhibitor on LPS-induced goblet cell metaplasia. Am J Physiol Lung Cell Mol Physiol, 2004. 287(1):L127-L133.</p>\n\n<p>Kim, S., et al., E-cadherin promotes EGFR-mediated cell differentiation and MUC5AC mucin expression in cultured human airway epithelial cells. Am J Physiol Lung Cell Mol Physiol, 2005. 289(6):L1049-L1060.</p>\n\n<p>Kohri, K., et al., Neutrophil elastase induces mucin production by ligand-dependent epidermal growth factor receptor activation. Am J Physiol Lung Cell Mol Physiol, 2002. 283(3):L531-L540.</p>\n\n<p>Lee, Y.C., et al., 2,3,7,8-Tetrachlorodibenzo-p-dioxin&ndash;Induced MUC5AC Expression Aryl Hydrocarbon Receptor-Independent/EGFR/ERK/p38-Dependent SP1-Based Transcription. Am J Respir Cell Mol Biol, 2011. 45(2):270-276.</p>\n\n<p>Lemjabbar, H., et al., Tobacco smoke-induced lung cell proliferation mediated by tumor necrosis factor alpha-converting enzyme and amphiregulin. J Biol Chem, 2003. 278(28):26202-7.</p>\n\n<p>Marina, A., et al., Expression of Epidermal Growth Factor (EGF) and its receptors (EGFR1 and EGFR2) in chronic bronchitis. Rom J Morphol Embryol, 2011. 53(4):957-966.</p>\n\n<p>Nex&oslash;, E., and Hansen, H.F. (1985). Binding of epidermal growth factor from man, rat and mouse to the human epidermal growth factor receptor. Biochim Biophys Acta 843(1-2):101&ndash;106.</p>\n\n<p>O&rsquo;Donnell, R., et al., Expression of ErbB receptors and mucins in the airways of long term current smokers. Thorax, 2004. 59(12):1032-1040.</p>\n\n<p>Paulsen, C.E., et al., Peroxide-dependent sulfenylation of the EGFR catalytic site enhances kinase activity. Nat Chem Biol, 2011. 8(1):57-64.</p>\n\n<p>Polosa, R., et al., Expression of c-erbB receptors and ligands in human bronchial mucosa. Am J Resp Cell Mol Biol 1999. 20(5):914-923.</p>\n\n<p>Ravid, T., et al., Epidermal growth factor receptor activation under oxidative stress fails to promote c-Cbl mediated down-regulation. J Biol Chem, 2002. 277(34):31214-31219.</p>\n\n<p>Rumelhard, M., et al., Expression and role of EGFR ligands induced in airway cells by PM2.5 and its components. Eur Resp J, 2007. 30(6):1064-1073.</p>\n\n<p>Shao, M.X.G., et al., Cigarette smoke induces MUC5AC mucin overproduction via tumor necrosis factor-alpha-converting enzyme in human airway epithelial (NCI-H292) cells. Am J Physiol Lung Cell Mol Physiol, 2004. 287(2), L420&ndash;L427.</p>\n\n<p>Shao, M.X.G. and J.A. Nadel, Neutrophil Elastase Induces MUC5AC Mucin Production in Human Airway Epithelial Cells via a Cascade Involving Protein Kinase C, Reactive Oxygen Species, and TNF-&alpha;-Converting Enzyme. J Immunol, 2005. 175(6):4009-4016.</p>\n\n<p>Shim, J.J., et al., IL-13 induces mucin production by stimulating epidermal growth factor receptors and by activating neutrophils. Am J Physiol Lung Cell Mol Physiol, 2001. 280(1):L134-L140.</p>\n\n<p>Takeyama, K., et al., Oxidative stress causes mucin synthesis via transactivation of epidermal growth factor receptor: role of neutrophils. J Immunol, 2000. 164(3):1546-1552.</p>\n\n<p>Takeyama, K., et al., Activation of epidermal growth factor receptors is responsible for mucin synthesis induced by cigarette smoke. Am J Physiol Lung Cell Mol Physiol, 2001. 280(1):L165-L172.</p>\n\n<p>Truong, T.H. and K.S. Carroll, Redox regulation of EGFR signaling through cysteine oxidation. Biochemistry, 2012. 51(50):9954-9965.</p>\n\n<p>Truong, T.H., et al., Molecular basis for redox activation of epidermal growth factor receptor kinase. Cell Chem Biol 2016. 23(7):837-848.</p>\n\n<p>Val, S., et al., Fine PM induce airway MUC5AC expression through the autocrine effect of amphiregulin. Arch Toxicol, 2012. 86(12):1851-1859.</p>\n\n<p>Van Winkle, L.S., J.M. Isaac, and C.G. Plopper, Distribution of epidermal growth factor receptor and ligands during bronchiolar epithelial repair from naphthalene-induced Clara cell injury in the mouse. Am J Pathol, 1997. 151(2):443-459.</p>\n\n<p>Yoshisue, H. and K. Hasegawa, Effect of MMP/ADAM inhibitors on goblet cell hyperplasia in cultured human bronchial epithelial cells. Biosci Biotechnol Biochem, 2004. 68(10):2024-2031.</p>\n\n<p>Yu, H., et al., Regulation of Cigarette Smoke-Induced Mucin Expression by Neuregulin1&beta;/ErbB3 Signalling in Human Airway Epithelial Cells. Basic Clin Pharmacol Toxicol, 2011. 109(1):63-72.</p>\n\n<p>Yu, Q., et al., Caveolin-1 aggravates cigarette smoke extract-induced MUC5AC secretion in human airway epithelial cells. Intl J&nbsp;Mol Med, 2015. 35(5):1435-1442.</p>\n\n<p>&nbsp;</p>\n\n<p>&nbsp;</p>\n\n<p>&nbsp;</p>\n","biologicalOrganisationLevel":"Molecular","organTerm":{},"biologicalEvents":[{"action":"occurrence","process":"epidermal growth factor-activated receptor activity","object":{"name":"epidermal growth factor receptor","source":"PR","sourceId":"PR:000006933"}}],"id":941}
{"title":"Increase, Mucin production","references":"<p style=\"text-align: justify;\">Casalino-Matsuda, S., Monzon, M., Day, A., and Forteza, R. (2009). Hyaluronan fragments/CD44 mediate oxidative stress-induced MUC5B up-regulation in airway epithelium. Am J Respir Cell Mol Biol 40, 277&ndash;285.</p>\n\n<p style=\"text-align: justify;\">Dohrman, A., Miyata, S., Gallup, M., Li, J.D., Chapelin, C., Coste, A., Escudier, E., Nadel, J., and Basbaum, C. (1998). Mucin gene (MUC 2 and MUC 5AC) upregulation by Gram-positive and Gram-negative bacteria. Biochim Biophys Acta 1406, 251&ndash;259.</p>\n\n<p style=\"text-align: justify;\">Hao, Y., Kuang, Z., Jing, J., Miao, J., Mei, L.Y., Lee, R.J., Kim, S., Choe, S., Krause, D.C., and Lau, G.W. (2014). Mycoplasma pneumoniae Modulates STAT3-STAT6/EGFR-FOXA2 Signaling To Induce Overexpression of Airway Mucins. Infect Immun 82, 5246&ndash;5255.</p>\n\n<p style=\"text-align: justify;\">Hewson, C., Edbrooke, M., and Johnston, S. (2004). PMA induces the MUC5AC respiratory mucin in human bronchial epithelial cells, via PKC, EGF/TGF-alpha, Ras/Raf, MEK, ERK and Sp1-dependent mechanisms. J Mol Biol 344, 683&ndash;695.</p>\n\n<p style=\"text-align: justify;\">Lamb, D., and Reid, L. (1968). Mitotic rates, goblet cell increase and histochemical changes in mucus in rat bronchial epithelium during exposure to sulphur dioxide. J Pathol Bacteriol 96, 97&ndash;111.</p>\n\n<p style=\"text-align: justify;\">Lee, Y.C., Oslund, K.L., Thai, P., Velichko, S., Fujisawa, T., Duong, T., Denison, M.S., and Wu, R. (2011). 2,3,7,8-Tetrachlorodibenzo-p-dioxin&ndash;Induced MUC5AC Expression. Am J Respir Cell Mol Biol 45, 270&ndash;276.</p>\n\n<p style=\"text-align: justify;\">Lillehoj, E. P., Kato, K., Lu, W., &amp; Kim, K. C. (2013). Cellular and Molecular Biology of Airway Mucins. Int Rev Cell Mol Biol, <em>303</em>, 139&ndash;202.</p>\n\n<p style=\"text-align: justify;\">Nadel, J.A. (2013). Mucous hypersecretion and relationship to cough. Pulmonary Pharmacology &amp; Therapeutics<em> 26</em>, 510-513.</p>\n\n<p style=\"text-align: justify;\">Rose, M.C., and Voynow, J.A. (2006). Respiratory tract mucin genes and mucin glycoproteins in health and disease. Physiol Rev<em> 86</em>, 245-278.</p>\n\n<p style=\"text-align: justify;\">Shao, M., Nakanaga, T., and Nadel, J. (2004). Cigarette smoke induces MUC5AC mucin overproduction via tumor necrosis factor-alpha-converting enzyme in human airway epithelial (NCI-H292) cells. Am J Physiol Lung Cell Mol Physiol 287, L420&ndash;L427.</p>\n\n<p style=\"text-align: justify;\">Takeyama, K., Jung, B., Shim, J., Burgerl, P., Dao-Pick, T., Ueki, I., Protin, U., Kroschel, P., and Nadel, J. (2001). Activation of epidermal growth factor receptors is responsible for mucin synthesis induced by cigarette smoke. Am J Physiol Lung Cell Mol Physiol 280, L165&ndash;L172.</p>\n\n<p style=\"text-align: justify;\">Turner, J., and Jones, C.E. (2009). Regulation of mucin expression in respiratory diseases (Portland Press Limited).</p>\n\n<div style=\"text-align: justify;\">Wagner, J. G., Van Dyken, S. J., Wierenga, J. R., Hotchkiss, J. A., &amp; Harkema, J. R. (2003). Ozone exposure enhances endotoxin-induced mucous cell metaplasia in rat pulmonary airways. Toxicol Sci 74, 437-446.</div>\n\n<p style=\"text-align: justify;\">Yu, H., Li, Q., Zhou, X., Kolosov, V., and Perelman, J. (2011). Role of hyaluronan and CD44 in reactive oxygen species-induced mucus hypersecretion. Mol Cell Biochem 352, 65&ndash;75.</p>\n\n<p style=\"text-align: justify;\">Zhu, L., Lee, P., Lee, W., Zhao, Y., Yu, D., &amp; Chen, Y. (2009). Rhinovirus-Induced Major Airway Mucin Production Involves a Novel TLR3-EGFR&ndash;Dependent Pathway. Am J Resp Cell Mol Biol 40, 610&ndash;619.</p>\n","biologicalOrganisationLevel":"Cellular","organTerm":{"name":"lung","sourceId":"UBERON:0002048"},"biologicalEvents":[{"action":"increased","process":"gene expression","object":{"name":"mucin-5AC","source":"PR","sourceId":"PR:000031343"}},{"action":"increased","process":"secretion","object":{"name":"mucin-5AC","source":"PR","sourceId":"PR:000031343"}}],"id":962}
{"title":"Increase, Mucin production","references":"<p style=\"text-align: justify;\">Casalino-Matsuda, S., Monzon, M., Day, A., and Forteza, R. (2009). Hyaluronan fragments/CD44 mediate oxidative stress-induced MUC5B up-regulation in airway epithelium. Am J Respir Cell Mol Biol 40, 277&ndash;285.</p>\n\n<p style=\"text-align: justify;\">Dohrman, A., Miyata, S., Gallup, M., Li, J.D., Chapelin, C., Coste, A., Escudier, E., Nadel, J., and Basbaum, C. (1998). Mucin gene (MUC 2 and MUC 5AC) upregulation by Gram-positive and Gram-negative bacteria. Biochim Biophys Acta 1406, 251&ndash;259.</p>\n\n<p style=\"text-align: justify;\">Hao, Y., Kuang, Z., Jing, J., Miao, J., Mei, L.Y., Lee, R.J., Kim, S., Choe, S., Krause, D.C., and Lau, G.W. (2014). Mycoplasma pneumoniae Modulates STAT3-STAT6/EGFR-FOXA2 Signaling To Induce Overexpression of Airway Mucins. Infect Immun 82, 5246&ndash;5255.</p>\n\n<p style=\"text-align: justify;\">Hewson, C., Edbrooke, M., and Johnston, S. (2004). PMA induces the MUC5AC respiratory mucin in human bronchial epithelial cells, via PKC, EGF/TGF-alpha, Ras/Raf, MEK, ERK and Sp1-dependent mechanisms. J Mol Biol 344, 683&ndash;695.</p>\n\n<p style=\"text-align: justify;\">Lamb, D., and Reid, L. (1968). Mitotic rates, goblet cell increase and histochemical changes in mucus in rat bronchial epithelium during exposure to sulphur dioxide. J Pathol Bacteriol 96, 97&ndash;111.</p>\n\n<p style=\"text-align: justify;\">Lee, Y.C., Oslund, K.L., Thai, P., Velichko, S., Fujisawa, T., Duong, T., Denison, M.S., and Wu, R. (2011). 2,3,7,8-Tetrachlorodibenzo-p-dioxin&ndash;Induced MUC5AC Expression. Am J Respir Cell Mol Biol 45, 270&ndash;276.</p>\n\n<p style=\"text-align: justify;\">Lillehoj, E. P., Kato, K., Lu, W., &amp; Kim, K. C. (2013). Cellular and Molecular Biology of Airway Mucins. Int Rev Cell Mol Biol, <em>303</em>, 139&ndash;202.</p>\n\n<p style=\"text-align: justify;\">Nadel, J.A. (2013). Mucous hypersecretion and relationship to cough. Pulmonary Pharmacology &amp; Therapeutics<em> 26</em>, 510-513.</p>\n\n<p style=\"text-align: justify;\">Rose, M.C., and Voynow, J.A. (2006). Respiratory tract mucin genes and mucin glycoproteins in health and disease. Physiol Rev<em> 86</em>, 245-278.</p>\n\n<p style=\"text-align: justify;\">Shao, M., Nakanaga, T., and Nadel, J. (2004). Cigarette smoke induces MUC5AC mucin overproduction via tumor necrosis factor-alpha-converting enzyme in human airway epithelial (NCI-H292) cells. Am J Physiol Lung Cell Mol Physiol 287, L420&ndash;L427.</p>\n\n<p style=\"text-align: justify;\">Takeyama, K., Jung, B., Shim, J., Burgerl, P., Dao-Pick, T., Ueki, I., Protin, U., Kroschel, P., and Nadel, J. (2001). Activation of epidermal growth factor receptors is responsible for mucin synthesis induced by cigarette smoke. Am J Physiol Lung Cell Mol Physiol 280, L165&ndash;L172.</p>\n\n<p style=\"text-align: justify;\">Turner, J., and Jones, C.E. (2009). Regulation of mucin expression in respiratory diseases (Portland Press Limited).</p>\n\n<div style=\"text-align: justify;\">Wagner, J. G., Van Dyken, S. J., Wierenga, J. R., Hotchkiss, J. A., &amp; Harkema, J. R. (2003). Ozone exposure enhances endotoxin-induced mucous cell metaplasia in rat pulmonary airways. Toxicol Sci 74, 437-446.</div>\n\n<p style=\"text-align: justify;\">Yu, H., Li, Q., Zhou, X., Kolosov, V., and Perelman, J. (2011). Role of hyaluronan and CD44 in reactive oxygen species-induced mucus hypersecretion. Mol Cell Biochem 352, 65&ndash;75.</p>\n\n<p style=\"text-align: justify;\">Zhu, L., Lee, P., Lee, W., Zhao, Y., Yu, D., &amp; Chen, Y. (2009). Rhinovirus-Induced Major Airway Mucin Production Involves a Novel TLR3-EGFR&ndash;Dependent Pathway. Am J Resp Cell Mol Biol 40, 610&ndash;619.</p>\n","biologicalOrganisationLevel":"Cellular","organTerm":{"name":"lung","sourceId":"UBERON:0002048"},"biologicalEvents":[{"action":"increased","process":"gene expression","object":{"name":"mucin-5AC","source":"PR","sourceId":"PR:000031343"}},{"action":"increased","process":"secretion","object":{"name":"mucin-5AC","source":"PR","sourceId":"PR:000031343"}}],"id":962}
{"title":"Decrease, Lung function","references":"<div style=\"text-align:justify\">\n<p style=\"text-align:justify\"><span style=\"font-size:10px\"><span style=\"background-color:white\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-family:&quot;Segoe UI&quot;,sans-serif\"><span style=\"color:black\">Bates, J.H.T. (2017). CORP: Measurement of lung function in small animals. Journal of Applied Physiology. 123, 1039-1046.</span></span></span></span></span></p>\n\n<p style=\"text-align:justify\"><span style=\"font-size:10px\"><span style=\"background-color:white\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-family:&quot;Segoe UI&quot;,sans-serif\"><span style=\"color:black\">Baumgartner, K.B., Samet, J.M., Coultas, D.B., Stidley, C.A., Hunt, W.C., Colby, T.V., and J.A. Waldron (2000). Occupational and environmental risk factors for idiopathic pulmonary fibrosis: a multicenter case-control study. Collaborating Centers. American Journal of Epidemiology 152, 307-315.</span></span></span></span></span></p>\n\n<p style=\"text-align:justify\"><span style=\"font-size:10px\"><span style=\"background-color:white\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-family:&quot;Segoe UI&quot;,sans-serif\"><span style=\"color:black\">Celli, B. R. (2010). Predictors of mortality in COPD. Respiratory Medicine 104, 773-779.</span></span></span></span></span></p>\n\n<p style=\"text-align:justify\"><span style=\"font-size:10px\"><span style=\"background-color:white\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-family:&quot;Segoe UI&quot;,sans-serif\"><span style=\"color:black\">Cheresh, P., Kim, S.J., Tulasiram, S., and D.W. Kamp (2013). Oxidative stress and pulmonary fibrosis. Biochimica et Biophysica Acta, 1832, 1028&ndash;1040. </span></span></span></span></span></p>\n\n<p style=\"text-align:justify\"><span style=\"font-size:10px\"><span style=\"background-color:white\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-family:&quot;Segoe UI&quot;,sans-serif\"><span style=\"color:black\">Cosgrove, M.P. (2015). Pulmonary fibrosis and exposure to steel welding fume. Occupational Medicine (Lond) 65, 706-712.</span></span></span></span></span></p>\n\n<p style=\"text-align:justify\"><span style=\"font-size:10px\"><span style=\"background-color:white\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-family:&quot;Segoe UI&quot;,sans-serif\"><span style=\"color:black\">Cri&eacute;e, C.P., Sorichter, S., Smith, H.J., Kardos, P., Merget, R., Heise, D., Berdel, D., K&ouml;hler, D., Magnussen, H., Marek, W. and H. Mitfessel (2011). Body plethysmography&ndash;its principles and clinical use. Respiratory medicine 105, 959-971.</span></span></span></span></span></p>\n\n<p style=\"text-align:justify\"><span style=\"font-size:10px\"><span style=\"background-color:white\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-family:&quot;Segoe UI&quot;,sans-serif\"><span style=\"color:black\">Dalbey, W., Henry, M., Holmberg, R., Moneyhun, J., Schmoyer, R. and S. Lock (1987). Role of exposure parameters in toxicity of aerosolized diesel fuel in the rat. Journal of Applied Toxicology 7; 265-275.</span></span></span></span></span></p>\n\n<p style=\"text-align:justify\"><span style=\"font-size:10px\"><span style=\"background-color:white\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-family:&quot;Segoe UI&quot;,sans-serif\"><span style=\"color:black\">Dias, O.M., Baldi, B.G., Costa, A.N., C.R. Carvalho (2014). Combined pulmonary fibrosis and emphysema: an increasingly recognized condition. Jornal Brasileiro de Pneumologia 40, 304-312.&nbsp;</span></span></span></span></span></p>\n\n<p style=\"text-align:justify\"><span style=\"font-size:10px\"><span style=\"background-color:white\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-family:&quot;Segoe UI&quot;,sans-serif\"><span style=\"color:black\">Fallica, J., Das, S., Horton, M., and W. Mitzner (2011). Application of carbon monoxide diffusing capacity in the mouse lung. Journal of Applied Physiology 110, 1455&ndash;1459. </span></span></span></span></span></p>\n\n<p style=\"text-align:justify\"><span style=\"font-size:10px\"><span style=\"background-color:white\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-family:&quot;Segoe UI&quot;,sans-serif\"><span style=\"color:black\">Gorguner, M., and M. Akgun (2010). Acute inhalation injury. The Eurasian Journal of Medicine 42, 28&ndash;35. </span></span></span></span></span></p>\n\n<p style=\"text-align:justify\"><span style=\"font-size:10px\"><span style=\"background-color:white\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-family:&quot;Segoe UI&quot;,sans-serif\"><span style=\"color:black\">Graham, B.L., Brusasco, V., Burgos, F., Cooper, B.G., Jensen, R., Kendrick, A., MacIntyre, N.R., Thompson, B.R. and J. Wanger (2017). 2017 ERS/ATS standards for single-breath carbon monoxide uptake in the lung. European Respiratory Journal 49, 1600016.</span></span></span></span></span></p>\n\n<p style=\"text-align:justify\"><span style=\"font-size:10px\"><span style=\"background-color:white\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-family:&quot;Segoe UI&quot;,sans-serif\"><span style=\"color:black\">Graham, B.L., Steenbruggen, I., Miller, M.R., Barjaktarevic, I.Z., Cooper, B.G., Hall, G.L., Hallstrand, T.S., Kaminsky, D.A., McCarthy, K., McCormack, M.C. and C.E. Oropez (2019). Standardization of spirometry 2019 update. An official American Thoracic Society and European Respiratory Society technical statement. American Journal of Respiratory and Critical Care Medicine 200, e70-e88.</span></span></span></span></span></p>\n\n<p style=\"text-align:justify\"><span style=\"font-size:10px\"><span style=\"background-color:white\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-family:&quot;Segoe UI&quot;,sans-serif\"><span style=\"color:black\">Harvey, B.G., Strulovici-Barel, Y., Kaner, R.J., Sanders, A., Vincent, T.L., Mezey, J.G. and R.G. Crystal (2016). Progression to COPD in smokers with normal spirometry/low DLCO using different methods to determine normal levels. European Respiratory Journal 47, 1888-1889.</span></span></span></span></span></p>\n\n<p style=\"text-align:justify\"><span style=\"font-size:10px\"><span style=\"background-color:white\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-family:&quot;Segoe UI&quot;,sans-serif\"><span style=\"color:black\">Hert, R. and R.K. Albert (1994). Sequelae of the adult respiratory distress syndrome. Thorax 49, 8-13.</span></span></span></span></span></p>\n\n<p style=\"text-align:justify\"><span style=\"font-size:10px\"><span style=\"background-color:white\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-family:&quot;Segoe UI&quot;,sans-serif\"><span style=\"color:black\">Hoymann, H.G. (2012). Lung function measurements in rodents in safety pharmacology studies. Frontiers in Pharmacology 3, 156.</span></span></span></span></span></p>\n\n<p style=\"text-align:justify\"><span style=\"font-size:10px\"><span style=\"background-color:white\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-family:&quot;Segoe UI&quot;,sans-serif\"><span style=\"color:black\">Johnson, J. D., and W. M. Theurer (2014). A stepwise approach to the interpretation of pulmonary function tests. American Family Physician 89, 359-366.</span></span></span></span></span></p>\n\n<p style=\"text-align:justify\"><span style=\"font-size:10px\"><span style=\"background-color:white\"><span style=\"font-family:Calibri,sans-serif\">&nbsp;</span></span></span><span style=\"background-color:white; color:black; font-family:&quot;Segoe UI&quot;,sans-serif; font-size:10px\">Kandhare, A.D., Mukherjee, A., Ghosh, P. and S.L. Bodhankar (2016). Efficacy of antioxidant in idiopathic pulmonary fibrosis: A systematic review and meta-analysis. EXCLI Journal 15, 636.</span></p>\n\n<p style=\"text-align:justify\"><span style=\"background-color:white; color:black; font-family:&quot;Segoe UI&quot;,sans-serif; font-size:10px\">Lee, H. M., Liu, M. A., Barrett-Connor, E., and N. D. Wong (2014). Association of Lung Function with Coronary Heart Disease and Cardiovascular Disease Outcomes in Elderly: The Rancho Bernardo Study. Respiratory Medicine 108, 1779&ndash;1785.</span></p>\n\n<p style=\"text-align:justify\"><span style=\"background-color:white; color:black; font-family:&quot;Segoe UI&quot;,sans-serif; font-size:10px\">Lettieri, C.J., Nathan, S.D., Barnett, S.D., Ahmad, S. and A.F. Shorr (2006). Prevalence and outcomes of pulmonary arterial hypertension in advanced idiopathic pulmonary fibrosis. Chest 129, 746-752.</span></p>\n\n<p style=\"text-align:justify\"><span style=\"background-color:white; color:black; font-family:&quot;Segoe UI&quot;,sans-serif; font-size:10px\">Limjunyawong, N., Fallica, J., Ramakrishnan, A., Datta, K., Gabrielson, M., Horton, M., and W. Mitzner (2015). Phenotyping mouse pulmonary function in vivo with the lung diffusing capacity. Journal of visualized experiments: JoVE 95, e52216.</span></p>\n\n<p style=\"text-align:justify\"><span style=\"background-color:white; color:black; font-family:&quot;Segoe UI&quot;,sans-serif; font-size:10px\">Matheson, M.C., Raven, J., Johns, D.P., Abramson, M.J. and E.H. Walters (2007). Associations between reduced diffusing capacity and airflow obstruction in community-based subjects. Respiratory Medicine 101, 1730-1737.</span></p>\n\n<p style=\"text-align:justify\"><span style=\"background-color:white; color:black; font-family:&quot;Segoe UI&quot;,sans-serif; font-size:10px\">Matthay, M.A., Zemans, R.L., Zimmerman, G.A., Arabi, Y.M., Beitler, J.R., Mercat, A., Herridge, M., Randolph, A.G. and C.S. Calfee (2019). Acute respiratory distress syndrome. Nature Reviews Disease Primers 5, 1-22.</span></p>\n\n<p style=\"text-align:justify\"><span style=\"background-color:white; color:black; font-family:&quot;Segoe UI&quot;,sans-serif; font-size:10px\">McGovern, T.K., Robichaud, A., Fereydoonzad, L., Schuessler, T.F., and J.G. Martin (2013) Evaluation of respiratory system mechanics in mice using the forced oscillation technique. Journal of Visualized Experiments 75, e50172.</span></p>\n\n<p style=\"text-align:justify\"><span style=\"background-color:white; color:black; font-family:&quot;Segoe UI&quot;,sans-serif; font-size:10px\">Meltzer, E.B., and P.W. Noble (2008). Idiopathic pulmonary fibrosis. Orphanet Journal of Rare Diseases, 3, 8.</span></p>\n\n<p style=\"text-align:justify\"><span style=\"background-color:white; color:black; font-family:&quot;Segoe UI&quot;,sans-serif; font-size:10px\">Miller, K. and A. Chang (2003). Acute inhalation injury. Emergency Medicine Clinics of North America 21, 533-557.</span></p>\n\n<p style=\"text-align:justify\"><span style=\"background-color:white; color:black; font-family:&quot;Segoe UI&quot;,sans-serif; font-size:10px\">Miller, M.R., Crapo, R., Hankinson, J., Brusasco, V., Burgos, F., Casaburi, R., Coates, A., Enright, P., van der Grinten, C.M., and P. Gustafsson (2005a). General considerations for lung function testing. European Respiratory Journal 26, 153-161.</span></p>\n\n<p style=\"text-align:justify\"><span style=\"font-size:10px\"><span style=\"background-color:white\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-family:&quot;Segoe UI&quot;,sans-serif\"><span style=\"color:black\">Miller, M.R., Hankinson, J., Brusasco, V., Burgos, F., Casaburi, R., Coates, A., Crapo, R., Enright, P., van der Grinten, C., and P. Gustafsson (2005b). Standardisation of spirometry. European Respiratory Journal 26, 319-338.</span></span></span></span></span></p>\n\n<p style=\"text-align:justify\"><span style=\"font-size:10px\"><span style=\"background-color:white\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-family:&quot;Segoe UI&quot;,sans-serif\"><span style=\"color:black\">Moore, V.C. (2012). Spirometry: step by step. Breathe 8, 232-240.</span></span></span></span></span></p>\n\n<p style=\"text-align:justify\"><span style=\"font-size:10px\"><span style=\"background-color:white\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-family:&quot;Segoe UI&quot;,sans-serif\"><span style=\"color:black\">OECD (2018a).</span></span> <span style=\"font-family:&quot;Segoe UI&quot;,sans-serif\"><span style=\"color:black\">OECD Guidance Document on Inhalation Toxicity Studies, GD 39.</span></span></span></span></span></p>\n\n<p style=\"text-align:justify\"><span style=\"font-size:10px\"><span style=\"background-color:white\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-family:&quot;Segoe UI&quot;,sans-serif\"><span style=\"color:black\">OECD (2018b), Test No. 412: Subacute Inhalation Toxicity: 28-Day Study, OECD Guidelines for the Testing of Chemicals, Section 4, OECD Publishing, Paris, </span></span><span style=\"color:black\"><a href=\"https://doi.org/10.1787/9789264070783-en\" style=\"color:blue; text-decoration:underline\"><span style=\"font-family:&quot;Segoe UI&quot;,sans-serif\">https://doi.org/10.1787/9789264070783-en</span></a></span><span style=\"font-family:&quot;Segoe UI&quot;,sans-serif\"><span style=\"color:black\">.</span></span></span></span></span></p>\n\n<p style=\"text-align:justify\"><span style=\"font-size:10px\"><span style=\"background-color:white\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-family:&quot;Segoe UI&quot;,sans-serif\"><span style=\"color:black\">OECD (2018), Test No. 413: Subchronic Inhalation Toxicity: 90-day Study, OECD Guidelines for the Testing of Chemicals, Section 4, OECD Publishing, Paris, </span></span><span style=\"color:black\"><a href=\"https://doi.org/10.1787/9789264070806-en\" style=\"color:blue; text-decoration:underline\"><span style=\"font-family:&quot;Segoe UI&quot;,sans-serif\">https://doi.org/10.1787/9789264070806-en</span></a></span><span style=\"font-family:&quot;Segoe UI&quot;,sans-serif\"><span style=\"color:black\">.</span></span></span></span></span></p>\n\n<p style=\"text-align:justify\"><span style=\"font-size:10px\"><span style=\"background-color:white\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-family:&quot;Segoe UI&quot;,sans-serif\"><span style=\"color:black\">Park, Y., Ahn, C., and T.H. Kim (2021) Occupational and environmental risk factors of idiopathic pulmonary fibrosis: a systematic review and meta-analyses. Scientific Reports 11, 4318.</span></span></span></span></span></p>\n\n<p style=\"text-align:justify\"><span style=\"font-size:10px\"><span style=\"background-color:white\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-family:&quot;Segoe UI&quot;,sans-serif\"><span style=\"color:black\">Prada-Dacasa, P., Urpi, A., S&aacute;nchez-Benito, L., Bianchi, P., A. Quintana (2020). Measuring Breathing Patterns in Mice Using Whole-body Plethysmography. Biological Protocols 10, e3741.</span></span></span></span></span></p>\n\n<p style=\"text-align:justify\"><span style=\"font-size:10px\"><span style=\"background-color:white\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-family:&quot;Segoe UI&quot;,sans-serif\"><span style=\"color:black\">Pellegrino, R., Viegi, G., Brusasco, V., Crapo, R., Burgos, F., Casaburi, R., Coates, A., van der Grinten, C., Gustafsson, P., and J. Hankinson (2005). Interpretative strategies for lung function tests. European Respiratory Journal 26, 948-968.</span></span></span></span></span></p>\n\n<p style=\"text-align:justify\"><span style=\"font-size:10px\"><span style=\"background-color:white\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-family:&quot;Segoe UI&quot;,sans-serif\"><span style=\"color:black\">Raghu, G., Remy-Jardin, M., Myers, J.L., Richeldi, L., Ryerson, C.J., Lederer, D.J., Behr, J., Cottin, V., Danoff, S.K., Morell, F., and K.R. Flaherty (2018). Diagnosis of idiopathic pulmonary fibrosis. An official ATS/ERS/JRS/ALAT clinical practice guideline. American Journal of Respiratory and Critical Care Medicine 198, e44-e68.</span></span></span></span></span></p>\n\n<p style=\"text-align:justify\"><span style=\"font-size:10px\"><span style=\"background-color:white\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-family:&quot;Segoe UI&quot;,sans-serif\"><span style=\"color:black\">Reilly, J.P., Zhao, Z., Shashaty, M.G., Koyama, T., Christie, J.D., Lanken, P.N., Wang, C., Balmes, J.R., Matthay, M.A., Calfee, C.S. and L.B. Ware (2019). Low to moderate air pollutant exposure and acute respiratory distress syndrome after severe trauma. American Journal of Respiratory and Critical,Care Medicine 199, 62-70.</span></span></span></span></span></p>\n\n<p style=\"text-align:justify\"><span style=\"font-size:10px\"><span style=\"background-color:white\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-family:&quot;Segoe UI&quot;,sans-serif\"><span style=\"color:black\">Reinhard. C., Eder, G., Fuchs, H., Ziesenis, A., Heyder, J. and H. Schulz H (2002). Inbred strain variation in lung function. Mammalian Genome 13, 429-437.</span></span></span></span></span></p>\n\n<p style=\"text-align:justify\"><span style=\"font-size:10px\"><span style=\"background-color:white\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-family:&quot;Segoe UI&quot;,sans-serif\"><span style=\"color:black\">Seeger, W., Adir, Y., Barber&agrave;, J.A., Champion, H., Coghlan, J.G., Cottin, V., De Marco, T., Gali&egrave;, N., Ghio, S., Gibbs, S. and F.J. Martinez (2013). Pulmonary hypertension in chronic lung diseases. Journal of the American College of Cardiology 62 Suppl. 25, D109-D116.</span></span></span></span></span></p>\n\n<p><span style=\"font-size:10px\"><span style=\"background-color:white\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-family:&quot;Segoe UI&quot;,sans-serif\"><span style=\"color:black\">Sin, D. D., Wu, L., and S. P. Man (2005). The relationship between reduced lung function and cardiovascular mortality: a population-based study and a systematic review of the literature. Chest 127, 1952-1959.</span></span></span></span></span></p>\n\n<p><span style=\"font-size:10px\"><span style=\"background-color:white\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-family:&quot;Segoe UI&quot;,sans-serif\"><span style=\"color:black\">Takezawa, J., Miller, F.J. and J.J. O&#39;Neil (1980). Single-breath diffusing capacity and lung volumes in small laboratory mammals. Journal of Applied Physiology 48, 1052-1059.</span></span></span></span></span></p>\n\n<p><span style=\"font-size:10px\"><span style=\"background-color:white\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-family:&quot;Segoe UI&quot;,sans-serif\"><span style=\"color:black\">Trethewey, S. P., and G. I. Walters (2018). The Role of Occupational and Environmental Exposures in the Pathogenesis of Idiopathic Pulmonary Fibrosis: A Narrative Literature Review. Medicina (Kaunas, Lithuania) 54, 108. </span></span></span></span></span></p>\n\n<p style=\"text-align:justify\"><span style=\"font-size:10px\"><span style=\"background-color:white\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-family:&quot;Segoe UI&quot;,sans-serif\"><span style=\"color:black\">Vestbo, J., Anderson, W., Coxson, H.O., Crim, C., Dawber, F., Edwards, L., Hagan, G., Knobil, K., Lomas, D.A., MacNee, W. and E.K. Silverman (2008). Evaluation of COPD longitudinally to identify predictive surrogate end-points (ECLIPSE). Eur Respir J 31, 869-73.</span></span></span></span></span></p>\n\n<p style=\"text-align:justify\"><span style=\"font-size:10px\"><span style=\"background-color:white\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-family:&quot;Segoe UI&quot;,sans-serif\"><span style=\"color:black\">Wanger, J., Clausen, J.L., Coates, A., Pedersen, O.F., Brusasco, V., Burgos, F., Casaburi, R., Crapo, R., Enright, P., Van Der Grinten, C.P.M. and P. Gustafsson (2005). Standardisation of the measurement of lung volumes. European respiratory journal 26, 511-522.</span></span></span></span></span></p>\n\n<p style=\"text-align:justify\"><span style=\"background-color:white; font-family:&quot;Segoe UI&quot;,sans-serif; font-size:10px\"><span style=\"color:black\">Weinstock, T, and J. McCannon (2017). Pulmonary Medicine. Pulmonary Function Testing. </span></span><span style=\"background-color:white; color:black; font-family:Calibri,sans-serif; font-size:10px\"><a href=\"https://www.pulmonologyadvisor.com/home/decision-support-in-medicine/pulmonary-medicine/pulmonary-function-testing/\" style=\"color: blue; text-decoration-line: underline;\"><span style=\"font-family:&quot;Segoe UI&quot;,sans-serif\">https://www.pulmonologyadvisor.com/home/decision-support-in-medicine/pulmonary-medicine/pulmonary-function-testing/</span></a></span><span style=\"background-color:white; font-family:&quot;Segoe UI&quot;,sans-serif; font-size:10px\"><span style=\"color:black\"> (accessed 22 March 2021). Decision Support in Medicine, LLC.</span></span></p>\n\n<p style=\"text-align:justify\"><span style=\"background-color:white; color:black; font-family:&quot;Segoe UI&quot;,sans-serif; font-size:10px\">Wise, R. A. (2006). The value of forced expiratory volume in 1 second decline in the assessment of chronic obstructive pulmonary disease progression. American Journal of Medicine 119, 4-11.</span></p>\n</div>\n\n<p>&nbsp;</p>\n","biologicalOrganisationLevel":"Individual","organTerm":{},"biologicalEvents":[{"action":"decreased","process":"respiratory function trait","object":{}}],"id":1250}
{"title":"Chronic, Mucus hypersecretion","references":"<p style=\"text-align: justify;\">Allinson, J.P., Hardy, R., Donaldson, G.C., Shaheen, S.O., Kuh, D., and Wedzicha, J.A. (2016). The presence of chronic mucus hypersecretion across adult life in relation to chronic obstructive pulmonary disease development. Am J Resp Crit Care Med<em> </em>193, 662-672.</p>\n\n<p style=\"text-align: justify;\">Chen, P., Deng, Z., Wang, T., Chen, L., Li, J., Feng, Y., ... &amp; Ou, X. (2013). The potential interaction of MARCKS-related peptide and diltiazem on acrolin-induced airway mucus hypersecretion in rats. Intl Immunopharmacol 17, 625-632.</p>\n\n<p>Deshmukh, H.S., Shaver, C., Case, L.M., Dietsch, M., Wesselkamper, S.C., Hardie, W.D., Korfhagen, T.R., Corradi, M., Nadel, J.A., and Borchers, M.T. (2008). Acrolein-activated matrix metalloproteinase 9 contributes to persistent mucin production. AmJ Resp Cell Mol Biol 38, 446-454.</p>\n\n<div style=\"text-align: justify;\">Evans, C. M., Kim, K., Tuvim, M. J., &amp; Dickey, B. F. (2009). Mucus hypersecretion in asthma: causes and effects. Curr Opin Pulm Med 15, 4&ndash;11.</div>\n\n<div style=\"text-align: justify;\">&nbsp;</div>\n\n<div style=\"text-align: justify;\">\n<div>Liu, Z., Geng, W., Jiang, C., Zhao, S., Liu, Y., Zhang, Y., ... &amp; Si, Y. (2017). Hydrogen-rich saline inhibits tobacco smoke-induced chronic obstructive pulmonary disease by alleviating airway inflammation and mucus hypersecretion in rats. Exp Biol Med 242, 1534-1541.</div>\n\n<div>\n<p>Shim, J.J., Dabbagh, K., Ueki, I.F., Dao-Pick, T., Burgel, P.R., Takeyama, K., Tam, D.C.W., and Nadel, J.A. (2001). IL-13 induces mucin production by stimulating epidermal growth factor receptors and by activating neutrophils. Am J Physiol&nbsp;Lung Cell Mol Physiol 280, L134-140.</p>\n</div>\n</div>\n\n<div style=\"text-align: justify;\">Singer, M., Martin, L. D., Vargaftig, B. B., Park, J., Gruber, A. D., Li, Y., &amp; Adler, K. B. (2004). A MARCKS-related peptide blocks mucus hypersecretion in a mouse model of asthma. Nature Med 10, 193.</div>\n\n<div style=\"text-align: justify;\">&nbsp;</div>\n\n<div style=\"text-align: justify;\">\n<p>Song, L., Tang, H., Liu, D., Song, J., Wu, Y., Qu, S., and Li, Y. (2016). The chronic and short-term effects of gefinitib on airway remodeling and inflammation in a mouse model of asthma. Cell Physiol Biochem<em> </em>38, 194-206.</p>\n</div>\n\n<p style=\"text-align: justify;\">Vestbo, J. (2002). Epidemiological studies in mucus hypersecretion. Novartis Found Symp 248, 3-12; discussion: 12-19, 277-282.</p>\n\n<div>Vlahos, R., &amp; Bozinovski, S. (2015). Preclinical murine models of chronic obstructive pulmonary disease. Eur J Pharmacol&nbsp;759, 265-271.</div>\n\n<p>Wang, H., Yang, T., Wang, T., Hao, N., Shen, Y., Wu, Y., ... &amp; Wen, F. (2018). Phloretin attenuates mucus hypersecretion and airway inflammation induced by cigarette smoke. Intl Immunopharmacol 55, 112-119.</p>\n\n<div>Yang, T., Luo, F., Shen, Y., An, J., Li, X., Liu, X., ... &amp; Wang, T. (2012). Quercetin attenuates airway inflammation and mucus production induced by cigarette smoke in rats. Intl Immunopharmacol 13, 73-81.</div>\n","biologicalOrganisationLevel":"Tissue","organTerm":{},"biologicalEvents":[{"action":"occurrence","process":"mucus secretion","object":{}}],"id":1251}
{"title":"KE1 : S-Glutathionylation, eNOS","references":"<p>Chen, C.-A., Wang, T.-Y., Varadharaj, S., Reyes, L.A., Hemann, C., Talukder, M.A.H., Chen, Y.-R., Druhan, L.J., and Zweier, J.L. (2010). S-glutathionylation uncouples eNOS and regulates its cellular and vascular function. Nature 468, 1115&ndash;1118.</p>\n\n<p>Chen CA,&nbsp;Lin CH,&nbsp;Druhan LJ,&nbsp;Wang TY,&nbsp;Chen YR,&nbsp;Zweier JL. &nbsp;Superoxide induces endothelial nitric-oxide synthase protein thiyl radical formation, a novel mechanism regulating&nbsp;eNOS&nbsp;function and coupling. &nbsp;J Biol Chem.&nbsp;2011 286(33):29098-107.</p>\n\n<p>De Pascali, F., Hemann, C., Samons, K., Chen, C.-A., and Zweier, J.L. (2014). Hypoxia and reoxygenation induce endothelial nitric oxide synthase uncoupling in endothelial cells through tetrahydrobiopterin depletion and S-glutathionylation. Biochemistry (Mosc.) 53, 3679&ndash;3688.</p>\n\n<p>Du, Y., Navab, M., Shen, M., Hill, J., Pakbin, P., Sioutas, C., Hsiai, T.K., and Li, R. (2013). Ambient ultrafine particles reduce endothelial nitric oxide production via S-glutathionylation of eNOS. Biochem. Biophys. Res. Commun. 436, 462&ndash;466.</p>\n\n<p>Pastore, A., and Piemonte, F. (2013). Protein glutathionylation in cardiovascular diseases. Int. J. Mol. Sci. 14, 20845&ndash;20876.</p>\n\n<p>Schuppe I, Mold&eacute;us P, and Cotgreave IA. Protein-specific S-thiolation in human endothelial cells during oxidative stress. (1992) Biochem. Pharmacol. 44: 1757&ndash;1764.</p>\n","biologicalOrganisationLevel":"Molecular","organTerm":{},"biologicalEvents":[{"action":"increased","process":"protein glutathionylation","object":{"name":"nitric oxide synthase, endothelial","source":"PR","sourceId":"PR:000011328"}},{"action":"increased","process":"protein glutathionylation","object":{"name":"cysteine residue","source":"CHEBI","sourceId":"CHEBI:32460"}}],"keyEventStressors":["Reactive oxygen species"],"id":927}
{"title":"KE1 : S-Glutathionylation, eNOS","references":"<p>Chen, C.-A., Wang, T.-Y., Varadharaj, S., Reyes, L.A., Hemann, C., Talukder, M.A.H., Chen, Y.-R., Druhan, L.J., and Zweier, J.L. (2010). S-glutathionylation uncouples eNOS and regulates its cellular and vascular function. Nature 468, 1115&ndash;1118.</p>\n\n<p>Chen CA,&nbsp;Lin CH,&nbsp;Druhan LJ,&nbsp;Wang TY,&nbsp;Chen YR,&nbsp;Zweier JL. &nbsp;Superoxide induces endothelial nitric-oxide synthase protein thiyl radical formation, a novel mechanism regulating&nbsp;eNOS&nbsp;function and coupling. &nbsp;J Biol Chem.&nbsp;2011 286(33):29098-107.</p>\n\n<p>De Pascali, F., Hemann, C., Samons, K., Chen, C.-A., and Zweier, J.L. (2014). Hypoxia and reoxygenation induce endothelial nitric oxide synthase uncoupling in endothelial cells through tetrahydrobiopterin depletion and S-glutathionylation. Biochemistry (Mosc.) 53, 3679&ndash;3688.</p>\n\n<p>Du, Y., Navab, M., Shen, M., Hill, J., Pakbin, P., Sioutas, C., Hsiai, T.K., and Li, R. (2013). Ambient ultrafine particles reduce endothelial nitric oxide production via S-glutathionylation of eNOS. Biochem. Biophys. Res. Commun. 436, 462&ndash;466.</p>\n\n<p>Pastore, A., and Piemonte, F. (2013). Protein glutathionylation in cardiovascular diseases. Int. J. Mol. Sci. 14, 20845&ndash;20876.</p>\n\n<p>Schuppe I, Mold&eacute;us P, and Cotgreave IA. Protein-specific S-thiolation in human endothelial cells during oxidative stress. (1992) Biochem. Pharmacol. 44: 1757&ndash;1764.</p>\n","biologicalOrganisationLevel":"Molecular","organTerm":{},"biologicalEvents":[{"action":"increased","process":"protein glutathionylation","object":{"name":"nitric oxide synthase, endothelial","source":"PR","sourceId":"PR:000011328"}},{"action":"increased","process":"protein glutathionylation","object":{"name":"cysteine residue","source":"CHEBI","sourceId":"CHEBI:32460"}}],"keyEventStressors":["Reactive oxygen species"],"id":927}
{"title":"KE2 : Decrease, GTPCH-1","references":"<p>AbdelGhany, T., Ismail, R., Elmahdy, M., Mansoor F, Zweier J, Lowe, F., and Zweier, JL. (2017). Cigarette Smoke Constituents Cause Endothelial Nitric Oxide Synthase Dysfunction and Uncoupling due to Depletion of Tetrahydrobiopterin with Degradation of GTP Cyclohydrolase.&nbsp;&nbsp;Nitric Oxide&nbsp;(Under review).</p>\n\n<p>Belik J,&nbsp;McIntyre BA,&nbsp;Enomoto M,&nbsp;Pan J,&nbsp;Grasemann H,&nbsp;Vasquez-Vivar J. &nbsp;Pulmonary hypertension in the newborn GTP cyclohydrolase I-deficient mouse. &nbsp;Free Radic Biol Med.&nbsp;2011, 51(12):2227-33.</p>\n\n<p>Cervantes-P&eacute;rez, L.G., Ibarra-Lara, M. de la L., Escalante, B., Del Valle-Mondrag&oacute;n, L., Vargas-Robles, H., P&eacute;rez-Severiano, F., Pastel&iacute;n, G., and S&aacute;nchez-Mendoza, M.A. (2012). Endothelial nitric oxide synthase impairment is restored by clofibrate treatment in an animal model of hypertension. Eur. J. Pharmacol. 685, 108&ndash;115.</p>\n\n<p>Chen, W., Li, L., Brod, T., Saeed, O., Thabet, S., Jansen, T., Dikalov, S., Weyand, C., Goronzy, J., and Harrison, D.G. (2011). Role of increased guanosine triphosphate cyclohydrolase-1 expression and tetrahydrobiopterin levels upon T cell activation. J. Biol. Chem. 286, 13846&ndash;13851.</p>\n\n<p>Jayaram, R., Goodfellow, N., Zhang, M.H., Reilly, S., Crabtree, M., De Silva, R., Sayeed, R., and Casadei, B. (2015). Molecular mechanisms of myocardial nitroso-redox imbalance during on-pump cardiac surgery. Lancet Lond. Engl. 385 Suppl 1, S49.</p>\n\n<p>Khoo JP, Zhao L, Alp NJ, Bendall JK, Nicoli T, Rockett K, et al. Pivotal role for endothelial tetrahydrobiopterin in pulmonary hypertension.&nbsp;Circulation.&nbsp;2005;111:2126&ndash;33</p>\n\n<p>Nandi M, Miller A, Stidwill R, Jacques TS, Lam AA, Haworth S, et al. Pulmonary hypertension in a GTP-cyclohydrolase 1-deficient mouse.&nbsp;Circulation.&nbsp;2005;111:2086&ndash;90</p>\n\n<p>Wang, S., Xu, J., Song, P., Wu, Y., Zhang, J., Chul Choi, H., and Zou, M.-H. (2008). Acute inhibition of guanosine triphosphate cyclohydrolase 1 uncouples endothelial nitric oxide synthase and elevates blood pressure. Hypertension 52, 484&ndash;490.</p>\n\n<p>Zhao, Y., Wu, J., Zhu, H., Song, P., and Zou, M.-H. (2013). Peroxynitrite-dependent zinc release and inactivation of guanosine 5&rsquo;-triphosphate cyclohydrolase 1 instigate its ubiquitination in diabetes. Diabetes 62, 4247&ndash;4256.</p>\n","biologicalOrganisationLevel":"Cellular","organTerm":{},"biologicalEvents":[{"action":"decreased","process":"proteasome complex disassembly","object":{"name":"GTP cyclohydrolase 1","source":"PR","sourceId":"PR:000007893"}}],"id":935}
{"title":"KE3 : Decrease, Tetrahydrobiopterin","references":"<p>AbdelGhany, T., Ismail, R., Elmahdy, M., Mansoor F, Zweier J, Lowe, F., and Zweier, JL. (2017). Cigarette Smoke Constituents Cause Endothelial Nitric Oxide Synthase Dysfunction and Uncoupling due to Depletion of Tetrahydrobiopterin with Degradation of GTP Cyclohydrolase.&nbsp;&nbsp;Nitric Oxide&nbsp;(Under review).</p>\n\n<p>Adlam, D., Herring, N., Douglas, G., De Bono, J.P., Li, D., Danson, E.J., Tatham, A., Lu, C.-J., Jennings, K.A., Cragg, S.J., et al. (2012). Regulation of &beta;-adrenergic control of heart rate by GTP-cyclohydrolase 1 (GCH1) and tetrahydrobiopterin. Cardiovasc. Res. 93, 694&ndash;701.</p>\n\n<p>Carnicer, R., Hale, A.B., Suffredini, S., Liu, X., Reilly, S., Zhang, M.H., Surdo, N.C., Bendall, J.K., Crabtree, M.J., Lim, G.B.S., et al. (2012). Cardiomyocyte GTP cyclohydrolase 1 and tetrahydrobiopterin increase NOS1 activity and accelerate myocardial relaxation. Circ. Res. 111, 718&ndash;727.</p>\n\n<p>Cervantes-P&eacute;rez, L.G., Ibarra-Lara, M. de la L., Escalante, B., Del Valle-Mondrag&oacute;n, L., Vargas-Robles, H., P&eacute;rez-Severiano, F., Pastel&iacute;n, G., and S&aacute;nchez-Mendoza, M.A. (2012). Endothelial nitric oxide synthase impairment is restored by clofibrate treatment in an animal model of hypertension. Eur. J. Pharmacol. 685, 108&ndash;115.</p>\n\n<p>Chen, W., Li, L., Brod, T., Saeed, O., Thabet, S., Jansen, T., Dikalov, S., Weyand, C., Goronzy, J., and Harrison, D.G. (2011). Role of increased guanosine triphosphate cyclohydrolase-1 expression and tetrahydrobiopterin levels upon T cell activation. J. Biol. Chem. 286, 13846&ndash;13851.</p>\n\n<p>Crabtree, M.J., Tatham, A.L., Al-Wakeel, Y., Warrick, N., Hale, A.B., Cai, S., Channon, K.M., and Alp, N.J. (2009). Quantitative regulation of intracellular endothelial nitric-oxide synthase (eNOS) coupling by both tetrahydrobiopterin-eNOS stoichiometry and biopterin redox status: insights from cells with tet-regulated GTP cyclohydrolase I expression. J. Biol. Chem. 284, 1136&ndash;1144.</p>\n\n<p>Chuaiphichai, S., McNeill, E., Douglas, G., Crabtree, M.J., Bendall, J.K., Hale, A.B., Alp, N.J., and Channon, K.M. (2014). Cell-autonomous role of endothelial GTP cyclohydrolase 1 and tetrahydrobiopterin in blood pressure regulation. Hypertension 64, 530&ndash;540.</p>\n\n<p>Howells, D.W., Smith, I., and Hyland, K. (1986). Estimation of tetrahydrobiopterin and other pterins in cerebrospinal fluid using reversed-phase high-performance liquid chromatography with electrochemical and fluorescence detection. J. Chromatogr. 381, 285&ndash;294.</p>\n\n<p>Jayaram, R., Goodfellow, N., Zhang, M.H., Reilly, S., Crabtree, M., De Silva, R., Sayeed, R., and Casadei, B. (2015). Molecular mechanisms of myocardial nitroso-redox imbalance during on-pump cardiac surgery. Lancet Lond. Engl. 385 Suppl 1, S49.</p>\n\n<p>Tatham, A.L., Crabtree, M.J., Warrick, N., Cai, S., Alp, N.J., and Channon, K.M. (2009). GTP cyclohydrolase I expression, protein, and activity determine intracellular tetrahydrobiopterin levels, independent of GTP cyclohydrolase feedback regulatory protein expression. J. Biol. Chem. 284, 13660&ndash;13668.</p>\n\n<p>Wang, Q., Yang, M., Xu, H., and Yu, J. (2014). Tetrahydrobiopterin improves endothelial function in cardiovascular disease: a systematic review. Evid.-Based Complement. Altern. Med. ECAM 2014, 850312.</p>\n\n<p>Whitsett, J., Picklo, M.J., and Vasquez-Vivar, J. (2007). 4-Hydroxy-2-nonenal increases superoxide anion radical in endothelial cells via stimulated GTP cyclohydrolase proteasomal degradation. Arterioscler. Thromb. Vasc. Biol. 27, 2340&ndash;2347.</p>\n\n<p>Zhao Y,&nbsp;Cao J,&nbsp;Chen YS,&nbsp;Zhu Y,&nbsp;Patrick C,&nbsp;Chien B,&nbsp;Cheng A,&nbsp;Foehr ED. &nbsp;Detection of tetrahydrobiopterin by LC-MS/MS in plasma from multiple species. &nbsp;Bioanalysis.&nbsp;2009;1(5):895-903.</p>\n\n<p>&nbsp;</p>\n\n<p>&nbsp;</p>\n","biologicalOrganisationLevel":"Cellular","organTerm":{},"biologicalEvents":[{"action":"decreased","process":"biosynthetic process","object":{"name":"5,6,7,8-tetrahydrobiopterin","source":"CHEBI","sourceId":"CHEBI:15372"}}],"keyEventStressors":["Reactive oxygen species"],"id":934}
{"title":"KE4 : Uncoupling, eNOS","references":"<p>de Bono, J.P., Warrick, N., Bendall, J.K., Channon, K.M., and Alp, N.J. (2007). Radiochemical HPLC detection of arginine metabolism: Measurement of nitric oxide synthesis and arginase activity in vascular tissue. Nitric Oxide 16, 1&ndash;9.</p>\n\n<p>Chen, X., Xu, J., Feng, Z., Fan, M., Han, J., and Yang, Z. (2010). Simvastatin combined with nifedipine enhances endothelial cell protection by inhibiting ROS generation and activating Akt phosphorylation. Acta Pharmacol. Sin. 31, 813&ndash;820.</p>\n\n<p>Crabtree, M.J., Tatham, A.L., Al-Wakeel, Y., Warrick, N., Hale, A.B., Cai, S., Channon, K.M., and Alp, N.J. (2009). Quantitative regulation of intracellular endothelial nitric-oxide synthase (eNOS) coupling by both tetrahydrobiopterin-eNOS stoichiometry and biopterin redox status: insights from cells with tet-regulated GTP cyclohydrolase I expression. J. Biol. Chem. 284, 1136&ndash;1144.</p>\n\n<p>De Pascali, F., Hemann, C., Samons, K., Chen, C.-A., and Zweier, J.L. (2014). Hypoxia and reoxygenation induce endothelial nitric oxide synthase uncoupling in endothelial cells through tetrahydrobiopterin depletion and S-glutathionylation. Biochemistry (Mosc.) 53, 3679&ndash;3688.</p>\n\n<p>Du, Y., Navab, M., Shen, M., Hill, J., Pakbin, P., Sioutas, C., Hsiai, T.K., and Li, R. (2013). Ambient ultrafine particles reduce endothelial nitric oxide production via S-glutathionylation of eNOS. Biochem. Biophys. Res. Commun. 436, 462&ndash;466.</p>\n\n<p>Dumitrescu, C., Biondi, R., Xia, Y., Cardounel, A.J., Druhan, L.J., Ambrosio, G., and Zweier, J.L. (2007). Myocardial ischemia results in tetrahydrobiopterin (BH4) oxidation with impaired endothelial function ameliorated by BH4. Proc. Natl. Acad. Sci. U. S. A. 104, 15081&ndash;15086.</p>\n\n<p>Fink, B., Laude, K., McCann, L., Doughan, A., Harrison, D.G., and Dikalov, S. (2004). Detection of intracellular superoxide formation in endothelial cells and intact tissues using dihydroethidium and an HPLC-based assay. Am. J. Physiol. Cell Physiol. 287, C895&ndash;C902.</p>\n\n<p>F&ouml;rstermann, U., and M&uuml;nzel, T. (2006). Endothelial nitric oxide synthase in vascular disease: from marvel to menace. Circulation 113, 1708&ndash;1714.</p>\n\n<p>Itoh, Y., Ma, F.H., Hoshi, H., Oka, M., Noda, K., Ukai, Y., Kojima, H., Nagano, T., and Toda, N. (2000). Determination and bioimaging method for nitric oxide in biological specimens by diaminofluorescein fluorometry. Anal. Biochem. 287, 203&ndash;209.</p>\n\n<p>Jayaram, R., Goodfellow, N., Zhang, M.H., Reilly, S., Crabtree, M., De Silva, R., Sayeed, R., and Casadei, B. (2015). Molecular mechanisms of myocardial nitroso-redox imbalance during on-pump cardiac surgery. Lancet Lond. Engl. 385 Suppl 1, S49.</p>\n\n<p>M&uuml;nzel, T., Afanas&rsquo;ev, I.B., Kleschyov, A.L., and Harrison, D.G. (2002). Detection of Superoxide in Vascular Tissue. Arterioscler. Thromb. Vasc. Biol. 22, 1761&ndash;1768.</p>\n\n<p>Nagata, N., Momose, K., and Ishida, Y. (1999). Inhibitory effects of catecholamines and anti-oxidants on the fluorescence reaction of 4,5-diaminofluorescein, DAF-2, a novel indicator of nitric oxide. J. Biochem. (Tokyo) 125, 658&ndash;661.</p>\n\n<p>Qiu, W., Kass, D.A., Hu, Q., and Ziegelstein, R.C. (2001). Determinants of shear stress-stimulated endothelial nitric oxide production assessed in real-time by 4,5-diaminofluorescein fluorescence. Biochem. Biophys. Res. Commun. 286, 328&ndash;335.</p>\n\n<p>Roubaud, V., Sankarapandi, S., Kuppusamy, P., Tordo, P., and Zweier, J.L. (1997). Quantitative measurement of superoxide generation using the spin trap 5-(diethoxyphosphoryl)-5-methyl-1-pyrroline-N-oxide. Anal. Biochem. 247, 404&ndash;411.</p>\n\n<p>Tarpey, M.M., White, C.R., Suarez, E., Richardson, G., Radi, R., and Freeman, B.A. (1999). Chemiluminescent Detection of Oxidants in Vascular Tissue Lucigenin But Not Coelenterazine Enhances Superoxide Formation. Circ. Res. 84, 1203&ndash;1211.</p>\n\n<p>Xia, Y., Cardounel, A.J., Vanin, A.F., and Zweier, J.L. (2000). Electron paramagnetic resonance spectroscopy with N-methyl-D-glucamine dithiocarbamate iron complexes distinguishes nitric oxide and nitroxyl anion in a redox-dependent manner: applications in identifying nitrogen monoxide products from nitric oxide synthase. Free Radic. Biol. Med. 29, 793&ndash;797.</p>\n\n<p>Zhao, H., Kalivendi, S., Zhang, H., Joseph, J., Nithipatikom, K., V&aacute;squez-Vivar, J., and Kalyanaraman, B. (2003). Superoxide reacts with hydroethidine but forms a fluorescent product that is distinctly different from ethidium: potential implications in intracellular fluorescence detection of superoxide. Free Radic. Biol. Med. 34, 1359&ndash;1368.</p>\n","biologicalOrganisationLevel":"Cellular","organTerm":{},"biologicalEvents":[{"action":"functional change","object":{"name":"nitric oxide synthase, endothelial","source":"PR","sourceId":"PR:000011328"}}],"id":932}
{"title":"KE6 : Depletion, Nitric Oxide","references":"<p>de Bono, J.P., Warrick, N., Bendall, J.K., Channon, K.M., and Alp, N.J. (2007). Radiochemical HPLC detection of arginine metabolism: Measurement of nitric oxide synthesis and arginase activity in vascular tissue. Nitric Oxide 16, 1&ndash;9.</p>\n\n<p>Chen, X., Xu, J., Feng, Z., Fan, M., Han, J., and Yang, Z. (2010). Simvastatin combined with nifedipine enhances endothelial cell protection by inhibiting ROS generation and activating Akt phosphorylation. Acta Pharmacol. Sin. 31, 813&ndash;820.</p>\n\n<p>Crabtree, M.J., Tatham, A.L., Al-Wakeel, Y., Warrick, N., Hale, A.B., Cai, S., Channon, K.M., and Alp, N.J. (2009). Quantitative regulation of intracellular endothelial nitric-oxide synthase (eNOS) coupling by both tetrahydrobiopterin-eNOS stoichiometry and biopterin redox status: insights from cells with tet-regulated GTP cyclohydrolase I expression. J. Biol. Chem. 284, 1136&ndash;1144.</p>\n\n<p>De Pascali, F., Hemann, C., Samons, K., Chen, C.-A., and Zweier, J.L. (2014). Hypoxia and reoxygenation induce endothelial nitric oxide synthase uncoupling in endothelial cells through tetrahydrobiopterin depletion and S-glutathionylation. Biochemistry (Mosc.) 53, 3679&ndash;3688.</p>\n\n<p>Du, Y., Navab, M., Shen, M., Hill, J., Pakbin, P., Sioutas, C., Hsiai, T.K., and Li, R. (2013). Ambient ultrafine particles reduce endothelial nitric oxide production via S-glutathionylation of eNOS. Biochem. Biophys. Res. Commun. 436, 462&ndash;466.</p>\n\n<p>Dumitrescu, C., Biondi, R., Xia, Y., Cardounel, A.J., Druhan, L.J., Ambrosio, G., and Zweier, J.L. (2007). Myocardial ischemia results in tetrahydrobiopterin (BH4) oxidation with impaired endothelial function ameliorated by BH4. Proc. Natl. Acad. Sci. U. S. A. 104, 15081&ndash;15086.</p>\n\n<p>Itoh, Y., Ma, F.H., Hoshi, H., Oka, M., Noda, K., Ukai, Y., Kojima, H., Nagano, T., and Toda, N. (2000). Determination and bioimaging method for nitric oxide in biological specimens by diaminofluorescein fluorometry. Anal. Biochem. 287, 203&ndash;209.</p>\n\n<p>Jayaram, R., Goodfellow, N., Zhang, M.H., Reilly, S., Crabtree, M., De Silva, R., Sayeed, R., and Casadei, B. (2015). Molecular mechanisms of myocardial nitroso-redox imbalance during on-pump cardiac surgery. Lancet Lond. Engl. 385 Suppl 1, S49.</p>\n\n<p>Luo, Z., Fujio, Y., Kureishi, Y., Rudic, R.D., Daumerie, G., Fulton, D., Sessa, W.C., and Walsh, K. (2000). Acute modulation of endothelial Akt/PKB activity alters nitric oxide&ndash;dependent vasomotor activity in vivo. J. Clin. Invest. 106, 493&ndash;499.</p>\n\n<p>Nagata, N., Momose, K., and Ishida, Y. (1999). Inhibitory effects of catecholamines and anti-oxidants on the fluorescence reaction of 4,5-diaminofluorescein, DAF-2, a novel indicator of nitric oxide. J. Biochem. (Tokyo) 125, 658&ndash;661.</p>\n\n<p>Qiu, W., Kass, D.A., Hu, Q., and Ziegelstein, R.C. (2001). Determinants of shear stress-stimulated endothelial nitric oxide production assessed in real-time by 4,5-diaminofluorescein fluorescence. Biochem. Biophys. Res. Commun. 286, 328&ndash;335.</p>\n\n<p>Xia, Y., Cardounel, A.J., Vanin, A.F., and Zweier, J.L. (2000). Electron paramagnetic resonance spectroscopy with N-methyl-D-glucamine dithiocarbamate iron complexes distinguishes nitric oxide and nitroxyl anion in a redox-dependent manner: applications in identifying nitrogen monoxide products from nitric oxide synthase. Free Radic. Biol. Med. 29, 793&ndash;797.</p>\n","biologicalOrganisationLevel":"Cellular","organTerm":{"name":"blood","sourceId":"UBERON:0000178"},"biologicalEvents":[{"action":"decreased","process":"nitric oxide biosynthetic process","object":{"name":"nitric oxide","source":"CHEBI","sourceId":"CHEBI:16480"}}],"keyEventStressors":["Reactive oxygen species"],"id":933}
{"title":"KE7 : Impaired, Vasodilation","references":"<p>Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery</p>\n\n<p>Corretti&nbsp;MC, Anderson&nbsp;TJ, Benjamin&nbsp;EJ, Celermajer D, Charbonneau F, Creager MA,&nbsp;Deanfield J,&nbsp;Drexler H, Gerhard-Herman M, Herrington D, Vallance P, Vita J, Vogel R. &nbsp;Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery. &nbsp;Journal of the American College of Cardiology,&nbsp;2002,&nbsp;39&nbsp;(2)&nbsp;257-265</p>\n\n<p>Durand, M.J., and Gutterman, D.D. (2013). Diversity in mechanisms of endothelium-dependent vasodilation in health and disease. Microcirc. N. Y. N 1994 20, 239&ndash;247.</p>\n\n<p>Raitakari, O.T., and Celermajer, D.S. (2000). Flow-mediated dilatation. Br. J. Clin. Pharmacol. 50, 397&ndash;404.</p>\n\n<p>Siddiqui, A. (2011). Effects of Vasodilation and Arterial Resistance on Cardiac Output. J. Clin. Exp. Cardiol. 02.</p>\n\n<p>Silva, B.R., Pernomian, L., and Bendhack, L.M. (2012). Contribution of oxidative stress to endothelial dysfunction in hypertension. Front. Physiol. 3, 441.</p>\n","biologicalOrganisationLevel":"Organ","organTerm":{"name":"circulatory system","sourceId":"UBERON:0001009"},"biologicalEvents":[{"action":"abnormal","process":"vasodilation","object":{"name":"blood vessel","source":"UBERON","sourceId":"UBERON:0001981"}}],"id":937}
{"title":"KE8 : Increase, Vascular Resistance","references":"<p>Siddiqui, A. (2011). Effects of Vasodilation and Arterial Resistance on Cardiac Output. J. Clin. Exp. Cardiol. 02.</p>\n\n<p>Dikalova A,&nbsp;Aschner JL,&nbsp;Kaplowitz MR,&nbsp;Summar M,&nbsp;Fike CD. &nbsp;Tetrahydrobiopterin oral therapy recouples&nbsp;eNOS&nbsp;and ameliorates chronic hypoxia-induced pulmonary hypertension in newborn pigs. &nbsp;Am J Physiol Lung Cell Mol Physiol.&nbsp;2016, 1;311(4):L743-L753.</p>\n\n<p>&nbsp;</p>\n\n<p>&nbsp;</p>\n","biologicalOrganisationLevel":"Organ","organTerm":{"name":"circulatory system","sourceId":"UBERON:0001009"},"biologicalEvents":[{"action":"increased","process":"increased systemic vascular resistance","object":{}}],"id":951}
{"title":"Hypertension","references":"<p>Durand, M.J., and Gutterman, D.D. (2013). Diversity in mechanisms of endothelium-dependent vasodilation in health and disease. Microcirc. N. Y. N 1994 20, 239&ndash;247.</p>\n\n<p>Kizhakekuttu, T.J., and Widlansky, M.E. (2010). Natural antioxidants and hypertension: promise and challenges. Cardiovasc. Ther. 28, e20&ndash;e32.</p>\n\n<p>Leong, X.-F., Ng, C.-Y., Jaarin, K., Leong, X.-F., Ng, C.-Y., and Jaarin, K. (2015). Animal Models in Cardiovascular Research: Hypertension and Atherosclerosis, Animal Models in Cardiovascular Research: Hypertension and Atherosclerosis. BioMed Res. Int. BioMed Res. Int. 2015, 2015, e528757.</p>\n\n<p>Silva, B.R., Pernomian, L., and Bendhack, L.M. (2012). Contribution of oxidative stress to endothelial dysfunction in hypertension. Front. Physiol. 3, 441.</p>\n","biologicalOrganisationLevel":"Individual","organTerm":{},"biologicalEvents":[{"action":"increased","process":"hypertension","object":{}}],"keyEventStressors":["Reactive oxygen species"],"id":952}
{"title":"KE5 : Decrease, AKT/eNOS activity","references":"<p>Atochin, D.N., Wang, A., Liu, V.W.T., Critchlow, J.D., Dantas, A.P.V., Looft-Wilson, R., Murata, T., Salomone, S., Shin, H.K., Ayata, C., et al. (2007). The phosphorylation state of eNOS modulates vascular reactivity and outcome of cerebral ischemia in vivo. J. Clin. Invest. 117, 1961&ndash;1967.</p>\n\n<p>Das A,&nbsp;Gopalakrishnan B,&nbsp;Druhan LJ,&nbsp;Wang TY,&nbsp;De Pascali F,&nbsp;Rockenbauer A,&nbsp;Racoma I,&nbsp;Varadharaj S,&nbsp;Zweier JL,&nbsp;Cardounel AJ,&nbsp;Villamena FA. &nbsp;Reversal&nbsp;of&nbsp;SIN-1-induced&nbsp;eNOS&nbsp;dysfunction&nbsp;by the&nbsp;spin&nbsp;trap,&nbsp;DMPO, in&nbsp;bovine&nbsp;aortic&nbsp;endothelialcells&nbsp;via&nbsp;eNOS&nbsp;phosphorylation. &nbsp;Br J Pharmacol.&nbsp;2014, 171(9):2321-34. doi: 10.1111/bph.12572.</p>\n\n<p>Dhar A,&nbsp;Dhar I,&nbsp;Desai KM,&nbsp;Wu L. &nbsp;Methylglyoxal&nbsp;scavengers attenuate endothelial dysfunction induced by&nbsp;methylglyoxal&nbsp;and high concentrations of glucose. &nbsp;Br J Pharmacol.&nbsp;2010, 161(8):1843-56.</p>\n\n<p>Dimmeler, S., Fleming, I., Fisslthaler, B., Hermann, C., Busse, R., and Zeiher, A.M. (1999). Activation of nitric oxide synthase in endothelial cells by Akt-dependent phosphorylation. Nature 399, 601&ndash;605.</p>\n\n<p>Fulton, D., Gratton, J.P., McCabe, T.J., Fontana, J., Fujio, Y., Walsh, K., Franke, T.F., Papapetropoulos, A., and Sessa, W.C. (1999). Regulation of endothelium-derived nitric oxide production by the protein kinase AKT. Nature 399, 597&ndash;601.</p>\n\n<p>Huang PL,&nbsp;Huang Z,&nbsp;Mashimo H,&nbsp;Bloch KD,&nbsp;Moskowitz MA,&nbsp;Bevan JA,&nbsp;Fishman MC. &nbsp; &nbsp;Hypertension&nbsp;in&nbsp;mice&nbsp;lacking&nbsp;the&nbsp;gene&nbsp;for&nbsp;endothelial nitric oxide synthase. &nbsp;Nature.&nbsp;1995, 377(6546):239-42.</p>\n\n<p>Li JY,&nbsp;Huang WQ,&nbsp;Tu RH,&nbsp;Zhong GQ,&nbsp;Luo BB,&nbsp;He Y. &nbsp;Resveratrol rescues hyperglycemia-induced endothelial dysfunction via activation of&nbsp;Akt. &nbsp;Acta Pharmacol Sin.&nbsp;2017, 38(2):182-191.</p>\n\n<p>Michaud SE,&nbsp;Dussault S,&nbsp;Groleau J,&nbsp;Haddad P,&nbsp;Rivard A.J. Cigarette smoke exposure impairs VEGF-induced endothelial cell migration: role of NO and reactive oxygen species. &nbsp;Mol Cell Cardiol.&nbsp;2006 Aug;41(2):275-84.</p>\n\n<p>Qian, J., and Fulton, D. (2013). Post-translational regulation of endothelial nitric oxide synthase in vascular endothelium. Oxid. Physiol. 4, 347.</p>\n","biologicalOrganisationLevel":"Cellular","organTerm":{},"biologicalEvents":[{"action":"decreased","process":"catalytic activity","object":{"name":"nitric oxide synthase, endothelial","source":"PR","sourceId":"PR:000011328"}},{"action":"decreased","process":"catalytic activity","object":{"name":"AKT kinase","source":"PR","sourceId":"PR:000029189"}}],"keyEventStressors":["Reactive oxygen species"],"id":973}
{"title":"KE5 : Decrease, AKT/eNOS activity","references":"<p>Atochin, D.N., Wang, A., Liu, V.W.T., Critchlow, J.D., Dantas, A.P.V., Looft-Wilson, R., Murata, T., Salomone, S., Shin, H.K., Ayata, C., et al. (2007). The phosphorylation state of eNOS modulates vascular reactivity and outcome of cerebral ischemia in vivo. J. Clin. Invest. 117, 1961&ndash;1967.</p>\n\n<p>Das A,&nbsp;Gopalakrishnan B,&nbsp;Druhan LJ,&nbsp;Wang TY,&nbsp;De Pascali F,&nbsp;Rockenbauer A,&nbsp;Racoma I,&nbsp;Varadharaj S,&nbsp;Zweier JL,&nbsp;Cardounel AJ,&nbsp;Villamena FA. &nbsp;Reversal&nbsp;of&nbsp;SIN-1-induced&nbsp;eNOS&nbsp;dysfunction&nbsp;by the&nbsp;spin&nbsp;trap,&nbsp;DMPO, in&nbsp;bovine&nbsp;aortic&nbsp;endothelialcells&nbsp;via&nbsp;eNOS&nbsp;phosphorylation. &nbsp;Br J Pharmacol.&nbsp;2014, 171(9):2321-34. doi: 10.1111/bph.12572.</p>\n\n<p>Dhar A,&nbsp;Dhar I,&nbsp;Desai KM,&nbsp;Wu L. &nbsp;Methylglyoxal&nbsp;scavengers attenuate endothelial dysfunction induced by&nbsp;methylglyoxal&nbsp;and high concentrations of glucose. &nbsp;Br J Pharmacol.&nbsp;2010, 161(8):1843-56.</p>\n\n<p>Dimmeler, S., Fleming, I., Fisslthaler, B., Hermann, C., Busse, R., and Zeiher, A.M. (1999). Activation of nitric oxide synthase in endothelial cells by Akt-dependent phosphorylation. Nature 399, 601&ndash;605.</p>\n\n<p>Fulton, D., Gratton, J.P., McCabe, T.J., Fontana, J., Fujio, Y., Walsh, K., Franke, T.F., Papapetropoulos, A., and Sessa, W.C. (1999). Regulation of endothelium-derived nitric oxide production by the protein kinase AKT. Nature 399, 597&ndash;601.</p>\n\n<p>Huang PL,&nbsp;Huang Z,&nbsp;Mashimo H,&nbsp;Bloch KD,&nbsp;Moskowitz MA,&nbsp;Bevan JA,&nbsp;Fishman MC. &nbsp; &nbsp;Hypertension&nbsp;in&nbsp;mice&nbsp;lacking&nbsp;the&nbsp;gene&nbsp;for&nbsp;endothelial nitric oxide synthase. &nbsp;Nature.&nbsp;1995, 377(6546):239-42.</p>\n\n<p>Li JY,&nbsp;Huang WQ,&nbsp;Tu RH,&nbsp;Zhong GQ,&nbsp;Luo BB,&nbsp;He Y. &nbsp;Resveratrol rescues hyperglycemia-induced endothelial dysfunction via activation of&nbsp;Akt. &nbsp;Acta Pharmacol Sin.&nbsp;2017, 38(2):182-191.</p>\n\n<p>Michaud SE,&nbsp;Dussault S,&nbsp;Groleau J,&nbsp;Haddad P,&nbsp;Rivard A.J. Cigarette smoke exposure impairs VEGF-induced endothelial cell migration: role of NO and reactive oxygen species. &nbsp;Mol Cell Cardiol.&nbsp;2006 Aug;41(2):275-84.</p>\n\n<p>Qian, J., and Fulton, D. (2013). Post-translational regulation of endothelial nitric oxide synthase in vascular endothelium. Oxid. Physiol. 4, 347.</p>\n","biologicalOrganisationLevel":"Cellular","organTerm":{},"biologicalEvents":[{"action":"decreased","process":"catalytic activity","object":{"name":"nitric oxide synthase, endothelial","source":"PR","sourceId":"PR:000011328"}},{"action":"decreased","process":"catalytic activity","object":{"name":"AKT kinase","source":"PR","sourceId":"PR:000029189"}}],"keyEventStressors":["Reactive oxygen species"],"id":973}
{"title":"reduced dimerization, ARNT/HIF1-alpha","references":"<p><br />\n1. Forsythe, J. A., Jiang, B. H., Iyer, N. V., Agani, F., Leung, S. W., Koos, R. D., and Semenza, G. L. (1996). Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1. Mol. Cell Biol. 16(9), 4604-4613.</p>\n\n<p>2. Goldberg, M. A., and Schneider, T. J. (1994). Similarities between the oxygen-sensing mechanisms regulating the expression of vascular endothelial growth factor and erythropoietin. J. Biol. Chem. 269(6), 4355-4359.</p>\n\n<p>3. Heid, S. E., Walker, M. K., and Swanson, H. I. (2001). Correlation of cardiotoxicity mediated by halogenated aromatic hydrocarbons to aryl hydrocarbon receptor activation. Toxicol. Sci 61(1), 187-196.</p>\n\n<p>4. Jiang, B. H., Rue, E., Wang, G. L., Roe, R., and Semenza, G. L. (1996). Dimerization, DNA binding, and transactivation properties of hypoxia-inducible factor 1. J. Biol. Chem. 271(30), 17771-17778.</p>\n\n<p>5. Maxwell, P. H., Dachs, G. U., Gleadle, J. M., Nicholls, L. G., Harris, A. L., Stratford, I. J., Hankinson, O., Pugh, C. W., and Ratcliffe, P. J. (1997). Hypoxia-inducible factor-1 modulates gene expression in solid tumors and influences both angiogenesis and tumor growth. Proc. Natl. Acad. Sci U. S. A 94(15), 8104-8109.</p>\n\n<p>6. Shweiki, D., Itin, A., Soffer, D., and Keshet, E. (1992). Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature 359(6398), 843-845.</p>\n\n<p>7. Walker, M. K., Pollenz, R. S., and Smith, S. M. (1997). Expression of the aryl hydrocarbon receptor (AhR) and AhR nuclear translocator during chick cardiogenesis is consistent with 2,3,7,8-tetrachlorodibenzo-p-dioxin-induced heart defects. Toxicol. Appl. Pharmacol. 143(2), 407-419.</p>\n\n<p>8. Wikenheiser, J., Wolfram, J. A., Gargesha, M., Yang, K., Karunamuni, G., Wilson, D. L., Semenza, G. L., Agani, F., Fisher, S. A., Ward, N., and Watanabe, M. (2009). Altered hypoxia-inducible factor-1 alpha expression levels correlate with coronary vessel anomalies. <em>Dev. Dyn. </em><strong>238</strong>(10), 2688-2700.</p>\n\n<p>9. Livingston DM, Shivdasani R. (2001). Toward mechanism-based cancer care. <em>JAMA</em> <strong>285</strong>:588&ndash;593.</p>\n\n<p>10. Semenza GL. (2003). Targeting HIF-1 for cancer therapy. <em>Nat Rev Cancer</em> <strong>3</strong>: 721&ndash;732.</p>\n\n<p>11. Dery M-A C, Michaud MD, Richard DE. (2005). Hypoxia-inducible factor 1: regulation by hypoxic and non-hypoxic activators. <em>Int J Biochem Cell Biol</em> <strong>37</strong>: 535&ndash;540.</p>\n\n<p>12. Jain S, Maltepe E, Lu MM, Simon C, and Bradfield CA (1998) Expression of ARNT, ARNT2, HIF1 alpha, HIF2 alpha and Ah receptor mRNAs in the developing mouse. <em>Mech Dev</em> <strong>73</strong>:117&ndash;123.</p>\n\n<p>13. <span style=\"font-family:calibri,sans-serif; font-size:11.0pt\">Tipoe, G. L., and Fung, M. L. (2003). Expression of HIF-1alpha, VEGF and VEGF receptors in the carotid body of chronically hypoxic rat. <em>Respir. Physiol Neurobiol.</em> <strong>138</strong>(2-3), 143-154.</span></p>\n\n<p><span style=\"font-family:calibri,sans-serif; font-size:11.0pt\">14.&nbsp;</span>Heise, K., Estevez, M.S., Puntarulo, S., Galleano, M., Nikinmaa, M., Portner, H.O., and Abele, D. (2007) Effects of seasonal and latitudinal cold on oxidative stress parameters and activation of hypoxia inducible factor (HIF-1) in zoarcid fish. <em>Biochem. Syst. Environ. Physiol.</em> <strong>177</strong>: 765-77</p>\n\n<p>15. Rissanen, E., Tranberg, H.K., Sollid, J., Nilsson, G.E., and Nikinmaa, M. (2006) Temperature regulates hypoxia-inducible factor-1 (HIF-1) in a poikilothermic vertebrate, crucian carp (Carassius carassius<em>) J. Exp. Biol</em>. <strong>209</strong> (6): 994-1003</p>\n\n<p>16. Greenald, D., Jeyakani, J., Pelster, B., Sealy, I., Mathavan, S., and van Eeden, F.J. (2015) Genome-wide mapping of Hif-1 alpha binding sites in zebrafish. <em>BMC Genomics</em>. <strong>16</strong>: 923</p>\n\n<p>17. M.A. Schults; L. Timmermans; R.W. Godschalk; J. Theys; B.G. Wouters; F.J. van Schooten and R.K. Chiu (2010) Diminished Carcinogen Detoxification Is a Novel Mechanism for Hypoxia-inducible Factor 1-mediated Genetic Instability. <em>The Journal of Biological Chemistry</em> <strong>285</strong>:14558-14564. doi: 10.1074/jbc.M109.076323.</p>\n\n<p>&nbsp;</p>\n","biologicalOrganisationLevel":"Molecular","organTerm":{},"biologicalEvents":[{"action":"decreased","process":"protein dimerization activity","object":{"name":"hypoxia-inducible factor 1-alpha","source":"PR","sourceId":"PR:000008555"}},{"action":"decreased","process":"protein dimerization activity","object":{"name":"aryl hydrocarbon receptor nuclear translocator","source":"PR","sourceId":"PR:000004303"}}],"id":945}
{"title":"reduced dimerization, ARNT/HIF1-alpha","references":"<p><br />\n1. Forsythe, J. A., Jiang, B. H., Iyer, N. V., Agani, F., Leung, S. W., Koos, R. D., and Semenza, G. L. (1996). Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1. Mol. Cell Biol. 16(9), 4604-4613.</p>\n\n<p>2. Goldberg, M. A., and Schneider, T. J. (1994). Similarities between the oxygen-sensing mechanisms regulating the expression of vascular endothelial growth factor and erythropoietin. J. Biol. Chem. 269(6), 4355-4359.</p>\n\n<p>3. Heid, S. E., Walker, M. K., and Swanson, H. I. (2001). Correlation of cardiotoxicity mediated by halogenated aromatic hydrocarbons to aryl hydrocarbon receptor activation. Toxicol. Sci 61(1), 187-196.</p>\n\n<p>4. Jiang, B. H., Rue, E., Wang, G. L., Roe, R., and Semenza, G. L. (1996). Dimerization, DNA binding, and transactivation properties of hypoxia-inducible factor 1. J. Biol. Chem. 271(30), 17771-17778.</p>\n\n<p>5. Maxwell, P. H., Dachs, G. U., Gleadle, J. M., Nicholls, L. G., Harris, A. L., Stratford, I. J., Hankinson, O., Pugh, C. W., and Ratcliffe, P. J. (1997). Hypoxia-inducible factor-1 modulates gene expression in solid tumors and influences both angiogenesis and tumor growth. Proc. Natl. Acad. Sci U. S. A 94(15), 8104-8109.</p>\n\n<p>6. Shweiki, D., Itin, A., Soffer, D., and Keshet, E. (1992). Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature 359(6398), 843-845.</p>\n\n<p>7. Walker, M. K., Pollenz, R. S., and Smith, S. M. (1997). Expression of the aryl hydrocarbon receptor (AhR) and AhR nuclear translocator during chick cardiogenesis is consistent with 2,3,7,8-tetrachlorodibenzo-p-dioxin-induced heart defects. Toxicol. Appl. Pharmacol. 143(2), 407-419.</p>\n\n<p>8. Wikenheiser, J., Wolfram, J. A., Gargesha, M., Yang, K., Karunamuni, G., Wilson, D. L., Semenza, G. L., Agani, F., Fisher, S. A., Ward, N., and Watanabe, M. (2009). Altered hypoxia-inducible factor-1 alpha expression levels correlate with coronary vessel anomalies. <em>Dev. Dyn. </em><strong>238</strong>(10), 2688-2700.</p>\n\n<p>9. Livingston DM, Shivdasani R. (2001). Toward mechanism-based cancer care. <em>JAMA</em> <strong>285</strong>:588&ndash;593.</p>\n\n<p>10. Semenza GL. (2003). Targeting HIF-1 for cancer therapy. <em>Nat Rev Cancer</em> <strong>3</strong>: 721&ndash;732.</p>\n\n<p>11. Dery M-A C, Michaud MD, Richard DE. (2005). Hypoxia-inducible factor 1: regulation by hypoxic and non-hypoxic activators. <em>Int J Biochem Cell Biol</em> <strong>37</strong>: 535&ndash;540.</p>\n\n<p>12. Jain S, Maltepe E, Lu MM, Simon C, and Bradfield CA (1998) Expression of ARNT, ARNT2, HIF1 alpha, HIF2 alpha and Ah receptor mRNAs in the developing mouse. <em>Mech Dev</em> <strong>73</strong>:117&ndash;123.</p>\n\n<p>13. <span style=\"font-family:calibri,sans-serif; font-size:11.0pt\">Tipoe, G. L., and Fung, M. L. (2003). Expression of HIF-1alpha, VEGF and VEGF receptors in the carotid body of chronically hypoxic rat. <em>Respir. Physiol Neurobiol.</em> <strong>138</strong>(2-3), 143-154.</span></p>\n\n<p><span style=\"font-family:calibri,sans-serif; font-size:11.0pt\">14.&nbsp;</span>Heise, K., Estevez, M.S., Puntarulo, S., Galleano, M., Nikinmaa, M., Portner, H.O., and Abele, D. (2007) Effects of seasonal and latitudinal cold on oxidative stress parameters and activation of hypoxia inducible factor (HIF-1) in zoarcid fish. <em>Biochem. Syst. Environ. Physiol.</em> <strong>177</strong>: 765-77</p>\n\n<p>15. Rissanen, E., Tranberg, H.K., Sollid, J., Nilsson, G.E., and Nikinmaa, M. (2006) Temperature regulates hypoxia-inducible factor-1 (HIF-1) in a poikilothermic vertebrate, crucian carp (Carassius carassius<em>) J. Exp. Biol</em>. <strong>209</strong> (6): 994-1003</p>\n\n<p>16. Greenald, D., Jeyakani, J., Pelster, B., Sealy, I., Mathavan, S., and van Eeden, F.J. (2015) Genome-wide mapping of Hif-1 alpha binding sites in zebrafish. <em>BMC Genomics</em>. <strong>16</strong>: 923</p>\n\n<p>17. M.A. Schults; L. Timmermans; R.W. Godschalk; J. Theys; B.G. Wouters; F.J. van Schooten and R.K. Chiu (2010) Diminished Carcinogen Detoxification Is a Novel Mechanism for Hypoxia-inducible Factor 1-mediated Genetic Instability. <em>The Journal of Biological Chemistry</em> <strong>285</strong>:14558-14564. doi: 10.1074/jbc.M109.076323.</p>\n\n<p>&nbsp;</p>\n","biologicalOrganisationLevel":"Molecular","organTerm":{},"biologicalEvents":[{"action":"decreased","process":"protein dimerization activity","object":{"name":"hypoxia-inducible factor 1-alpha","source":"PR","sourceId":"PR:000008555"}},{"action":"decreased","process":"protein dimerization activity","object":{"name":"aryl hydrocarbon receptor nuclear translocator","source":"PR","sourceId":"PR:000004303"}}],"id":945}
{"title":"reduced production, VEGF","references":"<p><br />\n1. Cecilia Y. Cheung (1997) Vascular Endothelial Growth Factor: Possible Role in Fetal Development and Placental Function. <em>J Soc Gynecol Invest. </em><strong>4</strong>: 169-77</p>\n\n<p>2. <span style=\"font-family:calibri,sans-serif; font-size:11.0pt\">Ahluwalia, A., and Tarnawski, A. S. (2012). Critical role of hypoxia sensor--HIF-1alpha in VEGF gene activation. Implications for angiogenesis and tissue injury healing. <em>Curr. Med. Chem.</em> <strong>19</strong>(1), 90-97.</span></p>\n\n<p><span style=\"font-family:calibri,sans-serif; font-size:11.0pt\">3. </span>Holmes, K., Roberts, O. L., Thomas, A. M., and Cross, M. J. (2007). Vascular endothelial growth factor receptor-2: structure, function, intracellular signalling and therapeutic inhibition. <em>Cell Signal.</em> <strong>19</strong>(10), 2003-2012.</p>\n\n<p>4. Ivnitski-Steele, I. D., Friggens, M., Chavez, M., and Walker, M. K. (2005). 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) inhibition of coronary vasculogenesis is mediated, in part, by reduced responsiveness to endogenous angiogenic stimuli, including vascular endothelial growth factor A (VEGF-A). Birth Defects Res. A Clin Mol. Teratol. 73(6), 440-446.</p>\n\n<p>5. Zhu, D., Fang Y., Gao, &nbsp;K., Shen, J., Zhong, T.P., and Li, &nbsp;F. (2017) Vegfa Impacts Early Myocardium Development in Zebrafish. <em>Int J Mol Sci. </em><strong>18</strong>(2): 444.</p>\n\n<p>6. Eichmann, A., Marcelle, C., Breant, C., and Le Douarin, N.M. (1996). Molecular cloning of Quek 1 and 2, two quail vascular endothelial growth factor (VEGF) receptor-like molecules. <em>Gene</em> <strong>174</strong>, 3&ndash;8.</p>\n\n<p>7. Masabumi Shibuya (2002) Vascular Endothelial Growth Factor Receptor Family Genes: When Did the Three Genes Phylogenetically Segregate? <em>Biol. Chem.</em>, <strong>383</strong>: 1573 &ndash; 1579.</p>\n\n<p>8. Li, X.; Liu, X.; Guo, H.; Zhao, Z.; Li, Y.S. and Chen, G. (2016) The significance of the increased expression of phosphorylated MeCP2 in the membranes from patients with proliferative diabetic retinopathy. <em>Scientific Reports, </em>volume 6, Article&nbsp;number:&nbsp;32850. 10.1038/srep32850</p>\n\n<p>9. Medford, A. R., Douglas, S. K., Godinho, S. I., Uppington, K. M., Armstrong, L., Gillespie, K. M., van Zyl, B., Tetley, T.D., Ibrahim, N.B.N. and Millar, A. B. (2009). Vascular Endothelial Growth Factor (VEGF) isoform expression and activity in human and murine lung injury. <em>Respiratory Research</em>, <strong>10</strong>(1), 27. http://doi.org/10.1186/1465-9921-10-27</p>\n\n<p>&nbsp;</p>\n","biologicalOrganisationLevel":"Cellular","organTerm":{},"biologicalEvents":[{"action":"decreased","process":"gene expression","object":{"name":"vascular endothelial growth factor A","source":"PR","sourceId":"PR:000017284"}},{"action":"decreased","process":"abnormal protein level","object":{"name":"vascular endothelial growth factor A","source":"PR","sourceId":"PR:000017284"}}],"id":948}
{"title":"reduced production, VEGF","references":"<p><br />\n1. Cecilia Y. Cheung (1997) Vascular Endothelial Growth Factor: Possible Role in Fetal Development and Placental Function. <em>J Soc Gynecol Invest. </em><strong>4</strong>: 169-77</p>\n\n<p>2. <span style=\"font-family:calibri,sans-serif; font-size:11.0pt\">Ahluwalia, A., and Tarnawski, A. S. (2012). Critical role of hypoxia sensor--HIF-1alpha in VEGF gene activation. Implications for angiogenesis and tissue injury healing. <em>Curr. Med. Chem.</em> <strong>19</strong>(1), 90-97.</span></p>\n\n<p><span style=\"font-family:calibri,sans-serif; font-size:11.0pt\">3. </span>Holmes, K., Roberts, O. L., Thomas, A. M., and Cross, M. J. (2007). Vascular endothelial growth factor receptor-2: structure, function, intracellular signalling and therapeutic inhibition. <em>Cell Signal.</em> <strong>19</strong>(10), 2003-2012.</p>\n\n<p>4. Ivnitski-Steele, I. D., Friggens, M., Chavez, M., and Walker, M. K. (2005). 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) inhibition of coronary vasculogenesis is mediated, in part, by reduced responsiveness to endogenous angiogenic stimuli, including vascular endothelial growth factor A (VEGF-A). Birth Defects Res. A Clin Mol. Teratol. 73(6), 440-446.</p>\n\n<p>5. Zhu, D., Fang Y., Gao, &nbsp;K., Shen, J., Zhong, T.P., and Li, &nbsp;F. (2017) Vegfa Impacts Early Myocardium Development in Zebrafish. <em>Int J Mol Sci. </em><strong>18</strong>(2): 444.</p>\n\n<p>6. Eichmann, A., Marcelle, C., Breant, C., and Le Douarin, N.M. (1996). Molecular cloning of Quek 1 and 2, two quail vascular endothelial growth factor (VEGF) receptor-like molecules. <em>Gene</em> <strong>174</strong>, 3&ndash;8.</p>\n\n<p>7. Masabumi Shibuya (2002) Vascular Endothelial Growth Factor Receptor Family Genes: When Did the Three Genes Phylogenetically Segregate? <em>Biol. Chem.</em>, <strong>383</strong>: 1573 &ndash; 1579.</p>\n\n<p>8. Li, X.; Liu, X.; Guo, H.; Zhao, Z.; Li, Y.S. and Chen, G. (2016) The significance of the increased expression of phosphorylated MeCP2 in the membranes from patients with proliferative diabetic retinopathy. <em>Scientific Reports, </em>volume 6, Article&nbsp;number:&nbsp;32850. 10.1038/srep32850</p>\n\n<p>9. Medford, A. R., Douglas, S. K., Godinho, S. I., Uppington, K. M., Armstrong, L., Gillespie, K. M., van Zyl, B., Tetley, T.D., Ibrahim, N.B.N. and Millar, A. B. (2009). Vascular Endothelial Growth Factor (VEGF) isoform expression and activity in human and murine lung injury. <em>Respiratory Research</em>, <strong>10</strong>(1), 27. http://doi.org/10.1186/1465-9921-10-27</p>\n\n<p>&nbsp;</p>\n","biologicalOrganisationLevel":"Cellular","organTerm":{},"biologicalEvents":[{"action":"decreased","process":"gene expression","object":{"name":"vascular endothelial growth factor A","source":"PR","sourceId":"PR:000017284"}},{"action":"decreased","process":"abnormal protein level","object":{"name":"vascular endothelial growth factor A","source":"PR","sourceId":"PR:000017284"}}],"id":948}
{"title":"abnormal, placental labyrinth vasculature morphology","references":"","biologicalOrganisationLevel":"Tissue","organTerm":{},"biologicalEvents":[{"object":{}}],"id":1891}
{"title":"increase, placental insufficiency","references":"","biologicalOrganisationLevel":"Organ","organTerm":{},"biologicalEvents":[{"object":{}}],"id":1892}
{"title":"increase, Preeclampsia","references":"","biologicalOrganisationLevel":"Individual","organTerm":{},"biologicalEvents":[{"object":{}}],"id":1893}
{"title":"Binding, Transthyretin in serum","references":"<p>Alshehri, B., D&rsquo;Souza, D. G., Lee, J. Y., Petratos, S., &amp; Richardson, S. J. (2015). The Diversity of Mechanisms Influenced by Transthyretin in Neurobiology: Development, Disease and Endocrine Disruption. Journal of Neuroendocrinology, 27(5), 303&ndash;323. <a class=\"external free\" href=\"http://doi.org/10.1111/jne.12271\" rel=\"nofollow\" target=\"_blank\">http://doi.org/10.1111/jne.12271</a></p>\n\n<p>Andrea et al. 1980</p>\n\n<p>Blake et al 1978</p>\n\n<p>Cao, J., Y. Lin, L.H. Guo, A.Q. Zhang, Y. Wei, and Y. Yang. 2010. Structure-based investigation on the binding interaction of hydroxylated polybrominated diphenyl ethers with thyroxine transport proteins. Toxicology 277(1-3):20-8.</p>\n\n<p>Chauhan, K. R., Kodavanti, P. R. S., &amp; McKinney, J. D. (2000). Assessing the Role of ortho-Substitution on Polychlorinated Biphenyl Binding to Transthyretin, a Thyroxine Transport Protein. Toxicology and Applied Pharmacology, 162(1), 10&ndash;21. <a class=\"external free\" href=\"http://doi.org/10.1006/taap.1999.8826\" rel=\"nofollow\" target=\"_blank\">http://doi.org/10.1006/taap.1999.8826</a></p>\n\n<p>Ferguson et al. 1975</p>\n\n<p>Lans, M. C., Klasson-Wehler, E., Willemsen, M., Meussen, E., Safe, S., &amp; Brouwer, A. (1993). STRUCTURE-DEPENDENT, COMPETITIVE INTERACTION OF HYDROXY-POLYCHLOROBIPHENYLS, -DIBENZO-p-DIOXINS AND -DIBENZOFURANS WITH HUMAN TRANSTHYRETIN. Chemico-Biological Interactions, 88, 7&ndash;21.</p>\n\n<p>Lans, M. C., Spiertz, C., Brouwer, a, &amp; Koeman, J. H. (1994). Different competition of thyroxine binding to transthyretin and thyroxine-binding globulin by hydroxy-PCBs, PCDDs and PCDFs. European Journal of Pharmacology, 270(2-3), 129&ndash;136. <a class=\"external free\" href=\"http://doi.org/10.1016/0926-6917(94)90054-X\" rel=\"nofollow\" target=\"_blank\">http://doi.org/10.1016/0926-6917(94)90054-X</a></p>\n\n<p>Loubiere et al 2010</p>\n\n<p>Ren, X. M., &amp; Guo, L. H. (2012). Assessment of the binding of hydroxylated polybrominated diphenyl ethers to thyroid hormone transport proteins using a site-specific fluorescence probe. Environmental Science and Technology, 46(8), 4633&ndash;4640. <a class=\"external free\" href=\"http://doi.org/10.1021/es2046074\" rel=\"nofollow\" target=\"_blank\">http://doi.org/10.1021/es2046074</a></p>\n\n<p>Richardson, S. J. (2007). Cell and molecular biology of transthyretin and thyroid hormones. International Review of Cytology, 258(January), 137&ndash;93. <a class=\"external free\" href=\"http://doi.org/10.1016/S0074-7696(07)58003-4\" rel=\"nofollow\" target=\"_blank\">http://doi.org/10.1016/S0074-7696(07)58003-4</a></p>\n\n<p>Schreiber, G. (2002). The evolutionary and integrative roles of transthyrein in thyroid hormone homeostasis. Journal of Endocrinology, 175(1), 61&ndash;73. <a class=\"external free\" href=\"http://doi.org/10.1677/joe.0.1750061\" rel=\"nofollow\" target=\"_blank\">http://doi.org/10.1677/joe.0.1750061</a></p>\n\n<p>Schweizer and Kohrle 2013</p>\n\n<p>Van den Berg, K. J. (1990). Interaction of chlorinated phenols with thyroxine binding sites of human transthyretin, albumin and thyroid binding globulin. Chemico-Biological Interactions, 76(1), 63&ndash;75. <a class=\"external free\" href=\"http://doi.org/10.1016/0009-2797(90)90034-K\" rel=\"nofollow\" target=\"_blank\">http://doi.org/10.1016/0009-2797(90)90034-K</a></p>\n\n<p>Van den Berg, K. J., Van Raaij, J. a G. M., Bragt, P. C., &amp; Notten, W. R. F. (1991). Interactions of halogenated industrial chemicals with transthyretin and effects on thyroid hormone levels in vivo. Archives of Toxicology, 65(1), 15&ndash;19. <a class=\"external free\" href=\"http://doi.org/10.1007/BF01973497\" rel=\"nofollow\" target=\"_blank\">http://doi.org/10.1007/BF01973497</a></p>\n\n<p>Weiss et al 2009</p>\n\n<p>Weiss, J. M., Andersson, P. L., Zhang, J., Simon, E., Leonards, P. E. G., Hamers, T., &amp; Lamoree, M. H. (2015). Tracing thyroid hormone-disrupting compounds: database compilation and structure-activity evaluation for an effect-directed analysis of sediment. Analytical and Bioanalytical Chemistry, 5625&ndash;5634. <a class=\"external free\" href=\"http://doi.org/10.1007/s00216-015-8736-9\" rel=\"nofollow\" target=\"_blank\">http://doi.org/10.1007/s00216-015-8736-9</a></p>\n\n<p>&nbsp;</p>\n","biologicalOrganisationLevel":"Molecular","organTerm":{"name":"serum","sourceId":"UBERON:0001977"},"biologicalEvents":[{"action":"increased","process":"binding","object":{"name":"transthyretin","source":"PR","sourceId":"PR:000016801"}}],"keyEventStressors":["Halogenated phenols","Polychlorinated biphenyl"],"id":957}
{"title":"Displacement, Serum thyroxine (T4) from transthyretin","references":"<p>Abdalla, S.M. and A.C. Bianco. (2014) Defending plasma T3 is a biological priority.&nbsp; Clin. Endocrinol. (Oxf)&nbsp; 81(5): 633-641.</p>\n\n<p>Alshehri, B., D&rsquo;Souza, D. G., Lee, J. Y., Petratos, S., &amp; Richardson, S. J. (2015). The Diversity of Mechanisms Influenced by Transthyretin in Neurobiology: Development, Disease and Endocrine Disruption. Journal of Neuroendocrinology, 27(5), 303&ndash;323.&nbsp;<a href=\"http://doi.org/10.1111/jne.12271\" target=\"_blank\">http://doi.org/10.1111/jne.12271</a></p>\n\n<p>Andrea, T.A., R.R. Cavalieri, I.D. Goldfine and E.C. Jorgensen (1980) Binding of thyroid hormones and analogues to the human plasma protein prealbumin. Biochemistry&nbsp; 19(1): 55-63.</p>\n\n<p>Aqai, P., C. Fryganas, M. Mizuguchi, W. Haasnoot and M.W. Nielen. (2012) Triple bioaffinity mass spectrometry concept for thyroid transporter ligands.&nbsp; Anal. Chem.&nbsp; 84(15): 6488-6493.</p>\n\n<p>Athanasiadou, M., S.N. Cuadra, G. Marsh, A&gt; Bergman, and K. Jakobsson. (2008) Polybrominated diphenyl ethers (PBDEs) and bioaccumulative hydroxylated PBDE metabolites in young humans from Managua, Nicaragua.&nbsp; Environ. Health Perspect. 116(3): 400-408.</p>\n\n<p>Barter, R.A. and C.D. Klaassen. (1994) Reduction of thyroid hormone levels and alteration of thyroid function by four representative UDP-glucuronosyltransferase inducers in rats.&nbsp; Toxicol. Appl. Pharmacol.&nbsp; 128(1): 9-17.</p>\n\n<p>Blake, C.C., J.M. Burridge and S.J. Oatley. (1978) X-ray analysis of thyroid hormone binding to prealbumin. Biochem Soc. Trans. 6(6): 1114-1118.</p>\n\n<p>Bloom, M.S., J.E. Vena, J.R. Olson and P.J. Kostyniak.&nbsp; (2009)&nbsp; Assessment of polychlorinated biphenyl congeners, thyroid stimulating hormone, and free thyroxine among New York state anglers.&nbsp; Int. J. Hyg. Environ. Health&nbsp; 212(6): 599-611.</p>\n\n<p>Branchi, I., E. Alleva and L.G. Costa.&nbsp; (2002)&nbsp; Effects of perinatal exposure to a polybrominated diphenyl ether (PBDE 99) on mouse neurobehavioural development.&nbsp; Neurotoxicology&nbsp; 23(3): 375-384.</p>\n\n<p>Brouwer, a, &amp; van den Berg, K. J. (1986). Binding of a metabolite of 3,4,3&rsquo;,4&#39;-tetrachlorobiphenyl to transthyretin reduces serum vitamin A transport by inhibiting the formation of the protein complex carrying both retinol and thyroxin. Toxicology and Applied Pharmacology, 85(3), 301&ndash;312.</p>\n\n<p>Calvo, R.M., E. Jauniaux, B. Gulbis, M. Asuncion, C. Gervy, B. Contempre and G. Morreale de Escobar.&nbsp; (2002)&nbsp; Fetal tissues are exposed to biologically relevant free thyroxine concentrations during early phases of development.&nbsp; J. Clin. Endocrinol. Metab.&nbsp; 87(4); 1768-1777.</p>\n\n<p>Cao, J., L.H. Guo, B. Wan and Y. Wei. (2011) In vitro fluorescence displacement investigation of thyroxine transport disruption by bisphenol A.&nbsp; J. Environ Sci, (China)&nbsp; 23(2): 315-321.</p>\n\n<p>Cao, J., Y. Lin, L.H. Guo, A.Q. Zhang, Y. Wei and Y. Yang. (2010) Structure-based investigation on the binding interaction of hydroxylated polybrominated diphenyl ethers with thyroxine transport proteins.&nbsp; Toxicology&nbsp; 277(1-3): 20-28.</p>\n\n<p>Chan, S.Y., J.A. Franklyn, H.N. Pemberton, J.N. Bulmer, T.J. Visser, C.J. McCabe and M.D. Kilby.&nbsp; (2006)&nbsp; Monocarboxylate transporter 8 expression in the human placenta: the effects of severe intrauterine growth restriction.&nbsp; J. Endocrinol.&nbsp; 189(3): 465-471.</p>\n\n<p>Chan, S., S. Kachilele, C.J. McCabe, L.A. Tannahill, K. Boelaert, N.J. Gittoes, T.J. Visser, J.A. Franklyn and M.D. Kilby.&nbsp; (2002)&nbsp; Early expression of thyroid hormone deiodinases and receptors in human fetal cerebral cortex.&nbsp; Brain Res. Dev. Brain Res.&nbsp; 138(2): 109-116.</p>\n\n<p>Chang, S.C., J.R. Thibodeaux, M.L. Eastvold, D.J. Ehresman, J.A. Bjork, J.W. Froehlich, C. Lau, R.J. Singh, K.B. Wallace and J.L. Butenhoff. (2008) Thyroid hormone status and pituitary function in adult rats given oral doses of perfluorooctanesulfonate (PFOS).&nbsp; Toxicology&nbsp; 243(3): 330-339.</p>\n\n<p>Chanoine, J.-P., Alex, S., Fang, S. L., Stone, S., Leonard, J. L., Kohrle, J., &amp; Braverman, L. E. (1992). Role of transthyretin in the transport of thyroxine from the blood to the choroid plexus, the cerebrospinal fluid and the brain. Endocrinology, 130(2), 933&ndash;938.</p>\n\n<p>Chauhan, K. R., Kodavanti, P. R. S., &amp; McKinney, J. D. (2000). Assessing the Role of ortho-Substitution on Polychlorinated Biphenyl Binding to Transthyretin, a Thyroxine Transport Protein. Toxicology and Applied Pharmacology, 162(1), 10&ndash;21.&nbsp;<a href=\"http://doi.org/10.1006/taap.1999.8826\" target=\"_blank\">http://doi.org/10.1006/taap.1999.8826</a></p>\n\n<p>Cheek, A.O., K. Kow, J. Chen and J.A. McLachlan. (1999) Potential mechanisms of thyroid disruption in humans: interaction of organochlorine compounds with thyroid receptor, transthyretin, and thyroid-binding globulin.&nbsp; Environ. Health Perspect.&nbsp; 107(4): 273-278.</p>\n\n<p>Chevrier, J., K.G. Harley, A. Bradman, M. Gharbi, A. Sjodin and B. Eskenazi.&nbsp; (2010)&nbsp; Polybrominated diphenyl ether (PBDE) flame retardants and thyroid hormone during pregnancy.&nbsp; Environ. Health Perspect.&nbsp; 118(10) : 1444-1449.</p>\n\n<p>Chopra, I.J., P. Taing and L. Mikus. (1996) Direct determination of free triiodothyronine (T3) in undiluted serum by equilibrium dialysis/radioimmunoassay (RIA).&nbsp; Thyroid&nbsp; 6(4): 255-259.</p>\n\n<p>Costa, L.G., R. de Laat, S. Tagliaferri and C. Pellacani.&nbsp; (2014)&nbsp; A mechanistic view of polybrominated diphenyl ether (PBDE) developmental neurotoxicity.&nbsp; 230(2): 282-294.</p>\n\n<p>Dallaire, R., G. Muckle, E. Dewailly, S.W. Jacobson, J.L. Jacobson, T.M. Sandanger, C.D. Sandau and P. Ayotte. (2009a)&nbsp; Thyroid hormone levels of pregnant inuit women and their infants exposed to environmental contaminants.&nbsp; Environ. Health Perspect.&nbsp; 117(6): 1014-1020.</p>\n\n<p>Dallaire, R., E. Dewailly, D. Pereg, S. Dery and P. Ayotte.&nbsp; (2009b)&nbsp; Thyroid function and plasma concentrations of polyhalogenated compounds in Inuit adults.&nbsp; Environ. Health Perspect.&nbsp; 117(9): 1380-1386.</p>\n\n<p>Darnerud, P.O., D. Morse, E. Klasson-Wehler and A Brouwer.&nbsp; (1996)&nbsp; Binding of a 3,3&#39;, 4,4&#39;-tetrachlorobiphenyl (CB-77) metabolite to fetal transthyretin and effects on fetal thyroid hormone levels in mice.&nbsp; Toxicology&nbsp; 106(1-3): 105-114.</p>\n\n<p>De Escobar, G.M., M.J. Obregon and F.E. del Rey.&nbsp; (2004)&nbsp; Maternal thyroid hormones early in pregnancy and fetal brain development.&nbsp; Best Pract. Res. Clin. Endocrinol. Metab.&nbsp; 18(2): 225-248.</p>\n\n<p>Dirinck, E., A.C. Dirtu, G. Malarvanna, A. Covaci, P.G. Jorens and L.F. Van Gall. (2016) A Preliminary Link between Hydroxylated Metabolites of Polychlorinated Biphenyls and Free Thyroxin in Humans.&nbsp; Int. J. Environ. Res. Public Health&nbsp; 13(4): 421.</p>\n\n<p>Eguchi, A., K. Nomiyama, N. Minh Tue, P.T. Trang, P. Hung Viet, S. Takahashi and S. Tanabe.&nbsp; (2015)&nbsp; Residue profiles of organohalogen compounds in human serum from e-waste recycling sites in North Vietnam: Association with thyroid hormone levels.&nbsp; Environ. Res.&nbsp; 137: 440-449.</p>\n\n<p>Emerson, C.H., J.H. Cohen III, R.A Yung, S. Alex and S.L. Fang. (1990) Gender-related differences of serum thyroxine-binding proteins in the rat. Acta Endocrinol. (Copenh)&nbsp; 123(1): 72-78.</p>\n\n<p>Erratico, C.A., A. Steitz and S.M. Bandiera. (2013) Biotransformation of 2,2&#39;,4,4&#39;-tetrabromodiphenyl ether (BDE-47) by human liver microsomes: identification of cytochrome P450 2B6 as the major enzyme involved.&nbsp; Chem. Res. Toxicol.&nbsp; 26(5): 721-731.</p>\n\n<p>Erratico, C.A., S.C. Moffatt and S.M. Bandiera. (2011) Comparative oxidative metabolism of BDE-47 and BDE-99 by rat hepatic microsomes.&nbsp; Toxicol. Sci.&nbsp; 123(1): 37-47.</p>\n\n<p>Eskenazi, B., J. Chevrier, S.A. Rauch, K. Kogul, K.G. Harley, C. Johnson, C. Trujillo, A. Sjodin and A. Bradman.&nbsp; (2013)&nbsp; In utero and childhood polybrominated diphenyl ether (PBDE) exposures and neurodevelopment in the CHAMACOS study.&nbsp; 121(2) : 257-262.</p>\n\n<p>Feo, M.L., M.S. Gross, B.P. McGarrigle, E. Eljarrat, D. Barcelo, D.S. Aga and J.R. Olson. (2013) Biotransformation of BDE-47 to potentially toxic metabolites is predominantly mediated by human CYP2B6.&nbsp; Environ. Health Persepct.&nbsp; 121(4): 440-446.</p>\n\n<p>Ferguson, R.N., H. Edelhoch, H.A. Saroff, J. Robbins and H.J. Cahnmann (1975) Negative cooperativity in the binding of thyroxine to human serum prealbumin. Preparation of tritium-labeled 8-anilino-1-naphthalenesulfonic acid.&nbsp; Biochemistry&nbsp; 14(2): 282-289.</p>\n\n<p>Friesema EC, Jansen J, Jachtenberg JW, Visser WE, Kester MH, Visser TJ 2008 Effective cellular uptake and efflux of thyroid hormone by human monocarboxylate transporter 10. Molecular endocrinology (Baltimore, Md 22:1357-1369</p>\n\n<p>Friesema EC, Kuiper GG, Jansen J, Visser TJ, Kester MH 2006 Thyroid hormone transport by the human monocarboxylate transporter 8 and its rate-limiting role in intracellular metabolism. Molecular endocrinology (Baltimore, Md 20:2761-2772</p>\n\n<p>Friesma, E.C., J. Jansen and T.J. Visser. (2005) Thyroid hormone transporters.&nbsp; Biochem. Soc. Trans.&nbsp; 33(part 1): 228-232.</p>\n\n<p>Friesema EC, Ganguly S, Abdalla A, Manning Fox JE, Halestrap AP, Visser TJ 2003 Identification of monocarboxylate transporter 8 as a specific thyroid hormone transporter. J Biol Chem 278:40128-40135</p>\n\n<p>Grimm, F. a., Lehmler, H. J., He, X., Robertson, L. W., &amp; Duffel, M. W. (2013). Sulfated metabolites of polychlorinated biphenyls are high-affinity ligands for the thyroid hormone transport protein transthyretin. Environmental Health Perspectives, 121(6), 657&ndash;662.</p>\n\n<p>Gutshall, D.M., G.D. Pilcher and A.E. Langley. (1989) Mechanism of the serum thyroid hormone lowering effect of perfluoro-n-decanoic acid (PFDA) in rats. J. Toxicol. Environ. Health&nbsp;&nbsp; 28(1): 53-65.</p>\n\n<p>Hagenbuch, B. (2007)&nbsp; Cellular entry of thyroid hormones by organic anion transporting polypeptides.&nbsp; Best Pract. Res. Clin. Endocrinol. Metab.&nbsp; 21(2): 209-221.</p>\n\n<p>Hagenbuch B, Meier PJ 2004 Organic anion transporting polypeptides of the OATP/ SLC21 family: phylogenetic classification as OATP/ SLCO superfamily, new nomenclature and molecular/functional properties. Pflugers Arch 447:653-665</p>\n\n<p>Hagmar, L., L. Rylander, E. Dyremark, E. Klasson-Wehler and E.M. Erfurth. (2001a).&nbsp; Plasma concentrations of persistent organochlorines in relation to thyrotropin and thyroid hormone levels in women.&nbsp; Int. Arch. Occup. Environ. Health&nbsp; 74(3): 184-188.</p>\n\n<p>Hagmar, L., J. Bjork, A. Sjodin, A. Bergman and E.M. Erfurth. (2001b) Plasma levels of persistent organohalogens and hormone levels in adult male humans.&nbsp; Arch. Environ. Health&nbsp; 56(2): 138-143.</p>\n\n<p>Hallgren, S., T. Sinjari, H. Hakansson and P.O. Darnerud. (2001) Effects of polybrominated diphenyl ethers (PBDEs) and polychlorinated biphenyls (PCBs) on thyroid hormone and vitamin A levels in rats and mice.&nbsp; 75(4): 200-208.</p>\n\n<p>Hallgren, S. and P.O. Darnerud. (2002) Polybrominated diphenyl ethers (PBDEs), polychlorinated biphenyls (PCBs) and chlorinated paraffins (CPs) in rats-testing interactions and mechanisms for thyroid hormone effects.&nbsp; Toxicology&nbsp; 177(203): 227-243.</p>\n\n<p>Hamers, T., J.H. Kamstra, E. Sonneveld, A.J. Murk, M.H. Kester, P.L. Andersson, J. Legler and A. Brouwer. (2006) In vitro profiling of the endocrine-disrupting potency of brominated flame retardants.&nbsp; Toxicol. Sci.&nbsp; 92(1): 157-173.</p>\n\n<p>Hamers, T., Kamstra, E. Sonneveld, A.J. Murk, T.J. Visser, M.J. Van Velzen, A. Brouwer and A. Bergman. (2008) Biotransformation of brominated flame retardants into potentially endocrine-disrupting metabolites, with special attention to 2,2&#39;,4,4&#39;-tetrabromodiphenyl ether (BDE-47).&nbsp; Mol. Nutr. Food Res.&nbsp; 52(2): 284-298.</p>\n\n<p>Harley, K.G., A.R. Marks, J. Chevrier, A. Bradman, A. Sjodin and B. Eskenazi.&nbsp; (2010)&nbsp; PBDE concentrations in women&#39;s serum and fecundability.&nbsp; Environ. Health Perspect.&nbsp; 118(5): 699-704.</p>\n\n<p>Henneman, G., R. Docter, E.C. Friesma, M. de Jong, E.P. Krenning and T.J. Visser.&nbsp; (2001)&nbsp; Plasma membrane transport of thyroid hormones and its role in thyroid hormone metabolism and bioavailability.&nbsp; Endocr. Rev.&nbsp; 22(4): 451-476.</p>\n\n<p>Heuer, H. &nbsp;(2007)&nbsp; The importance of thyroid hormone transporters for brain development and function.&nbsp; Best Pract. Res. Clin. Endocrinol. Metab.&nbsp; 21(2):&nbsp; 265-276.</p>\n\n<p>Hood, A. and C.D. Klaassen. (2000a) Differential effects of microsomal enzyme inducers on in vitro thyroxine (T(4)) and triiodothyronine (T(3)) glucuronidation.&nbsp; Toxicol. Sci.&nbsp; 55(1): 78-84.</p>\n\n<p>Hood, A. and C.D. Klaassen.&nbsp; (2000b)&nbsp; Effects of microsomal enzyme inducers on outer-ring deiodinase activity toward thyroid hormones in various rat tissues.&nbsp; Toxicol. Appl. Pharmacol.&nbsp; 163(3): 240-248.</p>\n\n<p>Hovander, L., M. Athanasiadou, L. Asplund, S. Jensen and E.K. Wehler. (2000). Extraction and cleanup methods for analysis of phenolic and neutral organohalogens in plasma.&nbsp; 24(8): 696-703.</p>\n\n<p>Hume, R., J. Simpson, C. Delahunty, H. van Toor, S.Y. Wu, F.L. Williams, T.J. Visser et al.&nbsp; (2004) Human fetal and cord serum thyroid hormones: developmental trends and interrelationships.&nbsp; J. Clin. Endocrinol. Metab.&nbsp; 89(8): 4097-4103.</p>\n\n<p>Inoue, K., F. Okada, R. Ito, S. Kato, S. Sasaki, S. Nakajima, A. Uno, Y. Saijo, F. Sata, Y. Yoshimura, R. Kishi and H. Nakazawa. (2004) Perfluorooctane sulfonate (PFOS) and related perfluorinated compounds in human maternal and cord blood samples: assessment of PFOS exposure in a susceptible population during pregnancy.&nbsp; Environ. Health Perspect.&nbsp; 112(11): 1204-1207.</p>\n\n<p>Kato, Y., K. Haraguchi, M. Onishi, S. Ikushiro, T. Endo, C. Ohta, N. Koga, S Yamada and M. Degawa. (2014) 3,3&#39;,4,4&#39;-Tetrachlorobiphenyl-mediated decrease of serum thyroxine level in C57BL/6 and DBA/2 mice occurs mainly through enhanced accumulation of thyroxine in the liver.&nbsp; Biol. Pharm. Bull.&nbsp; 37(3) 504-509.</p>\n\n<p>Kato, Y., M. Onishi, K. Haraguchi, S. Ikushiro, C. Ohta, N. Koga, T. Endo, S. Yamada and M. Degawa. (2013) A possible mechanism for 2,3&#39;,4,4&#39;,5&#39;-pentachlorobiphenyl-mediated decrease in serum thyroxine level in mice.&nbsp; Biol. Pharm. Bull.&nbsp; 36(10): 1594-1601.</p>\n\n<p>Kato, Y., S. Tamaki, K. Haraguchi, S. Ikushiro, M. Sekimoto, C. Ohta, T. Endo, N. Koga, S. Yamada and M. Degawa. (2012) Comparative study on 2,2&#39;,4,5,5&#39;-pentachlorobiphenyl-mediated decrease in serum thyroxine level between C57BL/6 and its transthyretin-deficient mice.&nbsp; Toxicol. Appl. Pharmacol.&nbsp; 263(3): 323-329.</p>\n\n<p>Kato, Y., M. Onishi, K. Haraguchi, S. Ikushiro, C. Ohta, N. Koga, T. Endo, S. Yamada and M. Degawa. (2011) A possible mechanism for 2,2&#39;,4,4&#39;,5,5&#39;-hexachlorobiphenyl-mediated decrease in serum thyroxine level in mice.&nbsp; Toxicol. Appl. Pharmacol.&nbsp; 254(1): 48-55.</p>\n\n<p>Kato, Y., K. Haraguchi, M. Kubota, Y. Seto, S. Ikushiro, T. Sakaki, N. Koga, S. Yamada and M. Degawa. (2009) 4-Hydroxy-2,2&#39;,3,4&#39;,5,5&#39;,6-heptachlorobiphenyl-mediated decrease in serum thyroxine level in mice occurs through increase in accumulation of thyroxine in the liver.&nbsp; Drug Metab. Dispos.&nbsp; 37(10): 2095-2102.</p>\n\n<p>Kato, Y., S. Ikushiro, R. Takiguchi, K. Haraguchi, N. Koga, S. Uchida, T. Sakaki, S. Yamada, J. Kanno and M. Degawa. (2007) A novel mechanism for polychlorinated biphenyl-induced decrease in serum thyroxine level in rats.&nbsp; Drug Metab. Dispos. 35(10) : 1949-1955.</p>\n\n<p>Kato, Y., S. Ikushiro, K. Haraguchi, T. Yamazaki, Y. Ito, H. Suzuki, R. Kimura, S. Yamada, T. Inoue and M. Degawa. (2004) A possible mechanism for decrease in serum thyroxine level by polychlorinated biphenyls in Wistar and Gunn rats.&nbsp; Toxicol. Sci.&nbsp; 81(2): 309-315.</p>\n\n<p>Kato, Y., K. Haraguchi, T. Yamazuki, Y. Ito, S. Miyajima, K. Nemoto, N. Koga, R. Kimura and M. Degawa. (2003) Effects of polychlorinated biphenyls, kanechlor-500, on serum thyroid hormone levels in rats and mice.&nbsp; Toxicol. Sci.&nbsp; 72(2): 235-241.</p>\n\n<p>Kim, S.Y., E.S. Choi, H.J. Lee, C. Moon and E. Kim.&nbsp; (2015)&nbsp; Transthyretin as a new transporter of nanoparticles for receptor-mediated transcytosis in rat brain microvessels.&nbsp; Colloids Surf B Biointerfaces&nbsp; 136: 989-996.</p>\n\n<p>Kim do K, Kanai Y, Matsuo H, Kim JY, Chairoungdua A, Kobayashi Y, Enomoto A, Cha SH, Goya T, Endou H 2002 The human T-type amino acid transporter-1: characterization, gene organization, and chromosomal location. Genomics 79:95-103</p>\n\n<p>Kohrle, J., S.L. Fang, Y. Yang, K. Irmscher, R.D. Hesch, S. Pino, S. Alex, and L.E. Braverman. (1989). Rapid effects of the flavonoid EMD 21388 on serum thyroid hormone binding and thyrotropin regulation in the rat. Endocrinoloy 125: 532-537</p>\n\n<p>Koopman-Essenboom, C., D.C. Morse, N. Weisglas-Kuperus, I.J. Lutkeschipholt, C.G. Van der Paauw, L.G. Tuinstra, A. Brouwer and P.J. Sauer.&nbsp; (1994)&nbsp; Effects of dioxins and polychlorinated biphenyls on thyroid hormone status of pregnant women and their infants.&nbsp; Pediatr. Res.&nbsp; 36(4): 468-473.</p>\n\n<p>Lans, M. C., Klasson-Wehler, E., Willemsen, M., Meussen, E., Safe, S., &amp; Brouwer, A. (1993). STRUCTURE-DEPENDENT, COMPETITIVE INTERACTION OF HYDROXY-POLYCHLOROBIPHENYLS, -DIBENZO-p-DIOXINS AND -DIBENZOFURANS WITH HUMAN TRANSTHYRETIN. Chemico-Biological Interactions, 88, 7&ndash;21.</p>\n\n<p>Lans, M. C., Spiertz, C., Brouwer, a, &amp; Koeman, J. H. (1994). Different competition of thyroxine binding to transthyretin and thyroxine-binding globulin by hydroxy-PCBs, PCDDs and PCDFs. European Journal of Pharmacology, 270(2-3), 129&ndash;136.&nbsp;<a href=\"http://doi.org/10.1016/0926-6917(94)90054-X\" target=\"_blank\">http://doi.org/10.1016/0926-6917(94)90054-X</a></p>\n\n<p>Larsson, M., Pettersson, T., &amp; Carlstr&ouml;m, a. (1985). Thyroid hormone binding in serum of 15 vertebrate species: isolation of thyroxine-binding globulin and prealbumin analogs. General and Comparative Endocrinology, 58(3), 360&ndash;375.</p>\n\n<p>Loubiere, L.S., E. Vasilopoulou, J.N. Bulmer, P.M. Taylor, B. Stieger, F. Verrey, C.J. McCabe, J.A. Franklyn, M.D. Kilby and S.Y. Chan. (2010)&nbsp; Expression of thyroid hormone transporters in the human placenta and changes associated with intrauterine growth restriction.&nbsp; Placenta&nbsp; 31(4): 295-304.</p>\n\n<p>Lueprasitsakul, W., Alex, S., Fang, S. L., Pino, S., Irmscher, K., K&ouml;hrle, J., &amp; Braverman, L. E. (1990). Flavonoid administration immediately displaces thyroxine (T4) from serum transthyretin, increases serum free T4, and decreases serum thyrotropin in the rat. Endocrinology 126 (6)</p>\n\n<p>Lupton, S.J., P. McGarrigle, J.R. Olson, T.D. Wood and D.S. Aga. (2010) Analysis of hydroxylated polybrominated diphenyl ether metabolites by liquid chromatography/atmospheric pressure chemical ionization tandem mass spectrometry.&nbsp; Rapid Commun. Mass. Spectrom.&nbsp; 24(15): 2227-2235.</p>\n\n<p>Lupton, S.J., B.P. McGarrigle, J.R. Olson, T.D. Wood and D.S. Aga. (2009)&nbsp; Analysis of hydroxylated polybrominated diphenyl ether metabolites by liquid chromatography/atmospheric pressure chemical ionization tandem mass spectrometry.&nbsp; 22(11): 1802-1809.</p>\n\n<p>Malmberg, T., M. Athanasiadou, G. Marsh, I. Brandt and A. Bergman.&nbsp; (2005) Identification of hydroxylated polybrominated diphenyl ether metabolites in blood plasma from polybrominated diphenyl ether exposed rats.&nbsp; 39(14): 5342-5348.</p>\n\n<p>Marchesini, G.R., E. Meulenberg, W. Haasnoot, M. Mizuguchi and H. Irth.&nbsp; (2006) Biosensor recognition of thyroid-disrupting chemicals using transport proteins.&nbsp; Anal. Chem.&nbsp; 78(4): 1107-1114.</p>\n\n<p>Marchesini, G.R., A. Meimaridou, W. Haasnoot, E. Meulenberg, F. Albertus, M. Mizuguchi, M. Takeuchi, H. Irth and A.J. Murk. (2008) iosensor discovery of thyroxine transport disrupting chemicals.&nbsp; Toxicol. Appl. Pharmacol.&nbsp; 232(1): 150-160.</p>\n\n<p>Martin, L.A., D.T. Wilson, K.R&gt; Reuhl, M.A. Gallo and C.D. Klaassen. (2012) Polychlorinated biphenyl congeners that increase the glucuronidation and biliary excretion of thyroxine are distinct from the congeners that enhance the serum disappearance of thyroxine.&nbsp; Drug Metab. Dispos.&nbsp; 40(3): 588-595.</p>\n\n<p>Martin, L. and C.D. Klaassen. (2010) Differential effects of polychlorinated biphenyl congeners on serum thyroid hormone levels in rats.&nbsp; Toxicol. Sci.&nbsp; 117(1): 36-44.</p>\n\n<p>Meerts, I.A., Y. Assink, P.H. Cenjin, J.H. Van Den Berg, B.M. Weijers, A. Bergman, J.H. Koeman and A. Brouwer. (2002) Placental transfer of a hydroxylated polychlorinated biphenyl and effects on fetal and maternal thyroid hormone homeostasis in the rat.&nbsp; Toxicol. Sci. 68(2): 361-371.</p>\n\n<p>Meerts, I.A., J.J. van Zanden, E.A. Lujiks, I. van Leeuwen-Bol, G. Marsh, E. Jakobsson, A. Bergman and A. Brouwer. (2000) Potent competitive interactions of some brominated flame retardants and related compounds with human transthyretin in vitro.&nbsp; Toxicol. Sci.&nbsp; 56(1): 95-104.</p>\n\n<p>Mendel, C. M. (1989). Modeling thyroxine transport to liver&nbsp;: rejection of the &ldquo;enhanced dissociation&rdquo; hypothesis as applied to thyroxine. Am J Physiol, 257(Endocrinol Metab 20), E764&ndash;E771.</p>\n\n<p>Mendel, C. M., Cavalieri, R. R., &amp; Kohrle, J. (1992). Thyroxine (T4) transport and distribution in rats treated with EMD 21388, a synthetic flavonoid that displaces T4 from transthyretin. Endocrinology, 130(3), 1525&ndash;1532.</p>\n\n<p>Midgley, J. E. (2001) Direct and indirect free thyroxine assay methods: theory and practice.&nbsp; Clin. Chem.&nbsp; 47(8): 1353-1363.</p>\n\n<p>Miksys, S. and R.F. Tyndale. (2004) The unique regulation of brain cytochrome P450 2 (CYP2) family enzymes by drugs and genetics.&nbsp; Drug Metab. Rev.&nbsp; 36(2): 313-333.</p>\n\n<p>Montano, M., E. Coccco, C. Guignard, G. Marsh, L. Hoffmann, A. Bergman, A.C. Gutleb and A.J. Murk. (2012) New approaches to assess the transthyretin binding capacity of bioactivated thyroid hormone disruptors.&nbsp; Toxicol. Sci.&nbsp; 130(1): 94-105.</p>\n\n<p>Morse, D.C., E.K. Wehler, W. Wesseling, J.H. Koeman and A. Brouwer.&nbsp; (1996)&nbsp; Alterations in rat brain thyroid hormone status following pre- and postnatal exposure to polychlorinated biphenyls (Aroclor 1254).&nbsp; Toxicol. Appl. Pharmacol.&nbsp; 136(2): 269-279.</p>\n\n<p>Morse, D.C., D. Groen, M. Veerman, C.J. van Amerongen, H.B. Koeter, A.E. Smits van Proojie, T.J. Visser, J.H. Koeman and A. Brouwer.&nbsp; (1993)&nbsp; Interference of polychlorinated biphenyls in hepatic and brain thyroid hormone metabolism in fetal and neonatal rats.&nbsp; Toxicol. Appl. Pharmacol.&nbsp; 122(1) :27-33.</p>\n\n<p>Munro, S.L., C.F. Lim, J.G. Hall, J.W. Barlow, D.J. Craik, D.J. Topliss and J.R. Stockigt (1989) Drug competition for thyroxine binding to transthyretin (prealbumin): comparison with effects on thyroxine-binding globulin. J. Clin. Endocrinol. Metab.&nbsp; 68(6): 1141-1147,</p>\n\n<p>Nishimura M, Naito S 2008 Tissue-specific mRNA expression profiles of human solute carrier transporter superfamilies. Drug Metab Pharmacokinet 23:22-44</p>\n\n<p>Pedraza, P., Calvo, R., Obreg&oacute;n, M. J., Asuncion, M., Escobar Del Rey, F., &amp; Morreale De Escobar, G. (1996). Displacement of T4 from transthyretin by the synthetic flavonoid EMD 21388 results in increased production of T3 from T4 in rat dams and fetuses. Endocrinology, 137(11), 4902&ndash;4914.&nbsp;<a href=\"http://doi.org/10.1210/en.137.11.4902\" target=\"_blank\">http://doi.org/10.1210/en.137.11.4902</a></p>\n\n<p>Purkey, H.E., M.I. Dorrell and J.W. Kelly. (2001) Evaluating the binding selectivity of transthyretin amyloid fibril inhibitors in blood plasma.&nbsp; Proc. Natl. Acad. Sci. USA&nbsp; 98(10): 5566-5571.</p>\n\n<p>Refetoff, S., N.I. Robin and V.S. Fang. (1970) Parameters of thyroid function in serum of 16 selected vertebrate species: a study of PBI, serum T4, free T4, and the pattern of T4 and T3 binding to serum proteins.&nbsp; Endocrinology&nbsp; 86(4): 793-805.</p>\n\n<p>Refetoff, S. (2015) Thyroid Hormone Serum Transport Proteins. In: De Groot LJ, Chrousos G, Dungan K, Feingold KR, Grossman A, Hershman JM, Koch C, Korbonits M, McLachlan R, New M, Purnell J, Rebar R, Singer F, Vinik A, editors. Endotext [Internet]. South Dartmouth (MA): MDText.com, Inc.; 2000.</p>\n\n<p>Ren, X.M., L.H. Guo, Y. Gao, B.T. Zhang and B. Wan. (2013) Hydroxylated polybrominated diphenyl ethers exhibit different activities on thyroid hormone receptors depending on their degree of bromination.&nbsp; Toxicol. Appl. Pharamacol.&nbsp; 268(3): 256-263.</p>\n\n<p>Ren, X. M., &amp; Guo, L. H. (2012). Assessment of the binding of hydroxylated polybrominated diphenyl ethers to thyroid hormone transport proteins using a site-specific fluorescence probe. Environmental Science and Technology, 46(8), 4633&ndash;4640.&nbsp;<a href=\"http://doi.org/10.1021/es2046074\" target=\"_blank\">http://doi.org/10.1021/es2046074</a></p>\n\n<p>Rerat, C. and H.G. Schwick (1967) [Crystallographic data of blood plasma prealbumin]. [Article in French] Acta Crystallogr.&nbsp; 22(3): 441-442.</p>\n\n<p>Richardson, S. J. (2007). Cell and molecular biology of transthyretin and thyroid hormones. International Review of Cytology, 258(January), 137&ndash;93.&nbsp;<a href=\"http://doi.org/10.1016/S0074-7696(07)58003-4\" target=\"_blank\">http://doi.org/10.1016/S0074-7696(07)58003-4</a></p>\n\n<p>Richardson, S. J., Wijayagunaratne, R. C., D&rsquo;Souza, D. G., Darras, V. M., &amp; Van Herck, S. L. J. (2015). Transport of thyroid hormones via the choroid plexus into the brain: the roles of transthyretin and thyroid hormone transmembrane transporters. Frontiers in Neuroscience, 9(March), 1&ndash;8.</p>\n\n<p>Rickenbacher, U., McKinney, J. D., Oatley, S. J., &amp; Blake, C. C. (1986). Structurally specific binding of halogenated biphenyls to thyroxine transport protein. Journal of Medicinal Chemistry, 29(5), 641&ndash;648.</p>\n\n<p>Ritchie, J.W. and P.M. Taylor.&nbsp; (2001)&nbsp; Role of the System L permease LAT1 in amino acid and iodothyronine transport in placenta.&nbsp; Biochem. J.&nbsp; 356(Part 3); 719-725.</p>\n\n<p>Riu, A., J.P. Cravedi, L. Debrauwer, A. Garcia, C. Canlet, I. Jouanin and D. Zalko. (2008) Environ. Int. 34(3): 318-329.</p>\n\n<p>Roberts LM, Woodford K, Zhou M, Black DS, Haggerty JE, Tate EH, Grindstaff KK, Mengesha W, Raman C, Zerangue N 2008 Expression of the thyroid hormone transporters MCT8 (SLC16A2) and OATP14 (SLCO1C1) at the blood-brain barrier. Endocrinology 149:6251-6261</p>\n\n<p>Rotroff, D.M., B.A. Wetmore, D.J. Dix, S.S. Ferguson, H.J. Clewell, K.A. Houck, E.L. Lecluyse, M.E. Anersen, R.S. Judson, C.M. Smith, M.A. Sochaski, R.J. Kavlock, F. Boellmann, M.T. Martin, D.M. Reif, J.F. Wambaugh and R.S. Thomas. (2010) Incorporating human dosimetry and exposure into high-throughput in vitro toxicity screening.&nbsp; 117(2): 348-358.</p>\n\n<p>Sato, K., J. Sugawara, T. Sato, H. Mizutamari, T. Suzuki, A. Ito, T. Mikkaichi, T. Onogawa, M. Tanemoto, M. Unno, T. Abe and K. Okamura.&nbsp; (2003)&nbsp; Expression of organic anion transporting polypeptide E (OATP-E) in human placenta.&nbsp; Placenta&nbsp; 24(2-3): 144-148.</p>\n\n<p>Schreiber, G. (2002). The evolutionary and integrative roles of transthyrein in thyroid hormone homeostasis. Journal of Endocrinology, 175(1), 61&ndash;73.&nbsp;<a href=\"http://doi.org/10.1677/joe.0.1750061\" target=\"_blank\">http://doi.org/10.1677/joe.0.1750061</a></p>\n\n<p>Schroder van der Elst, J.P., D. van der Heide, H. Rokos, G. Morreale de Escobar and J. Kohrlre. (1998) Synthetic flavonoids cross the placenta in the rat and are found in fetal brain.&nbsp; Am. J. Physiol.&nbsp; 274(2 Psrt 1): E253-E256.</p>\n\n<p>Schroder van der Elst, J.P., D. van der Heide, H. Rokos, J. Kohrle and G. Morreale de Escobar. (1997)&nbsp; Different tissue distribution, elimination, and kinetics of thyroxine and its conformational analog, the synthetic flavonoid EMD 49209 in the rat.&nbsp; Endocrinology&nbsp; 138(1): 79-84.</p>\n\n<p>Schuur, A.G., F.M. Boekhorst, A. Brouwer and T.J. Visser. (1997) Extrathyroidal effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin on thyroid hormone turnover in male Sprague-Dawley rats.&nbsp; Endocrinology&nbsp; 138(9): 3727-3734.</p>\n\n<p>Sinjari, T. and P.O. Darnerud. (1998) Hydroxylated polychlorinated biphenyls: placental transfer and effects on thyroxine in the foetal mouse.&nbsp; Xenobiotica&nbsp; 28(1): 21-30.</p>\n\n<p>Sparkes, R.S., H. Sasaki, T. Mohandas, K. Yoshioka, I. Kilsak, Y. Sasaki, C. Heinzmann and M.I. Simon. (1987) Assignment of the prealbumin (PALB) gene (familial amyloidotic polyneuropathy) to human chromosome region 18q11.2-q12.1. Hum. Genet.&nbsp; 75(2): 151-154.</p>\n\n<p>Stapleton, H.M., S.M. Kelly, R. Pei, R.J. Letcher and C. Gunsch.&nbsp; (2009) Metabolism of polybrominated diphenyl ethers (PBDEs) by human hepatocytes in vitro.&nbsp; Environ. Health Perspect.&nbsp; 117(2): 197-202.</p>\n\n<p>Tohyama K, Kusuhara H, Sugiyama Y 2004 Involvement of multispecific organic anion transporter, Oatp14 (Slc21a14), in the transport of thyroxine across the blood-brain barrier. Endocrinology</p>\n\n<p>Ucan-Marin, F., A. Arukwe, A.S. Mortensen, G.W. Gabrielsen and R.J. Letcher. (2010) Recombinant albumin and transthyretin transport proteins from two gull species and human: chlorinated and brominated contaminant binding and thyroid hormones.&nbsp; Environ. Sci. Technol.&nbsp; 44(1): 497-504.</p>\n\n<p>Van Birgelen, A.P., E.A. Smit, I.M. Kampen, C.N. Groeneveld, K.M. Case, J. Van der Kolk, H. Poiger, M. Van den Berg, J.H. Koeman and A. Brouwer. (1995) Subchronic effects of 2,3,7,8-TCDD or PCBs on thyroid hormone metabolism: use in risk assessment.&nbsp; Eur. J. Pharmacol.&nbsp; 293(1) : 77-85.</p>\n\n<p>Van den Berg, K. J. (1990). Interaction of chlorinated phenols with thyroxine binding sites of human transthyretin, albumin and thyroid binding globulin. Chemico-Biological Interactions, 76(1), 63&ndash;75.</p>\n\n<p>Van den Berg, K. J., Van Raaij, J. a G. M., Bragt, P. C., &amp; Notten, W. R. F. (1991). Interactions of halogenated industrial chemicals with transthyretin and effects on thyroid hormone levels in vivo. Archives of Toxicology, 65(1), 15&ndash;19.</p>\n\n<p>Viberg, H., A. Fredriksson and P. Eriksson. (2002) Neonatal exposure to the brominated flame retardant 2,2&#39;,4,4&#39;,5-pentabromodiphenyl ether causes altered susceptibility in the cholinergic transmitter system in the adult mouse.&nbsp; Toxicol. Sci. 67(1): 104-107.</p>\n\n<p>Viollon-Abadie, C., D. Lassere, E. Debruyne, L. Nicod, N. Carmichael and L. Richert. (1999) Phenobarbital, beta-naphthoflavone, clofibrate, and pregnenolone-16alpha-carbonitrile do not affect hepatic thyroid hormone UDP-glucuronosyl transferase activity, and thyroid gland function in mice.&nbsp; Toxicol. Appl. Pharmacol.&nbsp; 155(1) 1-12.</p>\n\n<p>Visser, T.J. and R.P. Peeters. (2012) Metabolism of thyroid hormone.&nbsp; In: De Groot LJ, Chrousos G, Dungan K, Feingold KR, Grossman A, Hershman JM, Koch C, Korbonits M, McLachlan R, New M, Purnell J, Rebar R, Singer F, Vinik A, editors. Endotext [Internet]. South Dartmouth (MA): MDText.com, Inc.; 2000-.</p>\n\n<p>Visser, T. J. (2010). Cellular Uptake of Thyroid Hormones. In: De Groot LJ, Chrousos G, Dungan K, Feingold KR, Grossman A, Hershman JM, Koch C, Korbonits M, McLachlan R, New M, Purnell J, Rebar R, Singer F, Vinik A, editors. Endotext [Internet]. South Dartmouth (MA): MDText.com, Inc.; 2000-.</p>\n\n<p>Visser, T.J. (1996) Role of sulfate in thyroid hormone sulfation.&nbsp; Eur. J. Endocrinol.&nbsp; 134(1): 12-14.</p>\n\n<p>Visser, T.J., E. Kaptein, J.A. van Raaij, C.T. Joe, T. Ebner and B. Burchell. (1993)</p>\n\n<p>Multiple UDP-glucuronyltransferases for the glucuronidation of thyroid hormone with preference for 3,3&#39;,5&#39;-triiodothyronine (reverse T3).&nbsp; FEBS Lett.&nbsp; 315(1): 65-68.</p>\n\n<p>Weiss, J.M., P.L. Andersson, M.H. Lamoree, P.E. Leonards, S.P. van Leeuwen and T. Hamers. (2009) Competitive binding of poly- and perfluorinated compounds to the thyroid hormone transport protein transthyretin.&nbsp; Toxicol. Sci.&nbsp; 109(2): 206-216.</p>\n\n<p>Weiss, J. M., Andersson, P. L., Zhang, J., Simon, E., Leonards, P. E. G., Hamers, T., &amp; Lamoree, M. H. (2015). Tracing thyroid hormone-disrupting compounds: database compilation and structure-activity evaluation for an effect-directed analysis of sediment. Analytical and Bioanalytical Chemistry, 5625&ndash;5634.&nbsp;<a href=\"http://doi.org/10.1007/s00216-015-8736-9\" target=\"_blank\">http://doi.org/10.1007/s00216-015-8736-9</a></p>\n\n<p>Yamauchi, K., A. Ishihara, H. Fukazawa and Y. Terao.&nbsp; (2003) Competitive interactions of chlorinated phenol compounds with 3,3&#39;,5-triiodothyronine binding to transthyretin: detection of possible thyroid-disrupting chemicals in environmental waste water.&nbsp; Toxicol. Appl. Pharmacol.&nbsp; 187(2): 110-117.</p>\n\n<p>Yen, P. M. (2001). Physiological and molecular basis of thyroid hormone action. Physiological Reviews, 81(3), 1097&ndash;1142.</p>\n\n<p>Zhang, J., J.H. Kamstra, M. Ghorbanzadeh, J.M. Weiss, T. Hamers and P.L. Andersson. (2015) In Silico Approach To Identify Potential Thyroid Hormone Disruptors among Currently Known Dust Contaminants and Their Metabolites.&nbsp; Environ. Sci. Technol.&nbsp; 49(16): 10099-10107.</p>\n\n<p>Zoeller, R. T., Tan, S. W., &amp; Tyl, R. W. (2007). General background on the hypothalamic-pituitary-thyroid (HPT) axis. Critical Reviews in Toxicology, 37(1-2), 11&ndash;53.</p>\n\n<p>Zoeller, R.T. and J. Rovet.&nbsp; (2004)&nbsp; Timing of thyroid hormone action in the developing brain: clinical observations and experimental findings.&nbsp; J. Neuroendocrinol.&nbsp; 16(10): 809-818.</p>\n","biologicalOrganisationLevel":"Molecular","organTerm":{},"biologicalEvents":[{"action":"increased","object":{"name":"thyroxine","source":"CHEBI","sourceId":"CHEBI:30660"}}],"id":958}
{"title":"Increased, Free serum thyroxine (T4)","references":"<p>Abdalla, S.M. and A.C. Bianco. (2014) Defending plasma T3 is a biological priority.&nbsp; Clin. Endocrinol. (Oxf)&nbsp; 81(5): 633-641.</p>\n\n<p>Alshehri, B., D&rsquo;Souza, D. G., Lee, J. Y., Petratos, S., &amp; Richardson, S. J. (2015). The Diversity of Mechanisms Influenced by Transthyretin in Neurobiology: Development, Disease and Endocrine Disruption. Journal of Neuroendocrinology, 27(5), 303&ndash;323.&nbsp;<a href=\"http://doi.org/10.1111/jne.12271\" target=\"_blank\">http://doi.org/10.1111/jne.12271</a></p>\n\n<p>Andrea, T.A., R.R. Cavalieri, I.D. Goldfine and E.C. Jorgensen (1980) Binding of thyroid hormones and analogues to the human plasma protein prealbumin. Biochemistry&nbsp; 19(1): 55-63.</p>\n\n<p>Aqai, P., C. Fryganas, M. Mizuguchi, W. Haasnoot and M.W. Nielen. (2012) Triple bioaffinity mass spectrometry concept for thyroid transporter ligands.&nbsp; Anal. Chem.&nbsp; 84(15): 6488-6493.</p>\n\n<p>Athanasiadou, M., S.N. Cuadra, G. Marsh, A&gt; Bergman, and K. Jakobsson. (2008) Polybrominated diphenyl ethers (PBDEs) and bioaccumulative hydroxylated PBDE metabolites in young humans from Managua, Nicaragua.&nbsp; Environ. Health Perspect. 116(3): 400-408.</p>\n\n<p>Barter, R.A. and C.D. Klaassen. (1994) Reduction of thyroid hormone levels and alteration of thyroid function by four representative UDP-glucuronosyltransferase inducers in rats.&nbsp; Toxicol. Appl. Pharmacol.&nbsp; 128(1): 9-17.</p>\n\n<p>Blake, C.C., J.M. Burridge and S.J. Oatley. (1978) X-ray analysis of thyroid hormone binding to prealbumin. Biochem Soc. Trans. 6(6): 1114-1118.</p>\n\n<p>Bloom, M.S., J.E. Vena, J.R. Olson and P.J. Kostyniak.&nbsp; (2009)&nbsp; Assessment of polychlorinated biphenyl congeners, thyroid stimulating hormone, and free thyroxine among New York state anglers.&nbsp; Int. J. Hyg. Environ. Health&nbsp; 212(6): 599-611.</p>\n\n<p>Branchi, I., E. Alleva and L.G. Costa.&nbsp; (2002)&nbsp; Effects of perinatal exposure to a polybrominated diphenyl ether (PBDE 99) on mouse neurobehavioural development.&nbsp; Neurotoxicology&nbsp; 23(3): 375-384.</p>\n\n<p>Brouwer, a, &amp; van den Berg, K. J. (1986). Binding of a metabolite of 3,4,3&rsquo;,4&#39;-tetrachlorobiphenyl to transthyretin reduces serum vitamin A transport by inhibiting the formation of the protein complex carrying both retinol and thyroxin. Toxicology and Applied Pharmacology, 85(3), 301&ndash;312.</p>\n\n<p>Calvo, R.M., E. Jauniaux, B. Gulbis, M. Asuncion, C. Gervy, B. Contempre and G. Morreale de Escobar.&nbsp; (2002)&nbsp; Fetal tissues are exposed to biologically relevant free thyroxine concentrations during early phases of development.&nbsp; J. Clin. Endocrinol. Metab.&nbsp; 87(4); 1768-1777.</p>\n\n<p>Cao, J., L.H. Guo, B. Wan and Y. Wei. (2011) In vitro fluorescence displacement investigation of thyroxine transport disruption by bisphenol A.&nbsp; J. Environ Sci, (China)&nbsp; 23(2): 315-321.</p>\n\n<p>Cao, J., Y. Lin, L.H. Guo, A.Q. Zhang, Y. Wei and Y. Yang. (2010) Structure-based investigation on the binding interaction of hydroxylated polybrominated diphenyl ethers with thyroxine transport proteins.&nbsp; Toxicology&nbsp; 277(1-3): 20-28.</p>\n\n<p>Chan, S.Y., J.A. Franklyn, H.N. Pemberton, J.N. Bulmer, T.J. Visser, C.J. McCabe and M.D. Kilby.&nbsp; (2006)&nbsp; Monocarboxylate transporter 8 expression in the human placenta: the effects of severe intrauterine growth restriction.&nbsp; J. Endocrinol.&nbsp; 189(3): 465-471.</p>\n\n<p>Chan, S., S. Kachilele, C.J. McCabe, L.A. Tannahill, K. Boelaert, N.J. Gittoes, T.J. Visser, J.A. Franklyn and M.D. Kilby.&nbsp; (2002)&nbsp; Early expression of thyroid hormone deiodinases and receptors in human fetal cerebral cortex.&nbsp; Brain Res. Dev. Brain Res.&nbsp; 138(2): 109-116.</p>\n\n<p>Chang, S.C., J.R. Thibodeaux, M.L. Eastvold, D.J. Ehresman, J.A. Bjork, J.W. Froehlich, C. Lau, R.J. Singh, K.B. Wallace and J.L. Butenhoff. (2008) Thyroid hormone status and pituitary function in adult rats given oral doses of perfluorooctanesulfonate (PFOS).&nbsp; Toxicology&nbsp; 243(3): 330-339.</p>\n\n<p>Chanoine, J.-P., Alex, S., Fang, S. L., Stone, S., Leonard, J. L., Kohrle, J., &amp; Braverman, L. E. (1992). Role of transthyretin in the transport of thyroxine from the blood to the choroid plexus, the cerebrospinal fluid and the brain. Endocrinology, 130(2), 933&ndash;938.</p>\n\n<p>Chauhan, K. R., Kodavanti, P. R. S., &amp; McKinney, J. D. (2000). Assessing the Role of ortho-Substitution on Polychlorinated Biphenyl Binding to Transthyretin, a Thyroxine Transport Protein. Toxicology and Applied Pharmacology, 162(1), 10&ndash;21.&nbsp;<a href=\"http://doi.org/10.1006/taap.1999.8826\" target=\"_blank\">http://doi.org/10.1006/taap.1999.8826</a></p>\n\n<p>Cheek, A.O., K. Kow, J. Chen and J.A. McLachlan. (1999) Potential mechanisms of thyroid disruption in humans: interaction of organochlorine compounds with thyroid receptor, transthyretin, and thyroid-binding globulin.&nbsp; Environ. Health Perspect.&nbsp; 107(4): 273-278.</p>\n\n<p>Chevrier, J., K.G. Harley, A. Bradman, M. Gharbi, A. Sjodin and B. Eskenazi.&nbsp; (2010)&nbsp; Polybrominated diphenyl ether (PBDE) flame retardants and thyroid hormone during pregnancy.&nbsp; Environ. Health Perspect.&nbsp; 118(10) : 1444-1449.</p>\n\n<p>Chopra, I.J., P. Taing and L. Mikus. (1996) Direct determination of free triiodothyronine (T3) in undiluted serum by equilibrium dialysis/radioimmunoassay (RIA).&nbsp; Thyroid&nbsp; 6(4): 255-259.</p>\n\n<p>Costa, L.G., R. de Laat, S. Tagliaferri and C. Pellacani.&nbsp; (2014)&nbsp; A mechanistic view of polybrominated diphenyl ether (PBDE) developmental neurotoxicity.&nbsp; 230(2): 282-294.</p>\n\n<p>Dallaire, R., G. Muckle, E. Dewailly, S.W. Jacobson, J.L. Jacobson, T.M. Sandanger, C.D. Sandau and P. Ayotte. (2009a)&nbsp; Thyroid hormone levels of pregnant inuit women and their infants exposed to environmental contaminants.&nbsp; Environ. Health Perspect.&nbsp; 117(6): 1014-1020.</p>\n\n<p>Dallaire, R., E. Dewailly, D. Pereg, S. Dery and P. Ayotte.&nbsp; (2009b)&nbsp; Thyroid function and plasma concentrations of polyhalogenated compounds in Inuit adults.&nbsp; Environ. Health Perspect.&nbsp; 117(9): 1380-1386.</p>\n\n<p>Darnerud, P.O., D. Morse, E. Klasson-Wehler and A Brouwer.&nbsp; (1996)&nbsp; Binding of a 3,3&#39;, 4,4&#39;-tetrachlorobiphenyl (CB-77) metabolite to fetal transthyretin and effects on fetal thyroid hormone levels in mice.&nbsp; Toxicology&nbsp; 106(1-3): 105-114.</p>\n\n<p>De Escobar, G.M., M.J. Obregon and F.E. del Rey.&nbsp; (2004)&nbsp; Maternal thyroid hormones early in pregnancy and fetal brain development.&nbsp; Best Pract. Res. Clin. Endocrinol. Metab.&nbsp; 18(2): 225-248.</p>\n\n<p>Dirinck, E., A.C. Dirtu, G. Malarvanna, A. Covaci, P.G. Jorens and L.F. Van Gall. (2016) A Preliminary Link between Hydroxylated Metabolites of Polychlorinated Biphenyls and Free Thyroxin in Humans.&nbsp; Int. J. Environ. Res. Public Health&nbsp; 13(4): 421.</p>\n\n<p>Eguchi, A., K. Nomiyama, N. Minh Tue, P.T. Trang, P. Hung Viet, S. Takahashi and S. Tanabe.&nbsp; (2015)&nbsp; Residue profiles of organohalogen compounds in human serum from e-waste recycling sites in North Vietnam: Association with thyroid hormone levels.&nbsp; Environ. Res.&nbsp; 137: 440-449.</p>\n\n<p>Emerson, C.H., J.H. Cohen III, R.A Yung, S. Alex and S.L. Fang. (1990) Gender-related differences of serum thyroxine-binding proteins in the rat. Acta Endocrinol. (Copenh)&nbsp; 123(1): 72-78.</p>\n\n<p>Erratico, C.A., A. Steitz and S.M. Bandiera. (2013) Biotransformation of 2,2&#39;,4,4&#39;-tetrabromodiphenyl ether (BDE-47) by human liver microsomes: identification of cytochrome P450 2B6 as the major enzyme involved.&nbsp; Chem. Res. Toxicol.&nbsp; 26(5): 721-731.</p>\n\n<p>Erratico, C.A., S.C. Moffatt and S.M. Bandiera. (2011) Comparative oxidative metabolism of BDE-47 and BDE-99 by rat hepatic microsomes.&nbsp; Toxicol. Sci.&nbsp; 123(1): 37-47.</p>\n\n<p>Eskenazi, B., J. Chevrier, S.A. Rauch, K. Kogul, K.G. Harley, C. Johnson, C. Trujillo, A. Sjodin and A. Bradman.&nbsp; (2013)&nbsp; In utero and childhood polybrominated diphenyl ether (PBDE) exposures and neurodevelopment in the CHAMACOS study.&nbsp; 121(2) : 257-262.</p>\n\n<p>Feo, M.L., M.S. Gross, B.P. McGarrigle, E. Eljarrat, D. Barcelo, D.S. Aga and J.R. Olson. (2013) Biotransformation of BDE-47 to potentially toxic metabolites is predominantly mediated by human CYP2B6.&nbsp; Environ. Health Persepct.&nbsp; 121(4): 440-446.</p>\n\n<p>Ferguson, R.N., H. Edelhoch, H.A. Saroff, J. Robbins and H.J. Cahnmann (1975) Negative cooperativity in the binding of thyroxine to human serum prealbumin. Preparation of tritium-labeled 8-anilino-1-naphthalenesulfonic acid.&nbsp; Biochemistry&nbsp; 14(2): 282-289.</p>\n\n<p>Friesema EC, Jansen J, Jachtenberg JW, Visser WE, Kester MH, Visser TJ 2008 Effective cellular uptake and efflux of thyroid hormone by human monocarboxylate transporter 10. Molecular endocrinology (Baltimore, Md 22:1357-1369</p>\n\n<p>Friesema EC, Kuiper GG, Jansen J, Visser TJ, Kester MH 2006 Thyroid hormone transport by the human monocarboxylate transporter 8 and its rate-limiting role in intracellular metabolism. Molecular endocrinology (Baltimore, Md 20:2761-2772</p>\n\n<p>Friesma, E.C., J. Jansen and T.J. Visser. (2005) Thyroid hormone transporters.&nbsp; Biochem. Soc. Trans.&nbsp; 33(part 1): 228-232.</p>\n\n<p>Friesema EC, Ganguly S, Abdalla A, Manning Fox JE, Halestrap AP, Visser TJ 2003 Identification of monocarboxylate transporter 8 as a specific thyroid hormone transporter. J Biol Chem 278:40128-40135</p>\n\n<p>Grimm, F. a., Lehmler, H. J., He, X., Robertson, L. W., &amp; Duffel, M. W. (2013). Sulfated metabolites of polychlorinated biphenyls are high-affinity ligands for the thyroid hormone transport protein transthyretin. Environmental Health Perspectives, 121(6), 657&ndash;662.</p>\n\n<p>Gutshall, D.M., G.D. Pilcher and A.E. Langley. (1989) Mechanism of the serum thyroid hormone lowering effect of perfluoro-n-decanoic acid (PFDA) in rats. J. Toxicol. Environ. Health&nbsp;&nbsp; 28(1): 53-65.</p>\n\n<p>Hagenbuch, B. (2007)&nbsp; Cellular entry of thyroid hormones by organic anion transporting polypeptides.&nbsp; Best Pract. Res. Clin. Endocrinol. Metab.&nbsp; 21(2): 209-221.</p>\n\n<p>Hagenbuch B, Meier PJ 2004 Organic anion transporting polypeptides of the OATP/ SLC21 family: phylogenetic classification as OATP/ SLCO superfamily, new nomenclature and molecular/functional properties. Pflugers Arch 447:653-665</p>\n\n<p>Hagmar, L., L. Rylander, E. Dyremark, E. Klasson-Wehler and E.M. Erfurth. (2001a).&nbsp; Plasma concentrations of persistent organochlorines in relation to thyrotropin and thyroid hormone levels in women.&nbsp; Int. Arch. Occup. Environ. Health&nbsp; 74(3): 184-188.</p>\n\n<p>Hagmar, L., J. Bjork, A. Sjodin, A. Bergman and E.M. Erfurth. (2001b) Plasma levels of persistent organohalogens and hormone levels in adult male humans.&nbsp; Arch. Environ. Health&nbsp; 56(2): 138-143.</p>\n\n<p>Hallgren, S., T. Sinjari, H. Hakansson and P.O. Darnerud. (2001) Effects of polybrominated diphenyl ethers (PBDEs) and polychlorinated biphenyls (PCBs) on thyroid hormone and vitamin A levels in rats and mice.&nbsp; 75(4): 200-208.</p>\n\n<p>Hallgren, S. and P.O. Darnerud. (2002) Polybrominated diphenyl ethers (PBDEs), polychlorinated biphenyls (PCBs) and chlorinated paraffins (CPs) in rats-testing interactions and mechanisms for thyroid hormone effects.&nbsp; Toxicology&nbsp; 177(203): 227-243.</p>\n\n<p>Hamers, T., J.H. Kamstra, E. Sonneveld, A.J. Murk, M.H. Kester, P.L. Andersson, J. Legler and A. Brouwer. (2006) In vitro profiling of the endocrine-disrupting potency of brominated flame retardants.&nbsp; Toxicol. Sci.&nbsp; 92(1): 157-173.</p>\n\n<p>Hamers, T., Kamstra, E. Sonneveld, A.J. Murk, T.J. Visser, M.J. Van Velzen, A. Brouwer and A. Bergman. (2008) Biotransformation of brominated flame retardants into potentially endocrine-disrupting metabolites, with special attention to 2,2&#39;,4,4&#39;-tetrabromodiphenyl ether (BDE-47).&nbsp; Mol. Nutr. Food Res.&nbsp; 52(2): 284-298.</p>\n\n<p>Harley, K.G., A.R. Marks, J. Chevrier, A. Bradman, A. Sjodin and B. Eskenazi.&nbsp; (2010)&nbsp; PBDE concentrations in women&#39;s serum and fecundability.&nbsp; Environ. Health Perspect.&nbsp; 118(5): 699-704.</p>\n\n<p>Henneman, G., R. Docter, E.C. Friesma, M. de Jong, E.P. Krenning and T.J. Visser.&nbsp; (2001)&nbsp; Plasma membrane transport of thyroid hormones and its role in thyroid hormone metabolism and bioavailability.&nbsp; Endocr. Rev.&nbsp; 22(4): 451-476.</p>\n\n<p>Heuer, H. &nbsp;(2007)&nbsp; The importance of thyroid hormone transporters for brain development and function.&nbsp; Best Pract. Res. Clin. Endocrinol. Metab.&nbsp; 21(2):&nbsp; 265-276.</p>\n\n<p>Hood, A. and C.D. Klaassen. (2000a) Differential effects of microsomal enzyme inducers on in vitro thyroxine (T(4)) and triiodothyronine (T(3)) glucuronidation.&nbsp; Toxicol. Sci.&nbsp; 55(1): 78-84.</p>\n\n<p>Hood, A. and C.D. Klaassen.&nbsp; (2000b)&nbsp; Effects of microsomal enzyme inducers on outer-ring deiodinase activity toward thyroid hormones in various rat tissues.&nbsp; Toxicol. Appl. Pharmacol.&nbsp; 163(3): 240-248.</p>\n\n<p>Hovander, L., M. Athanasiadou, L. Asplund, S. Jensen and E.K. Wehler. (2000). Extraction and cleanup methods for analysis of phenolic and neutral organohalogens in plasma.&nbsp; 24(8): 696-703.</p>\n\n<p>Hume, R., J. Simpson, C. Delahunty, H. van Toor, S.Y. Wu, F.L. Williams, T.J. Visser et al.&nbsp; (2004) Human fetal and cord serum thyroid hormones: developmental trends and interrelationships.&nbsp; J. Clin. Endocrinol. Metab.&nbsp; 89(8): 4097-4103.</p>\n\n<p>Inoue, K., F. Okada, R. Ito, S. Kato, S. Sasaki, S. Nakajima, A. Uno, Y. Saijo, F. Sata, Y. Yoshimura, R. Kishi and H. Nakazawa. (2004) Perfluorooctane sulfonate (PFOS) and related perfluorinated compounds in human maternal and cord blood samples: assessment of PFOS exposure in a susceptible population during pregnancy.&nbsp; Environ. Health Perspect.&nbsp; 112(11): 1204-1207.</p>\n\n<p>Kato, Y., K. Haraguchi, M. Onishi, S. Ikushiro, T. Endo, C. Ohta, N. Koga, S Yamada and M. Degawa. (2014) 3,3&#39;,4,4&#39;-Tetrachlorobiphenyl-mediated decrease of serum thyroxine level in C57BL/6 and DBA/2 mice occurs mainly through enhanced accumulation of thyroxine in the liver.&nbsp; Biol. Pharm. Bull.&nbsp; 37(3) 504-509.</p>\n\n<p>Kato, Y., M. Onishi, K. Haraguchi, S. Ikushiro, C. Ohta, N. Koga, T. Endo, S. Yamada and M. Degawa. (2013) A possible mechanism for 2,3&#39;,4,4&#39;,5&#39;-pentachlorobiphenyl-mediated decrease in serum thyroxine level in mice.&nbsp; Biol. Pharm. Bull.&nbsp; 36(10): 1594-1601.</p>\n\n<p>Kato, Y., S. Tamaki, K. Haraguchi, S. Ikushiro, M. Sekimoto, C. Ohta, T. Endo, N. Koga, S. Yamada and M. Degawa. (2012) Comparative study on 2,2&#39;,4,5,5&#39;-pentachlorobiphenyl-mediated decrease in serum thyroxine level between C57BL/6 and its transthyretin-deficient mice.&nbsp; Toxicol. Appl. Pharmacol.&nbsp; 263(3): 323-329.</p>\n\n<p>Kato, Y., M. Onishi, K. Haraguchi, S. Ikushiro, C. Ohta, N. Koga, T. Endo, S. Yamada and M. Degawa. (2011) A possible mechanism for 2,2&#39;,4,4&#39;,5,5&#39;-hexachlorobiphenyl-mediated decrease in serum thyroxine level in mice.&nbsp; Toxicol. Appl. Pharmacol.&nbsp; 254(1): 48-55.</p>\n\n<p>Kato, Y., K. Haraguchi, M. Kubota, Y. Seto, S. Ikushiro, T. Sakaki, N. Koga, S. Yamada and M. Degawa. (2009) 4-Hydroxy-2,2&#39;,3,4&#39;,5,5&#39;,6-heptachlorobiphenyl-mediated decrease in serum thyroxine level in mice occurs through increase in accumulation of thyroxine in the liver.&nbsp; Drug Metab. Dispos.&nbsp; 37(10): 2095-2102.</p>\n\n<p>Kato, Y., S. Ikushiro, R. Takiguchi, K. Haraguchi, N. Koga, S. Uchida, T. Sakaki, S. Yamada, J. Kanno and M. Degawa. (2007) A novel mechanism for polychlorinated biphenyl-induced decrease in serum thyroxine level in rats.&nbsp; Drug Metab. Dispos. 35(10) : 1949-1955.</p>\n\n<p>Kato, Y., S. Ikushiro, K. Haraguchi, T. Yamazaki, Y. Ito, H. Suzuki, R. Kimura, S. Yamada, T. Inoue and M. Degawa. (2004) A possible mechanism for decrease in serum thyroxine level by polychlorinated biphenyls in Wistar and Gunn rats.&nbsp; Toxicol. Sci.&nbsp; 81(2): 309-315.</p>\n\n<p>Kato, Y., K. Haraguchi, T. Yamazuki, Y. Ito, S. Miyajima, K. Nemoto, N. Koga, R. Kimura and M. Degawa. (2003) Effects of polychlorinated biphenyls, kanechlor-500, on serum thyroid hormone levels in rats and mice.&nbsp; Toxicol. Sci.&nbsp; 72(2): 235-241.</p>\n\n<p>Kim, S.Y., E.S. Choi, H.J. Lee, C. Moon and E. Kim.&nbsp; (2015)&nbsp; Transthyretin as a new transporter of nanoparticles for receptor-mediated transcytosis in rat brain microvessels.&nbsp; Colloids Surf B Biointerfaces&nbsp; 136: 989-996.</p>\n\n<p>Kim do K, Kanai Y, Matsuo H, Kim JY, Chairoungdua A, Kobayashi Y, Enomoto A, Cha SH, Goya T, Endou H 2002 The human T-type amino acid transporter-1: characterization, gene organization, and chromosomal location. Genomics 79:95-103</p>\n\n<p>Kohrle, J., S.L. Fang, Y. Yang, K. Irmscher, R.D. Hesch, S. Pino, S. Alex, and L.E. Braverman. (1989). Rapid effects of the flavonoid EMD 21388 on serum thyroid hormone binding and thyrotropin regulation in the rat. Endocrinoloy 125: 532-537</p>\n\n<p>Koopman-Essenboom, C., D.C. Morse, N. Weisglas-Kuperus, I.J. Lutkeschipholt, C.G. Van der Paauw, L.G. Tuinstra, A. Brouwer and P.J. Sauer.&nbsp; (1994)&nbsp; Effects of dioxins and polychlorinated biphenyls on thyroid hormone status of pregnant women and their infants.&nbsp; Pediatr. Res.&nbsp; 36(4): 468-473.</p>\n\n<p>Lans, M. C., Klasson-Wehler, E., Willemsen, M., Meussen, E., Safe, S., &amp; Brouwer, A. (1993). STRUCTURE-DEPENDENT, COMPETITIVE INTERACTION OF HYDROXY-POLYCHLOROBIPHENYLS, -DIBENZO-p-DIOXINS AND -DIBENZOFURANS WITH HUMAN TRANSTHYRETIN. Chemico-Biological Interactions, 88, 7&ndash;21.</p>\n\n<p>Lans, M. C., Spiertz, C., Brouwer, a, &amp; Koeman, J. H. (1994). Different competition of thyroxine binding to transthyretin and thyroxine-binding globulin by hydroxy-PCBs, PCDDs and PCDFs. European Journal of Pharmacology, 270(2-3), 129&ndash;136.&nbsp;<a href=\"http://doi.org/10.1016/0926-6917(94)90054-X\" target=\"_blank\">http://doi.org/10.1016/0926-6917(94)90054-X</a></p>\n\n<p>Larsson, M., Pettersson, T., &amp; Carlstr&ouml;m, a. (1985). Thyroid hormone binding in serum of 15 vertebrate species: isolation of thyroxine-binding globulin and prealbumin analogs. General and Comparative Endocrinology, 58(3), 360&ndash;375.</p>\n\n<p>Loubiere, L.S., E. Vasilopoulou, J.N. Bulmer, P.M. Taylor, B. Stieger, F. Verrey, C.J. McCabe, J.A. Franklyn, M.D. Kilby and S.Y. Chan. (2010)&nbsp; Expression of thyroid hormone transporters in the human placenta and changes associated with intrauterine growth restriction.&nbsp; Placenta&nbsp; 31(4): 295-304.</p>\n\n<p>Lueprasitsakul, W., Alex, S., Fang, S. L., Pino, S., Irmscher, K., K&ouml;hrle, J., &amp; Braverman, L. E. (1990). Flavonoid administration immediately displaces thyroxine (T4) from serum transthyretin, increases serum free T4, and decreases serum thyrotropin in the rat. Endocrinology 126 (6)</p>\n\n<p>Lupton, S.J., P. McGarrigle, J.R. Olson, T.D. Wood and D.S. Aga. (2010) Analysis of hydroxylated polybrominated diphenyl ether metabolites by liquid chromatography/atmospheric pressure chemical ionization tandem mass spectrometry.&nbsp; Rapid Commun. Mass. Spectrom.&nbsp; 24(15): 2227-2235.</p>\n\n<p>Lupton, S.J., B.P. McGarrigle, J.R. Olson, T.D. Wood and D.S. Aga. (2009)&nbsp; Analysis of hydroxylated polybrominated diphenyl ether metabolites by liquid chromatography/atmospheric pressure chemical ionization tandem mass spectrometry.&nbsp; 22(11): 1802-1809.</p>\n\n<p>Malmberg, T., M. Athanasiadou, G. Marsh, I. Brandt and A. Bergman.&nbsp; (2005) Identification of hydroxylated polybrominated diphenyl ether metabolites in blood plasma from polybrominated diphenyl ether exposed rats.&nbsp; 39(14): 5342-5348.</p>\n\n<p>Marchesini, G.R., E. Meulenberg, W. Haasnoot, M. Mizuguchi and H. Irth.&nbsp; (2006) Biosensor recognition of thyroid-disrupting chemicals using transport proteins.&nbsp; Anal. Chem.&nbsp; 78(4): 1107-1114.</p>\n\n<p>Marchesini, G.R., A. Meimaridou, W. Haasnoot, E. Meulenberg, F. Albertus, M. Mizuguchi, M. Takeuchi, H. Irth and A.J. Murk. (2008) iosensor discovery of thyroxine transport disrupting chemicals.&nbsp; Toxicol. Appl. Pharmacol.&nbsp; 232(1): 150-160.</p>\n\n<p>Martin, L.A., D.T. Wilson, K.R&gt; Reuhl, M.A. Gallo and C.D. Klaassen. (2012) Polychlorinated biphenyl congeners that increase the glucuronidation and biliary excretion of thyroxine are distinct from the congeners that enhance the serum disappearance of thyroxine.&nbsp; Drug Metab. Dispos.&nbsp; 40(3): 588-595.</p>\n\n<p>Martin, L. and C.D. Klaassen. (2010) Differential effects of polychlorinated biphenyl congeners on serum thyroid hormone levels in rats.&nbsp; Toxicol. Sci.&nbsp; 117(1): 36-44.</p>\n\n<p>Meerts, I.A., Y. Assink, P.H. Cenjin, J.H. Van Den Berg, B.M. Weijers, A. Bergman, J.H. Koeman and A. Brouwer. (2002) Placental transfer of a hydroxylated polychlorinated biphenyl and effects on fetal and maternal thyroid hormone homeostasis in the rat.&nbsp; Toxicol. Sci. 68(2): 361-371.</p>\n\n<p>Meerts, I.A., J.J. van Zanden, E.A. Lujiks, I. van Leeuwen-Bol, G. Marsh, E. Jakobsson, A. Bergman and A. Brouwer. (2000) Potent competitive interactions of some brominated flame retardants and related compounds with human transthyretin in vitro.&nbsp; Toxicol. Sci.&nbsp; 56(1): 95-104.</p>\n\n<p>Mendel, C. M. (1989). Modeling thyroxine transport to liver&nbsp;: rejection of the &ldquo;enhanced dissociation&rdquo; hypothesis as applied to thyroxine. Am J Physiol, 257(Endocrinol Metab 20), E764&ndash;E771.</p>\n\n<p>Mendel, C. M., Cavalieri, R. R., &amp; Kohrle, J. (1992). Thyroxine (T4) transport and distribution in rats treated with EMD 21388, a synthetic flavonoid that displaces T4 from transthyretin. Endocrinology, 130(3), 1525&ndash;1532.</p>\n\n<p>Midgley, J. E. (2001) Direct and indirect free thyroxine assay methods: theory and practice.&nbsp; Clin. Chem.&nbsp; 47(8): 1353-1363.</p>\n\n<p>Miksys, S. and R.F. Tyndale. (2004) The unique regulation of brain cytochrome P450 2 (CYP2) family enzymes by drugs and genetics.&nbsp; Drug Metab. Rev.&nbsp; 36(2): 313-333.</p>\n\n<p>Montano, M., E. Coccco, C. Guignard, G. Marsh, L. Hoffmann, A. Bergman, A.C. Gutleb and A.J. Murk. (2012) New approaches to assess the transthyretin binding capacity of bioactivated thyroid hormone disruptors.&nbsp; Toxicol. Sci.&nbsp; 130(1): 94-105.</p>\n\n<p>Morse, D.C., E.K. Wehler, W. Wesseling, J.H. Koeman and A. Brouwer.&nbsp; (1996)&nbsp; Alterations in rat brain thyroid hormone status following pre- and postnatal exposure to polychlorinated biphenyls (Aroclor 1254).&nbsp; Toxicol. Appl. Pharmacol.&nbsp; 136(2): 269-279.</p>\n\n<p>Morse, D.C., D. Groen, M. Veerman, C.J. van Amerongen, H.B. Koeter, A.E. Smits van Proojie, T.J. Visser, J.H. Koeman and A. Brouwer.&nbsp; (1993)&nbsp; Interference of polychlorinated biphenyls in hepatic and brain thyroid hormone metabolism in fetal and neonatal rats.&nbsp; Toxicol. Appl. Pharmacol.&nbsp; 122(1) :27-33.</p>\n\n<p>Munro, S.L., C.F. Lim, J.G. Hall, J.W. Barlow, D.J. Craik, D.J. Topliss and J.R. Stockigt (1989) Drug competition for thyroxine binding to transthyretin (prealbumin): comparison with effects on thyroxine-binding globulin. J. Clin. Endocrinol. Metab.&nbsp; 68(6): 1141-1147,</p>\n\n<p>Nishimura M, Naito S 2008 Tissue-specific mRNA expression profiles of human solute carrier transporter superfamilies. Drug Metab Pharmacokinet 23:22-44</p>\n\n<p>Pedraza, P., Calvo, R., Obreg&oacute;n, M. J., Asuncion, M., Escobar Del Rey, F., &amp; Morreale De Escobar, G. (1996). Displacement of T4 from transthyretin by the synthetic flavonoid EMD 21388 results in increased production of T3 from T4 in rat dams and fetuses. Endocrinology, 137(11), 4902&ndash;4914.&nbsp;<a href=\"http://doi.org/10.1210/en.137.11.4902\" target=\"_blank\">http://doi.org/10.1210/en.137.11.4902</a></p>\n\n<p>Purkey, H.E., M.I. Dorrell and J.W. Kelly. (2001) Evaluating the binding selectivity of transthyretin amyloid fibril inhibitors in blood plasma.&nbsp; Proc. Natl. Acad. Sci. USA&nbsp; 98(10): 5566-5571.</p>\n\n<p>Refetoff, S., N.I. Robin and V.S. Fang. (1970) Parameters of thyroid function in serum of 16 selected vertebrate species: a study of PBI, serum T4, free T4, and the pattern of T4 and T3 binding to serum proteins.&nbsp; Endocrinology&nbsp; 86(4): 793-805.</p>\n\n<p>Refetoff, S. (2015) Thyroid Hormone Serum Transport Proteins. In: De Groot LJ, Chrousos G, Dungan K, Feingold KR, Grossman A, Hershman JM, Koch C, Korbonits M, McLachlan R, New M, Purnell J, Rebar R, Singer F, Vinik A, editors. Endotext [Internet]. South Dartmouth (MA): MDText.com, Inc.; 2000.</p>\n\n<p>Ren, X.M., L.H. Guo, Y. Gao, B.T. Zhang and B. Wan. (2013) Hydroxylated polybrominated diphenyl ethers exhibit different activities on thyroid hormone receptors depending on their degree of bromination.&nbsp; Toxicol. Appl. Pharamacol.&nbsp; 268(3): 256-263.</p>\n\n<p>Ren, X. M., &amp; Guo, L. H. (2012). Assessment of the binding of hydroxylated polybrominated diphenyl ethers to thyroid hormone transport proteins using a site-specific fluorescence probe. Environmental Science and Technology, 46(8), 4633&ndash;4640.&nbsp;<a href=\"http://doi.org/10.1021/es2046074\" target=\"_blank\">http://doi.org/10.1021/es2046074</a></p>\n\n<p>Rerat, C. and H.G. Schwick (1967) [Crystallographic data of blood plasma prealbumin]. [Article in French] Acta Crystallogr.&nbsp; 22(3): 441-442.</p>\n\n<p>Richardson, S. J. (2007). Cell and molecular biology of transthyretin and thyroid hormones. International Review of Cytology, 258(January), 137&ndash;93.&nbsp;<a href=\"http://doi.org/10.1016/S0074-7696(07)58003-4\" target=\"_blank\">http://doi.org/10.1016/S0074-7696(07)58003-4</a></p>\n\n<p>Richardson, S. J., Wijayagunaratne, R. C., D&rsquo;Souza, D. G., Darras, V. M., &amp; Van Herck, S. L. J. (2015). Transport of thyroid hormones via the choroid plexus into the brain: the roles of transthyretin and thyroid hormone transmembrane transporters. Frontiers in Neuroscience, 9(March), 1&ndash;8.</p>\n\n<p>Rickenbacher, U., McKinney, J. D., Oatley, S. J., &amp; Blake, C. C. (1986). Structurally specific binding of halogenated biphenyls to thyroxine transport protein. Journal of Medicinal Chemistry, 29(5), 641&ndash;648.</p>\n\n<p>Ritchie, J.W. and P.M. Taylor.&nbsp; (2001)&nbsp; Role of the System L permease LAT1 in amino acid and iodothyronine transport in placenta.&nbsp; Biochem. J.&nbsp; 356(Part 3); 719-725.</p>\n\n<p>Riu, A., J.P. Cravedi, L. Debrauwer, A. Garcia, C. Canlet, I. Jouanin and D. Zalko. (2008) Environ. Int. 34(3): 318-329.</p>\n\n<p>Roberts LM, Woodford K, Zhou M, Black DS, Haggerty JE, Tate EH, Grindstaff KK, Mengesha W, Raman C, Zerangue N 2008 Expression of the thyroid hormone transporters MCT8 (SLC16A2) and OATP14 (SLCO1C1) at the blood-brain barrier. Endocrinology 149:6251-6261</p>\n\n<p>Rotroff, D.M., B.A. Wetmore, D.J. Dix, S.S. Ferguson, H.J. Clewell, K.A. Houck, E.L. Lecluyse, M.E. Anersen, R.S. Judson, C.M. Smith, M.A. Sochaski, R.J. Kavlock, F. Boellmann, M.T. Martin, D.M. Reif, J.F. Wambaugh and R.S. Thomas. (2010) Incorporating human dosimetry and exposure into high-throughput in vitro toxicity screening.&nbsp; 117(2): 348-358.</p>\n\n<p>Sato, K., J. Sugawara, T. Sato, H. Mizutamari, T. Suzuki, A. Ito, T. Mikkaichi, T. Onogawa, M. Tanemoto, M. Unno, T. Abe and K. Okamura.&nbsp; (2003)&nbsp; Expression of organic anion transporting polypeptide E (OATP-E) in human placenta.&nbsp; Placenta&nbsp; 24(2-3): 144-148.</p>\n\n<p>Schreiber, G. (2002). The evolutionary and integrative roles of transthyrein in thyroid hormone homeostasis. Journal of Endocrinology, 175(1), 61&ndash;73.&nbsp;<a href=\"http://doi.org/10.1677/joe.0.1750061\" target=\"_blank\">http://doi.org/10.1677/joe.0.1750061</a></p>\n\n<p>Schroder van der Elst, J.P., D. van der Heide, H. Rokos, G. Morreale de Escobar and J. Kohrlre. (1998) Synthetic flavonoids cross the placenta in the rat and are found in fetal brain.&nbsp; Am. J. Physiol.&nbsp; 274(2 Psrt 1): E253-E256.</p>\n\n<p>Schroder van der Elst, J.P., D. van der Heide, H. Rokos, J. Kohrle and G. Morreale de Escobar. (1997)&nbsp; Different tissue distribution, elimination, and kinetics of thyroxine and its conformational analog, the synthetic flavonoid EMD 49209 in the rat.&nbsp; Endocrinology&nbsp; 138(1): 79-84.</p>\n\n<p>Schuur, A.G., F.M. Boekhorst, A. Brouwer and T.J. Visser. (1997) Extrathyroidal effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin on thyroid hormone turnover in male Sprague-Dawley rats.&nbsp; Endocrinology&nbsp; 138(9): 3727-3734.</p>\n\n<p>Sinjari, T. and P.O. Darnerud. (1998) Hydroxylated polychlorinated biphenyls: placental transfer and effects on thyroxine in the foetal mouse.&nbsp; Xenobiotica&nbsp; 28(1): 21-30.</p>\n\n<p>Sparkes, R.S., H. Sasaki, T. Mohandas, K. Yoshioka, I. Kilsak, Y. Sasaki, C. Heinzmann and M.I. Simon. (1987) Assignment of the prealbumin (PALB) gene (familial amyloidotic polyneuropathy) to human chromosome region 18q11.2-q12.1. Hum. Genet.&nbsp; 75(2): 151-154.</p>\n\n<p>Stapleton, H.M., S.M. Kelly, R. Pei, R.J. Letcher and C. Gunsch.&nbsp; (2009) Metabolism of polybrominated diphenyl ethers (PBDEs) by human hepatocytes in vitro.&nbsp; Environ. Health Perspect.&nbsp; 117(2): 197-202.</p>\n\n<p>Tohyama K, Kusuhara H, Sugiyama Y 2004 Involvement of multispecific organic anion transporter, Oatp14 (Slc21a14), in the transport of thyroxine across the blood-brain barrier. Endocrinology</p>\n\n<p>Ucan-Marin, F., A. Arukwe, A.S. Mortensen, G.W. Gabrielsen and R.J. Letcher. (2010) Recombinant albumin and transthyretin transport proteins from two gull species and human: chlorinated and brominated contaminant binding and thyroid hormones.&nbsp; Environ. Sci. Technol.&nbsp; 44(1): 497-504.</p>\n\n<p>Van Birgelen, A.P., E.A. Smit, I.M. Kampen, C.N. Groeneveld, K.M. Case, J. Van der Kolk, H. Poiger, M. Van den Berg, J.H. Koeman and A. Brouwer. (1995) Subchronic effects of 2,3,7,8-TCDD or PCBs on thyroid hormone metabolism: use in risk assessment.&nbsp; Eur. J. Pharmacol.&nbsp; 293(1) : 77-85.</p>\n\n<p>Van den Berg, K. J. (1990). Interaction of chlorinated phenols with thyroxine binding sites of human transthyretin, albumin and thyroid binding globulin. Chemico-Biological Interactions, 76(1), 63&ndash;75.</p>\n\n<p>Van den Berg, K. J., Van Raaij, J. a G. M., Bragt, P. C., &amp; Notten, W. R. F. (1991). Interactions of halogenated industrial chemicals with transthyretin and effects on thyroid hormone levels in vivo. Archives of Toxicology, 65(1), 15&ndash;19.</p>\n\n<p>Viberg, H., A. Fredriksson and P. Eriksson. (2002) Neonatal exposure to the brominated flame retardant 2,2&#39;,4,4&#39;,5-pentabromodiphenyl ether causes altered susceptibility in the cholinergic transmitter system in the adult mouse.&nbsp; Toxicol. Sci. 67(1): 104-107.</p>\n\n<p>Viollon-Abadie, C., D. Lassere, E. Debruyne, L. Nicod, N. Carmichael and L. Richert. (1999) Phenobarbital, beta-naphthoflavone, clofibrate, and pregnenolone-16alpha-carbonitrile do not affect hepatic thyroid hormone UDP-glucuronosyl transferase activity, and thyroid gland function in mice.&nbsp; Toxicol. Appl. Pharmacol.&nbsp; 155(1) 1-12.</p>\n\n<p>Visser, T.J. and R.P. Peeters. (2012) Metabolism of thyroid hormone.&nbsp; In: De Groot LJ, Chrousos G, Dungan K, Feingold KR, Grossman A, Hershman JM, Koch C, Korbonits M, McLachlan R, New M, Purnell J, Rebar R, Singer F, Vinik A, editors. Endotext [Internet]. South Dartmouth (MA): MDText.com, Inc.; 2000-.</p>\n\n<p>Visser, T. J. (2010). Cellular Uptake of Thyroid Hormones. In: De Groot LJ, Chrousos G, Dungan K, Feingold KR, Grossman A, Hershman JM, Koch C, Korbonits M, McLachlan R, New M, Purnell J, Rebar R, Singer F, Vinik A, editors. Endotext [Internet]. South Dartmouth (MA): MDText.com, Inc.; 2000-.</p>\n\n<p>Visser, T.J. (1996) Role of sulfate in thyroid hormone sulfation.&nbsp; Eur. J. Endocrinol.&nbsp; 134(1): 12-14.</p>\n\n<p>Visser, T.J., E. Kaptein, J.A. van Raaij, C.T. Joe, T. Ebner and B. Burchell. (1993)</p>\n\n<p>Multiple UDP-glucuronyltransferases for the glucuronidation of thyroid hormone with preference for 3,3&#39;,5&#39;-triiodothyronine (reverse T3).&nbsp; FEBS Lett.&nbsp; 315(1): 65-68.</p>\n\n<p>Weiss, J.M., P.L. Andersson, M.H. Lamoree, P.E. Leonards, S.P. van Leeuwen and T. Hamers. (2009) Competitive binding of poly- and perfluorinated compounds to the thyroid hormone transport protein transthyretin.&nbsp; Toxicol. Sci.&nbsp; 109(2): 206-216.</p>\n\n<p>Weiss, J. M., Andersson, P. L., Zhang, J., Simon, E., Leonards, P. E. G., Hamers, T., &amp; Lamoree, M. H. (2015). Tracing thyroid hormone-disrupting compounds: database compilation and structure-activity evaluation for an effect-directed analysis of sediment. Analytical and Bioanalytical Chemistry, 5625&ndash;5634.&nbsp;<a href=\"http://doi.org/10.1007/s00216-015-8736-9\" target=\"_blank\">http://doi.org/10.1007/s00216-015-8736-9</a></p>\n\n<p>Yamauchi, K., A. Ishihara, H. Fukazawa and Y. Terao.&nbsp; (2003) Competitive interactions of chlorinated phenol compounds with 3,3&#39;,5-triiodothyronine binding to transthyretin: detection of possible thyroid-disrupting chemicals in environmental waste water.&nbsp; Toxicol. Appl. Pharmacol.&nbsp; 187(2): 110-117.</p>\n\n<p>Yen, P. M. (2001). Physiological and molecular basis of thyroid hormone action. Physiological Reviews, 81(3), 1097&ndash;1142.</p>\n\n<p>Zhang, J., J.H. Kamstra, M. Ghorbanzadeh, J.M. Weiss, T. Hamers and P.L. Andersson. (2015) In Silico Approach To Identify Potential Thyroid Hormone Disruptors among Currently Known Dust Contaminants and Their Metabolites.&nbsp; Environ. Sci. Technol.&nbsp; 49(16): 10099-10107.</p>\n\n<p>Zoeller, R. T., Tan, S. W., &amp; Tyl, R. W. (2007). General background on the hypothalamic-pituitary-thyroid (HPT) axis. Critical Reviews in Toxicology, 37(1-2), 11&ndash;53.</p>\n\n<p>Zoeller, R.T. and J. Rovet.&nbsp; (2004)&nbsp; Timing of thyroid hormone action in the developing brain: clinical observations and experimental findings.&nbsp; J. Neuroendocrinol.&nbsp; 16(10): 809-818.</p>\n","biologicalOrganisationLevel":"Tissue","organTerm":{"name":"blood","sourceId":"UBERON:0000178"},"biologicalEvents":[{"action":"increased","object":{"name":"thyroxine","source":"CHEBI","sourceId":"CHEBI:30660"}}],"id":959}
{"title":"Increased, Uptake of thyroxine into tissue","references":"<p>Abdalla, S.M. and A.C. Bianco. (2014) Defending plasma T3 is a biological priority.&nbsp; Clin. Endocrinol. (Oxf)&nbsp; 81(5): 633-641.</p>\n\n<p>Alshehri, B., D&rsquo;Souza, D. G., Lee, J. Y., Petratos, S., &amp; Richardson, S. J. (2015). The Diversity of Mechanisms Influenced by Transthyretin in Neurobiology: Development, Disease and Endocrine Disruption. Journal of Neuroendocrinology, 27(5), 303&ndash;323.&nbsp;<a href=\"http://doi.org/10.1111/jne.12271\" target=\"_blank\">http://doi.org/10.1111/jne.12271</a></p>\n\n<p>Andrea, T.A., R.R. Cavalieri, I.D. Goldfine and E.C. Jorgensen (1980) Binding of thyroid hormones and analogues to the human plasma protein prealbumin. Biochemistry&nbsp; 19(1): 55-63.</p>\n\n<p>Aqai, P., C. Fryganas, M. Mizuguchi, W. Haasnoot and M.W. Nielen. (2012) Triple bioaffinity mass spectrometry concept for thyroid transporter ligands.&nbsp; Anal. Chem.&nbsp; 84(15): 6488-6493.</p>\n\n<p>Athanasiadou, M., S.N. Cuadra, G. Marsh, A&gt; Bergman, and K. Jakobsson. (2008) Polybrominated diphenyl ethers (PBDEs) and bioaccumulative hydroxylated PBDE metabolites in young humans from Managua, Nicaragua.&nbsp; Environ. Health Perspect. 116(3): 400-408.</p>\n\n<p>Barter, R.A. and C.D. Klaassen. (1994) Reduction of thyroid hormone levels and alteration of thyroid function by four representative UDP-glucuronosyltransferase inducers in rats.&nbsp; Toxicol. Appl. Pharmacol.&nbsp; 128(1): 9-17.</p>\n\n<p>Blake, C.C., J.M. Burridge and S.J. Oatley. (1978) X-ray analysis of thyroid hormone binding to prealbumin. Biochem Soc. Trans. 6(6): 1114-1118.</p>\n\n<p>Bloom, M.S., J.E. Vena, J.R. Olson and P.J. Kostyniak.&nbsp; (2009)&nbsp; Assessment of polychlorinated biphenyl congeners, thyroid stimulating hormone, and free thyroxine among New York state anglers.&nbsp; Int. J. Hyg. Environ. Health&nbsp; 212(6): 599-611.</p>\n\n<p>Branchi, I., E. Alleva and L.G. Costa.&nbsp; (2002)&nbsp; Effects of perinatal exposure to a polybrominated diphenyl ether (PBDE 99) on mouse neurobehavioural development.&nbsp; Neurotoxicology&nbsp; 23(3): 375-384.</p>\n\n<p>Brouwer, a, &amp; van den Berg, K. J. (1986). Binding of a metabolite of 3,4,3&rsquo;,4&#39;-tetrachlorobiphenyl to transthyretin reduces serum vitamin A transport by inhibiting the formation of the protein complex carrying both retinol and thyroxin. Toxicology and Applied Pharmacology, 85(3), 301&ndash;312.</p>\n\n<p>Calvo, R.M., E. Jauniaux, B. Gulbis, M. Asuncion, C. Gervy, B. Contempre and G. Morreale de Escobar.&nbsp; (2002)&nbsp; Fetal tissues are exposed to biologically relevant free thyroxine concentrations during early phases of development.&nbsp; J. Clin. Endocrinol. Metab.&nbsp; 87(4); 1768-1777.</p>\n\n<p>Cao, J., L.H. Guo, B. Wan and Y. Wei. (2011) In vitro fluorescence displacement investigation of thyroxine transport disruption by bisphenol A.&nbsp; J. Environ Sci, (China)&nbsp; 23(2): 315-321.</p>\n\n<p>Cao, J., Y. Lin, L.H. Guo, A.Q. Zhang, Y. Wei and Y. Yang. (2010) Structure-based investigation on the binding interaction of hydroxylated polybrominated diphenyl ethers with thyroxine transport proteins.&nbsp; Toxicology&nbsp; 277(1-3): 20-28.</p>\n\n<p>Chan, S.Y., J.A. Franklyn, H.N. Pemberton, J.N. Bulmer, T.J. Visser, C.J. McCabe and M.D. Kilby.&nbsp; (2006)&nbsp; Monocarboxylate transporter 8 expression in the human placenta: the effects of severe intrauterine growth restriction.&nbsp; J. Endocrinol.&nbsp; 189(3): 465-471.</p>\n\n<p>Chan, S., S. Kachilele, C.J. McCabe, L.A. Tannahill, K. Boelaert, N.J. Gittoes, T.J. Visser, J.A. Franklyn and M.D. Kilby.&nbsp; (2002)&nbsp; Early expression of thyroid hormone deiodinases and receptors in human fetal cerebral cortex.&nbsp; Brain Res. Dev. Brain Res.&nbsp; 138(2): 109-116.</p>\n\n<p>Chang, S.C., J.R. Thibodeaux, M.L. Eastvold, D.J. Ehresman, J.A. Bjork, J.W. Froehlich, C. Lau, R.J. Singh, K.B. Wallace and J.L. Butenhoff. (2008) Thyroid hormone status and pituitary function in adult rats given oral doses of perfluorooctanesulfonate (PFOS).&nbsp; Toxicology&nbsp; 243(3): 330-339.</p>\n\n<p>Chanoine, J.-P., Alex, S., Fang, S. L., Stone, S., Leonard, J. L., Kohrle, J., &amp; Braverman, L. E. (1992). Role of transthyretin in the transport of thyroxine from the blood to the choroid plexus, the cerebrospinal fluid and the brain. Endocrinology, 130(2), 933&ndash;938.</p>\n\n<p>Chauhan, K. R., Kodavanti, P. R. S., &amp; McKinney, J. D. (2000). Assessing the Role of ortho-Substitution on Polychlorinated Biphenyl Binding to Transthyretin, a Thyroxine Transport Protein. Toxicology and Applied Pharmacology, 162(1), 10&ndash;21.&nbsp;<a href=\"http://doi.org/10.1006/taap.1999.8826\" target=\"_blank\">http://doi.org/10.1006/taap.1999.8826</a></p>\n\n<p>Cheek, A.O., K. Kow, J. Chen and J.A. McLachlan. (1999) Potential mechanisms of thyroid disruption in humans: interaction of organochlorine compounds with thyroid receptor, transthyretin, and thyroid-binding globulin.&nbsp; Environ. Health Perspect.&nbsp; 107(4): 273-278.</p>\n\n<p>Chevrier, J., K.G. Harley, A. Bradman, M. Gharbi, A. Sjodin and B. Eskenazi.&nbsp; (2010)&nbsp; Polybrominated diphenyl ether (PBDE) flame retardants and thyroid hormone during pregnancy.&nbsp; Environ. Health Perspect.&nbsp; 118(10) : 1444-1449.</p>\n\n<p>Chopra, I.J., P. Taing and L. Mikus. (1996) Direct determination of free triiodothyronine (T3) in undiluted serum by equilibrium dialysis/radioimmunoassay (RIA).&nbsp; Thyroid&nbsp; 6(4): 255-259.</p>\n\n<p>Costa, L.G., R. de Laat, S. Tagliaferri and C. Pellacani.&nbsp; (2014)&nbsp; A mechanistic view of polybrominated diphenyl ether (PBDE) developmental neurotoxicity.&nbsp; 230(2): 282-294.</p>\n\n<p>Dallaire, R., G. Muckle, E. Dewailly, S.W. Jacobson, J.L. Jacobson, T.M. Sandanger, C.D. Sandau and P. Ayotte. (2009a)&nbsp; Thyroid hormone levels of pregnant inuit women and their infants exposed to environmental contaminants.&nbsp; Environ. Health Perspect.&nbsp; 117(6): 1014-1020.</p>\n\n<p>Dallaire, R., E. Dewailly, D. Pereg, S. Dery and P. Ayotte.&nbsp; (2009b)&nbsp; Thyroid function and plasma concentrations of polyhalogenated compounds in Inuit adults.&nbsp; Environ. Health Perspect.&nbsp; 117(9): 1380-1386.</p>\n\n<p>Darnerud, P.O., D. Morse, E. Klasson-Wehler and A Brouwer.&nbsp; (1996)&nbsp; Binding of a 3,3&#39;, 4,4&#39;-tetrachlorobiphenyl (CB-77) metabolite to fetal transthyretin and effects on fetal thyroid hormone levels in mice.&nbsp; Toxicology&nbsp; 106(1-3): 105-114.</p>\n\n<p>De Escobar, G.M., M.J. Obregon and F.E. del Rey.&nbsp; (2004)&nbsp; Maternal thyroid hormones early in pregnancy and fetal brain development.&nbsp; Best Pract. Res. Clin. Endocrinol. Metab.&nbsp; 18(2): 225-248.</p>\n\n<p>Dirinck, E., A.C. Dirtu, G. Malarvanna, A. Covaci, P.G. Jorens and L.F. Van Gall. (2016) A Preliminary Link between Hydroxylated Metabolites of Polychlorinated Biphenyls and Free Thyroxin in Humans.&nbsp; Int. J. Environ. Res. Public Health&nbsp; 13(4): 421.</p>\n\n<p>Eguchi, A., K. Nomiyama, N. Minh Tue, P.T. Trang, P. Hung Viet, S. Takahashi and S. Tanabe.&nbsp; (2015)&nbsp; Residue profiles of organohalogen compounds in human serum from e-waste recycling sites in North Vietnam: Association with thyroid hormone levels.&nbsp; Environ. Res.&nbsp; 137: 440-449.</p>\n\n<p>Emerson, C.H., J.H. Cohen III, R.A Yung, S. Alex and S.L. Fang. (1990) Gender-related differences of serum thyroxine-binding proteins in the rat. Acta Endocrinol. (Copenh)&nbsp; 123(1): 72-78.</p>\n\n<p>Erratico, C.A., A. Steitz and S.M. Bandiera. (2013) Biotransformation of 2,2&#39;,4,4&#39;-tetrabromodiphenyl ether (BDE-47) by human liver microsomes: identification of cytochrome P450 2B6 as the major enzyme involved.&nbsp; Chem. Res. Toxicol.&nbsp; 26(5): 721-731.</p>\n\n<p>Erratico, C.A., S.C. Moffatt and S.M. Bandiera. (2011) Comparative oxidative metabolism of BDE-47 and BDE-99 by rat hepatic microsomes.&nbsp; Toxicol. Sci.&nbsp; 123(1): 37-47.</p>\n\n<p>Eskenazi, B., J. Chevrier, S.A. Rauch, K. Kogul, K.G. Harley, C. Johnson, C. Trujillo, A. Sjodin and A. Bradman.&nbsp; (2013)&nbsp; In utero and childhood polybrominated diphenyl ether (PBDE) exposures and neurodevelopment in the CHAMACOS study.&nbsp; 121(2) : 257-262.</p>\n\n<p>Feo, M.L., M.S. Gross, B.P. McGarrigle, E. Eljarrat, D. Barcelo, D.S. Aga and J.R. Olson. (2013) Biotransformation of BDE-47 to potentially toxic metabolites is predominantly mediated by human CYP2B6.&nbsp; Environ. Health Persepct.&nbsp; 121(4): 440-446.</p>\n\n<p>Ferguson, R.N., H. Edelhoch, H.A. Saroff, J. Robbins and H.J. Cahnmann (1975) Negative cooperativity in the binding of thyroxine to human serum prealbumin. Preparation of tritium-labeled 8-anilino-1-naphthalenesulfonic acid.&nbsp; Biochemistry&nbsp; 14(2): 282-289.</p>\n\n<p>Friesema EC, Jansen J, Jachtenberg JW, Visser WE, Kester MH, Visser TJ 2008 Effective cellular uptake and efflux of thyroid hormone by human monocarboxylate transporter 10. Molecular endocrinology (Baltimore, Md 22:1357-1369</p>\n\n<p>Friesema EC, Kuiper GG, Jansen J, Visser TJ, Kester MH 2006 Thyroid hormone transport by the human monocarboxylate transporter 8 and its rate-limiting role in intracellular metabolism. Molecular endocrinology (Baltimore, Md 20:2761-2772</p>\n\n<p>Friesma, E.C., J. Jansen and T.J. Visser. (2005) Thyroid hormone transporters.&nbsp; Biochem. Soc. Trans.&nbsp; 33(part 1): 228-232.</p>\n\n<p>Friesema EC, Ganguly S, Abdalla A, Manning Fox JE, Halestrap AP, Visser TJ 2003 Identification of monocarboxylate transporter 8 as a specific thyroid hormone transporter. J Biol Chem 278:40128-40135</p>\n\n<p>Grimm, F. a., Lehmler, H. J., He, X., Robertson, L. W., &amp; Duffel, M. W. (2013). Sulfated metabolites of polychlorinated biphenyls are high-affinity ligands for the thyroid hormone transport protein transthyretin. Environmental Health Perspectives, 121(6), 657&ndash;662.</p>\n\n<p>Gutshall, D.M., G.D. Pilcher and A.E. Langley. (1989) Mechanism of the serum thyroid hormone lowering effect of perfluoro-n-decanoic acid (PFDA) in rats. J. Toxicol. Environ. Health&nbsp;&nbsp; 28(1): 53-65.</p>\n\n<p>Hagenbuch, B. (2007)&nbsp; Cellular entry of thyroid hormones by organic anion transporting polypeptides.&nbsp; Best Pract. Res. Clin. Endocrinol. Metab.&nbsp; 21(2): 209-221.</p>\n\n<p>Hagenbuch B, Meier PJ 2004 Organic anion transporting polypeptides of the OATP/ SLC21 family: phylogenetic classification as OATP/ SLCO superfamily, new nomenclature and molecular/functional properties. Pflugers Arch 447:653-665</p>\n\n<p>Hagmar, L., L. Rylander, E. Dyremark, E. Klasson-Wehler and E.M. Erfurth. (2001a).&nbsp; Plasma concentrations of persistent organochlorines in relation to thyrotropin and thyroid hormone levels in women.&nbsp; Int. Arch. Occup. Environ. Health&nbsp; 74(3): 184-188.</p>\n\n<p>Hagmar, L., J. Bjork, A. Sjodin, A. Bergman and E.M. Erfurth. (2001b) Plasma levels of persistent organohalogens and hormone levels in adult male humans.&nbsp; Arch. Environ. Health&nbsp; 56(2): 138-143.</p>\n\n<p>Hallgren, S., T. Sinjari, H. Hakansson and P.O. Darnerud. (2001) Effects of polybrominated diphenyl ethers (PBDEs) and polychlorinated biphenyls (PCBs) on thyroid hormone and vitamin A levels in rats and mice.&nbsp; 75(4): 200-208.</p>\n\n<p>Hallgren, S. and P.O. Darnerud. (2002) Polybrominated diphenyl ethers (PBDEs), polychlorinated biphenyls (PCBs) and chlorinated paraffins (CPs) in rats-testing interactions and mechanisms for thyroid hormone effects.&nbsp; Toxicology&nbsp; 177(203): 227-243.</p>\n\n<p>Hamers, T., J.H. Kamstra, E. Sonneveld, A.J. Murk, M.H. Kester, P.L. Andersson, J. Legler and A. Brouwer. (2006) In vitro profiling of the endocrine-disrupting potency of brominated flame retardants.&nbsp; Toxicol. Sci.&nbsp; 92(1): 157-173.</p>\n\n<p>Hamers, T., Kamstra, E. Sonneveld, A.J. Murk, T.J. Visser, M.J. Van Velzen, A. Brouwer and A. Bergman. (2008) Biotransformation of brominated flame retardants into potentially endocrine-disrupting metabolites, with special attention to 2,2&#39;,4,4&#39;-tetrabromodiphenyl ether (BDE-47).&nbsp; Mol. Nutr. Food Res.&nbsp; 52(2): 284-298.</p>\n\n<p>Harley, K.G., A.R. Marks, J. Chevrier, A. Bradman, A. Sjodin and B. Eskenazi.&nbsp; (2010)&nbsp; PBDE concentrations in women&#39;s serum and fecundability.&nbsp; Environ. Health Perspect.&nbsp; 118(5): 699-704.</p>\n\n<p>Henneman, G., R. Docter, E.C. Friesma, M. de Jong, E.P. Krenning and T.J. Visser.&nbsp; (2001)&nbsp; Plasma membrane transport of thyroid hormones and its role in thyroid hormone metabolism and bioavailability.&nbsp; Endocr. Rev.&nbsp; 22(4): 451-476.</p>\n\n<p>Heuer, H. &nbsp;(2007)&nbsp; The importance of thyroid hormone transporters for brain development and function.&nbsp; Best Pract. Res. Clin. Endocrinol. Metab.&nbsp; 21(2):&nbsp; 265-276.</p>\n\n<p>Hood, A. and C.D. Klaassen. (2000a) Differential effects of microsomal enzyme inducers on in vitro thyroxine (T(4)) and triiodothyronine (T(3)) glucuronidation.&nbsp; Toxicol. Sci.&nbsp; 55(1): 78-84.</p>\n\n<p>Hood, A. and C.D. Klaassen.&nbsp; (2000b)&nbsp; Effects of microsomal enzyme inducers on outer-ring deiodinase activity toward thyroid hormones in various rat tissues.&nbsp; Toxicol. Appl. Pharmacol.&nbsp; 163(3): 240-248.</p>\n\n<p>Hovander, L., M. Athanasiadou, L. Asplund, S. Jensen and E.K. Wehler. (2000). Extraction and cleanup methods for analysis of phenolic and neutral organohalogens in plasma.&nbsp; 24(8): 696-703.</p>\n\n<p>Hume, R., J. Simpson, C. Delahunty, H. van Toor, S.Y. Wu, F.L. Williams, T.J. Visser et al.&nbsp; (2004) Human fetal and cord serum thyroid hormones: developmental trends and interrelationships.&nbsp; J. Clin. Endocrinol. Metab.&nbsp; 89(8): 4097-4103.</p>\n\n<p>Inoue, K., F. Okada, R. Ito, S. Kato, S. Sasaki, S. Nakajima, A. Uno, Y. Saijo, F. Sata, Y. Yoshimura, R. Kishi and H. Nakazawa. (2004) Perfluorooctane sulfonate (PFOS) and related perfluorinated compounds in human maternal and cord blood samples: assessment of PFOS exposure in a susceptible population during pregnancy.&nbsp; Environ. Health Perspect.&nbsp; 112(11): 1204-1207.</p>\n\n<p>Kato, Y., K. Haraguchi, M. Onishi, S. Ikushiro, T. Endo, C. Ohta, N. Koga, S Yamada and M. Degawa. (2014) 3,3&#39;,4,4&#39;-Tetrachlorobiphenyl-mediated decrease of serum thyroxine level in C57BL/6 and DBA/2 mice occurs mainly through enhanced accumulation of thyroxine in the liver.&nbsp; Biol. Pharm. Bull.&nbsp; 37(3) 504-509.</p>\n\n<p>Kato, Y., M. Onishi, K. Haraguchi, S. Ikushiro, C. Ohta, N. Koga, T. Endo, S. Yamada and M. Degawa. (2013) A possible mechanism for 2,3&#39;,4,4&#39;,5&#39;-pentachlorobiphenyl-mediated decrease in serum thyroxine level in mice.&nbsp; Biol. Pharm. Bull.&nbsp; 36(10): 1594-1601.</p>\n\n<p>Kato, Y., S. Tamaki, K. Haraguchi, S. Ikushiro, M. Sekimoto, C. Ohta, T. Endo, N. Koga, S. Yamada and M. Degawa. (2012) Comparative study on 2,2&#39;,4,5,5&#39;-pentachlorobiphenyl-mediated decrease in serum thyroxine level between C57BL/6 and its transthyretin-deficient mice.&nbsp; Toxicol. Appl. Pharmacol.&nbsp; 263(3): 323-329.</p>\n\n<p>Kato, Y., M. Onishi, K. Haraguchi, S. Ikushiro, C. Ohta, N. Koga, T. Endo, S. Yamada and M. Degawa. (2011) A possible mechanism for 2,2&#39;,4,4&#39;,5,5&#39;-hexachlorobiphenyl-mediated decrease in serum thyroxine level in mice.&nbsp; Toxicol. Appl. Pharmacol.&nbsp; 254(1): 48-55.</p>\n\n<p>Kato, Y., K. Haraguchi, M. Kubota, Y. Seto, S. Ikushiro, T. Sakaki, N. Koga, S. Yamada and M. Degawa. (2009) 4-Hydroxy-2,2&#39;,3,4&#39;,5,5&#39;,6-heptachlorobiphenyl-mediated decrease in serum thyroxine level in mice occurs through increase in accumulation of thyroxine in the liver.&nbsp; Drug Metab. Dispos.&nbsp; 37(10): 2095-2102.</p>\n\n<p>Kato, Y., S. Ikushiro, R. Takiguchi, K. Haraguchi, N. Koga, S. Uchida, T. Sakaki, S. Yamada, J. Kanno and M. Degawa. (2007) A novel mechanism for polychlorinated biphenyl-induced decrease in serum thyroxine level in rats.&nbsp; Drug Metab. Dispos. 35(10) : 1949-1955.</p>\n\n<p>Kato, Y., S. Ikushiro, K. Haraguchi, T. Yamazaki, Y. Ito, H. Suzuki, R. Kimura, S. Yamada, T. Inoue and M. Degawa. (2004) A possible mechanism for decrease in serum thyroxine level by polychlorinated biphenyls in Wistar and Gunn rats.&nbsp; Toxicol. Sci.&nbsp; 81(2): 309-315.</p>\n\n<p>Kato, Y., K. Haraguchi, T. Yamazuki, Y. Ito, S. Miyajima, K. Nemoto, N. Koga, R. Kimura and M. Degawa. (2003) Effects of polychlorinated biphenyls, kanechlor-500, on serum thyroid hormone levels in rats and mice.&nbsp; Toxicol. Sci.&nbsp; 72(2): 235-241.</p>\n\n<p>Kim, S.Y., E.S. Choi, H.J. Lee, C. Moon and E. Kim.&nbsp; (2015)&nbsp; Transthyretin as a new transporter of nanoparticles for receptor-mediated transcytosis in rat brain microvessels.&nbsp; Colloids Surf B Biointerfaces&nbsp; 136: 989-996.</p>\n\n<p>Kim do K, Kanai Y, Matsuo H, Kim JY, Chairoungdua A, Kobayashi Y, Enomoto A, Cha SH, Goya T, Endou H 2002 The human T-type amino acid transporter-1: characterization, gene organization, and chromosomal location. Genomics 79:95-103</p>\n\n<p>Kohrle, J., S.L. Fang, Y. Yang, K. Irmscher, R.D. Hesch, S. Pino, S. Alex, and L.E. Braverman. (1989). Rapid effects of the flavonoid EMD 21388 on serum thyroid hormone binding and thyrotropin regulation in the rat. Endocrinoloy 125: 532-537</p>\n\n<p>Koopman-Essenboom, C., D.C. Morse, N. Weisglas-Kuperus, I.J. Lutkeschipholt, C.G. Van der Paauw, L.G. Tuinstra, A. Brouwer and P.J. Sauer.&nbsp; (1994)&nbsp; Effects of dioxins and polychlorinated biphenyls on thyroid hormone status of pregnant women and their infants.&nbsp; Pediatr. Res.&nbsp; 36(4): 468-473.</p>\n\n<p>Lans, M. C., Klasson-Wehler, E., Willemsen, M., Meussen, E., Safe, S., &amp; Brouwer, A. (1993). STRUCTURE-DEPENDENT, COMPETITIVE INTERACTION OF HYDROXY-POLYCHLOROBIPHENYLS, -DIBENZO-p-DIOXINS AND -DIBENZOFURANS WITH HUMAN TRANSTHYRETIN. Chemico-Biological Interactions, 88, 7&ndash;21.</p>\n\n<p>Lans, M. C., Spiertz, C., Brouwer, a, &amp; Koeman, J. H. (1994). Different competition of thyroxine binding to transthyretin and thyroxine-binding globulin by hydroxy-PCBs, PCDDs and PCDFs. European Journal of Pharmacology, 270(2-3), 129&ndash;136.&nbsp;<a href=\"http://doi.org/10.1016/0926-6917(94)90054-X\" target=\"_blank\">http://doi.org/10.1016/0926-6917(94)90054-X</a></p>\n\n<p>Larsson, M., Pettersson, T., &amp; Carlstr&ouml;m, a. (1985). Thyroid hormone binding in serum of 15 vertebrate species: isolation of thyroxine-binding globulin and prealbumin analogs. General and Comparative Endocrinology, 58(3), 360&ndash;375.</p>\n\n<p>Loubiere, L.S., E. Vasilopoulou, J.N. Bulmer, P.M. Taylor, B. Stieger, F. Verrey, C.J. McCabe, J.A. Franklyn, M.D. Kilby and S.Y. Chan. (2010)&nbsp; Expression of thyroid hormone transporters in the human placenta and changes associated with intrauterine growth restriction.&nbsp; Placenta&nbsp; 31(4): 295-304.</p>\n\n<p>Lueprasitsakul, W., Alex, S., Fang, S. L., Pino, S., Irmscher, K., K&ouml;hrle, J., &amp; Braverman, L. E. (1990). Flavonoid administration immediately displaces thyroxine (T4) from serum transthyretin, increases serum free T4, and decreases serum thyrotropin in the rat. Endocrinology 126 (6)</p>\n\n<p>Lupton, S.J., P. McGarrigle, J.R. Olson, T.D. Wood and D.S. Aga. (2010) Analysis of hydroxylated polybrominated diphenyl ether metabolites by liquid chromatography/atmospheric pressure chemical ionization tandem mass spectrometry.&nbsp; Rapid Commun. Mass. Spectrom.&nbsp; 24(15): 2227-2235.</p>\n\n<p>Lupton, S.J., B.P. McGarrigle, J.R. Olson, T.D. Wood and D.S. Aga. (2009)&nbsp; Analysis of hydroxylated polybrominated diphenyl ether metabolites by liquid chromatography/atmospheric pressure chemical ionization tandem mass spectrometry.&nbsp; 22(11): 1802-1809.</p>\n\n<p>Malmberg, T., M. Athanasiadou, G. Marsh, I. Brandt and A. Bergman.&nbsp; (2005) Identification of hydroxylated polybrominated diphenyl ether metabolites in blood plasma from polybrominated diphenyl ether exposed rats.&nbsp; 39(14): 5342-5348.</p>\n\n<p>Marchesini, G.R., E. Meulenberg, W. Haasnoot, M. Mizuguchi and H. Irth.&nbsp; (2006) Biosensor recognition of thyroid-disrupting chemicals using transport proteins.&nbsp; Anal. Chem.&nbsp; 78(4): 1107-1114.</p>\n\n<p>Marchesini, G.R., A. Meimaridou, W. Haasnoot, E. Meulenberg, F. Albertus, M. Mizuguchi, M. Takeuchi, H. Irth and A.J. Murk. (2008) iosensor discovery of thyroxine transport disrupting chemicals.&nbsp; Toxicol. Appl. Pharmacol.&nbsp; 232(1): 150-160.</p>\n\n<p>Martin, L.A., D.T. Wilson, K.R&gt; Reuhl, M.A. Gallo and C.D. Klaassen. (2012) Polychlorinated biphenyl congeners that increase the glucuronidation and biliary excretion of thyroxine are distinct from the congeners that enhance the serum disappearance of thyroxine.&nbsp; Drug Metab. Dispos.&nbsp; 40(3): 588-595.</p>\n\n<p>Martin, L. and C.D. Klaassen. (2010) Differential effects of polychlorinated biphenyl congeners on serum thyroid hormone levels in rats.&nbsp; Toxicol. Sci.&nbsp; 117(1): 36-44.</p>\n\n<p>Meerts, I.A., Y. Assink, P.H. Cenjin, J.H. Van Den Berg, B.M. Weijers, A. Bergman, J.H. Koeman and A. Brouwer. (2002) Placental transfer of a hydroxylated polychlorinated biphenyl and effects on fetal and maternal thyroid hormone homeostasis in the rat.&nbsp; Toxicol. Sci. 68(2): 361-371.</p>\n\n<p>Meerts, I.A., J.J. van Zanden, E.A. Lujiks, I. van Leeuwen-Bol, G. Marsh, E. Jakobsson, A. Bergman and A. Brouwer. (2000) Potent competitive interactions of some brominated flame retardants and related compounds with human transthyretin in vitro.&nbsp; Toxicol. Sci.&nbsp; 56(1): 95-104.</p>\n\n<p>Mendel, C. M. (1989). Modeling thyroxine transport to liver&nbsp;: rejection of the &ldquo;enhanced dissociation&rdquo; hypothesis as applied to thyroxine. Am J Physiol, 257(Endocrinol Metab 20), E764&ndash;E771.</p>\n\n<p>Mendel, C. M., Cavalieri, R. R., &amp; Kohrle, J. (1992). Thyroxine (T4) transport and distribution in rats treated with EMD 21388, a synthetic flavonoid that displaces T4 from transthyretin. Endocrinology, 130(3), 1525&ndash;1532.</p>\n\n<p>Midgley, J. E. (2001) Direct and indirect free thyroxine assay methods: theory and practice.&nbsp; Clin. Chem.&nbsp; 47(8): 1353-1363.</p>\n\n<p>Miksys, S. and R.F. Tyndale. (2004) The unique regulation of brain cytochrome P450 2 (CYP2) family enzymes by drugs and genetics.&nbsp; Drug Metab. Rev.&nbsp; 36(2): 313-333.</p>\n\n<p>Montano, M., E. Coccco, C. Guignard, G. Marsh, L. Hoffmann, A. Bergman, A.C. Gutleb and A.J. Murk. (2012) New approaches to assess the transthyretin binding capacity of bioactivated thyroid hormone disruptors.&nbsp; Toxicol. Sci.&nbsp; 130(1): 94-105.</p>\n\n<p>Morse, D.C., E.K. Wehler, W. Wesseling, J.H. Koeman and A. Brouwer.&nbsp; (1996)&nbsp; Alterations in rat brain thyroid hormone status following pre- and postnatal exposure to polychlorinated biphenyls (Aroclor 1254).&nbsp; Toxicol. Appl. Pharmacol.&nbsp; 136(2): 269-279.</p>\n\n<p>Morse, D.C., D. Groen, M. Veerman, C.J. van Amerongen, H.B. Koeter, A.E. Smits van Proojie, T.J. Visser, J.H. Koeman and A. Brouwer.&nbsp; (1993)&nbsp; Interference of polychlorinated biphenyls in hepatic and brain thyroid hormone metabolism in fetal and neonatal rats.&nbsp; Toxicol. Appl. Pharmacol.&nbsp; 122(1) :27-33.</p>\n\n<p>Munro, S.L., C.F. Lim, J.G. Hall, J.W. Barlow, D.J. Craik, D.J. Topliss and J.R. Stockigt (1989) Drug competition for thyroxine binding to transthyretin (prealbumin): comparison with effects on thyroxine-binding globulin. J. Clin. Endocrinol. Metab.&nbsp; 68(6): 1141-1147,</p>\n\n<p>Nishimura M, Naito S 2008 Tissue-specific mRNA expression profiles of human solute carrier transporter superfamilies. Drug Metab Pharmacokinet 23:22-44</p>\n\n<p>Pedraza, P., Calvo, R., Obreg&oacute;n, M. J., Asuncion, M., Escobar Del Rey, F., &amp; Morreale De Escobar, G. (1996). Displacement of T4 from transthyretin by the synthetic flavonoid EMD 21388 results in increased production of T3 from T4 in rat dams and fetuses. Endocrinology, 137(11), 4902&ndash;4914.&nbsp;<a href=\"http://doi.org/10.1210/en.137.11.4902\" target=\"_blank\">http://doi.org/10.1210/en.137.11.4902</a></p>\n\n<p>Purkey, H.E., M.I. Dorrell and J.W. Kelly. (2001) Evaluating the binding selectivity of transthyretin amyloid fibril inhibitors in blood plasma.&nbsp; Proc. Natl. Acad. Sci. USA&nbsp; 98(10): 5566-5571.</p>\n\n<p>Refetoff, S., N.I. Robin and V.S. Fang. (1970) Parameters of thyroid function in serum of 16 selected vertebrate species: a study of PBI, serum T4, free T4, and the pattern of T4 and T3 binding to serum proteins.&nbsp; Endocrinology&nbsp; 86(4): 793-805.</p>\n\n<p>Refetoff, S. (2015) Thyroid Hormone Serum Transport Proteins. In: De Groot LJ, Chrousos G, Dungan K, Feingold KR, Grossman A, Hershman JM, Koch C, Korbonits M, McLachlan R, New M, Purnell J, Rebar R, Singer F, Vinik A, editors. Endotext [Internet]. South Dartmouth (MA): MDText.com, Inc.; 2000.</p>\n\n<p>Ren, X.M., L.H. Guo, Y. Gao, B.T. Zhang and B. Wan. (2013) Hydroxylated polybrominated diphenyl ethers exhibit different activities on thyroid hormone receptors depending on their degree of bromination.&nbsp; Toxicol. Appl. Pharamacol.&nbsp; 268(3): 256-263.</p>\n\n<p>Ren, X. M., &amp; Guo, L. H. (2012). Assessment of the binding of hydroxylated polybrominated diphenyl ethers to thyroid hormone transport proteins using a site-specific fluorescence probe. Environmental Science and Technology, 46(8), 4633&ndash;4640.&nbsp;<a href=\"http://doi.org/10.1021/es2046074\" target=\"_blank\">http://doi.org/10.1021/es2046074</a></p>\n\n<p>Rerat, C. and H.G. Schwick (1967) [Crystallographic data of blood plasma prealbumin]. [Article in French] Acta Crystallogr.&nbsp; 22(3): 441-442.</p>\n\n<p>Richardson, S. J. (2007). Cell and molecular biology of transthyretin and thyroid hormones. International Review of Cytology, 258(January), 137&ndash;93.&nbsp;<a href=\"http://doi.org/10.1016/S0074-7696(07)58003-4\" target=\"_blank\">http://doi.org/10.1016/S0074-7696(07)58003-4</a></p>\n\n<p>Richardson, S. J., Wijayagunaratne, R. C., D&rsquo;Souza, D. G., Darras, V. M., &amp; Van Herck, S. L. J. (2015). Transport of thyroid hormones via the choroid plexus into the brain: the roles of transthyretin and thyroid hormone transmembrane transporters. Frontiers in Neuroscience, 9(March), 1&ndash;8.</p>\n\n<p>Rickenbacher, U., McKinney, J. D., Oatley, S. J., &amp; Blake, C. C. (1986). Structurally specific binding of halogenated biphenyls to thyroxine transport protein. Journal of Medicinal Chemistry, 29(5), 641&ndash;648.</p>\n\n<p>Ritchie, J.W. and P.M. Taylor.&nbsp; (2001)&nbsp; Role of the System L permease LAT1 in amino acid and iodothyronine transport in placenta.&nbsp; Biochem. J.&nbsp; 356(Part 3); 719-725.</p>\n\n<p>Riu, A., J.P. Cravedi, L. Debrauwer, A. Garcia, C. Canlet, I. Jouanin and D. Zalko. (2008) Environ. Int. 34(3): 318-329.</p>\n\n<p>Roberts LM, Woodford K, Zhou M, Black DS, Haggerty JE, Tate EH, Grindstaff KK, Mengesha W, Raman C, Zerangue N 2008 Expression of the thyroid hormone transporters MCT8 (SLC16A2) and OATP14 (SLCO1C1) at the blood-brain barrier. Endocrinology 149:6251-6261</p>\n\n<p>Rotroff, D.M., B.A. Wetmore, D.J. Dix, S.S. Ferguson, H.J. Clewell, K.A. Houck, E.L. Lecluyse, M.E. Anersen, R.S. Judson, C.M. Smith, M.A. Sochaski, R.J. Kavlock, F. Boellmann, M.T. Martin, D.M. Reif, J.F. Wambaugh and R.S. Thomas. (2010) Incorporating human dosimetry and exposure into high-throughput in vitro toxicity screening.&nbsp; 117(2): 348-358.</p>\n\n<p>Sato, K., J. Sugawara, T. Sato, H. Mizutamari, T. Suzuki, A. Ito, T. Mikkaichi, T. Onogawa, M. Tanemoto, M. Unno, T. Abe and K. Okamura.&nbsp; (2003)&nbsp; Expression of organic anion transporting polypeptide E (OATP-E) in human placenta.&nbsp; Placenta&nbsp; 24(2-3): 144-148.</p>\n\n<p>Schreiber, G. (2002). The evolutionary and integrative roles of transthyrein in thyroid hormone homeostasis. Journal of Endocrinology, 175(1), 61&ndash;73.&nbsp;<a href=\"http://doi.org/10.1677/joe.0.1750061\" target=\"_blank\">http://doi.org/10.1677/joe.0.1750061</a></p>\n\n<p>Schroder van der Elst, J.P., D. van der Heide, H. Rokos, G. Morreale de Escobar and J. Kohrlre. (1998) Synthetic flavonoids cross the placenta in the rat and are found in fetal brain.&nbsp; Am. J. Physiol.&nbsp; 274(2 Psrt 1): E253-E256.</p>\n\n<p>Schroder van der Elst, J.P., D. van der Heide, H. Rokos, J. Kohrle and G. Morreale de Escobar. (1997)&nbsp; Different tissue distribution, elimination, and kinetics of thyroxine and its conformational analog, the synthetic flavonoid EMD 49209 in the rat.&nbsp; Endocrinology&nbsp; 138(1): 79-84.</p>\n\n<p>Schuur, A.G., F.M. Boekhorst, A. Brouwer and T.J. Visser. (1997) Extrathyroidal effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin on thyroid hormone turnover in male Sprague-Dawley rats.&nbsp; Endocrinology&nbsp; 138(9): 3727-3734.</p>\n\n<p>Sinjari, T. and P.O. Darnerud. (1998) Hydroxylated polychlorinated biphenyls: placental transfer and effects on thyroxine in the foetal mouse.&nbsp; Xenobiotica&nbsp; 28(1): 21-30.</p>\n\n<p>Sparkes, R.S., H. Sasaki, T. Mohandas, K. Yoshioka, I. Kilsak, Y. Sasaki, C. Heinzmann and M.I. Simon. (1987) Assignment of the prealbumin (PALB) gene (familial amyloidotic polyneuropathy) to human chromosome region 18q11.2-q12.1. Hum. Genet.&nbsp; 75(2): 151-154.</p>\n\n<p>Stapleton, H.M., S.M. Kelly, R. Pei, R.J. Letcher and C. Gunsch.&nbsp; (2009) Metabolism of polybrominated diphenyl ethers (PBDEs) by human hepatocytes in vitro.&nbsp; Environ. Health Perspect.&nbsp; 117(2): 197-202.</p>\n\n<p>Tohyama K, Kusuhara H, Sugiyama Y 2004 Involvement of multispecific organic anion transporter, Oatp14 (Slc21a14), in the transport of thyroxine across the blood-brain barrier. Endocrinology</p>\n\n<p>Ucan-Marin, F., A. Arukwe, A.S. Mortensen, G.W. Gabrielsen and R.J. Letcher. (2010) Recombinant albumin and transthyretin transport proteins from two gull species and human: chlorinated and brominated contaminant binding and thyroid hormones.&nbsp; Environ. Sci. Technol.&nbsp; 44(1): 497-504.</p>\n\n<p>Van Birgelen, A.P., E.A. Smit, I.M. Kampen, C.N. Groeneveld, K.M. Case, J. Van der Kolk, H. Poiger, M. Van den Berg, J.H. Koeman and A. Brouwer. (1995) Subchronic effects of 2,3,7,8-TCDD or PCBs on thyroid hormone metabolism: use in risk assessment.&nbsp; Eur. J. Pharmacol.&nbsp; 293(1) : 77-85.</p>\n\n<p>Van den Berg, K. J. (1990). Interaction of chlorinated phenols with thyroxine binding sites of human transthyretin, albumin and thyroid binding globulin. Chemico-Biological Interactions, 76(1), 63&ndash;75.</p>\n\n<p>Van den Berg, K. J., Van Raaij, J. a G. M., Bragt, P. C., &amp; Notten, W. R. F. (1991). Interactions of halogenated industrial chemicals with transthyretin and effects on thyroid hormone levels in vivo. Archives of Toxicology, 65(1), 15&ndash;19.</p>\n\n<p>Viberg, H., A. Fredriksson and P. Eriksson. (2002) Neonatal exposure to the brominated flame retardant 2,2&#39;,4,4&#39;,5-pentabromodiphenyl ether causes altered susceptibility in the cholinergic transmitter system in the adult mouse.&nbsp; Toxicol. Sci. 67(1): 104-107.</p>\n\n<p>Viollon-Abadie, C., D. Lassere, E. Debruyne, L. Nicod, N. Carmichael and L. Richert. (1999) Phenobarbital, beta-naphthoflavone, clofibrate, and pregnenolone-16alpha-carbonitrile do not affect hepatic thyroid hormone UDP-glucuronosyl transferase activity, and thyroid gland function in mice.&nbsp; Toxicol. Appl. Pharmacol.&nbsp; 155(1) 1-12.</p>\n\n<p>Visser, T.J. and R.P. Peeters. (2012) Metabolism of thyroid hormone.&nbsp; In: De Groot LJ, Chrousos G, Dungan K, Feingold KR, Grossman A, Hershman JM, Koch C, Korbonits M, McLachlan R, New M, Purnell J, Rebar R, Singer F, Vinik A, editors. Endotext [Internet]. South Dartmouth (MA): MDText.com, Inc.; 2000-.</p>\n\n<p>Visser, T. J. (2010). Cellular Uptake of Thyroid Hormones. In: De Groot LJ, Chrousos G, Dungan K, Feingold KR, Grossman A, Hershman JM, Koch C, Korbonits M, McLachlan R, New M, Purnell J, Rebar R, Singer F, Vinik A, editors. Endotext [Internet]. South Dartmouth (MA): MDText.com, Inc.; 2000-.</p>\n\n<p>Visser, T.J. (1996) Role of sulfate in thyroid hormone sulfation.&nbsp; Eur. J. Endocrinol.&nbsp; 134(1): 12-14.</p>\n\n<p>Visser, T.J., E. Kaptein, J.A. van Raaij, C.T. Joe, T. Ebner and B. Burchell. (1993)</p>\n\n<p>Multiple UDP-glucuronyltransferases for the glucuronidation of thyroid hormone with preference for 3,3&#39;,5&#39;-triiodothyronine (reverse T3).&nbsp; FEBS Lett.&nbsp; 315(1): 65-68.</p>\n\n<p>Weiss, J.M., P.L. Andersson, M.H. Lamoree, P.E. Leonards, S.P. van Leeuwen and T. Hamers. (2009) Competitive binding of poly- and perfluorinated compounds to the thyroid hormone transport protein transthyretin.&nbsp; Toxicol. Sci.&nbsp; 109(2): 206-216.</p>\n\n<p>Weiss, J. M., Andersson, P. L., Zhang, J., Simon, E., Leonards, P. E. G., Hamers, T., &amp; Lamoree, M. H. (2015). Tracing thyroid hormone-disrupting compounds: database compilation and structure-activity evaluation for an effect-directed analysis of sediment. Analytical and Bioanalytical Chemistry, 5625&ndash;5634.&nbsp;<a href=\"http://doi.org/10.1007/s00216-015-8736-9\" target=\"_blank\">http://doi.org/10.1007/s00216-015-8736-9</a></p>\n\n<p>Yamauchi, K., A. Ishihara, H. Fukazawa and Y. Terao.&nbsp; (2003) Competitive interactions of chlorinated phenol compounds with 3,3&#39;,5-triiodothyronine binding to transthyretin: detection of possible thyroid-disrupting chemicals in environmental waste water.&nbsp; Toxicol. Appl. Pharmacol.&nbsp; 187(2): 110-117.</p>\n\n<p>Yen, P. M. (2001). Physiological and molecular basis of thyroid hormone action. Physiological Reviews, 81(3), 1097&ndash;1142.</p>\n\n<p>Zhang, J., J.H. Kamstra, M. Ghorbanzadeh, J.M. Weiss, T. Hamers and P.L. Andersson. (2015) In Silico Approach To Identify Potential Thyroid Hormone Disruptors among Currently Known Dust Contaminants and Their Metabolites.&nbsp; Environ. Sci. Technol.&nbsp; 49(16): 10099-10107.</p>\n\n<p>Zoeller, R. T., Tan, S. W., &amp; Tyl, R. W. (2007). General background on the hypothalamic-pituitary-thyroid (HPT) axis. Critical Reviews in Toxicology, 37(1-2), 11&ndash;53.</p>\n\n<p>Zoeller, R.T. and J. Rovet.&nbsp; (2004)&nbsp; Timing of thyroid hormone action in the developing brain: clinical observations and experimental findings.&nbsp; J. Neuroendocrinol.&nbsp; 16(10): 809-818.</p>\n","biologicalOrganisationLevel":"Cellular","organTerm":{},"biologicalEvents":[{"action":"increased","process":"transport","object":{"name":"thyroxine","source":"CHEBI","sourceId":"CHEBI:30660"}}],"id":960}
{"title":"Increased, Clearance of thyroxine from serum","references":"<p>Abdalla, S.M. and A.C. Bianco. (2014) Defending plasma T3 is a biological priority.&nbsp; Clin. Endocrinol. (Oxf)&nbsp; 81(5): 633-641.</p>\n\n<p>Alshehri, B., D&rsquo;Souza, D. G., Lee, J. Y., Petratos, S., &amp; Richardson, S. J. (2015). The Diversity of Mechanisms Influenced by Transthyretin in Neurobiology: Development, Disease and Endocrine Disruption. Journal of Neuroendocrinology, 27(5), 303&ndash;323.&nbsp;<a href=\"http://doi.org/10.1111/jne.12271\" target=\"_blank\">http://doi.org/10.1111/jne.12271</a></p>\n\n<p>Andrea, T.A., R.R. Cavalieri, I.D. Goldfine and E.C. Jorgensen (1980) Binding of thyroid hormones and analogues to the human plasma protein prealbumin. Biochemistry&nbsp; 19(1): 55-63.</p>\n\n<p>Aqai, P., C. Fryganas, M. Mizuguchi, W. Haasnoot and M.W. Nielen. (2012) Triple bioaffinity mass spectrometry concept for thyroid transporter ligands.&nbsp; Anal. Chem.&nbsp; 84(15): 6488-6493.</p>\n\n<p>Athanasiadou, M., S.N. Cuadra, G. Marsh, A&gt; Bergman, and K. Jakobsson. (2008) Polybrominated diphenyl ethers (PBDEs) and bioaccumulative hydroxylated PBDE metabolites in young humans from Managua, Nicaragua.&nbsp; Environ. Health Perspect. 116(3): 400-408.</p>\n\n<p>Barter, R.A. and C.D. Klaassen. (1994) Reduction of thyroid hormone levels and alteration of thyroid function by four representative UDP-glucuronosyltransferase inducers in rats.&nbsp; Toxicol. Appl. Pharmacol.&nbsp; 128(1): 9-17.</p>\n\n<p>Blake, C.C., J.M. Burridge and S.J. Oatley. (1978) X-ray analysis of thyroid hormone binding to prealbumin. Biochem Soc. Trans. 6(6): 1114-1118.</p>\n\n<p>Bloom, M.S., J.E. Vena, J.R. Olson and P.J. Kostyniak.&nbsp; (2009)&nbsp; Assessment of polychlorinated biphenyl congeners, thyroid stimulating hormone, and free thyroxine among New York state anglers.&nbsp; Int. J. Hyg. Environ. Health&nbsp; 212(6): 599-611.</p>\n\n<p>Branchi, I., E. Alleva and L.G. Costa.&nbsp; (2002)&nbsp; Effects of perinatal exposure to a polybrominated diphenyl ether (PBDE 99) on mouse neurobehavioural development.&nbsp; Neurotoxicology&nbsp; 23(3): 375-384.</p>\n\n<p>Brouwer, a, &amp; van den Berg, K. J. (1986). Binding of a metabolite of 3,4,3&rsquo;,4&#39;-tetrachlorobiphenyl to transthyretin reduces serum vitamin A transport by inhibiting the formation of the protein complex carrying both retinol and thyroxin. Toxicology and Applied Pharmacology, 85(3), 301&ndash;312.</p>\n\n<p>Calvo, R.M., E. Jauniaux, B. Gulbis, M. Asuncion, C. Gervy, B. Contempre and G. Morreale de Escobar.&nbsp; (2002)&nbsp; Fetal tissues are exposed to biologically relevant free thyroxine concentrations during early phases of development.&nbsp; J. Clin. Endocrinol. Metab.&nbsp; 87(4); 1768-1777.</p>\n\n<p>Cao, J., L.H. Guo, B. Wan and Y. Wei. (2011) In vitro fluorescence displacement investigation of thyroxine transport disruption by bisphenol A.&nbsp; J. Environ Sci, (China)&nbsp; 23(2): 315-321.</p>\n\n<p>Cao, J., Y. Lin, L.H. Guo, A.Q. Zhang, Y. Wei and Y. Yang. (2010) Structure-based investigation on the binding interaction of hydroxylated polybrominated diphenyl ethers with thyroxine transport proteins.&nbsp; Toxicology&nbsp; 277(1-3): 20-28.</p>\n\n<p>Chan, S.Y., J.A. Franklyn, H.N. Pemberton, J.N. Bulmer, T.J. Visser, C.J. McCabe and M.D. Kilby.&nbsp; (2006)&nbsp; Monocarboxylate transporter 8 expression in the human placenta: the effects of severe intrauterine growth restriction.&nbsp; J. Endocrinol.&nbsp; 189(3): 465-471.</p>\n\n<p>Chan, S., S. Kachilele, C.J. McCabe, L.A. Tannahill, K. Boelaert, N.J. Gittoes, T.J. Visser, J.A. Franklyn and M.D. Kilby.&nbsp; (2002)&nbsp; Early expression of thyroid hormone deiodinases and receptors in human fetal cerebral cortex.&nbsp; Brain Res. Dev. Brain Res.&nbsp; 138(2): 109-116.</p>\n\n<p>Chang, S.C., J.R. Thibodeaux, M.L. Eastvold, D.J. Ehresman, J.A. Bjork, J.W. Froehlich, C. Lau, R.J. Singh, K.B. Wallace and J.L. Butenhoff. (2008) Thyroid hormone status and pituitary function in adult rats given oral doses of perfluorooctanesulfonate (PFOS).&nbsp; Toxicology&nbsp; 243(3): 330-339.</p>\n\n<p>Chanoine, J.-P., Alex, S., Fang, S. L., Stone, S., Leonard, J. L., Kohrle, J., &amp; Braverman, L. E. (1992). Role of transthyretin in the transport of thyroxine from the blood to the choroid plexus, the cerebrospinal fluid and the brain. Endocrinology, 130(2), 933&ndash;938.</p>\n\n<p>Chauhan, K. R., Kodavanti, P. R. S., &amp; McKinney, J. D. (2000). Assessing the Role of ortho-Substitution on Polychlorinated Biphenyl Binding to Transthyretin, a Thyroxine Transport Protein. Toxicology and Applied Pharmacology, 162(1), 10&ndash;21.&nbsp;<a href=\"http://doi.org/10.1006/taap.1999.8826\" target=\"_blank\">http://doi.org/10.1006/taap.1999.8826</a></p>\n\n<p>Cheek, A.O., K. Kow, J. Chen and J.A. McLachlan. (1999) Potential mechanisms of thyroid disruption in humans: interaction of organochlorine compounds with thyroid receptor, transthyretin, and thyroid-binding globulin.&nbsp; Environ. Health Perspect.&nbsp; 107(4): 273-278.</p>\n\n<p>Chevrier, J., K.G. Harley, A. Bradman, M. Gharbi, A. Sjodin and B. Eskenazi.&nbsp; (2010)&nbsp; Polybrominated diphenyl ether (PBDE) flame retardants and thyroid hormone during pregnancy.&nbsp; Environ. Health Perspect.&nbsp; 118(10) : 1444-1449.</p>\n\n<p>Chopra, I.J., P. Taing and L. Mikus. (1996) Direct determination of free triiodothyronine (T3) in undiluted serum by equilibrium dialysis/radioimmunoassay (RIA).&nbsp; Thyroid&nbsp; 6(4): 255-259.</p>\n\n<p>Costa, L.G., R. de Laat, S. Tagliaferri and C. Pellacani.&nbsp; (2014)&nbsp; A mechanistic view of polybrominated diphenyl ether (PBDE) developmental neurotoxicity.&nbsp; 230(2): 282-294.</p>\n\n<p>Dallaire, R., G. Muckle, E. Dewailly, S.W. Jacobson, J.L. Jacobson, T.M. Sandanger, C.D. Sandau and P. Ayotte. (2009a)&nbsp; Thyroid hormone levels of pregnant inuit women and their infants exposed to environmental contaminants.&nbsp; Environ. Health Perspect.&nbsp; 117(6): 1014-1020.</p>\n\n<p>Dallaire, R., E. Dewailly, D. Pereg, S. Dery and P. Ayotte.&nbsp; (2009b)&nbsp; Thyroid function and plasma concentrations of polyhalogenated compounds in Inuit adults.&nbsp; Environ. Health Perspect.&nbsp; 117(9): 1380-1386.</p>\n\n<p>Darnerud, P.O., D. Morse, E. Klasson-Wehler and A Brouwer.&nbsp; (1996)&nbsp; Binding of a 3,3&#39;, 4,4&#39;-tetrachlorobiphenyl (CB-77) metabolite to fetal transthyretin and effects on fetal thyroid hormone levels in mice.&nbsp; Toxicology&nbsp; 106(1-3): 105-114.</p>\n\n<p>De Escobar, G.M., M.J. Obregon and F.E. del Rey.&nbsp; (2004)&nbsp; Maternal thyroid hormones early in pregnancy and fetal brain development.&nbsp; Best Pract. Res. Clin. Endocrinol. Metab.&nbsp; 18(2): 225-248.</p>\n\n<p>Dirinck, E., A.C. Dirtu, G. Malarvanna, A. Covaci, P.G. Jorens and L.F. Van Gall. (2016) A Preliminary Link between Hydroxylated Metabolites of Polychlorinated Biphenyls and Free Thyroxin in Humans.&nbsp; Int. J. Environ. Res. Public Health&nbsp; 13(4): 421.</p>\n\n<p>Eguchi, A., K. Nomiyama, N. Minh Tue, P.T. Trang, P. Hung Viet, S. Takahashi and S. Tanabe.&nbsp; (2015)&nbsp; Residue profiles of organohalogen compounds in human serum from e-waste recycling sites in North Vietnam: Association with thyroid hormone levels.&nbsp; Environ. Res.&nbsp; 137: 440-449.</p>\n\n<p>Emerson, C.H., J.H. Cohen III, R.A Yung, S. Alex and S.L. Fang. (1990) Gender-related differences of serum thyroxine-binding proteins in the rat. Acta Endocrinol. (Copenh)&nbsp; 123(1): 72-78.</p>\n\n<p>Erratico, C.A., A. Steitz and S.M. Bandiera. (2013) Biotransformation of 2,2&#39;,4,4&#39;-tetrabromodiphenyl ether (BDE-47) by human liver microsomes: identification of cytochrome P450 2B6 as the major enzyme involved.&nbsp; Chem. Res. Toxicol.&nbsp; 26(5): 721-731.</p>\n\n<p>Erratico, C.A., S.C. Moffatt and S.M. Bandiera. (2011) Comparative oxidative metabolism of BDE-47 and BDE-99 by rat hepatic microsomes.&nbsp; Toxicol. Sci.&nbsp; 123(1): 37-47.</p>\n\n<p>Eskenazi, B., J. Chevrier, S.A. Rauch, K. Kogul, K.G. Harley, C. Johnson, C. Trujillo, A. Sjodin and A. Bradman.&nbsp; (2013)&nbsp; In utero and childhood polybrominated diphenyl ether (PBDE) exposures and neurodevelopment in the CHAMACOS study.&nbsp; 121(2) : 257-262.</p>\n\n<p>Feo, M.L., M.S. Gross, B.P. McGarrigle, E. Eljarrat, D. Barcelo, D.S. Aga and J.R. Olson. (2013) Biotransformation of BDE-47 to potentially toxic metabolites is predominantly mediated by human CYP2B6.&nbsp; Environ. Health Persepct.&nbsp; 121(4): 440-446.</p>\n\n<p>Ferguson, R.N., H. Edelhoch, H.A. Saroff, J. Robbins and H.J. Cahnmann (1975) Negative cooperativity in the binding of thyroxine to human serum prealbumin. Preparation of tritium-labeled 8-anilino-1-naphthalenesulfonic acid.&nbsp; Biochemistry&nbsp; 14(2): 282-289.</p>\n\n<p>Friesema EC, Jansen J, Jachtenberg JW, Visser WE, Kester MH, Visser TJ 2008 Effective cellular uptake and efflux of thyroid hormone by human monocarboxylate transporter 10. Molecular endocrinology (Baltimore, Md 22:1357-1369</p>\n\n<p>Friesema EC, Kuiper GG, Jansen J, Visser TJ, Kester MH 2006 Thyroid hormone transport by the human monocarboxylate transporter 8 and its rate-limiting role in intracellular metabolism. Molecular endocrinology (Baltimore, Md 20:2761-2772</p>\n\n<p>Friesma, E.C., J. Jansen and T.J. Visser. (2005) Thyroid hormone transporters.&nbsp; Biochem. Soc. Trans.&nbsp; 33(part 1): 228-232.</p>\n\n<p>Friesema EC, Ganguly S, Abdalla A, Manning Fox JE, Halestrap AP, Visser TJ 2003 Identification of monocarboxylate transporter 8 as a specific thyroid hormone transporter. J Biol Chem 278:40128-40135</p>\n\n<p>Grimm, F. a., Lehmler, H. J., He, X., Robertson, L. W., &amp; Duffel, M. W. (2013). Sulfated metabolites of polychlorinated biphenyls are high-affinity ligands for the thyroid hormone transport protein transthyretin. Environmental Health Perspectives, 121(6), 657&ndash;662.</p>\n\n<p>Gutshall, D.M., G.D. Pilcher and A.E. Langley. (1989) Mechanism of the serum thyroid hormone lowering effect of perfluoro-n-decanoic acid (PFDA) in rats. J. Toxicol. Environ. Health&nbsp;&nbsp; 28(1): 53-65.</p>\n\n<p>Hagenbuch, B. (2007)&nbsp; Cellular entry of thyroid hormones by organic anion transporting polypeptides.&nbsp; Best Pract. Res. Clin. Endocrinol. Metab.&nbsp; 21(2): 209-221.</p>\n\n<p>Hagenbuch B, Meier PJ 2004 Organic anion transporting polypeptides of the OATP/ SLC21 family: phylogenetic classification as OATP/ SLCO superfamily, new nomenclature and molecular/functional properties. Pflugers Arch 447:653-665</p>\n\n<p>Hagmar, L., L. Rylander, E. Dyremark, E. Klasson-Wehler and E.M. Erfurth. (2001a).&nbsp; Plasma concentrations of persistent organochlorines in relation to thyrotropin and thyroid hormone levels in women.&nbsp; Int. Arch. Occup. Environ. Health&nbsp; 74(3): 184-188.</p>\n\n<p>Hagmar, L., J. Bjork, A. Sjodin, A. Bergman and E.M. Erfurth. (2001b) Plasma levels of persistent organohalogens and hormone levels in adult male humans.&nbsp; Arch. Environ. Health&nbsp; 56(2): 138-143.</p>\n\n<p>Hallgren, S., T. Sinjari, H. Hakansson and P.O. Darnerud. (2001) Effects of polybrominated diphenyl ethers (PBDEs) and polychlorinated biphenyls (PCBs) on thyroid hormone and vitamin A levels in rats and mice.&nbsp; 75(4): 200-208.</p>\n\n<p>Hallgren, S. and P.O. Darnerud. (2002) Polybrominated diphenyl ethers (PBDEs), polychlorinated biphenyls (PCBs) and chlorinated paraffins (CPs) in rats-testing interactions and mechanisms for thyroid hormone effects.&nbsp; Toxicology&nbsp; 177(203): 227-243.</p>\n\n<p>Hamers, T., J.H. Kamstra, E. Sonneveld, A.J. Murk, M.H. Kester, P.L. Andersson, J. Legler and A. Brouwer. (2006) In vitro profiling of the endocrine-disrupting potency of brominated flame retardants.&nbsp; Toxicol. Sci.&nbsp; 92(1): 157-173.</p>\n\n<p>Hamers, T., Kamstra, E. Sonneveld, A.J. Murk, T.J. Visser, M.J. Van Velzen, A. Brouwer and A. Bergman. (2008) Biotransformation of brominated flame retardants into potentially endocrine-disrupting metabolites, with special attention to 2,2&#39;,4,4&#39;-tetrabromodiphenyl ether (BDE-47).&nbsp; Mol. Nutr. Food Res.&nbsp; 52(2): 284-298.</p>\n\n<p>Harley, K.G., A.R. Marks, J. Chevrier, A. Bradman, A. Sjodin and B. Eskenazi.&nbsp; (2010)&nbsp; PBDE concentrations in women&#39;s serum and fecundability.&nbsp; Environ. Health Perspect.&nbsp; 118(5): 699-704.</p>\n\n<p>Henneman, G., R. Docter, E.C. Friesma, M. de Jong, E.P. Krenning and T.J. Visser.&nbsp; (2001)&nbsp; Plasma membrane transport of thyroid hormones and its role in thyroid hormone metabolism and bioavailability.&nbsp; Endocr. Rev.&nbsp; 22(4): 451-476.</p>\n\n<p>Heuer, H. &nbsp;(2007)&nbsp; The importance of thyroid hormone transporters for brain development and function.&nbsp; Best Pract. Res. Clin. Endocrinol. Metab.&nbsp; 21(2):&nbsp; 265-276.</p>\n\n<p>Hood, A. and C.D. Klaassen. (2000a) Differential effects of microsomal enzyme inducers on in vitro thyroxine (T(4)) and triiodothyronine (T(3)) glucuronidation.&nbsp; Toxicol. Sci.&nbsp; 55(1): 78-84.</p>\n\n<p>Hood, A. and C.D. Klaassen.&nbsp; (2000b)&nbsp; Effects of microsomal enzyme inducers on outer-ring deiodinase activity toward thyroid hormones in various rat tissues.&nbsp; Toxicol. Appl. Pharmacol.&nbsp; 163(3): 240-248.</p>\n\n<p>Hovander, L., M. Athanasiadou, L. Asplund, S. Jensen and E.K. Wehler. (2000). Extraction and cleanup methods for analysis of phenolic and neutral organohalogens in plasma.&nbsp; 24(8): 696-703.</p>\n\n<p>Hume, R., J. Simpson, C. Delahunty, H. van Toor, S.Y. Wu, F.L. Williams, T.J. Visser et al.&nbsp; (2004) Human fetal and cord serum thyroid hormones: developmental trends and interrelationships.&nbsp; J. Clin. Endocrinol. Metab.&nbsp; 89(8): 4097-4103.</p>\n\n<p>Inoue, K., F. Okada, R. Ito, S. Kato, S. Sasaki, S. Nakajima, A. Uno, Y. Saijo, F. Sata, Y. Yoshimura, R. Kishi and H. Nakazawa. (2004) Perfluorooctane sulfonate (PFOS) and related perfluorinated compounds in human maternal and cord blood samples: assessment of PFOS exposure in a susceptible population during pregnancy.&nbsp; Environ. Health Perspect.&nbsp; 112(11): 1204-1207.</p>\n\n<p>Kato, Y., K. Haraguchi, M. Onishi, S. Ikushiro, T. Endo, C. Ohta, N. Koga, S Yamada and M. Degawa. (2014) 3,3&#39;,4,4&#39;-Tetrachlorobiphenyl-mediated decrease of serum thyroxine level in C57BL/6 and DBA/2 mice occurs mainly through enhanced accumulation of thyroxine in the liver.&nbsp; Biol. Pharm. Bull.&nbsp; 37(3) 504-509.</p>\n\n<p>Kato, Y., M. Onishi, K. Haraguchi, S. Ikushiro, C. Ohta, N. Koga, T. Endo, S. Yamada and M. Degawa. (2013) A possible mechanism for 2,3&#39;,4,4&#39;,5&#39;-pentachlorobiphenyl-mediated decrease in serum thyroxine level in mice.&nbsp; Biol. Pharm. Bull.&nbsp; 36(10): 1594-1601.</p>\n\n<p>Kato, Y., S. Tamaki, K. Haraguchi, S. Ikushiro, M. Sekimoto, C. Ohta, T. Endo, N. Koga, S. Yamada and M. Degawa. (2012) Comparative study on 2,2&#39;,4,5,5&#39;-pentachlorobiphenyl-mediated decrease in serum thyroxine level between C57BL/6 and its transthyretin-deficient mice.&nbsp; Toxicol. Appl. Pharmacol.&nbsp; 263(3): 323-329.</p>\n\n<p>Kato, Y., M. Onishi, K. Haraguchi, S. Ikushiro, C. Ohta, N. Koga, T. Endo, S. Yamada and M. Degawa. (2011) A possible mechanism for 2,2&#39;,4,4&#39;,5,5&#39;-hexachlorobiphenyl-mediated decrease in serum thyroxine level in mice.&nbsp; Toxicol. Appl. Pharmacol.&nbsp; 254(1): 48-55.</p>\n\n<p>Kato, Y., K. Haraguchi, M. Kubota, Y. Seto, S. Ikushiro, T. Sakaki, N. Koga, S. Yamada and M. Degawa. (2009) 4-Hydroxy-2,2&#39;,3,4&#39;,5,5&#39;,6-heptachlorobiphenyl-mediated decrease in serum thyroxine level in mice occurs through increase in accumulation of thyroxine in the liver.&nbsp; Drug Metab. Dispos.&nbsp; 37(10): 2095-2102.</p>\n\n<p>Kato, Y., S. Ikushiro, R. Takiguchi, K. Haraguchi, N. Koga, S. Uchida, T. Sakaki, S. Yamada, J. Kanno and M. Degawa. (2007) A novel mechanism for polychlorinated biphenyl-induced decrease in serum thyroxine level in rats.&nbsp; Drug Metab. Dispos. 35(10) : 1949-1955.</p>\n\n<p>Kato, Y., S. Ikushiro, K. Haraguchi, T. Yamazaki, Y. Ito, H. Suzuki, R. Kimura, S. Yamada, T. Inoue and M. Degawa. (2004) A possible mechanism for decrease in serum thyroxine level by polychlorinated biphenyls in Wistar and Gunn rats.&nbsp; Toxicol. Sci.&nbsp; 81(2): 309-315.</p>\n\n<p>Kato, Y., K. Haraguchi, T. Yamazuki, Y. Ito, S. Miyajima, K. Nemoto, N. Koga, R. Kimura and M. Degawa. (2003) Effects of polychlorinated biphenyls, kanechlor-500, on serum thyroid hormone levels in rats and mice.&nbsp; Toxicol. Sci.&nbsp; 72(2): 235-241.</p>\n\n<p>Kim, S.Y., E.S. Choi, H.J. Lee, C. Moon and E. Kim.&nbsp; (2015)&nbsp; Transthyretin as a new transporter of nanoparticles for receptor-mediated transcytosis in rat brain microvessels.&nbsp; Colloids Surf B Biointerfaces&nbsp; 136: 989-996.</p>\n\n<p>Kim do K, Kanai Y, Matsuo H, Kim JY, Chairoungdua A, Kobayashi Y, Enomoto A, Cha SH, Goya T, Endou H 2002 The human T-type amino acid transporter-1: characterization, gene organization, and chromosomal location. Genomics 79:95-103</p>\n\n<p>Kohrle, J., S.L. Fang, Y. Yang, K. Irmscher, R.D. Hesch, S. Pino, S. Alex, and L.E. Braverman. (1989). Rapid effects of the flavonoid EMD 21388 on serum thyroid hormone binding and thyrotropin regulation in the rat. Endocrinoloy 125: 532-537</p>\n\n<p>Koopman-Essenboom, C., D.C. Morse, N. Weisglas-Kuperus, I.J. Lutkeschipholt, C.G. Van der Paauw, L.G. Tuinstra, A. Brouwer and P.J. Sauer.&nbsp; (1994)&nbsp; Effects of dioxins and polychlorinated biphenyls on thyroid hormone status of pregnant women and their infants.&nbsp; Pediatr. Res.&nbsp; 36(4): 468-473.</p>\n\n<p>Lans, M. C., Klasson-Wehler, E., Willemsen, M., Meussen, E., Safe, S., &amp; Brouwer, A. (1993). STRUCTURE-DEPENDENT, COMPETITIVE INTERACTION OF HYDROXY-POLYCHLOROBIPHENYLS, -DIBENZO-p-DIOXINS AND -DIBENZOFURANS WITH HUMAN TRANSTHYRETIN. Chemico-Biological Interactions, 88, 7&ndash;21.</p>\n\n<p>Lans, M. C., Spiertz, C., Brouwer, a, &amp; Koeman, J. H. (1994). Different competition of thyroxine binding to transthyretin and thyroxine-binding globulin by hydroxy-PCBs, PCDDs and PCDFs. European Journal of Pharmacology, 270(2-3), 129&ndash;136.&nbsp;<a href=\"http://doi.org/10.1016/0926-6917(94)90054-X\" target=\"_blank\">http://doi.org/10.1016/0926-6917(94)90054-X</a></p>\n\n<p>Larsson, M., Pettersson, T., &amp; Carlstr&ouml;m, a. (1985). Thyroid hormone binding in serum of 15 vertebrate species: isolation of thyroxine-binding globulin and prealbumin analogs. General and Comparative Endocrinology, 58(3), 360&ndash;375.</p>\n\n<p>Loubiere, L.S., E. Vasilopoulou, J.N. Bulmer, P.M. Taylor, B. Stieger, F. Verrey, C.J. McCabe, J.A. Franklyn, M.D. Kilby and S.Y. Chan. (2010)&nbsp; Expression of thyroid hormone transporters in the human placenta and changes associated with intrauterine growth restriction.&nbsp; Placenta&nbsp; 31(4): 295-304.</p>\n\n<p>Lueprasitsakul, W., Alex, S., Fang, S. L., Pino, S., Irmscher, K., K&ouml;hrle, J., &amp; Braverman, L. E. (1990). Flavonoid administration immediately displaces thyroxine (T4) from serum transthyretin, increases serum free T4, and decreases serum thyrotropin in the rat. Endocrinology 126 (6)</p>\n\n<p>Lupton, S.J., P. McGarrigle, J.R. Olson, T.D. Wood and D.S. Aga. (2010) Analysis of hydroxylated polybrominated diphenyl ether metabolites by liquid chromatography/atmospheric pressure chemical ionization tandem mass spectrometry.&nbsp; Rapid Commun. Mass. Spectrom.&nbsp; 24(15): 2227-2235.</p>\n\n<p>Lupton, S.J., B.P. McGarrigle, J.R. Olson, T.D. Wood and D.S. Aga. (2009)&nbsp; Analysis of hydroxylated polybrominated diphenyl ether metabolites by liquid chromatography/atmospheric pressure chemical ionization tandem mass spectrometry.&nbsp; 22(11): 1802-1809.</p>\n\n<p>Malmberg, T., M. Athanasiadou, G. Marsh, I. Brandt and A. Bergman.&nbsp; (2005) Identification of hydroxylated polybrominated diphenyl ether metabolites in blood plasma from polybrominated diphenyl ether exposed rats.&nbsp; 39(14): 5342-5348.</p>\n\n<p>Marchesini, G.R., E. Meulenberg, W. Haasnoot, M. Mizuguchi and H. Irth.&nbsp; (2006) Biosensor recognition of thyroid-disrupting chemicals using transport proteins.&nbsp; Anal. Chem.&nbsp; 78(4): 1107-1114.</p>\n\n<p>Marchesini, G.R., A. Meimaridou, W. Haasnoot, E. Meulenberg, F. Albertus, M. Mizuguchi, M. Takeuchi, H. Irth and A.J. Murk. (2008) iosensor discovery of thyroxine transport disrupting chemicals.&nbsp; Toxicol. Appl. Pharmacol.&nbsp; 232(1): 150-160.</p>\n\n<p>Martin, L.A., D.T. Wilson, K.R&gt; Reuhl, M.A. Gallo and C.D. Klaassen. (2012) Polychlorinated biphenyl congeners that increase the glucuronidation and biliary excretion of thyroxine are distinct from the congeners that enhance the serum disappearance of thyroxine.&nbsp; Drug Metab. Dispos.&nbsp; 40(3): 588-595.</p>\n\n<p>Martin, L. and C.D. Klaassen. (2010) Differential effects of polychlorinated biphenyl congeners on serum thyroid hormone levels in rats.&nbsp; Toxicol. Sci.&nbsp; 117(1): 36-44.</p>\n\n<p>Meerts, I.A., Y. Assink, P.H. Cenjin, J.H. Van Den Berg, B.M. Weijers, A. Bergman, J.H. Koeman and A. Brouwer. (2002) Placental transfer of a hydroxylated polychlorinated biphenyl and effects on fetal and maternal thyroid hormone homeostasis in the rat.&nbsp; Toxicol. Sci. 68(2): 361-371.</p>\n\n<p>Meerts, I.A., J.J. van Zanden, E.A. Lujiks, I. van Leeuwen-Bol, G. Marsh, E. Jakobsson, A. Bergman and A. Brouwer. (2000) Potent competitive interactions of some brominated flame retardants and related compounds with human transthyretin in vitro.&nbsp; Toxicol. Sci.&nbsp; 56(1): 95-104.</p>\n\n<p>Mendel, C. M. (1989). Modeling thyroxine transport to liver&nbsp;: rejection of the &ldquo;enhanced dissociation&rdquo; hypothesis as applied to thyroxine. Am J Physiol, 257(Endocrinol Metab 20), E764&ndash;E771.</p>\n\n<p>Mendel, C. M., Cavalieri, R. R., &amp; Kohrle, J. (1992). Thyroxine (T4) transport and distribution in rats treated with EMD 21388, a synthetic flavonoid that displaces T4 from transthyretin. Endocrinology, 130(3), 1525&ndash;1532.</p>\n\n<p>Midgley, J. E. (2001) Direct and indirect free thyroxine assay methods: theory and practice.&nbsp; Clin. Chem.&nbsp; 47(8): 1353-1363.</p>\n\n<p>Miksys, S. and R.F. Tyndale. (2004) The unique regulation of brain cytochrome P450 2 (CYP2) family enzymes by drugs and genetics.&nbsp; Drug Metab. Rev.&nbsp; 36(2): 313-333.</p>\n\n<p>Montano, M., E. Coccco, C. Guignard, G. Marsh, L. Hoffmann, A. Bergman, A.C. Gutleb and A.J. Murk. (2012) New approaches to assess the transthyretin binding capacity of bioactivated thyroid hormone disruptors.&nbsp; Toxicol. Sci.&nbsp; 130(1): 94-105.</p>\n\n<p>Morse, D.C., E.K. Wehler, W. Wesseling, J.H. Koeman and A. Brouwer.&nbsp; (1996)&nbsp; Alterations in rat brain thyroid hormone status following pre- and postnatal exposure to polychlorinated biphenyls (Aroclor 1254).&nbsp; Toxicol. Appl. Pharmacol.&nbsp; 136(2): 269-279.</p>\n\n<p>Morse, D.C., D. Groen, M. Veerman, C.J. van Amerongen, H.B. Koeter, A.E. Smits van Proojie, T.J. Visser, J.H. Koeman and A. Brouwer.&nbsp; (1993)&nbsp; Interference of polychlorinated biphenyls in hepatic and brain thyroid hormone metabolism in fetal and neonatal rats.&nbsp; Toxicol. Appl. Pharmacol.&nbsp; 122(1) :27-33.</p>\n\n<p>Munro, S.L., C.F. Lim, J.G. Hall, J.W. Barlow, D.J. Craik, D.J. Topliss and J.R. Stockigt (1989) Drug competition for thyroxine binding to transthyretin (prealbumin): comparison with effects on thyroxine-binding globulin. J. Clin. Endocrinol. Metab.&nbsp; 68(6): 1141-1147,</p>\n\n<p>Nishimura M, Naito S 2008 Tissue-specific mRNA expression profiles of human solute carrier transporter superfamilies. Drug Metab Pharmacokinet 23:22-44</p>\n\n<p>Pedraza, P., Calvo, R., Obreg&oacute;n, M. J., Asuncion, M., Escobar Del Rey, F., &amp; Morreale De Escobar, G. (1996). Displacement of T4 from transthyretin by the synthetic flavonoid EMD 21388 results in increased production of T3 from T4 in rat dams and fetuses. Endocrinology, 137(11), 4902&ndash;4914.&nbsp;<a href=\"http://doi.org/10.1210/en.137.11.4902\" target=\"_blank\">http://doi.org/10.1210/en.137.11.4902</a></p>\n\n<p>Purkey, H.E., M.I. Dorrell and J.W. Kelly. (2001) Evaluating the binding selectivity of transthyretin amyloid fibril inhibitors in blood plasma.&nbsp; Proc. Natl. Acad. Sci. USA&nbsp; 98(10): 5566-5571.</p>\n\n<p>Refetoff, S., N.I. Robin and V.S. Fang. (1970) Parameters of thyroid function in serum of 16 selected vertebrate species: a study of PBI, serum T4, free T4, and the pattern of T4 and T3 binding to serum proteins.&nbsp; Endocrinology&nbsp; 86(4): 793-805.</p>\n\n<p>Refetoff, S. (2015) Thyroid Hormone Serum Transport Proteins. In: De Groot LJ, Chrousos G, Dungan K, Feingold KR, Grossman A, Hershman JM, Koch C, Korbonits M, McLachlan R, New M, Purnell J, Rebar R, Singer F, Vinik A, editors. Endotext [Internet]. South Dartmouth (MA): MDText.com, Inc.; 2000.</p>\n\n<p>Ren, X.M., L.H. Guo, Y. Gao, B.T. Zhang and B. Wan. (2013) Hydroxylated polybrominated diphenyl ethers exhibit different activities on thyroid hormone receptors depending on their degree of bromination.&nbsp; Toxicol. Appl. Pharamacol.&nbsp; 268(3): 256-263.</p>\n\n<p>Ren, X. M., &amp; Guo, L. H. (2012). Assessment of the binding of hydroxylated polybrominated diphenyl ethers to thyroid hormone transport proteins using a site-specific fluorescence probe. Environmental Science and Technology, 46(8), 4633&ndash;4640.&nbsp;<a href=\"http://doi.org/10.1021/es2046074\" target=\"_blank\">http://doi.org/10.1021/es2046074</a></p>\n\n<p>Rerat, C. and H.G. Schwick (1967) [Crystallographic data of blood plasma prealbumin]. [Article in French] Acta Crystallogr.&nbsp; 22(3): 441-442.</p>\n\n<p>Richardson, S. J. (2007). Cell and molecular biology of transthyretin and thyroid hormones. International Review of Cytology, 258(January), 137&ndash;93.&nbsp;<a href=\"http://doi.org/10.1016/S0074-7696(07)58003-4\" target=\"_blank\">http://doi.org/10.1016/S0074-7696(07)58003-4</a></p>\n\n<p>Richardson, S. J., Wijayagunaratne, R. C., D&rsquo;Souza, D. G., Darras, V. M., &amp; Van Herck, S. L. J. (2015). Transport of thyroid hormones via the choroid plexus into the brain: the roles of transthyretin and thyroid hormone transmembrane transporters. Frontiers in Neuroscience, 9(March), 1&ndash;8.</p>\n\n<p>Rickenbacher, U., McKinney, J. D., Oatley, S. J., &amp; Blake, C. C. (1986). Structurally specific binding of halogenated biphenyls to thyroxine transport protein. Journal of Medicinal Chemistry, 29(5), 641&ndash;648.</p>\n\n<p>Ritchie, J.W. and P.M. Taylor.&nbsp; (2001)&nbsp; Role of the System L permease LAT1 in amino acid and iodothyronine transport in placenta.&nbsp; Biochem. J.&nbsp; 356(Part 3); 719-725.</p>\n\n<p>Riu, A., J.P. Cravedi, L. Debrauwer, A. Garcia, C. Canlet, I. Jouanin and D. Zalko. (2008) Environ. Int. 34(3): 318-329.</p>\n\n<p>Roberts LM, Woodford K, Zhou M, Black DS, Haggerty JE, Tate EH, Grindstaff KK, Mengesha W, Raman C, Zerangue N 2008 Expression of the thyroid hormone transporters MCT8 (SLC16A2) and OATP14 (SLCO1C1) at the blood-brain barrier. Endocrinology 149:6251-6261</p>\n\n<p>Rotroff, D.M., B.A. Wetmore, D.J. Dix, S.S. Ferguson, H.J. Clewell, K.A. Houck, E.L. Lecluyse, M.E. Anersen, R.S. Judson, C.M. Smith, M.A. Sochaski, R.J. Kavlock, F. Boellmann, M.T. Martin, D.M. Reif, J.F. Wambaugh and R.S. Thomas. (2010) Incorporating human dosimetry and exposure into high-throughput in vitro toxicity screening.&nbsp; 117(2): 348-358.</p>\n\n<p>Sato, K., J. Sugawara, T. Sato, H. Mizutamari, T. Suzuki, A. Ito, T. Mikkaichi, T. Onogawa, M. Tanemoto, M. Unno, T. Abe and K. Okamura.&nbsp; (2003)&nbsp; Expression of organic anion transporting polypeptide E (OATP-E) in human placenta.&nbsp; Placenta&nbsp; 24(2-3): 144-148.</p>\n\n<p>Schreiber, G. (2002). The evolutionary and integrative roles of transthyrein in thyroid hormone homeostasis. Journal of Endocrinology, 175(1), 61&ndash;73.&nbsp;<a href=\"http://doi.org/10.1677/joe.0.1750061\" target=\"_blank\">http://doi.org/10.1677/joe.0.1750061</a></p>\n\n<p>Schroder van der Elst, J.P., D. van der Heide, H. Rokos, G. Morreale de Escobar and J. Kohrlre. (1998) Synthetic flavonoids cross the placenta in the rat and are found in fetal brain.&nbsp; Am. J. Physiol.&nbsp; 274(2 Psrt 1): E253-E256.</p>\n\n<p>Schroder van der Elst, J.P., D. van der Heide, H. Rokos, J. Kohrle and G. Morreale de Escobar. (1997)&nbsp; Different tissue distribution, elimination, and kinetics of thyroxine and its conformational analog, the synthetic flavonoid EMD 49209 in the rat.&nbsp; Endocrinology&nbsp; 138(1): 79-84.</p>\n\n<p>Schuur, A.G., F.M. Boekhorst, A. Brouwer and T.J. Visser. (1997) Extrathyroidal effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin on thyroid hormone turnover in male Sprague-Dawley rats.&nbsp; Endocrinology&nbsp; 138(9): 3727-3734.</p>\n\n<p>Sinjari, T. and P.O. Darnerud. (1998) Hydroxylated polychlorinated biphenyls: placental transfer and effects on thyroxine in the foetal mouse.&nbsp; Xenobiotica&nbsp; 28(1): 21-30.</p>\n\n<p>Sparkes, R.S., H. Sasaki, T. Mohandas, K. Yoshioka, I. Kilsak, Y. Sasaki, C. Heinzmann and M.I. Simon. (1987) Assignment of the prealbumin (PALB) gene (familial amyloidotic polyneuropathy) to human chromosome region 18q11.2-q12.1. Hum. Genet.&nbsp; 75(2): 151-154.</p>\n\n<p>Stapleton, H.M., S.M. Kelly, R. Pei, R.J. Letcher and C. Gunsch.&nbsp; (2009) Metabolism of polybrominated diphenyl ethers (PBDEs) by human hepatocytes in vitro.&nbsp; Environ. Health Perspect.&nbsp; 117(2): 197-202.</p>\n\n<p>Tohyama K, Kusuhara H, Sugiyama Y 2004 Involvement of multispecific organic anion transporter, Oatp14 (Slc21a14), in the transport of thyroxine across the blood-brain barrier. Endocrinology</p>\n\n<p>Ucan-Marin, F., A. Arukwe, A.S. Mortensen, G.W. Gabrielsen and R.J. Letcher. (2010) Recombinant albumin and transthyretin transport proteins from two gull species and human: chlorinated and brominated contaminant binding and thyroid hormones.&nbsp; Environ. Sci. Technol.&nbsp; 44(1): 497-504.</p>\n\n<p>Van Birgelen, A.P., E.A. Smit, I.M. Kampen, C.N. Groeneveld, K.M. Case, J. Van der Kolk, H. Poiger, M. Van den Berg, J.H. Koeman and A. Brouwer. (1995) Subchronic effects of 2,3,7,8-TCDD or PCBs on thyroid hormone metabolism: use in risk assessment.&nbsp; Eur. J. Pharmacol.&nbsp; 293(1) : 77-85.</p>\n\n<p>Van den Berg, K. J. (1990). Interaction of chlorinated phenols with thyroxine binding sites of human transthyretin, albumin and thyroid binding globulin. Chemico-Biological Interactions, 76(1), 63&ndash;75.</p>\n\n<p>Van den Berg, K. J., Van Raaij, J. a G. M., Bragt, P. C., &amp; Notten, W. R. F. (1991). Interactions of halogenated industrial chemicals with transthyretin and effects on thyroid hormone levels in vivo. Archives of Toxicology, 65(1), 15&ndash;19.</p>\n\n<p>Viberg, H., A. Fredriksson and P. Eriksson. (2002) Neonatal exposure to the brominated flame retardant 2,2&#39;,4,4&#39;,5-pentabromodiphenyl ether causes altered susceptibility in the cholinergic transmitter system in the adult mouse.&nbsp; Toxicol. Sci. 67(1): 104-107.</p>\n\n<p>Viollon-Abadie, C., D. Lassere, E. Debruyne, L. Nicod, N. Carmichael and L. Richert. (1999) Phenobarbital, beta-naphthoflavone, clofibrate, and pregnenolone-16alpha-carbonitrile do not affect hepatic thyroid hormone UDP-glucuronosyl transferase activity, and thyroid gland function in mice.&nbsp; Toxicol. Appl. Pharmacol.&nbsp; 155(1) 1-12.</p>\n\n<p>Visser, T.J. and R.P. Peeters. (2012) Metabolism of thyroid hormone.&nbsp; In: De Groot LJ, Chrousos G, Dungan K, Feingold KR, Grossman A, Hershman JM, Koch C, Korbonits M, McLachlan R, New M, Purnell J, Rebar R, Singer F, Vinik A, editors. Endotext [Internet]. South Dartmouth (MA): MDText.com, Inc.; 2000-.</p>\n\n<p>Visser, T. J. (2010). Cellular Uptake of Thyroid Hormones. In: De Groot LJ, Chrousos G, Dungan K, Feingold KR, Grossman A, Hershman JM, Koch C, Korbonits M, McLachlan R, New M, Purnell J, Rebar R, Singer F, Vinik A, editors. Endotext [Internet]. South Dartmouth (MA): MDText.com, Inc.; 2000-.</p>\n\n<p>Visser, T.J. (1996) Role of sulfate in thyroid hormone sulfation.&nbsp; Eur. J. Endocrinol.&nbsp; 134(1): 12-14.</p>\n\n<p>Visser, T.J., E. Kaptein, J.A. van Raaij, C.T. Joe, T. Ebner and B. Burchell. (1993)</p>\n\n<p>Multiple UDP-glucuronyltransferases for the glucuronidation of thyroid hormone with preference for 3,3&#39;,5&#39;-triiodothyronine (reverse T3).&nbsp; FEBS Lett.&nbsp; 315(1): 65-68.</p>\n\n<p>Weiss, J.M., P.L. Andersson, M.H. Lamoree, P.E. Leonards, S.P. van Leeuwen and T. Hamers. (2009) Competitive binding of poly- and perfluorinated compounds to the thyroid hormone transport protein transthyretin.&nbsp; Toxicol. Sci.&nbsp; 109(2): 206-216.</p>\n\n<p>Weiss, J. M., Andersson, P. L., Zhang, J., Simon, E., Leonards, P. E. G., Hamers, T., &amp; Lamoree, M. H. (2015). Tracing thyroid hormone-disrupting compounds: database compilation and structure-activity evaluation for an effect-directed analysis of sediment. Analytical and Bioanalytical Chemistry, 5625&ndash;5634.&nbsp;<a href=\"http://doi.org/10.1007/s00216-015-8736-9\" target=\"_blank\">http://doi.org/10.1007/s00216-015-8736-9</a></p>\n\n<p>Yamauchi, K., A. Ishihara, H. Fukazawa and Y. Terao.&nbsp; (2003) Competitive interactions of chlorinated phenol compounds with 3,3&#39;,5-triiodothyronine binding to transthyretin: detection of possible thyroid-disrupting chemicals in environmental waste water.&nbsp; Toxicol. Appl. Pharmacol.&nbsp; 187(2): 110-117.</p>\n\n<p>Yen, P. M. (2001). Physiological and molecular basis of thyroid hormone action. Physiological Reviews, 81(3), 1097&ndash;1142.</p>\n\n<p>Zhang, J., J.H. Kamstra, M. Ghorbanzadeh, J.M. Weiss, T. Hamers and P.L. Andersson. (2015) In Silico Approach To Identify Potential Thyroid Hormone Disruptors among Currently Known Dust Contaminants and Their Metabolites.&nbsp; Environ. Sci. Technol.&nbsp; 49(16): 10099-10107.</p>\n\n<p>Zoeller, R. T., Tan, S. W., &amp; Tyl, R. W. (2007). General background on the hypothalamic-pituitary-thyroid (HPT) axis. Critical Reviews in Toxicology, 37(1-2), 11&ndash;53.</p>\n\n<p>Zoeller, R.T. and J. Rovet.&nbsp; (2004)&nbsp; Timing of thyroid hormone action in the developing brain: clinical observations and experimental findings.&nbsp; J. Neuroendocrinol.&nbsp; 16(10): 809-818.</p>\n","biologicalOrganisationLevel":"Tissue","organTerm":{"name":"liver","sourceId":"UBERON:0002107"},"biologicalEvents":[{"action":"increased","process":"metabolic process","object":{"name":"thyroxine","source":"CHEBI","sourceId":"CHEBI:30660"}}],"id":961}
{"title":"Inhibition of Aromatase Enzyme, Chemical exposure during critical window of estrous cycle between diestrus 2 and proestrus inhibits aromatase conversion of testosterone to estradiol","references":"","biologicalOrganisationLevel":"Molecular","organTerm":{},"biologicalEvents":[{"action":"decreased","process":"signaling","object":{"name":"aromatase","source":"PR","sourceId":"PR:000006100"}}],"id":964}
{"title":"reduction in ovarian granulosa cells synthesis of estradiol, Reduced steroidogenic production of estradiol in granulosa cells","references":"","biologicalOrganisationLevel":"Cellular","organTerm":{},"biologicalEvents":[{"action":"decreased","process":"estrogen biosynthetic process","object":{"name":"17beta-estradiol","source":"CHEBI","sourceId":"CHEBI:16469"}}],"id":965}
{"title":"Reduced Estradiol in Circulation, Reduced steroidogenic production of estradiol in granulosa cells leading to decreased estradiol in circulation","references":"","biologicalOrganisationLevel":"Tissue","organTerm":{},"biologicalEvents":[{"action":"decreased","object":{"name":"17beta-estradiol","source":"CHEBI","sourceId":"CHEBI:16469"}}],"id":966}
{"title":"Decreased positive estrogenic feedback on hypothalamus, Reduced estradiol in circulation decreases estrogen concentration at hypothalamus","references":"","biologicalOrganisationLevel":"Organ","organTerm":{},"biologicalEvents":[{"action":"decreased","object":{"name":"estrogen","source":"CHEBI","sourceId":"CHEBI:50114"}}],"id":967}
{"title":"Decreased Kisspeptin release from neurons in AVPV, Decreased hypothalamic estrogen reduces kisspeptinergic neuron response ","references":"","biologicalOrganisationLevel":"Cellular","organTerm":{},"biologicalEvents":[{"action":"decreased","process":"neurotransmitter secretion","object":{"name":"metastasis-suppressor KiSS-1 (rat)","source":"PR","sourceId":"PR:Q7TSB7"}}],"id":968}
{"title":"Decreased GnRH Release, Decreased Kisspeptin stimulation of GnRH neurons ","references":"","biologicalOrganisationLevel":"Cellular","organTerm":{},"biologicalEvents":[{"action":"decreased","process":"hormone secretion","object":{"name":"Gonadotropin Releasing Hormone","source":"MESH","sourceId":"D007987"}}],"id":969}
{"title":"Decreased LH release from Anterior Pituitary, Decreased GnRH stimulation of Anterior Pituitary Gonadotrophs","references":"","biologicalOrganisationLevel":"Cellular","organTerm":{},"biologicalEvents":[{"action":"decreased","process":"luteinizing hormone secretion","object":{"name":"Luteinizing hormone","source":"CHEBI","sourceId":"CHEBI:81568"}}],"id":970}
{"title":"Ovulation of oocytes Reduced, Delayed, or Blocked, Decrease or delay in LH surge required for ovulation ","references":"","biologicalOrganisationLevel":"Individual","organTerm":{},"biologicalEvents":[{"action":"abnormal","process":"ovulation cycle","object":{}}],"id":971}
{"title":"Decreased fertility, Reduced number of oocytes ovulated ","references":"","biologicalOrganisationLevel":"Individual","organTerm":{},"biologicalEvents":[{"action":"decreased","process":"egg quantity","object":{}}],"id":972}
{"title":"Interference, nuclear localization of NFAT","references":"<ol>\n\t<li>Rao, A., Luo, C., and Hogan, PG. (1997). Transcription factors of the NFAT family: regulation and function. Annual Review of Immunology 15: 707-47.</li>\n\t<li>Beals, C.R., Clipstone, N.A., Ho, S.N. and Crabtree, G.R. (1997). Nuclear localization of NF-ATc by a calcineurin-dependent, cyclosporin-sensitive intramolecular interaction. Genes &amp; development 11 (7): 824-34.</li>\n\t<li>Zhu, J. and McKeon, F. (1999). NF-AT activation requires suppression of Crm1-dependent export by calcineurin. Nature. 398(6724): 256-60.</li>\n\t<li>Serfling, E., Berberich-Siebelt, F., Chuvpilo, S., Jankevics, E., Klein-Hessling, S., Twardzik, T., and Avots, A., (2000). The role of NF-AT transcription factors in T cell activation and differentiation. Biochimica et Biophysica Act 1498 (1): 1-18.</li>\n\t<li>Matsuda, S., Koyasu, S. (2000). A second target of cyclosporin A and FK506. Tanpakushitsu kakusan koso. 45(11): 1823-1831.</li>\n\t<li>Bhattacharyya, S., Deb, J., Patra, A.K., Thuy Pham, D.A., Chen, W., Vaeth, M., Berberich-Siebelt, F., Klein-Hessling, S., Lamperti, E.D., Reifenberg, K., Jellusova, J., Schweizer, A., Nitschke, L., Leich, E., Rosenwald, A., Brunner, C., Engelmann, S., Bommhardt, U., Avots, A., M&uuml;ller, M.R., Kondo, E. and Serfling, E. (2011). NFATc1 affects mouse splenic B cell function by controlling the calcineurin-NFAT signaling network. The Journal of experimental medicine 208 (4): 823-39.</li>\n\t<li>Flanagan, W.M., Corth&eacute;sy, B., Bram, R.J. and Crabtree, G.R. (1991). Nuclear association of a T-cell transcription factor blocked by FK-506 and cyclosporin A. Nature 352 (6338): 803-7.</li>\n\t<li>Maguire O., Tornatore K.M., O&#39;Loughlin K.L., Venuto R.C., Minderman H.(2013). Nuclear translocation of nuclear factor of activated T cells (NFAT) as a quantitative pharmacodynamic parameter for tacrolimus.</li>\n</ol>\n","biologicalOrganisationLevel":"Molecular","organTerm":{"name":"immune system","sourceId":"UBERON:0002405"},"biologicalEvents":[{"action":"increased","process":"genetic interference","object":{"name":"NFAT protein","source":"PR","sourceId":"PR:000003112"}}],"keyEventStressors":["Tacrolimus (also FK506)","Cyclosporin"],"id":979}
{"title":"Reduction, NFAT/AP-1 complex formation","references":"<ol>\n\t<li>Flanagan, W.M., Corth&eacute;sy, B., Bram, R.J. and Crabtree, G.R. (1991). Nuclear association of a T-cell transcription factor blocked by FK-506 and cyclosporin A. Nature 352 (6338): 803-7.</li>\n\t<li>Jain, J., McCaffrey, P. G., Valge-Archer, V. E. and Rao, A. (1992). Nuclear factor of activated T cells contains Fos and Jun. Nature. 356(6372): 801-804.</li>\n\t<li>Jain, J., Miner, Z. and Rao, A. (1993). Analysis of the preexisting and nuclear forms of nuclear factor of activated T cells. Journal of immunology. 151(2): 837-848.</li>\n\t<li>Macian, F. (2005). NFAT proteins: key regulators of T-cell development and function. Nature reviews. Immunology. 5(6): 472-84.</li>\n\t<li>Schreiber, SL., and Crabtree, GR. (1992). The mechanism of action of cyclosporin A and FK506. Immunology Today 13(4): 136-42.</li>\n</ol>\n","biologicalOrganisationLevel":"Cellular","organTerm":{"name":"immune system","sourceId":"UBERON:0002405"},"biologicalEvents":[{"action":"decreased","process":"cytokine production involved in inflammatory response","object":{"name":"NFAT activation molecule 1","source":"PR","sourceId":"PR:000011161"}},{"action":"increased","process":"cell activation","object":{}}],"keyEventStressors":["Tacrolimus (also FK506)","Cyclosporin"],"id":981}
{"title":"Reduction, NFAT/AP-1 complex formation","references":"<ol>\n\t<li>Flanagan, W.M., Corth&eacute;sy, B., Bram, R.J. and Crabtree, G.R. (1991). Nuclear association of a T-cell transcription factor blocked by FK-506 and cyclosporin A. Nature 352 (6338): 803-7.</li>\n\t<li>Jain, J., McCaffrey, P. G., Valge-Archer, V. E. and Rao, A. (1992). Nuclear factor of activated T cells contains Fos and Jun. Nature. 356(6372): 801-804.</li>\n\t<li>Jain, J., Miner, Z. and Rao, A. (1993). Analysis of the preexisting and nuclear forms of nuclear factor of activated T cells. Journal of immunology. 151(2): 837-848.</li>\n\t<li>Macian, F. (2005). NFAT proteins: key regulators of T-cell development and function. Nature reviews. Immunology. 5(6): 472-84.</li>\n\t<li>Schreiber, SL., and Crabtree, GR. (1992). The mechanism of action of cyclosporin A and FK506. Immunology Today 13(4): 136-42.</li>\n</ol>\n","biologicalOrganisationLevel":"Cellular","organTerm":{"name":"immune system","sourceId":"UBERON:0002405"},"biologicalEvents":[{"action":"decreased","process":"cytokine production involved in inflammatory response","object":{"name":"NFAT activation molecule 1","source":"PR","sourceId":"PR:000011161"}},{"action":"increased","process":"cell activation","object":{}}],"keyEventStressors":["Tacrolimus (also FK506)","Cyclosporin"],"id":981}
{"title":"Impairment, T-cell dependent antibody response","references":"<ol>\n\t<li>Alberts, B., Johnson, A., Lewis, L., Raff, M., Roberts, K. and Walter, P. (2008). Molecular Biology of the Cell. 5th ed., Garland Science, New York. 1539-1601</li>\n\t<li>Heidt, S., Roelen, D. L., Eijsink, C., Eikmans, M., van Kooten, C., Claas, F. H. and Mulder, A. (2010). Calcineurin inhibitors affect B cell antibody responses indirectly by interfering with T cell help. Clinical and experimental immunology. 159(2): 199-207.</li>\n\t<li>Sakuma, S., Kato, Y., Nishigaki, F., Magari, K., Miyata, S., Ohkubo, Y., and Goto, T. (2001b). Effects of FK506 and other immunosuppressive anti-rheumatic agents on T cell activation mediated IL-6 and IgM production in vitro. International Immunopharmacology 1(4): 749-57.</li>\n\t<li>Kino, T., Hatanaka, H., Hashimoto, M., Nishiyama, M., Goto, T., Okuhara, M., Kohsaka, M., Aoki, H. and Imanaka, H. (1987). FK-506, a novel immunosuppressant isolated from a Streptomyces. I. Fermentation, isolation, and physico-chemical and biological characteristics. Journal of antibiotics. 40(9): 1249-1255.</li>\n\t<li>Ulrich, P., Paul, G., Perentes, E., Mahl, A., and Roman D. (2004). Validation of immune function testing during a 4-week oral toxicity study with FK506. Toxicology Letters 149(1-3): 123-31.</li>\n\t<li>Dumont, F.J., Staruch, M.J., Fischer, P., DaSilva, C. and Camacho, R. (1998). Inhibition of T cell activation by pharmacologic disruption of the MEK1/ERK MAP kinase or calcineurin signaling pathways results in differential modulation of cytokine production. Journal of immunology 160 (6): 2579-89.</li>\n\t<li>Ekberg, H., Tedesco-Silva, H., Demirbas, A., V&iacute;tko, S., Nashan, B., G&uuml;rkan, A., Margreiter, R., Hugo, C., Griny&oacute;, J.M., Frei, U., Vanrenterghem, Y., Daloze, P. and Halloran, P.F.; ELITE-Symphony Study. (2007). Reduced exposure to calcineurin inhibitors in renal transplantation. The New England journal of medicine 357 (25): 2562-75.</li>\n\t<li>Fung, J., Abu-Elmagd, K., Jain, A., Gordon, R., Tzakis, A., Todo, S., Takaya, S., Alessiani, M., Demetris, A., Bronster, O., Martin, M., Mieles, L., Selby, R., Reyes, J., Doyle, H., Stieber, A., Casavilla, A. and Starzl, T. (1991). A randomized trial of primary liver transplantation under immunosuppression with FK 506 vs cyclosporine. Transplantation proceedings 23 (6): 2977-83.</li>\n\t<li>Luster, M.I., and Rosenthal, G.J. (1993). Environmental Health Perspectives. 100: 219-36.</li>\n\t<li>Alessandro B, Paola S, Alberto E. Paneraic, Tiziana P,Paola Palanzaa and Stefano P(2003). Chronic psychosocial stress-induced down-regulation of immunity depends upon individual factors Journal of Neuroimmunology 141: 58&ndash;64</li>\n\t<li>Donna C. S, Matthew J. S and Kimber L. W Jr. (2010) Systemic immunosuppression following a single pharyngeal aspiration of 1,2:5,6-dibenzanthracene in female B6C3F1 mice, Journal of Immunotoxicology, 7:3, 219-231</li>\n\t<li>Kevin G, Hossein S, Raju S, Valerie A, Anna K, Ming Z, Fen-Fen L, Hung Q. N, Lei Z, John K. S, Min W and Helen J. M(2015) Inhibition of CRAC with a human anti-ORAI1 monoclonal antibody inhibits T-cell-derived cytokine production but fails to inhibit a T-cell-dependent antibody response in the cynomolgus monkey, Journal of Immunotoxicology, 12:2, 164-173,</li>\n\t<li>Gangappa S, Wrammert J, Wang D, Li ZN, Liepkalns JS, Cao W, Chen J, Levine MZ, Stevens J, Sambhara S, Begley B, Mehta A, Pearson TC, Ahmed R, Larsen CP. (2019) Kinetics of antibody response to influenza vaccination in renal transplant recipients. Transpl Immunol. 53:51-60.</li>\n\t<li>Kawamura N, Furuta H, Tame A, Kobayashi I, Ariga T, Okano M, Sakiyama Y. (1997) Extremely high serum level of IgE during immunosuppressive therapy: paradoxical effect of cyclosporine A and tacrolimus. Int Arch Allergy Immunol. 112(4):422-4.</li>\n</ol>\n","biologicalOrganisationLevel":"Individual","organTerm":{},"biologicalEvents":[{"action":"increased","process":"Immunosuppression","object":{}}],"keyEventStressors":["Tacrolimus (also FK506)","Cyclosporin","1,2:5,6-dibenzanthracene","psychosocial stress"],"id":984}
{"title":"Suppression, IL-2 and IL-4 production","references":"<ol>\n\t<li>Dumont, F.J., Staruch, M.J., Fischer, P., DaSilva, C. and Camacho, R. (1998). Inhibition of T cell activation by pharmacologic disruption of the MEK1/ERK MAP kinase or calcineurin signaling pathways results in differential modulation of cytokine production. Journal of immunology 160 (6): 2579-89.</li>\n\t<li>Flanagan, W.M., Corth&eacute;sy, B., Bram, R.J. and Crabtree, G.R. (1991). Nuclear association of a T-cell transcription factor blocked by FK-506 and cyclosporin A. Nature 352 (6338): 803-7.</li>\n\t<li>Jain, J., McCaffrey, P. G., Valge-Archer, V. E. and Rao, A. (1992). Nuclear factor of activated T cells contains Fos and Jun. Nature. 356(6372): 801-804.</li>\n\t<li>Jain, J., Miner, Z. and Rao, A. (1993). Analysis of the preexisting and nuclear forms of nuclear factor of activated T cells. Journal of immunology. 151(2): 837-848.</li>\n\t<li>Kino, T., Hatanaka, H., Miyata, S., Inamura, N., Nishiyama, M., Yajima, T., Goto, T., Okuhara, M., Kohsaka, M. and Aoki, H. (1987a). FK-506, a novel immunosuppressant isolated from a Streptomyces. II. Immunosuppressive effect of FK-506 in vitro. Journal of antibiotics. 40(9): 1256-1265.</li>\n\t<li>Maci&aacute;n, F., L&oacute;pez-Rodr&iacute;guez, C. and Rao, A. (2001). Partners in transcription: NFAT and AP-1. Oncogene. 20(19): 2476-89.</li>\n\t<li>Novartis Pharma K.K. (2016). Drug interview form Simulect i.v. injection 20 mg. 10th edition.</li>\n\t<li>Sakuma, S., Higashi, Y., Sato, N., Sasakawa, T., Sengoku, T., Ohkubo, Y., Amaya, T., and Goto, T. (2001a). Tacrolimus suppressed the production of cytokines involved in atopic dermatitis by direct stimulation of human PBMC system. (Comparison with steroids). International Immunopharmacology 1(6): 1219-26.</li>\n\t<li>Schreiber, SL., and Crabtree, GR. (1992). The mechanism of action of cyclosporin A and FK506. Immunology Today 13(4): 136-42.</li>\n\t<li>Luster, M.I., and Rosenthal, G.J. (1993). Environmental Health Perspectives. 100: 219-36.</li>\n\t<li>Maruho Co.,Ltd. (2014) Drug interview form Protopic ointment 0.1% Revised 16th edition.</li>\n\t<li>Alessandro B, Paola S, Alberto E. Paneraic, Tiziana P,Paola Palanzaa and Stefano P(2003). Chronic psychosocial stress-induced down-regulation of immunity depends upon individual factors Journal of Neuroimmunology 141: 58&ndash;64</li>\n\t<li>Donna C. S, Matthew J. S and Kimber L. W Jr. (2010) Systemic immunosuppression following a single pharyngeal aspiration of 1,2:5,6-dibenzanthracene in female B6C3F1 mice, Journal of Immunotoxicology, 7:3, 219-231</li>\n\t<li>Kevin G, Hossein S, Raju S, Valerie A, Anna K, Ming Z, Fen-Fen L, Hung Q. N, Lei Z, John K. S, Min W and Helen J. M(2015) Inhibition of CRAC with a human anti-ORAI1 monoclonal antibody inhibits T-cell-derived cytokine production but fails to inhibit a T-cell-dependent antibody response in the cynomolgus monkey, Journal of Immunotoxicology, 12:2, 164-173,</li>\n\t<li>D.M. Lehmann, W.C. Williams.(2018) Development and Utilization of a Unique In Vitro Antigen Presentation Co-culture Model for Detection of Immunomodulating Substances. Toxicol In Vitro.53: 20&ndash;28.</li>\n</ol>\n","biologicalOrganisationLevel":"Cellular","organTerm":{"name":"immune system","sourceId":"UBERON:0002405"},"biologicalEvents":[{"action":"decreased","process":"interleukin-2 production","object":{"name":"interleukin-2","source":"PR","sourceId":"PR:000001379"}},{"action":"decreased","process":"interleukin-4 production","object":{"name":"interleukin-4","source":"PR","sourceId":"PR:000001391"}}],"keyEventStressors":["Tacrolimus (also FK506)","Cyclosporin","Benzo(a)pyrene","1,2:5,6-dibenzanthracene","Azathioprine","Methotrexate","psychosocial stress","Urethane","Dexamethasone"],"id":1202}
{"title":"Suppression, IL-2 and IL-4 production","references":"<ol>\n\t<li>Dumont, F.J., Staruch, M.J., Fischer, P., DaSilva, C. and Camacho, R. (1998). Inhibition of T cell activation by pharmacologic disruption of the MEK1/ERK MAP kinase or calcineurin signaling pathways results in differential modulation of cytokine production. Journal of immunology 160 (6): 2579-89.</li>\n\t<li>Flanagan, W.M., Corth&eacute;sy, B., Bram, R.J. and Crabtree, G.R. (1991). Nuclear association of a T-cell transcription factor blocked by FK-506 and cyclosporin A. Nature 352 (6338): 803-7.</li>\n\t<li>Jain, J., McCaffrey, P. G., Valge-Archer, V. E. and Rao, A. (1992). Nuclear factor of activated T cells contains Fos and Jun. Nature. 356(6372): 801-804.</li>\n\t<li>Jain, J., Miner, Z. and Rao, A. (1993). Analysis of the preexisting and nuclear forms of nuclear factor of activated T cells. Journal of immunology. 151(2): 837-848.</li>\n\t<li>Kino, T., Hatanaka, H., Miyata, S., Inamura, N., Nishiyama, M., Yajima, T., Goto, T., Okuhara, M., Kohsaka, M. and Aoki, H. (1987a). FK-506, a novel immunosuppressant isolated from a Streptomyces. II. Immunosuppressive effect of FK-506 in vitro. Journal of antibiotics. 40(9): 1256-1265.</li>\n\t<li>Maci&aacute;n, F., L&oacute;pez-Rodr&iacute;guez, C. and Rao, A. (2001). Partners in transcription: NFAT and AP-1. Oncogene. 20(19): 2476-89.</li>\n\t<li>Novartis Pharma K.K. (2016). Drug interview form Simulect i.v. injection 20 mg. 10th edition.</li>\n\t<li>Sakuma, S., Higashi, Y., Sato, N., Sasakawa, T., Sengoku, T., Ohkubo, Y., Amaya, T., and Goto, T. (2001a). Tacrolimus suppressed the production of cytokines involved in atopic dermatitis by direct stimulation of human PBMC system. (Comparison with steroids). International Immunopharmacology 1(6): 1219-26.</li>\n\t<li>Schreiber, SL., and Crabtree, GR. (1992). The mechanism of action of cyclosporin A and FK506. Immunology Today 13(4): 136-42.</li>\n\t<li>Luster, M.I., and Rosenthal, G.J. (1993). Environmental Health Perspectives. 100: 219-36.</li>\n\t<li>Maruho Co.,Ltd. (2014) Drug interview form Protopic ointment 0.1% Revised 16th edition.</li>\n\t<li>Alessandro B, Paola S, Alberto E. Paneraic, Tiziana P,Paola Palanzaa and Stefano P(2003). Chronic psychosocial stress-induced down-regulation of immunity depends upon individual factors Journal of Neuroimmunology 141: 58&ndash;64</li>\n\t<li>Donna C. S, Matthew J. S and Kimber L. W Jr. (2010) Systemic immunosuppression following a single pharyngeal aspiration of 1,2:5,6-dibenzanthracene in female B6C3F1 mice, Journal of Immunotoxicology, 7:3, 219-231</li>\n\t<li>Kevin G, Hossein S, Raju S, Valerie A, Anna K, Ming Z, Fen-Fen L, Hung Q. N, Lei Z, John K. S, Min W and Helen J. M(2015) Inhibition of CRAC with a human anti-ORAI1 monoclonal antibody inhibits T-cell-derived cytokine production but fails to inhibit a T-cell-dependent antibody response in the cynomolgus monkey, Journal of Immunotoxicology, 12:2, 164-173,</li>\n\t<li>D.M. Lehmann, W.C. Williams.(2018) Development and Utilization of a Unique In Vitro Antigen Presentation Co-culture Model for Detection of Immunomodulating Substances. Toxicol In Vitro.53: 20&ndash;28.</li>\n</ol>\n","biologicalOrganisationLevel":"Cellular","organTerm":{"name":"immune system","sourceId":"UBERON:0002405"},"biologicalEvents":[{"action":"decreased","process":"interleukin-2 production","object":{"name":"interleukin-2","source":"PR","sourceId":"PR:000001379"}},{"action":"decreased","process":"interleukin-4 production","object":{"name":"interleukin-4","source":"PR","sourceId":"PR:000001391"}}],"keyEventStressors":["Tacrolimus (also FK506)","Cyclosporin","Benzo(a)pyrene","1,2:5,6-dibenzanthracene","Azathioprine","Methotrexate","psychosocial stress","Urethane","Dexamethasone"],"id":1202}
{"title":"Inhibition, Calcineurin Activity","references":"<ol>\n\t<li>Barik, S. (2006). Immunophilins: for the love of proteins. Cellular and Molecular Life Sciences 63(24): 2889-900.</li>\n\t<li>Bierer, B.E., Holl&auml;nder, G., Fruman, D. and Burakoff, S.J. (1993). Cyclosporin A and FK506: molecular mechanisms of immunosuppression and probes for transplantation biology. Current opinion in immunology 5 (5): 763-73.</li>\n\t<li>Bram, R.J., Hung, D.T., Martin, P.K., Schreiber, S.L. and Crabtree, G.R. (1993). Identification of the immunophilins capable of mediating inhibition of signal transduction by cyclosporin A and FK506: roles of calcimeurin binding and cellular location. Molecular and cellular biology 13 (8): 4760-9.</li>\n\t<li>Cameron, A.M., Nucifora, F.C. Jr., Fung, E.T., Livingston, D.J., Aldape, R.A., Ross, C.A. and Snyder, S.H. (1997). FKBP12 binds the inositol 1, 4, 5-trisphosphate receptor at leucine-proline (1400-1401) and anchors calcineurin to this FK506-like domain. The Journal of biological chemistry 272 (44): 27582-8.</li>\n\t<li>Hultsch, T., Albers, M. W., Schreiber, S.L. and Hohman, R. J. (1991). Immunophilin ligands demonstrate common features of signal transduction leading to exocytosis or transcription. Proceedings of the national academic science of the United States of America. 14: 6229-6233.</li>\n\t<li>Kang, C. B., Hong, Y., Dhe-Paganon, S. and Yoon, H. S. (2008). FKBP family proteins: immunophilins with versatile biological function. Neurosignals. 16: 318-325.</li>\n\t<li>Kincaid, R..L. (1993). Calmodulin-dependent protein phosphatases from microorganisms to man. A study in structural conservatism and biological diversity. Adv Second Messenger Phosphoprotein Res. 1993;27:1-23.</li>\n\t<li>Klee, C. B., Draetta, G. F. and Hubbard, M. J. (1988). Calcineurin. Advances in enzymology and related areas of molecular biology. 61:149-200.</li>\n\t<li>Liu, J., Farmer, J. D. Jr., Lane, W. S., Friedman, J., Weissman, I., and Schreiber, S. L. (1991). Calcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK506 complexes. Cell. 66(4): 807-815.</li>\n\t<li>Liu, J. (1993). FK506 and cyclosporin, molecular probes for studying intracellular signal transduction. Immunology today. 14(6): 290-305.</li>\n\t<li>Quesniaux VF, Schreier MH, Wenger RM, Hiestand PC, Harding MW, Van Regenmortel MH(1987). Cyclophilin binds to the region of cyclosporine involved in its immunosuppressive activity.</li>\n\t<li>Panhans-Gross, A., Novak, N., Kraft, S., and Bieber, T. (2001). Human epidermal Langerhans&rsquo; cells are targets for the immunosuppressive macrolide tacrolimus (FK506). Journal of Allergy and Clinical Immunology 107(2): 345-52.</li>\n\t<li>Rao, A., Luo, C., and Hogan, PG. (1997). Transcription factors of the NFAT family: regulation and function. Annual Review of Immunology 15: 707-47.</li>\n\t<li>Schreiber, SL., and Crabtree, GR. (1992). The mechanism of action of cyclosporin A and FK506. Immunology Today 13(4): 136-42.</li>\n\t<li>Sieber M., Baumgrass R., (2009). Cell Commun Signal Oct 27;7:2.</li>\n\t<li>Siekierka, JJ., Hung, SH., Poe, M., Lin, CS., and Sigal, NH. (1989a). A cytosolic binding protein for the immunosuppressant FK506 has peptidyl-prolyl isomerase activity but is distinct from cyclophilin. Nature 341(6244): 755-57.</li>\n\t<li>Siekierka, JJ., Wiederrecht, G., Greulich, H., Boulton, D., Hung, SH., Cryan, J., Hodges, PJ., and Sigal, NH. (1990). The cytosolic-binding protein for the immunosuppressant FK-506 is both a ubiquitous an highly conserved peptidyl-prolyl cis-trans isomerase. Journal of Biological Chemistry 265(34): 21011-5.</li>\n\t<li>Zhang, B.W., Zimmer, G., Chen, J., Ladd, D., Li, E., Alt, F.W., Wiederrecht, G., Cryan, J., O&#39;Neill, E.A., Seidman, C.E., Abbas, A.K. and Seidman, J.G.. (1996). T cell responses in calcineurin A alpha-deficient mice. Journal of experimental medicine 183(2): 413-20.</li>\n</ol>\n","biologicalOrganisationLevel":"Molecular","organTerm":{},"biologicalEvents":[{"action":"increased","process":"binding","object":{"name":"FK506-binding protein 15","source":"PR","sourceId":"PR:000007535"}},{"action":"increased","process":"binding","object":{"name":"FKBP12 (Arabidopsis thaliana)","source":"TAIR","sourceId":"TAIR:AT5G64350"}}],"keyEventStressors":["Pimecrolimus","Tacrolimus (also FK506)","Cyclosporin","Dibefurin","Kaempferol","Ascomycin","1,5-dibenzoyloxymethyl-norcantharidin","Tacrorimus","Gossypol","Dodecylbenzene sulfonate"],"id":980}
{"title":"Inhibition, Calcineurin Activity","references":"<ol>\n\t<li>Barik, S. (2006). Immunophilins: for the love of proteins. Cellular and Molecular Life Sciences 63(24): 2889-900.</li>\n\t<li>Bierer, B.E., Holl&auml;nder, G., Fruman, D. and Burakoff, S.J. (1993). Cyclosporin A and FK506: molecular mechanisms of immunosuppression and probes for transplantation biology. Current opinion in immunology 5 (5): 763-73.</li>\n\t<li>Bram, R.J., Hung, D.T., Martin, P.K., Schreiber, S.L. and Crabtree, G.R. (1993). Identification of the immunophilins capable of mediating inhibition of signal transduction by cyclosporin A and FK506: roles of calcimeurin binding and cellular location. Molecular and cellular biology 13 (8): 4760-9.</li>\n\t<li>Cameron, A.M., Nucifora, F.C. Jr., Fung, E.T., Livingston, D.J., Aldape, R.A., Ross, C.A. and Snyder, S.H. (1997). FKBP12 binds the inositol 1, 4, 5-trisphosphate receptor at leucine-proline (1400-1401) and anchors calcineurin to this FK506-like domain. The Journal of biological chemistry 272 (44): 27582-8.</li>\n\t<li>Hultsch, T., Albers, M. W., Schreiber, S.L. and Hohman, R. J. (1991). Immunophilin ligands demonstrate common features of signal transduction leading to exocytosis or transcription. Proceedings of the national academic science of the United States of America. 14: 6229-6233.</li>\n\t<li>Kang, C. B., Hong, Y., Dhe-Paganon, S. and Yoon, H. S. (2008). FKBP family proteins: immunophilins with versatile biological function. Neurosignals. 16: 318-325.</li>\n\t<li>Kincaid, R..L. (1993). Calmodulin-dependent protein phosphatases from microorganisms to man. A study in structural conservatism and biological diversity. Adv Second Messenger Phosphoprotein Res. 1993;27:1-23.</li>\n\t<li>Klee, C. B., Draetta, G. F. and Hubbard, M. J. (1988). Calcineurin. Advances in enzymology and related areas of molecular biology. 61:149-200.</li>\n\t<li>Liu, J., Farmer, J. D. Jr., Lane, W. S., Friedman, J., Weissman, I., and Schreiber, S. L. (1991). Calcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK506 complexes. Cell. 66(4): 807-815.</li>\n\t<li>Liu, J. (1993). FK506 and cyclosporin, molecular probes for studying intracellular signal transduction. Immunology today. 14(6): 290-305.</li>\n\t<li>Quesniaux VF, Schreier MH, Wenger RM, Hiestand PC, Harding MW, Van Regenmortel MH(1987). Cyclophilin binds to the region of cyclosporine involved in its immunosuppressive activity.</li>\n\t<li>Panhans-Gross, A., Novak, N., Kraft, S., and Bieber, T. (2001). Human epidermal Langerhans&rsquo; cells are targets for the immunosuppressive macrolide tacrolimus (FK506). Journal of Allergy and Clinical Immunology 107(2): 345-52.</li>\n\t<li>Rao, A., Luo, C., and Hogan, PG. (1997). Transcription factors of the NFAT family: regulation and function. Annual Review of Immunology 15: 707-47.</li>\n\t<li>Schreiber, SL., and Crabtree, GR. (1992). The mechanism of action of cyclosporin A and FK506. Immunology Today 13(4): 136-42.</li>\n\t<li>Sieber M., Baumgrass R., (2009). Cell Commun Signal Oct 27;7:2.</li>\n\t<li>Siekierka, JJ., Hung, SH., Poe, M., Lin, CS., and Sigal, NH. (1989a). A cytosolic binding protein for the immunosuppressant FK506 has peptidyl-prolyl isomerase activity but is distinct from cyclophilin. Nature 341(6244): 755-57.</li>\n\t<li>Siekierka, JJ., Wiederrecht, G., Greulich, H., Boulton, D., Hung, SH., Cryan, J., Hodges, PJ., and Sigal, NH. (1990). The cytosolic-binding protein for the immunosuppressant FK-506 is both a ubiquitous an highly conserved peptidyl-prolyl cis-trans isomerase. Journal of Biological Chemistry 265(34): 21011-5.</li>\n\t<li>Zhang, B.W., Zimmer, G., Chen, J., Ladd, D., Li, E., Alt, F.W., Wiederrecht, G., Cryan, J., O&#39;Neill, E.A., Seidman, C.E., Abbas, A.K. and Seidman, J.G.. (1996). T cell responses in calcineurin A alpha-deficient mice. Journal of experimental medicine 183(2): 413-20.</li>\n</ol>\n","biologicalOrganisationLevel":"Molecular","organTerm":{},"biologicalEvents":[{"action":"increased","process":"binding","object":{"name":"FK506-binding protein 15","source":"PR","sourceId":"PR:000007535"}},{"action":"increased","process":"binding","object":{"name":"FKBP12 (Arabidopsis thaliana)","source":"TAIR","sourceId":"TAIR:AT5G64350"}}],"keyEventStressors":["Pimecrolimus","Tacrolimus (also FK506)","Cyclosporin","Dibefurin","Kaempferol","Ascomycin","1,5-dibenzoyloxymethyl-norcantharidin","Tacrorimus","Gossypol","Dodecylbenzene sulfonate"],"id":980}
{"title":"Inhibition, Deiodinase 2","references":"<p>Bianco, A.C., Salvatore, D., Gereben, B., Berry, M.J., Larsen, P.R., 2002. Biochemistry, cellular and molecular biology, and physiological roles of the iodothyronine selenodeiodinases. Endocrine Reviews 23, 38-89.</p>\n\n<p>Darras, V.M., Van Herck, S.L.J., 2012. Iodothyronine deiodinase structure and function: from ascidians to humans. Journal of Endocrinology 215, 189-206.</p>\n\n<p>Forhead, A.J., Curtis, K., Kaptein, E., Visser, T.J., Fowden, A.L., 2006. Developmental control of iodothyronine deiodinases by cortisol in the ovine fetus and placenta near term. Endocrinology 147, 5988-5994.</p>\n\n<p>Houbrechts, A.M., Delarue, J., Gabriels, I.J., Sourbron, J., Darras, V.M., 2016. Permanent Deiodinase Type 2 Deficiency Strongly Perturbs Zebrafish Development, Growth, and Fertility. Endocrinology 157, 3668-3681.</p>\n\n<p>Li, N.N., Jiang, Y.Q., Shan, Z.Y., Teng, W.P., 2012. Prolonged high iodine intake is associated with inhibition of type 2 deiodinase activity in pituitary and elevation of serum thyrotropin levels. British Journal of Nutrition 107, 674-682.</p>\n\n<p>Olker, J.H., Korte, J.J., Denny, J.S., Hartig, P.C., Cardon, M.C., Knutsen, C.N., Kent, P.M., Christensen, J.P., Degitz, S.J., Hornung, M.W., 2019. Screening the ToxCast Phase 1, Phase 2, and e1k Chemical Libraries for Inhibitors of Iodothyronine Deiodinases. Toxicological Sciences 168, 430-442.</p>\n\n<p>Orozco, A., Valverde, R.C., 2005. Thyroid hormone deiodination in fish. Thyroid 15, 799-813.</p>\n\n<p>Pavelka, S., 2010. Radiometric enzyme assays: development of methods for extremely sensitive determination of types 1, 2 and 3 iodothyronine deiodinase enzyme activities. Journal of Radioanalytical and Nuclear Chemistry 286, 861-865.</p>\n\n<p>Renko, K., Schache, S., Hoefig, C.S., Welsink, T., Schwiebert, C., Braun, D., Becker, N.P., Kohrle, J., Schomburg, L., 2015. An Improved Nonradioactive Screening Method Identifies Genistein and Xanthohumol as Potent Inhibitors of Iodothyronine Deiodinases. Thyroid 25, 962-968.</p>\n\n<p>Roberts, S.C., Bianco, A.C., Stapleton, H.M., 2015. Disruption of Type 2 Iodothyronine Deiodinase Activity in Cultured Human Glial Cells by Polybrominated Diphenyl Ethers. Chemical Research in Toxicology 28, 1265-1274.</p>\n\n<p>Stinckens, E., Vergauwen, L., Ankley, G.T., Blust, R., Darras, V.M., Villeneuve, D.L., Witters, H., Volz, D.C., Knapen, D., 2018. An AOP-based alternative testing strategy to predict the impact of thyroid hormone disruption on swim bladder inflation in zebrafish. Aquatic Toxicology 200, 1-12.</p>\n\n<p>Vergauwen, L., Cavallin, J.E., Ankley, G.T., Bars, C., Gabriels, I.J., Michiels, E.D.G., Fitzpatrick, K.R., Periz-Stanacev, J., Randolph, E.C., Robinson, S.L., Saari, T.W., Schroeder, A.L., Stinckens, E., Swintek, J., Van Cruchten, S.J., Verbueken, E., Villeneuve, D.L., Knapen, D., 2018. Gene transcription ontogeny of hypothalamic-pituitary-thyroid axis development in early-life stage fathead minnow and zebrafish. General and Comparative Endocrinology 266, 87-100.</p>\n\n<p>Walpita, C.N., Grommen, S.V., Darras, V.M., Van der Geyten, S., 2007. The influence of stress on thyroid hormone production and peripheral deiodination in the Nile tilapia (Oreochromis niloticus). Gen Comp Endocrinol 150, 18-25.</p>\n","biologicalOrganisationLevel":"Molecular","organTerm":{},"biologicalEvents":[{"action":"decreased","process":"catalytic activity","object":{"name":"type II iodothyronine deiodinase","source":"PR","sourceId":"PR:000006481"}}],"keyEventStressors":["PERFLUOROOCTANOIC ACID","iopanoic acid"],"id":1002}
{"title":"Decreased, Triiodothyronine (T3) in serum","references":"<ul>\n\t<li>Bartalena L, Robbins J.Thyroid hormone transport proteins.Clin Lab Med. 1993 Sep;13(3):583-98.</li>\n\t<li>Bassett JH, Harvey CB, Williams GR. (2003). Mechanisms of thyroid hormone receptor-specific nuclear and extra nuclear actions. Mol Cell Endocrinol. 213:1-11.</li>\n\t<li>Bianco AC, Kim BW. (2006). Deiodinases: implications of the local control of thyroid hormone action. J Clin Invest. 116: 2571&ndash;2579.</li>\n\t<li>Brent GA. (2012). Mechanisms of thyroid hormone action. J Clin Invest. 122: 3035-3043.</li>\n\t<li>Cheng SY, Leonard JL, Davis PJ. (2010).Molecular aspects of thyroid hormone actions. Endocr Rev. 31:139&ndash;170.</li>\n\t<li>Davis PJ, Zhou M, Davis FB, Lansing L, Mousa SA, Lin HY. (2010). Mini-review: Cell surface receptor for thyroid hormone and nongenomic regulation of ion fluxes in excitable cells. Physiol Behav. 99:237&ndash;239.</li>\n\t<li>DeVito M, Biegel L, Brouwer A, Brown S, Brucker-Davis F, Cheek AO, Christensen R, Colborn T, Cooke P, Crissman J, Crofton K, Doerge D, Gray E, Hauser P, Hurley P, Kohn M, Lazar J, McMaster S, McClain M, McConnell E, *Meier C, Miller R, Tietge J, Tyl R. (1999). Screening methods for thyroid hormone disruptors. Environ Health Perspect. 107:407-415.</li>\n\t<li>Eales JG. (1997). Iodine metabolism and thyroid related functions in organisms lacking thyroid follicles: Are thyroid hormones also vitamins? Proc Soc Exp Biol Med. 214:302-317.</li>\n\t<li>Friesema EC, Jansen J, Milici C, Visser TJ. (2005). Thyroid hormone transporters. Vitam Horm. 70: 137&ndash;167.</li>\n\t<li>Furlow JD, Neff ES. (2006). A developmental switch induced by thyroid hormone: Xenopus laevis metamorphosis. Trends Endocrinol Metab. 17:40&ndash;47.</li>\n\t<li>Gereben B, Zavacki AM, Ribich S, Kim BW, Huang SA, Simonides WS, Ze&ouml;ld A, Bianco AC. (2008). Cellular and molecular basis of deiodinase-regulated thyroid hormone signalling. Endocr Rev. 29:898&ndash;938.</li>\n\t<li>Gilbert ME, Rovet J, Chen Z, Koibuchi N. (2012).Developmental thyroid hormone disruption: prevalence, environmental contaminants and neurodevelopmental consequences. Neurotoxicology. 33: 842-852.</li>\n\t<li>Glinoer D. (2001).Potential consequences of maternal hypothyroidism on the offspring: evidence and implications. Horm Res. 55:109-114.</li>\n\t<li>Hennemann G, Docter R, Friesema EC, de Jong M, Krenning EP, Visser TJ. (2001). Plasma membrane transport of thyroid hormones and its role in thyroid hormone metabolism and bioavailability. Endocr Rev. 22:451-476.</li>\n\t<li>Heyland A, Hodin J. (2004). Heterochronic developmental shift caused by thyroid hormone in larval sand dollars and its implications for phenotypic plasticity and the evolution of non-feeding development. Evolution. 58: 524-538.</li>\n\t<li>Heyland A, Moroz LL. (2005). Cross-kingdom hormonal signaling: an insight from thyroid hormone functions in marine larvae. J Exp Biol. 208:4355-4361.</li>\n\t<li>Hornung, M.W., Kosian, P.A., Haselman, J.T., Korte, J.J., Challis, K., Macherla, C., Nevalainen, E., Degitz, S.J., 2015. In Vitro, Ex Vivo, and In Vivo Determination of Thyroid Hormone Modulating Activity of Benzothiazoles. Toxicological Sciences 146, 254-264.</li>\n\t<li>Hulbert A J. (2000). Thyroid hormones and their effects: A new perspective. Biol Rev. 75: 519-631.</li>\n\t<li>Jansen J, Friesema EC, Milici C, Visser TJ. (2005). Thyroid hormone transporters in health and disease. Thyroid. 15: 757-768.</li>\n\t<li>Larsen PR. (2009).Type 2 iodothyronine deiodinase in human skeletal muscle: new insights into its physiological role and regulation. J Clin Endocrinol Metab. 94:1893-1895.</li>\n\t<li>Manzon RG, Youson JH. (1997). The effects of exogenous thyroxine (T4) or triiodothyronine (T3), in the presence and absence of potassium perchlorate, on the incidence of metamorphosis and on serum T4 and T3 concentrations in larval sea lampreys (Petromyzon marinus L.). Gen Comp Endocrinol. 106:211-220.</li>\n\t<li>Miller MD, Crofton KM, Rice DC, Zoeller RT. (2009).Thyroid-disrupting chemicals: interpreting upstream biomarkers of adverse outcomes. Environ Health Perspect. 117:1033-1041.</li>\n\t<li>Moeller LC, Dumitrescu AM, Seo H, Refetoff S. (2006). Thyroid hormone mediated changes in gene expression can be initiated by cytosolic action of the thyroid hormone receptor &beta; through the phosphatidylinositol 3-kinase pathway. NRS. 4:1-4.Nelson, K., Schroeder, A., Ankley, G., Blackwell, B., Blanksma, C., Degitz, S., Flynn, K., Jensen, K., Johnson, R., Kahl, M., Knapen, D., Kosian, P., Milsk, R., Randolph, E., Saari, T., Stinckens, E., Vergauwen, L., Villeneuve, D., 2016. Impaired anterior swim bladder inflation following exposure to the thyroid peroxidase inhibitor 2-mercaptobenzothiazole part I: Fathead minnow. Aquatic Toxicology 173, 192-203.Obregon MJ, Mallol J, Escobar del Rey F, Morreale de Escobar G. (1981). Presence of l-thyroxine and 3,5,3-triiodo-l-thyronine in tissues from thyroidectomised rats. Endocrinology 109:908-913.</li>\n\t<li>Oetting A, Yen PM. (2007). New insights into thyroid hormone action. Best Pract Res Clin Endocrinol Metab. 21:193&ndash;208.</li>\n\t<li>Schussler, G.C. (2000). The thyroxine-binding proteins. Thyroid 10:141&ndash;149.</li>\n\t<li>Stinckens, E., Vergauwen, L., Schroeder, A., Maho, W., Blackwell, B., Witters, H., Blust, R., Ankley, G., Covaci, A., Villeneuve, D., Knapen, D., 2016. Impaired anterior swim bladder inflation following exposure to the thyroid peroxidase inhibitor 2-mercaptobenzothiazole part II: Zebrafish. Aquatic Toxicology 173, 204-217.</li>\n\t<li>Visser WE, Friesema EC, Jansen J, Visser TJ. (2008). Thyroid hormone transport in and out of cells. Trends Endocrinol Metab. 19:50-56.</li>\n\t<li>Williams GR. (2008). Neurodevelopmental and neurophysiological actions of thyroid hormone. J Neuroendocrinol. 20:784&ndash;794.</li>\n\t<li>Yamauchi K1, Ishihara A. Evolutionary changes to transthyretin: developmentally regulated and tissue-specific gene expression.FEBS J. 2009 Oct;276(19):5357-66.</li>\n\t<li>Yaoita Y, Brown DD. (1990). A correlation of thyroid hormone receptor gene expression with amphibian metamorphosis. Genes Dev. 4:1917-1924.</li>\n\t<li>Yen PM. (2001). Physiological and molecular basis of thyroid hormone action. Physiol Rev. 81:1097-1142.</li>\n\t<li>Zoeller RT, Tan SW, Tyl RW. General background on the hypothalamic-pituitary-thyroid (HPT) axis. Crit Rev Toxicol. 2007 Jan-Feb;37(1-2):11-53</li>\n</ul>\n\n<p>&nbsp;</p>\n","biologicalOrganisationLevel":"Tissue","organTerm":{"name":"serum","sourceId":"UBERON:0001977"},"biologicalEvents":[{"action":"decreased","process":"abnormal circulating hormone level","object":{"name":"3,3',5'-triiodothyronine","source":"CHEBI","sourceId":"CHEBI:28774"}}],"id":1003}
{"title":"Reduced, Posterior swim bladder inflation","references":"<p>Cavallin, J.E., Ankley, G.T., Blackwell, B.R., Blanksma, C.A., Fay, K.A., Jensen, K.M., Kahl, M.D., Knapen, D., Kosian, P.A., Poole, S.T., Randolph, E.C., Schroeder, A.L., Vergauwen, L., Villeneuve, D.L., 2017. Impaired swim bladder inflation in early life stage fathead minnows exposed to a deiodinase inhibitor, iopanoic acid. Environmental Toxicology and Chemistry 36, 2942-2952.</p>\n\n<p>Liu, Y.W., Chan, W.K., 2002. Thyroid hormones are important for embryonic tolarval transitory phase in zebrafish. Differentiation 70, 36&ndash;45, <a class=\"external free\" href=\"http://dx.doi.org/10.1046/j.1432-0436.2002.700104.x\" rel=\"nofollow\" target=\"_blank\">http://dx.doi.org/10.1046/j.1432-0436.2002.700104.x</a>.</p>\n\n<p>Maack, G., Segner, H., 2003. Morphological development of the gonads in zebrafish. Journal of Fish Biology 62, 895-906.</p>\n\n<p>Stinckens, E., Vergauwen, L., Ankley, G.T., Blust, R., Darras, V.M., Villeneuve, D.L., Witters, H., Volz, D.C., Knapen, D., 2018. An AOP-based alternative testing strategy to predict the impact of thyroid hormone disruption on swim bladder inflation in zebrafish. Aquatic Toxicology 200, 1-12.</p>\n\n<p>Wang, J.X., Shi, G.H., Yao, J.Z., Sheng, N., Cui, R.N., Su, Z.B., Guo, Y., Dai, J.Y., 2020. Perfluoropolyether carboxylic acids (novel alternatives to PFOA) impair zebrafish posterior swim bladder development via thyroid hormone disruption. Environment International 134.</p>\n\n<p>Winata, C.L., Korzh, S., Kondrychyn, I., Zheng, W., Korzh, V., Gong, Z., 2009.Development of zebrafish swimbladder: the requirement of Hedgehogsignaling in specification and organization of the three tissue layers. Dev. Biol.331, 222&ndash;236, <a class=\"external free\" href=\"http://dx.doi.org/10.1016/j.ydbio.2009.04.035\" rel=\"nofollow\" target=\"_blank\">http://dx.doi.org/10.1016/j.ydbio.2009.04.035</a>.</p>\n\n<p>Woolley, L.D., Qin, J.G., 2010. Swimbladder inflation and its implication to the culture of marine finfish larvae. Reviews in Aquaculture 2, 181-190.</p>\n","biologicalOrganisationLevel":"Organ","organTerm":{"name":"swim bladder","sourceId":"UBERON:0006860"},"biologicalEvents":[{"action":"decreased","process":"swim bladder inflation","object":{"name":"posterior chamber swim bladder","source":"UBERON","sourceId":"UBERON:2001278"}}],"id":1004}
{"title":"Reduced, Swimming performance","references":"<p>Fu C, Cao ZD, Fu SJ. 2013. The effects of caudal fin loss and regeneration on the swimming performance of three cyprinid fish species with different swimming capactities. The Journal of Experimental Biology 216:3164-3174. doi:10.1242/jeb.084244</p>\n\n<p>Hagenaars, A., Stinckens, E., Vergauwen, L., Bervoets, L., Knapen, D., 2014. PFOSaffects posterior swim bladder chamber inflation and swimming performanceof zebrafish larvae. Aquat. Toxicol. 157, 225&ndash;235.</p>\n\n<p>Stinckens, E., Vergauwen, L., Schroeder, A.L., Maho, W., Blackwell, B., Witter, H.,Blust, R., Ankley, G.T., Covaci, A., Villenueve, D.L., Knapen, D., 2016. Disruption of thyroid hormone balance after 2-mercaptobenzothiazole exposure causes swim bladder inflation impairment&mdash;part II: zebrafish. Aquat. Toxicol. 173:204-17.</p>\n\n<p>Vergauwen, Lucia; N&oslash;rgaard Schmidt, Stine; Maho, Walid; Stickens, Evelyn; Hagenaars, An; Blust, Ronny; Mayer, Philipp; Covaci, Adrian; Knapen, Dries. 2014. A high throughput passive dosing format for the Fish Embryo Acute Toxicity test. Chemosphere. 139: 9-17.</p>\n","biologicalOrganisationLevel":"Individual","organTerm":{},"biologicalEvents":[{"action":"decreased","process":"aquatic locomotion","object":{}}],"id":1005}
{"title":"Reduced, Anterior swim bladder inflation","references":"<ul>\n\t<li>Bang, P.I., Yelick, P.C., Malicko, J.J., Sewell, W.F. 2002. High-throughput behavioral screening method for detecting auditory response defects in zebrafish. Journal of Neuroscience Methods. 118, 177-187.</li>\n\t<li>Cavallin, J.E., Ankley, G.T., Blackwell, B.R., Blanksma, C.A., Fay, K.A., Jensen, K.M., Kahl, M.D., Knapen, D., Kosian, P.A., Poole, S.T., Randolph, E.C., Schroeder, A.L., Vergauwen, L., Villeneuve, D.L., 2017. Impaired swim bladder inflation in early life stage fathead minnows exposed to a deiodinase inhibitor, iopanoic acid. Environmental Toxicology and Chemistry 36, 2942-2952.</li>\n\t<li>Dumbarton, T.C., Stoyek, M., Croll, R.P., Smith, F.M., 2010. Adrenergic control of swimbladder deflation in the zebrafish (<em>Danio rerio</em>). J. Exp. Biol. 213,2536&ndash;2546, <a class=\"external free\" href=\"http://dx.doi.org/10.1242/jeb.039792\" rel=\"nofollow\" target=\"_blank\">http://dx.doi.org/10.1242/jeb.039792</a>.</li>\n\t<li>Godfrey, A., Hooser, B., Abdelmoneim, A., Horzmann, K.A., Freemanc, J.L., Sepulveda, M.S., 2017. Thyroid disrupting effects of halogenated and next generation chemicals on the swim bladder development of zebrafish. Aquatic Toxicology 193, 228-235.</li>\n\t<li>McMenamin, S.K., Parichy, D.M., 2013. Metamorphosis in Teleosts. Animal Metamorphosis 103, 127-165.</li>\n\t<li>Nelson KR, Schroeder AL, Ankley GT, Blackwell BR, Blanksma C, Degitz SJ, Flynn KM, Jensen KM, Johnson RD, Kahl MD, Knapen D, Kosian PA, Milsk RY, Randolph EC, Saari T, Stinckens E, Vergauwen L, Villeneuve DL. 2016. Impaired anterior swim bladder inflation following exposure to the thyroid peroxidase inhibitor 2-mercaptobenzothiazole &ndash; Part I: fathead minnow. Aquatic Toxicology 173: 192-203.</li>\n\t<li>Roberston, G.N., McGee, C.A.S., Dumbarton, T.C., Croll, R.P., Smith, F.M., 2007. Development of the swim bladder and its innervation in the zebrafish, <em>Danio rerio</em>. J. Morphol. 268, 967&ndash;985, <a class=\"external free\" href=\"http://dx.doi.org/10.1002/jmor\" rel=\"nofollow\" target=\"_blank\">http://dx.doi.org/10.1002/jmor</a>.</li>\n\t<li>Stinckens, E., Vergauwen, L., Schroeder, A., Maho, W., Blackwell, B., Witters, H., Blust, R., Ankley, G., Covaci, A., Villeneuve, D., Knapen, D., 2016. Impaired anterior swim bladder inflation following exposure to the thyroid peroxidase inhibitor 2-mercaptobenzothiazole part II: Zebrafish. Aquatic Toxicology 173, 204-217.</li>\n\t<li>Stinckens, E., Vergauwen, L., Blackwell, B.R., Anldey, G.T., Villeneuve, D.L., Knapen, D., 2020. Effect of Thyroperoxidase and Deiodinase Inhibition on Anterior Swim Bladder Inflation in the Zebrafish. Environmental Science &amp; Technology 54, 6213-6223.</li>\n\t<li>Woolley, L.D., Qin, J.G., 2010. Swimbladder inflation and its implication to the culture of marine finfish larvae. Reviews in Aquaculture 2, 181-190.</li>\n\t<li>Zheng, W., Wang, Z., Collins, J.E., Andrews, R.M., Stemple, D., Gong, Z. 2011. Comparative transcriptome analyses indicate molecular homology of zebrafish swim bladder and mammalian lung. PLoS One 6, <a class=\"external free\" href=\"http://dx.doi.org/10.1371/\" rel=\"nofollow\" target=\"_blank\">http://dx.doi.org/10.1371/</a></li>\n</ul>\n","biologicalOrganisationLevel":"Organ","organTerm":{"name":"swim bladder","sourceId":"UBERON:0006860"},"biologicalEvents":[{"action":"decreased","process":"swim bladder inflation","object":{"name":"anterior chamber swim bladder","source":"UBERON","sourceId":"UBERON:2001277"}}],"id":1007}
{"title":"Inhibition, Deiodinase 1","references":"<p>Butt, C.M., Wang, D.L., Stapleton, H.M., 2011. Halogenated Phenolic Contaminants Inhibit the In Vitro Activity of the Thyroid-Regulating Deiodinases in Human Liver. Toxicological Sciences 124, 339-347.</p>\n\n<p>Darras, V.M., Van Herck, S.L.J., 2012. Iodothyronine deiodinase structure and function: from ascidians to humans. Journal of Endocrinology 215, 189-206.</p>\n\n<p>Ferreira, A.C.F., Lisboa, P.C., Oliveira, K.J., Lima, L.P., Barros, I.A., Carvalho, D.P., 2002. Inhibition of thyroid type 1 deiodinase activity by flavonoids. Food and Chemical Toxicology 40, 913-917.</p>\n\n<p>Finnson, K.W., McLeese, J.M., Eales, J.G., 1999. Deiodination and deconjugation of thyroid hormone conjugates and type I deiodination in liver of rainbow trout, Oncorhynchus mykiss. General and Comparative Endocrinology 115, 387-397.</p>\n\n<p>Forhead, A.J., Curtis, K., Kaptein, E., Visser, T.J., Fowden, A.L., 2006. Developmental control of iodothyronine deiodinases by cortisol in the ovine fetus and placenta near term. Endocrinology 147, 5988-5994.</p>\n\n<p>Freyberger, A., Ahr, H.J., 2006. Studies on the goitrogenic mechanism of action of N,N,N&#39;,N&#39;-tetramethylthiourea. Toxicology 217, 169-175.</p>\n\n<p>Hernandez, A., Martinez, M.E., Fiering, S., Galton, V.A., St Germain, D., 2006. Type 3 deiodinase is critical for the maturation and function of the thyroid axis. J Clin Invest 116, 476-484.</p>\n\n<p>Hornung, M.W., Korte, J.J., Olker, J.H., Denny, J.S., Knutsen, C., Hartig, P.C., Cardon, M.C., Degitz, S.J., 2018. Screening the ToxCast Phase 1 Chemical Library for Inhibition of Deiodinase Type 1 Activity. Toxicological Sciences 162, 570-581.</p>\n\n<p>Klaren, P.H.M., Haasdijk, R., Metz, J.R., Nitsch, L.M.C., Darras, V.M., Van der Geyten, S., Flik, G., 2005. Characterization of an iodothyronine 5 &#39;-deiodinase in gilthead seabream (Sparus auratus) that is inhibited by dithiothreitol. Endocrinology 146, 5621-5630.</p>\n\n<p>Kuiper, G., Klootwijk, W., Dubois, G.M., Destree, O., Darras, V.M., Van der Geyten, S., Demeneix, B., Visser, T.J., 2006. Characterization of recombinant Xenopus laevis type I iodothyronine deiodinase: substitution of a proline residue in the catalytic center by serine (Pro132Ser) restores sensitivity to 6-propyl-2-thiouracil. Endocrinology 147, 3519-3529.</p>\n\n<p>Marsili, A., Zavacki, A.M., Harney, J.W., Larsen, P.R., 2011. Physiological role and regulation of iodothyronine deiodinases: A 2011 update. Journal of Endocrinological Investigation 34, 395-407.</p>\n\n<p>Noyes, P.D., Hinton, D.E., Stapleton, H.M., 2011. Accumulation and Debromination of Decabromodiphenyl Ether (BDE-209) in Juvenile Fathead Minnows (Pimephales promelas) Induces Thyroid Disruption and Liver Alterations. Toxicological Sciences 122, 265-274.</p>\n\n<p>Olker, J.H., Korte, J.J., Denny, J.S., Hartig, P.C., Cardon, M.C., Knutsen, C.N., Kent, P.M., Christensen, J.P., Degitz, S.J., Hornung, M.W., 2019. Screening the ToxCast Phase 1, Phase 2, and e1k Chemical Libraries for Inhibitors of Iodothyronine Deiodinases. Toxicological Sciences 168, 430-442.</p>\n\n<p>Orozco, A., Valverde, R.C., 2005. Thyroid hormone deiodination in fish. Thyroid 15, 799-813.</p>\n\n<p>Orozco, A., Villalobos, P., Jeziorski, M.C., Valverde, C., 2003. The liver of Fundulus heteroclitus expresses deiodinase type 1 mRNA. General and Comparative Endocrinology 130, 84-91.</p>\n\n<p>Pavelka, S., 2010. Radiometric enzyme assays: development of methods for extremely sensitive determination of types 1, 2 and 3 iodothyronine deiodinase enzyme activities. Journal of Radioanalytical and Nuclear Chemistry 286, 861-865.</p>\n\n<p>Renko, K., Hoefig, C.S., Hiller, F., Schomburg, L., Kohrle, J., 2012. Identification of Iopanoic Acid as Substrate of Type 1 Deiodinase by a Novel Nonradioactive Iodide-Release Assay. Endocrinology 153, 2506-2513.</p>\n\n<p>Stinckens, E., Vergauwen, L., Ankley, G.T., Blust, R., Darras, V.M., Villeneuve, D.L., Witters, H., Volz, D.C., Knapen, D., 2018. An AOP-based alternative testing strategy to predict the impact of thyroid hormone disruption on swim bladder inflation in zebrafish. Aquatic Toxicology 200, 1-12.</p>\n\n<p>Vergauwen, L., Cavallin, J.E., Ankley, G.T., Bars, C., Gabriels, I.J., Michiels, E.D.G., Fitzpatrick, K.R., Periz-Stanacev, J., Randolph, E.C., Robinson, S.L., Saari, T.W., Schroeder, A.L., Stinckens, E., Swintek, J., Van Cruchten, S.J., Verbueken, E., Villeneuve, D.L., Knapen, D., 2018. Gene transcription ontogeny of hypothalamic-pituitary-thyroid axis development in early-life stage fathead minnow and zebrafish. General and Comparative Endocrinology 266, 87-100.</p>\n\n<p>Visser, T.J., Van Overmeeren, E., Fekkes, D., Docter, R., Hennemann, G. 1979. Inhibition of iodothyronine 5&#39;-deiodinase by thioureylenes: structure-activity relationship. FEBS Letters, 103, 2.</p>\n\n<p>Walpita, C.N., Crawford, A.D., Darras, V.M., 2010. Combined antisense knockdown of type 1 and type 2 iodothyronine deiodinases disrupts embryonic development in zebrafish (Danio rerio). Gen Comp Endocrinol 166, 134-141.</p>\n\n<p>Walpita, C.N., Grommen, S.V., Darras, V.M., Van der Geyten, S., 2007. The influence of stress on thyroid hormone production and peripheral deiodination in the Nile tilapia (Oreochromis niloticus). Gen Comp Endocrinol 150, 18-25.</p>\n","biologicalOrganisationLevel":"Molecular","organTerm":{},"biologicalEvents":[{"action":"decreased","process":"catalytic activity","object":{"name":"type I iodothyronine deiodinase","source":"PR","sourceId":"PR:000006480"}}],"keyEventStressors":["Propylthiouracil","iopanoic acid"],"id":1009}
{"title":"Activation, ionotropic GABA Receptor chloride channel","references":"","biologicalOrganisationLevel":"Molecular","organTerm":{},"biologicalEvents":[{"action":"decreased","process":"GABA-gated chloride ion channel activity","object":{"name":"chloride","source":"CHEBI","sourceId":"CHEBI:17996"}}],"id":762}
{"title":"Increased, Inhibitory postsynaptic potential","references":"","biologicalOrganisationLevel":"Cellular","organTerm":{},"biologicalEvents":[{"action":"increased","process":"inhibitory postsynaptic potential","object":{}}],"id":1012}
{"title":"Induction, Somatic muscle paralysis","references":"","biologicalOrganisationLevel":"Tissue","organTerm":{"name":"somatic muscle","sourceId":"UBERON:0014895"},"biologicalEvents":[{"action":"increased","process":"paralysis","object":{}}],"id":1014}
{"title":"Increased, Neuronal synaptic inhibition","references":"","biologicalOrganisationLevel":"Cellular","organTerm":{},"biologicalEvents":[{"action":"decreased","process":"negative regulation of synaptic transmission","object":{"name":"GABA receptor complex","source":"GO","sourceId":"GO:1902710"}}],"id":1015}
{"title":"Inhibition, Feeding","references":"","biologicalOrganisationLevel":"Individual","organTerm":{},"biologicalEvents":[{"action":"decreased","process":"feeding behavior","object":{}}],"id":1016}
{"title":"Activation, Glutamate-gated chloride channels","references":"","biologicalOrganisationLevel":"Molecular","organTerm":{},"biologicalEvents":[{"action":"increased","process":"chloride channel activity","object":{"name":"glutamate-gated chloride channel (fruit fly)","source":"PR","sourceId":"PR:Q94900"}}],"id":1018}
{"title":"Induction, pharyngeal muscle paralysis","references":"","biologicalOrganisationLevel":"Tissue","organTerm":{"name":"pharyngeal muscle","sourceId":"UBERON:0000933"},"biologicalEvents":[{"action":"increased","process":"paralysis","object":{}}],"id":1019}
{"title":"Increased, induction of UDPGT's in liver","references":"","biologicalOrganisationLevel":"Cellular","organTerm":{},"biologicalEvents":[{"action":"increased","process":"gene expression","object":{"name":"UDP-glucuronosyltransferase","source":"PR","sourceId":"PR:000024849"}}],"id":1020}
{"title":"Increased, T4/T3 catabolism","references":"","biologicalOrganisationLevel":"Cellular","organTerm":{},"biologicalEvents":[{"action":"increased","process":"hormone catabolic process","object":{"name":"thyroxine","source":"CHEBI","sourceId":"CHEBI:30660"}}],"id":1021}
{"title":"Decreased, serum T4/T3","references":"","biologicalOrganisationLevel":"Tissue","organTerm":{"name":"serum","sourceId":"UBERON:0001977"},"biologicalEvents":[{"action":"decreased","object":{"name":"thyroxine","source":"CHEBI","sourceId":"CHEBI:30660"}}],"id":1022}
{"title":"Increased, Thyroid-stimulating hormone (TSH)","references":"","biologicalOrganisationLevel":"Tissue","organTerm":{"name":"serum","sourceId":"UBERON:0001977"},"biologicalEvents":[{"action":"increased","object":{"name":"Thyroid stimulating hormone","source":"CHEBI","sourceId":"CHEBI:81567"}}],"id":1023}
{"title":"Increased, Hypertrophy and proliferation (follicular cell)","references":"","biologicalOrganisationLevel":"Cellular","organTerm":{},"biologicalEvents":[{"action":"increased","process":"cell proliferation","object":{"name":"thyroid follicular cell","source":"CL","sourceId":"CL:0002258"}},{"action":"increased","process":"hypertrophy","object":{"name":"thyroid follicular cell","source":"CL","sourceId":"CL:0002258"}}],"id":1024}
{"title":"Increased, Hypertrophy and proliferation (follicular cell)","references":"","biologicalOrganisationLevel":"Cellular","organTerm":{},"biologicalEvents":[{"action":"increased","process":"cell proliferation","object":{"name":"thyroid follicular cell","source":"CL","sourceId":"CL:0002258"}},{"action":"increased","process":"hypertrophy","object":{"name":"thyroid follicular cell","source":"CL","sourceId":"CL:0002258"}}],"id":1024}
{"title":"Increased, Hyperplasia (follicular cells)","references":"","biologicalOrganisationLevel":"Tissue","organTerm":{"name":"thyroid gland","sourceId":"UBERON:0002046"},"biologicalEvents":[{"action":"increased","process":"hyperplasia","object":{"name":"thyroid follicular cell","source":"CL","sourceId":"CL:0002258"}}],"id":1025}
{"title":"Increased Apoptosis, Adenomas/carcinomas (follicular cell)","references":"","biologicalOrganisationLevel":"Tissue","organTerm":{"name":"thyroid gland","sourceId":"UBERON:0002046"},"biologicalEvents":[{"action":"increased","object":{"name":"Adenoma","source":"MESH","sourceId":"D000236"}},{"action":"increased","object":{"name":"Carcinoma","source":"MESH","sourceId":"D002277"}}],"id":1026}
{"title":"Increased Apoptosis, Adenomas/carcinomas (follicular cell)","references":"","biologicalOrganisationLevel":"Tissue","organTerm":{"name":"thyroid gland","sourceId":"UBERON:0002046"},"biologicalEvents":[{"action":"increased","object":{"name":"Adenoma","source":"MESH","sourceId":"D000236"}},{"action":"increased","object":{"name":"Carcinoma","source":"MESH","sourceId":"D002277"}}],"id":1026}
{"title":"Increased, adipogenesis","references":"","biologicalOrganisationLevel":"Cellular","organTerm":{},"biologicalEvents":[{"action":"increased","process":"fat cell differentiation","object":{}}],"id":1029}
{"title":"Increased, secretion of local growth factors","references":"","biologicalOrganisationLevel":"Cellular","organTerm":{},"biologicalEvents":[{"action":"increased","process":"secretion","object":{"name":"eukaryotic protein","source":"PR","sourceId":"PR:000036194"}}],"id":1032}
{"title":"Increased, proliferation of mesenchymal cells","references":"","biologicalOrganisationLevel":"Cellular","organTerm":{},"biologicalEvents":[{"action":"increased","process":"mesenchymal cell proliferation","object":{"name":"mesenchymal cell","source":"CL","sourceId":"CL:0008019"}}],"id":1033}
{"title":"Increased, IGF-1 (mouse)","references":"","biologicalOrganisationLevel":"Cellular","organTerm":{},"biologicalEvents":[{"action":"increased","process":"gene expression","object":{"name":"IGF-like family receptor 1 (mouse)","source":"PR","sourceId":"PR:Q3U4N7"}}],"id":1034}
{"title":"Increased, Firbrosarcoma","references":"","biologicalOrganisationLevel":"Tissue","organTerm":{"name":"fibrous connective tissue","sourceId":"UBERON:0011824"},"biologicalEvents":[{"action":"increased","object":{"name":"Fibrosarcoma","source":"MESH","sourceId":"D005354"}}],"id":1035}
{"title":"Increased, liposarcoma","references":"","biologicalOrganisationLevel":"Tissue","organTerm":{"name":"adipose tissue","sourceId":"UBERON:0001013"},"biologicalEvents":[{"action":"increased","object":{"name":"liposarcoma","source":"MESH","sourceId":"D008080"}}],"id":1036}
{"title":"Increased, hemagiosarcoma","references":"","biologicalOrganisationLevel":"Tissue","organTerm":{"name":"blood vessel endothelium","sourceId":"UBERON:0004638"},"biologicalEvents":[{"action":"increased","object":{"name":"hemangiosarcoma","source":"MESH","sourceId":"D006394"}}],"id":1037}
{"title":"Activation, beta-2 adrenergic receptor","references":"","biologicalOrganisationLevel":"Molecular","organTerm":{},"biologicalEvents":[{"action":"increased","process":"beta-2 adrenergic receptor binding","object":{"name":"beta-2 adrenergic receptor","source":"PR","sourceId":"PR:000001193"}}],"id":1038}
{"title":"Increased activity, beta-2 adrenergic receptor","references":"","biologicalOrganisationLevel":"Molecular","organTerm":{},"biologicalEvents":[{"action":"increased","process":"beta2-adrenergic receptor activity","object":{"name":"beta-2 adrenergic receptor","source":"PR","sourceId":"PR:000001193"}}],"id":1039}
{"title":"relaxation, smooth muscle","references":"","biologicalOrganisationLevel":"Tissue","organTerm":{},"biologicalEvents":[{"action":"increased","process":"relaxation of smooth muscle","object":{}}],"id":1040}
{"title":"Proliferation/Clonal Expansion, smooth muscle","references":"","biologicalOrganisationLevel":"Cellular","organTerm":{},"biologicalEvents":[{"action":"increased","process":"cell proliferation","object":{"name":"smooth muscle cell","source":"CL","sourceId":"CL:0000192"}}],"id":1042}
{"title":"Hypertrophy/hyperplasia, smooth muscle","references":"","biologicalOrganisationLevel":"Cellular","organTerm":{},"biologicalEvents":[{"action":"increased","process":"hypertrophy","object":{"name":"smooth muscle tissue","source":"UBERON","sourceId":"UBERON:0001135"}}],"id":1043}
{"title":"Promotion, mesovarian leiomyomas","references":"","biologicalOrganisationLevel":"Tissue","organTerm":{"name":"uterus","sourceId":"UBERON:0000995"},"biologicalEvents":[{"action":"increased","object":{"name":"leiomyoma","source":"MESH","sourceId":"D007889"}}],"id":1044}
{"title":"Decreased, Ovarian E2","references":"","biologicalOrganisationLevel":"Tissue","organTerm":{"name":"female gonad","sourceId":"UBERON:0000992"},"biologicalEvents":[{"action":"decreased","object":{"name":"estradiol","source":"CHEBI","sourceId":"CHEBI:23965"}}],"id":1045}
{"title":"Suppression, Estrogen receptor (ER) activity","references":"","biologicalOrganisationLevel":"Molecular","organTerm":{},"biologicalEvents":[{"action":"decreased","process":"estrogen receptor activity","object":{"name":"estrogen receptor","source":"PR","sourceId":"PR:000007204"}}],"id":1046}
{"title":"Increased, secretion of GnRH from hypothalamus","references":"","biologicalOrganisationLevel":"Cellular","organTerm":{},"biologicalEvents":[{"action":"decreased","process":"hormone secretion","object":{"name":"Gonadotropin Releasing Hormone","source":"MESH","sourceId":"D007987"}}],"id":1047}
{"title":"Increased, secrection of FSH from anterior pituitary","references":"","biologicalOrganisationLevel":"Cellular","organTerm":{},"biologicalEvents":[{"action":"decreased","process":"follicle-stimulating hormone secretion","object":{"name":"Follicle stimulating hormone","source":"CHEBI","sourceId":"CHEBI:81569"}}],"id":1049}
{"title":"Increased, secretion of LH from anterior pituitary","references":"","biologicalOrganisationLevel":"Cellular","organTerm":{},"biologicalEvents":[{"action":"decreased","process":"luteinizing hormone secretion","object":{"name":"Luteinizing hormone","source":"CHEBI","sourceId":"CHEBI:81568"}}],"id":1050}
{"title":"Hyperplasia, ovarian stromal cells","references":"","biologicalOrganisationLevel":"Cellular","organTerm":{},"biologicalEvents":[{"action":"increased","process":"hyperplasia","object":{"name":"stromal cell of ovary","source":"CL","sourceId":"CL:0002132"}}],"id":1051}
{"title":"Hyperplasia, ovarian epithelium","references":"","biologicalOrganisationLevel":"Tissue","organTerm":{"name":"epithelium of female gonad","sourceId":"UBERON:0004911"},"biologicalEvents":[{"action":"increased","process":"hyperplasia","object":{"name":"epithelium of female gonad","source":"UBERON","sourceId":"UBERON:0004911"}}],"id":1052}
{"title":"Promotion, ovarian adenomas","references":"","biologicalOrganisationLevel":"Tissue","organTerm":{},"biologicalEvents":[{"action":"increased","object":{"name":"Adenoma","source":"MESH","sourceId":"D000236"}}],"id":1053}
{"title":"Promotion, ovarian granular cell tumors","references":"","biologicalOrganisationLevel":"Cellular","organTerm":{},"biologicalEvents":[{"action":"increased","object":{"name":"Granular Cell Tumor","source":"MESH","sourceId":"D016586"}}],"id":1054}
{"title":"Decrease, E2 blood concentrations at hypothalamus","references":"","biologicalOrganisationLevel":"Tissue","organTerm":{"name":"blood","sourceId":"UBERON:0000178"},"biologicalEvents":[{"action":"decreased","object":{"name":"17beta-estradiol","source":"CHEBI","sourceId":"CHEBI:16469"}}],"id":1056}
{"title":"Increased, PPAR-alpha activation","references":"","biologicalOrganisationLevel":"Molecular","organTerm":{},"biologicalEvents":[{"action":"decreased","process":"peroxisome proliferator activated receptor signaling pathway","object":{"name":"peroxisome proliferator-activated receptor alpha","source":"PR","sourceId":"PR:000013056"}}],"id":1057}
{"title":"Decreased, bile flow","references":"","biologicalOrganisationLevel":"Organ","organTerm":{"name":"bile canaliculi","sourceId":"UBERON:0001283"},"biologicalEvents":[{"action":"decreased","object":{"name":"bile","source":"UBERON","sourceId":"UBERON:0001970"}}],"id":1058}
{"title":"Increased, cholestasis","references":"","biologicalOrganisationLevel":"Organ","organTerm":{"name":"bile duct","sourceId":"UBERON:0002394"},"biologicalEvents":[{"action":"occurrence","object":{"name":"cholestasis","source":"MESH","sourceId":"D002779"}}],"id":1059}
{"title":"Alteration, lipid metabolism","references":"","biologicalOrganisationLevel":"Cellular","organTerm":{},"biologicalEvents":[{"action":"abnormal","process":"lipid metabolic process","object":{}}],"id":1060}
{"title":"prolonged, elevation of serun CCK","references":"","biologicalOrganisationLevel":"Tissue","organTerm":{"name":"serum","sourceId":"UBERON:0001977"},"biologicalEvents":[{"action":"increased","object":{"name":"cholecystokinin","source":"PR","sourceId":"PR:000005110"}}],"id":1061}
{"title":"Increased, Cellular proliferation / hyperplasia of acinar cells","references":"","biologicalOrganisationLevel":"Cellular","organTerm":{},"biologicalEvents":[{"action":"increased","process":"cell proliferation","object":{"name":"acinar cell","source":"CL","sourceId":"CL:0000622"}}],"id":1062}
{"title":"Increased, Pancreatic acinar tumors","references":"","biologicalOrganisationLevel":"Organ","organTerm":{"name":"pancreas","sourceId":"UBERON:0001264"},"biologicalEvents":[{"action":"increased","object":{"name":"Carcinoma","source":"MESH","sourceId":"D002277"}}],"id":1063}
{"title":"prepubertal increase, Estrogen receptor (ER) activity","references":"","biologicalOrganisationLevel":"Molecular","organTerm":{},"biologicalEvents":[{"action":"increased","process":"estrogen receptor activity","object":{"name":"estrogen receptor","source":"PR","sourceId":"PR:000007204"}}],"id":1064}
{"title":"Activation, estrogen receptor alpha","references":"","biologicalOrganisationLevel":"Molecular","organTerm":{},"biologicalEvents":[{"action":"increased","process":"intracellular estrogen receptor signaling pathway","object":{"name":"estrogen receptor alpha complex","source":"PR","sourceId":"PR:000027727"}}],"id":1065}
{"title":"Promotion, SIX-1 postive basal-type progenitor cells","references":"","biologicalOrganisationLevel":"Cellular","organTerm":{},"biologicalEvents":[{"action":"increased","process":"gene expression","object":{"name":"homeobox protein SIX1","source":"PR","sourceId":"PR:000014896"}}],"id":1066}
{"title":"Proliferation/Clonal Expansion, aberrant basal cells","references":"","biologicalOrganisationLevel":"Cellular","organTerm":{},"biologicalEvents":[{"action":"increased","process":"cell proliferation","object":{"name":"basal cell","source":"CL","sourceId":"CL:0000646"}}],"id":1067}
{"title":"squamous metaplasia, aberrant basal cells","references":"","biologicalOrganisationLevel":"Tissue","organTerm":{},"biologicalEvents":[{"action":"morphological change","object":{"name":"Metaplasia","source":"MESH","sourceId":"D008679"}}],"id":1068}
{"title":"Increased, Hyperplasia (glandular epithelial cells of endometrium)","references":"","biologicalOrganisationLevel":"Cellular","organTerm":{},"biologicalEvents":[{"action":"increased","process":"hyperplasia","object":{"name":"glandular epithelial cell","source":"CL","sourceId":"CL:0000150"}}],"id":1069}
{"title":"Increased, adenosquamous carcinomas of endometrium","references":"","biologicalOrganisationLevel":"Tissue","organTerm":{"name":"endometrium","sourceId":"UBERON:0001295"},"biologicalEvents":[{"action":"increased","object":{"name":"adenosquamous carcinoma","source":"MESH","sourceId":"D018196"}}],"id":1070}
{"title":"Decreased, GnRH pulsatility/release in hypothalamus","references":"","biologicalOrganisationLevel":"Cellular","organTerm":{},"biologicalEvents":[{"action":"decreased","process":"hormone secretion","object":{"name":"Gonadotropin Releasing Hormone","source":"MESH","sourceId":"D007987"}}],"id":1071}
{"title":"Decreased, LH Surge from anterior pituitary","references":"","biologicalOrganisationLevel":"Cellular","organTerm":{},"biologicalEvents":[{"action":"decreased","process":"hormone secretion","object":{"name":"Luteinizing hormone","source":"CHEBI","sourceId":"CHEBI:81568"}}],"id":1072}
{"title":"interruption, Ovulation","references":"","biologicalOrganisationLevel":"Individual","organTerm":{},"biologicalEvents":[{"action":"disrupted","process":"abnormal ovulation","object":{}}],"id":1074}
{"title":"prolonged, estrus","references":"","biologicalOrganisationLevel":"Individual","organTerm":{},"biologicalEvents":[{"action":"delayed","process":"estrus","object":{}}],"id":1075}
{"title":"Increased, circulating estrogen levels","references":"","biologicalOrganisationLevel":"Organ","organTerm":{},"biologicalEvents":[{"action":"increased","object":{"name":"estrogen","source":"CHEBI","sourceId":"CHEBI:50114"}}],"id":1076}
{"title":"Increased, prolactin exposure","references":"","biologicalOrganisationLevel":"Tissue","organTerm":{},"biologicalEvents":[{"action":"increased","object":{"name":"prolactin","source":"PR","sourceId":"PR:000013246"}}],"id":1077}
{"title":"Hyperplasia, Mammary gland","references":"","biologicalOrganisationLevel":"Tissue","organTerm":{"name":"mammary gland","sourceId":"UBERON:0001911"},"biologicalEvents":[{"action":"increased","process":"mammary gland hyperplasia","object":{}}],"id":1078}
{"title":"Increased, Adenomas/carcinomas (mammary)","references":"","biologicalOrganisationLevel":"Tissue","organTerm":{"name":"mammary gland","sourceId":"UBERON:0001911"},"biologicalEvents":[{"action":"increased","object":{"name":"Adenoma","source":"MESH","sourceId":"D000236"}},{"action":"increased","object":{"name":"Carcinoma","source":"MESH","sourceId":"D002277"}}],"id":1079}
{"title":"Increased, Adenomas/carcinomas (mammary)","references":"","biologicalOrganisationLevel":"Tissue","organTerm":{"name":"mammary gland","sourceId":"UBERON:0001911"},"biologicalEvents":[{"action":"increased","object":{"name":"Adenoma","source":"MESH","sourceId":"D000236"}},{"action":"increased","object":{"name":"Carcinoma","source":"MESH","sourceId":"D002277"}}],"id":1079}
{"title":"Increased, latency period","references":"","biologicalOrganisationLevel":"Individual","organTerm":{},"biologicalEvents":[{"action":"increased","process":"abnormal tumor latency","object":{}}],"id":1080}
{"title":"Increased, lactotroph hyperplasia and hypertrophy","references":"","biologicalOrganisationLevel":"Cellular","organTerm":{},"biologicalEvents":[{"action":"increased","process":"hyperplasia","object":{"name":"prolactin secreting cell","source":"CL","sourceId":"CL:0000439"}},{"action":"increased","process":"hypertrophy","object":{"name":"prolactin secreting cell","source":"CL","sourceId":"CL:0000439"}}],"id":1081}
{"title":"Increased, lactotroph hyperplasia and hypertrophy","references":"","biologicalOrganisationLevel":"Cellular","organTerm":{},"biologicalEvents":[{"action":"increased","process":"hyperplasia","object":{"name":"prolactin secreting cell","source":"CL","sourceId":"CL:0000439"}},{"action":"increased","process":"hypertrophy","object":{"name":"prolactin secreting cell","source":"CL","sourceId":"CL:0000439"}}],"id":1081}
{"title":"Increased, adenomas (pituitary)","references":"","biologicalOrganisationLevel":"Tissue","organTerm":{"name":"pituitary gland","sourceId":"UBERON:0000007"},"biologicalEvents":[{"action":"increased","process":"Pituitary adenoma","object":{"name":"Adenoma","source":"MESH","sourceId":"D000236"}}],"id":1082}
{"title":"Decreased, Dopaminergic activity","references":"","biologicalOrganisationLevel":"Cellular","organTerm":{},"biologicalEvents":[{"action":"increased","process":"synaptic transmission, dopaminergic","object":{"name":"dopaminergic neuron","source":"CL","sourceId":"CL:0000700"}}],"id":1083}
{"title":"Increased, prolactin secretion","references":"","biologicalOrganisationLevel":"Tissue","organTerm":{},"biologicalEvents":[{"action":"increased","process":"prolactin secretion","object":{"name":"prolactin","source":"PR","sourceId":"PR:000013246"}}],"id":1084}
{"title":"Increased, hyperplasia (mammary gland)","references":"","biologicalOrganisationLevel":"Tissue","organTerm":{"name":"mammary gland","sourceId":"UBERON:0001911"},"biologicalEvents":[{"action":"increased","process":"hyperplasia","object":{"name":"mammary gland","source":"UBERON","sourceId":"UBERON:0001911"}}],"id":1085}
{"title":"persistent, cytotoxicity (pleura or peritoneum)","references":"","biologicalOrganisationLevel":"Cellular","organTerm":{"name":"pleura","sourceId":"UBERON:0000977"},"biologicalEvents":[{"action":"increased","process":"cell death","object":{"name":"pleura","source":"UBERON","sourceId":"UBERON:0000977"}}],"id":1086}
{"title":"Increased, inflammation","references":"","biologicalOrganisationLevel":"Cellular","organTerm":{},"biologicalEvents":[{"action":"increased","process":"inflammatory response","object":{}}],"id":1087}
{"title":"Increased, Cell Proliferation (mesothelium)","references":"","biologicalOrganisationLevel":"Cellular","organTerm":{"name":"mesothelium","sourceId":"UBERON:0001136"},"biologicalEvents":[{"action":"increased","process":"cell proliferation","object":{"name":"mesothelium","source":"UBERON","sourceId":"UBERON:0001136"}}],"id":1089}
{"title":"Increased, mesotheliomas","references":"","biologicalOrganisationLevel":"Tissue","organTerm":{},"biologicalEvents":[{"action":"increased","object":{"name":"mesothelioma","source":"MESH","sourceId":"D008654"}}],"id":1090}
{"title":"Interaction with the lung resident cell membrane components","references":"<ol>\n\t<li>Behzadi, S., Serpooshan, V., Tao, W., Hamaly, M., Alkawareek, M., Dreaden, E., Brown, D., Alkilany, A., Farokhzad, O. and Mahmoudi, M. (2017). Cellular uptake of nanoparticles: journey inside the cell. <em>Chemical Society Reviews</em>, 46(14), pp.4218-4244.</li>\n\t<li>Desai, O., Winkler, J., Minasyan, M. and Herzog, E. (2018). The Role of Immune and Inflammatory Cells in Idiopathic Pulmonary Fibrosis. <em>Frontiers in Medicine</em>, 5.</li>\n\t<li>Dinis-Oliveira, R., Duarte, J., S&aacute;nchez-Navarro, A., Remi&atilde;o, F., Bastos, M. and Carvalho, F. (2008). Paraquat Poisonings: Mechanisms of Lung Toxicity, Clinical Features, and Treatment. <em>Critical Reviews in Toxicology</em>, 38(1), pp.13-71.</li>\n\t<li>Donaldson, K., Murphy, F., Duffin, R. and Poland, C. (2010). Asbestos, carbon nanotubes and the pleural mesothelium: a review and the hypothesis regarding the role of long fibre retention in the parietal pleura, inflammation and mesothelioma. <em>Particle and Fibre Toxicology</em>, 7(1), p.5.</li>\n\t<li>Franks, T., Colby, T., Travis, W., Tuder, R., Reynolds, H., Brody, A., Cardoso, W., Crystal, R., Drake, C., Engelhardt, J., Frid, M., Herzog, E., Mason, R., Phan, S., Randell, S., Rose, M., Stevens, T., Serge, J., Sunday, M., Voynow, J., Weinstein, B., Whitsett, J. and Williams, M. (2008). Resident Cellular Components of the Human Lung: Current Knowledge and Goals for Research on Cell Phenotyping and Function. <em>Proceedings of the American Thoracic Society</em>, 5(7), pp.763-766.</li>\n\t<li>Kierdorf, K., Prinz, M., Geissmann, F. and Gomez Perdiguero, E. (2015). Development and function of tissue resident macrophages in mice. <em>Seminars in Immunology</em>, 27(6), pp.369-378.</li>\n\t<li>Li, X., Jiang, D., Huang, X., Guo, S., Yuan, W. and Dai, H. (2015). Toll-like receptor 4 promotes fibrosis in bleomycin-induced lung injury in mice. <em>Genetics and Molecular Research</em>, 14(4), pp.17391-17398.</li>\n\t<li>Matzinger, P. (2002). The Danger Model: A Renewed Sense of Self. <em>Science</em>, 296(5566), pp.301-305.</li>\n\t<li>MOSSMAN, B. and CHURG, A. (1998). Mechanisms in the Pathogenesis of Asbestosis and Silicosis. <em>American Journal of Respiratory and Critical Care Medicine</em>, 157(5), pp.1666-1680.</li>\n\t<li>Murthy, S., Larson-Casey, J., Ryan, A., He, C., Kobzik, L. and Carter, A. (2015). Alternative activation of macrophages and pulmonary fibrosis are modulated by scavenger receptor, macrophage receptor with collagenous structure. <em>The FASEB Journal</em>, 29(8), pp.3527-3536.</li>\n\t<li>Nakayama, M. (2018). Macrophage Recognition of Crystals and Nanoparticles. <em>Frontiers in Immunology</em>, 9.</li>\n\t<li>Bianchi, M. (2006). DAMPs, PAMPs and alarmins: all we need to know about danger. <em>Journal of Leukocyte Biology</em>, 81(1), pp.1-5.</li>\n\t<li>Boyles, M., Young, L., Brown, D., MacCalman, L., Cowie, H., Moisala, A., Smail, F., Smith, P., Proudfoot, L., Windle, A. and Stone, V. (2015). Multi-walled carbon nanotube induced frustrated phagocytosis, cytotoxicity and pro-inflammatory conditions in macrophages are length dependent and greater than that of asbestos. <em>Toxicology in Vitro</em>, 29(7), pp.1513-1528.</li>\n\t<li>Brown, D., Kinloch, I., Bangert, U., Windle, A., Walter, D., Walker, G., Scotchford, C., Donaldson, K. and Stone, V. (2007). An in vitro study of the potential of carbon nanotubes and nanofibres to induce inflammatory mediators and frustrated phagocytosis. <em>Carbon</em>, 45(9), pp.1743-1756.</li>\n\t<li>Cheng, L., Jiang, X., Wang, J., Chen, C. and Liu, R. (2013). Nano&ndash;bio effects: interaction of nanomaterials with cells. <em>Nanoscale</em>, 5(9), p.3547.</li>\n\t<li>Denholm, E. and Phan, S. (1990). Bleomycin Binding Sites on Alveolar Macrophages. <em>Journal of Leukocyte Biology</em>, 48(6), pp.519-523.</li>\n\t<li>Di Paolo, N. and Shayakhmetov, D. (2016). Interleukin 1&alpha; and the inflammatory process. <em>Nature Immunology</em>, 17(8), pp.906-913.</li>\n\t<li>D&ouml;rger, M., M&uuml;nzing, S., Allmeling, A., Messmer, K. and Krombach, F. (2001). Differential Responses of Rat Alveolar and Peritoneal Macrophages to Man-Made Vitreous Fibers in Vitro. <em>Environmental Research</em>, 85(3), pp.207-214.</li>\n\t<li>Kim, J., Lim, H., Minai-Tehrani, A., Kwon, J., Shin, J., Woo, C., Choi, M., Baek, J., Jeong, D., Ha, Y., Chae, C., Song, K., Ahn, K., Lee, J., Sung, H., Yu, I., Beck, G. and Cho, M. (2010). Toxicity and Clearance of Intratracheally Administered Multiwalled Carbon Nanotubes from Murine Lung. <em>Journal of Toxicology and Environmental Health, Part A</em>, 73(21-22), pp.1530-1543.</li>\n\t<li>Murthy, S., Larson-Casey, J., Ryan, A., He, C., Kobzik, L. and Carter, A. (2015). Alternative activation of macrophages and pulmonary fibrosis are modulated by scavenger receptor, macrophage receptor with collagenous structure. <em>The FASEB Journal</em>, 29(8), pp.3527-3536.</li>\n\t<li>National Institute of Occupational Safety and Health (NIOSH) (2011). <em>Asbestos fibers and other elongate mineral particles: state of the science and roadmap for research.</em>. pp.Current Intelligence Bulletin 62. Publication Number 2011-159.</li>\n\t<li>Nel, A., M&auml;dler, L., Velegol, D., Xia, T., Hoek, E., Somasundaran, P., Klaessig, F., Castranova, V. and Thompson, M. (2009). Understanding biophysicochemical interactions at the nano&ndash;bio interface. <em>Nature Materials</em>, 8(7), pp.543-557.</li>\n\t<li>Nikota, J., Banville, A., Goodwin, L., Wu, D., Williams, A., Yauk, C., Wallin, H., Vogel, U. and Halappanavar, S. (2017). Stat-6 signaling pathway and not Interleukin-1 mediates multi-walled carbon nanotube-induced lung fibrosis in mice: insights from an adverse outcome pathway framework. <em>Particle and Fibre Toxicology</em>, 14(1).</li>\n\t<li>Pascolo, L., Gianoncelli, A., Schneider, G., Salom&eacute;, M., Schneider, M., Calligaro, C., Kiskinova, M., Melato, M. and Rizzardi, C. (2013). The interaction of asbestos and iron in lung tissue revealed by synchrotron-based scanning X-ray microscopy. <em>Scientific Reports</em>, 3(1).</li>\n\t<li>Poland, C., Duffin, R., Kinloch, I., Maynard, A., Wallace, W., Seaton, A., Stone, V., Brown, S., MacNee, W. and Donaldson, K. (2008). Carbon nanotubes introduced into the abdominal cavity of mice show asbestos-like pathogenicity in a pilot study. <em>Nature Nanotechnology</em>, 3(7), pp.423-428.</li>\n\t<li>Rabolli, V., Badissi, A., Devosse, R., Uwambayinema, F., Yakoub, Y., Palmai-Pallag, M., Lebrun, A., De Gussem, V., Couillin, I., Ryffel, B., Marbaix, E., Lison, D. and Huaux, F. (2014). The alarmin IL-1&alpha; is a master cytokine in acute lung inflammation induced by silica micro- and nanoparticles. <em>Particle and Fibre Toxicology</em>, 11(1).</li>\n\t<li>Suwara, M., Green, N., Borthwick, L., Mann, J., Mayer-Barber, K., Barron, L., Corris, P., Farrow, S., Wynn, T., Fisher, A. and Mann, D. (2013). IL-1&alpha; released from damaged epithelial cells is sufficient and essential to trigger inflammatory responses in human lung fibroblasts. <em>Mucosal Immunology</em>, 7(3), pp.684-693.</li>\n\t<li>Amsen, D. and De Visser, K. (2009). <em>Approaches to Determine Expression of Inflammatory Cytokines. Methods in molecular biology.</em>. 511th ed. (Clifton, NJ), pp.107-142.</li>\n\t<li>Decan, N., Wu, D., Williams, A., Bernatchez, S., Johnston, M., Hill, M. and Halappanavar, S. (2016). Characterization of in vitro genotoxic, cytotoxic and transcriptomic responses following exposures to amorphous silica of different sizes. <em>Mutation Research/Genetic Toxicology and Environmental Mutagenesis</em>, 796, pp.8-22.</li>\n\t<li>Di Paolo, N. and Shayakhmetov, D. (2016). Interleukin 1&alpha; and the inflammatory process. <em>Nature Immunology</em>, 17(8), pp.906-913.</li>\n\t<li>Donaldson, K., Murphy, F., Duffin, R. and Poland, C. (2010). Asbestos, carbon nanotubes and the pleural mesothelium: a review and the hypothesis regarding the role of long fibre retention in the parietal pleura, inflammation and mesothelioma. <em>Particle and Fibre Toxicology</em>, 7(1), p.5.</li>\n\t<li>Nikota, J., Banville, A., Goodwin, L., Wu, D., Williams, A., Yauk, C., Wallin, H., Vogel, U. and Halappanavar, S. (2017). Stat-6 signaling pathway and not Interleukin-1 mediates multi-walled carbon nanotube-induced lung fibrosis in mice: insights from an adverse outcome pathway framework. <em>Particle and Fibre Toxicology</em>, 14(1).</li>\n\t<li>Rabolli, V., Badissi, A., Devosse, R., Uwambayinema, F., Yakoub, Y., Palmai-Pallag, M., Lebrun, A., De Gussem, V., Couillin, I., Ryffel, B., Marbaix, E., Lison, D. and Huaux, F. (2014). The alarmin IL-1&alpha; is a master cytokine in acute lung inflammation induced by silica micro- and nanoparticles. <em>Particle and Fibre Toxicology</em>, 11(1).</li>\n\t<li>Suwara, M., Green, N., Borthwick, L., Mann, J., Mayer-Barber, K., Barron, L., Corris, P., Farrow, S., Wynn, T., Fisher, A. and Mann, D. (2013). IL-1&alpha; released from damaged epithelial cells is sufficient and essential to trigger inflammatory responses in human lung fibroblasts. <em>Mucosal Immunology</em>, 7(3), pp.684-693.</li>\n\t<li>Varela, J., Bexiga, M., &Aring;berg, C., Simpson, J. and Dawson, K. (2012). Quantifying size-dependent interactions between fluorescently labeled polystyrene nanoparticles and mammalian cells. <em>Journal of Nanobiotechnology</em>, 10(1), p.39.</li>\n</ol>\n","biologicalOrganisationLevel":"Molecular","organTerm":{},"biologicalEvents":[{"object":{}}],"id":1495}
{"title":"Increased, secretion of proinflammatory and profibrotic mediators","references":"<ol>\n\t<li>Alberts, D., Chen, H., Woolfenden, J., Moon, T., Chang, S., Hall, J., Himmelstein, K., Gross, J. and Salmon, S. (1979). Pharmacokinetics of bleomycin in man. <em>Cancer Chemotherapy and Pharmacology</em>, 3(1).</li>\n\t<li>Br&ouml;mme, D., Rossi, A., Smeekens, S., Anderson, D. and Payan, D. (1996). Human Bleomycin Hydrolase:&nbsp; Molecular Cloning, Sequencing, Functional Expression, and Enzymatic Characterization. <em>Biochemistry</em>, 35(21), pp.6706-6714.</li>\n\t<li>Canellos, G., Anderson, J., Propert, K., Nissen, N., Cooper, M., Henderson, E., Green, M., Gottlieb, A. and Peterson, B. (1992). Chemotherapy of Advanced Hodgkin&#39;s Disease with MOPP, ABVD, or MOPP Alternating with ABVD. <em>New England Journal of Medicine</em>, 327(21), pp.1478-1484.</li>\n\t<li>Claussen, C. and Long, E. (1999). Nucleic Acid Recognition by Metal Complexes of Bleomycin. <em>Chemical Reviews</em>, 99(9), pp.2797-2816.</li>\n\t<li><span style=\"color:rgb(0, 0, 0)\">Forn-Cun&iacute;, G., Varela, M., Pereiro, P., Novoa, B. and Figueras, A. (2017). Conserved gene regulation during acute inflammation between zebrafish and mammals. <em>Scientific Reports</em>, 7(1).</span></li>\n\t<li>Froudarakis, M., Hatzimichael, E., Kyriazopoulou, L., Lagos, K., Pappas, P., Tzakos, A., Karavasilis, V., Daliani, D., Papandreou, C. and Briasoulis, E. (2013). Revisiting bleomycin from pathophysiology to safe clinical use. <em>Critical Reviews in Oncology/Hematology</em>, 87(1), pp.90-100.</li>\n\t<li>Hay, J., Shahzeidi, S. and Laurent, G. (1991). Mechanisms of bleomycin-induced lung damage. <em>Archives of Toxicology</em>, 65(2), pp.81-94.</li>\n\t<li>Hubbard, A., Timblin, C., Shukla, A., Rinc&oacute;n, M. and Mossman, B. (2002). Activation of NF-&kappa;B-dependent gene expression by&nbsp; silica in lungs of luciferase reporter mice. <em>American Journal of Physiology-Lung Cellular and Molecular Physiology</em>, 282(5), pp.L968-L975.</li>\n\t<li>Ohnuma, T., Holland, J., Masuda, H., Waligunda, J. and Goldberg, G. (1974). Microbiological assay of bleomycin: Inactivation, tissue distribution, and clearance. <em>Cancer</em>, 33(5), pp.1230-1238.</li>\n\t<li>Sleijfer, S. (2001). Bleomycin-Induced Pneumonitis. <em>Chest</em>, 120(2), pp.617-624.</li>\n\t<li>Tashiro, J., Rubio, G., Limper, A., Williams, K., Elliot, S., Ninou, I., Aidinis, V., Tzouvelekis, A. and Glassberg, M. (2017). Exploring Animal Models That Resemble Idiopathic Pulmonary Fibrosis. <em>Frontiers in Medicine</em>, 4.</li>\n\t<li>Twentyman, P. (1983). Bleomycin&mdash;mode of action with particular reference to the cell cycle. <em>Pharmacology &amp; Therapeutics</em>, 23(3), pp.417-441.</li>\n\t<li>Umezawa, H., Maeda, K., Takeuchi, T. and Okami, Y. (1966). NEW ANTIBIOTICS, BLEOMYCIN A AND B. <em>The Journal of Antibiotics</em>, XIX(5), pp.200-209.</li>\n\t<li>Umezawa, H., Suhara, Y., Takita, T. and Maeda, K. (2019). PURIFICATION OF BLEOMYCINS. <em>Journal of Antibiotics</em>, XIX(5), pp.210-215.</li>\n\t<li>Yu, Z., Schmaltz, R., Bozeman, T., Paul, R., Rishel, M., Tsosie, K. and Hecht, S. (2013). Selective Tumor Cell Targeting by the Disaccharide Moiety of Bleomycin. <em>Journal of the American Chemical Society</em>, 135(8), pp.2883-2886.</li>\n</ol>\n","biologicalOrganisationLevel":"Cellular","organTerm":{},"biologicalEvents":[{"object":{}}],"id":1496}
{"title":"Increased, recruitment of inflammatory cells","references":"<ol>\n\t<li><span style=\"color:rgb(0, 0, 0)\">Cho, W., Duffin, R., Poland, C., Howie, S., MacNee, W., Bradley, M., Megson, I. and Donaldson, K. (2010). Metal Oxide Nanoparticles Induce Unique Inflammatory Footprints in the Lung: Important Implications for Nanoparticle Testing. <em>Environmental Health Perspectives</em>, 118(12), pp.1699-1706.</span></li>\n\t<li>Ingersoll, M., Platt, A., Potteaux, S. and Randolph, G. (2011). Monocyte trafficking in acute and chronic inflammation. <em>Trends in Immunology</em>, 32(10), pp.470-477.</li>\n\t<li>K&oslash;bler, C., Poulsen, S., Saber, A., Jacobsen, N., Wallin, H., Yauk, C., Halappanavar, S., Vogel, U., Qvortrup, K. and M&oslash;lhave, K. (2015). Time-Dependent Subcellular Distribution and Effects of Carbon Nanotubes in Lungs of Mice. <em>PLOS ONE</em>, 10(1), p.e0116481.</li>\n\t<li>Kolaczkowska, E. and Kubes, P. (2013). Neutrophil recruitment and function in health and inflammation. <em>Nature Reviews Immunology</em>, 13(3), pp.159-175.</li>\n\t<li>Kopf, M., Schneider, C. and Nobs, S. (2014). The development and function of lung-resident macrophages and dendritic cells. <em>Nature Immunology</em>, 16(1), pp.36-44.</li>\n\t<li>Phan, S., Thrall, R. and Ward, P. (1980). Bleomycin-induced Pulmonary Fibrosis in Rats: Biochemical Demonstration of Increased Rate of Collagen Synthesis1,2. <em>American Review of Respiratory Disease</em>, 121(3), pp.501-506.</li>\n\t<li>Poulsen, S., Saber, A., Williams, A., Andersen, O., K&oslash;bler, C., Atluri, R., Pozzebon, M., Mucelli, S., Simion, M., Rickerby, D., Mortensen, A., Jackson, P., Kyjovska, Z., M&oslash;lhave, K., Jacobsen, N., Jensen, K., Yauk, C., Wallin, H., Halappanavar, S. and Vogel, U. (2015). MWCNTs of different physicochemical properties cause similar inflammatory responses, but differences in transcriptional and histological markers of fibrosis in mouse lungs. <em>Toxicology and Applied Pharmacology</em>, 284(1), pp.16-32.</li>\n\t<li>Rahman, L., Jacobsen, N., Aziz, S., Wu, D., Williams, A., Yauk, C., White, P., Wallin, H., Vogel, U. and Halappanavar, S. (2017). Multi-walled carbon nanotube-induced genotoxic, inflammatory and pro-fibrotic responses in mice: Investigating the mechanisms of pulmonary carcinogenesis. <em>Mutation Research/Genetic Toxicology and Environmental Mutagenesis</em>, 823, pp.28-44.</li>\n\t<li>Rahman, L., Wu, D., Johnston, M., Williams, A. and Halappanavar, S. (2016). Toxicogenomics analysis of mouse lung responses following exposure to titanium dioxide nanomaterials reveal their disease potential at high doses. <em>Mutagenesis</em>, 32(1), pp.59-76.</li>\n\t<li>Reynolds, H., Fulmer, J., Kazmierowski, J., Roberts, W., Frank, M. and Crystal, R. (1977). Analysis of cellular and protein content of broncho-alveolar lavage fluid from patients with idiopathic pulmonary fibrosis and chronic hypersensitivity pneumonitis. <em>Journal of Clinical Investigation</em>, 59(1), pp.165-175.</li>\n\t<li>Shi, C. and Pamer, E. (2011). Monocyte recruitment during infection and inflammation. <em>Nature Reviews Immunology</em>, 11(11), pp.762-774.</li>\n\t<li>Shvedova, A., Kisin, E., Mercer, R., Murray, A., Johnson, V., Potapovich, A., Tyurina, Y., Gorelik, O., Arepalli, S., Schwegler-Berry, D., Hubbs, A., Antonini, J., Evans, D., Ku, B., Ramsey, D., Maynard, A., Kagan, V., Castranova, V. and Baron, P. (2005). Unusual inflammatory and fibrogenic pulmonary responses to single-walled carbon nanotubes in mice. <em>American Journal of Physiology-Lung Cellular and Molecular Physiology</em>, 289(5), pp.L698-L708.</li>\n\t<li>Smith, R., Stricter, R., Zhang, K., Phan, S., Standiford, T., Lukacs, N. and Kunkel, S. (1995). A role for C-C chemokines in fibrotic lung disease. <em>Journal of Leukocyte Biology</em>, 57(5), pp.782-787.</li>\n</ol>\n","biologicalOrganisationLevel":"Tissue","organTerm":{},"biologicalEvents":[{"object":{}}],"id":1497}
{"title":"Loss of alveolar capillary membrane integrity","references":"<ol>\n\t<li>Almeida, C., Nagarajan, D., Tian, J., Leal, S., Wheeler, K., Munley, M., Blackstock, W. and Zhao, W. (2013). The Role of Alveolar Epithelium in Radiation-Induced Lung Injury. <em>PLoS ONE</em>, 8(1), p.e53628.</li>\n\t<li>Beamer, C., Girtsman, T., Seaver, B., Finsaas, K., Migliaccio, C., Perry, V., Rottman, J., Smith, D. and Holian, A. (2012). IL-33 mediates multi-walled carbon nanotube (MWCNT)-induced airway hyper-reactivity via the mobilization of innate helper cells in the lung. <em>Nanotoxicology</em>, 7(6), pp.1070-1081.</li>\n\t<li>Brody, A., Soler, P., Basset, F., Haschek, W. and Witschi, H. (1981). Epithelial-Mesenchymal Associations of Cells in Human Pulmonary Fibrosis and in BHT-Oxygen-Induced Fibrosis in Mice. <em>Experimental Lung Research</em>, 2(3), pp.207-220.</li>\n\t<li>Cassel, S., Eisenbarth, S., Iyer, S., Sadler, J., Colegio, O., Tephly, L., Carter, A., Rothman, P., Flavell, R. and Sutterwala, F. (2008). The Nalp3 inflammasome is essential for the development of silicosis. <em>Proceedings of the National Academy of Sciences</em>, 105(26), pp.9035-9040.</li>\n\t<li>Chua, F., Gauldie, J. and Laurent, G. (2005). Pulmonary Fibrosis. <em>American Journal of Respiratory Cell and Molecular Biology</em>, 33(1), pp.9-13.</li>\n\t<li>Costabel, U., Bonella, F. and Guzman, J. (2012). Chronic Hypersensitivity Pneumonitis. <em>Clinics in Chest Medicine</em>, 33(1), pp.151-163.</li>\n\t<li>Dostert, C., Petrilli, V., Van Bruggen, R., Steele, C., Mossman, B. and Tschopp, J. (2008). Innate Immune Activation Through Nalp3 Inflammasome Sensing of Asbestos and Silica. <em>Science</em>, 320(5876), pp.674-677.</li>\n\t<li>Ernst, H., Rittinghausen, S., Bartsch, W., Creutzenberg, O., Dasenbrock, C., G&ouml;rlitz, B., Hecht, M., Kairies, U., Muhle, H., M&uuml;ller, M., Heinrich, U. and Pott, F. (2002). Pulmonary inflammation in rats after intratracheal instillation of quartz, amorphous SiO2, carbon black, and coal dust and the influence of poly-2-vinylpyridine-N-oxide (PVNO). <em>Experimental and Toxicologic Pathology</em>, 54(2), pp.109-126.</li>\n\t<li>Gabazza, E., Kasper, M., Ohta, K., Keane, M., D&#39;Alessandro-Gabazza, C., Fujimoto, H., Nishii, Y., Nakahara, H., Takagi, T., Menon, A., Adachi, Y., Suzuki, K. and Taguchi, O. (2004). Decreased expression of aquaporin-5 in bleomycin-induced lung fibrosis in the mouse. <em>Pathology International</em>, 54(10), pp.774-780.</li>\n\t<li>Ghio, A., Kadiiska, M., Xiang, Q. and Mason, R. (1998). In Vivo Evidence of Free Radical Formation After Asbestos Instillation. <em>Free Radical Biology and Medicine</em>, 24(1), pp.11-17.</li>\n\t<li>Hamilton, R., Thakur, S. and Holian, A. (2008). Silica binding and toxicity in alveolar macrophages. <em>Free Radical Biology and Medicine</em>, 44(7), pp.1246-1258.</li>\n\t<li>He, C., Murthy, S., McCormick, M., Spitz, D., Ryan, A. and Carter, A. (2011). Mitochondrial Cu,Zn-Superoxide Dismutase Mediates Pulmonary Fibrosis by Augmenting H<sub>2</sub>O<sub>2 </sub>Generation. <em>Journal of Biological Chemistry</em>, 286(17), pp.15597-15607.</li>\n\t<li>Johnson, E. and Matthay, M. (2010). Acute Lung Injury: Epidemiology, Pathogenesis, and Treatment. <em>Journal of Aerosol Medicine and Pulmonary Drug Delivery</em>, 23(4), pp.243-252.</li>\n\t<li>Kolb, M., Margetts, P., Anthony, D., Pitossi, F. and Gauldie, J. (2001). Transient expression of IL-1&beta; induces acute lung injury and chronic repair leading to pulmonary fibrosis. <em>Journal of Clinical Investigation</em>, 107(12), pp.1529-1536.</li>\n\t<li>Kulkarni, T., de Andrade, J., Zhou, Y., Luckhardt, T. and Thannickal, V. (2016). Alveolar epithelial disintegrity in pulmonary fibrosis. <em>American Journal of Physiology-Lung Cellular and Molecular Physiology</em>, 311(2), pp.L185-L191.</li>\n\t<li>Lenz, A., Costabel, U. and Maier, K. (1996). Oxidized BAL fluid proteins in patients with interstitial lung diseases. <em>European Respiratory Journal</em>, 9(2), pp.307-312.</li>\n\t<li>Miyoshi, K., Yanagi, S., Kawahara, K., Nishio, M., Tsubouchi, H., Imazu, Y., Koshida, R., Matsumoto, N., Taguchi, A., Yamashita, S., Suzuki, A. and Nakazato, M. (2013). Epithelial Pten Controls Acute Lung Injury and Fibrosis by Regulating Alveolar Epithelial Cell Integrity. <em>American Journal of Respiratory and Critical Care Medicine</em>, 187(3), pp.262-275.</li>\n\t<li>Parra, E., Kairalla, R., Ribeiro de Carvalho, C., Eher, E. and Capelozzi, V. (2006). Inflammatory Cell Phenotyping of the Pulmonary Interstitium in Idiopathic Interstitial Pneumonia. <em>Respiration</em>, 74(2), pp.159-169.</li>\n\t<li>Psathakis, K., Mermigkis, D., Papatheodorou, G., Loukides, S., Panagou, P., Polychronopoulos, V., Siafakas, N. and Bouros, D. (2006). Exhaled markers of oxidative stress in idiopathic pulmonary fibrosis. <em>European Journal of Clinical Investigation</em>, 36(5), pp.362-367.</li>\n\t<li>Quinlan, T., BeruBe, K., Hacker, M., Taatjes, D., Timblin, C., Goldberg, J., Kimberley, P., O&rsquo;Shaughnessy, P., Hemenway, D., Torino, J., Jimenez, L. and Mossman, B. (1998). Mechanisms of Asbestos-induced Nitric Oxide Production by Rat Alveolar Macrophages in Inhalation and in vitro Models. <em>Free Radical Biology and Medicine</em>, 24(5), pp.778-788.</li>\n\t<li>Schamberger, A., Mise, N., Jia, J., Genoyer, E., Yildirim, A., Meiners, S. and Eickelberg, O. (2014). Cigarette Smoke&ndash;Induced Disruption of Bronchial Epithelial Tight Junctions Is Prevented by Transforming Growth Factor-&beta;. <em>American Journal of Respiratory Cell and Molecular Biology</em>, 50(6), pp.1040-1052.</li>\n\t<li>Schmekel, B., Bos, J., Khan, A., Wohlfart, B., Lachmann, B. and Wollmer, P. (1992). Integrity of the alveolar-capillary barrier and alveolar surfactant system in smokers. <em>Thorax</em>, 47(8), pp.603-608.</li>\n\t<li>Schwartz, D., Helmers, R., Dayton, C., Merchant, R. and Hunninghake, G. (1991). Determinants of bronchoalveolar lavage cellularity in idiopathic pulmonary fibrosis. <em>Journal of Applied Physiology</em>, 71(5), pp.1688-1693.</li>\n\t<li>Schwarz, M. (2001). Acute lung injury: cellular mechanisms and derangements. <em>Paediatric Respiratory Reviews</em>, 2(1), pp.3-9.</li>\n\t<li>Shi, J., Karlsson, H., Johansson, K., Gogvadze, V., Xiao, L., Li, J., Burks, T., Garcia-Bennett, A., Uheida, A., Muhammed, M., Mathur, S., Morgenstern, R., Kagan, V. and Fadeel, B. (2012). Microsomal Glutathione Transferase 1 Protects Against Toxicity Induced by Silica Nanoparticles but Not by Zinc Oxide Nanoparticles. <em>ACS Nano</em>, 6(3), pp.1925-1938.</li>\n\t<li>Shvedova, A., Kisin, E., Mercer, R., Murray, A., Johnson, V., Potapovich, A., Tyurina, Y., Gorelik, O., Arepalli, S., Schwegler-Berry, D., Hubbs, A., Antonini, J., Evans, D., Ku, B., Ramsey, D., Maynard, A., Kagan, V., Castranova, V. and Baron, P. (2005). Unusual inflammatory and fibrogenic pulmonary responses to single-walled carbon nanotubes in mice. <em>American Journal of Physiology-Lung Cellular and Molecular Physiology</em>, 289(5), pp.L698-L708.</li>\n\t<li>Shvedova, A., Kisin, E., Murray, A., Kommineni, C., Castranova, V., Fadeel, B. and Kagan, V. (2008). Increased accumulation of neutrophils and decreased fibrosis in the lung of NADPH oxidase-deficient C57BL/6 mice exposed to carbon nanotubes. <em>Toxicology and Applied Pharmacology</em>, 231(2), pp.235-240.</li>\n\t<li>Sime, P., Marr, R., Gauldie, D., Xing, Z., Hewlett, B., Graham, F. and Gauldie, J. (1998). Transfer of Tumor Necrosis Factor-&alpha; to Rat Lung Induces Severe Pulmonary Inflammation and Patchy Interstitial Fibrogenesis with Induction of Transforming Growth Factor-&beta;1 and Myofibroblasts. <em>The American Journal of Pathology</em>, 153(3), pp.825-832.</li>\n\t<li>Thakur, S., Hamilton, R. and Holian, A. (2008). Role of Scavenger Receptor A Family in Lung Inflammation from Exposure to Environmental Particles. <em>Journal of Immunotoxicology</em>, 5(2), pp.151-157.</li>\n\t<li>Tyurina, Y., Kisin, E., Murray, A., Tyurin, V., Kapralova, V., Sparvero, L., Amoscato, A., Samhan-Arias, A., Swedin, L., Lahesmaa, R., Fadeel, B., Shvedova, A. and Kagan, V. (2011). Global Phospholipidomics Analysis Reveals Selective Pulmonary Peroxidation Profiles upon Inhalation of Single-Walled Carbon Nanotubes. <em>ACS Nano</em>, 5(9), pp.7342-7353.</li>\n\t<li>YASUOKA, S., NAKAYAMA, T., KAWANO, T., OGUSHI, F., DOI, H., HAYASHI, H. and TSUBURA, E. (1985). Comparison of cell profiles on bronchial and bronchoalveolar lavage fluids between normal subjects and patient with idiopathic pulmonary fibrosis. <em>The Tohoku Journal of Experimental Medicine</em>, 146(1), pp.33-45.</li>\n</ol>\n","biologicalOrganisationLevel":"Tissue","organTerm":{},"biologicalEvents":[{"object":{}}],"id":1498}
{"title":"Increased, activation of T (T) helper (h) type 2 cells","references":"<ol>\n\t<li>Barbarin, V., Xing, Z., Delos, M., Lison, D. and Huaux, F. (2005). Pulmonary overexpression of IL-10 augments lung fibrosis and Th2 responses induced by silica particles. <em>American Journal of Physiology-Lung Cellular and Molecular Physiology</em>, 288(5), pp.L841-L848.</li>\n\t<li>Dong, J. and Ma, Q. (2016). In vivo activation of a T helper 2-driven innate immune response in lung fibrosis induced by multi-walled carbon nanotubes. <em>Archives of Toxicology</em>, 90(9), pp.2231-2248.</li>\n\t<li>Fatkhutdinova, L., Khaliullin, T., Vasil&#39;yeva, O., Zalyalov, R., Mustafin, I., Kisin, E., Birch, M., Yanamala, N. and Shvedova, A. (2016). Fibrosis biomarkers in workers exposed to MWCNTs. <em>Toxicology and Applied Pharmacology</em>, 299, pp.125-131.</li>\n\t<li>He, C., Ryan, A., Murthy, S. and Carter, A. (2013). Accelerated Development of Pulmonary Fibrosis via Cu,Zn-superoxide Dismutase-induced Alternative Activation of Macrophages. <em>Journal of Biological Chemistry</em>, 288(28), pp.20745-20757.</li>\n\t<li>Huaux, F., Liu, T., McGarry, B., Ullenbruch, M., Xing, Z. and Phan, S. (2003). Eosinophils and T Lymphocytes Possess Distinct Roles in Bleomycin-Induced Lung Injury and Fibrosis. <em>The Journal of Immunology</em>, 171(10), pp.5470-5481.</li>\n\t<li>Lee, C., Homer, R., Zhu, Z., Lanone, S., Wang, X., Koteliansky, V., Shipley, J., Gotwals, P., Noble, P., Chen, Q., Senior, R. and Elias, J. (2001). Interleukin-13 Induces Tissue Fibrosis by Selectively Stimulating and Activating Transforming Growth Factor &beta;1. <em>The Journal of Experimental Medicine</em>, 194(6), pp.809-822.</li>\n\t<li>Li, D., Guabiraba, R., Besnard, A., Komai-Koma, M., Jabir, M., Zhang, L., Graham, G., Kurowska-Stolarska, M., Liew, F., McSharry, C. and Xu, D. (2014). IL-33 promotes ST2-dependent lung fibrosis by the induction&nbsp;of alternatively activated macrophages and innate&nbsp;lymphoid cells in mice. <em>Journal of Allergy and Clinical Immunology</em>, 134(6), pp.1422-1432.e11.</li>\n\t<li>Park, E., Roh, J., Kim, S., Kang, M., Han, Y., Kim, Y., Hong, J. and Choi, K. (2011). A single intratracheal instillation of single-walled carbon nanotubes induced early lung fibrosis and subchronic tissue damage in mice. <em>Archives of Toxicology</em>, 85(9), pp.1121-1131.</li>\n\t<li>Shaykhiev, R., Krause, A., Salit, J., Strulovici-Barel, Y., Harvey, B., O&#39;Connor, T. and Crystal, R. (2009). Smoking-Dependent Reprogramming of Alveolar Macrophage Polarization: Implication for Pathogenesis of Chronic Obstructive Pulmonary Disease. <em>The Journal of Immunology</em>, 183(4), pp.2867-2883.</li>\n\t<li>Stahl, M., Schupp, J., J&auml;ger, B., Schmid, M., Zissel, G., M&uuml;ller-Quernheim, J. and Prasse, A. (2013). Lung Collagens Perpetuate Pulmonary Fibrosis via CD204 and M2 Macrophage Activation. <em>PLoS ONE</em>, 8(11), p.e81382.</li>\n\t<li>Tao, B., Jin, W., Xu, J., Liang, Z., Yao, J., Zhang, Y., Wang, K., Cheng, H., Zhang, X. and Ke, Y. (2014). Myeloid-Specific Disruption of Tyrosine Phosphatase Shp2 Promotes Alternative Activation of Macrophages and Predisposes Mice to Pulmonary Fibrosis. <em>The Journal of Immunology</em>, 193(6), pp.2801-2811.</li>\n\t<li>Zhu, Z., Homer, R., Wang, Z., Chen, Q., Geba, G., Wang, J., Zhang, Y. and Elias, J. (1999). Pulmonary expression of interleukin-13 causes inflammation, mucus hypersecretion, subepithelial fibrosis, physiologic abnormalities, and eotaxin production. <em>Journal of Clinical Investigation</em>, 103(6), pp.779-788.</li>\n</ol>\n","biologicalOrganisationLevel":"Tissue","organTerm":{},"biologicalEvents":[{"object":{}}],"id":1499}
{"title":"Increased, fibroblast proliferation and myofibroblast differentiation","references":"<ol>\n\t<li>Abe, R., Donnelly, S., Peng, T., Bucala, R. and Metz, C. (2001). Peripheral Blood Fibrocytes: Differentiation Pathway and Migration to Wound Sites. The Journal of Immunology, 166(12), pp.7556-7562.</li>\n\t<li>Azad N, Iyer A.K.V., Lu Y., Wang L., Rojanasakul Y. (2013). P38/MAPK Regulates Single-walled Carbon Nanotube-Induced Fibroblast Proliferation and Collagen Production. Nanotoxicology, 7(2), 157&ndash;168.</li>\n\t<li>Bucala, R., Spiegel, L., Chesney, J., Hogan, M. and Cerami, A. (1994). Circulating Fibrocytes Define a New Leukocyte Subpopulation That Mediates Tissue Repair. Molecular Medicine, 1(1), pp.71-81.</li>\n\t<li>Chesney J, Metz C, Stavitsky A-B, et al. (1998) Regulated production of type I collagen and inflammatory cytokines by peripheral blood fibrocytes. J Immunol 160:419&ndash;425.</li>\n\t<li>Dong, J., Porter, D., Batteli, L., Wolfarth, M., Richardson, D. and Ma, Q. (2014). Pathologic and molecular profiling of rapid-onset fibrosis and inflammation induced by multi-walled carbon nanotubes. Archives of Toxicology, 89(4), pp.621-633.</li>\n\t<li>Hashimoto, S., Gon, Y., Takeshita, I., Maruoka, S. and Horie, T. (2001). IL-4 and IL-13 induce myofibroblastic phenotype of human lung fibroblasts through c-Jun NH2-terminal kinase&ndash;dependent pathway. Journal of Allergy and Clinical Immunology, 107(6), pp.1001-1008.</li>\n\t<li>Hussain, S., Sangtian, S., Anderson, S., Snyder, R., Marshburn, J., Rice, A., Bonner, J. and Garantziotis, S. (2014). Inflammasome activation in airway epithelial cells after multi-walled carbon nanotube exposure mediates a profibrotic response in lung fibroblasts. Particle and Fibre Toxicology, 11(1), p.28.</li>\n\t<li>Kim, K., Kugler, M., Wolters, P., Robillard, L., Galvez, M., Brumwell, A., Sheppard, D. and Chapman, H. (2006). Alveolar epithelial cell mesenchymal transition develops in vivo during pulmonary fibrosis and is regulated by the extracellular matrix. Proceedings of the National Academy of Sciences, 103(35), pp.13180-13185.</li>\n\t<li>Lemaire I, Beaudoin H, Mass&eacute; S, Grondin C. (1986). Alveolar macrophage stimulation of lung fibroblast growth in asbestos-induced pulmonary fibrosis. Am J Pathol. 122(2):205&ndash;211.</li>\n\t<li>Phillips, R., Burdick, M., Hong, K., Lutz, M., Murray, L., Xue, Y., Belperio, J., Keane, M. and Strieter, R. (2004). Circulating fibrocytes traffic to the lungs in response to CXCL12 and mediate fibrosis. Journal of Clinical Investigation, 114(3), pp.438-446.</li>\n\t<li>Serini, G. and Gabbiani, G. (1999). Mechanisms of Myofibroblast Activity and Phenotypic Modulation. Experimental Cell Research, 250(2), pp.273-283.</li>\n\t<li>Smithmyer, M., Sawicki, L. and Kloxin, A. (2014). Hydrogel scaffolds asin vitromodels to study fibroblast activation in wound healing and disease. Biomater. Sci., 2(5), pp.634-650.</li>\n\t<li>Tamminen, J., Myll&auml;rniemi, M., Hyyti&auml;inen, M., Keski-Oja, J. and Koli, K. (2012). Asbestos exposure induces alveolar epithelial cell plasticity through MAPK/Erk signaling. Journal of Cellular Biochemistry, 113(7), pp.2234-2247.</li>\n\t<li>Vietti, G., Ibouraadaten, S., Palmai-Pallag, M., Yakoub, Y., Bailly, C., Fenoglio, I., Marbaix, E., Lison, D. and van den Brule, S. (2013). Towards predicting the lung fibrogenic activity of nanomaterials: experimental validation of an in vitro fibroblast proliferation assay. Particle and Fibre Toxicology, 10(1), p.52.</li>\n\t<li>Vyalov SL, Gabbiani G, Kapanci Y. (1993). Rat alveolar myofibroblasts acquire alpha-smooth muscle actin expression during bleomycin-induced pulmonary fibrosis. Am J Pathol. 143(6):1754&ndash;1765.</li>\n\t<li>Wang, L., Mercer, R., Rojanasakul, Y., Qiu, A., Lu, Y., Scabilloni, J., Wu, N. and Castranova, V. (2010). Direct Fibrogenic Effects of Dispersed Single-Walled Carbon Nanotubes on Human Lung Fibroblasts. Journal of Toxicology and Environmental Health, Part A, 73(5-6), pp.410-422.</li>\n\t<li>Wang, X., Xia, T., Ntim, S., Ji, Z., George, S., Meng, H., Zhang, H., Castranova, V., Mitra, S. and Nel, A. (2010). Quantitative Techniques for Assessing and Controlling the Dispersion and Biological Effects of Multiwalled Carbon Nanotubes in Mammalian Tissue Culture Cells. ACS Nano, 4(12), pp.7241-7252.</li>\n\t<li>Zhang K. (1994). Myofibroblasts and Their Role in Lung Collagen Gene Expression during Pulmonary Fibrosis. American Journal of Pathology, Vol. 145, No. 1.</li>\n</ol>\n","biologicalOrganisationLevel":"Tissue","organTerm":{},"biologicalEvents":[{"object":{}}],"id":1500}
{"title":"Increased, extracellular matrix deposition","references":"<ol>\n\t<li>Bateman, E., Turner-Warwick, M. and Adelmann-Grill, B. (1981). Immunohistochemical study of collagen types in human foetal lung and fibrotic lung disease. <em>Thorax</em>, 36(9), pp.645-653.</li>\n\t<li>Bensadoun, E., Burke, A., Hogg, J. and Roberts, C. (1996). Proteoglycan deposition in pulmonary fibrosis. <em>American Journal of Respiratory and Critical Care Medicine</em>, 154(6), pp.1819-1828.</li>\n\t<li>Chen, C. and Raghunath, M. (2009). Focus on collagen: in vitro systems to study fibrogenesis and antifibrosis _ state of the art. <em>Fibrogenesis &amp; Tissue Repair</em>, 2(1).</li>\n\t<li>Crabb, R., Chau, E., Decoteau, D. and Hubel, A. (2006). Microstructural Characteristics of Extracellular Matrix Produced by Stromal Fibroblasts. <em>Annals of Biomedical Engineering</em>, 34(10), pp.1615-1627.</li>\n\t<li>HINZ, B. (2006). Masters and servants of the force: The role of matrix adhesions in myofibroblast force perception and transmission. <em>European Journal of Cell Biology</em>, 85(3-4), pp.175-181.</li>\n\t<li>Kuhn C, McDonald JA. The roles of the myofibroblast in idiopathic pulmonary fibrosis. Ultrastructural and immunohistochemical features of sites of active extracellular matrix synthesis. Am J Pathol. 1991;138(5):1257&ndash;1265.</li>\n\t<li>Klingberg, F., Hinz, B. and White, E. (2012). The myofibroblast matrix: implications for tissue repair and&nbsp;fibrosis. <em>The Journal of Pathology</em>, 229(2), pp.298-309.</li>\n\t<li>McKleroy, W., Lee, T. and Atabai, K. (2013). Always cleave up your mess: targeting collagen degradation to treat tissue fibrosis. <em>American Journal of Physiology-Lung Cellular and Molecular Physiology</em>, 304(11), pp.L709-L721.</li>\n\t<li>Nikota, J., Banville, A., Goodwin, L., Wu, D., Williams, A., Yauk, C., Wallin, H., Vogel, U. and Halappanavar, S. (2017). Stat-6 signaling pathway and not Interleukin-1 mediates multi-walled carbon nanotube-induced lung fibrosis in mice: insights from an adverse outcome pathway framework. <em>Particle and Fibre Toxicology</em>, 14(1).</li>\n\t<li>Nimni, M. (1983). Collagen: Structure, function, and metabolism in normal and fibrotic tissues. <em>Seminars in Arthritis and Rheumatism</em>, 13(1), pp.1-86.</li>\n\t<li>Rozin, G., Gomes, M., Parra, E., Kairalla, R., de Carvalho, C. and Capelozzi, V. (2005). Collagen and elastic system in the remodelling process of major types of idiopathic interstitial pneumonias (IIP). <em>Histopathology</em>, 46(4), pp.413-421.</li>\n\t<li>Sivakumar, P., Ntolios, P., Jenkins, G. and Laurent, G. (2012). Into the matrix. <em>Current Opinion in Pulmonary Medicine</em>, 18(5), pp.462-469.</li>\n\t<li>White, E. (2015). Lung Extracellular Matrix and Fibroblast Function. <em>Annals of the American Thoracic Society</em>, 12(Supplement 1), pp.S30-S33.</li>\n\t<li>Wynn, T. (2011). Integrating mechanisms of pulmonary fibrosis. <em>The Journal of Experimental Medicine</em>, 208(7), pp.1339-1350.</li>\n\t<li>Zhang K, Rekhter MD, Gordon D, Phan SH. Myofibroblasts and their role in lung collagen gene expression during pulmonary fibrosis. A combined immunohistochemical and in situ hybridization study. <em>Am J Pathol</em>. 1994;145(1):114&ndash;125.</li>\n</ol>\n","biologicalOrganisationLevel":"Tissue","organTerm":{},"biologicalEvents":[{"object":{}}],"id":1501}
{"title":"Pulmonary fibrosis","references":"<ol>\n\t<li>Gracey DR, Divertie MB and Brown Jr. AL. Alveolar-Capillary Membrane in Idiopathic Interstitial Pulmonary Fibrosis. 1968. American Review of Respiratory Disease, 98(1), pp. 16&ndash;21.</li>\n\t<li>Ashcroft, T., J.M. Simpson, and V. Timbrell. 1988. Simple method of estimating severity of pulmonary fibrosis on a numerical scale. J. Clin. Pathol. 41:467-470.</li>\n\t<li>Ralf-Harto H&uuml;bner, Wolfram Gitter, Nour Eddine El Mokhtari, Micaela Mathiak, Marcus Both,Hendrik Bolte, Sandra Freitag-Wolf, and Burkhard Bewig. 2008. BioTechniques 44:507-517.</li>\n\t<li>Nikota J, Banville A, Goodwin LR, Wu D, Williams A, Yauk CL, Wallin H, Vogel U, Halappanavar S. Stat-6 signaling pathway and not Interleukin-1 mediates multi-walled carbon nanotube-induced lung fibrosis in mice: insights from an adverse outcome pathway framework. Part Fibre Toxicol. 2017 Sep 13;14(1):37.</li>\n</ol>\n","biologicalOrganisationLevel":"Organ","organTerm":{},"biologicalEvents":[{"object":{}}],"keyEventStressors":["Bleomycin","Carbon nanotubes, Multi-walled carbon nanotubes, single-walled carbon nanotubes, carbon nanofibres"],"id":1458}
{"title":"Altered, Amphibian metamorphosis","references":"<p><br />\nBrown, D.D. and Cai, L., 2007. Amphibian metamorphosis. Developmental biology, 306(1), pp.20-33.</p>\n\n<p>Degitz, S.J., Holcombe, G.W., Flynn, K.M., Kosian, P.A., Korte, J.J. and Tietge, J.E., 2005. Progress towards development of an amphibian-based thyroid screening assay using Xenopus laevis. Organismal and thyroidal responses to the model compounds 6-propylthiouracil, methimazole, and thyroxine. Toxicological sciences, 87(2), pp.353-364.</p>\n\n<p>Gosner, K.L., 1960. A simplified table for staging anuran embryos and larvae with notes on identification.&nbsp;<em>Herpetologica</em>,&nbsp;<em>16</em>(3), pp.183-190.</p>\n\n<p>Green, J.W., Springer, T.A., Saulnier, A.N. and Swintek, J., 2014. Statistical analysis of histopathological endpoints.&nbsp;<em>Environmental toxicology and chemistry</em>,&nbsp;<em>33</em>(5), pp.1108-1116.</p>\n\n<p>Hornung, M.W., Degitz, S.J., Korte, L.M., Olson, J.M., Kosian, P.A., Linnum, A.L. and Tietge, J.E., 2010. Inhibition of thyroid hormone release from cultured amphibian thyroid glands by methimazole, 6-propylthiouracil, and perchlorate. Toxicological Sciences, 118(1), pp.42-51.</p>\n\n<p>Laudet, V., 2011. The origins and evolution of vertebrate metamorphosis. Current Biology, 21(18), pp.R726-R737.</p>\n\n<p>Nieuwkoop, P.D. and Faber, J., 1994. Normal Table of Xenopus laevis (Daudin) Garland Publishing.&nbsp;<em>New York</em>,&nbsp;<em>252</em>.</p>\n\n<p>OECD. (2009). Test No. 231: Amphibian Metamorphosis Assay, OECD Guidelines for the Testing of Chemicals, Section 2. OECD Publishing, Paris.</p>\n\n<p>OECD. (2015). Test No. 241: The Larval Amphibian Growth and Development Assay (LAGDA), OECD Guidelines for the Testing of Chemicals, Section 2. OECD Publishing, Paris.</p>\n\n<p>Tietge, J.E., Butterworth, B.C., Haselman, J.T., Holcombe, G.W., Hornung, M.W., Korte, J.J., Kosian, P.A., Wolfe, M. and Degitz, S.J., 2010. Early temporal effects of three thyroid hormone synthesis inhibitors in Xenopus laevis. Aquatic Toxicology, 98(1), pp.44-50.</p>\n\n<p>Tietge, J.E., Holcombe, G.W., Flynn, K.M., Kosian, P.A., Korte, J.J., Anderson, L.E., Wolf, D.C. and Degitz, S.J., 2005. Metamorphic inhibition of Xenopus laevis by sodium perchlorate: effects on development and thyroid histology. Environmental Toxicology and Chemistry, 24(4), pp.926-933.</p>\n\n<p>Tietge, J.E., Degitz, S.J., Haselman, J.T., Butterworth, B.C., Korte, J.J., Kosian, P.A., Lindberg-Livingston, A.J., Burgess, E.M., Blackshear, P.E. and Hornung, M.W., 2013. Inhibition of the thyroid hormone pathway in Xenopus laevis by 2-mercaptobenzothiazole. Aquatic toxicology, 126, pp.128-136.</p>\n\n<p>U.S. EPA. (2009). OCSPP 890.1100: Amphibian Metamorphosis Assay (AMA), Endocrine Disruptor Screening Program Test Guidelines, 890 Series. Available at: www.regulations.gov, ID: EPA-HQ-OPPT-2009-0576-0002. Accessed March 20, 2020.</p>\n\n<p>U.S. EPA. (2015). OCSPP 890.2300: Larval Amphibian Growth and Development Assay (LAGDA), Endocrine Disruptor Screening Program Test Guidelines, 890 Series. Available at: www.regulations.gov, ID: EPA-HQ-OPPT-2014-0766-0020. Accessed March 20, 2020.</p>\n","biologicalOrganisationLevel":"Organ","organTerm":{},"biologicalEvents":[{"action":"delayed","process":"metamorphosis","object":{}},{"action":"increased","process":"metamorphosis","object":{}}],"keyEventStressors":["Perchlorate","Mercaptobenzothiazole","Methimazole","Stressor:48 Propylthiouracil"],"id":1101}
{"title":"Altered, Amphibian metamorphosis","references":"<p><br />\nBrown, D.D. and Cai, L., 2007. Amphibian metamorphosis. Developmental biology, 306(1), pp.20-33.</p>\n\n<p>Degitz, S.J., Holcombe, G.W., Flynn, K.M., Kosian, P.A., Korte, J.J. and Tietge, J.E., 2005. Progress towards development of an amphibian-based thyroid screening assay using Xenopus laevis. Organismal and thyroidal responses to the model compounds 6-propylthiouracil, methimazole, and thyroxine. Toxicological sciences, 87(2), pp.353-364.</p>\n\n<p>Gosner, K.L., 1960. A simplified table for staging anuran embryos and larvae with notes on identification.&nbsp;<em>Herpetologica</em>,&nbsp;<em>16</em>(3), pp.183-190.</p>\n\n<p>Green, J.W., Springer, T.A., Saulnier, A.N. and Swintek, J., 2014. Statistical analysis of histopathological endpoints.&nbsp;<em>Environmental toxicology and chemistry</em>,&nbsp;<em>33</em>(5), pp.1108-1116.</p>\n\n<p>Hornung, M.W., Degitz, S.J., Korte, L.M., Olson, J.M., Kosian, P.A., Linnum, A.L. and Tietge, J.E., 2010. Inhibition of thyroid hormone release from cultured amphibian thyroid glands by methimazole, 6-propylthiouracil, and perchlorate. Toxicological Sciences, 118(1), pp.42-51.</p>\n\n<p>Laudet, V., 2011. The origins and evolution of vertebrate metamorphosis. Current Biology, 21(18), pp.R726-R737.</p>\n\n<p>Nieuwkoop, P.D. and Faber, J., 1994. Normal Table of Xenopus laevis (Daudin) Garland Publishing.&nbsp;<em>New York</em>,&nbsp;<em>252</em>.</p>\n\n<p>OECD. (2009). Test No. 231: Amphibian Metamorphosis Assay, OECD Guidelines for the Testing of Chemicals, Section 2. OECD Publishing, Paris.</p>\n\n<p>OECD. (2015). Test No. 241: The Larval Amphibian Growth and Development Assay (LAGDA), OECD Guidelines for the Testing of Chemicals, Section 2. OECD Publishing, Paris.</p>\n\n<p>Tietge, J.E., Butterworth, B.C., Haselman, J.T., Holcombe, G.W., Hornung, M.W., Korte, J.J., Kosian, P.A., Wolfe, M. and Degitz, S.J., 2010. Early temporal effects of three thyroid hormone synthesis inhibitors in Xenopus laevis. Aquatic Toxicology, 98(1), pp.44-50.</p>\n\n<p>Tietge, J.E., Holcombe, G.W., Flynn, K.M., Kosian, P.A., Korte, J.J., Anderson, L.E., Wolf, D.C. and Degitz, S.J., 2005. Metamorphic inhibition of Xenopus laevis by sodium perchlorate: effects on development and thyroid histology. Environmental Toxicology and Chemistry, 24(4), pp.926-933.</p>\n\n<p>Tietge, J.E., Degitz, S.J., Haselman, J.T., Butterworth, B.C., Korte, J.J., Kosian, P.A., Lindberg-Livingston, A.J., Burgess, E.M., Blackshear, P.E. and Hornung, M.W., 2013. Inhibition of the thyroid hormone pathway in Xenopus laevis by 2-mercaptobenzothiazole. Aquatic toxicology, 126, pp.128-136.</p>\n\n<p>U.S. EPA. (2009). OCSPP 890.1100: Amphibian Metamorphosis Assay (AMA), Endocrine Disruptor Screening Program Test Guidelines, 890 Series. Available at: www.regulations.gov, ID: EPA-HQ-OPPT-2009-0576-0002. Accessed March 20, 2020.</p>\n\n<p>U.S. EPA. (2015). OCSPP 890.2300: Larval Amphibian Growth and Development Assay (LAGDA), Endocrine Disruptor Screening Program Test Guidelines, 890 Series. Available at: www.regulations.gov, ID: EPA-HQ-OPPT-2014-0766-0020. Accessed March 20, 2020.</p>\n","biologicalOrganisationLevel":"Organ","organTerm":{},"biologicalEvents":[{"action":"delayed","process":"metamorphosis","object":{}},{"action":"increased","process":"metamorphosis","object":{}}],"keyEventStressors":["Perchlorate","Mercaptobenzothiazole","Methimazole","Stressor:48 Propylthiouracil"],"id":1101}
{"title":"Decreased, Prostaglandin F2alpha concentration, plasma ","references":"","biologicalOrganisationLevel":"Tissue","organTerm":{"name":"blood plasma","sourceId":"UBERON:0001969"},"biologicalEvents":[{"action":"decreased","object":{"name":"prostaglandin F2alpha","source":"CHEBI","sourceId":"CHEBI:15553"}}],"id":1104}
{"title":"Occurrence, renal ischemia","references":"","biologicalOrganisationLevel":"Tissue","organTerm":{},"biologicalEvents":[{"action":"occurrence","process":"ischemia","object":{"name":"kidney","source":"UBERON","sourceId":"UBERON:0002113"}}],"id":1105}
{"title":"Inhibition, Cyclooxygenase 1 activity","references":"","biologicalOrganisationLevel":"Molecular","organTerm":{},"biologicalEvents":[{"action":"decreased","process":"prostaglandin-endoperoxide synthase activity","object":{"name":"prostaglandin G/H synthase 1","source":"PR","sourceId":"PR:000013427"}}],"id":1103}
{"title":"Increased, Deformed Wing Virus levels","references":"","biologicalOrganisationLevel":"Individual","organTerm":{},"biologicalEvents":[{"action":"increased","object":{"name":"Viral load","source":"MESH","sourceId":"D019562"}}],"id":1109}
{"title":"Increased, Energetic demands and therefore metabolic stress","references":"","biologicalOrganisationLevel":"Individual","organTerm":{},"biologicalEvents":[{"action":"increased","process":"increased energy expenditure","object":{}},{"action":"increased","process":"Stress, Physiological","object":{}}],"id":1110}
{"title":"Increased, Energetic demands and therefore metabolic stress","references":"","biologicalOrganisationLevel":"Individual","organTerm":{},"biologicalEvents":[{"action":"increased","process":"increased energy expenditure","object":{}},{"action":"increased","process":"Stress, Physiological","object":{}}],"id":1110}
{"title":"Unknown, MIE","references":"","biologicalOrganisationLevel":"Molecular","organTerm":{},"biologicalEvents":[{"object":{}}],"id":1114}
{"title":"Increased, Reactive oxygen species","references":"","biologicalOrganisationLevel":"Cellular","organTerm":{},"biologicalEvents":[{"action":"increased","object":{"name":"reactive oxygen species","source":"CHEBI","sourceId":"CHEBI:26523"}}],"id":1115}
{"title":"Under carboxylated clotting factors will not assemble on cell surfaces to form clot, Failure of secondary hemostasis  ","references":"","biologicalOrganisationLevel":"Tissue","organTerm":{},"biologicalEvents":[{"action":"abnormal","process":"hemostasis","object":{}}],"id":1122}
{"title":"Failure in vascular repair mechanisms, Unresolved blood loss (hemorrhage)","references":"","biologicalOrganisationLevel":"Organ","organTerm":{"name":"vascular system","sourceId":"UBERON:0007798"},"biologicalEvents":[{"action":"increased","process":"hemorrhage","object":{}},{"action":"abnormal","process":"wound healing","object":{}}],"id":1130}
{"title":"Failure in vascular repair mechanisms, Unresolved blood loss (hemorrhage)","references":"","biologicalOrganisationLevel":"Organ","organTerm":{"name":"vascular system","sourceId":"UBERON:0007798"},"biologicalEvents":[{"action":"increased","process":"hemorrhage","object":{}},{"action":"abnormal","process":"wound healing","object":{}}],"id":1130}
{"title":"Failure in gamma-glutamyl carboxylation of  clotting factors II, VII, IX and X, Under carboxylation of clotting factors (e.g., des-gamma-carboxy prothrombin) ","references":"","biologicalOrganisationLevel":"Molecular","organTerm":{},"biologicalEvents":[{"action":"decreased","process":"carboxylation reaction","object":{"name":"prothrombin","source":"PR","sourceId":"PR:000007299"}},{"action":"decreased","process":"carboxylation reaction","object":{"name":"coagulation factor VII (mouse)","source":"PR","sourceId":"PR:P70375"}},{"action":"decreased","process":"carboxylation reaction","object":{"name":"coagulation factor IX (mouse)","source":"PR","sourceId":"PR:P16294"}},{"action":"decreased","process":"carboxylation reaction","object":{"name":"coagulation factor X (mouse)","source":"PR","sourceId":"PR:O88947"}}],"id":1131}
{"title":"Failure in gamma-glutamyl carboxylation of  clotting factors II, VII, IX and X, Under carboxylation of clotting factors (e.g., des-gamma-carboxy prothrombin) ","references":"","biologicalOrganisationLevel":"Molecular","organTerm":{},"biologicalEvents":[{"action":"decreased","process":"carboxylation reaction","object":{"name":"prothrombin","source":"PR","sourceId":"PR:000007299"}},{"action":"decreased","process":"carboxylation reaction","object":{"name":"coagulation factor VII (mouse)","source":"PR","sourceId":"PR:P70375"}},{"action":"decreased","process":"carboxylation reaction","object":{"name":"coagulation factor IX (mouse)","source":"PR","sourceId":"PR:P16294"}},{"action":"decreased","process":"carboxylation reaction","object":{"name":"coagulation factor X (mouse)","source":"PR","sourceId":"PR:O88947"}}],"id":1131}
{"title":"Failure in gamma-glutamyl carboxylation of  clotting factors II, VII, IX and X, Under carboxylation of clotting factors (e.g., des-gamma-carboxy prothrombin) ","references":"","biologicalOrganisationLevel":"Molecular","organTerm":{},"biologicalEvents":[{"action":"decreased","process":"carboxylation reaction","object":{"name":"prothrombin","source":"PR","sourceId":"PR:000007299"}},{"action":"decreased","process":"carboxylation reaction","object":{"name":"coagulation factor VII (mouse)","source":"PR","sourceId":"PR:P70375"}},{"action":"decreased","process":"carboxylation reaction","object":{"name":"coagulation factor IX (mouse)","source":"PR","sourceId":"PR:P16294"}},{"action":"decreased","process":"carboxylation reaction","object":{"name":"coagulation factor X (mouse)","source":"PR","sourceId":"PR:O88947"}}],"id":1131}
{"title":"Failure in gamma-glutamyl carboxylation of  clotting factors II, VII, IX and X, Under carboxylation of clotting factors (e.g., des-gamma-carboxy prothrombin) ","references":"","biologicalOrganisationLevel":"Molecular","organTerm":{},"biologicalEvents":[{"action":"decreased","process":"carboxylation reaction","object":{"name":"prothrombin","source":"PR","sourceId":"PR:000007299"}},{"action":"decreased","process":"carboxylation reaction","object":{"name":"coagulation factor VII (mouse)","source":"PR","sourceId":"PR:P70375"}},{"action":"decreased","process":"carboxylation reaction","object":{"name":"coagulation factor IX (mouse)","source":"PR","sourceId":"PR:P16294"}},{"action":"decreased","process":"carboxylation reaction","object":{"name":"coagulation factor X (mouse)","source":"PR","sourceId":"PR:O88947"}}],"id":1131}
{"title":"Blood loss and development of anemia, Impaired oxygen delivery and nutrient delivery to tissue, impaired carbon dioxide and waste product removal","references":"","biologicalOrganisationLevel":"Cellular","organTerm":{},"biologicalEvents":[{"action":"decreased","process":"transport","object":{"name":"nutrient","source":"CHEBI","sourceId":"CHEBI:33284"}},{"action":"abnormal","process":"cellular detoxification","object":{}},{"action":"occurrence","process":"anemia","object":{}}],"id":1132}
{"title":"Blood loss and development of anemia, Impaired oxygen delivery and nutrient delivery to tissue, impaired carbon dioxide and waste product removal","references":"","biologicalOrganisationLevel":"Cellular","organTerm":{},"biologicalEvents":[{"action":"decreased","process":"transport","object":{"name":"nutrient","source":"CHEBI","sourceId":"CHEBI:33284"}},{"action":"abnormal","process":"cellular detoxification","object":{}},{"action":"occurrence","process":"anemia","object":{}}],"id":1132}
{"title":"Blood loss and development of anemia, Impaired oxygen delivery and nutrient delivery to tissue, impaired carbon dioxide and waste product removal","references":"","biologicalOrganisationLevel":"Cellular","organTerm":{},"biologicalEvents":[{"action":"decreased","process":"transport","object":{"name":"nutrient","source":"CHEBI","sourceId":"CHEBI:33284"}},{"action":"abnormal","process":"cellular detoxification","object":{}},{"action":"occurrence","process":"anemia","object":{}}],"id":1132}
{"title":"Hemostasis, Depletion from blood of fully functional carboxylated clotting factors","references":"","biologicalOrganisationLevel":"Tissue","organTerm":{},"biologicalEvents":[{"action":"decreased","object":{"name":"blood coagulation factors","source":"MESH","sourceId":"D001779"}},{"action":"decreased","process":"hemostasis","object":{}}],"id":1133}
{"title":"Hemostasis, Depletion from blood of fully functional carboxylated clotting factors","references":"","biologicalOrganisationLevel":"Tissue","organTerm":{},"biologicalEvents":[{"action":"decreased","object":{"name":"blood coagulation factors","source":"MESH","sourceId":"D001779"}},{"action":"decreased","process":"hemostasis","object":{}}],"id":1133}
{"title":"Irreversible inhibition of hepatic VKOR by binding of AR at tyrosine 139, Failure to cycle vitamin K epoxide to vitamin K to form vitamin K hydroquinone","references":"","biologicalOrganisationLevel":"Molecular","organTerm":{},"biologicalEvents":[{"action":"abnormal","process":"vitamin K metabolic process","object":{"name":"vitamin K","source":"CHEBI","sourceId":"CHEBI:28384"}},{"action":"decreased","process":"signaling","object":{"name":"androgen receptor","source":"PR","sourceId":"PR:000004191"}},{"action":"decreased","process":"catalytic activity","object":{"name":"Vitamin K Epoxide Reductases","source":"MESH","sourceId":"D064417"}}],"id":1134}
{"title":"Irreversible inhibition of hepatic VKOR by binding of AR at tyrosine 139, Failure to cycle vitamin K epoxide to vitamin K to form vitamin K hydroquinone","references":"","biologicalOrganisationLevel":"Molecular","organTerm":{},"biologicalEvents":[{"action":"abnormal","process":"vitamin K metabolic process","object":{"name":"vitamin K","source":"CHEBI","sourceId":"CHEBI:28384"}},{"action":"decreased","process":"signaling","object":{"name":"androgen receptor","source":"PR","sourceId":"PR:000004191"}},{"action":"decreased","process":"catalytic activity","object":{"name":"Vitamin K Epoxide Reductases","source":"MESH","sourceId":"D064417"}}],"id":1134}
{"title":"Irreversible inhibition of hepatic VKOR by binding of AR at tyrosine 139, Failure to cycle vitamin K epoxide to vitamin K to form vitamin K hydroquinone","references":"","biologicalOrganisationLevel":"Molecular","organTerm":{},"biologicalEvents":[{"action":"abnormal","process":"vitamin K metabolic process","object":{"name":"vitamin K","source":"CHEBI","sourceId":"CHEBI:28384"}},{"action":"decreased","process":"signaling","object":{"name":"androgen receptor","source":"PR","sourceId":"PR:000004191"}},{"action":"decreased","process":"catalytic activity","object":{"name":"Vitamin K Epoxide Reductases","source":"MESH","sourceId":"D064417"}}],"id":1134}
{"title":"Reduced fitness or even mortality, Acidosis, hypovolemic shock and organ dysfunction","references":"","biologicalOrganisationLevel":"Tissue","organTerm":{},"biologicalEvents":[{"action":"increased","process":"acidosis","object":{}},{"action":"increased","process":"hypovolemia","object":{}},{"action":"functional change","object":{"name":"organ","source":"UBERON","sourceId":"UBERON:0000062"}},{"action":"decreased","process":"wellness/fitness trait","object":{}},{"action":"increased","process":"mortality","object":{}}],"id":1135}
{"title":"Reduced fitness or even mortality, Acidosis, hypovolemic shock and organ dysfunction","references":"","biologicalOrganisationLevel":"Tissue","organTerm":{},"biologicalEvents":[{"action":"increased","process":"acidosis","object":{}},{"action":"increased","process":"hypovolemia","object":{}},{"action":"functional change","object":{"name":"organ","source":"UBERON","sourceId":"UBERON:0000062"}},{"action":"decreased","process":"wellness/fitness trait","object":{}},{"action":"increased","process":"mortality","object":{}}],"id":1135}
{"title":"Reduced fitness or even mortality, Acidosis, hypovolemic shock and organ dysfunction","references":"","biologicalOrganisationLevel":"Tissue","organTerm":{},"biologicalEvents":[{"action":"increased","process":"acidosis","object":{}},{"action":"increased","process":"hypovolemia","object":{}},{"action":"functional change","object":{"name":"organ","source":"UBERON","sourceId":"UBERON:0000062"}},{"action":"decreased","process":"wellness/fitness trait","object":{}},{"action":"increased","process":"mortality","object":{}}],"id":1135}
{"title":"Reduced fitness or even mortality, Acidosis, hypovolemic shock and organ dysfunction","references":"","biologicalOrganisationLevel":"Tissue","organTerm":{},"biologicalEvents":[{"action":"increased","process":"acidosis","object":{}},{"action":"increased","process":"hypovolemia","object":{}},{"action":"functional change","object":{"name":"organ","source":"UBERON","sourceId":"UBERON:0000062"}},{"action":"decreased","process":"wellness/fitness trait","object":{}},{"action":"increased","process":"mortality","object":{}}],"id":1135}
{"title":"Reduced fitness or even mortality, Acidosis, hypovolemic shock and organ dysfunction","references":"","biologicalOrganisationLevel":"Tissue","organTerm":{},"biologicalEvents":[{"action":"increased","process":"acidosis","object":{}},{"action":"increased","process":"hypovolemia","object":{}},{"action":"functional change","object":{"name":"organ","source":"UBERON","sourceId":"UBERON:0000062"}},{"action":"decreased","process":"wellness/fitness trait","object":{}},{"action":"increased","process":"mortality","object":{}}],"id":1135}
{"title":"Impaired recruitment , Population trajectory","references":"","biologicalOrganisationLevel":"Population","organTerm":{},"biologicalEvents":[{"action":"decreased","process":"population growth rate","object":{}}],"id":1136}
{"title":"Uncoupling of oxidative phosphorylation, Reduced ability to generate ATP","references":"","biologicalOrganisationLevel":"Molecular","organTerm":{},"biologicalEvents":[{"action":"decreased","process":"ATP biosynthetic process","object":{"name":"ATP","source":"CHEBI","sourceId":"CHEBI:15422"}},{"action":"increased","process":"oxidative phosphorylation uncoupler activity","object":{}}],"id":1138}
{"title":"Uncoupling of oxidative phosphorylation, Reduced ability to generate ATP","references":"","biologicalOrganisationLevel":"Molecular","organTerm":{},"biologicalEvents":[{"action":"decreased","process":"ATP biosynthetic process","object":{"name":"ATP","source":"CHEBI","sourceId":"CHEBI:15422"}},{"action":"increased","process":"oxidative phosphorylation uncoupler activity","object":{}}],"id":1138}
{"title":"Osteoporosis and vascular calcification, Bone deterioration","references":"","biologicalOrganisationLevel":"Individual","organTerm":{},"biologicalEvents":[{"action":"increased","process":"osteoporosis","object":{}},{"action":"increased","process":"vascular calcification","object":{"name":"vasculature","source":"UBERON","sourceId":"UBERON:0002049"}}],"id":1151}
{"title":"Osteoporosis and vascular calcification, Bone deterioration","references":"","biologicalOrganisationLevel":"Individual","organTerm":{},"biologicalEvents":[{"action":"increased","process":"osteoporosis","object":{}},{"action":"increased","process":"vascular calcification","object":{"name":"vasculature","source":"UBERON","sourceId":"UBERON:0002049"}}],"id":1151}
{"title":"Anticoagulant rodenticide interferes with carboxylation of Gla proteins in bone, Impairment of post-translational modification (carboxylation) of osteocalcin","references":"","biologicalOrganisationLevel":"Molecular","organTerm":{},"biologicalEvents":[{"action":"abnormal","process":"post-translational protein modification","object":{"name":"osteocalcin","source":"PR","sourceId":"PR:000030444"}},{"action":"decreased","process":"carboxylation reaction","object":{"name":"matrix Gla protein (mouse)","source":"PR","sourceId":"PR:P19788"}}],"id":1169}
{"title":"Anticoagulant rodenticide interferes with carboxylation of Gla proteins in bone, Impairment of post-translational modification (carboxylation) of osteocalcin","references":"","biologicalOrganisationLevel":"Molecular","organTerm":{},"biologicalEvents":[{"action":"abnormal","process":"post-translational protein modification","object":{"name":"osteocalcin","source":"PR","sourceId":"PR:000030444"}},{"action":"decreased","process":"carboxylation reaction","object":{"name":"matrix Gla protein (mouse)","source":"PR","sourceId":"PR:P19788"}}],"id":1169}
{"title":"Inhibition, Iodotyrosine deiodinase (IYD)","references":"","biologicalOrganisationLevel":"Molecular","organTerm":{},"biologicalEvents":[{"action":"decreased","process":"catalytic activity","object":{"name":"iodotyrosine deiodinase 1 (human)","source":"PR","sourceId":"PR:Q6PHW0"}}],"id":1152}
{"title":"Decreased, Triiodothyronine (T3) in tissues","references":"<p><br />\nAckermans, M.T., KettelarijHaas, Y., Boelen, A. and Endert, E., 2012. Determination of thyroid hormones and their metabolites in tissue using SPE UPLCtandem MS. Biomedical Chromatography, 26(4), pp.485-490.</p>\n\n<p>Bastian, T.W., Prohaska, J.R., Georgieff, M.K. and Anderson, G.W., 2010. Perinatal iron and copper deficiencies alter neonatal rat circulating and brain thyroid hormone concentrations. Endocrinology, 151(8), pp.4055-4065.</p>\n\n<p>Bastian, T.W., Anderson, J.A., Fretham, S.J., Prohaska, J.R., Georgieff, M.K. and Anderson, G.W., 2012. Fetal and neonatal iron deficiency reduces thyroid hormone-responsive gene mRNA levels in the neonatal rat hippocampus and cerebral cortex. Endocrinology, 153(11), pp.5668-5680.</p>\n\n<p>Bastian, T.W., Prohaska, J.R., Georgieff, M.K. and Anderson, G.W., 2013. Fetal and neonatal iron deficiency exacerbates mild thyroid hormone insufficiency effects on male thyroid hormone levels and brain thyroid hormone-responsive gene expression. Endocrinology, 155(3), pp.1157-1167.</p>\n\n<p>Crane, H.M., Pickford, D.B., Hutchinson, T.H. and Brown, J.A., 2004. Developmental changes of thyroid hormones in the fathead minnow, Pimephales promelas. General and comparative endocrinology, 139(1), pp.55-60.</p>\n\n<p>Donzelli, R., Colligiani, D., Kusmic, C., Sabatini, M., Lorenzini, L., Accorroni, A., Nannipieri, M., Saba, A., Iervasi, G. and Zucchi, R., 2016. Effect of Hypothyroidism and Hyperthyroidism on Tissue Thyroid Hormone Concentrations in Rat. European thyroid journal, 5(1), pp.27-34.</p>\n\n<p>ESCOBAR, G.M.D., Pastor, R., Obreg&oacute;n, M.J. and REY, F.E.D., 1985. Effects of Maternal Hypothyroidism on the Weight and Thyroid Hormone Content of Rat Embryonic Tissues, before and after Onset of Fetal Thyroid Function*. Endocrinology, 117(5), pp.1890-1900.</p>\n\n<p>Gilbert, M.E., Hedge, J.M., Valent&iacute;n-Blasini, L., Blount, B.C., Kannan, K., Tietge, J., Zoeller, R.T., Crofton, K.M., Jarrett, J.M. and Fisher, J.W., 2013. An animal model of marginal iodine deficiency during development: the thyroid axis and neurodevelopmental outcome. toxicological sciences, p.kfs335.</p>\n\n<p>Hornung, M.W., Kosian, P.A., Haselman, J.T., Korte, J.J., Challis, K., Macherla, C., Nevalainen, E. and Degitz, S.J., 2015. In vitro, ex vivo, and in vivo determination of thyroid hormone modulating activity of benzothiazoles. Toxicological Sciences, 146(2), pp.254-264.</p>\n\n<p>Kunisue, T., Fisher, J.W., Fatuyi, B. and Kannan, K., 2010. A method for the analysis of six thyroid hormones in thyroid gland by liquid chromatography&ndash;tandem mass spectrometry. Journal of Chromatography B, 878(21), pp.1725-1730.</p>\n\n<p>Kunisue, T., Fisher, J.W. and Kannan, K., 2011. Determination of six thyroid hormones in the brain and thyroid gland using isotope-dilution liquid chromatography/tandem mass spectrometry. Analytical chemistry, 83(1), pp.417-424.</p>\n\n<p>Lavado-Autric, R., Calvo, R.M., de Mena, R.M., de Escobar, G.M. and Obregon, M.J., 2012. Deiodinase activities in thyroids and tissues of iodine-deficient female rats. Endocrinology, 154(1), pp.529-536.</p>\n\n<p>Pinna, G., Hiedra, L., Prengel, H., Broedel, O., Eravci, M., Meinhold, H. and Baumgartner, A., 1999. Extraction and quantification of thyroid hormones in selected regions and subcellular fractions of the rat brain. Brain Research Protocols, 4(1), pp.19-28.</p>\n\n<p>Simon, R., Tietge, J., Michalke, B., Degitz, S. and Schramm, K.W., 2002. Iodine species and the endocrine system: thyroid hormone levels in adult Danio rerio and developing Xenopus laevis. Analytical and bioanalytical chemistry, 372(3), pp.481-485.</p>\n\n<p>Saba, A., Donzelli, R., Colligiani, D., Raffaelli, A., Nannipieri, M., Kusmic, C., Dos Remedios, C.G., Simonides, W.S., Iervasi, G. and Zucchi, R., 2014. Quantification of thyroxine and 3, 5, 3&prime;-triiodo-thyronine in human and animal hearts by a novel liquid chromatography-tandem mass spectrometry method. Hormone and Metabolic Research, 46(09), pp.628-634.</p>\n\n<p>Tietge, J.E., Butterworth, B.C., Haselman, J.T., Holcombe, G.W., Hornung, M.W., Korte, J.J., Kosian, P.A., Wolfe, M. and Degitz, S.J., 2010. Early temporal effects of three thyroid hormone synthesis inhibitors in Xenopus laevis. Aquatic Toxicology, 98(1), pp.44-50.</p>\n\n<p>Tietge, J.E., Degitz, S.J., Haselman, J.T., Butterworth, B.C., Korte, J.J., Kosian, P.A., Lindberg-Livingston, A.J., Burgess, E.M., Blackshear, P.E. and Hornung, M.W., 2013. Inhibition of the thyroid hormone pathway in Xenopus laevis by 2-mercaptobenzothiazole. Aquatic toxicology, 126, pp.128-136.</p>\n","biologicalOrganisationLevel":"Tissue","organTerm":{},"biologicalEvents":[{"action":"increased","object":{"name":"3,3',5-triiodo-L-thyronine","source":"CHEBI","sourceId":"CHEBI:18258"}},{"action":"decreased","object":{"name":"3,3',5-triiodo-L-thyronine","source":"CHEBI","sourceId":"CHEBI:18258"}}],"keyEventStressors":["Perchlorate","Mercaptobenzothiazole","Methimazole","Propylthiouracil"],"id":1116}
{"title":"Decreased, Triiodothyronine (T3) in tissues","references":"<p><br />\nAckermans, M.T., KettelarijHaas, Y., Boelen, A. and Endert, E., 2012. Determination of thyroid hormones and their metabolites in tissue using SPE UPLCtandem MS. Biomedical Chromatography, 26(4), pp.485-490.</p>\n\n<p>Bastian, T.W., Prohaska, J.R., Georgieff, M.K. and Anderson, G.W., 2010. Perinatal iron and copper deficiencies alter neonatal rat circulating and brain thyroid hormone concentrations. Endocrinology, 151(8), pp.4055-4065.</p>\n\n<p>Bastian, T.W., Anderson, J.A., Fretham, S.J., Prohaska, J.R., Georgieff, M.K. and Anderson, G.W., 2012. Fetal and neonatal iron deficiency reduces thyroid hormone-responsive gene mRNA levels in the neonatal rat hippocampus and cerebral cortex. Endocrinology, 153(11), pp.5668-5680.</p>\n\n<p>Bastian, T.W., Prohaska, J.R., Georgieff, M.K. and Anderson, G.W., 2013. Fetal and neonatal iron deficiency exacerbates mild thyroid hormone insufficiency effects on male thyroid hormone levels and brain thyroid hormone-responsive gene expression. Endocrinology, 155(3), pp.1157-1167.</p>\n\n<p>Crane, H.M., Pickford, D.B., Hutchinson, T.H. and Brown, J.A., 2004. Developmental changes of thyroid hormones in the fathead minnow, Pimephales promelas. General and comparative endocrinology, 139(1), pp.55-60.</p>\n\n<p>Donzelli, R., Colligiani, D., Kusmic, C., Sabatini, M., Lorenzini, L., Accorroni, A., Nannipieri, M., Saba, A., Iervasi, G. and Zucchi, R., 2016. Effect of Hypothyroidism and Hyperthyroidism on Tissue Thyroid Hormone Concentrations in Rat. European thyroid journal, 5(1), pp.27-34.</p>\n\n<p>ESCOBAR, G.M.D., Pastor, R., Obreg&oacute;n, M.J. and REY, F.E.D., 1985. Effects of Maternal Hypothyroidism on the Weight and Thyroid Hormone Content of Rat Embryonic Tissues, before and after Onset of Fetal Thyroid Function*. Endocrinology, 117(5), pp.1890-1900.</p>\n\n<p>Gilbert, M.E., Hedge, J.M., Valent&iacute;n-Blasini, L., Blount, B.C., Kannan, K., Tietge, J., Zoeller, R.T., Crofton, K.M., Jarrett, J.M. and Fisher, J.W., 2013. An animal model of marginal iodine deficiency during development: the thyroid axis and neurodevelopmental outcome. toxicological sciences, p.kfs335.</p>\n\n<p>Hornung, M.W., Kosian, P.A., Haselman, J.T., Korte, J.J., Challis, K., Macherla, C., Nevalainen, E. and Degitz, S.J., 2015. In vitro, ex vivo, and in vivo determination of thyroid hormone modulating activity of benzothiazoles. Toxicological Sciences, 146(2), pp.254-264.</p>\n\n<p>Kunisue, T., Fisher, J.W., Fatuyi, B. and Kannan, K., 2010. A method for the analysis of six thyroid hormones in thyroid gland by liquid chromatography&ndash;tandem mass spectrometry. Journal of Chromatography B, 878(21), pp.1725-1730.</p>\n\n<p>Kunisue, T., Fisher, J.W. and Kannan, K., 2011. Determination of six thyroid hormones in the brain and thyroid gland using isotope-dilution liquid chromatography/tandem mass spectrometry. Analytical chemistry, 83(1), pp.417-424.</p>\n\n<p>Lavado-Autric, R., Calvo, R.M., de Mena, R.M., de Escobar, G.M. and Obregon, M.J., 2012. Deiodinase activities in thyroids and tissues of iodine-deficient female rats. Endocrinology, 154(1), pp.529-536.</p>\n\n<p>Pinna, G., Hiedra, L., Prengel, H., Broedel, O., Eravci, M., Meinhold, H. and Baumgartner, A., 1999. Extraction and quantification of thyroid hormones in selected regions and subcellular fractions of the rat brain. Brain Research Protocols, 4(1), pp.19-28.</p>\n\n<p>Simon, R., Tietge, J., Michalke, B., Degitz, S. and Schramm, K.W., 2002. Iodine species and the endocrine system: thyroid hormone levels in adult Danio rerio and developing Xenopus laevis. Analytical and bioanalytical chemistry, 372(3), pp.481-485.</p>\n\n<p>Saba, A., Donzelli, R., Colligiani, D., Raffaelli, A., Nannipieri, M., Kusmic, C., Dos Remedios, C.G., Simonides, W.S., Iervasi, G. and Zucchi, R., 2014. Quantification of thyroxine and 3, 5, 3&prime;-triiodo-thyronine in human and animal hearts by a novel liquid chromatography-tandem mass spectrometry method. Hormone and Metabolic Research, 46(09), pp.628-634.</p>\n\n<p>Tietge, J.E., Butterworth, B.C., Haselman, J.T., Holcombe, G.W., Hornung, M.W., Korte, J.J., Kosian, P.A., Wolfe, M. and Degitz, S.J., 2010. Early temporal effects of three thyroid hormone synthesis inhibitors in Xenopus laevis. Aquatic Toxicology, 98(1), pp.44-50.</p>\n\n<p>Tietge, J.E., Degitz, S.J., Haselman, J.T., Butterworth, B.C., Korte, J.J., Kosian, P.A., Lindberg-Livingston, A.J., Burgess, E.M., Blackshear, P.E. and Hornung, M.W., 2013. Inhibition of the thyroid hormone pathway in Xenopus laevis by 2-mercaptobenzothiazole. Aquatic toxicology, 126, pp.128-136.</p>\n","biologicalOrganisationLevel":"Tissue","organTerm":{},"biologicalEvents":[{"action":"increased","object":{"name":"3,3',5-triiodo-L-thyronine","source":"CHEBI","sourceId":"CHEBI:18258"}},{"action":"decreased","object":{"name":"3,3',5-triiodo-L-thyronine","source":"CHEBI","sourceId":"CHEBI:18258"}}],"keyEventStressors":["Perchlorate","Mercaptobenzothiazole","Methimazole","Propylthiouracil"],"id":1116}
{"title":"Increased, Thyroxine (T4) in serum","references":"","biologicalOrganisationLevel":"Organ","organTerm":{},"biologicalEvents":[{"object":{}}],"id":1828}
{"title":"Altered, Thyroid hormone-dependent gene expression","references":"","biologicalOrganisationLevel":"Molecular","organTerm":{},"biologicalEvents":[{"object":{}}],"id":1829}
{"title":"Inhibition, Deiodinase 3","references":"","biologicalOrganisationLevel":"Molecular","organTerm":{},"biologicalEvents":[{"action":"decreased","process":"catalytic activity","object":{"name":"type III iodothyronine deiodinase","source":"PR","sourceId":"PR:000006482"}}],"id":1153}
{"title":"Increased, Triiodothyronine (T3) in tissues","references":"","biologicalOrganisationLevel":"Tissue","organTerm":{},"biologicalEvents":[{"action":"decreased","object":{"name":"3,3',5-triiodo-L-thyronine","source":"CHEBI","sourceId":"CHEBI:18258"}}],"id":1154}
{"title":"Inhibition, Pendrin","references":"","biologicalOrganisationLevel":"Molecular","organTerm":{},"biologicalEvents":[{"action":"decreased","process":"signaling","object":{"name":"pendrin","source":"PR","sourceId":"PR:000015039"}}],"id":1155}
{"title":"Inhibition, Dual oxidase","references":"","biologicalOrganisationLevel":"Molecular","organTerm":{},"biologicalEvents":[{"action":"decreased","process":"catalytic activity","object":{"name":"dual oxidase 1","source":"PR","sourceId":"PR:000006727"}}],"id":1156}
{"title":"Activation, Hepatic nuclear receptor(s)","references":"","biologicalOrganisationLevel":"Molecular","organTerm":{},"biologicalEvents":[{"action":"increased","process":"signaling","object":{"name":"protein","source":"PR","sourceId":"PR:000000001"}}],"id":1157}
{"title":"Increased, Hepatic thyroid hormone uptake/transport","references":"","biologicalOrganisationLevel":"Tissue","organTerm":{},"biologicalEvents":[{"action":"increased","process":"transport","object":{"name":"thyroid hormone","source":"CHEBI","sourceId":"CHEBI:60311"}}],"id":1158}
{"title":"Increased, oocyte maturation","references":"<p>Fong 1994, Hirai 1988, alvarado-alvarez 1996, Osanai 1988</p>\n","biologicalOrganisationLevel":"Organ","organTerm":{},"biologicalEvents":[{"action":"increased","process":"cell maturation","object":{"name":"gamete","source":"CL","sourceId":"CL:0000300"}}],"id":1161}
{"title":"Increased, Population","references":"","biologicalOrganisationLevel":"Population","organTerm":{},"biologicalEvents":[{"action":"increased","object":{"name":"population of organisms","source":"PCO","sourceId":"PCO:0000001"}}],"id":1164}
{"title":"induced spawning","references":"","biologicalOrganisationLevel":"Individual","organTerm":{},"biologicalEvents":[{"action":"premature","object":{"name":"spawning","source":"MESH","sourceId":"C82476"}}],"id":1255}
{"title":"Increased, Reproductive Success","references":"","biologicalOrganisationLevel":"Individual","organTerm":{},"biologicalEvents":[{"action":"increased","process":"reproductive process","object":{}}],"id":1163}
{"title":"Increase, cilia movement","references":"<p>Bardales, J. R., J. L. Cascallana and A. Villamar&iacute;n (2011). &quot;Differential distribution of cAMP-dependent protein kinase isoforms in various tissues of the bivalve mollusc Mytilus galloprovincialis.&quot; Acta Histochemica 113(7): 743-748.</p>\n\n<p>Schmid, A., G. Bai, N. Schmid, M. Zaccolo, L. E. Ostrowski, G. E. Conner, N. Fregien and M. Salathe (2006). &quot;Real-time analysis of cAMP-mediated regulation of ciliary motility in single primary human airway epithelial cells.&quot; Journal of Cell Science 119(20): 4176-4186.</p>\n","biologicalOrganisationLevel":"Tissue","organTerm":{},"biologicalEvents":[{"object":{}}],"id":621}
{"title":"TRPA1 activation, TRPA1 Receptor","references":"","biologicalOrganisationLevel":"Molecular","organTerm":{},"biologicalEvents":[{"action":"increased","process":"signaling","object":{"name":"transient receptor potential cation channel TRPV1","source":"PR","sourceId":"PR:000001065"}}],"id":1215}
{"title":"Opening of calcium channel, Calcium influx","references":"","biologicalOrganisationLevel":"Cellular","organTerm":{},"biologicalEvents":[{"action":"increased","process":"calcium ion transport","object":{"name":"calcium ion","source":"CHEBI","sourceId":"CHEBI:39124"}}],"id":1218}
{"title":"Trigeminal nerve activation","references":"","biologicalOrganisationLevel":"Tissue","organTerm":{"name":"respiratory tract","sourceId":"UBERON:0000065"},"biologicalEvents":[{"action":"decreased","process":"rhythmic excitation","object":{"name":"vagus nerve","source":"UBERON","sourceId":"UBERON:0001759"}}],"id":1220}
{"title":"SP (Substance P) release, Local increase of SP","references":"","biologicalOrganisationLevel":"Cellular","organTerm":{},"biologicalEvents":[{"action":"increased","process":"neuropeptide hormone activity","object":{"name":"Substance P","source":"CHEBI","sourceId":"CHEBI:80308"}}],"id":1222}
{"title":"Trigeminal and/or vagal nerve excitation causes Airway Hyper-responsiveness,Cough, Dyspnea","references":"","biologicalOrganisationLevel":"Tissue","organTerm":{"name":"respiratory tract","sourceId":"UBERON:0000065"},"biologicalEvents":[{"action":"increased","process":"reflex","object":{"name":"trigeminal nerve","source":"UBERON","sourceId":"UBERON:0001645"}},{"action":"increased","object":{"name":"cough","source":"MESH","sourceId":"D003371"}},{"action":"increased","object":{"name":"Respiratory Hypersensitivity","source":"MESH","sourceId":"D012130"}},{"action":"increased","object":{"name":"Dyspnea","source":"MESH","sourceId":"D004417"}}],"id":1223}
{"title":"Trigeminal and/or vagal nerve excitation causes Airway Hyper-responsiveness,Cough, Dyspnea","references":"","biologicalOrganisationLevel":"Tissue","organTerm":{"name":"respiratory tract","sourceId":"UBERON:0000065"},"biologicalEvents":[{"action":"increased","process":"reflex","object":{"name":"trigeminal nerve","source":"UBERON","sourceId":"UBERON:0001645"}},{"action":"increased","object":{"name":"cough","source":"MESH","sourceId":"D003371"}},{"action":"increased","object":{"name":"Respiratory Hypersensitivity","source":"MESH","sourceId":"D012130"}},{"action":"increased","object":{"name":"Dyspnea","source":"MESH","sourceId":"D004417"}}],"id":1223}
{"title":"Trigeminal and/or vagal nerve excitation causes Airway Hyper-responsiveness,Cough, Dyspnea","references":"","biologicalOrganisationLevel":"Tissue","organTerm":{"name":"respiratory tract","sourceId":"UBERON:0000065"},"biologicalEvents":[{"action":"increased","process":"reflex","object":{"name":"trigeminal nerve","source":"UBERON","sourceId":"UBERON:0001645"}},{"action":"increased","object":{"name":"cough","source":"MESH","sourceId":"D003371"}},{"action":"increased","object":{"name":"Respiratory Hypersensitivity","source":"MESH","sourceId":"D012130"}},{"action":"increased","object":{"name":"Dyspnea","source":"MESH","sourceId":"D004417"}}],"id":1223}
{"title":"Trigeminal and/or vagal nerve excitation causes Airway Hyper-responsiveness,Cough, Dyspnea","references":"","biologicalOrganisationLevel":"Tissue","organTerm":{"name":"respiratory tract","sourceId":"UBERON:0000065"},"biologicalEvents":[{"action":"increased","process":"reflex","object":{"name":"trigeminal nerve","source":"UBERON","sourceId":"UBERON:0001645"}},{"action":"increased","object":{"name":"cough","source":"MESH","sourceId":"D003371"}},{"action":"increased","object":{"name":"Respiratory Hypersensitivity","source":"MESH","sourceId":"D012130"}},{"action":"increased","object":{"name":"Dyspnea","source":"MESH","sourceId":"D004417"}}],"id":1223}
{"title":"Increased Respiratory irritability and Chronic Cough, ","references":"","biologicalOrganisationLevel":"Organ","organTerm":{},"biologicalEvents":[{"action":"increased","process":"inflammatory response","object":{"name":"respiratory system","source":"UBERON","sourceId":"UBERON:0001004"}},{"action":"increased","object":{"name":"cough","source":"MESH","sourceId":"D003371"}}],"id":1226}
{"title":"Increased Respiratory irritability and Chronic Cough, ","references":"","biologicalOrganisationLevel":"Organ","organTerm":{},"biologicalEvents":[{"action":"increased","process":"inflammatory response","object":{"name":"respiratory system","source":"UBERON","sourceId":"UBERON:0001004"}},{"action":"increased","object":{"name":"cough","source":"MESH","sourceId":"D003371"}}],"id":1226}
{"title":"Increased CGRP, neuronal release of CGRP","references":"","biologicalOrganisationLevel":"Cellular","organTerm":{"name":"respiratory tract","sourceId":"UBERON:0000065"},"biologicalEvents":[{"action":"increased","process":"neuropeptide hormone activity","object":{"name":"Calcitonin gene-related peptide 1","source":"CHEBI","sourceId":"CHEBI:80337"}}],"id":1433}
{"title":"Irritation of nasal mucosa inducing sneeze reflex","references":"","biologicalOrganisationLevel":"Tissue","organTerm":{"name":"nasal cavity respiratory epithelium","sourceId":"UBERON:0005385"},"biologicalEvents":[{"action":"increased","process":"reflex","object":{"name":"sneezing","source":"MESH","sourceId":"D012912"}}],"id":1434}
{"title":"Increased neurokinin A (NKA) by neuronal cells","references":"","biologicalOrganisationLevel":"Cellular","organTerm":{"name":"respiratory tract","sourceId":"UBERON:0000065"},"biologicalEvents":[{"action":"increased","process":"neuropeptide hormone activity","object":{"name":"Neurokinin A","source":"CHEBI","sourceId":"CHEBI:80311"}}],"id":1435}
{"title":"Decreased, sodium conductance 2","references":"","biologicalOrganisationLevel":"Cellular","organTerm":{},"biologicalEvents":[{"action":"decreased","process":"transport","object":{"name":"sodium(1+)","source":"CHEBI","sourceId":"CHEBI:29101"}}],"id":1176}
{"title":"Decreased, GABA release","references":"","biologicalOrganisationLevel":"Cellular","organTerm":{},"biologicalEvents":[{"action":"decreased","process":"transport","object":{"name":"gamma-aminobutyric acid","source":"CHEBI","sourceId":"CHEBI:16865"}}],"id":1179}
{"title":"Activation, Estrogen receptor","references":"","biologicalOrganisationLevel":"Molecular","organTerm":{},"biologicalEvents":[{"action":"increased","process":"signaling","object":{"name":"estrogen receptor","source":"PR","sourceId":"PR:000007204"}}],"id":1181}
{"title":"Increase, Cell Proliferation (Epithelial Cells)","references":"<p><a name=\"_ENREF_1\">Croce, C. M. (2008). &quot;Oncogenes and cancer.&quot; The New England journal of medicine 358(5): 502-511.</a></p>\n\n<p><a name=\"_ENREF_2\">Fernald, K. and M. Kurokawa (2013). &quot;Evading apoptosis in cancer.&quot; Trends in cell biology 23(12): 620-633.</a></p>\n\n<p><a name=\"_ENREF_3\">Fogarty, C. E. and A. Bergmann (2017). &quot;Killers creating new life: caspases drive apoptosis-induced proliferation in tissue repair and disease.&quot; Cell death and differentiation 24(8): 1390-1400.</a></p>\n\n<p><a name=\"_ENREF_4\">Francis, S. M., J. Bergsied, et al. (2009). &quot;A functional connection between pRB and transforming growth factor beta in growth inhibition and mammary gland development.&quot; Molecular and cellular biology 29(16): 4455-4466.</a></p>\n\n<p><a name=\"_ENREF_5\">Francis, S. M., S. Chakrabarti, et al. (2011). &quot;A context-specific role for retinoblastoma protein-dependent negative growth control in suppressing mammary tumorigenesis.&quot; PLoS One 6(2): e16434.</a></p>\n\n<p><a name=\"_ENREF_6\">Franco, O. E., D. R. Tyson, et al. (2016). &quot;Altered TGF-alpha/beta signaling drives cooperation between breast cancer cell populations.&quot; FASEB journal : official publication of the Federation of American Societies for Experimental Biology 30(10): 3441-3452.</a></p>\n\n<p><a name=\"_ENREF_7\">Garbe, J. C., S. Bhattacharya, et al. (2009). &quot;Molecular distinctions between stasis and telomere attrition senescence barriers shown by long-term culture of normal human mammary epithelial cells.&quot; Cancer research 69(19): 7557-7568.</a></p>\n\n<p><a name=\"_ENREF_8\">Gustin, J. P., B. Karakas, et al. (2009). &quot;Knockin of mutant PIK3CA activates multiple oncogenic pathways.&quot; Proceedings of the National Academy of Sciences of the United States of America 106(8): 2835-2840.</a></p>\n\n<p><a name=\"_ENREF_9\">Hanahan, D. and R. A. Weinberg (2011). &quot;Hallmarks of cancer: the next generation.&quot; Cell 144(5): 646-674.</a></p>\n\n<p><a name=\"_ENREF_10\">Kiraly, O., G. Gong, et al. (2015). &quot;Inflammation-induced cell proliferation potentiates DNA damage-induced mutations in vivo.&quot; PLoS Genet 11(2): e1004901.</a></p>\n\n<p><a name=\"_ENREF_11\">Marusyk, A., D. P. Tabassum, et al. (2014). &quot;Non-cell-autonomous driving of tumour growth supports sub-clonal heterogeneity.&quot; Nature 514(7520): 54-58.</a></p>\n\n<p><a name=\"_ENREF_12\">Polyak, K., J. Y. Kato, et al. (1994). &quot;p27Kip1, a cyclin-Cdk inhibitor, links transforming growth factor-beta and contact inhibition to cell cycle arrest.&quot; Genes &amp; development 8(1): 9-22.</a></p>\n\n<p><a name=\"_ENREF_13\">Romar, G. A., T. S. Kupper, et al. (2016). &quot;Research Techniques Made Simple: Techniques to Assess Cell Proliferation.&quot; The Journal of investigative dermatology 136(1): e1-7.</a></p>\n\n<p><a name=\"_ENREF_14\">Shay, J. W. and W. E. Wright (2011). &quot;Role of telomeres and telomerase in cancer.&quot; Seminars in cancer biology 21(6): 349-353.</a></p>\n\n<p><a name=\"_ENREF_15\">Weber, R. J., T. A. Desai, et al. (2017). &quot;Non-autonomous cell proliferation in the mammary gland and cancer.&quot; Current opinion in cell biology 45: 55-61.</a></p>\n","biologicalOrganisationLevel":"Cellular","organTerm":{},"biologicalEvents":[{"action":"increased","process":"cell proliferation","object":{}}],"keyEventStressors":["Ionizing Radiation"],"id":1182}
{"title":"Decreased, Apoptosis (Epithelial Cells)","references":"","biologicalOrganisationLevel":"Cellular","organTerm":{},"biologicalEvents":[{"action":"decreased","process":"apoptotic process","object":{}}],"id":1183}
{"title":"Increased, ER binding to DNA (classical pathway) ","references":"","biologicalOrganisationLevel":"Molecular","organTerm":{},"biologicalEvents":[{"action":"increased","process":"estrogen receptor binding","object":{"name":"deoxyribonucleic acid","source":"CHEBI","sourceId":"CHEBI:16991"}}],"id":1187}
{"title":"Increased, ER binding to T.F. to DNA (non-classical pathway)","references":"","biologicalOrganisationLevel":"Molecular","organTerm":{},"biologicalEvents":[{"action":"increased","process":"estrogen receptor binding","object":{"name":"serotransferrin","source":"PR","sourceId":"PR:000016261"}}],"id":1188}
{"title":"Increased, Proliferation (Endothelial cells) ","references":"","biologicalOrganisationLevel":"Cellular","organTerm":{},"biologicalEvents":[{"action":"increased","process":"endothelial cell proliferation","object":{}}],"id":1189}
{"title":"Increased, Migration (Endothelial Cells)","references":"","biologicalOrganisationLevel":"Cellular","organTerm":{},"biologicalEvents":[{"action":"increased","process":"endothelial cell migration","object":{}}],"id":1190}
{"title":"Increased, Non-genomic signaling","references":"","biologicalOrganisationLevel":"Cellular","organTerm":{},"biologicalEvents":[{"action":"increased","process":"signaling","object":{}}],"id":1191}
{"title":"Increased, Ductal Hyperplasia ","references":"","biologicalOrganisationLevel":"Tissue","organTerm":{"name":"mammary duct","sourceId":"UBERON:0001765"},"biologicalEvents":[{"action":"increased","process":"hyperplasia","object":{}}],"id":1192}
{"title":"N/A, Breast Cancer","references":"<p><a name=\"_ENREF_1\">(IOM) Institute of Medicine (2012). Breast Cancer and the Environment: A Life Course Approach. Washington, DC, The National Academies Press.</a></p>\n\n<p><a name=\"_ENREF_2\">Badowska-Kozakiewicz, A. M., J. Patera, et al. (2015). &quot;The role of oestrogen and progesterone receptors in breast cancer - immunohistochemical evaluation of oestrogen and progesterone receptor expression in invasive breast cancer in women.&quot; Contemp Oncol (Pozn) 19(3): 220-225.</a></p>\n\n<p><a name=\"_ENREF_3\">Begg, C. B., I. Ostrovnaya, et al. (2016). &quot;Clonal relationships between lobular carcinoma in situ and other breast malignancies.&quot; Breast cancer research : BCR 18(1): 66.</a></p>\n\n<p><a name=\"_ENREF_4\">CGAN (Cancer Genome Atlas Network) (2012). &quot;Comprehensive molecular portraits of human breast tumours.&quot; Nature 490(7418): 61-70.</a></p>\n\n<p><a name=\"_ENREF_5\">Chhabra, R. S., J. E. Huff, et al. (1990). &quot;An overview of prechronic and chronic toxicity/carcinogenicity experimental study designs and criteria used by the National Toxicology Program.&quot; Environmental health perspectives 86: 313-321.</a></p>\n\n<p><a name=\"_ENREF_6\">Cohn, B. A., M. La Merrill, et al. (2015). &quot;DDT Exposure in Utero and Breast Cancer.&quot; J Clin Endocrinol Metab 100(8): 2865-2872.</a></p>\n\n<p><a name=\"_ENREF_7\">Croce, C. M. (2008). &quot;Oncogenes and cancer.&quot; The New England journal of medicine 358(5): 502-511.</a></p>\n\n<p><a name=\"_ENREF_8\">EPA (Environmental Protection Agency) (2005). Guidelines for carcinogen risk assessment. Washington, DC, U.S. Environmental Protection Agency, Risk Assessment Forum: 1-166.</a></p>\n\n<p><a name=\"_ENREF_9\">FDA (Food and Drug Administration) (2007). Redbook 2000: Guidance for industry and other stakeholders. Toxicological principles for the safety assessment of food ingredients. Silver Spring, MD, U.S. Department of Health and Human Services, Food and Drug Administration.</a></p>\n\n<p><a name=\"_ENREF_10\">Floor, S. L., J. E. Dumont, et al. (2012). &quot;Hallmarks of cancer: of all cancer cells, all the time?&quot; Trends Mol Med 18(9): 509-515.</a></p>\n\n<p><a name=\"_ENREF_11\">Glass, A. G., J. V. Lacey, Jr., et al. (2007). &quot;Breast cancer incidence, 1980-2006: combined roles of menopausal hormone therapy, screening mammography, and estrogen receptor status.&quot; Journal of the National Cancer Institute 99(15): 1152-1161.</a></p>\n\n<p><a name=\"_ENREF_12\">Goodson, W. H., 3rd, L. Lowe, et al. (2015). &quot;Assessing the carcinogenic potential of low-dose exposures to chemical mixtures in the environment: the challenge ahead.&quot; Carcinogenesis 36 Suppl 1: S254-296.</a></p>\n\n<p><a name=\"_ENREF_13\">Grashow, R. G., V. Y. De La Rosa, et al. (2018). &quot;BCScreen: A gene panel to test for breast carcinogenesis in chemical safety screening.&quot; Computational Toxicology 5: 16-24.</a></p>\n\n<p><a name=\"_ENREF_14\">Greenman, C., P. Stephens, et al. (2007). &quot;Patterns of somatic mutation in human cancer genomes.&quot; Nature 446(7132): 153-158.</a></p>\n\n<p><a name=\"_ENREF_15\">Gustin, J. P., B. Karakas, et al. (2009). &quot;Knockin of mutant PIK3CA activates multiple oncogenic pathways.&quot; Proceedings of the National Academy of Sciences of the United States of America 106(8): 2835-2840.</a></p>\n\n<p><a name=\"_ENREF_16\">Hanahan, D. and R. A. Weinberg (2011). &quot;Hallmarks of cancer: the next generation.&quot; Cell 144(5): 646-674.</a></p>\n\n<p><a name=\"_ENREF_17\">Haseman, J. K., E. Young, et al. (1997). &quot;Body weight-tumor incidence correlations in long-term rodent carcinogenicity studies.&quot; Toxicologic pathology 25(3): 256-263.</a></p>\n\n<p><a name=\"_ENREF_18\">Imaoka, T., M. Nishimura, et al. (2013). &quot;Influence of age on the relative biological effectiveness of carbon ion radiation for induction of rat mammary carcinoma.&quot; International journal of radiation oncology, biology, physics 85(4): 1134-1140.</a></p>\n\n<p><a name=\"_ENREF_19\">Kaufmann, W. K., K. R. Nevis, et al. (2008). &quot;Defective cell cycle checkpoint functions in melanoma are associated with altered patterns of gene expression.&quot; J Invest Dermatol 128(1): 175-187.</a></p>\n\n<p><a name=\"_ENREF_20\">Kouros-Mehr, H., E. M. Slorach, et al. (2006). &quot;GATA-3 maintains the differentiation of the luminal cell fate in the mammary gland.&quot; Cell 127(5): 1041-1055.</a></p>\n\n<p><a name=\"_ENREF_21\">McDonald, E. S., A. S. Clark, et al. (2016). &quot;Clinical Diagnosis and Management of Breast Cancer.&quot; J Nucl Med 57 Suppl 1: 9S-16S.</a></p>\n\n<p><a name=\"_ENREF_22\">Narod, S. A. (2011). &quot;Hormone replacement therapy and the risk of breast cancer.&quot; Nature reviews. Clinical oncology 8(11): 669-676.</a></p>\n\n<p><a name=\"_ENREF_23\">OECD (2009). Test No. 451: Carcinogenicity Studies.</a></p>\n\n<p><a name=\"_ENREF_24\">OECD (2009). Test No. 453: Combined Chronic Toxicity/Carcinogenicity Studies.</a></p>\n\n<p><a name=\"_ENREF_25\">OECD (Organisation for Economic Cooperation and Development) (2018). OECD guidelines for the testing of chemicals Section 4. Paris, OECD.</a></p>\n\n<p><a name=\"_ENREF_26\">Palmer, J. R., L. A. Wise, et al. (2006). &quot;Prenatal diethylstilbestrol exposure and risk of breast cancer.&quot; Cancer epidemiology, biomarkers &amp; prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 15(8): 1509-1514.</a></p>\n\n<p><a name=\"_ENREF_27\">Roth, J. A., R. Etzioni, et al. (2014). &quot;Economic return from the Women&#39;s Health Initiative estrogen plus progestin clinical trial: a modeling study.&quot; Ann Intern Med 160(9): 594-602.</a></p>\n\n<p><a name=\"_ENREF_28\">Rudel, R. A., K. R. Attfield, et al. (2007). &quot;Chemicals causing mammary gland tumors in animals signal new directions for epidemiology, chemicals testing, and risk assessment for breast cancer prevention.&quot; Cancer 109(12 Suppl): 2635-2666.</a></p>\n\n<p><a name=\"_ENREF_29\">Rudel, R. A., S. E. Fenton, et al. (2011). &quot;Environmental exposures and mammary gland development: state of the science, public health implications, and research recommendations.&quot; Environmental health perspectives 119(8): 1053-1061.</a></p>\n\n<p><a name=\"_ENREF_30\">Russo, J. (2015). &quot;Significance of rat mammary tumors for human risk assessment.&quot; Toxicologic pathology 43(2): 145-170.</a></p>\n\n<p><a name=\"_ENREF_31\">Russo, J. and I. H. Russo (2000). &quot;Atlas and histologic classification of tumors of the rat mammary gland.&quot; J Mammary Gland Biol Neoplasia 5(2): 187-200.</a></p>\n\n<p><a name=\"_ENREF_32\">Schwarzman, M. R., J. M. Ackerman, et al. (2015). &quot;Screening for Chemical Contributions to Breast Cancer Risk: A Case Study for Chemical Safety Evaluation.&quot; Environmental health perspectives 123(12): 1255-1264.</a></p>\n\n<p><a name=\"_ENREF_33\">Shahi, P., C. Y. Wang, et al. (2017). &quot;GATA3 targets semaphorin 3B in mammary epithelial cells to suppress breast cancer progression and metastasis.&quot; Oncogene 36(40): 5567-5575.</a></p>\n\n<p><a name=\"_ENREF_34\">Smith, M. T., K. Z. Guyton, et al. (2016). &quot;Key Characteristics of Carcinogens as a Basis for Organizing Data on Mechanisms of Carcinogenesis.&quot; Environmental health perspectives 124(6): 713-721.</a></p>\n\n<p><a name=\"_ENREF_35\">Sonnenschein, C. and A. M. Soto (1999). The society of cells : cancer control of cell proliferation. Oxford New York, Bios Scientific Publishers ;Springer.</a></p>\n\n<p><a name=\"_ENREF_36\">Stratton, M. R., P. J. Campbell, et al. (2009). &quot;The cancer genome.&quot; Nature 458(7239): 719-724.</a></p>\n\n<p><a name=\"_ENREF_37\">Tucker, D. K., J. F. Foley, et al. (2017). &quot;Sectioning Mammary Gland Whole Mounts for Lesion Identification.&quot; Journal of visualized experiments : JoVE(125).</a></p>\n\n<p><a name=\"_ENREF_38\">Vandin, F., E. Upfal, et al. (2012). &quot;De novo discovery of mutated driver pathways in cancer.&quot; Genome research 22(2): 375-385.</a></p>\n\n<p><a name=\"_ENREF_39\">Wang, Y., J. Waters, et al. (2014). &quot;Clonal evolution in breast cancer revealed by single nucleus genome sequencing.&quot; Nature 512(7513): 155-160.</a></p>\n\n<p><a name=\"_ENREF_40\">Yates, L. R., M. Gerstung, et al. (2015). &quot;Subclonal diversification of primary breast cancer revealed by multiregion sequencing.&quot; Nat Med 21(7): 751-759.</a></p>\n","biologicalOrganisationLevel":"Individual","organTerm":{},"biologicalEvents":[{"action":"pathological","object":{"name":"Breast Neoplasms","source":"MESH","sourceId":"D001943"}}],"id":1193}
{"title":"Increase, DNA damage","references":"<p><a name=\"_ENREF_1\">Barnard, S., S. Bouffler, et al. (2013). &quot;The shape of the radiation dose response for DNA double-strand break induction and repair.&quot; Genome integrity 4(1): 1.</a></p>\n\n<p><a name=\"_ENREF_2\">Behjati, S., G. Gundem, et al. (2016). &quot;Mutational signatures of ionizing radiation in second malignancies.&quot; Nat Commun 7: 12605.</a></p>\n\n<p><a name=\"_ENREF_3\">Chaudhry, M. A. and M. Weinfeld (1997). &quot;Reactivity of human apurinic/apyrimidinic endonuclease and Escherichia coli exonuclease III with bistranded abasic sites in DNA.&quot; The Journal of biological chemistry 272(25): 15650-15655.</a></p>\n\n<p><a name=\"_ENREF_4\">Collins, A. R. (2004). &quot;The comet assay for DNA damage and repair: principles, applications, and limitations.&quot; Molecular biotechnology 26(3): 249-261.</a></p>\n\n<p><a name=\"_ENREF_5\">David, S. S., V. L. O&#39;Shea, et al. (2007). &quot;Base-excision repair of oxidative DNA damage.&quot; Nature 447(7147): 941-950.</a></p>\n\n<p><a name=\"_ENREF_6\">Dayal, D., S. M. Martin, et al. (2008). &quot;Hydrogen peroxide mediates the radiation-induced mutator phenotype in mammalian cells.&quot; Biochem J 413(1): 185-191.</a></p>\n\n<p><a name=\"_ENREF_7\">Ge, J., S. Prasongtanakij, et al. (2014). &quot;CometChip: a high-throughput 96-well platform for measuring DNA damage in microarrayed human cells.&quot; Journal of visualized experiments : JoVE(92): e50607.</a></p>\n\n<p><a name=\"_ENREF_8\">Gradzka, I. and T. Iwanenko (2005). &quot;A non-radioactive, PFGE-based assay for low levels of DNA double-strand breaks in mammalian cells.&quot; DNA repair 4(10): 1129-1139.</a></p>\n\n<p><a name=\"_ENREF_9\">Haag, J. D., L. C. Hsu, et al. (1996). &quot;Allelic imbalance in mammary carcinomas induced by either 7,12-dimethylbenz[a]anthracene or ionizing radiation in rats carrying genes conferring differential susceptibilities to mammary carcinogenesis.&quot; Mol Carcinog 17(3): 134-143.</a></p>\n\n<p><a name=\"_ENREF_10\">Kawashima, Y., N. Yamaguchi, et al. (2017). &quot;Detection of DNA double-strand breaks by pulsed-field gel electrophoresis.&quot; Genes to cells : devoted to molecular &amp; cellular mechanisms 22(1): 84-93.</a></p>\n\n<p><a name=\"_ENREF_11\">Kuhne, M., K. Rothkamm, et al. (2000). &quot;No dose-dependence of DNA double-strand break misrejoining following alpha-particle irradiation.&quot; International journal of radiation biology 76(7): 891-900.</a></p>\n\n<p><a name=\"_ENREF_12\">Kutanzi, K. and O. Kovalchuk (2013). &quot;Exposure to estrogen and ionizing radiation causes epigenetic dysregulation, activation of mitogen-activated protein kinase pathways, and genome instability in the mammary gland of ACI rats.&quot; Cancer Biol Ther 14(7): 564-573.</a></p>\n\n<p><a name=\"_ENREF_13\">Kuzminov, A. (2001). &quot;Single-strand interruptions in replicating chromosomes cause double-strand breaks.&quot; Proceedings of the National Academy of Sciences of the United States of America 98(15): 8241-8246.</a></p>\n\n<p><a name=\"_ENREF_14\">Liu, X., Y. He, et al. (2015). &quot;Caspase-3 promotes genetic instability and carcinogenesis.&quot; Mol Cell 58(2): 284-296.</a></p>\n\n<p><a name=\"_ENREF_15\">Lobrich, M., B. Rydberg, et al. (1995). &quot;Repair of x-ray-induced DNA double-strand breaks in specific Not I restriction fragments in human fibroblasts: joining of correct and incorrect ends.&quot; Proceedings of the National Academy of Sciences of the United States of America 92(26): 12050-12054.</a></p>\n\n<p><a name=\"_ENREF_16\">Lorat, Y., C. U. Brunner, et al. (2015). &quot;Nanoscale analysis of clustered DNA damage after high-LET irradiation by quantitative electron microscopy--the heavy burden to repair.&quot; DNA repair 28: 93-106.</a></p>\n\n<p><a name=\"_ENREF_17\">Lorat, Y., S. Timm, et al. (2016). &quot;Clustered double-strand breaks in heterochromatin perturb DNA repair after high linear energy transfer irradiation.&quot; Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 121(1): 154-161.</a></p>\n\n<p><a name=\"_ENREF_18\">Madugundu, G. S., J. Cadet, et al. (2014). &quot;Hydroxyl-radical-induced oxidation of 5-methylcytosine in isolated and cellular DNA.&quot; Nucleic acids research 42(11): 7450-7460.</a></p>\n\n<p><a name=\"_ENREF_19\">Morishita, M., T. Muramatsu, et al. (2016). &quot;Chromothripsis-like chromosomal rearrangements induced by ionizing radiation using proton microbeam irradiation system.&quot; Oncotarget 7(9): 10182-10192.</a></p>\n\n<p><a name=\"_ENREF_20\">Murnane, J. P. (2012). &quot;Telomere dysfunction and chromosome instability.&quot; Mutation research 730(1-2): 28-36.</a></p>\n\n<p><a name=\"_ENREF_21\">Nikitaki, Z., V. Nikolov, et al. (2016). &quot;Measurement of complex DNA damage induction and repair in human cellular systems after exposure to ionizing radiations of varying linear energy transfer (LET).&quot; Free radical research 50(sup1): S64-S78.</a></p>\n\n<p><a name=\"_ENREF_22\">OECD (1997). Test No. 486: Unscheduled DNA Synthesis (UDS) Test with Mammalian Liver Cells in vivo.</a></p>\n\n<p><a name=\"_ENREF_23\">OECD (2016). Test No. 473: In Vitro Mammalian Chromosomal Aberration Test.</a></p>\n\n<p><a name=\"_ENREF_24\">OECD (2016). Test No. 475: Mammalian Bone Marrow Chromosomal Aberration Test.</a></p>\n\n<p><a name=\"_ENREF_25\">OECD (2016). Test No. 483: Mammalian Spermatogonial Chromosomal Aberration Test.</a></p>\n\n<p><a name=\"_ENREF_26\">OECD (2016). Test No. 487: In Vitro Mammalian Cell Micronucleus Test.</a></p>\n\n<p><a name=\"_ENREF_27\">OECD (2016). Test No. 489: In Vivo Mammalian Alkaline Comet Assay.</a></p>\n\n<p><a name=\"_ENREF_28\">OECD (Organisation for Economic Co-operation and Development) (2016). Overview of the set of OECD Genetic Toxicology Test Guidelines and updates performed in 2014&ndash;2015. No. 238.</a></p>\n\n<p><a name=\"_ENREF_29\">Ogawa, Y., T. Kobayashi, et al. (2003). &quot;Radiation-induced oxidative DNA damage, 8-oxoguanine, in human peripheral T cells.&quot; International journal of molecular medicine 11(1): 27-32.</a></p>\n\n<p><a name=\"_ENREF_30\">Ojima, M., N. Ban, et al. (2008). &quot;DNA double-strand breaks induced by very low X-ray doses are largely due to bystander effects.&quot; Radiation research 170(3): 365-371.</a></p>\n\n<p><a name=\"_ENREF_31\">Pernot, E., J. Hall, et al. (2012). &quot;Ionizing radiation biomarkers for potential use in epidemiological studies.&quot; Mutation research 751(2): 258-286.</a></p>\n\n<p><a name=\"_ENREF_32\">Pinto, M., K. M. Prise, et al. (2005). &quot;Evidence for complexity at the nanometer scale of radiation-induced DNA DSBs as a determinant of rejoining kinetics.&quot; Radiation research 164(1): 73-85.</a></p>\n\n<p><a name=\"_ENREF_33\">Ponnaiya, B., M. N. Cornforth, et al. (1997). &quot;Induction of chromosomal instability in human mammary cells by neutrons and gamma rays.&quot; Radiation research 147(3): 288-294.</a></p>\n\n<p><a name=\"_ENREF_34\">Ponnaiya, B., M. N. Cornforth, et al. (1997). &quot;Radiation-induced chromosomal instability in BALB/c and C57BL/6 mice: the difference is as clear as black and white.&quot; Radiation research 147(2): 121-125.</a></p>\n\n<p><a name=\"_ENREF_35\">Ravanat, J. L., J. Breton, et al. (2014). &quot;Radiation-mediated formation of complex damage to DNA: a chemical aspect overview.&quot; Br J Radiol 87(1035): 20130715.</a></p>\n\n<p><a name=\"_ENREF_36\">Regulus, P., B. Duroux, et al. (2007). &quot;Oxidation of the sugar moiety of DNA by ionizing radiation or bleomycin could induce the formation of a cluster DNA lesion.&quot; Proceedings of the National Academy of Sciences of the United States of America 104(35): 14032-14037.</a></p>\n\n<p><a name=\"_ENREF_37\">Rothkamm, K. and M. Lobrich (2003). &quot;Evidence for a lack of DNA double-strand break repair in human cells exposed to very low x-ray doses.&quot; Proceedings of the National Academy of Sciences of the United States of America 100(9): 5057-5062.</a></p>\n\n<p><a name=\"_ENREF_38\">Rydberg, B., B. Cooper, et al. (2005). &quot;Dose-dependent misrejoining of radiation-induced DNA double-strand breaks in human fibroblasts: experimental and theoretical study for high- and low-LET radiation.&quot; Radiation research 163(5): 526-534.</a></p>\n\n<p><a name=\"_ENREF_39\">Sharma, V., L. B. Collins, et al. (2016). &quot;Oxidative stress at low levels can induce clustered DNA lesions leading to NHEJ mediated mutations.&quot; Oncotarget 7(18): 25377-25390.</a></p>\n\n<p><a name=\"_ENREF_40\">Shiraishi, I., N. Shikazono, et al. (2017). &quot;Efficiency of radiation-induced base lesion excision and the order of enzymatic treatment.&quot; International journal of radiation biology 93(3): 295-302.</a></p>\n\n<p><a name=\"_ENREF_41\">Sishc, B. J., C. B. Nelson, et al. (2015). &quot;Telomeres and Telomerase in the Radiation Response: Implications for Instability, Reprograming, and Carcinogenesis.&quot; Front Oncol 5: 257.</a></p>\n\n<p><a name=\"_ENREF_42\">Stenerlow, B., E. Hoglund, et al. (2000). &quot;Rejoining of DNA fragments produced by radiations of different linear energy transfer.&quot; International journal of radiation biology 76(4): 549-557.</a></p>\n\n<p><a name=\"_ENREF_43\">Sykora, P., K. L. Witt, et al. (2018). &quot;Next generation high throughput DNA damage detection platform for genotoxic compound screening.&quot; Sci Rep 8(1): 2771.</a></p>\n\n<p><a name=\"_ENREF_44\">Unger, K., J. Wienberg, et al. (2010). &quot;Novel gene rearrangements in transformed breast cells identified by high-resolution breakpoint analysis of chromosomal aberrations.&quot; Endocrine-related cancer 17(1): 87-98.</a></p>\n\n<p><a name=\"_ENREF_45\">Vispe, S. and M. S. Satoh (2000). &quot;DNA repair patch-mediated double strand DNA break formation in human cells.&quot; The Journal of biological chemistry 275(35): 27386-27392.</a></p>\n\n<p><a name=\"_ENREF_46\">Yang, T.-H., L. M. Craise, et al. (1992). &quot;Chromosomal changes in cultured human epithelial cells transformed by low- and high-LET radiation.&quot; Adv Space Res 12(2-3): 127-136.</a></p>\n\n<p><a name=\"_ENREF_47\">Yang, T. C., K. A. Georgy, et al. (1997). &quot;Initiation of oncogenic transformation in human mammary epithelial cells by charged particles.&quot; Radiat Oncol Investig 5(3): 134-138.</a></p>\n\n<p><a name=\"_ENREF_48\">Yin, Z., D. Menendez, et al. (2012). &quot;RAP80 is critical in maintaining genomic stability and suppressing tumor development.&quot; Cancer research 72(19): 5080-5090.</a></p>\n\n<p><a name=\"_ENREF_49\">Yu, Y., R. Okayasu, et al. (2001). &quot;Elevated breast cancer risk in irradiated BALB/c mice associates with unique functional polymorphism of the Prkdc (DNA-dependent protein kinase catalytic subunit) gene.&quot; Cancer Res 61(5): 1820-1824.</a></p>\n","biologicalOrganisationLevel":"Molecular","organTerm":{},"biologicalEvents":[{"action":"functional change","object":{"name":"deoxyribonucleic acid","source":"CHEBI","sourceId":"CHEBI:16991"}}],"keyEventStressors":["Estrogen","Ionizing Radiation"],"id":1194}
{"title":"modulation, Extracellular Matrix Composition ","references":"","biologicalOrganisationLevel":"Cellular","organTerm":{},"biologicalEvents":[{"action":"morphological change","object":{"name":"extracellular matrix","source":"GO","sourceId":"GO:0031012"}}],"id":1195}
{"title":"Increased, Invasion","references":"","biologicalOrganisationLevel":"Cellular","organTerm":{"name":"mammary duct","sourceId":"UBERON:0001765"},"biologicalEvents":[{"action":"increased","object":{"name":"epithelial cell","source":"CL","sourceId":"CL:0000066"}}],"id":1196}
{"title":"Activation, Fibroblasts","references":"","biologicalOrganisationLevel":"Cellular","organTerm":{},"biologicalEvents":[{"action":"decreased","process":"cell activation","object":{}}],"id":1197}
{"title":"Activation, Macrophages","references":"","biologicalOrganisationLevel":"Cellular","organTerm":{},"biologicalEvents":[{"action":"decreased","process":"macrophage activation","object":{}}],"id":1198}
{"title":"Increased, Angiogenesis","references":"","biologicalOrganisationLevel":"Cellular","organTerm":{},"biologicalEvents":[{"action":"increased","process":"angiogenesis","object":{}}],"id":1213}
{"title":"Altered, Gene Expression","references":"","biologicalOrganisationLevel":"Molecular","organTerm":{},"biologicalEvents":[{"action":"abnormal","process":"gene expression","object":{}}],"id":1239}
{"title":"Altered, Protein Production","references":"","biologicalOrganisationLevel":"Cellular","organTerm":{},"biologicalEvents":[{"action":"abnormal","process":"translation","object":{"name":"protein","source":"PR","sourceId":"PR:000000001"}}],"id":1240}
{"title":"Increased, Motility","references":"","biologicalOrganisationLevel":"Cellular","organTerm":{},"biologicalEvents":[{"action":"increased","process":"cell motility","object":{}}],"id":1241}
{"title":"Increased, Second Messenger Production","references":"","biologicalOrganisationLevel":"Cellular","organTerm":{},"biologicalEvents":[{"action":"increased","process":"second-messenger-mediated signaling","object":{}}],"id":1242}
{"title":"Activation, Juvenile hormone receptor","references":"","biologicalOrganisationLevel":"Molecular","organTerm":{},"biologicalEvents":[{"action":"increased","process":"signaling","object":{"name":"juvenile hormone","source":"CHEBI","sourceId":"CHEBI:24943"}}],"id":1205}
{"title":"Induction, Doublesex1 gene","references":"","biologicalOrganisationLevel":"Molecular","organTerm":{},"biologicalEvents":[{"action":"increased","process":"gene expression","object":{"name":"protein doublesex (fruit fly)","source":"PR","sourceId":"PR:P23023"}}],"id":1206}
{"title":"Increased, Male offspring","references":"","biologicalOrganisationLevel":"Population","organTerm":{},"biologicalEvents":[{"action":"increased","process":"offspring quantity","object":{}},{"action":"increased","object":{"name":"male organism","source":"UBERON","sourceId":"UBERON:0003101"}}],"id":1208}
{"title":"Increased, Male offspring","references":"","biologicalOrganisationLevel":"Population","organTerm":{},"biologicalEvents":[{"action":"increased","process":"offspring quantity","object":{}},{"action":"increased","object":{"name":"male organism","source":"UBERON","sourceId":"UBERON:0003101"}}],"id":1208}
{"title":"Induction, Male reproductive tract","references":"","biologicalOrganisationLevel":"Organ","organTerm":{"name":"male reproductive system","sourceId":"UBERON:0000079"},"biologicalEvents":[{"action":"increased","object":{"name":"male reproductive organ","source":"UBERON","sourceId":"UBERON:0003135"}}],"id":1209}
{"title":"Alteration, Food-web structures","references":"","biologicalOrganisationLevel":"Population","organTerm":{},"biologicalEvents":[{"action":"abnormal","object":{"name":"Food Chain","source":"MESH","sourceId":"D020387"}}],"id":1210}
{"title":"Binding to (interferes with) topoisomerase II enzyme","references":"<p style=\"margin-left:14.2pt\">Alexander FE, Patheal SL, Biondi A, Brandalise S, Cabrera ME, Chan LC, Chen Z, Cimino G, Cordoba JC, Gu LJ, Hussein H, Ishii E, Kamel AM, Labra S, Magalhaes IQ, Mizutani S, Petridou E, de Oliveira MP, Yuen P, Wiemels JL, Greaves MF. Transplacental chemical exposure and risk of infant leukemia with MLL gene fusion. Cancer Res. 2001 Mar 15;61(6):2542-6.</p>\n\n<p style=\"margin-left:14.2pt\">Hande KR. Etoposide: four decades of development of a topoisomerase II inhibitor.&nbsp;Eur. J. Cancer.&nbsp;1998;34:1514&ndash;1521.</p>\n\n<p style=\"margin-left:14.2pt\">Azarova AM, Lin RK, Tsai YC, Liu LF, Lin CP, Lyu YL. Genistein induces topoisomerase IIbeta- and proteasome-mediated DNA sequence rearrangements: Implications in infant leukemia. Biochem Biophys Res Commun. 2010 Aug 13;399(1):66-71. doi: 10.1016/j.bbrc.2010.07.043.</p>\n\n<p style=\"margin-left:14.2pt\">Bandele OJ, Osheroff N. Bioflavonoids as poisons of human topoisomerase II alpha and II beta. Biochemistry. 2007 May 22;46(20):6097-108.</p>\n\n<p style=\"margin-left:14.2pt\">Barjesteh van Waalwijk van Doorn-Khosrovani S, Janssen J, Maas LM, Godschalk RW, Nijhuis JG, van Schooten FJ. Dietary flavonoids induce MLL translocations in primary human CD34+ cells. Carcinogenesis. 2007 Aug;28(8):1703-9.</p>\n\n<p style=\"margin-left:14.2pt\">Casta&ntilde;o J, Herrero AB, Bursen A, Gonz&aacute;lez F, Marschalek R, Guti&eacute;rrez NC, Menendez P.Expression of MLL.AF4 or 1 AF4.MLL fusions 2 does not impact the efficiency of DNA damage repair. Nucl Acid Res 2016; in press</p>\n\n<p style=\"margin-left:14.2pt\">Cowell IG, Austin CA. Mechanism of generation of therapy related leukemia in response to anti-topoisomerase II agents. Int J Environ Res Public Health. 2012 Jun;9(6):2075-91. doi: 10.3390/ijerph9062075.</p>\n\n<p style=\"margin-left:14.2pt\">Fortune JM, Osheroff&nbsp; N. Merbarone inhibits the catalytic activity of human topoisomerase IIalpha by blocking DNA cleavage. J Biol Chem. 1998; 273(28): 17643-17650.</p>\n\n<p style=\"margin-left:14.2pt\">Gordon ON, Luis PB, Ashley RE, Osheroff N, Schneider C. Oxidative Transformation of Demethoxy- and Bisdemethoxycurcumin: Products, Mechanism of Formation, and Poisoning of Human Topoisomerase II&beta;. Chem Res Toxicol. 2015; 28(5): 989-996. doi: 10.1021/acs.chemrestox.5b00009.</p>\n\n<p style=\"margin-left:14.2pt\">Hernandez Jerez A and Menendez P. Linking pesticide exposure with pediatric leukemia: potential underlying mechanisms. Int J Mol Sci 2016; 17: 461.</p>\n\n<p style=\"margin-left:14.2pt\">Lanoue L, Green KK, Kwik-Uribe C, Keen CL. Dietary factors and the risk for acute infant leukemia: evaluating the effects of cocoa-derived flavanols on DNA topoisomerase activity. Exp Biol Med (Maywood). 2010; 235(1): 77-89. doi: 10.1258/ebm.2009.009184.</p>\n\n<p style=\"margin-left:14.2pt\">Li Z, Sun B, Clewell RA, Adeleye Y, Andersen ME, Zhang Q. Dose-response modeling of etoposide-induced DNA damage response. Toxicol Sci. 2014 Feb;137(2):371-84. doi: 10.1093/toxsci/kft259.</p>\n\n<p style=\"margin-left:14.2pt\">Lopez-Lazaro M, Willmore E, Austin CA. The dietary flavonoids myricetin and fisetin act as dual inhibitors of DNA topoisomerases I and II in cells. Mutat Res. 2010 Feb;696(1):41-7. doi: 10.1016/j.mrgentox.2009.12.010.</p>\n\n<p style=\"margin-left:14.2pt\">Lu C, Liu X, Liu C, Wang J, Li C, Liu Q, Li Y, Li S, Sun S, Yan J, Shao J. Chlorpyrifos Induces MLL Translocations Through Caspase 3-Dependent Genomic Instability and Topoisomerase II Inhibition in Human Fetal Liver Hematopoietic Stem Cells. Toxicol Sci. 2015; 147(2): 588-606. doi: 10.1093/toxsci/kfv153.</p>\n\n<p style=\"margin-left:14.2pt\"><a href=\"https://www.ncbi.nlm.nih.gov/pubmed/?term=Nitiss%20JL%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=22684721\">Nitiss JL</a>,&nbsp;<a href=\"https://www.ncbi.nlm.nih.gov/pubmed/?term=Soans%20E%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=22684721\">Soans E</a>,&nbsp;<a href=\"https://www.ncbi.nlm.nih.gov/pubmed/?term=Rogojina%20A%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=22684721\">Rogojina A</a>,&nbsp;<a href=\"https://www.ncbi.nlm.nih.gov/pubmed/?term=Seth%20A%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=22684721\">Seth A</a>,&nbsp;<a href=\"https://www.ncbi.nlm.nih.gov/pubmed/?term=Mishina%20M%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=22684721\">Mishina M</a>. 2012, Topoisomerase assays.<a href=\"https://www.ncbi.nlm.nih.gov/pubmed/22684721#\" title=\"Current protocols in pharmacology.\">Curr Protoc Pharmacol.</a>&nbsp;2012 Jun;Chapter 3:Unit 3.3.. doi: 10.1002/0471141755.ph0303s57.</p>\n\n<p style=\"margin-left:14.2pt\">Pendleton M, Lindsey RH Jr, Felix CA, Grimwade D, Osheroff N. Topoisomerase II and leukemia. Ann N Y Acad Sci. 2014 Mar;1310:98-110. doi: 10.1111/nyas.12358.</p>\n\n<p style=\"margin-left:14.2pt\">Rodr&iacute;guezCortez, V C,&nbsp;Men&eacute;ndez, P,&nbsp;2020.&nbsp;Genotoxicity of permethrin and clorpyriphos on human stem and progenitor cells at different ontogeny stages: implications in leukaemia development.&nbsp;<em>EFSA supporting publication</em>&nbsp;2020:&nbsp;17(&nbsp;5): EN1866. 35 pp. doi:&nbsp;<a href=\"https://doi.org/10.2903/sp.efsa.2020.EN-1866\" target=\"_blank\" title=\"Link to external resource: 10.2903/sp.efsa.2020.EN1866\">10.2903/sp.efsa.2020.EN1866</a></p>\n\n<p style=\"margin-left:14.2pt\">Ross JA, Potter JD, Reaman GH, Pendergrass TW, Robison LL. Maternal exposure to potential inhibitors of DNA topoisomerase II and infant leukemia (United States): a report from the Children&#39;s Cancer Group. Cancer Causes Control. 1996 Nov;7(6):581-590.</p>\n\n<p style=\"margin-left:14.2pt\">Ross W, Rowe T, Glisson B, Yalowich J, Liu L. Role of topoisomerase II in mediating epipodophyllotoxin-induced DNA cleavage.&nbsp;Cancer Res.&nbsp;1984;44:5857&ndash;5860.</p>\n\n<p style=\"margin-left:14.2pt\">Sanjuan-Pla A, Bueno C, Prieto C, Acha P, Stam RW, Marschalek R, Menendez P. Revisiting the biology of infant t(4;11)/MLL-AF4+ B-cell acute lymphoblastic leukemia. Blood. 2015; 126(25): 2676-2685 DOI 10.1182/blood-2015-09-667378.</p>\n\n<p style=\"margin-left:14.2pt\">Schellenberg, M. J.,&nbsp;Lieberman, J. A.,&nbsp;HerreroRuiz, A.,&nbsp;Butler, L. R.,&nbsp;Williams, J. G.&nbsp;and&nbsp;Mu&ntilde;ozCabello, A. M.&nbsp;Williams, R. S.&nbsp;(2017).&nbsp;ZATT (ZNF451)mediated resolution of topoisomerase 2 DNAprotein crosslinks.&nbsp;Science,&nbsp;357(6358),&nbsp;1412&ndash;1416.&nbsp;<a href=\"https://doi.org/10.1126/science.aam6468\">https://doi.org/10.1126/science.aam6468</a></p>\n\n<p style=\"margin-left:14.2pt\">Schroeter A, Groh IA, Favero GD, Pignitter M, Schueller K, Somoza V, Marko D. Inhibition of topoisomerase II by phase II metabolites of resveratrol in human colon cancer cells. Mol Nutr Food Res. 2015 Oct 12. doi: 10.1002/mnfr.201500352.</p>\n\n<p style=\"margin-left:14.2pt\">Smith NA, Byl JA, Mercer SL, Deweese JE, Osheroff N. Etoposide quinone is a covalent poison of human topoisomerase II&beta;. Biochemistry. 2014; 53(19): 3229-3236. doi: 10.1021/bi500421q.</p>\n\n<p style=\"margin-left:14.2pt\">Spector LG, Xie Y, Robison LL, Heerema NA, Hilden JM, Lange B, Felix CA, Davies SM, Slavin J, Potter JD, Blair CK, Reaman GH, Ross JA. Maternal diet and infant leukemia: the DNA topoisomerase II inhibitor hypothesis: a report from the children&#39;s oncology group. Cancer Epidemiol Biomarkers Prev. 2005 Mar;14(3):651-655.</p>\n\n<p style=\"margin-left:14.2pt\">Strick R, Strissel PL, Borgers S, Smith SL, Rowley JD. Dietary bioflavonoids induce cleavage in the MLL gene and may contribute to infant leukemia. Proc Natl Acad Sci U S A. 2000 Apr 25;97(9):4790-5.</p>\n\n<p style=\"margin-left:14.2pt\">Udroiu I., Sgura A. Genotoxicity sensitivity of the developing hematopoietic system. 2012. Mutation Research 2012; 767: 1-7.</p>\n\n<p style=\"margin-left:14.2pt\">Wilstermann A. M.; Bender R. P.; Godfrey M.; Choi S.; Anklin C.; Berkowitz D. B.; Osheroff N.; Graves D. E. (2007)&nbsp;Topoisomerase II-drug interaction domains: Identification of substituents on etoposide that interact with the enzyme.&nbsp;Biochemistry&nbsp;46, 8217&ndash;8225.</p>\n","biologicalOrganisationLevel":"Molecular","organTerm":{},"biologicalEvents":[{"action":"abnormal","process":"DNA topoisomerase II activity","object":{}}],"keyEventStressors":["Etoposide","etoposide quinone"],"id":1252}
{"title":" MLL chromosomal translocation","references":"<p style=\"margin-left:14.2pt\">Ernest P, Fisher JK, Avery W, Sade S, Foy D, Korsmeyer SJ. Definitive hematopoiesis requires the mixed-lineage leukemia gene. Dev Cell 2004; 6: 437-443.</p>\n\n<p style=\"margin-left:14.2pt\">Ford AM, Ridge SA, Cabrera ME, Mahmoud H, Steel CM, Chan LC, et al. In utero rearrangements in the trithorax-related oncogene in infant leukaemias. Nature. 1993; 363(6427):358&ndash;60. doi: 10.1038/363358a0</p>\n\n<p style=\"margin-left:14.2pt\">Gale KB, Ford AM, Repp R, Borkhardt A, Keller C, Eden OB, et al. Backtracking leukemia to birth: identification of clonotypic gene fusion sequences in neonatal blood spots. Proc Natl Acad Sci USA. 1997; 94(25):13950&ndash;4.</p>\n\n<p style=\"margin-left:14.2pt\">Greaves M. When one mutation is all it takes. Cancer Cell. 2015; 27(4): 433-434.</p>\n\n<p style=\"margin-left:14.2pt\">Hess JL, Yu BD, Li B, Hanson RD, Korsmeyer SJ, Defect in yolk sac hematopoiesis in mll-null embryos. Blood 1997; 90: 1799-1806.</p>\n\n<p style=\"margin-left:14.2pt\">Jansen MW, Corral L, van der Velden VH, Panzer-Grumayer R, Schrappe M, Schrauder A et al. Immunobiological diversity in infant acute lymphoblastic leukemiais related to the occurence and type of MLL rearrangment. Leukemia 2007; 21(4): 633-641.</p>\n\n<p style=\"margin-left:14.2pt\">Z-Y&nbsp;Li, D-P&nbsp;Liu<span style=\"font-size:10.8333px\"> </span>and C-C&nbsp;Liang. 2005.&nbsp;New insight into the molecular mechanisms of&nbsp;<em>MLL</em>-associated leukemia.&nbsp;<em>Leukemia</em>&nbsp;(2005)&nbsp;<strong>19</strong>, 183&ndash;190. doi:10.1038/sj.leu.2403602 Published online 16 December 2004.</p>\n\n<p style=\"margin-left:14.2pt\">Menendez P, Catalina P, Rodriguez R, Melen GJ, Bueno C, Arriero M, Garcia-Sanchez F, Lassaletta A, Garcia-Sanz R, Garcia-Castro J. Bone marrow mesenchymal stem cells from infants with MLL-AF4+ acute leukemia harbor and express the MLL-AF4 fusion gene. J Exp Med. 2009 Dec 21;206(13):3131-41. doi: 10.1084/jem.20091050.</p>\n\n<p style=\"margin-left:14.2pt\">Meyer C, Hofmann J, Burmeister T, et al. The MLL recombinome of acute leukemias in 2013. Leukemia 2013;27(11):2165-2176.</p>\n\n<p style=\"margin-left:14.2pt\"><a href=\"https://www.ncbi.nlm.nih.gov/pubmed/?term=Meyer%20C%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=15626757\">Meyer</a>&nbsp;Claus,&nbsp;<a href=\"https://www.ncbi.nlm.nih.gov/pubmed/?term=Schneider%20B%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=15626757\">Bjoern Schneider</a>,&nbsp;<a href=\"https://www.ncbi.nlm.nih.gov/pubmed/?term=Reichel%20M%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=15626757\">Martin Reichel</a>,&nbsp;<a href=\"https://www.ncbi.nlm.nih.gov/pubmed/?term=Angermueller%20S%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=15626757\">Sieglinde Angermueller</a>,&nbsp;<a href=\"https://www.ncbi.nlm.nih.gov/pubmed/?term=Strehl%20S%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=15626757\">Sabine Strehl</a>,&nbsp;<a href=\"https://www.ncbi.nlm.nih.gov/pubmed/?term=Schnittger%20S%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=15626757\">Susanne Schnittger</a>,<a href=\"https://www.ncbi.nlm.nih.gov/pubmed/?term=Schoch%20C%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=15626757\">Claudia Schoch</a>,&nbsp;<a href=\"https://www.ncbi.nlm.nih.gov/pubmed/?term=Jansen%20MW%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=15626757\">Mieke W. J. C. Jansen</a>,&nbsp;<a href=\"https://www.ncbi.nlm.nih.gov/pubmed/?term=van%20Dongen%20JJ%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=15626757\">Jacques J. van Dongen</a>,&nbsp;<a href=\"https://www.ncbi.nlm.nih.gov/pubmed/?term=Pieters%20R%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=15626757\">Rob Pieters</a>,&nbsp;<a href=\"https://www.ncbi.nlm.nih.gov/pubmed/?term=Haas%20OA%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=15626757\">Oskar A. Haas</a>,&nbsp;<a href=\"https://www.ncbi.nlm.nih.gov/pubmed/?term=Dingermann%20T%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=15626757\">Theo Dingermann</a>,<a href=\"https://www.ncbi.nlm.nih.gov/pubmed/?term=Klingebiel%20T%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=15626757\">Thomas Klingebiel</a>,and&nbsp;<a href=\"https://www.ncbi.nlm.nih.gov/pubmed/?term=Marschalek%20R%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=15626757\">Rolf Marschalek</a>. 2005. Diagnostic tool for the identification of&nbsp;<em>MLL</em>&nbsp;rearrangements including unknown partner genes.&nbsp;<a href=\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC544299/#\">Proc Natl Acad Sci U S A</a>. 2005 Jan 11; 102(2): 449&ndash;454.Published online 2004 Dec 30.&nbsp;doi:&nbsp;&nbsp;<a href=\"https://dx.doi.org/10.1073%2Fpnas.0406994102\" target=\"pmc_ext\">10.1073/pnas.0406994102</a>&nbsp;PMCID:&nbsp;PMC544299 Medical Sciences</p>\n\n<p style=\"margin-left:14.2pt\">Nanya M, Sato M, Tanimoto K, Tozuka M, Mizutani S, Takagi M (2015) Dysregulation of the DNA Damage Response and KMT2A Rearrangement in Fetal Liver Hematopoietic Cells.PLoS ONE 10(12): e0144540. doi:10.1371/journal. pone.0144540</p>\n\n<p style=\"margin-left:14.2pt\">Sam TN, Kersey JH, Linabery AM, Johnson KJ, Heerema NA, Hilden JM, et al. MLL gene rearrangements in infant leukaemia vary with age at diagnosis and selected demographic factors: a Children&rsquo;s Oncology Group (COG) study. Pediatr Blood cancer. 2012; 58 (6): 836-839.</p>\n\n<p style=\"margin-left:14.2pt\">Sanjuan-Pla A, Bueno C, Prieto C, Acha P, Stam RW, Marschalek R, Menendez P. Revisiting the biology of infant t(4;11)/MLL-AF4+ B-cell acute lymphoblastic leukemia. Blood. 2015; 126(25): 2676-2685 DOI 10.1182/blood-2015-09-667378.</p>\n\n<p style=\"margin-left:14.2pt\">M&nbsp;van der Burg, T S&nbsp;Poulsen, S P&nbsp;Hunger<span style=\"font-size:10.8333px\">,</span>&nbsp;H B&nbsp;Beverloo, E M E&nbsp;Smit, K&nbsp;Vang-Nielsen, A W&nbsp;Langerak&nbsp;and J J M&nbsp;van Dongen. 2004. Split-signal FISH for detection of chromosome aberrations in acute lymphoblastic leukemia.&nbsp;<em>Leukemia</em>&nbsp;(2004)&nbsp;<strong>18,</strong>&nbsp;895&ndash;908. doi:10.1038/sj.leu.2403340 Published online 25 March 2004.</p>\n\n<p style=\"margin-left:14.2pt\">&nbsp;</p>\n","biologicalOrganisationLevel":"Cellular","organTerm":{},"biologicalEvents":[{"action":"occurrence","process":"Translocation, Genetic","object":{}}],"keyEventStressors":["Etoposide"],"id":1253}
{"title":"Infant leukaemia","references":"<p style=\"margin-left:14.2pt\">Bardini M, Woll PS, Corral L, Luc S, Wittmann L, Ma Z, Lo Nigro L, Basso G, Biondi A, Cazzaniga G, Jacobsen SE. Clonal variegation and dynamic competition of leukemia-initiating cells in infant acute lymphoblastic leukemia with MLL rearrangement. Leukemia. 2015 Jan;29(1):38-50. doi: 10.1038/leu.2014.154.</p>\n\n<p style=\"margin-left:14.2pt\">Bueno C, Catalina P, Melen GJ, Montes R, Sanchez L, Ligero G, Garcia-Perez JL, Menendez P. Etoposide induces MLL rearrangements and other chromosomal abnormalities in human embryonic stem cells. Carcinogenesis 2009; 30(9): 1628-1637. doi: 10.1093/carcin/bgp169.</p>\n\n<p style=\"margin-left:14.2pt\">Ezoe S. Secondary leukemia associated with the anti-cancer agent, etoposide, a topoisomerase II inhibitor. Int J Environ Res Public Health. 2012 Jul;9(7):2444-53. doi: 10.3390/ijerph9072444.</p>\n\n<p style=\"margin-left:14.2pt\">Gole B, Wiesm&uuml;ller L. Leukemogenic rearrangements at the mixed lineage leukemia gene (MLL)-multiple rather than a single mechanism. Front Cell Dev Biol. 2015 Jun 25;3:41. doi: 10.3389/fcell.2015.00041.</p>\n\n<p style=\"margin-left:14.2pt\">Hernandez A and Menendez P. Linking pesticide exposure with pediatric leukemia: potential underlying mechanisms. Int J Mol Sci 2016; 17: 461.</p>\n\n<p style=\"margin-left:14.2pt\">Hunger SP, Mullighan CG. Acute Lymphoblastic Leukemia in Children. N Engl J Med 2015; 73: 1541-1552.</p>\n\n<p style=\"margin-left:14.2pt\">Li Z, Sun B, Clewell RA, Adeleye Y, Andersen ME, Zhang Q. Dose-response modeling of etoposide-induced DNA damage response. Toxicol Sci. 2014 Feb;137(2):371-84. doi: 10.1093/toxsci/kft259.&nbsp;</p>\n\n<p style=\"margin-left:14.2pt\">Moneypenny CG, Shao J, Song Y, Gallagher EP. MLL rearrangements are induced by low doses of etoposide in human fetal hematopoietic stem cells. Carcinogenesis. 2006; 27(4):874&ndash;81. Epub 2005/12/27. doi: 10.1093/carcin/bgi322</p>\n\n<p style=\"margin-left:14.2pt\">Pendleton M, Lindsey RH Jr, Felix CA, Grimwade D, Osheroff N. Topoisomerase II and leukemia. Ann N Y Acad Sci. 2014 Mar;1310:98-110. doi: 10.1111/nyas.12358.</p>\n","biologicalOrganisationLevel":"Individual","organTerm":{},"biologicalEvents":[{"object":{}}],"keyEventStressors":["Etoposide"],"id":1254}
{"title":"DNA double-strand break ","references":"<p>Ager, D. D., W. C. Dewey, K. Gardiner, W. Harvey, R. T. Johnson, and C. A. Waldren.&nbsp;Measurement of radiation-induced DNA double-strand breaks by pulsed-field gel electrophoresis.&nbsp;Radiat. Res 122:181&ndash;187.1990</p>\n\n<p>Bl&ouml;cher, D., M. Einspenner, and J. Zajackowski.&nbsp;CHEF electrophoresis, a sensitive technique for the determination of DNA double-strand breaks.&nbsp;Int. J. Radiat. Biol 56:437&ndash;448.1989.</p>\n\n<p>Bl&ouml;cher, D.&nbsp;In CHEF electrophoresis a linear induction of dsb correspond to a nonlinear fraction of extracted DNA with dose.&nbsp;Int. J. Radiat. Biol 57:7&ndash;12.1990</p>\n\n<p>Bl&ouml;cher, D.&nbsp;In CHEF electrophoresis a linear induction of dsb correspond to a nonlinear fraction of extracted DNA with dose.&nbsp;Int. J. Radiat. Biol 57:7&ndash;12.1990.</p>\n\n<p>Erixon, K., B. Cedervall, and R. Lewensohn.&nbsp;Pulsed-field gel electrophoresis for measuring radiation-induced DNA double-strand breaks. Comparison to the method of neutral filter elution.&nbsp;In&nbsp;<em>Ionizing Radiation Damage to DNA: Molecular Aspects</em>&nbsp;(R. Painter and S. Wallace, Eds.), pp. 69&ndash;80. UCLA Symposium on Molecular and Cellular Biology, New Series, Vol. 136, Wiley-Liss, New York, 1990.</p>\n\n<p>Gravel S., Chapman JR., magill C., and jackson SP. 2008. DNA helicases Sgs1 and BLM promote DNA double-strand break resectio. Genes &amp; Dev. 22:2767-2772.</p>\n\n<p>Nitiss JL, Soans E, Rogoljina A, Seth A, Mishina M. 2012 Topoisiomerase assays. Current Protoc Pharmacol. Chapter: Unit 3.3.</p>\n\n<p>Olive. PL, Wlodek D., Banath JP. 1991. DNA double-strand break measured in individual cells subjected to gel electrophoresis. Cnancer research. 51, 4671-4676, September 1.</p>\n\n<p>Pfeiffer P., Goedeke W. and Gunter Obe. 2000. mechanisms of DNA double-strand break repair and their potential to induce chromosomal aberrations. Mutagenesis vol15 n 4 289-302.</p>\n\n<p>Raynard S., Niu H. and Sung P. 2017. 2002. DNA double-strand break processing: the beginning of the end. Genes &amp; Dev. 22: 2903-2907.</p>\n\n<p>Shrivastav M, De Haro LP, Nickoloff JA. 2008. Regulation of DNA double-strand break repair pathway choice. Cell Research, 18: 134-147.</p>\n\n<p><a href=\"https://www.ncbi.nlm.nih.gov/pubmed/?term=Seluanov%20A%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=20864925\">Seluanov</a>&nbsp;A,&nbsp;<a href=\"https://www.ncbi.nlm.nih.gov/pubmed/?term=Mao%20Z%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=20864925\">Zhiyong Mao</a>, and&nbsp;<a href=\"https://www.ncbi.nlm.nih.gov/pubmed/?term=Gorbunova%20V%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=20864925\">Vera Gorbunova</a>. 2002. Analysis of DNA Double-strand Break (DSB) Repair in Mammalian Cells.&nbsp;<a href=\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3157866/#\">J Vis Exp</a>. 2010; (43): 2002. Published online 2010 Sep 8.&nbsp;doi:&nbsp;&nbsp;<a href=\"https://dx.doi.org/10.3791%2F2002\" target=\"pmc_ext\">10.3791/2002</a>&nbsp;PMCID:&nbsp;PMC3157866</p>\n\n<p>Stamato, T. D. and N. Denko.&nbsp;Asymmetric field inversion gel electrophoresis: A new method for detecting DNA double-strand breaks in mammalian cells.&nbsp;Radiat. Res 121:196&ndash;205.1990.&nbsp;</p>\n\n<p>Stenerlow, B., J. Carlsson, E. Blomquist, and K. Erixon.&nbsp;Clonogenic cell survival and rejoining of DNA double-strand breaks: Comparisons between three cell lines after photon or He ion irradiation.&nbsp;Int. J. Radiat. Biol 65:631&ndash;639.1994.&nbsp;</p>\n\n<p><a href=\"http://www.bioone.org/doi/abs/10.1667/0033-7587%282003%29159%5B0502%3AMOPDDS%5D2.0.CO%3B2?journalCode=rare#\" id=\"author1\">Stenerl&ouml;w</a>&nbsp;B.,&nbsp;<a href=\"http://www.bioone.org/doi/abs/10.1667/0033-7587%282003%29159%5B0502%3AMOPDDS%5D2.0.CO%3B2?journalCode=rare#\" id=\"author2\">Karin H. Karlsson</a>,&nbsp;<a href=\"http://www.bioone.org/doi/abs/10.1667/0033-7587%282003%29159%5B0502%3AMOPDDS%5D2.0.CO%3B2?journalCode=rare#\" id=\"author3\">Brian Cooper</a>,&nbsp;<a href=\"http://www.bioone.org/doi/abs/10.1667/0033-7587%282003%29159%5B0502%3AMOPDDS%5D2.0.CO%3B2?journalCode=rare#\" id=\"author4\">Bj&ouml;rn Rydberg</a>&nbsp;2003 Measurement of Prompt DNA Double-Strand Breaks in Mammalian Cells without Including Heat-Labile Sites: Results for Cells Deficient in Nonhomologous End JoiningRadiation Research 159(4):502-510. <a href=\"https://doi.org/10.1667/0033-7587(2003)159[0502:MOPDDS]2.0.CO;2\">https://doi.org/10.1667/0033-7587(2003)159[0502:MOPDDS]2.0.CO;2</a></p>\n\n<p>&nbsp;</p>\n\n<h5>&nbsp;</h5>\n\n<p><img alt=\"No Access\" src=\"http://www.bioone.org/templates/jsp/_style2/_AP/_bioone/images/access_no.gif\" title=\"No Access\" /></p>\n\n<p>&nbsp;</p>\n","biologicalOrganisationLevel":"Molecular","organTerm":{},"biologicalEvents":[{"object":{}}],"id":1461}
{"title":"increased mantel display","references":"","biologicalOrganisationLevel":"Organ","organTerm":{},"biologicalEvents":[{"object":{}}],"id":1256}
{"title":"Induced parturition","references":"","biologicalOrganisationLevel":"Individual","organTerm":{},"biologicalEvents":[{"object":{}}],"id":1257}
{"title":"Decreased, Reproductive Success","references":"","biologicalOrganisationLevel":"Individual","organTerm":{},"biologicalEvents":[{"object":{}}],"id":1141}
{"title":"Decompartmentalization","references":"","biologicalOrganisationLevel":"Cellular","organTerm":{},"biologicalEvents":[{"action":"abnormal","process":"cellular component organization","object":{}}],"id":1258}
{"title":"Direct mitochondrial inhibition","references":"","biologicalOrganisationLevel":"Molecular","organTerm":{},"biologicalEvents":[{"action":"decreased","process":"function","object":{"name":"mitochondrion","source":"GO","sourceId":"GO:0005739"}}],"id":1260}
{"title":"narcosis","references":"","biologicalOrganisationLevel":"Cellular","organTerm":{},"biologicalEvents":[{"action":"abnormal","process":"plasma membrane organization","object":{}}],"id":1259}
{"title":"Mitochondrial impairment","references":"","biologicalOrganisationLevel":"Molecular","organTerm":{},"biologicalEvents":[{"action":"functional change","object":{"name":"mitochondrion","source":"GO","sourceId":"GO:0005739"}}],"id":1261}
{"title":"Apoptosis","references":"<p><span style=\"font-size:16px\"><span style=\"font-family:Arial,Helvetica,sans-serif\">Archana, M. et al. (2013), &quot;Various methods available for detection of apoptotic cells&quot;, Indian J Cancer 50:274-283</span></span></p>\n\n<p><span style=\"font-size:16px\"><span style=\"font-family:Arial,Helvetica,sans-serif\">Elmore, S. (2007), &quot;Apoptosis: a review of programmed cell death&quot;, Toxicol Pathol 35:495-516</span></span></p>\n\n<p><span style=\"font-size:16px\"><span style=\"font-family:Arial,Helvetica,sans-serif\">Glaser, K.B. et al. (2003), &quot;Gene expression profiling of multiple histone deacetylase (HDAC) inhibitors: defining a common gene set produced by HDAC inhibition in T24 and MDA carcinoma cell lines&quot;, Mol Cancer Ther 2:151-163</span></span></p>\n\n<p><span style=\"font-size:16px\"><span style=\"font-family:Arial,Helvetica,sans-serif\">Kerr, J.F.R. et al. (1972), &quot;Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics&quot;, Br J Cancer 26:239-257</span></span></p>\n\n<p><span style=\"font-size:16px\"><span style=\"font-family:Arial,Helvetica,sans-serif\">Kressel, M. and Groscurth, P. (1994), &quot;Distinction of apoptotic and necrotic cell death by in situ labelling of fragmented DNA&quot;, Cell Tissue Res 278:549-556</span></span></p>\n\n<p><span style=\"font-size:16px\"><span style=\"font-family:Arial,Helvetica,sans-serif\">Martinez, M.M. et al. (2010), &quot;Detection of apoptosis: A review of conventioinal and novel techniques&quot;, Anal Methods 2:996-1004</span></span></p>\n\n<p><span style=\"font-size:16px\"><span style=\"font-family:Arial,Helvetica,sans-serif\">Parajuli, K.R. et al. (2014), &quot;Methoxyacetic acid suppresses prostate cancer cell growth by inducing growth arrest and apoptosis&quot;, Am J Clin Exp Urol 2:300-313</span></span></p>\n\n<p><span style=\"font-size:16px\"><span style=\"font-family:Arial,Helvetica,sans-serif\">Pucci, B. et al. (2000), &quot;Cell cycle and apoptosis&quot;, Neoplasia 2:291-299</span></span></p>\n\n<p><span style=\"font-size:16px\"><span style=\"font-family:Arial,Helvetica,sans-serif\">Taatjes, D.J. et al. (2008), &quot;Morphological and cytochemical determination of cell death by apoptosis&quot;, Histochem Cell Biol 129:33-43</span></span></p>\n\n<p><span style=\"font-size:16px\"><span style=\"font-family:Arial,Helvetica,sans-serif\">Wade, M.G. et al. (2008), &quot;Methoxyacetic acid-induced spermatocyte death is associated with histone hyperacetylation in rats&quot;, Biol Reprod 78:822-831</span></span></p>\n\n<p><span style=\"font-size:16px\"><span style=\"font-family:Arial,Helvetica,sans-serif\">Wang, C. et al. (2017), &quot;CD147 regulates extrinsic apoptosis in spermatocytes by modulating NFkB signaling pathways&quot;, Oncotarget 8:3132-3143</span></span></p>\n\n<p><span style=\"font-size:16px\"><span style=\"font-family:Arial,Helvetica,sans-serif\">Wu, R. et al. (2016), &quot;microRNA-497 induces apoptosis and suppressed proliferation via the Bcl-2/Bax-caspase9-caspase 3 pathway and cyclin D2 protein in HUVECs&quot;, PLoS One 11:e0167052</span></span></p>\n\n<p><span style=\"font-size:16px\"><span style=\"font-family:Arial,Helvetica,sans-serif\"><span style=\"color:black\">Yasuhara, S. et al. (2003), </span>&quot;<span style=\"color:black\">Comparison of comet assay, electron microscopy, and flow cytometry for detection of apoptosis</span>&quot;<span style=\"color:black\">, J Histochem Cytochem 51:873-885</span></span></span></p>\n\n<p><span style=\"font-size:16px\"><span style=\"font-family:Arial,Helvetica,sans-serif\">Zupkovitz, G. et al. (2010), &quot;The cyclin-dependent kinase inhibitor p21 is a crucial target for histone deacetylase 1 as a regulator of cellular proliferation&quot;, Mol Cell Biol 30:1171-1181</span></span></p>\n","biologicalOrganisationLevel":"Cellular","organTerm":{"name":"organ","sourceId":"UBERON:0000062"},"biologicalEvents":[{"action":"increased","process":"apoptotic process","object":{}}],"id":1262}
{"title":"Necrosis","references":"","biologicalOrganisationLevel":"Tissue","organTerm":{},"biologicalEvents":[{"action":"increased","process":"necrotic cell death","object":{}}],"id":1263}
{"title":"Inactivation of PPAR","references":"","biologicalOrganisationLevel":"Molecular","organTerm":{},"biologicalEvents":[{"object":{}}],"id":1270}
{"title":"Activation of TGF- signaling","references":"","biologicalOrganisationLevel":"Cellular","organTerm":{},"biologicalEvents":[{"object":{}}],"id":1271}
{"title":"Collagen Deposition","references":"","biologicalOrganisationLevel":"Tissue","organTerm":{},"biologicalEvents":[{"object":{}}],"id":1275}
{"title":"Lung fibrosis","references":"","biologicalOrganisationLevel":"Organ","organTerm":{},"biologicalEvents":[{"object":{}}],"id":1276}
{"title":"Induction, Epithelial Mesenchymal Transition","references":"<p>Borthwick, L. A., Parker, S. M., Brougham, K. A., Johnson, G. E., Gorowiec, M. R., Ward, C., &hellip; Fisher, A. J. (2009). Epithelial to mesenchymal transition (EMT) and airway remodelling after human lung transplantation. <em>Thorax</em>, <em>64</em>(9), 770&ndash;777. <a href=\"https://doi.org/10.1136/thx.2008.104133\"><u>https://doi.org/10.1136/thx.2008.104133</u></a></p>\n\n<p>Borthwick, L. A., McIlroy, E. I., Gorowiec, M. R., Brodlie, M., Johnson, G. E., Ward, C., &hellip; Fisher, A. J. (2010). Inflammation and epithelial to mesenchymal transition in lung transplant recipients: Role in dysregulated epithelial wound repair. <em>American Journal of Transplantation</em>, <em>10</em>(3), 498&ndash;509. <a href=\"https://doi.org/10.1111/j.1600-6143.2009.02953.x\"><u>https://doi.org/10.1111/j.1600-6143.2009.02953.x</u></a></p>\n","biologicalOrganisationLevel":"Cellular","organTerm":{},"biologicalEvents":[{"object":{}}],"id":1457}
{"title":"Activation, NADPH Oxidase","references":"","biologicalOrganisationLevel":"Molecular","organTerm":{},"biologicalEvents":[{"action":"increased","process":"signaling","object":{"name":"NADPH Oxidase","source":"MESH","sourceId":"D019255"}}],"id":1174}
{"title":"Reproductive failure","references":"","biologicalOrganisationLevel":"Individual","organTerm":{},"biologicalEvents":[{"action":"decreased","process":"reproduction","object":{}}],"id":1277}
{"title":"ROS formation","references":"","biologicalOrganisationLevel":"Molecular","organTerm":{},"biologicalEvents":[{"action":"increased","process":"biosynthetic process","object":{"name":"reactive oxygen species","source":"CHEBI","sourceId":"CHEBI:26523"}}],"id":1278}
{"title":"Increase, Oxidative Stress / Activation, PMK-1 P38 MAPK","references":"","biologicalOrganisationLevel":"Cellular","organTerm":{},"biologicalEvents":[{"action":"increased","process":"oxidative stress","object":{}},{"action":"increased","process":"signaling","object":{"name":"map kinase p38","source":"PR","sourceId":"PR:000003106"}}],"id":1279}
{"title":"Increase, Oxidative Stress / Activation, PMK-1 P38 MAPK","references":"","biologicalOrganisationLevel":"Cellular","organTerm":{},"biologicalEvents":[{"action":"increased","process":"oxidative stress","object":{}},{"action":"increased","process":"signaling","object":{"name":"map kinase p38","source":"PR","sourceId":"PR:000003106"}}],"id":1279}
{"title":"Activation, HIF-1","references":"","biologicalOrganisationLevel":"Cellular","organTerm":{},"biologicalEvents":[{"action":"increased","process":"signaling","object":{"name":"hypoxia-inducible factor 1 (Caenorhabditis elegans)","source":"PR","sourceId":"PR:G5EGD2"}}],"id":1280}
{"title":"Increased, DNA Damage-Repair","references":"","biologicalOrganisationLevel":"Cellular","organTerm":{},"biologicalEvents":[{"action":"increased","process":"DNA repair","object":{"name":"deoxyribonucleic acid","source":"CHEBI","sourceId":"CHEBI:16991"}}],"id":1281}
{"title":"Activation, JAK/STAT pathway","references":"","biologicalOrganisationLevel":"Cellular","organTerm":{},"biologicalEvents":[{"action":"increased","process":"signaling","object":{"name":"Janus kinase","source":"PR","sourceId":"PR:000025748"}},{"action":"increased","process":"signaling","object":{"name":"signal transducer and transcription activator STAT","source":"PR","sourceId":"PR:000001933"}}],"id":1282}
{"title":"Activation, JAK/STAT pathway","references":"","biologicalOrganisationLevel":"Cellular","organTerm":{},"biologicalEvents":[{"action":"increased","process":"signaling","object":{"name":"Janus kinase","source":"PR","sourceId":"PR:000025748"}},{"action":"increased","process":"signaling","object":{"name":"signal transducer and transcription activator STAT","source":"PR","sourceId":"PR:000001933"}}],"id":1282}
{"title":"Activation, TGF-beta pathway","references":"","biologicalOrganisationLevel":"Cellular","organTerm":{},"biologicalEvents":[{"action":"increased","process":"signaling","object":{"name":"TGF-beta","source":"PR","sourceId":"PR:000000046"}}],"id":1283}
{"title":"Up Regulation, SREBF2","references":"","biologicalOrganisationLevel":"Cellular","organTerm":{},"biologicalEvents":[{"action":"increased","process":"gene expression","object":{"name":"sterol regulatory element-binding protein 2 proteolytic cleavage product","source":"PR","sourceId":"PR:000021564"}}],"id":1284}
{"title":"Up Regulation, Unsaturated fatty acid","references":"","biologicalOrganisationLevel":"Cellular","organTerm":{},"biologicalEvents":[{"action":"increased","process":"unsaturated fatty acid biosynthetic process","object":{"name":"unsaturated fatty acid","source":"CHEBI","sourceId":"CHEBI:27208"}}],"id":1285}
{"title":"Down Regulation, GSS and GSTs gene","references":"","biologicalOrganisationLevel":"Cellular","organTerm":{},"biologicalEvents":[{"action":"decreased","process":"glutathione synthase activity","object":{"name":"glutathione synthetase","source":"PR","sourceId":"PR:000008293"}},{"action":"decreased","process":"glutathione transferase activity","object":{"name":"glutathione S-transferase","source":"PR","sourceId":"PR:000029945"}}],"id":1286}
{"title":"Down Regulation, GSS and GSTs gene","references":"","biologicalOrganisationLevel":"Cellular","organTerm":{},"biologicalEvents":[{"action":"decreased","process":"glutathione synthase activity","object":{"name":"glutathione synthetase","source":"PR","sourceId":"PR:000008293"}},{"action":"decreased","process":"glutathione transferase activity","object":{"name":"glutathione S-transferase","source":"PR","sourceId":"PR:000029945"}}],"id":1286}
{"title":"Glutathione synthesis","references":"","biologicalOrganisationLevel":"Cellular","organTerm":{},"biologicalEvents":[{"action":"decreased","process":"glutathione biosynthetic process","object":{"name":"glutathione","source":"CHEBI","sourceId":"CHEBI:16856"}}],"id":1287}
{"title":"Activation, 3-hydroxy-3-methylglutaryl-CoA reductase gene","references":"","biologicalOrganisationLevel":"Cellular","organTerm":{},"biologicalEvents":[{"action":"decreased","process":"3-hydroxyacyl-CoA dehydrogenase activity","object":{"name":"3-hydroxyacyl-CoA dehydrogenase type-2","source":"PR","sourceId":"PR:000008774"}}],"id":1288}
{"title":"Perturbation of cholesterol","references":"","biologicalOrganisationLevel":"Cellular","organTerm":{},"biologicalEvents":[{"action":"abnormal","object":{"name":"cholesterol","source":"CHEBI","sourceId":"CHEBI:16113"}}],"id":1289}
{"title":"Glutathione homeostasis","references":"","biologicalOrganisationLevel":"Cellular","organTerm":{},"biologicalEvents":[{"action":"abnormal","object":{"name":"glutathione","source":"CHEBI","sourceId":"CHEBI:16856"}}],"id":1290}
{"title":"Hepatotoxicity","references":"","biologicalOrganisationLevel":"Cellular","organTerm":{},"biologicalEvents":[{"object":{}}],"id":1291}
{"title":"Activation, JNK","references":"","biologicalOrganisationLevel":"Cellular","organTerm":{},"biologicalEvents":[{"action":"increased","process":"signaling","object":{"name":"JNK Mitogen-Activated Protein Kinases","source":"MESH","sourceId":"D048031"}}],"id":1292}
{"title":"Activation, FOXO","references":"","biologicalOrganisationLevel":"Cellular","organTerm":{},"biologicalEvents":[{"action":"increased","process":"signaling","object":{"name":"forkhead box protein O (Caenorhabditis elegans)","source":"PR","sourceId":"PR:O16850"}}],"id":1293}
{"title":"Inhibition, Wnt pathway","references":"","biologicalOrganisationLevel":"Cellular","organTerm":{},"biologicalEvents":[{"action":"abnormal","process":"signaling","object":{"name":"Wnt signalosome","source":"GO","sourceId":"GO:1990909"}}],"id":1294}
{"title":"Defect of Embryogenesis","references":"","biologicalOrganisationLevel":"Tissue","organTerm":{"name":"embryo","sourceId":"UBERON:0000922"},"biologicalEvents":[{"action":"abnormal","process":"embryo development","object":{}}],"id":1295}
{"title":"Histone deacetylase inhibition","references":"<p>Ansari, J. et al. (2016), &quot;Epigenetics in non-small cell lung cancer: from basics to therapeutics&quot;, Transl Lung Cancer Res 5:155-171</p>\n\n<p>Barneda-Zahonero, B. and Parra, M. (2012), &quot;Histone deacetylases and cancer&quot;, Mol Oncol 6:579-589</p>\n\n<p>Bell, E.L. et al. (2014), &quot;SirT1 is required in the male germ cell for differentiation and fecundity in mice&quot;, Development 141:3495-3504</p>\n\n<p>Chung, Y.L. et al. (2003), &quot;A therapeutic strategy uses histone deacetylase inhibitors to modulate the expression of genes involved in the pathogenesis of rheumatoid arthritis&quot;, Mol Ther 8:707-717</p>\n\n<p>Damaskos, C. et al. (2016), &quot;Histone deacetylase inhibitors: a novel therapeutic weapon against medullary thyroid cancer?&quot;, Anticancer Res 36:5019-5024</p>\n\n<p>Damaskos, C. et al. (2017), &quot;Histone deacetylase inhibitors: an attractive therapeutic strategy against breast cancer&quot;, Anticancer Research 37:35-46</p>\n\n<p>Decroos, C. et al. (2015), &quot;Biochemical and structural characterization of HDAC8 mutants associated with cornelia de lange syndrome spectrum disorders&quot;, Biochemistry 54:6501&ndash;6513</p>\n\n<p>Desjardins, D. et al. (2016), &quot;Histone deacetylase inhibition restores retinal pigment epithelium function in hyperglycemia&quot;, PLoS ONE 11:e0162596</p>\n\n<p>Di Renzo, F. et al. (2007), &quot;Boric acid inhibits embryonic histone deacetylases: A suggested mechanism to explain boric acid-related teratogenicity&quot;, Toxicol and Appl Pharmacol 220:178-185</p>\n\n<p>Dreser, N. et al. (2015), &quot;Grouping of histone deacetylase inhibitors and other toxicants disturbing neural crest migration by transcriptional profiling&quot;, Neurotoxicology 50:56&ndash;70</p>\n\n<p>Drummond, D.C. et al. (2005), &quot;Clinical development of histone deacetylase inhibitors as anticancer agents&quot;, Annu Rev Pharmacol Toxicol 45:495&ndash;528</p>\n\n<p>Finnin, M.S. et al. (1999), &quot;Structures of a histone deacetylase homologue bound to the TSA and SAHA inhibitors&quot;, Nature 401:188&ndash;193</p>\n\n<p>G&ouml;ttlicher, M. et al. (2001), &quot;Valproic acid defines a novel class of HDAC inhibitors inducing differentiation of transformed cells&quot;, EMBO J 20:6969&ndash;6978</p>\n\n<p>Gregoretti, I.V. et al. (2004), &quot;Molecular evolution of the histone deacetylase family: functional implications of phylogenetic analysis&quot;, J Mol Biol 338:17&ndash;31</p>\n\n<p>Hockly, E. et al. (2003), &quot;Suberoylanilide hydroxamic acid, a histone deacetylase inhibitor, ameliorates motor deficits in a mouse model of Huntington&rsquo;s disease&quot;, Proc Nat Acad Sci 100:2041-2046</p>\n\n<p>Hu, E. et al. (2003), &quot;Identification of novel isoform-selective inhibitors within class I histone deacetylases&quot;, J Pharmacol Exp Ther 307:720-728</p>\n\n<p>Huang, Y.X. et al. (2016), &quot;Virtual screening and experimental validation of novel histone deacetylase inhibitors&quot;, BMC Pharmacol Toxicol 17(1):32</p>\n\n<p>Jansen, M.S. et al. (2014), &quot;Short-chain fatty acids enhance nuclear receptor activity through mitogen-activated protein kinase activation and histone deacetylase inhibition&quot;, Proc Natl Acad Sci USA 101(18):7199-7204</p>\n\n<p>Luckhurst, C.A. et al. (2016), &quot;Potent, Selective, and CNS-Penetrant Tetrasubstituted Cyclopropane Class IIa Histone Deacetylase (HDAC) Inhibitors&quot;, ACS Med Chem Lett 7:34&ndash;39</p>\n\n<p>Mishra, N. et al. (2003), &quot;Histone deacetylase inhibitors modulate renal disease in the MRL-lpr/lpr mouse&quot;, J Clin Invest 111:539-552</p>\n\n<p>Miyanaga, A. et al. (2008), &quot;Antitumor activity of histone deacetylase inhibitors in non-small cell lung cancer cells: development of a molecular predictive model&quot;, Mol Cancer Ther 7:1923-1930</p>\n\n<p><span style=\"font-family:Arial,Helvetica,sans-serif\"><span style=\"font-size:16px\">Ooi, J.Y.Y., et al. (2015), &ldquo;HDAC inhibition attenuates cardiac hypertrophy by acetylation and deacetylation of target genes&rdquo;, Epigenetics&nbsp;10:418-430</span></span></p>\n\n<p><span style=\"font-size:16px\"><span style=\"font-family:Arial,Helvetica,sans-serif\">Park M.J. and Sohrabi F. (2016), &ldquo;The histone deacetylase inhibitor, sodium butyrate, exhibits neuroprotective effects for ischemic stroke in middle-aged female rats&rdquo;, J Neuroinflammation 13:300</span></span></p>\n\n<p>Porter, N.J., and Christianson, D.W. (2017), &quot;Binding of the microbial cyclic tetrapeptide trapoxin A to the Class I histone deacetylase HDAC8&quot;, ACS Chem Biol 12:2281&ndash;2286</p>\n\n<p>Richon, V.M. et al. (2003), &quot;Histone deacetylase inhibitors: assays to assess effectiveness in vitro and in vivo&quot;, Methods Enzymol. 376:199-205</p>\n\n<p>Ropero, S. and Esteller, M. (2007), &quot;The role of histone deacetylases (HDACs) in human cancer&quot;, Mol Oncol 1:19-25</p>\n\n<p>Sekhavat, A. et al. (2007), &quot;Competitive inhibition of histone deacetylase activity by trichostatin A and butyrate&quot;, Biochemistry and Cell Biology 85:751-758</p>\n\n<p>Taunton, J. et al. (1996), &quot;A mammalian histone deacetylase related to the Yeast transcriptional regulator Rpd3p&quot;, Science 272:408-411</p>\n\n<p>Villar-Garea, A. and Esteller, M. (2004), &quot;Histone deacetylase inhibitors: understanding a new wave of anticancer agents&quot;, Int J Cancer 112:171-178</p>\n\n<p>Wade, M.G. et al. (2008), &quot;Methoxyacetic acid-induced spermatocyte death is associated with histone hyperacetylation in rats&quot;, Biol Reprod 78:822-831</p>\n\n<p><span style=\"font-size:16px\"><span style=\"font-family:Arial,Helvetica,sans-serif\">Wagner F.F. et al. (2015), &ldquo;Kinetically selective inhibitors of histone deacetylase 2 (HDAC2) as cognition enhances&rdquo;, Chem Sci 6:804</span></span></p>\n\n<p>Weichert, W. (2009) &quot;HDAC expression and clinical prognosis in human malignancies&quot;, Cancer Letters 280:168-176</p>\n\n<p>Yanuar, A. et al. (2016), &quot;In silico approach to finding new active compounds from histone deacetylase (HDAC) family&quot;, Curr Pharm Des 22:3488-3497</p>\n\n<p>Zwick, V. et al. (2016), &quot;Cell-based multi-substrate assay coupled to UHPLC-ESI-MS/MS for a quick identification of class-specific HDAC inhibitors&quot;, J Enzyme Inhib Med Chem 31:209-214</p>\n","biologicalOrganisationLevel":"Molecular","organTerm":{"name":"organ","sourceId":"UBERON:0000062"},"biologicalEvents":[{"action":"decreased","process":"enzyme inhibitor activity","object":{"name":"histone deacetylase 1","source":"PR","sourceId":"PR:000008478"}}],"keyEventStressors":["MS-275","Valproic acid","Butyrate","Apicidin","Methoxyacetic acid","Trichostatin A","Suberoylanilide hydroxamic acid"],"id":1502}
{"title":"Histone acetylation, increase","references":"<p>Dayan, C. and Hales, B.F. (2014), &quot;Effects of ethylene glycol monomethyl ether and its metabolite, 2-methoxyacetic acid, on organogenesis stage mouse limbs in vitro&quot;, Birth Defects Res (Part B) 101:254-261</p>\n\n<p>Di Renzo, F. et al. (2007a), &quot;Boric acid inhibits embryonic histone deacetylases: A suggested mechanism to explain boric acid-related teratogenicity&quot;, Toxicol and Appl Pharmacol 220:178-185</p>\n\n<p>Di Renzo, F. et al. (2007b), &quot;Relationship between embryonic histonic hyperacetylation and axial skeletal defects in mouse exposed to the three HDAC inhibitors apicidin, MS-275, and sodium butyrate&quot;, Toxicol Sci 98:582-588</p>\n\n<p>Gunjan, A. et al. (2001), &quot;Core histone acetylation is regulated by linker histone stoichiometry in vivo&quot;, J Biol Chem 276:3635-3640</p>\n\n<p>Jansen, M.S. et al. (2014), &quot;Short-chain fatty acids enhance nuclear receptor activity through mitogen-activated protein kinase activation and histone deacetylase inhibition&quot;, Proc Natl Acad Sci USA 101:7199-7204</p>\n\n<p>Richon, V.M. et al. (2004), &quot;Histone deacetylase inhibitors: assays to assess effectiveness in vitro and in vivo&quot;, Methods Enzymol 376:199-205</p>\n\n<p>Wade, M.G. et al. (2008), &quot;Methoxyacetic acid-induced spermatocyte death is associated with histone hyperacetylation in rats&quot;, Biol Reprod 78:822-831</p>\n","biologicalOrganisationLevel":"Cellular","organTerm":{"name":"organ","sourceId":"UBERON:0000062"},"biologicalEvents":[{"action":"increased","process":"regulation of protein modification process","object":{"name":"histone","source":"CHEBI","sourceId":"CHEBI:15358"}}],"id":1503}
{"title":"Cell cycle, disrupted","references":"<p>Bajar, B.T. et al. (2016), &quot;Fluorescent indicators for simultaneous reporting of all four cell cycle phases&quot;, Nat Methods 13:993-996&nbsp;</p>\n\n<p>Heintz, N. et al. (1983), &quot;Regulation of human histone gene expression: Kinetics of accumulation and changes in the rate of synthesis and in the half-lives of individual histone mRNAs during the HeLa cell cycle&quot;, Molecular and Cellular Biology 3:539-550</p>\n\n<p>Li, Q. et al. (2013), &quot;Glyphosate and AMPA inhibit cancer cell growth through inhibiting intracellular glycine synthesis&quot;, Drug Des Devel Ther 7:635-643</p>\n","biologicalOrganisationLevel":"Cellular","organTerm":{"name":"organ","sourceId":"UBERON:0000062"},"biologicalEvents":[{"action":"disrupted","process":"regulation of cell cycle","object":{"name":"cell cycle-related cyclin","source":"PR","sourceId":"PR:000029191"}}],"id":1505}
{"title":"Testicular atrophy","references":"<p>Anderson, D. et al. (1987), &quot;Effect of ethylene glycol monomethyl ether on spermatogenesis, dominant lethality, and F1 abnormalities in the rat and the mouse after treatment of F0 males&quot;, Teratog Carcinog Mutagen 7:141-158</p>\n\n<p>Casarett &amp; Doull&rsquo;s Toxicology, the Basic Science of Poisons, 7th Edition, Edited by Curtis D. Klaassen, Chapter 20 Toxic responses of the reproductive system</p>\n\n<p>Foote, R.H. et al. (1995), &quot;Ethylene glycol monomethyl ether effects on health and reproduction in male rabbits&quot;, Reprod Toxicol 9:527-539</p>\n\n<p>Foster, P.M. et al. (1983), &quot;Testicular toxicity of ethylene glycol monomethyl and monoethyl ethers in the rats&quot;, Toxicol Appl Pharmacol 69:385-399</p>\n\n<p>Ku, W.W. et al. (1994), &quot;Comparison of the testicular effects of 2-methoxyethanol (ME) in rats and guinea pigs&quot;, Exp Mol Pathol 61:119-133</p>\n\n<p>McDowell, E.M. and Trump, B.F. (1976), &quot;Histologic fixatives suitable for diagnostic light and electron microscopy&quot;, Arch Pathol Lab Med 100:405-414</p>\n\n<p>Mercantepe, T. et al. (2018), &quot;Protective effects of amifostine, curcumin and caffeic acid phenethyl ester against cisplatin-induced testis tissue damage in rats&quot;, Exp Ther Med 15:3404-3412</p>\n\n<p>Miller, R. et al. (1982), &quot;Toxicity of methoxyacetic acid in rats&quot;, Fundam Appl Toxicol 2:158-160</p>\n\n<p>Moss, E.J. et al. (1985), &quot;The role of metabolism in 2-methoxyethanol-induced testicular toxicity&quot;, Toxicol Appl Pharmacol 79:480-489</p>\n\n<p>Poon, R. et al. (2004), &quot;Short-term oral toxicity of pentyl ether, 1,4-diethoxybutane, and 1,6-dimethoxyhexane in male rats&quot;, Toxicol Sci 77:142-150</p>\n\n<p>Wade, M.G. et al. (2006), &quot;Testicular toxicity of candidate fuel additive 1,6-dimethoxyhexane: comparison with several similar aliphatic ethers&quot;, Toxicol Sci 89:304-313</p>\n","biologicalOrganisationLevel":"Organ","organTerm":{"name":"testis","sourceId":"UBERON:0000473"},"biologicalEvents":[{"action":"increased","process":"Testicular atrophy","object":{"name":"Testis","source":"FMA","sourceId":"FMA:7210"}}],"id":1506}
{"title":"Spermatocyte depletion","references":"<p><span style=\"font-size:14px\">de Kretser, D.M. et al. (2016), &quot;Endocrinology: Adult and Pediatric (Seventh Edition)&quot;, W.B. Saunders, Chapter 136-Spermatogenesis, pages 2325-2353.e9, Editors: J. Larry Jameson, Leslie J De Groot, David M. de Kretser, Linda C. Giudice, Ashley B. Grossman, Shlomo Melmed, John T. Potts, Gordon C. Weir</span></p>\n\n<p><span style=\"font-size:14px\">Oishi, S. (2001), &quot;Effects of butylparaben on the male reproductive system in rats&quot;, Toxicol Indust Health 17:31-39</span></p>\n\n<p><span style=\"font-size:14px\">Rooij, D.G. (2001), &quot;Proliferation and differentiation of spermatogonial stem cells&quot;, Reproduction 121:347-354</span></p>\n\n<p><span style=\"font-size:14px\">Wade, M.G. et al. (2006), &quot;Testicular toxicity of candidate fuel additive 1,6-dimethoxyhexane: comparison with several similar aliphatic ethers&quot;, Toxicol Sci 89:304-313</span></p>\n\n<p><span style=\"font-size:14px\">Wade, M.G. et al. (2008), &quot;Methoxyacetic acid-induced spermatocyte death is associated with histone hyperacetylation in rats&quot;, Biol Reprod 78:822-831</span></p>\n\n<p><span style=\"font-size:14px\">Zindy, F. et al. (2001), &quot;Control of spermatogenesis in mice by the cyclin D-dependent kinase inhibitors p18Ink4c and p19Ink4d&quot;, Mol Cell Biol 21:3244-3255</span></p>\n","biologicalOrganisationLevel":"Tissue","organTerm":{"name":"testis","sourceId":"UBERON:0000473"},"biologicalEvents":[{"action":"decreased","object":{"name":"spermatocyte","source":"CL","sourceId":"CL:0000017"}}],"id":1515}
{"title":"Increase, cytosolic fatty acid","references":"","biologicalOrganisationLevel":"Cellular","organTerm":{},"biologicalEvents":[{"object":{}}],"id":1305}
{"title":"N/A, Steatohepatisis","references":"","biologicalOrganisationLevel":"Organ","organTerm":{},"biologicalEvents":[{"object":{}}],"id":1489}
{"title":"Inhibition, Fatty Acid Beta Oxidation","references":"","biologicalOrganisationLevel":"Molecular","organTerm":{},"biologicalEvents":[{"object":{}}],"id":1490}
{"title":"Increased, Oncotic Necrosis","references":"","biologicalOrganisationLevel":"Tissue","organTerm":{},"biologicalEvents":[{"object":{}}],"id":1491}
{"title":"Inhibit, serotonin transporter activity","references":"","biologicalOrganisationLevel":"Molecular","organTerm":{},"biologicalEvents":[{"object":{}}],"id":1316}
{"title":"Decreased, serotonin transporter activity","references":"","biologicalOrganisationLevel":"Molecular","organTerm":{},"biologicalEvents":[{"object":{}}],"id":1317}
{"title":"Decreased, extracellular sodium (Na+) ","references":"","biologicalOrganisationLevel":"Molecular","organTerm":{},"biologicalEvents":[{"object":{}}],"id":1318}
{"title":"Decreased, extracellular chloride (Cl-)","references":"","biologicalOrganisationLevel":"Molecular","organTerm":{},"biologicalEvents":[{"object":{}}],"id":1319}
{"title":"Increased, extracellular serotonin","references":"","biologicalOrganisationLevel":"Molecular","organTerm":{},"biologicalEvents":[{"object":{}}],"id":1320}
{"title":"Increased, intracellular sodium (Na+)","references":"","biologicalOrganisationLevel":"Molecular","organTerm":{},"biologicalEvents":[{"object":{}}],"id":1321}
{"title":"Increased, intracellular chloride (Cl-)","references":"","biologicalOrganisationLevel":"Molecular","organTerm":{},"biologicalEvents":[{"object":{}}],"id":1322}
{"title":"Decreased, intracellular serotonin","references":"","biologicalOrganisationLevel":"Molecular","organTerm":{},"biologicalEvents":[{"object":{}}],"id":1323}
{"title":"Decreased, packaged serotonin","references":"","biologicalOrganisationLevel":"Molecular","organTerm":{},"biologicalEvents":[{"object":{}}],"id":1324}
{"title":"Decreased, synaptic release","references":"","biologicalOrganisationLevel":"Molecular","organTerm":{},"biologicalEvents":[{"object":{}}],"id":1325}
{"title":"Increased, 5-HT3 (5-hydroxytryptamine)","references":"","biologicalOrganisationLevel":"Molecular","organTerm":{},"biologicalEvents":[{"object":{}}],"id":1326}
{"title":"Inactivated, 5-HTR (serotonin receptors)","references":"","biologicalOrganisationLevel":"Molecular","organTerm":{},"biologicalEvents":[{"object":{}}],"id":1328}
{"title":"Reduce expression, BDNF (Brain-derived neurotrophic factor)","references":"","biologicalOrganisationLevel":"Molecular","organTerm":{},"biologicalEvents":[{"object":{}}],"id":1329}
{"title":"Decreased, neuroplasticity","references":"","biologicalOrganisationLevel":"Molecular","organTerm":{},"biologicalEvents":[{"object":{}}],"id":1330}
{"title":"Increase, cortisone","references":"","biologicalOrganisationLevel":"Molecular","organTerm":{},"biologicalEvents":[{"object":{}}],"id":1334}
{"title":"Reduced, BDNF (Brain-derived neurotrophic factor)","references":"","biologicalOrganisationLevel":"Molecular","organTerm":{},"biologicalEvents":[{"object":{}}],"id":1335}
{"title":"Activation, 5-HT2A (Serotonin 2A)","references":"","biologicalOrganisationLevel":"Molecular","organTerm":{},"biologicalEvents":[{"object":{}}],"id":1336}
{"title":"Activate, PLC (Phospholipase C)","references":"","biologicalOrganisationLevel":"Molecular","organTerm":{},"biologicalEvents":[{"object":{}}],"id":1337}
{"title":"Increase, inositol triphosphate","references":"","biologicalOrganisationLevel":"Molecular","organTerm":{},"biologicalEvents":[{"object":{}}],"id":1338}
{"title":"Increase, intracellular calcium","references":"","biologicalOrganisationLevel":"Cellular","organTerm":{},"biologicalEvents":[{"object":{}}],"id":1339}
{"title":"Activate, calmodulin","references":"","biologicalOrganisationLevel":"Molecular","organTerm":{},"biologicalEvents":[{"object":{}}],"id":1340}
{"title":"Increase, myosin light chain phosphorylation","references":"","biologicalOrganisationLevel":"Molecular","organTerm":{},"biologicalEvents":[{"object":{}}],"id":1341}
{"title":"Increase, vascular smooth muscle contraction","references":"","biologicalOrganisationLevel":"Molecular","organTerm":{},"biologicalEvents":[{"object":{}}],"id":1342}
{"title":"Increased, seizure","references":"","biologicalOrganisationLevel":"Individual","organTerm":{},"biologicalEvents":[{"object":{}}],"id":1344}
{"title":"Increased, agitation","references":"","biologicalOrganisationLevel":"Molecular","organTerm":{},"biologicalEvents":[{"object":{}}],"id":1345}
{"title":"Increased, depression","references":"","biologicalOrganisationLevel":"Individual","organTerm":{},"biologicalEvents":[{"object":{}}],"id":1346}
{"title":"Increase, hypertension","references":"","biologicalOrganisationLevel":"Individual","organTerm":{},"biologicalEvents":[{"object":{}}],"id":1343}
{"title":"Decreased, extracellular serotonin","references":"","biologicalOrganisationLevel":"Molecular","organTerm":{},"biologicalEvents":[{"object":{}}],"id":1347}
{"title":"Increase, seizure","references":"","biologicalOrganisationLevel":"Individual","organTerm":{},"biologicalEvents":[{"object":{}}],"id":1348}
{"title":"Activated, presynaptic neuron 1","references":"","biologicalOrganisationLevel":"Molecular","organTerm":{},"biologicalEvents":[{"object":{}}],"id":1349}
{"title":"Increased, glutamate","references":"","biologicalOrganisationLevel":"Molecular","organTerm":{},"biologicalEvents":[{"object":{}}],"id":1350}
{"title":"Activated, NMDA receptor","references":"","biologicalOrganisationLevel":"Molecular","organTerm":{},"biologicalEvents":[{"object":{}}],"id":1351}
{"title":"Activated, voltage-gated sodium channel","references":"","biologicalOrganisationLevel":"Molecular","organTerm":{},"biologicalEvents":[{"object":{}}],"id":1352}
{"title":"Inhibit, voltage-gated sodium channel","references":"","biologicalOrganisationLevel":"Molecular","organTerm":{},"biologicalEvents":[{"object":{}}],"id":1353}
{"title":"Treat, carbamazepine","references":"","biologicalOrganisationLevel":"Molecular","organTerm":{},"biologicalEvents":[{"object":{}}],"id":1354}
{"title":"Activated, membrane depolarization","references":"","biologicalOrganisationLevel":"Cellular","organTerm":{},"biologicalEvents":[{"object":{}}],"id":1355}
{"title":"Inactive, membrane depolarization","references":"","biologicalOrganisationLevel":"Molecular","organTerm":{},"biologicalEvents":[{"object":{}}],"id":1356}
{"title":"Increased, RDX dose","references":"","biologicalOrganisationLevel":"Molecular","organTerm":{},"biologicalEvents":[{"object":{}}],"id":1357}
{"title":"Repress, GABA-A receptor","references":"","biologicalOrganisationLevel":"Molecular","organTerm":{},"biologicalEvents":[{"object":{}}],"id":1358}
{"title":"Activate, GABA-A receptor","references":"","biologicalOrganisationLevel":"Molecular","organTerm":{},"biologicalEvents":[{"object":{}}],"id":1359}
{"title":"Activate, presynaptic neuron 2","references":"","biologicalOrganisationLevel":"Molecular","organTerm":{},"biologicalEvents":[{"object":{}}],"id":1360}
{"title":"Increase, GABA","references":"","biologicalOrganisationLevel":"Molecular","organTerm":{},"biologicalEvents":[{"object":{}}],"id":1361}
{"title":"Increased, hippocampal hyperdepolarization","references":"","biologicalOrganisationLevel":"Molecular","organTerm":{},"biologicalEvents":[{"object":{}}],"id":1362}
{"title":"Increased, epilepsy","references":"","biologicalOrganisationLevel":"Individual","organTerm":{},"biologicalEvents":[{"object":{}}],"id":1363}
{"title":"Increase, Oxidative DNA damage","references":"","biologicalOrganisationLevel":"Molecular","organTerm":{},"biologicalEvents":[{"object":{}}],"id":1608}
{"title":"Increase, Apoptosis","references":"","biologicalOrganisationLevel":"Cellular","organTerm":{},"biologicalEvents":[{"object":{}}],"id":1365}
{"title":"Increase, Follicular atresia","references":"","biologicalOrganisationLevel":"Organ","organTerm":{},"biologicalEvents":[{"object":{}}],"id":1444}
{"title":"Decrease, Oogenesis","references":"","biologicalOrganisationLevel":"Organ","organTerm":{},"biologicalEvents":[{"object":{}}],"id":1366}
{"title":"Decrease, Fecundity","references":"","biologicalOrganisationLevel":"Individual","organTerm":{},"biologicalEvents":[{"object":{}}],"id":328}
{"title":"Inhibit, gastric ulcer formation","references":"","biologicalOrganisationLevel":"Organ","organTerm":{},"biologicalEvents":[{"object":{}}],"id":1367}
{"title":"Inhibition, PTGS-1 (Prostaglandin-endoperoxide synthase 1)","references":"","biologicalOrganisationLevel":"Molecular","organTerm":{},"biologicalEvents":[{"object":{}}],"id":1368}
{"title":"Activation, PTGS-1 (Prostaglandin-endoperoxide synthase 1)","references":"","biologicalOrganisationLevel":"Molecular","organTerm":{},"biologicalEvents":[{"object":{}}],"id":1369}
{"title":"Activation, PTGS-2 (Prostaglandin-endoperoxide synthase 2)","references":"","biologicalOrganisationLevel":"Molecular","organTerm":{},"biologicalEvents":[{"object":{}}],"id":1370}
{"title":"Inhibition, PTGS-2 (Prostaglandin-endoperoxide synthase 2)","references":"","biologicalOrganisationLevel":"Molecular","organTerm":{},"biologicalEvents":[{"object":{}}],"id":1371}
{"title":"Increase, bicarbonate ","references":"","biologicalOrganisationLevel":"Molecular","organTerm":{},"biologicalEvents":[{"object":{}}],"id":1372}
{"title":"Increase, mucous","references":"","biologicalOrganisationLevel":"Molecular","organTerm":{},"biologicalEvents":[{"object":{}}],"id":1373}
{"title":"Increase, mucosal blood flow","references":"","biologicalOrganisationLevel":"Tissue","organTerm":{},"biologicalEvents":[{"object":{}}],"id":1374}
{"title":"Increase, platelet aggregation","references":"","biologicalOrganisationLevel":"Tissue","organTerm":{},"biologicalEvents":[{"object":{}}],"id":1375}
{"title":"Increase, angiogenesis","references":"","biologicalOrganisationLevel":"Tissue","organTerm":{},"biologicalEvents":[{"object":{}}],"id":1376}
{"title":"Decrease, leukocyte adherence","references":"","biologicalOrganisationLevel":"Tissue","organTerm":{},"biologicalEvents":[{"object":{}}],"id":1377}
{"title":"Increase, leukocyte adherence","references":"","biologicalOrganisationLevel":"Tissue","organTerm":{},"biologicalEvents":[{"object":{}}],"id":1378}
{"title":"Activate, leukocyte ","references":"","biologicalOrganisationLevel":"Cellular","organTerm":{},"biologicalEvents":[{"object":{}}],"id":1379}
{"title":"Activate, mucosal defense","references":"","biologicalOrganisationLevel":"Tissue","organTerm":{},"biologicalEvents":[{"object":{}}],"id":1380}
{"title":"Increase, surfactant","references":"","biologicalOrganisationLevel":"Molecular","organTerm":{},"biologicalEvents":[{"object":{}}],"id":1381}
{"title":"Decrease, surfactant","references":"","biologicalOrganisationLevel":"Molecular","organTerm":{},"biologicalEvents":[{"object":{}}],"id":1382}
{"title":"Activate, phospholipase","references":"","biologicalOrganisationLevel":"Molecular","organTerm":{},"biologicalEvents":[{"object":{}}],"id":1383}
{"title":"Increase, ammonium (NH4+)","references":"","biologicalOrganisationLevel":"Molecular","organTerm":{},"biologicalEvents":[{"object":{}}],"id":1384}
{"title":"Activated, gastric ulcer formation","references":"","biologicalOrganisationLevel":"Organ","organTerm":{},"biologicalEvents":[{"object":{}}],"id":1385}
{"title":"CYP7B activity, inhibition","references":"<p>Dulos, J., van der Vleuten, M.A., Kavelaars, A., Heijnen, C.J., and Boots, A.M. (2005). CYP7B expression and activity in fibroblast-like synoviocytes from patients with rheumatoid arthritis: regulation by proinflammatory cytokines. Arthritis Rheum 52, 770-778.</p>\n\n<p>Handschin C., Gnerre C., Fraser DJ., Martinez-Jimenez C., Jover R., Mever UA., (2005) Species-specific mechanisms for cholesterol 7&alpha;-hydroxylase (CYP7A1) regulation by drugs and bile acids, Archives of Biochemistry and Biophysics, Vol 434-1, pp75-85</p>\n\n<p>Haraguchi, S., Koyama, T., Hasunuma, I., Okuyama, S., Ubuka, T., Kikuyama, S., Do Rego, J.L., Vaudry, H., and Tsutsui, K. (2012). Acute stress increases the synthesis of 7alpha-hydroxypregnenolone, a new key neurosteroid stimulating locomotor activity, through corticosterone action in newts. Endocrinology 153, 794-805.</p>\n\n<p>Haraguchi, S., Yamamoto, Y., Suzuki, Y., Hyung Chang, J., Koyama, T., Sato, M., Mita, M., Ueda, H., and Tsutsui, K. (2015). 7alpha-Hydroxypregnenolone, a key neuronal modulator of locomotion, stimulates upstream migration by means of the dopaminergic system in salmon. Sci Rep 5, 12546.</p>\n\n<p>Li-Hawkins, J., Lund, E.G., Turley, S.D., and Russell, D.W. (2000). Disruption of the oxysterol 7alpha-hydroxylase gene in mice. J Biol Chem 275, 16536-16542.</p>\n\n<p>Liu, C., Yang, X.V., Wu, J., Kuei, C., Mani, N.S., Zhang, L., Yu, J., Sutton, S.W., Qin, N., Banie, H., et al. (2011). Oxysterols direct B-cell migration through EBI2. Nature 475, 519-523.</p>\n\n<p>Martin, C., Bean, R., Rose, K., Habib, F., and Seckl, J. (2001). cyp7b1 catalyses the 7alpha-hydroxylation of dehydroepiandrosterone and 25-hydroxycholesterol in rat prostate. Biochem J 355, 509-515.</p>\n\n<p>Martin, C., Ross, M., Chapman, K.E., Andrew, R., Bollina, P., Seckl, J.R., and Habib, F.K. (2004). CYP7B generates a selective estrogen receptor beta agonist in human prostate. J Clin Endocrinol Metab 89, 2928-2935.</p>\n\n<p>Matsunaga, M., Ukena, K., Baulieu, E.E., and Tsutsui, K. (2004). 7alpha-Hydroxypregnenolone acts as a neuronal activator to stimulate locomotor activity of breeding newts by means of the dopaminergic system. Proc Natl Acad Sci U S A 101, 17282-17287.</p>\n\n<p>Rose, K., Allan, A., Gauldie, S., Stapleton, G., Dobbie, L., Dott, K., Martin, C., Wang, L., Hedlund, E., Seckl, J.R., et al. (2001). Neurosteroid hydroxylase CYP7B: vivid reporter activity in dentate gyrus of gene-targeted mice and abolition of a widespread pathway of steroid and oxysterol hydroxylation. J Biol Chem 276, 23937-23944.</p>\n\n<p>Rose, K.A., Stapleton, G., Dott, K., Kieny, M.P., Best, R., Schwarz, M., Russell, D.W., Bjorkhem, I., Seckl, J., and Lathe, R. (1997). Cyp7b, a novel brain cytochrome P450, catalyzes the synthesis of neurosteroids 7alpha-hydroxy dehydroepiandrosterone and 7alpha-hydroxy pregnenolone. Proc Natl Acad Sci U S A 94, 4925-4930.</p>\n\n<p>Souidi, M., Parquet, M., Dubrac, S., Audas, O., Becue, T., and Lutton, C. (2000). Assay of microsomal oxysterol 7alpha-hydroxylase activity in the hamster liver by a sensitive method: in vitro modulation by oxysterols. Biochim Biophys Acta 1487, 74-81.</p>\n\n<p>Toll, A., Wikvall, K., Sudjana-Sugiaman, E., Kondo, K.H., and Bjorkhem, I. (1994). 7 alpha hydroxylation of 25-hydroxycholesterol in liver microsomes. Evidence that the enzyme involved is different from cholesterol 7 alpha-hydroxylase. Eur J Biochem 224, 309-316.</p>\n\n<p>Tsutsui, K., Inoue, K., Miyabara, H., Suzuki, S., Ogura, Y., and Haraguchi, S. (2008). 7Alpha-hydroxypregnenolone mediates melatonin action underlying diurnal locomotor rhythms. J Neurosci 28, 2158-2167.</p>\n\n<p>Weihua, Z., Lathe, R., Warner, M., and Gustafsson, J.A. (2002). An endocrine pathway in the prostate, ERbeta, AR, 5alpha-androstane-3beta,17beta-diol, and CYP7B1, regulates prostate growth. Proc Natl Acad Sci U S A 99, 13589-13594.</p>\n\n<p>Yantsevich, A.V., Dichenko, Y.V., Mackenzie, F., Mukha, D.V., Baranovsky, A.V., Gilep, A.A., Usanov, S.A., and Strushkevich, N.V. (2014). Human steroid and oxysterol 7alpha-hydroxylase CYP7B1: substrate specificity, azole binding and misfolding of clinically relevant mutants. FEBS J 281, 1700-1713.</p>\n","biologicalOrganisationLevel":"Molecular","organTerm":{},"biologicalEvents":[{"object":{}}],"keyEventStressors":["Ketoconazole","Fluconazole","Clotrimazole","Miconazole","Tioconazole","Tebuconazole","Propiconazole","Voriconazole"],"id":1386}
{"title":"7-hydroxypregnenolone synthesis in the brain, decreased","references":"<p style=\"text-align: justify;\">Haraguchi, S., Koyama, T., Hasunuma, I., Vaudry, H., and Tsutsui, K. (2010). Prolactin increases the synthesis of 7alpha-hydroxypregnenolone, a key factor for induction of locomotor activity, in breeding male Newts. Endocrinology 151, 2211-2222.</p>\n\n<p style=\"text-align: justify;\">Haraguchi, S., Yamamoto, Y., Suzuki, Y., Hyung Chang, J., Koyama, T., Sato, M., Mita, M., Ueda, H., and Tsutsui, K. (2015). 7alpha-Hydroxypregnenolone, a key neuronal modulator of locomotion, stimulates upstream migration by means of the dopaminergic system in salmon. Sci Rep 5, 12546.</p>\n\n<p style=\"text-align: justify;\">Matsunaga, M., Ukena, K., Baulieu, E.E., and Tsutsui, K. (2004). 7alpha-Hydroxypregnenolone acts as a neuronal activator to stimulate locomotor activity of breeding newts by means of the dopaminergic system. Proc Natl Acad Sci U S A 101, 17282-17287.</p>\n\n<p style=\"text-align: justify;\">Petkam, R., Renaud, R.L., Freitas, A.M., Canario, A.V., Raeside, J.I., Kime, D.E., and Leatherland, J.F. (2003). In vitro metabolism of pregnenolone to 7alpha-hydroxypregnenolone by rainbow trout embryos. Gen Comp Endocrinol 131, 241-249.</p>\n\n<p style=\"text-align: justify;\">Tsutsui, K., Inoue, K., Miyabara, H., Suzuki, S., Ogura, Y., and Haraguchi, S. (2008). 7Alpha-hydroxypregnenolone mediates melatonin action underlying diurnal locomotor rhythms. J Neurosci 28, 2158-2167.</p>\n\n<p style=\"text-align: justify;\">Tsutsui, K., and Yamazaki, T. (1995). Avian neurosteroids. I. Pregnenolone biosynthesis in the quail brain. Brain Res 678, 1-9.</p>\n\n<p style=\"text-align: justify;\">Yau, J.L., Noble, J., Graham, M., and Seckl, J.R. (2006). Central administration of a cytochrome P450-7B product 7 alpha-hydroxypregnenolone improves spatial memory retention in cognitively impaired aged rats. J Neurosci 26, 11034-11040.</p>\n","biologicalOrganisationLevel":"Cellular","organTerm":{},"biologicalEvents":[{"object":{}}],"keyEventStressors":["Ketoconazole"],"id":1387}
{"title":"Dopamine release in the brain, decreased","references":"<p>Barron, A.B., Sovik, E., and Cornish, J.L. (2010). The roles of dopamine and related compounds in reward-seeking behavior across animal phyla. Front Behav Neurosci 4, 163.</p>\n\n<p>Carlsson, A., Lindqvist, M., and Magnusson, T. (1957). 3,4-Dihydroxyphenylalanine and 5-hydroxytryptophan as reserpine antagonists. Nature 180, 1200.</p>\n\n<p>Matsunaga, M., Ukena, K., Baulieu, E.E., and Tsutsui, K. (2004). 7alpha-Hydroxypregnenolone acts as a neuronal activator to stimulate locomotor activity of breeding newts by means of the dopaminergic system. Proc Natl Acad Sci U S A 101, 17282-17287.</p>\n\n<p>Stoof, J.C., and Kebabian, J.W. (1984). Two dopamine receptors: biochemistry, physiology and pharmacology. Life Sci 35, 2281-2296.</p>\n\n<p>Vallender, E.J., Xie, Z., Westmoreland, S.V., and Miller, G.M. (2010). Functional evolution of the trace amine associated receptors in mammals and the loss of TAAR1 in dogs. BMC Evol Biol 10, 51.</p>\n\n<p>&nbsp;</p>\n\n<p>&nbsp;</p>\n","biologicalOrganisationLevel":"Tissue","organTerm":{},"biologicalEvents":[{"object":{}}],"id":1388}
{"title":"Locomotor activity, decreased","references":"<p>Gowans A. R. D., Armstrong J. D., Priede I. G. &amp; Mckelvey S. (2003). Movements of Atlantic salmon migrating upstream through a fish-pass complex in Scotland.&nbsp;Ecol. Freshw. Fish&nbsp;12, 177&ndash;189.</p>\n\n<p>Lowry, C.A., Burke, K.A., Renner, K.J., Moore, F.L., and Orchinik, M. (2001). Rapid changes in monoamine levels following administration of corticotropin-releasing factor or corticosterone are localized in the dorsomedial hypothalamus. Horm Behav 39, 195-205.</p>\n\n<p>Moore, F.L., Roberts, J., Bevers, J. (1984). Corticotropin-releasing factor (CRF) stimulates locomotor activity in intact and hypophysectomized newts (Amphibia). J Exp Zool 231, 331-333.</p>\n\n<p>Nagai, K.,&nbsp;T. Oishi. T. (1998). Behavioral rhythms of&nbsp;the Japanese newts, Cynops pyrrhogaster, under a semi-natural condition. Int. J. Biometeorol. 41: 105&ndash;112.</p>\n\n<p>Levens N., Akins C.K. (2001).&nbsp;Cocaine induces conditioned place preference and increases locomotor activity in Japanese quail. Pharmacol Biochem Behav. 68-1, 71-80</p>\n\n<p>Tsutsui, K., Haraguchi, S., Fukada, Y., and Vaudry, H. (2013). Brain and pineal 7alpha-hydroxypregnenolone stimulating locomotor activity: identification, mode of action and regulation of biosynthesis. Front Neuroendocrinol 34, 179-189.</p>\n\n<p>Tsutsui, K., Inoue, K., Miyabara, H., Suzuki, S., Ogura, Y., and Haraguchi, S. (2008). 7Alpha-hydroxypregnenolone mediates melatonin action underlying diurnal locomotor rhythms. J Neurosci 28, 2158-2167.</p>\n\n<p>Wada, M. (1981). Effects of photostimulation, castration, and testosterone replacement on daily patterns of calling and locomotor activity in Japanese quail. Horm Behav 15, 270-281.</p>\n\n<p>Watson, A. (1970). Territorial and reproductive behaviour of red grouse. J Reprod Fertil Suppl 11, Suppl 11:13-14.</p>\n","biologicalOrganisationLevel":"Individual","organTerm":{},"biologicalEvents":[{"object":{}}],"id":1389}
{"title":"Decreased, Population trajectory","references":"","biologicalOrganisationLevel":"Population","organTerm":{},"biologicalEvents":[{"action":"decreased","process":"population growth rate","object":{}}],"id":442}
{"title":"Sexual behavior, decreased","references":"<p>Adkins, E. K. and N. T. Adler. 1972. Hormonal control of behavior in the Japanese quail. J. Comp. Physiol. Psychol.81:27-36.</p>\n\n<p>Halldin, K., Berg, C., Brandt, I., and Brunstrom, B. (1999). Sexual behavior in Japanese quail as a test end point for endocrine disruption: effects of in ovo exposure to ethinylestradiol and diethylstilbestrol. Environ Health Perspect 107, 861-866.</p>\n\n<p>Hutchison, R.E. (1978). Hormonal differentiation of sexual behavior in Japanese quail. Horm Behav 11, 363-387.</p>\n\n<p>Ogura, Y., Haraguchi, S., Nagino, K., Ishikawa, K., Fukahori, Y., and Tsutsui, K. (2016). 7alpha-Hydroxypregnenolone regulates diurnal changes in sexual behavior of male quail. Gen Comp Endocrinol 227, 130-135.</p>\n\n<p>Sachs, B.D. (1967). Photoperiodic control of the cloacal gland of the Japanese quail. Science 157, 201-203.</p>\n\n<p>Toyoda, F., Ito, M., Tanaka, S., and Kikuyama, S. (1993). Hormonal induction of male courtship behavior in the Japanese newt, Cynops pyrrhogaster. Horm Behav 27, 511-522.</p>\n","biologicalOrganisationLevel":"Individual","organTerm":{},"biologicalEvents":[{"object":{}}],"id":1390}
{"title":"Activation of Cyp2E1","references":"<p>Bardag-Gorce, F., Yuan, Q.X., Li, J., French, B.A., Fang, C., Ingelman-Sundberg, M., French, S.W., 2000. The effect of ethanol-induced cytochrome p4502E1 on the inhibition of proteasome activity by alcohol. Biochem. Biophys. Res. Commun. 279, 23-29.</p>\n\n<p>Bondoc, F.Y., Bao, Z., Hu, W.Y., Gonzalez, F.J., Wang, Y., Yang, C.S., Hong, J.Y., 1999. Acetone catabolism by cytochrome P450 2E1: studies with CYP2E1-null mice. Biochem. Pharmacol. 58, 461-463.</p>\n\n<p>Cederbaum, A.I., 2014. Methodology to assay CYP2E1 mixed function oxidase catalytic activity and its induction. Redox Biol. 2C, 1048-1054.</p>\n\n<p>Cheng, J., Chen, C., Kristopher, K.W., Manna, S.K., Scerba, M., Friedman, F.K., Luecke, H., Idle, J.R., Gonzalez, F.J., 2013. Identification of 2-piperidone as a biomarker of CYP2E1 activity through metabolomic phenotyping. Toxicol. Sci. 135, 37-47.</p>\n\n<p>Cheung, C., Gonzalez, F.J., 2008. Humanized mouse lines and their application for prediction of human drug metabolism and toxicological risk assessment. J. Pharmacol. Exp. Ther. 327, 288-299.</p>\n\n<p>Chilakapati, J., Korrapati, M.C., Shankar, K., Hill, R.A., Warbritton, A., Latendresse, J.R., Mehendale, H.M., 2007. Role of CYP2E1 and saturation kinetics in the bioactivation of thioacetamide: Effects of diet restriction and phenobarbital. Toxicol. Appl. Pharmacol. 219, 72-84.</p>\n\n<p>El Hadri, L., Chanas, B., Ghanayem, B.I., 2005. Comparative metabolism of methacrylonitrile and acrylonitrile to cyanide using cytochrome P4502E1 and microsomal epoxide hydrolase-null mice. Toxicol. Appl. Pharmacol. 205, 116-125.</p>\n\n<p>Fort, D.J., McLaughlin, D.W., Rogers, R.L., Buzzard, B.O., 2003. Evaluation of the developmental toxicities of ethanol, acetaldehyde, and thioacetamide using FETAX. Drug Chem. Toxicol. 26, 23-34.</p>\n\n<p>Girre, C., Lucas, D., Hispard, E., Menez, C., Dally, S., Menez, J.F., 1994. Assessment of cytochrome P4502E1 induction in alcoholic patients by chlorzoxazone pharmacokinetics. Biochem. Pharmacol. 47, 1503-1508.</p>\n\n<p>Gonzalez, F.J., 2007. The 2006 Bernard B. Brodie Award Lecture. Cyp2e1. Drug metabolism and disposition: the biological fate of chemicals 35, 1-8.</p>\n\n<p>Hoffler, U., El-Masri, H.A., Ghanayem, B.I., 2003. Cytochrome P450 2E1 (CYP2E1) is the principal enzyme responsible for urethane metabolism: comparative studies using CYP2E1-null and wild-type mice. J. Pharmacol. Exp. Ther. 305, 557-564.</p>\n\n<p>Hoffler, U., Ghanayem, B.I., 2005. Increased bioaccumulation of urethane in CYP2E1-/- versus CYP2E1+/+ mice. Drug Metab. Dispos. 33, 1144-1150.</p>\n\n<p>Howarth, D.L., Passeri, M., Sadler, K.C., 2011. Drinks Like a Fish: Using Zebrafish to Understand Alcoholic Liver Disease. Alcohol. Clin. Exp. Res. 35, 826-829.</p>\n\n<p>Ingelman-Sundberg, M., Johansson, I., Penttila, K.E., Glaumann, H., Lindros, K.O., 1988. Centrilobular expression of ethanol-inducible cytochrome P-450 (IIE1) in rat liver. Biochem. Biophys. Res. Commun. 157, 55-60.</p>\n\n<p>Kim, D., Ghanayem, B.I., 2006. Comparative metabolism and disposition of trichloroethylene in Cyp2e1-/-and wild-type mice. Drug Metab. Dispos. 34, 2020-2027.</p>\n\n<p>Koop, D.R., 1986. Hydroxylation of p-nitrophenol by rabbit ethanol-inducible cytochrome P-450 isozyme 3a. Mol. Pharmacol. 29, 399-404.</p>\n\n<p>Koop, D.R., Laethem, C.L., Tierney, D.J., 1989. The utility of p-nitrophenol hydroxylation in P450IIE1 analysis. Drug Metab. Rev. 20, 541-551.</p>\n\n<p>Lee, S.S., Buters, J.T., Pineau, T., Fernandez-Salguero, P., Gonzalez, F.J., 1996. Role of CYP2E1 in the hepatotoxicity of acetaminophen. J. Biol. Chem. 271, 12063-12067.</p>\n\n<p>Lieber, C.S., 1997. Cytochrome P-4502E1: its physiological and pathological role. Physiol. Rev. 77, 517-544.</p>\n\n<p><span style=\"color:#ff0000\">Morishima, Y., Peng, H-M., Lin, H-L., Hollenberg, P.F., Sunahara, R., K., Osawa, Y., Pratt, W.B. Regulation of Cytochrome P450 2E1 by Heat Shock Protein 90-Dependent Stabilization and CHIP-Dependent Proteasomal Degradation. 2005. Biochemistry. 44, 49, 16333-16340.</span></p>\n\n<p>Morgan, K., French, S.W., Morgan, T.R., 2002. Production of a cytochrome P450 2E1 transgenic mouse and initial evaluation of alcoholic liver damage. Hepatology 36, 122-134.</p>\n\n<p>Powley, M.W., Carlson, G.P., 2001. Hepatic and pulmonary microsomal benzene metabolism in CYP2E1 knockout mice. Toxicology 169, 187-194.</p>\n\n<p>Reinke, L.A., Moyer, M.J., 1985. p-Nitrophenol hydroxylation. A microsomal oxidation which is highly inducible by ethanol. Drug Metab. Dispos. 13, 548-552.</p>\n\n<p>Saito, H., Ohi, H., Sugata, E., Murayama, N., Fujita, Y., Higuchi, S., 1997. Purification and characterization of a cytochrome P450 from liver microsomes of Xenopus laevis. Arch. Biochem. Biophys. 345, 56-64.</p>\n\n<p>Song, B.J., Veech, R.L., Park, S.S., Gelboin, H.V., Gonzalez, F.J., 1989. Induction of rat hepatic N-nitrosodimethylamine demethylase by acetone is due to protein stabilization. J. Biol. Chem. 264, 3568-3572.</p>\n\n<p>Tanaka, E., Terada, M., Misawa, S., 2000. Cytochrome P450 2E1: its clinical and toxicological role. J. Clin. Pharm. Ther. 25, 165-175.</p>\n\n<p>Tsutsumi, M., Lasker, J.M., Shimizu, M., Rosman, A.S., Lieber, C.S., 1989. The intralobular distribution of ethanol-inducible P450IIE1 in rat and human liver. Hepatology 10, 437-446.</p>\n\n<p>Wu, D., Cederbaum, A.I., 2005. Oxidative stress mediated toxicity exerted by ethanol-inducible CYP2E1. Toxicol. Appl. Pharmacol. 207, 70-76.</p>\n\n<p>Zaher, H., Buters, J.T., Ward, J.M., Bruno, M.K., Lucas, A.M., Stern, S.T., Cohen, S.D., Gonzalez, F.J., 1998. Protection against acetaminophen toxicity in CYP1A2 and CYP2E1 double-null mice. Toxicol. Appl. Pharmacol. 152, 193-199.</p>\n\n<p>&nbsp;</p>\n","biologicalOrganisationLevel":"Molecular","organTerm":{},"biologicalEvents":[{"object":{}}],"keyEventStressors":["acetone","furan","Ethanol","Chloroform","Acetaminophen"],"id":1391}
{"title":"Hepatocytotoxicity","references":"<p>Chan, F.K., Moriwaki, K., De Rosa, M.J., 2013. Detection of necrosis by release of lactate dehydrogenase activity. Methods Mol. Biol. 979, 65-70.</p>\n\n<p>Eguchi, A., Wree, A., Feldstein, A.E., 2014. Biomarkers of liver cell death. J. Hepatol. 60, 1063-1074.</p>\n\n<p>Lozano, G.M., Bejarano, I., Espino, J., Gonzalez, D., Ortiz, A., Garcia, J.F., Rodriguez, A.B., Pariente, J.A., 2009. Relationship between caspase activity and apoptotic markers in human sperm in response to hydrogen peroxide and progesterone. J. Reprod. Dev. 55, 615-621.</p>\n\n<p>Luedde, T., Kaplowitz, N., Schwabe, R.F., 2014. Cell death and cell death responses in liver disease: mechanisms and clinical relevance. Gastroenterology 147, 765-783.e4.</p>\n\n<p>Pessayre, D., Mansouri, A., Berson, A., Fromenty, B., 2010. Mitochondrial involvement in drug-induced liver injury. Handb. Exp. Pharmacol. (196):311-65. doi, 311-365.</p>\n\n<p>Rasola, A., Bernardi, P., 2007. The mitochondrial permeability transition pore and its involvement in cell death and in disease pathogenesis. Apoptosis 12, 815-833.</p>\n\n<p>Riedl, S.J., Shi, Y., 2004. Molecular mechanisms of caspase regulation during apoptosis. Nat. Rev. Mol. Cell Biol. 5, 897-907.</p>\n\n<p>Riss, T.L., Moravec, R.A., Niles, A.L., Duellman, S., Benink, H.A., Worzella, T.J., Minor, L., 2004. Cell Viability Assays, in: Sittampalam, G.S., Coussens, N.P., Nelson, H., Arkin, M., Auld, D., Austin, C., Bejcek, B., Glicksman, M., Inglese, J., Iversen, P.W., Li, Z., McGee, J., McManus, O., Minor, L., Napper, A., Peltier, J.M., Riss, T., Trask OJ, J., Weidner, J. (Eds.), Assay Guidance Manual, Bethesda (MD).</p>\n\n<p>Strober, W., 2015. Trypan Blue Exclusion Test of Cell Viability. Curr. Protoc. Immunol. 111, A3.B.1-3.</p>\n\n<p>Vandenabeele, P., Galluzzi, L., Vanden Berghe, T., Kroemer, G., 2010. Molecular mechanisms of necroptosis: an ordered cellular explosion. Nat. Rev. Mol. Cell Biol. 11, 700-714.</p>\n\n<p>Youle, R.J., Strasser, A., 2008. The BCL-2 protein family: opposing activities that mediate cell death. Nat. Rev. Mol. Cell Biol. 9, 47-59.</p>\n","biologicalOrganisationLevel":"Cellular","organTerm":{"name":"liver","sourceId":"UBERON:0002107"},"biologicalEvents":[{"object":{}}],"keyEventStressors":["acetone","furan","Ethanol","Chloroform","Acetaminophen"],"id":1393}
{"title":"Induction, persistent proliferation/sustained proliferation","references":"<p>Alcorn, J.A., Feitelberg, S.P., Brenner, D.A., 1990. Transient induction of c-jun during hepatic regeneration. Hepatology 11, 909-915.</p>\n\n<p>Behrens, A., Sibilia, M., David, J.P., M&ouml;hle-Steinlein, U., Tronche, F., Sch&uuml;tz, G., Wagner, E.F., 2002. Impaired postnatal hepatocyte proliferation and liver regeneration in mice lacking c-jun in the liver. EMBO J. 21, 1782-1790.</p>\n\n<p>Boulter L, Govaere O, Bird TG, Radulescu S, Ramachandran P, Pellicoro A, Ridgway RA, et al. Macrophage-derived Wnt opposes Notch signaling to specify hepatic progenitor cell fate in chronic liver disease. Nat Med. 2012 Mar 4;18(4):572-9. doi: 10.1038/nm.2667.</p>\n\n<p>Burkhart DL, Sage J. Cellular mechanisms of tumour suppression by the retinoblastoma gene. Nat Rev Cancer. 2008 Sep;8(9):671-82. doi: 10.1038/nrc2399.</p>\n\n<p>Cox, A.G., Goessling, W., 2015. The lure of zebrafish in liver research: regulation of hepatic growth in development and regeneration. Curr. Opin. Genet. Dev. 32, 153-161.</p>\n\n<p>Cressman, D.E., Greenbaum, L.E., Haber, B.A., Taub, R., 1994. Rapid activation of post-hepatectomy factor/nuclear factor &kappa;B in hepatocytes, a primary response in the regenerating liver. J. Biol. Chem. 269, 30429-30435.</p>\n\n<p>Eferl, R., Sibilia, M., Hilberg, F., Fuchsbichler, A., Kufferath, I., Guertl, B., Zenz, R., Wagner, E.F., Zatloukal, K., 1999. Functions of c-Jun in liver and heart development. J. Cell Biol. 145, 1049-1061.</p>\n\n<p>FitzGerald, M.J., Webber, E.M., Donovan, J.R., Fausto, N., 1995. Rapid DNA binding by nuclear factor &kappa;B in hepatocytes at the start of liver regeneration. Cell Growth and Differentiation 6, 417-427.</p>\n\n<p>Goessling, W., Sadler, K.C., 2015. Zebrafish: an important tool for liver disease research. Gastroenterology 149, 1361-1377.</p>\n\n<p>Gregory MA, Qi Y, Hann SR. Phosphorylation by glycogen synthase kinase- controls c-myc proteolysis and subnuclear localization. J Biol Chem. 2003 Dec 19;278(51):51606-12. Epub 2003 Oct 16. PubMed PMID: 14563837.</p>\n\n<p>Higashitsuji H, Liu Y, Mayer RJ, Fujita J. The oncoprotein gankyrin negatively regulates both p53 and RB by enhancing proteasomal degradation. Cell Cycle. 2005 Oct;4(10):1335-7. Epub 2005 Oct 17. PubMed PMID: 16177571.<br />\n<br />\nJho EH, Zhang T, Domon C, Joo CK, Freund JN, Costantini F. Wnt/beta-catenin/Tcf signaling induces the transcription of Axin2, a negative regulator of the signaling pathway. Mol Cell Biol. 2002 Feb;22(4):1172-83<br />\n<br />\nKatoh M. Canonical and non-canonical WNT signaling in cancer stem cells and their niches: Cellular heterogeneity, omics reprogramming, targeted therapy and tumor plasticity (Review). Int J Oncol. 2017 Nov;51(5):1357-1369. doi: 10.3892/ijo.2017.4129.<br />\n<br />\nJochum, W., Passegu&eacute;, E., Wagner, E.F., 2001. AP-1 in mouse development and tumorigenesis. Oncogene 20, 2401-2412.</p>\n\n<p>Kwon, Y.J., Lee, K.G., Choi, D., 2015. Clinical implications of advances in liver regeneration. Clin. Mol. Hepatol. 21, 7-13.</p>\n\n<p>Li, Q., Van Antwerp, D., Mercurio, F., Lee, K.F., Verma, I.M., 1999. Severe liver degeneration in mice lacking the IkappaB kinase 2 gene. Science 284, 321-325.</p>\n\n<p>Mao, S.A., Glorioso, J.M., Nyberg, S.L., 2014. Liver regeneration. Transl. Res. 163, 352-362.</p>\n\n<p>Mitchell, C., Willenbring, H., 2008. A reproducible and well-tolerated method for 2/3 partial hepatectomy in mice. Nat. Protoc. 3, 1167-1170.</p>\n\n<p>Mitchell, C., Willenbring, H., 2014. Addendum: A reproducible and well-tolerated method for 2/3 partial hepatectomy in mice. Nat. Protoc. 9, 10.1038/nprot.2014.122.</p>\n\n<p>OECD (2018), Test No. 442B: Skin Sensitization: Local Lymph Node Assay: BrdU-ELISA or &ndash;FCM, OECD Guidelines for the Testing of Chemicals, Section 4, OECD Publishing, Paris, https://doi.org/10.1787/9789264090996-en.</p>\n\n<p>Rudolph, D., Yeh, W.-., Wakeham, A., Rudolph, B., Nallainathan, D., Potter, J., Elia, A.J., Mak, T.W., 2000. Severe liver degeneration and lack of NF-&kappa;B activation in NEMO/IKK &gamma;- deficient mice. Genes and Development 14, 854-862.</p>\n\n<p>Schrum, L.W., Black, D., Iimuro, Y., Rippe, R.A., Brenner, D.A., Behrns, K.E., 2000. c-Jun does not mediate hepatocyte apoptosis following NF&kappa;B inhibition and partial hepatectomy. J. Surg. Res. 88, 142-149.</p>\n\n<p>Schuijers J, Mokry M, Hatzis P, Cuppen E, Clevers H. Wnt-induced transcriptional activation is exclusively mediated by TCF/LEF. EMBO J. 2014 Jan 13;33(2):146-56. doi: 10.1002/embj.201385358.</p>\n\n<p>Stanger, B.Z., 2015. Cellular homeostasis and repair in the mammalian liver. Annu. Rev. Physiol. 77, 179-200.</p>\n\n<p>Takigawa Y, Brown AM. Wnt signaling in liver cancer. Curr Drug Targets. 2008; 9:1013-24<br />\n<br />\nTiburcio PD, Choi H, Huang LE. Complex role of HIF in cancer: the known, the unknown, and the unexpected. Hypoxia (Auckl). 2014 Jun 18;2:59-70.</p>\n\n<p>&nbsp;</p>\n\n<p>Vannella KM, Wynn TA. Mechanisms of Organ Injury and Repair by Macrophages. Annu Rev Physiol. 2017 Feb 10;79:593-617. doi:10.1146/annurev-physiol-022516-034356.</p>\n\n<p>&nbsp;</p>\n\n<p>Wang C, Lisanti MP, Liao DJ. Reviewing once more the c-myc and Ras collaboration: converging at the cyclin D1-CDK4 complex and challenging basic concepts of cancer biology. Cell Cycle. 2011 Jan 1;10(1):57-67.</p>\n\n<p>&nbsp;</p>\n\n<p>Wang IC, Chen YJ, Hughes DE, Ackerson T, Major ML, Kalinichenko VV, Costa RH, Raychaudhuri P, Tyner AL, Lau LF. FoxM1 regulates transcription of JNK1 to promote the G1/S transition and tumor cell invasiveness. J Biol Chem. 2008 Jul 25;283(30):20770-8. doi: 10.1074/jbc.M709892200.</p>\n\n<p>&nbsp;</p>\n\n<p>Whyte JL, Smith AA, Helms JA. Wnt signaling and injury repair. Cold Spring Harb Perspect Biol. 2012 Aug 1;4(8):a008078. doi: 10.1101/cshperspect.a008078.<br />\n<br />\nWierstra I, Alves J. FOXM1, a typical proliferation-associated transcription factor. Biol Chem. 2007 Dec;388(12):1257-74.</p>\n\n<p>&nbsp;</p>\n\n<p>Wierstra I, Alves J. FOXM1c is activated by cyclin E/Cdk2, cyclin A/Cdk2, and cyclin A/Cdk1, but repressed by GSK-3alpha. Biochem Biophys Res Commun. 2006 Sep15;348(1):99-108.</p>\n\n<p>Wood, C.E., Hukkanen, R.R., Sura, R., Jacobson-Kram, D., Nolte, T., Odin, M., Cohen, S.M., 2015. Scientific and Regulatory Policy Committee (SRPC) Review: Interpretation and Use of Cell Proliferation Data in Cancer Risk Assessment. Toxicol. Pathol. 43, 760-775.</p>\n\n<p>Yanger, K., Stanger, B.Z., 2011. Facultative stem cells in liver and pancreas: fact and fancy. Dev. Dyn. 240, 521-529.</p>\n\n<p>Zhan T, Rindtorff N, Boutros M. Wnt signaling in cancer. Oncogene. 2017;36:146-1473</p>\n","biologicalOrganisationLevel":"Cellular","organTerm":{},"biologicalEvents":[{"action":"increased","process":"cellular response to oxidative stress","object":{}},{"action":"increased","process":"macrophage activation involved in immune response","object":{"name":"macrophage","source":"CL","sourceId":"CL:0000235"}},{"action":"decreased","process":"hypoxia","object":{"name":"hypoxia-inducible factor 1-alpha","source":"PR","sourceId":"PR:000008555"}},{"action":"decreased","process":"hypoxia","object":{"name":"von Hippel-Lindau disease tumor suppressor","source":"PR","sourceId":"PR:000017294"}}],"keyEventStressors":["furan","Ethanol","Chloroform","Acetaminophen"],"id":1394}
{"title":"Induction, persistent proliferation/sustained proliferation","references":"<p>Alcorn, J.A., Feitelberg, S.P., Brenner, D.A., 1990. Transient induction of c-jun during hepatic regeneration. Hepatology 11, 909-915.</p>\n\n<p>Behrens, A., Sibilia, M., David, J.P., M&ouml;hle-Steinlein, U., Tronche, F., Sch&uuml;tz, G., Wagner, E.F., 2002. Impaired postnatal hepatocyte proliferation and liver regeneration in mice lacking c-jun in the liver. EMBO J. 21, 1782-1790.</p>\n\n<p>Boulter L, Govaere O, Bird TG, Radulescu S, Ramachandran P, Pellicoro A, Ridgway RA, et al. Macrophage-derived Wnt opposes Notch signaling to specify hepatic progenitor cell fate in chronic liver disease. Nat Med. 2012 Mar 4;18(4):572-9. doi: 10.1038/nm.2667.</p>\n\n<p>Burkhart DL, Sage J. Cellular mechanisms of tumour suppression by the retinoblastoma gene. Nat Rev Cancer. 2008 Sep;8(9):671-82. doi: 10.1038/nrc2399.</p>\n\n<p>Cox, A.G., Goessling, W., 2015. The lure of zebrafish in liver research: regulation of hepatic growth in development and regeneration. Curr. Opin. Genet. Dev. 32, 153-161.</p>\n\n<p>Cressman, D.E., Greenbaum, L.E., Haber, B.A., Taub, R., 1994. Rapid activation of post-hepatectomy factor/nuclear factor &kappa;B in hepatocytes, a primary response in the regenerating liver. J. Biol. Chem. 269, 30429-30435.</p>\n\n<p>Eferl, R., Sibilia, M., Hilberg, F., Fuchsbichler, A., Kufferath, I., Guertl, B., Zenz, R., Wagner, E.F., Zatloukal, K., 1999. Functions of c-Jun in liver and heart development. J. Cell Biol. 145, 1049-1061.</p>\n\n<p>FitzGerald, M.J., Webber, E.M., Donovan, J.R., Fausto, N., 1995. Rapid DNA binding by nuclear factor &kappa;B in hepatocytes at the start of liver regeneration. Cell Growth and Differentiation 6, 417-427.</p>\n\n<p>Goessling, W., Sadler, K.C., 2015. Zebrafish: an important tool for liver disease research. Gastroenterology 149, 1361-1377.</p>\n\n<p>Gregory MA, Qi Y, Hann SR. Phosphorylation by glycogen synthase kinase- controls c-myc proteolysis and subnuclear localization. J Biol Chem. 2003 Dec 19;278(51):51606-12. Epub 2003 Oct 16. PubMed PMID: 14563837.</p>\n\n<p>Higashitsuji H, Liu Y, Mayer RJ, Fujita J. The oncoprotein gankyrin negatively regulates both p53 and RB by enhancing proteasomal degradation. Cell Cycle. 2005 Oct;4(10):1335-7. Epub 2005 Oct 17. PubMed PMID: 16177571.<br />\n<br />\nJho EH, Zhang T, Domon C, Joo CK, Freund JN, Costantini F. Wnt/beta-catenin/Tcf signaling induces the transcription of Axin2, a negative regulator of the signaling pathway. Mol Cell Biol. 2002 Feb;22(4):1172-83<br />\n<br />\nKatoh M. Canonical and non-canonical WNT signaling in cancer stem cells and their niches: Cellular heterogeneity, omics reprogramming, targeted therapy and tumor plasticity (Review). Int J Oncol. 2017 Nov;51(5):1357-1369. doi: 10.3892/ijo.2017.4129.<br />\n<br />\nJochum, W., Passegu&eacute;, E., Wagner, E.F., 2001. AP-1 in mouse development and tumorigenesis. Oncogene 20, 2401-2412.</p>\n\n<p>Kwon, Y.J., Lee, K.G., Choi, D., 2015. Clinical implications of advances in liver regeneration. Clin. Mol. Hepatol. 21, 7-13.</p>\n\n<p>Li, Q., Van Antwerp, D., Mercurio, F., Lee, K.F., Verma, I.M., 1999. Severe liver degeneration in mice lacking the IkappaB kinase 2 gene. Science 284, 321-325.</p>\n\n<p>Mao, S.A., Glorioso, J.M., Nyberg, S.L., 2014. Liver regeneration. Transl. Res. 163, 352-362.</p>\n\n<p>Mitchell, C., Willenbring, H., 2008. A reproducible and well-tolerated method for 2/3 partial hepatectomy in mice. Nat. Protoc. 3, 1167-1170.</p>\n\n<p>Mitchell, C., Willenbring, H., 2014. Addendum: A reproducible and well-tolerated method for 2/3 partial hepatectomy in mice. Nat. Protoc. 9, 10.1038/nprot.2014.122.</p>\n\n<p>OECD (2018), Test No. 442B: Skin Sensitization: Local Lymph Node Assay: BrdU-ELISA or &ndash;FCM, OECD Guidelines for the Testing of Chemicals, Section 4, OECD Publishing, Paris, https://doi.org/10.1787/9789264090996-en.</p>\n\n<p>Rudolph, D., Yeh, W.-., Wakeham, A., Rudolph, B., Nallainathan, D., Potter, J., Elia, A.J., Mak, T.W., 2000. Severe liver degeneration and lack of NF-&kappa;B activation in NEMO/IKK &gamma;- deficient mice. Genes and Development 14, 854-862.</p>\n\n<p>Schrum, L.W., Black, D., Iimuro, Y., Rippe, R.A., Brenner, D.A., Behrns, K.E., 2000. c-Jun does not mediate hepatocyte apoptosis following NF&kappa;B inhibition and partial hepatectomy. J. Surg. Res. 88, 142-149.</p>\n\n<p>Schuijers J, Mokry M, Hatzis P, Cuppen E, Clevers H. Wnt-induced transcriptional activation is exclusively mediated by TCF/LEF. EMBO J. 2014 Jan 13;33(2):146-56. doi: 10.1002/embj.201385358.</p>\n\n<p>Stanger, B.Z., 2015. Cellular homeostasis and repair in the mammalian liver. Annu. Rev. Physiol. 77, 179-200.</p>\n\n<p>Takigawa Y, Brown AM. Wnt signaling in liver cancer. Curr Drug Targets. 2008; 9:1013-24<br />\n<br />\nTiburcio PD, Choi H, Huang LE. Complex role of HIF in cancer: the known, the unknown, and the unexpected. Hypoxia (Auckl). 2014 Jun 18;2:59-70.</p>\n\n<p>&nbsp;</p>\n\n<p>Vannella KM, Wynn TA. Mechanisms of Organ Injury and Repair by Macrophages. Annu Rev Physiol. 2017 Feb 10;79:593-617. doi:10.1146/annurev-physiol-022516-034356.</p>\n\n<p>&nbsp;</p>\n\n<p>Wang C, Lisanti MP, Liao DJ. Reviewing once more the c-myc and Ras collaboration: converging at the cyclin D1-CDK4 complex and challenging basic concepts of cancer biology. Cell Cycle. 2011 Jan 1;10(1):57-67.</p>\n\n<p>&nbsp;</p>\n\n<p>Wang IC, Chen YJ, Hughes DE, Ackerson T, Major ML, Kalinichenko VV, Costa RH, Raychaudhuri P, Tyner AL, Lau LF. FoxM1 regulates transcription of JNK1 to promote the G1/S transition and tumor cell invasiveness. J Biol Chem. 2008 Jul 25;283(30):20770-8. doi: 10.1074/jbc.M709892200.</p>\n\n<p>&nbsp;</p>\n\n<p>Whyte JL, Smith AA, Helms JA. Wnt signaling and injury repair. Cold Spring Harb Perspect Biol. 2012 Aug 1;4(8):a008078. doi: 10.1101/cshperspect.a008078.<br />\n<br />\nWierstra I, Alves J. FOXM1, a typical proliferation-associated transcription factor. Biol Chem. 2007 Dec;388(12):1257-74.</p>\n\n<p>&nbsp;</p>\n\n<p>Wierstra I, Alves J. FOXM1c is activated by cyclin E/Cdk2, cyclin A/Cdk2, and cyclin A/Cdk1, but repressed by GSK-3alpha. Biochem Biophys Res Commun. 2006 Sep15;348(1):99-108.</p>\n\n<p>Wood, C.E., Hukkanen, R.R., Sura, R., Jacobson-Kram, D., Nolte, T., Odin, M., Cohen, S.M., 2015. Scientific and Regulatory Policy Committee (SRPC) Review: Interpretation and Use of Cell Proliferation Data in Cancer Risk Assessment. Toxicol. Pathol. 43, 760-775.</p>\n\n<p>Yanger, K., Stanger, B.Z., 2011. Facultative stem cells in liver and pancreas: fact and fancy. Dev. Dyn. 240, 521-529.</p>\n\n<p>Zhan T, Rindtorff N, Boutros M. Wnt signaling in cancer. Oncogene. 2017;36:146-1473</p>\n","biologicalOrganisationLevel":"Cellular","organTerm":{},"biologicalEvents":[{"action":"increased","process":"cellular response to oxidative stress","object":{}},{"action":"increased","process":"macrophage activation involved in immune response","object":{"name":"macrophage","source":"CL","sourceId":"CL:0000235"}},{"action":"decreased","process":"hypoxia","object":{"name":"hypoxia-inducible factor 1-alpha","source":"PR","sourceId":"PR:000008555"}},{"action":"decreased","process":"hypoxia","object":{"name":"von Hippel-Lindau disease tumor suppressor","source":"PR","sourceId":"PR:000017294"}}],"keyEventStressors":["furan","Ethanol","Chloroform","Acetaminophen"],"id":1394}
{"title":"Induction, persistent proliferation/sustained proliferation","references":"<p>Alcorn, J.A., Feitelberg, S.P., Brenner, D.A., 1990. Transient induction of c-jun during hepatic regeneration. Hepatology 11, 909-915.</p>\n\n<p>Behrens, A., Sibilia, M., David, J.P., M&ouml;hle-Steinlein, U., Tronche, F., Sch&uuml;tz, G., Wagner, E.F., 2002. Impaired postnatal hepatocyte proliferation and liver regeneration in mice lacking c-jun in the liver. EMBO J. 21, 1782-1790.</p>\n\n<p>Boulter L, Govaere O, Bird TG, Radulescu S, Ramachandran P, Pellicoro A, Ridgway RA, et al. Macrophage-derived Wnt opposes Notch signaling to specify hepatic progenitor cell fate in chronic liver disease. Nat Med. 2012 Mar 4;18(4):572-9. doi: 10.1038/nm.2667.</p>\n\n<p>Burkhart DL, Sage J. Cellular mechanisms of tumour suppression by the retinoblastoma gene. Nat Rev Cancer. 2008 Sep;8(9):671-82. doi: 10.1038/nrc2399.</p>\n\n<p>Cox, A.G., Goessling, W., 2015. The lure of zebrafish in liver research: regulation of hepatic growth in development and regeneration. Curr. Opin. Genet. Dev. 32, 153-161.</p>\n\n<p>Cressman, D.E., Greenbaum, L.E., Haber, B.A., Taub, R., 1994. Rapid activation of post-hepatectomy factor/nuclear factor &kappa;B in hepatocytes, a primary response in the regenerating liver. J. Biol. Chem. 269, 30429-30435.</p>\n\n<p>Eferl, R., Sibilia, M., Hilberg, F., Fuchsbichler, A., Kufferath, I., Guertl, B., Zenz, R., Wagner, E.F., Zatloukal, K., 1999. Functions of c-Jun in liver and heart development. J. Cell Biol. 145, 1049-1061.</p>\n\n<p>FitzGerald, M.J., Webber, E.M., Donovan, J.R., Fausto, N., 1995. Rapid DNA binding by nuclear factor &kappa;B in hepatocytes at the start of liver regeneration. Cell Growth and Differentiation 6, 417-427.</p>\n\n<p>Goessling, W., Sadler, K.C., 2015. Zebrafish: an important tool for liver disease research. Gastroenterology 149, 1361-1377.</p>\n\n<p>Gregory MA, Qi Y, Hann SR. Phosphorylation by glycogen synthase kinase- controls c-myc proteolysis and subnuclear localization. J Biol Chem. 2003 Dec 19;278(51):51606-12. Epub 2003 Oct 16. PubMed PMID: 14563837.</p>\n\n<p>Higashitsuji H, Liu Y, Mayer RJ, Fujita J. The oncoprotein gankyrin negatively regulates both p53 and RB by enhancing proteasomal degradation. Cell Cycle. 2005 Oct;4(10):1335-7. Epub 2005 Oct 17. PubMed PMID: 16177571.<br />\n<br />\nJho EH, Zhang T, Domon C, Joo CK, Freund JN, Costantini F. Wnt/beta-catenin/Tcf signaling induces the transcription of Axin2, a negative regulator of the signaling pathway. Mol Cell Biol. 2002 Feb;22(4):1172-83<br />\n<br />\nKatoh M. Canonical and non-canonical WNT signaling in cancer stem cells and their niches: Cellular heterogeneity, omics reprogramming, targeted therapy and tumor plasticity (Review). Int J Oncol. 2017 Nov;51(5):1357-1369. doi: 10.3892/ijo.2017.4129.<br />\n<br />\nJochum, W., Passegu&eacute;, E., Wagner, E.F., 2001. AP-1 in mouse development and tumorigenesis. Oncogene 20, 2401-2412.</p>\n\n<p>Kwon, Y.J., Lee, K.G., Choi, D., 2015. Clinical implications of advances in liver regeneration. Clin. Mol. Hepatol. 21, 7-13.</p>\n\n<p>Li, Q., Van Antwerp, D., Mercurio, F., Lee, K.F., Verma, I.M., 1999. Severe liver degeneration in mice lacking the IkappaB kinase 2 gene. Science 284, 321-325.</p>\n\n<p>Mao, S.A., Glorioso, J.M., Nyberg, S.L., 2014. Liver regeneration. Transl. Res. 163, 352-362.</p>\n\n<p>Mitchell, C., Willenbring, H., 2008. A reproducible and well-tolerated method for 2/3 partial hepatectomy in mice. Nat. Protoc. 3, 1167-1170.</p>\n\n<p>Mitchell, C., Willenbring, H., 2014. Addendum: A reproducible and well-tolerated method for 2/3 partial hepatectomy in mice. Nat. Protoc. 9, 10.1038/nprot.2014.122.</p>\n\n<p>OECD (2018), Test No. 442B: Skin Sensitization: Local Lymph Node Assay: BrdU-ELISA or &ndash;FCM, OECD Guidelines for the Testing of Chemicals, Section 4, OECD Publishing, Paris, https://doi.org/10.1787/9789264090996-en.</p>\n\n<p>Rudolph, D., Yeh, W.-., Wakeham, A., Rudolph, B., Nallainathan, D., Potter, J., Elia, A.J., Mak, T.W., 2000. Severe liver degeneration and lack of NF-&kappa;B activation in NEMO/IKK &gamma;- deficient mice. Genes and Development 14, 854-862.</p>\n\n<p>Schrum, L.W., Black, D., Iimuro, Y., Rippe, R.A., Brenner, D.A., Behrns, K.E., 2000. c-Jun does not mediate hepatocyte apoptosis following NF&kappa;B inhibition and partial hepatectomy. J. Surg. Res. 88, 142-149.</p>\n\n<p>Schuijers J, Mokry M, Hatzis P, Cuppen E, Clevers H. Wnt-induced transcriptional activation is exclusively mediated by TCF/LEF. EMBO J. 2014 Jan 13;33(2):146-56. doi: 10.1002/embj.201385358.</p>\n\n<p>Stanger, B.Z., 2015. Cellular homeostasis and repair in the mammalian liver. Annu. Rev. Physiol. 77, 179-200.</p>\n\n<p>Takigawa Y, Brown AM. Wnt signaling in liver cancer. Curr Drug Targets. 2008; 9:1013-24<br />\n<br />\nTiburcio PD, Choi H, Huang LE. Complex role of HIF in cancer: the known, the unknown, and the unexpected. Hypoxia (Auckl). 2014 Jun 18;2:59-70.</p>\n\n<p>&nbsp;</p>\n\n<p>Vannella KM, Wynn TA. Mechanisms of Organ Injury and Repair by Macrophages. Annu Rev Physiol. 2017 Feb 10;79:593-617. doi:10.1146/annurev-physiol-022516-034356.</p>\n\n<p>&nbsp;</p>\n\n<p>Wang C, Lisanti MP, Liao DJ. Reviewing once more the c-myc and Ras collaboration: converging at the cyclin D1-CDK4 complex and challenging basic concepts of cancer biology. Cell Cycle. 2011 Jan 1;10(1):57-67.</p>\n\n<p>&nbsp;</p>\n\n<p>Wang IC, Chen YJ, Hughes DE, Ackerson T, Major ML, Kalinichenko VV, Costa RH, Raychaudhuri P, Tyner AL, Lau LF. FoxM1 regulates transcription of JNK1 to promote the G1/S transition and tumor cell invasiveness. J Biol Chem. 2008 Jul 25;283(30):20770-8. doi: 10.1074/jbc.M709892200.</p>\n\n<p>&nbsp;</p>\n\n<p>Whyte JL, Smith AA, Helms JA. Wnt signaling and injury repair. Cold Spring Harb Perspect Biol. 2012 Aug 1;4(8):a008078. doi: 10.1101/cshperspect.a008078.<br />\n<br />\nWierstra I, Alves J. FOXM1, a typical proliferation-associated transcription factor. Biol Chem. 2007 Dec;388(12):1257-74.</p>\n\n<p>&nbsp;</p>\n\n<p>Wierstra I, Alves J. FOXM1c is activated by cyclin E/Cdk2, cyclin A/Cdk2, and cyclin A/Cdk1, but repressed by GSK-3alpha. Biochem Biophys Res Commun. 2006 Sep15;348(1):99-108.</p>\n\n<p>Wood, C.E., Hukkanen, R.R., Sura, R., Jacobson-Kram, D., Nolte, T., Odin, M., Cohen, S.M., 2015. Scientific and Regulatory Policy Committee (SRPC) Review: Interpretation and Use of Cell Proliferation Data in Cancer Risk Assessment. Toxicol. Pathol. 43, 760-775.</p>\n\n<p>Yanger, K., Stanger, B.Z., 2011. Facultative stem cells in liver and pancreas: fact and fancy. Dev. Dyn. 240, 521-529.</p>\n\n<p>Zhan T, Rindtorff N, Boutros M. Wnt signaling in cancer. Oncogene. 2017;36:146-1473</p>\n","biologicalOrganisationLevel":"Cellular","organTerm":{},"biologicalEvents":[{"action":"increased","process":"cellular response to oxidative stress","object":{}},{"action":"increased","process":"macrophage activation involved in immune response","object":{"name":"macrophage","source":"CL","sourceId":"CL:0000235"}},{"action":"decreased","process":"hypoxia","object":{"name":"hypoxia-inducible factor 1-alpha","source":"PR","sourceId":"PR:000008555"}},{"action":"decreased","process":"hypoxia","object":{"name":"von Hippel-Lindau disease tumor suppressor","source":"PR","sourceId":"PR:000017294"}}],"keyEventStressors":["furan","Ethanol","Chloroform","Acetaminophen"],"id":1394}
{"title":"Induction, persistent proliferation/sustained proliferation","references":"<p>Alcorn, J.A., Feitelberg, S.P., Brenner, D.A., 1990. Transient induction of c-jun during hepatic regeneration. Hepatology 11, 909-915.</p>\n\n<p>Behrens, A., Sibilia, M., David, J.P., M&ouml;hle-Steinlein, U., Tronche, F., Sch&uuml;tz, G., Wagner, E.F., 2002. Impaired postnatal hepatocyte proliferation and liver regeneration in mice lacking c-jun in the liver. EMBO J. 21, 1782-1790.</p>\n\n<p>Boulter L, Govaere O, Bird TG, Radulescu S, Ramachandran P, Pellicoro A, Ridgway RA, et al. Macrophage-derived Wnt opposes Notch signaling to specify hepatic progenitor cell fate in chronic liver disease. Nat Med. 2012 Mar 4;18(4):572-9. doi: 10.1038/nm.2667.</p>\n\n<p>Burkhart DL, Sage J. Cellular mechanisms of tumour suppression by the retinoblastoma gene. Nat Rev Cancer. 2008 Sep;8(9):671-82. doi: 10.1038/nrc2399.</p>\n\n<p>Cox, A.G., Goessling, W., 2015. The lure of zebrafish in liver research: regulation of hepatic growth in development and regeneration. Curr. Opin. Genet. Dev. 32, 153-161.</p>\n\n<p>Cressman, D.E., Greenbaum, L.E., Haber, B.A., Taub, R., 1994. Rapid activation of post-hepatectomy factor/nuclear factor &kappa;B in hepatocytes, a primary response in the regenerating liver. J. Biol. Chem. 269, 30429-30435.</p>\n\n<p>Eferl, R., Sibilia, M., Hilberg, F., Fuchsbichler, A., Kufferath, I., Guertl, B., Zenz, R., Wagner, E.F., Zatloukal, K., 1999. Functions of c-Jun in liver and heart development. J. Cell Biol. 145, 1049-1061.</p>\n\n<p>FitzGerald, M.J., Webber, E.M., Donovan, J.R., Fausto, N., 1995. Rapid DNA binding by nuclear factor &kappa;B in hepatocytes at the start of liver regeneration. Cell Growth and Differentiation 6, 417-427.</p>\n\n<p>Goessling, W., Sadler, K.C., 2015. Zebrafish: an important tool for liver disease research. Gastroenterology 149, 1361-1377.</p>\n\n<p>Gregory MA, Qi Y, Hann SR. Phosphorylation by glycogen synthase kinase- controls c-myc proteolysis and subnuclear localization. J Biol Chem. 2003 Dec 19;278(51):51606-12. Epub 2003 Oct 16. PubMed PMID: 14563837.</p>\n\n<p>Higashitsuji H, Liu Y, Mayer RJ, Fujita J. The oncoprotein gankyrin negatively regulates both p53 and RB by enhancing proteasomal degradation. Cell Cycle. 2005 Oct;4(10):1335-7. Epub 2005 Oct 17. PubMed PMID: 16177571.<br />\n<br />\nJho EH, Zhang T, Domon C, Joo CK, Freund JN, Costantini F. Wnt/beta-catenin/Tcf signaling induces the transcription of Axin2, a negative regulator of the signaling pathway. Mol Cell Biol. 2002 Feb;22(4):1172-83<br />\n<br />\nKatoh M. Canonical and non-canonical WNT signaling in cancer stem cells and their niches: Cellular heterogeneity, omics reprogramming, targeted therapy and tumor plasticity (Review). Int J Oncol. 2017 Nov;51(5):1357-1369. doi: 10.3892/ijo.2017.4129.<br />\n<br />\nJochum, W., Passegu&eacute;, E., Wagner, E.F., 2001. AP-1 in mouse development and tumorigenesis. Oncogene 20, 2401-2412.</p>\n\n<p>Kwon, Y.J., Lee, K.G., Choi, D., 2015. Clinical implications of advances in liver regeneration. Clin. Mol. Hepatol. 21, 7-13.</p>\n\n<p>Li, Q., Van Antwerp, D., Mercurio, F., Lee, K.F., Verma, I.M., 1999. Severe liver degeneration in mice lacking the IkappaB kinase 2 gene. Science 284, 321-325.</p>\n\n<p>Mao, S.A., Glorioso, J.M., Nyberg, S.L., 2014. Liver regeneration. Transl. Res. 163, 352-362.</p>\n\n<p>Mitchell, C., Willenbring, H., 2008. A reproducible and well-tolerated method for 2/3 partial hepatectomy in mice. Nat. Protoc. 3, 1167-1170.</p>\n\n<p>Mitchell, C., Willenbring, H., 2014. Addendum: A reproducible and well-tolerated method for 2/3 partial hepatectomy in mice. Nat. Protoc. 9, 10.1038/nprot.2014.122.</p>\n\n<p>OECD (2018), Test No. 442B: Skin Sensitization: Local Lymph Node Assay: BrdU-ELISA or &ndash;FCM, OECD Guidelines for the Testing of Chemicals, Section 4, OECD Publishing, Paris, https://doi.org/10.1787/9789264090996-en.</p>\n\n<p>Rudolph, D., Yeh, W.-., Wakeham, A., Rudolph, B., Nallainathan, D., Potter, J., Elia, A.J., Mak, T.W., 2000. Severe liver degeneration and lack of NF-&kappa;B activation in NEMO/IKK &gamma;- deficient mice. Genes and Development 14, 854-862.</p>\n\n<p>Schrum, L.W., Black, D., Iimuro, Y., Rippe, R.A., Brenner, D.A., Behrns, K.E., 2000. c-Jun does not mediate hepatocyte apoptosis following NF&kappa;B inhibition and partial hepatectomy. J. Surg. Res. 88, 142-149.</p>\n\n<p>Schuijers J, Mokry M, Hatzis P, Cuppen E, Clevers H. Wnt-induced transcriptional activation is exclusively mediated by TCF/LEF. EMBO J. 2014 Jan 13;33(2):146-56. doi: 10.1002/embj.201385358.</p>\n\n<p>Stanger, B.Z., 2015. Cellular homeostasis and repair in the mammalian liver. Annu. Rev. Physiol. 77, 179-200.</p>\n\n<p>Takigawa Y, Brown AM. Wnt signaling in liver cancer. Curr Drug Targets. 2008; 9:1013-24<br />\n<br />\nTiburcio PD, Choi H, Huang LE. Complex role of HIF in cancer: the known, the unknown, and the unexpected. Hypoxia (Auckl). 2014 Jun 18;2:59-70.</p>\n\n<p>&nbsp;</p>\n\n<p>Vannella KM, Wynn TA. Mechanisms of Organ Injury and Repair by Macrophages. Annu Rev Physiol. 2017 Feb 10;79:593-617. doi:10.1146/annurev-physiol-022516-034356.</p>\n\n<p>&nbsp;</p>\n\n<p>Wang C, Lisanti MP, Liao DJ. Reviewing once more the c-myc and Ras collaboration: converging at the cyclin D1-CDK4 complex and challenging basic concepts of cancer biology. Cell Cycle. 2011 Jan 1;10(1):57-67.</p>\n\n<p>&nbsp;</p>\n\n<p>Wang IC, Chen YJ, Hughes DE, Ackerson T, Major ML, Kalinichenko VV, Costa RH, Raychaudhuri P, Tyner AL, Lau LF. FoxM1 regulates transcription of JNK1 to promote the G1/S transition and tumor cell invasiveness. J Biol Chem. 2008 Jul 25;283(30):20770-8. doi: 10.1074/jbc.M709892200.</p>\n\n<p>&nbsp;</p>\n\n<p>Whyte JL, Smith AA, Helms JA. Wnt signaling and injury repair. Cold Spring Harb Perspect Biol. 2012 Aug 1;4(8):a008078. doi: 10.1101/cshperspect.a008078.<br />\n<br />\nWierstra I, Alves J. FOXM1, a typical proliferation-associated transcription factor. Biol Chem. 2007 Dec;388(12):1257-74.</p>\n\n<p>&nbsp;</p>\n\n<p>Wierstra I, Alves J. FOXM1c is activated by cyclin E/Cdk2, cyclin A/Cdk2, and cyclin A/Cdk1, but repressed by GSK-3alpha. Biochem Biophys Res Commun. 2006 Sep15;348(1):99-108.</p>\n\n<p>Wood, C.E., Hukkanen, R.R., Sura, R., Jacobson-Kram, D., Nolte, T., Odin, M., Cohen, S.M., 2015. Scientific and Regulatory Policy Committee (SRPC) Review: Interpretation and Use of Cell Proliferation Data in Cancer Risk Assessment. Toxicol. Pathol. 43, 760-775.</p>\n\n<p>Yanger, K., Stanger, B.Z., 2011. Facultative stem cells in liver and pancreas: fact and fancy. Dev. Dyn. 240, 521-529.</p>\n\n<p>Zhan T, Rindtorff N, Boutros M. Wnt signaling in cancer. Oncogene. 2017;36:146-1473</p>\n","biologicalOrganisationLevel":"Cellular","organTerm":{},"biologicalEvents":[{"action":"increased","process":"cellular response to oxidative stress","object":{}},{"action":"increased","process":"macrophage activation involved in immune response","object":{"name":"macrophage","source":"CL","sourceId":"CL:0000235"}},{"action":"decreased","process":"hypoxia","object":{"name":"hypoxia-inducible factor 1-alpha","source":"PR","sourceId":"PR:000008555"}},{"action":"decreased","process":"hypoxia","object":{"name":"von Hippel-Lindau disease tumor suppressor","source":"PR","sourceId":"PR:000017294"}}],"keyEventStressors":["furan","Ethanol","Chloroform","Acetaminophen"],"id":1394}
{"title":"Liver Cancer","references":"<p>Bonder, A., Afdhal, N., 2012. Evaluation of liver lesions. Clin. Liver Dis. 16, 271-283.</p>\n\n<p>Ellison, L.F., Wilkins, K., 2012. Canadian Trends in Cancer Prevalence. Health Reports 23.</p>\n\n<p>OECD, 2009. OECD Guideline for the Testing of Chemicals: Carcinogenicity Studies (Test Guideline 451).</p>\n\n<p>Paradis, V., 2013. Histopathology of hepatocellular carcinoma. Recent Results Cancer Res. 190, 21-32.</p>\n\n<p>Venkatesh, S.K., Chandan, V., Roberts, L.R., 2014. Liver masses: a clinical, radiologic, and pathologic perspective. Clin. Gastroenterol. Hepatol. 12, 1414-1429.</p>\n\n<p>&nbsp;</p>\n","biologicalOrganisationLevel":"Organ","organTerm":{"name":"liver","sourceId":"UBERON:0002107"},"biologicalEvents":[{"object":{}}],"keyEventStressors":["furan","Chloroform","too many stressors to list"],"id":1395}
{"title":"Increased, glucocorticoid receptor activity","references":"","biologicalOrganisationLevel":"Molecular","organTerm":{},"biologicalEvents":[{"object":{}}],"id":1396}
{"title":"Increased, serotonin transporter activity","references":"","biologicalOrganisationLevel":"Cellular","organTerm":{},"biologicalEvents":[{"object":{}}],"id":1397}
{"title":"Increased, intracellular serotonin","references":"","biologicalOrganisationLevel":"Cellular","organTerm":{},"biologicalEvents":[{"object":{}}],"id":1398}
{"title":"Increased, packaged serotonin","references":"","biologicalOrganisationLevel":"Cellular","organTerm":{},"biologicalEvents":[{"object":{}}],"id":1399}
{"title":"Increased, synaptic release","references":"","biologicalOrganisationLevel":"Cellular","organTerm":{},"biologicalEvents":[{"object":{}}],"id":1400}
{"title":"Decreased, 5-HT3","references":"","biologicalOrganisationLevel":"Tissue","organTerm":{},"biologicalEvents":[{"object":{}}],"id":1401}
{"title":"Reduced, PTGS1 function","references":"","biologicalOrganisationLevel":"Molecular","organTerm":{},"biologicalEvents":[{"object":{}}],"id":1402}
{"title":"Reduced, platelet aggregation","references":"","biologicalOrganisationLevel":"Tissue","organTerm":{},"biologicalEvents":[{"object":{}}],"id":1403}
{"title":"Decreased, mucosal blood flow","references":"","biologicalOrganisationLevel":"Tissue","organTerm":{},"biologicalEvents":[{"object":{}}],"id":1404}
{"title":"Reduced, mucosal defense","references":"","biologicalOrganisationLevel":"Tissue","organTerm":{},"biologicalEvents":[{"object":{}}],"id":1405}
{"title":"Decreased, mucous","references":"","biologicalOrganisationLevel":"Tissue","organTerm":{},"biologicalEvents":[{"object":{}}],"id":1406}
{"title":"Decreased, bicarbonate","references":"","biologicalOrganisationLevel":"Tissue","organTerm":{},"biologicalEvents":[{"object":{}}],"id":1407}
{"title":"Reduced, PTGS2 function","references":"","biologicalOrganisationLevel":"Cellular","organTerm":{},"biologicalEvents":[{"object":{}}],"id":1408}
{"title":"Decreased, angiogenesis","references":"","biologicalOrganisationLevel":"Tissue","organTerm":{},"biologicalEvents":[{"object":{}}],"id":1409}
{"title":"Increased, leukocyte adherence","references":"","biologicalOrganisationLevel":"Tissue","organTerm":{},"biologicalEvents":[{"object":{}}],"id":1410}
{"title":"Increased, leukocyte activation","references":"","biologicalOrganisationLevel":"Tissue","organTerm":{},"biologicalEvents":[{"object":{}}],"id":1411}
{"title":"Helicobacter pylori infection","references":"","biologicalOrganisationLevel":"Tissue","organTerm":{},"biologicalEvents":[{"object":{}}],"id":1412}
{"title":"Reduced, presynaptic neuron 2 activity","references":"","biologicalOrganisationLevel":"Cellular","organTerm":{},"biologicalEvents":[{"object":{}}],"id":1413}
{"title":"Decreased, GABA","references":"","biologicalOrganisationLevel":"Cellular","organTerm":{},"biologicalEvents":[{"object":{}}],"id":1414}
{"title":"Reduced, GABA-A receptor activation","references":"","biologicalOrganisationLevel":"Molecular","organTerm":{},"biologicalEvents":[{"object":{}}],"id":1415}
{"title":"Decreased, intracellular chloride","references":"","biologicalOrganisationLevel":"Cellular","organTerm":{},"biologicalEvents":[{"object":{}}],"id":1416}
{"title":"NFE2/Nrf2 repression","references":"","biologicalOrganisationLevel":"Molecular","organTerm":{},"biologicalEvents":[{"object":{}}],"id":1417}
{"title":"Increased, steatosis","references":"","biologicalOrganisationLevel":"Organ","organTerm":{},"biologicalEvents":[{"object":{}}],"id":1418}
{"title":"Reduced, FXR activity","references":"","biologicalOrganisationLevel":"Molecular","organTerm":{},"biologicalEvents":[{"object":{}}],"id":1419}
{"title":"Reduced, SHP activity","references":"","biologicalOrganisationLevel":"Molecular","organTerm":{},"biologicalEvents":[{"object":{}}],"id":1420}
{"title":"Activated, LXR","references":"","biologicalOrganisationLevel":"Molecular","organTerm":{},"biologicalEvents":[{"object":{}}],"id":1421}
{"title":"Reduced, PPARalpha","references":"","biologicalOrganisationLevel":"Molecular","organTerm":{},"biologicalEvents":[{"object":{}}],"id":1422}
{"title":"Reduced, HSD17B4 activity","references":"","biologicalOrganisationLevel":"Molecular","organTerm":{},"biologicalEvents":[{"object":{}}],"id":1423}
{"title":"Reduced, fatty acid beta oxidation","references":"","biologicalOrganisationLevel":"Molecular","organTerm":{},"biologicalEvents":[{"object":{}}],"id":1424}
{"title":"Mu Opioid Receptor Agonism","references":"","biologicalOrganisationLevel":"Molecular","organTerm":{},"biologicalEvents":[{"object":{}}],"id":1425}
{"title":"Release of G Proteins","references":"","biologicalOrganisationLevel":"Cellular","organTerm":{},"biologicalEvents":[{"object":{}}],"id":1426}
{"title":"Opening of G protein gated inward rectifying K channels","references":"","biologicalOrganisationLevel":"Cellular","organTerm":{},"biologicalEvents":[{"object":{}}],"id":1427}
{"title":"Analgesia","references":"","biologicalOrganisationLevel":"Individual","organTerm":{},"biologicalEvents":[{"object":{}}],"id":1428}
{"title":"Inhibition of N-type Ca ion channels","references":"","biologicalOrganisationLevel":"Cellular","organTerm":{},"biologicalEvents":[{"object":{}}],"id":1429}
{"title":"Inhibition of neurotransmitter vesicle release","references":"","biologicalOrganisationLevel":"Cellular","organTerm":{},"biologicalEvents":[{"object":{}}],"id":1430}
{"title":"Serotonin 1A Receptor Agonism","references":"","biologicalOrganisationLevel":"Molecular","organTerm":{},"biologicalEvents":[{"object":{}}],"id":1431}
{"title":"Anti-depressant Activity","references":"","biologicalOrganisationLevel":"Individual","organTerm":{},"biologicalEvents":[{"object":{}}],"id":1432}
{"title":"Sensing of the stressor by pulmonary cells","references":"","biologicalOrganisationLevel":"Molecular","organTerm":{},"biologicalEvents":[{"object":{}}],"id":1437}
{"title":"Increased production of pulmonary, pro-inflammatory cytokines","references":"","biologicalOrganisationLevel":"Molecular","organTerm":{},"biologicalEvents":[{"object":{}}],"id":1438}
{"title":"Increased production of pulmonary SAA","references":"","biologicalOrganisationLevel":"Molecular","organTerm":{},"biologicalEvents":[{"object":{}}],"id":1439}
{"title":"Formation of HDL-SAA","references":"","biologicalOrganisationLevel":"Cellular","organTerm":{},"biologicalEvents":[{"object":{}}],"id":1440}
{"title":"Increased systemic total cholesterol pool","references":"","biologicalOrganisationLevel":"Organ","organTerm":{},"biologicalEvents":[{"object":{}}],"id":1441}
{"title":"Foam cell formation","references":"","biologicalOrganisationLevel":"Organ","organTerm":{},"biologicalEvents":[{"object":{}}],"id":1442}
{"title":"Plaque progression in arteries","references":"","biologicalOrganisationLevel":"Individual","organTerm":{},"biologicalEvents":[{"object":{}}],"id":1443}
{"title":"Increase, Lipid peroxidation","references":"","biologicalOrganisationLevel":"Molecular","organTerm":{},"biologicalEvents":[{"object":{}}],"id":1445}
{"title":"Increase, Differentiation of fibroblasts","references":"","biologicalOrganisationLevel":"Cellular","organTerm":{},"biologicalEvents":[{"object":{}}],"id":1456}
{"title":"Activation, Latent Transforming Growth Factor Beta 1","references":"","biologicalOrganisationLevel":"Molecular","organTerm":{},"biologicalEvents":[{"object":{}}],"id":1468}
{"title":"Activation, Transforming Growth Factor beta pathway","references":"","biologicalOrganisationLevel":"Molecular","organTerm":{},"biologicalEvents":[{"object":{}}],"id":1469}
{"title":"Thiol group of chemicals interact with sulfuhydryl groups of proteins to form thiol adducts","references":"","biologicalOrganisationLevel":"Molecular","organTerm":{},"biologicalEvents":[{"object":{}}],"id":1462}
{"title":"Inhibition of lysyl oxidase","references":"","biologicalOrganisationLevel":"Cellular","organTerm":{},"biologicalEvents":[{"object":{}}],"id":1463}
{"title":"Reduction of collagen crosslinking","references":"","biologicalOrganisationLevel":"Tissue","organTerm":{},"biologicalEvents":[{"object":{}}],"id":1464}
{"title":"Weak collagen matrix","references":"","biologicalOrganisationLevel":"Tissue","organTerm":{},"biologicalEvents":[{"object":{}}],"id":1465}
{"title":"Notochord distortion or malformations","references":"","biologicalOrganisationLevel":"Organ","organTerm":{},"biologicalEvents":[{"object":{}}],"id":1466}
{"title":"Growth, reduction","references":"","biologicalOrganisationLevel":"Individual","organTerm":{},"biologicalEvents":[{"object":{}}],"id":1467}
{"title":"Increase, Uncoupling of photophosphorylation","references":"","biologicalOrganisationLevel":"Cellular","organTerm":{},"biologicalEvents":[{"object":{}}],"id":1471}
{"title":"Decrease, ATP production","references":"","biologicalOrganisationLevel":"Cellular","organTerm":{},"biologicalEvents":[{"object":{}}],"id":1472}
{"title":"Decrease, Chlorophyll synthesis","references":"","biologicalOrganisationLevel":"Cellular","organTerm":{},"biologicalEvents":[{"object":{}}],"id":1473}
{"title":"Decrease, Light harvest capacity","references":"","biologicalOrganisationLevel":"Cellular","organTerm":{},"biologicalEvents":[{"object":{}}],"id":1474}
{"title":"Decrease, Photosynthesis","references":"","biologicalOrganisationLevel":"Cellular","organTerm":{},"biologicalEvents":[{"object":{}}],"id":1475}
{"title":"Decrease, Glycolysis","references":"","biologicalOrganisationLevel":"Cellular","organTerm":{},"biologicalEvents":[{"object":{}}],"id":1476}
{"title":"Decrease, Oxidative phosphorylation","references":"<p>Abe, Yoshifusa et al. 2010. &ldquo;Bioenergetic Characterization of Mouse Podocytes.&rdquo; American Journal of Physiology. Cell Physiology 299(2):C464-76. Retrieved December 5, 2017 (http://www.ncbi.nlm.nih.gov/pubmed/20445170).</p>\n\n<p>Limonciel, A. et al. 2011. &ldquo;Lactate Is an Ideal Non-Invasive Marker for Evaluating Temporal Alterations in Cell Stress and Toxicity in Repeat Dose Testing Regimes.&rdquo; Toxicology in Vitro 25(8).</p>\n\n<p>Sakamuru, Srilatha et al. 2012. &ldquo;Application of a Homogenous Membrane Potential Assay to Assess Mitochondrial Function.&rdquo; Physiological Genomics 44(9):495&ndash;503. Retrieved December 5, 2017 (http://www.ncbi.nlm.nih.gov/pubmed/22433785).</p>\n","biologicalOrganisationLevel":"Cellular","organTerm":{},"biologicalEvents":[{"object":{}}],"id":1477}
{"title":"Decrease, Leaf cell mitosis","references":"","biologicalOrganisationLevel":"Tissue","organTerm":{},"biologicalEvents":[{"object":{}}],"id":1478}
{"title":"Decrease, Leaf development","references":"","biologicalOrganisationLevel":"Organ","organTerm":{},"biologicalEvents":[{"object":{}}],"id":1479}
{"title":"Decrease, Growth","references":"<p style=\"text-align: justify;\"><!--[if supportFields]><span style='mso-element:\nfield-begin'></span><span style='mso-spacerun:yes'></span>ADDIN EN.REFLIST <span\nstyle='mso-element:field-separator'></span><![endif]-->Conlon I, Raff M. 1999. Size control in animal development. <em>Cell</em> 96:235-244. DOI: 10.1016/s0092-8674(00)80563-2.</p>\n\n<p><!--[if supportFields]><span style='font-size:11.0pt;font-family:;mso-ascii-theme-font:\nminor-latin;mso-fareast-theme-font:minor-fareast;mso-hansi-theme-font:minor-latin;\nmso-bidi-font-family:Arial;mso-bidi-theme-font:minor-bidi;mso-ansi-language:\nEN-US;mso-fareast-language:ZH-CN;mso-bidi-language:AR-SA'><span\nstyle='mso-element:field-end'></span></span><![endif]--></p>\n","biologicalOrganisationLevel":"Individual","organTerm":{},"biologicalEvents":[{"action":"decreased","process":"growth","object":{"name":"multicellular organism","source":"UBERON","sourceId":"UBERON:0000468"}}],"keyEventStressors":["Malonoben","Carbonyl cyanide-p-trifluoromethoxyphenylhydrazone","Triclosan","2,4-Dinitrophenol","Emodin","Carbonyl cyanide m-chlorophenyl hydrazone","Pentachlorophenol"],"id":1521}
{"title":"Inhibition of mitochondrial DNA polymerase gamma (Pol gamma)","references":"","biologicalOrganisationLevel":"Molecular","organTerm":{},"biologicalEvents":[{"object":{}}],"id":1481}
{"title":"Depletion, mtDNA ","references":"","biologicalOrganisationLevel":"Cellular","organTerm":{},"biologicalEvents":[{"object":{}}],"id":1482}
{"title":"Dysfunction, Mitochondria ","references":"","biologicalOrganisationLevel":"Cellular","organTerm":{},"biologicalEvents":[{"object":{}}],"id":1483}
{"title":"Binding of substrate, endocytic receptor","references":"","biologicalOrganisationLevel":"Molecular","organTerm":{},"biologicalEvents":[{"object":{}}],"id":1486}
{"title":"CYP2E1 Activation","references":"<p><span style=\"font-size:12px\"><span style=\"font-family:arial,helvetica,sans-serif\">Garci&aacute;-Su&aacute;stegui, W. A. <em>et al.</em> The Role of CYP2E1 in the Drug Metabolism or Bioactivation in the Brain. <em>Oxidative Medicine and Cellular Longevity</em> <strong>2017,</strong> (2017)</span></span></p>\n\n<p><span style=\"font-size:12px\"><span style=\"font-family:arial,helvetica,sans-serif\">Howard, L. A., Miksys, S., Hoffmann, E., Mash, D. &amp; Tyndale, R. F. Brain CYP2E1 is induced by nicotine and ethanol in rat and is higher in smokers and alcoholics. <em>Br. J. Pharmacol.</em> <strong>138,</strong> 1376&ndash;1386 (2003).</span></span></p>\n\n<p><span style=\"font-size:12px\"><span style=\"font-family:arial,helvetica,sans-serif\">Neafsey, P. <em>et al.</em> Genetic polymorphism in CYP2E1: Population distribution of CYP2E1 activity. <em>Journal of Toxicology and Environmental Health - Part B: Critical Reviews</em> <strong>12,</strong> 362&ndash;388 (2009)</span></span></p>\n\n<p><span style=\"font-size:12px\"><span style=\"font-family:arial,helvetica,sans-serif\">Toselli, F. <em>et al.</em> Expression of CYP2E1 and CYP2U1 proteins in amygdala and prefrontal cortex: Influence of alcoholism and smoking. <em>Alcohol. Clin. Exp. Res.</em> <strong>39,</strong> 790&ndash;797 (2015)</span></span></p>\n\n<p><span style=\"font-size:12px\"><span style=\"font-family:arial,helvetica,sans-serif\">Valencia-Olvera, A. C., Mor&aacute;n, J., Camacho-Carranza, R., Prosp&eacute;ro-Garc&iacute;a, O. &amp; Espinosa-Aguirre, J. J. CYP2E1 induction leads to oxidative stress and cytotoxicity in glutathione-depleted cerebellar granule neurons. <em>Toxicol. Vitr.</em> <strong>28,</strong> 1206&ndash;1214 (2014)</span></span></p>\n\n<p><span style=\"font-size:12px\"><span style=\"font-family:arial,helvetica,sans-serif\">Zimatkin, S. M., Pronko, S. P., Vasiliou, V., Gonzalez, F. J. &amp; Deitrich, R. A. Enzymatic mechanisms of ethanol oxidation in the brain. <em>Alcohol. Clin. Exp. Res.</em> <strong>30,</strong> 1500&ndash;1505 (2006)</span></span></p>\n","biologicalOrganisationLevel":"Molecular","organTerm":{"name":"prefrontal cortex","sourceId":"UBERON:0000451"},"biologicalEvents":[{"object":{}}],"keyEventStressors":["Sevoflurane","Methoxyflurane","Chemical:584015 (1-~13~C)Aniline","Enflurane","Ethanol","Halothane","Isoniazid","Chlorzoxazone","Titanium oxide (TiO)","Acetaminophen","Isoflurane"],"id":1508}
{"title":"Protein Adduct Formation","references":"<p><span style=\"font-family:calibri,sans-serif; font-size:11pt\">LoPachin, R. M. &amp; DeCaprio, A. P. Protein adduct formation as a molecular mechanism in neurotoxicity. <em>Toxicological Sciences</em> <strong>86,</strong> 214&ndash;225 (2005)</span></p>\n\n<p>Gan, J., Zhang, H. &amp; Humphreys, W. G. Drug-Protein Adducts: Chemistry, Mechanisms of Toxicity, and Methods of Characterization. <em>Chemical Research in Toxicology</em> <strong>29,</strong> 2040&ndash;2057 (2016)</p>\n","biologicalOrganisationLevel":"Molecular","organTerm":{"name":"brain","sourceId":"UBERON:0000955"},"biologicalEvents":[{"object":{}}],"keyEventStressors":["2,4-Dithiobiuret","Styrene","Acrolein","Nitrogen mustard","2,5-Hexanedione","Isoniazid","Acetyldehyde","Acrylonitrile ","4-Hydroxy Nonenal","Acrylamide"],"id":1509}
{"title":"Oxidative Stress in Brain","references":"<p><span style=\"font-family:calibri,sans-serif; font-size:11pt\">Halpin, L. E., Collins, S. A. &amp; Yamamoto, B. K. Neurotoxicity of methamphetamine and 3,4-methylenedioxymethamphetamine. <em>Life Sciences</em> <strong>97,</strong> 37&ndash;44 (2014).</span></p>\n\n<p>Valencia-Olvera, A. C., Mor&aacute;n, J., Camacho-Carranza, R., Prosp&eacute;ro-Garc&iacute;a, O. &amp; Espinosa-Aguirre, J. J. CYP2E1 induction leads to oxidative stress and cytotoxicity in glutathione-depleted cerebellar granule neurons. <em>Toxicol. Vitr.</em> <strong>28,</strong> 1206&ndash;1214 (2014).</p>\n\n<p><span style=\"font-family:calibri,sans-serif; font-size:11pt\">Nguyen, T., Nioi, P. &amp; Pickett, C. B. The Nrf2-antioxidant response element signaling pathway and its activation by oxidative stress. <em>J. Biol. Chem.</em> <strong>284,</strong> 13291&ndash;5 (2009).</span></p>\n\n<p>&nbsp;</p>\n","biologicalOrganisationLevel":"Molecular","organTerm":{},"biologicalEvents":[{"object":{}}],"id":1510}
{"title":"Lipid Peroxidation","references":"<p>Ayala, A., Mu&ntilde;oz, M. F. &amp; Arg&uuml;elles, S. Lipid peroxidation: Production, metabolism, and signaling mechanisms of malondialdehyde and 4-hydroxy-2-nonenal. <em>Oxidative Medicine and Cellular Longevity</em> <strong>2014,</strong> (2014)</p>\n\n<p><span style=\"font-family:calibri,sans-serif; font-size:11pt\">Andringa, K. K., Udoh, U. S., Landar, A. &amp; Bailey, S. M. Proteomic analysis of 4-hydroxynonenal (4-HNE) modified proteins in liver mitochondria from chronic ethanol-fed rats. <em>Redox Biol.</em> <strong>2,</strong> 1038&ndash;1047 (2014)</span></p>\n\n<p><span style=\"font-family:calibri,sans-serif; font-size:11pt\">Smathers, R. L., Galligan, J. J., Stewart, B. J. &amp; Petersen, D. R. Overview of lipid peroxidation products and hepatic protein modification in alcoholic liver disease. in <em>Chemico-Biological Interactions</em> <strong>192,</strong> 107&ndash;112 (2011)</span></p>\n\n<p>&nbsp;</p>\n","biologicalOrganisationLevel":"Molecular","organTerm":{},"biologicalEvents":[{"object":{}}],"id":1511}
{"title":"Unfolded Protein Response","references":"<p><span style=\"font-family:calibri,sans-serif; font-size:11pt\">Yang, F. &amp; Luo, J. Endoplasmic reticulum stress and ethanol neurotoxicity. <em>Biomolecules</em> <strong>5,</strong> 2538&ndash;2553 (2015).</span></p>\n\n<p>Guan, M. <em>et al.</em> MDA-9 and GRP78 as potential diagnostic biomarkers for early detection of melanoma metastasis. <em>Tumour Biol.</em> <strong>36,</strong> 2973&ndash;82 (2015).</p>\n\n<p>Foufelle, F. &amp; Fromenty, B. Role of endoplasmic reticulum stress in drug-induced toxicity. <em>Pharmacol. Res. Perspect.</em> <strong>4,</strong> e00211 (2016).</p>\n\n<p>Takayanagi, S., Fukuda, R., Takeuchi, Y., Tsukada, S., &amp; Yoshida, K. (2013). Gene regulatory network of unfolded protein response genes in endoplasmic reticulum stress. <em>Cell Stress and Chaperones</em>, <em>18</em>(1), 11&ndash;23. <a href=\"https://doi.org/10.1007/s12192-012-0351-5\"><u>https://doi.org/10.1007/s12192-012-0351-5</u></a></p>\n\n<p>Wink, S., Hiemstra, S., Huppelschoten, S., Danen, E., Niemeijer, M., Hendriks, G., &hellip; Van De Water, B. (2014). Quantitative high content imaging of cellular adaptive stress response pathways in toxicity for chemical safety assessment. <em>Chemical Research in Toxicology</em>, <em>27</em>(3), 338&ndash;355. https://doi.org/10.1021/tx4004038</p>\n","biologicalOrganisationLevel":"Molecular","organTerm":{},"biologicalEvents":[{"object":{}}],"id":1512}
{"title":"General Apoptosis","references":"<p>Shtilbans, V., Wu, M. &amp; Burstein, D. E. Evaluation of apoptosis in cytologic specimens. <em>Diagnostic Cytopathology</em> <strong>38,</strong> 685&ndash;697 (2010).</p>\n\n<p>Wu, J., Sun, J. &amp; Xue, Y. Involvement of JNK and P53 activation in G2/M cell cycle arrest and apoptosis induced by titanium dioxide nanoparticles in neuron cells. <em>Toxicol. Lett.</em> <strong>199,</strong> 269&ndash;276 (2010).</p>\n\n<p>Redza-Dutordoir, M. &amp; Averill-Bates, D. A. Activation of apoptosis signalling pathways by reactive oxygen species. <em>Biochim. Biophys. Acta - Mol. Cell Res.</em> <strong>1863,</strong> 2977&ndash;2992 (2016).</p>\n\n<p>Lossi, L., Castagna, C. &amp; Merighi, A. Neuronal cell death: An overview of its different forms in central and peripheral neurons. in <em>Neuronal Cell Death: Methods and Protocols</em> 1&ndash;18 (2014). doi:10.1007/978-1-4939-2152-2_1</p>\n\n<p>Van Engeland, M., Nieland, L. J. W., Ramaekers, F. C. S., Schutte, B. &amp; Reutelingsperger, C. P. M. Annexin V-affinity assay: A review on an apoptosis detection system based on phosphatidylserine exposure. <em>Cytometry</em> <strong>31,</strong> 1&ndash;9 (1998).</p>\n\n<p>Shamsipur, M., Molaabasi, F., Hosseinkhani, S. &amp; Rahmati, F. Detection of Early Stage Apoptotic Cells Based on Label-Free Cytochrome c Assay Using Bioconjugated Metal Nanoclusters as Fluorescent Probes. <em>Anal. Chem.</em> <strong>88,</strong> 2188&ndash;2197 (2016).</p>\n","biologicalOrganisationLevel":"Cellular","organTerm":{},"biologicalEvents":[{"object":{}}],"id":1513}
{"title":"Neurodegeneration","references":"<p>Uttara, B., Singh, A. V, Zamboni, P. &amp; Mahajan, R. T. Oxidative stress and neurodegenerative diseases: a review of upstream and downstream antioxidant therapeutic options. <em>Curr. Neuropharmacol.</em> <strong>7,</strong> 65&ndash;74 (2009).</p>\n\n<p>Pritt, M. L. <em>et al.</em> Initial biological qualification of SBDP-145 as a biomarker of compound-induced neurodegeneration in the rat. <em>Toxicol. Sci.</em> <strong>141,</strong> 398&ndash;408 (2014).</p>\n","biologicalOrganisationLevel":"Organ","organTerm":{},"biologicalEvents":[{"object":{}}],"id":1514}
{"title":"Blockade, L-Type Calcium Channels ","references":"","biologicalOrganisationLevel":"Molecular","organTerm":{"name":"heart","sourceId":"UBERON:0000948"},"biologicalEvents":[{"object":{}}],"id":1529}
{"title":"Decrease, Calcium currents","references":"","biologicalOrganisationLevel":"Cellular","organTerm":{},"biologicalEvents":[{"object":{}}],"id":1530}
{"title":"Decrease, Calcium binding to Troponin C","references":"","biologicalOrganisationLevel":"Cellular","organTerm":{},"biologicalEvents":[{"object":{}}],"id":1531}
{"title":"Decrease, Cardiac contractility ","references":"","biologicalOrganisationLevel":"Organ","organTerm":{},"biologicalEvents":[{"object":{}}],"id":1532}
{"title":"Decrease, Cardiac ejection fraction ","references":"","biologicalOrganisationLevel":"Organ","organTerm":{},"biologicalEvents":[{"object":{}}],"id":1533}
{"title":"Heart failure ","references":"","biologicalOrganisationLevel":"Organ","organTerm":{},"biologicalEvents":[{"object":{}}],"id":1535}
{"title":"Disruption, Intracellular calcium mobilization","references":"","biologicalOrganisationLevel":"Cellular","organTerm":{},"biologicalEvents":[{"object":{}}],"id":1536}
{"title":"Disruption, Sarcomere assembly","references":"","biologicalOrganisationLevel":"Cellular","organTerm":{},"biologicalEvents":[{"object":{}}],"id":1537}
{"title":"Decrease, Coupling of oxidative phosphorylation","references":"<p style=\"text-align:justify\"><!--[if supportFields]><span\nstyle='mso-element:field-begin'></span><span\nstyle='mso-spacerun:yes'></span>ADDIN EN.REFLIST <span style='mso-element:\nfield-separator'></span><![endif]-->Affourtit C, Wong H-S, Brand MD. 2018. Measurement of proton leak in isolated mitochondria. In Palmeira CM, Moreno AJ, eds, <em>Mitochondrial Bioenergetics: Methods and Protocols</em>. Springer New York, New York, NY, pp 157-170.</p>\n\n<p style=\"text-align:justify\">Attene-Ramos MS, Huang R, Sakamuru S, Witt KL, Beeson GC, Shou L, Schnellmann RG, Beeson CC, Tice RR, Austin CP, Xia M. 2013. Systematic study of mitochondrial toxicity of environmental chemicals using quantitative high throughput screening. <em>Chemical Research in Toxicology</em> 26:1323-1332. DOI: 10.1021/tx4001754.</p>\n\n<p style=\"text-align:justify\">Attene-Ramos MS, Huang RL, Michael S, Witt KL, Richard A, Tice RR, Simeonov A, Austin CP, Xia MH. 2015. Profiling of the Tox21 chemical collection for mitochondrial function to identify compounds that acutely decrease mitochondrial membrane potential. <em>Environ Health Persp</em> 123:49-56. DOI: 10.1289/ehp.1408642.</p>\n\n<p style=\"text-align:justify\">Divakaruni AS, Paradyse A, Ferrick DA, Murphy AN, Jastroch M. 2014. Chapter Sixteen - Analysis and Interpretation of Microplate-Based Oxygen Consumption and pH Data. In Murphy AN, Chan DC, eds, <em>Methods in Enzymology</em>. Vol 547. Academic Press, pp 309-354.</p>\n\n<p style=\"text-align:justify\">Dreier DA, Denslow ND, Martyniuk CJ. 2019. Computational <em>in vitro</em> toxicology uncovers chemical structures impairing mitochondrial membrane potential. <em>J Chem Inf Model</em> 59:702-712. DOI: 10.1021/acs.jcim.8b00433.</p>\n\n<p style=\"text-align:justify\">Escher BI, Schwarzenbach RP. 2002. Mechanistic studies on baseline toxicity and uncoupling of organic compounds as a basis for modeling effective membrane concentrations in aquatic organisms. <em>Aquatic Sciences</em> 64:20-35. DOI: 10.1007/s00027-002-8052-2.</p>\n\n<p style=\"text-align:justify\">Legradi J, Dahlberg A-K, Cenijn P, Marsh G, Asplund L, Bergman &Aring;, Legler J. 2014. Disruption of Oxidative Phosphorylation (OXPHOS) by Hydroxylated Polybrominated Diphenyl Ethers (OH-PBDEs) Present in the Marine Environment. <em>Environmental Science &amp; Technology</em> 48:14703-14711. DOI: 10.1021/es5039744.</p>\n\n<p style=\"text-align:justify\">Naven RT, Swiss R, Klug-Mcleod J, Will Y, Greene N. 2012. The development of structure-activity relationships for mitochondrial dysfunction: Uncoupling of oxidative phosphorylation. <em>Toxicol Sci</em> 131:271-278. DOI: 10.1093/toxsci/kfs279.</p>\n\n<p style=\"text-align:justify\">Perry SW, Norman JP, Barbieri J, Brown EB, Gelbard HA. 2011. Mitochondrial membrane potential probes and the proton gradient: a practical usage guide. <em>BioTechniques</em> 50:98-115. DOI: 10.2144/000113610.</p>\n\n<p style=\"text-align:justify\">Roger AJ, Munoz-Gomez SA, Kamikawa R. 2017. The origin and diversification of mitochondria. <em>Curr Biol</em> 27:R1177-R1192. DOI: 10.1016/j.cub.2017.09.015.</p>\n\n<p style=\"text-align:justify\">Russom CL, Bradbury SP, Broderius SJ, Hammermeister DE, Drummond RA. 1997. Predicting modes of toxic action from chemical structure: Acute toxicity in the fathead minnow (Pimephales promelas). <em>Environ Toxicol Chem</em> 16:948-967. DOI: <a href=\"https://doi.org/10.1002/etc.5620160514\">https://doi.org/10.1002/etc.5620160514</a>.</p>\n\n<p style=\"text-align:justify\">Schultz TW, Cronin MTD. 1997. Quantitative structure-activity relationships for weak acid respiratory uncouplers to Vibrio fisheri. <em>Environ Toxicol Chem</em> 16:357-360. DOI: <a href=\"https://doi.org/10.1002/etc.5620160235\">https://doi.org/10.1002/etc.5620160235</a>.</p>\n\n<p style=\"text-align:justify\">Shim J, Weatherly LM, Luc RH, Dorman MT, Neilson A, Ng R, Kim CH, Millard PJ, Gosse JA. 2016. Triclosan is a mitochondrial uncoupler in live zebrafish. <em>J Appl Toxicol</em> 36:1662-1667. DOI: 10.1002/jat.3311.</p>\n\n<p style=\"text-align:justify\">Sugiyama Y, Shudo T, Hosokawa S, Watanabe A, Nakano M, Kakizuka A. 2019. Emodin, as a mitochondrial uncoupler, induces strong decreases in adenosine triphosphate (ATP) levels and proliferation of B16F10 cells, owing to their poor glycolytic reserve. <em>Genes to Cells</em> 24:569-584. DOI: <a href=\"https://doi.org/10.1111/gtc.12712\">https://doi.org/10.1111/gtc.12712</a>.</p>\n\n<p style=\"text-align:justify\">Terada H. 1990. Uncouplers of oxidative phosphorylation. <em>Environ Health Perspect</em> 87:213-218. DOI: 10.1289/ehp.9087213.</p>\n\n<p style=\"text-align:justify\">Troger F, Delp J, Funke M, van der Stel W, Colas C, Leist M, van de Water B, Ecker GF. 2020. Identification of mitochondrial toxicants by combined in silico and in vitro studies &ndash; A structure-based view on the adverse outcome pathway. <em>Computational Toxicology</em> 14:100123. DOI: <a href=\"https://doi.org/10.1016/j.comtox.2020.100123\">https://doi.org/10.1016/j.comtox.2020.100123</a>.</p>\n\n<p style=\"text-align:justify\">Weatherly LM, Shim J, Hashmi HN, Kennedy RH, Hess ST, Gosse JA. 2016. Antimicrobial agent triclosan is a proton ionophore uncoupler of mitochondria in living rat and human mast cells and in primary human keratinocytes. <em>Journal of Applied Toxicology</em> 36:777-789. DOI: <a href=\"https://doi.org/10.1002/jat.3209\">https://doi.org/10.1002/jat.3209</a>.</p>\n\n<p style=\"text-align:justify\">Xia M, Huang R, Shi Q, Boyd WA, Zhao J, Sun N, Rice JR, Dunlap PE, Hackstadt AJ, Bridge MF, Smith MV, Dai S, Zheng W, Chu PH, Gerhold D, Witt KL, DeVito M, Freedman JH, Austin CP, Houck KA, Thomas RS, Paules RS, Tice RR, Simeonov A. 2018. Comprehensive analyses and prioritization of Tox21 10K chemicals affecting mitochondrial function by in-depth mechanistic studies. <em>Environ Health Perspect</em> 126:077010. DOI: 10.1289/EHP2589.</p>\n\n<p><!--[if supportFields]><span style='font-size:11.0pt;font-family:\"Calibri\",sans-serif;\nmso-fareast-font-family:;mso-fareast-theme-font:minor-fareast;mso-ansi-language:\nEN-US;mso-fareast-language:ZH-CN;mso-bidi-language:AR-SA'><span\nstyle='mso-element:field-end'></span></span><![endif]--></p>\n","biologicalOrganisationLevel":"Molecular","organTerm":{},"biologicalEvents":[{"action":"increased","process":"oxidative phosphorylation uncoupler activity","object":{}}],"keyEventStressors":["Malonoben","Carbonyl cyanide-p-trifluoromethoxyphenylhydrazone","Triclosan","2,4-Dinitrophenol","Emodin","Carbonyl cyanide m-chlorophenyl hydrazone","Pentachlorophenol"],"id":1446}
{"title":"Decrease, Adenosine triphosphate pool","references":"<p><!--[if supportFields]><span\nstyle='mso-element:field-begin'></span><span\nstyle='mso-spacerun:yes'></span>ADDIN EN.REFLIST <span style='mso-element:\nfield-separator'></span><![endif]-->Bonora M, Patergnani S, Rimessi A, De Marchi E, Suski JM, Bononi A, Giorgi C, Marchi S, Missiroli S, Poletti F, Wieckowski MR, Pinton P. 2012. ATP synthesis and storage. <em>Purinergic Signalling</em> 8:343-357. DOI: 10.1007/s11302-012-9305-8.</p>\n\n<p>Lemasters JJ, Hackenbrock CR. 1978. [4] Firefly luciferase assay for ATP production by mitochondria. <em>Methods in Enzymology</em>. Vol 57. Academic Press, pp 36-50.</p>\n\n<p>Wibom R, Lundin A, Hultman E. 1990. A sensitive method for measuring ATP-formation in rat muscle mitochondria. <em>Scandinavian Journal of Clinical and Laboratory Investigation</em> 50:143-152. DOI: 10.1080/00365519009089146.</p>\n\n<p><!--[if supportFields]><span style='font-size:11.0pt;font-family:\"Calibri\",sans-serif;\nmso-fareast-font-family:;mso-fareast-theme-font:minor-fareast;mso-ansi-language:\nEN-US;mso-fareast-language:ZH-CN;mso-bidi-language:AR-SA'><span\nstyle='mso-element:field-end'></span></span><![endif]--></p>\n","biologicalOrganisationLevel":"Cellular","organTerm":{},"biologicalEvents":[{"action":"decreased","process":"ATP biosynthetic process","object":{"name":"ATP","source":"CHEBI","sourceId":"CHEBI:15422"}}],"keyEventStressors":["Malonoben","Carbonyl cyanide-p-trifluoromethoxyphenylhydrazone","Triclosan","2,4-Dinitrophenol","Emodin","Carbonyl cyanide m-chlorophenyl hydrazone","Pentachlorophenol"],"id":1771}
{"title":"Decrease, Cell proliferation","references":"<p style=\"text-align:justify\">Conlon I, Raff M. 1999. Size control in animal development. <em>Cell</em> 96:235-244. DOI: 10.1016/s0092-8674(00)80563-2.</p>\n\n<p style=\"text-align:justify\">DeBerardinis RJ, Lum JJ, Hatzivassiliou G, Thompson CB. 2008. The biology of cancer: metabolic reprogramming fuels cell growth and proliferation. <em>Cell Metabolism</em> 7:11-20. DOI: <a href=\"https://doi.org/10.1016/j.cmet.2007.10.002\">https://doi.org/10.1016/j.cmet.2007.10.002</a>.</p>\n\n<p style=\"text-align:justify\">Muir D, Varon S, Manthorpe M. 1990. An enzyme-linked immunosorbent assay for bromodeoxyuridine incorporation using fixed microcultures. <em>Analytical Biochemistry</em> 185:377-382. DOI: <a href=\"https://doi.org/10.1016/0003-2697(90)90310-6\">https://doi.org/10.1016/0003-2697(90)90310-6</a>.</p>\n\n<p style=\"text-align:justify\">Raza A, Spiridonidis C, Ucar K, Mayers G, Bankert R, Preisler HD. 1985. Double labeling of S-phase murine cells with bromodeoxyuridine and a second DNA-specific probe. <em>Cancer Research</em> 45:2283-2287.</p>\n","biologicalOrganisationLevel":"Cellular","organTerm":{},"biologicalEvents":[{"action":"decreased","process":"cell proliferation","object":{"name":"cell","source":"GO","sourceId":"GO:0005623"}}],"keyEventStressors":["Malonoben","Carbonyl cyanide-p-trifluoromethoxyphenylhydrazone","Triclosan","2,4-Dinitrophenol","Emodin","Carbonyl cyanide m-chlorophenyl hydrazone","Pentachlorophenol"],"id":1821}
{"title":"Increase, Cell death","references":"","biologicalOrganisationLevel":"Cellular","organTerm":{},"biologicalEvents":[{"object":{}}],"id":1825}
{"title":"Increase, Fatty acid beta-oxidation","references":"","biologicalOrganisationLevel":"Cellular","organTerm":{},"biologicalEvents":[{"object":{}}],"id":1312}
{"title":"Decrease, Lipid storage","references":"","biologicalOrganisationLevel":"Cellular","organTerm":{},"biologicalEvents":[{"object":{}}],"id":1823}
{"title":"Increase, Oxygen consumption","references":"","biologicalOrganisationLevel":"Cellular","organTerm":{},"biologicalEvents":[{"object":{}}],"id":1826}
{"title":"Increase, Protein oxidation","references":"","biologicalOrganisationLevel":"Molecular","organTerm":{},"biologicalEvents":[{"object":{}}],"id":1767}
{"title":"Direct Deposition of Energy","references":"<p><span style=\"font-size:12px\"><span style=\"font-family:Arial,Helvetica,sans-serif\">Alloni, AD. et al.(2014),&rdquo; Modeling Dose Deposition and DNA Damage Due to Low-Energy &beta; &ndash; Emitters.&rdquo;, Radiation Research.182(3):322&ndash;330. doi:10.1667/RR13664.1.</span></span></p>\n\n<p><span style=\"font-size:12px\"><span style=\"font-family:Arial,Helvetica,sans-serif\">Beir, V. et al. (1999), &ldquo; The Mechanistic Basis of Radon-Induced Lung Cancer.&rdquo;, https://www.ncbi.nlm.nih.gov/books/NBK233261/.</span></span></p>\n\n<p><span style=\"font-size:12px\"><span style=\"font-family:Arial,Helvetica,sans-serif\">Douglass, M. et al. (2013),&rdquo; Monte Carlo investigation of the increased radiation deposition due to gold nanoparticles using kilovoltage and megavoltage photons in a 3D randomized cell model.&rdquo;, Med Phys. 40(7), 071710. doi:10.1118/1.4808150.</span></span></p>\n\n<p><span style=\"font-size:12px\"><span style=\"font-family:Arial,Helvetica,sans-serif\">Douglass, M. et al. (2012),&rdquo; Development of a randomized 3D cell model for Monte Carlo microdosimetry simulations.&rdquo;, Med Phys. 39(6):3509-3519, doi:10.1118/1.4719963.</span></span></p>\n\n<p><span style=\"font-size:12px\"><span style=\"font-family:Arial,Helvetica,sans-serif\">Friedland, W. et al. (2017),&rdquo; Comprehensive track-structure based evaluation of DNA damage by light ions from radiotherapy- relevant energies down to stopping.&rdquo;, Nat Publ Gr.1&ndash;15. doi:10.1038/srep45161.</span></span></p>\n\n<p><span style=\"font-size:12px\"><span style=\"font-family:Arial,Helvetica,sans-serif\">Hada, M. &amp; Georgakilas, AG. (2008), &ldquo;Formation of Clustered DNA Damage after High-LET Irradiation.&rdquo; J Radiat Res. 49(3):203&ndash;210. doi:10.1269/jrr.07123.</span></span></p>\n\n<p><span style=\"font-size:12px\"><span style=\"font-family:Arial,Helvetica,sans-serif\">Hunter, N. &amp; Muirhead, CR. (2009).&rdquo; Review of relative biological effectiveness dependence on linear energy transfer for low-LET radiations Review of relative biological effectiveness dependence.&rdquo;, Journal of Radiological Protection. 29(1):5-21. doi:10.1088/0952-4746/29/1/R01.</span></span></p>\n\n<p><span style=\"font-size:12px\"><span style=\"font-family:Arial,Helvetica,sans-serif\">Kodaira, S. &amp; Konishi, T. (2015), &ldquo;Co-visualization of DNA damage and ion traversals in live mammalian cells using a fluorescent nuclear track detector.&rdquo; Journal of Radiation Research. 360&ndash;365. doi:10.1093/jrr/rru091.</span></span></p>\n\n<p><span style=\"font-size:12px\"><span style=\"font-family:Arial,Helvetica,sans-serif\">Liamsuwan, T. (2014).&rdquo; Microdosimetry of proton and carbon ions.&rdquo;, &nbsp;Med Phys. 41(8):081721. doi: 10.1118/1.4888338.</span></span></p>\n\n<p><span style=\"font-size:12px\"><span style=\"font-family:Arial,Helvetica,sans-serif\">Lorat, Y. (2015),&rdquo; Nanoscale analysis of clustered DNA damage after high-LET irradiation by quantitative electron microscopy &ndash; The heavy burden to repair.&rdquo;, &nbsp;DNA Repair (Amst). 28:93&ndash;106. doi:10.1016/j.dnarep.2015.01.007.</span></span></p>\n\n<p><span style=\"font-size:12px\"><span style=\"font-family:Arial,Helvetica,sans-serif\">Nikitaki, Z. et al. (2016), &ldquo;Measurement of complex DNA damage induction and repair in human cellular systems after exposure to ionizing radiations of varying linear energy transfer ( LET ).&rdquo;,Free Radical Research. 50(sup1):S64-S78.doi:10.1080/10715762.2016.1232484.</span></span></p>\n\n<p><span style=\"font-size:12px\"><span style=\"font-family:Arial,Helvetica,sans-serif\">Niklas, M. et al. (2013), &ldquo;Engineering cell-fluorescent ion track hybrid detectors.&rdquo;, Radiation Oncology. 8:141. doi: 10.1186/1748-717X-8-141.</span></span></p>\n\n<p><span style=\"font-size:12px\"><span style=\"font-family:Arial,Helvetica,sans-serif\">Okayasu, R. (2012a), &ldquo;heavy ions &mdash; a mini review.&rdquo;, Int J Cancer. 1000:991&ndash;1000. doi:10.1002/ijc.26445.</span></span></p>\n\n<p><span style=\"font-size:12px\"><span style=\"font-family:Arial,Helvetica,sans-serif\">Okayasu, R. (2012b), &ldquo;Repair of DNA damage induced by accelerated heavy ions-A mini review.&rdquo;, &nbsp;Int J Cancer. 130(5):991&ndash;1000. doi:10.1002/ijc.26445.</span></span></p>\n\n<p><span style=\"font-size:12px\"><span style=\"font-family:Arial,Helvetica,sans-serif\">Robertson, &nbsp;A. et al. (2013), &ldquo;The Cellular and Molecular Carcinogenic Effects of Radon Exposure.&rdquo;, &nbsp;Int J Mol Sci.14(7):14024-63. doi: 10.3390/ijms140714024.</span></span></p>\n\n<p><span style=\"font-size:12px\"><span style=\"font-family:Arial,Helvetica,sans-serif\">Sawakuchi, GO. &amp; Akselrod, MS. (2016), &nbsp;&ldquo;Nanoscale measurements of proton tracks using fluorescent nuclear track detectors.&rdquo;,Med Phys. 43(5):2485&ndash;2490. doi:10.1118/1.4947128.</span></span></p>\n\n<p><span style=\"font-size:12px\"><span style=\"font-family:Arial,Helvetica,sans-serif\">Wyrobek, A. J. et al. (2005), &ldquo;Relative susceptibilities of male germ cells to genetic defects induced by cancer chemotherapies.&rdquo;, J Natl Cancer Inst Monogr.(34)&rdquo; 31-35. doi:10.1093/jncimonographs/lgi001.</span></span></p>\n","biologicalOrganisationLevel":"Molecular","organTerm":{},"biologicalEvents":[{"object":{}}],"keyEventStressors":["Ionizing Radiation"],"id":1686}
{"title":"Increase, DNA strand breaks","references":"<p><span style=\"color:rgb(0, 0, 205)\">Ager, D. D. et al. (1990). &ldquo;Measurement of Radiation- Induced DNA Double-Strand Breaks by Pulsed-Field Gel Electrophoresis.&rdquo; Radiat Res. 122(2), 181-7.</span></p>\n\n<p><span style=\"color:rgb(0, 0, 205)\">Anderson, D. &amp; Laubenthal J. (2013), &ldquo;Analysis of DNA Damage via Single-Cell Electrophoresis. In: Makovets S, editor. DNA Electrophoresis. Totowa.&rdquo;, NJ: Humana Press. p 209-218.</span></p>\n\n<p>Asaithamby, A., B. Hu and D.J. Chen. (2011) Unrepaired clustered DNA lesions induce chromosome breakage in human cells. Proc Natl Acad Sci U S A 108(20): 8293-8298 .</p>\n\n<p>Barbieri, S., G. Babini, J. Morini et a l (2019). . Predicting DNA damage foci and their experimental readout with 2D microscopy: a unified approach applied to photon and neutron exposures. Scientific Reports 9(1): 14019</p>\n\n<p><span style=\"color:rgb(0, 0, 205)\">Bryce, S. et al. (2016), &ldquo;Genotoxic mode of action predictions from a multiplexed flow cytometric assay and a machine learning approach.&rdquo;, Environ Mol Mutagen. 57:171-189. Doi: 10.1002/em.21996.</span></p>\n\n<p><span style=\"color:rgb(0, 0, 205)\">Burma, S. et al. (2001), &ldquo;ATM phosphorylates histone H2AX in response to DNA double-strand breaks.&rdquo;, J Biol Chem, 276(45): 42462-42467. doi:10.1074/jbc.C100466200</span></p>\n\n<p><span style=\"color:rgb(0, 0, 205)\">Charlton, E. D. et al. (1989), &ldquo;Calculation of Initial Yields of Single and Double Stranded Breaks in Cell Nuclei from Electrons, Protons, and Alpha Particles.&rdquo;, &nbsp;Int. J. Radiat. Biol. 56(1): 1-19. doi: 10.1080/09553008914551141.</span></p>\n\n<p><span style=\"color:rgb(0, 0, 205)\">Collins, R. A. (2004), &ldquo;The Comet Assay for DNA Damage and Repair. Molecular Biotechnology.&rdquo;, Mol Biotechnol. 26(3): 249-61. doi:10.1385/MB:26:3:249</span></p>\n\n<p><span style=\"color:rgb(0, 0, 205)\">Garcia-Canton, C. et al. (2013), &ldquo;Assessment of the in vitro p-H2AX assay by High Content Screening asa novel genotoxicity test.&rdquo;, Mutat Res. 757:158-166.&nbsp; Doi: &nbsp;10.1016/j.mrgentox.2013.08.002</span></p>\n\n<p><span style=\"color:rgb(0, 0, 205)\">Gardiner, K. et al. (1986), &ldquo;Fractionation of Large Mammalian DNA Restriction Fragments Using Vertical Pulsed-Field Gradient Gel Electrophoresis.&rdquo;, &nbsp;Somatic Cell and Molecular Genetics. 12(2): 185-95.Doi: 10.1007/bf01560665.</span></p>\n\n<p><span style=\"color:rgb(0, 0, 205)\">Herschleb, J. et al. (2007), &ldquo;Pulsed-field gel electrophoresis.&rdquo;, &nbsp;Nat Protoc. 2(3): 677-684. doi:10.1038/nprot.2007.94</span></p>\n\n<p><span style=\"color:rgb(0, 0, 205)\">Iliakis, G. et al. (2015), &ldquo;Alternative End-Joining Repair Pathways Are the Ultimate Backup for Abrogated Classical Non-Homologous End-Joining and Homologous Recombination Repair: Implications for the Formation of Chromosome Translocations.&rdquo;, &nbsp;Mutation Research/Genetic Toxicology and Environmental Mutagenesis. 2(3): 677-84. doi: 10.1038/nprot.2007.94</span></p>\n\n<p><span style=\"color:rgb(0, 0, 205)\">Jackson, S. (2002). &ldquo;Sensing and repairing DNA double-strand breaks.&rdquo;, &nbsp;Carcinogenesis. 23:687-696. Doi:10.1093/carcin/23.5.687.</span></p>\n\n<p><span style=\"color:rgb(0, 0, 205)\">Ji, J. et al. (2017), &ldquo;Phosphorylated fraction of H2AX as a measurement for DNA damage in cancer cells and potential applications of a novel assay.&rdquo;, &nbsp;PLoS One. 12(2): e0171582. doi:10.1371/journal.pone.0171582</span></p>\n\n<p><span style=\"color:rgb(0, 0, 205)\">Kawashima, Y.(2017), &ldquo;Detection of DNA double-strand breaks by pulsed-field gel electrophoresis.&rdquo;, &nbsp;Genes Cells 22:84-93. Doi: 10.1111/gtc.12457.</span></p>\n\n<p><span style=\"color:rgb(0, 0, 205)\">Khoury, L. et al. (2013), &ldquo;Validation of high-throughput genotoxicity assay screening using cH2AX in-cell Western assay on HepG2 cells.&rdquo;, Environ Mol Mutagen, 54:737-746. Doi: &nbsp;10.1002/em.21817.</span></p>\n\n<p><span style=\"color:rgb(0, 0, 205)\">Khoury, L. et al. (2016), &ldquo;Evaluation of four human cell lines with distinct biotransformation properties for genotoxic screening.&rdquo;, Mutagenesis, 31:83-96. Doi: </span><a href=\"https://doi.org/10.1093/mutage/gev058\" target=\"_blank\"><span style=\"color:rgb(0, 0, 205)\">10.1093/mutage/gev058</span></a><span style=\"color:rgb(0, 0, 205)\">.</span></p>\n\n<p><span style=\"color:rgb(0, 0, 205)\">Loo, DT. (2011), &ldquo;In Situ Detection of Apoptosis by the TUNEL Assay: An Overview of Techniques. In: Didenko V, editor. DNA Damage Detection In Situ, Ex Vivo, and In Vivo. Totowa.&rdquo;, NJ: Humana Press. p 3-13.doi: </span><a href=\"https://doi.org/10.1007/978-1-60327-409-8_1\" target=\"_blank\"><span style=\"color:rgb(0, 0, 205)\">10.1007/978-1-60327-409-8_1</span></a><span style=\"color:rgb(0, 0, 205)\">.</span></p>\n\n<p><span style=\"color:rgb(0, 0, 205)\">Mah, L. J. et al. (2010), &ldquo;Quantification of gammaH2AX foci in response to ionising radiation.&rdquo;, &nbsp;J Vis Exp(38). doi:10.3791/1957.</span></p>\n\n<p><span style=\"color:rgb(0, 0, 205)\">Nikolova, T., F. et al. (2017), &ldquo;Genotoxicity testing: Comparison of the &gamma;H2AX focus assay with the alkaline and neutral comet assays.&rdquo;, &nbsp;Mutat Res&nbsp;822:10-18. Doi: </span><a href=\"https://doi.org/10.1016/j.mrgentox.2017.07.004\" target=\"_blank\"><span style=\"color:rgb(0, 0, 205)\">10.1016/j.mrgentox.2017.07.004</span></a><span style=\"color:rgb(0, 0, 205)\">.</span></p>\n\n<p><span style=\"color:rgb(0, 0, 205)\">Nitiss, J. L. et al. (2012), &ldquo;Topoisomerase assays. &rdquo;, Curr Protoc Pharmacol. Chapter 3: Unit 3 3.</span></p>\n\n<p><span style=\"color:rgb(0, 0, 205)\">OECD. (2014). Test No. 489: &ldquo;In vivo mammalian alkaline comet assay.&rdquo; &nbsp;OECD Guideline for the Testing of Chemicals, Section 4 .</span></p>\n\n<p><span style=\"color:rgb(0, 0, 205)\">Olive, P. L., &amp; Ban&aacute;th, J. P. (2006), &ldquo;The comet assay: a method to measure DNA damage in individual cells.&rdquo;, &nbsp;Nature Protocols. 1(1): 23-29. doi:10.1038/nprot.2006.5.</span></p>\n\n<p><span style=\"color:rgb(0, 0, 205)\">Platel A. et al. (2011), &ldquo;Study of oxidative DNA damage in TK6 human lymphoblastoid cells by use of the thymidine kinase gene-mutation assay and the&nbsp;<em>in vitro&nbsp;</em>modified comet assay: Determination of No-Observed-Genotoxic-Effect-Levels.&rdquo;, &nbsp;Mutat Res 726:151-159. Doi: 10.1016/j.mrgentox.2011.09.003.</span></p>\n\n<p><span style=\"color:rgb(0, 0, 205)\">Redon, C. et al. (2010), &ldquo;The use of gamma-H2AX as a biodosimeter for total-body radiation exposure in non-human primates.&rdquo;, &nbsp;PLoS One. 5(11): e15544. doi:10.1371/journal.pone.0015544</span></p>\n\n<p><span style=\"color:rgb(0, 0, 205)\">Revet, I. et al. (2011), &ldquo;Functional relevance of the histone &gamma;H2Ax in the response to DNA damaging agents.&rdquo; Proc Natl Acad Sci USA.108:8663-8667. Doi: 10.1073/pnas.1105866108</span></p>\n\n<p><span style=\"color:rgb(0, 0, 205)\">Rogakou, E.P. et al. (1998), &ldquo;DNA Double-stranded Breaks Induce Histone H2AX Phosphorylation on Serine 139.&rdquo; , J Biol Chem, 273:5858-5868. Doi: 10.1074/jbc.273.10.5858</span></p>\n\n<p><span style=\"color:rgb(0, 0, 205)\">Rothkamm, K. &amp; Horn, S. (2009), &ldquo;&gamma;-H2AX as protein biomarker for radiation exposure.&rdquo;, &nbsp;Ann Ist Super Sanit&agrave;, 45(3): 265-71.</span></p>\n","biologicalOrganisationLevel":"Molecular","organTerm":{},"biologicalEvents":[{"object":{}}],"keyEventStressors":["Radiomimetic compounds","Topoisomerase inhibitors","Ionizing Radiation"],"id":1635}
{"title":"Increase, Chromosomal aberrations","references":"<p><span style=\"color:rgb(0, 0, 205)\"><span style=\"font-size:14px\"><span style=\"font-family:arial,helvetica,sans-serif\">Abe, Y et al. (2018), &ldquo;Dose-response curves for analyzing of dicentric chromosomes and chromosome translocations following doses of 1000 mGy or less, based on irradiated peripheral blood samples from five healthy individuals&rdquo;, &nbsp;<em>J Radiat Res</em>. 59(1), 35-42. doi:10.1093/jrr/rrx052</span></span></span></p>\n\n<p><span style=\"color:rgb(0, 0, 205)\"><span style=\"font-size:14px\"><span style=\"font-family:arial,helvetica,sans-serif\">Adewoye, A.B.et al. (2015), &ldquo;The genome-wide effects of ionizing radiation on mutation induction in the mammalian germline&rdquo;, <em>Nat. Commun</em>. 6:66-84. doi: 10.1038/ncomms7684.</span></span></span></p>\n\n<p><span style=\"color:rgb(0, 0, 205)\"><span style=\"font-size:14px\"><span style=\"font-family:arial,helvetica,sans-serif\">Arlt MF, Wilson TE, Glover TW. (2012), &ldquo;Replication stress and mechanisms of CNV formation&rdquo;, <em>Curr Opin Genet Dev</em>. 22(3):204-10. doi: 10.1016/j.gde.2012.01.009.</span></span></span></p>\n\n<p><span style=\"color:rgb(0, 0, 205)\"><span style=\"font-size:14px\"><span style=\"font-family:arial,helvetica,sans-serif\">Arlt, MF. Et al. (2014), &ldquo;Copy number variants are produced in response to low-dose ionizing radiation in cultured cells&rdquo;, <em>Environ Mol Mutagen</em>. 55(2):103-13. doi: 10.1002/em.21840.</span></span></span></p>\n\n<p><span style=\"color:rgb(0, 0, 205)\"><span style=\"font-size:14px\"><span style=\"font-family:arial,helvetica,sans-serif\">Beaton, L. A. et al. (2013), &ldquo;Investigating chromosome damage using fluorescent in situ hybridization to identify biomarkers of radiosensitivity in prostate cancer patients&rdquo;, Int J Radiat Biol. 89(12): 1087-1093. doi:10.3109/09553002.2013.825060</span></span></span></p>\n\n<p><span style=\"color:rgb(0, 0, 205)\"><span style=\"font-size:14px\"><span style=\"font-family:arial,helvetica,sans-serif\">Boei, J.J., Vermeulen, S., Natarajan, A.T. (1996), &ldquo;Detection of chromosomal aberrations by fluorescence in situ hybridization in the first three postirradiation divisions of human lymphocytes&rdquo;, Mutat Res, 349:127-135. Doi: 10.1016/0027-5107(95)00171-9.</span></span></span></p>\n\n<p><span style=\"color:rgb(0, 0, 205)\"><span style=\"font-size:14px\"><span style=\"font-family:arial,helvetica,sans-serif\">Bonassi, S. &nbsp;(2008),&rdquo;Chromosomal aberration&nbsp;frequency&nbsp;in&nbsp;lymphocytes&nbsp;predicts&nbsp;the&nbsp;risk of&nbsp;cancer: results from a pooled cohort study of 22 358 subjects in 11 countries&rdquo;, <em>Carcinogenesis.</em> 29(6):1178-83. doi: 10.1093/carcin/bgn075.</span></span></span></p>\n\n<p><span style=\"color:rgb(0, 0, 205)\"><span style=\"font-size:14px\"><span style=\"font-family:arial,helvetica,sans-serif\">Bryce, S. et al. (2014), &ldquo;Interpreting In VitroMicronucleus Positive Results: Simple Biomarker Matrix Discriminates Clastogens, Aneugens, and Misleading Positive Agents&rdquo;, Environ Mol Mutagen, 55:542-555. Doi:10.1002/em.21868.</span></span></span></p>\n\n<p><span style=\"color:rgb(0, 0, 205)\"><span style=\"font-size:14px\"><span style=\"font-family:arial,helvetica,sans-serif\">Bryce, S. et al.(2016), &ldquo;Genotoxic mode of action predictions from a multiplexed flow cytometric assay and a machine learning approach&rdquo;, Environ Mol Mutagen, 57:171-189. Doi: 10.1002/em.21996.</span></span></span></p>\n\n<p><span style=\"color:rgb(0, 0, 205)\"><span style=\"font-size:14px\"><span style=\"font-family:arial,helvetica,sans-serif\">Bunting, S. F., &amp; Nussenzweig, A. (2013), &ldquo;End-joining, translocations and cancer&rdquo;, Nature Reviews Cancer.13 (7): 443-454. doi:10.1038/nrc3537</span></span></span></p>\n\n<p><span style=\"color:rgb(0, 0, 205)\"><span style=\"font-size:14px\"><span style=\"font-family:arial,helvetica,sans-serif\">Curtis, C. et al. (2012), &ldquo;The&nbsp;genomic&nbsp;and&nbsp;transcriptomic&nbsp;architecture&nbsp;of 2,000&nbsp;breast tumours&nbsp;reveals novel subgroups&rdquo;, Nature. 486(7403):346-52. doi: 10.1038/nature10983.</span></span></span></p>\n\n<p><span style=\"font-size:14px\"><span style=\"font-family:arial,helvetica,sans-serif\"><span style=\"color:rgb(0, 0, 205)\">Dertinger, S.D. et al.(2004), &ldquo;Three-color labeling method for flow cytometric measurement of cytogenetic damage in rodent and human blood&rdquo;, Environ Mol Mutagen, 44:427-435. Doi:&nbsp;</span><a href=\"https://doi.org/10.1002/em.20075\" target=\"_blank\"><span style=\"color:rgb(0, 0, 205)\">10.1002/em.20075</span></a><span style=\"color:rgb(0, 0, 205)\">.</span></span></span></p>\n\n<p>&nbsp;</p>\n\n<p><span style=\"color:rgb(0, 0, 205)\"><span style=\"font-size:14px\"><span style=\"font-family:arial,helvetica,sans-serif\">El-Zein, RA. Et al. (2014), &ldquo;The&nbsp;cytokinesis-blocked&nbsp;micronucleus assay&nbsp;as a&nbsp;strong&nbsp;predictor&nbsp;of&nbsp;lung cancer: extension of a&nbsp;lung cancer&nbsp;risk prediction model&rdquo;, &nbsp;Cancer&nbsp;Epidemiol Biomarkers Prev. 23(11):2462-70. doi: 10.1158/1055-9965.EPI-14-0462.</span></span></span></p>\n\n<p><span style=\"color:rgb(0, 0, 205)\"><span style=\"font-size:14px\"><span style=\"font-family:arial,helvetica,sans-serif\">Fenech, M. (2000), &ldquo;The in vitro micronucleus technique&rdquo;, Mutation Research. 455(1-2), 81-95. Doi: 10.1016/s0027-5107(00)00065-8</span></span></span></p>\n\n<p><span style=\"color:rgb(0, 0, 205)\"><span style=\"font-size:14px\"><span style=\"font-family:arial,helvetica,sans-serif\">Griffiths, A. J. F., Miller, J. H., &amp; Suzuki, D. T. (2000), &ldquo;An Introduction to Genetic Analysis&rdquo;, 7th edition. New York: W. H. Freeman. Available from: https://www.ncbi.nlm.nih.gov/books/NBK21766/</span></span></span></p>\n\n<p><span style=\"color:rgb(0, 0, 205)\"><span style=\"font-size:14px\"><span style=\"font-family:arial,helvetica,sans-serif\">Hagmar, L. et al. (2004), &ldquo;Impact&nbsp;of&nbsp;types&nbsp;of&nbsp;lymphocyte&nbsp;chromosomal aberrations&nbsp;on&nbsp;human&nbsp;cancer risk: results from Nordic and Italian cohorts&rdquo;, Cancer Res. 64(6):2258-63.</span></span></span></p>\n\n<p><span style=\"color:rgb(0, 0, 205)\"><span style=\"font-size:14px\"><span style=\"font-family:arial,helvetica,sans-serif\">Hastings PJ, Ira G &amp; Lupski JR. (2009), &ldquo;A microhomology-mediated&nbsp;break-induced&nbsp;replication&nbsp;model&nbsp;for the&nbsp;origin&nbsp;of human copy number variation&rdquo;. PLoS Genet. 2009 Jan;5(1): e1000327. doi: 10.1371/journal.pgen.1000327.</span></span></span></p>\n\n<p><span style=\"color:rgb(0, 0, 205)\"><span style=\"font-size:14px\"><span style=\"font-family:arial,helvetica,sans-serif\">Hendriks, G. et al. (2012), &ldquo;The ToxTracker assay: novel GFP reporter systems that provide mechanistic insight into the genotoxic properties of chemicals&rdquo;, Toxicol Sci, 125:285-298. Doi: 10.1093/toxsci/kfr281.</span></span></span></p>\n\n<p><span style=\"color:rgb(0, 0, 205)\"><span style=\"font-size:14px\"><span style=\"font-family:arial,helvetica,sans-serif\">Hendriks, G. et al. (2016), &ldquo;The Extended ToxTracker Assay Discriminates Between Induction of DNA Damage, Oxidative Stress, and Protein Misfolding&rdquo;, Toxicol Sci, 150:190-203. Doi: 10.1093/toxsci/kfv323.</span></span></span></p>\n\n<p><span style=\"color:rgb(0, 0, 205)\"><span style=\"font-size:14px\"><span style=\"font-family:arial,helvetica,sans-serif\">Keren, B. (2014),&rdquo;The advantages of SNP arrays over CGH arrays&rdquo;, Molecular Cytogenetics.7( 1):I31. Doi: 10.1186/1755-8166-7-S1-I31.</span></span></span></p>\n\n<p><span style=\"color:rgb(0, 0, 205)\"><span style=\"font-size:14px\"><span style=\"font-family:arial,helvetica,sans-serif\">Khoury, L., Zalko, D., Audebert, M. (2016), &ldquo;Evaluation of four human cell lines with distinct biotransformation properties for genotoxic screening&rdquo;, Mutagenesis. 31:83-96. Doi: 10.1093/mutage/gev058.</span></span></span></p>\n\n<p><span style=\"color:rgb(0, 0, 205)\"><span style=\"font-size:14px\"><span style=\"font-family:arial,helvetica,sans-serif\">Khoury, L., Zalko, D., Audebert, M. (2013), &ldquo;Validation of high-throughput genotoxicity assay screening using cH2AX in-cell Western assay on HepG2 cells&rdquo;, Environ Mol Mutagen, 54:737-746. Doi: 10.1002/em.21817.</span></span></span></p>\n\n<p><span style=\"color:rgb(0, 0, 205)\"><span style=\"font-size:14px\"><span style=\"font-family:arial,helvetica,sans-serif\">Lee JA, Carvalho CM, Lupski JR. (2007). &ldquo;Replication mechanism for generating nonrecurrent rearrangements&nbsp;associated&nbsp;with&nbsp;genomic&nbsp;disorders&rdquo;, Cell. 131(7):1235-47. Doi: 10.1016/j.cell.2007.11.037.</span></span></span></p>\n\n<p><span style=\"color:rgb(0, 0, 205)\"><span style=\"font-size:14px\"><span style=\"font-family:arial,helvetica,sans-serif\">Liu B. et al. (2013). &ldquo;Computational methods for detecting copy number variations in cancer genome using next generation sequencing: principles and challenges&rdquo;, Oncotarget. 4(11):1868-81. Doi: 10.18632/oncotarget.1537.</span></span></span></p>\n\n<p><span style=\"color:rgb(0, 0, 205)\"><span style=\"font-size:14px\"><span style=\"font-family:arial,helvetica,sans-serif\">Mitelman, F. (1982), &ldquo;Application of cytogenetic methods to analysis of etiologic factors in carcinogenesis&rdquo;, IARC Sci Publ, 39:481-496.</span></span></span></p>\n\n<p><span style=\"color:rgb(0, 0, 205)\"><span style=\"font-size:14px\"><span style=\"font-family:arial,helvetica,sans-serif\">Mukherjee. S. et al. (2017),&nbsp;&ldquo;Addition&nbsp;of&nbsp;chromosomal&nbsp;microarray&nbsp;and&nbsp;next generation sequencing&nbsp;to&nbsp;FISH&nbsp;and classical cytogenetics enhances genomic profiling of myeloid malignancies, Cancer Genet. 216-217:128-141. doi: 10.1016/j.cancergen.2017.07.010.</span></span></span></p>\n\n<p><span style=\"color:rgb(0, 0, 205)\"><span style=\"font-size:14px\"><span style=\"font-family:arial,helvetica,sans-serif\">Obe, G. et al. (2002), &ldquo;Chromosomal Aberrations: formation, Identification, and Distribution&rdquo;, Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis. 504(1-2), 17-36. Doi: 10.1016/s0027-5107(02)00076-3.</span></span></span></p>\n\n<p><span style=\"color:rgb(0, 0, 205)\"><span style=\"font-size:14px\"><span style=\"font-family:arial,helvetica,sans-serif\">Savage, J.R. (1976), &ldquo;Classification and relationships of induced chromosomal structual changes&rdquo;, J Med Genet, 13:103-122. Doi: 10.1136/jmg.13.2.103.</span></span></span></p>\n\n<p><span style=\"color:rgb(0, 0, 205)\"><span style=\"font-size:14px\"><span style=\"font-family:arial,helvetica,sans-serif\">OECD. (2016a), &ldquo;In Vitro Mammalian Chromosomal Aberration Test 473.&rdquo;</span></span></span></p>\n\n<p><span style=\"color:rgb(0, 0, 205)\"><span style=\"font-size:14px\"><span style=\"font-family:arial,helvetica,sans-serif\">OECD. (2016b), &ldquo;Test No. 474: Mammalian Erythrocyte Micronucleus Test. OECD Guideline for the Testing of Chemicals, Section 4.&rdquo;Paris: OECD Publishing.</span></span></span></p>\n\n<p><span style=\"color:rgb(0, 0, 205)\"><span style=\"font-size:14px\"><span style=\"font-family:arial,helvetica,sans-serif\">OECD. (2016c). Test No. 475: Mammalian Bone Marrow Chromosomal Aberration Test. OECD Guideline for the Testing of Chemicals, Section 4.&nbsp;Paris: OECD Publishing.</span></span></span></p>\n\n<p><span style=\"color:rgb(0, 0, 205)\"><span style=\"font-size:14px\"><span style=\"font-family:arial,helvetica,sans-serif\">OECD. (2015). Test No. 483: Mammalian Spermatogonial Chromosomal Aberration Test. Paris: OECD Publishing.</span></span></span></p>\n\n<p><span style=\"color:rgb(0, 0, 205)\"><span style=\"font-size:14px\"><span style=\"font-family:arial,helvetica,sans-serif\">OECD. (2014). Test No. 487: In Vitro Mammalian Cell Micronucleus Test.&nbsp;Paris: OECD Publishing.</span></span></span></p>\n\n<p><span style=\"color:rgb(0, 0, 205)\"><span style=\"font-size:14px\"><span style=\"font-family:arial,helvetica,sans-serif\">Pathak, R., Koturbash, I., &amp; Hauer-Jensen, M. (2017), &ldquo;Detection of Inter-chromosomal Stable Aberrations by Multiple Fluorescence In Situ Hybridization (mFISH) and Spectral Karyotyping (SKY) in Irradiated Mice&rdquo;, J Vis Exp(119). doi:10.3791/55162.</span></span></span></p>\n\n<p><span style=\"color:rgb(0, 0, 205)\"><span style=\"font-size:14px\"><span style=\"font-family:arial,helvetica,sans-serif\">Redon, R. et al. (2006), &ldquo;Global&nbsp;variation&nbsp;in&nbsp;copy&nbsp;number&nbsp;in the&nbsp;human genome&rdquo;, Nature.&nbsp;444(7118):444-54. 10.1038/nature05329.</span></span></span></p>\n\n<p><span style=\"color:rgb(0, 0, 205)\"><span style=\"font-size:14px\"><span style=\"font-family:arial,helvetica,sans-serif\">Rodrigues, M. A., Beaton-Green, L. A., &amp; Wilkins, R. C. (2016), &ldquo;Validation of the Cytokinesis-block Micronucleus Assay Using Imaging Flow Cytometry for High Throughput Radiation Biodosimetry&rdquo;, Health Phys. 110(1): 29-36. doi:10.1097/HP.0000000000000371</span></span></span></p>\n\n<p><span style=\"color:rgb(0, 0, 205)\"><span style=\"font-size:14px\"><span style=\"font-family:arial,helvetica,sans-serif\">Shahane S, Nishihara K, Xia M. (2016), &ldquo;High-Throughput and High-Content Micronucleus Assay in CHO-K1 Cells&rdquo;, In: Zhu H, Xia M, editors. High-Throughput Screening Assays in Toxicology. New York, NY: Humana Press. p 77-85.</span></span></span></p>\n\n<p><span style=\"color:rgb(0, 0, 205)\"><span style=\"font-size:14px\"><span style=\"font-family:arial,helvetica,sans-serif\">Shen.TW, &nbsp;(2016),&rdquo;Concurrent&nbsp;detection&nbsp;of&nbsp;targeted&nbsp;copy&nbsp;number&nbsp;variants&nbsp;and&nbsp;mutations&nbsp;using a myeloid malignancy next generation sequencing panel allows comprehensive genetic analysis using a single testing strategy&rdquo;, Br J Haematol. 173(1):49-58. doi: 10.1111/bjh.13921.</span></span></span></p>\n\n<p><span style=\"color:rgb(0, 0, 205)\"><span style=\"font-size:14px\"><span style=\"font-family:arial,helvetica,sans-serif\">Shlien A, Malkin D. (2009), &ldquo;Copy&nbsp;number&nbsp;variations&nbsp;and&nbsp;cancer&rdquo;, Genome Med.&nbsp;1(6):62. doi: 10.1186/gm62.</span></span></span></p>\n\n<p><span style=\"color:rgb(0, 0, 205)\"><span style=\"font-size:14px\"><span style=\"font-family:arial,helvetica,sans-serif\">Tucker, J.D., Preston, R.J. (1996), &ldquo;Chromosome aberrations, micronuclei, aneuploidy, sister chromatid exchanges, and cancer risk assessment&rdquo;, Mutat Res, 365:147-159.</span></span></span></p>\n\n<p><span style=\"color:rgb(0, 0, 205)\"><span style=\"font-size:14px\"><span style=\"font-family:arial,helvetica,sans-serif\">Wilson, TE. et al.&nbsp; (2015), &ldquo;Large transcription units unify copy number variants and common fragile sites arising under replication stress&rdquo;, Genome Res. 25(2):189-200. doi: 10.1101/gr.177121.114.</span></span></span></p>\n\n<p><span style=\"color:rgb(0, 0, 205)\"><span style=\"font-size:14px\"><span style=\"font-family:arial,helvetica,sans-serif\">Wink, S. et al. (2014), &ldquo;Quantitative high content imaging of cellular adaptive stress response pathways in toxicity for chemical safety assessment&rdquo;, Chem Res Toxicol, 27:338-355.</span></span></span></p>\n\n<p><span style=\"color:rgb(0, 0, 205)\"><span style=\"font-size:14px\"><span style=\"font-family:arial,helvetica,sans-serif\">Zhang N, Wang M, Zhang P, Huang T. 2016. Classification&nbsp;of&nbsp;cancers&nbsp;based&nbsp;on&nbsp;copy number variation&nbsp;landscapes. Biochim Biophys Acta.&nbsp; 1860(11 Pt B):2750-5. doi: 10.1016/j.bbagen.2016.06.003.</span></span></span></p>\n","biologicalOrganisationLevel":"Cellular","organTerm":{},"biologicalEvents":[{"object":{}}],"keyEventStressors":["Ionizing Radiation"],"id":1636}
{"title":"Increase, lung cancer","references":"<p>Aziz, F. (2012), &ldquo;Endobronchial ultrasound-guided transbronchial needle aspiration for staging of lung cancer: a concise review&rdquo;, Transl Lung Cancer Res, 1(3), 208-213. doi:10.3978/j.issn.2218-6751.2012.09.08.</p>\n\n<p>Bach, P. B. et al. (2012), &ldquo;Benefits and harms of CT screening for lung cancer: a systematic review&rdquo;, JAMA, 307(22), 2418-2429. doi:10.1001/jama.2012.5521</p>\n\n<p>Beasley, M. B., Brambilla, E., &amp; Travis, W. D. (2005), &ldquo;The 2004 World Health Organization classification of lung tumors&rdquo;, Seminars in Roentgenology, 40(2), 90-97. doi:10.1053/j.ro.2005.01.001</p>\n\n<p>Chen Y, Maeda A, Bu J, DaCosta R. (2016), &ldquo;Femur Window Chamber Model for In Vivo Cell Tracking in the Murine Bone Marrow&rdquo;, J Vis Exp. (113). doi: 10.3791/54205.</p>\n\n<p>Herbst, R. S., Heymach, J. V., &amp; Lippman, S. M. (2008), &ldquo;Lung cancer&rdquo;, N Engl J Med. 359, 1367&ndash; 80.</p>\n\n<p>Hubers, A. J. et al. (2013), &ldquo;Molecular sputum analysis for the diagnosis of lung cancer&rdquo;, Br J Cancer. 109(3), 530-537. doi:10.1038/bjc.2013.393</p>\n\n<p>Ikeda, N. et al. (2007), &ldquo;Comprehensive diagnostic bronchoscopy of central type early stage lung cancer&rdquo;, Lung Cancer, 56(3), 295-302. doi:10.1016/j.lungcan.2007.01.009</p>\n\n<p>Jin, Y. et al. (2018), &ldquo;Simvastatin inhibits the development of radioresistant esophageal cancer cells by increasing the radiosensitivity and reversing EMT process via the PTEN-PI3K/AKT pathway&rdquo;, Exp Cell Res.362(2):362-369. Doi: 10.1016/j.yexcr.2017.11.037.</p>\n\n<p>Keshamouni, V., Arenberg, D., &amp; Kalemkerian, G. (2009), &ldquo;Lung Cancer Metastasis: Novel Biological Mechanisms and Impact on Clinical Practice&rdquo;, Springer Science + Business Media. Doi: 10.1007/978-1-4419-0772-1.</p>\n\n<p>Khalil, A.et al. (2016), &ldquo;Contribution of magnetic resonance imaging in lung cancer imaging&rdquo;, Diagnostic and Interventional Imaging, 97(10), 991-1002. doi:10.1016/j.diii.2016.08.015</p>\n\n<p>Maronpot RR, Thoolen RJ, Hansen B. (2015), &ldquo;Two-year carcinogenicity study of acrylamide in Wistar Han rats with in utero exposure&rdquo;,Exp Toxicol Pathol. 67(2):189-95. doi: 10.1016/j.etp.2014.11.009.</p>\n\n<p>Matsumoto, M. et al. (2012), &ldquo;Carcinogenicity of ortho-phenylenediamine dihydrochloride in rats and mice by two-year drinking water treatment&rdquo;, &nbsp;Arch Toxicol. 86(5):791-804. doi: 10.1007/s00204-012-0800-z.</p>\n\n<p>Moeller, BJ. et al.(2004), &ldquo;Radiation activates HIF-1 to regulate vascular radiosensitivity in tumors: role of reoxygenation, free radicals, and stress granules&rdquo;, Cancer Cell. 5(5):429-41.</p>\n\n<p>Molina JR. et al. (2008), &ldquo;Non-small cell lung cancer: epidemiology, risk factors, treatment, and survivorship&rdquo;, Mayo Clin Proc. 83(5):584-94. doi: 10.4065/83.5.584.</p>\n\n<p>Nambiar PR. et al. (2015), &ldquo;Two-year carcinogenicity study in rats with a nonnucleoside reverse transcriptase inhibitor&rdquo;, Toxicol Pathol. 43(3):354-65. doi: 10.1177/0192623314544381.</p>\n\n<p>Navani, N. et al. (2015), &ldquo;Lung cancer diagnosis and staging with endobronchial ultrasound-guided transbronchial needle aspiration compared with conventional approaches: an open-label, pragmatic, randomised controlled trial&rdquo;, Lancet Respir Med. 3(4), 282-9. doi: 10.1016/S2213-2600(15)00029-6</p>\n\n<p>Ollier, M. et al. (2014), &ldquo;Chest CT scan screening for lung cancer in asbestos occupational exposure: a systematic review and meta-analysis&rdquo;, Chest. 145(6), 1339-1346. doi:10.1378/chest.13-2181</p>\n\n<p>Redpath, J. L. et al. (1987), &ldquo;Neoplastic Transformation of Human Hybrid Cells by y Radiation: A Quantitative Assay&rdquo;, Radiat.Res. 110, 468-472.</p>\n\n<p>Schafer R, Leung HM, Gmitro AF. (2014), &ldquo;Multi-modality imaging of a murine mammary window chamber for breast cancer research&rdquo;, Biotechniques. 57(1):45-50. Doi: 10.2144/000114191.</p>\n\n<p>Sher, T., Dy, G. K., &amp; Adjei, A. A. (2008), &ldquo;Small cell lung cancer&rdquo;, MayoClin Proc. 83(3), 335-367. doi: 10.4065/83.3.355</p>\n\n<p>Shi ZM. Et al.(2017), &ldquo;Downregulation of miR-218 contributes to epithelial-mesenchymal transition and tumor metastasis in lung cancer by targeting Slug/ZEB2 signaling&rdquo;, Oncogene. 36(18):2577-2588. Doi: 0.1038/onc.2016.414.</p>\n\n<p>Simon,&nbsp; G.R., &amp; Brustugun, O.T. (2015), &ldquo;Metastatic Patterns of Lung Cancer&rdquo;, Oncolex Oncology Encyclopedia.&nbsp;<a href=\"http://oncolex.org/Lung-cancer/Background/MetastaticPatterns\">http://oncolex.org/Lung-cancer/Background/MetastaticPatterns</a>.</p>\n\n<p>Spira, A., &amp; Ettinger, D. S. (2004), &ldquo;Multidisciplinary management of lung cancer&rdquo;,Engl J Med. 350(4), 379&ndash;92. doi: 10.1056/NEJMra035536</p>\n\n<p>Wang T. et al. (2017), &ldquo;Role of Nrf2 signaling pathway in the radiation tolerance of patients with head and neck squamous cell carcinoma: an in vivo and in vitro study&rdquo;, Onco Targets Ther. 2017 Mar 23;10:1809-1819.</p>\n\n<p>Wang L. et al. (2018), &ldquo;K-ras mutation promotes ionizing radiation-induced invasion and migration of lung cancer in part via the Cathepsin L/CUX1 pathway&rdquo;, Exp Cell Res. 362(2):424-435. Doi: 10.1016/j.yexcr.2017.12.006.</p>\n\n<p>Wu, N. Y. et al. (2011), &ldquo;Magnetic resonance imaging for lung cancer detection: experience in a population of more than 10,000 healthy individuals&rdquo;, BMC Cancer, 11, 242. doi:10.1186/1471-2407-11-242.</p>\n\n<p>Zhou, J. et al. (2012), &ldquo;Antitumor activity of Endostar combined with radiation against human nasopharyngeal carcinoma in mouse xenograft models&rdquo;, Oncol Lett. 4(5):976-980. Doi: 10.3892/ol.2012.856.</p>\n\n<p>Zhou, J. et al. (2017), &ldquo;Review of recent developments in determining volatile organic compounds in exhaled breath as biomarkers for lung cancer diagnosis&rdquo;, Anal Chim Acta, 996, 1-9. doi:10.1016/j.aca.2017.09.021</p>\n","biologicalOrganisationLevel":"Organ","organTerm":{},"biologicalEvents":[{"object":{}}],"keyEventStressors":["Ionizing Radiation"],"id":1556}
{"title":"Increase, Mitochondrial complex III antagonism","references":"","biologicalOrganisationLevel":"Molecular","organTerm":{},"biologicalEvents":[{"object":{}}],"keyEventStressors":["Antimycin A","Benzbromarone","Amiodarone"],"id":1542}
{"title":"Mitochondrial Complex IV inhibition","references":"","biologicalOrganisationLevel":"Molecular","organTerm":{},"biologicalEvents":[{"object":{}}],"keyEventStressors":["Entacapone","Benzbromarone","Metformin","Nefazodone","KCN","Amiodarone"],"id":1543}
{"title":"Mitochondrial Complex V inhibition","references":"","biologicalOrganisationLevel":"Molecular","organTerm":{},"biologicalEvents":[{"object":{}}],"keyEventStressors":["Oligomycin","Diclofenac sodium","Metformin","Aurovertin","Nefazodone","Amiodarone"],"id":1544}
{"title":"Decrease in mitochondrial oxidative phosphorylation","references":"","biologicalOrganisationLevel":"Cellular","organTerm":{},"biologicalEvents":[{"object":{}}],"id":1545}
{"title":"Increased reactive oxygen species (in the mitochondria)","references":"","biologicalOrganisationLevel":"Cellular","organTerm":{},"biologicalEvents":[{"object":{}}],"id":1546}
{"title":"Mitochondrial Injury","references":"","biologicalOrganisationLevel":"Cellular","organTerm":{},"biologicalEvents":[{"object":{}}],"id":1547}
{"title":"Necrotic Tissue","references":"<p>Guicciardi, M.E. et al., 2013. Apoptosis and Necrosis in the Liver. <em>Comprehensive Physiology</em>, 3(2), pp.977&ndash;1010. Available at: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3867948&amp;tool=pmcentrez&amp;rendertype=abstract.</p>\n\n<p>Weng, H. et al., 2015. Two sides of one coin: Massive hepatic necrosis and progenitor cell-mediated regeneration in acute liver failure. <em>Frontiers in Physiology</em>, 6(MAY), pp.1&ndash;12.</p>\n","biologicalOrganisationLevel":"Tissue","organTerm":{},"biologicalEvents":[{"object":{}}],"id":1548}
{"title":"Liver Injury","references":"<p>Landesmann, B. (2016). Adverse Outcome Pathway on Protein Alkylation Leading to Liver Fibrosis, (2).</p>\n\n<p>Guicciardi ME, Malhi H, Mott JL, Gores GJ (2013) Apoptosis and Necrosis in the Liver Maria. Compr Physiol 3:977&ndash;1010 . doi: 10.1002/cphy.c120020.Apoptosis</p>\n\n<p>Musana, K.A., Yale, S.H. &amp; Abdulkarim, A.S., 2004. Tests of liver injury. <em>Clin Med Res</em>, 2(2), pp.129&ndash;131.</p>\n\n<p>Gowda, S. et al., 2009. A review on laboratory liver function tests. <em>The Pan African medical journal</em>, 3(November), p.17. Available at: http://www.ncbi.nlm.nih.gov/pubmed/21532726%5Cnhttp://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=PMC2984286.</p>\n","biologicalOrganisationLevel":"Organ","organTerm":{},"biologicalEvents":[{"object":{}}],"id":1549}
{"title":"Binding of inhibitor to mitochondrial complex III","references":"","biologicalOrganisationLevel":"Molecular","organTerm":{},"biologicalEvents":[{"object":{}}],"id":1653}
{"title":"Binding of inhibitor to mitochondrial complex IV","references":"","biologicalOrganisationLevel":"Molecular","organTerm":{},"biologicalEvents":[{"object":{}}],"id":1654}
{"title":"Binding of inhibitor to mitochondrial complex V","references":"","biologicalOrganisationLevel":"Molecular","organTerm":{},"biologicalEvents":[{"object":{}}],"id":1655}
{"title":"Neural crest cell migration, reduced","references":"<p>Britsch, S., Goerich, D.E., Riethmacher, D., Peirano, R.I., Rossner, M., Nave, K.A., et al. (2001), Genes Dev 15: 66&ndash;78.</p>\n\n<p>DeLaurier, A., Nakamura, Y., Braasch, I., Khanna, V., Kato, H., Wakitani, S., et al. (2012), BMC Dev Biol 12: 16.</p>\n\n<p>Dreser, N., Zimmer, B., Dietz, C., S&uuml;gis, E., Pallocca, G., Nyffeler, J., et al. (2015), Neurotoxicology 50: 56&ndash;70.</p>\n\n<p>Hubbert, C., Guardiola, A., Shao, R., Kawaguchi, Y., Ito, A., Nixon, A., et al. (2002), Nature 417: 455&ndash;458.</p>\n\n<p>Pallocca, G., Grinberg, M., Henry, M., Frickey, T., Hengstler, J.G., Waldmann, T., et al. (2016), Arch Toxicol 90: 159&ndash;180.</p>\n\n<p>&nbsp;</p>\n","biologicalOrganisationLevel":"Cellular","organTerm":{},"biologicalEvents":[{"object":{}}],"id":1557}
{"title":"Collagen production, reduced","references":"<p>Bhatt, S., Diaz, R., Trainor, P. a, Wu, D.K., Kelley, M.W., Tam, P.L., et al. (2013), Cold Spring Harb Perspect Biol 5: 1&ndash;20.</p>\n\n<p>Hammond, C.L., and Schulte-Merker, S. (2009), Development 136: 3991&ndash;4000.</p>\n\n<p>&nbsp;</p>\n","biologicalOrganisationLevel":"Tissue","organTerm":{},"biologicalEvents":[{"object":{}}],"id":1558}
{"title":"Facial cartilage structures are reduced in size and morphologically distorted","references":"","biologicalOrganisationLevel":"Tissue","organTerm":{},"biologicalEvents":[{"object":{}}],"id":1559}
{"title":"Altered differentiation","references":"","biologicalOrganisationLevel":"Cellular","organTerm":{},"biologicalEvents":[{"object":{}}],"id":1560}
{"title":"Neural tube defects","references":"","biologicalOrganisationLevel":"Tissue","organTerm":{},"biologicalEvents":[{"object":{}}],"id":1561}
{"title":"Decreased Na/K ATPase activity","references":"<p>Baginski, E. S., P. P. Foa, and B. Zak. 1967. &ldquo;Determination of Phosphate: Study of Labile Organic Phosphate Interference.&rdquo;&nbsp;Clinica Chimica Acta 15(1):155&ndash;58. Retrieved December 6, 2017</p>\n\n<p>Nowak, Grazyna. 2002. &ldquo;Protein Kinase C-Alpha and ERK1/2 Mediate Mitochondrial Dysfunction, Decreases in Active Na+ Transport, and Cisplatin-Induced Apoptosis in Renal Cells.&rdquo; The Journal of Biological Chemistry 277(45):43377&ndash;88. Retrieved December 5, 2017 (http://www.ncbi.nlm.nih.gov/pubmed/12218054).</p>\n","biologicalOrganisationLevel":"Cellular","organTerm":{},"biologicalEvents":[{"object":{}}],"id":1562}
{"title":"Decreased proximal tubular vectorial transport","references":"<p>Wilmes, A., L. Aschauer, A. Limonciel, W. Pfaller, and P. Jennings. 2014. &ldquo;Evidence for a Role of Claudin 2 as a Proximal Tubular Stress Responsive Paracellular Water Channel.&rdquo; Toxicology and Applied Pharmacology 279(2)</p>\n","biologicalOrganisationLevel":"Tissue","organTerm":{},"biologicalEvents":[{"object":{}}],"id":1563}
{"title":"Chemical induced Fanconi syndrome","references":"<p>Hall, A. M., P. Bass, and R. J. Unwin. 2014. &ldquo;Drug-Induced Renal Fanconi Syndrome.&rdquo; Qjm 107(4):261&ndash;69.</p>\n\n<p>Herlitz, Leal C. et al. 2010. &ldquo;Tenofovir Nephrotoxicity: Acute Tubular Necrosis with Distinctive Clinical, Pathological, and Mitochondrial Abnormalities.&rdquo; Kidney International 78(11):1171&ndash;77. Retrieved&nbsp;(http://dx.doi.org/10.1038/ki.2010.318).</p>\n","biologicalOrganisationLevel":"Individual","organTerm":{},"biologicalEvents":[{"object":{}}],"id":1564}
{"title":"Impaired IL-1R1 signaling","references":"<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot; &quot;,sans-serif\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\">Alten, R., Gram, H., Joosten, L.A., et al. (2008), The human anti-IL-1 beta monoclonal antibody ACZ885 is effective in joint inflammation models in mice and in a proof-of-concept study in patients with rheumatoid arthritis.<em> Arthritis Res Ther</em> 10: R67, 10.1186/ar2438</span></span></span></p>\n\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot; &quot;,sans-serif\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\">Bhaskaran, N., Faddoul, F., Paes da Silva, A., et al. (2020), IL-1beta-MyD88-mTOR Axis Promotes Immune-Protective IL-17A(+)Foxp3(+) Cells During Mucosal Infection and Is Dysregulated With Aging.<em> Front Immunol</em> 11: 595936, 10.3389/fimmu.2020.595936</span></span></span></p>\n\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot; &quot;,sans-serif\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\">Chaudhary, D., Robinson, S., Romero, D.L. (2015), Recent advances in the discovery of small molecule inhibitors of interleukin-1 receptor-associated kinase 4 (IRAK4) as a therapeutic target for inflammation and oncology disorders.<em> J Med Chem</em> 58: 96-110, 10.1021/jm5016044</span></span></span></p>\n\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot; &quot;,sans-serif\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\">Church, L.D., McDermott, M.F. (2009), Canakinumab, a fully-human mAb against IL-1beta for the potential treatment of inflammatory disorders.<em> Curr Opin Mol Ther</em> 11: 81-89, </span></span></span></p>\n\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot; &quot;,sans-serif\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\">Dripps, D.J., Brandhuber, B.J., Thompson, R.C., et al. (1991), Interleukin-1 (IL-1) receptor antagonist binds to the 80-kDa IL-1 receptor but does not initiate IL-1 signal transduction.<em> J Biol Chem</em> 266: 10331-10336, </span></span></span></p>\n\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot; &quot;,sans-serif\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\">Fenini, G., Contassot, E., French, L.E. (2017), Potential of IL-1, IL-18 and Inflammasome Inhibition for the Treatment of Inflammatory Skin Diseases.<em> Front Pharmacol</em> 8: 278, 10.3389/fphar.2017.00278</span></span></span></p>\n\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot; &quot;,sans-serif\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\">Finch-Arietta, M.B., Cochran, F.R. (1991), Cytokine production in whole blood ex vivo.<em> Agents Actions</em> 34: 49-52, 10.1007/BF01993235</span></span></span></p>\n\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot; &quot;,sans-serif\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\">Fuchs, O. (2010), Transcription factor NF-kappaB inhibitors as single therapeutic agents or in combination with classical chemotherapeutic agents for the treatment of hematologic malignancies.<em> Curr Mol Pharmacol</em> 3: 98-122, 10.2174/1874467211003030098</span></span></span></p>\n\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot; &quot;,sans-serif\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\">Ho, S.C., Chang, Y.H., Chang, K.S. (2018), Structural Moieties Required for Cinnamaldehyde-Related Compounds to Inhibit Canonical IL-1beta Secretion.<em> Molecules</em> 23, 10.3390/molecules23123241</span></span></span></p>\n\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot; &quot;,sans-serif\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\">Huang, H., Wang, Y. (2017), The protective effect of cinnamaldehyde on lipopolysaccharide induced acute lung injury in mice.<em> Cell Mol Biol (Noisy-le-grand)</em> 63: 58-63, 10.14715/cmb/2017.63.8.13</span></span></span></p>\n\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot; &quot;,sans-serif\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\">Jeon, Y.J., Han, S.H., Lee, Y.W., et al. (2000), Dexamethasone inhibits IL-1 beta gene expression in LPS-stimulated RAW 264.7 cells by blocking NF-kappa B/Rel and AP-1 activation.<em> Immunopharmacology</em> 48: 173-183, 10.1016/s0162-3109(00)00199-5</span></span></span></p>\n\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot; &quot;,sans-serif\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\">Kapur, S., Bonk, M.E. (2009), Rilonacept (arcalyst), an interleukin-1 trap for the treatment of cryopyrin-associated periodic syndromes.<em> P t</em> 34: 138-141, </span></span></span></p>\n\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot; &quot;,sans-serif\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\">Klein, S.L., Flanagan, K.L. (2016), Sex differences in immune responses.<em> Nat Rev Immunol</em> 16: 626-638, 10.1038/nri.2016.90</span></span></span></p>\n\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot; &quot;,sans-serif\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\">Kuipers, K., Lokken, K.L., Zangari, T., et al. (2018), Age-related differences in IL-1 signaling and capsule serotype affect persistence of Streptococcus pneumoniae colonization.<em> PLoS Pathog</em> 14: e1007396, 10.1371/journal.ppat.1007396</span></span></span></p>\n\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot; &quot;,sans-serif\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\">Lee, K.L., Ambler, C.M., Anderson, D.R., et al. (2017), Discovery of Clinical Candidate 1-{[(2S,3S,4S)-3-Ethyl-4-fluoro-5-oxopyrrolidin-2-yl]methoxy}-7-methoxyisoquinoli ne-6-carboxamide (PF-06650833), a Potent, Selective Inhibitor of Interleukin-1 Receptor Associated Kinase 4 (IRAK4), by Fragment-Based Drug Design.<em> J Med Chem</em> 60: 5521-5542, 10.1021/acs.jmedchem.7b00231</span></span></span></p>\n\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot; &quot;,sans-serif\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\">Matsunaga, N., Tsuchimori, N., Matsumoto, T., et al. (2011), TAK-242 (resatorvid), a small-molecule inhibitor of Toll-like receptor (TLR) 4 signaling, binds selectively to TLR4 and interferes with interactions between TLR4 and its adaptor molecules.<em> Mol Pharmacol</em> 79: 34-41, 10.1124/mol.110.068064</span></span></span></p>\n\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot; &quot;,sans-serif\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\">McGuire, V.A., Ruiz-Zorrilla Diez, T., Emmerich, C.H., et al. (2016), Dimethyl fumarate blocks pro-inflammatory cytokine production via inhibition of TLR induced M1 and K63 ubiquitin chain formation.<em> Sci Rep</em> 6: 31159, 10.1038/srep31159</span></span></span></p>\n\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot; &quot;,sans-serif\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\">McIntyre, K.W., Stepan, G.J., Kolinsky, K.D., et al. (1991), Inhibition of interleukin 1 (IL-1) binding and bioactivity in vitro and modulation of acute inflammation in vivo by IL-1 receptor antagonist and anti-IL-1 receptor monoclonal antibody.<em> J Exp Med</em> 173: 931-939, </span></span></span></p>\n\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot; &quot;,sans-serif\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\">Mills, K.H. (2011), TLR-dependent T cell activation in autoimmunity.<em> Nat Rev Immunol</em> 11: 807-822, 10.1038/nri3095</span></span></span></p>\n\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot; &quot;,sans-serif\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\">Morand, E.F., Rickard, D., Goulding, N.J. (1993), Lack of involvement of lipocortin 1 in dexamethasone suppression of IL-1 release.<em> Mediators Inflamm</em> 2: 49-52, 10.1155/S0962935193000067</span></span></span></p>\n\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot; &quot;,sans-serif\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\">Mucke, H.A. (2012), Iguratimod: a new disease-modifying antirheumatic drug.<em> Drugs Today (Barc)</em> 48: 577-586, 10.1358/dot.2012.48.9.1855758</span></span></span></p>\n\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot; &quot;,sans-serif\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\">Peng, H., Guerau-de-Arellano, M., Mehta, V.B., et al. (2012), Dimethyl fumarate inhibits dendritic cell maturation via nuclear factor kappaB (NF-kappaB) and extracellular signal-regulated kinase 1 and 2 (ERK1/2) and mitogen stress-activated kinase 1 (MSK1) signaling.<em> J Biol Chem</em> 287: 28017-28026, 10.1074/jbc.M112.383380</span></span></span></p>\n\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot; &quot;,sans-serif\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\">Pilkington, S.M., Ogden, S., Eaton, L.H., et al. (2018), Lower levels of interleukin-1beta gene expression are associated with impaired Langerhans&#39; cell migration in aged human skin.<em> Immunology</em> 153: 60-70, 10.1111/imm.12810</span></span></span></p>\n\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot; &quot;,sans-serif\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\">Qiu, H.B., Pan, J.Q., Zhao, Y.Q., et al. (1997), Effects of dexamethasone and ibuprofen on LPS-induced gene expression of TNF alpha, IL-1 beta, and MIP-1 alpha in rat lung.<em> Zhongguo Yao Li Xue Bao</em> 18: 165-168, </span></span></span></p>\n\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot; &quot;,sans-serif\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\">Quartier, P. (2011), Interleukin-1 antagonists in the treatment of autoinflammatory syndromes, including cryopyrin-associated periodic syndrome.<em> Open Access Rheumatol</em> 3: 9-18, 10.2147/oarrr.S6696</span></span></span></p>\n\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot; &quot;,sans-serif\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\">Ravizza, T., Lucas, S.M., Balosso, S., et al. (2006), Inactivation of caspase-1 in rodent brain: a novel anticonvulsive strategy.<em> Epilepsia</em> 47: 1160-1168, 10.1111/j.1528-1167.2006.00590.x</span></span></span></p>\n\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot; &quot;,sans-serif\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\">Roell, M.K., Issafras, H., Bauer, R.J., et al. (2010), Kinetic approach to pathway attenuation using XOMA 052, a regulatory therapeutic antibody that modulates interleukin-1beta activity.<em> J Biol Chem</em> 285: 20607-20614, 10.1074/jbc.M110.115790</span></span></span></p>\n\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot; &quot;,sans-serif\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\">Shuck, M.E., Eessalu, T.E., Tracey, D.E., et al. (1991), Cloning, heterologous expression and characterization of murine interleukin 1 receptor antagonist protein.<em> Eur J Immunol</em> 21: 2775-2780, 10.1002/eji.1830211119</span></span></span></p>\n\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot; &quot;,sans-serif\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\">Stack, J.H., Beaumont, K., Larsen, P.D., et al. (2005), IL-converting enzyme/caspase-1 inhibitor VX-765 blocks the hypersensitive response to an inflammatory stimulus in monocytes from familial cold autoinflammatory syndrome patients.<em> J Immunol</em> 175: 2630-2634, 10.4049/jimmunol.175.4.2630</span></span></span></p>\n\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot; &quot;,sans-serif\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\">Suzuki, E., Umezawa, K. (2006), Inhibition of macrophage activation and phagocytosis by a novel NF-kappaB inhibitor, dehydroxymethylepoxyquinomicin.<em> Biomed Pharmacother</em> 60: 578-586, 10.1016/j.biopha.2006.07.089</span></span></span></p>\n\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot; &quot;,sans-serif\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\">Vallabhapurapu, S., Karin, M. (2009), Regulation and function of NF-kappaB transcription factors in the immune system.<em> Annu Rev Immunol</em> 27: 693-733, 10.1146/annurev.immunol.021908.132641</span></span></span></p>\n\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot; &quot;,sans-serif\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\">van Furth, A.M., Seijmonsbergen, E.M., Langermans, J.A., et al. (1995), Effect of xanthine derivates and dexamethasone on Streptococcus pneumoniae-stimulated production of tumor necrosis factor alpha, interleukin-1 beta (IL-1 beta), and IL-10 by human leukocytes.<em> Clin Diagn Lab Immunol</em> 2: 689-692, </span></span></span></p>\n\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot; &quot;,sans-serif\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\">Vincent, J.A., Mohr, S. (2007), Inhibition of caspase-1/interleukin-1beta signaling prevents degeneration of retinal capillaries in diabetes and galactosemia.<em> Diabetes</em> 56: 224-230, 10.2337/db06-0427</span></span></span></p>\n\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot; &quot;,sans-serif\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\">Wang, A.L., Yu, A.C., Lau, L.T., et al. (2005), Minocycline inhibits LPS-induced retinal microglia activation.<em> Neurochem Int</em> 47: 152-158, 10.1016/j.neuint.2005.04.018</span></span></span></p>\n\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot; &quot;,sans-serif\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\">Wang, F., Han, Y., Xi, S., et al. (2020), Catechins reduce inflammation in lipopolysaccharide-stimulated dental pulp cells by inhibiting activation of the NF-kappaB pathway.<em> Oral Dis</em> 26: 815-821, 10.1111/odi.13290</span></span></span></p>\n\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot; &quot;,sans-serif\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\">Wang, Y., Tang, Q., Duan, P., et al. (2018), Curcumin as a therapeutic agent for blocking NF-kappaB activation in ulcerative colitis.<em> Immunopharmacol Immunotoxicol</em> 40: 476-482, 10.1080/08923973.2018.1469145</span></span></span></p>\n\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot; &quot;,sans-serif\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\">Weinberg, J.B., Mason, S.N., Wortham, T.S. (1992), Inhibition of tumor necrosis factor-alpha (TNF-alpha) and interleukin-1 beta (IL-1 beta) messenger RNA (mRNA) expression in HL-60 leukemia cells by pentoxifylline and dexamethasone: dissociation of acivicin-induced TNF-alpha and IL-1 beta mRNA expression from acivicin-induced monocytoid differentiation.<em> Blood</em> 79: 3337-3343, </span></span></span></p>\n\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot; &quot;,sans-serif\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\">Wheeler, D.S., Catravas, J.D., Odoms, K., et al. (2004), Epigallocatechin-3-gallate, a green tea-derived polyphenol, inhibits IL-1 beta-dependent proinflammatory signal transduction in cultured respiratory epithelial cells.<em> J Nutr</em> 134: 1039-1044, 10.1093/jn/134.5.1039</span></span></span></p>\n\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot; &quot;,sans-serif\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\">Xu, F., Wang, F., Wen, T., et al. (2017), Inhibition of NLRP3 inflammasome: a new protective mechanism of cinnamaldehyde in endotoxin poisoning of mice.<em> Immunopharmacol Immunotoxicol</em> 39: 296-304, 10.1080/08923973.2017.1355377</span></span></span></p>\n\n<p>&nbsp;</p>\n","biologicalOrganisationLevel":"Molecular","organTerm":{"name":"immune system","sourceId":"UBERON:0002405"},"biologicalEvents":[{"object":{}}],"keyEventStressors":["IL-1 receptor antagonistIL-1Ra(Anakinra)","anti-IL-1b antibody (Canakinumab)","IRAK4 inhibitors","curcumin","epigallocathechin gallate","soluble IL-1R (Rilonacept)","TAK-242","anti-IL-1b antibody (Gevokizumab)","Dimethyl fumarate","iguratimod","Dehydroxymethylepoxyquinomicin (DHMEQ)"],"id":1700}
{"title":"Suppression of  T cell activation","references":"<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Abadi MT Condensed Extra Bold&quot;,sans-serif\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\">Lin, D., Lei, L., Zhang, Y., et al. (2015), Secreted IL-1alpha promotes T-cell activation and expansion of CD11b(+) Gr1(+) cells in carbon tetrachloride-induced liver injury in mice.<em> Eur J Immunol</em> 45: 2084-2098, 10.1002/eji.201445195</span></span></span></p>\n\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Abadi MT Condensed Extra Bold&quot;,sans-serif\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\">Mok, M.Y. (2010), The immunological basis of B-cell therapy in systemic lupus erythematosus.<em> Int J Rheum Dis</em> 13: 3-11, 10.1111/j.1756-185X.2009.01458.x</span></span></span></p>\n\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Abadi MT Condensed Extra Bold&quot;,sans-serif\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\">Simeoni, L., Thurm, C., Kritikos, A., et al. (2016), Redox homeostasis, T cells and kidney diseases: three faces in the dark.<em> Clin Kidney J</em> 9: 1-10, 10.1093/ckj/sfv135</span></span></span></p>\n\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Abadi MT Condensed Extra Bold&quot;,sans-serif\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\">Weih, F., Carrasco, D., Durham, S.K., et al. (1995), Multiorgan inflammation and hematopoietic abnormalities in mice with a targeted disruption of RelB, a member of the NF-kappa B/Rel family.<em> Cell</em> 80: 331-340, </span></span></span></p>\n","biologicalOrganisationLevel":"Cellular","organTerm":{"name":"immune system","sourceId":"UBERON:0002405"},"biologicalEvents":[{"object":{}}],"id":1702}
{"title":"Increase, Increased susceptibility to infection","references":"<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot; &quot;,sans-serif\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\">De Benedetti, F., Gattorno, M., Anton, J., et al. (2018), Canakinumab for the Treatment of Autoinflammatory Recurrent Fever Syndromes.<em> N Engl J Med</em> 378: 1908-1919, 10.1056/NEJMoa1706314</span></span></span></p>\n\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot; &quot;,sans-serif\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\">Fischer, A., Notarangelo, L.D., Neven, B., et al. (2015), Severe combined immunodeficiencies and related disorders.<em> Nat Rev Dis Primers</em> 1: 15061, 10.1038/nrdp.2015.61</span></span></span></p>\n\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot; &quot;,sans-serif\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\">Fleischmann, R.M., Schechtman, J., Bennett, R., et al. (2003), Anakinra, a recombinant human interleukin-1 receptor antagonist (r-metHuIL-1ra), in patients with rheumatoid arthritis: A large, international, multicenter, placebo-controlled trial.<em> Arthritis Rheum</em> 48: 927-934, 10.1002/art.10870</span></span></span></p>\n\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot; &quot;,sans-serif\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\">Justiz Vaillant, A.A., Naik, R. 2021. HIV-1 Associated Opportunistic Infections, <em>StatPearls</em>. StatPearls Publishing</span></span></span></p>\n\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot; &quot;,sans-serif\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\">Copyright &copy; 2021, StatPearls Publishing LLC., Treasure Island (FL).</span></span></span></p>\n\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot; &quot;,sans-serif\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\">Tasdogan, B.E., Ma, M., Simsek, C., et al. (2019), Update on Immunosuppression in Liver Transplantation.<em> Euroasian J Hepatogastroenterol</em> 9: 96-101, 10.5005/jp-journals-10018-1301</span></span></span></p>\n\n<p>&nbsp;</p>\n","biologicalOrganisationLevel":"Individual","organTerm":{},"biologicalEvents":[{"object":{}}],"keyEventStressors":["IL-1 receptor antagonistIL-1Ra(Anakinra)","anti-IL-1b antibody (Canakinumab)","soluble IL-1R (Rilonacept)"],"id":986}
{"title":"Inhibition, IKK complex","references":"<p style=\"margin-left:24.0pt\">Burke, J.R. et al., 2003. BMS-345541 is a highly selective inhibitor of I??B kinase that binds at an allosteric site of the enzyme and blocks NF-??B-dependent transcription in mice. <em>Journal of Biological Chemistry</em>, 278(3), pp.1450&ndash;1456.</p>\n\n<p style=\"margin-left:24.0pt\">Gupta, S.C. et al., 2010. Inhibiting NF-??B activation by small molecules as a therapeutic strategy. <em>Biochimica et Biophysica Acta - Gene Regulatory Mechanisms</em>, 1799(10&ndash;12), pp.775&ndash;787. Available at: http://dx.doi.org/10.1016/j.bbagrm.2010.05.004.</p>\n\n<p style=\"margin-left:24.0pt\">Heyninck, K. et al., 2014. Withaferin A inhibits NF-kappaB activation by targeting cysteine 179 in IKK&beta;. <em>Biochemical Pharmacology</em>, 91(4), pp.501&ndash;509. Available at: http://dx.doi.org/10.1016/j.bcp.2014.08.004.</p>\n\n<p style=\"margin-left:24.0pt\">Kishore, N. et al., 2003. A selective IKK-2 inhibitor blocks NF-&kappa;B-dependent gene expression in interleukin-1&beta;-stimulated synovial fibroblasts. <em>Journal of Biological Chemistry</em>, 278(35), pp.32861&ndash;32871.</p>\n\n<p style=\"margin-left:24.0pt\">Zhou, P. et al., 2010. Flavokawain B, the hepatotoxic constituent from kava root, induces GSH-sensitive oxidative stress through modulation of IKK/NF-&nbsp;B and MAPK signaling pathways. <em>The FASEB Journal</em>, 24(12), pp.4722&ndash;4732. Available at: http://www.fasebj.org/cgi/doi/10.1096/fj.10-163311.</p>\n","biologicalOrganisationLevel":"Molecular","organTerm":{},"biologicalEvents":[{"object":{}}],"keyEventStressors":["Aspirin","Sulforaphane","Beta-carboline","Parthenolide","BMS 345541","Ibuprofen","Sulindac","Phenethyl isothiocyanate","Arsenite","SC-839"],"id":1574}
{"title":"Activation, Caspase 8 pathway","references":"<p>Melino, G. &amp; Vaux, D., 2010. <em>Cell Death</em> G. Melino &amp; D. Vaux, eds.,</p>\n\n<p>Frederiksson, L., 2012. <em>TNFalpha-signaling in drug induced liver injury</em>. University of Leiden.</p>\n\n<p>Cullen, S.P. &amp; Martin, S.J., 2009. Caspase activation pathways: Some recent progress. <em>Cell Death and Differentiation</em>, 16(7), pp.935&ndash;938. Available at: http://dx.doi.org/10.1038/cdd.2009.59.</p>\n\n<p>Fotin-Mleczek, M. et al., 2002. Apoptotic crosstalk of TNF receptors: TNF-R2-induces depletion of TRAF2 and IAP proteins and accelerates TNF-R1-dependent activation of caspase-8. <em>Journal of cell science</em>, 115(Pt 13), pp.2757&ndash;2770.</p>\n\n<p>Schattenberg, J.M. et al., 2011. Ablation of c-FLIP in hepatocytes enhances death-receptor mediated apoptosis and toxic liver injury in vivo. <em>Journal of Hepatology</em>, 55(6), pp.1272&ndash;1280. Available at: http://dx.doi.org/10.1016/j.jhep.2011.03.008.</p>\n","biologicalOrganisationLevel":"Molecular","organTerm":{},"biologicalEvents":[{"object":{}}],"id":1575}
{"title":"Activation, Tissue resident cells (Kuppfer cells)","references":"","biologicalOrganisationLevel":"Cellular","organTerm":{},"biologicalEvents":[{"object":{}}],"id":1576}
{"title":"Increase, proinflammatory mediators (TNFalpha)","references":"","biologicalOrganisationLevel":"Molecular","organTerm":{},"biologicalEvents":[{"object":{}}],"id":1579}
{"title":"Binding of microtubule stabilizing agents (MSA) to microtubules","references":"<p>1. Manfredi, J.J., J. Parness, and S.B. Horwitz, Taxol binds to cellular microtubules. The Journal of Cell Biology, 1982. 94(3): p. 688-696. Confidential</p>\n\n<p>2. Parness, J. and S. Horwitz, Taxol binds to polymerized tubulin in vitro. The Journal of Cell Biology, 1981. 91(2): p. 479-487.</p>\n\n<p>3. Riondel, J., et al., Therapeutic response to taxol of six human tumors xenografted into nude mice. Cancer Chemotherapy and Pharmacology, 1986. 17(2): p. 137-142.</p>\n\n<p>4. Wani, M.C., et al., Plant antitumor agents. VI. Isolation and structure of taxol, a novel antileukemic and antitumor agent from Taxus brevifolia. Journal of the American Chemical Society, 1971. 93(9): p. 2325-2327.</p>\n\n<p>5. Schiff, P.B., J. Fant, and S.B. Horwitz, Promotion of microtubule assembly in vitro by taxol. Nature, 1979.&nbsp;277(5698): p. 665-667.</p>\n\n<p>6. Bollag, D.M., et al., Epothilones, a New Class of Microtubule-stabilizing Agents with a Taxol-like Mechanism of Action. Cancer Research, 1995. 55(11): p. 2325-2333.</p>\n\n<p>7. Hung, D.T., J. Chen, and S.L. Schreiber, (+)-Discodermolide binds to microtubules in&nbsp;stoichiometric ratio to tubulin dimers, blocks taxol binding and results in mitotic arrest. Chemistry &amp; Biology, 1996. 3(4): p. 287-293.</p>\n\n<p>8. Kowalski, R.J., et al., The Microtubule-Stabilizing Agent Discodermolide Competitively Inhibits the Binding of Paclitaxel (Taxol) to Tubulin Polymers, Enhances Tubulin Nucleation Reactions More Potently than Paclitaxel, and Inhibits the Growth of Paclitaxel-Resistant Cells. Molecular Pharmacology, 1997. 52(4): p. 613-622.</p>\n\n<p>9. ter Haar, E., et al., Discodermolide, A Cytotoxic Marine Agent That Stabilizes Microtubules More Potently Than Taxol. Biochemistry, 1996. 35(1): p. 243-250.</p>\n\n<p>10. Combeau, C., et al., Predominant Labeling of. beta.-over. alpha.-Tubulin from Porcine Brain by a&nbsp;Photoactivatable Taxoid Derivative. Biochemistry, 1994. 33(21): p. 6676-6683. Confidential</p>\n\n<p>11. Dasgupta, D., et al., Synthesis of a photoaffinity taxol analog and its use in labeling tubulin. Journal of medicinal chemistry, 1994. 37(18): p. 2976-2980.</p>\n\n<p>12. Nogales, E., S.G. Wolf, and K.H. Downing, Structure of the &alpha;&beta; tubulin dimer by electron crystallography. Nature, 1998. 391: p. 199.</p>\n\n<p>13. Rao, S., S.B. Horwitz, and I. Ringel, Direct Photoaffinity Labeling of Tubulin With Taxol. JNCI: Journal of the National Cancer Institute, 1992. 84(10): p. 785-788.</p>\n\n<p>14. Rao, S., et al., 3&#39;-(p-azidobenzamido)taxol&nbsp;photolabels the N-terminal 31 amino acids of beta-tubulin. Journal of Biological Chemistry, 1994. 269(5): p. 3132-3134.</p>\n\n<p>15. Rao, S., et al., Characterization of the Taxol Binding&nbsp;Site on the Microtubule 2-(m-AZIDOBENZOYL) TAXOL PHOTOLABELS A PEPTIDE (AMINO ACIDS 217-231) of &beta;-TUBULIN. Journal of Biological Chemistry, 1995. 270(35): p. 20235-20238.</p>\n\n<p>16. Nogales, E., et al., Structure of tubulin at 6.5 &Aring; and location of the taxol-binding site. Nature, 1995. 375(6530): p. 424-427.</p>\n\n<p>17. Prota, A.E., et al., Molecular mechanism of action of microtubule-stabilizing anticancer agents. Science, 2013. 339(6119): p. 587-590.</p>\n\n<p>18. Rao, S., et al., Characterization of the Taxol Binding&nbsp;Site on the Microtubule: IDENTIFICATION OF Arg282 IN &beta;-TUBULIN AS THE SITE OF PHOTOINCORPORATION OF A 7-BENZOPHENONE ANALOGUE OF TAXOL. Journal of Biological Chemistry, 1999. 274(53): p. 37990-37994.</p>\n\n<p>19. Li, Y., et al., Conformation of Microtubule-Bound Paclitaxel Determined by Fluorescence Spectroscopy and REDOR NMR. Biochemistry, 2000. 39(2): p. 281-291.</p>\n\n<p>20. Snyder, J.P., et al., The binding conformation of Taxol&nbsp;in &beta;-tubulin: A model based on electron crystallographic density. Proceedings of the National Academy of Sciences, 2001. 98(9): p. 5312-5316.</p>\n","biologicalOrganisationLevel":"Molecular","organTerm":{},"biologicalEvents":[{"object":{}}],"keyEventStressors":["Zampanolide","Discodermolide","Epothilone B","Epothilone A","Paclitaxel"],"id":1580}
{"title":"Disturbance in microtubule dynamic instability","references":"<p>1. Conde, C. and A. Caceres, <em>Microtubule assembly, organization and dynamics in axons and dendrites.</em> Nat Rev Neurosci, 2009. <strong>10</strong>(5): p. 319-332.</p>\n\n<p>2. Mitchison, T. and M. Kirschner, <em>Dynamic instability of microtubule growth.</em> Nature, 1984. <strong>312</strong>(5991): p. 237-242.</p>\n\n<p>3. Baas, P.W., et al., <em>Stability properties of neuronal microtubules.</em> Cytoskeleton (Hoboken), 2016. <strong>73</strong>(9): p. 442-60.</p>\n\n<p>4. Griffin, J.W. and D.F. Watson, <em>Axonal transport in neurological disease.</em> Annals of Neurology, 1988. <strong>23</strong>(1): p. 3-13.</p>\n\n<p>5. Baas, P.W. and M.M. Black, <em>Individual microtubules in the axon consist of domains that differ in both composition and stability.</em> J Cell Biol, 1990. <strong>111</strong>(2): p. 495-509.</p>\n\n<p>6. Edson, K.J., et al., <em>FRAP analysis of the stability of the microtubule population along the neurites of chick sensory neurons.</em> Cell Motil Cytoskeleton, 1993. <strong>25</strong>(1): p. 59-72.</p>\n","biologicalOrganisationLevel":"Cellular","organTerm":{},"biologicalEvents":[{"object":{}}],"id":1581}
{"title":"Impaired axonial transport","references":"<p>1. Baas, P.W., et al., <em>Stability properties of neuronal microtubules.</em> Cytoskeleton (Hoboken), 2016. <strong>73</strong>(9): p. 442-60.</p>\n\n<p>2. Hirokawa, N., <em>Axonal transport and the cytoskeleton.</em> Current Opinion in Neurobiology, 1993. <strong>3</strong>(5): p. 724-731.</p>\n\n<p>3. Leopold, P.L., et al., <em>Association of kinesin with characterized membrane-bounded organelles.</em> Cell Motility and the Cytoskeleton, 1992. <strong>23</strong>(1): p. 19-33.</p>\n\n<p>4. Elluru, R.G., G.S. Bloom, and S.T. Brady, <em>Fast axonal transport of kinesin in the rat visual system: functionality of kinesin heavy chain isoforms.</em> Molecular Biology of the Cell, 1995. <strong>6</strong>(1): p. 21-40.</p>\n\n<p>5. Delcroix, J.-D., et al., <em>Trafficking the NGF signal: implications for normal and degenerating neurons</em>, in <em>Progress in Brain Research</em>. 2004, Elsevier. p. 1-23.</p>\n\n<p>6. Susalka, S.J. and K.K. Pfister, <em>Cytoplasmic dynein subunit heterogeneity: implications for axonal transport.</em> Journal of Neurocytology, 2000. <strong>29</strong>(11): p. 819-829.</p>\n\n<p>7. LaPointe, N.E., et al., <em>Effects of eribulin, vincristine, paclitaxel and ixabepilone on fast axonal transport and kinesin-1 driven microtubule gliding: implications for chemotherapy-induced peripheral neuropathy.</em> Neurotoxicology, 2013. <strong>37</strong>: p. 231-9.</p>\n\n<p>8. Morfini, G., et al., <em>Tau binding to microtubules does not directly affect microtubulebased vesicle motility.</em> Journal of Neuroscience Research, 2007. <strong>85</strong>(12): p. 2620-2630.</p>\n\n<p>9. Morfini, G., et al., <em>JNK mediates pathogenic effects of polyglutamine-expanded androgen receptor on fast axonal transport.</em> Nature Neuroscience, 2006. <strong>9</strong>: p. 907.</p>\n\n<p>10. Peck, A., et al., <em>Tau isoformspecific modulation of kinesindriven microtubule gliding rates and trajectories as determined with taustabilized microtubules.</em> Cytoskeleton, 2011. <strong>68</strong>(1): p. 44-55.</p>\n\n<p>11. Theiss, C. and K. Meller, <em>Taxol impairs anterograde axonal transport of microinjected horseradish peroxidase in dorsal root ganglia neurons in vitro.</em> Cell Tissue Res, 2000. <strong>299</strong>(2): p. 213-24.</p>\n\n<p>12. Smith, J.A., et al., <em>Structural Basis for Induction of Peripheral Neuropathy by Microtubule-Targeting Cancer Drugs.</em> Cancer Research, 2016. <strong>76</strong>(17): p. 5115-5123.</p>\n","biologicalOrganisationLevel":"Cellular","organTerm":{},"biologicalEvents":[{"object":{}}],"id":1582}
{"title":"Sensory axonal peripheral neuropathy","references":"<p>1. Benoy V. , d.Y.C., Van Den Bosch L. , Charcot-Marie-Tooth Disease and other peripheral neuropathies, in Young Perspectives for Old Diseases, M.H. G., Editor. 2015, Bentham Science Publishers. p. pp. 269-325.</p>\n\n<p>2. Yiu, G. and Z. He, Glial inhibition of CNS axon regeneration. Nature Reviews Neuroscience, 2006. 7: p. 617.</p>\n\n<p>3. Rowinsky, E.K., et al., Neurotoxicity of Taxol. J Natl Cancer Inst Monogr, 1993(15): p. 107-15.</p>\n\n<p>4. Rowinsky , E.K. and R.C. Donehower Paclitaxel (Taxol). New England Journal of Medicine, 1995. 332(15): p. 1004-1014.</p>\n\n<p>5. Donehower, R.C., et al., Phase I trial of taxol in patients with advanced cancer. Cancer treatment reports, 1987. 71(12): p. 1171-1177.</p>\n\n<p>6. Forsyth, P.a., et al., Prospective study of paclitaxel-induced peripheral neuropathy with quantitative sensory testing. Journal of Neuro-Oncology, 1997. 35(1): p. 47-53.</p>\n\n<p>7. Brown, T., et al., A phase I trial of taxol given by a 6-hour intravenous infusion. Journal of Clinical Oncology, 1991. 9(7): p. 1261-1267.</p>\n\n<p>8. Pignata, S., et al., Residual neurotoxicity in ovarian cancer patients in clinical remission after first-line chemotherapy with carboplatin and paclitaxel: The Multicenter Italian Trial in Ovarian cancer (MITO-4) retrospective study. BMC Cancer, 2006. 6(1): p. 5.</p>\n\n<p>9. Rowinsky, E.K., et al., Sequences of taxol and cisplatin: a phase I and pharmacologic study. Journal of Clinical Oncology, 1991. 9(9): p. 1692-1703.</p>\n\n<p>10. Chaudhry, V., et al., Peripheral neuropathy from taxol and cisplatin combination chemotherapy: Clinical and electrophysiological studies. Annals of Neurology, 1994. 35(3): p. 304-311.</p>\n\n<p>11. Arezzo, J.C., H.H. Schaumburg, and C. Laudadio, Thermal Sensitivity Tester: Device for Quantitative Assessment of Thermal Sense in Diabetic Neuropathy. Diabetes, 1986. 35(5): p. 590-592.</p>\n\n<p>12. Wiernik, P.H., et al., Phase I Clinical and Pharmacokinetic Study of Taxol. Cancer Research, 1987. 47(9): p. 2486-2493.</p>\n\n<p>13. Behse, F., F. Buchthal, and F. Carlsen, Nerve biopsy and conduction studies in diabetic neuropathy. Journal of Neurology, Neurosurgery, and Psychiatry, 1977. 40(11): p. 1072-1082.</p>\n","biologicalOrganisationLevel":"Individual","organTerm":{},"biologicalEvents":[{"object":{}}],"id":1583}
{"title":"Interaction of -diketones with arginine residues","references":"<p>Anders, M. W. (2017). Diacetyl and related flavorant &alpha;-Diketones: Biotransformation, cellular interactions, and respiratory-tract toxicity. <em>Toxicology</em>, <em>388</em>, 21&ndash;29. <a href=\"https://doi.org/10.1016/j.tox.2017.02.002\"><u>https://doi.org/10.1016/j.tox.2017.02.002</u></a></p>\n\n<p>Mathews, J. M., Watson, S. L., Snyder, R. W., Burgess, J. P., &amp; Morgan, D. L. (2010). Reaction of the butter flavorant diacetyl (2,3-Butanedione) with N-??-acetylarginine: A model for epitope formation with pulmonary proteins in the etiology of obliterative bronchiolitis. <em>Journal of Agricultural and Food Chemistry</em>, <em>58</em>(24), 12761&ndash;12768. <a href=\"https://doi.org/10.1021/jf103251w\"><u>https://doi.org/10.1021/jf103251w</u></a></p>\n\n<p>More, S. S., Raza, A., &amp; Vince, R. (2012). The butter flavorant, diacetyl, forms a covalent adduct with 2-deoxyguanosine, uncoils DNA, and leads to cell death. <em>Journal of Agricultural and Food Chemistry</em>, <em>60</em>(12), 3311&ndash;3317. <a href=\"https://doi.org/10.1021/jf300180e\"><u>https://doi.org/10.1021/jf300180e</u></a></p>\n\n<p>Saraiva, M. A., Borges, C. M., &amp; Helena Flor??ncio, M. (2016). Mass spectrometric studies of the reaction of a blocked arginine with diketonic??-dicarbonyls. <em>Amino Acids</em>, <em>48</em>(3), 873&ndash;885. <a href=\"https://doi.org/10.1007/s00726-015-2135-6\"><u>https://doi.org/10.1007/s00726-015-2135-6</u></a></p>\n","biologicalOrganisationLevel":"Molecular","organTerm":{},"biologicalEvents":[{"object":{}}],"keyEventStressors":["2,3-Pentanedione","2,3-Butanedione"],"id":1584}
{"title":"Proteasomal dysfunction","references":"<p>Chen, G., Chen, X., 2003. Arginine residues in the active site of human phenol sulfotransferase (SULT1A1). J. Biol. Chem. 278, 36358&ndash;36364.</p>\n\n<p>Hubbs, A. F., Fluharty, K. L., Edwards, R. J., Barnabei, J. L., Grantham, J. T., Palmer, S. M., &hellip; Sriram, K. (2016). Accumulation of Ubiquitin and Sequestosome-1 Implicate Protein Damage in Diacetyl-Induced Cytotoxicity. In <em>American Journal of Pathology</em> (Vol. 186, pp. 2887&ndash;2908). <a href=\"https://doi.org/10.1016/j.ajpath.2016.07.018\"><u>https://doi.org/10.1016/j.ajpath.2016.07.018</u></a></p>\n\n<p>More, S.S., et al., 2012a. The butter flavorant, diacetyl, forms a covalent adduct with 2-deoxyguanosine, uncoils DNA, and leads to cell death. J. Agric. Food Chem. 60, 3311&ndash;3317.</p>\n","biologicalOrganisationLevel":"Molecular","organTerm":{},"biologicalEvents":[{"object":{}}],"id":1585}
{"title":"Airway epithelial injury","references":"<p>Foster, M. W., Gwinn, W. M., Kelly, F. L., Brass, D. M., Valente, A. M., Moseley, M. A., &hellip; Palmer, S. M. (2017). Proteomic Analysis of Primary Human Airway Epithelial Cells Exposed to the Respiratory Toxicant Diacetyl. <em>Journal of Proteome Research</em>, <em>16</em>(2), 538&ndash;549. <a href=\"https://doi.org/10.1021/acs.jproteome.6b00672\"><u>https://doi.org/10.1021/acs.jproteome.6b00672</u></a></p>\n\n<p>Hubbs, A. F., Goldsmith, W. T., Kashon, M. L., Frazer, D., Mercer, R. R., Battelli, L. A., &hellip; Castranova, V. (2008). Respiratory Toxicologic Pathology of Inhaled Diacetyl in Sprague-Dawley Rats. <em>Toxicologic Pathology</em>, <em>36</em>(2), 330&ndash;344. https://doi.org/10.1177/0192623307312694</p>\n\n<p>Palmer, S. M., Flake, G. P., Kelly, F. L., Zhang, H. L., Nugent, J. L., Kirby, P. J., &hellip; Morgan, D. L. (2011). Severe airway epithelial injury, aberrant repair and Bronchiolitis obliterans develops after diacetyl instillation in rats. <em>PLoS ONE</em>, <em>6</em>(3). https://doi.org/10.1371/journal.pone.0017644</p>\n\n<p>Zaccone, E. J., Goldsmith, W. T., Shimko, M. J., Wells, J. R., Schwegler-Berry, D., Willard, P. A., &hellip; Fedan, J. S. (2015). Diacetyl and 2,3-pentanedione exposure of human cultured airway epithelial cells: Ion transport effects and metabolism of butter flavoring agents. <em>Toxicology and Applied Pharmacology</em>, <em>289</em>, 542&ndash;549. https://doi.org/10.1016/j.taap.2015.10.004</p>\n","biologicalOrganisationLevel":"Cellular","organTerm":{},"biologicalEvents":[{"object":{}}],"id":1586}
{"title":"Fibroproliferative airway lesions","references":"<p>Flake, G. P., &amp; Morgan, D. L. (2017). Pathology of diacetyl and 2,3-pentanedione airway lesions in a rat model of obliterative bronchiolitis. <em>Toxicology</em>, <em>388</em>, 40&ndash;47. <a href=\"https://doi.org/10.1016/j.tox.2016.10.013\"><u>https://doi.org/10.1016/j.tox.2016.10.013</u></a></p>\n\n<p>Morgan, D. L., Jokinen, M. P., Johnson, C. L., Price, H. C., Gwinn, W. M., Bousquet, R. W., &amp; Flake, G. P. (2016). Chemical Reactivity and Respiratory Toxicity of the alpha-Diketone Flavoring Agents: 2,3-Butanedione, 2,3-Pentanedione, and 2,3-Hexanedione. <em>Toxicologic Pathology</em>, <em>44</em>(5), 763&ndash;783. https://doi.org/10.1177/0192623316638962</p>\n","biologicalOrganisationLevel":"Tissue","organTerm":{},"biologicalEvents":[{"object":{}}],"id":1587}
{"title":"Bronchiolitis obliterans","references":"<p>Kreiss et al. 2002 (first report of DA induced BO)</p>\n\n<p>Kreiss 2014 (changes in the human lung after DA exposure)</p>\n","biologicalOrganisationLevel":"Individual","organTerm":{},"biologicalEvents":[{"object":{}}],"id":1588}
{"title":"Activation, Muscarinic Acetylcholine Receptors","references":"<p>Burke, R. D., S. W. Todd, E. Lumsden, R. J. Mullins, J. Mamczarz, W. P. Fawcett, R. P. Gullapalli, W. R. Randall, E. F. R. Pereira and E. X. Albuquerque (2017), &quot;Developmental neurotoxicity of the organophosphorus insecticide chlorpyrifos: from clinical findings to preclinical models and potential mechanisms&rdquo;, <em>Journal of Neurochemistry</em> <strong>142</strong>: 162-177. DOI: 10.1111/jnc.14077.</p>\n\n<p>Dickson, E. J., B. H. Falkenburger and B. Hille (2013), &quot;Quantitative properties and receptor reserve of the IP3 and calcium branch of Gq-coupled receptor signaling&rdquo;, <em>Journal of General Physiology</em> <strong>141</strong>(5): 521-535. DOI: 10.1085/jgp.201210886.</p>\n\n<p>D&ouml;rje, F., A. I. Levey and M. R. Brann (1991), &quot;Immunological detection of muscarinic receptor subtype proteins (m1-m5) in rabbit peripheral tissues&rdquo;, <em>Molecular Pharmacology</em> <strong>40</strong>(4): 459-462.</p>\n\n<p>Falkenburger, B. H., E. J. Dickson and B. Hille (2013), &quot;Quantitative properties and receptor reserve of the DAG and PKC branch of G<sub>q</sub>-coupled receptor signaling&rdquo;, <em>The Journal of General Physiology</em> <strong>141</strong>(5): 537-555. DOI: 10.1085/jgp.201210887.</p>\n\n<p>Faria, M., Prats, E., Padr&oacute;s, F., Soares, A. M., &amp; Rald&uacute;a, D. (2017). Zebrafish is a predictive model for identifying compounds that protect against brain toxicity in severe acute organophosphorus intoxication. Archives of toxicology, <strong>91</strong>(4), 1891-1901.</p>\n\n<p>Fitzgerald, B. B. and L. G. Costa (1993), &quot;Modulation of Muscarinic Receptors and Acetylcholinesterase Activity in Lymphocytes and in Brain Areas Following Repeated Organophosphate Exposure in Rats&rdquo;, <em>Fundamental and Applied Toxicology</em> <strong>20</strong>(2): 210-216. DOI: 10.1006/faat.1993.1028.</p>\n\n<p>Fonnum, F. and S. H. Sterri (2011), &ldquo;Tolerance Development to Toxicity of Cholinesterase Inhibitors&rdquo;, in <em>Toxicology of organophosphate and carbamate compounds</em>, R. C. Gupta, Ed., Academic Press: 257-267.</p>\n\n<p>Gainetdinov, R. R. and M. G. Caron (1999), &quot;Delineating muscarinic receptor functions&rdquo;, <em>Proceedings of the National Academy of Sciences of the United States of America</em> <strong>96</strong>(22): 12222-12223. DOI: 10.1073/pnas.96.22.12222.</p>\n\n<p>Garcia, G. R., P. D. Noyes and R. L. Tanguay (2016), &quot;Advancements in zebrafish applications for 21st century toxicology&rdquo;, <em>Pharmacology and Therapeutics</em> <strong>161</strong>: 11-21. DOI: 10.1016/j.pharmthera.2016.03.009.</p>\n\n<p>Gazit, H., I. Silman and Y. Dudai (1979), &quot;Administration of an organophosphate causes a decrease in muscarinic receptor levels in rat brain&rdquo;, <em>Brain Research</em> <strong>174</strong>(2): 351-356. DOI: 10.1016/0006-8993(79)90861-8.</p>\n\n<p>Haga, T. (2013), &quot;Molecular properties of muscarinic acetylcholine receptors&rdquo;, <em>Proceedings of the Japan Academy Series B: Physical and Biological Sciences</em> <strong>89</strong>(6): 226-256. DOI: 10.2183/pjab.89.226.</p>\n\n<p>Heikkil&auml;, J., C. Jansson and K. E. O. &Aring;kerman (1991), &quot;Differential coupling of muscarinic receptors to Ca2+ mobilization and cyclic AMP in SH-SY5Y and IMR 32 neuroblastoma cells&rdquo;, <em>European Journal of Pharmacology: Molecular Pharmacology</em> <strong>208</strong>(1): 9-15. DOI: 10.1016/0922-4106(91)90045-J.</p>\n\n<p>Jett, D. A. and P. J. Lein (2011), &ldquo;Noncholinesterase Mechanisms of Central and Peripheral Neurotoxicity: Muscarinic Receptors and Other Targets&rdquo;, in <em>Toxicology of organophosphate and carbamate compounds</em>, R. C. Gupta, Ed., Academic Press: 233-245.</p>\n\n<p>Kandel, E., J. Schwartz, T. Jessell, S. Siegelbaum and A. J. Hudspeth (2013), &ldquo;Modulation of Synaptic Transmission: Second Messengers&rdquo;, in <em>Principles of Neural Science, Fifth Edition</em>, Blacklick, United States, McGraw-Hill Publishing: 236-259.</p>\n\n<p>Miller, S. L. and H. H. Yeh (2016), &ldquo;Neurotransmitters and Neurotransmission in the Developing and Adult Nervous System&rdquo;, in <em>Conn&#39;s Translational Neuroscience</em>: 49-84.</p>\n\n<p>Raheja, G. and K. Dip Gill (2007), &quot;Altered cholinergic metabolism and muscarinic receptor linked second messenger pathways after chronic exposure to dichlorvos in rat brain&rdquo;, <em>Toxicology and Industrial Health</em> <strong>23</strong>(1): 25-37. DOI: 10.1177/0748233707072490.</p>\n\n<p>Salomon, Y., C. Londos and M. Rodbell (1974), &quot;A highly sensitive adenylate cyclase assay&rdquo;, <em>Anal Biochem</em> <strong>58</strong>(2): 541-548. DOI: 10.1016/0003-2697(74)90222-x.</p>\n\n<p>&nbsp;</p>\n","biologicalOrganisationLevel":"Molecular","organTerm":{},"biologicalEvents":[{"action":"increased","process":"G-protein coupled acetylcholine receptor binding","object":{"name":"muscarinic acetylcholine receptor","source":"PR","sourceId":"PR:000001488"}}],"id":1602}
{"title":"Occurrence, Focal Seizure","references":"<p dir=\"ltr\">Acon-Chen, C., J. A. Koenig, G. R. Smith, A. R. Truitt, T. P. Thomas and T. M. Shih (2016), &quot;Evaluation of acetylcholine, seizure activity and neuropathology following high-dose nerve agent exposure and delayed neuroprotective treatment drugs in freely moving rats&rdquo;, Toxicology Mechanisms and Methods 26(5): 378-388. DOI: 10.1080/15376516.2016.1197992.</p>\n\n<p dir=\"ltr\">Belelli, D., N. C. Lan and K. W. Gee (1990), &quot;Anticonvulsant steroids and the GABA/benzodiazepine receptor-chloride ionophore complex&rdquo;, Neuroscience &amp; Biobehavioral Reviews 14(3): 315-322. DOI:<a href=\"https://doi.org/10.1016/S0149-7634(05)80041-7\"> https://doi.org/10.1016/S0149-7634(05)80041-7</a>.</p>\n\n<p dir=\"ltr\">Braitman, D. J. and S. Sparenborg (1989), &quot;MK-801 protects against seizures induced by the cholinesterase inhibitor soman&rdquo;, Brain Research Bulletin 23(1-2): 145-148. DOI: 10.1016/0361-9230(89)90173-1.</p>\n\n<p dir=\"ltr\">Kandel, E., J. Schwartz, T. Jessell, S. Siegelbaum and A. J. Hudspeth (2013), &ldquo;Seizures and Epilepsy&rdquo;, in Principles of Neural Science, Fifth Edition, Blacklick, United States, McGraw-Hill Publishing: 1116-1139.</p>\n\n<p dir=\"ltr\">Li, K. and E. Xu (2008), &quot;The role and the mechanism of gamma-aminobutyric acid during central nervous system development&rdquo;, Neuroscience bulletin 24(3): 195-200. DOI: 10.1007/s12264-008-0109-3.</p>\n\n<p dir=\"ltr\">McDonough Jr, J. H. and T. M. Shih (1997), &quot;Neuropharmacological mechanisms of nerve agent-induced seizure and neuropathology&rdquo;, Neuroscience and Biobehavioral Reviews 21(5): 559-579. DOI: 10.1016/S0149-7634(96)00050-4.</p>\n\n<p dir=\"ltr\">Miller, S. L. (2015), The Efficacy of LY293558 in Blocking Seizures and Associated Morphological, and Behavioral Alterations Induced by Soman in Immature Male Rats and the Role of the M1 Muscarinic Acetylcholine Receptor in Organophosphate Induced Seizures. Doctor of philosophy in the neuroscience graduate program Doctoral dissertation, Uniformed Services University.</p>\n\n<p dir=\"ltr\">Myhrer, T. (2007), &quot;Neuronal structures involved in the induction and propagation of seizures caused by nerve agents: Implications for medical treatment&rdquo;, Toxicology 239(1-2): 1-14. DOI: 10.1016/j.tox.2007.06.099.</p>\n","biologicalOrganisationLevel":"Tissue","organTerm":{"name":"brain","sourceId":"UBERON:0000955"},"biologicalEvents":[{"action":"occurrence","process":"EEG with focal epileptiform discharges","object":{"name":"neuron","source":"CL","sourceId":"CL:0000540"}}],"id":1623}
{"title":"Status epilepticus","references":"<p>Acon-Chen, C., J. A. Koenig, G. R. Smith, A. R. Truitt, T. P. Thomas and T. M. Shih (2016), &quot;Evaluation of acetylcholine, seizure activity and neuropathology following high-dose nerve agent exposure and delayed neuroprotective treatment drugs in freely moving rats&rdquo;,&nbsp;<em>Toxicology Mechanisms and Methods</em>&nbsp;<strong>26</strong>(5): 378-388. DOI: 10.1080/15376516.2016.1197992.</p>\n\n<p>Kandel, E., J. Schwartz, T. Jessell, S. Siegelbaum and A. J. Hudspeth (2013), &ldquo;Seizures and Epilepsy&rdquo;, in&nbsp;<em>Principles of Neural Science, Fifth Edition</em>, Blacklick, United States, McGraw-Hill Publishing<strong>:&nbsp;</strong>1116-1139.</p>\n\n<p>Lallement, G., D. Clarencon, M. Galonnier, D. Baubichon, M. F. Burckhart and M. Peoc&#39;h (1999), &quot;Acute soman poisoning in primates neither pretreated nor receiving immediate therapy: value of gacyclidine (GK-11) in delayed medical support&rdquo;,&nbsp;<em>Arch Toxicol</em>&nbsp;<strong>73</strong>(2): 115-122. DOI: 10.1007/s002040050595.</p>\n\n<p>Lowenstein, D. H. and B. K. Alldredge (1998), &quot;Status Epilepticus&rdquo;,&nbsp;<em>New England Journal of Medicine</em>&nbsp;<strong>338</strong>(14): 970-976. DOI: 10.1056/nejm199804023381407.</p>\n\n<p>McDonough, J. H., Jr. and T. M. Shih (1997), &quot;Neuropharmacological mechanisms of nerve agent-induced seizure and neuropathology&rdquo;,&nbsp;<em>Neurosci Biobehav Rev</em>&nbsp;<strong>21</strong>(5): 559-579.</p>\n","biologicalOrganisationLevel":"Individual","organTerm":{},"biologicalEvents":[{"action":"occurrence","process":"secondary generalized seizure","object":{"name":"brain","source":"UBERON","sourceId":"UBERON:0000955"}}],"id":1788}
{"title":"ROS generation from photoactivated chemicals","references":"<p>Foote CS. Definition of type I and type II photosensitized oxidation. Photochem Photobiol. 1991;54:659.</p>\n\n<p>ICH. ICH Guideline S10 Guidance on Photosafety Evaluation of Pharmaceuticals.: International Council on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use; 2014.</p>\n\n<p>Onoue S, Hosoi K, Toda T, Takagi H, Osaki N, Matsumoto Y, et al. Intra-/inter-laboratory validation study on reactive oxygen species assay for chemical photosafety evaluation using two different solar simulators. Toxicology in vitro : an international journal published in association with BIBRA. 2014;28:515-23.</p>\n\n<p>Onoue S, Hosoi K, Wakuri S, Iwase Y, Yamamoto T, Matsuoka N, et al. Establishment and intra-/inter-laboratory validation of a standard protocol of reactive oxygen species assay for chemical photosafety evaluation. Journal of applied toxicology : JAT. 2013;33:1241-50.</p>\n\n<p>Onoue S, Kawamura K, Igarashi N, Zhou Y, Fujikawa M, Yamada H, et al. Reactive oxygen species assay-based risk assessment of drug-induced phototoxicity: classification criteria and application to drug candidates. J Pharm Biomed Anal. 2008;47:967-72.</p>\n\n<p>Onoue S, Seto Y, Gandy G, Yamada S. Drug-induced phototoxicity; an early<em> in vitro</em> identification of phototoxic potential of new drug entities in drug discovery and development. Current drug safety. 2009;4:123-36.</p>\n\n<p>Onoue S, Tsuda Y. Analytical studies on the prediction of photosensitive/phototoxic potential of pharmaceutical substances. Pharmaceutical research. 2006;23:156-64.</p>\n\n<p>PCPC. PCPC 2014 safety evaluation guidelines; Chapter 7: Evaluation of Photoirritation and Photoallergy potential. Personal Care Products Council; 2014.</p>\n\n<p>Seto Y, Kato M, Yamada S, Onoue S. Development of micellar reactive oxygen species assay for photosafety evaluation of poorly water-soluble chemicals. Toxicology in vitro : an international journal published in association with BIBRA. 2013;27:1838-46.</p>\n\n<p>&nbsp;</p>\n","biologicalOrganisationLevel":"Molecular","organTerm":{},"biologicalEvents":[{"object":{}}],"keyEventStressors":["Light (290-700 nm)","Photoreactive chemicals"],"id":1592}
{"title":"Oxidation of membrane lipids","references":"<p>Castell JV, Gomez-Lechon MJ, Grassa C, Martinez LA, Miranda MA, Tarrega P. Photodynamic lipid peroxidation by the photosensitizing nonsteroidal antiinflammatory drugs suprofen and tiaprofenic acid. Photochem Photobiol. 1994;59:35-9.</p>\n\n<p>Girotti AW. Photodynamic lipid peroxidation in biological systems. Photochem Photobiol. 1990;51:497-509.</p>\n\n<p>Girotti AW. Photosensitized oxidation of membrane lipids: reaction pathways, cytotoxic effects, and cytoprotective mechanisms. J Photochem Photobiol B. 2001;63:103-13.</p>\n\n<p>ICH. ICH Guideline S10 Guidance on Photosafety Evaluation of Pharmaceuticals.: International Council on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use; 2014.</p>\n\n<p>Onoue S, Seto Y, Ochi M, Inoue R, Ito H, Hatano T, et al. In vitro photochemical and phototoxicological characterization of major constituents in St. John&#39;s Wort (Hypericum perforatum) extracts. Phytochemistry. 2011;72:1814-20.</p>\n\n<p>Onoue S, Tsuda Y. Analytical studies on the prediction of photosensitive/phototoxic potential of pharmaceutical substances. Pharmaceutical research. 2006;23:156-64.</p>\n\n<p>Seto Y, Inoue R, Kato M, Yamada S, Onoue S. Photosafety assessments on pirfenidone: photochemical, photobiological, and pharmacokinetic characterization. J Photochem Photobiol B. 2013;120:44-51.</p>\n","biologicalOrganisationLevel":"Cellular","organTerm":{},"biologicalEvents":[{"object":{}}],"keyEventStressors":["Photoactivated chemicals","Reactive oxygen species"],"id":1594}
{"title":"Oxidation/denatuation of membrane proteins","references":"<p>Dalle Carbonare M, Pathak MA. Skin photosensitizing agents and the role of reactive oxygen species in photoaging. J Photochem Photobiol B. 1992;14:105-24.</p>\n\n<p>ICH. ICH Guideline S10 Guidance on Photosafety Evaluation of Pharmaceuticals.: International Council on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use; 2014.</p>\n\n<p>Onoue S, Tsuda Y. Analytical studies on the prediction of photosensitive/phototoxic potential of pharmaceutical substances. Pharmaceutical research. 2006;23:156-64.</p>\n","biologicalOrganisationLevel":"Cellular","organTerm":{},"biologicalEvents":[{"object":{}}],"keyEventStressors":["Photoactivated chemicals","Reactive oxygen species"],"id":1595}
{"title":"Inflamatory events in light-exposed tissues","references":"<p>Castell JV, Gomez-Lechon MJ, Grassa C, Martinez LA, Miranda MA, Tarrega P. Photodynamic lipid peroxidation by the photosensitizing nonsteroidal antiinflammatory drugs suprofen and tiaprofenic acid. Photochem Photobiol. 1994;59:35-9.</p>\n\n<p>Epstein S. The Photopatch Test; Its Technique, Manifestations, and Significance. Ann Allergy. 1964;22:1-11.</p>\n\n<p>ICH. ICH Guideline S10 Guidance on Photosafety Evaluation of Pharmaceuticals.: International Council on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use; 2014.</p>\n\n<p>Onoue S, Seto Y, Gandy G, Yamada S. Drug-induced phototoxicity; an early<em> in vitro</em> identification of phototoxic potential of new drug entities in drug discovery and development. Current drug safety. 2009;4:123-36.</p>\n","biologicalOrganisationLevel":"Organ","organTerm":{},"biologicalEvents":[{"object":{}}],"keyEventStressors":["Light (290-700 nm)","Reactive oxygen species","Photoreactive chemicals"],"id":1599}
{"title":"Oxidation, Glutathione (To be considered with MIE)","references":"<p>Ballatori, N., Krance, S.M., Notenboom, S., Shi, S., Tieu, K., and Hammond, C.L. (2009). Glutathione dysregulation and the etiology and progression of human diseases. Biol. Chem. 390, 191&ndash;214.</p>\n\n<p>Chen, C.-A., Wang, T.-Y., Varadharaj, S., Reyes, L.A., Hemann, C., Talukder, M.A.H., Chen, Y.-R., Druhan, L.J., and Zweier, J.L. (2010). S-glutathionylation uncouples eNOS and regulates its cellular and vascular function. Nature 468, 1115&ndash;1118.</p>\n\n<p>Giustarini, D., Dalle-Donne, I., Milzani, A., Fanti, P., and Rossi, R. (2013). Analysis of GSH and GSSG after derivatization with N-ethylmaleimide. Nat. Protoc. 8, 1660&ndash;1669.</p>\n\n<p>Kalinina, E.V., Chernov, N.N., and Novichkova, M.D. (2014). Role of glutathione, glutathione transferase, and glutaredoxin in regulation of redox-dependent processes. Biochem. Biokhimiia 79, 1562&ndash;1583.</p>\n\n<p>Kamencic, H., Lyon, A., Paterson, P.G., and Juurlink, B.H. (2000). Monochlorobimane fluorometric method to measure tissue glutathione. Anal. Biochem. 286, 35&ndash;37.</p>\n\n<p>Tipple, T.E., and Rogers, L.K. (2012). Methods for the Determination of Plasma or Tissue Glutathione Levels. Methods Mol. Biol. Clifton NJ 889, 315&ndash;324.</p>\n","biologicalOrganisationLevel":"Molecular","organTerm":{},"biologicalEvents":[{"action":"abnormal","process":"antioxidant activity","object":{"name":"glutathione","source":"CHEBI","sourceId":"CHEBI:16856"}}],"keyEventStressors":["Reactive oxygen species"],"id":926}
{"title":"Chronic kidney disease","references":"","biologicalOrganisationLevel":"Organ","organTerm":{},"biologicalEvents":[{"object":{}}],"id":1603}
{"title":"Inhibition of N-linked glycosylation","references":"<p>Adnan, H. et al. (2016) &lsquo;Endoplasmic reticulum-targeted subunit toxins provide a new approach to rescue misfolded mutant proteins and revert cell models of genetic diseases&rsquo;, PLoS ONE, 11(12), pp. 1&ndash;19. doi: 10.1371/journal.pone.0166948.</p>\n\n<p>Aebi, M. (2013) &lsquo;N-linked protein glycosylation in the ER&rsquo;, Biochimica et Biophysica Acta - Molecular Cell Research. Elsevier B.V., 1833(11), pp. 2430&ndash;2437. doi: 10.1016/j.bbamcr.2013.04.001.</p>\n\n<p>Araki, K. and Nagata, K. (2012) &lsquo;SUP: Protein folding and quality control in the ER.&rsquo;, Cold Spring Harbor perspectives in biology, 4(8), p. a015438. doi: 10.1101/cshperspect.a015438.</p>\n\n<p>Buckley, B. J. and Whorton, A. R. (1997) &lsquo;Tunicamycin increases intracellular calcium levels in bovine aortic endothelial cells&rsquo;, Am.J.Physiol, 273(0002&ndash;9513 (Print)), pp. C1298&ndash;C1305.</p>\n\n<p>Contessa, J. N. et al. (2012) &lsquo;Biosynthesis is a Novel Target for Cancer Therapy&rsquo;, 16(12), pp. 3205&ndash;3214. doi: 10.1158/1078-0432.CCR-09-3331.Molecular.</p>\n\n<p>Elbein, A.D., Pan, Y.T., Solf, R., and Vosbeck, K. (1983). Effect of swasinone, an inhibitor of glyciprotein processing, on cultured mammalian cells. J. Cell Physiol. 115:265-275.</p>\n\n<p>Esko JD, Stanley P. Glycosylation Mutants of Cultured Mammalian Cells. 2017. In: Varki A, Cummings RD, Esko JD, et al., editors. Essentials of Glycobiology [Internet]. 3rd edition. Cold Spring Harbor (NY): Cold Spring Harbor Laboratory Press; 2015-2017. Chapter 49.</p>\n\n<p>Esko JD, Bertozzi C, Schnaar RL. Chemical Tools for Inhibiting Glycosylation. 2017. In: Varki A, Cummings RD, Esko JD, et al., editors. Essentials of Glycobiology [Internet]. 3rd edition. Cold Spring Harbor (NY): Cold Spring Harbor Laboratory Press; 2015-2017. Chapter 55.</p>\n\n<p>Kim, W., Spear, E. D. and Ng, D. T. W. (2005) &lsquo;Yos9p detects and targets misfolded glycoproteins for ER-associated degradation&rsquo;, Molecular Cell, 19(6), pp. 753&ndash;764. doi: 10.1016/j.molcel.2005.08.010.</p>\n\n<p>Li, K. et al. (2011) &lsquo;Repression of N-glycosylation triggers the unfolded protein response (UPR) and overexpression of cell wall protein and chitin in aspergillus fumigatus&rsquo;, Microbiology, 157(7), pp. 1968&ndash;1979. doi: 10.1099/mic.0.047712-0.</p>\n\n<p>Lopez-Sambrooks, C. et al. (2016) &lsquo;Oligosaccharyltransferase inhibition induces senescence in RTK-driven tumor cells&rsquo;, Nature Chemical Biology, 12(12), pp. 1023&ndash;1030. doi: 10.1038/nchembio.2194.</p>\n\n<p>Mcdowell, W. et al. (1988) &lsquo;in influenza-virus-infected cells by x-D-mannopyranosylmethyl-&rsquo;, 255, pp. 991&ndash;998.</p>\n\n<p>Powell, L. (1995) &lsquo;Inhibition of N-Linked Glycosylation&rsquo;, Current Protocols in Immunology, 12(1995), pp. 1&ndash;12.</p>\n\n<p>Salzberger, W. et al. (2015) &lsquo;Influence of glycosylation inhibition on the binding of KIR3DL1 to HLA-B&lowast;57:01&rsquo;, PLoS ONE. doi: 10.1371/journal.pone.0145324.</p>\n\n<p>Schwarz, F. and Aebi, M. (2011) &lsquo;Mechanisms and principles of N-linked protein glycosylation&rsquo;, Current Opinion in Structural Biology. Elsevier Ltd, 21(5), pp. 576&ndash;582. doi: 10.1016/j.sbi.2011.08.005.</p>\n\n<p>Shao, S. and Hegde, R. S. (2016) &lsquo;Target Selection during Protein Quality Control&rsquo;, Trends in Biochemical Sciences. Elsevier Ltd, 41(2), pp. 124&ndash;137. doi: 10.1016/j.tibs.2015.10.007.</p>\n\n<p>Shental-Bechor, D. and Levy, Y. (2008) &lsquo;Effect of glycosylation on protein folding: A close look at thermodynamic stabilization&rsquo;, Proceedings of the National Academy of Sciences, 105(24), pp. 8256&ndash;8261. doi: 10.1073/pnas.0801340105.</p>\n\n<p>Stein, A. et al. (2014) &lsquo;Key Steps in ERAD of Luminal ER Proteins Reconstituted with Purified Components&rsquo;, Cell. doi: 10.1016/j.cell.2014.07.050.</p>\n\n<p>Varki A, Cummings RD, Esko JD, et al., editors. Essentials of Glycobiology. 2nd edition. Cold Spring Harbor (NY): Cold Spring Harbor Laboratory Press; 2009. Available from: https://www.ncbi.nlm.nih.gov/books/NBK1908/</p>\n\n<p>Wojtowicz, K. et al. (2012) &lsquo;Inhibitors of N-glycosylation as a potential tool for analysis of the mechanism of action and cellular localisation of glycoprotein P&rsquo;, Acta Biochimica Polonica, 59(4), pp. 445&ndash;450.</p>\n","biologicalOrganisationLevel":"Molecular","organTerm":{},"biologicalEvents":[{"object":{}}],"keyEventStressors":["Amphomycin","Tunicamycin"],"id":1604}
{"title":"Accumulation of misfolded proteins","references":"<p>Gregoire, Simpson; Irwin, Jacob; Kwon, I. (2013). Technique for monitoring protein misfolding and aggregation in vitro and in living cells. <em>Korean J Chem Eng</em>, <em>29</em>(6), 693&ndash;702. https://doi.org/10.1007/s11814-012-0060-x.Techniques</p>\n","biologicalOrganisationLevel":"Cellular","organTerm":{},"biologicalEvents":[{"object":{}}],"id":1605}
{"title":"Activation of hepatic stellate cells","references":"<p>Landesmann, B. (2016). Adverse Outcome Pathway on Protein Alkylation Leading to Liver Fibrosis, (2).</p>\n\n<p>https://doi.org/10.1016/j.molcel.2005.08.010</p>\n\n<p>Koo, J. H., Lee, H. J., Kim, W., &amp; Kim, S. G. (2016). Endoplasmic Reticulum Stress in Hepatic Stellate Cells Promotes Liver Fibrosis via PERK-Mediated Degradation of HNRNPA1 and Up-regulation of SMAD2. <em>Gastroenterology</em>, <em>150</em>(1), 181&ndash;193.e8. https://doi.org/10.1053/j.gastro.2015.09.039</p>\n","biologicalOrganisationLevel":"Cellular","organTerm":{},"biologicalEvents":[{"object":{}}],"id":1606}
{"title":"Inhibition, Cytochrome P450 enzyme (CYP17A1) activity","references":"<p style=\"text-align:justify\"><span style=\"font-size:14px\"><span style=\"font-family:times new roman,times,serif\"><sup>1</sup>&nbsp;Storbeck K., Swart P., Africander D., Conradie R., Louw R. and.Swart A.C. (2011) 16&alpha;-Hydroxyprogesterone: Origin, biosynthesis and receptor interaction. Molecular and Cellular Endocrinology, 336(1-2): 92-101<a href=\"https://www.google.com/url?q=https://doi.org/10.1016/j.mce.2010.11.016&amp;sa=D&amp;ust=1554888093195000\">https://doi.org/10.1016/j.mce.2010.11.016</a></span></span></p>\n\n<p style=\"text-align:justify\"><span style=\"font-family:times new roman,times,serif\"><span style=\"font-size:11.6667px\">2</span><span style=\"font-size:14px\"> Petrunak E.M., DeVore N.M., Patrick R. Porubsky PR.., and Scott E.E.(2014) Structures of human steroidogenic cytochrome P450 17A1 with substrates. Journal of Biological Chemistry, 289(47): 32952&ndash;32964 &nbsp;</span><a href=\"https://www.google.com/url?q=https://doi.org/10.1074/jbc.M114.610998&amp;sa=D&amp;ust=1554888093196000\" style=\"font-size: 14px;\">https://doi.org/10.1074/jbc.M114.610998</a><span style=\"font-size:14px\">&nbsp;</span></span></p>\n\n<p style=\"text-align:justify\"><span style=\"font-size:14px\"><span style=\"font-family:times new roman,times,serif\"><sup>3</sup>&nbsp;Liu Y., Yao ZX., and Papadopoulos V. (2005) Cytochrome P450 17&alpha; Hydroxylase/17,20 Lyase (CYP17) Function in Cholesterol Biosynthesis: Identification of Squalene Monooxygenase (Epoxidase) Activity Associated with CYP17 in Leydig Cells. Molecular Endocrinology, 19(7): 1918-1931&nbsp;<a href=\"https://www.google.com/url?q=https://doi.org/10.1210/me.2004-0271&amp;sa=D&amp;ust=1554888093196000\">https://doi.org/10.1210/me.2004-0271</a>&nbsp;</span></span></p>\n\n<p style=\"text-align: justify;\"><span style=\"font-size:14px\"><span style=\"font-family:times new roman,times,serif\"><sup>4</sup>&nbsp;Anitha B. Alex, Sumanta K. Pal, and Neeraj Agarwal (2016) CYP17 inhibitors in prostate cancer: latest evidence and clinical potential. Therapeutic Advances in Medical Oncology, 8(4):267-75 &nbsp;<a href=\"https://www.google.com/url?q=https://doi.org/10.1177/1758834016642370&amp;sa=D&amp;ust=1554888093193000\">https://doi.org/10.1177/1758834016642370</a></span></span></p>\n\n<p style=\"text-align: justify;\"><span style=\"font-size:14px\"><span style=\"font-family:times new roman,times,serif\"><sup>5</sup>&nbsp;Roelofs M.J., Piersma A.H., van den Berg M. and&nbsp;van Duursen M.B. (2013) The relevance of chemical interactions with CYP17 enzyme activity: assessment using a novel in vitro assay. Toxicology and Applied Pharmacology 1;268(3):309-17&nbsp;<a href=\"https://www.google.com/url?q=https://doi.org/10.1016/j.taap.2013.01.033&amp;sa=D&amp;ust=1554888093194000\">https://doi.org/10.1016/j.taap.2013.01.033</a>&nbsp;</span></span></p>\n\n<p style=\"text-align: justify;\"><span style=\"font-size:14px\"><span style=\"font-family:times new roman,times,serif\"><sup>6</sup>&nbsp;Vinggaard A.M., Christiansen S., Laier P., Poulsen M.E., Breinholt V, Jarfelt K., Jacobsen H., Dalgaard M., Nellemann C. and Hass U. (2005) Perinatal exposure to the fungicide prochloraz feminizes the male rat offspring. Toxicological Sciences, 85:886&ndash;897<a href=\"https://www.google.com/url?q=https://doi.org/10.1093/toxsci/kfi150&amp;sa=D&amp;ust=1554888093194000\">https://doi.org/10.1093/toxsci/kfi150</a>&nbsp;</span></span></p>\n","biologicalOrganisationLevel":"Molecular","organTerm":{},"biologicalEvents":[{"object":{}}],"id":1609}
{"title":"Reduction, 17-OH-pregnenolone conversion in DHEA","references":"<p style=\"text-align: justify;\"><span style=\"font-size:14px\"><span style=\"font-family:times new roman,times,serif\"><sup>1</sup>&nbsp;Miller Walter L. (1988) Molecular Biology of Steroid Hormone Synthesis. Endocrine Reviews, 9(3): 295-318.&nbsp;<a href=\"https://www.google.com/url?q=https://doi.org/10.1210/edrv-9-3-295&amp;sa=D&amp;ust=1554888093201000\">https://doi.org/10.1210/edrv-9-3-295</a>&nbsp;</span></span></p>\n\n<p style=\"text-align: justify;\"><span style=\"font-size:14px\"><span style=\"font-family:times new roman,times,serif\"><sup>2</sup>&nbsp;Miller W.L. and Auchus R.J. (2011) The Molecular Biology, Biochemistry, and Physiology of Human Steroidogenesis and Its Disorders. Endocrine Reviews, 32(1): 81-151.<a href=\"https://www.google.com/url?q=https://doi.org/10.1210/er.2010-0013&amp;sa=D&amp;ust=1554888093202000\">https://doi.org/10.1210/er.2010-0013</a>&nbsp;</span></span></p>\n","biologicalOrganisationLevel":"Cellular","organTerm":{},"biologicalEvents":[{"object":{}}],"id":1610}
{"title":"Reduction, 17-OH-progesterone conversion in androstenedione","references":"<table>\n\t<tbody>\n\t\t<tr>\n\t\t\t<td colspan=\"1\" rowspan=\"1\">\n\t\t\t<p style=\"text-align:justify\">&nbsp;</p>\n\t\t\t</td>\n\t\t\t<td colspan=\"1\" rowspan=\"1\">\n\t\t\t<p style=\"text-align:justify\"><span style=\"font-size:14px\"><span style=\"font-family:times new roman,times,serif\"><sup>1</sup>&nbsp;Miller Walter L. (1988) Molecular Biology of Steroid Hormone Synthesis. Endocrine Reviews, 9(3): 295-318.&nbsp;<a href=\"https://www.google.com/url?q=https://doi.org/10.1210/edrv-9-3-295&amp;sa=D&amp;ust=1554891396596000\">https://doi.org/10.1210/edrv-9-3-295</a>&nbsp;</span></span></p>\n\n\t\t\t<p style=\"text-align:justify\"><span style=\"font-size:14px\"><span style=\"font-family:times new roman,times,serif\"><sup>2</sup>&nbsp;Liu Y., Yao ZX., and Papadopoulos V. (2005) Cytochrome P450 17&alpha; Hydroxylase/17,20 Lyase (CYP17) Function in Cholesterol Biosynthesis: Identification of Squalene Monooxygenase (Epoxidase) Activity Associated with CYP17 in Leydig Cells. Molecular Endocrinology, 19(7): 1918-1931&nbsp;<a href=\"https://www.google.com/url?q=https://doi.org/10.1210/me.2004-0271&amp;sa=D&amp;ust=1554891396596000\">https://doi.org/10.1210/me.2004-0271</a>&nbsp;</span></span></p>\n\t\t\t</td>\n\t\t</tr>\n\t</tbody>\n</table>\n\n<p>&nbsp;</p>\n","biologicalOrganisationLevel":"Cellular","organTerm":{},"biologicalEvents":[{"object":{}}],"id":1611}
{"title":"Decrease, testosterone synthesis/level","references":"<table>\n\t<tbody>\n\t\t<tr>\n\t\t\t<td colspan=\"1\" rowspan=\"1\">\n\t\t\t<p style=\"text-align: justify;\">&nbsp;</p>\n\t\t\t</td>\n\t\t\t<td colspan=\"1\" rowspan=\"1\">\n\t\t\t<p style=\"text-align: justify;\"><span style=\"font-family:times new roman,times,serif\"><span style=\"font-size:14px\"><sup>1</sup>&nbsp;Miller Walter L. (1988) Molecular Biology of Steroid Hormone Synthesis. Endocrine Reviews, 9(3): 295-318.&nbsp;<a href=\"https://www.google.com/url?q=https://doi.org/10.1210/edrv-9-3-295&amp;sa=D&amp;ust=1554891396604000\">https://doi.org/10.1210/edrv-9-3-295</a>&nbsp;</span></span></p>\n\n\t\t\t<p style=\"text-align: justify;\"><span style=\"font-family:times new roman,times,serif\"><span style=\"font-size:14px\"><sup>2</sup>&nbsp;Elder P.A. and Lewis J.G. (1985) An enzyme-linked immunosorbent assay (ELISA) for plasma testosterone. Journal of steroid biochemistry, 22(5):635-8.</span></span></p>\n\n\t\t\t<p style=\"text-align: justify;\"><span style=\"font-family:times new roman,times,serif\"><span style=\"font-size:14px\"><sup>3&nbsp;</sup>Shiraishi S., Lee P.W., Leung A., Goh V.H., Swerdloff R.S. and Wang C. (2008) Simultaneous measurement of serum testosterone and dihydrotestosterone by liquid chromatography-tandem mass spectrometry. Clinical chemistry, 54(11): 1855-63.<a href=\"https://www.google.com/url?q=https://doi.org/10.1373/clinchem.2008.103846&amp;sa=D&amp;ust=1554891396605000\">https://doi.org/10.1373/clinchem.2008.103846</a>&nbsp;</span></span></p>\n\n\t\t\t<p style=\"text-align: justify;\"><span style=\"font-family:times new roman,times,serif\"><span style=\"font-size:14px\"><sup>4</sup>&nbsp;OECD Guideline For the Testing of Chemicals - H295R Steroidogenesis Assay (2011)<a href=\"https://www.google.com/url?q=https://ntp.niehs.nih.gov/iccvam/suppdocs/feddocs/oecd/oecd-tg456-2011-508.pdf&amp;sa=D&amp;ust=1554891396606000\">https://ntp.niehs.nih.gov/iccvam/suppdocs/feddocs/oecd/oecd-tg456-2011-508.pdf</a>&nbsp;</span></span></p>\n\t\t\t</td>\n\t\t</tr>\n\t</tbody>\n</table>\n","biologicalOrganisationLevel":"Cellular","organTerm":{},"biologicalEvents":[{"object":{}}],"id":1612}
{"title":"Decrease, dihydrotestosterone (DHT) level","references":"<table>\n\t<tbody>\n\t\t<tr>\n\t\t\t<td colspan=\"1\" rowspan=\"1\">\n\t\t\t<p style=\"text-align: justify;\"><span style=\"font-size:14px\"><span style=\"font-family:times new roman,times,serif\"><sup>1&nbsp;</sup>Miller Walter L. (1988) Molecular Biology of Steroid Hormone Synthesis. Endocrine Reviews, 9(3): 295-318.<a href=\"https://www.google.com/url?q=https://doi.org/10.1210/edrv-9-3-295&amp;sa=D&amp;ust=1554891396614000\">https://doi.org/10.1210/edrv-9-3-295</a>&nbsp;</span></span></p>\n\n\t\t\t<p style=\"text-align: justify;\">&nbsp;</p>\n\n\t\t\t<p style=\"text-align: justify;\"><span style=\"font-size:14px\"><span style=\"font-family:times new roman,times,serif\"><sup>2&nbsp;</sup>Miller W.L. and Auchus R.J. (2011) The Molecular Biology, Biochemistry, and Physiology of Human Steroidogenesis and Its Disorders. Endocrine Reviews, 32(1): 81-151.<a href=\"https://www.google.com/url?q=https://doi.org/10.1210/er.2010-0013&amp;sa=D&amp;ust=1554891396616000\">https://doi.org/10.1210/er.2010-0013</a>&nbsp;</span></span></p>\n\n\t\t\t<p style=\"text-align: justify;\">&nbsp;</p>\n\n\t\t\t<p style=\"text-align: justify;\"><span style=\"font-size:14px\"><span style=\"font-family:times new roman,times,serif\"><sup>3</sup>&nbsp;Shiraishi S., Lee P.W., Leung A., Goh V.H., Swerdloff R.S. and Wang C. (2008) Simultaneous measurement of serum testosterone and dihydrotestosterone by liquid chromatography-tandem mass spectrometry. Clinical chemistry, 54(11): 1855-63.<a href=\"https://www.google.com/url?q=https://doi.org/10.1373/clinchem.2008.103846&amp;sa=D&amp;ust=1554891396617000\">https://doi.org/10.1373/clinchem.2008.103846</a></span></span></p>\n\t\t\t</td>\n\t\t</tr>\n\t</tbody>\n</table>\n","biologicalOrganisationLevel":"Cellular","organTerm":{},"biologicalEvents":[{"object":{}}],"id":1613}
{"title":"Decrease, androgen receptors (AR) activation","references":"<table>\n\t<tbody>\n\t\t<tr>\n\t\t\t<td colspan=\"1\" rowspan=\"1\">\n\t\t\t<p>&nbsp;</p>\n\t\t\t</td>\n\t\t\t<td colspan=\"1\" rowspan=\"1\">\n\t\t\t<p><sup>1</sup> Davey R.A and Grossmann M. (2016) Androgen Receptor Structure, Function and Biology: From Bench to Bedside. Clinical Biochemist Reviews, 37(1): 3-15. PCM4810760</p>\n\n\t\t\t<p><sup>2&nbsp;</sup>Gao W., Bohl C.E. and Dalton J.T. (2005) Chemistry and Structural Biology of Androgen Receptor. Chemical Reviews 105(9): 3352-3370<a href=\"https://www.google.com/url?q=https://doi.org/10.1021/cr020456u&amp;sa=D&amp;ust=1554891396627000\">https://doi.org/10.1021/cr020456u</a>&nbsp;</p>\n\n\t\t\t<p><sup>3</sup>&nbsp;Kaftanovskaya E.M., Huang Z., Barbara A.M., De Gendt K., Verhoeven G., Ivan P. Gorlov, and Agoulnik A.I. (2012) Cryptorchidism in Mice with an Androgen Receptor Ablation in Gubernaculum Testis. Molecular Endocrinology, 26(4): 598-607.<a href=\"https://www.google.com/url?q=https://doi.org/10.1210/me.2011-1283&amp;sa=D&amp;ust=1554891396628000\">https://doi.org/10.1210/me.2011-1283</a>&nbsp;</p>\n\n\t\t\t<p><sup>4</sup>&nbsp;Hutson J.M. (1985) A biphasic model for the hormonal control of testicular descent. Lancet, 24;2(8452): 419-21<a href=\"https://www.google.com/url?q=http://dx.doi.org/10.1016/S0140-6736(85)92739-4&amp;sa=D&amp;ust=1554891396629000\">http://dx.doi.org/10.1016/S0140-6736(85)92739-4</a>&nbsp;</p>\n\n\t\t\t<p><sup>5</sup>&nbsp;van der Burg B., Winter R., Man HY., Vangenechten C., Berckmans P., Weimer M., Witters M. and van der Linden S. (2010) Optimization and prevalidation of the in vitro AR CALUX method to test androgenic and antiandrogenic activity of compounds. Reproductive Toxicology, 30(1):18-24&nbsp;<a href=\"https://www.google.com/url?q=https://doi.org/0.1016/j.reprotox.2010.04.012&amp;sa=D&amp;ust=1554891396630000\">https://doi.org/0.1016/j.reprotox.2010.04.012</a>&nbsp;</p>\n\t\t\t</td>\n\t\t</tr>\n\t</tbody>\n</table>\n","biologicalOrganisationLevel":"Cellular","organTerm":{},"biologicalEvents":[{"object":{}}],"id":1614}
{"title":"Impaired inguinoscrotal testicular descent phase","references":"<p style=\"text-align: justify;\"><span style=\"font-family:times new roman,times,serif\"><span style=\"font-size:14px\"><sup>1</sup>&nbsp;Hutson J.M., Li R., Southwell B.R., Newgreen D., and Cousinery M. (2015) Regulation of testicular descent. Pediatric Surgery International, 31(4): 317-325&nbsp;<a href=\"https://www.google.com/url?q=https://doi.org/10.1007/s00383-015-3673-4&amp;sa=D&amp;ust=1554891396640000\">https://doi.org/10.1007/s00383-015-3673-4</a>&nbsp;</span></span></p>\n","biologicalOrganisationLevel":"Organ","organTerm":{},"biologicalEvents":[{"object":{}}],"id":1615}
{"title":"Malformation, cryptorchidism - maldescended testis","references":"<p style=\"text-align: justify;\"><span style=\"font-size:14px\"><span style=\"font-family:times new roman,times,serif\"><sup>1</sup>&nbsp;Hutson J.M., Li R., Southwell B.R., Newgreen D., and Cousinery M. (2015) Regulation of testicular descent. Pediatric Surgery International, 31(4): 317-325.&nbsp;<a href=\"https://www.google.com/url?q=https://doi.org/10.1007/s00383-015-3673-4&amp;sa=D&amp;ust=1554891396648000\">https://doi.org/10.1007/s00383-015-3673-4</a>&nbsp;</span></span></p>\n\n<p style=\"text-align: justify;\"><span style=\"font-size:14px\"><span style=\"font-family:times new roman,times,serif\"><sup>2</sup>&nbsp;Boisen K.A., Kaleva M., Main K.M., Virtanen H.E., Haavisto A.M., Schmidt I.M., Chellakooty M., Damgaard I.N., Mau C., Reunanen M., Skakkebaek N.E. and Toppari J. (2004) Difference in prevalence of congenital cryptorchidism in infants between two Nordic countries. Lancet, 17;363(9417):1264-9&nbsp;<a href=\"https://www.google.com/url?q=https://doi.org/10.1016/S0140-6736(04)15998-9&amp;sa=D&amp;ust=1554891396649000\">https://doi.org/10.1016/S0140-6736(04)15998-9</a>&nbsp;</span></span></p>\n\n<p style=\"text-align: justify;\"><span style=\"font-size:14px\"><span style=\"font-family:times new roman,times,serif\"><sup>3</sup>&nbsp;Acerini C.L., Miles H.L., Dunger D.B., Ong K.K. and Hughes I.A. (2009) The descriptive epidemiology of congenital and acquired cryptorchidism in a UK infant cohort. Archives of disease in childhood, 94(11):868-72&nbsp;https://doi.org10.1136/adc.2008.150219&nbsp;</span></span></p>\n\n<p style=\"text-align: justify;\"><span style=\"font-size:14px\"><span style=\"font-family:times new roman,times,serif\"><sup>4</sup>&nbsp;Hutson J.M., et al. (2015) Cryptorchidism and Hypospadias.&nbsp;Endotext<a href=\"https://www.google.com/url?q=https://www.ncbi.nlm.nih.gov/books/NBK279106/&amp;sa=D&amp;ust=1554891396651000\">https://www.ncbi.nlm.nih.gov/books/NBK279106/</a>&nbsp;</span></span></p>\n","biologicalOrganisationLevel":"Organ","organTerm":{},"biologicalEvents":[{"object":{}}],"id":1616}
{"title":"5-reductase, inhibition","references":"","biologicalOrganisationLevel":"Molecular","organTerm":{},"biologicalEvents":[{"object":{}}],"id":1617}
{"title":"Increase, Mitochondrial ATP synthase antagonism","references":"","biologicalOrganisationLevel":"Molecular","organTerm":{},"biologicalEvents":[{"object":{}}],"id":1785}
{"title":"Inhibition of tyrosinase ","references":"","biologicalOrganisationLevel":"Molecular","organTerm":{},"biologicalEvents":[{"object":{}}],"id":1627}
{"title":"Reduction of L-Dopaquinone","references":"","biologicalOrganisationLevel":"Cellular","organTerm":{},"biologicalEvents":[{"object":{}}],"id":1628}
{"title":"Reduction in melanin level","references":"","biologicalOrganisationLevel":"Cellular","organTerm":{},"biologicalEvents":[{"object":{}}],"id":1629}
{"title":"Reduction of melanosome level","references":"","biologicalOrganisationLevel":"Tissue","organTerm":{},"biologicalEvents":[{"object":{}}],"id":1630}
{"title":"Reduction fo Pigmentation pattern ","references":"","biologicalOrganisationLevel":"Individual","organTerm":{},"biologicalEvents":[{"object":{}}],"id":1631}
{"title":"Increase in reactive oxygen and nitrogen species (RONS)","references":"<p style=\"margin-left:.5in\"><a name=\"_ENREF_1\">Calcerrada, P., G. Peluffo, et al. (2011). &quot;Nitric oxide-derived oxidants with a focus on peroxynitrite: molecular targets, cellular responses and therapeutic implications.&quot; <u>Curr Pharm Des</u> <strong>17</strong>(35): 3905-3932.</a></p>\n\n<p style=\"margin-left:.5in\"><a name=\"_ENREF_2\">Dickinson, B. C. and C. J. Chang (2011). &quot;Chemistry and biology of reactive oxygen species in signaling or stress responses.&quot; <u>Nature chemical biology</u> <strong>7</strong>(8): 504-511.</a></p>\n\n<p style=\"margin-left:.5in\"><a name=\"_ENREF_3\">Egea, J., I. Fabregat, et al. (2017). &quot;European contribution to the study of ROS: A summary of the findings and prospects for the future from the COST action BM1203 (EU-ROS).&quot; <u>Redox biology</u> <strong>13</strong>: 94-162.</a></p>\n\n<p style=\"margin-left:.5in\"><a name=\"_ENREF_4\">Go, Y. M. and D. P. Jones (2013). &quot;The redox proteome.&quot; <u>J Biol Chem</u> <strong>288</strong>(37): 26512-26520.</a></p>\n\n<p style=\"margin-left:.5in\"><a name=\"_ENREF_5\">Griendling, K. K., R. M. Touyz, et al. (2016). &quot;Measurement of Reactive Oxygen Species, Reactive Nitrogen Species, and Redox-Dependent Signaling in the Cardiovascular System: A Scientific Statement From the American Heart Association.&quot; <u>Circulation research</u> <strong>119</strong>(5): e39-75.</a></p>\n\n<p style=\"margin-left:.5in\"><a name=\"_ENREF_6\">Ravanat, J. L., J. Breton, et al. (2014). &quot;Radiation-mediated formation of complex damage to DNA: a chemical aspect overview.&quot; <u>Br J Radiol</u> <strong>87</strong>(1035): 20130715.</a></p>\n\n<p style=\"margin-left:.5in\"><a name=\"_ENREF_7\">Wang, X., H. Fang, et al. (2013). &quot;Imaging ROS signaling in cells and animals.&quot; <u>Journal of molecular medicine</u> <strong>91</strong>(8): 917-927.</a></p>\n","biologicalOrganisationLevel":"Molecular","organTerm":{},"biologicalEvents":[{"object":{}}],"keyEventStressors":["Ionizing Radiation"],"id":1632}
{"title":"Increase, Oxidative damage to DNA","references":"<p>Breton J, Sichel F, Bainchini F, Prevost V. (2003). Measurement of 8-Hydroxy-2&prime;-Deoxyguanosine by a Commercially Available ELISA Test: Comparison with HPLC/Electrochemical Detection in Calf Thymus DNA and Determination in Human Serum. Anal Lett 36:123-134.</p>\n\n<p>Chepelev N, Kennedy D, Gagne R, White T, Long A, Yauk C, White P. (2015). HPLC Measurement of the DNA Oxidation Biomarker, 8-oxo-7,8-dihydro-2&#39;-deoxyguanosine, in Cultured Cells and Animal Tissues. Journal of Visualized Experiments 102:e52697.</p>\n\n<p>Jovanovic S, Simic M. (1986). One-electron redox potential of purines and pyrimidines. J Phys Chem 90:974-978.</p>\n\n<p>Mangal D, Vudathala D, Park J, Lee S, Penning T, Blair I. (2009). Analysis of 7,8-Dihydro-8-oxo-2&prime;-deoxyguanosine in Cellular DNA during Oxidative Stress. Chem Res Toxicol 22:788-797.</p>\n\n<p>Platel A, Nesslany F, Gervais V, Claude N, Marzin D. (2011). Study of oxidative DNA damage in TK6 human lymphoblastoid cells by use of the thymidine kinase gene-mutation assay and the&nbsp;<em>in vitro&nbsp;</em>modified comet assay: Determination of No-Observed-Genotoxic-Effect-Levels. Mutat Res 726:151-159.</p>\n\n<p>Smith C, O&#39;Donovan M, Martin E. (2006). hOGG1 recognizes oxidative damage using the comet assay with greater specificity than FPG or ENDOIII. Mutagenesis 21:185-190.</p>\n\n<p>Swenberg J, Lu K, Moeller B, Gao L, Upton P, Nakamura J, Starr T. (2011). Endogenous versus Exogenous DNA Adducts: Their Role in Carcinogenesis, Epidemiology, and Risk Assessment. Toxicol Sci 120:S130-S145.</p>\n\n<p>Whitaker A, Schaich M, Smith MS, Flynn T, Freudenthal B. (2017). Base excision repair of oxidative DNA damage: from mechanism to disease. Front Biosci 22:1493-1522.</p>\n\n<p>Zhao M, Howard E, Guo Z, Parris A, Yang X. (2017). p53 pathway determines the cellular response to alcohol-induced DNA damage in MCF-7 breast cancer cells. PLoS One 12:e0175121.</p>\n","biologicalOrganisationLevel":"Molecular","organTerm":{"name":"organ","sourceId":"UBERON:0000062"},"biologicalEvents":[{"action":"occurrence","process":"regulation of response to reactive oxygen species","object":{"name":"reactive oxygen species","source":"CHEBI","sourceId":"CHEBI:26523"}}],"keyEventStressors":["Sodium arsenite","Potassium bromate","Hydrogen peroxide","Reactive oxygen species","Ionizing Radiation"],"id":1634}
{"title":"Retinaldehyde dehydrogenase inhibition","references":"","biologicalOrganisationLevel":"Molecular","organTerm":{},"biologicalEvents":[{"object":{}}],"id":1637}
{"title":"Altered, Photoreceptor patterning","references":"<p dir=\"ltr\"><strong>Allison, W.T., Dann, S.G., Veldhoen, K.M., Hawryshyn, C.W., 2006. Degeneration and regeneration of ultraviolet cone photoreceptors during development in rainbow trout. Journal of Comparative Neurology 499, 702-715.</strong></p>\n\n<p dir=\"ltr\"><strong>Arikawa, K., Wakakuwa, M., Qiu, X.D., Kurasawa, M., Stavenga, D.G., 2005. Sexual dimorphism of short-wavelength photoreceptors in the small white butterfly, Pieris rapae crucivora. Journal of Neuroscience 25, 5935-5942.</strong></p>\n\n<p dir=\"ltr\"><strong>Cheng, C.L., Flamarique, I.N., 2007. Chromatic organization of cone photoreceptors in the retina of rainbow trout: single cones irreversibly switch from UV (SWS1) to blue (SWS2) light sensitive opsin during natural development. Journal of Experimental Biology 210, 4123-4135.</strong></p>\n\n<p dir=\"ltr\"><strong>Cheng, C.L., Flamarique, I.N., Harosi, F.I., Rickers-Haunerland, J., Haunerland, N.H., 2006. Photoreceptor layer of salmonid fishes: Transformation and loss of single cones in juvenile fish. Journal of Comparative Neurology 495, 213-235.</strong></p>\n\n<p dir=\"ltr\"><strong>Chinen, A., Hamaoka, T., Yamada, Y., Kawamura, S., 2003. Gene duplication and spectral diversification of cone visual pigments of zebrafish. Genetics 163, 663-675.</strong></p>\n\n<p dir=\"ltr\"><strong>Cornish, E.E., Xiao, M., Yang, Z.T., Provis, J.M., Hendrickson, A.E., 2004. The role of opsin expression and apoptosis in determination of cone types in human retina. Experimental Eye Research 78, 1143-1154.</strong></p>\n\n<p dir=\"ltr\"><strong>DuVal, M.G., Allison, W.T., 2018. Photoreceptor Progenitors Depend Upon Coordination of gdf6a, thr beta, and tbx2b to Generate Precise Populations of Cone Photoreceptor Subtypes. Investigative Ophthalmology &amp; Visual Science 59, 6089-6101.</strong></p>\n\n<p dir=\"ltr\"><strong>DuVal, M.G., Oel, A.P., Allison, W.T., 2014. gdf6a Is Required for Cone Photoreceptor Subtype Differentiation and for the Actions of tbx2b in Determining Rod Versus Cone Photoreceptor Fate. Plos One 9.</strong></p>\n\n<p dir=\"ltr\"><strong>Gan, K.J., Flamarique, I.N., 2010. Thyroid Hormone Accelerates Opsin Expression During Early Photoreceptor Differentiation and Induces Opsin Switching in Differentiated TR alpha-Expressing Cones of the Salmonid Retina. Developmental Dynamics 239, 2700-2713.</strong></p>\n\n<p dir=\"ltr\"><strong>Glaschke, A., Glosmann, M., Peichl, L., 2010. Developmental Changes of Cone Opsin Expression but Not Retinal Morphology in the Hypothyroid Pax8 Knockout Mouse. Investigative Ophthalmology &amp; Visual Science 51, 1719-1727.</strong></p>\n\n<p dir=\"ltr\"><strong>Glaschke, A., Weiland, J., Del Turco, D., Steiner, M., Peichl, L., Glosmann, M., 2011. Thyroid Hormone Controls Cone Opsin Expression in the Retina of Adult Rodents. Journal of Neuroscience 31, 4844-4851.</strong></p>\n\n<p dir=\"ltr\"><strong>Hilbrant, M., Almudi, I., Leite, D.J., Kuncheria, L., Posnien, N., Nunes, M.D.S., McGregor, A.P., 2014. Sexual dimorphism and natural variation within and among species in the Drosophila retinal mosaic. Bmc Evolutionary Biology 14.</strong></p>\n\n<p dir=\"ltr\"><strong>Houbrechts, A.M., Vergauwen, L., Bagci, E., Van Houcke, J., Heijlen, M., Kulemeka, B., Hyde, D.R., Knapen, D., Darras, V.M., 2016. Deiodinase knockdown affects zebrafish eye development at the level of gene expression, morphology and function. Molecular and Cellular Endocrinology 424, 81-93.</strong></p>\n\n<p dir=\"ltr\"><strong>Jacobs, G.H., 2009. Evolution of colour vision in mammals. Philosophical Transactions of the Royal Society B-Biological Sciences 364, 2957-2967.</strong></p>\n\n<p dir=\"ltr\"><strong>Karagic, N., Harer, A., Meyer, A., Torres-Dowdall, J., 2018. Heterochronic opsin expression due to early light deprivation results in drastically shifted visual sensitivity in a cichlid fish: Possible role of thyroid hormone signaling. Journal of Experimental Zoology Part B-Molecular and Developmental Evolution 330, 202-214.</strong></p>\n\n<p dir=\"ltr\"><strong>Lamba, D., Karl, M., Rehl, T., 2008. Neural regeneration and cell replacement: A view from the eye. Cell Stem Cell 2, 538-549.</strong></p>\n\n<p dir=\"ltr\"><strong>Lukats, A., Szabo, A., Rohlich, P., Vigh, B., Szel, A., 2005. Photopigment coexpression in mammals: comparative and developmental aspects. Histology and Histopathology 20, 551-574.</strong></p>\n\n<p dir=\"ltr\"><strong>Maack, G., Segner, H., 2003. Morphological development of the gonads in zebrafish. Journal of Fish Biology 62, 895-906.</strong></p>\n\n<p dir=\"ltr\"><strong>Mackin, R.D., Frey, R.A., Gutierrez, C., Farre, A.A., Kawamura, S., Mitchell, D.M., Stenkamp, D.L., 2019. Endocrine regulation of multichromatic color vision. Proceedings of the National Academy of Sciences of the United States of America 116, 16882-16891.</strong></p>\n\n<p dir=\"ltr\"><strong>Mader, M., Cameron, D., 2006. Effects of induced systemic hypothyroidism upon the retina: Regulation of thyroid hormone receptor alpha and photoreceptor production. Molecular Vision 12, 915-930.</strong></p>\n\n<p dir=\"ltr\"><strong>Mader, M.M., Cameron, D.A., 2004. Photoreceptor differentiation during retinal development, growth, and regeneration in a metamorphic vertebrate. Journal of Neuroscience 24, 11463-11472.</strong></p>\n\n<p dir=\"ltr\"><strong>Matsumoto, T., Ishibashi, Y., 2016. Sequence analysis and expression patterns of opsin genes in the longtooth grouper Epinephelus bruneus. Fisheries Science 82, 17-27.</strong></p>\n\n<p dir=\"ltr\"><strong>Mitchell, D.M., Stevens, C.B., Frey, R.A., Hunter, S.S., Ashino, R., Kawamura, S., Stenkamp, D.L., 2015. Retinoic Acid Signaling Regulates Differential Expression of the Tandemly-Duplicated Long Wavelength-Sensitive Cone Opsin Genes in Zebrafish. Plos Genetics 11.</strong></p>\n\n<p dir=\"ltr\"><strong>Nathans, J., Thomas, D., Hogness, D.S., 1986. MOLECULAR-GENETICS OF HUMAN COLOR-VISION - THE GENES ENCODING BLUE, GREEN, AND RED PIGMENTS. Science 232, 193-202.</strong></p>\n\n<p dir=\"ltr\"><strong>Raymond, P.A., Colvin, S.M., Jabeen, Z., Nagashima, M., Barthel, L.K., Hadidjojo, J., Popova, L., Pejaver, V.R., Lubensky, D.K., 2014. Patterning the Cone Mosaic Array in Zebrafish Retina Requires Specification of Ultraviolet-Sensitive Cones. Plos One 9.</strong></p>\n\n<p dir=\"ltr\"><strong>Sajuthi, A., Carrillo-Zazueta, B., Hu, B., Wang, A., Brodnansky, L., Mayberry, J., Rivera, A.S., 2015. Sexually dimorphic gene expression in the lateral eyes of Euphilomedes carcharodonta (Ostracoda, Pancrustacea). Evodevo 6.</strong></p>\n\n<p dir=\"ltr\"><strong>Shand, J., Hart, N.S., Thomas, N., Partridge, J.C., 2002. Developmental changes in the cone visual pigments of black bream Acanthopagrus butcheri. Journal of Experimental Biology 205, 3661-3667.</strong></p>\n\n<p dir=\"ltr\"><strong>Shao, Y.T., Wang, F.Y., Fu, W.C., Yan, H.Y., Anraku, K., Chen, I.S., Borg, B., 2014. Androgens Increase Iws Opsin Expression and Red Sensitivity in Male Three-Spined Sticklebacks. Plos One 9.</strong></p>\n\n<p dir=\"ltr\"><strong>Tseng, W.H., Lin, J.W., Lou, C.H., Lee, K.H., Wu, L.S., Wang, T.Y., Wang, F.Y., Irschick, D.J., Lin, S.M., 2018. Opsin gene expression regulated by testosterone level in a sexually dimorphic lizard. Scientific Reports 8.</strong></p>\n\n<p dir=\"ltr\"><strong>Tsujimura, T., Hosoya, T., Kawamura, S., 2010. A Single Enhancer Regulating the Differential Expression of Duplicated Red-Sensitive Opsin Genes in Zebrafish. Plos Genetics 6.</strong></p>\n\n<p dir=\"ltr\"><strong>Van Gelder, R.N., Kaur, K., 2015. Vision Science: Can Rhodopsin Cure Blindness? Current Biology 25, R713-R715.</strong></p>\n\n<p dir=\"ltr\"><strong>Viets, K., Eldred, K.C., Johnston, R.J., 2016. Mechanisms of Photoreceptor Patterning in Vertebrates and Invertebrates. Trends in Genetics 32, 638-659.</strong></p>\n\n<p><br />\n&nbsp;</p>\n","biologicalOrganisationLevel":"Cellular","organTerm":{"name":"retina","sourceId":"UBERON:0000966"},"biologicalEvents":[{"object":{}}],"id":1640}
{"title":"Decreased retinoic acid (RA) synthesis","references":"","biologicalOrganisationLevel":"Cellular","organTerm":{},"biologicalEvents":[{"object":{}}],"id":1641}
{"title":"Decreased plasma RA level","references":"","biologicalOrganisationLevel":"Tissue","organTerm":{},"biologicalEvents":[{"object":{}}],"id":1642}
{"title":"Altered, Visual function","references":"<p dir=\"ltr\"><strong>Baumann, L., Ros, A., Rehberger, K., Neuhauss, S.C.F., Segner, H., 2016. Thyroid disruption in zebrafish (Danio rerio) larvae: Different molecular response patterns lead to impaired eye development and visual functions. Aquat. Toxicol. 172, 44&ndash;55. https://doi.org/10.1016/j.aquatox.2015.12.015</strong></p>\n\n<p dir=\"ltr\"><strong>Brastrom, L.K., Scott, C.A., Dawson, D. V., Slusarski, D.C., 2019. A High-Throughput Assay for Congenital and Age-Related Eye Diseases in Zebrafish. Biomedicines 7, 28. https://doi.org/10.3390/biomedicines7020028</strong></p>\n\n<p dir=\"ltr\"><strong>Carvalho, P.S.M., Noltie, D.B., Tillitt, D.E., 2002. Ontogenetic improvement of visual function in the medaka Oryzias latipes based on an optomotor testing system for larval and adult fish. Anim. Behav. 64, 1&ndash;10. https://doi.org/10.1006/anbe.2002.3028</strong></p>\n\n<p dir=\"ltr\"><strong>Corral-L&oacute;pez, A., Garate-Olaizola, M., Buechel, S.D., Kolm, N., Kotrschal, A., 2017. On the role of body size, brain size, and eye size in visual acuity. Behav. Ecol. Sociobiol. 71. https://doi.org/10.1007/s00265-017-2408-z</strong></p>\n\n<p dir=\"ltr\"><strong>Gao, D., Wu, M., Wang, C., Wang, Y., Zuo, Z., 2015. Chronic exposure to low benzo[a]pyrene level causes neurodegenerative disease-like syndromes in zebrafish (Danio rerio). Aquat. Toxicol. </strong></p>\n\n<p><br />\n&nbsp;</p>\n","biologicalOrganisationLevel":"Individual","organTerm":{},"biologicalEvents":[{"object":{}}],"id":1643}
{"title":"Epithelial-mesenchymal transition","references":"<p style=\"margin-left:36.0pt\">Colvin, H., Nishida, N., Konno, M., Haraguchi, N., Takahashi, H., Nishimura, J., . . . Ishii, H. (2016). Oncometabolite D-2-Hydroxyglurate Directly Induces Epithelial-Mesenchymal Transition and is Associated with Distant Metastasis in Colorectal Cancer. <em>Sci Rep, 6</em>, 36289. doi:10.1038/srep36289</p>\n\n<p style=\"margin-left:36.0pt\">Du, B., &amp; Shim, J. S. (2016). Targeting Epithelial-Mesenchymal Transition (EMT) to Overcome Drug Resistance in Cancer. <em>Molecules, 21</em>(7). doi:10.3390/molecules21070965</p>\n\n<p style=\"margin-left:36.0pt\">Fang, C. X., Ma, C. M., Jiang, L., Wang, X. M., Zhang, N., Ma, J. N., . . . Zhao, Y. D. (2018). p38 MAPK is Crucial for Wnt1- and LiCl-Induced Epithelial Mesenchymal Transition. <em>Curr Med Sci, 38</em>(3), 473-481. doi:10.1007/s11596-018-1903-4</p>\n\n<p style=\"margin-left:36.0pt\">Guerra, F., Guaragnella, N., Arbini, A. A., Bucci, C., Giannattasio, S., &amp; Moro, L. (2017). Mitochondrial Dysfunction: A Novel Potential Driver of Epithelial-to-Mesenchymal Transition in Cancer. <em>Front Oncol, 7</em>, 295. doi:10.3389/fonc.2017.00295</p>\n\n<p style=\"margin-left:36.0pt\">Hodge, D. Q., Cui, J., Gamble, M. J., &amp; Guo, W. (2018). Histone Variant MacroH2A1 Plays an Isoform-Specific Role in Suppressing Epithelial-Mesenchymal Transition. <em>Sci Rep, 8</em>(1), 841. doi:10.1038/s41598-018-19364-4</p>\n\n<p style=\"margin-left:36.0pt\">Jia, D., Park, J. H., Jung, K. H., Levine, H., &amp; Kaipparettu, B. A. (2018). Elucidating the Metabolic Plasticity of Cancer: Mitochondrial Reprogramming and Hybrid Metabolic States. <em>Cells, 7</em>(3). doi:10.3390/cells7030021</p>\n\n<p style=\"margin-left:36.0pt\">Kaufhold, S., &amp; Bonavida, B. (2014). Central role of Snail1 in the regulation of EMT and resistance in cancer: a target for therapeutic intervention. <em>J Exp Clin Cancer Res, 33</em>, 62. doi:10.1186/s13046-014-0062-0</p>\n\n<p style=\"margin-left:36.0pt\">Kim, K. K., Kugler, M. C., Wolters, P. J., Robillard, L., Galvez, M. G., Brumwell, A. N., . . . Chapman, H. A. (2006). Alveolar epithelial cell mesenchymal transition develops &amp;lt;em&amp;gt;in vivo&amp;lt;/em&amp;gt; during pulmonary fibrosis and is regulated by the extracellular matrix. <em>Proceedings of the National Academy of Sciences, 103</em>(35), 13180. doi:10.1073/pnas.0605669103</p>\n\n<p style=\"margin-left:36.0pt\">Kwon, Y. J., Baek, H. S., Ye, D. J., Shin, S., Kim, D., &amp; Chun, Y. J. (2016). CYP1B1 Enhances Cell Proliferation and Metastasis through Induction of EMT and Activation of Wnt/beta-Catenin Signaling via Sp1 Upregulation. <em>PLoS One, 11</em>(3), e0151598. doi:10.1371/journal.pone.0151598</p>\n\n<p style=\"margin-left:36.0pt\">Mani, S. A., Guo, W., Liao, M. J., Eaton, E. N., Ayyanan, A., Zhou, A. Y., . . . Weinberg, R. A. (2008). The epithelial-mesenchymal transition generates cells with properties of stem cells. <em>Cell, 133</em>(4), 704-715. doi:10.1016/j.cell.2008.03.027</p>\n\n<p style=\"margin-left:36.0pt\">Mishra, P., Tang, W., Putluri, V., Dorsey, T. H., Jin, F., Wang, F., . . . Ambs, S. (2018). ADHFE1 is a breast cancer oncogene and induces metabolic reprogramming. <em>J Clin Invest, 128</em>(1), 323-340. doi:10.1172/JCI93815</p>\n\n<p style=\"margin-left:36.0pt\">Sciacovelli, M., &amp; Frezza, C. (2017). Metabolic reprogramming and epithelial-to-mesenchymal transition in cancer. <em>FEBS J, 284</em>(19), 3132-3144. doi:10.1111/febs.14090</p>\n\n<p style=\"margin-left:36.0pt\">Suarez-Carmona, M., Lesage, J., Cataldo, D., &amp; Gilles, C. (2017). EMT and inflammation: inseparable actors of cancer progression. <em>Mol Oncol, 11</em>(7), 805-823. doi:10.1002/1878-0261.12095</p>\n\n<p style=\"margin-left:36.0pt\">Sun, J., Yang, X., Zhang, R., Liu, S., Gan, X., Xi, X., . . . Sun, Y. (2017). GOLPH3 induces epithelial-mesenchymal transition via Wnt/beta-catenin signaling pathway in epithelial ovarian cancer. <em>Cancer Med, 6</em>(4), 834-844. doi:10.1002/cam4.1040</p>\n\n<p style=\"margin-left:36.0pt\">Tanabe, S. (2017). Molecular markers and networks for cancer and stem cells. <em>J Embryol Stem Cell Res, 1</em>(1).</p>\n\n<p style=\"margin-left:36.0pt\">Tanabe, S., Kawabata, T., Aoyagi, K., Yokozaki, H., &amp; Sasaki, H. (2016). Gene expression and pathway analysis of CTNNB1 in cancer and stem cells. <em>World J Stem Cells, 8</em>(11), 384-395. doi:10.4252/wjsc.v8.i11.384</p>\n\n<p style=\"margin-left:36.0pt\">Tanabe, S., Komatsu, M., Kazuhiko, A., Yokozaki, H., &amp; Sasaki, H. (2015). Implications of epithelial-mesenchymal transition in gastric cancer. <em>Translational Gastrointestinal Cancer, 4</em>(4), 258-264. Retrieved from <a href=\"http://tgc.amegroups.com/article/view/6996\">http://tgc.amegroups.com/article/view/6996</a></p>\n\n<p style=\"margin-left:36.0pt\">Wang, B., Tang, Z., Gong, H., Zhu, L., &amp; Liu, X. (2017). Wnt5a promotes epithelial-to-mesenchymal transition and metastasis in non-small-cell lung cancer. <em>Biosci Rep, 37</em>(6). doi:10.1042/BSR20171092</p>\n\n<p style=\"margin-left:36.0pt\">Wendt, M. K., Smith, J. A., &amp; Schiemann, W. P. (2010). Transforming growth factor-beta-induced epithelial-mesenchymal transition facilitates epidermal growth factor-dependent breast cancer progression. <em>Oncogene, 29</em>(49), 6485-6498. doi:10.1038/onc.2010.377</p>\n\n<p style=\"margin-left:36.0pt\">Zhang, P., Sun, Y., &amp; Ma, L. (2015). ZEB1: at the crossroads of epithelial-mesenchymal transition, metastasis and therapy resistance. <em>Cell Cycle, 14</em>(4), 481-487. doi:10.1080/15384101.2015.1006048</p>\n\n<p style=\"margin-left:36.0pt\"><span style=\"font-family:Arial,Helvetica,sans-serif\"><span style=\"font-size:12pt\">Zhou, Y., Huang, Y., Cao, X., Xu, J., Zhang, L., Wang, J., . . . Zheng, M. (2016). WNT2 Promotes Cervical Carcinoma Metastasis and Induction of Epithelial-Mesenchymal Transition. <em>PLoS One, 11</em>(8), e0160414. doi:10.1371/journal.pone.0160414</span></span></p>\n","biologicalOrganisationLevel":"Cellular","organTerm":{"name":"organ","sourceId":"UBERON:0000062"},"biologicalEvents":[{"action":"occurrence","process":"epithelial to mesenchymal transition","object":{"name":"cellular_component","source":"GO","sourceId":"GO:0005575"}}],"keyEventStressors":["D-2-hydroxyglutarate","GOLPH3","LiCl"],"id":1650}
{"title":"Treatment-resistant gastric cancer","references":"<p style=\"margin-left:36.0pt\"><!--[if supportFields]><span\nlang=EN-US><span style='mso-element:field-begin'></span><span\nstyle='mso-spacerun:yes'></span>ADDIN EN.REFLIST <span style='mso-element:\nfield-separator'></span></span><![endif]-->Du, B., &amp; Shim, J. S. (2016). Targeting Epithelial-Mesenchymal Transition (EMT) to Overcome Drug Resistance in Cancer. <em>Molecules, 21</em>(7). doi:10.3390/molecules21070965</p>\n\n<p style=\"margin-left:36.0pt\">Smith, B. N., &amp; Bhowmick, N. A. (2016). Role of EMT in Metastasis and Therapy Resistance. <em>J Clin Med, 5</em>(2). doi:10.3390/jcm5020017</p>\n\n<p style=\"margin-left:36.0pt\">Tanabe, S., Aoyagi, K., Yokozaki, H., &amp; Sasaki, H. (2014). Gene expression signatures for identifying diffuse-type gastric cancer associated with epithelial-mesenchymal transition. <em>International journal of oncology, 44</em>(6), 1955-1970. doi:10.3892/ijo.2014.2387</p>\n\n<p style=\"margin-left:36.0pt\">Tanabe S, Quader S, Cabral H, Ono R. Interplay of EMT and CSC in Cancer and the Potential Therapeutic Strategies. <em>Front Pharmacol,</em>&nbsp;2020;11:904.</p>\n\n<p style=\"margin-left:36.0pt\">Tanabe S, Quader S, Ono R, Cabral H, Aoyagi K, Hirose A, et al. Molecular Network Profiling in Intestinal- and Diffuse-Type Gastric Cancer. <em>Cancers (Basel),</em>&nbsp;2020;12(12).</p>\n\n<p style=\"margin-left:36.0pt\">Zeisberg, M., &amp; Neilson, E. G. (2009). Biomarkers for epithelial-mesenchymal transitions. <em>J Clin Invest, 119</em>(6), 1429-1437. doi:10.1172/JCI36183</p>\n\n<p><!--[if supportFields]><span lang=EN-US style='font-size:12.0pt;font-family:\n\" \",sans-serif;mso-bidi-font-family:\" \";mso-font-kerning:0pt;\nmso-ansi-language:EN-US;mso-fareast-language:JA;mso-bidi-language:AR-SA'><span\nstyle='mso-element:field-end'></span></span><![endif]--></p>\n","biologicalOrganisationLevel":"Tissue","organTerm":{"name":"organ","sourceId":"UBERON:0000062"},"biologicalEvents":[{"action":"occurrence","process":"regulation of cellular response to drug","object":{}}],"id":1651}
{"title":"Chronic reactive oxygen species","references":"<p style=\"margin-left:36.0pt\"><span style=\"font-size:16px\"><span style=\"font-family:Arial,Helvetica,sans-serif\">Akai K, Tsuchiya K, Tokumura A, Kogure K, Ueno S, Shibata A, Tamaki T, Fukuzawa K.&nbsp;Free Radic Res. 2004 Sep;38(9):951-62. doi: 10.1080/1071576042000261945</span></span></p>\n\n<p style=\"margin-left:36.0pt\"><span style=\"font-size:16px\"><span style=\"font-family:Arial,Helvetica,sans-serif\">Ashoka, A. H., Ali, F., Tiwari, R., Kumari, R., Pramanik, S. K., &amp; Das, A. (2020). Recent Advances in Fluorescent Probes for Detection of HOCl and HNO. <em>ACS omega, 5</em>(4), 1730-1742. doi:10.1021/acsomega.9b03420</span></span></p>\n\n<p style=\"margin-left:36.0pt\"><span style=\"font-size:16px\"><span style=\"font-family:Arial,Helvetica,sans-serif\">Gu, H., Huang, T., Shen, Y., Liu, Y., Zhou, F., Jin, Y., . . . Wei, Y. (2018). Reactive Oxygen Species-Mediated Tumor Microenvironment Transformation: The Mechanism of Radioresistant Gastric Cancer. <em>Oxidative medicine and cellular longevity, 2018</em>, 5801209-5801209. doi:10.1155/2018/5801209</span></span></p>\n\n<p style=\"margin-left:36.0pt\"><span style=\"font-size:16px\"><span style=\"font-family:Arial,Helvetica,sans-serif\">Kruk J, Aboul-Enein H. Y.&nbsp;(2017). Reactive Oxygen and Nitrogen Species in Carcinogenesis: Implications of Oxidative Stress on the Progression and Development of Several Cancer TypesJournal Name: Mini-Reviews in Medicinal Chemistry, 17:11. doi:10.2174/1389557517666170228115324)</span></span></p>\n\n<p style=\"margin-left:36.0pt\"><span style=\"font-size:16px\"><span style=\"font-family:Arial,Helvetica,sans-serif\">Lee, D. Y., Kang, S., Lee, Y., Kim, J. Y., Yoo, D., Jung, W., . . . Jon, S. (2020). PEGylated Bilirubin-coated Iron Oxide Nanoparticles as a Biosensor for Magnetic Relaxation Switching-based ROS Detection in Whole Blood. <em>Theranostics, 10</em>(5), 1997-2007. doi:10.7150/thno.39662</span></span></p>\n\n<p style=\"margin-left:36.0pt\"><span style=\"font-size:16px\"><span style=\"font-family:Arial,Helvetica,sans-serif\">Liou GY, Storz P. Reactive oxygen species in cancer. Free Radic Res. 2010 May;44(5):479-96. doi:10.3109/10715761003667554. PMID: 20370557; PMCID: PMC3880197.</span></span></p>\n\n<p style=\"margin-left:36.0pt\"><span style=\"font-size:16px\"><span style=\"font-family:Arial,Helvetica,sans-serif\">Tsuchiya K, Akai K, Tokumura A, Abe S, Tamaki T, Takiguchi Y, Fukuzawa K.&nbsp;Biochim Biophys Acta. 2005 Aug 30;1725(1):111-9. doi:10.1016/j.bbagen.2005.05.001</span></span></p>\n\n<p style=\"margin-left:36.0pt\"><span style=\"font-size:16px\"><span style=\"font-family:Arial,Helvetica,sans-serif\">Zhang, Z., Wang, X., Cheng, S., Sun, L., Son, Y.-O., Yao, H., . . . Shi, X. (2011). Reactive oxygen species mediate arsenic induced cell transformation and tumorigenesis through Wnt/&beta;-catenin pathway in human colorectal adenocarcinoma DLD1 cells.&nbsp;<em>Toxicology and Applied Pharmacology, 256</em>(2), 114-121. doi:<a href=\"https://doi.org/10.1016/j.taap.2011.07.016\">10.1016/j.taap.2011.07.016</a></span></span></p>\n\n<p>&nbsp;</p>\n","biologicalOrganisationLevel":"Molecular","organTerm":{"name":"organ","sourceId":"UBERON:0000062"},"biologicalEvents":[{"action":"increased","process":"response to reactive oxygen species","object":{"name":"reactive oxygen species","source":"CHEBI","sourceId":"CHEBI:26523"}}],"keyEventStressors":["ferric nitrilotriacetate","Arsenic","Ionizing Radiation"],"id":1753}
{"title":"Sustained tissue damage / macrophage activation / porcupine-induced Wnt secretion","references":"<p style=\"margin-left:36.0pt\"><span style=\"font-size:12px\"><span style=\"font-family:arial,helvetica,sans-serif\">Banziger, C., Soldini, D., Schutt, C., Zipperlen, P., Hausmann, G., &amp; Basler, K. (2006). Wntless, a conserved membrane protein dedicated to the secretion of Wnt proteins from signaling cells. <em>Cell, 125</em>(3), 509-522. doi:10.1016/j.cell.2006.02.049</span></span></p>\n\n<p style=\"margin-left:36.0pt\"><span style=\"font-size:12px\"><span style=\"font-family:arial,helvetica,sans-serif\">Bhanot, P., Brink, M., Samos, C. H., Hsieh, J.-C., Wang, Y., Macke, J. P., . . . Nusse, R. (1996). A new member of the frizzled family from Drosophila functions as a Wingless receptor. <em>Nature, 382</em>, 225. doi:10.1038/382225a0</span></span></p>\n\n<p style=\"margin-left:36.0pt\"><span style=\"font-size:12px\"><span style=\"font-family:arial,helvetica,sans-serif\">Ching, W., &amp; Nusse, R. (2006). A dedicated Wnt secretion factor. <em>Cell, 125</em>(3), 432-433. doi:10.1016/j.cell.2006.04.018</span></span></p>\n\n<p style=\"margin-left:36.0pt\"><span style=\"font-size:12px\"><span style=\"font-family:arial,helvetica,sans-serif\">Clevers, H. (2006). Wnt/beta-catenin signaling in development and disease. <em>Cell, 127</em>(3), 469-480. doi:10.1016/j.cell.2006.10.018</span></span></p>\n\n<p style=\"margin-left:36.0pt\"><span style=\"font-size:12px\"><span style=\"font-family:arial,helvetica,sans-serif\">Clevers, H., &amp; Nusse, R. (2012). Wnt/beta-catenin signaling and disease. <em>Cell, 149</em>(6), 1192-1205. doi:10.1016/j.cell.2012.05.012</span></span></p>\n\n<p style=\"margin-left:36.0pt\"><span style=\"font-size:12px\"><span style=\"font-family:arial,helvetica,sans-serif\">De, A. (2011). Wnt/Ca2+ signaling pathway: a brief overview. <em>Acta Biochim Biophys Sin (Shanghai), 43</em>(10), 745-756. doi:10.1093/abbs/gmr079</span></span></p>\n\n<p style=\"margin-left:36.0pt\"><span style=\"font-size:12px\"><span style=\"font-family:arial,helvetica,sans-serif\">Du, J., Zu, Y., Li, J., Du, S., Xu, Y., Zhang, L., . . . Yang, C. (2016). Extracellular matrix stiffness dictates Wnt expression through integrin pathway. <em>Sci Rep, 6</em>, 20395. doi:10.1038/srep20395</span></span></p>\n\n<p style=\"margin-left:36.0pt\"><span style=\"font-size:12px\"><span style=\"font-family:arial,helvetica,sans-serif\">Foulquier, S., Daskalopoulos, E. P., Lluri, G., Hermans, K. C. M., Deb, A., &amp; Blankesteijn, W. M. (2018). WNT Signaling in Cardiac and Vascular Disease. <em>Pharmacol Rev, 70</em>(1), 68-141. doi:10.1124/pr.117.013896</span></span></p>\n\n<p style=\"margin-left:36.0pt\"><span style=\"font-size:12px\"><span style=\"font-family:arial,helvetica,sans-serif\">Hua, Y., Yang, Y., Li, Q., He, X., Zhu, W., Wang, J., &amp; Gan, X. (2018). Oligomerization of Frizzled and LRP5/6 protein initiates intracellular signaling for the canonical WNT/beta-catenin pathway. <em>J Biol Chem, 293</em>(51), 19710-19724. doi:10.1074/jbc.RA118.004434</span></span></p>\n\n<p style=\"margin-left:36.0pt\"><span style=\"font-size:12px\"><span style=\"font-family:arial,helvetica,sans-serif\">Jiang, X., Charlat, O., Zamponi, R., Yang, Y., &amp; Cong, F. (2015). Dishevelled promotes Wnt receptor degradation through recruitment of ZNRF3/RNF43 E3 ubiquitin ligases. <em>Mol Cell, 58</em>(3), 522-533. doi:10.1016/j.molcel.2015.03.015</span></span></p>\n\n<p style=\"margin-left:36.0pt\"><span style=\"font-size:12px\"><span style=\"font-family:arial,helvetica,sans-serif\">Katoh, M. (2001). Molecular cloning and characterization of human WNT3. <em>International journal of oncology, 19</em>(5), 977-982. Retrieved from <a href=\"https://www.ncbi.nlm.nih.gov/pubmed/11604997\">https://www.ncbi.nlm.nih.gov/pubmed/11604997</a></span></span></p>\n\n<p style=\"margin-left:36.0pt\"><span style=\"font-size:12px\"><span style=\"font-family:arial,helvetica,sans-serif\">Kusserow, A., Pang, K., Sturm, C., Hrouda, M., Lentfer, J., Schmidt, H. A., . . . Holstein, T. W. (2005). Unexpected complexity of the Wnt gene family in a sea anemone. <em>Nature, 433</em>(7022), 156-160. doi:10.1038/nature03158</span></span></p>\n\n<p style=\"margin-left:36.0pt\"><span style=\"font-size:12px\"><span style=\"font-family:arial,helvetica,sans-serif\">Lai, S. L., Chien, A. J., &amp; Moon, R. T. (2009). Wnt/Fz signaling and the cytoskeleton: potential roles in tumorigenesis. <em>Cell Res, 19</em>(5), 532-545. doi:10.1038/cr.2009.41</span></span></p>\n\n<p style=\"margin-left:36.0pt\"><span style=\"font-size:12px\"><span style=\"font-family:arial,helvetica,sans-serif\">MacDonald, B. T., Tamai, K., &amp; He, X. (2009). Wnt/beta-catenin signaling: components, mechanisms, and diseases. <em>Dev Cell, 17</em>(1), 9-26. doi:10.1016/j.devcel.2009.06.016</span></span></p>\n\n<p style=\"margin-left:36.0pt\"><span style=\"font-size:12px\"><span style=\"font-family:arial,helvetica,sans-serif\">Mohammed, M. K., Shao, C., Wang, J., Wei, Q., Wang, X., Collier, Z., . . . Lee, M. J. (2016). Wnt/beta-catenin signaling plays an ever-expanding role in stem cell self-renewal, tumorigenesis and cancer chemoresistance. <em>Genes Dis, 3</em>(1), 11-40. doi:10.1016/j.gendis.2015.12.004</span></span></p>\n\n<p style=\"margin-left:36.0pt\"><span style=\"font-size:12px\"><span style=\"font-family:arial,helvetica,sans-serif\">Nile, A. H., Mukund, S., Stanger, K., Wang, W., &amp; Hannoush, R. N. (2017). Unsaturated fatty acyl recognition by Frizzled receptors mediates dimerization upon Wnt ligand binding. <em>Proc Natl Acad Sci U S A, 114</em>(16), 4147-4152. doi:10.1073/pnas.1618293114</span></span></p>\n\n<p style=\"margin-left:36.0pt\"><span style=\"font-size:12px\"><span style=\"font-family:arial,helvetica,sans-serif\">Saha, S., Aranda, E., Hayakawa, Y., Bhanja, P., Atay, S., Brodin, N. P., . . . Pollard, J. W. (2016). Macrophage-derived extracellular vesicle-packaged WNTs rescue intestinal stem cells and enhance survival after radiation injury. <em>Nature Communications, 7</em>(1), 13096. doi:10.1038/ncomms13096</span></span></p>\n\n<p style=\"margin-left:36.0pt\"><span style=\"font-size:12px\"><span style=\"font-family:arial,helvetica,sans-serif\">Saito-Diaz, K., Chen, T. W., Wang, X., Thorne, C. A., Wallace, H. A., Page-McCaw, A., &amp; Lee, E. (2013). The way Wnt works: components and mechanism. <em>Growth Factors, 31</em>(1), 1-31. doi:10.3109/08977194.2012.752737</span></span></p>\n\n<p style=\"margin-left:36.0pt\"><span style=\"font-size:12px\"><span style=\"font-family:arial,helvetica,sans-serif\">Wang, B., Tang, Z., Gong, H., Zhu, L., &amp; Liu, X. (2017). Wnt5a promotes epithelial-to-mesenchymal transition and metastasis in non-small-cell lung cancer. <em>Biosci Rep, 37</em>(6). doi:10.1042/BSR20171092</span></span></p>\n\n<p style=\"margin-left:36.0pt\"><span style=\"font-size:12px\"><span style=\"font-family:arial,helvetica,sans-serif\">Willert, K., &amp; Nusse, R. (2012). Wnt proteins. <em>Cold Spring Harb Perspect Biol, 4</em>(9), a007864. doi:10.1101/cshperspect.a007864</span></span></p>\n\n<p style=\"margin-left:36.0pt\"><span style=\"font-size:12px\"><span style=\"font-family:arial,helvetica,sans-serif\">Zeng, H., Lu, B., Zamponi, R., Yang, Z., Wetzel, K., Loureiro, J., . . . Cong, F. (2018). mTORC1 signaling suppresses Wnt/beta-catenin signaling through DVL-dependent regulation of Wnt receptor FZD level. <em>Proc Natl Acad Sci U S A, 115</em>(44), E10362-E10369. doi:10.1073/pnas.1808575115</span></span></p>\n\n<p style=\"margin-left:36.0pt\"><span style=\"font-size:12px\"><span style=\"font-family:arial,helvetica,sans-serif\">Zhou, Y., Huang, Y., Cao, X., Xu, J., Zhang, L., Wang, J., . . . Zheng, M. (2016). WNT2 Promotes Cervical Carcinoma Metastasis and Induction of Epithelial-Mesenchymal Transition. <em>PLoS One, 11</em>(8), e0160414. doi:10.1371/journal.pone.0160414</span></span></p>\n\n<p style=\"margin-left:36.0pt\"><span style=\"font-size:12px\"><span style=\"font-family:arial,helvetica,sans-serif\">Ziv, E., Yarmohammadi, H., Boas, F. E., Petre, E. N., Brown, K. T., Solomon, S. B., . . . Erinjeri, J. P. (2017). Gene Signature Associated with Upregulation of the Wnt/beta-Catenin Signaling Pathway Predicts Tumor Response to Transarterial Embolization. <em>J Vasc Interv Radiol, 28</em>(3), 349-355 e341. doi:10.1016/j.jvir.2016.11.004</span></span></p>\n","biologicalOrganisationLevel":"Tissue","organTerm":{"name":"organ","sourceId":"UBERON:0000062"},"biologicalEvents":[{"action":"increased","process":"Wnt protein secretion","object":{"name":"protein-serine O-palmitoleoyltransferase porcupine","source":"PR","sourceId":"PR:000030936"}}],"keyEventStressors":["Radiation"],"id":1754}
{"title":"Proliferation / beta-catenin activation","references":"<p style=\"margin-left:36.0pt\"><span style=\"font-size:14px\"><span style=\"font-family:arial,helvetica,sans-serif\"><span style=\"background-color:#ffffff; color:#333333\">Clevers, H., &amp; Nusse, R. (2012). Wnt/beta-catenin signaling and disease. </span><em>Cell, 149</em><span style=\"background-color:#ffffff; color:#333333\">(6), 1192-1205. doi:10.1016/j.cell.2012.05.012</span></span></span></p>\n\n<p style=\"margin-left:36.0pt\"><span style=\"font-size:14px\"><span style=\"font-family:arial,helvetica,sans-serif\"><span style=\"background-color:#ffffff; color:#333333\">Huang, J. Q., Wei, F. K., Xu, X. L., Ye, S. X., Song, J. W., Ding, P. K., . . . Gong, L. Y. (2019). SOX9 drives the epithelial-mesenchymal transition in non-small-cell lung cancer through the Wnt/beta-catenin pathway. </span><em>J Transl Med, 17</em><span style=\"background-color:#ffffff; color:#333333\">(1), 143. doi:10.1186/s12967-019-1895-2</span></span></span></p>\n\n<p style=\"margin-left:36.0pt\"><span style=\"font-size:14px\"><span style=\"font-family:arial,helvetica,sans-serif\"><span style=\"background-color:#ffffff; color:#333333\">Jiang, X., Charlat, O., Zamponi, R., Yang, Y., &amp; Cong, F. (2015). Dishevelled promotes Wnt receptor degradation through recruitment of ZNRF3/RNF43 E3 ubiquitin ligases. </span><em>Mol Cell, 58</em><span style=\"background-color:#ffffff; color:#333333\">(3), 522-533. doi:10.1016/j.molcel.2015.03.015</span></span></span></p>\n\n<p style=\"margin-left:36.0pt\"><span style=\"font-size:14px\"><span style=\"font-family:arial,helvetica,sans-serif\">Naujok, O., Lentes, J., Diekmann, U., Davenport, C., &amp; Lenzen, S. (2014). Cytotoxicity and activation of the Wnt/beta-catenin pathway in mouse embryonic stem cells treated with four GSK3 inhibitors. <em>BMC Res Notes, 7</em>, 273. doi:10.1186/1756-0500-7-273</span></span></p>\n\n<p style=\"margin-left:36.0pt\"><span style=\"font-size:14px\"><span style=\"font-family:arial,helvetica,sans-serif\">Tanabe, S. (2014). Role of mesenchymal stem cells in cell life and their signaling. <em>World journal of stem cells, 6</em>(1), 24-32. doi:10.4252/wjsc.v6.i1.24</span></span></p>\n\n<p style=\"margin-left:36.0pt\"><span style=\"font-size:14px\"><span style=\"font-family:arial,helvetica,sans-serif\"><span style=\"background-color:#ffffff; color:#333333\">Zeng, H., Lu, B., Zamponi, R., Yang, Z., Wetzel, K., Loureiro, J., . . . Cong, F. (2018). mTORC1 signaling suppresses Wnt/beta-catenin signaling through DVL-dependent regulation of Wnt receptor FZD level. </span><em>Proc Natl Acad Sci U S A, 115</em><span style=\"background-color:#ffffff; color:#333333\">(44), E10362-E10369. doi:10.1073/pnas.1808575115</span></span></span></p>\n","biologicalOrganisationLevel":"Cellular","organTerm":{"name":"organ","sourceId":"UBERON:0000062"},"biologicalEvents":[{"action":"occurrence","process":"regulation of beta-catenin-TCF complex assembly","object":{"name":"beta-catenin-TCF complex","source":"GO","sourceId":"GO:1990907"}}],"id":1755}
{"title":"Decrease, Fatty acid -oxidation","references":"","biologicalOrganisationLevel":"Cellular","organTerm":{},"biologicalEvents":[{"object":{}}],"id":1824}
{"title":"Antagonism, Thyroid Receptor ","references":"","biologicalOrganisationLevel":"Molecular","organTerm":{},"biologicalEvents":[{"object":{}}],"id":1656}
{"title":"Inhibition of cystathionine beta-synthase","references":"","biologicalOrganisationLevel":"Molecular","organTerm":{},"biologicalEvents":[{"object":{}}],"id":1657}
{"title":"Increased Homocysteine level ","references":"","biologicalOrganisationLevel":"Cellular","organTerm":{},"biologicalEvents":[{"object":{}}],"id":1661}
{"title":"Increased, Plasma HCY level","references":"","biologicalOrganisationLevel":"Tissue","organTerm":{},"biologicalEvents":[{"object":{}}],"id":1665}
{"title":"Induced, dysfunction of microcirculation","references":"","biologicalOrganisationLevel":"Organ","organTerm":{},"biologicalEvents":[{"object":{}}],"id":1666}
{"title":"Impaired,anterior-posterior axis development","references":"","biologicalOrganisationLevel":"Individual","organTerm":{},"biologicalEvents":[{"object":{}}],"id":1667}
{"title":"Reduced tidal volume ","references":"","biologicalOrganisationLevel":"Organ","organTerm":{},"biologicalEvents":[{"object":{}}],"id":1677}
{"title":"Inhibition of lung surfactant function","references":"","biologicalOrganisationLevel":"Molecular","organTerm":{},"biologicalEvents":[{"object":{}}],"id":1672}
{"title":"Alveolar collapse","references":"","biologicalOrganisationLevel":"Cellular","organTerm":{},"biologicalEvents":[{"object":{}}],"id":1673}
{"title":"Frustrated phagoytosis","references":"<p style=\"margin-left:36.0pt; margin-right:0cm; text-align:justify\"><span style=\"font-family:times new roman,serif; font-size:12.0pt\">1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Montano F, Grinstein S, Levin R. Quantitative Phagocytosis Assays in Primary and Cultured Macrophages. 2018;1784:151-63; doi: 10.1007/978-1-4939-7837-3_15.</span></p>\n\n<p style=\"margin-left:36.0pt; margin-right:0cm; text-align:justify\"><span style=\"font-family:times new roman,serif; font-size:12.0pt\">2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; safenano.org.</span></p>\n\n<p style=\"margin-left:36.0pt; margin-right:0cm; text-align:justify\"><span style=\"font-family:times new roman,serif; font-size:12.0pt\">3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Oberdorster G, Oberdorster E, Oberdorster J. Concepts of nanoparticle dose metric and response metric. 2007;115 6:A290; doi: 10.1289/ehp.115-1892118.</span></p>\n\n<p style=\"margin-left:36.0pt; margin-right:0cm; text-align:justify\"><span style=\"font-family:times new roman,serif; font-size:12.0pt\">4.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Donaldson K, Poland CA. Inhaled nanoparticles and lung cancer - what we can learn from conventional particle toxicology. 2012;142:w13547; doi: 10.4414/smw.2012.13547.</span></p>\n\n<p style=\"margin-left:36.0pt; margin-right:0cm; text-align:justify\"><span style=\"font-family:times new roman,serif; font-size:12.0pt\">5.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Sargent LM, Shvedova AA, Hubbs AF, Salisbury JL, Benkovic SA, Kashon ML, et al. Induction of aneuploidy by single-walled carbon nanotubes. 2009;50 8:708-17; doi: 10.1002/em.20529.</span></p>\n\n<p style=\"margin-left:36.0pt; margin-right:0cm; text-align:justify\"><span style=\"font-family:times new roman,serif; font-size:12.0pt\">6.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Sweeney S, Grandolfo D, Ruenraroengsak P, Tetley TD. Functional consequences for primary human alveolar macrophages following treatment with long, but not short, multiwalled carbon nanotubes. International journal of nanomedicine.<em> </em>2015;10:3115-29; doi: 10.2147/IJN.S77867.</span></p>\n\n<p style=\"margin-left:36.0pt; margin-right:0cm; text-align:justify\"><span style=\"font-family:times new roman,serif; font-size:12.0pt\">7.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Padmore T, Stark C, Turkevich LA, Champion JA. Quantitative analysis of the role of fiber length on phagocytosis and inflammatory response by alveolar macrophages. Biochimica et biophysica acta.<em> </em>2017;1861 2:58-67; doi: 10.1016/j.bbagen.2016.09.031.</span></p>\n\n<p style=\"margin-left:36.0pt; margin-right:0cm; text-align:justify\"><span style=\"font-family:times new roman,serif; font-size:12.0pt\">8.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Schinwald A, Donaldson K. Use of back-scatter electron signals to visualise cell/nanowires interactions in vitro and in vivo; frustrated phagocytosis of long fibres in macrophages and compartmentalisation in mesothelial cells in vivo. Particle and fibre toxicology.<em> </em>2012;9:34; doi: 10.1186/1743-8977-9-34.</span></p>\n\n<p style=\"margin-left:36.0pt; margin-right:0cm; text-align:justify\"><span style=\"font-family:times new roman,serif; font-size:12.0pt\">9.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Murphy FA, Schinwald A, Poland CA, Donaldson K. The mechanism of pleural inflammation by long carbon nanotubes: interaction of long fibres with macrophages stimulates them to amplify pro-inflammatory responses in mesothelial cells. Particle and fibre toxicology.<em> </em>2012;9:8; doi: 10.1186/1743-8977-9-8.</span></p>\n\n<p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <span style=\"font-family:times new roman,serif; font-size:12.0pt\">10.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Donaldson K, Murphy FA, Duffin R, Poland CA. Asbestos, carbon nanotubes and the pleural mesothelium: </span><span style=\"font-family:times new roman,serif; font-size:12.0pt\">&nbsp;&nbsp;&nbsp;&nbsp; &nbsp; &nbsp;&nbsp;&nbsp; a review of the hypothesis regarding the role of long fibre retention in the parietal pleura, inflammation and &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp; &nbsp;&nbsp; mesothelioma. 2010;7:5; doi: 10.1186/1743-8977-7-5.</span></p>\n","biologicalOrganisationLevel":"Cellular","organTerm":{},"biologicalEvents":[{"action":"decreased","process":"phagocytosis","object":{"name":"macrophage","source":"CL","sourceId":"CL:0000235"}}],"keyEventStressors":["High aspect ratio material"],"id":1668}
{"title":"Increased, DNA damage and mutation","references":"<p style=\"margin-left:36.0pt; margin-right:0cm; text-align:justify\"><span style=\"font-family:times new roman,serif; font-size:12.0pt\">1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Zhang Y. Cell toxicity mechanism and biomarker. 2018;7 1:34; doi: 10.1186/s40169-018-0212-7.</span></p>\n\n<p style=\"margin-left:36.0pt; margin-right:0cm; text-align:justify\"><span style=\"font-family:times new roman,serif; font-size:12.0pt\">2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Kato T, Totsuka Y, Ishino K, Matsumoto Y, Tada Y, Nakae D, et al. Genotoxicity of multi-walled carbon nanotubes in both in vitro and in vivo assay systems. Nanotoxicology.<em> </em>2013;7 4:452-61; doi: 10.3109/17435390.2012.674571.</span></p>\n\n<p style=\"margin-left:36.0pt; margin-right:0cm; text-align:justify\"><span style=\"font-family:times new roman,serif; font-size:12.0pt\">3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Pacurari M, Yin XJ, Zhao J, Ding M, Leonard SS, Schwegler-Berry D, et al. Raw single-wall carbon nanotubes induce oxidative stress and activate MAPKs, AP-1, NF-kappaB, and Akt in normal and malignant human mesothelial cells. 2008;116 9:1211-7; doi: 10.1289/ehp.10924.</span></p>\n\n<p style=\"margin-left:36.0pt; margin-right:0cm; text-align:justify\"><span style=\"font-family:times new roman,serif; font-size:12.0pt\">4.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Hiraku Y, Guo F, Ma N, Yamada T, Wang S, Kawanishi S, et al. Multi-walled carbon nanotube induces nitrative DNA damage in human lung epithelial cells via HMGB1-RAGE interaction and Toll-like receptor 9 activation. Particle and fibre toxicology.<em> </em>2016;13:16; doi: 10.1186/s12989-016-0127-7.</span></p>\n\n<p style=\"margin-left:36.0pt; margin-right:0cm; text-align:justify\"><span style=\"font-family:times new roman,serif; font-size:12.0pt\">5.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Catalan J, Siivola KM, Nymark P, Lindberg H, Suhonen S, Jarventaus H, et al. In vitro and in vivo genotoxic effects of straight versus tangled multi-walled carbon nanotubes. Nanotoxicology.<em> </em>2016;10 6:794-806; doi: 10.3109/17435390.2015.1132345.</span></p>\n\n<p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <span style=\"font-family:times new roman,serif; font-size:12.0pt\">6.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Fukai E, Sato H, Watanabe M, Nakae D, Totsuka Y. Establishment of an in vivo simulating co-culture assay &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; platform for genotoxicity of multi-walled carbon nanotubes. Cancer science.<em> </em>2018; doi: 10.1111/cas.13534.</span></p>\n","biologicalOrganisationLevel":"Cellular","organTerm":{},"biologicalEvents":[{"object":{}}],"keyEventStressors":["Reactive oxygen species"],"id":1669}
{"title":"Lung cancer","references":"","biologicalOrganisationLevel":"Organ","organTerm":{},"biologicalEvents":[{"object":{}}],"keyEventStressors":["High aspect ratio material"],"id":1670}
{"title":"Inhibition, TBX1","references":"","biologicalOrganisationLevel":"Molecular","organTerm":{},"biologicalEvents":[{"object":{}}],"id":1680}
{"title":"Disruption, Neural crest cell migration","references":"","biologicalOrganisationLevel":"Cellular","organTerm":{},"biologicalEvents":[{"object":{}}],"id":1681}
{"title":"Disruption, Progenitor cells of second heart field","references":"","biologicalOrganisationLevel":"Cellular","organTerm":{},"biologicalEvents":[{"object":{}}],"id":1682}
{"title":"Impairment, Fourth pharyngeal arch development","references":"","biologicalOrganisationLevel":"Tissue","organTerm":{},"biologicalEvents":[{"object":{}}],"id":1683}
{"title":"Abnormalities, Cardiac outflow tract formation","references":"","biologicalOrganisationLevel":"Organ","organTerm":{},"biologicalEvents":[{"object":{}}],"id":1684}
{"title":"Anomalies, Congenital cardiac conotruncal","references":"","biologicalOrganisationLevel":"Individual","organTerm":{},"biologicalEvents":[{"object":{}}],"id":1685}
{"title":"decrease, male anogenital distance","references":"<p><a name=\"_ENREF_1\">Aydoan Ahbab M, Barlas N (2015) Influence of in utero di-n-hexyl phthalate and dicyclohexyl phthalate on fetal testicular development in rats. <em>Toxicol Lett</em> <strong>233:</strong> 125-137</a></p>\n\n<p><a name=\"_ENREF_2\">Boberg J, Axelstad M, Svingen T, Mandrup K, Christiansen S, Vinggaard AM, Hass U (2016) Multiple endocrine disrupting effects in rats perinatally exposed to butylparaben. <em>Toxicol Sci</em> <strong>152:</strong> 244-256</a></p>\n\n<p><a name=\"_ENREF_3\">Boberg J, Metzdorff S, Wortziger R, Axelstad M, Brokken L, Vinggaard AM, Dalgaard M, Nellemann C (2008) Impact of diisobutyl phthalate and other PPAR agonists on steroidogenesis and plasma insulin and leptin levels in fetal rats. <em>Toxicology</em> <strong>250:</strong> 75-81</a></p>\n\n<p><a name=\"_ENREF_4\">Bowman CJ, Barlow NJ, Turner KJ, Wallace DG, Foster PM (2003) Effects of in utero exposure to finasteride on androgen-dependent reproductive development in the male rat. <em>Toxicol Sci</em> <strong>74:</strong> 393-406</a></p>\n\n<p><a name=\"_ENREF_5\">Christiansen S, Boberg J, Axelstad M, Dalgaard M, Vinggaard AM, Metzdorff SB, Hass U (2010) Low-dose perinatal exposure to di(2-ethylhexyl) phthalate induces anti-androgenic effects in male rats. <em>Reprod Toxicol</em> <strong>30:</strong> 313-321</a></p>\n\n<p><a name=\"_ENREF_6\">Christiansen S, Scholze M, Dalgaard M, Vinggaard AM, Axelstad M, Kortenkamp A, Hass U (2009) Synergistic disruption of external male sex organ development by a mixture of four antiandrogens. <em>Environ Health Perspect</em> <strong>117:</strong> 1839-1846</a></p>\n\n<p><a name=\"_ENREF_7\">Draskau MK, Boberg J, Taxvig C, Pedersen M, Frandsen HL, Christiansen S, Svingen T (2019) In vitro and in vivo endocrine disrupting effects of the azole fungicides triticonazole and flusilazole. <em>Environ Pollut</em> <strong>255:</strong> 113309</a></p>\n\n<p><a name=\"_ENREF_8\">Ema M, Miyawaki E (2002) Effects on development of the reproductive system in male offspring of rats given butyl benzyl phthalate during late pregnancy. <em>Reprod Toxicol</em> <strong>16:</strong> 71-76</a></p>\n\n<p><a name=\"_ENREF_9\">Ema M, Miyawaki E, Hirose A, Kamata E (2003) Decreased anogenital distance and increased incidence of undescended testes in fetuses of rats given monobenzyl phthalate, a major metabolite of butyl benzyl phthalate. <em>Reprod Toxicol</em> <strong>17:</strong> 407-412</a></p>\n\n<p><a name=\"_ENREF_10\">Foster PM, Harris MW (2005) Changes in androgen-mediated reproductive development in male rat offspring following exposure to a single oral dose of flutamide at different gestational ages. <em>Toxicol Sci</em> <strong>85:</strong> 1024-1032</a></p>\n\n<p><a name=\"_ENREF_11\">Gray LE, Jr., Ostby J, Furr J, Price M, Veeramachaneni DN, Parks L (2000) Perinatal exposure to the phthalates DEHP, BBP, and DINP, but not DEP, DMP, or DOTP, alters sexual differentiation of the male rat. <em>Toxicol Sci</em> <strong>58:</strong> 350-365</a></p>\n\n<p><a name=\"_ENREF_12\">Gray LEJ, Ostby JS, Kelce WR (1994) Developmental effects of an environmental antiandrogen: the fungicide vinclozolin alters sex differentiation of the male rat. <em>Toxicol Appl Pharmacol</em> <strong>129:</strong> 46-52</a></p>\n\n<p><a name=\"_ENREF_13\">Hass U, Boberg J, Christiansen S, Jacobsen PR, Vinggaard AM, Taxvig C, Poulsen ME, Herrmann SS, Jensen BH, Petersen A, Clemmensen LH, Axelstad M (2012) Adverse effects on sexual development in rat offspring after low dose exposure to a mixture of endocrine disrupting pesticides. <em>Reprod Toxicol</em> <strong>34:</strong> 261-274</a></p>\n\n<p><a name=\"_ENREF_14\">Hass U, Scholze M, Christiansen S, Dalgaard M, Vinggaard AM, Axelstad M, Metzdorff SB, Kortenkamp A (2007) Combined exposure to anti-androgens exacerbates disruption of sexual differentiation in the rat. <em>Environ Health Perspect</em> <strong>115 Suppl. 1:</strong> 122-128</a></p>\n\n<p><a name=\"_ENREF_15\">Hoshino N, Iwai M, Okazaki Y (2005) A two-generation reproductive toxicity study of dicyclohexyl phthalate in rats. <em>J Toxicol Sci</em> <strong>30 Spec No:</strong> 79-96</a></p>\n\n<p><a name=\"_ENREF_16\">Hotchkiss AK, Parks-Saldutti LG, Ostby JS, Lambright C, Furr J, Vandenbergh JG, Gray LEJ (2004) A mixture of the &quot;antiandrogens&quot; linuron and butyl benzyl phthalate alters sexual differentiation of the male rat in a cumulative fashion. <em>Biol Reprod</em> <strong>71:</strong> 1852-1861</a></p>\n\n<p><a name=\"_ENREF_17\">Howdeshell KL, Furr J, Lambright CR, Rider CV, Wilson VS, Gray LE, Jr. (2007) Cumulative effects of dibutyl phthalate and diethylhexyl phthalate on male rat reproductive tract development: altered fetal steroid hormones and genes. <em>Toxicol Sci</em> <strong>99:</strong> 190-202</a></p>\n\n<p><a name=\"_ENREF_18\">Ipulan LA, Suzuki K, Sakamoto Y, Murashima A, Imai Y, Omori A, Nakagata N, Nishinakamura R, Valasek P, Yamada G (2014) Nonmyocytic androgen receptor regulates the sexually dimorphic development of the embryonic bulbocavernosus muscle. <em>Endocrinology</em> <strong>155:</strong> 2467-2479</a></p>\n\n<p><a name=\"_ENREF_19\">Jarfelt K, Dalgaard M, Hass U, Borch J, Jacobsen H, Ladefoged O (2005) Antiandrogenic effects in male rats perinatally exposed to a mixture of di(2-ethylhexyl) phthalate and di(2-ethylhexyl) adipate. <em>Reprod Toxicol</em> <strong>19:</strong> 505-515</a></p>\n\n<p><a name=\"_ENREF_20\">Jost A (1953) Problems of fetal endocrinology: The gonadal and hypophyseal hormones. <em>Recent Prog Horm Res</em> <strong>8:</strong> 379-418</a></p>\n\n<p><a name=\"_ENREF_21\">Juul A, Almstrup K, Andersson AM, Jensen TK, Jorgensen N, Main KM, Rajpert-De Meyts E, Toppari J, Skakkebaek NE (2014) Possible fetal determinants of male infertility. <em>Nat Rev Endocrinol</em> <strong>10:</strong> 553-562</a></p>\n\n<p><a name=\"_ENREF_22\">Kita DH, Meyer KB, Venturelli AC, Adams R, Machado DL, Morais RN, Swan SH, Gennings C, Martino-Andrade AJ (2016) Manipulation of pre and postnatal androgen environments and anogenital distance in rats. <em>Toxicology</em> <strong>368-369:</strong> 152-161</a></p>\n\n<p><a name=\"_ENREF_23\">Laier P, Metzdorff SB, Borch J, Hagen ML, Hass U, Christiansen S, Axelstad M, Kledal T, Dalgaard M, McKinnell C, Brokken LJ, Vinggaard AM (2006) Mechanisms of action underlying the antiandrogenic effects of the fungicide prochloraz. <em>Toxicol Appl Pharmacol</em> <strong>213:</strong> 2</a></p>\n\n<p><a name=\"_ENREF_24\">Li M, Qiu L, Zhang Y, Hua Y, Tu S, He Y, Wen S, Wang Q, Wei G (2013) Dose-related effect by maternal exposure to di-(2-ethylhexyl) phthalate plasticizer on inducing hypospadiac male rats. <em>Environ Toxicol Pharmacol</em> <strong>35:</strong> 55-60</a></p>\n\n<p><a name=\"_ENREF_25\">Lin H, Lian QQ, Hu GX, Jin Y, Zhang Y, Hardy DO, Chen GR, Lu ZQ, Sottas CM, Hardy MP, Ge RS (2009) In utero and lactational exposures to diethylhexyl-phthalate affect two populations of Leydig cells in male Long-Evans rats. <em>Biol Reprod</em> <strong>80:</strong> 882-888</a></p>\n\n<p><a name=\"_ENREF_26\">Loeffler IK, Peterson RE (1999) Interactive effects of TCDD and p,p&#39;-DDE on male reproductive tract development in in utero and lactationally exposed rats. <em>Toxicol Appl Pharmacol</em> <strong>154:</strong> 28-39</a></p>\n\n<p><a name=\"_ENREF_27\">MacLeod DJ, Sharpe RM, Welsh M, Fisken M, Scott HM, Hutchison GR, Drake AJ, van den Driesche S (2010) Androgen action in the masculinization programming window and development of male reproductive organs. <em>Int J Androl</em> <strong>33:</strong> 279-287</a></p>\n\n<p><a name=\"_ENREF_28\">Matsuura I, Saitoh T, Ashina M, Wako Y, Iwata H, Toyota N, Ishizuka Y, Namiki M, Hoshino N, Tsuchitani M (2005) Evaluation of a two-generation reproduction toxicity study adding endpoints to detect endocrine disrupting activity using vinclozolin. <em>J Toxicol Sci</em> <strong>30 Spec No:</strong> 163-168</a></p>\n\n<p><a name=\"_ENREF_29\">McIntyre BS, Barlow NJ, Foster PM (2001) Androgen-mediated development in male rat offspring exposed to flutamide in utero: permanence and correlation of early postnatal changes in anogenital distance and nipple retention with malformations in androgen-dependent tissues. <em>Toxicol Sci</em> <strong>62:</strong> 236-249</a></p>\n\n<p><a name=\"_ENREF_30\">McIntyre BS, Barlow NJ, Sar M, Wallace DG, Foster PM (2002) Effects of in utero linuron exposure on rat Wolffian duct development. <em>Reprod Toxicol</em> <strong>16:</strong> 131-139</a></p>\n\n<p><a name=\"_ENREF_31\">Melching-Kollmuss S, Fussell KC, Schneider S, Buesen R, Groeters S, Strauss V, van Ravenzwaay B (2017) Comparing effect levels of regulatory studies with endpoints derived in targeted anti-androgenic studies: example prochloraz. <em>Arch Toxicol</em> <strong>91:</strong> 143-162</a></p>\n\n<p><a name=\"_ENREF_32\">Moore RW, Rudy TA, Lin TM, Ko K, Peterson RE (2001) Abnormalities of sexual development in male rats with in utero and lactational exposure to the antiandrogenic plasticizer Di(2-ethylhexyl) phthalate. <em>Environ Health Perspect</em> <strong>109:</strong> 229-237</a></p>\n\n<p><a name=\"_ENREF_33\">Mylchreest E, Sar M, Cattley RC, Foster PM (1999) Disruption of androgen-regulated male reproductive development by di(n-butyl) phthalate during late gestation in rats is different from flutamide. <em>Toxicol Appl Pharmacol</em> <strong>156:</strong> 81-95</a></p>\n\n<p><a name=\"_ENREF_34\">Nagao T, Ohta R, Marumo H, Shindo T, Yoshimura S, Ono H (2000) Effect of butyl benzyl phthalate in Sprague-Dawley rats after gavage administration: a two-generation reproductive study. <em>Reprod Toxicol</em> <strong>14:</strong> 513-532</a></p>\n\n<p><a name=\"_ENREF_35\">Nardelli TC, Albert O, Lalancette C, Culty M, Hales BF, Robaire B (2017) In utero and lactational exposure study in rats to identify replacements for di(2-ethylhexyl) phthalate. <em>Sci Rep</em> <strong>7:</strong> 3862</a></p>\n\n<p><a name=\"_ENREF_36\">Noriega NC, Ostby J, Lambright C, Wilson VS, Gray LE, Jr. (2005) Late gestational exposure to the fungicide prochloraz delays the onset of parturition and causes reproductive malformations in male but not female rat offspring. <em>Biol Reprod</em> <strong>72:</strong> 1324-1335</a></p>\n\n<p><a name=\"_ENREF_37\">OECD. (2013) Guidance document in support of the test guideline on the extended one generation reproductive toxicity study No. 151.</a></p>\n\n<p><a name=\"_ENREF_38\">Ostby J, Kelce WR, Lambright C, Wolf CJ, Mann P, Gray CLJ (1999) The fungicide procymidone alters sexual differentiation in the male rat by acting as an androgen-receptor antagonist in vivo and in vitro. <em>Toxicol Ind Health</em> <strong>15:</strong> 80-93</a></p>\n\n<p><a name=\"_ENREF_39\">Saillenfait AM, Gallissot F, Sabat&eacute; JP (2009a) Differential developmental toxicities of di-n-hexyl phthalate and dicyclohexyl phthalate administered orally to rats. <em>J Appl Toxicol</em> <strong>29:</strong> 510-521</a></p>\n\n<p><a name=\"_ENREF_40\">Saillenfait AM, Roudot AC, Gallissot F, Sabat&eacute; JP (2011) Prenatal developmental toxicity studies on di-n-heptyl and di-n-octyl phthalates in Sprague-Dawley rats. <em>Reprod Toxicol</em> <strong>32:</strong> 268-276</a></p>\n\n<p><a name=\"_ENREF_41\">Saillenfait AM, Sabat&eacute; JP, Gallissot F (2009b) Effects of in utero exposure to di-n-hexyl phthalate on the reproductive development of the male rat. <em>Reprod Toxicol</em> <strong>28:</strong> 468-476</a></p>\n\n<p><a name=\"_ENREF_42\">Salazar-Martinez E, Romano-Riquer P, Yanez-Marquez E, Longnecker MP, Hernandez-Avila M (2004) Anogenital distance in human male and female newborns: a descriptive, cross-sectional study. <em>Environ Health</em> <strong>3:</strong> 8</a></p>\n\n<p><a name=\"_ENREF_43\">Schneider S, Kaufmann W, Strauss V, van Ravenzwaay B (2011) Vinclozolin: a feasibility and sensitivity study of the ILSI-HESI F1-extended one-generation rat reproduction protocol. <em>Regulatory Toxicology and Pharmacology</em> <strong>59:</strong> 91-100</a></p>\n\n<p><a name=\"_ENREF_44\">Schwartz CL, Christiansen S, Vinggaard AM, Axelstad M, Hass U, Svingen T (2019) Anogenital distance as a toxicological or clinical marker for fetal androgen action and risk for reproductive disorders. <em>Arch Toxicol</em> <strong>93:</strong> 253-272</a></p>\n\n<p><a name=\"_ENREF_45\">Scott HM, Hutchison GR, Mahood IK, Hallmark N, Welsh M, De Gendt K, Verhoeven H, O&#39;Shaughnessy P, Sharpe RM (2007) Role of androgens in fetal testis development and dysgenesis. <em>Endocrinology</em> <strong>148:</strong> 2027-2036</a></p>\n\n<p><a name=\"_ENREF_46\">Skakkebaek NE, Rajpert-De Meyts E, Main KM (2001) Testicular dysgenesis syndrome: an increasingly common developmental disorder with environmental aspects. <em>Hum Reprod</em> <strong>16:</strong> 972-978</a></p>\n\n<p><a name=\"_ENREF_47\">Taxvig C, Vinggaard AM, Hass U, Axelstad M, Metzdorff S, Nellemann C (2008) Endocrine-disrupting properties in vivo of widely used azole fungicides. <em>Int J Androl</em> <strong>31:</strong> 170-177</a></p>\n\n<p><a name=\"_ENREF_48\">Turner KJ, Barlow NJ, Struve MF, Wallace DG, Gaido KW, Dorman DC, Foster PM (2002) Effects of in utero exposure to the organophosphate insecticide fenitrothion on androgen-dependent reproductive development in the Crl:CD(SD)BR rat. <em>Toxicol Sci</em> <strong>68:</strong> 174-183</a></p>\n\n<p><a name=\"_ENREF_49\">Tyl RW, Myers CB, Marr MC, Fail PA, Seely JC, Brine DR, Barter RA, Butala JH (2004) Reproductive toxicity evaluation of dietary butyl benzyl phthalate (BBP) in rats. <em>Reprod Toxicol</em> <strong>18:</strong> 241-264</a></p>\n\n<p><a name=\"_ENREF_50\">Van den Driesche S, Kolovos P, Platts S, Drake AJ, Sharpe RM (2012) Inter-relationship between testicular dysgenesis and Leydig cell function in the masculinization programming window in the rat. <em>PloS one</em> <strong>7:</strong> e30111</a></p>\n\n<p><a name=\"_ENREF_51\">Welsh M, Saunders PT, Fisken M, Scott HM, Hutchison GR, Smith LB, Sharpe RM (2008) Identification in rats of a programming window for reproductive tract masculinization, disruption of which leads to hypospadias and cryptorchidism. <em>J Clin Invest</em> <strong>118:</strong> 1479-1490</a></p>\n\n<p><a name=\"_ENREF_52\">Welsh M, Saunders PT, Sharpe RM (2007) The critical time window for androgen-dependent development of the Wolffian duct in the rat. <em>Endocrinology</em> <strong>148:</strong> 3185-3195</a></p>\n\n<p><a name=\"_ENREF_53\">Wolf CJ, LeBlanc GA, Gray LE, Jr. (2004) Interactive effects of vinclozolin and testosterone propionate on pregnancy and sexual differentiation of the male and female SD rat. <em>Toxicol Sci</em> <strong>78:</strong> 135-143</a></p>\n\n<p><a name=\"_ENREF_54\">Wolf CJJ, Lambright C, Mann P, Price M, Cooper RL, Ostby J, Gray CLJ (1999) Administration of potentially antiandrogenic pesticides (procymidone, linuron, iprodione, chlozolinate, p,p&#39;-DDE, and ketoconazole) and toxic substances (dibutyl- and diethylhexyl phthalate, PCB 169, and ethane dimethane sulphonate) during sexual differentiation produces diverse profiles of reproductive malformations in the male rat. <em>Toxicol Ind Health</em> <strong>15:</strong> 94-118</a></p>\n\n<p><a name=\"_ENREF_55\">Zhang L, Dong L, Ding S, Qiao P, Wang C, Zhang M, Zhang L, Du Q, Li Y, Tang N, Chang B (2014) Effects of n-butylparaben on steroidogenesis and spermatogenesis through changed E levels in male rat offspring. <em>Environ Toxicol Pharmacol</em> <strong>37:</strong> 705-717</a></p>\n","biologicalOrganisationLevel":"Tissue","organTerm":{"name":"perineum","sourceId":"UBERON:0002356"},"biologicalEvents":[{"action":"disrupted","process":"androgen receptor signaling pathway","object":{"name":"Musculature of male perineum","source":"FMA","sourceId":"FMA:264621"}}],"keyEventStressors":["p,p'-DDE","Fenitrothion","Linuron","Ketoconazole","monobenzyl phthalate","di-n-heptyl phthalate","Butylparaben","Dexamethasone","Procymidone","Prochloraz","butyl benzyl phthalate","Bis(2-ethylhexyl) phthalate","Flutamide","di-n-hexyl phthalate","Triticonazole","Finasteride","Vinclozolin","Dicyclohexyl phthalate"],"id":1688}
{"title":"Antagonism, Androgen receptor","references":"<p><a name=\"_ENREF_1\">Alapi EM, Fischer J (2006) Table of Selected Analogue Classes. In <em>Analogue-based Drug Discovery</em>, Fischer J, Ganellin CR (eds), p 515. Weinheim: Wiley-VCH Verlag GmbH &amp; Co</a></p>\n\n<p>&nbsp;</p>\n\n<p><a name=\"_ENREF_2\">Davey RA, Grossmann M (2016) Androgen Receptor Structure, Function and Biology: From Bench to Bedside. <em>Clinical Biochemist Reviews</em> <strong>37:</strong> 3-15</a></p>\n\n<p>&nbsp;</p>\n\n<p><a name=\"_ENREF_3\">Draskau MK, Boberg J, Taxvig C, Pedersen M, Frandsen HL, Christiansen S, Svingen T (2019) In vitro and in vivo endocrine disrupting effects of the azole fungicides triticonazole and flusilazole. <em>Environ Pollut</em> <strong>255:</strong> 113309</a></p>\n\n<p>&nbsp;</p>\n\n<p><a name=\"_ENREF_4\">Foster PM, Harris MW (2005) Changes in androgen-mediated reproductive development in male rat offspring following exposure to a single oral dose of flutamide at different gestational ages. <em>Toxicol Sci</em> <strong>85:</strong> 1024-1032</a></p>\n\n<p>&nbsp;</p>\n\n<p><a name=\"_ENREF_5\">Hass U, Scholze M, Christiansen S, Dalgaard M, Vinggaard AM, Axelstad M, Metzdorff SB, Kortenkamp A (2007) Combined exposure to anti-androgens exacerbates disruption of sexual differentiation in the rat. <em>Environ Health Perspect</em> <strong>115 Suppl. 1:</strong> 122-128</a></p>\n\n<p>&nbsp;</p>\n\n<p><a name=\"_ENREF_6\">Heemers HV, Tindall DJ (2007) Androgen receptor (AR) coregulators: a diversity of functions converging on and regulating the AR transcriptional complex. <em>Endocr Rev</em> <strong>28:</strong> 778-808</a></p>\n\n<p>&nbsp;</p>\n\n<p><a name=\"_ENREF_7\">Heinlein CA, Chang C (2002) The roles of androgen receptors and androgen-binding proteins in nongenomic androgen actions. <em>Mol Endocrinol</em> <strong>16:</strong> 2181-2187</a></p>\n\n<p>&nbsp;</p>\n\n<p><a name=\"_ENREF_8\">Kita DH, Meyer KB, Venturelli AC, Adams R, Machado DL, Morais RN, Swan SH, Gennings C, Martino-Andrade AJ (2016) Manipulation of pre and postnatal androgen environments and anogenital distance in rats. <em>Toxicology</em> <strong>368-369:</strong> 152-161</a></p>\n\n<p>&nbsp;</p>\n\n<p><a name=\"_ENREF_9\">Kj&aelig;rstad MB, Taxvig C, Nellemann C, Vinggaard AM, Andersen HR (2010) Endocrine disrupting effects in vitro of conazole antifungals used as pesticides and pharmaceuticals. <em>Reprod Toxicol</em> <strong>30:</strong> 573-582</a></p>\n\n<p>&nbsp;</p>\n\n<p><a name=\"_ENREF_10\">K&ouml;rner W, Vinggaard AM, T&eacute;rouanne B, Ma R, Wieloch C, Schlumpf M, Sultan C, Soto AM (2004) Interlaboratory comparison of four in vitro assays for assessing androgenic and antiandrogenic activity of environmental chemicals. <em>Environ Health Perspect</em> <strong>112:</strong> 695-702</a></p>\n\n<p>&nbsp;</p>\n\n<p><a name=\"_ENREF_11\">MacLean HE, Chu S, Warne GL, Zajac JD (1993) Related individuals with different androgen receptor gene deletions. <em>J Clin Invest</em> <strong>91:</strong> 1123-1128</a></p>\n\n<p>&nbsp;</p>\n\n<p><a name=\"_ENREF_12\">MacLeod DJ, Sharpe RM, Welsh M, Fisken M, Scott HM, Hutchison GR, Drake AJ, van den Driesche S (2010) Androgen action in the masculinization programming window and development of male reproductive organs. <em>Int J Androl</em> <strong>33:</strong> 279-287</a></p>\n\n<p>&nbsp;</p>\n\n<p><a name=\"_ENREF_13\">OECD. (2016) Test No. 458: Stably Transfected Human Androgen Receptor Transcriptional Activation Assay for Detection of Androgenic Agonist and Antagonist Activity of Chemicals. <em>OECD Guidelines for the Testing of Chemicals, Section 4</em>, Paris.</a></p>\n\n<p>&nbsp;</p>\n\n<p><a name=\"_ENREF_14\">Rana K, davey RA, Zajac JD (2014) Human androgen deficiency: insights gained from androgen receptor knockout mouse models. <em>Asian J Androl</em> <strong>16:</strong> 169-177</a></p>\n\n<p>&nbsp;</p>\n\n<p><a name=\"_ENREF_15\">Satoh K, Ohyama K, Aoki N, Iida M, Nagai F (2004) Study on anti-androgenic effects of bisphenol a diglycidyl ether (BADGE), bisphenol F diglycidyl ether (BFDGE) and their derivatives using cells stably transfected with human androgen receptor, AR-EcoScreen. <em>Food Chem Toxicol</em> <strong>42:</strong> 983-993</a></p>\n\n<p>&nbsp;</p>\n\n<p><a name=\"_ENREF_16\">Schwartz CL, Christiansen S, Vinggaard AM, Axelstad M, Hass U, Svingen T (2019) Anogenital distance as a toxicological or clinical marker for fetal androgen action and risk for reproductive disorders. <em>Arch Toxicol</em> <strong>93:</strong> 253-272</a></p>\n\n<p>&nbsp;</p>\n\n<p><a name=\"_ENREF_17\">Sonneveld E, Jansen HJ, Riteco JA, Brouwer A, van der Burg B (2005) Development of androgen- and estrogen-responsive bioassays, members of a panel of human cell line-based highly selective steroid-responsive bioassays. <em>Toxicol Sci</em> <strong>83:</strong> 136-148</a></p>\n\n<p>&nbsp;</p>\n\n<p><a name=\"_ENREF_18\">van der Burg B, Winter R, Man HY, Vangenechten C, Berckmans P, Weimer M, Witters H, van der Linden S (2010) Optimization and prevalidation of the in vitro AR CALUX method to test androgenic and antiandrogenic activity of compounds. <em>Reprod Toxicol</em> <strong>30:</strong> 18-24</a></p>\n\n<p>&nbsp;</p>\n\n<p><a name=\"_ENREF_19\">Vinggaard AM, Niemel&auml; J, Wedebye EB, Jensen GE (2008) Screening of 397 chemicals and development of a quantitative structure--activity relationship model for androgen receptor antagonism. <em>Chem Res Toxicol</em> <strong>21:</strong> 813-823</a></p>\n\n<p>&nbsp;</p>\n\n<p><a name=\"_ENREF_20\">Walters KA, Simanainen U, Handelsman DJ (2010) Molecular insights into androgen actions in male and female reproductive function from androgen receptor knockout models. <em>Hum Reprod Update</em> <strong>16:</strong> 543-558</a></p>\n\n<p>&nbsp;</p>\n","biologicalOrganisationLevel":"Molecular","organTerm":{},"biologicalEvents":[{"object":{}}],"keyEventStressors":["Prochloraz","Epoxiconazole","Cyproterone acetate","Tebuconazole","Mercaptobenzole","Flusilazole","Triticonazole","Flutamide","Propiconazole","Vinclozolin"],"id":26}
{"title":"decrease, transcription of genes by AR ","references":"","biologicalOrganisationLevel":"Cellular","organTerm":{},"biologicalEvents":[{"object":{}}],"id":1687}
{"title":"reduction, testosterone levels ","references":"","biologicalOrganisationLevel":"Tissue","organTerm":{},"biologicalEvents":[{"object":{}}],"id":1690}
{"title":"Antagonism,LH receptor","references":"","biologicalOrganisationLevel":"Molecular","organTerm":{},"biologicalEvents":[{"object":{}}],"id":1691}
{"title":"Reduction, Progesterone synthesis","references":"","biologicalOrganisationLevel":"Cellular","organTerm":{},"biologicalEvents":[{"object":{}}],"id":1692}
{"title":"Reduction, Plasma progesterone concentration ","references":"","biologicalOrganisationLevel":"Tissue","organTerm":{},"biologicalEvents":[{"object":{}}],"id":1693}
{"title":"Reduction, progesterone uptake, decresed maturation ","references":"","biologicalOrganisationLevel":"Cellular","organTerm":{},"biologicalEvents":[{"object":{}}],"id":1694}
{"title":"Impaired ovulation","references":"","biologicalOrganisationLevel":"Organ","organTerm":{},"biologicalEvents":[{"object":{}}],"id":1695}
{"title":"Decrease of egg production and cummulative fecundity","references":"","biologicalOrganisationLevel":"Individual","organTerm":{},"biologicalEvents":[{"object":{}}],"id":1696}
{"title":"Decline, Population trajectory","references":"","biologicalOrganisationLevel":"Population","organTerm":{},"biologicalEvents":[{"action":"decreased","process":"population growth rate","object":{}}],"id":679}
{"title":"Increase, DNA methyltransferase expression","references":"","biologicalOrganisationLevel":"Molecular","organTerm":{},"biologicalEvents":[{"object":{}}],"id":1697}
{"title":"Increase, hypermethylation of the promotor region of gonadotropin releasing hormone receptor","references":"","biologicalOrganisationLevel":"Molecular","organTerm":{},"biologicalEvents":[{"object":{}}],"id":1698}
{"title":"Decrease, expression of gonadotropin releasing hormone receptor","references":"","biologicalOrganisationLevel":"Molecular","organTerm":{},"biologicalEvents":[{"object":{}}],"id":1699}
{"title":"Decrease, Mitochondrial membrane potential","references":"","biologicalOrganisationLevel":"Cellular","organTerm":{},"biologicalEvents":[{"object":{}}],"id":1770}
{"title":"Impaired coordination and movement","references":"","biologicalOrganisationLevel":"Individual","organTerm":{},"biologicalEvents":[{"object":{}}],"id":1705}
{"title":"Stimulation, TLR7/8","references":"<ol>\n\t<li>Akira, S., Uematsu, S. and Takeuchi, O. (2006). Pathogen recognition and innate immunity. Cell 124(4): 783-801.</li>\n\t<li>Blasius, A.L. and Beutler, B. (2010). Intracellular toll-like receptors. Immunity 32(3), 305-315.</li>\n\t<li>Chuang, T.H. and Ulevitch R.J. (2000). Cloning and characterization of a sub-family of human toll-like receptors: hTLR7, hTLR8 and hTLR9. European cytokine network 11(3), 372-378.</li>\n\t<li>Diaz, M.O., Bohlander, S. and Allen, G. (1993). Nomenclature of the human interferon genes. Journal of interferon research 13(3), 243-244.</li>\n\t<li>Ganguly, D., Chamilos, G., Lande, R., Gregorio, J., Meller, S., Facchinetti, V., Homey, B., Barrat, F.J., Zal, T. and Gilliet, M. (2009). Self-RNA-antimicrobial peptide complexes activate human dendritic cells through TLR7 and TLR8. Journal of experimental medicine 206(9), 1983-1994.</li>\n\t<li>G&eacute;nin, P., Lin, R., Hiscott, J. and Civas, A. (2009). Differential regulation of human interferon A gene expression by interferon regulatory factor 3 and 7. Molecular and cellular biology 29(12), 3435-3450.</li>\n\t<li>Gibson, S.J., Lindh, J.M., Riter, T.R., Gleason, R.M., Rogers, L.M., Fuller, A.E., Oesterich, J.L., Gorden, K.B., Qiu, X., McKane, S.W., Noelle, R.J., Kedl, R.M., Fitzgerald-Bocarsly, P. Tomai, M.A. and Vasilakos, J.P. (2002). Plasmacytoid dendritic cells produce cytokines and mature in response to the TLR7 agonists, imiquimod and resiquimod. Cellular immunology 218(1-2), 74-86.</li>\n\t<li>Gilliet, M., Cao, W. and Liu, Y.J. (2008). Plasmacytoid dendritic cells: sensing nucleic acids in viral infection and autoimmune diseases. Nature reviews immunology 8(8), 594-606.</li>\n\t<li>Gupta, C.L., Akhtar, S., Sayyed, U., Pathak, N. and Bajpai P. (2016). In silico analysis of human toll-like receptor 7 ligand binding domain. Biotechnology and applied biochemistry 63(3), 441-450.</li>\n\t<li>H&auml;nsel, A., G&uuml;nther, C., Ingwersen, J., Starke, J., Schmitz, M., Bechmann, M., Meurer, M., Rieber, E.P. and Sch&auml;kel, K. (2011). Human slan (6-sulfoLacNAc) dendritic cells are inflammatory dermal dendritic cells in psoriasis and drive strong TH17/TH1 T-cell responses. Journal of allergy and clinical immunology 127(3), 787-794.</li>\n\t<li>Itoh, H., Tatematsu, M., Watanabe, A., Iwano, K., Funami, K., Seya, T. and Matsumoto, M. (2011). UNC93B1 physically associates with human TLR8 and regulates TLR8-mediated signaling. PLoS One 6(12), e28500.</li>\n\t<li>Iwasaki, A. and Medzhitov, R. (2004). Toll-like receptor control of the adaptive immune responses. Nature immunology 5(10), 987-995.</li>\n\t<li>Jurk, M., Heil, F., Vollmer, J., Schetter, C., Krieg, AM., Wagner, H., Lipford, G. and Bauer, S. (2002). Human TLR7 and TLR8 independently confer responsiveness to the antiviral compound R848. Nature immunology 3(6), 499.</li>\n\t<li>Kawai, T. and Akira, S. (2008). Toll-like receptor and RIG-I-like receptor signaling. Annals of the New York academy of sciences 1143, 1-20.</li>\n\t<li>Kawai, T. and Akira, S. (2010). The role of pattern-recognition receptors in innate immunity:update on toll-like receptors. Nature immunology 11(5), 373-384.</li>\n\t<li>Kawai, T. and Akira, S. (2011). Toll-like receptors and their crosstalk with other innate receptors in infection and immunity. Immunity 34(5), 637-650.</li>\n\t<li>Lai, C.Y., Su, Y.W., Lin, K.I., Hsu, L.C. and Chuang, T.H. (2017). Natural modulators of endosomal toll-like receptor-mediated psoriatic skin inflammation. Journal of immunology research 7807313, 15 pages.</li>\n\t<li>Reizis, B., Bunin, A., Ghosh, H.S., Lewis, K.L. and Sisirak, V. (2011). Plasmacytoid dendritic cells: recent progress and open questions. Annual reviews of immunology 29, 163-183.</li>\n\t<li>Tanji, H., Ohto, U., Shibata, T., Miyake, K. and Shimizu, T. (2013). Structural reorganization of the toll-like receptor 8 dimer induced by agonistic ligands. Science 339(6126), 1426-1429.</li>\n\t<li>Tanji, H., Ohto, U., Shibata, T., Taoka, M., Yamauchi, Y., Isobe, T., Miyake, K. and Shimizu, T. (2015). Toll-like receptor 8 senses degradation products of single-stranded RNA. Nature structural and molecular biology 22(2), 109-115.</li>\n\t<li>Zhang, Z., Ohto, U., Shibata, T., Krayukhina, E., Taoka, M., Yamauchi, Y., Tanji, H., Isobe, T., Uchiyama, S., Miyake, K. and Shimizu, T. (2016). Structural analysis reveals that toll-like receptor 7 is a dual receptor for guanosine and single-stranded RNA. Immunity 45(4), 737-748.</li>\n</ol>\n","biologicalOrganisationLevel":"Molecular","organTerm":{},"biologicalEvents":[{"object":{}}],"id":1706}
{"title":"Increase, IL-23 from matured dendritic cells","references":"<ol>\n\t<li>Farkas, A. and Kem&eacute;ny, L. (2011). Interferon-&alpha; in the generation of monocyte-derived dendritic cells: recent advances and implications for dermatology. British journal of dermatology 165(2), 247-254.</li>\n\t<li>Guilliams, M., Ginhoux, F., Jakubzick, C., Naik, S.H., Onai, N., Schraml, B.U., Segura, E., Tussiwand, R. and Yona, S. (2014). Dendritic cells, monocytes and macrophages: a unified nomenclature based on ontogeny. Nature review immunology 14(8), 571-578.</li>\n\t<li>H&auml;nsel, A., G&uuml;nther, C., Ingwersen, J., Starke, J., Schmitz, M., Bechmann, M., Meurer, M., Rieber, E.P. and Sch&auml;kel, K. (2011). Human slan (6-sulfoLacNAc) dendritic cells are inflammatory dermal dendritic cells in psoriasis and drive strong TH17/TH1 T-cell responses. Journal of allergy and clinical immunology 127(3), 787-794.</li>\n\t<li>Lee, E., Trepicchio, W.L., Oestreicher, J.L., Pittman, D., Wang, F., Chamian, F., Dhodapkar, M. and Krueger, J.G. (2004). Increased expression of interleukin 23 p19 and p40 in lesional skin of patients with psoriasis vulgaris. Journal of experimental medicine 199(1), 125-130.</li>\n\t<li>Lowes, M.A., Chamian, F., Abello, M.V., Fuentes-Duculan, J., Lin, S.L., Nussbaum, R., Novitskaya, I., Carbonaro, H., Cardinale, I., Kikuchi, T., Gilleaudeau, P., Sullivan-Whalen, M., Wittkowski, K.M., Papp, K., Garovoy, M., Dummer, W., Steinman, R.M. and Krueger, J.G. (2005). Increase in TNF-alpha and inducible nitric oxide synthase-expressing dendritic cells in psoriasis and reduction with efalizumab (anti-CD11a). Proceedings of the national academy of sciences of the United States of America 102(52), 19057-19062.</li>\n\t<li>Schwarz, H., Posselt, G., Wurm, P., Ulbing, M., Duschl, A. and Horejs-Hoeck, J. (2013). TLR8 and NOD signaling synergistically induce the production of IL-1&beta; and IL-23 in monocyte-derived DCs and enhance the expression of the feedback inhibitor SOCS2. Immunobiology 218(4), 533-42.</li>\n\t<li>Wilsmann-Theis, D., Koch, S., Mindnich, C., Bonness, S., Schnautz, D., von Bubnoff, D. and Bieber, D. (2013). Generation and functional analysis of human TNF-&alpha;/iNOS-producing dendritic cells (Tip-DC). Allergy 68(7), 890-898.</li>\n</ol>\n","biologicalOrganisationLevel":"Cellular","organTerm":{"name":"immune system","sourceId":"UBERON:0002405"},"biologicalEvents":[{"object":{}}],"id":1707}
{"title":"Th17 cell migration and inflammation induction","references":"<p style=\"margin-left:10.5pt\">Lisa C. Zaba, Irma Cardinale, Patricia Gilleaudeau, Mary Sullivan-Whalen, Mayte Su&aacute;rez-Fari&ntilde;as, Judilyn Fuentes-Duculan, Inna Novitskaya, Artemis Khatcherian, Mark J. Bluth, Michelle A. Lowes, James G. Krueger. Amelioration of epidermal hyperplasia by TNF inhibition is associated with reduced Th17 responses. J. Exp. Med. 2007, 204, 3183-3194.</p>\n\n<p style=\"margin-left:10.5pt\">Mayte Suarez-Farinas, Robert Arbert, Weiwen Jiang, Francesca S. Ortenzio, Tim Sullivan, James G, Krueger.Suppression of Molecular Inflammatory Pathways by Toll-Like Receptor7,8 and 9 Antagonists in a Model of IL-23-Induced Skin Inflammmation. PLOS ONE, December 2013/Vol 8/Issue 12/e84634</p>\n\n<p style=\"margin-left:10.5pt\">Chamian F, Lowes MA, Lin SL, Lee E, Kikuchi T et al. (2005)Alefacept reduces infiltrating T cells, activated dendritic cells, and inflammatory genes in psoriasis vulgaris. Proc Natl Acad Sci U S A 102: 2075-2080.</p>\n\n<p style=\"margin-left:11.0pt\">Harrington LE, Hatton RD, Mangan PR, Turner H, Murphy&nbsp; TL et al. (2005) Interleukin 17-producing&nbsp; CD4+ effector&nbsp; T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat Immunol 6:1123-1132.</p>\n\n<p style=\"margin-left:10.5pt\">Veldhoen M, Hocking RJ, Atkins CJ, Locksley RM, Stockinger B(2006) novo differentiation of IL-17-producing&nbsp; T cells. Immunity 24:179-189.</p>\n\n<p style=\"margin-left:10.5pt\">Liang SC, Tan XY, Luxenberg DP, Karim R, Dunussi-Joannopoulos K et al. (2006) Interleukin (IL)-22 and IL-17 are coexpressed by Th17 cells and cooperatively enhance expression of antimicrobial peptides. J Exp Med 203:2271-2279. &nbsp;</p>\n\n<p style=\"margin-left:10.5pt\">Lisa M. Paloma Perez. Glucocorticoids and Glucocorticoid-Induced-Leucine-Zipper (GILZ) in Psoriasis:Published online 2019 Sep 13.</p>\n\n<p style=\"margin-left:10.5pt\">Boehncke WH, Schon MP. Psoriasis. Lancet (2015)386(9997);983-94.10.1016/S0140-6736(14)61909-7</p>\n\n<p style=\"margin-left:10.5pt\">Helen Benham, Jane C Goodall, Mihir D Wechalekar, and Dliver Fitzgerald. Th17 and Th22 cells in psoriatic arthritis and psoriasis. Arthritis research &amp; therapy September 2013.</p>\n\n<p style=\"margin-left:10.5pt\">Journal of Allergy and Clinical Immunology</p>\n\n<p style=\"margin-left:10.5pt\">Zuzana Zakostelska, Jana Malkova, Kiara Klimesova, Pavel Rossmann, Michaela Hornova, Iva Novosadova, Zuzana Stehlikova, Martin Kostovcik, Tomas Hudcovic, Ranata Stepankova, Katerina Juzlova, Jana Hercogova, Helena Tlaskalova-Hogenova, Miloslav Kverka. Intestinal MicrobiotaPromotes Psoriasis-Like Skin Inflammation by Enhancing Th17 Response. PLOS ONE. 2016;Jul 19.</p>\n","biologicalOrganisationLevel":"Cellular","organTerm":{"name":"immune system","sourceId":"UBERON:0002405"},"biologicalEvents":[{"object":{}}],"id":1708}
{"title":"Psoriatic skin disease","references":"<p style=\"margin-left:11.0pt\">Harrington LE, Hatton RD, Mangan PR, Turner H, Murphy&nbsp; TL et al. (2005) Interleukin 17-producing&nbsp; CD4+ effector&nbsp; T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat Immunol 6:1123-1132.</p>\n\n<p style=\"margin-left:10.5pt\">Wagner EF, Schonthaler HB, Guinea-Viniegra J, Tschachler E. Psoriasis: what we have learned from mouse models. Nat Rev Rheumatol. (2010) 6:704&ndash;14. doi: 10.1038/nrrheum.2010.157</p>\n\n<p style=\"margin-left:10.5pt\">Kanagawa Psoriasis Treatment Study Group 2013.</p>\n\n<p style=\"margin-left:10.5pt\">Michel Gilliet,Curdin Conrad, Michael Geiges, Antonio Cozzio, Wolfgang Th&uuml;rlimann, G&uuml;nter Burg, Frank O. Nestle, Reinhard Dummer. Psoriasis triggered by toll-like receptor 7 agonist imiquimod in the presence of dermal plasmacytoid dendritic cell precursors.Arch.Dermatol.2004, 140, 1490-1495.</p>\n\n<p style=\"margin-left:10.5pt\">John K. Geisse, Phoebe Rich, Amit Pandya, Kenneth Gross, Kara Andres, Angie Ginkel, Mary Owens. Imiquimod 5% cream for the treatment of superficial basal cell carcinoma: a double-blind, randomized, vehicle-controlled study. J. Am. Acad. Dermatol. 2002, 47, 390-398.</p>\n\n<p style=\"margin-left:10.5pt\">Stanley Cheuk, Maria Wik&eacute;n, Lennart Blomqvist, Susanne Nyl&eacute;n, Toomas Talme, Mona St&aring;hle and Liv Eidsmo. Epidermal Th22 and Tc17 Cells Form a Localized Disease Memory in Clinically Healed PsoriasisJ Immunol. 2014, Apr 1; 192(7): 3111-3120.</p>\n\n<p style=\"margin-left:10.5pt\">Komene M, Karakawa M, Takekoshi T, Sakurai N, Minatani Y, Mitsui H, Tada Y, Saeki H, Asahina A, and Tamaki K. Early inflammatory changes in the &ldquo;perilesional skin&rdquo; of psoriatic plaques: is there interaction betweendendritic cells and keratinocytes?&nbsp; J Invest Dermatol. 2007, Aug; 127(8): 1915-22. Epub 2007 Apr 19.</p>\n\n<p style=\"margin-left:10.5pt\">Tanizaki H, Nakahigashi K, Miyachi Y, and Kabashima K. Comparison of the efficacy of fexofenadine 120 and 240 mg/day on chronic idiopathic urticarial and histamine-induced skin responses in Japanese populations. J Dermatolog Treat. 2013; Dec; 24(6): 477-80.</p>\n\n<p style=\"margin-left:10.5pt\">Kyowa Hakko Kirin Co., Ltd. Clinical pharmacology study, internal data</p>\n\n<p style=\"margin-left:10.5pt\">Conrad C, Gilliet M, Psoriasis: from pathogenesis to targeted therapies. Clin Rev Allergy Immunol(2018)54(1):102-13.10.1007/s12016-018-8668-1</p>\n\n<p style=\"margin-left:10.5pt\">Cook PW, Piepkorn M, Clegg CH, Plowman GD, DeMay JM, et al. Transgenic expression of the human amphiregulin gene induces a psoriasis-like phenotype. J Clin Investig.1997;100:2286-94.</p>\n\n<p>&nbsp;</p>\n","biologicalOrganisationLevel":"Individual","organTerm":{},"biologicalEvents":[{"object":{}}],"id":1709}
{"title":"Maturation of TNF/iNOS-Producing Dendritic Cells","references":"<ol>\n\t<li>Farkas, A. and Kem&eacute;ny, L. (2011). Interferon-&alpha; in the generation of monocyte-derived dendritic cells: recent advances and implications for dermatology. British journal of dermatology 165(2), 247-254.</li>\n\t<li>Guilliams, M., Ginhoux, F., Jakubzick, C., Naik, S.H., Onai, N., Schraml, B.U., Segura, E., Tussiwand, R. and Yona, S. (2014). Dendritic cells, monocytes and macrophages: a unified nomenclature based on ontogeny. Nature review immunology 14(8), 571-578.</li>\n\t<li>Le&oacute;n, B., L&oacute;pez-Bravo, M. and Ardav&iacute;n, C. (2005). Monocyte-derived dendritic cells. Seminars in immunology 17(4), 314-318.</li>\n\t<li>Lowes, M.A., Chamian, F., Abello, M.V., Fuentes-Duculan, J., Lin, S.L., Nussbaum, R., Novitskaya, I., Carbonaro, H., Cardinale, I., Kikuchi, T., Gilleaudeau, P., Sullivan-Whalen, M., Wittkowski, K.M., Papp, K., Garovoy, M., Dummer, W., Steinman, R.M. and Krueger, J.G. (2005). Increase in TNF-alpha and inducible nitric oxide synthase-expressing dendritic cells in psoriasis and reduction with efalizumab (anti-CD11a). Proceedings of the national academy of sciences of the United States of America 102(52), 19057-19062.</li>\n\t<li>Sprangers, S., Vries, T.J. and Everts, V. (2016). Monocyte Heterogeneity: Consequences for monocyte-derived immune cells. Journal of immunology research 1475435.</li>\n\t<li>Tang-Huau, T., Segura, E. (2019). Human in vivo-differentiated monocyte-derived dendritic cells. Seminars in Cell &amp; Developmental Biology 86, 44-49.</li>\n\t<li>Wilsmann-Theis, D., Koch, S., Mindnich, C., Bonness, S., Schnautz, D., von Bubnoff, D. and Bieber, D. (2013). Generation and functional analysis of human TNF-&alpha;/iNOS-producing dendritic cells (Tip-DC). Allergy 68(7), 890-898.</li>\n</ol>\n","biologicalOrganisationLevel":"Cellular","organTerm":{},"biologicalEvents":[{"object":{}}],"id":1822}
{"title":"Binding to estrogen receptor (ER)- in immune cells","references":"<ol>\n\t<li>Eick GN, Thornton JW. Evolution of steroid receptors from an estrogen-sensitive ancestral receptor. Molecular and cellular endocrinology. 2011; 334: 31-38.</li>\n\t<li>Melissa, C. and Gary, G (2011). Estrogen Receptors in Immunity and Autoimmunity. Clinical Reviews in Allergy &amp; Immunology 40:66-73.</li>\n\t<li>Salem ML. (2004). Estrogen, a double-edged sword: modulation of Th1- and Th2-mediated inflammations by differential regulation of Th1/Th2 cytokine production. Current Drug Targets - Inflammation &amp; Allergy 3(1): 97-104.</li>\n\t<li>Robinson DP, Hall, O. J., Nilles, T. L., Bream, J.H. and Klein, S.L. (2014). 17&beta;-estradiol protects females against influenza by recruiting neutrophils and increasing virus-specific CD8 T cell responses in the lungs. Journal of Virology 88 (9): 4711-4720.</li>\n\t<li>Parker MG, Arbuckle N, Dauvois S, Danielian P, White R. Structure and function of the estrogen receptor. Ann N Y Acad Sci. 1993. 684:119-26.</li>\n\t<li>Goldstein RA, Katzenellenbogen JA, Wolynes PG, et al. Three-dimensional model for the hormone binding domains of steroid receptors. Proc Natl Acad Sci. 1993;90 (21):9949-53.</li>\n\t<li>Sasson S. Equilibrium binding analysis of estrogen agonists and antagonists: relation to the activation of the estrogen receptor. Pathol Biol (Paris). 1991;39(1):59-69.</li>\n\t<li>Brandt ME, Vickery LE. Cooperativity and dimerization of recombinant human estrogen receptor hormone-binding domain. J Biol Chem. 1997;272(8):4843-9.</li>\n\t<li>Carolyn MK. Estrogen receptor interaction with estrogen response elements. Nucleic Acids Res. 2001 Jul 15; 29(14): 2905-2919.</li>\n\t<li>Takayanagi, S. Tokunaga, T., et al. (2006). &nbsp;Endocrine disruptor bisphenol A strongly binds to human estrogen-related receptor &gamma; (ERR&gamma;) with high constitutive activity. Toxicology Letters, 167 (2):95-105.</li>\n\t<li>OECD Guideline for the Testing of Chemicals [Test No. 440: Uterotrophic Bioassay in Rodents]</li>\n\t<li>OECD Guideline for the Testing of Chemicals [Test No. 455: <a href=\"https://www.oecd-ilibrary.org/environment/test-no-455-performance-based-test-guideline-for-stably-transfected-transactivation-in-vitro-assays-to-detect-estrogen-receptor-agonists-and-antagonists_9789264265295-en\">Performance-Based Test Guideline for Stably Transfected Transactivation In Vitro Assays to Detect Estrogen Receptor Agonists and Antagonists</a>]</li>\n\t<li>Kraichely, DM. Sun, J. Katzenellenbogen, JA. Katzenellenbogen, BS. (2000). Conformational changes and coactivator recruitment by novel ligands for estrogen receptor-&alpha; and estrogen receptor-&beta;: correlations with biological character and distinct differences among SRC coactivator family members. Endocrinology, 141 (10):3534&ndash;3545.</li>\n\t<li>Carlson, KE. Choli, I. Gee, A. Katzenellenbogen, BS. Katzenellenbogen, JA. (1997) Altered Ligand Binding Properties and Enhanced Stability of a Constitutively Active Estrogen Receptor:&thinsp; Evidence That an Open Pocket Conformation Is Required for Ligand Interaction. Biochemistry, 36:14897-14905.</li>\n\t<li>Maria, B., Ruixin, H., Chin-Yo, L., Cecilia, W., Jan-Ake, G. (2015). Estrogen receptor signaling during vertebrate development. Biochim Biophys Acta 1849: 142-151.</li>\n\t<li>Green S, Walter P, Chambon P, et al. Human oestrogen receptor cDNA: sequence, expression and homology to v-erb-A. Nature. 1986; 320:134-139.</li>\n\t<li>Kumar V, Green S, Chambon P, et al. Localisation of the oestradiol-binding and putative DNA-binding domains of the human oestrogen receptor. The EMBO journal. 1986; 5: 2231-2236.</li>\n\t<li>Warnmark A, Treuter E, Gustafsson JA, et al. Activation functions 1 and 2 of nuclear receptors: molecular strategies for transcriptional activation. Molecular endocrinology (Baltimore, Md). 2003; 17:1901-1909.</li>\n\t<li>White, R., Lees, JA., Needham, M., Ham, J. and Parker, M. (1987). Structural Organization and Expression of the Mouse Estrogen Receptor. Molecular Endocrinology 1 (10): 735-744.</li>\n\t<li>Couse JF, Lindzey J, Grandien K, Gustafsson JA, Korach KS. (1997) Tissue distribution and quantitative analysis of estrogen receptor-alpha (ERalpha) and estrogen receptor-beta (ERbeta) messenger ribonucleic acid in the wild-type and ERalphaknockout mouse. Endocrinology 138(11):4613-4621.</li>\n\t<li>Fagerberg L, Hallstrom BM, Edlund K, et al. Analysis of the human tissue- specific expression by genome-wide integration of transcriptomics and antibody-based proteomics. Molecular &amp; cellular proteomics. 2014; 13:397-406.</li>\n\t<li>Sayers EW, Barrett T, Federhen S, et al. Database resources of the National Center for Biotechnology Information. Nucleic acids research. 2012; 40: D13-25.</li>\n\t<li>Offner H, Adlard K, Zamora A, Vandenbark AA. Estrogen potentiates treatment with T-cell receptor protein of female mice with experimental encephalomyelitis. J Clin Invest. 2000;105(10):1465-72.</li>\n\t<li>Monroe DG, Secreto FJ, Subramaniam M, Getz BJ, Khosla S, Spelsberg TC. Estrogen receptor alpha and beta heterodimers exert unique effects on estrogen- and tamoxifen-dependent gene expression in human U2OS osteosarcoma cells. Molecular endocrinology (Baltimore, Md). 2005; 19:1555&ndash;1568.</li>\n\t<li>Papoutsi Z, Zhao C, Putnik M, Gustafsson JA, Dahlman-Wright K. Binding of estrogen receptor alpha/beta heterodimers to chromatin in MCF-7 cells. J Mol Endocrinol. 2009; 43:65-72.</li>\n\t<li>Okasha SA, Ryu S, Do Y, McKallip RJ, Nagarkatti M, Nagarkatti PS. Evidence for estradiol-induced apoptosis and dysregulated T cell maturation in the thymus. Toxicology. 2001, 163 (1):49-62.</li>\n\t<li>Takayanagi S, Tokunaga T, Liu X, Okada H, Matsushima A, Shimohigashi Y. &nbsp;Endocrine disruptor bisphenol A strongly binds to human estrogen-related receptor &gamma; (ERR&gamma;) with high constitutive activity. Toxicology Letters, 2006, 167 (2):95-105.</li>\n\t<li>Krishnan, AV., Stathis, P., Permuth, S. F., Tokes, L. and Feldman, D. (1993). Bisphenol-A: an estrogenic substance is released from polycarbonate flasks during autoclaving. Endocrinology 132; 2279-2286.</li>\n\t<li>Li, J., McMurray, RW. (2006). Effects of estrogen receptor subtype-selective agonists on immune functions in ovariectomized mice. International Immunopharmacology, 6 (9):1413-1423.</li>\n</ol>\n","biologicalOrganisationLevel":"Molecular","organTerm":{"name":"immune system","sourceId":"UBERON:0002405"},"biologicalEvents":[{"object":{}}],"keyEventStressors":["Bisphenol A","17beta-Estradiol","Propylpyrazoletriol"],"id":1710}
{"title":"Induction of GATA3 expression","references":"<ol>\n\t<li>Zhu J, Yamane H, Paul WE. Differentiation of effector CD4 T cell populations. Annu Rev Immunol. 2010; 28:445-89.</li>\n\t<li><a href=\"https://www.nature.com/articles/ni1115#auth-1\">Spilianakis</a> CG &amp; <a href=\"https://www.nature.com/articles/ni1115#auth-2\">Flavell</a> RA, Long-range intrachromosomal interactions in the T helper type 2 cytokine locus. <a href=\"https://www.nature.com/ni\">Nature Immunology</a>. 2004; 5: 1017-1027.</li>\n\t<li>Zhu J, Paul WE. Peripheral CD4 T cell differentiation regulated by networks of cytokines and transcription factors. Immunol Rev. 2010; 238(1):247-62.</li>\n\t<li>Sung-Yun, Morgan L. T. I-Cheng H. (2004). GATA-3 deficiency abrogates the development and maintenance of T helper type 2 cells. Proceedings of the National Academy of Sciences. 101 (7): 1993-1998.</li>\n\t<li>Zhu J, Min B, Paul WE, et al. Conditional deletion of Gata3 shows its essential function in T(H)1-T(H)2 responses. Nat Immunol. 2004;5(11):1157-65.</li>\n\t<li>Zheng W, Flavell RA. The transcription factor GATA-3 is necessary and sufficient for Th2 cytokine gene expression in CD4 T cells. Cell. 1997. 16;89(4):587-96.</li>\n\t<li>Zhang DH, Cohn L, Ray P, Bottomly K, Ray A. Transcription factor GATA-3 is differentially expressed in murine Th1 and Th2 cells and controls Th2-specific expression of the interleukin-5 gene. J Biol Chem. 1997. 22;272(34):21597-603.</li>\n\t<li>Ho IC, Tai TS, Pai SY. GATA3 and the T-cell lineage: essential functions before and after Thelper-2-cell differentiation. Nat Rev Immunol. 2009;9(2):125-35.</li>\n\t<li>Zheng H, Guo X, Zhu Y, et al., Distinct role of Tim-3 in systemic lupus erythematosus and clear cell renal cell carcinoma. Int J Clin Exp Med 2015;8(5):7029-7038.</li>\n\t<li>Sonia GR, et al. Altered AKT1 and MAPK1 Gene Expression on Peripheral Blood Mononuclear Cells and Correlation with T-Helper-Transcription Factors in Systemic Lupus Erythematosus Patients. Mediators of Inflammation 2012, Article ID 495934</li>\n\t<li>Lambert KC, Curran EM, et al. <a href=\"https://pubmed.ncbi.nlm.nih.gov/16237062/?from_term=Estrogen+Receptor%2C+Deficiency+in+macrophages+results+in+increased+stimulation&amp;from_pos=2\">Estrogen receptor alpha (ERalpha) deficiency in macrophages results in increased stimulation of CD4+ T cells while 17beta-estradiol acts through ERalpha to increase IL-4 and GATA-3 expression in CD4+ T cells independent of antigen presentation.</a> J Immunol. 2005; 175(9): 5716-23.</li>\n\t<li>Kurata, H., Lee, H. J., O&rsquo;Garra, A. and Arai, N. (1999). Ectopic expression of activated STAT6 induces the expression of Th2-specific cytokines and transcription factors in developing Th1 cells. Immunity 11: 677-688.</li>\n\t<li>Zhu, J., Guo, L., Watson, C. J., Hu-Li, J. and Paul, W. E. (2001). STAT6 is necessary and sufficient for IL-4&#39;s role in Th2 differentiation and cell expansion. The Journal of Immunology 166(12): 7276-7281.</li>\n\t<li><a href=\"https://www.ncbi.nlm.nih.gov/pubmed/?term=Tremblay%20M%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=30348673\">Tremblay M</a>, GATA transcription factors in development and disease. 2018; 22:145(20).</li>\n\t<li>Guo H, Liu T, Ling F, et al. Bisphenol A in combination with TNF-alpha selectively induces Th2 cell-promoting dendritic cells in vitro with an estrogen-like activity. Cell Mol Immunol. 2010;7(3):227-34.</li>\n</ol>\n","biologicalOrganisationLevel":"Cellular","organTerm":{"name":"immune system","sourceId":"UBERON:0002405"},"biologicalEvents":[{"object":{}}],"keyEventStressors":["4-Hydroxytamoxifen","Bisphenol A","17beta-Estradiol"],"id":1711}
{"title":"Increase of Th2 cells producing IL-4","references":"<ol>\n\t<li>Aste-Amezaga M, Ma X, Sartori A, Trinchieri G. Molecular mechanisms of the induction of IL-12 and its inhibition by IL-10. J Immunol. 1998. 15;160(12):5936-44.</li>\n\t<li>Zhu J, Min B, Paul WE, et al. Conditional deletion of Gata3 shows its essential function in T(H)1-T(H)2 responses. Nat Immunol. 2004;5(11):1157-65.</li>\n\t<li>Pai SY, Truitt ML, Ho IC. GATA-3 deficiency abrogates the development and maintenance of T helper type 2 cells. Proc Natl Acad Sci U S A.&nbsp;2004 Feb 17;101(7):1993-8.</li>\n\t<li>Lee, MH, Chung, S. W., Kang, B. Y., Park, J., Lee, C. H., Hwang, S. Y. and Kim, T. S. (2003). Enhanced interleukin-4 production in CD4+ T cells and elevated immunoglobulin E levels in antigen-primed mice by bisphenol A and nonylphenol, endocrine disruptors: involvement of nuclear factor-AT and Ca2+. Immunology 109(1): 76-86.</li>\n\t<li>Huimin, Y., Masaya, T. and Kazuo, S. (2008).<font color=\"#0782c1\">&nbsp;</font>Exposure to Bisphenol A Prenatally or in Adulthood Promotes Th2 Cytokine Production Associated with Reduction of CD4+CD25+ Regulatory T Cells.&nbsp;Environmental Health Perspective 116(4): 514&ndash;519.</li>\n\t<li>Lee, J. and Lim K. T. (2010). Plant-originated glycoprotein (36kDa) suppresses interleukin-4 and -10 in bisphenol A-stimulated primary cultured mouse lymphocytes. Drug and Chemical Toxicology. 33(4): 421-429.</li>\n\t<li>Lambert KC, Curran EM, et al. <a href=\"https://pubmed.ncbi.nlm.nih.gov/16237062/?from_term=Estrogen+Receptor%2C+Deficiency+in+macrophages+results+in+increased+stimulation&amp;from_pos=2\">Estrogen receptor alpha (ERalpha) deficiency in macrophages results in increased stimulation of CD4+ T cells while 17beta-estradiol acts through ERalpha to increase IL-4 and GATA-3 expression in CD4+ T cells independent of antigen presentation.</a> J Immunol. 2005; 175(9): 5716-23.</li>\n</ol>\n","biologicalOrganisationLevel":"Cellular","organTerm":{"name":"immune system","sourceId":"UBERON:0002405"},"biologicalEvents":[{"object":{}}],"keyEventStressors":["Bisphenol A","17beta-Estradiol"],"id":1712}
{"title":"Increase of anti-DNA antibody from autoreactive B cell","references":"<ol>\n\t<li>Daniel, P., Allison, S., Yiming, Y., Ying-Yi, Z. and Laurence, M. Murine Models of Systemic Lupus erythematosus. Journal of Biomedicine and Biotechnology 2011: ArticleID 271694</li>\n\t<li>Wu WM., Lin, B.-F., Su, Y.-C., Suen, J.-L. Chiang, B.-L. (2000). Tamoxifen decreases renal inflammation and alleviates disease severity in autoimmune NZB/W F1 mice. Scandinavian Journal of Immunology 52(4): 393-400.</li>\n\t<li>Peeva, E., Venkatesh, J. and Diamond, B. (2005). Tamoxifen Blocks Estrogen-Induced B Cell Maturation but Not Survival. The Journal of Immunology 175: 1415-1423.</li>\n\t<li>Bynote, KK., Hackenberg, J. M., Korach, K.S., Lubahn, D. B., Lane, P. H.and Gould, K. A. (2008). Estrogen receptor-alpha&nbsp; deficiency attenuates autoimmune disease in (NZB xNZW) F1 mice. Genes and Immunity. 9: 137-152.</li>\n\t<li>Isenberg, DA., Manson, JJ., Ehrenstein, MR. and Rahman, A. (2007). Fifty years of anti-ds DNA antibodies: are we approaching journey&rsquo;s end? Rheumatology 46:1052-6.</li>\n\t<li>Yurino, H., Ishikawa, S., Sato, T., Akadegawa, K., Ito, T., Ueha, S., Inadera, H. and Matsushima, K. (2004). Endocrine disruptors (environmental estrogens) enhance autoantibody production by B1 cells. Toxicological Sciences 81(1): 139-147.</li>\n\t<li>Kanda N. and Tamaki, K. (1999). Estrogen enhances immunoglobulin production&nbsp;by human PBMCs. The Journal of Allergy and Clinical Immunology 103(2): 282-288.</li>\n\t<li>Grimaldi CM, Cleary J, Dagtas AS, Moussai D, Diamond&nbsp;B. Estrogen alters thresholds for B cell apoptosis and activation. J Clin Invest. 2002;109(12):1625-33.</li>\n\t<li>Peeva E, Grimaldi C, Spatz L, Diamond B. Bromocriptine restores tolerance in estrogen-treated mice. J Clin Invest. 2000;106(11):1373-9.</li>\n\t<li>Gabriela, T., Yessia, H., Maria, R. B. and Mario, R. (2019), A Spontaneous Mouse Model of Lupus: Physiology and Therapy. IntechOpen Limited: 1-24.</li>\n\t<li>John, L. S., Jackie, E., Phil, R., Kenneth, S. K. and Gary, S. G. (2008), Impact of estrogen receptor deficiency on disease expression in the NZM2410 lupus prone mouse. Clin Immunol. 128(2): 259-268.</li>\n\t<li>Wang, Y., Hu, Q., Madri, J. A., Rollins, S.A., Chodera, A, and Matis, L. A. (1996), Amelioration of lupus-like autoimmune disease in NZB/W F1 mice after treatment with a blocking monoclonal antibody specific for complement component C5. Proc Natl Acad Sci U S A. 93(16):8563-8568.</li>\n\t<li>Bynoe MS, Grimaldi CM, Diamond B. Estrogen up-regulates Bcl-2 and blocks tolerance induction of na&uml;ve B cells. PNAS 2000; 97(6):2703-8.</li>\n</ol>\n","biologicalOrganisationLevel":"Cellular","organTerm":{"name":"immune system","sourceId":"UBERON:0002405"},"biologicalEvents":[{"object":{}}],"keyEventStressors":["Diethylstilbestrol","Bisphenol A","17beta-Estradiol"],"id":1713}
{"title":"Exacerbation of systemic lupus erythematosus (SLE)","references":"<ol>\n\t<li>Nguyet-Cam Vu Lam, Maria V. Ghetu and Marzena L. BIENIEK. Systemic Lupus Erythematosus: Primary Care Approach to Diagnosis and Management. American Family Physician, 2016; 94 (4): 284-294.</li>\n\t<li>Bernard Thong and Nancy J. Olsen. Systemic lupus erythematosus diagnosis and management. Rheumatology 2017; 56: i3-i13.</li>\n\t<li>Daniel, P., Allison, S., Yiming, Y., Ying-Yi, Z. and Laurence, M. Murine Models of Systemic Lupus erythematosus. Journal of Biomedicine and Biotechnology 2011: ArticleID 271694</li>\n\t<li>Bynote, KK, Hackenberg, JM., Korach, K.S., Lubahn, D. B., Lane, P. H. and Gould, K. A. (2008). Estrogen receptor-alpha deficiency attenuates autoimmune disease in (NZB xNZW) F1 mice. Genes and Immunity. 9: 137-152.</li>\n\t<li>Inui A, Ogasawara H, Ogawa H, et al. Estrogen receptor expression by peripheral blood mononuclear cells of patients with systemic lupus erythematosus. Clin Rheumatol. 2007;26(10):1675-8.</li>\n\t<li>Zhang DH, Cohn L, Ray P, Bottomly K, Ray A. Transcription factor GATA-3 is differentially expressed in murine Th1 and Th2 cells and controls Th2-specific expression of the interleukin-5 gene. J Biol Chem. 1997. 22;272(34):21597-603.</li>\n\t<li>Pai SY, Truitt ML, Ho IC. GATA-3 deficiency abrogates the development and maintenance of T helper type 2 cells. Proc Natl Acad Sci U S A. 2004 Feb 17;101(7):1993-8.</li>\n\t<li>Gabriela, T., Yessia, H., Maria, R. B. and Mario, R. (2019), A Spontaneous Mouse Model of Lupus: Physiology and Therapy. IntechOpen Limited: 1-24.</li>\n\t<li>John, L. S., Jackie, E., Phil, R., Kenneth, S. K. and Gary, S. G. (2008), Impact of estrogen receptor deficiency on disease expression in the NZM2410 lupus prone mouse. Clin Immunol. 128(2): 259-268.</li>\n\t<li>Wang, Y., Hu, Q., Madri, J. A., Rollins, S.A., Chodera, A, and Matis, L. A. (1996), Amelioration of lupus-like autoimmune disease in NZB/W F1 mice after treatment with a blocking monoclonal antibody specific for complement component C5. Proc Natl Acad Sci U S A. 93(16):8563-8568.</li>\n\t<li>Brian S. Andrews, Robert A. Eisenberg, Argyrios N. Theofilopoulos, S Izui, Curtis B. Wilson, Patricia J. McConahey, Edwin D. Murphy, John B. Roths and Frank J. Dixon. Spontaneous Murine Lupus-Like Syndromes. Clinical and Immunopathological Manifestations in Several Strains. J. EXP. Med. 1978; 148(5):1198-215</li>\n\t<li>Bertsias G, Ricard Cervera and Dimitrios T. Boumpas. Systemic Lupus Erythematosus: Pathogenesis and Clinical Features. 20_Eular_Fpp.indd. 2012; 476-505.</li>\n\t<li>Sanchez-Guerrero J. Karlson EW. Liang MH. Hunter DJ,. Speizer F. E, and Colditz. G. A. Past Use of Oral Contraceptives and the Risk of Developing Systemic Lupus Erythematosus. Arthritis Rheum. 1997; 40 (5): 804-808.</li>\n\t<li>Rider, V. and Abdou, N. I. (2001). Gender differences in autoimmunity: molecular basis for estrogen effects in systemic lupus erythematosus. International Immunopharmacology 1(6): 1009-1024.</li>\n\t<li>Luis, J. J., Gabriela, M., Pilar, C.-D., Carmen, N., Olga V.-L. and Miguel., A. S. (2014). Risk factors of systemic lupus erythematosus ares during pregnancy. Immunologic Research 60: 184-192</li>\n\t<li>Grainne, M. and David, I. (2013). Effect of gender on clinical presentation in systemic lupus erythematosus. Rheumatology 52: 2108-2115</li>\n\t<li>Doria, A., Iaccarino, L., Sarzi-Puttini, P., Ghirardello, A., Zampieri, S., Arienti, S., Cutolo, M. and Todesco, S. (2006). Estrogens in pregnancy and systemic lupus erythematosus. Annals of the New York Academy of Sciences 1069: 247-256.</li>\n\t<li>Carlsten H, Nilsson N, Tarkowski A, et al. Estrogen accelerates immune complex glomerulonephritis but ameliorates T cell-mediated vasculitis and sialadenitis in autoimmune MRL lpr/lpr mice. Cell Immunol. 1992;144(1):190-202.</li>\n\t<li>Melissa, C and Gary, G (2011). Estrogen Receptors in Immunity and Autoimmunity. Clinical Reviews in Allergy &amp; Immunology 40: 66-73.</li>\n\t<li>Maret, A., Coudert, J. D., Garidou, L., Foucras, G., Gourdy, P., Krust, A., Dupont, S., Chambon, P., Druet, P., Bayard, F. and Gu&eacute;ry, J. C. (2003).&nbsp;Estradiol enhances primary antigen-specific CD4 T cell responses and Th1 development in vivo. Essential role of estrogen receptor &alpha; expression in hematopoietic cells. The European Journal of Immunology 33: 512-521.</li>\n\t<li>Bebo, B. F. Jr., Fyfe-Johnson, A., Adlard, K., Beam, A. G., Vandenbark, A. A.and Offner, H. Low-Dose Estrogen Therapy Ameliorates Experimental Autoimmune Encephalomyelitis in Two Different Inbred Mouse Strains. (2001). The Journal of Immunology. 166: 2080-2089.</li>\n\t<li>Grimaldi CM, Cleary J, Dagtas AS, Moussai D, Diamond&nbsp;B. Estrogen alters thresholds for B cell apoptosis and activation. J Clin Invest. 2002;109(12):1625-33.</li>\n\t<li>Peeva E, Grimaldi C, Spatz L, Diamond B. Bromocriptine restores tolerance in estrogen-treated mice. J Clin Invest. 2000;106(11):1373-9.</li>\n\t<li>Buyon JP. Hormone replacement therapy in postmenopausal women with systemic lupus erythematosus. J Am Med Womens Assoc (1998) 53(1):13-17.</li>\n\t<li>OECD Series on Testing and Assessment [Revised Guidance Document 150 on Standardised Test Guidelines for Evaluating Chemicals for Endocrine Disruption. 2019].</li>\n</ol>\n","biologicalOrganisationLevel":"Individual","organTerm":{},"biologicalEvents":[{"object":{}}],"keyEventStressors":["Bisphenol A","17beta-Estradiol"],"id":1714}
{"title":"Inhibition of JAK3","references":"<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot; &quot;\"><span style=\"color:#333333\">Darnell JE, Jr. 1997. STATs and gene regulation. Science 277:1630-1635.</span></span></span></p>\n\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot; &quot;\"><span style=\"color:#333333\">Decker T, Kovarik P, Meinke A. 1997. GAS elements: a few nucleotides with a major impact on cytokine-induced gene expression. J Interferon Cytokine Res 17:121-134. DOI: 10.1089/jir.1997.17.121.</span></span></span></p>\n\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot; &quot;\"><span style=\"color:#333333\">Gaffen SL, Lai SY, Xu W, Gouilleux F, Groner B, Goldsmith MA, Greene WC. 1995. Signaling through the interleukin 2 receptor beta chain activates a STAT-5-like DNA-binding activity. Proc Natl Acad Sci U S A 92:7192-7196.</span></span></span></p>\n\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot; &quot;\"><span style=\"color:#333333\">Gianti E, Zauhar RJ. 2015. An SH2 domain model of STAT5 in complex with phospho-peptides define &quot;STAT5 Binding Signatures&quot;. J Comput Aided Mol Des 29:451-470. DOI: 10.1007/s10822-015-9835-6.</span></span></span></p>\n\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot; &quot;\"><span style=\"color:#333333\">Pei H, He L, Shao M, Yang Z, Ran Y, Li D, Zhou Y, Tang M, Wang T, Gong Y, Chen X, Yang S, Xiang M, Chen L. 2018. Discovery of a highly selective JAK3 inhibitor for the treatment of rheumatoid arthritis. Sci Rep 8:5273. DOI: 10.1038/s41598-018-23569-y.</span></span></span></p>\n\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot; &quot;\"><span style=\"color:#333333\">Peschon JJ, Morrissey PJ, Grabstein KH, Ramsdell FJ, Maraskovsky E, Gliniak BC, Park LS, Ziegler SF, Williams DE, Ware CB, Meyer JD, Davison BL. 1994. Early lymphocyte expansion is severely impaired in interleukin 7 receptor-deficient mice. J Exp Med 180:1955-1960.</span></span></span></p>\n\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot; &quot;\"><span style=\"color:#333333\">Stahl N, Boulton TG, Farruggella T, Ip NY, Davis S, Witthuhn BA, Quelle FW, Silvennoinen O, Barbieri G, Pellegrini S, et al. 1994. Association and activation of Jak-Tyk kinases by CNTF-LIF-OSM-IL-6 beta receptor components. Science 263:92-95.</span></span></span></p>\n\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot; &quot;\"><span style=\"color:#333333\">Telliez JB, Dowty ME, Wang L, Jussif J, Lin T, Li L, Moy E, Balbo P, Li W, Zhao Y, Crouse K, Dickinson C, Symanowicz P, Hegen M, Banker ME, Vincent F, Unwalla R, Liang S, Gilbert AM, Brown MF, Hayward M, Montgomery J, Yang X, Bauman J, Trujillo JI, Casimiro-Garcia A, Vajdos FF, Leung L, Geoghegan KF, Quazi A, Xuan D, Jones L, Hett E, Wright K, Clark JD, Thorarensen A. 2016. Discovery of a JAK3-Selective Inhibitor: Functional Differentiation of JAK3-Selective Inhibition over pan-JAK or JAK1-Selective Inhibition. ACS Chem Biol 11:3442-3451. DOI: 10.1021/acschembio.6b00677.</span></span></span></p>\n\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot; &quot;\"><span style=\"color:#333333\">Thorarensen A, Dowty ME, Banker ME, Juba B, Jussif J, Lin T, Vincent F, Czerwinski RM, Casimiro-Garcia A, Unwalla R, Trujillo JI, Liang S, Balbo P, Che Y, Gilbert AM, Brown MF, Hayward M, Montgomery J, Leung L, Yang X, Soucy S, Hegen M, Coe J, Langille J, Vajdos F, Chrencik J, Telliez JB. 2017. Design of a Janus Kinase 3 (JAK3) Specific Inhibitor 1-((2S,5R)-5-((7H-Pyrrolo[2,3-d]pyrimidin-4-yl)amino)-2-methylpiperidin-1-yl)prop -2-en-1-one (PF-06651600) Allowing for the Interrogation of JAK3 Signaling in Humans. J Med Chem 60:1971-1993. DOI: 10.1021/acs.jmedchem.6b01694.</span></span></span></p>\n\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot; &quot;\"><span style=\"color:#333333\">Xu BC, Wang X, Darus CJ, Kopchick JJ. 1996. Growth hormone promotes the association of transcription factor STAT5 with the growth hormone receptor. J Biol Chem 271:19768-19773.</span></span></span></p>\n","biologicalOrganisationLevel":"Molecular","organTerm":{"name":"immune system","sourceId":"UBERON:0002405"},"biologicalEvents":[{"action":"decreased","process":"regulation of binding","object":{"name":"tyrosine-protein kinase JAK3","source":"PR","sourceId":"PR:000009198"}}],"keyEventStressors":["PF-06651600 (CAS No1792180-81-4), RB1"],"id":1715}
{"title":"Blockade of STAT5 phosphorylation","references":"<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot; &quot;\"><span style=\"color:#333333\">Gianti E, Zauhar RJ. 2015. An SH2 domain model of STAT5 in complex with phospho-peptides define &quot;STAT5 Binding Signatures&quot;. J Comput Aided Mol Des 29:451-470. DOI: 10.1007/s10822-015-9835-6.</span></span></span></p>\n\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot; &quot;\"><span style=\"color:#333333\">Kisseleva T, Bhattacharya S, Braunstein J, Schindler CW. 2002. Signaling through the JAK/STAT pathway, recent advances and future challenges. Gene 285:1-24.</span></span></span></p>\n\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot; &quot;\"><span style=\"color:#333333\">Muller J, Sperl B, Reindl W, Kiessling A, Berg T. 2008. Discovery of chromone-based inhibitors of the transcription factor STAT5. Chembiochem 9:723-727. DOI: 10.1002/cbic.200700701.</span></span></span></p>\n\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot; &quot;\"><span style=\"color:#333333\">Nelson EA, Walker SR, Weisberg E, Bar-Natan M, Barrett R, Gashin LB, Terrell S, Klitgaard JL, Santo L, Addorio MR, Ebert BL, Griffin JD, Frank DA. 2011. The STAT5 inhibitor pimozide decreases survival of chronic myelogenous leukemia cells resistant to kinase inhibitors. Blood 117:3421-3429. DOI: 10.1182/blood-2009-11-255232</span></span></span></p>\n\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot; &quot;\"><span style=\"color:#333333\">blood-2009-11-255232 [pii].</span></span></span></p>\n\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot; &quot;\"><span style=\"color:#333333\">Osinalde N, Sanchez-Quiles V, Blagoev B, Kratchmarova I. 2017. Data on interleukin (IL)-2- and IL-15-dependent changes in IL-2Rbeta and IL-2Rgamma complexes. Data Brief 11:499-506. DOI: 10.1016/j.dib.2017.02.030.</span></span></span></p>\n\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot; &quot;\"><span style=\"color:#333333\">Stahl N, Boulton TG, Farruggella T, Ip NY, Davis S, Witthuhn BA, Quelle FW, Silvennoinen O, Barbieri G, Pellegrini S, et al. 1994. Association and activation of Jak-Tyk kinases by CNTF-LIF-OSM-IL-6 beta receptor components. Science 263:92-95.</span></span></span></p>\n\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot; &quot;\"><span style=\"color:#333333\">Telliez JB, Dowty ME, Wang L, Jussif J, Lin T, Li L, Moy E, Balbo P, Li W, Zhao Y, Crouse K, Dickinson C, Symanowicz P, Hegen M, Banker ME, Vincent F, Unwalla R, Liang S, Gilbert AM, Brown MF, Hayward M, Montgomery J, Yang X, Bauman J, Trujillo JI, Casimiro-Garcia A, Vajdos FF, Leung L, Geoghegan KF, Quazi A, Xuan D, Jones L, Hett E, Wright K, Clark JD, Thorarensen A. 2016. Discovery of a JAK3-Selective Inhibitor: Functional Differentiation of JAK3-Selective Inhibition over pan-JAK or JAK1-Selective Inhibition. ACS Chem Biol 11:3442-3451. DOI: 10.1021/acschembio.6b00677.</span></span></span></p>\n\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot; &quot;\"><span style=\"color:#333333\">Thibault G, Paintaud G, Legendre C, Merville P, Coulon M, Chasseuil E, Ternant D, Rostaing L, Durrbach A, Di Giambattista F, Buchler M, Lebranchu Y. 2016. CD25 blockade in kidney transplant patients randomized to standard-dose or high-dose basiliximab with cyclosporine, or high-dose basiliximab in a calcineurin inhibitor-free regimen. Transpl Int 29:184-195. DOI: 10.1111/tri.12688.</span></span></span></p>\n\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot; &quot;\"><span style=\"color:#333333\">Wakao H, Schmitt-Ney M, Groner B. 1992. Mammary gland-specific nuclear factor is present in lactating rodent and bovine mammary tissue and composed of a single polypeptide of 89 kDa. J Biol Chem 267:16365-16370.</span></span></span></p>\n\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot; &quot;\"><span style=\"color:#333333\">Xu BC, Wang X, Darus CJ, Kopchick JJ. 1996. Growth hormone promotes the association of transcription factor STAT5 with the growth hormone receptor. J Biol Chem 271:19768-19773.</span></span></span></p>\n","biologicalOrganisationLevel":"Cellular","organTerm":{"name":"immune system","sourceId":"UBERON:0002405"},"biologicalEvents":[{"action":"decreased","process":"protein dephosphorylation","object":{"name":"signal transducer and transcription activator STAT","source":"PR","sourceId":"PR:000001933"}}],"keyEventStressors":["N-((4-Oxo-4H-chromen-3-yl)methylene)nicotinohydrazide Pimozide"],"id":1716}
{"title":"Suppression of STAT5 binding to cytokine gene promoters","references":"<div>\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot; &quot;\"><span style=\"color:#333333\">Beadling C, Guschin D, Witthuhn BA, Ziemiecki A, Ihle JN, Kerr IM, Cantrell DA. 1994. Activation of JAK kinases and STAT proteins by interleukin-2 and interferon alpha, but not the T cell antigen receptor, in human T lymphocytes. EMBO J 13:5605-5615.</span></span></span></p>\n\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot; &quot;\"><span style=\"color:#333333\">Darnell JE, Jr. 1997. STATs and gene regulation. Science 277:1630-1635.</span></span></span></p>\n\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot; &quot;\"><span style=\"color:#333333\">Decker T, Kovarik P, Meinke A. 1997. GAS elements: a few nucleotides with a major impact on cytokine-induced gene expression. J Interferon Cytokine Res 17:121-134. DOI: 10.1089/jir.1997.17.121.</span></span></span></p>\n\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot; &quot;\"><span style=\"color:#333333\">Gaffen SL, Lai SY, Xu W, Gouilleux F, Groner B, Goldsmith MA, Greene WC. 1995. Signaling through the interleukin 2 receptor beta chain activates a STAT-5-like DNA-binding activity. Proc Natl Acad Sci U S A 92:7192-7196.</span></span></span></p>\n\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot; &quot;\"><span style=\"color:#333333\">Gilmour KC, Pine R, Reich NC. 1995. Interleukin 2 activates STAT5 transcription factor (mammary gland factor) and specific gene expression in T lymphocytes. Proc Natl Acad Sci U S A 92:10772-10776. DOI: 10.1073/pnas.92.23.10772.</span></span></span></p>\n\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot; &quot;\"><span style=\"color:#333333\">Heidt S, Roelen DL, Eijsink C, Eikmans M, van Kooten C, Claas FH, Mulder A. 2010. Calcineurin inhibitors affect B cell antibody responses indirectly by interfering with T cell help. Clin Exp Immunol 159:199-207. DOI: 10.1111/j.1365-2249.2009.04051.x.</span></span></span></p>\n\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot; &quot;\"><span style=\"color:#333333\">Ihle JN. 1996. STATs: signal transducers and activators of transcription. Cell 84:331-334.</span></span></span></p>\n\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot; &quot;\"><span style=\"color:#333333\">Johnston JA, Bacon CM, Finbloom DS, Rees RC, Kaplan D, Shibuya K, Ortaldo JR, Gupta S, Chen YQ, Giri JD, et al. 1995. Tyrosine phosphorylation and activation of STAT5, STAT3, and Janus kinases by interleukins 2 and 15. Proc Natl Acad Sci U S A 92:8705-8709.</span></span></span></p>\n\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot; &quot;\"><span style=\"color:#333333\">Leonard WJ, O&#39;Shea JJ. 1998. Jaks and STATs: biological implications. Annu Rev Immunol 16:293-322. DOI: 10.1146/annurev.immunol.16.1.293.</span></span></span></p>\n\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot; &quot;\"><span style=\"color:#333333\">Liu J, Yoshida Y, Kunugita N, Noguchi J, Sugiura T, Ding N, Arashidani K, Fujimaki H, Yamashita U. 2010. Thymocytes are activated by toluene inhalation through the transcription factors NF-kappaB, STAT5 and NF-AT. J Appl Toxicol 30:656-660. DOI: 10.1002/jat.1536.</span></span></span></p>\n\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot; &quot;\"><span style=\"color:#333333\">Maeshima K, Yamaoka K, Kubo S, Nakano K, Iwata S, Saito K, Ohishi M, Miyahara H, Tanaka S, Ishii K, Yoshimatsu H, Tanaka Y. 2012. The JAK inhibitor tofacitinib regulates synovitis through inhibition of interferon-gamma and interleukin-17 production by human CD4+ T cells. Arthritis Rheum 64:1790-1798. DOI: 10.1002/art.34329.</span></span></span></p>\n\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot; &quot;\"><span style=\"color:#333333\">Muller J, Sperl B, Reindl W, Kiessling A, Berg T. 2008. Discovery of chromone-based inhibitors of the transcription factor STAT5. Chembiochem 9:723-727. DOI: 10.1002/cbic.200700701.</span></span></span></p>\n</div>\n","biologicalOrganisationLevel":"Cellular","organTerm":{"name":"immune system","sourceId":"UBERON:0002405"},"biologicalEvents":[{"action":"decreased","process":"negative regulation of DNA binding","object":{"name":"protein-DNA complex","source":"GO","sourceId":"GO:0032993"}}],"keyEventStressors":["N-((4-Oxo-4H-chromen-3-yl)methylene)nicotinohydrazide"],"id":1717}
{"title":"Suppression of IL-4 production","references":"<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot; &quot;\"><span style=\"color:#333333\">Choi P, Reiser H. 1998. IL-4: role in disease and regulation of production. Clin Exp Immunol 113:317-319. DOI: 10.1046/j.1365-2249.1998.00690.x.</span></span></span></p>\n\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot; &quot;\"><span style=\"color:#333333\">Cote-Sierra J, Foucras G, Guo L, Chiodetti L, Young HA, Hu-Li J, Zhu J, Paul WE. 2004. Interleukin 2 plays a central role in Th2 differentiation. Proc Natl Acad Sci U S A 101:3880-3885. DOI: 10.1073/pnas.0400339101.</span></span></span></p>\n\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot; &quot;\"><span style=\"color:#333333\">Dumont FJ, Staruch MJ, Fischer P, DaSilva C, Camacho R. 1998. Inhibition of T cell activation by pharmacologic disruption of the MEK1/ERK MAP kinase or calcineurin signaling pathways results in differential modulation of cytokine production. J Immunol 160:2579-2589.</span></span></span></p>\n\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot; &quot;\"><span style=\"color:#333333\">Ghoreschi K, Jesson MI, Li X, Lee JL, Ghosh S, Alsup JW, Warner JD, Tanaka M, Steward-Tharp SM, Gadina M, Thomas CJ, Minnerly JC, Storer CE, LaBranche TP, Radi ZA, Dowty ME, Head RD, Meyer DM, Kishore N, O&#39;Shea JJ. 2011. Modulation of innate and adaptive immune responses by tofacitinib (CP-690,550). J Immunol 186:4234-4243. DOI: 10.4049/jimmunol.1003668.</span></span></span></p>\n\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot; &quot;\"><span style=\"color:#333333\">Kagami S, Nakajima H, Suto A, Hirose K, Suzuki K, Morita S, Kato I, Saito Y, Kitamura T, Iwamoto I. 2001. Stat5a regulates T helper cell differentiation by several distinct mechanisms. Blood 97:2358-2365. DOI: 10.1182/blood.v97.8.2358.</span></span></span></p>\n\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot; &quot;\"><span style=\"color:#333333\">Levy DE, Darnell JE, Jr. 2002. Stats: transcriptional control and biological impact. Nat Rev Mol Cell Biol 3:651-662. DOI: 10.1038/nrm909.</span></span></span></p>\n\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot; &quot;\"><span style=\"color:#333333\">Migita K, Miyashita T, Izumi Y, Koga T, Komori A, Maeda Y, Jiuchi Y, Aiba Y, Yamasaki S, Kawakami A, Nakamura M, Ishibashi H. 2011. Inhibitory effects of the JAK inhibitor CP690,550 on human CD4(+) T lymphocyte cytokine production. BMC Immunol 12:51. DOI: 10.1186/1471-2172-12-51.</span></span></span></p>\n\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot; &quot;\"><span style=\"color:#333333\">Moriggl R, Topham DJ, Teglund S, Sexl V, McKay C, Wang D, Hoffmeyer A, van Deursen J, Sangster MY, Bunting KD, Grosveld GC, Ihle JN. 1999. Stat5 is required for IL-2-induced cell cycle progression of peripheral T cells. Immunity 10:249-259.</span></span></span></p>\n\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot; &quot;\"><span style=\"color:#333333\">Zhu J, Cote-Sierra J, Guo L, Paul WE. 2003. Stat5 activation plays a critical role in Th2 differentiation. Immunity 19:739-748. DOI: 10.1016/s1074-7613(03)00292-9.</span></span></span></p>\n\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot; &quot;\"><span style=\"color:#333333\">Zhu J, Guo L, Watson CJ, Hu-Li J, Paul WE. 2001. Stat6 is necessary and sufficient for IL-4&#39;s role in Th2 differentiation and cell expansion. J Immunol 166:7276-7281. DOI: 10.4049/jimmunol.166.12.7276.</span></span></span></p>\n","biologicalOrganisationLevel":"Cellular","organTerm":{"name":"immune system","sourceId":"UBERON:0002405"},"biologicalEvents":[{"action":"decreased","process":"interleukin-4 production","object":{"name":"interleukin-4","source":"PR","sourceId":"PR:000001391"}}],"keyEventStressors":["Tofacitinib  (CP690,550)"],"id":1718}
{"title":"Impairment of T-cell dependent antibody response","references":"<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot; &quot;\"><span style=\"color:#333333\">Aversa G, Punnonen J, Cocks BG, de Waal Malefyt R, Vega F, Jr., Zurawski SM, Zurawski G, de Vries JE. 1993. An interleukin 4 (IL-4) mutant protein inhibits both IL-4 or IL-13-induced human immunoglobulin G4 (IgG4) and IgE synthesis and B cell proliferation: support for a common component shared by IL-4 and IL-13 receptors. J Exp Med 178:2213-2218. DOI: 10.1084/jem.178.6.2213.</span></span></span></p>\n\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot; &quot;\"><span style=\"color:#333333\">Dewitt JC, Copeland CB, Strynar MJ, Luebke RW. 2008. Perfluorooctanoic acid-induced immunomodulation in adult C57BL/6J or C57BL/6N female mice. Environ Health Perspect 116:644-650. DOI: 10.1289/ehp.10896.</span></span></span></p>\n\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot; &quot;\"><span style=\"color:#333333\">DeWitt JC, Shnyra A, Badr MZ, Loveless SE, Hoban D, Frame SR, Cunard R, Anderson SE, Meade BJ, Peden-Adams MM, Luebke RW, Luster MI. 2009. Immunotoxicity of perfluorooctanoic acid and perfluorooctane sulfonate and the role of peroxisome proliferator-activated receptor alpha. Crit Rev Toxicol 39:76-94. DOI: 10.1080/10408440802209804.</span></span></span></p>\n\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot; &quot;\"><span style=\"color:#333333\">Gaida K, Salimi-Moosavi H, Subramanian R, Almon V, Knize A, Zhang M, Lin FF, Nguyen HQ, Zhou L, Sullivan JK, Wong M, McBride HJ. 2015. Inhibition of CRAC with a human anti-ORAI1 monoclonal antibody inhibits T-cell-derived cytokine production but fails to inhibit a T-cell-dependent antibody response in the cynomolgus monkey. J Immunotoxicol 12:164-173. DOI: 10.3109/1547691X.2014.915897.</span></span></span></p>\n\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot; &quot;\"><span style=\"color:#333333\">Heidt S, Roelen DL, Eijsink C, Eikmans M, van Kooten C, Claas FH, Mulder A. 2010. Calcineurin inhibitors affect B cell antibody responses indirectly by interfering with T cell help. Clin Exp Immunol 159:199-207. DOI: 10.1111/j.1365-2249.2009.04051.x.</span></span></span></p>\n\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot; &quot;\"><span style=\"color:#333333\">Justiz Vaillant AA, Qurie A. 2020. Interleukin. In <em>StatPearls</em>: Treasure Island (FL)</span></span></span></p>\n\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot; &quot;\"><span style=\"color:#333333\">Kino T, Hatanaka H, Hashimoto M, Nishiyama M, Goto T, Okuhara M, Kohsaka M, Aoki H, Imanaka H. 1987. FK-506, a novel immunosuppressant isolated from a Streptomyces. I. Fermentation, isolation, and physico-chemical and biological characteristics. J Antibiot (Tokyo) 40:1249-1255. DOI: 10.7164/antibiotics.40.1249.</span></span></span></p>\n\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot; &quot;\"><span style=\"color:#333333\">Onda M, Ghoreschi K, Steward-Tharp S, Thomas C, O&#39;Shea JJ, Pastan IH, FitzGerald DJ. 2014. Tofacitinib suppresses antibody responses to protein therapeutics in murine hosts. J Immunol 193:48-55. DOI: 10.4049/jimmunol.1400063.</span></span></span></p>\n\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot; &quot;\"><span style=\"color:#333333\">Sakuma S, Kato Y, Nishigaki F, Magari K, Miyata S, Ohkubo Y, Goto T. 2001. Effects of FK506 and other immunosuppressive anti-rheumatic agents on T cell activation mediated IL-6 and IgM production in vitro. Int Immunopharmacol 1:749-757.</span></span></span></p>\n\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot; &quot;\"><span style=\"color:#333333\">Schultz HS, Reedtz-Runge SL, Backstrom BT, Lamberth K, Pedersen CR, Kvarnhammar AM, consortium A. 2017. Quantitative analysis of the CD4+ T cell response to therapeutic antibodies in healthy donors using a novel T cell:PBMC assay. PLoS One 12:e0178544. DOI: 10.1371/journal.pone.0178544.</span></span></span></p>\n\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot; &quot;\"><span style=\"color:#333333\">Smith DC, Smith MJ, White KL. 2010. Systemic immunosuppression following a single pharyngeal aspiration of 1,2:5,6-dibenzanthracene in female B6C3F1 mice. J Immunotoxicol 7:219-231. DOI: 10.3109/1547691X.2010.487193.</span></span></span></p>\n\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot; &quot;\"><span style=\"color:#333333\">Ulrich P, Paul G, Perentes E, Mahl A, Roman D. 2004. Validation of immune function testing during a 4-week oral toxicity study with FK506. Toxicol Lett 149:123-131. DOI: 10.1016/j.toxlet.2003.12.069.</span></span></span></p>\n\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot; &quot;\"><span style=\"color:#333333\">Yang Q, Abedi-Valugerdi M, Xie Y, Zhao XY, Moller G, Nelson BD, DePierre JW. 2002. Potent suppression of the adaptive immune response in mice upon dietary exposure to the potent peroxisome proliferator, perfluorooctanoic acid. Int Immunopharmacol 2:389-397. DOI: 10.1016/s1567-5769(01)00164-3.</span></span></span></p>\n","biologicalOrganisationLevel":"Individual","organTerm":{},"biologicalEvents":[{"action":"decreased","process":"T cell activation involved in immune response","object":{}}],"keyEventStressors":["Cyclosporin, FK506, Basiliximab, PFOA (perfluorooctanoic acid)","Tacrolimus (also FK506)"],"id":1719}
{"title":"Trypsin inhibition","references":"<p style=\"margin-left: 28pt;\">&nbsp;1.&nbsp;&nbsp;&nbsp;&nbsp; AACCI (2009) American Association of Cereal Chemists. Approved methods of analysis, 11th Ed. Method 22-40.01. Measurement of trypsin inhibitor activity of soy products&mdash;spectrophotometric method. First approval Nov 7, 1973; Reapproved Nov 3, 1999. AACC International, St. Paul. doi: 10.1094/AACCIntMethod-22-40.01</p>\n\n<p style=\"margin-left: 28pt;\">&nbsp;2.&nbsp;&nbsp;&nbsp; AOCS (2017) American Oil Chemists&rsquo; Society. Official and tentative methods of the American Oil Society, 3rd Ed. Method Ba 12-75. Trypsin inhibitor activity. First approval 1980; Reapproved 2009. American Oil Chemist Society, Champaign</p>\n\n<p style=\"margin-left: 28pt;\">&nbsp;3.&nbsp;&nbsp;&nbsp; Baird Jr TT, Craik CS: Trypsin. Academic Press, Cambridge, Massachusetts (pp)2594-2600,2013</p>\n\n<p style=\"margin-left: 28pt;\">&nbsp;4.&nbsp;&nbsp;&nbsp; Baird Jr TT: Trypsin. Elsevier,2017</p>\n\n<p style=\"margin-left: 28pt;\">&nbsp;5.&nbsp;&nbsp;&nbsp; Caron J, Domenger D, Dhulster P, Ravallec R, Cudennec B: Protein digestion-derived peptides and the peripheral regulation of food intake. Front Endocrinol (Lausanne) 8:85,2017</p>\n\n<p style=\"margin-left: 28pt;\">&nbsp;6.&nbsp;&nbsp;&nbsp; Chen J-M, Claude F&eacute;rec C: Human trypsins. Academic Press, Cambridge, Massachusetts (pp) 2600-2609,2013</p>\n\n<p style=\"margin-left: 28pt;\">&nbsp;7.&nbsp;&nbsp;&nbsp; Cuber JC, Bernard G, Fushiki T, Bernard C, Yamanishi R, Sugimoto E, Chayvialle JA: Luminal CCK-releasing factors in the isolated vascularly perfused rat duodenojejunum. Am J Physiol 259:G191-197,1990</p>\n\n<p style=\"margin-left: 28pt;\">&nbsp;8.&nbsp;&nbsp;&nbsp; Fukuoka S, Nyaruhucha CM: Expression and functional analysis of rat P23, a gut hormone-inducible isoform of trypsin, reveals its resistance to proteinaceous trypsin inhibitors. Biochim Biophys Acta 1588:106-112,2002</p>\n\n<p style=\"margin-left: 28pt;\">&nbsp;9.&nbsp;&nbsp;&nbsp; Green GM, Miyasaka K: Rat pancreatic response to intestinal infusion of intact and hydrolyzed protein. Am J Physiol 245:G394-8,1983</p>\n\n<p style=\"margin-left: 28pt;\">10.&nbsp;&nbsp;&nbsp; ISO (2012) International Organization for Standardization. Standard 14902:2001. Animal feeding stuffs&mdash;determination of trypsin inhibitor activity of soya products. Approved Oct 2001; Reapproved Aug 2012. International Organization for Standardization, Geneva</p>\n\n<p style=\"margin-left: 28pt;\">11.&nbsp;&nbsp;&nbsp; Komarnytsky S, Cook A, Raskin I: Potato protease inhibitors inhibit food intake and increase circulating cholecystokinin levels by a trypsin-dependent mechanism. Int J Obes (Lond) 35:236-243,2011</p>\n\n<p style=\"margin-left: 28pt;\">12.&nbsp;&nbsp;&nbsp; Liddle RA: Regulation of cholecystokinin secretion by intraluminal releasing factors. Am J Physiol 269:G319-27,1995</p>\n\n<p style=\"margin-left: 10mm;\">13.&nbsp;&nbsp;&nbsp;&nbsp; Liu K: Soybean trypsin inhibitor assay: further improvement of the standard method approved and reapproved by American Oil Chemists&rsquo; Society and American Association of Cereal Chemists International. J Am Oil Chem Soc 96: 635&ndash;645,2019</p>\n\n<p style=\"margin-left: 28pt;\">14.&nbsp;&nbsp;&nbsp; Miyasaka K, Nakamura R, Funakoshi A, Kitani K: Stimulatory effect of monitor peptide and human pancreatic secretory trypsin inhibitor on pancreatic secretion and cholecystokinin release in conscious rats. Pancreas 4:139-144,1989</p>\n\n<p style=\"margin-left: 28pt;\">15.&nbsp;&nbsp;&nbsp; Miyasaka K, Funakoshi A: Luminal feedback regulation, monitor peptide, CCK-releasing peptide, and CCK receptors. Pancreas 16:277-283,1998</p>\n\n<p style=\"margin-left: 28pt;\">16.&nbsp;&nbsp;&nbsp; Santos AMC, de Oliveira JS, Bittar ER, da Silva AL, dos Mares Guia ML, Bemquerer MP, Santoro MM: Improved purification process of &beta;- and &alpha;-trypsin isoforms by ion-exchange chromatography. Braz Arch Biol Technol 51: 711-721,2008</p>\n\n<p style=\"margin-left: 28pt;\">17.&nbsp;&nbsp;&nbsp; Savage GP, Morrison SC: Trypsin inhibitors. Elsevier (pp) 5878-5884,2003</p>\n\n<p style=\"margin-left: 10mm;\">18.&nbsp;&nbsp;&nbsp;&nbsp; Sueiro S, Hermida M, Gonz&aacute;lez M, Lois A, Rodr&iacute;guez?Otero JL: A comparison of the ISO and AACC methods for determining the activity of trypsin Inhibitors in soybean meal. J Am Oil Chem Soc 92:1391&ndash;1397,2015</p>\n\n<p style=\"margin-left: 28pt;\">19.&nbsp;&nbsp;&nbsp; Voet D, Voet JG: Biochemistry (2nd ed.). John Wiley &amp; Sons (pp) 396-400,1995</p>\n\n<p style=\"margin-left: 28pt;\">20.&nbsp;&nbsp;&nbsp; Wang BJ, Cui ZJ: How does cholecystokinin stimulate exocrine pancreatic secretion? From birds, rodents, to humans.. Am J Physiol Regul Integr Comp Physiol 292:R666-78,2007</p>\n","biologicalOrganisationLevel":"Molecular","organTerm":{},"biologicalEvents":[{"object":{}}],"id":1720}
{"title":"Increased intestinal monitor peptide level","references":"<p style=\"margin-left: 28pt;\">&nbsp;1.&nbsp;&nbsp;&nbsp; Eddeland A, Ohlsson K: Purification of canine pancreatic secretory trypsin inhibitor and interaction in vitro with complexes of trypsin-alpha-macroglobulin.. Scand J Clin Lab Invest 36:815-820,1976</p>\n\n<p style=\"margin-left: 28pt;\">&nbsp;2.&nbsp;&nbsp;&nbsp; Fushiki T, Kajiura H, Fukuoka S, Kido K, Semba T, Iwai K: Evidence for an intraluminal mediator in rat pancreatic enzyme secretion: reconstitution of the pancreatic response with dietary protein, trypsin and the monitor peptide.. J Nutr 119:622-627,1989</p>\n\n<p style=\"margin-left: 28pt;\">&nbsp;3.&nbsp;&nbsp;&nbsp; Graf R, Klauser S, Fukuoka SI, Schiesser M, Bimmler D: The bifunctional rat pancreatic secretory trypsin inhibitor/monitor peptide provides protection against premature activation of pancreatic juice. Pancreatology 3:195-206,2003</p>\n\n<p style=\"margin-left: 28pt;\">&nbsp;4.&nbsp;&nbsp;&nbsp; Graf R, Bimmler D: Biochemistry and biology of SPINK-PSTI and monitor peptide.. Endocrinol Metab Clin North Am 35:333-43, ix,2006</p>\n\n<p style=\"margin-left: 27.55pt;\">5.&nbsp; Greene LJ, DiCarlo JJ, Sussman AJ, Bartelt DC: Two trypsin inhibitors from porcine pancreatic juice. J Biol Chem 243:1804-1815,1968</p>\n\n<p style=\"margin-left: 28pt;\">&nbsp;6.&nbsp;&nbsp;&nbsp; Guan D, Ohta H, Tawil T, Liddle RA, Green GM: CCK-releasing activity of rat intestinal secretion: effect of atropine and comparison with monitor peptide. Pancreas 5:677-684,1990</p>\n\n<p style=\"margin-left: 28pt;\">&nbsp;7.&nbsp;&nbsp;&nbsp; Iwai K, Fukuoka S, Fushiki T, Tsujikawa M, Hirose M, Tsunasawa S, Sakiyama F: Purification and sequencing of a trypsin-sensitive cholecystokinin-releasing peptide from rat pancreatic juice. Its homology with pancreatic secretory trypsin inhibitor.. J Biol Chem 262:8956-8959,1987</p>\n\n<p style=\"margin-left: 28pt;\">&nbsp;8.&nbsp;&nbsp;&nbsp; Iwai K, Fushiki T, Fukuoka S: Pancreatic enzyme secretion mediated by novel peptide: monitor peptide hypothesis. Pancreas 3:720-728,1988</p>\n\n<p style=\"margin-left: 28pt;\">&nbsp;9.&nbsp;&nbsp;&nbsp; Kikuchi N, Nagata K, Yoshida N, Ogawa M: The multiplicity of human pancreatic secretory trypsin inhibitor. J Biochem 98:687-694,1985</p>\n\n<p style=\"margin-left: 28pt;\">10.&nbsp;&nbsp;&nbsp; Liddle RA, Misukonis MA, Pacy L, Balber AE: Cholecystokinin cells purified by fluorescence-activated cell sorting respond to monitor peptide with an increase in intracellular calcium. Proc Natl Acad Sci U S A 89:5147-5151,1992</p>\n\n<p style=\"margin-left: 28pt;\">11.&nbsp;&nbsp;&nbsp; Liddle RA: Regulation of cholecystokinin secretion by intraluminal releasing factors. Am J Physiol 269:G319-27,1995</p>\n\n<p style=\"margin-left: 28pt;\">12.&nbsp;&nbsp;&nbsp; Liddle RA: Cholecystokinin cells. Annu Rev Physiol 59:221-242,1997</p>\n\n<p style=\"margin-left: 28pt;\">13.&nbsp;&nbsp;&nbsp; Lin YZ, Isaac DD, Tam JP: Synthesis and properties of cholecystokinin-releasing peptide (monitor peptide), a 61-residue trypsin inhibitor. Int J Pept Protein Res 36:433-439,1990</p>\n\n<p style=\"margin-left: 28pt;\">14.&nbsp;&nbsp;&nbsp; Miyasaka K, Nakamura R, Funakoshi A, Kitani K: Stimulatory effect of monitor peptide and human pancreatic secretory trypsin inhibitor on pancreatic secretion and cholecystokinin release in conscious rats. Pancreas 4:139-144,1989</p>\n\n<p style=\"margin-left: 28pt;\">15.&nbsp;&nbsp;&nbsp; Miyasaka K, Funakoshi A: Luminal feedback regulation, monitor peptide, CCK-releasing peptide, and CCK receptors. Pancreas 16:277-283,1998</p>\n\n<p style=\"margin-left: 28pt;\">16.&nbsp;&nbsp;&nbsp; Pubols MH, Bartelt DC, Greene LJ: Trypsin inhibitor from human pancreas and pancreatic juice. J Biol Chem 249:2235-2242,1974</p>\n\n<p style=\"margin-left: 28pt;\">17.&nbsp;&nbsp;&nbsp; Tsuzuki S, Fushiki T, Kondo A, Murayama H, Sugimoto E: Effect of a high-protein diet on the gene expression of a trypsin-sensitive, cholecystokinin-releasing peptide (monitor peptide) in the pancreas. Eur J Biochem 199:245-252,1991</p>\n\n<p style=\"margin-left: 28pt;\">18.&nbsp;&nbsp;&nbsp; Tsuzuki S, Miura Y, Fushiki T, Oomori T, Satoh T, Natori Y, Sugimoto E: Molecular cloning and characterization of genes encoding rat pancreatic cholecystokinin (CCK)-releasing peptide (monitor peptide) and pancreatic secretory trypsin inhibitor (PSTI). Biochim Biophys Acta 1132:199-202,1992</p>\n\n<p style=\"margin-left: 28pt;\">19.&nbsp;&nbsp;&nbsp; Voet D, Voet JG: Biochemistry (2nd ed.). John Wiley &amp; Sons (pp) 396-400,1995</p>\n\n<p style=\"margin-left: 28pt;\">20.&nbsp;&nbsp;&nbsp; Wang Y, Prpic V, Green GM, Reeve JR Jr, Liddle RA: Luminal CCK-releasing factor stimulates CCK release from human intestinal endocrine and STC-1 cells.. Am J Physiol Gastrointest Liver Physiol 282:G16-22,2002</p>\n\n<p style=\"margin-left: 28pt;\">21.&nbsp;&nbsp;&nbsp; Wang BJ, Cui ZJ: How does cholecystokinin stimulate exocrine pancreatic secretion? From birds, rodents, to humans. Am J Physiol Regul Integr Comp Physiol 292:R666-78,2007</p>\n\n<p style=\"margin-left: 28pt;\">22.&nbsp;&nbsp;&nbsp; Yamanishi R, Kotera J, Fushiki T, Soneda T, Iwanaga T, Sugimoto E: Characteristic and localization of the monitor peptide receptor. Biosci Biotechnol Biochem 57:1153-1156,1993</p>\n\n<p style=\"margin-left: 28pt;\">23.&nbsp;&nbsp;&nbsp; Yamanishi R, Kotera J, Fushiki T, Soneda T, Saitoh T, Oomori T, Satoh T, Sugimoto E: A specific binding of the cholecystokinin-releasing peptide (monitor peptide) to isolated rat small-intestinal cells. Biochem J 291 ( Pt 1):57-63,1993</p>\n","biologicalOrganisationLevel":"Organ","organTerm":{},"biologicalEvents":[{"object":{}}],"id":1721}
{"title":"Increased blood CCK level","references":"<p style=\"margin-left: 28pt;\">&nbsp;1.&nbsp;&nbsp;&nbsp; Caron J, Domenger D, Dhulster P, Ravallec R, Cudennec B: Protein digestion-derived peptides and the peripheral regulation of food intake. Front Endocrinol (Lausanne) 8:85,2017</p>\n\n<p style=\"margin-left: 28pt;\">&nbsp;2.&nbsp;&nbsp;&nbsp; Foltz M, Ansems P, Schwarz J, Tasker MC, Lourbakos A, Gerhardt CC: Protein hydrolysates induce CCK release from enteroendocrine cells and act as partial agonists of the CCK1 receptor. J Agric Food Chem 56:837-843,2008</p>\n\n<p style=\"margin-left: 28pt;\">&nbsp;3.&nbsp;&nbsp;&nbsp; Goke B, Printz H, Koop I, Rausch U, Richter G, Arnold R, Adler G: Endogenous CCK release and pancreatic growth in rats after feeding a proteinase inhibitor (camostate). Pancreas 1:509-515,1986</p>\n\n<p style=\"margin-left: 28pt;\">&nbsp;4.&nbsp;&nbsp;&nbsp; Liddle RA, Goldfine ID, Williams JA: Bioassay of plasma cholecystokinin in rats: effects of food, trypsin inhibitor, and alcohol. Gastroenterology 87:542-549,1984</p>\n\n<p style=\"margin-left: 28pt;\">&nbsp;5.&nbsp;&nbsp;&nbsp; Liddle RA: Regulation of cholecystokinin secretion by intraluminal releasing factors. Am J Physiol 269:G319-27,1995</p>\n\n<p style=\"margin-left: 28pt;\">&nbsp;6.&nbsp;&nbsp;&nbsp; Liddle RA: Cholecystokinin cells. Annu Rev Physiol 59:221-242,1997</p>\n\n<p style=\"margin-left: 28pt;\">&nbsp;7.&nbsp;&nbsp;&nbsp; Liddle RA: Regulation of cholecystokinin secretion in humans. J Gastroenterol 35:181-187,2000</p>\n\n<p style=\"margin-left: 28pt;\">&nbsp;8.&nbsp;&nbsp;&nbsp; Miyasaka K, Funakoshi A: Luminal feedback regulation, monitor peptide, CCK-releasing peptide, and CCK receptors. Pancreas 16:277-283,1998</p>\n\n<p style=\"margin-left: 28pt;\">&nbsp;9.&nbsp;&nbsp;&nbsp; Rehfeld JF, Sun G, Christensen T, Hillingso JG: The predominant cholecystokinin in human plasma and intestine is cholecystokinin-33. J Clin Endocrinol Metab 86:251-258,2001</p>\n\n<p style=\"margin-left: 28pt;\">10.&nbsp;&nbsp;&nbsp; Rehfeld JF, Bungaard JR, Friis-Hansen L, Goetze JP: On the tissue-specific processing of procholecystokinin in the brain and gut--a short review. J Physiol Pharmacol 54 Suppl 4:73-79,2003</p>\n\n<p style=\"margin-left: 28pt;\">11.&nbsp;&nbsp;&nbsp; Rehfeld JF: Cholecystokinin-From Local Gut Hormone to Ubiquitous Messenger. Front Endocrinol (Lausanne) 8:47,2017</p>\n\n<p style=\"margin-left: 28pt;\">12.&nbsp;&nbsp;&nbsp; Singer MV, Niebergall-Roth E: Secretion from acinar cells of the exocrine pancreas: role of enteropancreatic reflexes and cholecystokinin. Cell Biol Int 33:1-9,2009</p>\n\n<p style=\"margin-left: 28pt;\">13.&nbsp;&nbsp;&nbsp; Wang BJ, Cui ZJ: How does cholecystokinin stimulate exocrine pancreatic secretion? From birds, rodents, to humans. Am J Physiol Regul Integr Comp Physiol 292:R666-78,2007</p>\n\n<p style=\"margin-left: 28pt;\">14.&nbsp;&nbsp;&nbsp; Wang Y, Prpic V, Green GM, Reeve JR Jr, Liddle RA: Luminal CCK-releasing factor stimulates CCK release from human intestinal endocrine and STC-1 cells. Am J Physiol Gastrointest Liver Physiol 282:G16-22,2002</p>\n\n<p style=\"margin-left: 28pt;\">15.&nbsp;&nbsp;&nbsp; Wang Y, Chandra R, Samsa LA, Gooch B, Fee BE, Cook JM, Vigna SR, Grant AO, Liddle RA: Amino acids stimulate cholecystokinin release through the Ca2+-sensing receptor. Am J Physiol Gastrointest Liver Physiol 300:G528-537,2011</p>\n\n<p style=\"margin-left: 28pt;\">&nbsp;</p>\n\n<p>&nbsp;</p>\n","biologicalOrganisationLevel":"Organ","organTerm":{},"biologicalEvents":[{"object":{}}],"id":1722}
{"title":"Increased exocrine secretion from pancreatic acinar cells","references":"<p style=\"margin-left: 28pt;\">&nbsp;1.&nbsp;&nbsp;&nbsp; Adler G: Regulation of human pancreatic secretion. Digestion 58 Suppl 1:39-41,1997</p>\n\n<p style=\"margin-left: 28pt;\">&nbsp;2.&nbsp;&nbsp;&nbsp; Berg JM, Tymoczko JL, Stryer L: Many enzymes are activated by specific proteolytic cleavage. Biochemistry. 5th edition. New York: W H Freeman, Section 10.5,2002</p>\n\n<p style=\"margin-left: 28pt;\">&nbsp;3.&nbsp;&nbsp;&nbsp; Bourassa J, Laine J, Kruse ML, Gagnon MC, Calvo E, Morisset J: Ontogeny and species differences in the pancreatic expression and localization of the CCK(A) receptors. Biochem Biophys Res Commun 260:820-828,1999</p>\n\n<p style=\"margin-left: 28pt;\">&nbsp;4.&nbsp;&nbsp;&nbsp; Chandra R, Liddle RA: Neural and hormonal regulation of pancreatic secretion. Curr Opin Gastroenterol 25:441-446,2009</p>\n\n<p style=\"margin-left: 28pt;\">&nbsp;5.&nbsp;&nbsp;&nbsp; Dufresne M, Seva C, Fourmy D: Cholecystokinin and gastrin receptors. Physiol Rev 86:805-847,2006</p>\n\n<p style=\"margin-left: 28pt;\">&nbsp;6.&nbsp;&nbsp;&nbsp; Folsch UR, Winckler K, Wormsley KG: Influence of repeated administration of cholecystokinin and secretin on the pancreas of the rat. Scand J Gastroenterol 13:663-671,1978</p>\n\n<p style=\"margin-left: 10mm;\">&nbsp;7.&nbsp;&nbsp;&nbsp;&nbsp; Geron E, Schejter ED, Shilo BZ: Assessing the secretory capacity of pancreatic acinar cells. J Vis Exp,2014</p>\n\n<p style=\"margin-left: 28pt;\">&nbsp;8.&nbsp;&nbsp;&nbsp; Goke B, Printz H, Koop I, Rausch U, Richter G, Arnold R, Adler G: Endogenous CCK release and pancreatic growth in rats after feeding a proteinase inhibitor (camostate). Pancreas 1:509-515,1986</p>\n\n<p style=\"margin-left: 28pt;\">&nbsp;9.&nbsp;&nbsp;&nbsp; Green GM, Miyasaka K: Rat pancreatic response to intestinal infusion of intact and hydrolyzed protein. Am J Physiol 245:G394-8,1983</p>\n\n<p style=\"margin-left: 28pt;\">10.&nbsp;&nbsp;&nbsp; Ji B, Bi Y, Simeone D, Mortensen RM, Logsdon CD: Human pancreatic acinar cells lack functional responses to cholecystokinin and gastrin. Gastroenterology 121:1380-1390,2001</p>\n\n<p style=\"margin-left: 28pt;\">11.&nbsp;&nbsp;&nbsp; Li Y, Hao Y, Owyang C: High-affinity CCK-A receptors on the vagus nerve mediate CCK-stimulated pancreatic secretion in rats. Am J Physiol 273:G679-85,1997</p>\n\n<p style=\"margin-left: 28pt;\">12.&nbsp;&nbsp;&nbsp; Miyasaka K, Shinozaki H, Jimi A, Funakoshi A: Amylase secretion from dispersed human pancreatic acini: neither cholecystokinin A nor cholecystokinin B receptors mediate amylase secretion in vitro. Pancreas 25:161-165,2002</p>\n\n<p style=\"margin-left: 28pt;\">13.&nbsp;&nbsp;&nbsp; Nishimori I, Kamakura M, Fujikawa-Adachi K, Nojima M, Onishi S, Hollingsworth MA, Harris A: Cholecystokinin A and B receptor mRNA expression in human pancreas. Pancreas 19:109-113,1999</p>\n\n<p style=\"margin-left: 28pt;\">14.&nbsp;&nbsp;&nbsp; Owyang C: Physiological mechanisms of cholecystokinin action on pancreatic secretion. Am J Physiol 271:G1-7,1996</p>\n\n<p style=\"margin-left: 28pt;\">15.&nbsp;&nbsp;&nbsp; Pandiri AR: Overview of exocrine pancreatic pathobiology. Toxicol Pathol 42:207-216,2014</p>\n\n<p style=\"margin-left: 28pt;\">16.&nbsp;&nbsp;&nbsp; Rehfeld JF: Cholecystokinin-from local gut hormone to ubiquitous messenger. Front Endocrinol (Lausanne) 8:47,2017</p>\n\n<p style=\"margin-left: 28pt;\">17.&nbsp;&nbsp;&nbsp; Singer MV, Niebergall-Roth E: Secretion from acinar cells of the exocrine pancreas: role of enteropancreatic reflexes and cholecystokinin. Cell Biol Int 33:1-9,2009</p>\n\n<p style=\"margin-left: 28pt;\">18.&nbsp;&nbsp;&nbsp; Wang BJ, Cui ZJ: How does cholecystokinin stimulate exocrine pancreatic secretion? From birds, rodents, to humans. Am J Physiol Regul Integr Comp Physiol 292:R666-78,2007</p>\n\n<p style=\"margin-left: 28pt;\">19.&nbsp;&nbsp;&nbsp; Wank SA: Cholecystokinin receptors. Am J Physiol 269:G628-646,1995</p>\n\n<p>&nbsp;</p>\n","biologicalOrganisationLevel":"Cellular","organTerm":{},"biologicalEvents":[{"object":{}}],"id":1723}
{"title":"Acinar cell proliferation","references":"<p style=\"margin-left: 28pt;\">&nbsp;1.&nbsp;&nbsp;&nbsp; Adler G: Regulation of human pancreatic secretion. Digestion 58 Suppl 1:39-41,1997</p>\n\n<p style=\"margin-left: 28pt;\">&nbsp;2.&nbsp;&nbsp;&nbsp; Berg JM, Tymoczko JL, Stryer L: Many enzymes are activated by specific proteolytic cleavage. Biochemistry. 5th edition. New York: W H Freeman, Section 10.5,2002</p>\n\n<p style=\"margin-left: 28pt;\">&nbsp;3.&nbsp;&nbsp;&nbsp; Bourassa J, Laine J, Kruse ML, Gagnon MC, Calvo E, Morisset J: Ontogeny and species differences in the pancreatic expression and localization of the CCK(A) receptors. Biochem Biophys Res Commun 260:820-828,1999</p>\n\n<p style=\"margin-left: 28pt;\">&nbsp;4.&nbsp;&nbsp;&nbsp; Chandra R, Liddle RA: Neural and hormonal regulation of pancreatic secretion. Curr Opin Gastroenterol 25:441-446,2009</p>\n\n<p style=\"margin-left: 28pt;\">&nbsp;5.&nbsp;&nbsp;&nbsp; Dufresne M, Seva C, Fourmy D: Cholecystokinin and gastrin receptors. Physiol Rev 86:805-847,2006</p>\n\n<p style=\"margin-left: 28pt;\">&nbsp;6.&nbsp;&nbsp;&nbsp; Folsch UR, Winckler K, Wormsley KG: Influence of repeated administration of cholecystokinin and secretin on the pancreas of the rat. Scand J Gastroenterol 13:663-671,1978</p>\n\n<p style=\"margin-left: 10mm;\">&nbsp;7.&nbsp;&nbsp;&nbsp;&nbsp; Geron E, Schejter ED, Shilo BZ: Assessing the secretory capacity of pancreatic acinar cells. J Vis Exp,2014</p>\n\n<p style=\"margin-left: 28pt;\">&nbsp;8.&nbsp;&nbsp;&nbsp; Goke B, Printz H, Koop I, Rausch U, Richter G, Arnold R, Adler G: Endogenous CCK release and pancreatic growth in rats after feeding a proteinase inhibitor (camostate). Pancreas 1:509-515,1986</p>\n\n<p style=\"margin-left: 28pt;\">&nbsp;9.&nbsp;&nbsp;&nbsp; Green GM, Miyasaka K: Rat pancreatic response to intestinal infusion of intact and hydrolyzed protein. Am J Physiol 245:G394-8,1983</p>\n\n<p style=\"margin-left: 28pt;\">10.&nbsp;&nbsp;&nbsp; Ji B, Bi Y, Simeone D, Mortensen RM, Logsdon CD: Human pancreatic acinar cells lack functional responses to cholecystokinin and gastrin. Gastroenterology 121:1380-1390,2001</p>\n\n<p style=\"margin-left: 28pt;\">11.&nbsp;&nbsp;&nbsp; Li Y, Hao Y, Owyang C: High-affinity CCK-A receptors on the vagus nerve mediate CCK-stimulated pancreatic secretion in rats. Am J Physiol 273:G679-85,1997</p>\n\n<p style=\"margin-left: 28pt;\">12.&nbsp;&nbsp;&nbsp; Miyasaka K, Shinozaki H, Jimi A, Funakoshi A: Amylase secretion from dispersed human pancreatic acini: neither cholecystokinin A nor cholecystokinin B receptors mediate amylase secretion in vitro. Pancreas 25:161-165,2002</p>\n\n<p style=\"margin-left: 28pt;\">13.&nbsp;&nbsp;&nbsp; Nishimori I, Kamakura M, Fujikawa-Adachi K, Nojima M, Onishi S, Hollingsworth MA, Harris A: Cholecystokinin A and B receptor mRNA expression in human pancreas. Pancreas 19:109-113,1999</p>\n\n<p style=\"margin-left: 28pt;\">14.&nbsp;&nbsp;&nbsp; Owyang C: Physiological mechanisms of cholecystokinin action on pancreatic secretion. Am J Physiol 271:G1-7,1996</p>\n\n<p style=\"margin-left: 28pt;\">15.&nbsp;&nbsp;&nbsp; Pandiri AR: Overview of exocrine pancreatic pathobiology. Toxicol Pathol 42:207-216,2014</p>\n\n<p style=\"margin-left: 28pt;\">16.&nbsp;&nbsp;&nbsp; Rehfeld JF: Cholecystokinin-from local gut hormone to ubiquitous messenger. Front Endocrinol (Lausanne) 8:47,2017</p>\n\n<p style=\"margin-left: 28pt;\">17.&nbsp;&nbsp;&nbsp; Singer MV, Niebergall-Roth E: Secretion from acinar cells of the exocrine pancreas: role of enteropancreatic reflexes and cholecystokinin. Cell Biol Int 33:1-9,2009</p>\n\n<p style=\"margin-left: 28pt;\">18.&nbsp;&nbsp;&nbsp; Wang BJ, Cui ZJ: How does cholecystokinin stimulate exocrine pancreatic secretion? From birds, rodents, to humans. Am J Physiol Regul Integr Comp Physiol 292:R666-78,2007</p>\n\n<p style=\"margin-left: 28pt;\">19.&nbsp;&nbsp;&nbsp; Wank SA: Cholecystokinin receptors. Am J Physiol 269:G628-646,1995</p>\n\n<p>&nbsp;</p>\n","biologicalOrganisationLevel":"Cellular","organTerm":{},"biologicalEvents":[{"object":{}}],"id":1724}
{"title":"Pancreatic acinar cell tumors","references":"<p style=\"margin-left: 28pt;\">&nbsp;1.&nbsp;&nbsp;&nbsp; Calam J, Bojarski JC, Springer CJ: Raw soya-bean flour increases cholecystokinin release in man. Br J Nutr 58:175-179,1987</p>\n\n<p style=\"margin-left: 28pt;\">&nbsp;2.&nbsp;&nbsp;&nbsp; Folsch UR, Winckler K, Wormsley KG: Influence of repeated administration of cholecystokinin and secretin on the pancreas of the rat. Scand J Gastroenterol 13:663-671,1978</p>\n\n<p style=\"margin-left: 28pt;\">&nbsp;3.&nbsp;&nbsp;&nbsp; Jordan J, Greenway FL, Leiter LA, Li Z, Jacobson P, Murphy K, Hill J, Kler L, Aftring RP: Stimulation of cholecystokinin-A receptors with GI181771X does not cause weight loss in overweight or obese patients. Clin Pharmacol Ther 83:281-287,2008</p>\n\n<p style=\"margin-left: 28pt;\">&nbsp;4.&nbsp;&nbsp;&nbsp; Messina M, Messina V: Increasing use of soyfoods and their potential role in cancer prevention. J Am Diet Assoc 91:836-840,1991</p>\n\n<p style=\"margin-left: 28pt;\">&nbsp;5.&nbsp;&nbsp;&nbsp; Miller RV: Epidemiology. Alan R. Liss, New York (pp) 39-57,1978</p>\n\n<p style=\"margin-left: 28pt;\">&nbsp;6.&nbsp;&nbsp;&nbsp; Myer JR, Romach EH, Elangbam CS: Species- and dose-specific pancreatic responses and progression in single- and repeat-dose studies with GI181771X: a novel cholecystokinin 1 receptor agonist in mice, rats, and monkeys. Toxicol Pathol 42:260-274,2014</p>\n\n<p style=\"margin-left: 28pt;\">&nbsp;7.&nbsp;&nbsp;&nbsp; Obourn JD, Frame SR, Chiu T, Solomon TE, Cook JC: Evidence that A8947 enhances pancreas growth via a trypsin inhibitor mechanism. Toxicol Appl Pharmacol 146:116-126,1997</p>\n\n<p style=\"margin-left: 28pt;\">&nbsp;8.&nbsp;&nbsp;&nbsp; Povoski SP, Zhou W, Longnecker DS, Jensen RT, Mantey SA, Bell RH Jr: Stimulation of in vivo pancreatic growth in the rat is mediated specifically by way of cholecystokinin-A receptors. Gastroenterology 107:1135-1146,1994</p>\n\n<p style=\"margin-left: 28pt;\">&nbsp;9.&nbsp;&nbsp;&nbsp; Tashiro M, Samuelson LC, Liddle RA, Williams JA: Calcineurin mediates pancreatic growth in protease inhibitor-treated mice. Am J Physiol Gastrointest Liver Physiol 286:G784-790,2004</p>\n\n<p style=\"margin-left: 28pt;\">10.&nbsp;&nbsp;&nbsp; Yamamoto M, Otani M, Jia DM, Fukumitsu K, Yoshikawa H, Akiyama T, Otsuki M: Differential mechanism and site of action of CCK on the pancreatic secretion and growth in rats. Am J Physiol Gastrointest Liver Physiol 285:G681-687,2003</p>\n\n<p>&nbsp;</p>\n","biologicalOrganisationLevel":"Molecular","organTerm":{},"biologicalEvents":[{"object":{}}],"id":1725}
{"title":"Decreased, Mitochondrial Fatty Acid Beta Oxidation","references":"<p><br />\nAoyama, T., Peters, J.M., Iritani, N., Nakajima, T., Furihata, K., Hashimoto, T., et al., 1998. Altered constitutive expression of fatty acid-metabolizing enzymes in mice lacking the peroxisome proliferator-activated receptor alpha (PPARalpha). Journal of Biological Chemistry 273:5678e5684.</p>\n\n<p>Brandt, J.M., Djouadi, F., Kelly, D.P., 1998. Fatty acids activate transcription of the muscle carnitine palmitoyltransferase I gene in cardiac myocytes via the peroxisome proliferator-activated receptor alpha. Journal of Biological Chemistry 273:23786e23792.</p>\n\n<p>Desvergne B, Wahli W (1999) Peroxisome proliferator-activated receptors: nuclear control of metabolism. Endocrine Reviews 20(5): 649-688.</p>\n\n<p>Gulick, T., Cresci, S., Caira, T., Moore, D.D., Kelly, D.P., 1994. The peroxisome proliferator-activated receptor regulates mitochondrial fatty acid oxidative enzyme gene expression. Proceedings of the National Academy of Sciences of the United States of America 91:11012e11016.</p>\n\n<p>Kersten S. 2014. Integrated physiology and systems biology of PPARalpha. Molecular Metabolism 2014, 3(4):354-371.</p>\n\n<p>Mascaro, C., Acosta, E., Ortiz, J.A., Marrero, P.F., Hegardt, F.G., Haro, D., 1998. Control of human muscle-type carnitine palmitoyltransferase I gene transcription by peroxisome proliferator-activated receptor. Journal of Biological Chemistry 273:8560e8563.</p>\n\n<p>Sanderson, L.M., de Groot, P.J., Hooiveld, G.J., Koppen, A., Kalkhoven, E., Muller, M., et al., 2008. Effect of synthetic dietary triglycerides: a novel research paradigm for nutrigenomics. PLoS One 3:e1681.</p>\n","biologicalOrganisationLevel":"Molecular","organTerm":{},"biologicalEvents":[{"action":"decreased","process":"fatty acid beta-oxidation","object":{"name":"fatty acid","source":"CHEBI","sourceId":"CHEBI:35366"}}],"keyEventStressors":["PPARalpha antagonists"],"id":860}
{"title":"Decrease, Acyl-CoA dehydrogenases","references":"","biologicalOrganisationLevel":"Molecular","organTerm":{},"biologicalEvents":[{"object":{}}],"id":1834}
{"title":"Increase plasma Ang II","references":"","biologicalOrganisationLevel":"Tissue","organTerm":{},"biologicalEvents":[{"object":{}}],"id":1743}
{"title":"Increased Angiotensin II ","references":"","biologicalOrganisationLevel":"Cellular","organTerm":{},"biologicalEvents":[{"object":{}}],"id":1752}
{"title":"ACE2 inhibition","references":"","biologicalOrganisationLevel":"Molecular","organTerm":{},"biologicalEvents":[{"object":{}}],"id":1740}
{"title":"Increased susceptibility to viral entry","references":"<p style=\"margin-left:48px\"><span style=\"font-size:11pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">BAUGHN, L. B., SHARMA, N., ELHAIK, E., SEKULIC, A., BRYCE, A. H. &amp; FONSECA, R. 2020. Targeting TMPRSS2 in SARS-CoV-2 Infection. <em>Mayo Clin Proc,</em> 95<strong>,</strong> 1989-1999.</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-size:11pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">BESTLE, D., HEINDL, M. R., LIMBURG, H., VAN LAM VAN, T., PILGRAM, O., MOULTON, H., STEIN, D. A., HARDES, K., EICKMANN, M., DOLNIK, O., ROHDE, C., KLENK, H.-D., GARTEN, W., STEINMETZER, T. &amp; B&Ouml;TTCHER-FRIEBERTSH&Auml;USER, E. 2020a. TMPRSS2 and furin are both essential for proteolytic activation of SARS-CoV-2 in human airway cells. <em>Life Science Alliance,</em> 3.</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-size:11pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">BESTLE, D., HEINDL, M. R., LIMBURG, H., VAN LAM VAN, T., PILGRAM, O., MOULTON, H., STEIN, D. A., HARDES, K., EICKMANN, M., DOLNIK, O., ROHDE, C., KLENK, H. D., GARTEN, W., STEINMETZER, T. &amp; BOTTCHER-FRIEBERTSHAUSER, E. 2020b. TMPRSS2 and furin are both essential for proteolytic activation of SARS-CoV-2 in human airway cells. <em>Life Sci Alliance,</em> 3.</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-size:11pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">CANTUTI-CASTELVETRI, L., OJHA, R., PEDRO, L. D., DJANNATIAN, M., FRANZ, J., KUIVANEN, S., VAN DER MEER, F., KALLIO, K., KAYA, T., ANASTASINA, M., SMURA, T., LEVANOV, L., SZIROVICZA, L., TOBI, A., KALLIO-KOKKO, H., OSTERLUND, P., JOENSUU, M., MEUNIER, F. A., BUTCHER, S. J., WINKLER, M. S., MOLLENHAUER, B., HELENIUS, A., GOKCE, O., TEESALU, T., HEPOJOKI, J., VAPALAHTI, O., STADELMANN, C., BALISTRERI, G. &amp; SIMONS, M. 2020. Neuropilin-1 facilitates SARS-CoV-2 cell entry and infectivity. <em>Science,</em> 370<strong>,</strong> 856-860.</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-size:11pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">CAO, H., LI, Y., HUANG, L., BAI, B. &amp; XU, Z. 2020. Clinicopathological Significance of Neuropilin 1 Expression in Gastric Cancer: A Meta-Analysis. <em>Dis Markers,</em> 2020<strong>,</strong> 4763492.</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-size:11pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">CENTERS FOR DISEASE CONTROL AND PREVENTION, U. S. D. O. H. A. H. S. 2020. Covid-19 Science Update 2020.</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-size:11pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">CHEN, L., LI, X., CHEN, M., FENG, Y. &amp; XIONG, C. 2020. The ACE2 expression in human heart indicates new potential mechanism of heart injury among patients infected with SARS-CoV-2. <em>Cardiovasc Res,</em> 116<strong>,</strong> 1097-1100.</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-size:11pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">DALY, J. L., SIMONETTI, B., KLEIN, K., CHEN, K. E., WILLIAMSON, M. K., ANTON-PLAGARO, C., SHOEMARK, D. K., SIMON-GRACIA, L., BAUER, M., HOLLANDI, R., GREBER, U. F., HORVATH, P., SESSIONS, R. B., HELENIUS, A., HISCOX, J. A., TEESALU, T., MATTHEWS, D. A., DAVIDSON, A. D., COLLINS, B. M., CULLEN, P. J. &amp; YAMAUCHI, Y. 2020. Neuropilin-1 is a host factor for SARS-CoV-2 infection. <em>Science,</em> 370<strong>,</strong> 861-865.</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-size:11pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">DAVIES, J., RANDEVA, H. S., CHATHA, K., HALL, M., SPANDIDOS, D. A., KARTERIS, E. &amp; KYROU, I. 2020. Neuropilin1 as a new potential SARSCoV2 infection mediator implicated in the neurologic features and central nervous system involvement of COVID19. <em>Mol Med Rep,</em> 22<strong>,</strong> 4221-4226.</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-size:11pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">GELFAND, M. V., HAGAN, N., TATA, A., OH, W. J., LACOSTE, B., KANG, K. T., KOPYCINSKA, J., BISCHOFF, J., WANG, J. H. &amp; GU, C. 2014. Neuropilin-1 functions as a VEGFR2 co-receptor to guide developmental angiogenesis independent of ligand binding. <em>Elife,</em> 3<strong>,</strong> e03720.</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-size:11pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">HARTENIAN, E., NANDAKUMAR, D., LARI, A., LY, M., TUCKER, J. M. &amp; GLAUNSINGER, B. A. 2020. The molecular virology of coronaviruses. <em>J Biol Chem,</em> 295<strong>,</strong> 12910-12934.</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-size:11pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">HASAN, A., PARAY, B. A., HUSSAIN, A., QADIR, F. A., ATTAR, F., AZIZ, F. M., SHARIFI, M., DERAKHSHANKHAH, H., RASTI, B., MEHRABI, M., SHAHPASAND, K., SABOURY, A. A. &amp; FALAHATI, M. 2020. A review on the cleavage priming of the spike protein on coronavirus by angiotensin-converting enzyme-2 and furin. <em>J Biomol Struct Dyn</em><strong>,</strong> 1-9.</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-size:11pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">HOFFMANN, M., KLEINE-WEBER, H. &amp; POHLMANN, S. 2020a. A Multibasic Cleavage Site in the Spike Protein of SARS-CoV-2 Is Essential for Infection of Human Lung Cells. <em>Mol Cell,</em> 78<strong>,</strong> 779-784 e5.</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-size:11pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">HOFFMANN, M., KLEINE-WEBER, H., SCHROEDER, S., KRUGER, N., HERRLER, T., ERICHSEN, S., SCHIERGENS, T. S., HERRLER, G., WU, N. H., NITSCHE, A., MULLER, M. A., DROSTEN, C. &amp; POHLMANN, S. 2020b. SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor. <em>Cell,</em> 181<strong>,</strong> 271-280 e8.</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-size:11pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">HUGGINS, D. J. 2020. Structural analysis of experimental drugs binding to the SARS-CoV-2 target TMPRSS2. <em>J Mol Graph Model,</em> 100<strong>,</strong> 107710.</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-size:11pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">JING, Y., RUN-QIAN, L., HAO-RAN, W., HAO-RAN, C., YA-BIN, L., YANG, G. &amp; FEI, C. 2020. Potential influence of COVID-19/ACE2 on the female reproductive system. <em>Mol Hum Reprod,</em> 26<strong>,</strong> 367-373.</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-size:11pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">JOHNSON, B. A., XIE, X., KALVERAM, B., LOKUGAMAGE, K. G., MURUATO, A., ZOU, J., ZHANG, X., JUELICH, T., SMITH, J. K., ZHANG, L., BOPP, N., SCHINDEWOLF, C., VU, M., VANDERHEIDEN, A., SWETNAM, D., PLANTE, J. A., AGUILAR, P., PLANTE, K. S., LEE, B., WEAVER, S. C., SUTHAR, M. S., ROUTH, A. L., REN, P., KU, Z., AN, Z., DEBBINK, K., SHI, P. Y., FREIBERG, A. N. &amp; MENACHERY, V. D. 2020. Furin Cleavage Site Is Key to SARS-CoV-2 Pathogenesis. <em>bioRxiv</em>.</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-size:11pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">JU, B., ZHANG, Q., GE, J., WANG, R., SUN, J., GE, X., YU, J., SHAN, S., ZHOU, B., SONG, S., TANG, X., YU, J., LAN, J., YUAN, J., WANG, H., ZHAO, J., ZHANG, S., WANG, Y., SHI, X., LIU, L., ZHAO, J., WANG, X., ZHANG, Z. &amp; ZHANG, L. 2020. Human neutralizing antibodies elicited by SARS-CoV-2 infection. <em>Nature,</em> 584<strong>,</strong> 115-119.</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-size:11pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">JURASZEK, J., RUTTEN, L., BLOKLAND, S., BOUCHIER, P., VOORZAAT, R., RITSCHEL, T., BAKKERS, M. J. G., RENAULT, L. L. R. &amp; LANGEDIJK, J. P. M. 2021. Stabilizing the closed SARS-CoV-2 spike trimer. <em>Nat Commun,</em> 12<strong>,</strong> 244.</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-size:11pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">KANG, Y.-L., CHOU, Y.-Y., ROTHLAUF, P. W., LIU, Z., SOH, T. K., CURETON, D., CASE, J. B., CHEN, R. E., DIAMOND, M. S., WHELAN, S. P. J. &amp; KIRCHHAUSEN, T. 2020. Inhibition of PIKfyve kinase prevents infection by Zaire ebolavirus and SARS-CoV-2. <em>bioRxiv</em><strong>,</strong> 2020.04.21.053058.</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-size:11pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">KAWASE, M., SHIRATO, K., VAN DER HOEK, L., TAGUCHI, F. &amp; MATSUYAMA, S. 2012. Simultaneous treatment of human bronchial epithelial cells with serine and cysteine protease inhibitors prevents severe acute respiratory syndrome coronavirus entry. <em>J Virol,</em> 86<strong>,</strong> 6537-45.</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-size:11pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">LAM, S. D., BORDIN, N., WAMAN, V. P., SCHOLES, H. M., ASHFORD, P., SEN, N., VAN DORP, L., RAUER, C., DAWSON, N. L., PANG, C. S. M., ABBASIAN, M., SILLITOE, I., EDWARDS, S. J. L., FRATERNALI, F., LEES, J. G., SANTINI, J. M. &amp; ORENGO, C. A. 2020. SARS-CoV-2 spike protein predicted to form complexes with host receptor protein orthologues from a broad range of mammals. <em>Sci Rep,</em> 10<strong>,</strong> 16471.</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-size:11pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">LAMERS, M. M., BEUMER, J., VAN DER VAART, J., KNOOPS, K., PUSCHHOF, J., BREUGEM, T. I., RAVELLI, R. B. G., PAUL VAN SCHAYCK, J., MYKYTYN, A. Z., DUIMEL, H. Q., VAN DONSELAAR, E., RIESEBOSCH, S., KUIJPERS, H. J. H., SCHIPPER, D., VAN DE WETERING, W. J., DE GRAAF, M., KOOPMANS, M., CUPPEN, E., PETERS, P. J., HAAGMANS, B. L. &amp; CLEVERS, H. 2020. SARS-CoV-2 productively infects human gut enterocytes. <em>Science,</em> 369<strong>,</strong> 50-54.</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-size:11pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">LAN, J., GE, J., YU, J., SHAN, S., ZHOU, H., FAN, S., ZHANG, Q., SHI, X., WANG, Q., ZHANG, L. &amp; WANG, X. 2020. Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor. <em>Nature,</em> 581<strong>,</strong> 215-220.</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-size:11pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">LETKO, M., MARZI, A. &amp; MUNSTER, V. 2020. Functional assessment of cell entry and receptor usage for SARS-CoV-2 and other lineage B betacoronaviruses. <em>Nat Microbiol,</em> 5<strong>,</strong> 562-569.</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-size:11pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">LI, F. 2016. Structure, Function, and Evolution of Coronavirus Spike Proteins. <em>Annu Rev Virol,</em> 3<strong>,</strong> 237-261.</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-size:11pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">LIN, B., FERGUSON, C., WHITE, J. T., WANG, S., VESSELLA, R., TRUE, L. D., HOOD, L. &amp; NELSON, P. S. 1999. Prostate-localized and androgen-regulated expression of the membrane-bound serine protease TMPRSS2. <em>Cancer Res,</em> 59<strong>,</strong> 4180-4.</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-size:11pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">LIU, L., WANG, P., NAIR, M. S., YU, J., RAPP, M., WANG, Q., LUO, Y., CHAN, J. F., SAHI, V., FIGUEROA, A., GUO, X. V., CERUTTI, G., BIMELA, J., GORMAN, J., ZHOU, T., CHEN, Z., YUEN, K. Y., KWONG, P. D., SODROSKI, J. G., YIN, M. T., SHENG, Z., HUANG, Y., SHAPIRO, L. &amp; HO, D. D. 2020. Potent neutralizing antibodies against multiple epitopes on SARS-CoV-2 spike. <em>Nature,</em> 584<strong>,</strong> 450-456.</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-size:11pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">LU, Y. &amp; MENG, Y. G. 2015. Quantitation of Circulating Neuropilin-1 in Human, Monkey, Mouse, and Rat Sera by ELISA. <em>Methods Mol Biol,</em> 1332<strong>,</strong> 39-48.</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-size:11pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">LUCAS, J. M., TRUE, L., HAWLEY, S., MATSUMURA, M., MORRISSEY, C., VESSELLA, R. &amp; NELSON, P. S. 2008. The androgen-regulated type II serine protease TMPRSS2 is differentially expressed and mislocalized in prostate adenocarcinoma. <em>J Pathol,</em> 215<strong>,</strong> 118-25.</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-size:11pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">LUKASSEN, S., CHUA, R. L., TREFZER, T., KAHN, N. C., SCHNEIDER, M. A., MULEY, T., WINTER, H., MEISTER, M., VEITH, C., BOOTS, A. W., HENNIG, B. P., KREUTER, M., CONRAD, C. &amp; EILS, R. 2020. SARS-CoV-2 receptor ACE2 and TMPRSS2 are primarily expressed in bronchial transient secretory cells. <em>EMBO J,</em> 39<strong>,</strong> e105114.</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-size:11pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">MADJID, M., SAFAVI-NAEINI, P., SOLOMON, S. D. &amp; VARDENY, O. 2020. Potential Effects of Coronaviruses on the Cardiovascular System: A Review. <em>JAMA Cardiol,</em> 5<strong>,</strong> 831-840.</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-size:11pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">MAYI, B. S., LEIBOWITZ, J. A., WOODS, A. T., AMMON, K. A., LIU, A. E. &amp; RAJA, A. 2021. The role of Neuropilin-1 in COVID-19. <em>PLoS Pathog,</em> 17<strong>,</strong> e1009153.</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-size:11pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">MILLET, J. K. &amp; WHITTAKER, G. R. 2018. Physiological and molecular triggers for SARS-CoV membrane fusion and entry into host cells. <em>Virology,</em> 517<strong>,</strong> 3-8.</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-size:11pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">MIRABELLI, C., WOTRING, J. W., ZHANG, C. J., MCCARTY, S. M., FURSMIDT, R., FRUM, T., KADAMBI, N. S., AMIN, A. T., O&rsquo;MEARA, T. R., PRETTO, C. D., SPENCE, J. R., HUANG, J., ALYSANDRATOS, K. D., KOTTON, D. N., HANDELMAN, S. K., WOBUS, C. E., WEATHERWAX, K. J., MASHOUR, G. A., O&rsquo;MEARA, M. J. &amp; SEXTON, J. Z. 2020. Morphological Cell Profiling of SARS-CoV-2 Infection Identifies Drug Repurposing Candidates for COVID-19. <em>bioRxiv</em><strong>,</strong> 2020.05.27.117184.</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-size:11pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">MOUTAL, A., MARTIN, L. F., BOINON, L., GOMEZ, K., RAN, D., ZHOU, Y., STRATTON, H. J., CAI, S., LUO, S., GONZALEZ, K. B., PEREZ-MILLER, S., PATWARDHAN, A., IBRAHIM, M. M. &amp; KHANNA, R. 2020. SARS-CoV-2 Spike protein co-opts VEGF-A/Neuropilin-1 receptor signaling to induce analgesia. <em>bioRxiv</em>.</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-size:11pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">MUHL, L., FOLESTAD, E. B., GLADH, H., WANG, Y., MOESSINGER, C., JAKOBSSON, L. &amp; ERIKSSON, U. 2017. Neuropilin 1 binds PDGF-D and is a co-receptor in PDGF-D-PDGFRbeta signaling. <em>J Cell Sci,</em> 130<strong>,</strong> 1365-1378.</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-size:11pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">MUKHERJEE, S. &amp; PAHAN, K. 2021. Is COVID-19 Gender-sensitive? <em>J Neuroimmune Pharmacol,</em> 16<strong>,</strong> 38-47.</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-size:11pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">MURGOLO, N., THERIEN, A. G., HOWELL, B., KLEIN, D., KOEPLINGER, K., LIEBERMAN, L. A., ADAM, G. C., FLYNN, J., MCKENNA, P., SWAMINATHAN, G., HAZUDA, D. J. &amp; OLSEN, D. B. 2021. SARS-CoV-2 tropism, entry, replication, and propagation: Considerations for drug discovery and development. <em>PLoS Pathog,</em> 17<strong>,</strong> e1009225.</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-size:11pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">PAN, X. W., XU, D., ZHANG, H., ZHOU, W., WANG, L. H. &amp; CUI, X. G. 2020. Identification of a potential mechanism of acute kidney injury during the COVID-19 outbreak: a study based on single-cell transcriptome analysis. <em>Intensive Care Med,</em> 46<strong>,</strong> 1114-1116.</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-size:11pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">PEREZ-MILLER, S., PATEK, M., MOUTAL, A., CABEL, C. R., THORNE, C. A., CAMPOS, S. K. &amp; KHANNA, R. 2020. In silico identification and validation of inhibitors of the interaction between neuropilin receptor 1 and SARS-CoV-2 Spike protein. <em>bioRxiv</em>.</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-size:11pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">PREMKUMAR, L., SEGOVIA-CHUMBEZ, B., JADI, R., MARTINEZ, D. R., RAUT, R., MARKMANN, A., CORNABY, C., BARTELT, L., WEISS, S., PARK, Y., EDWARDS, C. E., WEIMER, E., SCHERER, E. M., ROUPHAEL, N., EDUPUGANTI, S., WEISKOPF, D., TSE, L. V., HOU, Y. J., MARGOLIS, D., SETTE, A., COLLINS, M. H., SCHMITZ, J., BARIC, R. S. &amp; DE SILVA, A. M. 2020. The receptor binding domain of the viral spike protein is an immunodominant and highly specific target of antibodies in SARS-CoV-2 patients. <em>Sci Immunol,</em> 5.</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-size:11pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">QIAO, Y., WANG, X. M., MANNAN, R., PITCHIAYA, S., ZHANG, Y., WOTRING, J. W., XIAO, L., ROBINSON, D. R., WU, Y. M., TIEN, J. C., CAO, X., SIMKO, S. A., APEL, I. J., BAWA, P., KREGEL, S., NARAYANAN, S. P., RASKIND, G., ELLISON, S. J., PAROLIA, A., ZELENKA-WANG, S., MCMURRY, L., SU, F., WANG, R., CHENG, Y., DELEKTA, A. D., MEI, Z., PRETTO, C. D., WANG, S., MEHRA, R., SEXTON, J. Z. &amp; CHINNAIYAN, A. M. 2020. Targeting transcriptional regulation of SARS-CoV-2 entry factors ACE2 and TMPRSS2. <em>Proc Natl Acad Sci U S A</em>.</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-size:11pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">RAHMAN, N., BASHARAT, Z., YOUSUF, M., CASTALDO, G., RASTRELLI, L. &amp; KHAN, H. 2020. Virtual Screening of Natural Products against Type II Transmembrane Serine Protease (TMPRSS2), the Priming Agent of Coronavirus 2 (SARS-CoV-2). <em>Molecules,</em> 25.</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-size:11pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">RAIMONDI, C., BRASH, J. T., FANTIN, A. &amp; RUHRBERG, C. 2016. NRP1 function and targeting in neurovascular development and eye disease. <em>Prog Retin Eye Res,</em> 52<strong>,</strong> 64-83.</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-size:11pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">RIVA, L., YUAN, S., YIN, X., MARTIN-SANCHO, L., MATSUNAGA, N., BURGSTALLER-MUEHLBACHER, S., PACHE, L., DE JESUS, P. P., HULL, M. V., CHANG, M., CHAN, J. F.-W., CAO, J., POON, V. K.-M., HERBERT, K., NGUYEN, T.-T., PU, Y., NGUYEN, C., RUBANOV, A., MARTINEZ-SOBRIDO, L., LIU, W.-C., MIORIN, L., WHITE, K. M., JOHNSON, J. R., BENNER, C., SUN, R., SCHULTZ, P. G., SU, A., GARCIA-SASTRE, A., CHATTERJEE, A. K., YUEN, K.-Y. &amp; CHANDA, S. K. 2020. A Large-scale Drug Repositioning Survey for SARS-CoV-2 Antivirals. <em>bioRxiv</em><strong>,</strong> 2020.04.16.044016.</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-size:11pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">ROBBIANI, D. F., GAEBLER, C., MUECKSCH, F., LORENZI, J. C. C., WANG, Z., CHO, A., AGUDELO, M., BARNES, C. O., GAZUMYAN, A., FINKIN, S., HAGGLOF, T., OLIVEIRA, T. Y., VIANT, C., HURLEY, A., HOFFMANN, H. H., MILLARD, K. G., KOST, R. G., CIPOLLA, M., GORDON, K., BIANCHINI, F., CHEN, S. T., RAMOS, V., PATEL, R., DIZON, J., SHIMELIOVICH, I., MENDOZA, P., HARTWEGER, H., NOGUEIRA, L., PACK, M., HOROWITZ, J., SCHMIDT, F., WEISBLUM, Y., MICHAILIDIS, E., ASHBROOK, A. W., WALTARI, E., PAK, J. E., HUEY-TUBMAN, K. E., KORANDA, N., HOFFMAN, P. R., WEST, A. P., JR., RICE, C. M., HATZIIOANNOU, T., BJORKMAN, P. J., BIENIASZ, P. D., CASKEY, M. &amp; NUSSENZWEIG, M. C. 2020. Convergent antibody responses to SARS-CoV-2 in convalescent individuals. <em>Nature,</em> 584<strong>,</strong> 437-442.</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-size:11pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">ROSSI, A., DEVERAUX, Q., TURK, B. &amp; SALI, A. 2004. Comprehensive search for cysteine cathepsins in the human genome. <em>Biol Chem,</em> 385<strong>,</strong> 363-72.</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-size:11pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">SHANG, J., WAN, Y., LUO, C., YE, G., GENG, Q., AUERBACH, A. &amp; LI, F. 2020. Cell entry mechanisms of SARS-CoV-2. <em>Proc Natl Acad Sci U S A,</em> 117<strong>,</strong> 11727-11734.</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-size:11pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">SHIRATO, K., KAWASE, M. &amp; MATSUYAMA, S. 2018. Wild-type human coronaviruses prefer cell-surface TMPRSS2 to endosomal cathepsins for cell entry. <em>Virology,</em> 517<strong>,</strong> 9-15.</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-size:11pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">SIMMONS, G., GOSALIA, D. N., RENNEKAMP, A. J., REEVES, J. D., DIAMOND, S. L. &amp; BATES, P. 2005. Inhibitors of cathepsin L prevent severe acute respiratory syndrome coronavirus entry. <em>Proc Natl Acad Sci U S A,</em> 102<strong>,</strong> 11876-81.</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-size:11pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">SINGH, M., BANSAL, V. &amp; FESCHOTTE, C. 2020. A single-cell RNA expression map of human coronavirus entry factors. <em>bioRxiv</em>.</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-size:11pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">SUBRAMANIAN, A., VERNON, K. A., SLYPER, M., WALDMAN, J., LUECKEN, M. D., GOSIK, K., DUBINSKY, D., CUOCO, M. S., KELLER, K., PURNELL, J., NGUYEN, L., DIONNE, D., ROZENBLATT-ROSEN, O., WEINS, A., REGEV, A. &amp; GREKA, A. 2020. RAAS blockade, kidney disease, and expression of ACE2, the entry receptor for SARS-CoV-2, in kidney epithelial and endothelial cells.</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-size:11pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">UNIPROTKB - O14786 (NRP1_HUMAN) </span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-size:11pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">WALLS, A. C., TORTORICI, M. A., BOSCH, B. J., FRENZ, B., ROTTIER, P. J. M., DIMAIO, F., REY, F. A. &amp; VEESLER, D. 2016. Cryo-electron microscopy structure of a coronavirus spike glycoprotein trimer. <em>Nature,</em> 531<strong>,</strong> 114-117.</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-size:11pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">WANG, Y., LIU, M. &amp; GAO, J. 2020. Enhanced receptor binding of SARS-CoV-2 through networks of hydrogen-bonding and hydrophobic interactions. <em>Proc Natl Acad Sci U S A,</em> 117<strong>,</strong> 13967-13974.</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-size:11pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">YAMAMOTO, M., KISO, M., SAKAI-TAGAWA, Y., IWATSUKI-HORIMOTO, K., IMAI, M., TAKEDA, M., KINOSHITA, N., OHMAGARI, N., GOHDA, J., SEMBA, K., MATSUDA, Z., KAWAGUCHI, Y., KAWAOKA, Y. &amp; INOUE, J. I. 2020. The Anticoagulant Nafamostat Potently Inhibits SARS-CoV-2 S Protein-Mediated Fusion in a Cell Fusion Assay System and Viral Infection In Vitro in a Cell-Type-Dependent Manner. <em>Viruses,</em> 12.</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-size:11pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">YANG, N. &amp; SHEN, H.-M. 2020. Targeting the Endocytic Pathway and Autophagy Process as a Novel Therapeutic Strategy in COVID-19. <em>International Journal of Biological Sciences,</em> 16<strong>,</strong> 1724-1731.</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-size:11pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">YUAN, M., WU, N. C., ZHU, X., LEE, C. D., SO, R. T. Y., LV, H., MOK, C. K. P. &amp; WILSON, I. A. 2020. A highly conserved cryptic epitope in the receptor binding domains of SARS-CoV-2 and SARS-CoV. <em>Science,</em> 368<strong>,</strong> 630-633.</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-size:11pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">ZANG, R., GOMEZ CASTRO, M. F., MCCUNE, B. T., ZENG, Q., ROTHLAUF, P. W., SONNEK, N. M., LIU, Z., BRULOIS, K. F., WANG, X., GREENBERG, H. B., DIAMOND, M. S., CIORBA, M. A., WHELAN, S. P. J. &amp; DING, S. 2020. TMPRSS2 and TMPRSS4 promote SARS-CoV-2 infection of human small intestinal enterocytes. <em>Sci Immunol,</em> 5.</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-size:11pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">ZIEGLER, C. G. K., ALLON, S. J., NYQUIST, S. K., MBANO, I. M., MIAO, V. N., TZOUANAS, C. N., CAO, Y., YOUSIF, A. S., BALS, J., HAUSER, B. M., FELDMAN, J., MUUS, C., WADSWORTH, M. H., 2ND, KAZER, S. W., HUGHES, T. K., DORAN, B., GATTER, G. J., VUKOVIC, M., TALIAFERRO, F., MEAD, B. E., GUO, Z., WANG, J. P., GRAS, D., PLAISANT, M., ANSARI, M., ANGELIDIS, I., ADLER, H., SUCRE, J. M. S., TAYLOR, C. J., LIN, B., WAGHRAY, A., MITSIALIS, V., DWYER, D. F., BUCHHEIT, K. M., BOYCE, J. A., BARRETT, N. A., LAIDLAW, T. M., CARROLL, S. L., COLONNA, L., TKACHEV, V., PETERSON, C. W., YU, A., ZHENG, H. B., GIDEON, H. P., WINCHELL, C. G., LIN, P. L., BINGLE, C. D., SNAPPER, S. B., KROPSKI, J. A., THEIS, F. J., SCHILLER, H. B., ZARAGOSI, L. E., BARBRY, P., LESLIE, A., KIEM, H. P., FLYNN, J. L., FORTUNE, S. M., BERGER, B., FINBERG, R. W., KEAN, L. S., GARBER, M., SCHMIDT, A. G., LINGWOOD, D., SHALEK, A. K., ORDOVAS-MONTANES, J., LUNG-NETWORK@HUMANCELLATLAS.ORG, H. C. A. L. B. N. E. A. &amp; NETWORK, H. C. A. L. B. 2020. SARS-CoV-2 Receptor ACE2 Is an Interferon-Stimulated Gene in Human Airway Epithelial Cells and Is Detected in Specific Cell Subsets across Tissues. <em>Cell,</em> 181<strong>,</strong> 1016-1035 e19.</span></span></p>\n","biologicalOrganisationLevel":"Molecular","organTerm":{"name":"organ","sourceId":"UBERON:0000062"},"biologicalEvents":[{"action":"increased","process":"endocytosis involved in viral entry into host cell","object":{}},{"action":"increased","process":"protease binding","object":{}},{"action":"increased","process":"neuropilin binding","object":{}}],"keyEventStressors":["Sars-CoV-2"],"id":1738}
{"title":"Increased susceptibility to viral entry","references":"<p style=\"margin-left:48px\"><span style=\"font-size:11pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">BAUGHN, L. B., SHARMA, N., ELHAIK, E., SEKULIC, A., BRYCE, A. H. &amp; FONSECA, R. 2020. Targeting TMPRSS2 in SARS-CoV-2 Infection. <em>Mayo Clin Proc,</em> 95<strong>,</strong> 1989-1999.</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-size:11pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">BESTLE, D., HEINDL, M. R., LIMBURG, H., VAN LAM VAN, T., PILGRAM, O., MOULTON, H., STEIN, D. A., HARDES, K., EICKMANN, M., DOLNIK, O., ROHDE, C., KLENK, H.-D., GARTEN, W., STEINMETZER, T. &amp; B&Ouml;TTCHER-FRIEBERTSH&Auml;USER, E. 2020a. TMPRSS2 and furin are both essential for proteolytic activation of SARS-CoV-2 in human airway cells. <em>Life Science Alliance,</em> 3.</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-size:11pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">BESTLE, D., HEINDL, M. R., LIMBURG, H., VAN LAM VAN, T., PILGRAM, O., MOULTON, H., STEIN, D. A., HARDES, K., EICKMANN, M., DOLNIK, O., ROHDE, C., KLENK, H. D., GARTEN, W., STEINMETZER, T. &amp; BOTTCHER-FRIEBERTSHAUSER, E. 2020b. TMPRSS2 and furin are both essential for proteolytic activation of SARS-CoV-2 in human airway cells. <em>Life Sci Alliance,</em> 3.</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-size:11pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">CANTUTI-CASTELVETRI, L., OJHA, R., PEDRO, L. D., DJANNATIAN, M., FRANZ, J., KUIVANEN, S., VAN DER MEER, F., KALLIO, K., KAYA, T., ANASTASINA, M., SMURA, T., LEVANOV, L., SZIROVICZA, L., TOBI, A., KALLIO-KOKKO, H., OSTERLUND, P., JOENSUU, M., MEUNIER, F. A., BUTCHER, S. J., WINKLER, M. S., MOLLENHAUER, B., HELENIUS, A., GOKCE, O., TEESALU, T., HEPOJOKI, J., VAPALAHTI, O., STADELMANN, C., BALISTRERI, G. &amp; SIMONS, M. 2020. Neuropilin-1 facilitates SARS-CoV-2 cell entry and infectivity. <em>Science,</em> 370<strong>,</strong> 856-860.</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-size:11pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">CAO, H., LI, Y., HUANG, L., BAI, B. &amp; XU, Z. 2020. Clinicopathological Significance of Neuropilin 1 Expression in Gastric Cancer: A Meta-Analysis. <em>Dis Markers,</em> 2020<strong>,</strong> 4763492.</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-size:11pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">CENTERS FOR DISEASE CONTROL AND PREVENTION, U. S. D. O. H. A. H. S. 2020. Covid-19 Science Update 2020.</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-size:11pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">CHEN, L., LI, X., CHEN, M., FENG, Y. &amp; XIONG, C. 2020. The ACE2 expression in human heart indicates new potential mechanism of heart injury among patients infected with SARS-CoV-2. <em>Cardiovasc Res,</em> 116<strong>,</strong> 1097-1100.</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-size:11pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">DALY, J. L., SIMONETTI, B., KLEIN, K., CHEN, K. E., WILLIAMSON, M. K., ANTON-PLAGARO, C., SHOEMARK, D. K., SIMON-GRACIA, L., BAUER, M., HOLLANDI, R., GREBER, U. F., HORVATH, P., SESSIONS, R. B., HELENIUS, A., HISCOX, J. A., TEESALU, T., MATTHEWS, D. A., DAVIDSON, A. D., COLLINS, B. M., CULLEN, P. J. &amp; YAMAUCHI, Y. 2020. Neuropilin-1 is a host factor for SARS-CoV-2 infection. <em>Science,</em> 370<strong>,</strong> 861-865.</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-size:11pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">DAVIES, J., RANDEVA, H. S., CHATHA, K., HALL, M., SPANDIDOS, D. A., KARTERIS, E. &amp; KYROU, I. 2020. Neuropilin1 as a new potential SARSCoV2 infection mediator implicated in the neurologic features and central nervous system involvement of COVID19. <em>Mol Med Rep,</em> 22<strong>,</strong> 4221-4226.</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-size:11pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">GELFAND, M. V., HAGAN, N., TATA, A., OH, W. J., LACOSTE, B., KANG, K. T., KOPYCINSKA, J., BISCHOFF, J., WANG, J. H. &amp; GU, C. 2014. Neuropilin-1 functions as a VEGFR2 co-receptor to guide developmental angiogenesis independent of ligand binding. <em>Elife,</em> 3<strong>,</strong> e03720.</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-size:11pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">HARTENIAN, E., NANDAKUMAR, D., LARI, A., LY, M., TUCKER, J. M. &amp; GLAUNSINGER, B. A. 2020. The molecular virology of coronaviruses. <em>J Biol Chem,</em> 295<strong>,</strong> 12910-12934.</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-size:11pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">HASAN, A., PARAY, B. A., HUSSAIN, A., QADIR, F. A., ATTAR, F., AZIZ, F. M., SHARIFI, M., DERAKHSHANKHAH, H., RASTI, B., MEHRABI, M., SHAHPASAND, K., SABOURY, A. A. &amp; FALAHATI, M. 2020. A review on the cleavage priming of the spike protein on coronavirus by angiotensin-converting enzyme-2 and furin. <em>J Biomol Struct Dyn</em><strong>,</strong> 1-9.</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-size:11pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">HOFFMANN, M., KLEINE-WEBER, H. &amp; POHLMANN, S. 2020a. A Multibasic Cleavage Site in the Spike Protein of SARS-CoV-2 Is Essential for Infection of Human Lung Cells. <em>Mol Cell,</em> 78<strong>,</strong> 779-784 e5.</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-size:11pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">HOFFMANN, M., KLEINE-WEBER, H., SCHROEDER, S., KRUGER, N., HERRLER, T., ERICHSEN, S., SCHIERGENS, T. S., HERRLER, G., WU, N. H., NITSCHE, A., MULLER, M. A., DROSTEN, C. &amp; POHLMANN, S. 2020b. SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor. <em>Cell,</em> 181<strong>,</strong> 271-280 e8.</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-size:11pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">HUGGINS, D. J. 2020. Structural analysis of experimental drugs binding to the SARS-CoV-2 target TMPRSS2. <em>J Mol Graph Model,</em> 100<strong>,</strong> 107710.</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-size:11pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">JING, Y., RUN-QIAN, L., HAO-RAN, W., HAO-RAN, C., YA-BIN, L., YANG, G. &amp; FEI, C. 2020. Potential influence of COVID-19/ACE2 on the female reproductive system. <em>Mol Hum Reprod,</em> 26<strong>,</strong> 367-373.</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-size:11pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">JOHNSON, B. A., XIE, X., KALVERAM, B., LOKUGAMAGE, K. G., MURUATO, A., ZOU, J., ZHANG, X., JUELICH, T., SMITH, J. K., ZHANG, L., BOPP, N., SCHINDEWOLF, C., VU, M., VANDERHEIDEN, A., SWETNAM, D., PLANTE, J. A., AGUILAR, P., PLANTE, K. S., LEE, B., WEAVER, S. C., SUTHAR, M. S., ROUTH, A. L., REN, P., KU, Z., AN, Z., DEBBINK, K., SHI, P. Y., FREIBERG, A. N. &amp; MENACHERY, V. D. 2020. Furin Cleavage Site Is Key to SARS-CoV-2 Pathogenesis. <em>bioRxiv</em>.</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-size:11pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">JU, B., ZHANG, Q., GE, J., WANG, R., SUN, J., GE, X., YU, J., SHAN, S., ZHOU, B., SONG, S., TANG, X., YU, J., LAN, J., YUAN, J., WANG, H., ZHAO, J., ZHANG, S., WANG, Y., SHI, X., LIU, L., ZHAO, J., WANG, X., ZHANG, Z. &amp; ZHANG, L. 2020. Human neutralizing antibodies elicited by SARS-CoV-2 infection. <em>Nature,</em> 584<strong>,</strong> 115-119.</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-size:11pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">JURASZEK, J., RUTTEN, L., BLOKLAND, S., BOUCHIER, P., VOORZAAT, R., RITSCHEL, T., BAKKERS, M. J. G., RENAULT, L. L. R. &amp; LANGEDIJK, J. P. M. 2021. Stabilizing the closed SARS-CoV-2 spike trimer. <em>Nat Commun,</em> 12<strong>,</strong> 244.</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-size:11pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">KANG, Y.-L., CHOU, Y.-Y., ROTHLAUF, P. W., LIU, Z., SOH, T. K., CURETON, D., CASE, J. B., CHEN, R. E., DIAMOND, M. S., WHELAN, S. P. J. &amp; KIRCHHAUSEN, T. 2020. Inhibition of PIKfyve kinase prevents infection by Zaire ebolavirus and SARS-CoV-2. <em>bioRxiv</em><strong>,</strong> 2020.04.21.053058.</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-size:11pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">KAWASE, M., SHIRATO, K., VAN DER HOEK, L., TAGUCHI, F. &amp; MATSUYAMA, S. 2012. Simultaneous treatment of human bronchial epithelial cells with serine and cysteine protease inhibitors prevents severe acute respiratory syndrome coronavirus entry. <em>J Virol,</em> 86<strong>,</strong> 6537-45.</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-size:11pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">LAM, S. D., BORDIN, N., WAMAN, V. P., SCHOLES, H. M., ASHFORD, P., SEN, N., VAN DORP, L., RAUER, C., DAWSON, N. L., PANG, C. S. M., ABBASIAN, M., SILLITOE, I., EDWARDS, S. J. L., FRATERNALI, F., LEES, J. G., SANTINI, J. M. &amp; ORENGO, C. A. 2020. SARS-CoV-2 spike protein predicted to form complexes with host receptor protein orthologues from a broad range of mammals. <em>Sci Rep,</em> 10<strong>,</strong> 16471.</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-size:11pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">LAMERS, M. M., BEUMER, J., VAN DER VAART, J., KNOOPS, K., PUSCHHOF, J., BREUGEM, T. I., RAVELLI, R. B. G., PAUL VAN SCHAYCK, J., MYKYTYN, A. Z., DUIMEL, H. Q., VAN DONSELAAR, E., RIESEBOSCH, S., KUIJPERS, H. J. H., SCHIPPER, D., VAN DE WETERING, W. J., DE GRAAF, M., KOOPMANS, M., CUPPEN, E., PETERS, P. J., HAAGMANS, B. L. &amp; CLEVERS, H. 2020. SARS-CoV-2 productively infects human gut enterocytes. <em>Science,</em> 369<strong>,</strong> 50-54.</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-size:11pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">LAN, J., GE, J., YU, J., SHAN, S., ZHOU, H., FAN, S., ZHANG, Q., SHI, X., WANG, Q., ZHANG, L. &amp; WANG, X. 2020. Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor. <em>Nature,</em> 581<strong>,</strong> 215-220.</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-size:11pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">LETKO, M., MARZI, A. &amp; MUNSTER, V. 2020. Functional assessment of cell entry and receptor usage for SARS-CoV-2 and other lineage B betacoronaviruses. <em>Nat Microbiol,</em> 5<strong>,</strong> 562-569.</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-size:11pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">LI, F. 2016. Structure, Function, and Evolution of Coronavirus Spike Proteins. <em>Annu Rev Virol,</em> 3<strong>,</strong> 237-261.</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-size:11pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">LIN, B., FERGUSON, C., WHITE, J. T., WANG, S., VESSELLA, R., TRUE, L. D., HOOD, L. &amp; NELSON, P. S. 1999. Prostate-localized and androgen-regulated expression of the membrane-bound serine protease TMPRSS2. <em>Cancer Res,</em> 59<strong>,</strong> 4180-4.</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-size:11pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">LIU, L., WANG, P., NAIR, M. S., YU, J., RAPP, M., WANG, Q., LUO, Y., CHAN, J. F., SAHI, V., FIGUEROA, A., GUO, X. V., CERUTTI, G., BIMELA, J., GORMAN, J., ZHOU, T., CHEN, Z., YUEN, K. Y., KWONG, P. D., SODROSKI, J. G., YIN, M. T., SHENG, Z., HUANG, Y., SHAPIRO, L. &amp; HO, D. D. 2020. Potent neutralizing antibodies against multiple epitopes on SARS-CoV-2 spike. <em>Nature,</em> 584<strong>,</strong> 450-456.</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-size:11pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">LU, Y. &amp; MENG, Y. G. 2015. Quantitation of Circulating Neuropilin-1 in Human, Monkey, Mouse, and Rat Sera by ELISA. <em>Methods Mol Biol,</em> 1332<strong>,</strong> 39-48.</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-size:11pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">LUCAS, J. M., TRUE, L., HAWLEY, S., MATSUMURA, M., MORRISSEY, C., VESSELLA, R. &amp; NELSON, P. S. 2008. The androgen-regulated type II serine protease TMPRSS2 is differentially expressed and mislocalized in prostate adenocarcinoma. <em>J Pathol,</em> 215<strong>,</strong> 118-25.</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-size:11pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">LUKASSEN, S., CHUA, R. L., TREFZER, T., KAHN, N. C., SCHNEIDER, M. A., MULEY, T., WINTER, H., MEISTER, M., VEITH, C., BOOTS, A. W., HENNIG, B. P., KREUTER, M., CONRAD, C. &amp; EILS, R. 2020. SARS-CoV-2 receptor ACE2 and TMPRSS2 are primarily expressed in bronchial transient secretory cells. <em>EMBO J,</em> 39<strong>,</strong> e105114.</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-size:11pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">MADJID, M., SAFAVI-NAEINI, P., SOLOMON, S. D. &amp; VARDENY, O. 2020. Potential Effects of Coronaviruses on the Cardiovascular System: A Review. <em>JAMA Cardiol,</em> 5<strong>,</strong> 831-840.</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-size:11pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">MAYI, B. S., LEIBOWITZ, J. A., WOODS, A. T., AMMON, K. A., LIU, A. E. &amp; RAJA, A. 2021. The role of Neuropilin-1 in COVID-19. <em>PLoS Pathog,</em> 17<strong>,</strong> e1009153.</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-size:11pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">MILLET, J. K. &amp; WHITTAKER, G. R. 2018. Physiological and molecular triggers for SARS-CoV membrane fusion and entry into host cells. <em>Virology,</em> 517<strong>,</strong> 3-8.</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-size:11pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">MIRABELLI, C., WOTRING, J. W., ZHANG, C. J., MCCARTY, S. M., FURSMIDT, R., FRUM, T., KADAMBI, N. S., AMIN, A. T., O&rsquo;MEARA, T. R., PRETTO, C. D., SPENCE, J. R., HUANG, J., ALYSANDRATOS, K. D., KOTTON, D. N., HANDELMAN, S. K., WOBUS, C. E., WEATHERWAX, K. J., MASHOUR, G. A., O&rsquo;MEARA, M. J. &amp; SEXTON, J. Z. 2020. Morphological Cell Profiling of SARS-CoV-2 Infection Identifies Drug Repurposing Candidates for COVID-19. <em>bioRxiv</em><strong>,</strong> 2020.05.27.117184.</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-size:11pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">MOUTAL, A., MARTIN, L. F., BOINON, L., GOMEZ, K., RAN, D., ZHOU, Y., STRATTON, H. J., CAI, S., LUO, S., GONZALEZ, K. B., PEREZ-MILLER, S., PATWARDHAN, A., IBRAHIM, M. M. &amp; KHANNA, R. 2020. SARS-CoV-2 Spike protein co-opts VEGF-A/Neuropilin-1 receptor signaling to induce analgesia. <em>bioRxiv</em>.</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-size:11pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">MUHL, L., FOLESTAD, E. B., GLADH, H., WANG, Y., MOESSINGER, C., JAKOBSSON, L. &amp; ERIKSSON, U. 2017. Neuropilin 1 binds PDGF-D and is a co-receptor in PDGF-D-PDGFRbeta signaling. <em>J Cell Sci,</em> 130<strong>,</strong> 1365-1378.</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-size:11pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">MUKHERJEE, S. &amp; PAHAN, K. 2021. Is COVID-19 Gender-sensitive? <em>J Neuroimmune Pharmacol,</em> 16<strong>,</strong> 38-47.</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-size:11pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">MURGOLO, N., THERIEN, A. G., HOWELL, B., KLEIN, D., KOEPLINGER, K., LIEBERMAN, L. A., ADAM, G. C., FLYNN, J., MCKENNA, P., SWAMINATHAN, G., HAZUDA, D. J. &amp; OLSEN, D. B. 2021. SARS-CoV-2 tropism, entry, replication, and propagation: Considerations for drug discovery and development. <em>PLoS Pathog,</em> 17<strong>,</strong> e1009225.</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-size:11pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">PAN, X. W., XU, D., ZHANG, H., ZHOU, W., WANG, L. H. &amp; CUI, X. G. 2020. Identification of a potential mechanism of acute kidney injury during the COVID-19 outbreak: a study based on single-cell transcriptome analysis. <em>Intensive Care Med,</em> 46<strong>,</strong> 1114-1116.</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-size:11pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">PEREZ-MILLER, S., PATEK, M., MOUTAL, A., CABEL, C. R., THORNE, C. A., CAMPOS, S. K. &amp; KHANNA, R. 2020. In silico identification and validation of inhibitors of the interaction between neuropilin receptor 1 and SARS-CoV-2 Spike protein. <em>bioRxiv</em>.</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-size:11pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">PREMKUMAR, L., SEGOVIA-CHUMBEZ, B., JADI, R., MARTINEZ, D. R., RAUT, R., MARKMANN, A., CORNABY, C., BARTELT, L., WEISS, S., PARK, Y., EDWARDS, C. E., WEIMER, E., SCHERER, E. M., ROUPHAEL, N., EDUPUGANTI, S., WEISKOPF, D., TSE, L. V., HOU, Y. J., MARGOLIS, D., SETTE, A., COLLINS, M. H., SCHMITZ, J., BARIC, R. S. &amp; DE SILVA, A. M. 2020. The receptor binding domain of the viral spike protein is an immunodominant and highly specific target of antibodies in SARS-CoV-2 patients. <em>Sci Immunol,</em> 5.</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-size:11pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">QIAO, Y., WANG, X. M., MANNAN, R., PITCHIAYA, S., ZHANG, Y., WOTRING, J. W., XIAO, L., ROBINSON, D. R., WU, Y. M., TIEN, J. C., CAO, X., SIMKO, S. A., APEL, I. J., BAWA, P., KREGEL, S., NARAYANAN, S. P., RASKIND, G., ELLISON, S. J., PAROLIA, A., ZELENKA-WANG, S., MCMURRY, L., SU, F., WANG, R., CHENG, Y., DELEKTA, A. D., MEI, Z., PRETTO, C. D., WANG, S., MEHRA, R., SEXTON, J. Z. &amp; CHINNAIYAN, A. M. 2020. Targeting transcriptional regulation of SARS-CoV-2 entry factors ACE2 and TMPRSS2. <em>Proc Natl Acad Sci U S A</em>.</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-size:11pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">RAHMAN, N., BASHARAT, Z., YOUSUF, M., CASTALDO, G., RASTRELLI, L. &amp; KHAN, H. 2020. Virtual Screening of Natural Products against Type II Transmembrane Serine Protease (TMPRSS2), the Priming Agent of Coronavirus 2 (SARS-CoV-2). <em>Molecules,</em> 25.</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-size:11pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">RAIMONDI, C., BRASH, J. T., FANTIN, A. &amp; RUHRBERG, C. 2016. NRP1 function and targeting in neurovascular development and eye disease. <em>Prog Retin Eye Res,</em> 52<strong>,</strong> 64-83.</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-size:11pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">RIVA, L., YUAN, S., YIN, X., MARTIN-SANCHO, L., MATSUNAGA, N., BURGSTALLER-MUEHLBACHER, S., PACHE, L., DE JESUS, P. P., HULL, M. V., CHANG, M., CHAN, J. F.-W., CAO, J., POON, V. K.-M., HERBERT, K., NGUYEN, T.-T., PU, Y., NGUYEN, C., RUBANOV, A., MARTINEZ-SOBRIDO, L., LIU, W.-C., MIORIN, L., WHITE, K. M., JOHNSON, J. R., BENNER, C., SUN, R., SCHULTZ, P. G., SU, A., GARCIA-SASTRE, A., CHATTERJEE, A. K., YUEN, K.-Y. &amp; CHANDA, S. K. 2020. A Large-scale Drug Repositioning Survey for SARS-CoV-2 Antivirals. <em>bioRxiv</em><strong>,</strong> 2020.04.16.044016.</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-size:11pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">ROBBIANI, D. F., GAEBLER, C., MUECKSCH, F., LORENZI, J. C. C., WANG, Z., CHO, A., AGUDELO, M., BARNES, C. O., GAZUMYAN, A., FINKIN, S., HAGGLOF, T., OLIVEIRA, T. Y., VIANT, C., HURLEY, A., HOFFMANN, H. H., MILLARD, K. G., KOST, R. G., CIPOLLA, M., GORDON, K., BIANCHINI, F., CHEN, S. T., RAMOS, V., PATEL, R., DIZON, J., SHIMELIOVICH, I., MENDOZA, P., HARTWEGER, H., NOGUEIRA, L., PACK, M., HOROWITZ, J., SCHMIDT, F., WEISBLUM, Y., MICHAILIDIS, E., ASHBROOK, A. W., WALTARI, E., PAK, J. E., HUEY-TUBMAN, K. E., KORANDA, N., HOFFMAN, P. R., WEST, A. P., JR., RICE, C. M., HATZIIOANNOU, T., BJORKMAN, P. J., BIENIASZ, P. D., CASKEY, M. &amp; NUSSENZWEIG, M. C. 2020. Convergent antibody responses to SARS-CoV-2 in convalescent individuals. <em>Nature,</em> 584<strong>,</strong> 437-442.</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-size:11pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">ROSSI, A., DEVERAUX, Q., TURK, B. &amp; SALI, A. 2004. Comprehensive search for cysteine cathepsins in the human genome. <em>Biol Chem,</em> 385<strong>,</strong> 363-72.</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-size:11pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">SHANG, J., WAN, Y., LUO, C., YE, G., GENG, Q., AUERBACH, A. &amp; LI, F. 2020. Cell entry mechanisms of SARS-CoV-2. <em>Proc Natl Acad Sci U S A,</em> 117<strong>,</strong> 11727-11734.</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-size:11pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">SHIRATO, K., KAWASE, M. &amp; MATSUYAMA, S. 2018. Wild-type human coronaviruses prefer cell-surface TMPRSS2 to endosomal cathepsins for cell entry. <em>Virology,</em> 517<strong>,</strong> 9-15.</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-size:11pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">SIMMONS, G., GOSALIA, D. N., RENNEKAMP, A. J., REEVES, J. D., DIAMOND, S. L. &amp; BATES, P. 2005. Inhibitors of cathepsin L prevent severe acute respiratory syndrome coronavirus entry. <em>Proc Natl Acad Sci U S A,</em> 102<strong>,</strong> 11876-81.</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-size:11pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">SINGH, M., BANSAL, V. &amp; FESCHOTTE, C. 2020. A single-cell RNA expression map of human coronavirus entry factors. <em>bioRxiv</em>.</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-size:11pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">SUBRAMANIAN, A., VERNON, K. A., SLYPER, M., WALDMAN, J., LUECKEN, M. D., GOSIK, K., DUBINSKY, D., CUOCO, M. S., KELLER, K., PURNELL, J., NGUYEN, L., DIONNE, D., ROZENBLATT-ROSEN, O., WEINS, A., REGEV, A. &amp; GREKA, A. 2020. RAAS blockade, kidney disease, and expression of ACE2, the entry receptor for SARS-CoV-2, in kidney epithelial and endothelial cells.</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-size:11pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">UNIPROTKB - O14786 (NRP1_HUMAN) </span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-size:11pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">WALLS, A. C., TORTORICI, M. A., BOSCH, B. J., FRENZ, B., ROTTIER, P. J. M., DIMAIO, F., REY, F. A. &amp; VEESLER, D. 2016. Cryo-electron microscopy structure of a coronavirus spike glycoprotein trimer. <em>Nature,</em> 531<strong>,</strong> 114-117.</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-size:11pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">WANG, Y., LIU, M. &amp; GAO, J. 2020. Enhanced receptor binding of SARS-CoV-2 through networks of hydrogen-bonding and hydrophobic interactions. <em>Proc Natl Acad Sci U S A,</em> 117<strong>,</strong> 13967-13974.</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-size:11pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">YAMAMOTO, M., KISO, M., SAKAI-TAGAWA, Y., IWATSUKI-HORIMOTO, K., IMAI, M., TAKEDA, M., KINOSHITA, N., OHMAGARI, N., GOHDA, J., SEMBA, K., MATSUDA, Z., KAWAGUCHI, Y., KAWAOKA, Y. &amp; INOUE, J. I. 2020. The Anticoagulant Nafamostat Potently Inhibits SARS-CoV-2 S Protein-Mediated Fusion in a Cell Fusion Assay System and Viral Infection In Vitro in a Cell-Type-Dependent Manner. <em>Viruses,</em> 12.</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-size:11pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">YANG, N. &amp; SHEN, H.-M. 2020. Targeting the Endocytic Pathway and Autophagy Process as a Novel Therapeutic Strategy in COVID-19. <em>International Journal of Biological Sciences,</em> 16<strong>,</strong> 1724-1731.</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-size:11pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">YUAN, M., WU, N. C., ZHU, X., LEE, C. D., SO, R. T. Y., LV, H., MOK, C. K. P. &amp; WILSON, I. A. 2020. A highly conserved cryptic epitope in the receptor binding domains of SARS-CoV-2 and SARS-CoV. <em>Science,</em> 368<strong>,</strong> 630-633.</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-size:11pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">ZANG, R., GOMEZ CASTRO, M. F., MCCUNE, B. T., ZENG, Q., ROTHLAUF, P. W., SONNEK, N. M., LIU, Z., BRULOIS, K. F., WANG, X., GREENBERG, H. B., DIAMOND, M. S., CIORBA, M. A., WHELAN, S. P. J. &amp; DING, S. 2020. TMPRSS2 and TMPRSS4 promote SARS-CoV-2 infection of human small intestinal enterocytes. <em>Sci Immunol,</em> 5.</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-size:11pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">ZIEGLER, C. G. K., ALLON, S. J., NYQUIST, S. K., MBANO, I. M., MIAO, V. N., TZOUANAS, C. N., CAO, Y., YOUSIF, A. S., BALS, J., HAUSER, B. M., FELDMAN, J., MUUS, C., WADSWORTH, M. H., 2ND, KAZER, S. W., HUGHES, T. K., DORAN, B., GATTER, G. J., VUKOVIC, M., TALIAFERRO, F., MEAD, B. E., GUO, Z., WANG, J. P., GRAS, D., PLAISANT, M., ANSARI, M., ANGELIDIS, I., ADLER, H., SUCRE, J. M. S., TAYLOR, C. J., LIN, B., WAGHRAY, A., MITSIALIS, V., DWYER, D. F., BUCHHEIT, K. M., BOYCE, J. A., BARRETT, N. A., LAIDLAW, T. M., CARROLL, S. L., COLONNA, L., TKACHEV, V., PETERSON, C. W., YU, A., ZHENG, H. B., GIDEON, H. P., WINCHELL, C. G., LIN, P. L., BINGLE, C. D., SNAPPER, S. B., KROPSKI, J. A., THEIS, F. J., SCHILLER, H. B., ZARAGOSI, L. E., BARBRY, P., LESLIE, A., KIEM, H. P., FLYNN, J. L., FORTUNE, S. M., BERGER, B., FINBERG, R. W., KEAN, L. S., GARBER, M., SCHMIDT, A. G., LINGWOOD, D., SHALEK, A. K., ORDOVAS-MONTANES, J., LUNG-NETWORK@HUMANCELLATLAS.ORG, H. C. A. L. B. N. E. A. &amp; NETWORK, H. C. A. L. B. 2020. SARS-CoV-2 Receptor ACE2 Is an Interferon-Stimulated Gene in Human Airway Epithelial Cells and Is Detected in Specific Cell Subsets across Tissues. <em>Cell,</em> 181<strong>,</strong> 1016-1035 e19.</span></span></p>\n","biologicalOrganisationLevel":"Molecular","organTerm":{"name":"organ","sourceId":"UBERON:0000062"},"biologicalEvents":[{"action":"increased","process":"endocytosis involved in viral entry into host cell","object":{}},{"action":"increased","process":"protease binding","object":{}},{"action":"increased","process":"neuropilin binding","object":{}}],"keyEventStressors":["Sars-CoV-2"],"id":1738}
{"title":"Increased susceptibility to viral entry","references":"<p style=\"margin-left:48px\"><span style=\"font-size:11pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">BAUGHN, L. B., SHARMA, N., ELHAIK, E., SEKULIC, A., BRYCE, A. H. &amp; FONSECA, R. 2020. Targeting TMPRSS2 in SARS-CoV-2 Infection. <em>Mayo Clin Proc,</em> 95<strong>,</strong> 1989-1999.</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-size:11pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">BESTLE, D., HEINDL, M. R., LIMBURG, H., VAN LAM VAN, T., PILGRAM, O., MOULTON, H., STEIN, D. A., HARDES, K., EICKMANN, M., DOLNIK, O., ROHDE, C., KLENK, H.-D., GARTEN, W., STEINMETZER, T. &amp; B&Ouml;TTCHER-FRIEBERTSH&Auml;USER, E. 2020a. TMPRSS2 and furin are both essential for proteolytic activation of SARS-CoV-2 in human airway cells. <em>Life Science Alliance,</em> 3.</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-size:11pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">BESTLE, D., HEINDL, M. R., LIMBURG, H., VAN LAM VAN, T., PILGRAM, O., MOULTON, H., STEIN, D. A., HARDES, K., EICKMANN, M., DOLNIK, O., ROHDE, C., KLENK, H. D., GARTEN, W., STEINMETZER, T. &amp; BOTTCHER-FRIEBERTSHAUSER, E. 2020b. TMPRSS2 and furin are both essential for proteolytic activation of SARS-CoV-2 in human airway cells. <em>Life Sci Alliance,</em> 3.</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-size:11pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">CANTUTI-CASTELVETRI, L., OJHA, R., PEDRO, L. D., DJANNATIAN, M., FRANZ, J., KUIVANEN, S., VAN DER MEER, F., KALLIO, K., KAYA, T., ANASTASINA, M., SMURA, T., LEVANOV, L., SZIROVICZA, L., TOBI, A., KALLIO-KOKKO, H., OSTERLUND, P., JOENSUU, M., MEUNIER, F. A., BUTCHER, S. J., WINKLER, M. S., MOLLENHAUER, B., HELENIUS, A., GOKCE, O., TEESALU, T., HEPOJOKI, J., VAPALAHTI, O., STADELMANN, C., BALISTRERI, G. &amp; SIMONS, M. 2020. Neuropilin-1 facilitates SARS-CoV-2 cell entry and infectivity. <em>Science,</em> 370<strong>,</strong> 856-860.</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-size:11pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">CAO, H., LI, Y., HUANG, L., BAI, B. &amp; XU, Z. 2020. Clinicopathological Significance of Neuropilin 1 Expression in Gastric Cancer: A Meta-Analysis. <em>Dis Markers,</em> 2020<strong>,</strong> 4763492.</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-size:11pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">CENTERS FOR DISEASE CONTROL AND PREVENTION, U. S. D. O. H. A. H. S. 2020. Covid-19 Science Update 2020.</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-size:11pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">CHEN, L., LI, X., CHEN, M., FENG, Y. &amp; XIONG, C. 2020. The ACE2 expression in human heart indicates new potential mechanism of heart injury among patients infected with SARS-CoV-2. <em>Cardiovasc Res,</em> 116<strong>,</strong> 1097-1100.</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-size:11pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">DALY, J. L., SIMONETTI, B., KLEIN, K., CHEN, K. E., WILLIAMSON, M. K., ANTON-PLAGARO, C., SHOEMARK, D. K., SIMON-GRACIA, L., BAUER, M., HOLLANDI, R., GREBER, U. F., HORVATH, P., SESSIONS, R. B., HELENIUS, A., HISCOX, J. A., TEESALU, T., MATTHEWS, D. A., DAVIDSON, A. D., COLLINS, B. M., CULLEN, P. J. &amp; YAMAUCHI, Y. 2020. Neuropilin-1 is a host factor for SARS-CoV-2 infection. <em>Science,</em> 370<strong>,</strong> 861-865.</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-size:11pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">DAVIES, J., RANDEVA, H. S., CHATHA, K., HALL, M., SPANDIDOS, D. A., KARTERIS, E. &amp; KYROU, I. 2020. Neuropilin1 as a new potential SARSCoV2 infection mediator implicated in the neurologic features and central nervous system involvement of COVID19. <em>Mol Med Rep,</em> 22<strong>,</strong> 4221-4226.</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-size:11pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">GELFAND, M. V., HAGAN, N., TATA, A., OH, W. J., LACOSTE, B., KANG, K. T., KOPYCINSKA, J., BISCHOFF, J., WANG, J. H. &amp; GU, C. 2014. Neuropilin-1 functions as a VEGFR2 co-receptor to guide developmental angiogenesis independent of ligand binding. <em>Elife,</em> 3<strong>,</strong> e03720.</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-size:11pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">HARTENIAN, E., NANDAKUMAR, D., LARI, A., LY, M., TUCKER, J. M. &amp; GLAUNSINGER, B. A. 2020. The molecular virology of coronaviruses. <em>J Biol Chem,</em> 295<strong>,</strong> 12910-12934.</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-size:11pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">HASAN, A., PARAY, B. A., HUSSAIN, A., QADIR, F. A., ATTAR, F., AZIZ, F. M., SHARIFI, M., DERAKHSHANKHAH, H., RASTI, B., MEHRABI, M., SHAHPASAND, K., SABOURY, A. A. &amp; FALAHATI, M. 2020. A review on the cleavage priming of the spike protein on coronavirus by angiotensin-converting enzyme-2 and furin. <em>J Biomol Struct Dyn</em><strong>,</strong> 1-9.</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-size:11pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">HOFFMANN, M., KLEINE-WEBER, H. &amp; POHLMANN, S. 2020a. A Multibasic Cleavage Site in the Spike Protein of SARS-CoV-2 Is Essential for Infection of Human Lung Cells. <em>Mol Cell,</em> 78<strong>,</strong> 779-784 e5.</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-size:11pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">HOFFMANN, M., KLEINE-WEBER, H., SCHROEDER, S., KRUGER, N., HERRLER, T., ERICHSEN, S., SCHIERGENS, T. S., HERRLER, G., WU, N. H., NITSCHE, A., MULLER, M. A., DROSTEN, C. &amp; POHLMANN, S. 2020b. SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor. <em>Cell,</em> 181<strong>,</strong> 271-280 e8.</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-size:11pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">HUGGINS, D. J. 2020. Structural analysis of experimental drugs binding to the SARS-CoV-2 target TMPRSS2. <em>J Mol Graph Model,</em> 100<strong>,</strong> 107710.</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-size:11pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">JING, Y., RUN-QIAN, L., HAO-RAN, W., HAO-RAN, C., YA-BIN, L., YANG, G. &amp; FEI, C. 2020. Potential influence of COVID-19/ACE2 on the female reproductive system. <em>Mol Hum Reprod,</em> 26<strong>,</strong> 367-373.</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-size:11pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">JOHNSON, B. A., XIE, X., KALVERAM, B., LOKUGAMAGE, K. G., MURUATO, A., ZOU, J., ZHANG, X., JUELICH, T., SMITH, J. K., ZHANG, L., BOPP, N., SCHINDEWOLF, C., VU, M., VANDERHEIDEN, A., SWETNAM, D., PLANTE, J. A., AGUILAR, P., PLANTE, K. S., LEE, B., WEAVER, S. C., SUTHAR, M. S., ROUTH, A. L., REN, P., KU, Z., AN, Z., DEBBINK, K., SHI, P. Y., FREIBERG, A. N. &amp; MENACHERY, V. D. 2020. Furin Cleavage Site Is Key to SARS-CoV-2 Pathogenesis. <em>bioRxiv</em>.</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-size:11pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">JU, B., ZHANG, Q., GE, J., WANG, R., SUN, J., GE, X., YU, J., SHAN, S., ZHOU, B., SONG, S., TANG, X., YU, J., LAN, J., YUAN, J., WANG, H., ZHAO, J., ZHANG, S., WANG, Y., SHI, X., LIU, L., ZHAO, J., WANG, X., ZHANG, Z. &amp; ZHANG, L. 2020. Human neutralizing antibodies elicited by SARS-CoV-2 infection. <em>Nature,</em> 584<strong>,</strong> 115-119.</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-size:11pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">JURASZEK, J., RUTTEN, L., BLOKLAND, S., BOUCHIER, P., VOORZAAT, R., RITSCHEL, T., BAKKERS, M. J. G., RENAULT, L. L. R. &amp; LANGEDIJK, J. P. M. 2021. Stabilizing the closed SARS-CoV-2 spike trimer. <em>Nat Commun,</em> 12<strong>,</strong> 244.</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-size:11pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">KANG, Y.-L., CHOU, Y.-Y., ROTHLAUF, P. W., LIU, Z., SOH, T. K., CURETON, D., CASE, J. B., CHEN, R. E., DIAMOND, M. S., WHELAN, S. P. J. &amp; KIRCHHAUSEN, T. 2020. Inhibition of PIKfyve kinase prevents infection by Zaire ebolavirus and SARS-CoV-2. <em>bioRxiv</em><strong>,</strong> 2020.04.21.053058.</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-size:11pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">KAWASE, M., SHIRATO, K., VAN DER HOEK, L., TAGUCHI, F. &amp; MATSUYAMA, S. 2012. Simultaneous treatment of human bronchial epithelial cells with serine and cysteine protease inhibitors prevents severe acute respiratory syndrome coronavirus entry. <em>J Virol,</em> 86<strong>,</strong> 6537-45.</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-size:11pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">LAM, S. D., BORDIN, N., WAMAN, V. P., SCHOLES, H. M., ASHFORD, P., SEN, N., VAN DORP, L., RAUER, C., DAWSON, N. L., PANG, C. S. M., ABBASIAN, M., SILLITOE, I., EDWARDS, S. J. L., FRATERNALI, F., LEES, J. G., SANTINI, J. M. &amp; ORENGO, C. A. 2020. SARS-CoV-2 spike protein predicted to form complexes with host receptor protein orthologues from a broad range of mammals. <em>Sci Rep,</em> 10<strong>,</strong> 16471.</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-size:11pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">LAMERS, M. M., BEUMER, J., VAN DER VAART, J., KNOOPS, K., PUSCHHOF, J., BREUGEM, T. I., RAVELLI, R. B. G., PAUL VAN SCHAYCK, J., MYKYTYN, A. Z., DUIMEL, H. Q., VAN DONSELAAR, E., RIESEBOSCH, S., KUIJPERS, H. J. H., SCHIPPER, D., VAN DE WETERING, W. J., DE GRAAF, M., KOOPMANS, M., CUPPEN, E., PETERS, P. J., HAAGMANS, B. L. &amp; CLEVERS, H. 2020. SARS-CoV-2 productively infects human gut enterocytes. <em>Science,</em> 369<strong>,</strong> 50-54.</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-size:11pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">LAN, J., GE, J., YU, J., SHAN, S., ZHOU, H., FAN, S., ZHANG, Q., SHI, X., WANG, Q., ZHANG, L. &amp; WANG, X. 2020. Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor. <em>Nature,</em> 581<strong>,</strong> 215-220.</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-size:11pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">LETKO, M., MARZI, A. &amp; MUNSTER, V. 2020. Functional assessment of cell entry and receptor usage for SARS-CoV-2 and other lineage B betacoronaviruses. <em>Nat Microbiol,</em> 5<strong>,</strong> 562-569.</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-size:11pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">LI, F. 2016. Structure, Function, and Evolution of Coronavirus Spike Proteins. <em>Annu Rev Virol,</em> 3<strong>,</strong> 237-261.</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-size:11pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">LIN, B., FERGUSON, C., WHITE, J. T., WANG, S., VESSELLA, R., TRUE, L. D., HOOD, L. &amp; NELSON, P. S. 1999. Prostate-localized and androgen-regulated expression of the membrane-bound serine protease TMPRSS2. <em>Cancer Res,</em> 59<strong>,</strong> 4180-4.</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-size:11pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">LIU, L., WANG, P., NAIR, M. S., YU, J., RAPP, M., WANG, Q., LUO, Y., CHAN, J. F., SAHI, V., FIGUEROA, A., GUO, X. V., CERUTTI, G., BIMELA, J., GORMAN, J., ZHOU, T., CHEN, Z., YUEN, K. Y., KWONG, P. D., SODROSKI, J. G., YIN, M. T., SHENG, Z., HUANG, Y., SHAPIRO, L. &amp; HO, D. D. 2020. Potent neutralizing antibodies against multiple epitopes on SARS-CoV-2 spike. <em>Nature,</em> 584<strong>,</strong> 450-456.</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-size:11pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">LU, Y. &amp; MENG, Y. G. 2015. Quantitation of Circulating Neuropilin-1 in Human, Monkey, Mouse, and Rat Sera by ELISA. <em>Methods Mol Biol,</em> 1332<strong>,</strong> 39-48.</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-size:11pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">LUCAS, J. M., TRUE, L., HAWLEY, S., MATSUMURA, M., MORRISSEY, C., VESSELLA, R. &amp; NELSON, P. S. 2008. The androgen-regulated type II serine protease TMPRSS2 is differentially expressed and mislocalized in prostate adenocarcinoma. <em>J Pathol,</em> 215<strong>,</strong> 118-25.</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-size:11pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">LUKASSEN, S., CHUA, R. L., TREFZER, T., KAHN, N. C., SCHNEIDER, M. A., MULEY, T., WINTER, H., MEISTER, M., VEITH, C., BOOTS, A. W., HENNIG, B. P., KREUTER, M., CONRAD, C. &amp; EILS, R. 2020. SARS-CoV-2 receptor ACE2 and TMPRSS2 are primarily expressed in bronchial transient secretory cells. <em>EMBO J,</em> 39<strong>,</strong> e105114.</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-size:11pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">MADJID, M., SAFAVI-NAEINI, P., SOLOMON, S. D. &amp; VARDENY, O. 2020. Potential Effects of Coronaviruses on the Cardiovascular System: A Review. <em>JAMA Cardiol,</em> 5<strong>,</strong> 831-840.</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-size:11pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">MAYI, B. S., LEIBOWITZ, J. A., WOODS, A. T., AMMON, K. A., LIU, A. E. &amp; RAJA, A. 2021. The role of Neuropilin-1 in COVID-19. <em>PLoS Pathog,</em> 17<strong>,</strong> e1009153.</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-size:11pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">MILLET, J. K. &amp; WHITTAKER, G. R. 2018. Physiological and molecular triggers for SARS-CoV membrane fusion and entry into host cells. <em>Virology,</em> 517<strong>,</strong> 3-8.</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-size:11pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">MIRABELLI, C., WOTRING, J. W., ZHANG, C. J., MCCARTY, S. M., FURSMIDT, R., FRUM, T., KADAMBI, N. S., AMIN, A. T., O&rsquo;MEARA, T. R., PRETTO, C. D., SPENCE, J. R., HUANG, J., ALYSANDRATOS, K. D., KOTTON, D. N., HANDELMAN, S. K., WOBUS, C. E., WEATHERWAX, K. J., MASHOUR, G. A., O&rsquo;MEARA, M. J. &amp; SEXTON, J. Z. 2020. Morphological Cell Profiling of SARS-CoV-2 Infection Identifies Drug Repurposing Candidates for COVID-19. <em>bioRxiv</em><strong>,</strong> 2020.05.27.117184.</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-size:11pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">MOUTAL, A., MARTIN, L. F., BOINON, L., GOMEZ, K., RAN, D., ZHOU, Y., STRATTON, H. J., CAI, S., LUO, S., GONZALEZ, K. B., PEREZ-MILLER, S., PATWARDHAN, A., IBRAHIM, M. M. &amp; KHANNA, R. 2020. SARS-CoV-2 Spike protein co-opts VEGF-A/Neuropilin-1 receptor signaling to induce analgesia. <em>bioRxiv</em>.</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-size:11pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">MUHL, L., FOLESTAD, E. B., GLADH, H., WANG, Y., MOESSINGER, C., JAKOBSSON, L. &amp; ERIKSSON, U. 2017. Neuropilin 1 binds PDGF-D and is a co-receptor in PDGF-D-PDGFRbeta signaling. <em>J Cell Sci,</em> 130<strong>,</strong> 1365-1378.</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-size:11pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">MUKHERJEE, S. &amp; PAHAN, K. 2021. Is COVID-19 Gender-sensitive? <em>J Neuroimmune Pharmacol,</em> 16<strong>,</strong> 38-47.</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-size:11pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">MURGOLO, N., THERIEN, A. G., HOWELL, B., KLEIN, D., KOEPLINGER, K., LIEBERMAN, L. A., ADAM, G. C., FLYNN, J., MCKENNA, P., SWAMINATHAN, G., HAZUDA, D. J. &amp; OLSEN, D. B. 2021. SARS-CoV-2 tropism, entry, replication, and propagation: Considerations for drug discovery and development. <em>PLoS Pathog,</em> 17<strong>,</strong> e1009225.</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-size:11pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">PAN, X. W., XU, D., ZHANG, H., ZHOU, W., WANG, L. H. &amp; CUI, X. G. 2020. Identification of a potential mechanism of acute kidney injury during the COVID-19 outbreak: a study based on single-cell transcriptome analysis. <em>Intensive Care Med,</em> 46<strong>,</strong> 1114-1116.</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-size:11pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">PEREZ-MILLER, S., PATEK, M., MOUTAL, A., CABEL, C. R., THORNE, C. A., CAMPOS, S. K. &amp; KHANNA, R. 2020. In silico identification and validation of inhibitors of the interaction between neuropilin receptor 1 and SARS-CoV-2 Spike protein. <em>bioRxiv</em>.</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-size:11pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">PREMKUMAR, L., SEGOVIA-CHUMBEZ, B., JADI, R., MARTINEZ, D. R., RAUT, R., MARKMANN, A., CORNABY, C., BARTELT, L., WEISS, S., PARK, Y., EDWARDS, C. E., WEIMER, E., SCHERER, E. M., ROUPHAEL, N., EDUPUGANTI, S., WEISKOPF, D., TSE, L. V., HOU, Y. J., MARGOLIS, D., SETTE, A., COLLINS, M. H., SCHMITZ, J., BARIC, R. S. &amp; DE SILVA, A. M. 2020. The receptor binding domain of the viral spike protein is an immunodominant and highly specific target of antibodies in SARS-CoV-2 patients. <em>Sci Immunol,</em> 5.</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-size:11pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">QIAO, Y., WANG, X. M., MANNAN, R., PITCHIAYA, S., ZHANG, Y., WOTRING, J. W., XIAO, L., ROBINSON, D. R., WU, Y. M., TIEN, J. C., CAO, X., SIMKO, S. A., APEL, I. J., BAWA, P., KREGEL, S., NARAYANAN, S. P., RASKIND, G., ELLISON, S. J., PAROLIA, A., ZELENKA-WANG, S., MCMURRY, L., SU, F., WANG, R., CHENG, Y., DELEKTA, A. D., MEI, Z., PRETTO, C. D., WANG, S., MEHRA, R., SEXTON, J. Z. &amp; CHINNAIYAN, A. M. 2020. Targeting transcriptional regulation of SARS-CoV-2 entry factors ACE2 and TMPRSS2. <em>Proc Natl Acad Sci U S A</em>.</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-size:11pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">RAHMAN, N., BASHARAT, Z., YOUSUF, M., CASTALDO, G., RASTRELLI, L. &amp; KHAN, H. 2020. Virtual Screening of Natural Products against Type II Transmembrane Serine Protease (TMPRSS2), the Priming Agent of Coronavirus 2 (SARS-CoV-2). <em>Molecules,</em> 25.</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-size:11pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">RAIMONDI, C., BRASH, J. T., FANTIN, A. &amp; RUHRBERG, C. 2016. NRP1 function and targeting in neurovascular development and eye disease. <em>Prog Retin Eye Res,</em> 52<strong>,</strong> 64-83.</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-size:11pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">RIVA, L., YUAN, S., YIN, X., MARTIN-SANCHO, L., MATSUNAGA, N., BURGSTALLER-MUEHLBACHER, S., PACHE, L., DE JESUS, P. P., HULL, M. V., CHANG, M., CHAN, J. F.-W., CAO, J., POON, V. K.-M., HERBERT, K., NGUYEN, T.-T., PU, Y., NGUYEN, C., RUBANOV, A., MARTINEZ-SOBRIDO, L., LIU, W.-C., MIORIN, L., WHITE, K. M., JOHNSON, J. R., BENNER, C., SUN, R., SCHULTZ, P. G., SU, A., GARCIA-SASTRE, A., CHATTERJEE, A. K., YUEN, K.-Y. &amp; CHANDA, S. K. 2020. A Large-scale Drug Repositioning Survey for SARS-CoV-2 Antivirals. <em>bioRxiv</em><strong>,</strong> 2020.04.16.044016.</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-size:11pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">ROBBIANI, D. F., GAEBLER, C., MUECKSCH, F., LORENZI, J. C. C., WANG, Z., CHO, A., AGUDELO, M., BARNES, C. O., GAZUMYAN, A., FINKIN, S., HAGGLOF, T., OLIVEIRA, T. Y., VIANT, C., HURLEY, A., HOFFMANN, H. H., MILLARD, K. G., KOST, R. G., CIPOLLA, M., GORDON, K., BIANCHINI, F., CHEN, S. T., RAMOS, V., PATEL, R., DIZON, J., SHIMELIOVICH, I., MENDOZA, P., HARTWEGER, H., NOGUEIRA, L., PACK, M., HOROWITZ, J., SCHMIDT, F., WEISBLUM, Y., MICHAILIDIS, E., ASHBROOK, A. W., WALTARI, E., PAK, J. E., HUEY-TUBMAN, K. E., KORANDA, N., HOFFMAN, P. R., WEST, A. P., JR., RICE, C. M., HATZIIOANNOU, T., BJORKMAN, P. J., BIENIASZ, P. D., CASKEY, M. &amp; NUSSENZWEIG, M. C. 2020. Convergent antibody responses to SARS-CoV-2 in convalescent individuals. <em>Nature,</em> 584<strong>,</strong> 437-442.</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-size:11pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">ROSSI, A., DEVERAUX, Q., TURK, B. &amp; SALI, A. 2004. Comprehensive search for cysteine cathepsins in the human genome. <em>Biol Chem,</em> 385<strong>,</strong> 363-72.</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-size:11pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">SHANG, J., WAN, Y., LUO, C., YE, G., GENG, Q., AUERBACH, A. &amp; LI, F. 2020. Cell entry mechanisms of SARS-CoV-2. <em>Proc Natl Acad Sci U S A,</em> 117<strong>,</strong> 11727-11734.</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-size:11pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">SHIRATO, K., KAWASE, M. &amp; MATSUYAMA, S. 2018. Wild-type human coronaviruses prefer cell-surface TMPRSS2 to endosomal cathepsins for cell entry. <em>Virology,</em> 517<strong>,</strong> 9-15.</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-size:11pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">SIMMONS, G., GOSALIA, D. N., RENNEKAMP, A. J., REEVES, J. D., DIAMOND, S. L. &amp; BATES, P. 2005. Inhibitors of cathepsin L prevent severe acute respiratory syndrome coronavirus entry. <em>Proc Natl Acad Sci U S A,</em> 102<strong>,</strong> 11876-81.</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-size:11pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">SINGH, M., BANSAL, V. &amp; FESCHOTTE, C. 2020. A single-cell RNA expression map of human coronavirus entry factors. <em>bioRxiv</em>.</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-size:11pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">SUBRAMANIAN, A., VERNON, K. A., SLYPER, M., WALDMAN, J., LUECKEN, M. D., GOSIK, K., DUBINSKY, D., CUOCO, M. S., KELLER, K., PURNELL, J., NGUYEN, L., DIONNE, D., ROZENBLATT-ROSEN, O., WEINS, A., REGEV, A. &amp; GREKA, A. 2020. RAAS blockade, kidney disease, and expression of ACE2, the entry receptor for SARS-CoV-2, in kidney epithelial and endothelial cells.</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-size:11pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">UNIPROTKB - O14786 (NRP1_HUMAN) </span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-size:11pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">WALLS, A. C., TORTORICI, M. A., BOSCH, B. J., FRENZ, B., ROTTIER, P. J. M., DIMAIO, F., REY, F. A. &amp; VEESLER, D. 2016. Cryo-electron microscopy structure of a coronavirus spike glycoprotein trimer. <em>Nature,</em> 531<strong>,</strong> 114-117.</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-size:11pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">WANG, Y., LIU, M. &amp; GAO, J. 2020. Enhanced receptor binding of SARS-CoV-2 through networks of hydrogen-bonding and hydrophobic interactions. <em>Proc Natl Acad Sci U S A,</em> 117<strong>,</strong> 13967-13974.</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-size:11pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">YAMAMOTO, M., KISO, M., SAKAI-TAGAWA, Y., IWATSUKI-HORIMOTO, K., IMAI, M., TAKEDA, M., KINOSHITA, N., OHMAGARI, N., GOHDA, J., SEMBA, K., MATSUDA, Z., KAWAGUCHI, Y., KAWAOKA, Y. &amp; INOUE, J. I. 2020. The Anticoagulant Nafamostat Potently Inhibits SARS-CoV-2 S Protein-Mediated Fusion in a Cell Fusion Assay System and Viral Infection In Vitro in a Cell-Type-Dependent Manner. <em>Viruses,</em> 12.</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-size:11pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">YANG, N. &amp; SHEN, H.-M. 2020. Targeting the Endocytic Pathway and Autophagy Process as a Novel Therapeutic Strategy in COVID-19. <em>International Journal of Biological Sciences,</em> 16<strong>,</strong> 1724-1731.</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-size:11pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">YUAN, M., WU, N. C., ZHU, X., LEE, C. D., SO, R. T. Y., LV, H., MOK, C. K. P. &amp; WILSON, I. A. 2020. A highly conserved cryptic epitope in the receptor binding domains of SARS-CoV-2 and SARS-CoV. <em>Science,</em> 368<strong>,</strong> 630-633.</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-size:11pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">ZANG, R., GOMEZ CASTRO, M. F., MCCUNE, B. T., ZENG, Q., ROTHLAUF, P. W., SONNEK, N. M., LIU, Z., BRULOIS, K. F., WANG, X., GREENBERG, H. B., DIAMOND, M. S., CIORBA, M. A., WHELAN, S. P. J. &amp; DING, S. 2020. TMPRSS2 and TMPRSS4 promote SARS-CoV-2 infection of human small intestinal enterocytes. <em>Sci Immunol,</em> 5.</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-size:11pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">ZIEGLER, C. G. K., ALLON, S. J., NYQUIST, S. K., MBANO, I. M., MIAO, V. N., TZOUANAS, C. N., CAO, Y., YOUSIF, A. S., BALS, J., HAUSER, B. M., FELDMAN, J., MUUS, C., WADSWORTH, M. H., 2ND, KAZER, S. W., HUGHES, T. K., DORAN, B., GATTER, G. J., VUKOVIC, M., TALIAFERRO, F., MEAD, B. E., GUO, Z., WANG, J. P., GRAS, D., PLAISANT, M., ANSARI, M., ANGELIDIS, I., ADLER, H., SUCRE, J. M. S., TAYLOR, C. J., LIN, B., WAGHRAY, A., MITSIALIS, V., DWYER, D. F., BUCHHEIT, K. M., BOYCE, J. A., BARRETT, N. A., LAIDLAW, T. M., CARROLL, S. L., COLONNA, L., TKACHEV, V., PETERSON, C. W., YU, A., ZHENG, H. B., GIDEON, H. P., WINCHELL, C. G., LIN, P. L., BINGLE, C. D., SNAPPER, S. B., KROPSKI, J. A., THEIS, F. J., SCHILLER, H. B., ZARAGOSI, L. E., BARBRY, P., LESLIE, A., KIEM, H. P., FLYNN, J. L., FORTUNE, S. M., BERGER, B., FINBERG, R. W., KEAN, L. S., GARBER, M., SCHMIDT, A. G., LINGWOOD, D., SHALEK, A. K., ORDOVAS-MONTANES, J., LUNG-NETWORK@HUMANCELLATLAS.ORG, H. C. A. L. B. N. E. A. &amp; NETWORK, H. C. A. L. B. 2020. SARS-CoV-2 Receptor ACE2 Is an Interferon-Stimulated Gene in Human Airway Epithelial Cells and Is Detected in Specific Cell Subsets across Tissues. <em>Cell,</em> 181<strong>,</strong> 1016-1035 e19.</span></span></p>\n","biologicalOrganisationLevel":"Molecular","organTerm":{"name":"organ","sourceId":"UBERON:0000062"},"biologicalEvents":[{"action":"increased","process":"endocytosis involved in viral entry into host cell","object":{}},{"action":"increased","process":"protease binding","object":{}},{"action":"increased","process":"neuropilin binding","object":{}}],"keyEventStressors":["Sars-CoV-2"],"id":1738}
{"title":"ACE2 binding to viral S-protein ","references":"<p><span style=\"font-size:11pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong><span style=\"color:#0070c0\">COVID19 References related to CNS:</span></strong></span></span></p>\n\n<p><span style=\"font-size:11pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#0070c0\">de Morais SDB, et al. Integrative Physiological Aspects of Brain RAS in Hypertension. Curr Hypertens Rep. 2018 Feb 26; 20(2):10.</span></span></span></p>\n\n<p><span style=\"font-size:11pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#0070c0\">Gallagher PE, et al. Distinct roles for ANG II and ANG-(1-7) in the regulation of angiotensin-converting enzyme 2 in rat astrocytes. Am J Physiol Cell Physiol. 2006 Feb; 290(2):C420-6.</span></span></span></p>\n\n<p><span style=\"font-size:11pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#0070c0\">Gowrisankar YV, Clark MA. Angiotensin II regulation of angiotensin-converting enzymes in spontaneously hypertensive rat primary astrocyte cultures. J Neurochem. 2016 Jul; 138(1):74-85.</span></span></span></p>\n\n<p><span style=\"font-size:11pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#0070c0\">Hamming I et al. Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis. J Pathol. 2004 Jun;203(2):631-7.</span></span></span></p>\n\n<p><span style=\"font-size:11pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#0070c0\">Jakhmola S, et al. SARS-CoV-2, an Underestimated Pathogen of the Nervous System. SN Compr Clin Med. 2020.</span></span></span></p>\n\n<p><span style=\"font-size:11pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#0070c0\">Lukiw WJ et al. SARS-CoV-2 Infectivity and Neurological Targets in the Brain. Cell Mol Neurobiol. 2020 Aug 25;1-8.</span></span></span></p>\n\n<p><span style=\"font-size:11pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#0070c0\">Matsushita T, et al. CSF angiotensin II and angiotensin-converting enzyme levels in anti-aquaporin-4 autoimmunity. J Neurol Sci. 2010 Aug 15; 295(1-2):41-5.</span></span></span></p>\n\n<p><span style=\"font-size:11pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#0070c0\">Murta et al. Severe Acute Respiratory Syndrome Coronavirus 2 Impact on the Central Nervous System: Are Astrocytes and Microglia Main Players or Merely Bystanders? ASN Neuro. 2020. PMID: 32878468</span></span></span></p>\n\n<p><span style=\"font-size:11pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#0070c0\">Shi A, et al. Isolation, purification and molecular mechanism of a peanut protein-derived ACE-inhibitory peptide. PLoS One. 2014; 9(10):e111188.</span></span></span></p>\n\n<p><span style=\"font-size:11pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#0070c0\">Xia, H. and Lazartigues, E.&nbsp; Angiotensin-Converting Enzyme 2: Central Regulator for Cardiovascular Function. Curr. Hypertens. 2010&nbsp; Rep. 12 (3), 170&ndash; 175</span></span></span></p>\n","biologicalOrganisationLevel":"Molecular","organTerm":{},"biologicalEvents":[{"object":{}}],"keyEventStressors":["Sars-CoV-2"],"id":1739}
{"title":"Increase, the risk of acute respiratory failure","references":"","biologicalOrganisationLevel":"Organ","organTerm":{},"biologicalEvents":[{"object":{}}],"id":1748}
{"title":"Increased inflammatory immune responses","references":"","biologicalOrganisationLevel":"Tissue","organTerm":{},"biologicalEvents":[{"object":{}}],"id":1750}
{"title":"Induced Toll Like Receptor (TLR) Dysregulation","references":"<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-size:11.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">AKIRA, S., 2003. Toll-like receptor signaling. <em>Journal of Biological Chemistry, </em><strong>278</strong>(40), pp. 38105-38108.</span></span></span></span></p>\n\n<div>\n<div>Gillina F. G. Bezemer, Seil Sagar, Jeroen van Bergenhenegouwen, Niki A. Georgiou, Johan Garssen, Aletta D. Kraneveld and Gert Folkerts</div>\n</div>\n\n<div>Dual role of TLRs in asthma and COPD. <em>Pharmacological Reviews</em> April 1, 2012, 64 (2) 337-358; DOI: https://doi.org/10.1124/pr.111.004622</div>\n\n<div>&nbsp;</div>\n\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-size:11.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">BEZEMER, G.F.G. and GARSSEN, J., 2021. TLR9 and COVID-19: A Multidisciplinary Theory of a Multifaceted Therapeutic Target. <em>Frontiers in pharmacology, </em><strong>11</strong>, pp. 601685.</span></span></span></span></p>\n\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-size:11.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">KAWAI, T. and AKIRA, S., 2011. Toll-like Receptors and Their Crosstalk with Other Innate Receptors in Infection and Immunity. <em>Immunity, </em><strong>34</strong>(5), pp. 637-650.</span></span></span></span></p>\n\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-size:11.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">PASARE, C. and MEDZHITOV, R., 2005. Toll-like receptors: Linking innate and adaptive immunity. <em>Mechanisms of Lymphocyte Activation and Immune Regulation X: Innate Immunity, </em><strong>560</strong>, pp. 11-18.</span></span></span></span></p>\n\n<p>Piccinini AM, Midwood KS. DAMPening inflammation by modulating TLR signalling. <em>Mediators Inflamm</em>. 2010;2010:672395. doi:10.1155/2010/672395</p>\n\n<p>Shaw AC, Panda A, Joshi SR, Qian F, Allore HG, Montgomery RR. Dysregulation of human Toll-like receptor function in aging. <em>Ageing Res Rev</em>. 2011;10(3):346-353. doi:10.1016/j.arr.2010.10.007</p>\n\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-size:11.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">TAKEDA, K. and AKIRA, S., 2004. TLR signaling pathways. <em>Seminars in immunology, </em><strong>16</strong>(1), pp. 3-9.</span></span></span></span></p>\n\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-size:11.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">TAL, Y., ADINI, A., ERAN, A. and ADINI, I., 2020. Racial disparity in Covid-19 mortality rates - A plausible explanation. </span></span><em><span style=\"font-size:11.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Clinical immunology (Orlando, Fla.), </span></span></em><strong><span style=\"font-size:11.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">217</span></span></strong><span style=\"font-size:11.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">, pp. 108481.</span></span></span></span></p>\n\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-size:11.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">VAN DER MADE, C.I., SIMONS, A., SCHUURS-HOEIJMAKERS, J., VAN DEN HEUVEL, G., MANTERE, T., KERSTEN, S., VAN DEUREN, R.C., STEEHOUWER, M., VAN REIJMERSDAL, S.V., JAEGER, M., HOFSTE, T., ASTUTI, G., COROMINAS GALBANY, J., VAN DER SCHOOT, V., VAN DER HOEVEN, H., HAGMOLEN OF TEN HAVE, W., KLIJN, E., VAN DEN MEER, C., FIDDELAERS, J., DE MAST, Q., BLEEKER-ROVERS, C.P., JOOSTEN, L.A.B., YNTEMA, H.G., GILISSEN, C., NELEN, M., VAN DER MEER, J.W.M., BRUNNER, H.G., NETEA, M.G., VAN DE VEERDONK, F.L. and HOISCHEN, A., 2020. </span></span><span style=\"font-size:11.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Presence of Genetic Variants Among Young Men With Severe COVID-19. </span></span><em><span style=\"font-size:11.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Jama, </span></span></em><span style=\"font-size:11.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">.</span></span></span></span></p>\n\n<p><span style=\"font-size:11pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Kovats, Cell Immunol. 2015 April; 294(2): 63&ndash;69; </span></span></p>\n\n<p>Takahashi and Iwasaki, Science. 2021 Jan 22;371(6527):347-348</p>\n\n<div>Libert et al., Nat Rev Immunol. 2010 Aug;10(8):594-604</div>\n\n<p>Scully EP, et al. Nat Rev Immunol. 2020. PMID: 32528136</p>\n\n<p>&nbsp;</p>\n","biologicalOrganisationLevel":"Molecular","organTerm":{},"biologicalEvents":[{"object":{}}],"keyEventStressors":["SARS-CoV","Pathogen Associated Molecular Patterns (PAMPs)","Sars-CoV-2","Danger Associated Molecular Patters (DAMPs)","cell free mitochondrial DNA (mtDNA)"],"id":1848}
{"title":"Increased coronavirus production","references":"<p style=\"margin-left:48px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-family:Arial,Helvetica,sans-serif\">1.&nbsp; &nbsp; &nbsp; &nbsp; &nbsp;D. Kim<em> et al.</em>, The Architecture of SARS-CoV-2 Transcriptome. <em>Cell</em> <strong>181</strong>, 914-921 e910 (2020).</span></span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-family:Arial,Helvetica,sans-serif\"><span style=\"font-size:11pt\">2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; E. J. Snijder<em> et al.</em>, Unique and Conserved Features of Genome and Proteome of SARS-coronavirus, an Early Split-off From the Coronavirus Group 2 Lineage. <em>Journal of Molecular Biology</em> <strong>331</strong>, 991-1004 (2003).</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-family:Arial,Helvetica,sans-serif\"><span style=\"font-size:11pt\">3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; N. C. Huston<em> et al.</em>, Comprehensive in vivo secondary structure of the SARS-CoV-2 genome reveals novel regulatory motifs and mechanisms. <em>Mol Cell</em> <strong>81</strong>, 584-598 e585 (2021).</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-family:Arial,Helvetica,sans-serif\"><span style=\"font-size:11pt\">4.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; C. J. Budzilowicz, S. P. Wilczynski, S. R. Weiss, Three intergenic regions of coronavirus mouse hepatitis virus strain A59 genome RNA contain a common nucleotide sequence that is homologous to the 3&#39; end of the viral mRNA leader sequence. <em>J Virol</em> <strong>53</strong>, 834-840 (1985).</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-family:Arial,Helvetica,sans-serif\"><span style=\"font-size:11pt\">5.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; H. Di, A. A. McIntyre, M. A. Brinton, New insights about the regulation of Nidovirus subgenomic mRNA synthesis. <em>Virology</em> <strong>517</strong>, 38-43 (2018).</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-family:Arial,Helvetica,sans-serif\"><span style=\"font-size:11pt\">6.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; M. D. Sacco<em> et al.</em>, Structure and inhibition of the SARS-CoV-2 main protease reveal strategy for developing dual inhibitors against M(pro) and cathepsin L. <em>Sci Adv</em> <strong>6</strong>,&nbsp; (2020).</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-family:Arial,Helvetica,sans-serif\"><span style=\"font-size:11pt\">7.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; S. Klein<em> et al.</em>, SARS-CoV-2 structure and replication characterized by in situ cryo-electron tomography. <em>BioRxiv</em>,&nbsp; (2020).</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-family:Arial,Helvetica,sans-serif\"><span style=\"font-size:11pt\">8.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; E. J. Snijder<em> et al.</em>, A unifying structural and functional model of the coronavirus replication organelle: Tracking down RNA synthesis. <em>PLoS Biol</em> <strong>18</strong>, e3000715 (2020).</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-family:Arial,Helvetica,sans-serif\"><span style=\"font-size:11pt\">9.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; P. V&#39;Kovski, A. Kratzel, S. Steiner, H. Stalder, V. Thiel, Coronavirus biology and replication: implications for SARS-CoV-2. <em>Nat Rev Microbiol</em>,&nbsp; (2020).</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-family:Arial,Helvetica,sans-serif\"><span style=\"font-size:11pt\">10.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; P. Liu, J. Leibowitz, in <em>Molecular Biology of the SARS-Coronavirus</em>. (2010),&nbsp; chap. Chapter 4, pp. 47-61.</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-family:Arial,Helvetica,sans-serif\"><span style=\"font-size:11pt\">11.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; V. B. O&#39;Leary, O. J. Dolly, C. Hoschl, M. Cerna, S. V. Ovsepian, Unpacking Pandora From Its Box: Deciphering the Molecular Basis of the SARS-CoV-2 Coronavirus. <em>Int J Mol Sci</em> <strong>22</strong>,&nbsp; (2020).</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-family:Arial,Helvetica,sans-serif\"><span style=\"font-size:11pt\">12.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Y. Finkel<em> et al.</em>, The coding capacity of SARS-CoV-2. <em>Nature</em> <strong>589</strong>, 125-130 (2021).</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-family:Arial,Helvetica,sans-serif\"><span style=\"font-size:11pt\">13.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; H. A. Hussein, R. Y. A. Hassan, M. Chino, F. Febbraio, Point-of-Care Diagnostics of COVID-19: From Current Work to Future Perspectives. <em>Sensors (Basel)</em> <strong>20</strong>,&nbsp; (2020).</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-family:Arial,Helvetica,sans-serif\"><span style=\"font-size:11pt\">14.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; M. Thoms<em> et al.</em>, Structural basis for translational shutdown and immune evasion by the Nsp1 protein of SARS-CoV-2. <em>Science</em> <strong>369</strong>, 1249-1255 (2020).</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-family:Arial,Helvetica,sans-serif\"><span style=\"font-size:11pt\">15.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; A. K. Banerjee<em> et al.</em>, SARS-CoV-2 Disrupts Splicing, Translation, and Protein Trafficking to Suppress Host Defenses. <em>Cell</em> <strong>183</strong>, 1325-1339 e1321 (2020).</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-family:Arial,Helvetica,sans-serif\"><span style=\"font-size:11pt\">16.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; H. Xia<em> et al.</em>, Evasion of Type I Interferon by SARS-CoV-2. <em>Cell Rep</em> <strong>33</strong>, 108234 (2020).</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-family:Arial,Helvetica,sans-serif\"><span style=\"font-size:11pt\">17.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; P. Ahlquist, RNA-dependent RNA polymerases, viruses, and RNA silencing. <em>Science</em> <strong>296</strong>, 1270-1273 (2002).</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-family:Arial,Helvetica,sans-serif\"><span style=\"font-size:11pt\">18.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; M. Schwartz<em> et al.</em>, A Positive-Strand RNA Virus Replication Complex Parallels Form and Function of Retrovirus Capsids. <em>Molecular Cell</em> <strong>9</strong>, 505-514 (2002).</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-family:Arial,Helvetica,sans-serif\"><span style=\"font-size:11pt\">19.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; W. A. Miller, G. Koev, Synthesis of subgenomic RNAs by positive-strand RNA viruses. <em>Virology</em> <strong>273</strong>, 1-8 (2000).</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-family:Arial,Helvetica,sans-serif\"><span style=\"font-size:11pt\">20.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; N. S. Ogando<em> et al.</em>, SARS-coronavirus-2 replication in Vero E6 cells: replication kinetics, rapid adaptation and cytopathology. <em>J Gen Virol</em> <strong>101</strong>, 925-940 (2020).</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-family:Arial,Helvetica,sans-serif\"><span style=\"font-size:11pt\">21.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; I. Sola, F. Almazan, S. Zuniga, L. Enjuanes, Continuous and Discontinuous RNA Synthesis in Coronaviruses. <em>Annu Rev Virol</em> <strong>2</strong>, 265-288 (2015).</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-family:Arial,Helvetica,sans-serif\"><span style=\"font-size:11pt\">22.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; I. Sola, J. L. Moreno, S. Zuniga, S. Alonso, L. Enjuanes, Role of nucleotides immediately flanking the transcription-regulating sequence core in coronavirus subgenomic mRNA synthesis. <em>J Virol</em> <strong>79</strong>, 2506-2516 (2005).</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-family:Arial,Helvetica,sans-serif\"><span style=\"font-size:11pt\">23.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; X. Zhang, C. L. Liao, M. M. Lai, Coronavirus leader RNA regulates and initiates subgenomic mRNA transcription both in trans and in cis. <em>J Virol</em> <strong>68</strong>, 4738-4746 (1994).</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-family:Arial,Helvetica,sans-serif\"><span style=\"font-size:11pt\">24.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; S. G. Sawicki, D. L. Sawicki, S. G. Siddell, A contemporary view of coronavirus transcription. <em>J Virol</em> <strong>81</strong>, 20-29 (2007).</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-family:Arial,Helvetica,sans-serif\"><span style=\"font-size:11pt\">25.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Y. Yang, W. Yan, B. Hall, X. Jiang, Characterizing transcriptional regulatory sequences in coronaviruses and their role in recombination. <em>bioRxiv</em>,&nbsp; (2020).</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-family:Arial,Helvetica,sans-serif\"><span style=\"font-size:11pt\">26.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; F. Wu<em> et al.</em>, A new coronavirus associated with human respiratory disease in China. <em>Nature</em> <strong>579</strong>, 265-269 (2020).</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-family:Arial,Helvetica,sans-serif\"><span style=\"font-size:11pt\">27.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; A. Vandelli<em> et al.</em>, Structural analysis of SARS-CoV-2 genome and predictions of the human interactome. <em>Nucleic Acids Res</em> <strong>48</strong>, 11270-11283 (2020).</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-family:Arial,Helvetica,sans-serif\"><span style=\"font-size:11pt\">28.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; J. R. Cohen, L. D. Lin, C. E. Machamer, Identification of a Golgi complex-targeting signal in the cytoplasmic tail of the severe acute respiratory syndrome coronavirus envelope protein. <em>J Virol</em> <strong>85</strong>, 5794-5803 (2011).</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-family:Arial,Helvetica,sans-serif\"><span style=\"font-size:11pt\">29.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; A. Perrier<em> et al.</em>, The C-terminal domain of the MERS coronavirus M protein contains a trans-Golgi network localization signal. <em>J Biol Chem</em> <strong>294</strong>, 14406-14421 (2019).</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-family:Arial,Helvetica,sans-serif\"><span style=\"font-size:11pt\">30.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; D. E. Gordon<em> et al.</em>, A SARS-CoV-2 protein interaction map reveals targets for drug repurposing. <em>Nature</em> <strong>583</strong>, 459-468 (2020).</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-family:Arial,Helvetica,sans-serif\"><span style=\"font-size:11pt\">31.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; R. McBride, M. van Zyl, B. C. Fielding, The coronavirus nucleocapsid is a multifunctional protein. <em>Viruses</em> <strong>6</strong>, 2991-3018 (2014).</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-family:Arial,Helvetica,sans-serif\"><span style=\"font-size:11pt\">32.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; S. Alberti, S. Carra, Quality Control of Membraneless Organelles. <em>Journal of Molecular Biology</em> <strong>430</strong>, 4711-4729 (2018).</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-family:Arial,Helvetica,sans-serif\"><span style=\"font-size:11pt\">33.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; S. F. Banani, H. O. Lee, A. A. Hyman, M. K. Rosen, Biomolecular condensates: organizers of cellular biochemistry. <em>Nature Reviews Molecular Cell Biology</em> <strong>18</strong>, 285-298 (2017).</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-family:Arial,Helvetica,sans-serif\"><span style=\"font-size:11pt\">34.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; A. Savastano, A. I. de Opakua, M. Rankovic, M. Zweckstetter, Nucleocapsid protein of SARS-CoV-2 phase separates into RNA-rich polymerase-containing condensates. &nbsp;(2020).</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-family:Arial,Helvetica,sans-serif\"><span style=\"font-size:11pt\">35.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; H. Chen<em> et al.</em>, Liquid-liquid phase separation by SARS-CoV-2 nucleocapsid protein and RNA. <em>Cell Res</em>,&nbsp; (2020).</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-family:Arial,Helvetica,sans-serif\"><span style=\"font-size:11pt\">36.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; C. Iserman<em> et al.</em>, Specific viral RNA drives the SARS CoV-2 nucleocapsid to phase separate. <em>bioRxiv</em>,&nbsp; (2020).</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-family:Arial,Helvetica,sans-serif\"><span style=\"font-size:11pt\">37.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; T. M. Perdikari<em> et al.</em>, SARS-CoV-2 nucleocapsid protein undergoes liquid-liquid phase separation stimulated by RNA and partitions into phases of human ribonucleoproteins. <em>bioRxiv</em>,&nbsp; (2020).</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-family:Arial,Helvetica,sans-serif\"><span style=\"font-size:11pt\">38.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; J. Cubuk<em> et al.</em>, The SARS-CoV-2 nucleocapsid protein is dynamic, disordered, and phase separates with RNA. <em>bioRxiv</em>,&nbsp; (2020).</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-family:Arial,Helvetica,sans-serif\"><span style=\"font-size:11pt\">39.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; C. Iserman<em> et al.</em> (Cold Spring Harbor Laboratory, 2020).</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-family:Arial,Helvetica,sans-serif\"><span style=\"font-size:11pt\">40.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; C. R. Carlson<em> et al.</em>, Phosphoregulation of phase separation by the SARS-CoV-2 N protein suggests abiophysical basis for its dual functions. <em>Molecular Cell</em>,&nbsp; (2020).</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-family:Arial,Helvetica,sans-serif\"><span style=\"font-size:11pt\">41.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; L. Mendonca<em> et al.</em>, SARS-CoV-2 Assembly and Egress Pathway Revealed by Correlative Multi-modal Multi-scale Cryo-imaging. <em>bioRxiv</em>,&nbsp; (2020).</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-family:Arial,Helvetica,sans-serif\"><span style=\"font-size:11pt\">42.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; S. Ghosh<em> et al.</em>, beta-Coronaviruses Use Lysosomes for Egress Instead of the Biosynthetic Secretory Pathway. <em>Cell</em> <strong>183</strong>, 1520-1535 e1514 (2020).</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-family:Arial,Helvetica,sans-serif\"><span style=\"font-size:11pt\">43.&nbsp; &nbsp; &nbsp; &nbsp;Schubert, K., Karousis, E.D., Jomaa, A.&nbsp;<em>et al.</em>&nbsp;SARS-CoV-2 Nsp1 binds the ribosomal mRNA channel to inhibit translation.&nbsp;<em>Nat Struct Mol Biol</em>&nbsp;<strong>27,&nbsp;</strong>959&ndash;966 (2020).&nbsp;</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-family:Arial,Helvetica,sans-serif\"><span style=\"font-size:11pt\">44.&nbsp; &nbsp; &nbsp; &nbsp;Chan, Jasper Fuk-Woo et al. Improved Molecular Diagnosis of COVID-19 by the Novel, Highly Sensitive and Specific COVID-19-RdRp/Hel Real-Time Reverse Transcription-PCR Assay Validated&nbsp;<em>In Vitro</em>&nbsp;and with Clinical Specimens.&nbsp;J Clin Microbiol.&nbsp;2020:58(5)e00310-20. doi:10.1128/JCM.00310-20</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-family:Arial,Helvetica,sans-serif\"><span style=\"font-size:11pt\">45.&nbsp; &nbsp; &nbsp; &nbsp;Nagura-Ikeda M, Imai K, Tabata S, et al. Clinical Evaluation of Self-Collected Saliva by Quantitative Reverse Transcription-PCR (RT-qPCR), Direct RT-qPCR, Reverse Transcription-Loop-Mediated Isothermal Amplification, and a Rapid Antigen Test To Diagnose COVID-19. J Clin Microbiol. 2020;58(9):e01438-20. doi:10.1128/JCM.01438-20</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-family:Arial,Helvetica,sans-serif\"><span style=\"font-size:11pt\">46.&nbsp; &nbsp; &nbsp; &nbsp;Conceicao C, Thakur N, Human S, Kelly JT, Logan L, Bialy D, et al. (2020) The SARS-CoV-2 Spike protein has a broad tropism for mammalian ACE2 proteins. PLoS Biol 18(12): e3001016. https://doi.org/10.1371/journal.pbio.3001016</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-family:Arial,Helvetica,sans-serif\"><span style=\"font-size:11pt\">47.&nbsp; &nbsp; &nbsp; &nbsp;Damas J, Hughes GM, Keough KC, Painter CA, Persky NS, Corbo M, Hiller M, Koepfli KP, Pfenning AR, Zhao H, Genereux DP, Swofford R, Pollard KS, Ryder OA, Nweeia MT, Lindblad-Toh K, Teeling EC, Karlsson EK, Lewin HA. Broad host range of SARS-CoV-2 predicted by comparative and structural analysis of ACE2 in vertebrates. Proc Natl Acad Sci U S A. 2020 Sep 8;117(36):22311-22322. doi: 10.1073/pnas.2010146117. Epub 2020 Aug 21. PMID: 32826334; PMCID: PMC7486773.</span></span></p>\n","biologicalOrganisationLevel":"Cellular","organTerm":{"name":"organ","sourceId":"UBERON:0000062"},"biologicalEvents":[{"action":"increased","process":"viral RNA genome replication","object":{"name":"viral RNA-directed RNA polymerase complex","source":"GO","sourceId":"GO:0031381"}},{"action":"increased","process":"positive stranded viral RNA replication","object":{"name":"viral RNA-directed RNA polymerase complex","source":"GO","sourceId":"GO:0031381"}},{"action":"increased","process":"viral RNA genome packaging","object":{"name":"viral assembly compartment","source":"GO","sourceId":"GO:0072516"}},{"action":"increased","process":"mRNA transcription","object":{"name":"ssRNA viral genome","source":"GO","sourceId":"GO:0019024"}},{"action":"increased","process":"viral translation","object":{"name":"ssRNA viral genome","source":"GO","sourceId":"GO:0019024"}}],"keyEventStressors":["Sars-CoV-2"],"id":1847}
{"title":"Increased coronavirus production","references":"<p style=\"margin-left:48px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-family:Arial,Helvetica,sans-serif\">1.&nbsp; &nbsp; &nbsp; &nbsp; &nbsp;D. Kim<em> et al.</em>, The Architecture of SARS-CoV-2 Transcriptome. <em>Cell</em> <strong>181</strong>, 914-921 e910 (2020).</span></span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-family:Arial,Helvetica,sans-serif\"><span style=\"font-size:11pt\">2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; E. J. Snijder<em> et al.</em>, Unique and Conserved Features of Genome and Proteome of SARS-coronavirus, an Early Split-off From the Coronavirus Group 2 Lineage. <em>Journal of Molecular Biology</em> <strong>331</strong>, 991-1004 (2003).</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-family:Arial,Helvetica,sans-serif\"><span style=\"font-size:11pt\">3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; N. C. Huston<em> et al.</em>, Comprehensive in vivo secondary structure of the SARS-CoV-2 genome reveals novel regulatory motifs and mechanisms. <em>Mol Cell</em> <strong>81</strong>, 584-598 e585 (2021).</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-family:Arial,Helvetica,sans-serif\"><span style=\"font-size:11pt\">4.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; C. J. Budzilowicz, S. P. Wilczynski, S. R. Weiss, Three intergenic regions of coronavirus mouse hepatitis virus strain A59 genome RNA contain a common nucleotide sequence that is homologous to the 3&#39; end of the viral mRNA leader sequence. <em>J Virol</em> <strong>53</strong>, 834-840 (1985).</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-family:Arial,Helvetica,sans-serif\"><span style=\"font-size:11pt\">5.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; H. Di, A. A. McIntyre, M. A. Brinton, New insights about the regulation of Nidovirus subgenomic mRNA synthesis. <em>Virology</em> <strong>517</strong>, 38-43 (2018).</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-family:Arial,Helvetica,sans-serif\"><span style=\"font-size:11pt\">6.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; M. D. Sacco<em> et al.</em>, Structure and inhibition of the SARS-CoV-2 main protease reveal strategy for developing dual inhibitors against M(pro) and cathepsin L. <em>Sci Adv</em> <strong>6</strong>,&nbsp; (2020).</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-family:Arial,Helvetica,sans-serif\"><span style=\"font-size:11pt\">7.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; S. Klein<em> et al.</em>, SARS-CoV-2 structure and replication characterized by in situ cryo-electron tomography. <em>BioRxiv</em>,&nbsp; (2020).</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-family:Arial,Helvetica,sans-serif\"><span style=\"font-size:11pt\">8.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; E. J. Snijder<em> et al.</em>, A unifying structural and functional model of the coronavirus replication organelle: Tracking down RNA synthesis. <em>PLoS Biol</em> <strong>18</strong>, e3000715 (2020).</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-family:Arial,Helvetica,sans-serif\"><span style=\"font-size:11pt\">9.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; P. V&#39;Kovski, A. Kratzel, S. Steiner, H. Stalder, V. Thiel, Coronavirus biology and replication: implications for SARS-CoV-2. <em>Nat Rev Microbiol</em>,&nbsp; (2020).</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-family:Arial,Helvetica,sans-serif\"><span style=\"font-size:11pt\">10.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; P. Liu, J. Leibowitz, in <em>Molecular Biology of the SARS-Coronavirus</em>. (2010),&nbsp; chap. Chapter 4, pp. 47-61.</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-family:Arial,Helvetica,sans-serif\"><span style=\"font-size:11pt\">11.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; V. B. O&#39;Leary, O. J. Dolly, C. Hoschl, M. Cerna, S. V. Ovsepian, Unpacking Pandora From Its Box: Deciphering the Molecular Basis of the SARS-CoV-2 Coronavirus. <em>Int J Mol Sci</em> <strong>22</strong>,&nbsp; (2020).</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-family:Arial,Helvetica,sans-serif\"><span style=\"font-size:11pt\">12.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Y. Finkel<em> et al.</em>, The coding capacity of SARS-CoV-2. <em>Nature</em> <strong>589</strong>, 125-130 (2021).</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-family:Arial,Helvetica,sans-serif\"><span style=\"font-size:11pt\">13.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; H. A. Hussein, R. Y. A. Hassan, M. Chino, F. Febbraio, Point-of-Care Diagnostics of COVID-19: From Current Work to Future Perspectives. <em>Sensors (Basel)</em> <strong>20</strong>,&nbsp; (2020).</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-family:Arial,Helvetica,sans-serif\"><span style=\"font-size:11pt\">14.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; M. Thoms<em> et al.</em>, Structural basis for translational shutdown and immune evasion by the Nsp1 protein of SARS-CoV-2. <em>Science</em> <strong>369</strong>, 1249-1255 (2020).</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-family:Arial,Helvetica,sans-serif\"><span style=\"font-size:11pt\">15.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; A. K. Banerjee<em> et al.</em>, SARS-CoV-2 Disrupts Splicing, Translation, and Protein Trafficking to Suppress Host Defenses. <em>Cell</em> <strong>183</strong>, 1325-1339 e1321 (2020).</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-family:Arial,Helvetica,sans-serif\"><span style=\"font-size:11pt\">16.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; H. Xia<em> et al.</em>, Evasion of Type I Interferon by SARS-CoV-2. <em>Cell Rep</em> <strong>33</strong>, 108234 (2020).</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-family:Arial,Helvetica,sans-serif\"><span style=\"font-size:11pt\">17.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; P. Ahlquist, RNA-dependent RNA polymerases, viruses, and RNA silencing. <em>Science</em> <strong>296</strong>, 1270-1273 (2002).</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-family:Arial,Helvetica,sans-serif\"><span style=\"font-size:11pt\">18.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; M. Schwartz<em> et al.</em>, A Positive-Strand RNA Virus Replication Complex Parallels Form and Function of Retrovirus Capsids. <em>Molecular Cell</em> <strong>9</strong>, 505-514 (2002).</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-family:Arial,Helvetica,sans-serif\"><span style=\"font-size:11pt\">19.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; W. A. Miller, G. Koev, Synthesis of subgenomic RNAs by positive-strand RNA viruses. <em>Virology</em> <strong>273</strong>, 1-8 (2000).</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-family:Arial,Helvetica,sans-serif\"><span style=\"font-size:11pt\">20.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; N. S. Ogando<em> et al.</em>, SARS-coronavirus-2 replication in Vero E6 cells: replication kinetics, rapid adaptation and cytopathology. <em>J Gen Virol</em> <strong>101</strong>, 925-940 (2020).</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-family:Arial,Helvetica,sans-serif\"><span style=\"font-size:11pt\">21.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; I. Sola, F. Almazan, S. Zuniga, L. Enjuanes, Continuous and Discontinuous RNA Synthesis in Coronaviruses. <em>Annu Rev Virol</em> <strong>2</strong>, 265-288 (2015).</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-family:Arial,Helvetica,sans-serif\"><span style=\"font-size:11pt\">22.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; I. Sola, J. L. Moreno, S. Zuniga, S. Alonso, L. Enjuanes, Role of nucleotides immediately flanking the transcription-regulating sequence core in coronavirus subgenomic mRNA synthesis. <em>J Virol</em> <strong>79</strong>, 2506-2516 (2005).</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-family:Arial,Helvetica,sans-serif\"><span style=\"font-size:11pt\">23.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; X. Zhang, C. L. Liao, M. M. Lai, Coronavirus leader RNA regulates and initiates subgenomic mRNA transcription both in trans and in cis. <em>J Virol</em> <strong>68</strong>, 4738-4746 (1994).</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-family:Arial,Helvetica,sans-serif\"><span style=\"font-size:11pt\">24.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; S. G. Sawicki, D. L. Sawicki, S. G. Siddell, A contemporary view of coronavirus transcription. <em>J Virol</em> <strong>81</strong>, 20-29 (2007).</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-family:Arial,Helvetica,sans-serif\"><span style=\"font-size:11pt\">25.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Y. Yang, W. Yan, B. Hall, X. Jiang, Characterizing transcriptional regulatory sequences in coronaviruses and their role in recombination. <em>bioRxiv</em>,&nbsp; (2020).</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-family:Arial,Helvetica,sans-serif\"><span style=\"font-size:11pt\">26.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; F. Wu<em> et al.</em>, A new coronavirus associated with human respiratory disease in China. <em>Nature</em> <strong>579</strong>, 265-269 (2020).</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-family:Arial,Helvetica,sans-serif\"><span style=\"font-size:11pt\">27.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; A. Vandelli<em> et al.</em>, Structural analysis of SARS-CoV-2 genome and predictions of the human interactome. <em>Nucleic Acids Res</em> <strong>48</strong>, 11270-11283 (2020).</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-family:Arial,Helvetica,sans-serif\"><span style=\"font-size:11pt\">28.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; J. R. Cohen, L. D. Lin, C. E. Machamer, Identification of a Golgi complex-targeting signal in the cytoplasmic tail of the severe acute respiratory syndrome coronavirus envelope protein. <em>J Virol</em> <strong>85</strong>, 5794-5803 (2011).</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-family:Arial,Helvetica,sans-serif\"><span style=\"font-size:11pt\">29.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; A. Perrier<em> et al.</em>, The C-terminal domain of the MERS coronavirus M protein contains a trans-Golgi network localization signal. <em>J Biol Chem</em> <strong>294</strong>, 14406-14421 (2019).</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-family:Arial,Helvetica,sans-serif\"><span style=\"font-size:11pt\">30.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; D. E. Gordon<em> et al.</em>, A SARS-CoV-2 protein interaction map reveals targets for drug repurposing. <em>Nature</em> <strong>583</strong>, 459-468 (2020).</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-family:Arial,Helvetica,sans-serif\"><span style=\"font-size:11pt\">31.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; R. McBride, M. van Zyl, B. C. Fielding, The coronavirus nucleocapsid is a multifunctional protein. <em>Viruses</em> <strong>6</strong>, 2991-3018 (2014).</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-family:Arial,Helvetica,sans-serif\"><span style=\"font-size:11pt\">32.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; S. Alberti, S. Carra, Quality Control of Membraneless Organelles. <em>Journal of Molecular Biology</em> <strong>430</strong>, 4711-4729 (2018).</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-family:Arial,Helvetica,sans-serif\"><span style=\"font-size:11pt\">33.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; S. F. Banani, H. O. Lee, A. A. Hyman, M. K. Rosen, Biomolecular condensates: organizers of cellular biochemistry. <em>Nature Reviews Molecular Cell Biology</em> <strong>18</strong>, 285-298 (2017).</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-family:Arial,Helvetica,sans-serif\"><span style=\"font-size:11pt\">34.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; A. Savastano, A. I. de Opakua, M. Rankovic, M. Zweckstetter, Nucleocapsid protein of SARS-CoV-2 phase separates into RNA-rich polymerase-containing condensates. &nbsp;(2020).</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-family:Arial,Helvetica,sans-serif\"><span style=\"font-size:11pt\">35.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; H. Chen<em> et al.</em>, Liquid-liquid phase separation by SARS-CoV-2 nucleocapsid protein and RNA. <em>Cell Res</em>,&nbsp; (2020).</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-family:Arial,Helvetica,sans-serif\"><span style=\"font-size:11pt\">36.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; C. Iserman<em> et al.</em>, Specific viral RNA drives the SARS CoV-2 nucleocapsid to phase separate. <em>bioRxiv</em>,&nbsp; (2020).</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-family:Arial,Helvetica,sans-serif\"><span style=\"font-size:11pt\">37.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; T. M. Perdikari<em> et al.</em>, SARS-CoV-2 nucleocapsid protein undergoes liquid-liquid phase separation stimulated by RNA and partitions into phases of human ribonucleoproteins. <em>bioRxiv</em>,&nbsp; (2020).</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-family:Arial,Helvetica,sans-serif\"><span style=\"font-size:11pt\">38.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; J. Cubuk<em> et al.</em>, The SARS-CoV-2 nucleocapsid protein is dynamic, disordered, and phase separates with RNA. <em>bioRxiv</em>,&nbsp; (2020).</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-family:Arial,Helvetica,sans-serif\"><span style=\"font-size:11pt\">39.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; C. Iserman<em> et al.</em> (Cold Spring Harbor Laboratory, 2020).</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-family:Arial,Helvetica,sans-serif\"><span style=\"font-size:11pt\">40.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; C. R. Carlson<em> et al.</em>, Phosphoregulation of phase separation by the SARS-CoV-2 N protein suggests abiophysical basis for its dual functions. <em>Molecular Cell</em>,&nbsp; (2020).</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-family:Arial,Helvetica,sans-serif\"><span style=\"font-size:11pt\">41.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; L. Mendonca<em> et al.</em>, SARS-CoV-2 Assembly and Egress Pathway Revealed by Correlative Multi-modal Multi-scale Cryo-imaging. <em>bioRxiv</em>,&nbsp; (2020).</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-family:Arial,Helvetica,sans-serif\"><span style=\"font-size:11pt\">42.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; S. Ghosh<em> et al.</em>, beta-Coronaviruses Use Lysosomes for Egress Instead of the Biosynthetic Secretory Pathway. <em>Cell</em> <strong>183</strong>, 1520-1535 e1514 (2020).</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-family:Arial,Helvetica,sans-serif\"><span style=\"font-size:11pt\">43.&nbsp; &nbsp; &nbsp; &nbsp;Schubert, K., Karousis, E.D., Jomaa, A.&nbsp;<em>et al.</em>&nbsp;SARS-CoV-2 Nsp1 binds the ribosomal mRNA channel to inhibit translation.&nbsp;<em>Nat Struct Mol Biol</em>&nbsp;<strong>27,&nbsp;</strong>959&ndash;966 (2020).&nbsp;</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-family:Arial,Helvetica,sans-serif\"><span style=\"font-size:11pt\">44.&nbsp; &nbsp; &nbsp; &nbsp;Chan, Jasper Fuk-Woo et al. Improved Molecular Diagnosis of COVID-19 by the Novel, Highly Sensitive and Specific COVID-19-RdRp/Hel Real-Time Reverse Transcription-PCR Assay Validated&nbsp;<em>In Vitro</em>&nbsp;and with Clinical Specimens.&nbsp;J Clin Microbiol.&nbsp;2020:58(5)e00310-20. doi:10.1128/JCM.00310-20</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-family:Arial,Helvetica,sans-serif\"><span style=\"font-size:11pt\">45.&nbsp; &nbsp; &nbsp; &nbsp;Nagura-Ikeda M, Imai K, Tabata S, et al. Clinical Evaluation of Self-Collected Saliva by Quantitative Reverse Transcription-PCR (RT-qPCR), Direct RT-qPCR, Reverse Transcription-Loop-Mediated Isothermal Amplification, and a Rapid Antigen Test To Diagnose COVID-19. J Clin Microbiol. 2020;58(9):e01438-20. doi:10.1128/JCM.01438-20</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-family:Arial,Helvetica,sans-serif\"><span style=\"font-size:11pt\">46.&nbsp; &nbsp; &nbsp; &nbsp;Conceicao C, Thakur N, Human S, Kelly JT, Logan L, Bialy D, et al. (2020) The SARS-CoV-2 Spike protein has a broad tropism for mammalian ACE2 proteins. PLoS Biol 18(12): e3001016. https://doi.org/10.1371/journal.pbio.3001016</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-family:Arial,Helvetica,sans-serif\"><span style=\"font-size:11pt\">47.&nbsp; &nbsp; &nbsp; &nbsp;Damas J, Hughes GM, Keough KC, Painter CA, Persky NS, Corbo M, Hiller M, Koepfli KP, Pfenning AR, Zhao H, Genereux DP, Swofford R, Pollard KS, Ryder OA, Nweeia MT, Lindblad-Toh K, Teeling EC, Karlsson EK, Lewin HA. Broad host range of SARS-CoV-2 predicted by comparative and structural analysis of ACE2 in vertebrates. Proc Natl Acad Sci U S A. 2020 Sep 8;117(36):22311-22322. doi: 10.1073/pnas.2010146117. Epub 2020 Aug 21. PMID: 32826334; PMCID: PMC7486773.</span></span></p>\n","biologicalOrganisationLevel":"Cellular","organTerm":{"name":"organ","sourceId":"UBERON:0000062"},"biologicalEvents":[{"action":"increased","process":"viral RNA genome replication","object":{"name":"viral RNA-directed RNA polymerase complex","source":"GO","sourceId":"GO:0031381"}},{"action":"increased","process":"positive stranded viral RNA replication","object":{"name":"viral RNA-directed RNA polymerase complex","source":"GO","sourceId":"GO:0031381"}},{"action":"increased","process":"viral RNA genome packaging","object":{"name":"viral assembly compartment","source":"GO","sourceId":"GO:0072516"}},{"action":"increased","process":"mRNA transcription","object":{"name":"ssRNA viral genome","source":"GO","sourceId":"GO:0019024"}},{"action":"increased","process":"viral translation","object":{"name":"ssRNA viral genome","source":"GO","sourceId":"GO:0019024"}}],"keyEventStressors":["Sars-CoV-2"],"id":1847}
{"title":"Increased coronavirus production","references":"<p style=\"margin-left:48px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-family:Arial,Helvetica,sans-serif\">1.&nbsp; &nbsp; &nbsp; &nbsp; &nbsp;D. Kim<em> et al.</em>, The Architecture of SARS-CoV-2 Transcriptome. <em>Cell</em> <strong>181</strong>, 914-921 e910 (2020).</span></span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-family:Arial,Helvetica,sans-serif\"><span style=\"font-size:11pt\">2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; E. J. Snijder<em> et al.</em>, Unique and Conserved Features of Genome and Proteome of SARS-coronavirus, an Early Split-off From the Coronavirus Group 2 Lineage. <em>Journal of Molecular Biology</em> <strong>331</strong>, 991-1004 (2003).</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-family:Arial,Helvetica,sans-serif\"><span style=\"font-size:11pt\">3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; N. C. Huston<em> et al.</em>, Comprehensive in vivo secondary structure of the SARS-CoV-2 genome reveals novel regulatory motifs and mechanisms. <em>Mol Cell</em> <strong>81</strong>, 584-598 e585 (2021).</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-family:Arial,Helvetica,sans-serif\"><span style=\"font-size:11pt\">4.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; C. J. Budzilowicz, S. P. Wilczynski, S. R. Weiss, Three intergenic regions of coronavirus mouse hepatitis virus strain A59 genome RNA contain a common nucleotide sequence that is homologous to the 3&#39; end of the viral mRNA leader sequence. <em>J Virol</em> <strong>53</strong>, 834-840 (1985).</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-family:Arial,Helvetica,sans-serif\"><span style=\"font-size:11pt\">5.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; H. Di, A. A. McIntyre, M. A. Brinton, New insights about the regulation of Nidovirus subgenomic mRNA synthesis. <em>Virology</em> <strong>517</strong>, 38-43 (2018).</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-family:Arial,Helvetica,sans-serif\"><span style=\"font-size:11pt\">6.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; M. D. Sacco<em> et al.</em>, Structure and inhibition of the SARS-CoV-2 main protease reveal strategy for developing dual inhibitors against M(pro) and cathepsin L. <em>Sci Adv</em> <strong>6</strong>,&nbsp; (2020).</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-family:Arial,Helvetica,sans-serif\"><span style=\"font-size:11pt\">7.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; S. Klein<em> et al.</em>, SARS-CoV-2 structure and replication characterized by in situ cryo-electron tomography. <em>BioRxiv</em>,&nbsp; (2020).</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-family:Arial,Helvetica,sans-serif\"><span style=\"font-size:11pt\">8.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; E. J. Snijder<em> et al.</em>, A unifying structural and functional model of the coronavirus replication organelle: Tracking down RNA synthesis. <em>PLoS Biol</em> <strong>18</strong>, e3000715 (2020).</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-family:Arial,Helvetica,sans-serif\"><span style=\"font-size:11pt\">9.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; P. V&#39;Kovski, A. Kratzel, S. Steiner, H. Stalder, V. Thiel, Coronavirus biology and replication: implications for SARS-CoV-2. <em>Nat Rev Microbiol</em>,&nbsp; (2020).</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-family:Arial,Helvetica,sans-serif\"><span style=\"font-size:11pt\">10.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; P. Liu, J. Leibowitz, in <em>Molecular Biology of the SARS-Coronavirus</em>. (2010),&nbsp; chap. Chapter 4, pp. 47-61.</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-family:Arial,Helvetica,sans-serif\"><span style=\"font-size:11pt\">11.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; V. B. O&#39;Leary, O. J. Dolly, C. Hoschl, M. Cerna, S. V. Ovsepian, Unpacking Pandora From Its Box: Deciphering the Molecular Basis of the SARS-CoV-2 Coronavirus. <em>Int J Mol Sci</em> <strong>22</strong>,&nbsp; (2020).</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-family:Arial,Helvetica,sans-serif\"><span style=\"font-size:11pt\">12.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Y. Finkel<em> et al.</em>, The coding capacity of SARS-CoV-2. <em>Nature</em> <strong>589</strong>, 125-130 (2021).</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-family:Arial,Helvetica,sans-serif\"><span style=\"font-size:11pt\">13.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; H. A. Hussein, R. Y. A. Hassan, M. Chino, F. Febbraio, Point-of-Care Diagnostics of COVID-19: From Current Work to Future Perspectives. <em>Sensors (Basel)</em> <strong>20</strong>,&nbsp; (2020).</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-family:Arial,Helvetica,sans-serif\"><span style=\"font-size:11pt\">14.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; M. Thoms<em> et al.</em>, Structural basis for translational shutdown and immune evasion by the Nsp1 protein of SARS-CoV-2. <em>Science</em> <strong>369</strong>, 1249-1255 (2020).</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-family:Arial,Helvetica,sans-serif\"><span style=\"font-size:11pt\">15.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; A. K. Banerjee<em> et al.</em>, SARS-CoV-2 Disrupts Splicing, Translation, and Protein Trafficking to Suppress Host Defenses. <em>Cell</em> <strong>183</strong>, 1325-1339 e1321 (2020).</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-family:Arial,Helvetica,sans-serif\"><span style=\"font-size:11pt\">16.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; H. Xia<em> et al.</em>, Evasion of Type I Interferon by SARS-CoV-2. <em>Cell Rep</em> <strong>33</strong>, 108234 (2020).</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-family:Arial,Helvetica,sans-serif\"><span style=\"font-size:11pt\">17.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; P. Ahlquist, RNA-dependent RNA polymerases, viruses, and RNA silencing. <em>Science</em> <strong>296</strong>, 1270-1273 (2002).</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-family:Arial,Helvetica,sans-serif\"><span style=\"font-size:11pt\">18.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; M. Schwartz<em> et al.</em>, A Positive-Strand RNA Virus Replication Complex Parallels Form and Function of Retrovirus Capsids. <em>Molecular Cell</em> <strong>9</strong>, 505-514 (2002).</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-family:Arial,Helvetica,sans-serif\"><span style=\"font-size:11pt\">19.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; W. A. Miller, G. Koev, Synthesis of subgenomic RNAs by positive-strand RNA viruses. <em>Virology</em> <strong>273</strong>, 1-8 (2000).</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-family:Arial,Helvetica,sans-serif\"><span style=\"font-size:11pt\">20.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; N. S. Ogando<em> et al.</em>, SARS-coronavirus-2 replication in Vero E6 cells: replication kinetics, rapid adaptation and cytopathology. <em>J Gen Virol</em> <strong>101</strong>, 925-940 (2020).</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-family:Arial,Helvetica,sans-serif\"><span style=\"font-size:11pt\">21.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; I. Sola, F. Almazan, S. Zuniga, L. Enjuanes, Continuous and Discontinuous RNA Synthesis in Coronaviruses. <em>Annu Rev Virol</em> <strong>2</strong>, 265-288 (2015).</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-family:Arial,Helvetica,sans-serif\"><span style=\"font-size:11pt\">22.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; I. Sola, J. L. Moreno, S. Zuniga, S. Alonso, L. Enjuanes, Role of nucleotides immediately flanking the transcription-regulating sequence core in coronavirus subgenomic mRNA synthesis. <em>J Virol</em> <strong>79</strong>, 2506-2516 (2005).</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-family:Arial,Helvetica,sans-serif\"><span style=\"font-size:11pt\">23.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; X. Zhang, C. L. Liao, M. M. Lai, Coronavirus leader RNA regulates and initiates subgenomic mRNA transcription both in trans and in cis. <em>J Virol</em> <strong>68</strong>, 4738-4746 (1994).</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-family:Arial,Helvetica,sans-serif\"><span style=\"font-size:11pt\">24.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; S. G. Sawicki, D. L. Sawicki, S. G. Siddell, A contemporary view of coronavirus transcription. <em>J Virol</em> <strong>81</strong>, 20-29 (2007).</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-family:Arial,Helvetica,sans-serif\"><span style=\"font-size:11pt\">25.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Y. Yang, W. Yan, B. Hall, X. Jiang, Characterizing transcriptional regulatory sequences in coronaviruses and their role in recombination. <em>bioRxiv</em>,&nbsp; (2020).</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-family:Arial,Helvetica,sans-serif\"><span style=\"font-size:11pt\">26.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; F. Wu<em> et al.</em>, A new coronavirus associated with human respiratory disease in China. <em>Nature</em> <strong>579</strong>, 265-269 (2020).</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-family:Arial,Helvetica,sans-serif\"><span style=\"font-size:11pt\">27.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; A. Vandelli<em> et al.</em>, Structural analysis of SARS-CoV-2 genome and predictions of the human interactome. <em>Nucleic Acids Res</em> <strong>48</strong>, 11270-11283 (2020).</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-family:Arial,Helvetica,sans-serif\"><span style=\"font-size:11pt\">28.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; J. R. Cohen, L. D. Lin, C. E. Machamer, Identification of a Golgi complex-targeting signal in the cytoplasmic tail of the severe acute respiratory syndrome coronavirus envelope protein. <em>J Virol</em> <strong>85</strong>, 5794-5803 (2011).</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-family:Arial,Helvetica,sans-serif\"><span style=\"font-size:11pt\">29.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; A. Perrier<em> et al.</em>, The C-terminal domain of the MERS coronavirus M protein contains a trans-Golgi network localization signal. <em>J Biol Chem</em> <strong>294</strong>, 14406-14421 (2019).</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-family:Arial,Helvetica,sans-serif\"><span style=\"font-size:11pt\">30.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; D. E. Gordon<em> et al.</em>, A SARS-CoV-2 protein interaction map reveals targets for drug repurposing. <em>Nature</em> <strong>583</strong>, 459-468 (2020).</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-family:Arial,Helvetica,sans-serif\"><span style=\"font-size:11pt\">31.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; R. McBride, M. van Zyl, B. C. Fielding, The coronavirus nucleocapsid is a multifunctional protein. <em>Viruses</em> <strong>6</strong>, 2991-3018 (2014).</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-family:Arial,Helvetica,sans-serif\"><span style=\"font-size:11pt\">32.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; S. Alberti, S. Carra, Quality Control of Membraneless Organelles. <em>Journal of Molecular Biology</em> <strong>430</strong>, 4711-4729 (2018).</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-family:Arial,Helvetica,sans-serif\"><span style=\"font-size:11pt\">33.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; S. F. Banani, H. O. Lee, A. A. Hyman, M. K. Rosen, Biomolecular condensates: organizers of cellular biochemistry. <em>Nature Reviews Molecular Cell Biology</em> <strong>18</strong>, 285-298 (2017).</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-family:Arial,Helvetica,sans-serif\"><span style=\"font-size:11pt\">34.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; A. Savastano, A. I. de Opakua, M. Rankovic, M. Zweckstetter, Nucleocapsid protein of SARS-CoV-2 phase separates into RNA-rich polymerase-containing condensates. &nbsp;(2020).</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-family:Arial,Helvetica,sans-serif\"><span style=\"font-size:11pt\">35.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; H. Chen<em> et al.</em>, Liquid-liquid phase separation by SARS-CoV-2 nucleocapsid protein and RNA. <em>Cell Res</em>,&nbsp; (2020).</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-family:Arial,Helvetica,sans-serif\"><span style=\"font-size:11pt\">36.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; C. Iserman<em> et al.</em>, Specific viral RNA drives the SARS CoV-2 nucleocapsid to phase separate. <em>bioRxiv</em>,&nbsp; (2020).</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-family:Arial,Helvetica,sans-serif\"><span style=\"font-size:11pt\">37.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; T. M. Perdikari<em> et al.</em>, SARS-CoV-2 nucleocapsid protein undergoes liquid-liquid phase separation stimulated by RNA and partitions into phases of human ribonucleoproteins. <em>bioRxiv</em>,&nbsp; (2020).</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-family:Arial,Helvetica,sans-serif\"><span style=\"font-size:11pt\">38.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; J. Cubuk<em> et al.</em>, The SARS-CoV-2 nucleocapsid protein is dynamic, disordered, and phase separates with RNA. <em>bioRxiv</em>,&nbsp; (2020).</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-family:Arial,Helvetica,sans-serif\"><span style=\"font-size:11pt\">39.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; C. Iserman<em> et al.</em> (Cold Spring Harbor Laboratory, 2020).</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-family:Arial,Helvetica,sans-serif\"><span style=\"font-size:11pt\">40.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; C. R. Carlson<em> et al.</em>, Phosphoregulation of phase separation by the SARS-CoV-2 N protein suggests abiophysical basis for its dual functions. <em>Molecular Cell</em>,&nbsp; (2020).</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-family:Arial,Helvetica,sans-serif\"><span style=\"font-size:11pt\">41.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; L. Mendonca<em> et al.</em>, SARS-CoV-2 Assembly and Egress Pathway Revealed by Correlative Multi-modal Multi-scale Cryo-imaging. <em>bioRxiv</em>,&nbsp; (2020).</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-family:Arial,Helvetica,sans-serif\"><span style=\"font-size:11pt\">42.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; S. Ghosh<em> et al.</em>, beta-Coronaviruses Use Lysosomes for Egress Instead of the Biosynthetic Secretory Pathway. <em>Cell</em> <strong>183</strong>, 1520-1535 e1514 (2020).</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-family:Arial,Helvetica,sans-serif\"><span style=\"font-size:11pt\">43.&nbsp; &nbsp; &nbsp; &nbsp;Schubert, K., Karousis, E.D., Jomaa, A.&nbsp;<em>et al.</em>&nbsp;SARS-CoV-2 Nsp1 binds the ribosomal mRNA channel to inhibit translation.&nbsp;<em>Nat Struct Mol Biol</em>&nbsp;<strong>27,&nbsp;</strong>959&ndash;966 (2020).&nbsp;</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-family:Arial,Helvetica,sans-serif\"><span style=\"font-size:11pt\">44.&nbsp; &nbsp; &nbsp; &nbsp;Chan, Jasper Fuk-Woo et al. Improved Molecular Diagnosis of COVID-19 by the Novel, Highly Sensitive and Specific COVID-19-RdRp/Hel Real-Time Reverse Transcription-PCR Assay Validated&nbsp;<em>In Vitro</em>&nbsp;and with Clinical Specimens.&nbsp;J Clin Microbiol.&nbsp;2020:58(5)e00310-20. doi:10.1128/JCM.00310-20</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-family:Arial,Helvetica,sans-serif\"><span style=\"font-size:11pt\">45.&nbsp; &nbsp; &nbsp; &nbsp;Nagura-Ikeda M, Imai K, Tabata S, et al. Clinical Evaluation of Self-Collected Saliva by Quantitative Reverse Transcription-PCR (RT-qPCR), Direct RT-qPCR, Reverse Transcription-Loop-Mediated Isothermal Amplification, and a Rapid Antigen Test To Diagnose COVID-19. J Clin Microbiol. 2020;58(9):e01438-20. doi:10.1128/JCM.01438-20</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-family:Arial,Helvetica,sans-serif\"><span style=\"font-size:11pt\">46.&nbsp; &nbsp; &nbsp; &nbsp;Conceicao C, Thakur N, Human S, Kelly JT, Logan L, Bialy D, et al. (2020) The SARS-CoV-2 Spike protein has a broad tropism for mammalian ACE2 proteins. PLoS Biol 18(12): e3001016. https://doi.org/10.1371/journal.pbio.3001016</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-family:Arial,Helvetica,sans-serif\"><span style=\"font-size:11pt\">47.&nbsp; &nbsp; &nbsp; &nbsp;Damas J, Hughes GM, Keough KC, Painter CA, Persky NS, Corbo M, Hiller M, Koepfli KP, Pfenning AR, Zhao H, Genereux DP, Swofford R, Pollard KS, Ryder OA, Nweeia MT, Lindblad-Toh K, Teeling EC, Karlsson EK, Lewin HA. Broad host range of SARS-CoV-2 predicted by comparative and structural analysis of ACE2 in vertebrates. Proc Natl Acad Sci U S A. 2020 Sep 8;117(36):22311-22322. doi: 10.1073/pnas.2010146117. Epub 2020 Aug 21. PMID: 32826334; PMCID: PMC7486773.</span></span></p>\n","biologicalOrganisationLevel":"Cellular","organTerm":{"name":"organ","sourceId":"UBERON:0000062"},"biologicalEvents":[{"action":"increased","process":"viral RNA genome replication","object":{"name":"viral RNA-directed RNA polymerase complex","source":"GO","sourceId":"GO:0031381"}},{"action":"increased","process":"positive stranded viral RNA replication","object":{"name":"viral RNA-directed RNA polymerase complex","source":"GO","sourceId":"GO:0031381"}},{"action":"increased","process":"viral RNA genome packaging","object":{"name":"viral assembly compartment","source":"GO","sourceId":"GO:0072516"}},{"action":"increased","process":"mRNA transcription","object":{"name":"ssRNA viral genome","source":"GO","sourceId":"GO:0019024"}},{"action":"increased","process":"viral translation","object":{"name":"ssRNA viral genome","source":"GO","sourceId":"GO:0019024"}}],"keyEventStressors":["Sars-CoV-2"],"id":1847}
{"title":"Increased coronavirus production","references":"<p style=\"margin-left:48px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-family:Arial,Helvetica,sans-serif\">1.&nbsp; &nbsp; &nbsp; &nbsp; &nbsp;D. Kim<em> et al.</em>, The Architecture of SARS-CoV-2 Transcriptome. <em>Cell</em> <strong>181</strong>, 914-921 e910 (2020).</span></span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-family:Arial,Helvetica,sans-serif\"><span style=\"font-size:11pt\">2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; E. J. Snijder<em> et al.</em>, Unique and Conserved Features of Genome and Proteome of SARS-coronavirus, an Early Split-off From the Coronavirus Group 2 Lineage. <em>Journal of Molecular Biology</em> <strong>331</strong>, 991-1004 (2003).</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-family:Arial,Helvetica,sans-serif\"><span style=\"font-size:11pt\">3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; N. C. Huston<em> et al.</em>, Comprehensive in vivo secondary structure of the SARS-CoV-2 genome reveals novel regulatory motifs and mechanisms. <em>Mol Cell</em> <strong>81</strong>, 584-598 e585 (2021).</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-family:Arial,Helvetica,sans-serif\"><span style=\"font-size:11pt\">4.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; C. J. Budzilowicz, S. P. Wilczynski, S. R. Weiss, Three intergenic regions of coronavirus mouse hepatitis virus strain A59 genome RNA contain a common nucleotide sequence that is homologous to the 3&#39; end of the viral mRNA leader sequence. <em>J Virol</em> <strong>53</strong>, 834-840 (1985).</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-family:Arial,Helvetica,sans-serif\"><span style=\"font-size:11pt\">5.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; H. Di, A. A. McIntyre, M. A. Brinton, New insights about the regulation of Nidovirus subgenomic mRNA synthesis. <em>Virology</em> <strong>517</strong>, 38-43 (2018).</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-family:Arial,Helvetica,sans-serif\"><span style=\"font-size:11pt\">6.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; M. D. Sacco<em> et al.</em>, Structure and inhibition of the SARS-CoV-2 main protease reveal strategy for developing dual inhibitors against M(pro) and cathepsin L. <em>Sci Adv</em> <strong>6</strong>,&nbsp; (2020).</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-family:Arial,Helvetica,sans-serif\"><span style=\"font-size:11pt\">7.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; S. Klein<em> et al.</em>, SARS-CoV-2 structure and replication characterized by in situ cryo-electron tomography. <em>BioRxiv</em>,&nbsp; (2020).</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-family:Arial,Helvetica,sans-serif\"><span style=\"font-size:11pt\">8.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; E. J. Snijder<em> et al.</em>, A unifying structural and functional model of the coronavirus replication organelle: Tracking down RNA synthesis. <em>PLoS Biol</em> <strong>18</strong>, e3000715 (2020).</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-family:Arial,Helvetica,sans-serif\"><span style=\"font-size:11pt\">9.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; P. V&#39;Kovski, A. Kratzel, S. Steiner, H. Stalder, V. Thiel, Coronavirus biology and replication: implications for SARS-CoV-2. <em>Nat Rev Microbiol</em>,&nbsp; (2020).</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-family:Arial,Helvetica,sans-serif\"><span style=\"font-size:11pt\">10.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; P. Liu, J. Leibowitz, in <em>Molecular Biology of the SARS-Coronavirus</em>. (2010),&nbsp; chap. Chapter 4, pp. 47-61.</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-family:Arial,Helvetica,sans-serif\"><span style=\"font-size:11pt\">11.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; V. B. O&#39;Leary, O. J. Dolly, C. Hoschl, M. Cerna, S. V. Ovsepian, Unpacking Pandora From Its Box: Deciphering the Molecular Basis of the SARS-CoV-2 Coronavirus. <em>Int J Mol Sci</em> <strong>22</strong>,&nbsp; (2020).</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-family:Arial,Helvetica,sans-serif\"><span style=\"font-size:11pt\">12.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Y. Finkel<em> et al.</em>, The coding capacity of SARS-CoV-2. <em>Nature</em> <strong>589</strong>, 125-130 (2021).</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-family:Arial,Helvetica,sans-serif\"><span style=\"font-size:11pt\">13.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; H. A. Hussein, R. Y. A. Hassan, M. Chino, F. Febbraio, Point-of-Care Diagnostics of COVID-19: From Current Work to Future Perspectives. <em>Sensors (Basel)</em> <strong>20</strong>,&nbsp; (2020).</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-family:Arial,Helvetica,sans-serif\"><span style=\"font-size:11pt\">14.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; M. Thoms<em> et al.</em>, Structural basis for translational shutdown and immune evasion by the Nsp1 protein of SARS-CoV-2. <em>Science</em> <strong>369</strong>, 1249-1255 (2020).</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-family:Arial,Helvetica,sans-serif\"><span style=\"font-size:11pt\">15.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; A. K. Banerjee<em> et al.</em>, SARS-CoV-2 Disrupts Splicing, Translation, and Protein Trafficking to Suppress Host Defenses. <em>Cell</em> <strong>183</strong>, 1325-1339 e1321 (2020).</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-family:Arial,Helvetica,sans-serif\"><span style=\"font-size:11pt\">16.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; H. Xia<em> et al.</em>, Evasion of Type I Interferon by SARS-CoV-2. <em>Cell Rep</em> <strong>33</strong>, 108234 (2020).</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-family:Arial,Helvetica,sans-serif\"><span style=\"font-size:11pt\">17.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; P. Ahlquist, RNA-dependent RNA polymerases, viruses, and RNA silencing. <em>Science</em> <strong>296</strong>, 1270-1273 (2002).</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-family:Arial,Helvetica,sans-serif\"><span style=\"font-size:11pt\">18.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; M. Schwartz<em> et al.</em>, A Positive-Strand RNA Virus Replication Complex Parallels Form and Function of Retrovirus Capsids. <em>Molecular Cell</em> <strong>9</strong>, 505-514 (2002).</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-family:Arial,Helvetica,sans-serif\"><span style=\"font-size:11pt\">19.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; W. A. Miller, G. Koev, Synthesis of subgenomic RNAs by positive-strand RNA viruses. <em>Virology</em> <strong>273</strong>, 1-8 (2000).</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-family:Arial,Helvetica,sans-serif\"><span style=\"font-size:11pt\">20.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; N. S. Ogando<em> et al.</em>, SARS-coronavirus-2 replication in Vero E6 cells: replication kinetics, rapid adaptation and cytopathology. <em>J Gen Virol</em> <strong>101</strong>, 925-940 (2020).</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-family:Arial,Helvetica,sans-serif\"><span style=\"font-size:11pt\">21.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; I. Sola, F. Almazan, S. Zuniga, L. Enjuanes, Continuous and Discontinuous RNA Synthesis in Coronaviruses. <em>Annu Rev Virol</em> <strong>2</strong>, 265-288 (2015).</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-family:Arial,Helvetica,sans-serif\"><span style=\"font-size:11pt\">22.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; I. Sola, J. L. Moreno, S. Zuniga, S. Alonso, L. Enjuanes, Role of nucleotides immediately flanking the transcription-regulating sequence core in coronavirus subgenomic mRNA synthesis. <em>J Virol</em> <strong>79</strong>, 2506-2516 (2005).</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-family:Arial,Helvetica,sans-serif\"><span style=\"font-size:11pt\">23.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; X. Zhang, C. L. Liao, M. M. Lai, Coronavirus leader RNA regulates and initiates subgenomic mRNA transcription both in trans and in cis. <em>J Virol</em> <strong>68</strong>, 4738-4746 (1994).</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-family:Arial,Helvetica,sans-serif\"><span style=\"font-size:11pt\">24.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; S. G. Sawicki, D. L. Sawicki, S. G. Siddell, A contemporary view of coronavirus transcription. <em>J Virol</em> <strong>81</strong>, 20-29 (2007).</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-family:Arial,Helvetica,sans-serif\"><span style=\"font-size:11pt\">25.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Y. Yang, W. Yan, B. Hall, X. Jiang, Characterizing transcriptional regulatory sequences in coronaviruses and their role in recombination. <em>bioRxiv</em>,&nbsp; (2020).</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-family:Arial,Helvetica,sans-serif\"><span style=\"font-size:11pt\">26.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; F. Wu<em> et al.</em>, A new coronavirus associated with human respiratory disease in China. <em>Nature</em> <strong>579</strong>, 265-269 (2020).</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-family:Arial,Helvetica,sans-serif\"><span style=\"font-size:11pt\">27.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; A. Vandelli<em> et al.</em>, Structural analysis of SARS-CoV-2 genome and predictions of the human interactome. <em>Nucleic Acids Res</em> <strong>48</strong>, 11270-11283 (2020).</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-family:Arial,Helvetica,sans-serif\"><span style=\"font-size:11pt\">28.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; J. R. Cohen, L. D. Lin, C. E. Machamer, Identification of a Golgi complex-targeting signal in the cytoplasmic tail of the severe acute respiratory syndrome coronavirus envelope protein. <em>J Virol</em> <strong>85</strong>, 5794-5803 (2011).</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-family:Arial,Helvetica,sans-serif\"><span style=\"font-size:11pt\">29.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; A. Perrier<em> et al.</em>, The C-terminal domain of the MERS coronavirus M protein contains a trans-Golgi network localization signal. <em>J Biol Chem</em> <strong>294</strong>, 14406-14421 (2019).</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-family:Arial,Helvetica,sans-serif\"><span style=\"font-size:11pt\">30.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; D. E. Gordon<em> et al.</em>, A SARS-CoV-2 protein interaction map reveals targets for drug repurposing. <em>Nature</em> <strong>583</strong>, 459-468 (2020).</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-family:Arial,Helvetica,sans-serif\"><span style=\"font-size:11pt\">31.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; R. McBride, M. van Zyl, B. C. Fielding, The coronavirus nucleocapsid is a multifunctional protein. <em>Viruses</em> <strong>6</strong>, 2991-3018 (2014).</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-family:Arial,Helvetica,sans-serif\"><span style=\"font-size:11pt\">32.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; S. Alberti, S. Carra, Quality Control of Membraneless Organelles. <em>Journal of Molecular Biology</em> <strong>430</strong>, 4711-4729 (2018).</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-family:Arial,Helvetica,sans-serif\"><span style=\"font-size:11pt\">33.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; S. F. Banani, H. O. Lee, A. A. Hyman, M. K. Rosen, Biomolecular condensates: organizers of cellular biochemistry. <em>Nature Reviews Molecular Cell Biology</em> <strong>18</strong>, 285-298 (2017).</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-family:Arial,Helvetica,sans-serif\"><span style=\"font-size:11pt\">34.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; A. Savastano, A. I. de Opakua, M. Rankovic, M. Zweckstetter, Nucleocapsid protein of SARS-CoV-2 phase separates into RNA-rich polymerase-containing condensates. &nbsp;(2020).</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-family:Arial,Helvetica,sans-serif\"><span style=\"font-size:11pt\">35.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; H. Chen<em> et al.</em>, Liquid-liquid phase separation by SARS-CoV-2 nucleocapsid protein and RNA. <em>Cell Res</em>,&nbsp; (2020).</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-family:Arial,Helvetica,sans-serif\"><span style=\"font-size:11pt\">36.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; C. Iserman<em> et al.</em>, Specific viral RNA drives the SARS CoV-2 nucleocapsid to phase separate. <em>bioRxiv</em>,&nbsp; (2020).</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-family:Arial,Helvetica,sans-serif\"><span style=\"font-size:11pt\">37.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; T. M. Perdikari<em> et al.</em>, SARS-CoV-2 nucleocapsid protein undergoes liquid-liquid phase separation stimulated by RNA and partitions into phases of human ribonucleoproteins. <em>bioRxiv</em>,&nbsp; (2020).</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-family:Arial,Helvetica,sans-serif\"><span style=\"font-size:11pt\">38.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; J. Cubuk<em> et al.</em>, The SARS-CoV-2 nucleocapsid protein is dynamic, disordered, and phase separates with RNA. <em>bioRxiv</em>,&nbsp; (2020).</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-family:Arial,Helvetica,sans-serif\"><span style=\"font-size:11pt\">39.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; C. Iserman<em> et al.</em> (Cold Spring Harbor Laboratory, 2020).</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-family:Arial,Helvetica,sans-serif\"><span style=\"font-size:11pt\">40.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; C. R. Carlson<em> et al.</em>, Phosphoregulation of phase separation by the SARS-CoV-2 N protein suggests abiophysical basis for its dual functions. <em>Molecular Cell</em>,&nbsp; (2020).</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-family:Arial,Helvetica,sans-serif\"><span style=\"font-size:11pt\">41.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; L. Mendonca<em> et al.</em>, SARS-CoV-2 Assembly and Egress Pathway Revealed by Correlative Multi-modal Multi-scale Cryo-imaging. <em>bioRxiv</em>,&nbsp; (2020).</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-family:Arial,Helvetica,sans-serif\"><span style=\"font-size:11pt\">42.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; S. Ghosh<em> et al.</em>, beta-Coronaviruses Use Lysosomes for Egress Instead of the Biosynthetic Secretory Pathway. <em>Cell</em> <strong>183</strong>, 1520-1535 e1514 (2020).</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-family:Arial,Helvetica,sans-serif\"><span style=\"font-size:11pt\">43.&nbsp; &nbsp; &nbsp; &nbsp;Schubert, K., Karousis, E.D., Jomaa, A.&nbsp;<em>et al.</em>&nbsp;SARS-CoV-2 Nsp1 binds the ribosomal mRNA channel to inhibit translation.&nbsp;<em>Nat Struct Mol Biol</em>&nbsp;<strong>27,&nbsp;</strong>959&ndash;966 (2020).&nbsp;</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-family:Arial,Helvetica,sans-serif\"><span style=\"font-size:11pt\">44.&nbsp; &nbsp; &nbsp; &nbsp;Chan, Jasper Fuk-Woo et al. Improved Molecular Diagnosis of COVID-19 by the Novel, Highly Sensitive and Specific COVID-19-RdRp/Hel Real-Time Reverse Transcription-PCR Assay Validated&nbsp;<em>In Vitro</em>&nbsp;and with Clinical Specimens.&nbsp;J Clin Microbiol.&nbsp;2020:58(5)e00310-20. doi:10.1128/JCM.00310-20</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-family:Arial,Helvetica,sans-serif\"><span style=\"font-size:11pt\">45.&nbsp; &nbsp; &nbsp; &nbsp;Nagura-Ikeda M, Imai K, Tabata S, et al. Clinical Evaluation of Self-Collected Saliva by Quantitative Reverse Transcription-PCR (RT-qPCR), Direct RT-qPCR, Reverse Transcription-Loop-Mediated Isothermal Amplification, and a Rapid Antigen Test To Diagnose COVID-19. J Clin Microbiol. 2020;58(9):e01438-20. doi:10.1128/JCM.01438-20</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-family:Arial,Helvetica,sans-serif\"><span style=\"font-size:11pt\">46.&nbsp; &nbsp; &nbsp; &nbsp;Conceicao C, Thakur N, Human S, Kelly JT, Logan L, Bialy D, et al. (2020) The SARS-CoV-2 Spike protein has a broad tropism for mammalian ACE2 proteins. PLoS Biol 18(12): e3001016. https://doi.org/10.1371/journal.pbio.3001016</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-family:Arial,Helvetica,sans-serif\"><span style=\"font-size:11pt\">47.&nbsp; &nbsp; &nbsp; &nbsp;Damas J, Hughes GM, Keough KC, Painter CA, Persky NS, Corbo M, Hiller M, Koepfli KP, Pfenning AR, Zhao H, Genereux DP, Swofford R, Pollard KS, Ryder OA, Nweeia MT, Lindblad-Toh K, Teeling EC, Karlsson EK, Lewin HA. Broad host range of SARS-CoV-2 predicted by comparative and structural analysis of ACE2 in vertebrates. Proc Natl Acad Sci U S A. 2020 Sep 8;117(36):22311-22322. doi: 10.1073/pnas.2010146117. Epub 2020 Aug 21. PMID: 32826334; PMCID: PMC7486773.</span></span></p>\n","biologicalOrganisationLevel":"Cellular","organTerm":{"name":"organ","sourceId":"UBERON:0000062"},"biologicalEvents":[{"action":"increased","process":"viral RNA genome replication","object":{"name":"viral RNA-directed RNA polymerase complex","source":"GO","sourceId":"GO:0031381"}},{"action":"increased","process":"positive stranded viral RNA replication","object":{"name":"viral RNA-directed RNA polymerase complex","source":"GO","sourceId":"GO:0031381"}},{"action":"increased","process":"viral RNA genome packaging","object":{"name":"viral assembly compartment","source":"GO","sourceId":"GO:0072516"}},{"action":"increased","process":"mRNA transcription","object":{"name":"ssRNA viral genome","source":"GO","sourceId":"GO:0019024"}},{"action":"increased","process":"viral translation","object":{"name":"ssRNA viral genome","source":"GO","sourceId":"GO:0019024"}}],"keyEventStressors":["Sars-CoV-2"],"id":1847}
{"title":"Increased coronavirus production","references":"<p style=\"margin-left:48px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-family:Arial,Helvetica,sans-serif\">1.&nbsp; &nbsp; &nbsp; &nbsp; &nbsp;D. Kim<em> et al.</em>, The Architecture of SARS-CoV-2 Transcriptome. <em>Cell</em> <strong>181</strong>, 914-921 e910 (2020).</span></span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-family:Arial,Helvetica,sans-serif\"><span style=\"font-size:11pt\">2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; E. J. Snijder<em> et al.</em>, Unique and Conserved Features of Genome and Proteome of SARS-coronavirus, an Early Split-off From the Coronavirus Group 2 Lineage. <em>Journal of Molecular Biology</em> <strong>331</strong>, 991-1004 (2003).</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-family:Arial,Helvetica,sans-serif\"><span style=\"font-size:11pt\">3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; N. C. Huston<em> et al.</em>, Comprehensive in vivo secondary structure of the SARS-CoV-2 genome reveals novel regulatory motifs and mechanisms. <em>Mol Cell</em> <strong>81</strong>, 584-598 e585 (2021).</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-family:Arial,Helvetica,sans-serif\"><span style=\"font-size:11pt\">4.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; C. J. Budzilowicz, S. P. Wilczynski, S. R. Weiss, Three intergenic regions of coronavirus mouse hepatitis virus strain A59 genome RNA contain a common nucleotide sequence that is homologous to the 3&#39; end of the viral mRNA leader sequence. <em>J Virol</em> <strong>53</strong>, 834-840 (1985).</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-family:Arial,Helvetica,sans-serif\"><span style=\"font-size:11pt\">5.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; H. Di, A. A. McIntyre, M. A. Brinton, New insights about the regulation of Nidovirus subgenomic mRNA synthesis. <em>Virology</em> <strong>517</strong>, 38-43 (2018).</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-family:Arial,Helvetica,sans-serif\"><span style=\"font-size:11pt\">6.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; M. D. Sacco<em> et al.</em>, Structure and inhibition of the SARS-CoV-2 main protease reveal strategy for developing dual inhibitors against M(pro) and cathepsin L. <em>Sci Adv</em> <strong>6</strong>,&nbsp; (2020).</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-family:Arial,Helvetica,sans-serif\"><span style=\"font-size:11pt\">7.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; S. Klein<em> et al.</em>, SARS-CoV-2 structure and replication characterized by in situ cryo-electron tomography. <em>BioRxiv</em>,&nbsp; (2020).</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-family:Arial,Helvetica,sans-serif\"><span style=\"font-size:11pt\">8.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; E. J. Snijder<em> et al.</em>, A unifying structural and functional model of the coronavirus replication organelle: Tracking down RNA synthesis. <em>PLoS Biol</em> <strong>18</strong>, e3000715 (2020).</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-family:Arial,Helvetica,sans-serif\"><span style=\"font-size:11pt\">9.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; P. V&#39;Kovski, A. Kratzel, S. Steiner, H. Stalder, V. Thiel, Coronavirus biology and replication: implications for SARS-CoV-2. <em>Nat Rev Microbiol</em>,&nbsp; (2020).</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-family:Arial,Helvetica,sans-serif\"><span style=\"font-size:11pt\">10.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; P. Liu, J. Leibowitz, in <em>Molecular Biology of the SARS-Coronavirus</em>. (2010),&nbsp; chap. Chapter 4, pp. 47-61.</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-family:Arial,Helvetica,sans-serif\"><span style=\"font-size:11pt\">11.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; V. B. O&#39;Leary, O. J. Dolly, C. Hoschl, M. Cerna, S. V. Ovsepian, Unpacking Pandora From Its Box: Deciphering the Molecular Basis of the SARS-CoV-2 Coronavirus. <em>Int J Mol Sci</em> <strong>22</strong>,&nbsp; (2020).</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-family:Arial,Helvetica,sans-serif\"><span style=\"font-size:11pt\">12.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Y. Finkel<em> et al.</em>, The coding capacity of SARS-CoV-2. <em>Nature</em> <strong>589</strong>, 125-130 (2021).</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-family:Arial,Helvetica,sans-serif\"><span style=\"font-size:11pt\">13.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; H. A. Hussein, R. Y. A. Hassan, M. Chino, F. Febbraio, Point-of-Care Diagnostics of COVID-19: From Current Work to Future Perspectives. <em>Sensors (Basel)</em> <strong>20</strong>,&nbsp; (2020).</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-family:Arial,Helvetica,sans-serif\"><span style=\"font-size:11pt\">14.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; M. Thoms<em> et al.</em>, Structural basis for translational shutdown and immune evasion by the Nsp1 protein of SARS-CoV-2. <em>Science</em> <strong>369</strong>, 1249-1255 (2020).</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-family:Arial,Helvetica,sans-serif\"><span style=\"font-size:11pt\">15.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; A. K. Banerjee<em> et al.</em>, SARS-CoV-2 Disrupts Splicing, Translation, and Protein Trafficking to Suppress Host Defenses. <em>Cell</em> <strong>183</strong>, 1325-1339 e1321 (2020).</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-family:Arial,Helvetica,sans-serif\"><span style=\"font-size:11pt\">16.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; H. Xia<em> et al.</em>, Evasion of Type I Interferon by SARS-CoV-2. <em>Cell Rep</em> <strong>33</strong>, 108234 (2020).</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-family:Arial,Helvetica,sans-serif\"><span style=\"font-size:11pt\">17.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; P. Ahlquist, RNA-dependent RNA polymerases, viruses, and RNA silencing. <em>Science</em> <strong>296</strong>, 1270-1273 (2002).</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-family:Arial,Helvetica,sans-serif\"><span style=\"font-size:11pt\">18.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; M. Schwartz<em> et al.</em>, A Positive-Strand RNA Virus Replication Complex Parallels Form and Function of Retrovirus Capsids. <em>Molecular Cell</em> <strong>9</strong>, 505-514 (2002).</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-family:Arial,Helvetica,sans-serif\"><span style=\"font-size:11pt\">19.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; W. A. Miller, G. Koev, Synthesis of subgenomic RNAs by positive-strand RNA viruses. <em>Virology</em> <strong>273</strong>, 1-8 (2000).</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-family:Arial,Helvetica,sans-serif\"><span style=\"font-size:11pt\">20.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; N. S. Ogando<em> et al.</em>, SARS-coronavirus-2 replication in Vero E6 cells: replication kinetics, rapid adaptation and cytopathology. <em>J Gen Virol</em> <strong>101</strong>, 925-940 (2020).</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-family:Arial,Helvetica,sans-serif\"><span style=\"font-size:11pt\">21.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; I. Sola, F. Almazan, S. Zuniga, L. Enjuanes, Continuous and Discontinuous RNA Synthesis in Coronaviruses. <em>Annu Rev Virol</em> <strong>2</strong>, 265-288 (2015).</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-family:Arial,Helvetica,sans-serif\"><span style=\"font-size:11pt\">22.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; I. Sola, J. L. Moreno, S. Zuniga, S. Alonso, L. Enjuanes, Role of nucleotides immediately flanking the transcription-regulating sequence core in coronavirus subgenomic mRNA synthesis. <em>J Virol</em> <strong>79</strong>, 2506-2516 (2005).</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-family:Arial,Helvetica,sans-serif\"><span style=\"font-size:11pt\">23.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; X. Zhang, C. L. Liao, M. M. Lai, Coronavirus leader RNA regulates and initiates subgenomic mRNA transcription both in trans and in cis. <em>J Virol</em> <strong>68</strong>, 4738-4746 (1994).</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-family:Arial,Helvetica,sans-serif\"><span style=\"font-size:11pt\">24.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; S. G. Sawicki, D. L. Sawicki, S. G. Siddell, A contemporary view of coronavirus transcription. <em>J Virol</em> <strong>81</strong>, 20-29 (2007).</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-family:Arial,Helvetica,sans-serif\"><span style=\"font-size:11pt\">25.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Y. Yang, W. Yan, B. Hall, X. Jiang, Characterizing transcriptional regulatory sequences in coronaviruses and their role in recombination. <em>bioRxiv</em>,&nbsp; (2020).</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-family:Arial,Helvetica,sans-serif\"><span style=\"font-size:11pt\">26.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; F. Wu<em> et al.</em>, A new coronavirus associated with human respiratory disease in China. <em>Nature</em> <strong>579</strong>, 265-269 (2020).</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-family:Arial,Helvetica,sans-serif\"><span style=\"font-size:11pt\">27.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; A. Vandelli<em> et al.</em>, Structural analysis of SARS-CoV-2 genome and predictions of the human interactome. <em>Nucleic Acids Res</em> <strong>48</strong>, 11270-11283 (2020).</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-family:Arial,Helvetica,sans-serif\"><span style=\"font-size:11pt\">28.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; J. R. Cohen, L. D. Lin, C. E. Machamer, Identification of a Golgi complex-targeting signal in the cytoplasmic tail of the severe acute respiratory syndrome coronavirus envelope protein. <em>J Virol</em> <strong>85</strong>, 5794-5803 (2011).</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-family:Arial,Helvetica,sans-serif\"><span style=\"font-size:11pt\">29.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; A. Perrier<em> et al.</em>, The C-terminal domain of the MERS coronavirus M protein contains a trans-Golgi network localization signal. <em>J Biol Chem</em> <strong>294</strong>, 14406-14421 (2019).</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-family:Arial,Helvetica,sans-serif\"><span style=\"font-size:11pt\">30.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; D. E. Gordon<em> et al.</em>, A SARS-CoV-2 protein interaction map reveals targets for drug repurposing. <em>Nature</em> <strong>583</strong>, 459-468 (2020).</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-family:Arial,Helvetica,sans-serif\"><span style=\"font-size:11pt\">31.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; R. McBride, M. van Zyl, B. C. Fielding, The coronavirus nucleocapsid is a multifunctional protein. <em>Viruses</em> <strong>6</strong>, 2991-3018 (2014).</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-family:Arial,Helvetica,sans-serif\"><span style=\"font-size:11pt\">32.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; S. Alberti, S. Carra, Quality Control of Membraneless Organelles. <em>Journal of Molecular Biology</em> <strong>430</strong>, 4711-4729 (2018).</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-family:Arial,Helvetica,sans-serif\"><span style=\"font-size:11pt\">33.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; S. F. Banani, H. O. Lee, A. A. Hyman, M. K. Rosen, Biomolecular condensates: organizers of cellular biochemistry. <em>Nature Reviews Molecular Cell Biology</em> <strong>18</strong>, 285-298 (2017).</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-family:Arial,Helvetica,sans-serif\"><span style=\"font-size:11pt\">34.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; A. Savastano, A. I. de Opakua, M. Rankovic, M. Zweckstetter, Nucleocapsid protein of SARS-CoV-2 phase separates into RNA-rich polymerase-containing condensates. &nbsp;(2020).</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-family:Arial,Helvetica,sans-serif\"><span style=\"font-size:11pt\">35.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; H. Chen<em> et al.</em>, Liquid-liquid phase separation by SARS-CoV-2 nucleocapsid protein and RNA. <em>Cell Res</em>,&nbsp; (2020).</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-family:Arial,Helvetica,sans-serif\"><span style=\"font-size:11pt\">36.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; C. Iserman<em> et al.</em>, Specific viral RNA drives the SARS CoV-2 nucleocapsid to phase separate. <em>bioRxiv</em>,&nbsp; (2020).</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-family:Arial,Helvetica,sans-serif\"><span style=\"font-size:11pt\">37.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; T. M. Perdikari<em> et al.</em>, SARS-CoV-2 nucleocapsid protein undergoes liquid-liquid phase separation stimulated by RNA and partitions into phases of human ribonucleoproteins. <em>bioRxiv</em>,&nbsp; (2020).</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-family:Arial,Helvetica,sans-serif\"><span style=\"font-size:11pt\">38.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; J. Cubuk<em> et al.</em>, The SARS-CoV-2 nucleocapsid protein is dynamic, disordered, and phase separates with RNA. <em>bioRxiv</em>,&nbsp; (2020).</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-family:Arial,Helvetica,sans-serif\"><span style=\"font-size:11pt\">39.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; C. Iserman<em> et al.</em> (Cold Spring Harbor Laboratory, 2020).</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-family:Arial,Helvetica,sans-serif\"><span style=\"font-size:11pt\">40.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; C. R. Carlson<em> et al.</em>, Phosphoregulation of phase separation by the SARS-CoV-2 N protein suggests abiophysical basis for its dual functions. <em>Molecular Cell</em>,&nbsp; (2020).</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-family:Arial,Helvetica,sans-serif\"><span style=\"font-size:11pt\">41.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; L. Mendonca<em> et al.</em>, SARS-CoV-2 Assembly and Egress Pathway Revealed by Correlative Multi-modal Multi-scale Cryo-imaging. <em>bioRxiv</em>,&nbsp; (2020).</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-family:Arial,Helvetica,sans-serif\"><span style=\"font-size:11pt\">42.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; S. Ghosh<em> et al.</em>, beta-Coronaviruses Use Lysosomes for Egress Instead of the Biosynthetic Secretory Pathway. <em>Cell</em> <strong>183</strong>, 1520-1535 e1514 (2020).</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-family:Arial,Helvetica,sans-serif\"><span style=\"font-size:11pt\">43.&nbsp; &nbsp; &nbsp; &nbsp;Schubert, K., Karousis, E.D., Jomaa, A.&nbsp;<em>et al.</em>&nbsp;SARS-CoV-2 Nsp1 binds the ribosomal mRNA channel to inhibit translation.&nbsp;<em>Nat Struct Mol Biol</em>&nbsp;<strong>27,&nbsp;</strong>959&ndash;966 (2020).&nbsp;</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-family:Arial,Helvetica,sans-serif\"><span style=\"font-size:11pt\">44.&nbsp; &nbsp; &nbsp; &nbsp;Chan, Jasper Fuk-Woo et al. Improved Molecular Diagnosis of COVID-19 by the Novel, Highly Sensitive and Specific COVID-19-RdRp/Hel Real-Time Reverse Transcription-PCR Assay Validated&nbsp;<em>In Vitro</em>&nbsp;and with Clinical Specimens.&nbsp;J Clin Microbiol.&nbsp;2020:58(5)e00310-20. doi:10.1128/JCM.00310-20</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-family:Arial,Helvetica,sans-serif\"><span style=\"font-size:11pt\">45.&nbsp; &nbsp; &nbsp; &nbsp;Nagura-Ikeda M, Imai K, Tabata S, et al. Clinical Evaluation of Self-Collected Saliva by Quantitative Reverse Transcription-PCR (RT-qPCR), Direct RT-qPCR, Reverse Transcription-Loop-Mediated Isothermal Amplification, and a Rapid Antigen Test To Diagnose COVID-19. J Clin Microbiol. 2020;58(9):e01438-20. doi:10.1128/JCM.01438-20</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-family:Arial,Helvetica,sans-serif\"><span style=\"font-size:11pt\">46.&nbsp; &nbsp; &nbsp; &nbsp;Conceicao C, Thakur N, Human S, Kelly JT, Logan L, Bialy D, et al. (2020) The SARS-CoV-2 Spike protein has a broad tropism for mammalian ACE2 proteins. PLoS Biol 18(12): e3001016. https://doi.org/10.1371/journal.pbio.3001016</span></span></p>\n\n<p style=\"margin-left:48px\"><span style=\"font-family:Arial,Helvetica,sans-serif\"><span style=\"font-size:11pt\">47.&nbsp; &nbsp; &nbsp; &nbsp;Damas J, Hughes GM, Keough KC, Painter CA, Persky NS, Corbo M, Hiller M, Koepfli KP, Pfenning AR, Zhao H, Genereux DP, Swofford R, Pollard KS, Ryder OA, Nweeia MT, Lindblad-Toh K, Teeling EC, Karlsson EK, Lewin HA. Broad host range of SARS-CoV-2 predicted by comparative and structural analysis of ACE2 in vertebrates. Proc Natl Acad Sci U S A. 2020 Sep 8;117(36):22311-22322. doi: 10.1073/pnas.2010146117. Epub 2020 Aug 21. PMID: 32826334; PMCID: PMC7486773.</span></span></p>\n","biologicalOrganisationLevel":"Cellular","organTerm":{"name":"organ","sourceId":"UBERON:0000062"},"biologicalEvents":[{"action":"increased","process":"viral RNA genome replication","object":{"name":"viral RNA-directed RNA polymerase complex","source":"GO","sourceId":"GO:0031381"}},{"action":"increased","process":"positive stranded viral RNA replication","object":{"name":"viral RNA-directed RNA polymerase complex","source":"GO","sourceId":"GO:0031381"}},{"action":"increased","process":"viral RNA genome packaging","object":{"name":"viral assembly compartment","source":"GO","sourceId":"GO:0072516"}},{"action":"increased","process":"mRNA transcription","object":{"name":"ssRNA viral genome","source":"GO","sourceId":"GO:0019024"}},{"action":"increased","process":"viral translation","object":{"name":"ssRNA viral genome","source":"GO","sourceId":"GO:0019024"}}],"keyEventStressors":["Sars-CoV-2"],"id":1847}
{"title":"Reduce, Sperm count","references":"","biologicalOrganisationLevel":"Individual","organTerm":{},"biologicalEvents":[{"object":{}}],"id":1757}
{"title":"Decreased,  plasma 11-ketotestosterone level","references":"<p>Fraz, S. et al. (2018) &ldquo;Gemfibrozil and carbamazepine decrease steroid production in zebrafish testes (<em>Danio rerio</em>)&rdquo;,&nbsp;<em>Aquatic Toxicology</em>,&nbsp;Vol. 198, Elsevier, pp. 1-9.&nbsp;https://doi.org/10.1016/j.aquatox.2018.02.006&nbsp;</p>\n\n<p>Golshan, M. &amp; S.M.H.&nbsp;Alvai&nbsp;(2019) &ldquo;Androgen signaling in male fishes: Examples of anti-androgenic chemicals that cause reproductive disorders&rdquo;,&nbsp;<em>Theriogenology</em>,&nbsp;Vol. 139, Elsevier, pp.&nbsp;58-71.&nbsp;https://doi.org/10.1016/j.theriogenology.2019.07.020&nbsp;</p>\n\n<p>Hattori, R.S. et al. (2009) &ldquo;Cortisol-induced masculinization: Does thermal stress affect gonadal fate in pejerrey, a teleost fish with temperature-dependent sex determination?&rdquo;, <em>PLoS ONE</em>, Vol. 4(8), pp. 1-7. doi:10.1371/journal.pone.0006548</p>\n\n<p>Imamichi, Y. et al. (2016) &ldquo;11-Ketotestosterone is a major androgen produced in human gonads&rdquo;, <em>The Journal of Clinical Endocrinology &amp; Metabolism, </em>Vol. 101(10), Oxford Academic, pp. 3582-3591. https://doi.org/10.1210/jc.2016-2311</p>\n\n<p>Kindler, P. M. et al. (1989) &ldquo;Serum 11-ketotestosterone and testosterone concentrations associated with reproduction in male bluegill (<em>Lepomis macrochirus: </em>Centrarchidae)&rdquo;, <em>General and Comparative Endocrinology, </em>Vol. 75(3), Elsevier, pp. 446-453. https://doi.org/10.1016/0016-6480(89)90180-9</p>\n\n<p>Lee, G. et al. (2019) &ldquo;Effects of gemfibrozil on sex hormones and reproduction related performances of <em>Oryzias latipes </em>following long-term (155 d) and short-term (21 d) exposure&rdquo;, <em>Ecotoxicology and Environmental Safety, </em>Vol. 173, Elsevier, pp. 174-181. https://doi.org/10.1016/j.ecoenv.2019.02.015</p>\n\n<p>Lokman, P.M. et al. (2002) &ldquo;11-Oxygenated androgens in female teleosts: prevalence, abundance, and life history implications&rdquo;, <em>General and Comparative Endocrinology, </em>Vol. 129, Academic Press, pp. 1-12. doi: 10.1016/s0016-6480(02)00562-2</p>\n\n<p>Lorenzi, V. et al. (2008) &ldquo;Diurnal patterns and sex differences in cortisol, 11-ketotestosterone, testosterone, and 17&beta;-estradiol in the bluebanded goby (<em>Lythrypnus dalli)</em>&rdquo;, <em>General and Comparative Endocrinology, </em>Vol. 155(2)., Elsevier, pp. 438-446. https://doi.org/10.1016/j.ygcen.2007.07.010</p>\n\n<p>MacLatchy, D.L. and G.J. Vanderkraak (1995) &ldquo;The phytoestrogen &beta;-sitosterol alters the reproductive endocrine status of goldfish&rdquo;, <em>Toxicology and Applied Pharmacology, </em>Vol. 134(2), Elsevier, pp. 305-312. https://doi.org/10.1006/taap.1995.1196</p>\n\n<p>Manire, C.A., L.E. Rasmussen &amp; T.S. Gross (1999) &ldquo;Serum steroid hormones including 11-ketotestosterone, 11-ketoandrostenedione, and&nbsp;dihydroprogesterone&nbsp;in juvenile and adult bonnethead sharks,&nbsp;<em>Sphyrna&nbsp;tiburo</em>&rdquo;, <em>Journal of Experimental Zoology</em>,&nbsp;Vol. 284(5), Wiley-Blackwell, pp. 595-603.&nbsp;DOI:&nbsp;10.1002/(sici)1097-010x(19991001)284:5&lt;595::aid-jez15&gt;3.0.co&nbsp;</p>\n\n<p>P&aacute;ll, M. K., I. Mayer and&nbsp;B. Borg (2002) &ldquo;Androgen and behavior in the male three-spined stickleback, <em>Gasterosteus aculeatus </em>I. &ndash; Changes in 11-ketotestosterone levels during nesting cycle&rdquo;, <em>Hormones and Behavior, </em>Vol. 41(4), Elsevier, pp. 377-383. https://doi.org/10.1006/hbeh.2002.1777</p>\n\n<p>Shu, T. et al. (2020) &ldquo;Zebrafish cyp17a1 knockout reveals that androgen-mediated signaling is important for male brain sex differentiation&rdquo;,&nbsp;<em>General and Comparative Endocrinology</em>,&nbsp;Vol. 295. doi:10.1016/j.ygcen.2020.113490&nbsp;</p>\n\n<p>Singh, P.B. &amp; V. Singh (2008) &ldquo;Cypermethrin induced histological changes in gonadotrophic cells, liver, gonads, plasma levels of estradiol-17beta and 11-ketotestosterone, and sperm motility in&nbsp;<em>Heteropneustes&nbsp;fossilis&nbsp;</em>(Bloch)&rdquo;,&nbsp;<em>Chemosphere</em>,&nbsp;Vol. 72(3),&nbsp;Elsevier, pp. 422-431.&nbsp;DOI:&nbsp;10.1016/j.chemosphere.2008.02.026&nbsp;</p>\n\n<p>Span&oacute;, L. et al. (2004) &ldquo;Effects of atrazine on sex steroid dynamics, plasma vitellogenin concentration and gonad development in adult goldfish (<em>Carassius auratus</em>)&rdquo;, <em>Aquatic Toxicology, </em>Vol. 66(4), Elsevier, pp. 369-379. https://doi.org/10.1016/j.aquatox.2003.10.009</p>\n\n<p>Swart, A.C. et al. (2013) &ldquo;11&beta;-hydroxyandrostenedione, the product of androstenedione metabolism in the adrenal, is metabolized in LNCaP cells by 5&alpha;-reductase yielding 11&beta;-hydroxy-5&alpha;-androstanedione&rdquo;, <em>The Journal of Steroid Biochemistry and Molecular Biology, </em>Vol 138, Elsevier, pp. 132-142. https://doi.org/10.1016/j.jsbmb.2013.04.010</p>\n\n<p>Velasco-Santamar&iacute;a, Y.M. et al. (2011) &ldquo;Bezafibrate, a lipid-lowering pharmaceutical, as a potential endocrine disruptor in male zebrafish (<em>Danio rerio</em>)&rdquo;, <em>Aquatic Toxicology, </em>Vol. 105, Elsevier, pp. 107-118. doi:10.1016/j.aquatox.2011.05.018</p>\n\n<p>Wang, X.G. and&nbsp;L. Orban (2007) &ldquo;Anti-M&uuml;llerian hormone and 11&beta;-hydroxylase show reciprocal expression to that of aromatase in the transforming gonad of zebrafish males&rdquo;, <em>Developmental Dynamics, </em>Vol 236(5), Wiley-Liss, pp. 1329-1338. https://doi.org/10.1002/dvdy.21129</p>\n\n<p>Xia, H. et al. (2018) &ldquo;<em>Mettl3</em>&nbsp;mutation disrupts gamete maturation and reduced fertility in zebrafish&rdquo;,&nbsp;<em>Genetics</em>,&nbsp;Vol. 208(2),&nbsp;Genetics Society of America, pp. 729-743.&nbsp;DOI:&nbsp;10.1534/genetics.117.300574&nbsp;</p>\n\n<p>Yazawa, T. (2008) &ldquo;Cyp11b1 is induced in the murine gonad by luteinizing hormone/human chorionic gonadotropin and involved in the production of 11-ketotestosterone, a major fish androgen: Conservation and evolution of the androgen metabolic pathway&rdquo;, <em>Endocrinology, </em>Vol. 149(4), Oxford Academy, pp. 1786-1792. https://doi.org/10.1210/en.2007-1015</p>\n\n<p>Zheng, Q. et al. (2020) &ldquo;Loss of cyp11c1 causes delayed&nbsp;spermatogenesis due to the absence of 11-ketotestosterone&quot;,&nbsp;<em>Journal of Endocrinology,</em>&nbsp;Vol. 244(3),&nbsp;Bioscientifica, pp. 487-499.&nbsp;https://doi.org/10.1530/JOE-19-0438&nbsp;</p>\n","biologicalOrganisationLevel":"Tissue","organTerm":{"name":"blood plasma","sourceId":"UBERON:0001969"},"biologicalEvents":[{"action":"decreased","process":"androgen biosynthetic process","object":{"name":"11-Keto-testosterone","source":"CHEBI","sourceId":"CHEBI:34133"}}],"keyEventStressors":["Bis(2-ethylhexyl) phthalate","beta-Sitosterol","Bezafibrate","Carbamazepine","Cypermethrin","Gemfibrozil"],"id":1756}
{"title":"Impaired, Spermatogenesis","references":"<p>Golshan, M. &amp; S.M.H.&nbsp;Alvai&nbsp;(2019) &ldquo;Androgen signaling in male fishes: Examples of anti-androgenic chemicals that cause reproductive disorders&rdquo;,&nbsp;<em>Theriogenology</em>,&nbsp;Vol. 139, Elsevier, pp.&nbsp;58-71.&nbsp;https://doi.org/10.1016/j.theriogenology.2019.07.020&nbsp;</p>\n\n<p>Jensen, K.M. et al. (2004) &ldquo;Characterization of responses to the antiandrogen flutamide in a short-term reproduction assay with the fathead minnow&rdquo;,&nbsp;<em>Aquatic Toxicology</em>,&nbsp;Vol. 70(2), Elsevier, pp. 99-110.&nbsp;https://doi.org/10.1016/j.aquatox.2004.06.012&nbsp;</p>\n\n<p>Yin, P. et al. (2017) &ldquo;Diethylstilbestrol, flutamide and their combination impaired the spermatogenesis of male adult zebrafish through disrupting HPG axis, meiosis and apoptosis&rdquo;,&nbsp;<em>Aquatic Toxicology</em>,&nbsp;Vol. 185, Elsevier, pp. 129-137.&nbsp;https://doi.org/10.1016/j.aquatox.2017.02.013&nbsp;</p>\n","biologicalOrganisationLevel":"Organ","organTerm":{"name":"testis","sourceId":"UBERON:0000473"},"biologicalEvents":[{"action":"abnormal","process":"Abnormal spermatogenesis","object":{"name":"Mature sperm cell","source":"FMA","sourceId":"FMA:67338"}}],"keyEventStressors":["Bis(2-ethylhexyl) phthalate","Flutamide","Vinclozolin"],"id":1758}
{"title":"Increase, Reactive oxygen species","references":"","biologicalOrganisationLevel":"Molecular","organTerm":{},"biologicalEvents":[{"object":{}}],"id":1364}
{"title":"Increase, Global DNA methylation","references":"","biologicalOrganisationLevel":"Molecular","organTerm":{},"biologicalEvents":[{"object":{}}],"id":1827}
{"title":"Increase, Abnormal osmoregulation","references":"","biologicalOrganisationLevel":"Tissue","organTerm":{},"biologicalEvents":[{"object":{}}],"id":1768}
{"title":"Increase, Body fluid overload","references":"","biologicalOrganisationLevel":"Tissue","organTerm":{},"biologicalEvents":[{"object":{}}],"id":1769}
{"title":"Decrease, Neutral lipids","references":"","biologicalOrganisationLevel":"Tissue","organTerm":{},"biologicalEvents":[{"object":{}}],"id":1772}
{"title":"Increase, DNA double-strand break","references":"","biologicalOrganisationLevel":"Molecular","organTerm":{},"biologicalEvents":[{"object":{}}],"id":1766}
{"title":"Increase, Formation of DNA photoproducts","references":"","biologicalOrganisationLevel":"Molecular","organTerm":{},"biologicalEvents":[{"object":{}}],"id":1765}
{"title":"Increase, Cripto-1 expression","references":"<p style=\"margin-left:.5in\">Garland MA, Sengupta S, Mathew LK, Truong L, Jong ED, Piersma AH, Du JL, Tanguay RL. 2019. <em>Glucocorticoid receptor-dependent induction of </em>cripto-1<em> (one-eyed pinhead) inhibits zebrafish caudal fin regeneration. </em>Toxicology Reports 6:529-537. https://doi.org/10.1016/j.toxrep.2019.05.013</p>\n\n<p style=\"margin-left:.5in\">Ravisankar V, Signh TP, Manoj N.&nbsp;2011.&nbsp;<em>Molecular evolution of the EGF-CFC protein family.</em>&nbsp;Gene, 428:43-50. doi:10.1016/j.gene.2011.05.007</p>\n","biologicalOrganisationLevel":"Cellular","organTerm":{},"biologicalEvents":[{"action":"increased","process":"gene expression","object":{"name":"teratocarcinoma-derived growth factor 1","source":"PR","sourceId":"PR:000030513"}}],"id":1759}
{"title":"Inhibition, Activin signaling","references":"<p style=\"margin-left:.5in\">Gray PC, Harrison CA, Vale W. 2003. <em>Cripto forms a complex with activin and type II activin receptors and can block activin signaling.</em> Proceedings of the National Academy of Sciences of the United States of America 100(9):5193-5198. www.pnas.org/cgi/doi/10.1073/pnas.0531290100</p>\n\n<p style=\"margin-left:.5in\">Hinck AP. 2012.&nbsp;<em>Structural studies of the TGF-Bs and their Receptors - insights into evolution of the TGF-B superfamily.&nbsp;</em>Federation of European Biochemical Societies Letters 586: 1860-1870. doi.10.1016/j.febslet.2012.05.028</p>\n\n<p style=\"margin-left:.5in\">Kaneko H, 2016. <em>Handbook of Hormones: </em>Pages 295-297, e33B-2.</p>\n\n<p style=\"margin-left:.5in\">Kang HY, Shyr CR. 2011. <em>Activins and Cell Migration</em>. Vitamins and Hormons 85: 129-48. doi: 10.1016/B978-0-12-385961-7.00007-X.</p>\n\n<p style=\"margin-left:.5in\">Sakai R, Shiozaki M, Tabuchi M, Eto Y. 1992. <em>The measurement of activin/EDF in mouse serum: Evidence for extragonadal production.</em> Biochemical And Biophysical Research Communications 188(2):921-926. https://doi.org/10.1016/0006-291X(92)91143-E</p>\n\n<p style=\"margin-left:.5in\">Wehner D, Weidinger G. 2015. <em>Signaling networks organizing regenerative growth of the zebrafish fin.</em> Trends in Genetics 31 (6):336-343. http://dx.doi.org/10.1016/j.tig.2015.03.012</p>\n","biologicalOrganisationLevel":"Cellular","organTerm":{},"biologicalEvents":[{"action":"decreased","process":"activin receptor signaling pathway","object":{"name":"activin receptor complex","source":"GO","sourceId":"GO:0048179"}}],"id":1760}
{"title":"Inhibition, Fin regeneration","references":"<p style=\"margin-left:0.5in\">&nbsp;</p>\n\n<p style=\"margin-left:40px\">Ellis T, Hoyle I, Oidtmann B, Turnbull JF, Jacklin TE, Knowles TG. 2009. <em>Further development of the &ldquo;Fin Index&rdquo; method for quantifying fin erosion in rainbow trout.</em> Aquaculture 289: 283-288. doi:10.1016/j.aquaculture.2009.01.022</p>\n\n<p style=\"margin-left:40px\">Fu C, Cao ZD, Fu SJ. 2013. <em>The effects of caudal fin loss and regeneration on the swimming performance of three cyprinid fish species with different swimming capactities.</em> The Journal of Experimental Biology 216:3164-3174. doi:10.1242/jeb.084244</p>\n\n<p style=\"margin-left:40px\">Poss KD, Shen J, Keating MT, Nechiporuk A. 2003. <em>Tales of Regeneration in Zebrafish</em>. Developmental Dynamics 226:202-210. DOI 10.1002/dvdy.10220</p>\n\n<p style=\"margin-left:40px\">Wehner D, Weidinger G. 2015. <em>Signaling networks organizing regenerative growth of the zebrafish fin.</em> Trends in Genetics 31 (6):336-343. http://dx.doi.org/10.1016/j.tig.2015.03.012</p>\n","biologicalOrganisationLevel":"Tissue","organTerm":{"name":"fin","sourceId":"UBERON:0008897"},"biologicalEvents":[{"action":"decreased","process":"fin regeneration","object":{"name":"blastemal cell","source":"CL","sourceId":"CL:0000354"}}],"id":1761}
{"title":"Urothelial cell injury/death","references":"","biologicalOrganisationLevel":"Cellular","organTerm":{},"biologicalEvents":[{"object":{}}],"id":1762}
{"title":"Urothelial Tumor","references":"","biologicalOrganisationLevel":"Organ","organTerm":{},"biologicalEvents":[{"object":{}}],"id":1763}
{"title":"Increase, DNA methyltransferase inhibition","references":"","biologicalOrganisationLevel":"Molecular","organTerm":{},"biologicalEvents":[{"object":{}}],"id":1619}
{"title":"Decrease, Global DNA methylation","references":"","biologicalOrganisationLevel":"Molecular","organTerm":{},"biologicalEvents":[{"object":{}}],"id":1773}
{"title":"Increase, Caspase transcription","references":"","biologicalOrganisationLevel":"Molecular","organTerm":{},"biologicalEvents":[{"object":{}}],"id":1774}
{"title":"Increase, Oocyte apoptosis","references":"","biologicalOrganisationLevel":"Cellular","organTerm":{},"biologicalEvents":[{"object":{}}],"id":1775}
{"title":"Increase, Ovarian somatic cell apoptosis","references":"","biologicalOrganisationLevel":"Cellular","organTerm":{},"biologicalEvents":[{"object":{}}],"id":1776}
{"title":"Increase, Ovarian follicle breakdown","references":"","biologicalOrganisationLevel":"Organ","organTerm":{},"biologicalEvents":[{"object":{}}],"id":1777}
{"title":"Decrease, Heritable DNA methylation (F3)","references":"","biologicalOrganisationLevel":"Molecular","organTerm":{},"biologicalEvents":[{"object":{}}],"id":1778}
{"title":"Increase, Caspase transcription (F3)","references":"","biologicalOrganisationLevel":"Molecular","organTerm":{},"biologicalEvents":[{"object":{}}],"id":1779}
{"title":"Increase, Oocyte apoptosis (F3)","references":"","biologicalOrganisationLevel":"Cellular","organTerm":{},"biologicalEvents":[{"object":{}}],"id":1780}
{"title":"Decrease, Fecundity (F3)","references":"","biologicalOrganisationLevel":"Individual","organTerm":{},"biologicalEvents":[{"object":{}}],"id":1781}
{"title":"Decrease, Oogenesis (F3)","references":"","biologicalOrganisationLevel":"Organ","organTerm":{},"biologicalEvents":[{"object":{}}],"id":1782}
{"title":"Increase, Ovarian somatic cell apoptosis (F3)","references":"","biologicalOrganisationLevel":"Cellular","organTerm":{},"biologicalEvents":[{"object":{}}],"id":1783}
{"title":"Increase, Ovarian follicle breakdown (F3)","references":"","biologicalOrganisationLevel":"Organ","organTerm":{},"biologicalEvents":[{"object":{}}],"id":1784}
{"title":"Inhibition, Chitin synthase 1","references":"<p><span style=\"font-size:14px\">Arakane Y, Muthukrishnan S, Kramer KJ, Specht CA, Tomoyasu Y, Lorenzen MD, Kanost M, Beeman RW. 2005. The <em>Tribolium </em>&nbsp;chitin synthase genes TcCHS1 and TcCHS2 are specialized for synthesis of epidermal cuticle and midgut peritrophic matrix. Insect Mol Biol. 14(5):453&ndash;463. doi:10.1111/j.1365-2583.2005.00576.x.</span></p>\n\n<p><span style=\"font-size:14px\">Cohen E. 1982. In vitro chitin synthesis in an insect: formation and structure of microfibrils. Eur J Cell Biol. 26(2):289&ndash;294.</span></p>\n\n<p><span style=\"font-size:14px\">Cohen E, Casida JE. 1982. Properties and inhibition of insect integumental chitin synthetase. Pestic Biochem Physiol. 17(3):301&ndash;306. doi:10.1016/0048-3575(82)90141-9.</span></p>\n\n<p><span style=\"font-size:14px\">Cohen E, Casida JE. 1990. Insect and Fungal Chitin Synthetase Activity: Specificity of Lectins as Enhancers and Nucleoside Peptides as Inhibitors. Pestic Biochem Physiol. 37(3):249&ndash;253. doi:10.1016/0048-3575(90)90131-K.</span></p>\n\n<p><span style=\"font-size:14px\">Kuwano E, Cohen E. 1984. The use of a <em>Tribolium</em> chitin synthetase assay in studying the effects of benzimidazoles with a terpene moiety and related compounds. Agric Biol Chem. 48(6):1617&ndash;1620. doi:10.1080/00021369.1984.10866362.</span></p>\n\n<p><span style=\"font-size:14px\">Latg&eacute; JP. 2007. The cell wall: A carbohydrate armour for the fungal cell. Mol Microbiol. 66(2):279&ndash;290. doi:10.1111/j.1365-2958.2007.05872.x.</span></p>\n\n<p><span style=\"font-size:14px\">Lucero HA, Kuranda MJ, Bulik DA. 2002. A nonradioactive, high throughput assay for chitin synthase activity. Anal Biochem. 305(1):97&ndash;105. doi:10.1006/abio.2002.5594.</span></p>\n\n<p><span style=\"font-size:14px\">Lukens RJ, Sisler HD. 1958. 2-Thiazolidinethione-4-carboxylic acid from the reaction of captan with cysteine. Science (80- ). 127(3299):650. doi:10.1126/science.127.3299.650.</span></p>\n\n<p><span style=\"font-size:14px\">Merzendorfer H. 2006. Insect chitin synthases: A review. J Comp Physiol B Biochem Syst Environ Physiol. doi:10.1007/s00360-005-0005-3.</span></p>\n\n<p><span style=\"font-size:14px\">Merzendorfer H. 2011. The cellular basis of chitin synthesis in fungi and insects: Common principles and differences. Eur J Cell Biol. 90(9):759&ndash;769. doi:10.1016/j.ejcb.2011.04.014. http://dx.doi.org/10.1016/j.ejcb.2011.04.014.</span></p>\n\n<p><span style=\"font-size:14px\">Merzendorfer H, Zimoch L. 2003. Chitin metabolism in insects: structure, function and regulation of chitin synthases and chitinases. J Exp Biol. 206(24):4393 LP &ndash; 4412. doi:10.1242/jeb.00709. http://jeb.biologists.org/content/206/24/4393.abstract.</span></p>\n\n<p><span style=\"font-size:14px\">Osada H. 2019. Discovery and applications of nucleoside antibiotics beyond polyoxin. J Antibiot (Tokyo). 72(12):855&ndash;864. doi:10.1038/s41429-019-0237-1. http://dx.doi.org/10.1038/s41429-019-0237-1.</span></p>\n\n<p><span style=\"font-size:14px\">Zhang X, Yan Zhu K. 2013. Biochemical characterization of chitin synthase activity and inhibition in the African malaria mosquito, <em>Anopheles gambiae</em>. Insect Sci. 20(2):158&ndash;166. doi:10.1111/j.1744-7917.2012.01568.x.</span></p>\n\n<p><span style=\"font-size:14px\">Zhang X, Zhang J, Park Y, Zhu KY. 2012. Identification and characterization of two chitin synthase genes in African malaria mosquito, Anopheles gambiae. Insect Biochem Mol Biol. 42(9):674&ndash;682. doi:10.1016/j.ibmb.2012.05.005. http://dx.doi.org/10.1016/j.ibmb.2012.05.005.</span></p>\n","biologicalOrganisationLevel":"Molecular","organTerm":{"name":"epithelium","sourceId":"UBERON:0000483"},"biologicalEvents":[{"action":"decreased","process":"chitin synthase activity","object":{}}],"keyEventStressors":["Polyoxin B","Polyoxin D","Nikkomycins","Captan"],"id":1522}
{"title":"Decrease, Cuticular chitin content","references":"<p><span style=\"font-size:14px\">Arakane Y, Muthukrishnan S, Kramer KJ, Specht CA, Tomoyasu Y, Lorenzen MD, Kanost M, Beeman RW. 2005. The <em>Tribolium </em>&nbsp;chitin synthase genes TcCHS1 and TcCHS2 are specialized for synthesis of epidermal cuticle and midgut peritrophic matrix. Insect Mol Biol. 14(5):453&ndash;463. doi:10.1111/j.1365-2583.2005.00576.x.</span></p>\n\n<p><span style=\"font-size:14px\">Calcott PH, Fatig RO. 1984. Inhibition of Chitin metabolism by Avermectin in susceptible Organisms. J Antibiot (Tokyo). 37(3):253&ndash;259. doi:10.7164/antibiotics.37.253.</span></p>\n\n<p><span style=\"font-size:14px\">Clarke KU. 1957. On the Increase in Linear Size During Growth in <em>Locusta Migratoria</em> L. Proc R Entomol Soc London Ser A, Gen Entomol. 32(1&ndash;3):35&ndash;39. doi:10.1111/j.1365-3032.1957.tb00361.x.</span></p>\n\n<p><span style=\"font-size:14px\">Dall W, Smith DM, Press B. 1978. Water uptake at ecdysis in the western rock lobster. J Exp Mar Bio Ecol. 35(1960). doi:10.1016/0022-0981(78)90074-6.</span></p>\n\n<p><span style=\"font-size:14px\">deFur PL, Mangum CP, McMahon BR. 1985. Cardiovascular and Ventilatory Changes During Ecdysis in the Blue Crab <em>Callinectes Sapidus</em> Rathbun. J Crustac Biol. 5(2):207&ndash;215. doi:10.2307/1547867.</span></p>\n\n<p><span style=\"font-size:14px\">Ewer J. 2005. How the ecdysozoan changed its coat. PLoS Biol. 3(10):1696&ndash;1699. doi:10.1371/journal.pbio.0030349.</span></p>\n\n<p><span style=\"font-size:14px\">Gelman DB, Borkovec AB. 1986. The pharate adult clasper as a tool for measuring chitin synthesis and for identifying new chitin synthesis inhibitors. Comp Biochem Physiol Part C, Comp. 85(1):193&ndash;197. doi:10.1016/0742-8413(86)90073-3.</span></p>\n\n<p><span style=\"font-size:14px\">Gijswijt MJ, Deul DH, de Jong BJ. 1979. Inhibition of chitin synthesis by benzoyl-phenylurea insecticides, III. Similarity in action in <em>Pieris brassicae</em> (L.) with Polyoxin D. Pestic Biochem Physiol. 12(1):87&ndash;94. doi:10.1016/0048-3575(79)90098-1.</span></p>\n\n<p><span style=\"font-size:14px\">Henriques BS, Garcia ES, Azambuja P, Genta FA. 2020. Determination of Chitin Content in Insects: An Alternate Method Based on Calcofluor Staining. Front Physiol. 11(February):1&ndash;10. doi:10.3389/fphys.2020.00117.</span></p>\n\n<p><span style=\"font-size:14px\">Lee RM. 1961. The variation of blood volume with age in the desert locust (<em>Schistocerca gregaria</em> Forsk.). J Insect Physiol. 6(1):36&ndash;51. doi:10.1016/0022-1910(61)90090-7.</span></p>\n\n<p><span style=\"font-size:14px\">Lehmann PF, White LO. 1975. Chitin Assay Used to Demonstrate Renal Localization and Cortisone-Enhanced Growth of <em>Aspergillus fumigatus</em> Mycelium in Mice. Infect Immun. 12(5):987&ndash;992.</span></p>\n\n<p><span style=\"font-size:14px\">Lucero HA, Kuranda MJ, Bulik DA. 2002. A nonradioactive, high throughput assay for chitin synthase activity. Anal Biochem. 305(1):97&ndash;105.<br />\ndoi:10.1006/abio.2002.5594.</span></p>\n\n<p><span style=\"font-size:14px\">Lukens RJ, Sisler HD. 1958. 2-Thiazolidinethione-4-carboxylic acid from the reaction of captan with cysteine. Science (80- ). 127(3299):650. doi:10.1126/science.127.3299.650.</span></p>\n\n<p><span style=\"font-size:14px\">Muthukrishnan S, Merzendorfer H, Arakane Y, Kramer KJ. 2012. Chitin Metabolism in Insects. Elsevier B.V. http://dx.doi.org/10.1016/B978-0-12-384747-8.10007-8.</span></p>\n\n<p><span style=\"font-size:14px\">Osada H. 2019. Discovery and applications of nucleoside antibiotics beyond polyoxin. J Antibiot (Tokyo). 72(12):855&ndash;864. doi:10.1038/s41429-019-0237-1. http://dx.doi.org/10.1038/s41429-019-0237-1.</span></p>\n\n<p><span style=\"font-size:14px\">Reissig JL, Strominger JL, Leloir LF. 1955. A modified colorimetric method for the estimation of N-acetylamino sugars. J Biol Chem.:959&ndash;966.</span></p>\n\n<p><span style=\"font-size:14px\">Reynolds SE. 1987. The cuticle, growth and moulting in insects: The essential background to the action of acylurea insecticides. Pestic Sci. 20(2):131&ndash;146. doi:10.1002/ps.2780200207.</span></p>\n\n<p><span style=\"font-size:14px\">Turnbull IF, Howells AJ. 1982. Effects of several larvicidal compounds on chitin biosynthesis by isolated larval integuments of the sheep blowfly <em>Lucilia cuprina</em>. Aust J Biol Sci. 35(5):491&ndash;504. doi:10.1071/BI9820491.</span></p>\n\n<p><span style=\"font-size:14px\">Vincent JFV, Wegst UGK. 2004. Design and mechanical properties of insect cuticle. Arthropod Struct Dev. 33(3):187&ndash;199. doi:10.1016/j.asd.2004.05.006.</span></p>\n\n<p><span style=\"font-size:14px\">Zhang J, Zhu KY. 2006. Characterization of a chitin synthase cDNA and its increased mRNA level associated with decreased chitin synthesis in <em>Anopheles quadrimaculatus</em> exposed to diflubenzuron. Insect Biochem Mol Biol. 36(9):712&ndash;725. doi:10.1016/j.ibmb.2006.06.002.</span></p>\n\n<p><span style=\"font-size:14px\">Zhang X, Yan Zhu K. 2013. Biochemical characterization of chitin synthase activity and inhibition in the African malaria mosquito, Anopheles<br />\ngambiae. Insect Sci. 20(2):158&ndash;166. doi:10.1111/j.1744-7917.2012.01568.x.</span></p>\n\n<p><span style=\"font-size:14px\">Zhuo W, Fang Y, Kong L, Li X, Sima Y, Xu S. 2014. Chitin synthase A: A novel epidermal development regulation gene in the larvae of <em>Bombyx mori</em>. Mol Biol Rep. 41(7):4177&ndash;4186. doi:10.1007/s11033-014-3288-1.</span></p>\n","biologicalOrganisationLevel":"Tissue","organTerm":{"name":"cuticle","sourceId":"UBERON:0001002"},"biologicalEvents":[{"action":"decreased","process":"cuticle development","object":{"name":"cuticle","source":"UBERON","sourceId":"UBERON:0001002"}}],"keyEventStressors":["Folpet","Polyoxin D","Nikkomycins","Captan","Captafol"],"id":1523}
{"title":"Increase, Premature molting","references":"<p><span style=\"font-size:14px\"><span style=\"font-family:Arial,Helvetica,sans-serif\">Arakawa T, Yukuhiro F, Noda H. 2008. Insecticidal effect of a fungicide containing polyoxin B on the larvae of <em>Bombyx mori</em> (Lepidoptera: Bombycidae), <em>Mamestra brassicae</em>, <em>Mythimna separata</em>, and <em>Spodoptera litura</em> (Lepidoptera: Noctuidae). Appl Entomol Zool. 43(2):173&ndash;181. doi:10.1303/aez.2008.173.</span></span></p>\n\n<p><span style=\"font-size:14px\"><span style=\"font-family:Arial,Helvetica,sans-serif\">Chen, X.; Tian, H.; Zou, L.; Tang, B.; Hu, J.; Zhang, W. Disruption of Spodoptera Exigua Larval Development by Silencing Chitin Synthase Gene A with RNA Interference. Bull. Entomol. Res. 2008, 98 (6), 613&ndash;619. https://doi.org/10.1017/S0007485308005932.</span></span></p>\n\n<p><span style=\"font-size:14px\"><span style=\"font-family:Arial,Helvetica,sans-serif\">Clarke KU. 1957. On the Increase in Linear Size During Growth in Locusta Migratoria L. Proc R Entomol Soc London Ser A, Gen Entomol. 32(1&ndash;<br />\n3):35&ndash;39. doi:10.1111/j.1365-3032.1957.tb00361.x.</span></span></p>\n\n<p><span style=\"font-size:14px\"><span style=\"font-family:Arial,Helvetica,sans-serif\">Dall W, Smith DM, Press B. 1978. Water uptake at ecdysis in the western rock lobster. J Exp Mar Bio Ecol. 35(1960). doi:10.1016/0022-<br />\n0981(78)90074-6.</span></span></p>\n\n<p><span style=\"font-size:14px\"><span style=\"font-family:Arial,Helvetica,sans-serif\">deFur PL, Mangum CP, McMahon BR. 1985. Cardiovascular and Ventilatory Changes During Ecdysis in the Blue Crab Callinectes Sapidus<br />\nRathbun. J Crustac Biol. 5(2):207&ndash;215. doi:10.2307/1547867.</span></span></p>\n\n<p><span style=\"font-size:14px\"><span style=\"font-family:Arial,Helvetica,sans-serif\">Ewer J. 2005. How the ecdysozoan changed its coat. PLoS Biol. 3(10):1696&ndash;1699. doi:10.1371/journal.pbio.0030349.</span></span></p>\n\n<p><span style=\"font-size:14px\"><span style=\"font-family:Arial,Helvetica,sans-serif\">Gijswijt MJ, Deul DH, de Jong BJ. 1979. Inhibition of chitin synthesis by benzoyl-phenylurea insecticides, III. Similarity in action in <em>Pieris brassicae</em> (L.) with Polyoxin D. Pestic Biochem Physiol. 12(1):87&ndash;94. doi:10.1016/0048-3575(79)90098-1.</span></span></p>\n\n<p><span style=\"font-size:14px\"><span style=\"font-family:Arial,Helvetica,sans-serif\">Heming BS. 2018. Insect development and evolution. Ithaca: Cornell University Press.</span></span></p>\n\n<p><span style=\"font-size:14px\"><span style=\"font-family:Arial,Helvetica,sans-serif\">Mohammed, A. M. A.; DIab, M. R.; Abdelsattar, M.; Khalil, S. M. S. Characterization and RNAi-Mediated Knockdown of Chitin Synthase A in the Potato Tuber Moth, Phthorimaea Operculella. Sci. Rep. 2017, 7 (1), 1&ndash;12. https://doi.org/10.1038/s41598-017-09858-y.</span></span></p>\n\n<p><span style=\"font-size:14px\"><span style=\"font-family:Arial,Helvetica,sans-serif\">Lee RM. 1961. The variation of blood volume with age in the desert locust (Schistocerca gregaria Forsk.). J Insect Physiol. 6(1):36&ndash;51.<br />\ndoi:10.1016/0022-1910(61)90090-7.</span></span></p>\n\n<p><span style=\"font-size:14px\"><span style=\"font-family:Arial,Helvetica,sans-serif\">OECD&nbsp;(2003),&nbsp;Proposal for an Enhanced Test Guideline. Daphnia magna Reproduction Test. Draft OECD Guidel. Test. Chem. Enhanc. Tech. Guid. Doc. 211 21.</span></span></p>\n\n<p><span style=\"font-size:14px\"><span style=\"font-family:Arial,Helvetica,sans-serif\">OECD (2004),&nbsp;<em>Test No. 202: Daphnia sp. Acute Immobilisation Test</em>, OECD Guidelines for the Testing of Chemicals, Section 2, OECD Publishing, Paris,&nbsp;<a href=\"https://doi.org/10.1787/9789264069947-en\" title=\"\">https://doi.org/10.1787/9789264069947-en</a>.</span></span></p>\n\n<p><span style=\"font-size:14px\"><span style=\"font-family:Arial,Helvetica,sans-serif\">OECD (2012),&nbsp;<em>Test No. 211: Daphnia magna Reproduction Test</em>, OECD Guidelines for the Testing of Chemicals, Section 2, OECD Publishing, Paris,&nbsp;<a href=\"https://doi.org/10.1787/9789264185203-en\" title=\"\">https://doi.org/10.1787/9789264185203-en</a>.</span></span></p>\n\n<p><span style=\"font-size:14px\"><span style=\"font-family:Arial,Helvetica,sans-serif\">Tellam RL, Vuocolo T, Johnson SE, Jarmey J, Pearson RD. 2000. Insect chitin synthase. cDNA sequence, gene organization and expression. Eur J Biochem. 267(19):6025&ndash;6043. doi:10.1046/j.1432-1327.2000.01679.x.</span></span></p>\n\n<p><span style=\"font-size:14px\"><span style=\"font-family:Arial,Helvetica,sans-serif\">Wang, Z.; Yang, H.; Zhou, C.; Yang, W. J.; Jin, D. C.; Long, G. Y. Molecular Cloning, Expression, and Functional Analysis of the Chitin Synthase 1 Gene and Its Two Alternative Splicing Variants in the White-Backed Planthopper, Sogatella Furcifera (Hemiptera: Delphacidae). Sci. Rep. 2019, 9 (1), 1&ndash;14. https://doi.org/10.1038/s41598-018-37488-5.</span></span></p>\n","biologicalOrganisationLevel":"Individual","organTerm":{},"biologicalEvents":[{"action":"decreased","process":"ecdysis, chitin-based cuticle","object":{}}],"keyEventStressors":["Polyoxin D","Nikkomycins"],"id":1524}
{"title":"Increase, Sulfonylurea receptor binding","references":"","biologicalOrganisationLevel":"Molecular","organTerm":{},"biologicalEvents":[{"object":{}}],"id":1525}
{"title":"Increase, Cell membrane depolarization","references":"","biologicalOrganisationLevel":"Cellular","organTerm":{},"biologicalEvents":[{"object":{}}],"id":1527}
{"title":"Increase, Opening of voltage-dependent calcium channel","references":"","biologicalOrganisationLevel":"Cellular","organTerm":{},"biologicalEvents":[{"object":{}}],"id":1526}
{"title":"increase, retained nipples in males","references":"","biologicalOrganisationLevel":"Organ","organTerm":{},"biologicalEvents":[{"object":{}}],"id":1786}
{"title":"Granulosa cell proliferation of gonadotropin-independent follicles, Reduced","references":"<p>Adan, A., Kiraz, Y., &amp; Baran, Y. (2016). Cell Proliferation and Cytotoxicity Assays. Current Pharmaceutical Biotechnology, 17(14), 1213&ndash;1221. https://doi.org/10.2174/1389201017666160808160513</p>\n\n<p>Adhikari, D., &amp; Liu, K. (2009, August). Molecular mechanisms underlying the activation of mammalian primordial follicles. Endocrine Reviews, Vol. 30, pp. 438&ndash;464. https://doi.org/10.1210/er.2008-0048</p>\n\n<p>Carlsson, I. B., Scott, J. E., Visser, J. A., Ritvos, O., Themmen, A. P. N., &amp; Hovatta, O. (2006). Anti-M&uuml;llerian hormone inhibits initiation of growth of human primordial ovarian follicles in vitro. Human Reproduction, 21(9), 2223&ndash;2227. https://doi.org/10.1093/humrep/del165</p>\n\n<p>Dong, J., Albertini, D. F., Nishimori, K., Kumar, T. R., Lu, N., &amp; Matzuk, M. M. (1996). Growth differentiation factor-9 is required during early ovarian folliculogenesis. Nature, 383(6600), 531&ndash;535. https://doi.org/10.1038/383531a0</p>\n\n<p>Gougeon, A. (2010). Croissance folliculaire dans l&rsquo;ovaire humain: de l&rsquo;entr&eacute;e en croissance du follicule primordial jusqu&rsquo;&agrave; la maturation pr&eacute;ovulatoire. Annales d&rsquo;Endocrinologie, 71(3), 132&ndash;143. https://doi.org/10.1016/j.ando.2010.02.021</p>\n\n<p>Gougeon, A., &amp; Chainy, G. B. N. (1987). Morphometric studies of small follicles in ovaries of women at different ages. Journal of Reproduction and Fertility, 81(2), 433&ndash;442. https://doi.org/10.1530/jrf.0.0810433</p>\n\n<p>Hsueh, A. J. W., Kawamura, K., Cheng, Y., &amp; Fauser, B. C. J. M. (2015). Intraovarian control of early folliculogenesis. Endocrine Reviews, Vol. 36, pp. 1&ndash;24. https://doi.org/10.1210/er.2014-1020</p>\n\n<p>Kidder, G. M., &amp; Vanderhyden, B. C. (2010). Bidirectional communication between oocytes and follicle cells: Ensuring oocyte developmental competence. Canadian Journal of Physiology and Pharmacology, Vol. 88, pp. 399&ndash;413. https://doi.org/10.1139/Y10-009</p>\n\n<p>McGee, E. A., &amp; Hsueh, A. J. W. (2000). Initial and Cyclic Recruitment of Ovarian Follicles*. Endocrine Reviews, 21(2), 200&ndash;214. https://doi.org/10.1210/edrv.21.2.0394</p>\n\n<p>Nishi, Y., Yanase, T., Mu, Y.-M., Oba, K., Ichino, I., Saito, M., &hellip; Nawata, H. (2001). Establishment and Characterization of a Steroidogenic Human Granulosa-Like Tumor Cell Line, KGN, That Expresses Functional Follicle-Stimulating Hormone Receptor. Endocrinology, 142(1), 437&ndash;445. https://doi.org/10.1210/endo.142.1.7862</p>\n\n<p>Pankhurst, M. W., Kelley, R. L., Sanders, R. L., Woodcock, S. R., Oorschot, D. E., &amp; Batchelor, N. J. (2018). Anti-M&uuml;llerian hormone overexpression restricts preantral ovarian follicle survival. Journal of Endocrinology, 237(2), 153&ndash;163. https://doi.org/10.1530/JOE-18- 0005</p>\n\n<p>Test No. 443: Extended One-Generation Reproductive Toxicity Study. (2018). https://doi.org/10.1787/9789264185371-en</p>\n\n<p>Vitt, U. A., McGee, E. A., Hayashi, M., &amp; Hsueh, A. J. W. (2000). In vivo treatment with GDF-9 stimulates primordial and primary follicle progression and theca cell marker CYP17 in ovaries of immature rats. Endocrinology, 141(10), 3814&ndash;3820. https://doi.org/10.1210/endo.141.10.7732</p>\n","biologicalOrganisationLevel":"Cellular","organTerm":{"name":"female gonad","sourceId":"UBERON:0000992"},"biologicalEvents":[{"object":{}}],"id":1800}
{"title":"Reduction, 17beta-estradiol synthesis by the undifferentiated gonad ","references":"<p>Bondesson, M., Hao, R., Lin, C. Y., Williams, C., &amp; Gustafsson, J. &Aring;. (2015). Estrogen receptor signaling during vertebrate development.&nbsp;Biochimica et biophysica acta,&nbsp;1849(2), 142&ndash;151.&nbsp;</p>\n\n<p>Callard, G. V., Tarrant, A. M., Novillo, A., Yacci, P., Ciaccia, L., Vajda, S., Chuang, G. Y., Kozakov, D., Greytak, S. R., Sawyer, S., Hoover, C., &amp; Cotter, K. A. (2011). Evolutionary origins of the estrogen signaling system: insights from amphioxus.&nbsp;The Journal of steroid biochemistry and molecular biology,&nbsp;127(3-5), 176&ndash;188.&nbsp;</p>\n\n<p>Cheshenko, K., Pakdel, F., Segner, H., Kah, O., &amp; Eggen, R. I. (2008). Interference of endocrine disrupting chemicals with aromatase CYP19 expression or activity, and consequences for reproduction of teleost fish.&nbsp;<em>General and comparative endocrinology</em>,&nbsp;<em>155</em>(1), 31&ndash;62.&nbsp;</p>\n\n<p>Coumailleau, P., Pellegrini, E., Adrio, F., Diotel, N., Cano-Nicolau, J., Nasri, A., Vaillant, C., &amp; Kah, O. (2015). Aromatase, estrogen receptors and brain development in fish and amphibians.&nbsp;<em>Biochimica et biophysica acta</em>,&nbsp;<em>1849</em>(2), 152&ndash;162.&nbsp;</p>\n\n<p>Eick, G. N., &amp; Thornton, J. W. (2011). Evolution of steroid receptors from an estrogen-sensitive ancestral receptor.&nbsp;Molecular and cellular endocrinology,&nbsp;334(1-2), 31&ndash;38.&nbsp;</p>\n\n<p>Gorelick, D. A., &amp; Halpern, M. E. (2011). Visualization of estrogen receptor transcriptional activation in zebrafish.&nbsp;Endocrinology,&nbsp;152(7), 2690&ndash;2703. https://doi.org/10.1210/en.2010-1257</p>\n\n<p>Guiguen, Y., Fostier, A., Piferrer, F., &amp; Chang, C. F. (2010). Ovarian aromatase and estrogens: a pivotal role for gonadal sex differentiation and sex change in fish.&nbsp;<em>General and comparative endocrinology</em>,&nbsp;<em>165</em>(3), 352&ndash;366.&nbsp;</p>\n\n<p>Jones, B. L., Walker, C., Azizi, B., Tolbert, L., Williams, L. D., &amp; Snell, T. W. (2017). Conservation of estrogen receptor function in invertebrate reproduction.&nbsp;BMC evolutionary biology,&nbsp;17(1), 65.&nbsp;</p>\n\n<p>Li, M., Sun, L., &amp; Wang, D. (2019). Roles of estrogens in fish sexual plasticity and sex differentiation.&nbsp;<em>General and comparative endocrinology</em>,&nbsp;<em>277</em>, 9&ndash;16. https://doi.org/10.1016/j.ygcen.2018.11.015</p>\n\n<p>Ruksana, S., Pandit, N. P., &amp; Nakamura, M. (2010). Efficacy of exemestane, a new generation of aromatase inhibitor, on sex differentiation in a gonochoristic fish.&nbsp;Comparative biochemistry and physiology. Toxicology &amp; pharmacology : CBP,&nbsp;152(1), 69&ndash;74.&nbsp;</p>\n\n<p>Schroeder, A. L., Ankley, G. T., Habib, T., Garcia-Reyero, N., Escalon, B. L., Jensen, K. M., Kahl, M. D., Durhan, E. J., Makynen, E. A., Cavallin, J. E., Martinovic-Weigelt, D., Perkins, E. J., &amp; Villeneuve, D. L. (2017). Rapid effects of the aromatase inhibitor fadrozole on steroid production and gene expression in the ovary of female fathead minnows (Pimephales promelas).&nbsp;General and comparative endocrinology,&nbsp;252, 79&ndash;87.&nbsp;</p>\n\n<p>Thornton J. W. (2001). Evolution of vertebrate steroid receptors from an ancestral estrogen receptor by ligand exploitation and serial genome expansions.&nbsp;Proceedings of the National Academy of Sciences of the United States of America,&nbsp;98(10), 5671&ndash;5676.&nbsp;</p>\n\n<p>Warner, D. A., Addis, E., Du, W. G., Wibbels, T., &amp; Janzen, F. J. (2014). Exogenous application of estradiol to eggs unexpectedly induces male development in two turtle species with temperature-dependent sex determination.&nbsp;<em>General and comparative endocrinology</em>,&nbsp;<em>206</em>, 16&ndash;23.&nbsp;</p>\n\n<p>Yin, Y., Tang, H., Liu, Y., Chen, Y., Li, G., Liu, X., &amp; Lin, H. (2017). Targeted Disruption of Aromatase Reveals Dual Functions of cyp19a1a During Sex Differentiation in Zebrafish.&nbsp;<em>Endocrinology</em>,&nbsp;<em>158</em>(9), 3030&ndash;3041.&nbsp;</p>\n","biologicalOrganisationLevel":"Cellular","organTerm":{"name":"gonad","sourceId":"UBERON:0000991"},"biologicalEvents":[{"action":"decreased","process":"estrogen biosynthetic process","object":{"name":"17beta-estradiol","source":"CHEBI","sourceId":"CHEBI:16469"}}],"id":1789}
{"title":"Increased, Differentiation to Testis ","references":"<p>Capel, Blanche. (2017). Vertebrate sex determination: Evolutionary plasticity of a fundamental switch. Nature Reviews Genetics. 18. 10.1038/nrg.2017.60.&nbsp;</p>\n\n<p>Cutting, A., Chue, J., &amp; Smith, C. A. (2013). Just how conserved is vertebrate sex determination?.&nbsp;Developmental dynamics : an official publication of the American Association of Anatomists,&nbsp;242(4), 380&ndash;387.&nbsp;</p>\n\n<p>&nbsp;DeFalco T, Capel B. Gonad morphogenesis in vertebrates: divergent means to a convergent end.&nbsp;Annu Rev Cell Dev Biol. 2009;25:457-482. doi:10.1146/annurev.cellbio.042308.13350</p>\n\n<p>Marshall Graves, J. A., &amp; Peichel, C. L. (2010). Are homologies in vertebrate sex determination due to shared ancestry or to limited options?.&nbsp;Genome biology,&nbsp;11(4), 205. https://doi.org/10.1186/gb-2010-11-4-205</p>\n\n<p>McLaren A. (1998). Gonad development: assembling the mammalian testis.&nbsp;<em>Current biology : CB</em>,&nbsp;<em>8</em>(5), R175&ndash;R177. https://doi.org/10.1016/s0960-9822(98)70104-6</p>\n\n<p>Nishimura, T., &amp; Tanaka, M. (2014). Gonadal development in fish.&nbsp;<em>Sexual development : genetics, molecular biology, evolution, endocrinology, embryology, and pathology of sex determination and differentiation</em>,&nbsp;<em>8</em>(5), 252&ndash;261.&nbsp;</p>\n\n<p>Santos, D., Luzio, A., &amp; Coimbra, A. M. (2017). Zebrafish sex differentiation and gonad development: A review on the impact of environmental factors.&nbsp;<em>Aquatic toxicology (Amsterdam, Netherlands)</em>,&nbsp;<em>191</em>, 141&ndash;163.&nbsp;</p>\n\n<p>Trukhina, A. V., Lukina, N. A., Wackerow-Kouzova, N. D., &amp; Smirnov, A. F. (2013). The variety of vertebrate mechanisms of sex determination.&nbsp;BioMed research international,&nbsp;2013, 587460. https://doi.org/10.1155/2013/587460</p>\n","biologicalOrganisationLevel":"Tissue","organTerm":{"name":"testis","sourceId":"UBERON:0000473"},"biologicalEvents":[{"action":"increased","process":"male gonad development","object":{"name":"immature gonad","source":"UBERON","sourceId":"UBERON:2005272"}}],"id":1790}
{"title":"Increased, Male Biased Sex Ratio","references":"<p>Brown, A. R., Owen, S. F., Peters, J., Zhang, Y., Soffker, M., Paull, G. C., Hosken, D. J., Wahab, M. A., &amp; Tyler, C. R. (2015). Climate change and pollution speed declines in zebrafish populations.&nbsp;<em>Proceedings of the National Academy of Sciences of the United States of America</em>,&nbsp;<em>112</em>(11), E1237&ndash;E1246.&nbsp;</p>\n\n<p>Canesini, G.; Ramos, J.G.; Mu&ntilde;oz de Toro, Monica, M.(2018) Determinaci&oacute;n sexual y diferenciaci&oacute;n gonadal en Yacar&eacute; overo. Genes involucrados en su regulaci&oacute;n y efecto de la exposici&oacute;n a perturbadores endocrinos. (Unpublished Doctoral Thesis). Universidad Nacional Del Litoral</p>\n\n<p>Ospina-Alvarez, N., &amp; Piferrer, F. (2008). Temperature-dependent sex determination in fish revisited: prevalence, a single sex ratio response pattern, and possible effects of climate change.&nbsp;<em>PloS one</em>,&nbsp;<em>3</em>(7), e2837.&nbsp;</p>\n\n<p>Stewart, K. R., &amp; Dutton, P. H. (2014). Breeding sex ratios in adult leatherback turtles (Dermochelys coriacea) may compensate for female-biased hatchling sex ratios.&nbsp;<em>PloS one</em>,&nbsp;<em>9</em>(2), e88138. https://doi.org/10.1371/journal.pone.0088138</p>\n","biologicalOrganisationLevel":"Population","organTerm":{},"biologicalEvents":[{"action":"increased","process":"male sex differentiation","object":{"name":"population of organisms","source":"PCO","sourceId":"PCO:0000001"}}],"id":1791}
{"title":"Toll-like receptor 4 activation","references":"","biologicalOrganisationLevel":"Molecular","organTerm":{},"biologicalEvents":[{"object":{}}],"id":1792}
{"title":"Activator protein 1 activation","references":"","biologicalOrganisationLevel":"Cellular","organTerm":{},"biologicalEvents":[{"object":{}}],"id":1793}
{"title":"Pin-1 activation","references":"","biologicalOrganisationLevel":"Cellular","organTerm":{},"biologicalEvents":[{"object":{}}],"id":1794}
{"title":"Latent Transforming growth Factor beta expression","references":"","biologicalOrganisationLevel":"Cellular","organTerm":{},"biologicalEvents":[{"object":{}}],"id":1795}
{"title":"Inhibition of 11-HSD ","references":"","biologicalOrganisationLevel":"Molecular","organTerm":{},"biologicalEvents":[{"object":{}}],"id":1799}
{"title":"11-hydroxylase inhibition","references":"","biologicalOrganisationLevel":"Molecular","organTerm":{},"biologicalEvents":[{"object":{}}],"id":1796}
{"title":"Decreased spermatogenesis ","references":"","biologicalOrganisationLevel":"Organ","organTerm":{},"biologicalEvents":[{"object":{}}],"id":1798}
{"title":"Cortisol and 11-(OH) testosterone decreased","references":"","biologicalOrganisationLevel":"Cellular","organTerm":{},"biologicalEvents":[{"object":{}}],"id":1835}
{"title":"Decreased plasma Cortisol level","references":"","biologicalOrganisationLevel":"Tissue","organTerm":{},"biologicalEvents":[{"object":{}}],"id":1836}
{"title":"decreased oocyte maturation","references":"","biologicalOrganisationLevel":"Organ","organTerm":{},"biologicalEvents":[{"object":{}}],"id":1837}
{"title":"Increase, Chitinase inhibition","references":"","biologicalOrganisationLevel":"Molecular","organTerm":{},"biologicalEvents":[{"object":{}}],"id":1806}
{"title":"Decrease, Digestion of old cuticle","references":"","biologicalOrganisationLevel":"Organ","organTerm":{},"biologicalEvents":[{"object":{}}],"id":996}
{"title":"Increase, Chitobiase inhibition","references":"","biologicalOrganisationLevel":"Molecular","organTerm":{},"biologicalEvents":[{"object":{}}],"id":1807}
{"title":"benzoquinone imine and acylglucuronide metabolites","references":"","biologicalOrganisationLevel":"Molecular","organTerm":{},"biologicalEvents":[{"object":{}}],"id":1814}
{"title":"Mitochondrial dysfunction","references":"","biologicalOrganisationLevel":"Cellular","organTerm":{},"biologicalEvents":[{"object":{}}],"id":1816}
{"title":"Apoptotic cell death","references":"","biologicalOrganisationLevel":"Cellular","organTerm":{},"biologicalEvents":[{"object":{}}],"id":1817}
{"title":"Immune cell activation","references":"","biologicalOrganisationLevel":"Cellular","organTerm":{},"biologicalEvents":[{"object":{}}],"id":1818}
{"title":"IFN signaling","references":"","biologicalOrganisationLevel":"Cellular","organTerm":{},"biologicalEvents":[{"object":{}}],"id":1819}
{"title":"Increase in inflammation","references":"","biologicalOrganisationLevel":"Tissue","organTerm":{},"biologicalEvents":[{"object":{}}],"id":1633}
{"title":"Immune mediated hepatitis","references":"","biologicalOrganisationLevel":"Organ","organTerm":{},"biologicalEvents":[{"object":{}}],"id":1820}
{"title":"Activation of ER stress","references":"","biologicalOrganisationLevel":"Cellular","organTerm":{},"biologicalEvents":[{"object":{}}],"id":1815}
{"title":"Altered, retinal layer structure","references":"<ul>\n\t<li dir=\"ltr\">\n\t<p dir=\"ltr\"><strong>W&auml;ssle, H., Riemann, H.J., 1978. The mosaic of nerve cells in the mammalian retina. Proc. R. Soc. London B Biol. Sci. 200, 441&ndash;461.</strong></p>\n\t</li>\n\t<li dir=\"ltr\">\n\t<p dir=\"ltr\"><strong>Cameron, D.A., Carney, L.H., 2000. Cell mosaic patterns in the native and regenerated inner retina of zebrafish: implications for retinal assembly. J. Comp. Neurol. 416, 356&ndash;367.</strong></p>\n\t</li>\n\t<li dir=\"ltr\">\n\t<p dir=\"ltr\"><strong>Rockhill, R.L., Euler, T., Masland, R.H., 2000. Spatial order within but not between types of retinal neurons. Proc. Natl. Acad. Sci. USA 97, 2303&ndash;2307.</strong></p>\n\t</li>\n\t<li dir=\"ltr\">\n\t<p dir=\"ltr\"><strong>Fadool, J.M., 2003. Development of a rod photoreceptor mosaic revealed in transgenic zebrafish. Dev. Biol. 258, 277&ndash;290.</strong></p>\n\t</li>\n\t<li dir=\"ltr\">\n\t<p dir=\"ltr\"><strong>Gestri, G., Link, B. A., &amp; Neuhauss, S. C. (2012). The visual system of zebrafish and its use to model&nbsp;</strong></p>\n\t</li>\n\t<li dir=\"ltr\">\n\t<p dir=\"ltr\"><strong>Suzuki SC, Bleckert A, Williams PR, Takechi M, Kawamura S, Wong ROL. Cone photoreceptor types in zebrafish are generated by symmetric terminal divisions of dedicated precursors. Proc Natl Acad Sci U S A. 2013;110(37):15109-15114. doi:10.1073/pnas.1303551110</strong></p>\n\t</li>\n\t<li dir=\"ltr\">\n\t<p dir=\"ltr\"><strong>Strauss O. The retinal pigment epithelium in visual function. Physiol Rev. 2005 Jul;85(3):845-81. doi: 10.1152/physrev.00021.2004. PMID: 15987797.</strong></p>\n\t</li>\n\t<li dir=\"ltr\">\n\t<p dir=\"ltr\"><strong>Plafker SM, O&#39;Mealey GB, Szweda LI. Mechanisms for countering oxidative stress and damage in retinal pigment epithelium. Int Rev Cell Mol Biol. 2012;298:135-77. doi: 10.1016/B978-0-12-394309-5.00004-3. PMID: 22878106; PMCID: PMC3564215.</strong></p>\n\t</li>\n\t<li dir=\"ltr\">\n\t<p dir=\"ltr\"><strong>Ali S, Champagne DL, Richardson MK. Behavioral profiling of zebrafish embryos exposed to a panel of 60 water-soluble compounds. Behav Brain Res. 2012;228(2):272-283. doi:10.1016/j.bbr.2011.11.020</strong></p>\n\t</li>\n\t<li dir=\"ltr\">\n\t<p dir=\"ltr\"><strong>Bibliowicz J, Tittle RK, Gross JM. Toward a Better Understanding of Human Eye Disease: Insights from the Zebrafish, Danio Rerio. Vol 100.; 2011. doi:10.1016/B978-0-12-384878-9.00007-8</strong></p>\n\t</li>\n\t<li dir=\"ltr\">\n\t<p dir=\"ltr\"><strong>Lister JA. Development of pigment cells in the zebrafish embryo. Microsc Res Tech. 2002;58(6):435-441. doi:10.1002/jemt.10161</strong></p>\n\t</li>\n</ul>\n","biologicalOrganisationLevel":"Tissue","organTerm":{},"biologicalEvents":[{"object":{}}],"id":1877}
{"title":"Decreased, Eye size","references":"<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\">Baumann, L., Ros, A., Rehberger, K., Neuhauss, S.C.F., Segner, H., 2016. Thyroid disruption in zebrafish (Danio rerio) larvae: Different molecular response patterns lead to impaired eye development and visual functions. Aquat. Toxicol. 172, 44&ndash;55. https://doi.org/10.1016/j.aquatox.2015.12.015</span></span></p>\n\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\">Bejarano-Escobar, R., Blasco, M., DeGrip, W.J., Oyola-Velasco, J.A., Mart&iacute;n-Partido, G., Francisco-Morcillo, J., 2010. Eye development and retinal differentiation in an altricial fish species, the senegalese sole (Solea senegalensis, Kaup 1858). J. Exp. Zool. Part B Mol. Dev. Evol. 314 B, 580&ndash;605. https://doi.org/10.1002/jez.b.21363</span></span></p>\n\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\">Brooke, M.D.L., Hanley, S., Laughlin, S.B., 1999. The scaling of eye size with body mass in birds. Proc. R. Soc. B Biol. Sci. 266, 405&ndash;412. https://doi.org/10.1098/rspb.1999.0652</span></span></p>\n\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\">Caves, E.M., Sutton, T.T., Johnsen, S., 2017. Visual acuity in ray-finned fishes correlates with eye size and habitat. J. Exp. Biol. 220, 1586&ndash;1596. https://doi.org/10.1242/jeb.151183</span></span></p>\n\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\">Chawla, B., Swain, W., Williams, A.L., Bohnsack, B.L., 2018. Retinoic acid maintains function of neural crest&ndash;derived ocular and craniofacial structures in adult zebrafish. Investig. Ophthalmol. Vis. Sci. 59, 1924&ndash;1935. https://doi.org/10.1167/iovs.17-22845</span></span></p>\n\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\">Corral-L&oacute;pez, A., Garate-Olaizola, M., Buechel, S.D., Kolm, N., Kotrschal, A., 2017. On the role of body size, brain size, and eye size in visual acuity. Behav. Ecol. Sociobiol. 71. https://doi.org/10.1007/s00265-017-2408-z</span></span></p>\n\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\">Hall, M.I., 2008. Comparative analysis of the size and shape of the lizard eye. Zoology 111, 62&ndash;75. https://doi.org/10.1016/j.zool.2007.04.003</span></span></p>\n\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\">Kang, P., Wildsoet, C.F., 2016. Acute and short-term changes in visual function with multifocal soft contact lens wear in young adults. Contact Lens Anterior Eye 39, 133&ndash;140. https://doi.org/10.1016/j.clae.2015.09.004</span></span></p>\n\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\">Karvonen, A., Sepp&auml;l&auml;, O., 2008. Eye fluke infection and lens size reduction in fish: A quantitative analysis. Dis. Aquat. Organ. 80, 21&ndash;26. https://doi.org/10.3354/dao01918</span></span></p>\n\n<p><span style=\"font-size:11.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Kashyap, B., Frederickson, L.C., &amp; Stenkamp, D.L., 2008. Mechanisms for persistent microphthalmia following ethanol exposure during retinal neurogenesis in zebrafish embryos. Vis. Neurosci. 24(3), 409&ndash;421. https://doi.org/10.1017/S0952523807070423</span></span></p>\n\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\">Kirk, E.C., 2006. Effects of activity pattern on eye size and orbital aperture size in primates. J. Hum. Evol. 51, 159&ndash;170. https://doi.org/10.1016/j.jhevol.2006.02.004</span></span></p>\n\n<p><span style=\"font-size:11.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Le, H.G., Dowling, J.E., &amp; Cameron, D.J., 2012. Early retinoic acid deprivation in developing zebrafish results in microphthalmia. Vis. Neurosci</span></span>.<span style=\"font-size:11.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> 29(4&ndash;5), 219&ndash;228. https://doi.org/10.1017/S0952523812000296</span></span></p>\n\n<p><span style=\"font-size:11.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Marsh-Armstrong, N., Mccaffery, P., Gilbert, W., Dowling, J.E., &amp; Dr&auml;ger, U.C., 1994. Retinoic acid is necessary for development of the ventral retina in zebrafish.</span></span><span style=\"font-size:11.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Proc. Natl. Acad. Sci. U S A</span></span><span style=\"font-size:11.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">. <em>91</em>(15), 7286&ndash;7290. https://doi.org/10.1073/pnas.91.15.7286</span></span></p>\n\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\">Ross, C.F., Kirk, E.C., 2007. Evolution of eye size and shape in primates. J. Hum. Evol. 52, 294&ndash;313. https://doi.org/10.1016/j.jhevol.2006.09.006</span></span></p>\n\n<p><span style=\"font-size:11.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Stenkamp, D.L., Frey, R.A., Mallory, D.E., &amp; Shupe, E.E., 2002. Embryonic Retinal Gene Expression in Sonic-You Mutant Zebrafish. Dev. Dyn., 225, 344&ndash;350. https://doi.org/10.1002/dvdy.10165</span></span></p>\n\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\">Svanb&auml;ck, R., Johansson, F., 2019. Predation selects for smaller eye size in a vertebrate: Effects of environmental conditions and sex. Proc. R. Soc. B Biol. Sci. 286. https://doi.org/10.1098/rspb.2018.2625</span></span></p>\n\n<p><span style=\"font-size:11.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Wold, M., Beckmann, M., Poitra, S., Espinoza, A., Longie, R., Mersereau, E., Darland, D.C., Darland, T., 2017. The longitudinal effects of early developmental cadmium exposure on conditioned place preference and cardiovascular physiology in zebrafish. Aquat. Toxicol. 191, 73&ndash;84. https://doi.org/10.1016/j.aquatox.2017.07.017</span></span></p>\n","biologicalOrganisationLevel":"Organ","organTerm":{"name":"eye","sourceId":"UBERON:0000970"},"biologicalEvents":[{"action":"decreased","process":"microphthalmia","object":{"name":"eye","source":"UBERON","sourceId":"UBERON:0000970"}}],"keyEventStressors":["Ethanol","Citral","Diethylaminobenzaldehyde"],"id":1878}
{"title":"Displacement, Serum thyroxine (T4) from carrier protein","references":"","biologicalOrganisationLevel":"Molecular","organTerm":{},"biologicalEvents":[{"object":{}}],"id":1830}
{"title":"Binding, Thyroid binding globulin in serum","references":"","biologicalOrganisationLevel":"Molecular","organTerm":{},"biologicalEvents":[{"object":{}}],"id":1831}
{"title":"Inhibition, cytochrome oxidase","references":"","biologicalOrganisationLevel":"Molecular","organTerm":{},"biologicalEvents":[{"object":{}}],"id":1840}
{"title":"Testicular Cancer","references":"","biologicalOrganisationLevel":"Organ","organTerm":{},"biologicalEvents":[{"object":{}}],"id":1839}
{"title":"Encephalitis","references":"<p><span style=\"font-size:11pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Bohmwald K, et al. Neurologic Alterations Due to Respiratory Virus Infections. Front Cell Neurosci. 2018 Oct 26;12:386.</span></span></p>\n\n<p><span style=\"font-size:11pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Das G, et al. Neurological Insights of COVID-19 Pandemic. ACS Chem Neurosci. 2020 May 6; 11(9):1206-1209.</span></span></p>\n\n<p><span style=\"font-size:11pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Efe et al. COVID-19-Associated Encephalitis Mimicking Glial Tumor. World Neurosurg. 2020 Aug; 140: 46&ndash;48.</span></span></p>\n\n<p><span style=\"font-size:11pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ellul M., Solomon T. Acute encephalitis - diagnosis and management. Clin. Med. (Lond) 2018;18(2):155&ndash;159.</span></span></p>\n\n<p><span style=\"font-size:11pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Encephalitis, available at: <a href=\"https://www.columbianeurology.org/neurology/staywell/encephalitis\" style=\"color:blue; text-decoration:underline\">https://www.columbianeurology.org/neurology/staywell/encephalitis</a> </span></span></p>\n\n<p><span style=\"font-size:11pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Esp&iacute;ndola OM et al. Patients with COVID-19 and neurological manifestations show undetectable SARS-CoV-2 RNA levels in the cerebrospinal fluid. Int J Infect Dis. 2020 Jul;96:567-569.</span></span></p>\n\n<p><span style=\"font-size:11pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Gu J, et al. Multiple organ infection and the pathogenesis of SARS. J Exp Med. 2005;202:415&ndash;424.</span></span></p>\n\n<p><span style=\"font-size:11pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Guilmot A, et al. Immune-mediated neurological syndromes in SARS-CoV-2-infected patients. J Neurol. 2020 Jul 30;1-7.</span></span></p>\n\n<p><span style=\"font-size:11pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Iaconetta G et al. Meningoencephalitis Associated with SARS-Coronavirus-2. Transl Med UniSa. 2020 Dec 31;23:42-47.</span></span></p>\n\n<p><span style=\"font-size:11pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Johnson S. What is encephalitis? Healthline, 2018 available at <a href=\"https://www.healthline.com/health/encephalitis\" style=\"color:blue; text-decoration:underline\">https://www.healthline.com/health/encephalitis</a> </span></span></p>\n\n<p><span style=\"font-size:11pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Koralnik et al. COVID-19: A Global Threat to the Nervous System. Ann Neurol. 2020 Jul;88(1):1-11.</span></span></p>\n\n<p><span style=\"font-size:11pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Mayo Clinic, Encephalitis. 2021, available at <a href=\"https://www.mayoclinic.org/diseases-conditions/encephalitis/symptoms-causes/syc-20356136\" style=\"color:blue; text-decoration:underline\">https://www.mayoclinic.org/diseases-conditions/encephalitis/symptoms-causes/syc-20356136</a> </span></span></p>\n\n<p><span style=\"font-size:11pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Moriguchi T et al. A first case of meningitis/encephalitis associated with SARS-Coronavirus-2. Int J Infect Dis. 2020;94:55&ndash;58.</span></span></p>\n\n<p><span style=\"font-size:11pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Najjar et al. Central nervous system complications associated with SARS-CoV-2 infection: integrative concepts of pathophysiology and case reports. J Neuroinflammation. 2020 Aug 6;17(1):231.</span></span></p>\n\n<p><span style=\"font-size:11pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Pilotto A et al. Steroid-Responsive Encephalitis in Coronavirus Disease 2019. Ann Neurol. 2020 Aug;88(2):423-427.</span></span></p>\n\n<p><span style=\"font-size:11pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Shindler KS, et al. Experimental optic neuritis induced by a demyelinating strain of mouse hepatitis virus. J Virol. 2008 Sep; 82(17):8882-6.</span></span></p>\n\n<p><span style=\"font-size:11pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Tsai L.-K., et al. Neurological manifestations in severe acute respiratory syndrome. Acta Neurol Taiwanica. 2005;14:113&ndash;119</span></span></p>\n\n<p><span style=\"font-size:11pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Wu J. and Tang Y. Revisiting the Immune Balance Theory: A Neurological Insight Into the Epidemic of COVID-19 and Its Alike. Front Neurol. 2020 Oct 15;11:566680.</span></span></p>\n\n<p><span style=\"font-size:11pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Xiang P., et al. First case of 2019 novel coronavirus disease with Encephalitis. ChinaXiv. 2020;T202003:00015.</span></span></p>\n\n<p><span style=\"font-size:11pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ye M., et al. Encephalitis as a clinical manifestation of COVID-19. Brain, Behavior, and Immunity. 2020 S0889159120304657.</span></span></p>\n","biologicalOrganisationLevel":"Organ","organTerm":{"name":"brain","sourceId":"UBERON:0000955"},"biologicalEvents":[{"object":{}}],"keyEventStressors":["SARS-CoV","Sars-CoV-2","Virus","bacteria","fungi"],"id":1841}
{"title":"Prolonged TLR9 activation","references":"","biologicalOrganisationLevel":"Molecular","organTerm":{},"biologicalEvents":[{"object":{}}],"id":1842}
{"title":"Acute Respiratory Distress Syndrome and Multiple Organ Dysfunction","references":"","biologicalOrganisationLevel":"Individual","organTerm":{},"biologicalEvents":[{"object":{}}],"id":1843}
{"title":"systemic inflammatory response syndrome","references":"","biologicalOrganisationLevel":"Individual","organTerm":{},"biologicalEvents":[{"object":{}}],"id":1844}
{"title":"Coagulation","references":"<ol>\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:9.0pt\"><span style=\"background-color:white\"><span style=\"color:#222222\">Bernard I, Limonta D, Mahal LK, Hobman TC. Endothelium Infection and Dysregulation by SARS-CoV-2: Evidence and Caveats in COVID-19. <em>Viruses</em>. 2021; 13(1):29. DOI: </span></span></span><a href=\"https://doi.org/10.3390/v13010029\"><span style=\"font-size:9.0pt\"><span style=\"background-color:white\"><span style=\"color:#1155cc\">https://doi.org/10.3390/v13010029</span></span></span></a></span></span></li>\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:9.0pt\"><span style=\"background-color:white\"><span style=\"color:#222222\">Garvin et al. A mechanistic model and therapeutic interventions for COVID-19 involving a RAS-mediated bradykinin storm. <em>eLife</em> 2020;9:e59177. DOI: </span></span></span><a href=\"https://doi.org/10.7554/eLife.59177\"><span style=\"font-size:9.0pt\"><span style=\"background-color:white\"><span style=\"color:#1155cc\">https://doi.org/10.7554/eLife.59177</span></span></span></a></span></span></li>\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:9.0pt\"><span style=\"background-color:white\"><span style=\"color:#222222\">Di Nisio, Marcello et al. Interleukin-6 receptor blockade with subcutaneous tocilizumab improves coagulation activity in patients with COVID-19 European Journal of Internal Medicine, Volume 83, 34 - 38 DOI: </span></span></span><a href=\"https://doi.org/10.1016/j.ejim.2020.10.020\"><span style=\"font-size:9.0pt\"><span style=\"background-color:white\"><span style=\"color:#1155cc\">https://doi.org/10.1016/j.ejim.2020.10.020</span></span></span></a></span></span></li>\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:9.0pt\"><span style=\"background-color:white\"><span style=\"color:#222222\">Ekstrand-Hammarstr&ouml;m, B.; Hong, J.; Davoodpour, P.; Sandholm, K.; Ekdahl, K.N.; Bucht, A., Nilsson, B. TiO2 nanoparticles tested in a novel screening whole human blood model of toxicity trigger adverse activation of the kallikrein system at low concentrations. </span></span></span><span style=\"font-size:9.0pt\"><span style=\"background-color:white\"><span style=\"color:#222222\">Biomaterials 2015, 51, 58-68 DOI:</span></span></span><a href=\"https://doi.org/10.1016/j.biomaterials.2015.01.031\"><span style=\"font-size:9.0pt\"><span style=\"background-color:white\"><span style=\"color:#1155cc\">https://doi.org/10.1016/j.biomaterials.2015.01.031</span></span></span></a></span></span></li>\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:9.0pt\"><span style=\"background-color:white\"><span style=\"color:#222222\">Ekdahl, K.N.; Davoodpour, P.; Ekstrand-Hammarstr&ouml;m, B.; Fromell, K.; Hamad, O.A.; Hong, J.; Bucht, A.; Mohlin, C.; Seisenbaeva, G.A.; Kessler, V.G., Nilsson, B. Contact (kallikrein/kinin) system activation in whole human blood induced by low concentrations of &alpha;-Fe2O3 nanoparticles. Nanomedicine: Nanotechnology, Biology and Medicine 2018, 14, 735-744 [DOI: </span></span></span><a href=\"https://doi.org/10.1016/j.nano.2017.12.008\"><span style=\"font-size:9.0pt\"><span style=\"background-color:white\"><span style=\"color:#1155cc\">https://doi.org/10.1016/j.nano.2017.12.008</span></span></span></a><span style=\"font-size:9.0pt\"><span style=\"background-color:white\"><span style=\"color:#222222\">]</span></span></span></span></span></li>\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:9.0pt\"><span style=\"background-color:white\"><span style=\"color:#222222\">Kristina N Ekdahl, Karin Fromell, Camilla Mohlin, Yuji Teramura &amp; Bo Nilsson (2019) A human whole-blood model to study the activation of innate immunity system triggered by nanoparticles as a demonstrator for toxicity, Science and Technology of Advanced Materials, 20:1, 688-698, DOI: 10.1080/14686996.2019.1625721</span></span></span></span></span></li>\n</ol>\n","biologicalOrganisationLevel":"Cellular","organTerm":{"name":"blood plasma","sourceId":"UBERON:0001969"},"biologicalEvents":[{"object":{}}],"keyEventStressors":["Sars-CoV-2"],"id":1845}
{"title":"Thrombosis and Disseminated Intravascular Coagulation","references":"<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"color:#444444\">Hemostasis and Thrombosis Basic Principles and Clinical Practices Robert W Colman, Jack Hirsh, Victor J. Marder, Edwin W. Salzman (ed) Philadelphia, 1994.</span></span></span></span></span></p>\n\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"color:#444444\">Schwartzman RJ, Hill JB: Neurologic complications of DIC. Neurology 32:791, 1982</span></span></span></span></span></p>\n\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"color:#444444\">Robboy SJ, Minna JD, Colman RW et.al. Pulmonary hemorrhage syndrome as a manifestation of DIC: Analysis of 10 cases. Chest 63:718, 1973.</span></span></span></span></span></p>\n\n<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"color:#444444\">Stahl RL, Javid JP, Lackner H: Unrecognized pulmonary embolism presenting as DIC. SM J Med 76:772, 1984.</span></span></span></p>\n","biologicalOrganisationLevel":"Organ","organTerm":{"name":"blood","sourceId":"UBERON:0000178"},"biologicalEvents":[{"action":"increased","process":"Venous thrombosis","object":{"name":"platelet","source":"CL","sourceId":"CL:0000233"}}],"keyEventStressors":["Sars-CoV-2"],"id":1846}
{"title":"Oxidative stress response","references":"<p><span style=\"font-family:Arial,Helvetica,sans-serif\"><span style=\"font-size:16px\"><span style=\"background-color:white\"><span style=\"color:#212121\">1. Hassan SM, Jawad MJ, Ahjel SW, Singh RB, Singh J, Awad SM, Hadi NR. The Nrf2 Activator (DMF) and Covid-19: Is there a Possible Role? <em>Med Arch.</em> 2020 Apr;74(2):134-138. doi: 10.5455/medarh.2020.74.134-138. PMID: 32577056; PMCID: PMC7296400.</span></span></span></span></p>\n\n<p><span style=\"font-family:Arial,Helvetica,sans-serif\"><span style=\"font-size:16px\"><span style=\"background-color:white\"><span style=\"color:#222222\">2. Timpani CA, Rybalka E. Calming the (Cytokine) Storm: Dimethyl Fumarate as a Therapeutic Candidate for COVID-19.&nbsp;<em>Pharmaceuticals</em>. 2021; 14(1):15. </span></span><a href=\"https://doi.org/10.3390/ph14010015\" style=\"color:blue; text-decoration:underline\"><span style=\"background-color:white\">https://doi.org/10.3390/ph14010015</span></a></span></span></p>\n\n<p><span style=\"font-family:Arial,Helvetica,sans-serif\"><span style=\"font-size:16px\">3. Chepelev, N.L.; Kennedy, D.A.; Gagn&eacute;, R.; White, T.; Long, A.S.; Yauk, C.L., White, P.A. HPLC Measurement of the DNA Oxidation Biomarker, 8-oxo-7,8-dihydro-2&#39;-deoxyguanosine, in Cultured Cells and Animal Tissues. <em>J Vis Exp</em> <strong>2015</strong>, e52697-e52697 [PMID: 26273842 DOI: 10.3791/52697]</span></span></p>\n\n<p><span style=\"font-family:Arial,Helvetica,sans-serif\"><span style=\"font-size:16px\">4. Jackson, A.F.; Williams, A.; Recio, L.; Waters, M.D.; Lambert, I.B., Yauk, C.L. Case study on the utility of hepatic global gene expression profiling in the risk assessment of the carcinogen furan. <em>Toxicol Appl Pharmacol</em> <strong>2014</strong>, <em>274</em>, 63-77 [PMID: 24183702 DOI: 10.1016/j.taap.2013.10.019]</span></span></p>\n\n<p><span style=\"font-family:Arial,Helvetica,sans-serif\"><span style=\"font-size:16px\">5. Lee, D. Y., Kang, S., Lee, Y., Kim, J. Y., Yoo, D., Jung, W., . . . Jon, S. (2020). PEGylated Bilirubin-coated Iron Oxide Nanoparticles as a Biosensor for Magnetic Relaxation Switching-based ROS Detection in Whole Blood. Theranostics, 10(5), 1997-2007. doi:10.7150/thno.39662</span></span></p>\n\n<p><span style=\"font-family:Arial,Helvetica,sans-serif\"><span style=\"font-size:16px\">6. Ashoka, A. H., Ali, F., Tiwari, R., Kumari, R., Pramanik, S. K., &amp; Das, A. (2020). Recent Advances in Fluorescent Probes for Detection of HOCl and HNO.&nbsp;<em>ACS omega, 5</em>(4), 1730-1742. doi:10.1021/acsomega.9b03420</span></span></p>\n","biologicalOrganisationLevel":"Cellular","organTerm":{"name":"organ","sourceId":"UBERON:0000062"},"biologicalEvents":[{"action":"increased","process":"cellular response to oxidative stress","object":{"name":"reactive oxygen species","source":"CHEBI","sourceId":"CHEBI:26523"}},{"action":"increased","process":"response to reactive oxygen species","object":{"name":"reactive oxygen species","source":"CHEBI","sourceId":"CHEBI:26523"}}],"keyEventStressors":["Stressor:624 SARS-CoV-2"],"id":1869}
{"title":"Oxidative stress response","references":"<p><span style=\"font-family:Arial,Helvetica,sans-serif\"><span style=\"font-size:16px\"><span style=\"background-color:white\"><span style=\"color:#212121\">1. Hassan SM, Jawad MJ, Ahjel SW, Singh RB, Singh J, Awad SM, Hadi NR. The Nrf2 Activator (DMF) and Covid-19: Is there a Possible Role? <em>Med Arch.</em> 2020 Apr;74(2):134-138. doi: 10.5455/medarh.2020.74.134-138. PMID: 32577056; PMCID: PMC7296400.</span></span></span></span></p>\n\n<p><span style=\"font-family:Arial,Helvetica,sans-serif\"><span style=\"font-size:16px\"><span style=\"background-color:white\"><span style=\"color:#222222\">2. Timpani CA, Rybalka E. Calming the (Cytokine) Storm: Dimethyl Fumarate as a Therapeutic Candidate for COVID-19.&nbsp;<em>Pharmaceuticals</em>. 2021; 14(1):15. </span></span><a href=\"https://doi.org/10.3390/ph14010015\" style=\"color:blue; text-decoration:underline\"><span style=\"background-color:white\">https://doi.org/10.3390/ph14010015</span></a></span></span></p>\n\n<p><span style=\"font-family:Arial,Helvetica,sans-serif\"><span style=\"font-size:16px\">3. Chepelev, N.L.; Kennedy, D.A.; Gagn&eacute;, R.; White, T.; Long, A.S.; Yauk, C.L., White, P.A. HPLC Measurement of the DNA Oxidation Biomarker, 8-oxo-7,8-dihydro-2&#39;-deoxyguanosine, in Cultured Cells and Animal Tissues. <em>J Vis Exp</em> <strong>2015</strong>, e52697-e52697 [PMID: 26273842 DOI: 10.3791/52697]</span></span></p>\n\n<p><span style=\"font-family:Arial,Helvetica,sans-serif\"><span style=\"font-size:16px\">4. Jackson, A.F.; Williams, A.; Recio, L.; Waters, M.D.; Lambert, I.B., Yauk, C.L. Case study on the utility of hepatic global gene expression profiling in the risk assessment of the carcinogen furan. <em>Toxicol Appl Pharmacol</em> <strong>2014</strong>, <em>274</em>, 63-77 [PMID: 24183702 DOI: 10.1016/j.taap.2013.10.019]</span></span></p>\n\n<p><span style=\"font-family:Arial,Helvetica,sans-serif\"><span style=\"font-size:16px\">5. Lee, D. Y., Kang, S., Lee, Y., Kim, J. Y., Yoo, D., Jung, W., . . . Jon, S. (2020). PEGylated Bilirubin-coated Iron Oxide Nanoparticles as a Biosensor for Magnetic Relaxation Switching-based ROS Detection in Whole Blood. Theranostics, 10(5), 1997-2007. doi:10.7150/thno.39662</span></span></p>\n\n<p><span style=\"font-family:Arial,Helvetica,sans-serif\"><span style=\"font-size:16px\">6. Ashoka, A. H., Ali, F., Tiwari, R., Kumari, R., Pramanik, S. K., &amp; Das, A. (2020). Recent Advances in Fluorescent Probes for Detection of HOCl and HNO.&nbsp;<em>ACS omega, 5</em>(4), 1730-1742. doi:10.1021/acsomega.9b03420</span></span></p>\n","biologicalOrganisationLevel":"Cellular","organTerm":{"name":"organ","sourceId":"UBERON:0000062"},"biologicalEvents":[{"action":"increased","process":"cellular response to oxidative stress","object":{"name":"reactive oxygen species","source":"CHEBI","sourceId":"CHEBI:26523"}},{"action":"increased","process":"response to reactive oxygen species","object":{"name":"reactive oxygen species","source":"CHEBI","sourceId":"CHEBI:26523"}}],"keyEventStressors":["Stressor:624 SARS-CoV-2"],"id":1869}
{"title":"Impaired gustatory nerve","references":"","biologicalOrganisationLevel":"Tissue","organTerm":{},"biologicalEvents":[{"object":{}}],"id":1849}
{"title":"dysgeusia","references":"","biologicalOrganisationLevel":"Organ","organTerm":{},"biologicalEvents":[{"object":{}}],"id":1850}
{"title":"Downregulation, ACE2","references":"","biologicalOrganisationLevel":"Cellular","organTerm":{},"biologicalEvents":[{"object":{}}],"id":1787}
{"title":"Imbalanced salty and sweet taste responses","references":"","biologicalOrganisationLevel":"Tissue","organTerm":{},"biologicalEvents":[{"object":{}}],"id":1856}
{"title":"Binding of agonist, Angiotensin II receptor type 1 receptor (AT1R)","references":"","biologicalOrganisationLevel":"Molecular","organTerm":{},"biologicalEvents":[{"object":{}}],"id":1851}
{"title":"Increase activation, Nuclear factor kappa B (NF-kB)","references":"","biologicalOrganisationLevel":"Cellular","organTerm":{"name":"tissue","sourceId":"UBERON:0000479"},"biologicalEvents":[{"action":"increased","process":"regulation of I-kappaB kinase/NF-kappaB signaling","object":{}}],"keyEventStressors":["Reactive oxygen species"],"id":1172}
{"title":"Induced, Angiotensin (Ang) II accumulation","references":"","biologicalOrganisationLevel":"Tissue","organTerm":{},"biologicalEvents":[{"object":{}}],"id":1741}
{"title":"Increased Ang II type 1 receptor (AT1R)","references":"","biologicalOrganisationLevel":"Tissue","organTerm":{},"biologicalEvents":[{"object":{}}],"id":1852}
{"title":"Hyperactivation of ACE/Ang-II/AT1R axis","references":"","biologicalOrganisationLevel":"Molecular","organTerm":{},"biologicalEvents":[{"object":{}}],"id":1853}
{"title":"Increased Sodium-sensitive hypertension","references":"","biologicalOrganisationLevel":"Tissue","organTerm":{},"biologicalEvents":[{"object":{}}],"id":1855}
{"title":"Dysregulation, ACE2 expression and activity","references":"","biologicalOrganisationLevel":"Molecular","organTerm":{},"biologicalEvents":[{"object":{}}],"id":1854}
{"title":"Increase, D1 protein deactivation","references":"","biologicalOrganisationLevel":"Cellular","organTerm":{},"biologicalEvents":[{"object":{}}],"id":1861}
{"title":"Decrease, Photosystem II efficiency","references":"","biologicalOrganisationLevel":"Cellular","organTerm":{},"biologicalEvents":[{"object":{}}],"id":1862}
{"title":"Decrease, Reproduction","references":"","biologicalOrganisationLevel":"Individual","organTerm":{},"biologicalEvents":[{"object":{}}],"id":1863}
{"title":"Increase, Programmed cell death","references":"","biologicalOrganisationLevel":"Cellular","organTerm":{},"biologicalEvents":[{"object":{}}],"id":1864}
{"title":"Increase, Oxygen-evolving complex damage","references":"","biologicalOrganisationLevel":"Molecular","organTerm":{},"biologicalEvents":[{"object":{}}],"id":1865}
{"title":"Fibrinolysis, decreased","references":"<p dir=\"ltr\">1. D&acute;Alonzo et al. COVID-19 and pneumonia: a role for the uPA/uPAR system. Drug Discovery Today Volume 25, Issue 8, August 2020, Pages 1528-1534</p>\n\n<p dir=\"ltr\">2. Ekdahl, Kristina N et al. &ldquo;A human whole-blood model to study the activation of innate immunity system triggered by nanoparticles as a demonstrator for toxicity.&rdquo; Science and technology of advanced materials vol. 20,1 688-698. 24 Jun. 2019, doi:10.1080/14686996.2019.1625721&nbsp;</p>\n\n<p dir=\"ltr\">3. Bernard, I.; Limonta, D.; Mahal, L.K.; Hobman, T.C. Endothelium Infection and Dysregulation by SARS-CoV-2: Evidence and Caveats in COVID-19. Viruses 2021, 13, 29. <a href=\"https://doi.org/10.3390/v13010029\">https://doi.org/10.3390/v13010029</a>&nbsp;</p>\n\n<p dir=\"ltr\">4. Mast AE, Wolberg AS, Gailani D, Garvin MR, Alvarez C, Miller JI, Aronow B, Jacobson D. SARS-CoV-2 Suppresses Anticoagulant and Fibrinolytic Gene Expression in the Lung. eLife 2021;10:e64330 DOI: 10.7554/eLife.64330</p>\n\n<p dir=\"ltr\">5. Curry N.S, Davenport R, Pavord S, Mallett S.V, Kitchen D, Klein A.A, Maybury H, Collins P.W, Laffan M. The use of viscoelastic haemostatic assays in the management of major bleeding - A British Society for Haematology Guideline. British Journal of Haematology. 2018. doi: 10.1111/bjh.15524&nbsp;</p>\n\n<p dir=\"ltr\">6. Chapin JC &amp; Hajjar KA. Fibrinolysis and the control of blood coagulation. Blood Rev. 2015;29(1):17-24</p>\n\n<p>7. Pinsky DJ, Liao H, Lawson CA, Yan SF, Chen J, Carmeliet P et al. Coordinated Induction of Plasminogen Activator Inhibitor-1 (PAI-1) and Inhibition of Plasminogen Activator Gene Expression by Hypoxia Promotes Pulmonary Vascular Fibrin Deposition. J Clin Invest. 1998;102(5):919-928</p>\n\n<p>8. Hofman, Z., de Maat, S., Hack, C.E. et al. Bradykinin: Inflammatory Product of the Coagulation System. Clinic Rev Allerg Immunol 51, 152&ndash;161 (2016). <a href=\"https://doi.org/10.1007/s12016-016-8540-0\">https://doi.org/10.1007/s12016-016-8540-0</a></p>\n\n<p>9. Jacob et al. COVID-19-Associated Hyper-Fibrinolysis: Mechanism and Implementations. Front. Physiol., 16 December 2020 | <a href=\"https://doi.org/10.3389/fphys.2020.596057\">https://doi.org/10.3389/fphys.2020.596057</a>&nbsp;</p>\n\n<p>10. Lisa E. Gralinski, Armand Bankhead III, Sophia Jeng, Vineet D. Menachery, Sean Proll, Sarah E. Belisle, Melissa Matzke, Bobbie-Jo M. Webb-Robertson, Maria L. Luna, Anil K. Shukla, Martin T. Ferris, Meagan Bolles, Jean Chang, Lauri Aicher, Katrina M. Waters, Richard D. Smith, Thomas O. Metz, G. Lynn Law, Michael G. Katze, Shannon McWeeney, Ralph S. Baric. Mechanisms of Severe Acute Respiratory Syndrome Coronavirus-Induced Acute Lung Injury. mBio Aug 2013, 4 (4) e00271-13; DOI: 10.1128/mBio.00271-13</p>\n","biologicalOrganisationLevel":"Molecular","organTerm":{},"biologicalEvents":[{"action":"increased","process":"negative regulation of fibrinolysis","object":{}},{"action":"decreased","process":"negative regulation of blood coagulation","object":{}}],"keyEventStressors":["SARS-CoV","Sars-CoV-2","nanoparticles"],"id":1866}
{"title":"Fibrinolysis, decreased","references":"<p dir=\"ltr\">1. D&acute;Alonzo et al. COVID-19 and pneumonia: a role for the uPA/uPAR system. Drug Discovery Today Volume 25, Issue 8, August 2020, Pages 1528-1534</p>\n\n<p dir=\"ltr\">2. Ekdahl, Kristina N et al. &ldquo;A human whole-blood model to study the activation of innate immunity system triggered by nanoparticles as a demonstrator for toxicity.&rdquo; Science and technology of advanced materials vol. 20,1 688-698. 24 Jun. 2019, doi:10.1080/14686996.2019.1625721&nbsp;</p>\n\n<p dir=\"ltr\">3. Bernard, I.; Limonta, D.; Mahal, L.K.; Hobman, T.C. Endothelium Infection and Dysregulation by SARS-CoV-2: Evidence and Caveats in COVID-19. Viruses 2021, 13, 29. <a href=\"https://doi.org/10.3390/v13010029\">https://doi.org/10.3390/v13010029</a>&nbsp;</p>\n\n<p dir=\"ltr\">4. Mast AE, Wolberg AS, Gailani D, Garvin MR, Alvarez C, Miller JI, Aronow B, Jacobson D. SARS-CoV-2 Suppresses Anticoagulant and Fibrinolytic Gene Expression in the Lung. eLife 2021;10:e64330 DOI: 10.7554/eLife.64330</p>\n\n<p dir=\"ltr\">5. Curry N.S, Davenport R, Pavord S, Mallett S.V, Kitchen D, Klein A.A, Maybury H, Collins P.W, Laffan M. The use of viscoelastic haemostatic assays in the management of major bleeding - A British Society for Haematology Guideline. British Journal of Haematology. 2018. doi: 10.1111/bjh.15524&nbsp;</p>\n\n<p dir=\"ltr\">6. Chapin JC &amp; Hajjar KA. Fibrinolysis and the control of blood coagulation. Blood Rev. 2015;29(1):17-24</p>\n\n<p>7. Pinsky DJ, Liao H, Lawson CA, Yan SF, Chen J, Carmeliet P et al. Coordinated Induction of Plasminogen Activator Inhibitor-1 (PAI-1) and Inhibition of Plasminogen Activator Gene Expression by Hypoxia Promotes Pulmonary Vascular Fibrin Deposition. J Clin Invest. 1998;102(5):919-928</p>\n\n<p>8. Hofman, Z., de Maat, S., Hack, C.E. et al. Bradykinin: Inflammatory Product of the Coagulation System. Clinic Rev Allerg Immunol 51, 152&ndash;161 (2016). <a href=\"https://doi.org/10.1007/s12016-016-8540-0\">https://doi.org/10.1007/s12016-016-8540-0</a></p>\n\n<p>9. Jacob et al. COVID-19-Associated Hyper-Fibrinolysis: Mechanism and Implementations. Front. Physiol., 16 December 2020 | <a href=\"https://doi.org/10.3389/fphys.2020.596057\">https://doi.org/10.3389/fphys.2020.596057</a>&nbsp;</p>\n\n<p>10. Lisa E. Gralinski, Armand Bankhead III, Sophia Jeng, Vineet D. Menachery, Sean Proll, Sarah E. Belisle, Melissa Matzke, Bobbie-Jo M. Webb-Robertson, Maria L. Luna, Anil K. Shukla, Martin T. Ferris, Meagan Bolles, Jean Chang, Lauri Aicher, Katrina M. Waters, Richard D. Smith, Thomas O. Metz, G. Lynn Law, Michael G. Katze, Shannon McWeeney, Ralph S. Baric. Mechanisms of Severe Acute Respiratory Syndrome Coronavirus-Induced Acute Lung Injury. mBio Aug 2013, 4 (4) e00271-13; DOI: 10.1128/mBio.00271-13</p>\n","biologicalOrganisationLevel":"Molecular","organTerm":{},"biologicalEvents":[{"action":"increased","process":"negative regulation of fibrinolysis","object":{}},{"action":"decreased","process":"negative regulation of blood coagulation","object":{}}],"keyEventStressors":["SARS-CoV","Sars-CoV-2","nanoparticles"],"id":1866}
{"title":"Bradykinin system, hyperactivated","references":"<p dir=\"ltr\">1. Garvin et al. A mechanistic model and therapeutic interventions for COVID-19 involving a RAS-mediated bradykinin storm. eLife 2020;9:e59177 DOI: 10.7554/eLife.59177</p>\n\n<p dir=\"ltr\">2. Sidarta-Oliveira, D., Jara, C.P., Ferruzzi, A.J. et al. SARS-CoV-2 receptor is co-expressed with elements of the kinin&ndash;kallikrein, renin&ndash;angiotensin and coagulation systems in alveolar cells. Sci Rep 10, 19522 (2020). <a href=\"https://doi.org/10.1038/s41598-020-76488-2\">https://doi.org/10.1038/s41598-020-76488-2</a></p>\n\n<p dir=\"ltr\">3. Bernard et al. Endothelium Infection and Dysregulation by SARS-CoV-2: Evidence and Caveats in COVID-19. Viruses 2021, 13(1), 29; <a href=\"https://doi.org/10.3390/v13010029\">https://doi.org/10.3390/v13010029</a>&nbsp;</p>\n\n<p dir=\"ltr\">4. Veerdonk et al. Kallikrein-kinin blockade in patients with COVID-19 to prevent acute respiratory distress syndrome. eLife 2020;9:e57555 DOI: 10.7554/eLife.57555&nbsp;</p>\n\n<p dir=\"ltr\">5. Carvalho 2021 doi: 10.1016/j.peptides.2020.170428</p>\n\n<p dir=\"ltr\">6. Ekdahl 2019 doi: 10.1080/14686996.2019.1625721</p>\n\n<p dir=\"ltr\">7. Long 2015 doi:10.3109/17435390.2015.1088589</p>\n\n<p dir=\"ltr\">8. Atzatzi-Aguilar 2015 10.1186/s12989-015-0094-4</p>\n","biologicalOrganisationLevel":"Molecular","organTerm":{},"biologicalEvents":[{"action":"increased","process":"increased vascular permeability","object":{}},{"action":"increased","process":"vasodilation","object":{}},{"action":"increased","process":"vascular inflammation","object":{}}],"keyEventStressors":["Sars-CoV-2","nanoparticles"],"id":1867}
{"title":"Bradykinin system, hyperactivated","references":"<p dir=\"ltr\">1. Garvin et al. A mechanistic model and therapeutic interventions for COVID-19 involving a RAS-mediated bradykinin storm. eLife 2020;9:e59177 DOI: 10.7554/eLife.59177</p>\n\n<p dir=\"ltr\">2. Sidarta-Oliveira, D., Jara, C.P., Ferruzzi, A.J. et al. SARS-CoV-2 receptor is co-expressed with elements of the kinin&ndash;kallikrein, renin&ndash;angiotensin and coagulation systems in alveolar cells. Sci Rep 10, 19522 (2020). <a href=\"https://doi.org/10.1038/s41598-020-76488-2\">https://doi.org/10.1038/s41598-020-76488-2</a></p>\n\n<p dir=\"ltr\">3. Bernard et al. Endothelium Infection and Dysregulation by SARS-CoV-2: Evidence and Caveats in COVID-19. Viruses 2021, 13(1), 29; <a href=\"https://doi.org/10.3390/v13010029\">https://doi.org/10.3390/v13010029</a>&nbsp;</p>\n\n<p dir=\"ltr\">4. Veerdonk et al. Kallikrein-kinin blockade in patients with COVID-19 to prevent acute respiratory distress syndrome. eLife 2020;9:e57555 DOI: 10.7554/eLife.57555&nbsp;</p>\n\n<p dir=\"ltr\">5. Carvalho 2021 doi: 10.1016/j.peptides.2020.170428</p>\n\n<p dir=\"ltr\">6. Ekdahl 2019 doi: 10.1080/14686996.2019.1625721</p>\n\n<p dir=\"ltr\">7. Long 2015 doi:10.3109/17435390.2015.1088589</p>\n\n<p dir=\"ltr\">8. Atzatzi-Aguilar 2015 10.1186/s12989-015-0094-4</p>\n","biologicalOrganisationLevel":"Molecular","organTerm":{},"biologicalEvents":[{"action":"increased","process":"increased vascular permeability","object":{}},{"action":"increased","process":"vasodilation","object":{}},{"action":"increased","process":"vascular inflammation","object":{}}],"keyEventStressors":["Sars-CoV-2","nanoparticles"],"id":1867}
{"title":"Bradykinin system, hyperactivated","references":"<p dir=\"ltr\">1. Garvin et al. A mechanistic model and therapeutic interventions for COVID-19 involving a RAS-mediated bradykinin storm. eLife 2020;9:e59177 DOI: 10.7554/eLife.59177</p>\n\n<p dir=\"ltr\">2. Sidarta-Oliveira, D., Jara, C.P., Ferruzzi, A.J. et al. SARS-CoV-2 receptor is co-expressed with elements of the kinin&ndash;kallikrein, renin&ndash;angiotensin and coagulation systems in alveolar cells. Sci Rep 10, 19522 (2020). <a href=\"https://doi.org/10.1038/s41598-020-76488-2\">https://doi.org/10.1038/s41598-020-76488-2</a></p>\n\n<p dir=\"ltr\">3. Bernard et al. Endothelium Infection and Dysregulation by SARS-CoV-2: Evidence and Caveats in COVID-19. Viruses 2021, 13(1), 29; <a href=\"https://doi.org/10.3390/v13010029\">https://doi.org/10.3390/v13010029</a>&nbsp;</p>\n\n<p dir=\"ltr\">4. Veerdonk et al. Kallikrein-kinin blockade in patients with COVID-19 to prevent acute respiratory distress syndrome. eLife 2020;9:e57555 DOI: 10.7554/eLife.57555&nbsp;</p>\n\n<p dir=\"ltr\">5. Carvalho 2021 doi: 10.1016/j.peptides.2020.170428</p>\n\n<p dir=\"ltr\">6. Ekdahl 2019 doi: 10.1080/14686996.2019.1625721</p>\n\n<p dir=\"ltr\">7. Long 2015 doi:10.3109/17435390.2015.1088589</p>\n\n<p dir=\"ltr\">8. Atzatzi-Aguilar 2015 10.1186/s12989-015-0094-4</p>\n","biologicalOrganisationLevel":"Molecular","organTerm":{},"biologicalEvents":[{"action":"increased","process":"increased vascular permeability","object":{}},{"action":"increased","process":"vasodilation","object":{}},{"action":"increased","process":"vascular inflammation","object":{}}],"keyEventStressors":["Sars-CoV-2","nanoparticles"],"id":1867}
{"title":"Hyperinflammation","references":"<p>1. Caricchio R, et al.,&nbsp; Ann Rheum Dis doi:10.1136/ annrheumdis-2020-218323</p>\n\n<p>2. Channappanavar et al.,&nbsp; Cell Host Microbe 19 (2) (2016) 181&ndash;193,</p>\n\n<p>3. Chen G ei al., J Clin Invest. 2020;130(5):2620-2629</p>\n\n<p dir=\"ltr\">4. Cheng L et al.,Journal of Clinical Laboratory Analysis<a href=\"https://onlinelibrary.wiley.com/toc/10982825/2020/34/10\"> Volume34, Issue10</a>,&nbsp;October 2020 e23618,&nbsp;<a href=\"https://doi.org/10.1002/jcla.23618\">https://doi.org/10.1002/jcla.23618</a></p>\n\n<p dir=\"ltr\">5. Chu H, et al., Clin Infect Dis. 2020;71(6):1400-1409.</p>\n\n<p>6. Del Valle DM et al., Medrxiv : the Preprint Server for Health Sciences. 2020 May.</p>\n\n<p>7. J Clin.&nbsp; Invest. 2020;<a href=\"http://www.jci.org/130/5\">130(5)</a>:2620-2629. <a href=\"https://doi.org/10.1172/JCI137244\">https://doi.org/10.1172/JCI137244</a></p>\n\n<p>8. Jin J-M et al., Front. Public Health, 29 April 2020 | <a href=\"https://doi.org/10.3389/fpubh.2020.00152\">https://doi.org/10.3389/fpubh.2020.00152</a></p>\n\n<p>9. Hadjadj et al., Science doi: <a href=\"http://dx.doi.org/10.1126/science.abc6027\">10.1126/science.abc6027</a></p>\n\n<p>10. Henry B et al.,&nbsp; Acta Biomed. 2020;91(3):e2020008. doi:10.23750/abm.v91i3.10217</p>\n\n<p>11. Lazear H.M et al., Immunity. 2019;50:907&ndash;923.</p>\n\n<p dir=\"ltr\">12. Manson JJ et al.,<a href=\"https://www.sciencedirect.com/science/journal/26659913\"> The Lancet Rheumatology</a>&nbsp;<a href=\"https://www.sciencedirect.com/science/journal/26659913/2/10\">Volume 2, Issue 10</a>, October 2020, Pages e594-e602</p>\n\n<p dir=\"ltr\">13. Mojtabavi, H., et al., Eur Cytokine Netw 31, 44&ndash;49 (2020). https://doi.org/10.1684/ecn.2020.0448</p>\n\n<p>14. Zhang B, Zhou X, Qiu Y, et al. Clinical characteristics of 82 death cases with COVID19. medRxiv. 2020.</p>\n","biologicalOrganisationLevel":"Tissue","organTerm":{},"biologicalEvents":[{"object":{}}],"keyEventStressors":["SARS-CoV","Sars-CoV-2"],"id":1868}
{"title":"Sustentacular cells, decrease ","references":"<p><span style=\"font-size:10.5pt\"><span style=\"color:#3e3d40\"><span style=\"font-family:&quot;Georgia&quot;,serif\">Butowt, R., and von Bartheld, C. S. (2020). Anosmia in COVID-19: underlying mechanisms and assessment of an olfactory route to brain infection. <em>Neuroscientist</em> doi: 10.1177/1073858420956905</span></span></span></p>\n\n<p><span style=\"font-family:Times New Roman,Times,serif\"><span style=\"font-size:12pt\">Bryche B, St Albin A, Murri S, Lac&ocirc;te S, Pulido C, Ar Gouilh M, Lesellier S, Servat A, Wasniewski M, Picard-Meyer E, Monchatre-Leroy E, Volmer R, Rampin O, Le Goffic R, Marianneau P, Meunier N. Massive transient damage of the olfactory epithelium associated with infection of sustentacular cells by SARS-CoV-2 in golden Syrian hamsters. Brain Behav Immun. 2020 Oct;89:579-586. doi: 10.1016/j.bbi.2020.06.032. Epub 2020 Jul 3. PMID: 32629042; PMCID: PMC7332942.</span></span></p>\n\n<p><span style=\"font-family:Times New Roman,Times,serif\"><span style=\"font-size:12pt\">Torabi A., Mohammadbagheri E., Akbari Dilmaghani N., Bayat A.H., Fathi M., Vakili K., Alizadeh R., Rezaeimirghaed O., Hajiesmaeili M., Ramezani M., Simani L., Aliaghaei A. Proinflammatory cytokines in the olfactory mucosa result in COVID-19 induced anosmia. ACS Chem. Neurosci. 2020</span></span></p>\n\n<p>&nbsp;</p>\n\n<p>&nbsp;</p>\n","biologicalOrganisationLevel":"Cellular","organTerm":{},"biologicalEvents":[{"object":{}}],"id":1870}
{"title":"olfactory sensory neurons, decrease ","references":"<p style=\"margin-left:24px; text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"color:#000000\">Liang F. Sustentacular Cell Enwrapment of Olfactory Receptor Neuronal Dendrites: An Update. Genes (Basel). 2020 Apr 30;11(5):493. doi: 10.3390/genes11050493. PMID: 32365880; PMCID: PMC7291085.</span></span></span></p>\n","biologicalOrganisationLevel":"Cellular","organTerm":{},"biologicalEvents":[{"object":{}}],"id":1871}
{"title":"Olfactory epithelium degeneration","references":"","biologicalOrganisationLevel":"Tissue","organTerm":{},"biologicalEvents":[{"object":{}}],"id":1872}
{"title":"impaired olfactory function (anosmia) ","references":"","biologicalOrganisationLevel":"Organ","organTerm":{},"biologicalEvents":[{"object":{}}],"id":1873}
{"title":"blood brain barrier disruption ","references":"","biologicalOrganisationLevel":"Cellular","organTerm":{},"biologicalEvents":[{"object":{}}],"id":1874}
{"title":"Cerebrovascular disease (stroke)","references":"<p><span style=\"color:#000000\"><span style=\"font-family:Calibri\">Khaku AS, Tadi P. (2020) Cerebrovascular Disease. In: StatPearls. Treasure Island (FL): StatPearls Publishing; 2020 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK430927/</span></span></p>\n","biologicalOrganisationLevel":"Individual","organTerm":{},"biologicalEvents":[{"object":{}}],"id":1875}
{"title":"Direct Deposition of Ionizing Energy","references":"","biologicalOrganisationLevel":"Molecular","organTerm":{},"biologicalEvents":[{"object":{}}],"id":1550}
{"title":"Decreased, Population size","references":"","biologicalOrganisationLevel":"Population","organTerm":{},"biologicalEvents":[{"object":{}}],"id":997}
{"title":"Bulky DNA adducts, increase","references":"<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Avenir Book&quot;\"><span style=\"color:black\">Arlt VM, Stiborova M, Schmeiser HH.&nbsp;</span></span></span><span style=\"background-color:white\"><span style=\"font-family:&quot;Avenir Book&quot;\"><span style=\"color:black\">Mutagenesis.&nbsp;</span></span></span><span style=\"background-color:white\"><span style=\"font-family:&quot;Avenir Book&quot;\"><span style=\"color:black\">2002; 17:265&ndash;277.</span></span></span></span></span></p>\n\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Avenir Book&quot;\"><span style=\"color:black\">Barnes, J. L., Zubair, M., John, K., Poirier, M. C., &amp; Martin, F. L. (2018). Carcinogens and DNA damage.&nbsp;<em>Biochemical Society transactions</em>,&nbsp;<em>46</em>(5), 1213&ndash;1224. </span></span></span><a href=\"https://doi.org/10.1042/BST20180519\" style=\"color:#0563c1; text-decoration:underline\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Avenir Book&quot;\"><span style=\"color:black\">https://doi.org/10.1042/BST20180519</span></span></span></a></span></span></p>\n\n<p>&nbsp;</p>\n\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Avenir Book&quot;\"><span style=\"color:black\">Grollman, A. P., Shibutani, S., Moriya, M., Miller, F., Wu, L., Moll, U., Suzuki, N., Fernandes, A., Rosenquist, T., Medverec, Z., Jakovina, K., Brdar, B., Slade, N., Turesky, R. J., Goodenough, A. K., Rieger, R., Vukeli, M., &amp; Jelakovi, B. (2007). Aristolochic acid and the etiology of endemic (Balkan) nephropathy.&nbsp;<em>Proceedings of the National Academy of Sciences of the United States of America</em>,&nbsp;<em>104</em>(29), 12129&ndash;12134. </span></span></span><a href=\"https://doi.org/10.1073/pnas.0701248104\" style=\"color:#0563c1; text-decoration:underline\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Avenir Book&quot;\">https://doi.org/10.1073/pnas.0701248104</span></span></a></span></span></p>\n\n<p>&nbsp;</p>\n\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Avenir Book&quot;\"><span style=\"color:black\">Groopman, J. D., Croy, R. G., &amp; Wogan, G. N. (1981). In vitro reactions of aflatoxin B1-adducted DNA.&nbsp;<em>Proceedings of the National Academy of Sciences</em>,&nbsp;<em>78</em>(9), 5445-5449.</span></span></span></span></span></p>\n\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Avenir Book&quot;\"><span style=\"color:black\">Gupta, R. C., Reddy, M. V., &amp; Randerath, K. (1982). 32 P-postlabeling analysis of non-radioactive aromatic carcinogen&mdash;DNA adducts.&nbsp;<em>Carcinogenesis</em>,&nbsp;<em>3</em>(9), 1081-1092.</span></span></span></span></span></p>\n\n<p>&nbsp;</p>\n\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Avenir Book&quot;\"><span style=\"color:black\">Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011 Mar 4;144(5):646-74. doi: 10.1016/j.cell.2011.02.013. PMID: 21376230.</span></span></span></span></span></p>\n\n<p>&nbsp;</p>\n\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Avenir Book&quot;\"><span style=\"color:black\">Hwa Yun, B., Guo, J., Bellamri, M., &amp; Turesky, R. J. (2020). DNA adducts: Formation, biological effects, and new biospecimens for mass spectrometric measurements in humans.&nbsp;<em>Mass spectrometry reviews</em>,&nbsp;<em>39</em>(1-2), 55-82.</span></span></span></span></span></p>\n\n<p>&nbsp;</p>\n\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Avenir Book&quot;\"><span style=\"color:black\">IARC Some non-heterocyclic polycyclic aromatic hydrocarbons and some related exposures.&nbsp;IARC Monogr Eval Carcinog Risks Hum.&nbsp;2010;92:1&ndash;853.</span></span></span> <a href=\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4781319/\" style=\"color:#0563c1; text-decoration:underline\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Avenir Book&quot;\"><span style=\"color:black\">https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4781319/</span></span></span></a></span></span></p>\n\n<p>&nbsp;</p>\n\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Avenir Book&quot;\"><span style=\"color:black\">IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Chemical Agents and Related Occupations. Lyon (FR): International Agency for Research on Cancer; 2012. (IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, No. 100F.) BENZO[a]PYRENE.</span></span></span><span style=\"background-color:white\"><span style=\"font-family:&quot;Avenir Book&quot;\"><span style=\"color:black\">&nbsp;Available from: </span></span></span><a href=\"https://www.ncbi.nlm.nih.gov/books/NBK304415/\" style=\"color:#0563c1; text-decoration:underline\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Avenir Book&quot;\">https://www.ncbi.nlm.nih.gov/books/NBK304415/</span></span></a></span></span></p>\n\n<p>&nbsp;</p>\n\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Avenir Book&quot;\"><span style=\"color:black\">Jessica L. Barnes, Maria Zubair, Kaarthik John, Miriam C. Poirier, Francis L. Martin; Carcinogens and DNA damage.&nbsp;<em><span style=\"font-family:&quot;Avenir Book&quot;\">Biochem Soc Trans</span></em>&nbsp;19 October 2018; 46 (5): 1213&ndash;1224. doi:&nbsp;</span></span></span><a href=\"https://doi.org/10.1042/BST20180519\" style=\"color:#0563c1; text-decoration:underline\" target=\"_blank\"><strong><span style=\"background-color:white\"><span style=\"font-family:&quot;Avenir Book&quot;\"><span style=\"color:black\">https://doi.org/10.1042/BST20180519</span></span></span></strong></a></span></span></p>\n\n<p>&nbsp;</p>\n\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-family:&quot;Avenir Book&quot;\"><span style=\"color:black\">Li, X. L., Guo, X. Q., Wang, H. R., Chen, T., &amp; Mei, N. (2020). Aristolochic Acid-Induced Genotoxicity and Toxicogenomic Changes in Rodents.&nbsp;<strong>World journal of traditional Chinese medicine</strong>,&nbsp;6(1), 12&ndash;25. </span></span><a href=\"https://doi.org/10.4103/wjtcm.wjtcm_33_19\" style=\"color:#0563c1; text-decoration:underline\"><span style=\"font-family:&quot;Avenir Book&quot;\">https://doi.org/10.4103/wjtcm.wjtcm_33_19</span></a></span></span></p>\n\n<p>&nbsp;</p>\n\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-family:&quot;Avenir Book&quot;\"><span style=\"color:black\">McDaniel, L. P., Elander, E. R., Guo, X., Chen, T., Arlt, V. M., &amp; Mei, N. (2012). Mutagenicity and DNA adduct formation by aristolochic acid in the spleen of Big Blue&reg; rats. <strong>Environmental and molecular mutagenesis</strong>, 53(5), 358-368.</span></span></span></span></p>\n\n<p>&nbsp;</p>\n\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Avenir Book&quot;\"><span style=\"color:black\">Ngo, L. P., Owiti, N. A., Swartz, C., Winters, J., Su, Y., Ge, J., Xiong, A., Han, J., Recio, L., Samson, L. D., &amp; Engelward, B. P. (2020). Sensitive CometChip assay for screening potentially carcinogenic DNA adducts by trapping DNA repair intermediates.&nbsp;<em>Nucleic acids research</em>,&nbsp;<em>48</em>(3), e13. </span></span></span><a href=\"https://doi.org/10.1093/nar/gkz1077\" style=\"color:#0563c1; text-decoration:underline\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Avenir Book&quot;\">https://doi.org/10.1093/nar/gkz1077</span></span></a></span></span></p>\n\n<p>&nbsp;</p>\n\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Avenir Book&quot;\"><span style=\"color:black\">Phillips, D. H., &amp; Arlt, V. M. (2014). 32 P-Postlabeling Analysis of DNA Adducts. In&nbsp;<em>Molecular Toxicology Protocols</em>&nbsp;(pp. 127-138). Humana Press, Totowa, NJ.</span></span></span></span></span></p>\n\n<p>&nbsp;</p>\n\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"background-color:white\"><span style=\"font-family:&quot;Avenir Book&quot;\"><span style=\"color:black\">Yun, B. H., Sidorenko, V. S., Rosenquist, T. A., Dickman, K. G., Grollman, A. P., &amp; Turesky, R. J. (2015). New approaches for biomonitoring exposure to the human carcinogen aristolochic acid.&nbsp;<em>Toxicology research</em>,&nbsp;<em>4</em>(4), 763-776.</span></span></span></span></span></p>\n","biologicalOrganisationLevel":"Molecular","organTerm":{},"biologicalEvents":[{"action":"increased","object":{"name":"deoxyribonucleic acid","source":"CHEBI","sourceId":"CHEBI:16991"}}],"keyEventStressors":["Aflatoxin B1","Polycyclic aromatic hydrocarbons (PAHs)","Aristolochic acid"],"id":1879}
{"title":"Inhibition of ALDH1A2 (RALDH2)","references":"","biologicalOrganisationLevel":"Molecular","organTerm":{},"biologicalEvents":[{"object":{}}],"id":1880}
{"title":"Decreased all-trans retinoic acid (ATRA) concentration","references":"","biologicalOrganisationLevel":"Tissue","organTerm":{},"biologicalEvents":[{"object":{}}],"id":1881}
{"title":"Disrupted meiotic initiation of fetal oogonia of the ovary","references":"","biologicalOrganisationLevel":"Cellular","organTerm":{},"biologicalEvents":[{"object":{}}],"id":1882}
{"title":"Reduced size of the ovarian follicle pool ","references":"","biologicalOrganisationLevel":"Tissue","organTerm":{},"biologicalEvents":[{"object":{}}],"id":1883}
{"title":"Inhibition of Fyna","references":"<p style=\"margin-left:32px\"><span style=\"font-size:11pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Challa, A. K., &amp; Chatti, K. (2013). <em>Conservation and Early Expression of Zebrafish Tyrosine Kinases Support the Utility of Zebrafish as a Model for Tyrosine Kinase Biology</em>. <em>10</em>(3). https://doi.org/10.1089/zeb.2012.0781</span></span></p>\n\n<p style=\"margin-left:32px\"><span style=\"font-size:11pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Green, T. P., Fennell, M., Whittaker, R., Curwen, J., Jacobs, V., Allen, J., Logie, A., Hargreaves, J., Hickinson, D. M., Wilkinson, R. W., Elvin, P., Boyer, B., Carragher, N., Pl&eacute;, P. A., Bermingham, A., Holdgate, G. A., Ward, W. H. J., Hennequin, L. F., Davies, B. R., &amp; Costello, G. F. (2009). Preclinical anticancer activity of the potent, oral Src inhibitor AZD0530. <em>Molecular Oncology</em>, <em>3</em>(3), 248&ndash;261. https://doi.org/10.1016/j.molonc.2009.01.002</span></span></p>\n\n<p style=\"margin-left:32px\"><span style=\"font-size:11pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hanrs, S. K., &amp; Hunter, T. (1995). <em>The eukaryotic protein kinase superfamily: idnase. (catalytic) domam structure and classification</em>. https://doi.org/10.1096/fasebj.9.8.7768349</span></span></p>\n\n<p style=\"margin-left:32px\"><span style=\"font-size:11pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Jeli, D., Mildner, B., Ko&scaron;trun, S., Nuji, K., Verbanac, D., uli, O., Antolovi, R., &amp; Brandt, W. (2007). Homology modeling of human Fyn kinase structure: Discovery of rosmarinic acid as a new Fyn kinase inhibitor and in Silico study of its possible binding modes. <em>Journal of Medicinal Chemistry</em>, <em>50</em>(6), 1090&ndash;1100. https://doi.org/10.1021/jm0607202</span></span></p>\n\n<p style=\"margin-left:32px\"><span style=\"font-size:11pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Kinoshita, T., Matsubara, M., Ishiguro, H., Okita, K., &amp; Tada, T. (2006). Structure of human Fyn kinase domain complexed with staurosporine. <em>Biochemical and Biophysical Research Communications</em>, <em>346</em>(3), 840&ndash;844. https://doi.org/10.1016/j.bbrc.2006.05.212</span></span></p>\n\n<p style=\"margin-left:32px\"><span style=\"font-size:11pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Kr&auml;mer-Albers, E.-M., &amp; White, R. (2011). From axon-glial signalling to myelination: the integrating role of oligodendroglial Fyn kinase. <em>Cell. Mol. Life Sci.</em> https://doi.org/10.1007/s00018-010-0616-z</span></span></p>\n\n<p style=\"margin-left:32px\"><span style=\"font-size:11pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Lamers, M. B. A. C., Antson, A. A., Hubbard, R. E., Scott, R. K., &amp; Williams, D. H. (2003). <em>Structure of the Protein Tyrosine Kinase Domain of C-terminal Src Kinase (CSK) in Complexwith Staurosporine</em>. <em>J. Mol. Bi</em>(285), 713&ndash;725. papers2://publication/uuid/CBF6FE3B-FE88-4A68-9E4A-EC387CF85D43</span></span></p>\n\n<p style=\"margin-left:32px\"><span style=\"font-size:11pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">L&ouml;wenberg, M., Tuynman, J., Bilderbeek, J., Gaber, T., Buttgereit, F., Van Deventer, S., Peppelenbosch, M., &amp; Hommes, D. (2005). Rapid immunosuppressive effects of glucocorticoids mediated through Lck and Fyn. <em>Blood</em>, <em>106</em>(5), 1703&ndash;1710. https://doi.org/10.1182/blood-2004-12-4790</span></span></p>\n\n<p style=\"margin-left:32px\"><span style=\"font-size:11pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ma, B. D., Zegzouti, H., Ph, D., Vidugiriene, J., Ph, D., Goueli, S. A., Ph, D., &amp; Corporation, P. (n.d.). <em>FYN A Kinase Assay</em>. https://www.promega.com/-/media/files/resources/protocols/kinase-enzyme-appnotes/fyn-a-kinase-assay-protocol.pdf?la=en</span></span></p>\n\n<p style=\"margin-left:32px\"><span style=\"font-size:11pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Morisot, N., Berger, A. L., Phamluong, K., Cross, A., &amp; Ron, D. (2019). The Fyn kinase inhibitor, AZD0530, suppresses mouse alcohol self-administration and seeking. <em>Addiction Biology</em>, <em>24</em>(6), 1227&ndash;1234. https://doi.org/10.1111/adb.12699</span></span></p>\n\n<p style=\"margin-left:32px\"><span style=\"font-size:11pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Nygaard, H. B., Van Dyck, C. H., &amp; Strittmatter, S. M. (2014). Fyn kinase inhibition as a novel therapy for Alzheimer&rsquo;s disease. <em>Alzheimer&rsquo;s Research and Therapy</em>, <em>6</em>(1), 1&ndash;8. https://doi.org/10.1186/alzrt238</span></span></p>\n\n<p style=\"margin-left:32px\"><span style=\"font-size:11pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Saito, H. (2001). Histidine phosphorylation and two-component signaling in eukaryotic cells. <em>Chemical Reviews</em>, <em>101</em>(8), 2497&ndash;2509. https://doi.org/10.1021/cr000243+</span></span></p>\n\n<p style=\"margin-left:32px\"><span style=\"font-size:11.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">St. Clair, R. M., Emerson, S. E., D&rsquo;Elia, K. P., Weir, M. E., Schmoker, A. M., Ebert, A. M., &amp; Ballif, B. A. (2018). Fyn-dependent phosphorylation of PlexinA1 and PlexinA2 at conserved tyrosines is essential for zebrafish eye development. <em>FEBS Journal</em>, <em>285</em>(1), 72&ndash;86. https://doi.org/10.1111/febs.14313</span></span></p>\n\n<p style=\"margin-left:32px\"><span style=\"font-size:11pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Toullec, D., Pianetti, P., Coste, H., Bellevergue, P., Grand-Perret, T., Ajakane, M., Baudet, V., Boissin, P., Boursier, E., Loriolle, F., Duhamel, L., Charon, D., &amp; Kirilovsky, J. (1991). The bisindolylmaleimide GF 109203X is a potent and selective inhibitor of protein kinase C. <em>Journal of Biological Chemistry</em>, <em>266</em>(24), 15771&ndash;15781. https://doi.org/10.1016/s0021-9258(18)98476-0</span></span></p>\n\n<p><em><span style=\"font-size:11.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ZFIN Gene: fyna</span></span></em><span style=\"font-size:11.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">. (n.d.). Retrieved March 14, 2021, from https://zfin.org/ZDB-GENE-030903-5#phenotype</span></span></p>\n","biologicalOrganisationLevel":"Molecular","organTerm":{},"biologicalEvents":[{"action":"decreased","process":"protein tyrosine kinase activity","object":{"name":"tyrosine-protein kinase fyna (zebrafish)","source":"PR","sourceId":"PR:Q6EWH2"}}],"keyEventStressors":["Rosmarinic acid","Saracatinib","Staurosporine"],"id":1884}
{"title":"Inhibition of Plxna2","references":"<p style=\"margin-left:32px\"><span style=\"font-size:11pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Emerson, S. E., St. Clair, R. M., Waldron, A. L., Bruno, S. R., Duong, A., Driscoll, H. E., Ballif, B. A., McFarlane, S., &amp; Ebert, A. M. (2017). Identification of target genes downstream of semaphorin6A/PlexinA2 signaling in zebrafish. <em>Developmental Dynamics</em>, <em>246</em>(7), 539&ndash;549. https://doi.org/10.1002/dvdy.24512</span></span></p>\n\n<p style=\"margin-left:32px\"><span style=\"font-size:11pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Franco, M., &amp; Luca Tamagnone, &amp;. (2008). review Tyrosine phosphorylation in semaphorin signalling: shifting into overdrive. <em>EMBO Reports</em>, <em>9</em>, 865&ndash;871. https://doi.org/10.1038/embor.2008.139</span></span></p>\n\n<p style=\"margin-left:32px\"><span style=\"font-size:11pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hanrs, S. K., &amp; Hunter2, T. (n.d.). <em>The eukaryotic protein kinase superfamily: idnase. (catalytic) domam structure and classification</em>. https://doi.org/10.1096/fasebj.9.8.7768349</span></span></p>\n\n<p style=\"margin-left:32px\"><span style=\"font-size:11pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Johnson, L. N., &amp; Lewis, R. J. (2010). ChemInform Abstract: Structural Basis for Control by Phosphorylation. <em>ChemInform</em>, <em>32</em>(40), no--no. https://doi.org/10.1002/chin.200140284</span></span></p>\n\n<p style=\"margin-left:32px\"><span style=\"font-size:11pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Luo, Y., Raible, D., &amp; Raper, J. A. (1993). <em>Collapsin: A Protein in Brain That Induces the Collapse and Paralysis of Neuronal Growth Cones</em>. <em>75</em>(1984), 217&ndash;227.</span></span></p>\n\n<p style=\"margin-left:32px\"><span style=\"font-size:11pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Mellado, M., Rodr&iacute;guez-Frade, J. M., Ma&ntilde;es, S., &amp; Mart&iacute;nez-A., C. (2001). Chemokine signaling and functional responses: The role of receptor dimerization and TK pathway activation. <em>Annual Review of Immunology</em>, <em>19</em>, 397&ndash;421. https://doi.org/10.1146/annurev.immunol.19.1.397</span></span></p>\n\n<p style=\"margin-left:32px\"><span style=\"font-size:11pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Neufeld, G., &amp; Kessler, O. (2008). The semaphorins: Versatile regulators of tumour progression and tumour angiogenesis. <em>Nature Reviews Cancer</em>, <em>8</em>(8), 632&ndash;645. https://doi.org/10.1038/nrc2404</span></span></p>\n\n<p style=\"margin-left:32px\"><span style=\"font-size:11pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Oinuma, I., Ishikawa, Y., Katoh, H., &amp; Negishi, M. (2004). The Semaphorin 4D receptor Plexin-B1 is a GTPase activating protein for R-Ras. <em>Science</em>, <em>305</em>(5685), 862&ndash;865. https://doi.org/10.1126/science.1097545</span></span></p>\n\n<p style=\"margin-left:32px\"><span style=\"font-size:11pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">St. Clair, R. M., Emerson, S. E., D&rsquo;Elia, K. P., Marion, W. E., Schmoker, A. M., Ebert, A. M., &amp; Ballif, B. A. (2018). Fyn-dependent phosphorylation of PlexinA1 and PlexinA2 at conserved tyrosines is essential for zebrafish eye development. <em>FEBS Journal</em>, <em>285</em>(1), 72&ndash;86. https://doi.org/10.1111/febs.14313</span></span></p>\n\n<p style=\"margin-left:32px\"><span style=\"font-size:11pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Tamagnone, L., Artigiani, S., Chen, H., He, Z., Ming, G. L., Song, H. J., Chedotal, A., Winberg, M. L., Goodman, C. S., Poo, M. M., Tessier-Lavigne, M., &amp; Comoglio, P. M. (1999). Plexins are a large family of receptors for transmembrane, secreted, and GPI-anchored semaphorins in vertebrates. <em>Cell</em>, <em>99</em>(1), 71&ndash;80. https://doi.org/10.1016/S0092-8674(00)80063-X</span></span></p>\n\n<p style=\"margin-left:32px\"><span style=\"font-size:11pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><em>ZFIN Gene: plxna2</em>. (n.d.). Retrieved March 15, 2021, from http://zfin.org/ZDB-GENE-090311-6</span></span></p>\n","biologicalOrganisationLevel":"Molecular","organTerm":{"name":"brain","sourceId":"UBERON:0000955"},"biologicalEvents":[{"object":{}}],"id":1885}
{"title":"Increase, Overexpression of rasl11b","references":"<p style=\"margin-left:32px\"><span style=\"font-size:11pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Colicelli, J. (2004). Human RAS superfamily proteins and related GTPases. <em>Science&rsquo;s STKE: Signal Transduction Knowledge Environment</em>, <em>2004</em>(250). https://doi.org/10.1126/stke.2502004re13</span></span></p>\n\n<p style=\"margin-left:32px\"><span style=\"font-size:11pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Emerson, S. E., St. Clair, R. M., Waldron, A. L., Bruno, S. R., Duong, A., Driscoll, H. E., Ballif, B. A., McFarlane, S., &amp; Ebert, A. M. (2017). Identification of target genes downstream of semaphorin6A/PlexinA2 signaling in zebrafish. <em>Developmental Dynamics</em>, <em>246</em>(7), 539&ndash;549. https://doi.org/10.1002/dvdy.24512</span></span></p>\n\n<p style=\"margin-left:32px\"><span style=\"font-size:11pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">He, H., Dai, J., Zhuo, R., Zhao, J., Wang, H., Sun, F., Zhu, Y., &amp; Xu, D. (2018). Study on the mechanism behind lncRNA MEG3 affecting clear cell renal cell carcinoma by regulating miR-7/RASL11B signaling. <em>Journal of Cellular Physiology</em>, <em>233</em>(12), 9503&ndash;9515. https://doi.org/10.1002/jcp.26849</span></span></p>\n\n<p style=\"margin-left:32px\"><span style=\"font-size:11pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">P&eacute;zeron, G., Lambert, G., Dickmeis, T., Str&auml; Hle, U., D&eacute;, F., Rosa, R. M., &amp; Mourrain, P. (2008). Rasl11b Knock Down in Zebrafish Suppresses One-Eyed-Pinhead Mutant Phenotype. <em>PLoS ONE</em>. https://doi.org/10.1371/journal.pone.0001434</span></span></p>\n\n<p style=\"margin-left:32px\"><span style=\"font-size:11pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Stolle, K., Schnoor, M., Fuellen, G., Spitzer, M., Cullen, P., &amp; Lorkowski, S. (2007). Cloning, genomic organization, and tissue-specific expression of the RASL11B gene. <em>Biochimica et Biophysica Acta - Gene Structure and Expression</em>, <em>1769</em>(7&ndash;8), 514&ndash;524. https://doi.org/10.1016/j.bbaexp.2007.05.005</span></span></p>\n\n<p style=\"margin-left:32px\"><span style=\"font-size:11pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Wong, M. L., &amp; Medrano, J. F. (2005). <em>Real-time PCR for mRNA quantitation</em>. <em>39</em>(1), 75&ndash;85. https://doi.org/10.2144/05391RV01</span></span></p>\n\n<p style=\"margin-left:32px\"><span style=\"font-size:11pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><em>ZFIN Gene: rasl11b</em>. (n.d.). Retrieved March 19, 2021, from http://zfin.org/ZDB-GENE-040426-793</span></span></p>\n","biologicalOrganisationLevel":"Molecular","organTerm":{},"biologicalEvents":[{"object":{}}],"id":1886}
{"title":"Increased (ectopic) all-trans retinoic acid concentration","references":"","biologicalOrganisationLevel":"Tissue","organTerm":{},"biologicalEvents":[{"object":{}}],"id":1888}
{"title":"Premature initiation of meiosis in fetal male germ cells","references":"","biologicalOrganisationLevel":"Cellular","organTerm":{},"biologicalEvents":[{"object":{}}],"id":1889}
{"title":"Decrease (loss of) fetal male germ cells","references":"","biologicalOrganisationLevel":"Cellular","organTerm":{},"biologicalEvents":[{"object":{}}],"id":1890}
{"title":"NLRP3 inflammasome activity, increased","references":"<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\">Farag NS, Breitinger U, Breitinger HG, El Azizi MA (2020) Viroporins and inflammasomes: A key to understand virus-induced inflammation. <em>Int J Biochem Cell Biol</em> 122: 105738</span></span></p>\n\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\">Guo C, Fu R, Wang S, Huang Y, Li X, Zhou M, Zhao J, Yang N (2018) NLRP3 inflammasome activation contributes to the pathogenesis of rheumatoid arthritis. <em>Clin Exp Immunol</em> 194: 231-243</span></span></p>\n\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\">Martinez GJ, Robertson S, Barraclough J, Xia Q, Mallat Z, Bursill C, Celermajer DS, Patel S (2015) Colchicine Acutely Suppresses Local Cardiac Production of Inflammatory Cytokines in Patients With an Acute Coronary Syndrome. <em>J Am Heart Assoc</em> 4: e002128</span></span></p>\n\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\">Piancone F, Saresella M, Marventano I, La Rosa F, Santangelo MA, Caputo D, Mendozzi L, Rovaris M, Clerici M (2018) Monosodium Urate Crystals Activate the Inflammasome in Primary Progressive Multiple Sclerosis. <em>Front Immunol</em> 9: 983</span></span></p>\n\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\">Shah A (2020) Novel Coronavirus-Induced NLRP3 Inflammasome Activation: A Potential Drug Target in the Treatment of COVID-19. <em>Front Immunol</em> 11: 1021</span></span></p>\n\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\">Shi J, Zhao W, Ying H, Zhang Y, Du J, Chen S, Li J, Shen B (2018) Estradiol inhibits NLRP3 inflammasome in fibroblast-like synoviocytes activated by lipopolysaccharide and adenosine triphosphate. <em>Int J Rheum Dis</em> 21: 2002-2010</span></span></p>\n\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\">Sun X, Hao H, Han Q, Song X, Liu J, Dong L, Han W, Mu Y (2017) Human umbilical cord-derived mesenchymal stem cells ameliorate insulin resistance by suppressing NLRP3 inflammasome-mediated inflammation in type 2 diabetes rats. <em>Stem Cell Res Ther</em> 8: 241</span></span></p>\n\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\">Xu H, Chitre SA, Akinyemi IA, Loeb JC, Lednicky JA, McIntosh MT, Bhaduri-McIntosh S (2020) SARS-CoV-2 viroporin triggers the NLRP3 inflammatory pathway. <em>bioRxiv</em>: 2020.2010.2027.357731</span></span></p>\n\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\">Yaron JR, Gangaraju S, Rao MY, Kong X, Zhang L, Su F, Tian Y, Glenn HL, Meldrum DR (2015) K(+) regulates Ca(2+) to drive inflammasome signaling: dynamic visualization of ion flux in live cells. <em>Cell Death Dis</em> 6: e1954</span></span></p>\n\n<p><span style=\"font-size:11.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Zito G, Buscetta M, Cimino M, Dino P, Bucchieri F, Cipollina C (2020) Cellular Models and Assays to Study NLRP3 Inflammasome Biology. <em>Int J Mol Sci</em> 21</span></span></p>\n","biologicalOrganisationLevel":"Molecular","organTerm":{},"biologicalEvents":[{"object":{}}],"id":1895}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":142}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":57}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":887}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":177}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":889}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":188}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":890}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1264}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1265}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":988}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1266}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1267}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1268}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":993}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":990}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":350}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1000}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":858}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1528}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":861}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":862}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":863}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":219}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":3}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":295}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":401}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":281}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":280}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":756}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":757}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":758}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":64}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":669}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":682}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":616}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":195}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":52}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":381}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":55}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":188}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":52}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":195}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":381}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":382}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":385}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":386}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":383}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":55}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":202}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":152}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":168}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":145}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":403}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":155}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":185}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":10}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":39}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":445}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1703}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1538}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1392}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1488}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":55}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":188}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1492}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1493}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":386}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":266}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":447}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":413}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":446}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":289}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":310}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":240}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":286}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":944}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1269}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":317}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":947}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":129}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":274}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":3}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":219}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":285}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":221}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":309}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":78}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":219}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":285}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":309}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":3}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":78}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":221}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":50}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":178}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":40}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":257}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":193}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":166}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":288}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":214}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":87}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":149}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":249}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":209}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":243}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":49}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":106}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":119}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":78}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":220}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":307}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":252}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":285}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":221}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":309}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":78}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":21}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":211}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":250}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":118}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":131}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":246}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":161}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":173}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":77}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":164}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":147}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":270}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":269}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":347}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":294}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":54}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":115}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":66}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":264}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":116}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":258}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":89}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":291}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":176}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":169}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":327}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":140}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":179}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":8}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1170}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":716}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1171}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":55}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1492}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1493}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":265}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":68}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":151}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":398}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":272}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":826}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":398}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":272}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":139}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":853}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":854}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":277}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":281}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":280}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":756}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":757}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":758}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":28}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":110}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":298}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":376}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":409}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":491}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":493}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":177}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":55}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":352}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":388}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":389}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":618}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":188}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":414}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":415}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":416}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":446}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":413}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":447}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":418}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":220}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":419}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":421}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":422}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":425}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":277}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":281}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":280}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":381}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":851}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":385}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":386}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":450}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":451}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":327}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":216}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":291}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":54}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":465}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":466}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":467}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":80}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":462}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":457}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":66}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":458}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":454}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":54}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":462}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":463}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":451}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":327}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":470}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":465}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":471}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":179}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":472}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":474}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":462}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":54}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":465}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":477}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":454}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":327}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":480}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":227}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":482}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":451}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":483}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":878}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":879}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":880}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":881}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":458}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":484}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":457}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":488}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":685}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":495}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":496}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":413}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":446}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":520}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":277}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":281}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":280}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":186}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":192}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":655}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":656}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":657}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":655}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":660}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":656}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":655}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":657}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":656}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":645}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":647}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":648}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":649}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":525}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":651}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":652}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1028}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1448}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1449}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1450}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1451}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1452}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1453}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":528}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":529}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":530}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":531}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":532}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":533}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":534}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":535}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":536}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":655}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":540}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":541}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":177}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":341}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":560}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1107}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1243}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":177}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":386}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":341}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":564}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":565}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":177}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":568}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1107}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":177}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":570}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":571}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":664}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":573}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":574}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":560}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":564}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":565}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":403}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":576}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":577}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":403}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":576}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":560}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":578}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":579}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":580}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":564}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":561}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":177}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":341}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":560}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1107}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1108}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1243}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":341}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":560}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":663}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1107}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1243}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":663}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1243}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":341}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":560}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1107}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1108}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":341}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":564}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":565}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":663}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":386}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":585}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":586}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":585}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":586}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":444}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":445}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":590}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":585}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":585}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":586}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":587}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":588}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":599}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":600}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":601}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":602}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":625}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1139}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1142}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1143}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":624}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":622}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":626}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":626}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":627}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":629}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":633}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":634}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":635}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":341}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":671}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":672}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":673}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":674}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":674}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":678}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":681}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":671}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":687}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":689}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":690}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":691}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":692}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":694}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":693}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":687}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":689}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":690}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":691}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":692}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":695}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":696}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":698}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":699}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":708}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":709}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":710}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":767}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":720}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":721}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":752}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":723}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1214}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":716}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":774}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":768}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":209}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":726}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":769}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":733}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":734}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":735}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":739}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":740}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":753}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":771}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":743}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":744}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":754}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":747}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":748}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":749}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":772}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":761}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":763}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":764}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":775}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":776}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":777}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":778}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":149}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":781}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":782}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":710}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":784}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":716}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":774}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":787}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":774}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":788}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":739}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":740}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":753}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":771}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":791}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":744}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":792}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":794}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":795}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":796}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":799}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":800}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":3}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":219}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":285}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":221}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":309}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":799}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":802}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":800}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":219}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":3}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":285}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":221}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":309}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":805}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":807}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":808}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":809}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":848}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":529}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":530}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":531}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":532}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":533}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":534}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":535}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":536}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":426}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":819}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":820}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":821}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":813}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":823}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":824}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":818}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":825}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":829}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":831}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":832}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":833}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":835}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":837}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":838}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":839}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":836}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":850}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":844}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":845}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":846}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":277}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":425}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":281}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":280}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":756}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":757}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":758}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":426}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":868}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":870}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":869}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":768}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":876}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1096}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1097}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1098}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1102}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1106}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1088}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":155}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":185}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":155}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":185}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":898}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":177}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":55}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1493}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1494}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":265}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":68}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":919}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":920}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":921}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":923}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":924}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":914}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":962}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1251}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":927}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":935}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":934}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":932}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":933}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":937}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":951}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":973}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":944}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":945}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":948}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":110}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":317}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":944}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":945}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":948}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1891}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1892}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":958}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":959}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":960}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":961}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":281}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":280}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":756}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":757}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":758}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":965}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":966}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":967}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":968}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":969}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":970}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":971}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":979}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":981}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1202}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1003}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1004}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1005}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1003}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1007}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1005}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1003}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1004}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1005}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1003}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1007}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1005}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":277}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":281}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1003}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1007}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1005}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1012}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1014}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":761}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1015}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1016}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1015}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1012}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1016}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":761}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1019}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1020}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1021}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1022}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1023}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1024}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1025}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1029}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1032}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1033}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1034}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1035}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1036}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1037}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1039}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1040}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1042}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1043}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1045}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1046}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1047}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1049}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1050}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1051}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1052}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1056}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1057}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1058}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1059}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1060}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1061}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1062}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1065}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1066}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1067}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1068}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1069}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1071}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1072}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1074}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1075}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1076}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1077}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1078}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1080}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1071}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1072}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1075}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1074}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1076}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1081}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1083}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1084}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1085}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1080}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1086}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1087}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1088}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1032}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1089}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1496}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1497}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1498}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1499}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1500}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1501}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":277}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":281}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":425}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":277}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":281}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1104}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1105}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1097}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1098}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1106}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1088}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1096}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1102}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":177}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1107}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1109}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1107}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":560}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1107}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1107}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":560}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1107}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1110}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":560}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1107}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1108}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1107}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1107}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1115}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1088}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1097}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1098}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1106}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1122}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1130}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1131}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1132}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1133}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1135}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1151}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":425}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":277}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":426}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1116}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1003}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1116}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1023}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1828}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1829}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1154}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1829}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":277}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":426}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":277}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":426}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1158}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":295}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":401}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":281}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":626}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1161}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1255}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1142}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1163}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":621}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1218}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1220}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1222}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1433}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1435}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1176}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1179}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1182}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1183}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":177}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1088}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1187}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1188}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1189}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1190}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1191}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1192}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1194}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1195}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1196}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1197}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1198}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1213}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1239}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1240}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1241}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1242}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1206}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1209}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1461}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1253}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1142}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":621}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1256}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1257}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":626}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1142}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":621}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1257}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1256}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":626}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1261}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1271}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":149}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1275}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1457}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1278}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1279}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1280}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1281}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":176}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1262}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1282}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1283}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1284}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1285}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1286}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1287}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1288}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1289}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1290}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":209}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1292}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1293}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1294}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1295}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1503}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1505}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1262}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1515}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1305}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":459}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1115}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1491}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1316}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1317}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1318}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1319}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1320}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1347}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1321}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1322}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1323}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1324}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1325}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1326}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1328}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1329}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1330}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1334}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":122}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1335}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1336}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1337}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1338}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1339}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1340}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1341}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1342}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1349}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1350}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1351}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1321}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1352}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1353}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1354}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1355}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1356}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1357}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1358}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1359}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1360}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1361}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1322}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1608}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1365}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1444}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1366}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1368}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1369}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1370}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1371}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1372}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1373}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1374}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1375}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1376}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1377}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1378}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1379}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1380}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1381}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1382}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1383}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1384}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1387}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1388}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1389}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1141}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1387}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1388}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1390}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1141}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1392}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1393}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1394}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1335}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1330}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1328}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1347}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1325}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1324}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1323}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1317}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1320}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1329}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1335}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1329}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1328}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1330}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1347}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1317}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1320}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1325}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1324}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1323}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1320}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1347}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1398}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1399}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1400}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1401}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1398}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1399}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1400}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1320}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1347}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1328}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1329}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1330}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1397}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1398}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1399}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1320}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1347}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1328}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1329}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1330}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1400}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1323}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1324}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1325}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1320}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1347}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1336}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1337}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1338}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1339}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1340}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1341}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1342}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1403}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1404}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1405}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1406}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1407}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1409}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1410}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1411}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1384}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1383}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1382}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1405}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1350}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1351}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1321}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1352}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1354}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1353}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1355}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1362}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1344}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1414}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1415}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1416}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1355}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1362}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1344}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1357}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1419}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1420}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1421}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1422}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1423}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1424}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1426}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1427}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":763}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1426}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1429}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1430}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1426}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1427}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":763}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1426}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1429}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1430}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1438}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1439}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1440}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1441}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1442}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1445}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1365}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1444}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1366}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1456}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1457}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":68}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1469}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1463}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1464}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1465}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1466}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1005}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1472}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1473}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1474}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1475}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1476}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1477}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":40}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1478}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1479}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1482}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1483}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":709}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":831}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":898}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":709}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1483}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":40}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":709}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1510}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1511}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1512}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1513}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1530}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1531}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1532}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1533}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1536}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1537}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1771}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1821}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1771}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1825}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1771}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1312}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1823}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":257}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1826}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1608}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1825}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1826}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":257}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1445}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1825}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1826}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":257}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1767}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1825}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":277}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":408}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":219}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":285}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":221}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1635}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":155}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":185}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1636}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":870}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1545}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1546}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1547}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":889}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":55}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":177}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1557}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1558}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1503}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1239}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1560}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":887}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1477}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1562}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1563}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":202}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1702}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":202}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1575}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":55}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1576}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1579}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1581}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1582}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1585}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1586}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":149}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1457}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1587}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":10}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1602}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1623}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":388}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":389}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1788}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":55}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1594}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1595}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":926}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1538}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1392}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":178}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":768}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1605}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1512}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1262}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1606}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":459}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1771}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1821}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1771}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1825}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1610}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1611}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1612}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1613}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1614}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1615}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1613}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":219}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":221}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":78}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1771}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1821}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1771}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1825}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1628}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1629}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1630}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1631}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1492}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1493}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1632}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1494}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1182}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1182}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1492}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1493}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1494}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":155}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1635}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1640}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1641}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1642}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1643}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1754}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1755}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1650}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1445}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1823}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1824}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1771}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1366}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":756}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":757}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":758}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1661}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1665}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1666}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1673}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1498}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1677}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":87}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1497}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1115}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1669}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":870}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1681}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1682}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1683}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1684}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1613}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1614}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":286}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1614}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1687}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":413}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1690}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1613}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1614}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":286}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1692}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1693}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1694}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1695}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1696}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":944}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1697}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1698}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1699}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":3}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":219}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":285}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":221}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":309}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1770}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1477}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1771}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1366}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":10}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":39}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1705}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1822}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1707}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1708}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1711}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1712}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1713}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1716}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1717}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1718}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1721}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1722}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1723}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1724}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1834}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":860}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":291}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1752}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1743}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":68}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1738}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1847}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1848}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1496}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1750}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1748}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":155}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1635}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1365}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":807}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1756}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1758}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":406}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1771}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1366}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1364}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1608}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1365}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1366}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":257}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1827}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1365}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1366}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1767}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1768}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1769}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1770}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1477}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1771}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1445}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1772}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1771}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1608}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1766}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1365}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1766}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1365}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1759}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1760}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1761}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1005}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1762}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":795}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":796}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1773}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1774}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1775}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1366}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1773}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1774}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1776}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1777}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1366}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1766}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1774}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1775}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1366}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1766}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1774}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1776}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1777}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1366}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1773}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1778}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1779}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1780}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1782}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1773}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1778}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1779}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1783}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1784}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1782}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1523}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1524}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1527}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1526}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1523}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1524}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1614}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":286}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":286}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1800}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1789}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1790}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1791}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1292}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1793}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1794}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1795}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1283}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1457}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1756}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1758}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":406}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1835}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1756}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1836}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1798}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1837}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":406}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":996}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1524}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":996}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1524}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1523}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1524}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1527}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1526}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1523}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1524}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1816}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1815}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1817}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1818}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1819}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1633}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":277}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":281}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1003}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1877}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1643}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":277}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":281}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1003}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1878}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1643}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":277}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":281}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1003}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1640}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1643}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1830}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":959}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1158}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":401}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":281}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1830}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":959}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1158}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":401}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":281}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1825}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1614}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1687}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1616}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":188}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":352}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1790}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1791}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1848}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1844}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1869}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1845}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1787}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1752}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1856}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1849}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1115}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1172}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1496}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":68}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1741}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1852}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1115}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1501}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1752}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1852}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1115}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1855}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1854}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1787}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1752}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1861}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1862}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1475}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1472}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1479}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1770}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1477}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":40}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1479}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1864}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1479}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1862}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1475}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1472}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1479}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1496}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1497}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1738}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1870}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1871}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1872}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1738}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1874}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1846}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1088}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":752}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1775}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1798}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":406}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":155}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1881}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1882}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1883}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1885}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1886}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1821}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1878}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1643}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1889}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1890}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":10}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":39}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":386}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1738}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1847}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1869}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1895}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1738}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1847}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1869}
{"organTerm":{},"biologicalEvents":[{"object":{}}],"id":1895}
